data_2m2a_residue save_MolProbity _Software.Sf_category software _Software.Sf_framecode MolProbity _Software.Entry_ID ? _Software.ID 1 _Software.Name MolProbity _Software.Version 4.0 _Software.Details . save_ save_CYRANGE _Software.Sf_category software _Software.Sf_framecode CYRANGE _Software.Entry_ID ? _Software.ID 2 _Software.Name CYRANGE _Software.Version 2.0 _Software.Details . save_ save_Structure_validation_residue _Structure_validation_residue.Sf_category structure_validation _Structure_validation_residue.Sf_framecode Structure_validation_residue _Structure_validation_residue.Entry_ID ? _Structure_validation_residue.List_ID 1 _Structure_validation_residue.PDB_accession_code 2m2a _Structure_validation_residue.Date_analyzed 2016-10-07 loop_ _Residue_analysis_software.Software_ID _Residue_analysis_software.Software_label _Residue_analysis_software.Method_ID _Residue_analysis_software.Method_label _Residue_analysis_software.Entry_ID _Residue_analysis_software.Structure_validation_oneline_list_ID 1 MolProbity . . ? 1 2 CYRANGE . . ? 1 stop_ loop_ _Residue_analysis.ID _Residue_analysis.PDB_model_num _Residue_analysis.Hydrogen_positions _Residue_analysis.MolProbity_flips _Residue_analysis.Cyrange_core_flag _Residue_analysis.Two_letter_chain_ID _Residue_analysis.PDB_strand_ID _Residue_analysis.PDB_residue_no _Residue_analysis.PDB_ins_code _Residue_analysis.PDB_residue_name _Residue_analysis.Assembly_ID _Residue_analysis.Entity_assembly_ID _Residue_analysis.Entity_ID _Residue_analysis.Comp_ID _Residue_analysis.Comp_index_ID _Residue_analysis.Clash_value _Residue_analysis.Clash_source_PDB_atom_name _Residue_analysis.Clash_destination_PDB_atom_name _Residue_analysis.Clash_destination_PDB_strand_ID _Residue_analysis.Clash_destination_PDB_residue_no _Residue_analysis.Clash_destination_PDB_ins_code _Residue_analysis.Clash_destination_PDB_residue_name _Residue_analysis.Cbeta_deviation_value _Residue_analysis.Rotamer_score _Residue_analysis.Rotamer_name _Residue_analysis.Ramachandran_phi _Residue_analysis.Ramachandran_psi _Residue_analysis.Ramachandran_score _Residue_analysis.Ramachandran_evaluation _Residue_analysis.Ramachandran_type _Residue_analysis.Bond_outlier_count _Residue_analysis.Worst_bond _Residue_analysis.Worst_bond_value _Residue_analysis.Worst_bond_sigma _Residue_analysis.Angle_outlier_count _Residue_analysis.Worst_angle _Residue_analysis.Worst_angle_value _Residue_analysis.Worst_angle_sigma _Residue_analysis.RNA_phosphate_perpendicular_outlier _Residue_analysis.RNA_suitness_score _Residue_analysis.RNA_suite_conformer _Residue_analysis.RNA_suite_triage _Residue_analysis.Max_b_factor _Residue_analysis.Tau_angle _Residue_analysis.Omega_dihedral _Residue_analysis.Disulfide_chi1 _Residue_analysis.Disulfide_chi2 _Residue_analysis.Disulfide_chi3 _Residue_analysis.Disulfide_ss_angle _Residue_analysis.Disulfide_ss _Residue_analysis.Disulfide_ss_angle_prime _Residue_analysis.Disulfide_chi2prime _Residue_analysis.Disulfide_chi1prime _Residue_analysis.Outlier_count_separate_geometry _Residue_analysis.Outlier_count _Residue_analysis.Entry_ID _Residue_analysis.Structure_validation_residue_list_ID . 001 nuclear orig core ' A' A ' 2' ' ' SER . . . . . 0.438 ' HB3' ' HA ' ' A' ' 145' ' ' PRO . 6.2 p . . . . . 0 N--CA 1.455 -0.183 0 CA-C-O 121.145 0.498 . . . . 0.0 110.705 . . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 3.3 mp0 -77.38 -35.44 54.45 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-O 121.653 0.74 . . . . 0.0 109.77 -179.006 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 16.1 p -133.26 157.56 45.12 Favored 'General case' 0 C--N 1.315 -0.904 0 CA-C-N 114.893 -1.049 . . . . 0.0 109.745 -179.629 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . 0.588 HG12 ' O ' ' A' ' 52' ' ' LEU . 10.2 p -71.11 139.04 20.57 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.573 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.04 -178.04 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 6' ' ' GLN . . . . . . . . . . . . . 2.9 pt20 -142.7 164.15 30.88 Favored 'General case' 0 C--N 1.314 -0.954 0 N-CA-C 108.549 -0.908 . . . . 0.0 108.549 179.149 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 83.2 p -67.41 136.32 54.53 Favored 'General case' 0 C--N 1.316 -0.886 0 C-N-CA 120.724 -0.391 . . . . 0.0 110.453 -178.154 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 66.6 t30 71.27 28.43 3.0 Favored 'General case' 0 CA--C 1.538 0.488 0 C-N-CA 123.449 0.699 . . . . 0.0 111.667 -178.697 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 49.6 m -128.54 132.99 48.29 Favored 'General case' 0 C--N 1.327 -0.374 0 O-C-N 121.623 -0.673 . . . . 0.0 110.166 174.011 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -83.2 165.78 19.16 Favored 'General case' 0 C--N 1.322 -0.63 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.765 -171.862 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 33.0 m -143.46 139.7 26.25 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.685 0 CA-C-O 120.924 0.392 . . . . 0.0 110.281 -175.585 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 12' ' ' LEU . . . . . 0.418 HD12 ' HB3' ' A' ' 142' ' ' GLU . 75.7 mt -86.0 124.07 32.03 Favored 'General case' 0 C--N 1.319 -0.752 0 N-CA-C 108.127 -1.064 . . . . 0.0 108.127 173.253 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 13' ' ' VAL . . . . . 0.504 HG22 ' N ' ' A' ' 14' ' ' HIS . 3.5 p -136.06 153.24 31.6 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.912 0 CA-C-O 122.289 1.042 . . . . 0.0 112.993 -167.348 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 14' ' ' HIS . . . . . 0.504 ' N ' HG22 ' A' ' 13' ' ' VAL . 1.9 m-70 -123.72 116.16 22.59 Favored 'General case' 0 C--N 1.313 -1.008 0 CA-C-N 113.359 -1.746 . . . . 0.0 106.58 167.654 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 15' ' ' PHE . . . . . 0.55 ' HB2' ' O ' ' A' ' 137' ' ' ASP . 16.5 p90 -142.12 168.95 18.52 Favored 'General case' 0 C--N 1.317 -0.826 0 C-N-CA 119.2 -1.0 . . . . 0.0 112.531 -172.452 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 21.5 m -145.9 142.7 29.01 Favored 'General case' 0 C--N 1.321 -0.631 0 CA-C-N 115.076 -0.965 . . . . 0.0 110.438 176.253 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 17' ' ' LEU . . . . . 0.459 HD12 ' HB3' ' A' ' 136' ' ' PHE . 0.0 OUTLIER -105.68 128.43 53.66 Favored 'General case' 0 C--N 1.326 -0.424 0 N-CA-C 109.527 -0.545 . . . . 0.0 109.527 -175.621 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 18' ' ' LYS . . . . . 0.484 ' HA ' ' O ' ' A' ' 23' ' ' THR . 0.1 OUTLIER -125.56 136.85 53.75 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-O 121.663 0.744 . . . . 0.0 112.204 -174.256 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 19' ' ' LEU . . . . . 0.445 HD22 ' HB ' ' A' ' 23' ' ' THR . 3.5 mm? -78.2 174.74 10.87 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 114.96 -1.018 . . . . 0.0 109.963 172.683 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 23.9 m-20 -60.74 -27.83 68.23 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-O 120.797 0.332 . . . . 0.0 111.08 176.905 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 35.8 t70 -80.61 5.02 16.67 Favored 'General case' 0 N--CA 1.474 0.739 0 CA-C-O 122.224 1.011 . . . . 0.0 109.926 174.224 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 66.91 19.3 69.57 Favored Glycine 0 N--CA 1.451 -0.363 0 CA-C-N 114.259 -1.337 . . . . 0.0 112.478 -175.944 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 23' ' ' THR . . . . . 0.484 ' O ' ' HA ' ' A' ' 18' ' ' LYS . 17.4 m -72.55 142.7 48.46 Favored 'General case' 0 C--N 1.323 -0.544 0 N-CA-C 110.33 -0.248 . . . . 0.0 110.33 178.473 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 59.0 m -77.05 107.9 9.74 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-O 120.871 0.367 . . . . 0.0 111.026 179.32 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 25' ' ' ALA . . . . . 0.4 ' HB2' ' HB3' ' A' ' 17' ' ' LEU . . . -77.29 -35.51 55.04 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-O 121.405 0.621 . . . . 0.0 109.567 174.709 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 9.0 tp10 -160.48 142.72 12.85 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 115.033 -0.985 . . . . 0.0 108.896 -179.419 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 19.6 t -124.75 149.42 47.33 Favored 'General case' 0 C--N 1.313 -1.007 0 N-CA-C 109.09 -0.707 . . . . 0.0 109.09 175.125 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 28' ' ' THR . . . . . 0.439 ' O ' HG21 ' A' ' 28' ' ' THR . 36.6 m -148.23 44.55 1.05 Allowed 'General case' 0 N--CA 1.437 -1.113 0 CA-C-O 123.79 1.757 . . . . 0.0 106.819 172.764 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 52.9 ttp180 -151.65 -45.96 0.11 Allowed 'General case' 0 C--N 1.312 -1.052 0 CA-C-N 112.653 -2.067 . . . . 0.0 109.681 -178.784 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 91.6 m-20 -67.81 -25.73 65.73 Favored 'General case' 0 N--CA 1.464 0.272 0 CA-C-O 121.087 0.47 . . . . 0.0 110.549 177.643 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 71.8 m-20 -76.53 -12.66 60.06 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.595 -0.729 . . . . 0.0 110.65 179.898 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 83.01 -1.37 88.81 Favored Glycine 0 N--CA 1.45 -0.371 0 C-N-CA 120.989 -0.624 . . . . 0.0 111.804 -179.691 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 59.4 mttp -107.41 121.68 43.64 Favored Pre-proline 0 C--N 1.321 -0.659 0 CA-C-N 115.717 -0.242 . . . . 0.0 110.698 -177.952 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 7.8 Cg_exo -76.48 168.94 22.84 Favored 'Trans proline' 0 N--CA 1.46 -0.491 0 C-N-CA 122.938 2.426 . . . . 0.0 112.118 172.113 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -140.89 161.7 37.2 Favored 'General case' 0 C--N 1.312 -1.04 0 CA-C-N 115.097 -0.956 . . . . 0.0 109.592 179.383 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 3.8 tp -112.89 130.77 55.99 Favored 'General case' 0 N--CA 1.445 -0.722 0 N-CA-C 110.049 -0.352 . . . . 0.0 110.049 175.968 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 37' ' ' PHE . . . . . . . . . . . . . 9.4 m-30 -95.98 112.14 23.95 Favored 'General case' 0 C--N 1.318 -0.77 0 N-CA-C 110.055 -0.35 . . . . 0.0 110.055 175.411 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 38' ' ' ARG . . . . . 0.451 ' HB3' ' HB1' ' A' ' 42' ' ' ALA . 22.3 mmm180 -83.46 106.91 15.59 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-O 121.351 0.596 . . . . 0.0 110.957 -179.513 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 10.9 mp -81.84 154.18 26.01 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-N 115.104 -0.953 . . . . 0.0 110.979 178.278 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 91.79 41.11 5.11 Favored Glycine 0 N--CA 1.449 -0.455 0 C-N-CA 120.915 -0.66 . . . . 0.0 113.06 176.575 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 16.6 m-20 58.46 23.55 10.81 Favored 'General case' 0 N--CA 1.468 0.429 0 CA-C-O 120.873 0.368 . . . . 0.0 111.374 177.78 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 42' ' ' ALA . . . . . 0.451 ' HB1' ' HB3' ' A' ' 38' ' ' ARG . . . -86.48 -27.37 24.11 Favored 'General case' 0 C--N 1.323 -0.587 0 CA-C-O 121.027 0.441 . . . . 0.0 110.278 -178.162 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 40.8 m -154.31 -45.09 0.09 Allowed 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 115.821 -0.627 . . . . 0.0 109.532 175.585 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 51.5 mt -102.81 159.34 15.57 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 115.775 -0.648 . . . . 0.0 110.179 178.482 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 50.1 m -84.45 161.72 20.19 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-N 115.853 -0.612 . . . . 0.0 110.765 -177.546 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 45.2 mt-10 -57.4 -26.8 61.66 Favored 'General case' 0 N--CA 1.463 0.202 0 CA-C-N 115.858 -0.61 . . . . 0.0 111.715 -177.213 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -58.86 -36.72 88.6 Favored Glycine 0 N--CA 1.45 -0.403 0 C-N-CA 121.086 -0.578 . . . . 0.0 112.546 -175.808 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 48' ' ' LEU . . . . . 0.429 ' HA ' HD12 ' A' ' 65' ' ' LEU . 3.0 tt -76.22 -36.53 58.51 Favored 'General case' 0 CA--C 1.515 -0.387 0 CA-C-O 121.768 0.794 . . . . 0.0 110.388 -179.122 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 7.2 tt0 -66.79 -46.68 74.49 Favored 'General case' 0 C--N 1.318 -0.785 0 CA-C-N 114.273 -1.331 . . . . 0.0 108.827 -176.472 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 50' ' ' GLN . . . . . 0.477 ' HA ' HD21 ' A' ' 53' ' ' LEU . 82.9 mm-40 -62.67 -16.4 56.86 Favored 'General case' 0 C--N 1.314 -0.936 0 CA-C-N 113.504 -1.68 . . . . 0.0 112.396 -176.069 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 51' ' ' HIS . . . . . . . . . . . . . 14.1 m-70 -105.34 -3.48 22.67 Favored 'General case' 0 C--O 1.233 0.223 0 C-N-CA 120.221 -0.591 . . . . 0.0 111.663 176.21 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 52' ' ' LEU . . . . . 0.588 ' O ' HG12 ' A' ' 5' ' ' VAL . 6.1 mt -99.98 -23.66 14.85 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 116.461 -0.336 . . . . 0.0 111.866 -178.493 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 53' ' ' LEU . . . . . 0.48 ' HA ' HG13 ' A' ' 5' ' ' VAL . 0.0 OUTLIER -59.85 152.21 23.78 Favored 'General case' 0 CA--C 1.53 0.209 0 CA-C-O 121.316 0.579 . . . . 0.0 112.286 -177.124 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 94.26 -17.14 59.5 Favored Glycine 0 N--CA 1.451 -0.306 0 CA-C-N 115.296 -0.865 . . . . 0.0 113.557 175.964 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 55' ' ' LEU . . . . . 0.556 ' O ' HG11 ' A' ' 5' ' ' VAL . 16.0 tp -84.9 158.97 20.43 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-O 121.099 0.476 . . . . 0.0 110.975 177.677 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 56' ' ' LYS . . . . . 0.562 ' HD3' ' N ' ' A' ' 57' ' ' VAL . 12.8 tmtt? -120.11 162.89 18.54 Favored 'General case' 0 C--N 1.325 -0.487 0 N-CA-C 109.768 -0.456 . . . . 0.0 109.768 -176.331 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 57' ' ' VAL . . . . . 0.562 ' N ' ' HD3' ' A' ' 56' ' ' LYS . 42.1 t -57.76 147.74 6.04 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-O 120.889 0.376 . . . . 0.0 111.259 177.491 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 80.6 9.46 86.39 Favored Glycine 0 N--CA 1.451 -0.334 0 CA-C-N 115.852 -0.613 . . . . 0.0 113.575 -177.712 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 2.5 m-20 -121.53 162.55 20.36 Favored 'General case' 0 CA--C 1.513 -0.46 0 CA-C-O 121.022 0.439 . . . . 0.0 110.828 178.364 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 60' ' ' LYS . . . . . 0.536 ' HB3' ' HG2' ' A' ' 139' ' ' GLU . 1.1 ptmt -135.15 146.15 48.49 Favored 'General case' 0 C--N 1.316 -0.855 0 CA-C-N 115.576 -0.738 . . . . 0.0 109.133 179.136 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 12.1 t -142.76 143.35 32.17 Favored 'General case' 0 C--N 1.318 -0.793 0 CA-C-O 121.13 0.491 . . . . 0.0 109.754 -178.612 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 3.7 m -109.17 138.52 45.39 Favored 'General case' 0 C--N 1.311 -1.101 0 N-CA-C 108.889 -0.782 . . . . 0.0 108.889 176.668 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 63' ' ' PHE . . . . . 0.515 ' CZ ' HD13 ' A' ' 138' ' ' ILE . 31.4 p90 -158.36 158.85 35.07 Favored 'General case' 0 C--N 1.321 -0.653 0 CA-C-O 121.238 0.542 . . . . 0.0 111.42 -179.444 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 64' ' ' SER . . . . . 0.413 ' O ' ' HG ' ' A' ' 65' ' ' LEU . 26.1 t -104.73 159.42 15.8 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-N 115.197 -0.911 . . . . 0.0 109.71 -179.204 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 65' ' ' LEU . . . . . 0.479 HD13 ' O ' ' A' ' 69' ' ' ALA . 18.5 mt -161.09 151.38 17.71 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 116.302 -0.408 . . . . 0.0 110.698 -171.975 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 48.0 mt-10 -69.86 152.79 95.92 Favored Pre-proline 0 C--N 1.321 -0.662 0 CA-C-N 115.796 -0.638 . . . . 0.0 109.365 174.485 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 3.4 Cg_exo -42.45 -49.71 6.13 Favored 'Trans proline' 0 CA--C 1.532 0.406 0 C-N-CA 123.673 2.915 . . . . 0.0 113.865 -176.804 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -56.86 -31.12 64.48 Favored 'General case' 0 N--CA 1.468 0.439 0 CA-C-N 115.996 -0.547 . . . . 0.0 111.784 179.84 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 69' ' ' ALA . . . . . 0.479 ' O ' HD13 ' A' ' 65' ' ' LEU . . . -98.26 16.75 20.46 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.825 -175.67 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.323 -0.559 0 N-CA-C 108.944 -0.762 . . . . 0.0 108.944 -173.24 . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 75' ' ' SER . . . . . 0.4 ' HA ' ' HD2' ' A' ' 76' ' ' PRO . 54.7 m . . . . . 0 N--CA 1.447 -0.591 0 N-CA-C 112.031 0.382 . . . . 0.0 112.031 . . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 76' ' ' PRO . . . . . 0.4 ' HD2' ' HA ' ' A' ' 75' ' ' SER . 36.3 Cg_endo -67.53 -14.25 41.69 Favored 'Trans proline' 0 N--CA 1.462 -0.333 0 C-N-CA 122.692 2.261 . . . . 0.0 112.043 174.996 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 23.8 t70 -64.03 -19.61 65.32 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.689 -178.801 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 78' ' ' LEU . . . . . 0.546 ' HB3' ' HB2' ' A' ' 125' ' ' PHE . 3.0 mm? -88.66 -1.12 57.91 Favored 'General case' 0 CA--C 1.513 -0.469 0 C-N-CA 120.697 -0.401 . . . . 0.0 110.775 -179.611 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 79' ' ' ILE . . . . . 0.631 HG21 ' O ' ' A' ' 123' ' ' VAL . 20.2 mt -65.4 128.51 28.32 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.594 0 CA-C-O 121.921 0.867 . . . . 0.0 111.335 -178.243 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 80' ' ' GLN . . . . . 0.567 ' O ' ' HB ' ' A' ' 123' ' ' VAL . 49.5 mt-30 -135.81 138.88 43.02 Favored 'General case' 0 C--N 1.319 -0.76 0 CA-C-N 114.14 -1.391 . . . . 0.0 108.736 -174.274 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 81' ' ' TYR . . . . . 0.437 ' CE2' HG22 ' A' ' 122' ' ' THR . 73.1 m-85 -107.17 110.3 22.33 Favored 'General case' 0 C--N 1.32 -0.691 0 C-N-CA 119.707 -0.797 . . . . 0.0 110.276 -179.117 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 48.9 m-85 -104.81 168.55 8.99 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-N 115.881 -0.599 . . . . 0.0 110.684 172.495 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 22.6 t -87.22 157.99 19.21 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-O 121.365 0.603 . . . . 0.0 111.209 -176.883 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 12.5 ptm180 -61.86 -34.74 76.54 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 115.22 -0.9 . . . . 0.0 109.825 175.961 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 85' ' ' ARG . . . . . . . . . . . . . 5.1 mpt_? -54.7 -28.08 45.22 Favored 'General case' 0 C--N 1.32 -0.7 0 CA-C-N 113.952 -1.476 . . . . 0.0 111.781 176.092 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 21.2 mm-40 -79.86 -20.2 46.48 Favored 'General case' 0 C--N 1.32 -0.689 0 CA-C-O 121.105 0.478 . . . . 0.0 111.389 179.396 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 87' ' ' PHE . . . . . . . . . . . . . 57.0 m-85 -104.22 -20.5 13.77 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 116.093 -0.503 . . . . 0.0 111.558 -176.076 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 88' ' ' MET . . . . . . . . . . . . . 22.5 ttm -56.13 -38.37 70.72 Favored 'General case' 0 C--N 1.323 -0.556 0 N-CA-C 112.307 0.484 . . . . 0.0 112.307 -173.239 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 2.3 m-20 -53.98 -27.46 31.58 Favored 'General case' 0 C--N 1.328 -0.327 0 N-CA-C 112.362 0.504 . . . . 0.0 112.362 176.709 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -110.47 14.81 22.46 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-O 120.957 0.408 . . . . 0.0 110.554 179.834 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 92.3 138.85 8.57 Favored Glycine 0 N--CA 1.448 -0.566 0 C-N-CA 120.837 -0.696 . . . . 0.0 111.973 -178.554 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 63.6 mt-10 -62.47 122.13 71.53 Favored Pre-proline 0 C--N 1.324 -0.532 0 CA-C-O 121.148 0.499 . . . . 0.0 110.906 -179.632 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 43.9 Cg_endo -72.95 168.12 25.53 Favored 'Trans proline' 0 CA--C 1.516 -0.393 0 C-N-CA 123.777 2.984 . . . . 0.0 114.123 -173.214 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 3.4 mp0 -114.07 160.03 19.35 Favored 'General case' 0 N--CA 1.444 -0.742 0 CA-C-N 114.181 -1.372 . . . . 0.0 110.54 -172.357 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 95' ' ' ILE . . . . . 0.487 HG12 HG12 ' A' ' 116' ' ' ILE . 11.3 mt -78.2 131.7 33.99 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.446 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.535 178.829 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 71.76 24.02 77.24 Favored Glycine 0 N--CA 1.445 -0.708 0 CA-C-N 115.629 -0.714 . . . . 0.0 111.963 -176.626 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -103.29 117.42 34.47 Favored 'General case' 0 N--CA 1.449 -0.502 0 CA-C-O 121.937 0.875 . . . . 0.0 110.661 179.456 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 98' ' ' ILE . . . . . 0.546 HG12 ' HB ' ' A' ' 112' ' ' VAL . 4.1 mt -97.97 120.51 47.4 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.294 0 CA-C-N 114.481 -1.236 . . . . 0.0 108.726 -176.012 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 99' ' ' MET . . . . . 0.439 ' HE1' HD12 ' A' ' 113' ' ' ILE . 8.3 mtm -133.91 149.65 51.3 Favored 'General case' 0 N--CA 1.439 -0.99 0 N-CA-C 106.922 -1.51 . . . . 0.0 106.922 -177.949 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 3.2 mm? -70.38 119.7 14.94 Favored 'General case' 0 C--N 1.311 -1.087 0 CA-C-O 122.313 1.054 . . . . 0.0 113.044 -176.417 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 101' ' ' PHE . . . . . 0.617 ' O ' ' HA ' ' A' ' 108' ' ' GLU . 20.8 m-85 -109.7 175.89 5.28 Favored 'General case' 0 C--O 1.22 -0.452 0 CA-C-N 113.05 -1.886 . . . . 0.0 111.47 -175.533 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 9.2 m -124.84 109.65 13.31 Favored 'General case' 0 N--CA 1.466 0.373 0 C-N-CA 120.492 -0.483 . . . . 0.0 111.136 -166.248 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -77.3 170.3 16.78 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-N 115.733 -0.667 . . . . 0.0 112.483 178.659 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 104' ' ' MET . . . . . 0.417 ' C ' ' H ' ' A' ' 106' ' ' GLY . 3.7 mpp? -58.93 -37.71 77.31 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 115.659 -0.7 . . . . 0.0 111.193 -179.783 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 11.1 p-10 -78.59 22.97 0.33 Allowed 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 121.381 0.61 . . . . 0.0 110.665 177.774 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 106' ' ' GLY . . . . . 0.417 ' H ' ' C ' ' A' ' 104' ' ' MET . . . 66.39 -12.04 0.5 Allowed Glycine 0 C--N 1.337 0.623 0 CA-C-N 115.178 -0.919 . . . . 0.0 114.812 -174.869 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 46.6 t -65.74 132.72 49.43 Favored 'General case' 0 CA--C 1.501 -0.912 0 CA-C-O 122.063 0.935 . . . . 0.0 110.896 -171.909 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 108' ' ' GLU . . . . . 0.617 ' HA ' ' O ' ' A' ' 101' ' ' PHE . 2.1 tt0 -90.77 104.04 16.68 Favored 'General case' 0 C--N 1.297 -1.677 0 CA-C-N 114.146 -1.388 . . . . 0.0 109.128 178.907 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 109' ' ' MET . . . . . . . . . . . . . 1.7 mtm -102.63 148.32 35.34 Favored Pre-proline 0 CA--C 1.511 -0.549 0 N-CA-C 108.096 -1.076 . . . . 0.0 108.096 -178.138 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 29.6 Cg_endo -63.85 146.14 91.34 Favored 'Trans proline' 0 N--CA 1.45 -1.046 0 C-N-CA 121.325 1.35 . . . . 0.0 110.482 172.999 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 111' ' ' GLY . . . . . 0.488 ' HA3' ' CD2' ' A' ' 101' ' ' PHE . . . -143.35 107.76 0.48 Allowed Glycine 0 N--CA 1.439 -1.138 0 N-CA-C 109.763 -1.335 . . . . 0.0 109.763 -173.359 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 112' ' ' VAL . . . . . 0.546 ' HB ' HG12 ' A' ' 98' ' ' ILE . 2.9 p -87.57 107.55 17.37 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.876 0 C-N-CA 118.798 -1.161 . . . . 0.0 109.976 -174.779 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 113' ' ' ILE . . . . . 0.439 HD12 ' HE1' ' A' ' 99' ' ' MET . 34.8 mt -62.91 108.46 0.59 Allowed 'Isoleucine or valine' 0 N--CA 1.436 -1.168 0 N-CA-C 108.531 -0.915 . . . . 0.0 108.531 170.525 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 114' ' ' ARG . . . . . 0.471 ' O ' HG23 ' A' ' 95' ' ' ILE . 6.3 tpp180 -75.37 -42.72 53.36 Favored 'General case' 0 C--N 1.308 -1.203 0 CA-C-N 113.853 -1.521 . . . . 0.0 111.06 -168.969 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 8.3 tt0 -159.57 156.78 28.65 Favored 'General case' 0 C--N 1.32 -0.694 0 N-CA-C 109.622 -0.51 . . . . 0.0 109.622 -176.381 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 116' ' ' ILE . . . . . 0.487 HG12 HG12 ' A' ' 95' ' ' ILE . 38.8 mm -111.48 115.28 49.45 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.528 0 N-CA-C 109.907 -0.405 . . . . 0.0 109.907 179.68 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 117' ' ' ASN . . . . . 0.521 HD21 ' N ' ' A' ' 117' ' ' ASN . 0.8 OUTLIER -99.51 154.69 18.04 Favored 'General case' 0 C--N 1.316 -0.858 0 N-CA-C 108.8 -0.815 . . . . 0.0 108.8 176.672 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . -62.3 -28.0 70.19 Favored Glycine 0 N--CA 1.45 -0.395 0 CA-C-N 115.929 -0.578 . . . . 0.0 113.648 -173.78 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 11.8 t70 -114.87 -17.63 11.5 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 117.004 0.402 . . . . 0.0 111.77 179.08 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 120' ' ' SER . . . . . 0.44 ' O ' ' HB2' ' A' ' 117' ' ' ASN . 14.8 t -137.59 157.8 45.74 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-O 121.179 0.514 . . . . 0.0 111.281 -169.662 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 121' ' ' ILE . . . . . . . . . . . . . 45.1 mm -110.13 132.91 57.12 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.811 0 CA-C-N 116.102 -0.499 . . . . 0.0 109.963 177.376 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 122' ' ' THR . . . . . 0.437 HG22 ' CE2' ' A' ' 81' ' ' TYR . 4.6 m -92.44 103.34 15.78 Favored 'General case' 0 N--CA 1.442 -0.848 0 CA-C-O 122.142 0.972 . . . . 0.0 109.924 178.233 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 123' ' ' VAL . . . . . 0.631 ' O ' HG21 ' A' ' 79' ' ' ILE . 18.8 t -93.86 156.51 3.09 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.005 0 CA-C-N 113.54 -1.664 . . . . 0.0 110.355 177.581 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 124' ' ' ASP . . . . . 0.585 ' HA ' HG12 ' A' ' 79' ' ' ILE . 10.8 t0 -151.06 94.08 2.01 Favored 'General case' 0 C--N 1.317 -0.827 0 CA-C-N 115.216 -0.902 . . . . 0.0 109.684 -176.596 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 125' ' ' PHE . . . . . 0.546 ' HB2' ' HB3' ' A' ' 78' ' ' LEU . 84.4 m-85 -84.68 96.83 9.34 Favored 'General case' 0 CA--C 1.51 -0.593 0 CA-C-O 122.041 0.924 . . . . 0.0 110.517 177.537 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER . . . . . 0 C--N 1.299 -1.611 0 CA-C-N 114.297 -1.32 . . . . 0.0 109.763 173.261 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 133' ' ' THR . . . . . . . . . . . . . 24.0 m . . . . . 0 N--CA 1.455 -0.181 0 CA-C-O 120.82 0.343 . . . . 0.0 110.974 . . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 134' ' ' VAL . . . . . 0.431 ' HB ' ' CD1' ' A' ' 17' ' ' LEU . 2.6 m -134.2 146.29 31.57 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.362 0 N-CA-C 112.297 0.48 . . . . 0.0 112.297 -174.397 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 135' ' ' HIS . . . . . . . . . . . . . 26.1 m-70 -98.32 120.41 38.68 Favored 'General case' 0 N--CA 1.465 0.315 0 CA-C-N 116.0 -0.545 . . . . 0.0 110.618 178.734 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 136' ' ' PHE . . . . . 0.459 ' HB3' HD12 ' A' ' 17' ' ' LEU . 3.1 p90 -128.78 150.83 50.13 Favored 'General case' 0 C--N 1.321 -0.653 0 N-CA-C 113.894 1.072 . . . . 0.0 113.894 179.287 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 137' ' ' ASP . . . . . 0.55 ' O ' ' HB2' ' A' ' 15' ' ' PHE . 5.1 m-20 -100.38 140.29 34.84 Favored 'General case' 0 CA--C 1.508 -0.639 0 CA-C-N 114.139 -1.392 . . . . 0.0 107.706 174.666 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 138' ' ' ILE . . . . . 0.515 HD13 ' CZ ' ' A' ' 63' ' ' PHE . 60.2 mt -137.32 132.99 46.48 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.836 0 CA-C-O 120.761 0.315 . . . . 0.0 110.526 -179.911 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 139' ' ' GLU . . . . . 0.536 ' HG2' ' HB3' ' A' ' 60' ' ' LYS . 28.3 mt-10 -105.65 144.36 32.5 Favored 'General case' 0 CA--C 1.514 -0.439 0 CA-C-N 116.494 -0.321 . . . . 0.0 110.749 -179.3 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 140' ' ' VAL . . . . . 0.431 ' CG1' ' HA ' ' A' ' 57' ' ' VAL . 37.6 t -97.71 104.66 16.19 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.886 0 N-CA-C 108.366 -0.976 . . . . 0.0 108.366 169.415 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 41.1 mt -91.67 -51.62 5.15 Favored 'General case' 0 C--N 1.318 -0.769 0 N-CA-C 109.347 -0.612 . . . . 0.0 109.347 -178.362 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 142' ' ' GLU . . . . . 0.418 ' HB3' HD12 ' A' ' 12' ' ' LEU . 40.9 tt0 -150.95 148.61 28.62 Favored 'General case' 0 C--N 1.321 -0.654 0 CA-C-N 115.55 -0.75 . . . . 0.0 109.236 169.393 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 143' ' ' ILE . . . . . 0.499 HD13 HG22 ' A' ' 57' ' ' VAL . 74.5 mt -103.52 136.2 37.52 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.7 0 CA-C-O 120.811 0.339 . . . . 0.0 110.109 -178.152 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 144' ' ' ASP . . . . . . . . . . . . . 29.0 t70 -77.29 133.73 67.82 Favored Pre-proline 0 C--N 1.324 -0.523 0 CA-C-N 115.895 -0.593 . . . . 0.0 109.808 -177.295 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 145' ' ' PRO . . . . . 0.438 ' HA ' ' HB3' ' A' ' 2' ' ' SER . 24.4 Cg_endo . . . . . 0 C--N 1.345 0.389 0 C-N-CA 123.308 2.672 . . . . 0.0 113.048 -172.575 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 18.7 m . . . . . 0 N--CA 1.453 -0.324 0 CA-C-O 120.86 0.362 . . . . 0.0 110.516 . . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 7.2 mp0 -76.31 -29.77 57.46 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 121.55 0.69 . . . . 0.0 110.051 177.681 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 20.8 t -120.97 152.56 38.4 Favored 'General case' 0 C--N 1.317 -0.834 0 CA-C-N 115.031 -0.986 . . . . 0.0 109.698 -179.98 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 69.8 t -68.72 123.39 22.05 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.443 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.36 -178.595 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 6' ' ' GLN . . . . . . . . . . . . . 5.1 pt20 -140.49 160.67 39.48 Favored 'General case' 0 C--N 1.315 -0.929 0 CA-C-N 115.206 -0.906 . . . . 0.0 109.342 -177.667 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 41.4 p -62.64 145.33 54.82 Favored 'General case' 0 C--N 1.317 -0.837 0 O-C-N 123.215 0.322 . . . . 0.0 110.824 -178.47 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 21.3 t-20 77.24 -1.01 2.82 Favored 'General case' 0 N--CA 1.47 0.564 0 C-N-CA 123.762 0.825 . . . . 0.0 111.558 179.732 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 67.1 m -99.99 166.23 11.15 Favored 'General case' 0 C--N 1.327 -0.384 0 N-CA-C 108.983 -0.747 . . . . 0.0 108.983 172.693 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 10' ' ' ALA . . . . . 0.49 ' HB2' ' HB3' ' A' ' 144' ' ' ASP . . . -115.82 154.32 29.88 Favored 'General case' 0 C--N 1.316 -0.875 0 C-N-CA 120.598 -0.441 . . . . 0.0 110.209 178.705 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 8.6 m -129.69 133.57 64.73 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.786 0 CA-C-O 121.395 0.617 . . . . 0.0 110.575 177.776 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 12' ' ' LEU . . . . . 0.442 HD11 ' N ' ' A' ' 12' ' ' LEU . 5.9 mp -86.81 110.36 19.89 Favored 'General case' 0 C--N 1.316 -0.88 0 N-CA-C 107.173 -1.418 . . . . 0.0 107.173 172.923 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 13' ' ' VAL . . . . . 0.452 ' CG2' HG21 ' A' ' 138' ' ' ILE . 1.5 p -123.73 157.19 30.42 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.93 0 CA-C-O 121.089 0.471 . . . . 0.0 110.858 -171.963 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 14' ' ' HIS . . . . . 0.409 ' N ' HG23 ' A' ' 13' ' ' VAL . 0.0 OUTLIER -119.02 116.34 26.21 Favored 'General case' 0 C--N 1.317 -0.822 0 N-CA-C 106.376 -1.713 . . . . 0.0 106.376 174.197 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 15' ' ' PHE . . . . . 0.44 ' HB2' ' O ' ' A' ' 137' ' ' ASP . 21.2 p90 -150.81 161.69 42.17 Favored 'General case' 0 C--N 1.32 -0.695 0 C-N-CA 119.221 -0.992 . . . . 0.0 112.441 -169.448 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 13.8 m -128.58 122.99 32.25 Favored 'General case' 0 N--CA 1.448 -0.535 0 N-CA-C 109.09 -0.707 . . . . 0.0 109.09 173.101 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 7.3 tp -92.23 125.52 36.93 Favored 'General case' 0 C--N 1.319 -0.72 0 CA-C-O 121.407 0.622 . . . . 0.0 110.941 -173.505 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 18' ' ' LYS . . . . . 0.435 ' N ' ' HD3' ' A' ' 18' ' ' LYS . 0.0 OUTLIER -111.49 145.84 38.33 Favored 'General case' 0 C--N 1.321 -0.651 0 CA-C-N 114.849 -1.068 . . . . 0.0 111.247 -173.319 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 19' ' ' LEU . . . . . 0.458 ' CD2' ' HB2' ' A' ' 25' ' ' ALA . 4.0 mm? -86.69 166.43 15.33 Favored 'General case' 0 C--N 1.319 -0.74 0 N-CA-C 109.64 -0.504 . . . . 0.0 109.64 172.24 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 15.7 t70 -61.08 -33.75 73.83 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-O 121.243 0.544 . . . . 0.0 109.659 174.052 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 17.7 m-20 -80.08 9.34 5.64 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 115.46 -0.791 . . . . 0.0 111.899 -179.614 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 73.34 17.61 78.96 Favored Glycine 0 N--CA 1.453 -0.174 0 C-N-CA 121.146 -0.55 . . . . 0.0 113.004 178.439 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 9.3 m -85.69 152.54 23.0 Favored 'General case' 0 C--N 1.32 -0.694 0 N-CA-C 109.577 -0.527 . . . . 0.0 109.577 176.337 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 23.5 m -95.47 116.35 28.69 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-O 120.718 0.294 . . . . 0.0 110.828 179.038 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 25' ' ' ALA . . . . . 0.458 ' HB2' ' CD2' ' A' ' 19' ' ' LEU . . . -87.31 -50.67 6.43 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 116.258 -0.428 . . . . 0.0 111.567 -177.009 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 8.1 tp10 -145.62 129.29 17.13 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 115.78 -0.645 . . . . 0.0 109.468 -175.113 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 21.0 m -124.09 115.03 20.5 Favored 'General case' 0 C--N 1.318 -0.786 0 N-CA-C 110.474 -0.195 . . . . 0.0 110.474 -178.939 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 8.4 t -122.11 57.76 1.05 Allowed 'General case' 0 C--O 1.239 0.546 0 CA-C-O 122.653 1.216 . . . . 0.0 109.182 173.484 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 10.6 mmm180 -118.12 -71.78 0.72 Allowed 'General case' 0 C--N 1.323 -0.564 0 CA-C-N 114.152 -1.386 . . . . 0.0 110.366 173.089 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 11.0 p30 -65.49 -7.45 14.4 Favored 'General case' 0 N--CA 1.47 0.537 0 CA-C-N 116.096 -0.502 . . . . 0.0 111.765 -177.302 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -61.4 -35.31 77.15 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 115.877 -0.602 . . . . 0.0 110.62 -179.419 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 90.0 -1.36 80.35 Favored Glycine 0 N--CA 1.447 -0.584 0 N-CA-C 110.759 -0.936 . . . . 0.0 110.759 -172.22 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 65.6 mttm -128.71 138.53 33.32 Favored Pre-proline 0 C--N 1.326 -0.446 0 N-CA-C 109.06 -0.719 . . . . 0.0 109.06 179.792 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 37.0 Cg_endo -85.06 171.49 9.17 Favored 'Trans proline' 0 N--CA 1.451 -1.008 0 C-N-CA 122.933 2.422 . . . . 0.0 112.029 174.423 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -113.89 139.13 49.44 Favored 'General case' 0 C--N 1.309 -1.182 0 CA-C-N 115.019 -0.992 . . . . 0.0 109.115 -179.905 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 3.3 tm? -94.97 117.49 30.23 Favored 'General case' 0 C--N 1.316 -0.856 0 CA-C-O 121.27 0.557 . . . . 0.0 110.184 -178.629 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 37' ' ' PHE . . . . . . . . . . . . . 4.4 m-30 -98.51 107.84 20.39 Favored 'General case' 0 C--N 1.317 -0.84 0 CA-C-N 115.266 -0.879 . . . . 0.0 110.181 174.175 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 38' ' ' ARG . . . . . 0.406 ' HD2' ' HB3' ' A' ' 10' ' ' ALA . 19.2 tpt180 -92.84 109.39 20.83 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-N 116.265 -0.425 . . . . 0.0 109.858 178.95 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 14.7 mt -81.05 154.04 27.05 Favored 'General case' 0 C--N 1.321 -0.653 0 CA-C-N 115.611 -0.722 . . . . 0.0 109.77 -177.877 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 101.47 35.78 4.01 Favored Glycine 0 N--CA 1.444 -0.778 0 C-N-CA 120.754 -0.736 . . . . 0.0 112.349 -177.191 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER 62.99 14.94 7.98 Favored 'General case' 0 N--CA 1.47 0.556 0 N-CA-C 112.96 0.726 . . . . 0.0 112.96 175.515 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -62.73 -59.01 5.48 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-O 121.034 0.445 . . . . 0.0 110.663 179.92 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 16.4 t -134.53 2.86 3.26 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-O 121.303 0.573 . . . . 0.0 110.03 177.145 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 44' ' ' LEU . . . . . 0.461 HD12 ' CD2' ' A' ' 48' ' ' LEU . 78.9 mt -115.38 174.1 6.18 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-N 115.542 -0.754 . . . . 0.0 109.994 -178.09 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 12.9 t -104.65 154.91 19.36 Favored 'General case' 0 C--N 1.322 -0.608 0 N-CA-C 109.306 -0.627 . . . . 0.0 109.306 176.586 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 46' ' ' GLU . . . . . 0.539 ' O ' ' HG2' ' A' ' 50' ' ' GLN . 37.7 mt-10 -47.35 -46.17 25.37 Favored 'General case' 0 N--CA 1.466 0.335 0 O-C-N 123.605 0.565 . . . . 0.0 112.067 -175.221 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -61.24 -42.12 99.69 Favored Glycine 0 N--CA 1.446 -0.677 0 CA-C-N 115.975 -0.557 . . . . 0.0 113.581 -173.562 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 48' ' ' LEU . . . . . 0.461 ' CD2' HD12 ' A' ' 44' ' ' LEU . 2.6 tt -61.26 -48.95 79.07 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 117.325 0.563 . . . . 0.0 111.538 -176.749 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 49' ' ' GLU . . . . . 0.425 ' O ' HD12 ' A' ' 53' ' ' LEU . 11.7 pt-20 -64.5 -37.78 88.71 Favored 'General case' 0 C--N 1.325 -0.49 0 C-N-CA 120.555 -0.458 . . . . 0.0 109.907 -179.033 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 50' ' ' GLN . . . . . 0.539 ' HG2' ' O ' ' A' ' 46' ' ' GLU . 84.5 mm-40 -51.88 -29.3 19.26 Favored 'General case' 0 N--CA 1.464 0.249 0 N-CA-C 112.047 0.388 . . . . 0.0 112.047 175.475 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 51' ' ' HIS . . . . . . . . . . . . . 12.3 m-70 -97.63 -3.81 38.73 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-O 121.057 0.456 . . . . 0.0 110.973 -177.319 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 31.1 mt -102.84 -29.69 11.31 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 116.097 -0.501 . . . . 0.0 111.279 178.022 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 53' ' ' LEU . . . . . 0.425 HD12 ' O ' ' A' ' 49' ' ' GLU . 0.0 OUTLIER -59.47 139.08 57.42 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-O 121.158 0.504 . . . . 0.0 111.26 -179.465 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 93.67 -8.85 74.09 Favored Glycine 0 N--CA 1.45 -0.391 0 CA-C-N 115.743 -0.662 . . . . 0.0 112.589 -179.45 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 4.2 mm? -78.15 164.92 24.56 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-O 121.048 0.452 . . . . 0.0 110.918 176.857 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 56' ' ' LYS . . . . . 0.553 ' HZ1' ' HB2' ' A' ' 56' ' ' LYS . 0.1 OUTLIER -126.78 164.84 20.46 Favored 'General case' 0 C--N 1.321 -0.665 0 CA-C-N 116.197 -0.456 . . . . 0.0 109.874 -176.993 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 25.5 t -63.91 132.37 29.74 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 N-CA-C 109.908 -0.405 . . . . 0.0 109.908 172.377 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 79.93 9.93 86.18 Favored Glycine 0 N--CA 1.45 -0.373 0 C-N-CA 120.995 -0.621 . . . . 0.0 112.38 -176.133 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 59' ' ' ASP . . . . . 0.527 ' HB2' ' O ' ' A' ' 56' ' ' LYS . 0.4 OUTLIER -104.52 152.96 21.75 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-O 120.964 0.411 . . . . 0.0 110.634 178.732 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 60' ' ' LYS . . . . . 0.4 ' HE3' ' OE1' ' A' ' 139' ' ' GLU . 0.6 OUTLIER -112.18 132.35 54.95 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 115.671 -0.695 . . . . 0.0 110.412 -173.003 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 7.6 t -139.35 115.81 10.58 Favored 'General case' 0 C--N 1.319 -0.744 0 CA-C-O 121.562 0.696 . . . . 0.0 111.066 175.743 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 34.6 m -112.37 130.58 55.91 Favored 'General case' 0 C--N 1.318 -0.768 0 N-CA-C 108.986 -0.746 . . . . 0.0 108.986 173.492 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 28.4 p90 -148.71 146.84 28.29 Favored 'General case' 0 C--N 1.315 -0.903 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.252 -177.591 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 26.6 p -89.85 144.52 25.87 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.492 176.241 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 77.0 mt -138.55 133.1 32.14 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-O 121.356 0.598 . . . . 0.0 110.866 177.635 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 66' ' ' GLU . . . . . 0.423 ' HB2' ' OD1' ' A' ' 68' ' ' ASP . 4.3 mm-40 -88.61 161.84 40.88 Favored Pre-proline 0 C--N 1.313 -1.003 0 CA-C-N 115.157 -0.929 . . . . 0.0 108.728 174.671 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 99.1 Cg_exo -45.53 -35.47 12.47 Favored 'Trans proline' 0 C--N 1.349 0.586 0 C-N-CA 123.055 2.503 . . . . 0.0 114.367 -174.305 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 68' ' ' ASP . . . . . 0.423 ' OD1' ' HB2' ' A' ' 66' ' ' GLU . 6.8 p-10 -59.21 -29.41 67.48 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-O 120.723 0.297 . . . . 0.0 111.417 -178.889 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -115.04 11.8 16.53 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-O 120.76 0.314 . . . . 0.0 111.045 179.589 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.326 -0.453 0 CA-C-N 116.302 -0.408 . . . . 0.0 110.972 -174.349 . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 8.1 t . . . . . 0 N--CA 1.452 -0.335 0 CA-C-O 121.077 0.465 . . . . 0.0 110.955 . . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 57.1 Cg_endo -69.92 -17.84 36.61 Favored 'Trans proline' 0 C--N 1.347 0.462 0 C-N-CA 123.27 2.647 . . . . 0.0 113.615 -176.521 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 2.6 p-10 -70.85 -11.39 60.93 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-O 120.986 0.422 . . . . 0.0 110.522 -178.785 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 4.3 mm? -70.9 -18.86 62.66 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.002 -0.545 . . . . 0.0 110.589 174.645 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 79' ' ' ILE . . . . . 0.47 HG12 ' HA ' ' A' ' 124' ' ' ASP . 9.9 mt -85.46 106.76 15.51 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.643 0 CA-C-N 115.763 -0.653 . . . . 0.0 110.447 -175.94 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 30.8 mt-30 -121.79 122.01 38.53 Favored 'General case' 0 C--N 1.319 -0.759 0 CA-C-N 115.639 -0.71 . . . . 0.0 111.248 -178.501 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 81' ' ' TYR . . . . . 0.594 ' HB3' ' HA ' ' A' ' 122' ' ' THR . 0.1 OUTLIER -108.27 114.02 27.56 Favored 'General case' 0 C--N 1.315 -0.903 0 CA-C-N 115.914 -0.584 . . . . 0.0 111.55 176.945 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -116.55 177.93 4.52 Favored 'General case' 0 C--N 1.319 -0.748 0 CA-C-O 120.626 0.251 . . . . 0.0 111.125 168.394 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 83' ' ' SER . . . . . 0.414 ' HA ' ' O ' ' A' ' 119' ' ' ASP . 8.2 t -59.27 151.58 22.91 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-O 121.572 0.701 . . . . 0.0 111.963 -170.437 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -74.36 -12.72 60.6 Favored 'General case' 0 C--N 1.333 -0.131 0 CA-C-N 115.249 -0.887 . . . . 0.0 111.34 -169.681 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 85' ' ' ARG . . . . . . . . . . . . . 7.5 mpt_? -71.49 -20.52 62.05 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 121.51 0.671 . . . . 0.0 109.905 -177.574 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 30.6 mm-40 -79.48 -12.1 59.88 Favored 'General case' 0 C--N 1.321 -0.653 0 CA-C-N 114.959 -1.019 . . . . 0.0 109.797 176.206 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 87' ' ' PHE . . . . . 0.486 ' CE1' ' HB ' ' A' ' 121' ' ' ILE . 73.7 m-85 -105.0 -46.39 4.29 Favored 'General case' 0 C--N 1.319 -0.72 0 CA-C-N 114.709 -1.132 . . . . 0.0 110.538 -175.039 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 88' ' ' MET . . . . . . . . . . . . . 64.5 ttp -58.16 -22.35 50.95 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-N 115.325 -0.852 . . . . 0.0 110.216 178.666 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 32.1 t70 -53.3 -35.67 60.37 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 115.047 -0.979 . . . . 0.0 110.838 174.033 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -116.06 11.44 15.33 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.272 -179.919 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 113.58 141.26 7.84 Favored Glycine 0 N--CA 1.448 -0.505 0 C-N-CA 120.827 -0.701 . . . . 0.0 112.117 -178.301 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 44.2 mt-10 -64.41 125.81 89.23 Favored Pre-proline 0 C--N 1.324 -0.505 0 CA-C-O 121.017 0.437 . . . . 0.0 111.416 -178.842 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 93' ' ' PRO . . . . . 0.432 ' HB2' HD12 ' A' ' 113' ' ' ILE . 53.1 Cg_endo -78.83 167.06 22.76 Favored 'Trans proline' 0 C--O 1.232 0.217 0 C-N-CA 123.591 2.86 . . . . 0.0 114.146 -174.389 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 1.1 mp0 -120.08 155.65 32.57 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 115.015 -0.993 . . . . 0.0 111.352 -173.133 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 95' ' ' ILE . . . . . 0.542 ' CG1' HG12 ' A' ' 116' ' ' ILE . 13.7 mt -82.34 131.41 33.86 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.155 0 CA-C-N 116.301 -0.409 . . . . 0.0 111.01 178.778 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 68.13 30.05 73.66 Favored Glycine 0 N--CA 1.448 -0.544 0 CA-C-N 115.815 -0.63 . . . . 0.0 111.905 179.966 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -108.45 125.32 51.64 Favored 'General case' 0 N--CA 1.445 -0.695 0 CA-C-O 120.934 0.397 . . . . 0.0 109.939 179.828 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 98' ' ' ILE . . . . . 0.472 ' HA ' ' HA ' ' A' ' 112' ' ' VAL . 35.4 mt -86.52 102.47 11.95 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.867 0 N-CA-C 108.807 -0.812 . . . . 0.0 108.807 179.601 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 99' ' ' MET . . . . . 0.485 ' O ' ' HD2' ' A' ' 101' ' ' PHE . 7.0 mtm -105.39 126.63 52.33 Favored 'General case' 0 N--CA 1.438 -1.057 0 CA-C-O 121.665 0.745 . . . . 0.0 110.545 -175.279 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 4.4 mm? -62.75 147.81 48.65 Favored 'General case' 0 C--N 1.305 -1.331 0 CA-C-N 114.28 -1.327 . . . . 0.0 109.326 171.078 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 101' ' ' PHE . . . . . 0.485 ' HD2' ' O ' ' A' ' 99' ' ' MET . 0.4 OUTLIER -148.62 167.02 26.55 Favored 'General case' 0 CA--C 1.509 -0.619 0 CA-C-N 115.021 -0.99 . . . . 0.0 108.44 -152.806 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 1.5 m -121.78 122.15 38.86 Favored 'General case' 0 C--N 1.309 -1.179 0 C-N-CA 119.773 -0.771 . . . . 0.0 110.353 176.965 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -88.12 165.25 15.24 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-N 115.791 -0.64 . . . . 0.0 110.305 -177.779 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 104' ' ' MET . . . . . . . . . . . . . 2.0 mpt? -66.23 -12.73 58.01 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.807 -0.633 . . . . 0.0 112.002 -175.014 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 8.6 p-10 -99.71 15.44 26.8 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-O 120.737 0.304 . . . . 0.0 110.982 179.765 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 79.76 -11.95 31.3 Favored Glycine 0 CA--C 1.52 0.346 0 C-N-CA 121.121 -0.562 . . . . 0.0 113.88 177.824 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 24.6 t -79.71 151.13 30.61 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-O 121.203 0.525 . . . . 0.0 110.081 179.586 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 26.3 tt0 -94.56 100.26 12.26 Favored 'General case' 0 C--N 1.313 -1.016 0 CA-C-N 115.585 -0.734 . . . . 0.0 110.009 -178.019 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 109' ' ' MET . . . . . . . . . . . . . 3.1 mtp -92.25 147.85 35.42 Favored Pre-proline 0 C--N 1.324 -0.524 0 CA-C-N 115.3 -0.864 . . . . 0.0 110.842 179.998 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 55.2 Cg_endo -72.49 154.72 55.46 Favored 'Trans proline' 0 N--CA 1.458 -0.56 0 C-N-CA 122.009 1.806 . . . . 0.0 110.871 173.374 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 111' ' ' GLY . . . . . 0.494 ' HA2' ' O ' ' A' ' 124' ' ' ASP . . . -150.21 103.48 0.25 Allowed Glycine 0 N--CA 1.445 -0.736 0 C-N-CA 120.164 -1.017 . . . . 0.0 110.853 -171.637 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 112' ' ' VAL . . . . . 0.472 ' HA ' ' HA ' ' A' ' 98' ' ' ILE . 7.7 p -97.73 113.26 31.77 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.559 0 CA-C-N 119.237 1.518 . . . . 0.0 110.689 -179.462 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 113' ' ' ILE . . . . . 0.458 ' HA ' ' O ' ' A' ' 122' ' ' THR . 39.2 mt -72.6 111.14 6.47 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.897 0 CA-C-N 114.902 -1.045 . . . . 0.0 110.059 179.941 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 114' ' ' ARG . . . . . 0.508 ' HD3' ' O ' ' A' ' 114' ' ' ARG . 8.8 tpp180 -63.81 -46.73 83.81 Favored 'General case' 0 C--N 1.322 -0.625 0 CA-C-N 114.909 -1.041 . . . . 0.0 110.864 -177.669 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 14.5 tt0 -159.25 154.43 25.27 Favored 'General case' 0 C--N 1.324 -0.531 0 C-N-CA 120.705 -0.398 . . . . 0.0 110.882 -175.751 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 116' ' ' ILE . . . . . 0.542 HG12 ' CG1' ' A' ' 95' ' ' ILE . 37.4 mm -100.57 120.63 50.3 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 N-CA-C 109.183 -0.673 . . . . 0.0 109.183 175.987 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 117' ' ' ASN . . . . . 0.424 ' HB2' ' O ' ' A' ' 120' ' ' SER . 30.2 m-80 -110.41 157.46 19.53 Favored 'General case' 0 C--N 1.315 -0.913 0 CA-C-N 115.934 -0.575 . . . . 0.0 110.171 -179.755 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . -56.21 -40.59 84.53 Favored Glycine 0 C--O 1.227 -0.343 0 C-N-CA 120.688 -0.768 . . . . 0.0 113.694 -169.528 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 119' ' ' ASP . . . . . 0.414 ' O ' ' HA ' ' A' ' 83' ' ' SER . 24.8 m-20 -113.07 -15.69 12.77 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 117.169 0.484 . . . . 0.0 112.119 179.826 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 120' ' ' SER . . . . . 0.424 ' O ' ' HB2' ' A' ' 117' ' ' ASN . 13.6 t -130.73 156.49 44.86 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-O 120.923 0.392 . . . . 0.0 111.483 -169.999 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 121' ' ' ILE . . . . . 0.517 ' O ' ' HA ' ' A' ' 81' ' ' TYR . 49.5 mm -127.46 125.59 65.95 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.778 -178.626 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 122' ' ' THR . . . . . 0.594 ' HA ' ' HB3' ' A' ' 81' ' ' TYR . 10.7 m -95.38 103.32 15.18 Favored 'General case' 0 C--N 1.329 -0.323 0 N-CA-C 112.477 0.547 . . . . 0.0 112.477 -174.246 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 5.6 t -103.78 122.06 56.02 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 N-CA-C 113.307 0.854 . . . . 0.0 113.307 177.404 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 124' ' ' ASP . . . . . 0.494 ' O ' ' HA2' ' A' ' 111' ' ' GLY . 1.3 t70 -89.04 135.41 33.57 Favored 'General case' 0 C--N 1.322 -0.587 0 CA-C-N 115.191 -0.913 . . . . 0.0 111.508 170.285 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 125' ' ' PHE . . . . . . . . . . . . . 63.2 m-85 -117.98 59.15 0.8 Allowed 'General case' 0 C--N 1.331 -0.216 0 CA-C-O 122.115 0.96 . . . . 0.0 110.381 -176.118 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 13.2 m-80 . . . . . 0 C--N 1.307 -1.266 0 CA-C-N 114.311 -1.313 . . . . 0.0 111.496 -179.439 . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 133' ' ' THR . . . . . . . . . . . . . 20.5 m . . . . . 0 N--CA 1.443 -0.82 0 N-CA-C 108.85 -0.796 . . . . 0.0 108.85 . . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 134' ' ' VAL . . . . . . . . . . . . . 1.5 m -121.99 148.78 25.37 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.595 0 CA-C-O 121.894 0.854 . . . . 0.0 112.6 -172.271 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 135' ' ' HIS . . . . . . . . . . . . . 15.0 m-70 -112.42 147.38 36.58 Favored 'General case' 0 C--N 1.316 -0.89 0 CA-C-N 114.624 -1.171 . . . . 0.0 108.508 174.028 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 136' ' ' PHE . . . . . . . . . . . . . 12.5 m-85 -123.45 124.11 42.15 Favored 'General case' 0 C--N 1.31 -1.131 0 CA-C-N 116.028 -0.533 . . . . 0.0 111.71 -166.726 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 137' ' ' ASP . . . . . 0.44 ' O ' ' HB2' ' A' ' 15' ' ' PHE . 12.9 m-20 -116.58 96.42 5.5 Favored 'General case' 0 C--N 1.324 -0.525 0 N-CA-C 108.608 -0.886 . . . . 0.0 108.608 175.784 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 138' ' ' ILE . . . . . 0.452 HG21 ' CG2' ' A' ' 13' ' ' VAL . 1.9 mp -107.65 138.57 33.28 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.55 0 N-CA-C 112.599 0.592 . . . . 0.0 112.599 -177.794 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 139' ' ' GLU . . . . . 0.4 ' OE1' ' HE3' ' A' ' 60' ' ' LYS . 31.8 mt-10 -125.59 124.71 41.83 Favored 'General case' 0 CA--C 1.507 -0.676 0 N-CA-C 108.084 -1.08 . . . . 0.0 108.084 167.885 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 140' ' ' VAL . . . . . . . . . . . . . 71.6 t -78.16 121.47 31.05 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.747 0 C-N-CA 120.704 -0.398 . . . . 0.0 110.428 -176.947 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 19.2 mt -93.1 -44.05 8.57 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-O 121.262 0.553 . . . . 0.0 110.027 178.084 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 142' ' ' GLU . . . . . . . . . . . . . 10.2 tp10 -153.67 152.22 30.56 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-N 115.465 -0.789 . . . . 0.0 109.768 -179.336 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 143' ' ' ILE . . . . . . . . . . . . . 63.0 mt -116.9 121.16 67.13 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.421 0 CA-C-O 121.007 0.432 . . . . 0.0 110.317 178.531 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 144' ' ' ASP . . . . . 0.49 ' HB3' ' HB2' ' A' ' 10' ' ' ALA . 38.6 t70 -77.37 128.5 80.22 Favored Pre-proline 0 C--N 1.322 -0.618 0 CA-C-N 115.808 -0.633 . . . . 0.0 110.154 -179.341 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 145' ' ' PRO . . . . . . . . . . . . . 73.7 Cg_exo . . . . . 0 C--N 1.345 0.383 0 C-N-CA 123.29 2.66 . . . . 0.0 112.539 178.415 . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 4.8 t . . . . . 0 N--CA 1.451 -0.388 0 N-CA-C 109.25 -0.648 . . . . 0.0 109.25 . . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 3' ' ' GLU . . . . . 0.408 ' CG ' ' HE2' ' A' ' 56' ' ' LYS . 39.2 tt0 -74.5 -34.44 63.06 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-O 121.477 0.656 . . . . 0.0 110.554 -177.132 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 24.2 m -128.12 156.82 42.24 Favored 'General case' 0 C--N 1.314 -0.939 0 CA-C-N 115.302 -0.863 . . . . 0.0 109.604 179.621 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . 0.441 HG13 ' HA ' ' A' ' 53' ' ' LEU . 7.1 p -81.96 135.94 23.97 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.532 0 CA-C-O 121.021 0.439 . . . . 0.0 110.83 -177.58 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 6' ' ' GLN . . . . . 0.574 ' HG2' ' OG ' ' A' ' 9' ' ' SER . 0.6 OUTLIER -123.21 168.49 12.37 Favored 'General case' 0 C--N 1.318 -0.792 0 CA-C-N 115.933 -0.576 . . . . 0.0 109.632 177.866 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 29.4 t -54.23 122.77 11.01 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-O 120.765 0.317 . . . . 0.0 110.493 179.052 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 2.9 t30 73.5 41.25 0.46 Allowed 'General case' 0 N--CA 1.469 0.497 0 C-N-CA 123.935 0.894 . . . . 0.0 111.132 -177.238 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 9' ' ' SER . . . . . 0.574 ' OG ' ' HG2' ' A' ' 6' ' ' GLN . 67.0 m -122.2 134.74 54.71 Favored 'General case' 0 C--N 1.325 -0.473 0 N-CA-C 108.846 -0.798 . . . . 0.0 108.846 168.288 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -84.68 147.57 26.86 Favored 'General case' 0 C--N 1.315 -0.899 0 CA-C-N 116.533 -0.303 . . . . 0.0 110.233 -176.858 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 13.5 m -133.91 142.88 40.08 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.864 0 C-N-CA 120.712 -0.395 . . . . 0.0 110.335 179.971 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 30.6 tp -86.55 123.57 31.9 Favored 'General case' 0 C--N 1.319 -0.739 0 N-CA-C 108.271 -1.011 . . . . 0.0 108.271 174.797 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 13' ' ' VAL . . . . . 0.57 HG21 ' N ' ' A' ' 14' ' ' HIS . 4.4 p -131.93 156.28 42.38 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.778 0 CA-C-O 122.27 1.033 . . . . 0.0 113.057 -172.432 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 14' ' ' HIS . . . . . 0.57 ' N ' HG21 ' A' ' 13' ' ' VAL . 2.2 m-70 -118.77 120.85 38.59 Favored 'General case' 0 C--N 1.317 -0.835 0 N-CA-C 106.059 -1.83 . . . . 0.0 106.059 169.471 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 15' ' ' PHE . . . . . 0.521 ' CD1' ' HB ' ' A' ' 28' ' ' THR . 16.2 p90 -151.08 157.87 43.33 Favored 'General case' 0 C--N 1.324 -0.537 0 C-N-CA 118.181 -1.408 . . . . 0.0 113.948 -170.336 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 22.2 m -131.06 130.43 43.23 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 114.85 -1.068 . . . . 0.0 108.598 176.904 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 17' ' ' LEU . . . . . 0.456 ' HG ' ' HB3' ' A' ' 136' ' ' PHE . 2.2 tt -121.81 118.05 28.05 Favored 'General case' 0 N--CA 1.446 -0.637 0 N-CA-C 109.435 -0.58 . . . . 0.0 109.435 -173.678 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 18' ' ' LYS . . . . . 0.632 ' HB3' ' CE1' ' A' ' 135' ' ' HIS . 2.4 tppt? -126.19 155.63 41.46 Favored 'General case' 0 C--N 1.314 -0.94 0 C-N-CA 119.988 -0.685 . . . . 0.0 111.455 -174.885 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 3.1 mm? -99.52 171.5 7.89 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-N 115.291 -0.868 . . . . 0.0 109.339 173.813 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 35.5 t70 -64.72 -25.49 67.96 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-O 121.373 0.606 . . . . 0.0 109.866 176.099 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 5.0 m-20 -77.53 2.99 14.67 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.5 -0.773 . . . . 0.0 110.843 178.501 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 73.27 9.57 77.28 Favored Glycine 0 C--N 1.33 0.245 0 C-N-CA 121.387 -0.435 . . . . 0.0 113.28 -179.913 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 26.7 m -82.27 142.26 32.25 Favored 'General case' 0 C--N 1.321 -0.644 0 N-CA-C 109.835 -0.431 . . . . 0.0 109.835 177.093 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 20.9 m -89.59 112.57 23.82 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-O 120.747 0.308 . . . . 0.0 110.335 179.316 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -72.69 -38.09 67.66 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 121.134 0.493 . . . . 0.0 110.111 178.506 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 8.4 tp10 -157.32 141.24 16.04 Favored 'General case' 0 N--CA 1.446 -0.663 0 CA-C-N 115.732 -0.667 . . . . 0.0 110.132 178.682 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 36.9 p -124.53 119.72 29.91 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-O 121.125 0.488 . . . . 0.0 110.934 -178.828 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 28' ' ' THR . . . . . 0.641 ' O ' HG23 ' A' ' 28' ' ' THR . 96.8 m -139.62 11.26 2.49 Favored 'General case' 0 CA--C 1.547 0.848 0 CA-C-O 123.269 1.509 . . . . 0.0 110.562 177.187 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 8.7 tmm_? -104.27 -52.96 2.82 Favored 'General case' 0 C--N 1.308 -1.215 0 CA-C-N 115.099 -0.955 . . . . 0.0 109.921 167.481 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 4.8 p-10 -82.52 35.0 0.44 Allowed 'General case' 0 C--N 1.326 -0.436 0 CA-C-O 121.079 0.466 . . . . 0.0 111.472 -178.87 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 4.5 m-20 -120.33 -23.27 6.24 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.334 -0.394 . . . . 0.0 111.599 -178.788 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 84.85 -11.6 59.37 Favored Glycine 0 N--CA 1.453 -0.212 0 C-N-CA 120.435 -0.888 . . . . 0.0 110.905 -174.286 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 33' ' ' LYS . . . . . 0.448 ' HD2' ' HD2' ' A' ' 34' ' ' PRO . 56.1 tptt -120.53 118.16 31.09 Favored Pre-proline 0 C--N 1.321 -0.646 0 CA-C-N 114.896 -0.652 . . . . 0.0 110.054 -177.974 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 34' ' ' PRO . . . . . 0.448 ' HD2' ' HD2' ' A' ' 33' ' ' LYS . 73.9 Cg_endo -80.28 170.77 15.8 Favored 'Trans proline' 0 N--CA 1.457 -0.672 0 C-N-CA 122.506 2.137 . . . . 0.0 111.526 174.125 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -137.02 152.26 49.9 Favored 'General case' 0 C--N 1.311 -1.091 0 CA-C-N 115.671 -0.695 . . . . 0.0 110.463 -175.58 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 2.0 tp -90.69 138.24 31.73 Favored 'General case' 0 C--N 1.317 -0.807 0 N-CA-C 109.414 -0.588 . . . . 0.0 109.414 175.038 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 37' ' ' PHE . . . . . . . . . . . . . 2.4 m-30 -104.0 106.66 17.24 Favored 'General case' 0 C--N 1.317 -0.825 0 N-CA-C 108.67 -0.863 . . . . 0.0 108.67 175.535 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 6.5 tpp180 -86.07 105.6 16.61 Favored 'General case' 0 C--N 1.323 -0.569 0 N-CA-C 109.105 -0.702 . . . . 0.0 109.105 -179.733 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 39' ' ' LEU . . . . . 0.4 HD13 ' O ' ' A' ' 9' ' ' SER . 40.0 mt -90.38 156.39 18.27 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-N 115.363 -0.835 . . . . 0.0 111.666 -175.743 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 102.49 37.85 3.17 Favored Glycine 0 N--CA 1.45 -0.407 0 CA-C-N 115.335 -0.848 . . . . 0.0 111.996 -177.884 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 31.9 t70 65.74 0.53 1.52 Allowed 'General case' 0 N--CA 1.472 0.637 0 C-N-CA 123.509 0.724 . . . . 0.0 111.893 179.739 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -65.78 -48.34 72.12 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.781 -179.779 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 23.1 m -134.42 -39.79 0.82 Allowed 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 116.066 -0.515 . . . . 0.0 110.788 178.135 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 4.6 mm? -88.79 162.72 16.05 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-O 121.038 0.447 . . . . 0.0 111.19 -178.818 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 32.2 t -86.81 153.68 21.48 Favored 'General case' 0 C--N 1.324 -0.5 0 CA-C-N 115.356 -0.838 . . . . 0.0 110.212 -178.997 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 42.3 mt-10 -52.45 -42.9 64.58 Favored 'General case' 0 C--N 1.328 -0.336 0 N-CA-C 112.309 0.485 . . . . 0.0 112.309 -173.818 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -64.96 -37.68 94.57 Favored Glycine 0 N--CA 1.447 -0.62 0 C-N-CA 120.41 -0.9 . . . . 0.0 112.777 -174.699 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 48' ' ' LEU . . . . . 0.436 ' HA ' ' CD1' ' A' ' 65' ' ' LEU . 3.4 tm? -70.09 -53.63 16.6 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 121.003 0.43 . . . . 0.0 110.093 -176.934 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 10.4 pt-20 -58.3 -40.89 83.19 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 115.712 -0.676 . . . . 0.0 112.107 -177.868 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 50' ' ' GLN . . . . . 0.504 ' HA ' ' CD2' ' A' ' 53' ' ' LEU . 90.6 mm-40 -73.74 -15.14 61.22 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-O 120.811 0.338 . . . . 0.0 111.336 -173.003 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 51' ' ' HIS . . . . . . . . . . . . . 14.6 m-70 -107.48 -9.4 15.97 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-O 120.945 0.402 . . . . 0.0 110.45 179.255 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -98.62 -30.48 12.46 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.274 179.284 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 53' ' ' LEU . . . . . 0.504 ' CD2' ' HA ' ' A' ' 50' ' ' GLN . 3.0 pp -66.76 152.08 46.2 Favored 'General case' 0 N--CA 1.452 -0.331 0 N-CA-C 109.764 -0.458 . . . . 0.0 109.764 179.565 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 93.28 3.27 65.28 Favored Glycine 0 N--CA 1.445 -0.704 0 C-N-CA 120.872 -0.68 . . . . 0.0 112.824 -175.136 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 3.8 mm? -96.01 165.28 12.33 Favored 'General case' 0 C--O 1.233 0.228 0 CA-C-N 117.395 0.598 . . . . 0.0 110.703 177.759 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 56' ' ' LYS . . . . . 0.589 ' HD3' ' N ' ' A' ' 57' ' ' VAL . 11.0 tmtt? -117.62 151.3 37.48 Favored 'General case' 0 C--N 1.324 -0.53 0 N-CA-C 109.031 -0.729 . . . . 0.0 109.031 -177.969 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 57' ' ' VAL . . . . . 0.589 ' N ' ' HD3' ' A' ' 56' ' ' LYS . 42.6 t -58.44 136.91 21.42 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-O 121.134 0.492 . . . . 0.0 111.492 176.708 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 82.75 8.97 85.23 Favored Glycine 0 N--CA 1.446 -0.645 0 CA-C-N 115.116 -0.947 . . . . 0.0 111.973 -178.985 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 59' ' ' ASP . . . . . 0.455 ' HB2' ' O ' ' A' ' 56' ' ' LYS . 1.0 OUTLIER -99.56 134.09 42.94 Favored 'General case' 0 C--N 1.323 -0.544 0 N-CA-C 108.916 -0.772 . . . . 0.0 108.916 171.772 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 6.9 mmmm -106.52 128.35 54.03 Favored 'General case' 0 C--N 1.319 -0.744 0 N-CA-C 109.248 -0.649 . . . . 0.0 109.248 -175.753 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 4.7 t -136.64 113.8 10.65 Favored 'General case' 0 C--N 1.32 -0.694 0 CA-C-O 121.837 0.827 . . . . 0.0 111.525 -176.536 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 6.1 m -100.47 131.66 46.27 Favored 'General case' 0 C--N 1.317 -0.842 0 N-CA-C 108.238 -1.023 . . . . 0.0 108.238 172.084 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 63' ' ' PHE . . . . . 0.516 ' CE2' ' HE1' ' A' ' 136' ' ' PHE . 11.3 p90 -157.92 163.98 37.34 Favored 'General case' 0 C--N 1.321 -0.661 0 C-N-CA 120.063 -0.655 . . . . 0.0 111.818 -178.072 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 26.0 t -128.75 151.81 49.13 Favored 'General case' 0 C--N 1.318 -0.785 0 CA-C-N 115.187 -0.915 . . . . 0.0 109.829 179.816 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 65' ' ' LEU . . . . . 0.436 ' CD1' ' HA ' ' A' ' 48' ' ' LEU . 39.3 mt -135.85 150.94 49.57 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-N 116.219 -0.446 . . . . 0.0 109.981 -176.882 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 48.7 mt-10 -64.1 153.88 83.94 Favored Pre-proline 0 C--N 1.33 -0.282 0 CA-C-N 116.081 -0.509 . . . . 0.0 110.527 178.779 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 80.9 Cg_exo -46.35 -52.25 7.57 Favored 'Trans proline' 0 C--O 1.233 0.257 0 C-N-CA 123.103 2.535 . . . . 0.0 113.542 -175.777 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 1.9 p-10 -66.26 -24.96 66.67 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-O 120.921 0.391 . . . . 0.0 111.053 -174.784 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -79.85 -18.55 50.49 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 115.98 -0.554 . . . . 0.0 110.922 -178.581 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.449 -0.482 0 N-CA-C 111.953 0.353 . . . . 0.0 111.953 -178.093 . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 75' ' ' SER . . . . . 0.476 ' HB3' ' HB2' ' A' ' 78' ' ' LEU . 41.3 t . . . . . 0 N--CA 1.44 -0.959 0 N-CA-C 109.896 -0.409 . . . . 0.0 109.896 . . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 26.9 Cg_endo -65.44 -25.84 55.61 Favored 'Trans proline' 0 N--CA 1.459 -0.536 0 C-N-CA 121.729 1.619 . . . . 0.0 111.009 175.666 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 8.6 p-10 -77.36 -8.87 58.37 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 115.701 -0.681 . . . . 0.0 110.753 176.524 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 78' ' ' LEU . . . . . 0.51 ' CD2' ' HB2' ' A' ' 125' ' ' PHE . 4.4 tp -73.23 -23.06 60.31 Favored 'General case' 0 CA--C 1.511 -0.549 0 CA-C-O 121.596 0.712 . . . . 0.0 109.147 176.604 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 79' ' ' ILE . . . . . 0.626 HG23 ' O ' ' A' ' 123' ' ' VAL . 7.0 mt -68.3 124.24 23.43 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.724 0 CA-C-N 114.69 -1.141 . . . . 0.0 110.575 177.245 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 40.2 mt-30 -149.97 119.27 6.83 Favored 'General case' 0 CA--C 1.502 -0.885 0 CA-C-N 114.992 -1.004 . . . . 0.0 109.377 -176.184 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 81' ' ' TYR . . . . . 0.531 ' CE2' HG22 ' A' ' 122' ' ' THR . 1.8 m-85 -80.26 114.75 19.38 Favored 'General case' 0 C--N 1.307 -1.27 0 C-N-CA 118.76 -1.176 . . . . 0.0 111.902 174.97 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 23.6 m-85 -100.15 172.71 7.01 Favored 'General case' 0 C--N 1.322 -0.627 0 CA-C-N 113.782 -1.554 . . . . 0.0 110.141 172.399 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 83' ' ' SER . . . . . 0.412 ' HB3' ' HG3' ' A' ' 86' ' ' GLU . 23.2 t -63.24 159.34 18.01 Favored 'General case' 0 C--N 1.321 -0.657 0 CA-C-O 122.836 1.303 . . . . 0.0 112.485 -167.952 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 84' ' ' ARG . . . . . 0.521 ' HD3' ' HA ' ' A' ' 119' ' ' ASP . 36.5 ptt180 -77.5 -28.21 52.08 Favored 'General case' 0 C--N 1.315 -0.925 0 CA-C-N 112.604 -2.089 . . . . 0.0 108.118 -179.31 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 85' ' ' ARG . . . . . . . . . . . . . 6.6 mpt_? -71.53 -39.8 70.5 Favored 'General case' 0 CA--C 1.512 -0.5 0 CA-C-N 114.281 -1.327 . . . . 0.0 111.158 -176.99 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 86' ' ' GLU . . . . . 0.412 ' HG3' ' HB3' ' A' ' 83' ' ' SER . 41.4 mt-10 -56.02 -36.88 68.45 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 115.316 -0.857 . . . . 0.0 110.891 -175.941 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 87' ' ' PHE . . . . . 0.421 ' HB3' ' HG3' ' A' ' 93' ' ' PRO . 14.0 m-85 -93.18 -37.44 12.09 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.475 -0.329 . . . . 0.0 111.843 -179.601 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 88' ' ' MET . . . . . . . . . . . . . 58.6 ttp -58.53 -31.79 68.25 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.59 -173.382 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 33.9 t70 -57.55 -28.62 63.71 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-O 120.954 0.407 . . . . 0.0 110.912 177.443 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -102.79 -2.91 27.18 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.055 -0.52 . . . . 0.0 110.732 176.967 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 119.59 140.08 6.1 Favored Glycine 0 N--CA 1.447 -0.583 0 C-N-CA 121.035 -0.602 . . . . 0.0 112.117 -178.108 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 47.0 mt-10 -61.11 120.94 58.9 Favored Pre-proline 0 C--N 1.327 -0.398 0 CA-C-O 120.807 0.336 . . . . 0.0 110.887 178.465 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 93' ' ' PRO . . . . . 0.425 ' CB ' HD12 ' A' ' 113' ' ' ILE . 4.3 Cg_exo -71.7 167.42 26.57 Favored 'Trans proline' 0 C--N 1.344 0.312 0 C-N-CA 123.303 2.669 . . . . 0.0 112.895 -176.841 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -115.4 156.04 26.31 Favored 'General case' 0 C--N 1.321 -0.64 0 CA-C-N 115.04 -0.982 . . . . 0.0 111.045 -174.609 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 95' ' ' ILE . . . . . 0.493 HG12 HG12 ' A' ' 116' ' ' ILE . 21.6 mt -81.76 131.06 34.72 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.453 0 CA-C-N 115.909 -0.587 . . . . 0.0 110.875 -178.716 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 72.92 18.76 79.2 Favored Glycine 0 N--CA 1.449 -0.466 0 CA-C-N 115.709 -0.678 . . . . 0.0 112.422 -177.289 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 97' ' ' ALA . . . . . 0.412 ' O ' HG13 ' A' ' 113' ' ' ILE . . . -98.71 129.74 45.17 Favored 'General case' 0 C--N 1.324 -0.515 0 N-CA-C 109.674 -0.491 . . . . 0.0 109.674 177.385 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 98' ' ' ILE . . . . . 0.513 ' HA ' ' HA ' ' A' ' 112' ' ' VAL . 16.4 mt -97.79 130.08 47.04 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.725 0 N-CA-C 108.837 -0.801 . . . . 0.0 108.837 178.759 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 99' ' ' MET . . . . . . . . . . . . . 9.7 mtm -137.0 160.44 38.91 Favored 'General case' 0 N--CA 1.447 -0.594 0 N-CA-C 107.601 -1.259 . . . . 0.0 107.601 -179.721 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 2.6 mm? -69.77 103.63 2.22 Favored 'General case' 0 C--N 1.317 -0.814 0 CA-C-O 122.318 1.056 . . . . 0.0 111.046 175.307 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 101' ' ' PHE . . . . . . . . . . . . . 2.8 m-85 -94.2 171.63 8.71 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 113.151 -1.841 . . . . 0.0 112.612 -172.914 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 2.6 m -124.87 135.71 53.14 Favored 'General case' 0 C--N 1.313 -0.985 0 CA-C-N 114.439 -1.255 . . . . 0.0 109.382 -178.241 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -103.54 159.47 15.57 Favored 'General case' 0 C--N 1.32 -0.692 0 N-CA-C 109.316 -0.624 . . . . 0.0 109.316 -177.929 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 104' ' ' MET . . . . . . . . . . . . . 71.2 mtm -66.39 -12.49 57.22 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.057 -0.519 . . . . 0.0 111.798 -174.446 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 4.5 p-10 -93.59 3.96 54.7 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 120.848 0.356 . . . . 0.0 110.853 177.568 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 92.32 -10.83 73.51 Favored Glycine 0 N--CA 1.444 -0.788 0 C-N-CA 120.672 -0.775 . . . . 0.0 113.69 178.939 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 34.9 t -78.01 140.32 39.17 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-O 121.52 0.676 . . . . 0.0 111.072 -179.471 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 23.0 tt0 -94.74 98.78 11.01 Favored 'General case' 0 C--N 1.314 -0.97 0 CA-C-N 115.253 -0.885 . . . . 0.0 110.249 178.389 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 109' ' ' MET . . . . . . . . . . . . . 1.6 mtm -100.81 145.1 29.78 Favored Pre-proline 0 C--N 1.326 -0.421 0 CA-C-N 115.203 -0.908 . . . . 0.0 110.609 176.897 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 23.9 Cg_endo -66.61 116.35 4.04 Favored 'Trans proline' 0 N--CA 1.455 -0.741 0 C-N-CA 121.336 1.357 . . . . 0.0 110.631 173.227 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . -111.26 132.49 10.94 Favored Glycine 0 CA--C 1.502 -0.739 0 CA-C-N 115.518 -0.765 . . . . 0.0 112.223 -177.147 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 112' ' ' VAL . . . . . 0.513 ' HA ' ' HA ' ' A' ' 98' ' ' ILE . 3.0 p -94.62 133.22 36.29 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.739 0 N-CA-C 108.774 -0.825 . . . . 0.0 108.774 174.207 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 113' ' ' ILE . . . . . 0.425 HD12 ' CB ' ' A' ' 93' ' ' PRO . 20.3 mt -86.24 109.85 19.25 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.14 0 N-CA-C 108.201 -1.037 . . . . 0.0 108.201 -178.433 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 114' ' ' ARG . . . . . 0.486 ' O ' HG23 ' A' ' 95' ' ' ILE . 11.9 tpp180 -64.97 -46.75 80.19 Favored 'General case' 0 C--N 1.314 -0.957 0 CA-C-N 115.198 -0.91 . . . . 0.0 111.078 -174.395 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 115' ' ' GLU . . . . . 0.412 ' O ' ' HB ' ' A' ' 122' ' ' THR . 4.8 tt0 -159.7 160.05 33.66 Favored 'General case' 0 C--N 1.32 -0.71 0 C-N-CA 120.822 -0.351 . . . . 0.0 110.225 -176.324 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 116' ' ' ILE . . . . . 0.493 HG12 HG12 ' A' ' 95' ' ' ILE . 38.2 mm -114.61 121.78 67.39 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.436 0 CA-C-O 120.954 0.407 . . . . 0.0 110.36 177.99 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 117' ' ' ASN . . . . . . . . . . . . . 30.1 m-80 -112.64 154.1 26.59 Favored 'General case' 0 C--N 1.316 -0.87 0 N-CA-C 109.285 -0.635 . . . . 0.0 109.285 174.668 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . -75.94 -13.92 82.68 Favored Glycine 0 N--CA 1.449 -0.476 0 C-N-CA 120.74 -0.743 . . . . 0.0 113.021 -173.781 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 119' ' ' ASP . . . . . 0.521 ' HA ' ' HD3' ' A' ' 84' ' ' ARG . 30.2 t70 -112.82 -18.4 12.29 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-O 120.943 0.402 . . . . 0.0 111.594 -179.606 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 4.8 t -152.22 158.02 42.27 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 116.494 -0.321 . . . . 0.0 110.797 -172.997 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 121' ' ' ILE . . . . . 0.477 ' O ' ' HA ' ' A' ' 81' ' ' TYR . 47.7 mm -106.45 128.42 61.02 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.423 0 CA-C-O 121.218 0.533 . . . . 0.0 111.095 178.024 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 122' ' ' THR . . . . . 0.531 HG22 ' CE2' ' A' ' 81' ' ' TYR . 8.5 m -91.76 108.53 19.98 Favored 'General case' 0 C--N 1.321 -0.639 0 CA-C-O 122.19 0.995 . . . . 0.0 112.115 -178.429 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 123' ' ' VAL . . . . . 0.626 ' O ' HG23 ' A' ' 79' ' ' ILE . 15.5 t -99.63 157.79 3.81 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.555 0 CA-C-N 113.522 -1.672 . . . . 0.0 110.935 -177.755 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 124' ' ' ASP . . . . . 0.541 ' OD1' ' HB2' ' A' ' 126' ' ' ASN . 12.2 t0 -155.16 96.67 1.85 Allowed 'General case' 0 CA--C 1.537 0.474 0 N-CA-C 108.402 -0.962 . . . . 0.0 108.402 -176.025 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 125' ' ' PHE . . . . . 0.51 ' HB2' ' CD2' ' A' ' 78' ' ' LEU . 76.6 m-85 -90.31 23.62 2.86 Favored 'General case' 0 N--CA 1.47 0.541 0 O-C-N 120.618 -1.301 . . . . 0.0 111.478 -177.492 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 126' ' ' ASN . . . . . 0.541 ' HB2' ' OD1' ' A' ' 124' ' ' ASP . 27.1 m-80 . . . . . 0 C--N 1.328 -0.345 0 CA-C-O 122.096 0.951 . . . . 0.0 113.446 -174.817 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 133' ' ' THR . . . . . . . . . . . . . 1.5 m . . . . . 0 N--CA 1.444 -0.769 0 N-CA-C 109.808 -0.441 . . . . 0.0 109.808 . . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 134' ' ' VAL . . . . . . . . . . . . . 4.0 m -99.02 123.16 51.49 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.724 0 CA-C-O 121.447 0.641 . . . . 0.0 111.106 -175.126 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 135' ' ' HIS . . . . . 0.632 ' CE1' ' HB3' ' A' ' 18' ' ' LYS . 18.1 p80 -103.27 137.51 41.3 Favored 'General case' 0 C--N 1.318 -0.804 0 CA-C-N 115.112 -0.949 . . . . 0.0 110.189 174.152 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 136' ' ' PHE . . . . . 0.516 ' HE1' ' CE2' ' A' ' 63' ' ' PHE . 0.1 OUTLIER -134.48 138.33 44.63 Favored 'General case' 0 N--CA 1.442 -0.846 0 CA-C-O 121.55 0.69 . . . . 0.0 110.534 -175.153 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 137' ' ' ASP . . . . . 0.517 ' O ' ' HA ' ' A' ' 15' ' ' PHE . 37.6 t70 -98.93 108.07 20.66 Favored 'General case' 0 C--N 1.312 -1.062 0 CA-C-N 114.539 -1.21 . . . . 0.0 108.344 175.212 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 138' ' ' ILE . . . . . 0.493 HG22 HG22 ' A' ' 13' ' ' VAL . 62.5 mt -120.67 120.66 63.19 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.565 0 CA-C-O 121.396 0.617 . . . . 0.0 111.037 -167.851 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 30.2 mt-10 -110.8 111.32 22.4 Favored 'General case' 0 C--N 1.321 -0.671 0 CA-C-N 115.818 -0.628 . . . . 0.0 110.67 -178.703 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 140' ' ' VAL . . . . . 0.442 ' CG1' ' HA ' ' A' ' 57' ' ' VAL . 45.2 t -65.95 111.6 1.65 Allowed 'Isoleucine or valine' 0 C--O 1.234 0.266 0 CA-C-N 116.548 -0.296 . . . . 0.0 110.456 178.227 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 141' ' ' LEU . . . . . 0.475 HD12 ' CD2' ' A' ' 14' ' ' HIS . 48.0 mt -98.42 -49.74 4.56 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-O 120.746 0.307 . . . . 0.0 110.29 -179.943 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 142' ' ' GLU . . . . . . . . . . . . . 67.7 mm-40 -141.26 163.85 31.83 Favored 'General case' 0 CA--C 1.514 -0.413 0 CA-C-N 115.979 -0.555 . . . . 0.0 111.115 177.127 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 143' ' ' ILE . . . . . 0.41 ' CD1' HG23 ' A' ' 57' ' ' VAL . 94.4 mt -130.0 110.63 19.8 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.652 0 CA-C-N 115.168 -0.924 . . . . 0.0 110.381 176.605 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 144' ' ' ASP . . . . . . . . . . . . . 20.1 t70 -78.98 124.49 84.76 Favored Pre-proline 0 C--N 1.322 -0.617 0 CA-C-N 115.53 -0.759 . . . . 0.0 109.49 177.53 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 145' ' ' PRO . . . . . . . . . . . . . 41.3 Cg_endo . . . . . 0 C--O 1.234 0.32 0 C-N-CA 122.585 2.19 . . . . 0.0 112.29 -175.532 . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 2' ' ' SER . . . . . 0.428 ' CB ' ' HA ' ' A' ' 145' ' ' PRO . 14.6 t . . . . . 0 N--CA 1.452 -0.325 0 N-CA-C 109.84 -0.43 . . . . 0.0 109.84 . . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 3' ' ' GLU . . . . . 0.455 ' O ' ' HG3' ' A' ' 56' ' ' LYS . 32.3 mt-10 -74.5 -30.21 61.72 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 115.844 -0.616 . . . . 0.0 109.682 179.276 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 40.0 t -116.88 151.23 37.03 Favored 'General case' 0 C--N 1.318 -0.771 0 CA-C-N 114.904 -1.043 . . . . 0.0 109.389 -178.532 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 98.0 t -72.96 125.3 31.57 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.403 0 CA-C-O 121.036 0.446 . . . . 0.0 110.267 177.08 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 6' ' ' GLN . . . . . 0.63 ' HG2' ' OG ' ' A' ' 9' ' ' SER . 5.2 pt20 -119.34 166.94 12.39 Favored 'General case' 0 C--N 1.319 -0.718 0 CA-C-N 115.609 -0.723 . . . . 0.0 109.141 -179.557 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 7' ' ' SER . . . . . 0.455 ' O ' ' HB2' ' A' ' 8' ' ' ASN . 10.0 p -63.23 133.75 54.78 Favored 'General case' 0 C--N 1.316 -0.882 0 N-CA-C 109.857 -0.423 . . . . 0.0 109.857 177.832 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 8' ' ' ASN . . . . . 0.493 ' OD1' ' HA3' ' A' ' 40' ' ' GLY . 34.4 m-80 72.7 35.07 1.11 Allowed 'General case' 0 N--CA 1.471 0.596 0 O-C-N 123.755 0.659 . . . . 0.0 112.327 -176.78 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 9' ' ' SER . . . . . 0.63 ' OG ' ' HG2' ' A' ' 6' ' ' GLN . 49.6 m -92.82 167.03 12.13 Favored 'General case' 0 C--N 1.332 -0.152 0 CA-C-O 121.151 0.501 . . . . 0.0 110.785 173.006 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 10' ' ' ALA . . . . . 0.426 ' HB1' ' HB3' ' A' ' 144' ' ' ASP . . . -115.54 118.14 32.31 Favored 'General case' 0 C--N 1.319 -0.759 0 N-CA-C 108.558 -0.905 . . . . 0.0 108.558 170.808 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 4.3 m -127.5 142.75 42.75 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.729 0 C-N-CA 120.165 -0.614 . . . . 0.0 110.909 -174.05 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 12' ' ' LEU . . . . . 0.468 ' HB2' ' HB2' ' A' ' 142' ' ' GLU . 83.8 mt -93.96 133.4 37.44 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-N 115.818 -0.628 . . . . 0.0 109.346 176.566 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 17.2 m -131.68 167.11 27.07 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.941 0 CA-C-O 121.519 0.676 . . . . 0.0 112.262 -174.867 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 14' ' ' HIS . . . . . 0.545 ' CD2' HD13 ' A' ' 141' ' ' LEU . 0.3 OUTLIER -134.21 115.67 14.44 Favored 'General case' 0 C--N 1.322 -0.59 0 N-CA-C 106.433 -1.692 . . . . 0.0 106.433 166.159 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 45.4 p90 -145.8 156.14 43.38 Favored 'General case' 0 C--N 1.319 -0.726 0 C-N-CA 120.841 -0.344 . . . . 0.0 110.629 -171.084 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 60.1 m -121.63 131.47 54.13 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-O 120.884 0.373 . . . . 0.0 110.664 174.478 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 17' ' ' LEU . . . . . 0.448 ' CD2' ' HB3' ' A' ' 136' ' ' PHE . 6.3 mt -98.26 121.8 40.64 Favored 'General case' 0 C--N 1.328 -0.363 0 N-CA-C 112.662 0.616 . . . . 0.0 112.662 178.331 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 9.5 mptt -127.67 142.84 51.23 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-N 114.973 -1.012 . . . . 0.0 110.197 -179.236 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 19' ' ' LEU . . . . . 0.422 HD12 HG21 ' A' ' 134' ' ' VAL . 3.2 mm? -89.66 169.05 11.64 Favored 'General case' 0 C--N 1.325 -0.477 0 N-CA-C 109.487 -0.561 . . . . 0.0 109.487 175.918 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 1.8 p30 -67.27 -23.65 65.7 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 121.41 0.624 . . . . 0.0 109.965 177.163 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 36.3 m-20 -74.03 -0.49 16.55 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 115.139 -0.937 . . . . 0.0 111.447 175.826 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 73.8 15.47 79.51 Favored Glycine 0 N--CA 1.449 -0.442 0 C-N-CA 121.007 -0.616 . . . . 0.0 111.922 -179.124 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 27.0 m -88.34 151.79 22.37 Favored 'General case' 0 C--N 1.32 -0.68 0 N-CA-C 109.525 -0.546 . . . . 0.0 109.525 176.132 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 38.3 m -95.25 128.77 42.35 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-O 120.874 0.368 . . . . 0.0 110.969 178.167 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -91.8 -49.04 6.47 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.001 -0.545 . . . . 0.0 110.011 176.143 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 26' ' ' GLU . . . . . 0.433 ' O ' ' HB2' ' A' ' 17' ' ' LEU . 11.8 tp10 -160.9 120.29 2.63 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 115.88 -0.6 . . . . 0.0 109.872 178.352 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 46.8 m -105.31 99.08 8.7 Favored 'General case' 0 C--N 1.318 -0.777 0 C-N-CA 120.233 -0.587 . . . . 0.0 110.3 177.276 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 32.8 m -91.69 57.14 3.16 Favored 'General case' 0 C--N 1.318 -0.789 0 CA-C-O 122.171 0.986 . . . . 0.0 110.068 -178.756 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 21.2 ttt180 -146.44 -55.73 0.27 Allowed 'General case' 0 C--N 1.312 -1.043 0 CA-C-N 115.065 -0.971 . . . . 0.0 109.866 176.959 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 10.7 p30 -77.86 -1.58 32.38 Favored 'General case' 0 N--CA 1.465 0.279 0 C-N-CA 120.928 -0.309 . . . . 0.0 111.069 179.36 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 94.9 m-20 -74.35 -13.42 60.74 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-O 120.861 0.363 . . . . 0.0 110.239 175.338 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 77.81 2.38 81.31 Favored Glycine 0 N--CA 1.446 -0.648 0 N-CA-C 111.23 -0.748 . . . . 0.0 111.23 -178.114 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 35.4 mtmm -131.23 115.28 16.27 Favored Pre-proline 0 N--CA 1.449 -0.477 0 CA-C-N 115.631 -0.285 . . . . 0.0 110.497 -174.575 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 19.6 Cg_exo -69.13 166.88 25.28 Favored 'Trans proline' 0 C--O 1.233 0.265 0 C-N-CA 122.792 2.328 . . . . 0.0 112.002 173.482 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -130.85 155.52 46.57 Favored 'General case' 0 C--N 1.316 -0.891 0 CA-C-N 115.462 -0.79 . . . . 0.0 110.453 -177.767 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 3.1 tp -101.14 142.4 32.63 Favored 'General case' 0 C--N 1.316 -0.867 0 CA-C-N 115.849 -0.614 . . . . 0.0 110.348 177.825 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 37' ' ' PHE . . . . . . . . . . . . . 5.8 m-30 -109.46 108.09 18.46 Favored 'General case' 0 C--N 1.312 -1.046 0 N-CA-C 108.364 -0.976 . . . . 0.0 108.364 177.787 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -86.46 107.62 18.15 Favored 'General case' 0 C--N 1.321 -0.658 0 CA-C-O 121.129 0.49 . . . . 0.0 109.826 -179.595 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 39' ' ' LEU . . . . . 0.422 ' HG ' ' CB ' ' A' ' 49' ' ' GLU . 9.5 mp -81.77 153.02 26.71 Favored 'General case' 0 C--N 1.317 -0.837 0 CA-C-N 115.208 -0.906 . . . . 0.0 109.935 -179.928 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 40' ' ' GLY . . . . . 0.493 ' HA3' ' OD1' ' A' ' 8' ' ' ASN . . . 96.67 29.11 8.4 Favored Glycine 0 N--CA 1.447 -0.585 0 C-N-CA 120.537 -0.84 . . . . 0.0 112.171 -178.262 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 17.9 t70 60.32 15.77 5.67 Favored 'General case' 0 N--CA 1.469 0.496 0 CA-C-O 121.425 0.631 . . . . 0.0 111.122 178.341 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -79.85 -13.52 59.34 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 121.11 0.481 . . . . 0.0 110.746 -176.336 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 35.7 t -161.18 -54.36 0.05 OUTLIER 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 115.522 -0.763 . . . . 0.0 109.024 174.998 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 4.0 mm? -91.3 149.71 21.63 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 115.829 -0.623 . . . . 0.0 109.674 176.483 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 47.5 t -70.93 155.52 40.72 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-N 115.782 -0.645 . . . . 0.0 111.119 -177.292 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 46' ' ' GLU . . . . . 0.459 ' O ' ' HG2' ' A' ' 49' ' ' GLU . 28.5 tt0 -49.94 -40.27 43.02 Favored 'General case' 0 N--CA 1.45 -0.46 0 C-N-CA 122.981 0.513 . . . . 0.0 111.854 -179.856 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -56.69 -36.34 71.33 Favored Glycine 0 N--CA 1.448 -0.541 0 C-N-CA 120.567 -0.825 . . . . 0.0 112.447 -176.445 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 1.7 tt -64.26 -52.88 56.49 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 116.953 0.377 . . . . 0.0 111.745 176.57 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 49' ' ' GLU . . . . . 0.459 ' HG2' ' O ' ' A' ' 46' ' ' GLU . 13.8 pt-20 -63.91 -29.95 71.08 Favored 'General case' 0 N--CA 1.453 -0.299 0 CA-C-O 120.508 0.194 . . . . 0.0 111.02 -173.322 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 50' ' ' GLN . . . . . 0.485 ' HA ' HD23 ' A' ' 53' ' ' LEU . 16.9 mm-40 -65.67 -17.11 64.36 Favored 'General case' 0 N--CA 1.452 -0.347 0 CA-C-N 116.372 -0.376 . . . . 0.0 110.605 -173.936 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 51' ' ' HIS . . . . . . . . . . . . . 14.7 m-70 -107.27 -3.68 19.49 Favored 'General case' 0 N--CA 1.45 -0.449 0 CA-C-O 121.053 0.454 . . . . 0.0 110.022 -176.934 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 49.4 mt -103.04 -20.55 14.15 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 115.657 -0.702 . . . . 0.0 111.282 -178.865 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 53' ' ' LEU . . . . . 0.485 HD23 ' HA ' ' A' ' 50' ' ' GLN . 0.0 OUTLIER -60.59 135.91 57.9 Favored 'General case' 0 C--O 1.234 0.257 0 CA-C-O 120.875 0.369 . . . . 0.0 111.273 177.874 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 93.03 -5.96 76.01 Favored Glycine 0 N--CA 1.45 -0.399 0 CA-C-N 115.947 -0.57 . . . . 0.0 112.667 178.884 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 64.0 mt -84.47 163.54 19.37 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-O 121.208 0.528 . . . . 0.0 111.275 179.369 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 56' ' ' LYS . . . . . 0.455 ' HG3' ' O ' ' A' ' 3' ' ' GLU . 0.0 OUTLIER -127.39 169.52 13.52 Favored 'General case' 0 C--N 1.32 -0.695 0 CA-C-N 115.322 -0.854 . . . . 0.0 109.457 176.018 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 39.6 t -60.68 142.76 15.39 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.833 0 CA-C-O 121.068 0.461 . . . . 0.0 110.547 176.026 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 80.88 10.03 85.57 Favored Glycine 0 N--CA 1.448 -0.516 0 CA-C-N 115.673 -0.694 . . . . 0.0 112.659 -177.945 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 4.0 m-20 -98.92 150.52 21.84 Favored 'General case' 0 CA--C 1.511 -0.553 0 CA-C-O 121.073 0.463 . . . . 0.0 111.183 176.164 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 60' ' ' LYS . . . . . 0.45 ' H ' ' HG2' ' A' ' 60' ' ' LYS . 0.0 OUTLIER -120.88 129.55 53.55 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-N 115.189 -0.914 . . . . 0.0 109.382 -178.998 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 6.1 m -142.32 121.39 12.91 Favored 'General case' 0 N--CA 1.433 -1.298 0 CA-C-O 121.155 0.503 . . . . 0.0 110.502 -179.003 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 14.3 m -111.0 132.82 53.89 Favored 'General case' 0 C--N 1.316 -0.88 0 CA-C-N 115.754 -0.657 . . . . 0.0 109.872 177.277 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 32.0 p90 -146.7 172.79 13.07 Favored 'General case' 0 C--N 1.314 -0.972 0 CA-C-N 116.044 -0.525 . . . . 0.0 110.239 179.032 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 50.9 m -130.83 135.91 48.17 Favored 'General case' 0 C--N 1.32 -0.681 0 N-CA-C 108.783 -0.821 . . . . 0.0 108.783 -172.44 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 65' ' ' LEU . . . . . 0.421 ' HB2' ' HB1' ' A' ' 70' ' ' ALA . 61.1 mt -139.48 140.62 37.3 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-O 121.164 0.507 . . . . 0.0 111.406 -172.052 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 66' ' ' GLU . . . . . 0.418 ' HB3' ' HD2' ' A' ' 67' ' ' PRO . 44.1 mt-10 -75.54 162.12 73.74 Favored Pre-proline 0 C--N 1.326 -0.455 0 CA-C-N 115.037 -0.983 . . . . 0.0 109.842 174.597 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 67' ' ' PRO . . . . . 0.418 ' HD2' ' HB3' ' A' ' 66' ' ' GLU . 76.0 Cg_exo -42.04 -43.3 7.22 Favored 'Trans proline' 0 C--N 1.346 0.397 0 C-N-CA 123.513 2.809 . . . . 0.0 114.558 -177.837 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 6.6 p-10 -63.74 -18.77 64.39 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-O 120.782 0.325 . . . . 0.0 111.44 -177.505 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -114.35 -7.38 12.91 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 116.326 -0.397 . . . . 0.0 111.368 179.223 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 70' ' ' ALA . . . . . 0.421 ' HB1' ' HB2' ' A' ' 65' ' ' LEU . . . . . . . . 0 C--N 1.33 -0.253 0 CA-C-O 120.542 0.211 . . . . 0.0 111.431 -176.954 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 75' ' ' SER . . . . . 0.768 ' O ' ' HG ' ' A' ' 78' ' ' LEU . 46.1 m . . . . . 0 N--CA 1.445 -0.683 0 CA-C-O 120.758 0.313 . . . . 0.0 111.241 . . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 47.6 Cg_endo -69.73 -18.3 37.21 Favored 'Trans proline' 0 N--CA 1.463 -0.284 0 C-N-CA 122.18 1.92 . . . . 0.0 111.724 176.657 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 77' ' ' ASP . . . . . 0.618 ' OD1' ' HB3' ' A' ' 75' ' ' SER . 6.4 p-10 -76.83 -13.0 60.05 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.623 -0.717 . . . . 0.0 111.352 -179.644 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 78' ' ' LEU . . . . . 0.768 ' HG ' ' O ' ' A' ' 75' ' ' SER . 4.1 pp -91.62 -4.89 54.75 Favored 'General case' 0 CA--C 1.515 -0.396 0 C-N-CA 119.652 -0.819 . . . . 0.0 110.392 177.739 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 43.7 mt -80.31 138.51 19.67 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.611 0 N-CA-C 109.886 -0.413 . . . . 0.0 109.886 169.074 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 3.7 mp0 -142.2 142.64 32.68 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-N 116.122 -0.49 . . . . 0.0 109.84 -177.847 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 81' ' ' TYR . . . . . . . . . . . . . 43.0 m-85 -113.76 111.71 22.23 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-O 121.182 0.515 . . . . 0.0 109.983 -177.593 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 56.1 m-85 -109.73 171.17 7.6 Favored 'General case' 0 C--N 1.317 -0.814 0 CA-C-N 115.365 -0.834 . . . . 0.0 109.961 177.388 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 25.8 t -81.56 154.27 26.31 Favored 'General case' 0 C--N 1.321 -0.655 0 CA-C-O 121.368 0.604 . . . . 0.0 110.15 178.749 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 84' ' ' ARG . . . . . 0.496 ' HG3' ' HD2' ' A' ' 85' ' ' ARG . 13.0 ptm180 -68.89 -29.47 67.76 Favored 'General case' 0 C--N 1.32 -0.687 0 CA-C-N 115.383 -0.826 . . . . 0.0 109.649 178.108 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 85' ' ' ARG . . . . . 0.496 ' HD2' ' HG3' ' A' ' 84' ' ' ARG . 5.2 mpt_? -64.05 -34.06 77.16 Favored 'General case' 0 C--N 1.321 -0.667 0 CA-C-N 114.201 -1.363 . . . . 0.0 109.981 177.448 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 46.4 mt-10 -75.67 -10.8 59.75 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 115.757 -0.656 . . . . 0.0 110.565 178.119 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 87' ' ' PHE . . . . . 0.484 ' CE2' HG21 ' A' ' 121' ' ' ILE . 3.8 m-85 -103.3 -22.79 13.65 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 115.596 -0.729 . . . . 0.0 110.41 -179.748 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 88' ' ' MET . . . . . . . . . . . . . 46.4 ttm -60.14 -13.19 10.84 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 121.928 0.871 . . . . 0.0 109.679 172.375 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 25.0 t70 -61.09 -31.95 71.63 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-N 114.12 -1.4 . . . . 0.0 109.689 175.153 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -122.61 15.88 10.31 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 115.557 -0.747 . . . . 0.0 110.708 178.162 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 96.97 139.99 11.01 Favored Glycine 0 N--CA 1.45 -0.397 0 C-N-CA 120.6 -0.81 . . . . 0.0 111.925 -176.379 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 47.1 mt-10 -68.32 124.38 89.68 Favored Pre-proline 0 C--N 1.325 -0.494 0 CA-C-O 121.446 0.641 . . . . 0.0 111.48 -174.834 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 93' ' ' PRO . . . . . 0.511 ' HB2' ' CD1' ' A' ' 113' ' ' ILE . 83.8 Cg_endo -78.35 169.08 20.63 Favored 'Trans proline' 0 C--O 1.235 0.36 0 C-N-CA 124.669 3.579 . . . . 0.0 114.933 -169.373 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 94' ' ' GLU . . . . . 0.602 ' O ' HD13 ' A' ' 113' ' ' ILE . 1.4 mp0 -116.7 164.31 14.83 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 114.214 -1.357 . . . . 0.0 110.74 -174.616 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 95' ' ' ILE . . . . . 0.513 HG12 HG12 ' A' ' 116' ' ' ILE . 17.5 mt -82.78 133.96 27.97 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.377 0 CA-C-O 120.919 0.39 . . . . 0.0 110.909 179.35 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 70.69 29.89 69.07 Favored Glycine 0 N--CA 1.449 -0.447 0 CA-C-N 115.83 -0.623 . . . . 0.0 111.973 -179.194 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 97' ' ' ALA . . . . . 0.666 ' O ' HG13 ' A' ' 113' ' ' ILE . . . -106.42 140.0 40.02 Favored 'General case' 0 C--N 1.324 -0.52 0 N-CA-C 109.865 -0.42 . . . . 0.0 109.865 -179.777 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 98' ' ' ILE . . . . . 0.486 ' HA ' ' O ' ' A' ' 111' ' ' GLY . 72.5 mt -88.06 108.26 18.37 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.812 0 N-CA-C 109.972 -0.381 . . . . 0.0 109.972 -179.98 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 99' ' ' MET . . . . . 0.548 ' HB2' ' CE2' ' A' ' 101' ' ' PHE . 89.9 mtp -99.08 126.15 44.75 Favored 'General case' 0 N--CA 1.442 -0.835 0 CA-C-N 116.301 -0.409 . . . . 0.0 111.069 179.444 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 4.3 mm? -67.42 147.35 52.99 Favored 'General case' 0 C--N 1.307 -1.241 0 N-CA-C 108.327 -0.99 . . . . 0.0 108.327 163.2 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 101' ' ' PHE . . . . . 0.612 ' HB2' ' O ' ' A' ' 109' ' ' MET . 2.5 m-85 -149.49 169.78 20.12 Favored 'General case' 0 CA--C 1.51 -0.594 0 CA-C-N 116.001 -0.545 . . . . 0.0 109.925 -155.101 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 3.9 m -126.64 129.26 48.15 Favored 'General case' 0 C--N 1.31 -1.128 0 N-CA-C 108.913 -0.773 . . . . 0.0 108.913 170.663 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -97.4 154.89 17.17 Favored 'General case' 0 C--N 1.316 -0.853 0 N-CA-C 109.05 -0.722 . . . . 0.0 109.05 -175.878 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 104' ' ' MET . . . . . . . . . . . . . 4.7 mpp? -65.24 -12.77 54.95 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.945 -174.219 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 9.8 p-10 -95.21 6.86 47.88 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-O 120.728 0.299 . . . . 0.0 110.928 177.219 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 89.55 -10.95 71.62 Favored Glycine 0 N--CA 1.452 -0.272 0 C-N-CA 121.213 -0.518 . . . . 0.0 113.217 174.67 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 43.1 t -79.94 143.15 34.44 Favored 'General case' 0 C--N 1.32 -0.677 0 CA-C-O 121.37 0.605 . . . . 0.0 109.748 178.721 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 23.3 tt0 -92.18 99.03 11.9 Favored 'General case' 0 C--N 1.309 -1.175 0 CA-C-O 121.956 0.884 . . . . 0.0 109.443 179.28 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 109' ' ' MET . . . . . 0.612 ' O ' ' HB2' ' A' ' 101' ' ' PHE . 71.3 mtp -96.13 135.54 22.62 Favored Pre-proline 0 C--N 1.319 -0.73 0 CA-C-N 113.965 -1.471 . . . . 0.0 111.689 -178.964 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 30.3 Cg_endo -68.9 159.4 54.01 Favored 'Trans proline' 0 N--CA 1.456 -0.709 0 C-N-CA 121.92 1.746 . . . . 0.0 110.011 168.198 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 111' ' ' GLY . . . . . 0.486 ' O ' ' HA ' ' A' ' 98' ' ' ILE . . . -147.15 149.04 21.12 Favored Glycine 0 C--N 1.314 -0.639 0 C-N-CA 119.945 -1.121 . . . . 0.0 110.993 -172.849 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 2.7 p -118.9 111.26 32.82 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.618 0 CA-C-N 118.311 1.056 . . . . 0.0 110.305 170.917 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 113' ' ' ILE . . . . . 0.666 HG13 ' O ' ' A' ' 97' ' ' ALA . 0.5 OUTLIER -62.88 112.03 0.99 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.469 0 CA-C-N 115.729 -0.669 . . . . 0.0 110.175 175.223 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 114' ' ' ARG . . . . . 0.54 ' HD2' ' HB2' ' A' ' 115' ' ' GLU . 5.6 tmm_? -71.22 -43.36 67.51 Favored 'General case' 0 C--N 1.316 -0.883 0 CA-C-N 115.874 -0.603 . . . . 0.0 110.679 -176.983 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 115' ' ' GLU . . . . . 0.54 ' HB2' ' HD2' ' A' ' 114' ' ' ARG . 13.8 tt0 -159.42 154.76 25.46 Favored 'General case' 0 C--N 1.329 -0.313 0 N-CA-C 110.317 -0.253 . . . . 0.0 110.317 -179.871 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 116' ' ' ILE . . . . . 0.513 HG12 HG12 ' A' ' 95' ' ' ILE . 38.0 mm -98.55 112.42 30.62 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.501 0 N-CA-C 109.04 -0.726 . . . . 0.0 109.04 174.23 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 117' ' ' ASN . . . . . 0.492 HD21 ' N ' ' A' ' 117' ' ' ASN . 0.9 OUTLIER -88.18 159.68 18.07 Favored 'General case' 0 C--N 1.311 -1.094 0 N-CA-C 108.724 -0.843 . . . . 0.0 108.724 177.289 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . -55.26 -47.16 76.44 Favored Glycine 0 N--CA 1.45 -0.372 0 C-N-CA 120.518 -0.848 . . . . 0.0 113.129 -169.438 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 119' ' ' ASP . . . . . 0.442 ' O ' ' HG2' ' A' ' 84' ' ' ARG . 4.4 p-10 -114.78 -11.1 12.32 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 117.125 0.463 . . . . 0.0 111.343 175.171 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 120' ' ' SER . . . . . 0.426 ' O ' ' HB2' ' A' ' 117' ' ' ASN . 9.0 t -115.97 158.26 23.34 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-O 121.222 0.534 . . . . 0.0 111.656 -171.812 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 121' ' ' ILE . . . . . 0.484 HG21 ' CE2' ' A' ' 87' ' ' PHE . 46.7 mm -117.21 128.69 74.5 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.52 0 CA-C-N 116.112 -0.495 . . . . 0.0 110.436 177.263 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 18.7 m -93.47 102.55 14.77 Favored 'General case' 0 C--N 1.32 -0.686 0 CA-C-O 121.594 0.711 . . . . 0.0 110.907 177.97 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 42.9 t -104.4 108.16 24.1 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.385 0 CA-C-N 114.66 -1.155 . . . . 0.0 112.92 -179.983 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 124' ' ' ASP . . . . . 0.467 ' C ' ' H ' ' A' ' 126' ' ' ASN . 1.3 m-20 -98.04 106.57 18.88 Favored 'General case' 0 C--N 1.318 -0.762 0 CA-C-N 114.689 -1.141 . . . . 0.0 110.386 170.121 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 125' ' ' PHE . . . . . 0.518 ' CD2' ' HE3' ' A' ' 109' ' ' MET . 81.5 m-85 -75.07 18.9 0.16 Allowed 'General case' 0 N--CA 1.465 0.29 0 O-C-N 121.898 -0.501 . . . . 0.0 111.284 171.242 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 126' ' ' ASN . . . . . 0.467 ' H ' ' C ' ' A' ' 124' ' ' ASP . 11.4 m-80 . . . . . 0 C--N 1.328 -0.368 0 CA-C-N 115.818 -0.628 . . . . 0.0 110.622 176.285 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 133' ' ' THR . . . . . . . . . . . . . 21.9 m . . . . . 0 C--O 1.232 0.154 0 N-CA-C 110.507 -0.182 . . . . 0.0 110.507 . . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 134' ' ' VAL . . . . . 0.474 HG12 ' CE1' ' A' ' 136' ' ' PHE . 14.5 p -128.92 163.6 33.45 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.594 0 CA-C-O 121.093 0.473 . . . . 0.0 111.366 -174.709 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 135' ' ' HIS . . . . . . . . . . . . . 72.2 m-70 -123.19 115.82 22.39 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 115.803 -0.635 . . . . 0.0 109.633 -176.027 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 136' ' ' PHE . . . . . 0.482 ' CD1' ' N ' ' A' ' 136' ' ' PHE . 0.1 OUTLIER -125.42 138.26 54.01 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-O 121.112 0.482 . . . . 0.0 111.993 -176.463 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 137' ' ' ASP . . . . . . . . . . . . . 5.9 m-20 -103.73 107.11 17.83 Favored 'General case' 0 N--CA 1.468 0.436 0 CA-C-N 115.263 -0.88 . . . . 0.0 110.444 -178.846 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 138' ' ' ILE . . . . . . . . . . . . . 4.5 mp -96.95 138.89 20.74 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.492 0 CA-C-O 120.806 0.336 . . . . 0.0 111.77 -174.523 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 18.0 mt-10 -127.32 127.74 44.79 Favored 'General case' 0 CA--C 1.515 -0.379 0 N-CA-C 108.416 -0.957 . . . . 0.0 108.416 168.302 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 140' ' ' VAL . . . . . . . . . . . . . 91.3 t -78.95 111.25 15.58 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-O 120.925 0.393 . . . . 0.0 110.31 -178.078 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 141' ' ' LEU . . . . . 0.545 HD13 ' CD2' ' A' ' 14' ' ' HIS . 44.4 mt -85.38 -42.86 14.16 Favored 'General case' 0 C--N 1.316 -0.882 0 CA-C-O 121.371 0.605 . . . . 0.0 110.393 -179.855 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 142' ' ' GLU . . . . . 0.468 ' HB2' ' HB2' ' A' ' 12' ' ' LEU . 6.7 mm-40 -151.1 156.55 41.28 Favored 'General case' 0 C--N 1.321 -0.673 0 CA-C-N 115.135 -0.939 . . . . 0.0 111.271 -177.96 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 143' ' ' ILE . . . . . . . . . . . . . 78.7 mt -126.68 109.69 21.53 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.766 0 CA-C-N 115.619 -0.719 . . . . 0.0 109.876 178.773 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 144' ' ' ASP . . . . . 0.426 ' HB3' ' HB1' ' A' ' 10' ' ' ALA . 33.0 t70 -78.68 125.07 84.93 Favored Pre-proline 0 C--N 1.324 -0.512 0 N-CA-C 109.222 -0.659 . . . . 0.0 109.222 175.0 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 145' ' ' PRO . . . . . 0.428 ' HA ' ' CB ' ' A' ' 2' ' ' SER . 48.6 Cg_endo . . . . . 0 N--CA 1.461 -0.419 0 C-N-CA 122.537 2.158 . . . . 0.0 112.411 -175.688 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 14.3 p . . . . . 0 N--CA 1.467 0.394 0 CA-C-O 121.487 0.66 . . . . 0.0 112.396 . . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 3' ' ' GLU . . . . . 0.44 ' HG2' ' HD2' ' A' ' 56' ' ' LYS . 29.4 tt0 -99.05 -26.37 14.25 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 115.748 -0.66 . . . . 0.0 110.626 179.539 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 4' ' ' SER . . . . . 0.538 ' OG ' ' HE2' ' A' ' 56' ' ' LYS . 14.6 m -101.71 136.16 42.02 Favored 'General case' 0 C--N 1.318 -0.772 0 CA-C-N 115.543 -0.753 . . . . 0.0 111.034 -174.315 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 6.1 p -81.13 148.88 5.2 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.665 0 CA-C-O 121.453 0.644 . . . . 0.0 110.426 179.571 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 6' ' ' GLN . . . . . 0.671 ' HG2' ' OG ' ' A' ' 9' ' ' SER . 4.5 pt20 -140.53 166.16 25.48 Favored 'General case' 0 C--N 1.311 -1.067 0 CA-C-N 114.918 -1.037 . . . . 0.0 109.298 174.461 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 75.7 p -65.26 132.19 48.42 Favored 'General case' 0 N--CA 1.441 -0.916 0 N-CA-C 108.701 -0.851 . . . . 0.0 108.701 175.814 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 10.4 t30 75.08 38.06 0.45 Allowed 'General case' 0 CA--C 1.539 0.551 0 O-C-N 123.682 0.614 . . . . 0.0 110.95 -177.95 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 9' ' ' SER . . . . . 0.671 ' OG ' ' HG2' ' A' ' 6' ' ' GLN . 51.0 m -93.77 166.85 12.0 Favored 'General case' 0 CA--C 1.521 -0.167 0 CA-C-O 121.308 0.575 . . . . 0.0 110.821 172.462 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 10' ' ' ALA . . . . . 0.402 ' HB1' HD21 ' A' ' 36' ' ' LEU . . . -109.43 111.32 22.8 Favored 'General case' 0 N--CA 1.444 -0.769 0 N-CA-C 108.544 -0.91 . . . . 0.0 108.544 169.992 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 3.8 m -116.52 135.54 56.45 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.682 0 C-N-CA 119.767 -0.773 . . . . 0.0 111.351 -179.378 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 18.0 tp -86.36 128.43 34.93 Favored 'General case' 0 N--CA 1.447 -0.608 0 N-CA-C 108.914 -0.772 . . . . 0.0 108.914 177.837 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 13' ' ' VAL . . . . . 0.56 HG23 ' N ' ' A' ' 14' ' ' HIS . 3.8 p -131.92 158.67 43.33 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.987 0 CA-C-O 122.23 1.014 . . . . 0.0 112.618 -174.561 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 14' ' ' HIS . . . . . 0.566 ' ND1' ' HA ' ' A' ' 29' ' ' ARG . 0.2 OUTLIER -122.94 110.28 15.19 Favored 'General case' 0 C--N 1.313 -1.001 0 CA-C-N 113.443 -1.708 . . . . 0.0 106.996 167.919 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 15' ' ' PHE . . . . . 0.475 ' HA ' ' O ' ' A' ' 137' ' ' ASP . 12.8 p90 -133.64 166.02 23.56 Favored 'General case' 0 C--N 1.324 -0.532 0 C-N-CA 119.223 -0.991 . . . . 0.0 113.673 -174.621 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 22.3 m -140.98 142.09 34.33 Favored 'General case' 0 N--CA 1.444 -0.744 0 CA-C-N 113.952 -1.476 . . . . 0.0 107.914 174.913 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 17' ' ' LEU . . . . . 0.481 ' CD2' ' HB ' ' A' ' 134' ' ' VAL . 0.5 OUTLIER -126.86 112.62 15.54 Favored 'General case' 0 C--N 1.32 -0.716 0 N-CA-C 110.327 -0.249 . . . . 0.0 110.327 -173.624 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -118.85 152.53 36.09 Favored 'General case' 0 C--N 1.315 -0.913 0 CA-C-O 120.93 0.395 . . . . 0.0 111.392 -178.393 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 19' ' ' LEU . . . . . 0.442 HD23 ' HB1' ' A' ' 25' ' ' ALA . 3.4 mm? -103.82 170.47 7.91 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 115.844 -0.616 . . . . 0.0 109.627 174.372 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 2.2 m-20 -68.9 -18.92 64.19 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-O 120.952 0.406 . . . . 0.0 110.959 178.809 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 25.3 t70 -83.37 3.64 30.85 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 121.314 0.578 . . . . 0.0 110.279 175.32 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 74.26 9.88 81.3 Favored Glycine 0 N--CA 1.451 -0.305 0 CA-C-N 115.94 -0.573 . . . . 0.0 112.645 -175.958 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 23' ' ' THR . . . . . 0.436 ' HB ' HD21 ' A' ' 19' ' ' LEU . 12.1 m -72.55 141.07 48.46 Favored 'General case' 0 C--N 1.324 -0.53 0 N-CA-C 109.728 -0.471 . . . . 0.0 109.728 175.746 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 54.4 m -94.17 109.88 21.64 Favored 'General case' 0 C--N 1.319 -0.736 0 N-CA-C 109.854 -0.425 . . . . 0.0 109.854 174.658 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 25' ' ' ALA . . . . . 0.442 ' HB1' HD23 ' A' ' 19' ' ' LEU . . . -69.76 -40.41 76.14 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.975 -0.557 . . . . 0.0 110.027 179.692 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 10.2 tp10 -160.98 139.33 9.79 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 115.406 -0.815 . . . . 0.0 109.656 177.465 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 27' ' ' SER . . . . . 0.405 ' C ' ' HG1' ' A' ' 28' ' ' THR . 16.6 p -125.77 132.41 52.31 Favored 'General case' 0 C--N 1.317 -0.824 0 CA-C-O 120.838 0.352 . . . . 0.0 110.364 175.678 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 28' ' ' THR . . . . . 0.417 ' HB ' ' CE1' ' A' ' 15' ' ' PHE . 79.3 m -152.42 65.77 0.82 Allowed 'General case' 0 N--CA 1.441 -0.894 0 CA-C-O 122.116 0.96 . . . . 0.0 109.617 178.221 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 29' ' ' ARG . . . . . 0.566 ' HA ' ' ND1' ' A' ' 14' ' ' HIS . 26.9 ttt180 -154.11 -52.27 0.1 Allowed 'General case' 0 C--N 1.319 -0.733 0 N-CA-C 108.712 -0.847 . . . . 0.0 108.712 178.206 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 9.9 p30 -76.93 -4.24 42.9 Favored 'General case' 0 N--CA 1.464 0.228 0 CA-C-N 115.855 -0.611 . . . . 0.0 110.214 176.356 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 1.5 m-20 -69.46 -21.11 63.74 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 115.46 -0.791 . . . . 0.0 110.739 -178.958 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 85.3 4.1 86.51 Favored Glycine 0 N--CA 1.445 -0.711 0 C-N-CA 120.589 -0.815 . . . . 0.0 111.33 -173.723 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 56.5 mtpt -138.26 131.47 16.45 Favored Pre-proline 0 N--CA 1.452 -0.354 0 N-CA-C 109.995 -0.372 . . . . 0.0 109.995 179.14 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 91.8 Cg_endo -82.98 168.15 13.86 Favored 'Trans proline' 0 N--CA 1.453 -0.858 0 C-N-CA 122.393 2.062 . . . . 0.0 111.492 170.711 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -129.44 153.8 47.58 Favored 'General case' 0 C--N 1.319 -0.752 0 CA-C-N 116.256 -0.429 . . . . 0.0 109.942 -178.549 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 36' ' ' LEU . . . . . 0.402 HD21 ' HB1' ' A' ' 10' ' ' ALA . 4.6 tp -98.0 132.03 43.91 Favored 'General case' 0 C--N 1.315 -0.91 0 N-CA-C 109.967 -0.382 . . . . 0.0 109.967 176.87 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 37' ' ' PHE . . . . . 0.477 ' CD2' HD22 ' A' ' 44' ' ' LEU . 5.2 m-30 -95.79 107.33 19.55 Favored 'General case' 0 C--N 1.318 -0.802 0 N-CA-C 109.477 -0.564 . . . . 0.0 109.477 174.868 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 4.9 tpp180 -84.96 107.32 17.04 Favored 'General case' 0 N--CA 1.45 -0.468 0 CA-C-N 115.536 -0.756 . . . . 0.0 109.901 -178.269 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 63.4 mt -81.89 156.12 24.96 Favored 'General case' 0 C--N 1.32 -0.69 0 CA-C-N 115.807 -0.633 . . . . 0.0 111.156 -179.422 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 103.74 40.46 2.33 Favored Glycine 0 N--CA 1.446 -0.635 0 CA-C-N 115.724 -0.671 . . . . 0.0 111.592 -175.368 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 49.3 m-20 57.09 21.78 6.75 Favored 'General case' 0 N--CA 1.47 0.544 0 C-N-CA 123.16 0.584 . . . . 0.0 112.265 177.4 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -67.51 -40.24 85.15 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-O 121.03 0.443 . . . . 0.0 111.145 -178.852 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 41.8 m -154.17 -37.96 0.09 Allowed 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 116.034 -0.53 . . . . 0.0 110.832 -179.722 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 44' ' ' LEU . . . . . 0.477 HD22 ' CD2' ' A' ' 37' ' ' PHE . 6.7 mp -70.79 145.04 50.63 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 121.088 0.471 . . . . 0.0 110.969 -177.039 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 12.6 m -72.87 163.95 27.36 Favored 'General case' 0 C--N 1.322 -0.629 0 CA-C-N 115.373 -0.83 . . . . 0.0 110.228 175.628 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 41.7 mt-10 -51.59 -46.63 63.57 Favored 'General case' 0 C--N 1.329 -0.313 0 N-CA-C 112.72 0.637 . . . . 0.0 112.72 -173.753 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -63.75 -50.41 61.65 Favored Glycine 0 N--CA 1.448 -0.516 0 C-N-CA 119.572 -1.299 . . . . 0.0 112.539 -172.592 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 48' ' ' LEU . . . . . 0.412 HD12 HD23 ' A' ' 44' ' ' LEU . 0.0 OUTLIER -44.64 -50.88 9.59 Favored 'General case' 0 CA--C 1.517 -0.324 0 N-CA-C 113.803 1.038 . . . . 0.0 113.803 171.482 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 49' ' ' GLU . . . . . 0.499 ' O ' HD22 ' A' ' 53' ' ' LEU . 10.5 tt0 -70.8 -33.25 70.53 Favored 'General case' 0 C--N 1.312 -1.054 0 CA-C-O 120.987 0.422 . . . . 0.0 110.819 -169.369 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 19.3 mm-40 -87.08 -13.88 43.01 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-N 115.834 -0.621 . . . . 0.0 111.552 -172.827 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 51' ' ' HIS . . . . . . . . . . . . . 11.7 m-70 -100.39 -4.38 29.14 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-O 121.046 0.451 . . . . 0.0 110.545 -175.269 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 52' ' ' LEU . . . . . 0.408 HD23 ' HA ' ' A' ' 52' ' ' LEU . 11.5 mt -102.25 -14.01 17.16 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-N 115.763 -0.653 . . . . 0.0 111.757 -179.598 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 53' ' ' LEU . . . . . 0.499 HD22 ' O ' ' A' ' 49' ' ' GLU . 0.1 OUTLIER -65.43 151.49 46.2 Favored 'General case' 0 N--CA 1.451 -0.399 0 CA-C-O 120.881 0.372 . . . . 0.0 110.264 171.539 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 93.26 -16.99 59.29 Favored Glycine 0 CA--C 1.519 0.317 0 C-N-CA 121.226 -0.512 . . . . 0.0 112.85 -179.02 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 55' ' ' LEU . . . . . 0.535 HD22 ' HB3' ' A' ' 59' ' ' ASP . 7.2 mp -82.28 165.41 20.42 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-O 121.646 0.736 . . . . 0.0 112.493 -179.954 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 56' ' ' LYS . . . . . 0.538 ' HE2' ' OG ' ' A' ' 4' ' ' SER . 28.5 mmtp -119.41 170.25 9.3 Favored 'General case' 0 N--CA 1.444 -0.738 0 CA-C-N 114.963 -1.017 . . . . 0.0 110.268 175.016 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 57' ' ' VAL . . . . . 0.439 ' HA ' ' CG1' ' A' ' 140' ' ' VAL . 71.5 t -62.46 134.51 27.71 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.764 0 CA-C-N 115.696 -0.684 . . . . 0.0 109.973 173.91 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 80.82 21.95 62.55 Favored Glycine 0 N--CA 1.445 -0.732 0 C-N-CA 120.943 -0.646 . . . . 0.0 112.423 -179.67 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 59' ' ' ASP . . . . . 0.535 ' HB3' HD22 ' A' ' 55' ' ' LEU . 4.9 t70 -92.67 162.92 13.96 Favored 'General case' 0 C--N 1.323 -0.57 0 N-CA-C 108.823 -0.806 . . . . 0.0 108.823 175.441 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 2.5 mmmt -137.11 122.05 18.91 Favored 'General case' 0 C--N 1.318 -0.772 0 N-CA-C 107.716 -1.216 . . . . 0.0 107.716 -179.273 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 9.5 t -135.91 136.15 40.25 Favored 'General case' 0 C--N 1.321 -0.65 0 CA-C-O 122.039 0.923 . . . . 0.0 112.22 179.047 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 10.9 m -114.03 133.25 55.64 Favored 'General case' 0 N--CA 1.437 -1.118 0 CA-C-N 115.162 -0.926 . . . . 0.0 108.845 172.419 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 17.6 p90 -153.47 158.34 41.2 Favored 'General case' 0 C--N 1.316 -0.867 0 CA-C-O 120.963 0.411 . . . . 0.0 110.215 -178.575 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 46.2 m -129.43 132.97 47.1 Favored 'General case' 0 C--N 1.312 -1.057 0 N-CA-C 108.398 -0.964 . . . . 0.0 108.398 175.425 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 78.2 mt -100.44 146.83 26.55 Favored 'General case' 0 C--N 1.318 -0.762 0 CA-C-O 120.885 0.374 . . . . 0.0 110.386 -178.985 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 43.1 mt-10 -65.45 145.9 99.01 Favored Pre-proline 0 C--N 1.317 -0.846 0 N-CA-C 108.631 -0.877 . . . . 0.0 108.631 173.282 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 96.2 Cg_exo -41.76 -52.98 3.59 Favored 'Trans proline' 0 CA--C 1.531 0.345 0 C-N-CA 123.501 2.8 . . . . 0.0 114.5 -170.718 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 29.1 t70 -64.93 -24.62 67.58 Favored 'General case' 0 N--CA 1.466 0.363 0 CA-C-O 120.828 0.347 . . . . 0.0 111.675 -174.804 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -83.26 -10.94 58.25 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-O 120.77 0.319 . . . . 0.0 111.21 -178.605 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.327 -0.403 0 N-CA-C 112.054 0.39 . . . . 0.0 112.054 -178.897 . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 75' ' ' SER . . . . . 0.551 ' O ' ' HB2' ' A' ' 78' ' ' LEU . 28.5 t . . . . . 0 N--CA 1.446 -0.674 0 CA-C-O 120.588 0.232 . . . . 0.0 110.383 . . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 29.3 Cg_endo -65.93 -17.36 55.5 Favored 'Trans proline' 0 N--CA 1.461 -0.386 0 C-N-CA 122.493 2.129 . . . . 0.0 110.933 172.322 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 17.0 t70 -65.06 -26.81 68.4 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-O 121.798 0.808 . . . . 0.0 109.179 172.194 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 78' ' ' LEU . . . . . 0.551 ' HB2' ' O ' ' A' ' 75' ' ' SER . 0.5 OUTLIER -80.86 6.0 14.41 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 114.763 -1.108 . . . . 0.0 110.933 179.126 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 26.2 mt -126.66 99.1 5.26 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.874 0 N-CA-C 108.455 -0.943 . . . . 0.0 108.455 173.991 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 34.4 mt-30 -113.75 160.33 18.78 Favored 'General case' 0 C--N 1.309 -1.175 0 C-N-CA 119.021 -1.071 . . . . 0.0 112.527 174.357 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 81' ' ' TYR . . . . . 0.558 ' CE2' HG23 ' A' ' 122' ' ' THR . 66.6 m-85 -121.2 114.31 21.23 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.906 -0.588 . . . . 0.0 109.919 -179.796 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 49.6 m-85 -115.18 169.8 8.85 Favored 'General case' 0 C--N 1.316 -0.855 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.608 179.281 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 21.0 t -81.02 159.31 24.86 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-O 120.964 0.412 . . . . 0.0 110.97 -177.659 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 84' ' ' ARG . . . . . 0.576 ' HD2' ' O ' ' A' ' 118' ' ' GLY . 4.9 mtp180 -62.58 -36.89 84.15 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 122.1 0.952 . . . . 0.0 110.109 179.542 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 85' ' ' ARG . . . . . . . . . . . . . 8.5 mpt_? -63.14 -28.72 70.26 Favored 'General case' 0 C--N 1.319 -0.759 0 CA-C-N 113.794 -1.548 . . . . 0.0 111.447 -171.51 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 26.0 mm-40 -80.54 -10.34 59.74 Favored 'General case' 0 C--N 1.32 -0.707 0 CA-C-N 115.892 -0.595 . . . . 0.0 110.743 178.613 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 87' ' ' PHE . . . . . . . . . . . . . 17.0 m-85 -104.17 -36.6 7.62 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-N 115.712 -0.676 . . . . 0.0 110.501 -179.222 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 88' ' ' MET . . . . . . . . . . . . . 57.3 ttp -59.33 -23.41 62.46 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 121.776 0.798 . . . . 0.0 109.576 173.556 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 24.7 t70 -53.27 -34.35 56.9 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 114.246 -1.343 . . . . 0.0 110.46 173.073 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -122.57 16.73 10.4 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 115.644 -0.707 . . . . 0.0 111.501 -179.689 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 101.45 136.88 9.48 Favored Glycine 0 C--N 1.33 0.241 0 C-N-CA 120.629 -0.795 . . . . 0.0 112.415 -178.396 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 36.1 mt-10 -61.97 125.87 86.09 Favored Pre-proline 0 C--N 1.328 -0.333 0 CA-C-O 120.995 0.426 . . . . 0.0 111.494 -176.483 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 93' ' ' PRO . . . . . 0.525 ' HB2' HD13 ' A' ' 113' ' ' ILE . 57.7 Cg_endo -78.5 167.03 23.34 Favored 'Trans proline' 0 N--CA 1.459 -0.544 0 C-N-CA 123.266 2.644 . . . . 0.0 113.407 -173.436 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 94' ' ' GLU . . . . . 0.449 ' O ' HD11 ' A' ' 113' ' ' ILE . 24.7 mt-10 -118.32 164.34 15.36 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 115.982 -0.553 . . . . 0.0 110.6 -178.605 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 95' ' ' ILE . . . . . 0.487 HG12 HG12 ' A' ' 116' ' ' ILE . 12.9 mt -81.95 132.05 32.39 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.376 0 CA-C-O 120.594 0.235 . . . . 0.0 110.444 179.083 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 70.64 35.48 67.26 Favored Glycine 0 N--CA 1.448 -0.553 0 C-N-CA 121.185 -0.531 . . . . 0.0 111.785 -178.918 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 97' ' ' ALA . . . . . 0.543 ' O ' HG13 ' A' ' 113' ' ' ILE . . . -109.52 143.38 39.26 Favored 'General case' 0 C--N 1.322 -0.606 0 N-CA-C 109.744 -0.465 . . . . 0.0 109.744 -179.059 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 98' ' ' ILE . . . . . 0.495 ' HA ' ' O ' ' A' ' 111' ' ' GLY . 41.2 mt -94.48 107.9 20.0 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.115 0 CA-C-O 120.936 0.398 . . . . 0.0 110.479 -178.114 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 99' ' ' MET . . . . . 0.41 ' SD ' ' CD1' ' A' ' 113' ' ' ILE . 92.3 mtp -102.48 123.43 46.21 Favored 'General case' 0 N--CA 1.441 -0.925 0 CA-C-O 121.377 0.608 . . . . 0.0 111.404 -177.152 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 4.4 mm? -65.59 143.85 57.35 Favored 'General case' 0 C--N 1.302 -1.477 0 CA-C-N 114.655 -1.157 . . . . 0.0 108.451 166.13 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 101' ' ' PHE . . . . . 0.4 ' CE2' ' HB2' ' A' ' 99' ' ' MET . 1.8 m-85 -149.85 167.95 25.11 Favored 'General case' 0 CA--C 1.511 -0.528 0 N-CA-C 108.062 -1.088 . . . . 0.0 108.062 -157.907 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 1.5 m -122.95 126.63 47.59 Favored 'General case' 0 C--N 1.312 -1.055 0 C-N-CA 119.774 -0.77 . . . . 0.0 110.592 179.23 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 103' ' ' ALA . . . . . 0.539 ' HB3' ' SD ' ' A' ' 109' ' ' MET . . . -95.59 167.34 11.36 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 115.915 -0.584 . . . . 0.0 110.61 -178.019 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 104' ' ' MET . . . . . . . . . . . . . 66.8 mtt -66.35 -12.93 59.56 Favored 'General case' 0 N--CA 1.464 0.259 0 CA-C-N 115.648 -0.705 . . . . 0.0 112.544 -173.117 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 5.4 p-10 -100.27 12.56 36.8 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-O 120.553 0.216 . . . . 0.0 111.383 -178.184 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 82.33 -2.56 84.56 Favored Glycine 0 N--CA 1.45 -0.383 0 C-N-CA 120.602 -0.809 . . . . 0.0 113.168 179.59 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 42.7 t -84.9 146.66 27.17 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-O 121.216 0.531 . . . . 0.0 110.266 178.683 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 28.9 tt0 -94.51 99.0 11.25 Favored 'General case' 0 C--N 1.314 -0.964 0 CA-C-N 115.319 -0.855 . . . . 0.0 108.905 178.355 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 109' ' ' MET . . . . . 0.539 ' SD ' ' HB3' ' A' ' 103' ' ' ALA . 14.6 ptm -88.66 135.09 32.74 Favored Pre-proline 0 C--N 1.325 -0.46 0 CA-C-N 115.426 -0.806 . . . . 0.0 111.065 -178.9 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 29.1 Cg_endo -65.55 153.81 76.52 Favored 'Trans proline' 0 N--CA 1.451 -0.983 0 C-N-CA 121.817 1.678 . . . . 0.0 110.065 171.425 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 111' ' ' GLY . . . . . 0.495 ' O ' ' HA ' ' A' ' 98' ' ' ILE . . . -147.21 152.78 24.88 Favored Glycine 0 N--CA 1.434 -1.486 0 N-CA-C 108.632 -1.787 . . . . 0.0 108.632 -170.313 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 112' ' ' VAL . . . . . 0.474 ' O ' ' HB3' ' A' ' 124' ' ' ASP . 0.7 OUTLIER -126.53 114.59 38.65 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.335 0 CA-C-N 118.613 1.206 . . . . 0.0 110.397 172.369 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 113' ' ' ILE . . . . . 0.543 HG13 ' O ' ' A' ' 97' ' ' ALA . 0.6 OUTLIER -61.89 110.37 0.65 Allowed 'Isoleucine or valine' 0 C--N 1.317 -0.813 0 N-CA-C 109.022 -0.733 . . . . 0.0 109.022 174.314 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 114' ' ' ARG . . . . . . . . . . . . . 12.5 tpp180 -65.02 -52.57 55.26 Favored 'General case' 0 C--N 1.315 -0.927 0 CA-C-N 115.292 -0.867 . . . . 0.0 110.882 -177.695 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 10.8 tt0 -159.91 153.01 21.82 Favored 'General case' 0 C--N 1.321 -0.665 0 C-N-CA 120.887 -0.325 . . . . 0.0 110.329 -174.358 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 116' ' ' ILE . . . . . 0.487 HG12 HG12 ' A' ' 95' ' ' ILE . 43.6 mm -100.29 114.41 38.86 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.486 0 N-CA-C 109.646 -0.501 . . . . 0.0 109.646 176.231 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 117' ' ' ASN . . . . . 0.47 HD21 ' N ' ' A' ' 117' ' ' ASN . 0.9 OUTLIER -94.11 157.51 16.04 Favored 'General case' 0 C--N 1.317 -0.835 0 N-CA-C 109.266 -0.642 . . . . 0.0 109.266 177.901 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 118' ' ' GLY . . . . . 0.576 ' O ' ' HD2' ' A' ' 84' ' ' ARG . . . -56.94 -45.55 91.92 Favored Glycine 0 N--CA 1.451 -0.361 0 C-N-CA 120.537 -0.84 . . . . 0.0 112.91 -172.96 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 30.1 t70 -112.4 -10.66 13.74 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-O 121.107 0.479 . . . . 0.0 111.248 -179.107 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 120' ' ' SER . . . . . 0.459 ' O ' ' HB2' ' A' ' 117' ' ' ASN . 35.2 t -125.88 157.29 38.04 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.205 -171.893 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 121' ' ' ILE . . . . . . . . . . . . . 50.2 mm -114.31 123.12 69.67 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.567 0 CA-C-O 121.183 0.516 . . . . 0.0 110.054 175.808 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 122' ' ' THR . . . . . 0.558 HG23 ' CE2' ' A' ' 81' ' ' TYR . 24.0 m -94.56 102.2 14.11 Favored 'General case' 0 C--N 1.316 -0.85 0 CA-C-N 115.457 -0.792 . . . . 0.0 110.671 179.027 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 8.2 t -88.18 160.27 2.9 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.55 0 CA-C-N 115.267 -0.879 . . . . 0.0 111.853 174.765 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 124' ' ' ASP . . . . . 0.474 ' HB3' ' O ' ' A' ' 112' ' ' VAL . 27.0 t70 -145.91 145.9 30.88 Favored 'General case' 0 C--N 1.317 -0.808 0 CA-C-N 114.355 -1.293 . . . . 0.0 109.203 176.806 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 125' ' ' PHE . . . . . 0.456 ' CB ' ' HG ' ' A' ' 78' ' ' LEU . 98.1 m-85 -132.8 9.91 4.25 Favored 'General case' 0 C--N 1.312 -1.037 0 N-CA-C 108.534 -0.913 . . . . 0.0 108.534 179.87 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 126' ' ' ASN . . . . . 0.408 ' HB2' ' OD2' ' A' ' 124' ' ' ASP . 7.2 m-80 . . . . . 0 CA--C 1.516 -0.345 0 CA-C-N 113.996 -1.456 . . . . 0.0 111.691 -176.541 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 133' ' ' THR . . . . . . . . . . . . . 28.2 m . . . . . 0 N--CA 1.446 -0.674 0 N-CA-C 109.86 -0.422 . . . . 0.0 109.86 . . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 134' ' ' VAL . . . . . 0.481 ' HB ' ' CD2' ' A' ' 17' ' ' LEU . 16.8 m -98.95 149.96 5.24 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.688 0 CA-C-O 121.127 0.489 . . . . 0.0 110.216 -178.122 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 135' ' ' HIS . . . . . . . . . . . . . 95.2 m-70 -115.53 111.75 21.18 Favored 'General case' 0 C--N 1.314 -0.959 0 CA-C-N 115.161 -0.927 . . . . 0.0 109.577 -172.931 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 136' ' ' PHE . . . . . 0.434 ' CZ ' HD13 ' A' ' 17' ' ' LEU . 3.1 m-85 -107.92 124.1 49.61 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 115.373 -0.831 . . . . 0.0 111.116 -173.163 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 137' ' ' ASP . . . . . 0.475 ' O ' ' HA ' ' A' ' 15' ' ' PHE . 3.7 m-20 -110.38 100.85 9.63 Favored 'General case' 0 C--N 1.317 -0.815 0 N-CA-C 109.034 -0.728 . . . . 0.0 109.034 170.758 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 138' ' ' ILE . . . . . 0.548 HG21 ' CG2' ' A' ' 13' ' ' VAL . 54.2 mt -116.02 122.62 69.99 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.37 0 N-CA-C 112.701 0.63 . . . . 0.0 112.701 -171.905 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 80.4 mt-10 -110.52 137.95 47.54 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-N 115.838 -0.619 . . . . 0.0 110.076 173.491 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 140' ' ' VAL . . . . . 0.439 ' CG1' ' HA ' ' A' ' 57' ' ' VAL . 92.9 t -82.09 105.47 11.99 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.591 0 N-CA-C 108.473 -0.936 . . . . 0.0 108.473 177.435 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 39.1 mt -79.49 -44.45 21.22 Favored 'General case' 0 CA--C 1.508 -0.673 0 N-CA-C 109.839 -0.43 . . . . 0.0 109.839 -179.362 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 142' ' ' GLU . . . . . . . . . . . . . 14.5 pt-20 -169.32 158.12 7.93 Favored 'General case' 0 C--N 1.323 -0.549 0 N-CA-C 108.812 -0.81 . . . . 0.0 108.812 176.698 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 143' ' ' ILE . . . . . 0.433 HD11 HG22 ' A' ' 57' ' ' VAL . 82.3 mt -113.38 110.83 33.59 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.647 0 CA-C-O 121.231 0.538 . . . . 0.0 110.347 -179.444 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 144' ' ' ASP . . . . . . . . . . . . . 38.3 t70 -79.75 133.67 58.49 Favored Pre-proline 0 C--N 1.326 -0.423 0 CA-C-N 115.305 -0.861 . . . . 0.0 110.546 179.886 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 145' ' ' PRO . . . . . . . . . . . . . 90.1 Cg_exo . . . . . 0 C--N 1.35 0.617 0 C-N-CA 123.236 2.624 . . . . 0.0 112.538 177.581 . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 2' ' ' SER . . . . . 0.619 ' O ' ' HB ' ' A' ' 143' ' ' ILE . 33.2 t . . . . . 0 N--CA 1.45 -0.438 0 N-CA-C 108.73 -0.841 . . . . 0.0 108.73 . . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 42.5 tt0 -84.41 -26.21 28.47 Favored 'General case' 0 C--N 1.321 -0.666 0 CA-C-O 121.216 0.531 . . . . 0.0 110.073 179.416 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 7.0 m -104.64 141.72 35.93 Favored 'General case' 0 C--N 1.318 -0.762 0 CA-C-N 115.443 -0.798 . . . . 0.0 110.711 -177.884 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 9.4 p -82.07 149.95 4.61 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.416 0 CA-C-N 116.052 -0.522 . . . . 0.0 111.075 -176.647 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 6' ' ' GLN . . . . . 0.44 ' CG ' ' HB2' ' A' ' 9' ' ' SER . 3.3 pt20 -143.74 157.77 44.15 Favored 'General case' 0 C--N 1.321 -0.656 0 CA-C-N 115.644 -0.707 . . . . 0.0 110.387 178.673 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 7' ' ' SER . . . . . 0.44 ' O ' ' HB2' ' A' ' 8' ' ' ASN . 5.1 p -76.02 144.12 41.03 Favored 'General case' 0 C--N 1.319 -0.724 0 CA-C-N 116.209 -0.451 . . . . 0.0 109.994 178.533 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 8' ' ' ASN . . . . . 0.484 ' N ' HD21 ' A' ' 8' ' ' ASN . 0.8 OUTLIER 71.6 13.7 6.31 Favored 'General case' 0 N--CA 1.466 0.358 0 CA-C-N 115.405 -0.816 . . . . 0.0 111.815 -178.4 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 9' ' ' SER . . . . . 0.44 ' HB2' ' CG ' ' A' ' 6' ' ' GLN . 18.2 t -82.44 166.91 18.97 Favored 'General case' 0 C--N 1.328 -0.359 0 N-CA-C 109.879 -0.415 . . . . 0.0 109.879 175.518 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 10' ' ' ALA . . . . . 0.653 ' O ' ' HB2' ' A' ' 144' ' ' ASP . . . -110.5 111.93 23.51 Favored 'General case' 0 C--N 1.318 -0.78 0 N-CA-C 109.241 -0.651 . . . . 0.0 109.241 172.638 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 16.5 m -114.61 144.72 21.56 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.789 0 C-N-CA 120.231 -0.588 . . . . 0.0 111.106 -172.67 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 12' ' ' LEU . . . . . 0.44 ' HB2' ' HB2' ' A' ' 142' ' ' GLU . 9.7 mp -87.0 128.29 35.08 Favored 'General case' 0 C--N 1.325 -0.485 0 N-CA-C 109.393 -0.595 . . . . 0.0 109.393 176.423 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 22.3 m -119.72 155.88 22.37 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.928 0 CA-C-O 121.971 0.891 . . . . 0.0 112.905 -173.094 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 14' ' ' HIS . . . . . 0.521 ' CD2' HD13 ' A' ' 141' ' ' LEU . 0.2 OUTLIER -127.82 111.61 13.83 Favored 'General case' 0 C--N 1.315 -0.924 0 CA-C-N 114.044 -1.435 . . . . 0.0 107.456 162.932 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 15' ' ' PHE . . . . . 0.572 ' HA ' ' O ' ' A' ' 137' ' ' ASP . 33.9 p90 -139.07 171.25 14.59 Favored 'General case' 0 C--N 1.321 -0.654 0 N-CA-C 114.198 1.184 . . . . 0.0 114.198 -174.299 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 89.1 m -141.9 140.13 32.76 Favored 'General case' 0 C--N 1.314 -0.955 0 CA-C-N 113.092 -1.867 . . . . 0.0 106.662 175.205 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 17' ' ' LEU . . . . . 0.464 ' CD2' HG21 ' A' ' 134' ' ' VAL . 0.5 OUTLIER -127.22 108.32 10.77 Favored 'General case' 0 C--N 1.316 -0.85 0 C-N-CA 120.973 -0.291 . . . . 0.0 110.654 -171.163 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 9.7 mptt -116.48 160.49 20.52 Favored 'General case' 0 C--N 1.321 -0.653 0 CA-C-O 121.313 0.578 . . . . 0.0 111.643 -174.601 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 19' ' ' LEU . . . . . 0.452 HD13 HG23 ' A' ' 134' ' ' VAL . 3.1 mm? -106.25 171.58 7.27 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 115.022 -0.99 . . . . 0.0 109.644 173.447 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 18.5 t70 -58.07 -30.66 66.37 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-O 121.197 0.522 . . . . 0.0 110.258 175.793 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 10.1 m-20 -77.85 6.69 7.1 Favored 'General case' 0 N--CA 1.465 0.298 0 CA-C-N 115.736 -0.666 . . . . 0.0 111.351 178.858 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 70.18 9.29 63.51 Favored Glycine 0 N--CA 1.453 -0.21 0 C-N-CA 121.294 -0.479 . . . . 0.0 113.261 -179.337 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 14.2 m -79.13 148.35 32.39 Favored 'General case' 0 C--N 1.322 -0.62 0 N-CA-C 109.891 -0.411 . . . . 0.0 109.891 178.422 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 18.2 m -95.16 116.52 28.84 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-O 120.987 0.422 . . . . 0.0 110.965 179.931 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -78.42 -39.36 39.01 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 116.0 -0.545 . . . . 0.0 109.825 176.827 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 8.0 tp10 -157.25 143.0 17.56 Favored 'General case' 0 N--CA 1.451 -0.394 0 CA-C-N 115.823 -0.626 . . . . 0.0 109.957 176.134 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 29.0 p -125.28 121.56 34.39 Favored 'General case' 0 C--N 1.316 -0.852 0 CA-C-N 116.295 -0.411 . . . . 0.0 110.402 178.327 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 50.5 m -136.99 61.24 1.63 Allowed 'General case' 0 N--CA 1.442 -0.856 0 CA-C-O 122.371 1.082 . . . . 0.0 109.816 174.81 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 4.7 tmm_? -151.75 -61.15 0.17 Allowed 'General case' 0 C--N 1.319 -0.755 0 CA-C-N 114.824 -1.08 . . . . 0.0 109.39 -177.861 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 6.2 p30 -68.94 -11.72 60.93 Favored 'General case' 0 N--CA 1.465 0.321 0 CA-C-O 121.121 0.486 . . . . 0.0 110.337 179.645 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 1.3 m-20 -66.49 -36.72 83.42 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 115.412 -0.813 . . . . 0.0 110.702 -179.76 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 98.6 -3.86 59.48 Favored Glycine 0 N--CA 1.448 -0.502 0 CA-C-N 115.655 -0.702 . . . . 0.0 111.614 -175.228 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 60.2 mtpt -126.7 132.29 24.25 Favored Pre-proline 0 C--N 1.328 -0.367 0 N-CA-C 110.143 -0.317 . . . . 0.0 110.143 179.795 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 42.6 Cg_endo -83.9 171.55 10.48 Favored 'Trans proline' 0 N--CA 1.456 -0.724 0 C-N-CA 123.207 2.605 . . . . 0.0 112.24 174.563 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -129.84 163.09 27.04 Favored 'General case' 0 C--N 1.316 -0.889 0 CA-C-N 115.927 -0.579 . . . . 0.0 109.623 -176.641 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 36' ' ' LEU . . . . . 0.461 HD22 ' HB1' ' A' ' 10' ' ' ALA . 0.9 OUTLIER -105.85 122.53 46.29 Favored 'General case' 0 C--N 1.315 -0.916 0 C-N-CA 120.757 -0.377 . . . . 0.0 110.571 177.003 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 37' ' ' PHE . . . . . . . . . . . . . 6.0 m-30 -93.44 107.57 19.39 Favored 'General case' 0 C--N 1.316 -0.891 0 CA-C-N 115.966 -0.561 . . . . 0.0 109.762 172.113 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 18.9 tpt180 -85.87 106.86 17.38 Favored 'General case' 0 N--CA 1.445 -0.701 0 N-CA-C 109.194 -0.669 . . . . 0.0 109.194 178.26 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 39' ' ' LEU . . . . . 0.432 HD22 ' HB3' ' A' ' 49' ' ' GLU . 15.9 mt -82.15 156.06 24.68 Favored 'General case' 0 C--N 1.317 -0.842 0 CA-C-N 115.215 -0.902 . . . . 0.0 110.498 -176.276 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 101.77 32.27 5.13 Favored Glycine 0 C--N 1.319 -0.415 0 C-N-CA 121.177 -0.535 . . . . 0.0 112.838 -177.32 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 41' ' ' ASP . . . . . 0.496 ' HA ' ' O ' ' A' ' 44' ' ' LEU . 14.7 t70 60.28 23.39 12.83 Favored 'General case' 0 N--CA 1.471 0.601 0 CA-C-O 121.507 0.67 . . . . 0.0 111.436 176.762 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -84.24 -5.37 59.25 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-O 121.05 0.452 . . . . 0.0 110.909 179.298 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 26.5 p -166.32 -49.17 0.03 OUTLIER 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 115.78 -0.645 . . . . 0.0 110.292 179.787 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 44' ' ' LEU . . . . . 0.496 ' O ' ' HA ' ' A' ' 41' ' ' ASP . 40.9 mt -106.42 171.1 7.54 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 115.992 -0.549 . . . . 0.0 110.413 179.259 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 21.0 t -76.79 153.37 34.99 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 116.005 -0.543 . . . . 0.0 109.605 178.727 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 46' ' ' GLU . . . . . 0.478 ' O ' ' HG2' ' A' ' 49' ' ' GLU . 44.8 mt-10 -63.7 -24.54 67.82 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 115.902 -0.59 . . . . 0.0 111.545 -176.597 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -57.97 -35.01 74.07 Favored Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 120.916 -0.659 . . . . 0.0 112.32 175.528 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -60.03 -51.91 67.63 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 121.089 0.471 . . . . 0.0 109.912 177.423 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 49' ' ' GLU . . . . . 0.645 ' O ' HD11 ' A' ' 53' ' ' LEU . 14.8 pt-20 -68.15 -51.07 50.14 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 115.9 -0.591 . . . . 0.0 111.19 -174.627 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 50' ' ' GLN . . . . . 0.48 ' HA ' HD21 ' A' ' 53' ' ' LEU . 85.3 mm-40 -56.03 -15.14 3.14 Favored 'General case' 0 C--N 1.329 -0.308 0 N-CA-C 113.75 1.018 . . . . 0.0 113.75 -176.278 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 51' ' ' HIS . . . . . . . . . . . . . 11.6 m170 -106.15 -13.8 15.33 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-O 121.074 0.464 . . . . 0.0 110.716 -177.024 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 18.3 mt -88.16 -14.65 38.12 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-N 115.632 -0.713 . . . . 0.0 109.832 172.427 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 53' ' ' LEU . . . . . 0.645 HD11 ' O ' ' A' ' 49' ' ' GLU . 5.8 mp -61.05 150.38 33.98 Favored 'General case' 0 N--CA 1.445 -0.697 0 CA-C-N 115.554 -0.748 . . . . 0.0 110.596 170.541 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 93.3 -14.67 64.74 Favored Glycine 0 N--CA 1.447 -0.581 0 C-N-CA 121.014 -0.612 . . . . 0.0 111.988 -175.23 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 6.9 mp -85.24 165.84 17.02 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-O 121.726 0.774 . . . . 0.0 112.048 177.632 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 56' ' ' LYS . . . . . 0.434 ' O ' ' HB2' ' A' ' 59' ' ' ASP . 24.2 tptt -128.75 166.92 18.05 Favored 'General case' 0 C--N 1.318 -0.8 0 N-CA-C 107.829 -1.175 . . . . 0.0 107.829 178.16 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 57' ' ' VAL . . . . . 0.47 HG23 HD11 ' A' ' 143' ' ' ILE . 12.6 t -60.52 131.83 25.55 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.52 0 CA-C-O 121.014 0.435 . . . . 0.0 110.816 176.465 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 81.59 10.25 84.62 Favored Glycine 0 N--CA 1.451 -0.364 0 CA-C-N 115.482 -0.781 . . . . 0.0 113.071 -177.519 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 59' ' ' ASP . . . . . 0.434 ' HB2' ' O ' ' A' ' 56' ' ' LYS . 1.0 OUTLIER -93.85 138.13 32.34 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.93 0.395 . . . . 0.0 110.28 176.545 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 60' ' ' LYS . . . . . 0.412 ' HE3' ' OE2' ' A' ' 139' ' ' GLU . 3.4 mmmm -110.48 131.53 54.97 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 116.034 -0.53 . . . . 0.0 109.573 -176.256 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 7.5 t -141.29 145.16 35.16 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-O 121.659 0.742 . . . . 0.0 111.839 -179.908 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 17.4 m -118.0 143.04 46.73 Favored 'General case' 0 C--N 1.313 -0.988 0 N-CA-C 108.609 -0.885 . . . . 0.0 108.609 171.143 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 21.3 p90 -161.15 163.95 30.92 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-O 120.958 0.409 . . . . 0.0 111.107 -177.01 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 41.7 t -132.48 136.9 46.99 Favored 'General case' 0 C--N 1.32 -0.686 0 CA-C-N 115.778 -0.646 . . . . 0.0 109.317 179.815 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 87.6 mt -120.74 146.19 46.74 Favored 'General case' 0 C--N 1.313 -1.011 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.034 -178.352 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 14.5 mm-40 -64.44 152.99 87.82 Favored Pre-proline 0 N--CA 1.442 -0.828 0 CA-C-N 115.364 -0.835 . . . . 0.0 109.995 173.198 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 1.9 Cg_endo -42.61 -55.19 2.78 Favored 'Trans proline' 0 N--CA 1.464 -0.264 0 C-N-CA 123.797 2.998 . . . . 0.0 114.924 -171.513 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 7.0 p-10 -72.21 -14.76 61.87 Favored 'General case' 0 N--CA 1.465 0.304 0 CA-C-O 121.075 0.464 . . . . 0.0 111.502 -174.107 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -90.3 -8.79 50.01 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.676 179.175 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.329 -0.313 0 CA-C-N 116.142 -0.481 . . . . 0.0 111.864 -179.202 . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 39.6 t . . . . . 0 N--CA 1.449 -0.499 0 CA-C-O 120.97 0.414 . . . . 0.0 110.743 . . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 39.1 Cg_endo -69.49 -18.93 38.01 Favored 'Trans proline' 0 N--CA 1.464 -0.236 0 C-N-CA 122.789 2.326 . . . . 0.0 111.813 174.891 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 7.3 m-20 -76.19 -15.22 60.09 Favored 'General case' 0 CA--C 1.519 -0.231 0 CA-C-O 121.359 0.6 . . . . 0.0 109.838 176.742 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 78' ' ' LEU . . . . . 0.511 ' HG ' ' HB2' ' A' ' 125' ' ' PHE . 6.2 mp -87.01 8.17 24.51 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 115.407 -0.815 . . . . 0.0 109.89 175.966 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 49.8 mt -118.86 109.41 26.74 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.681 0 N-CA-C 108.203 -1.036 . . . . 0.0 108.203 172.686 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 74.7 mt-30 -131.43 136.37 47.93 Favored 'General case' 0 C--N 1.311 -1.086 0 CA-C-N 115.259 -0.882 . . . . 0.0 110.054 -169.523 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 81' ' ' TYR . . . . . . . . . . . . . 46.3 m-85 -107.02 112.73 25.82 Favored 'General case' 0 C--N 1.321 -0.638 0 C-N-CA 120.125 -0.63 . . . . 0.0 110.252 -179.885 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 60.0 m-85 -103.78 170.47 7.91 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-O 121.548 0.689 . . . . 0.0 112.822 178.868 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 9.7 m -79.1 139.98 37.94 Favored 'General case' 0 N--CA 1.445 -0.724 0 CA-C-N 114.745 -1.116 . . . . 0.0 111.288 174.634 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 84' ' ' ARG . . . . . 0.411 ' HD2' ' O ' ' A' ' 118' ' ' GLY . 10.8 ptm180 -68.57 -17.22 64.09 Favored 'General case' 0 C--N 1.325 -0.469 0 N-CA-C 113.714 1.005 . . . . 0.0 113.714 -175.186 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 85' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -74.04 -34.13 63.98 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-O 121.134 0.492 . . . . 0.0 109.879 -174.713 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 45.1 mt-10 -64.6 -16.37 62.6 Favored 'General case' 0 N--CA 1.465 0.3 0 CA-C-N 115.177 -0.919 . . . . 0.0 110.77 -179.936 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 87' ' ' PHE . . . . . . . . . . . . . 54.8 m-85 -102.5 -23.12 13.93 Favored 'General case' 0 C--N 1.319 -0.72 0 CA-C-N 115.185 -0.916 . . . . 0.0 110.135 -177.464 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 88' ' ' MET . . . . . . . . . . . . . 56.0 ttm -62.0 -35.56 78.89 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 115.94 -0.573 . . . . 0.0 110.836 -178.419 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 23.1 t70 -58.18 -25.86 62.07 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 121.144 0.497 . . . . 0.0 111.304 178.888 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -111.13 16.51 21.03 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-N 115.938 -0.573 . . . . 0.0 110.668 177.765 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 90.65 143.99 11.66 Favored Glycine 0 N--CA 1.447 -0.629 0 C-N-CA 120.762 -0.732 . . . . 0.0 111.637 -178.225 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 44.3 mt-10 -60.42 127.28 86.33 Favored Pre-proline 0 C--N 1.323 -0.545 0 CA-C-O 121.02 0.438 . . . . 0.0 110.848 -177.633 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 18.1 Cg_endo -71.11 164.91 34.12 Favored 'Trans proline' 0 N--CA 1.457 -0.627 0 C-N-CA 122.85 2.367 . . . . 0.0 112.313 -175.282 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 23.0 mt-10 -118.07 160.8 20.89 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 116.332 -0.395 . . . . 0.0 110.392 -177.603 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 95' ' ' ILE . . . . . 0.455 HG22 ' HA ' ' A' ' 115' ' ' GLU . 9.6 mt -82.33 131.67 33.23 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.51 0 CA-C-O 120.969 0.414 . . . . 0.0 110.607 -178.333 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 71.35 34.8 63.73 Favored Glycine 0 N--CA 1.444 -0.783 0 CA-C-N 115.706 -0.679 . . . . 0.0 111.518 -176.849 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -110.14 115.58 29.98 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 121.659 0.742 . . . . 0.0 112.553 -177.555 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 98' ' ' ILE . . . . . 0.61 ' HA ' ' HA ' ' A' ' 112' ' ' VAL . 5.5 mt -82.03 123.3 37.99 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.017 0 CA-C-N 114.826 -1.079 . . . . 0.0 108.504 175.926 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 99' ' ' MET . . . . . . . . . . . . . 10.0 mtm -136.64 152.78 50.81 Favored 'General case' 0 N--CA 1.443 -0.797 0 N-CA-C 106.37 -1.715 . . . . 0.0 106.37 179.811 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 3.2 mm? -71.54 102.85 2.81 Favored 'General case' 0 C--N 1.313 -1.003 0 CA-C-O 122.273 1.035 . . . . 0.0 111.856 -178.795 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 101' ' ' PHE . . . . . . . . . . . . . 8.2 m-30 -94.78 172.65 8.04 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 113.033 -1.894 . . . . 0.0 111.826 -179.512 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 5.3 m -118.56 130.14 55.73 Favored 'General case' 0 C--N 1.316 -0.887 0 CA-C-N 114.947 -1.024 . . . . 0.0 108.972 -178.716 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 103' ' ' ALA . . . . . 0.63 ' HB3' ' SD ' ' A' ' 109' ' ' MET . . . -94.57 158.47 15.52 Favored 'General case' 0 C--N 1.322 -0.605 0 N-CA-C 109.329 -0.619 . . . . 0.0 109.329 -177.889 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 104' ' ' MET . . . . . . . . . . . . . 2.0 mpt? -66.54 -12.65 58.7 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 115.732 -0.667 . . . . 0.0 111.953 -174.988 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 5.0 p-10 -97.63 11.27 37.55 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-O 120.893 0.378 . . . . 0.0 110.989 179.227 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 87.9 -12.22 64.53 Favored Glycine 0 N--CA 1.45 -0.392 0 C-N-CA 121.249 -0.5 . . . . 0.0 113.505 175.499 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 48.9 m -76.76 142.49 40.39 Favored 'General case' 0 C--N 1.317 -0.81 0 CA-C-N 116.816 0.308 . . . . 0.0 110.308 177.499 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 30.1 tt0 -93.65 100.57 12.79 Favored 'General case' 0 C--N 1.318 -0.778 0 CA-C-O 121.675 0.75 . . . . 0.0 109.536 178.473 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 109' ' ' MET . . . . . 0.63 ' SD ' ' HB3' ' A' ' 103' ' ' ALA . 16.0 ptm -100.3 139.58 20.79 Favored Pre-proline 0 C--N 1.323 -0.573 0 CA-C-N 114.889 -1.051 . . . . 0.0 111.262 -177.289 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 17.7 Cg_exo -64.6 143.37 81.15 Favored 'Trans proline' 0 N--CA 1.451 -1.02 0 C-N-CA 121.88 1.72 . . . . 0.0 110.061 171.874 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . -144.69 108.26 0.48 Allowed Glycine 0 N--CA 1.438 -1.212 0 N-CA-C 109.876 -1.29 . . . . 0.0 109.876 -171.512 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 112' ' ' VAL . . . . . 0.61 ' HA ' ' HA ' ' A' ' 98' ' ' ILE . 1.3 p -84.11 110.38 18.64 Favored 'Isoleucine or valine' 0 CA--C 1.51 -0.582 0 C-N-CA 119.202 -0.999 . . . . 0.0 110.879 -178.647 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 113' ' ' ILE . . . . . . . . . . . . . 45.9 mt -60.41 110.11 0.52 Allowed 'Isoleucine or valine' 0 N--CA 1.438 -1.071 0 CA-C-N 114.22 -1.355 . . . . 0.0 108.536 170.726 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 114' ' ' ARG . . . . . 0.443 ' O ' HG22 ' A' ' 95' ' ' ILE . 1.3 tmt_? -79.2 -27.55 42.56 Favored 'General case' 0 C--N 1.309 -1.188 0 CA-C-N 114.162 -1.381 . . . . 0.0 110.899 -168.214 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 115' ' ' GLU . . . . . 0.598 ' N ' ' HB ' ' A' ' 122' ' ' THR . 8.2 tt0 -160.28 159.93 31.96 Favored 'General case' 0 C--N 1.325 -0.484 0 N-CA-C 112.456 0.539 . . . . 0.0 112.456 -179.046 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 116' ' ' ILE . . . . . 0.429 HG12 HG12 ' A' ' 95' ' ' ILE . 33.4 mm -118.39 130.3 73.45 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.605 0 CA-C-N 114.981 -1.009 . . . . 0.0 109.444 174.218 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 117' ' ' ASN . . . . . 0.405 ' HB2' ' O ' ' A' ' 120' ' ' SER . 19.8 m-80 -122.21 159.3 27.57 Favored 'General case' 0 C--N 1.309 -1.192 0 CA-C-N 115.51 -0.768 . . . . 0.0 109.27 -179.782 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 118' ' ' GLY . . . . . 0.411 ' O ' ' HD2' ' A' ' 84' ' ' ARG . . . -55.28 -45.59 82.47 Favored Glycine 0 N--CA 1.452 -0.297 0 C-N-CA 120.653 -0.784 . . . . 0.0 112.896 -170.624 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 3.3 p-10 -114.17 -12.08 12.56 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 117.03 0.415 . . . . 0.0 111.032 173.534 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 120' ' ' SER . . . . . 0.405 ' O ' ' HB2' ' A' ' 117' ' ' ASN . 21.9 t -113.77 159.79 19.38 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-O 122.047 0.927 . . . . 0.0 112.122 -169.196 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 121' ' ' ILE . . . . . 0.469 ' CG2' ' H ' ' A' ' 122' ' ' THR . 45.1 mm -118.98 159.68 19.4 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.863 0 CA-C-N 114.292 -1.322 . . . . 0.0 109.52 -177.289 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 122' ' ' THR . . . . . 0.598 ' HB ' ' N ' ' A' ' 115' ' ' GLU . 8.8 m -139.18 139.14 37.47 Favored 'General case' 0 N--CA 1.448 -0.533 0 N-CA-C 106.844 -1.539 . . . . 0.0 106.844 -170.78 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 55.6 t -140.46 154.57 22.46 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.67 0 C-N-CA 117.555 -1.658 . . . . 0.0 109.872 -164.119 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 124' ' ' ASP . . . . . 0.418 ' HB3' HG11 ' A' ' 112' ' ' VAL . 35.6 t70 -154.7 94.9 1.72 Allowed 'General case' 0 C--N 1.309 -1.176 0 CA-C-N 115.593 -0.73 . . . . 0.0 109.684 176.671 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 125' ' ' PHE . . . . . 0.511 ' HB2' ' HG ' ' A' ' 78' ' ' LEU . 97.4 m-85 -82.01 3.37 26.88 Favored 'General case' 0 C--N 1.324 -0.534 0 O-C-N 120.724 -1.235 . . . . 0.0 110.376 173.699 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 37.0 m-80 . . . . . 0 C--N 1.325 -0.496 0 CA-C-O 122.478 1.132 . . . . 0.0 111.951 -177.92 . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 133' ' ' THR . . . . . . . . . . . . . 59.5 m . . . . . 0 CA--C 1.529 0.161 0 CA-C-O 120.85 0.357 . . . . 0.0 110.672 . . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 134' ' ' VAL . . . . . 0.464 HG21 ' CD2' ' A' ' 17' ' ' LEU . 2.7 p -116.96 166.78 10.91 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.501 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.803 -173.227 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 135' ' ' HIS . . . . . . . . . . . . . 81.8 m-70 -131.0 124.48 31.05 Favored 'General case' 0 C--N 1.322 -0.587 0 CA-C-N 115.848 -0.614 . . . . 0.0 111.089 -171.278 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 136' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -131.54 150.98 51.96 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 121.478 0.656 . . . . 0.0 111.907 -179.966 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 137' ' ' ASP . . . . . 0.572 ' O ' ' HA ' ' A' ' 15' ' ' PHE . 3.3 m-20 -115.89 101.18 8.56 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-N 114.706 -1.133 . . . . 0.0 108.604 174.244 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 138' ' ' ILE . . . . . . . . . . . . . 47.6 mt -116.65 130.51 71.38 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.532 0 CA-C-O 121.203 0.525 . . . . 0.0 111.789 -172.23 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 139' ' ' GLU . . . . . 0.412 ' OE2' ' HE3' ' A' ' 60' ' ' LYS . 11.7 pt-20 -118.45 142.8 47.21 Favored 'General case' 0 C--N 1.321 -0.642 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.103 178.064 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 140' ' ' VAL . . . . . 0.442 ' CG1' ' HA ' ' A' ' 57' ' ' VAL . 78.7 t -79.09 108.33 12.55 Favored 'Isoleucine or valine' 0 C--O 1.234 0.263 0 CA-C-O 121.068 0.461 . . . . 0.0 111.116 -179.199 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 141' ' ' LEU . . . . . 0.521 HD13 ' CD2' ' A' ' 14' ' ' HIS . 48.7 mt -90.45 -33.02 16.15 Favored 'General case' 0 C--N 1.321 -0.652 0 CA-C-O 121.632 0.729 . . . . 0.0 110.324 177.291 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 142' ' ' GLU . . . . . 0.44 ' HB2' ' HB2' ' A' ' 12' ' ' LEU . 0.0 OUTLIER -164.49 148.23 9.28 Favored 'General case' 0 C--N 1.316 -0.885 0 CA-C-N 114.083 -1.417 . . . . 0.0 111.811 -176.879 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 143' ' ' ILE . . . . . 0.619 ' HB ' ' O ' ' A' ' 2' ' ' SER . 78.3 mt -125.16 127.92 72.53 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.538 0 CA-C-N 115.455 -0.793 . . . . 0.0 109.91 178.834 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 144' ' ' ASP . . . . . 0.653 ' HB2' ' O ' ' A' ' 10' ' ' ALA . 31.4 t70 -62.15 137.52 95.76 Favored Pre-proline 0 C--N 1.326 -0.448 0 CA-C-N 115.82 -0.627 . . . . 0.0 110.715 -178.246 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 145' ' ' PRO . . . . . . . . . . . . . 25.3 Cg_endo . . . . . 0 N--CA 1.463 -0.32 0 C-N-CA 122.823 2.349 . . . . 0.0 111.627 178.334 . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 69.0 m . . . . . 0 N--CA 1.451 -0.415 0 CA-C-O 121.221 0.534 . . . . 0.0 111.005 . . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 33.4 mt-10 -80.33 -25.74 39.13 Favored 'General case' 0 C--N 1.323 -0.585 0 N-CA-C 108.442 -0.947 . . . . 0.0 108.442 172.851 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 23.6 t -117.47 132.8 56.49 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-N 114.027 -1.442 . . . . 0.0 109.004 175.048 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . 0.555 HG11 ' O ' ' A' ' 55' ' ' LEU . 8.9 p -76.9 142.77 13.85 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.494 0 CA-C-O 121.244 0.545 . . . . 0.0 110.428 -179.376 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 6' ' ' GLN . . . . . 0.445 ' HG2' ' HB2' ' A' ' 9' ' ' SER . 4.2 pt20 -127.39 168.3 15.03 Favored 'General case' 0 C--N 1.314 -0.963 0 CA-C-N 115.477 -0.783 . . . . 0.0 109.176 179.933 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 31.3 p -55.9 130.2 42.73 Favored 'General case' 0 C--N 1.317 -0.819 0 N-CA-C 109.955 -0.387 . . . . 0.0 109.955 174.946 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 66.7 t30 69.04 40.29 1.62 Allowed 'General case' 0 N--CA 1.47 0.549 0 CA-C-O 121.392 0.615 . . . . 0.0 110.914 -176.339 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 9' ' ' SER . . . . . 0.445 ' HB2' ' HG2' ' A' ' 6' ' ' GLN . 18.3 t -133.71 125.97 29.73 Favored 'General case' 0 C--N 1.327 -0.409 0 N-CA-C 108.638 -0.875 . . . . 0.0 108.638 173.311 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -83.27 148.67 27.25 Favored 'General case' 0 C--N 1.319 -0.755 0 CA-C-N 116.587 -0.279 . . . . 0.0 110.707 -171.233 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 8.0 m -123.92 140.15 48.23 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.687 0 CA-C-O 121.436 0.636 . . . . 0.0 111.322 179.249 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 12' ' ' LEU . . . . . 0.493 ' N ' HD13 ' A' ' 12' ' ' LEU . 5.1 mp -88.98 112.85 23.84 Favored 'General case' 0 C--N 1.315 -0.929 0 N-CA-C 107.584 -1.265 . . . . 0.0 107.584 173.667 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 13' ' ' VAL . . . . . 0.516 ' CG2' HG21 ' A' ' 138' ' ' ILE . 1.4 p -125.46 157.03 34.93 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.952 0 CA-C-O 121.185 0.517 . . . . 0.0 110.576 -171.462 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 14' ' ' HIS . . . . . 0.625 ' CE1' ' HA ' ' A' ' 29' ' ' ARG . 43.5 t60 -130.72 113.62 14.37 Favored 'General case' 0 C--N 1.316 -0.871 0 N-CA-C 106.12 -1.807 . . . . 0.0 106.12 176.502 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 15' ' ' PHE . . . . . 0.485 ' H ' ' HB ' ' A' ' 28' ' ' THR . 48.6 p90 -141.9 -179.07 5.99 Favored 'General case' 0 C--N 1.317 -0.81 0 CA-C-O 122.363 1.078 . . . . 0.0 113.329 -163.756 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 60.1 m -143.97 113.24 6.9 Favored 'General case' 0 C--N 1.318 -0.782 0 CA-C-N 113.721 -1.582 . . . . 0.0 108.336 -176.11 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 1.1 tt -100.89 120.96 40.92 Favored 'General case' 0 C--N 1.321 -0.657 0 CA-C-N 115.923 -0.58 . . . . 0.0 112.153 -176.916 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 10.0 mptt -120.18 142.76 48.68 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-N 115.339 -0.846 . . . . 0.0 110.714 -179.248 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 19' ' ' LEU . . . . . 0.462 ' CD2' ' HB3' ' A' ' 25' ' ' ALA . 3.6 mm? -84.58 173.69 10.59 Favored 'General case' 0 C--N 1.322 -0.599 0 N-CA-C 109.11 -0.7 . . . . 0.0 109.11 170.711 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 50.5 m-20 -57.2 -33.66 67.72 Favored 'General case' 0 C--N 1.327 -0.408 0 C-N-CA 120.786 -0.366 . . . . 0.0 110.631 177.057 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 23.3 t70 -78.16 4.08 13.46 Favored 'General case' 0 CA--C 1.535 0.398 0 CA-C-O 121.338 0.59 . . . . 0.0 111.201 178.957 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 73.57 9.41 78.23 Favored Glycine 0 CA--C 1.516 0.15 0 CA-C-N 116.137 -0.483 . . . . 0.0 113.264 -179.047 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 8.1 m -71.19 141.38 50.67 Favored 'General case' 0 C--N 1.323 -0.583 0 N-CA-C 109.529 -0.545 . . . . 0.0 109.529 174.776 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 7.3 m -88.8 112.25 22.99 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-O 120.923 0.392 . . . . 0.0 110.567 -178.665 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 25' ' ' ALA . . . . . 0.462 ' HB3' ' CD2' ' A' ' 19' ' ' LEU . . . -80.41 -38.38 30.33 Favored 'General case' 0 CA--C 1.516 -0.332 0 CA-C-N 116.009 -0.542 . . . . 0.0 111.033 -178.708 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 23.8 tt0 -154.24 121.14 5.59 Favored 'General case' 0 C--N 1.321 -0.668 0 CA-C-N 115.543 -0.753 . . . . 0.0 109.645 -176.735 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 14.9 p -114.08 101.65 9.43 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-O 121.677 0.751 . . . . 0.0 111.679 -178.09 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 28' ' ' THR . . . . . 0.485 ' HB ' ' H ' ' A' ' 15' ' ' PHE . 80.3 m -91.14 81.05 5.59 Favored 'General case' 0 N--CA 1.431 -1.393 0 N-CA-C 106.468 -1.678 . . . . 0.0 106.468 171.475 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 29' ' ' ARG . . . . . 0.625 ' HA ' ' CE1' ' A' ' 14' ' ' HIS . 43.0 ttt180 -174.07 -70.85 0.01 OUTLIER 'General case' 0 C--N 1.305 -1.354 0 CA-C-N 112.735 -2.03 . . . . 0.0 110.32 -162.54 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 73.2 m-20 -65.51 -29.12 69.72 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 121.1 0.476 . . . . 0.0 111.2 -176.968 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 93.6 m-20 -67.9 -22.06 65.1 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 115.82 -0.627 . . . . 0.0 111.391 179.915 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 78.08 12.71 84.1 Favored Glycine 0 N--CA 1.449 -0.466 0 C-N-CA 120.719 -0.753 . . . . 0.0 111.509 -178.895 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 66.9 mttm -133.34 128.48 20.31 Favored Pre-proline 0 C--N 1.324 -0.54 0 CA-C-N 115.455 -0.372 . . . . 0.0 110.156 -176.801 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 34' ' ' PRO . . . . . 0.42 ' HA ' ' CG2' ' A' ' 28' ' ' THR . 93.9 Cg_endo -80.17 154.58 22.18 Favored 'Trans proline' 0 N--CA 1.45 -1.038 0 C-N-CA 121.914 1.743 . . . . 0.0 111.112 174.231 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -113.59 150.53 32.95 Favored 'General case' 0 C--N 1.319 -0.749 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.211 -173.027 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 10.9 tp -94.51 126.94 40.11 Favored 'General case' 0 C--N 1.318 -0.797 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.574 178.547 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 37' ' ' PHE . . . . . . . . . . . . . 4.4 m-30 -94.97 107.43 19.46 Favored 'General case' 0 C--N 1.315 -0.907 0 CA-C-N 115.924 -0.58 . . . . 0.0 109.678 171.96 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 16.1 mmm180 -81.71 108.0 14.9 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 115.615 -0.72 . . . . 0.0 111.341 -178.311 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 39' ' ' LEU . . . . . 0.435 ' HG ' ' CB ' ' A' ' 49' ' ' GLU . 10.7 mp -81.77 154.55 25.91 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-N 114.897 -1.047 . . . . 0.0 110.567 177.466 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 101.35 34.23 4.56 Favored Glycine 0 N--CA 1.449 -0.481 0 C-N-CA 120.718 -0.753 . . . . 0.0 112.823 177.107 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 20.6 t70 65.68 6.05 3.66 Favored 'General case' 0 N--CA 1.471 0.619 0 CA-C-O 121.148 0.499 . . . . 0.0 111.994 176.676 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -68.7 -59.3 3.21 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-O 121.068 0.461 . . . . 0.0 111.127 -175.858 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 22.2 m -116.85 -31.21 5.51 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-O 121.306 0.574 . . . . 0.0 110.353 177.979 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 44' ' ' LEU . . . . . 0.402 HD12 HD13 ' A' ' 48' ' ' LEU . 49.9 mt -108.8 157.8 18.24 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-N 115.651 -0.704 . . . . 0.0 110.456 -175.291 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 49.1 m -89.07 171.27 9.96 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 115.825 -0.625 . . . . 0.0 111.018 179.654 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 46' ' ' GLU . . . . . 0.445 ' O ' ' HG3' ' A' ' 50' ' ' GLN . 59.0 mm-40 -47.89 -49.12 30.76 Favored 'General case' 0 C--N 1.33 -0.247 0 O-C-N 123.856 0.723 . . . . 0.0 112.201 -176.01 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . 0.449 ' HA3' ' HB1' ' A' ' 69' ' ' ALA . . . -58.73 -45.61 94.58 Favored Glycine 0 CA--C 1.519 0.303 0 C-N-CA 120.881 -0.676 . . . . 0.0 113.379 -175.155 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 48' ' ' LEU . . . . . 0.402 HD13 HD12 ' A' ' 44' ' ' LEU . 0.3 OUTLIER -60.12 -52.91 63.33 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 117.039 0.42 . . . . 0.0 110.324 -178.889 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 49' ' ' GLU . . . . . 0.435 ' CB ' ' HG ' ' A' ' 39' ' ' LEU . 7.6 pt-20 -68.06 -31.9 71.87 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 116.376 -0.375 . . . . 0.0 111.994 -172.212 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 50' ' ' GLN . . . . . 0.603 ' HA ' ' CD2' ' A' ' 53' ' ' LEU . 84.5 mt-30 -80.7 -8.39 59.63 Favored 'General case' 0 N--CA 1.452 -0.354 0 N-CA-C 111.814 0.302 . . . . 0.0 111.814 -170.642 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 51' ' ' HIS . . . . . . . . . . . . . 21.8 m-70 -108.81 -5.14 16.38 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-O 121.215 0.531 . . . . 0.0 110.18 -178.501 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 18.1 mt -103.72 -30.25 10.54 Favored 'General case' 0 C--N 1.32 -0.691 0 CA-C-N 115.684 -0.689 . . . . 0.0 111.601 177.216 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 53' ' ' LEU . . . . . 0.603 ' CD2' ' HA ' ' A' ' 50' ' ' GLN . 2.5 pp -67.57 151.34 47.49 Favored 'General case' 0 C--O 1.234 0.24 0 C-N-CA 120.991 -0.284 . . . . 0.0 110.584 -177.215 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 93.7 -5.15 73.17 Favored Glycine 0 CA--C 1.522 0.53 0 C-N-CA 120.996 -0.621 . . . . 0.0 113.049 -177.418 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 55' ' ' LEU . . . . . 0.555 ' O ' HG11 ' A' ' 5' ' ' VAL . 72.3 mt -92.51 164.66 13.37 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 117.082 0.441 . . . . 0.0 111.008 179.084 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 56' ' ' LYS . . . . . 0.445 ' O ' ' HB2' ' A' ' 59' ' ' ASP . 2.8 mptp? -111.59 169.87 8.52 Favored 'General case' 0 C--N 1.32 -0.717 0 CA-C-O 121.466 0.651 . . . . 0.0 109.345 175.583 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 57' ' ' VAL . . . . . 0.43 ' HA ' ' CG1' ' A' ' 140' ' ' VAL . 52.5 t -63.1 138.73 22.43 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.331 0 CA-C-N 114.954 -1.021 . . . . 0.0 110.027 174.086 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 81.49 10.95 83.82 Favored Glycine 0 N--CA 1.446 -0.651 0 C-N-CA 120.858 -0.687 . . . . 0.0 112.419 -177.35 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 59' ' ' ASP . . . . . 0.445 ' HB2' ' O ' ' A' ' 56' ' ' LYS . 3.3 m-20 -92.48 139.65 30.37 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-O 120.801 0.334 . . . . 0.0 110.306 175.317 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 6.8 mmmt -111.78 127.97 55.96 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 115.839 -0.619 . . . . 0.0 109.34 -177.767 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 11.3 t -142.43 141.28 32.19 Favored 'General case' 0 C--N 1.317 -0.836 0 CA-C-O 121.281 0.562 . . . . 0.0 111.103 -179.178 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 5.0 m -127.73 131.36 49.71 Favored 'General case' 0 C--N 1.316 -0.878 0 N-CA-C 109.049 -0.723 . . . . 0.0 109.049 174.789 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 63' ' ' PHE . . . . . 0.529 ' CE2' ' HE1' ' A' ' 136' ' ' PHE . 41.2 p90 -152.2 172.59 16.15 Favored 'General case' 0 C--N 1.319 -0.75 0 CA-C-O 120.648 0.261 . . . . 0.0 110.576 179.061 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 38.3 t -132.04 143.8 50.31 Favored 'General case' 0 C--N 1.319 -0.735 0 N-CA-C 108.743 -0.836 . . . . 0.0 108.743 -172.16 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 57.2 mt -139.48 139.18 36.92 Favored 'General case' 0 C--N 1.319 -0.758 0 CA-C-O 121.12 0.486 . . . . 0.0 111.501 -176.728 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 66' ' ' GLU . . . . . 0.447 ' CD ' ' H ' ' A' ' 66' ' ' GLU . 13.5 mp0 -64.84 148.36 97.44 Favored Pre-proline 0 N--CA 1.44 -0.928 0 CA-C-N 115.009 -0.996 . . . . 0.0 109.373 170.571 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 73.7 Cg_exo -50.44 -23.78 11.05 Favored 'Trans proline' 0 C--N 1.346 0.434 0 C-N-CA 124.024 3.15 . . . . 0.0 114.662 -174.697 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 32.8 t70 -66.8 -26.2 66.83 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-O 121.149 0.5 . . . . 0.0 110.697 177.867 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 69' ' ' ALA . . . . . 0.449 ' HB1' ' HA3' ' A' ' 47' ' ' GLY . . . -108.21 -6.34 16.43 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 115.954 -0.567 . . . . 0.0 111.524 -178.067 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.327 -0.374 0 CA-C-N 116.664 -0.244 . . . . 0.0 111.154 -176.009 . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 32.2 t . . . . . 0 N--CA 1.446 -0.642 0 CA-C-O 120.671 0.272 . . . . 0.0 110.276 . . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 39.5 Cg_endo -69.11 -24.47 32.61 Favored 'Trans proline' 0 N--CA 1.465 -0.173 0 C-N-CA 122.074 1.849 . . . . 0.0 111.245 175.463 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 5.8 p-10 -77.26 -9.09 58.59 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 115.869 -0.605 . . . . 0.0 110.781 177.314 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 78' ' ' LEU . . . . . 0.52 ' HG ' ' HB2' ' A' ' 125' ' ' PHE . 5.0 tp -69.42 -20.99 63.78 Favored 'General case' 0 N--CA 1.453 -0.298 0 CA-C-O 121.645 0.736 . . . . 0.0 109.249 175.388 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 79' ' ' ILE . . . . . 0.451 HG23 ' O ' ' A' ' 123' ' ' VAL . 65.2 mt -70.21 132.17 33.48 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.555 0 CA-C-N 114.473 -1.239 . . . . 0.0 110.396 178.653 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 42.6 mt-30 -152.8 118.24 5.27 Favored 'General case' 0 CA--C 1.509 -0.605 0 CA-C-N 116.099 -0.501 . . . . 0.0 109.983 -176.992 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 81' ' ' TYR . . . . . 0.422 ' HA ' ' O ' ' A' ' 121' ' ' ILE . 0.6 OUTLIER -83.51 121.71 27.57 Favored 'General case' 0 C--N 1.317 -0.846 0 N-CA-C 114.193 1.183 . . . . 0.0 114.193 -179.936 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 82' ' ' PHE . . . . . 0.433 ' HZ ' ' SD ' ' A' ' 104' ' ' MET . 7.5 m-85 -102.99 171.14 7.55 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 113.887 -1.506 . . . . 0.0 110.486 175.015 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 8.5 t -74.48 136.52 42.25 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-O 121.368 0.604 . . . . 0.0 110.904 -178.669 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 84' ' ' ARG . . . . . 0.583 ' HA ' ' CG1' ' A' ' 121' ' ' ILE . 12.1 ptm180 -61.36 -17.28 53.2 Favored 'General case' 0 C--N 1.326 -0.448 0 N-CA-C 113.734 1.013 . . . . 0.0 113.734 -178.187 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 85' ' ' ARG . . . . . 0.472 ' HD2' ' N ' ' A' ' 85' ' ' ARG . 6.7 mpt_? -73.92 -32.3 63.48 Favored 'General case' 0 C--N 1.321 -0.643 0 CA-C-O 121.203 0.525 . . . . 0.0 109.716 -176.396 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 32.7 mt-10 -63.28 -21.71 66.42 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 115.175 -0.921 . . . . 0.0 111.044 -179.102 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 87' ' ' PHE . . . . . . . . . . . . . 52.5 m-85 -96.83 -20.48 18.15 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 115.831 -0.622 . . . . 0.0 110.916 -178.308 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 88' ' ' MET . . . . . . . . . . . . . 55.7 ttm -60.91 -27.14 67.97 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 115.682 -0.69 . . . . 0.0 111.544 -175.915 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 60.8 m-20 -53.33 -34.57 58.01 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 116.426 -0.352 . . . . 0.0 111.538 177.022 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -109.79 16.58 21.95 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-O 121.014 0.435 . . . . 0.0 110.495 179.315 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 93.95 155.26 31.65 Favored Glycine 0 N--CA 1.448 -0.549 0 C-N-CA 121.088 -0.577 . . . . 0.0 111.734 -177.212 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 11.6 tt0 -64.73 127.86 92.97 Favored Pre-proline 0 N--CA 1.431 -1.402 0 CA-C-O 121.0 0.428 . . . . 0.0 109.945 -179.799 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 93' ' ' PRO . . . . . 0.486 ' CB ' HD11 ' A' ' 113' ' ' ILE . 31.8 Cg_endo -65.5 165.65 22.08 Favored 'Trans proline' 0 C--O 1.233 0.271 0 C-N-CA 123.398 2.732 . . . . 0.0 113.923 -176.196 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 94' ' ' GLU . . . . . 0.445 ' O ' ' HB ' ' A' ' 113' ' ' ILE . 14.2 mt-10 -114.22 154.53 27.74 Favored 'General case' 0 C--N 1.333 -0.145 0 CA-C-N 115.651 -0.704 . . . . 0.0 110.69 -177.385 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 95' ' ' ILE . . . . . 0.56 ' CG1' HG12 ' A' ' 116' ' ' ILE . 20.2 mt -82.27 129.66 37.1 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.386 0 CA-C-O 121.047 0.451 . . . . 0.0 111.576 -178.168 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 71.76 27.09 71.46 Favored Glycine 0 N--CA 1.45 -0.406 0 CA-C-N 115.49 -0.777 . . . . 0.0 113.208 179.076 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -109.52 129.02 55.59 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-O 120.634 0.254 . . . . 0.0 110.691 177.062 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 98' ' ' ILE . . . . . 0.623 ' HA ' ' HA ' ' A' ' 112' ' ' VAL . 4.1 mt -89.01 133.07 32.18 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.561 0 N-CA-C 108.68 -0.859 . . . . 0.0 108.68 177.02 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 99' ' ' MET . . . . . . . . . . . . . 10.3 mtm -136.64 157.59 46.42 Favored 'General case' 0 N--CA 1.444 -0.764 0 N-CA-C 106.648 -1.612 . . . . 0.0 106.648 177.194 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 100' ' ' LEU . . . . . 0.462 HD13 ' HG2' ' A' ' 108' ' ' GLU . 1.3 mm? -71.56 103.36 2.97 Favored 'General case' 0 C--N 1.313 -1.01 0 CA-C-O 122.438 1.113 . . . . 0.0 110.772 174.457 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 101' ' ' PHE . . . . . . . . . . . . . 2.7 m-85 -90.19 170.1 10.58 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-N 113.215 -1.811 . . . . 0.0 112.455 -174.144 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 1.6 m -126.37 140.52 52.44 Favored 'General case' 0 C--N 1.317 -0.829 0 CA-C-N 114.234 -1.348 . . . . 0.0 109.781 178.432 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -96.23 163.91 12.89 Favored 'General case' 0 C--N 1.321 -0.657 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.491 -179.598 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 104' ' ' MET . . . . . 0.433 ' SD ' ' HZ ' ' A' ' 82' ' ' PHE . 4.3 mpp? -66.73 -19.57 65.78 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 115.813 -0.63 . . . . 0.0 110.969 -179.272 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 6.2 p-10 -93.94 16.26 14.81 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.926 0.393 . . . . 0.0 111.458 -179.25 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 85.23 -11.15 61.45 Favored Glycine 0 N--CA 1.451 -0.364 0 C-N-CA 121.148 -0.548 . . . . 0.0 113.254 174.484 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 68.2 m -78.36 149.42 33.4 Favored 'General case' 0 C--N 1.316 -0.87 0 CA-C-O 121.18 0.514 . . . . 0.0 110.974 -179.652 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 108' ' ' GLU . . . . . 0.462 ' HG2' HD13 ' A' ' 100' ' ' LEU . 40.1 tt0 -91.21 146.57 23.72 Favored 'General case' 0 C--N 1.312 -1.043 0 CA-C-N 115.519 -0.764 . . . . 0.0 108.979 175.929 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 109' ' ' MET . . . . . . . . . . . . . 88.9 mmm -138.41 151.17 68.74 Favored Pre-proline 0 C--O 1.231 0.12 0 N-CA-C 106.016 -1.846 . . . . 0.0 106.016 -164.073 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 4.9 Cg_endo -81.63 113.24 2.53 Favored 'Trans proline' 0 N--CA 1.446 -1.285 0 CA-C-N 121.428 1.546 . . . . 0.0 109.671 162.962 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 111' ' ' GLY . . . . . 0.434 ' HA2' ' O ' ' A' ' 124' ' ' ASP . . . -121.39 126.21 6.45 Favored Glycine 0 N--CA 1.436 -1.354 0 C-N-CA 120.251 -0.975 . . . . 0.0 112.299 179.2 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 112' ' ' VAL . . . . . 0.623 ' HA ' ' HA ' ' A' ' 98' ' ' ILE . 0.2 OUTLIER -105.1 140.18 23.88 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.142 0 N-CA-C 108.587 -0.894 . . . . 0.0 108.587 174.023 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 113' ' ' ILE . . . . . 0.486 HD11 ' CB ' ' A' ' 93' ' ' PRO . 10.3 mt -89.2 108.61 19.3 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.374 0 N-CA-C 107.826 -1.175 . . . . 0.0 107.826 -174.194 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 114' ' ' ARG . . . . . 0.469 ' O ' HG22 ' A' ' 95' ' ' ILE . 10.9 tpp180 -64.88 -47.53 77.53 Favored 'General case' 0 C--N 1.317 -0.839 0 CA-C-N 115.284 -0.871 . . . . 0.0 111.513 -171.179 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 115' ' ' GLU . . . . . 0.458 ' N ' ' HB ' ' A' ' 122' ' ' THR . 8.6 tt0 -161.63 162.48 30.01 Favored 'General case' 0 C--N 1.317 -0.833 0 N-CA-C 109.445 -0.576 . . . . 0.0 109.445 -175.28 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 116' ' ' ILE . . . . . 0.56 HG12 ' CG1' ' A' ' 95' ' ' ILE . 28.7 mm -111.82 112.53 40.93 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.427 0 CA-C-O 121.174 0.511 . . . . 0.0 110.129 177.356 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 117' ' ' ASN . . . . . 0.462 HD21 ' N ' ' A' ' 117' ' ' ASN . 0.9 OUTLIER -96.31 158.93 15.21 Favored 'General case' 0 C--N 1.315 -0.896 0 CA-C-N 115.557 -0.747 . . . . 0.0 110.056 179.06 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . -57.18 -45.75 92.29 Favored Glycine 0 N--CA 1.452 -0.294 0 C-N-CA 120.612 -0.804 . . . . 0.0 113.304 -172.476 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 119' ' ' ASP . . . . . 0.421 ' O ' ' HG2' ' A' ' 84' ' ' ARG . 10.3 m-20 -113.39 -15.8 12.57 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-O 120.784 0.326 . . . . 0.0 111.53 178.397 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 120' ' ' SER . . . . . 0.453 ' O ' ' HB2' ' A' ' 117' ' ' ASN . 16.0 t -116.86 157.74 25.13 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-O 120.814 0.34 . . . . 0.0 111.09 -172.312 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 121' ' ' ILE . . . . . 0.583 ' CG1' ' HA ' ' A' ' 84' ' ' ARG . 38.8 mm -112.21 128.18 68.98 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.576 0 CA-C-O 121.746 0.784 . . . . 0.0 110.837 174.491 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 122' ' ' THR . . . . . 0.458 ' HB ' ' N ' ' A' ' 115' ' ' GLU . 0.6 OUTLIER -90.88 141.11 29.17 Favored 'General case' 0 C--N 1.307 -1.278 0 CA-C-N 114.338 -1.301 . . . . 0.0 109.382 178.236 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 123' ' ' VAL . . . . . 0.451 ' O ' HG23 ' A' ' 79' ' ' ILE . 43.8 t -138.39 158.93 31.91 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.41 0 N-CA-C 109.055 -0.72 . . . . 0.0 109.055 -156.522 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 124' ' ' ASP . . . . . 0.555 ' HB3' HG13 ' A' ' 112' ' ' VAL . 46.1 t0 -148.83 148.74 30.26 Favored 'General case' 0 C--N 1.305 -1.357 0 CA-C-N 116.058 -0.519 . . . . 0.0 110.256 174.781 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 125' ' ' PHE . . . . . 0.52 ' HB2' ' HG ' ' A' ' 78' ' ' LEU . 84.4 m-85 -135.97 3.71 2.95 Favored 'General case' 0 C--N 1.318 -0.804 0 CA-C-N 115.246 -0.888 . . . . 0.0 109.707 176.041 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 29.4 m-80 . . . . . 0 N--CA 1.449 -0.495 0 CA-C-N 114.685 -1.143 . . . . 0.0 110.571 176.103 . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 133' ' ' THR . . . . . . . . . . . . . 14.5 m . . . . . 0 N--CA 1.451 -0.39 0 CA-C-O 120.904 0.383 . . . . 0.0 110.552 . . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 134' ' ' VAL . . . . . . . . . . . . . 4.6 m -101.98 142.81 15.72 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.599 0 CA-C-O 121.236 0.541 . . . . 0.0 111.576 -176.483 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 135' ' ' HIS . . . . . . . . . . . . . 69.5 m-70 -124.87 113.24 17.61 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 115.328 -0.851 . . . . 0.0 109.076 -178.794 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 136' ' ' PHE . . . . . 0.529 ' HE1' ' CE2' ' A' ' 63' ' ' PHE . 0.1 OUTLIER -117.96 132.2 56.42 Favored 'General case' 0 C--N 1.316 -0.862 0 CA-C-O 121.103 0.478 . . . . 0.0 111.295 -175.787 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 137' ' ' ASP . . . . . . . . . . . . . 14.4 t70 -99.23 102.61 14.31 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-N 115.18 -0.918 . . . . 0.0 108.56 177.427 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 138' ' ' ILE . . . . . 0.516 HG21 ' CG2' ' A' ' 13' ' ' VAL . 40.6 mt -103.27 132.78 48.81 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.644 0 N-CA-C 112.716 0.635 . . . . 0.0 112.716 -166.912 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 24.0 mt-10 -125.7 114.46 18.68 Favored 'General case' 0 N--CA 1.45 -0.439 0 CA-C-N 115.24 -0.891 . . . . 0.0 109.131 178.781 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 140' ' ' VAL . . . . . 0.43 ' CG1' ' HA ' ' A' ' 57' ' ' VAL . 65.2 t -70.55 122.16 21.8 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.417 0 CA-C-N 117.824 0.284 . . . . 0.0 110.86 -179.498 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 141' ' ' LEU . . . . . 0.486 HD12 ' CB ' ' A' ' 14' ' ' HIS . 13.8 mt -100.76 -33.12 10.38 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-O 121.672 0.748 . . . . 0.0 110.426 178.739 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 142' ' ' GLU . . . . . 0.427 ' HB3' ' HB2' ' A' ' 12' ' ' LEU . 32.8 tt0 -163.88 151.59 12.64 Favored 'General case' 0 C--N 1.314 -0.971 0 CA-C-N 114.405 -1.27 . . . . 0.0 109.858 -178.334 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 143' ' ' ILE . . . . . . . . . . . . . 85.3 mt -122.1 113.82 40.28 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.397 0 CA-C-O 120.961 0.41 . . . . 0.0 110.932 -178.473 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 144' ' ' ASP . . . . . . . . . . . . . 37.4 t70 -79.15 126.17 82.19 Favored Pre-proline 0 C--N 1.323 -0.55 0 CA-C-N 115.807 -0.633 . . . . 0.0 110.291 177.998 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 145' ' ' PRO . . . . . . . . . . . . . 41.5 Cg_endo . . . . . 0 C--O 1.234 0.311 0 C-N-CA 123.016 2.477 . . . . 0.0 113.294 -175.864 . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 18.9 p . . . . . 0 N--CA 1.469 0.51 0 N-CA-C 112.464 0.542 . . . . 0.0 112.464 . . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 47.7 mt-10 -75.79 -33.24 60.13 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-O 121.215 0.531 . . . . 0.0 110.734 176.311 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 12.6 p -114.37 149.12 36.61 Favored 'General case' 0 C--N 1.319 -0.749 0 CA-C-N 115.558 -0.746 . . . . 0.0 110.647 -177.894 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . 0.483 HG13 ' O ' ' A' ' 55' ' ' LEU . 7.4 p -73.68 144.83 12.2 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.395 0 CA-C-N 115.61 -0.723 . . . . 0.0 110.598 -178.281 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 6' ' ' GLN . . . . . . . . . . . . . 3.4 pt20 -136.99 166.31 23.96 Favored 'General case' 0 N--CA 1.444 -0.727 0 N-CA-C 108.488 -0.93 . . . . 0.0 108.488 -179.592 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 34.2 p -63.93 138.68 58.58 Favored 'General case' 0 C--N 1.317 -0.812 0 CA-C-O 120.735 0.303 . . . . 0.0 110.94 -176.531 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 15.5 t30 70.92 15.59 6.72 Favored 'General case' 0 CA--C 1.542 0.641 0 CA-C-N 115.491 -0.777 . . . . 0.0 111.643 177.928 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 9' ' ' SER . . . . . 0.627 ' O ' HD22 ' A' ' 39' ' ' LEU . 8.8 t -108.15 134.36 51.11 Favored 'General case' 0 N--CA 1.451 -0.411 0 N-CA-C 108.079 -1.082 . . . . 0.0 108.079 177.276 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -82.19 149.07 28.11 Favored 'General case' 0 C--N 1.322 -0.599 0 N-CA-C 109.69 -0.485 . . . . 0.0 109.69 -174.02 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 6.3 m -134.33 145.05 33.51 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.755 0 C-N-CA 120.281 -0.568 . . . . 0.0 111.35 -175.869 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 12' ' ' LEU . . . . . 0.42 HD22 ' HB2' ' A' ' 142' ' ' GLU . 6.6 mp -91.74 119.36 31.51 Favored 'General case' 0 C--N 1.326 -0.456 0 N-CA-C 108.809 -0.811 . . . . 0.0 108.809 177.909 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 13' ' ' VAL . . . . . 0.45 HG23 ' N ' ' A' ' 14' ' ' HIS . 2.4 p -132.37 154.48 40.07 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.68 0 CA-C-O 122.146 0.974 . . . . 0.0 113.219 -172.12 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 14' ' ' HIS . . . . . 0.45 ' N ' HG23 ' A' ' 13' ' ' VAL . 0.2 OUTLIER -117.2 117.7 30.28 Favored 'General case' 0 C--N 1.32 -0.704 0 N-CA-C 106.225 -1.769 . . . . 0.0 106.225 170.936 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 32.1 p90 -148.27 157.35 43.44 Favored 'General case' 0 C--N 1.327 -0.396 0 C-N-CA 118.671 -1.212 . . . . 0.0 113.785 -167.523 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 85.9 m -128.88 118.77 23.25 Favored 'General case' 0 C--N 1.321 -0.653 0 CA-C-N 115.006 -0.997 . . . . 0.0 109.813 174.617 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 17' ' ' LEU . . . . . 0.502 HD21 ' CE2' ' A' ' 136' ' ' PHE . 1.4 mt -95.17 112.91 24.56 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-O 121.034 0.445 . . . . 0.0 111.163 179.045 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 10.2 mptt -109.05 128.01 54.61 Favored 'General case' 0 C--N 1.314 -0.945 0 CA-C-N 115.735 -0.666 . . . . 0.0 110.826 -179.251 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 19.8 tp -85.42 161.53 19.39 Favored 'General case' 0 N--CA 1.438 -1.069 0 CA-C-N 115.677 -0.692 . . . . 0.0 109.199 175.775 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 29.2 t70 -62.77 -24.69 67.85 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 121.431 0.634 . . . . 0.0 110.25 178.603 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 27.1 t70 -70.25 -3.66 18.12 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 115.162 -0.927 . . . . 0.0 111.385 177.646 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 74.81 9.08 82.99 Favored Glycine 0 C--N 1.332 0.333 0 C-N-CA 121.508 -0.377 . . . . 0.0 112.425 -175.593 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 52.7 m -91.45 140.28 29.9 Favored 'General case' 0 C--N 1.319 -0.745 0 CA-C-N 115.309 -0.446 . . . . 0.0 110.06 175.779 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 41.7 m -79.68 108.24 13.08 Favored 'General case' 0 C--N 1.318 -0.784 0 N-CA-C 110.05 -0.352 . . . . 0.0 110.05 177.197 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -69.86 -34.77 74.05 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.88 -0.6 . . . . 0.0 110.527 -177.969 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 44.2 tt0 -159.83 128.35 4.96 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 115.857 -0.611 . . . . 0.0 109.697 177.356 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 18.4 p -109.58 130.48 55.51 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-N 116.534 -0.303 . . . . 0.0 110.835 -178.289 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 28' ' ' THR . . . . . 0.684 ' O ' HG23 ' A' ' 28' ' ' THR . 62.2 m -148.59 14.48 0.96 Allowed 'General case' 0 CA--C 1.546 0.798 0 CA-C-O 122.831 1.301 . . . . 0.0 110.854 174.75 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 16.0 tpt180 -92.94 -68.99 0.77 Allowed 'General case' 0 C--N 1.307 -1.257 0 O-C-N 121.19 -0.944 . . . . 0.0 111.018 168.523 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 7.8 p30 -69.47 -10.61 58.77 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.407 -0.36 . . . . 0.0 111.452 -172.754 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 2.2 m-20 -58.37 -31.08 67.3 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.981 177.631 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 91.09 -13.39 66.37 Favored Glycine 0 N--CA 1.447 -0.593 0 C-N-CA 120.621 -0.8 . . . . 0.0 111.404 -175.813 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 75.4 mmtt -120.23 124.47 27.74 Favored Pre-proline 0 C--N 1.324 -0.533 0 N-CA-C 109.587 -0.524 . . . . 0.0 109.587 179.871 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 71.6 Cg_endo -76.53 168.85 22.98 Favored 'Trans proline' 0 N--CA 1.457 -0.659 0 C-N-CA 122.38 2.053 . . . . 0.0 111.889 176.438 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -131.75 149.86 52.34 Favored 'General case' 0 C--N 1.319 -0.719 0 CA-C-N 116.391 -0.368 . . . . 0.0 110.43 -177.234 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 4.9 tp -88.71 137.32 32.42 Favored 'General case' 0 C--N 1.318 -0.801 0 N-CA-C 109.769 -0.456 . . . . 0.0 109.769 174.711 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 37' ' ' PHE . . . . . . . . . . . . . 6.4 m-30 -98.37 119.89 37.84 Favored 'General case' 0 C--N 1.316 -0.862 0 N-CA-C 108.548 -0.908 . . . . 0.0 108.548 172.5 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 24.6 tpt180 -90.33 104.88 17.41 Favored 'General case' 0 N--CA 1.442 -0.832 0 N-CA-C 108.955 -0.757 . . . . 0.0 108.955 177.92 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 39' ' ' LEU . . . . . 0.627 HD22 ' O ' ' A' ' 9' ' ' SER . 2.2 mm? -89.97 156.26 18.54 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-N 115.455 -0.793 . . . . 0.0 111.137 -178.767 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 101.09 29.48 6.4 Favored Glycine 0 N--CA 1.445 -0.713 0 C-N-CA 120.723 -0.751 . . . . 0.0 112.103 -175.19 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 38.8 t70 68.87 3.42 3.97 Favored 'General case' 0 N--CA 1.472 0.627 0 CA-C-O 121.34 0.59 . . . . 0.0 111.823 175.357 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -74.53 -7.52 53.35 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-N 116.055 -0.52 . . . . 0.0 112.113 -179.305 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 32.7 t -163.68 -60.64 0.04 OUTLIER 'General case' 0 C--N 1.323 -0.556 0 N-CA-C 109.476 -0.564 . . . . 0.0 109.476 176.056 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 7.8 mp -90.01 161.46 15.85 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-N 115.87 -0.604 . . . . 0.0 110.502 178.096 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 46.9 t -77.99 145.87 35.75 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-N 115.438 -0.801 . . . . 0.0 109.752 178.273 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 46' ' ' GLU . . . . . 0.608 ' O ' ' HG2' ' A' ' 50' ' ' GLN . 12.1 tt0 -58.68 -16.69 17.44 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 115.078 -0.964 . . . . 0.0 112.004 -176.987 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -69.29 -32.06 71.99 Favored Glycine 0 N--CA 1.446 -0.634 0 C-N-CA 120.69 -0.766 . . . . 0.0 111.942 -177.812 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 1.6 tt -69.07 -53.0 22.64 Favored 'General case' 0 N--CA 1.45 -0.445 0 CA-C-O 120.672 0.272 . . . . 0.0 110.834 -178.298 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 49' ' ' GLU . . . . . 0.604 ' O ' HD21 ' A' ' 53' ' ' LEU . 14.2 pt-20 -58.04 -32.32 67.87 Favored 'General case' 0 N--CA 1.453 -0.305 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.61 179.497 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 50' ' ' GLN . . . . . 0.608 ' HG2' ' O ' ' A' ' 46' ' ' GLU . 69.9 mm-40 -57.32 -26.75 61.42 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 120.775 0.321 . . . . 0.0 110.904 -177.841 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 51' ' ' HIS . . . . . . . . . . . . . 12.1 m-70 -99.76 -14.02 19.03 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 116.397 -0.365 . . . . 0.0 111.03 -179.222 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 25.6 mt -95.76 -30.76 13.54 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 116.406 -0.361 . . . . 0.0 111.914 -177.401 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 53' ' ' LEU . . . . . 0.604 HD21 ' O ' ' A' ' 49' ' ' GLU . 0.0 OUTLIER -57.59 143.59 40.56 Favored 'General case' 0 C--O 1.234 0.26 0 CA-C-O 120.874 0.369 . . . . 0.0 111.246 -176.862 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 93.56 -2.7 70.75 Favored Glycine 0 N--CA 1.443 -0.845 0 C-N-CA 120.879 -0.677 . . . . 0.0 113.452 177.972 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 55' ' ' LEU . . . . . 0.483 ' O ' HG13 ' A' ' 5' ' ' VAL . 24.8 tp -94.41 164.22 13.1 Favored 'General case' 0 N--CA 1.453 -0.311 0 CA-C-N 118.052 0.926 . . . . 0.0 109.159 178.549 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 56' ' ' LYS . . . . . 0.667 ' HD2' ' N ' ' A' ' 57' ' ' VAL . 0.9 OUTLIER -117.15 157.79 25.34 Favored 'General case' 0 C--N 1.32 -0.708 0 N-CA-C 109.89 -0.411 . . . . 0.0 109.89 -174.803 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 57' ' ' VAL . . . . . 0.667 ' N ' ' HD2' ' A' ' 56' ' ' LYS . 8.8 t -57.61 141.74 14.23 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.243 0 CA-C-O 121.078 0.465 . . . . 0.0 111.357 177.954 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 82.87 10.12 83.5 Favored Glycine 0 N--CA 1.447 -0.576 0 CA-C-N 115.734 -0.666 . . . . 0.0 112.338 -178.859 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 8.5 m-20 -116.41 152.76 33.33 Favored 'General case' 0 C--N 1.324 -0.53 0 N-CA-C 109.543 -0.54 . . . . 0.0 109.543 174.291 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 60' ' ' LYS . . . . . 0.493 ' HE3' ' HG2' ' A' ' 139' ' ' GLU . 0.6 OUTLIER -131.73 149.38 52.5 Favored 'General case' 0 C--N 1.316 -0.877 0 CA-C-O 121.519 0.676 . . . . 0.0 111.76 -175.364 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 9.3 t -143.53 130.86 20.91 Favored 'General case' 0 C--N 1.314 -0.961 0 CA-C-N 114.714 -1.13 . . . . 0.0 110.884 -178.36 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 4.1 m -107.1 131.53 54.01 Favored 'General case' 0 N--CA 1.44 -0.944 0 N-CA-C 107.866 -1.161 . . . . 0.0 107.866 171.134 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 63' ' ' PHE . . . . . 0.43 ' HE1' ' CG1' ' A' ' 138' ' ' ILE . 1.5 p90 -158.24 153.46 25.65 Favored 'General case' 0 C--N 1.321 -0.631 0 CA-C-O 121.021 0.439 . . . . 0.0 110.937 -171.195 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 16.4 m -104.85 148.96 26.09 Favored 'General case' 0 C--N 1.319 -0.748 0 CA-C-N 115.727 -0.669 . . . . 0.0 110.644 -179.713 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 65' ' ' LEU . . . . . 0.451 ' O ' HG22 ' A' ' 133' ' ' THR . 82.8 mt -138.82 142.39 38.68 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.557 -0.292 . . . . 0.0 110.722 -176.039 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 66' ' ' GLU . . . . . 0.425 ' H ' ' CD ' ' A' ' 66' ' ' GLU . 1.6 mp0 -64.76 154.11 86.23 Favored Pre-proline 0 C--N 1.329 -0.311 0 CA-C-N 115.921 -0.581 . . . . 0.0 109.741 174.299 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 10.8 Cg_endo -56.65 -48.55 18.26 Favored 'Trans proline' 0 C--O 1.219 -0.431 0 C-N-CA 121.869 1.712 . . . . 0.0 113.563 -176.355 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 23.5 t70 -64.01 -21.99 66.74 Favored 'General case' 0 C--N 1.324 -0.511 0 O-C-N 121.515 -0.741 . . . . 0.0 110.072 178.534 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -86.35 -28.76 23.46 Favored 'General case' 0 N--CA 1.451 -0.406 0 CA-C-N 115.982 -0.554 . . . . 0.0 111.216 179.09 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.454 -0.262 0 N-CA-C 109.776 -0.453 . . . . 0.0 109.776 176.578 . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 75' ' ' SER . . . . . 0.572 ' HB3' ' OD1' ' A' ' 77' ' ' ASP . 30.8 m . . . . . 0 C--O 1.232 0.156 0 CA-C-O 120.774 0.321 . . . . 0.0 110.993 . . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 76' ' ' PRO . . . . . 0.401 ' HA ' HG13 ' A' ' 79' ' ' ILE . 53.1 Cg_endo -70.16 -17.28 35.87 Favored 'Trans proline' 0 CA--C 1.529 0.274 0 C-N-CA 123.199 2.599 . . . . 0.0 113.571 -178.118 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 77' ' ' ASP . . . . . 0.572 ' OD1' ' HB3' ' A' ' 75' ' ' SER . 5.2 p-10 -69.27 -4.75 19.2 Favored 'General case' 0 C--N 1.329 -0.325 0 N-CA-C 112.829 0.678 . . . . 0.0 112.829 -173.331 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 78' ' ' LEU . . . . . 0.625 ' HB2' ' O ' ' A' ' 125' ' ' PHE . 83.1 mt -112.57 -5.1 14.03 Favored 'General case' 0 C--N 1.324 -0.523 0 C-N-CA 120.742 -0.383 . . . . 0.0 110.963 176.399 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 79' ' ' ILE . . . . . 0.401 HG13 ' HA ' ' A' ' 76' ' ' PRO . 15.2 mt -77.39 104.81 5.64 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.736 0 C-N-CA 120.345 -0.542 . . . . 0.0 109.705 -173.695 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 73.0 mt-30 -108.95 164.06 12.75 Favored 'General case' 0 C--N 1.314 -0.937 0 CA-C-N 115.671 -0.695 . . . . 0.0 111.824 -172.806 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 81' ' ' TYR . . . . . . . . . . . . . 11.3 m-85 -129.48 115.67 17.82 Favored 'General case' 0 N--CA 1.444 -0.766 0 N-CA-C 107.514 -1.291 . . . . 0.0 107.514 -172.78 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 73.4 m-85 -111.24 168.29 9.63 Favored 'General case' 0 C--N 1.317 -0.844 0 CA-C-O 120.763 0.316 . . . . 0.0 110.863 -174.661 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 12.2 t -73.86 145.24 45.02 Favored 'General case' 0 C--N 1.323 -0.577 0 N-CA-C 108.849 -0.797 . . . . 0.0 108.849 176.692 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 84' ' ' ARG . . . . . 0.6 ' HD3' ' HA ' ' A' ' 119' ' ' ASP . 28.9 ptt180 -73.64 -29.72 62.51 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-O 121.576 0.703 . . . . 0.0 109.609 -173.895 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 85' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -64.7 -38.94 92.7 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 114.597 -1.183 . . . . 0.0 113.391 -171.015 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 86' ' ' GLU . . . . . 0.444 ' O ' ' HB3' ' A' ' 89' ' ' ASP . 44.1 mm-40 -60.65 -48.88 79.82 Favored 'General case' 0 C--N 1.317 -0.836 0 CA-C-O 122.269 1.033 . . . . 0.0 108.687 174.259 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 87' ' ' PHE . . . . . . . . . . . . . 55.6 m-85 -59.0 -31.85 69.18 Favored 'General case' 0 C--N 1.318 -0.783 0 CA-C-N 113.701 -1.591 . . . . 0.0 112.91 175.264 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 88' ' ' MET . . . . . . . . . . . . . 60.3 ttp -68.18 -41.45 81.43 Favored 'General case' 0 C--N 1.315 -0.898 0 CA-C-O 122.13 0.967 . . . . 0.0 109.521 174.025 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 89' ' ' ASP . . . . . 0.444 ' HB3' ' O ' ' A' ' 86' ' ' GLU . 19.3 t70 -55.17 -23.07 19.82 Favored 'General case' 0 C--N 1.321 -0.673 0 CA-C-N 113.387 -1.733 . . . . 0.0 110.164 176.029 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -112.86 8.63 18.75 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 115.646 -0.706 . . . . 0.0 111.799 178.938 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 92.08 137.61 7.85 Favored Glycine 0 C--N 1.331 0.265 0 C-N-CA 120.482 -0.866 . . . . 0.0 111.989 -177.453 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 8.8 tt0 -61.91 122.07 69.47 Favored Pre-proline 0 N--CA 1.442 -0.848 0 CA-C-O 121.116 0.484 . . . . 0.0 111.306 -172.271 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 93' ' ' PRO . . . . . 0.437 ' HB2' HD11 ' A' ' 113' ' ' ILE . 38.1 Cg_endo -77.75 165.96 26.03 Favored 'Trans proline' 0 N--CA 1.46 -0.497 0 C-N-CA 122.935 2.423 . . . . 0.0 112.875 -177.525 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 94' ' ' GLU . . . . . 0.509 ' O ' HD12 ' A' ' 113' ' ' ILE . 27.0 mt-10 -115.94 154.13 30.35 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.018 -0.537 . . . . 0.0 111.131 -176.135 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 95' ' ' ILE . . . . . 0.519 ' CG1' HG12 ' A' ' 116' ' ' ILE . 32.6 mt -77.17 134.16 29.24 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.384 0 CA-C-N 116.446 -0.343 . . . . 0.0 110.099 179.168 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 72.26 19.47 78.7 Favored Glycine 0 N--CA 1.449 -0.481 0 C-N-CA 121.032 -0.604 . . . . 0.0 112.407 -176.997 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 97' ' ' ALA . . . . . 0.452 ' O ' HG13 ' A' ' 113' ' ' ILE . . . -99.71 166.86 10.91 Favored 'General case' 0 C--N 1.323 -0.562 0 N-CA-C 109.562 -0.533 . . . . 0.0 109.562 175.27 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 38.8 mt -125.79 126.11 69.49 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.727 0 CA-C-O 120.876 0.37 . . . . 0.0 110.533 -175.598 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 99' ' ' MET . . . . . 0.439 ' SD ' HD13 ' A' ' 113' ' ' ILE . 2.7 mtp -124.72 161.58 26.06 Favored 'General case' 0 C--N 1.324 -0.527 0 N-CA-C 107.898 -1.149 . . . . 0.0 107.898 -179.922 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 3.9 mm? -77.24 153.62 33.82 Favored 'General case' 0 C--N 1.323 -0.587 0 CA-C-N 118.806 0.73 . . . . 0.0 111.078 167.635 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 101' ' ' PHE . . . . . 0.585 ' CE2' HG11 ' A' ' 123' ' ' VAL . 65.5 m-85 -149.42 155.52 40.57 Favored 'General case' 0 C--N 1.319 -0.761 0 CA-C-N 114.702 -1.136 . . . . 0.0 107.986 -170.334 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 3.1 m -121.11 111.44 17.45 Favored 'General case' 0 C--N 1.314 -0.958 0 C-N-CA 119.793 -0.763 . . . . 0.0 110.154 -178.348 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -77.78 166.25 23.18 Favored 'General case' 0 N--CA 1.448 -0.56 0 CA-C-N 115.4 -0.818 . . . . 0.0 110.868 -177.183 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 104' ' ' MET . . . . . . . . . . . . . 60.1 mtt -67.37 -14.32 62.81 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.128 -0.942 . . . . 0.0 111.901 -173.669 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 8.2 p-10 -96.51 11.38 35.27 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 116.551 -0.295 . . . . 0.0 111.383 -177.784 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 88.06 -11.33 67.52 Favored Glycine 0 N--CA 1.447 -0.602 0 C-N-CA 120.42 -0.895 . . . . 0.0 113.289 179.448 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 33.3 t -79.36 149.74 31.61 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-O 121.227 0.537 . . . . 0.0 110.692 -179.327 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 108' ' ' GLU . . . . . 0.422 ' HA ' ' O ' ' A' ' 101' ' ' PHE . 44.5 tt0 -120.51 104.11 9.71 Favored 'General case' 0 C--N 1.317 -0.845 0 CA-C-N 115.615 -0.72 . . . . 0.0 109.381 179.801 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 109' ' ' MET . . . . . 0.449 ' SD ' ' HD2' ' A' ' 125' ' ' PHE . 13.7 ptp -111.44 145.14 31.97 Favored Pre-proline 0 C--N 1.322 -0.614 0 CA-C-N 116.535 -0.302 . . . . 0.0 110.621 -175.579 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 12.2 Cg_exo -70.1 120.6 7.31 Favored 'Trans proline' 0 N--CA 1.462 -0.368 0 C-N-CA 122.475 2.117 . . . . 0.0 110.663 171.5 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . -117.41 153.88 17.01 Favored Glycine 0 C--N 1.321 -0.29 0 C-N-CA 120.752 -0.737 . . . . 0.0 112.447 -176.562 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER -100.77 121.29 51.39 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.426 0 CA-C-O 121.064 0.459 . . . . 0.0 110.249 -176.392 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 113' ' ' ILE . . . . . 0.509 HD12 ' O ' ' A' ' 94' ' ' GLU . 1.0 OUTLIER -67.05 111.22 1.85 Allowed 'Isoleucine or valine' 0 C--N 1.316 -0.85 0 CA-C-N 115.762 -0.654 . . . . 0.0 109.386 176.709 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 114' ' ' ARG . . . . . . . . . . . . . 13.2 tpp180 -63.29 -52.36 62.31 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 115.349 -0.841 . . . . 0.0 110.744 -178.085 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 5.2 tt0 -159.48 148.45 18.03 Favored 'General case' 0 C--N 1.32 -0.699 0 N-CA-C 110.11 -0.33 . . . . 0.0 110.11 -177.79 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 116' ' ' ILE . . . . . 0.519 HG12 ' CG1' ' A' ' 95' ' ' ILE . 45.9 mm -96.12 111.2 25.88 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.533 0 N-CA-C 108.879 -0.786 . . . . 0.0 108.879 176.197 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 117' ' ' ASN . . . . . . . . . . . . . 37.6 m-80 -101.47 155.8 17.85 Favored 'General case' 0 C--N 1.313 -1.012 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.057 -179.111 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . -57.22 -38.84 88.48 Favored Glycine 0 N--CA 1.448 -0.52 0 C-N-CA 120.453 -0.88 . . . . 0.0 112.925 -170.842 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 119' ' ' ASP . . . . . 0.6 ' HA ' ' HD3' ' A' ' 84' ' ' ARG . 4.7 p-10 -109.75 -12.55 14.61 Favored 'General case' 0 C--N 1.324 -0.516 0 N-CA-C 111.977 0.362 . . . . 0.0 111.977 -174.66 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 20.3 t -146.12 155.99 43.13 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 121.065 0.459 . . . . 0.0 111.899 -168.603 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 121' ' ' ILE . . . . . 0.416 HD13 ' HG2' ' A' ' 93' ' ' PRO . 35.1 mm -119.43 120.25 63.04 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 115.896 -0.593 . . . . 0.0 110.178 178.705 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 89.8 m -106.14 119.48 39.34 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 116.568 -0.287 . . . . 0.0 111.052 -177.504 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 123' ' ' VAL . . . . . 0.585 HG11 ' CE2' ' A' ' 101' ' ' PHE . 38.8 t -117.69 118.26 57.8 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.316 0 CA-C-O 119.482 -0.295 . . . . 0.0 110.539 179.049 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 9.4 p-10 -95.32 96.34 9.08 Favored 'General case' 0 N--CA 1.452 -0.345 0 N-CA-C 114.131 1.159 . . . . 0.0 114.131 -179.906 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 125' ' ' PHE . . . . . 0.625 ' O ' ' HB2' ' A' ' 78' ' ' LEU . 12.0 m-85 -68.78 98.0 0.87 Allowed 'General case' 0 N--CA 1.447 -0.616 0 N-CA-C 109.303 -0.629 . . . . 0.0 109.303 165.912 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 126' ' ' ASN . . . . . 0.408 ' N ' HD21 ' A' ' 126' ' ' ASN . 1.2 m-80 . . . . . 0 C--N 1.3 -1.585 0 CA-C-O 121.092 0.473 . . . . 0.0 110.934 177.237 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 133' ' ' THR . . . . . 0.451 HG22 ' O ' ' A' ' 65' ' ' LEU . 59.6 m . . . . . 0 C--O 1.234 0.242 0 CA-C-O 120.451 0.167 . . . . 0.0 111.13 . . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 134' ' ' VAL . . . . . . . . . . . . . 20.3 m -120.73 151.34 23.62 Favored 'Isoleucine or valine' 0 C--O 1.233 0.22 0 CA-C-O 121.526 0.679 . . . . 0.0 111.697 177.957 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 135' ' ' HIS . . . . . 0.46 ' O ' HD22 ' A' ' 17' ' ' LEU . 86.2 m-70 -90.58 134.94 34.02 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-N 114.728 -1.124 . . . . 0.0 110.375 174.225 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 136' ' ' PHE . . . . . 0.502 ' CE2' HD21 ' A' ' 17' ' ' LEU . 2.5 m-85 -120.94 125.68 48.04 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 116.252 -0.431 . . . . 0.0 111.113 -177.385 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 137' ' ' ASP . . . . . . . . . . . . . 36.0 t70 -113.11 109.52 18.93 Favored 'General case' 0 C--N 1.315 -0.911 0 N-CA-C 108.513 -0.921 . . . . 0.0 108.513 169.028 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 138' ' ' ILE . . . . . 0.43 ' CG1' ' HE1' ' A' ' 63' ' ' PHE . 43.1 mm -119.19 121.33 66.38 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.452 0 O-C-N 123.098 0.249 . . . . 0.0 111.262 -169.773 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 139' ' ' GLU . . . . . 0.493 ' HG2' ' HE3' ' A' ' 60' ' ' LYS . 33.3 mt-10 -107.73 115.55 30.35 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 120.59 0.233 . . . . 0.0 111.201 173.356 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 140' ' ' VAL . . . . . 0.4 ' CG1' ' HA ' ' A' ' 57' ' ' VAL . 38.8 t -71.12 107.47 2.31 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.568 0 CA-C-N 116.299 -0.409 . . . . 0.0 110.177 175.533 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 141' ' ' LEU . . . . . 0.405 HD11 ' CD2' ' A' ' 14' ' ' HIS . 40.1 mt -94.59 -49.64 5.55 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-O 120.885 0.374 . . . . 0.0 110.097 179.821 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 142' ' ' GLU . . . . . 0.42 ' HB2' HD22 ' A' ' 12' ' ' LEU . 37.1 mt-10 -143.7 163.15 34.11 Favored 'General case' 0 CA--C 1.513 -0.476 0 CA-C-N 115.847 -0.615 . . . . 0.0 109.88 172.38 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 143' ' ' ILE . . . . . 0.45 HD11 ' N ' ' A' ' 5' ' ' VAL . 94.8 mt -123.49 110.07 25.03 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.901 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.539 178.484 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 144' ' ' ASP . . . . . . . . . . . . . 27.1 t70 -78.57 111.89 22.58 Favored Pre-proline 0 C--N 1.325 -0.469 0 CA-C-N 115.487 -0.779 . . . . 0.0 110.058 178.408 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 145' ' ' PRO . . . . . . . . . . . . . 52.5 Cg_endo . . . . . 0 N--CA 1.459 -0.514 0 C-N-CA 122.186 1.924 . . . . 0.0 111.831 -177.207 . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 35.5 m . . . . . 0 N--CA 1.453 -0.307 0 CA-C-O 121.216 0.532 . . . . 0.0 110.603 . . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 3' ' ' GLU . . . . . 0.466 ' HG2' ' HE2' ' A' ' 56' ' ' LYS . 36.0 tt0 -99.54 -27.99 13.44 Favored 'General case' 0 C--N 1.319 -0.721 0 CA-C-N 115.533 -0.758 . . . . 0.0 110.525 -177.584 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 8.5 p -124.94 158.27 33.99 Favored 'General case' 0 C--N 1.318 -0.782 0 CA-C-N 115.415 -0.811 . . . . 0.0 109.998 178.489 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . 0.472 HG23 ' N ' ' A' ' 55' ' ' LEU . 3.7 m -83.22 151.89 3.95 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.41 0 CA-C-O 121.294 0.568 . . . . 0.0 111.032 -175.341 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 6' ' ' GLN . . . . . 0.614 ' HG2' ' OG ' ' A' ' 9' ' ' SER . 1.4 pt20 -141.88 168.42 19.81 Favored 'General case' 0 C--N 1.314 -0.948 0 CA-C-N 115.223 -0.899 . . . . 0.0 108.86 176.164 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 51.5 p -53.47 122.08 8.98 Favored 'General case' 0 C--N 1.318 -0.768 0 N-CA-C 109.928 -0.397 . . . . 0.0 109.928 176.073 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 8' ' ' ASN . . . . . 0.422 ' HA ' ' O ' ' A' ' 39' ' ' LEU . 3.6 t-20 80.53 41.43 0.06 Allowed 'General case' 0 N--CA 1.475 0.809 0 O-C-N 124.036 0.835 . . . . 0.0 111.507 178.332 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 9' ' ' SER . . . . . 0.614 ' OG ' ' HG2' ' A' ' 6' ' ' GLN . 47.8 m -103.86 160.77 14.51 Favored 'General case' 0 C--N 1.332 -0.16 0 O-C-N 121.994 -0.441 . . . . 0.0 111.039 174.17 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 10' ' ' ALA . . . . . 0.441 ' HB1' HD22 ' A' ' 36' ' ' LEU . . . -109.49 131.93 54.61 Favored 'General case' 0 C--N 1.322 -0.606 0 N-CA-C 108.779 -0.823 . . . . 0.0 108.779 171.964 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 11' ' ' VAL . . . . . 0.471 ' O ' ' HA ' ' A' ' 36' ' ' LEU . 6.4 m -138.8 136.88 43.15 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.435 0 C-N-CA 120.501 -0.48 . . . . 0.0 111.437 -174.305 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 89.3 mt -86.42 128.61 34.97 Favored 'General case' 0 C--N 1.324 -0.51 0 N-CA-C 108.251 -1.018 . . . . 0.0 108.251 173.238 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 13' ' ' VAL . . . . . 0.47 ' CG2' HG23 ' A' ' 138' ' ' ILE . 1.6 p -141.65 157.53 21.17 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.86 0 CA-C-O 121.117 0.485 . . . . 0.0 110.747 -173.196 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 14' ' ' HIS . . . . . 0.488 ' ND1' ' HA ' ' A' ' 29' ' ' ARG . 0.5 OUTLIER -124.98 116.42 22.13 Favored 'General case' 0 C--N 1.318 -0.802 0 N-CA-C 106.396 -1.705 . . . . 0.0 106.396 170.545 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 15' ' ' PHE . . . . . 0.456 ' CE1' ' HB ' ' A' ' 28' ' ' THR . 18.2 p90 -146.0 158.8 43.87 Favored 'General case' 0 C--N 1.316 -0.852 0 C-N-CA 120.427 -0.509 . . . . 0.0 110.77 -169.019 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 87.8 m -130.32 130.16 44.12 Favored 'General case' 0 C--N 1.318 -0.775 0 N-CA-C 109.859 -0.423 . . . . 0.0 109.859 174.434 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 17' ' ' LEU . . . . . 0.484 HD21 ' CE1' ' A' ' 136' ' ' PHE . 9.5 mt -95.77 138.8 32.91 Favored 'General case' 0 N--CA 1.445 -0.683 0 CA-C-O 121.714 0.769 . . . . 0.0 111.659 -179.008 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 4.3 mptp? -122.31 147.47 46.2 Favored 'General case' 0 C--N 1.314 -0.95 0 CA-C-N 114.314 -1.312 . . . . 0.0 110.031 -176.24 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 4.1 mm? -83.43 169.13 15.88 Favored 'General case' 0 C--N 1.312 -1.041 0 N-CA-C 108.716 -0.846 . . . . 0.0 108.716 170.755 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 29.3 t70 -68.88 -25.42 64.61 Favored 'General case' 0 C--N 1.318 -0.804 0 CA-C-O 121.323 0.583 . . . . 0.0 109.607 177.717 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 15.4 t70 -80.07 0.95 29.77 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.339 -0.846 . . . . 0.0 110.426 176.001 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 76.22 25.38 66.32 Favored Glycine 0 N--CA 1.45 -0.402 0 CA-C-N 116.175 -0.466 . . . . 0.0 113.155 178.64 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 14.1 m -90.11 154.73 19.56 Favored 'General case' 0 C--N 1.322 -0.607 0 N-CA-C 109.307 -0.627 . . . . 0.0 109.307 171.954 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 59.7 m -90.43 118.26 29.77 Favored 'General case' 0 C--N 1.32 -0.679 0 O-C-N 121.749 -0.594 . . . . 0.0 110.538 177.33 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -84.11 -48.85 9.43 Favored 'General case' 0 CA--C 1.516 -0.33 0 CA-C-O 121.498 0.666 . . . . 0.0 110.269 179.337 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 9.2 tp10 -151.41 119.95 6.47 Favored 'General case' 0 C--N 1.318 -0.774 0 CA-C-N 114.842 -1.072 . . . . 0.0 109.068 -179.498 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 12.8 t -111.72 101.14 9.53 Favored 'General case' 0 C--N 1.315 -0.921 0 C-N-CA 120.033 -0.667 . . . . 0.0 110.259 177.512 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 28' ' ' THR . . . . . 0.456 ' HB ' ' CE1' ' A' ' 15' ' ' PHE . 31.0 m -97.64 51.4 1.07 Allowed 'General case' 0 C--N 1.313 -0.984 0 CA-C-O 122.706 1.241 . . . . 0.0 109.302 175.978 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 29' ' ' ARG . . . . . 0.488 ' HA ' ' ND1' ' A' ' 14' ' ' HIS . 29.6 ttp180 -143.56 -67.94 0.34 Allowed 'General case' 0 C--N 1.314 -0.954 0 CA-C-N 114.785 -1.098 . . . . 0.0 110.618 -177.059 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 2.2 p-10 -80.69 33.8 0.32 Allowed 'General case' 0 N--CA 1.467 0.385 0 N-CA-C 111.972 0.36 . . . . 0.0 111.972 -177.805 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 92.4 m-20 -119.21 -7.82 10.23 Favored 'General case' 0 C--N 1.325 -0.472 0 N-CA-C 109.829 -0.434 . . . . 0.0 109.829 173.082 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 79.73 6.25 89.11 Favored Glycine 0 N--CA 1.447 -0.592 0 C-N-CA 121.055 -0.593 . . . . 0.0 111.635 -177.342 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 50.0 mmtm -114.28 112.91 46.29 Favored Pre-proline 0 C--N 1.325 -0.474 0 CA-C-N 115.885 -0.158 . . . . 0.0 110.7 -178.263 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 6.2 Cg_exo -79.3 169.82 18.34 Favored 'Trans proline' 0 N--CA 1.46 -0.454 0 C-N-CA 122.88 2.386 . . . . 0.0 112.434 172.45 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -144.55 158.79 43.6 Favored 'General case' 0 C--N 1.315 -0.926 0 CA-C-N 115.061 -0.972 . . . . 0.0 109.698 179.009 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 36' ' ' LEU . . . . . 0.471 ' HA ' ' O ' ' A' ' 11' ' ' VAL . 0.7 OUTLIER -108.63 134.54 51.23 Favored 'General case' 0 N--CA 1.445 -0.677 0 CA-C-O 120.749 0.309 . . . . 0.0 110.333 177.202 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 37' ' ' PHE . . . . . . . . . . . . . 4.7 m-30 -96.4 130.71 43.46 Favored 'General case' 0 C--N 1.318 -0.766 0 CA-C-N 116.05 -0.523 . . . . 0.0 109.911 174.187 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 2.1 tpp180 -111.59 107.98 17.31 Favored 'General case' 0 C--N 1.321 -0.649 0 CA-C-N 116.076 -0.511 . . . . 0.0 109.76 -177.443 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 39' ' ' LEU . . . . . 0.547 ' HG ' ' O ' ' A' ' 9' ' ' SER . 6.6 mt -83.71 154.87 23.4 Favored 'General case' 0 C--N 1.319 -0.739 0 CA-C-N 116.201 -0.454 . . . . 0.0 109.894 -178.092 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 40' ' ' GLY . . . . . 0.43 ' H ' ' CD ' ' A' ' 49' ' ' GLU . . . 100.41 33.66 5.04 Favored Glycine 0 C--N 1.312 -0.782 0 CA-C-N 115.807 -0.633 . . . . 0.0 112.494 -179.125 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 6.5 m-20 63.58 8.36 3.59 Favored 'General case' 0 N--CA 1.473 0.709 0 N-CA-C 112.538 0.569 . . . . 0.0 112.538 178.237 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -67.37 -31.39 71.6 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-O 120.803 0.335 . . . . 0.0 111.657 -176.773 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 11.9 p -137.31 -65.85 0.53 Allowed 'General case' 0 C--N 1.321 -0.638 0 CA-C-N 116.453 -0.339 . . . . 0.0 111.048 -178.931 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 7.5 mp -85.89 -178.74 6.66 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.392 -179.432 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 31.0 m -95.86 164.05 12.9 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-N 116.317 -0.401 . . . . 0.0 111.539 -176.603 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 46' ' ' GLU . . . . . 0.452 ' O ' ' HG2' ' A' ' 50' ' ' GLN . 41.6 mt-10 -52.38 -41.11 62.85 Favored 'General case' 0 N--CA 1.465 0.289 0 N-CA-C 112.876 0.695 . . . . 0.0 112.876 -172.576 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -61.9 -41.82 99.68 Favored Glycine 0 N--CA 1.449 -0.453 0 C-N-CA 120.571 -0.823 . . . . 0.0 112.284 -170.134 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 48' ' ' LEU . . . . . 0.428 ' C ' HD12 ' A' ' 48' ' ' LEU . 3.2 tm? -61.02 -53.6 55.24 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-O 120.495 0.188 . . . . 0.0 111.144 -179.426 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 49' ' ' GLU . . . . . 0.689 ' O ' HD12 ' A' ' 53' ' ' LEU . 9.7 pt-20 -68.77 -37.4 79.31 Favored 'General case' 0 C--N 1.325 -0.46 0 N-CA-C 111.621 0.23 . . . . 0.0 111.621 -173.633 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 50' ' ' GLN . . . . . 0.475 ' HA ' HD23 ' A' ' 53' ' ' LEU . 33.1 mm-40 -66.15 -12.47 56.01 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 120.845 0.355 . . . . 0.0 111.353 -176.42 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 51' ' ' HIS . . . . . . . . . . . . . 12.1 m-70 -103.38 -4.0 24.74 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 121.213 0.53 . . . . 0.0 110.485 177.629 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 52' ' ' LEU . . . . . 0.459 ' O ' HG21 ' A' ' 5' ' ' VAL . 12.0 mt -102.51 -11.72 18.33 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-N 115.762 -0.653 . . . . 0.0 111.16 177.76 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 53' ' ' LEU . . . . . 0.689 HD12 ' O ' ' A' ' 49' ' ' GLU . 1.1 mp -58.78 136.6 57.81 Favored 'General case' 0 N--CA 1.449 -0.511 0 CA-C-O 121.125 0.488 . . . . 0.0 111.47 177.805 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 94.39 -4.57 70.16 Favored Glycine 0 N--CA 1.447 -0.572 0 CA-C-N 115.592 -0.731 . . . . 0.0 113.091 -179.677 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 55' ' ' LEU . . . . . 0.472 ' N ' HG23 ' A' ' 5' ' ' VAL . 3.0 mm? -71.97 164.8 25.46 Favored 'General case' 0 CA--C 1.521 -0.15 0 CA-C-N 117.391 0.595 . . . . 0.0 110.935 177.876 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 56' ' ' LYS . . . . . 0.597 ' HD3' ' N ' ' A' ' 57' ' ' VAL . 12.3 tmtt? -140.73 154.99 46.55 Favored 'General case' 0 C--N 1.32 -0.699 0 N-CA-C 108.703 -0.851 . . . . 0.0 108.703 -175.031 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 57' ' ' VAL . . . . . 0.597 ' N ' ' HD3' ' A' ' 56' ' ' LYS . 29.8 t -59.66 125.65 16.09 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-O 121.261 0.553 . . . . 0.0 111.386 179.714 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 80.95 19.74 66.82 Favored Glycine 0 N--CA 1.447 -0.627 0 CA-C-N 115.521 -0.763 . . . . 0.0 112.399 -177.398 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 59' ' ' ASP . . . . . 0.482 ' OD1' ' HB3' ' A' ' 56' ' ' LYS . 1.6 m-20 -110.55 150.16 29.34 Favored 'General case' 0 C--N 1.321 -0.631 0 CA-C-O 121.021 0.439 . . . . 0.0 110.452 176.01 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 60' ' ' LYS . . . . . 0.509 ' CE ' ' HG2' ' A' ' 139' ' ' GLU . 0.3 OUTLIER -115.48 133.11 56.34 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-N 115.51 -0.768 . . . . 0.0 109.926 -171.424 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 13.0 t -143.3 134.67 26.08 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-O 121.557 0.694 . . . . 0.0 111.306 178.643 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 5.9 m -123.78 132.49 53.81 Favored 'General case' 0 C--N 1.319 -0.741 0 CA-C-N 115.686 -0.688 . . . . 0.0 109.176 176.293 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 31.7 p90 -152.52 149.19 28.26 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-O 121.013 0.435 . . . . 0.0 111.346 -178.101 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 14.9 m -96.6 156.06 16.5 Favored 'General case' 0 C--N 1.321 -0.647 0 CA-C-N 116.089 -0.505 . . . . 0.0 109.863 177.832 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 31.7 mt -150.67 134.82 16.91 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-O 120.996 0.427 . . . . 0.0 110.749 -177.155 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 22.4 mm-40 -70.71 150.21 95.32 Favored Pre-proline 0 C--N 1.322 -0.587 0 N-CA-C 108.922 -0.77 . . . . 0.0 108.922 173.674 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 5.1 Cg_endo -48.38 -49.04 15.3 Favored 'Trans proline' 0 C--N 1.345 0.344 0 C-N-CA 122.383 2.056 . . . . 0.0 112.515 -175.742 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 22.9 t70 -62.92 -32.09 73.31 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-O 120.823 0.344 . . . . 0.0 111.123 -179.524 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -95.24 13.26 26.1 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-O 121.086 0.47 . . . . 0.0 111.082 -178.244 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.323 -0.586 0 CA-C-O 121.247 0.546 . . . . 0.0 109.775 179.09 . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 75' ' ' SER . . . . . 0.512 ' HB2' ' O ' ' A' ' 125' ' ' PHE . 34.7 m . . . . . 0 N--CA 1.441 -0.892 0 N-CA-C 107.475 -1.306 . . . . 0.0 107.475 . . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 3.4 Cg_exo -73.49 -48.6 0.24 Allowed 'Trans proline' 0 CA--C 1.518 -0.317 0 C-N-CA 122.315 2.01 . . . . 0.0 113.014 -171.296 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 9.1 p-10 -69.71 -4.18 18.57 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-N 115.149 -0.932 . . . . 0.0 111.199 -177.597 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 78' ' ' LEU . . . . . 0.638 ' CB ' ' HB2' ' A' ' 125' ' ' PHE . 1.3 mm? -92.74 3.13 56.19 Favored 'General case' 0 C--N 1.325 -0.484 0 N-CA-C 109.6 -0.518 . . . . 0.0 109.6 178.323 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 68.5 mt -97.5 109.5 23.52 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.808 0 CA-C-O 121.544 0.688 . . . . 0.0 110.068 -173.97 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 39.0 mt-30 -129.1 135.43 48.89 Favored 'General case' 0 C--N 1.317 -0.83 0 CA-C-N 114.702 -1.136 . . . . 0.0 111.79 -168.149 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 81' ' ' TYR . . . . . . . . . . . . . 2.6 m-85 -90.63 114.98 27.38 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 121.554 0.692 . . . . 0.0 111.596 173.566 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 82' ' ' PHE . . . . . 0.437 ' CB ' ' HE1' ' A' ' 87' ' ' PHE . 25.3 m-85 -102.53 170.68 7.89 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 114.745 -1.116 . . . . 0.0 112.01 175.194 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 22.2 t -89.67 155.67 19.08 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 115.721 -0.672 . . . . 0.0 109.847 176.981 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 84' ' ' ARG . . . . . 0.49 ' HD2' ' O ' ' A' ' 118' ' ' GLY . 11.9 ptm180 -66.44 -21.49 66.2 Favored 'General case' 0 C--O 1.227 -0.114 0 N-CA-C 112.143 0.423 . . . . 0.0 112.143 -178.356 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 85' ' ' ARG . . . . . 0.401 HH12 ' CG ' ' A' ' 119' ' ' ASP . 7.5 mpt_? -71.83 -39.42 69.79 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 121.192 0.52 . . . . 0.0 110.357 -175.538 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 31.4 mt-10 -64.64 -30.38 71.4 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 115.06 -0.973 . . . . 0.0 110.406 -174.966 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 87' ' ' PHE . . . . . 0.437 ' HE1' ' CB ' ' A' ' 82' ' ' PHE . 4.3 m-85 -89.65 -46.05 8.91 Favored 'General case' 0 CA--C 1.512 -0.504 0 CA-C-N 115.584 -0.735 . . . . 0.0 111.091 179.291 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 88' ' ' MET . . . . . 0.467 ' HE2' ' NH2' ' A' ' 84' ' ' ARG . 53.3 ttm -61.75 -26.05 67.83 Favored 'General case' 0 C--N 1.321 -0.665 0 CA-C-N 115.497 -0.774 . . . . 0.0 111.045 -175.345 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 23.0 t70 -55.46 -33.24 63.46 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 121.178 0.513 . . . . 0.0 110.59 174.061 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -109.93 11.44 24.12 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-N 115.64 -0.709 . . . . 0.0 111.257 179.304 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 111.75 138.19 7.42 Favored Glycine 0 N--CA 1.449 -0.453 0 C-N-CA 120.771 -0.728 . . . . 0.0 112.282 -179.197 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 92' ' ' GLU . . . . . 0.426 ' HA ' ' HD3' ' A' ' 93' ' ' PRO . 42.3 mt-10 -62.22 128.32 90.89 Favored Pre-proline 0 C--N 1.324 -0.516 0 CA-C-O 120.882 0.372 . . . . 0.0 111.402 -177.073 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 93' ' ' PRO . . . . . 0.543 ' HB2' HD12 ' A' ' 113' ' ' ILE . 17.7 Cg_endo -78.06 165.36 26.19 Favored 'Trans proline' 0 N--CA 1.459 -0.552 0 C-N-CA 122.745 2.297 . . . . 0.0 112.612 -177.518 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 30.9 mt-10 -116.95 146.88 42.72 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.497 -0.32 . . . . 0.0 111.054 -178.452 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 95' ' ' ILE . . . . . 0.497 ' CG1' HG12 ' A' ' 116' ' ' ILE . 16.6 mt -71.16 130.73 35.0 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.424 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.688 179.31 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 71.9 16.32 76.41 Favored Glycine 0 N--CA 1.446 -0.694 0 CA-C-N 115.813 -0.631 . . . . 0.0 113.059 179.367 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 97' ' ' ALA . . . . . 0.464 ' O ' HG13 ' A' ' 113' ' ' ILE . . . -100.85 161.77 13.37 Favored 'General case' 0 C--N 1.327 -0.389 0 N-CA-C 108.962 -0.755 . . . . 0.0 108.962 174.217 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 98' ' ' ILE . . . . . 0.451 HG12 HG23 ' A' ' 112' ' ' VAL . 59.1 mt -107.53 143.92 17.24 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.872 0 N-CA-C 110.066 -0.346 . . . . 0.0 110.066 179.417 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 99' ' ' MET . . . . . 0.482 ' SD ' HD11 ' A' ' 113' ' ' ILE . 82.8 mtp -128.36 163.34 25.04 Favored 'General case' 0 N--CA 1.448 -0.542 0 N-CA-C 107.958 -1.127 . . . . 0.0 107.958 179.347 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 3.5 mm? -100.62 137.1 39.48 Favored 'General case' 0 C--N 1.309 -1.184 0 N-CA-C 109.991 -0.374 . . . . 0.0 109.991 174.139 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 101' ' ' PHE . . . . . 0.456 ' CE2' ' HB2' ' A' ' 99' ' ' MET . 50.9 m-85 -143.55 136.35 27.48 Favored 'General case' 0 C--N 1.319 -0.725 0 N-CA-C 108.998 -0.742 . . . . 0.0 108.998 -174.55 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 17.2 m -96.53 131.78 42.79 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-O 120.97 0.414 . . . . 0.0 110.55 178.825 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -95.46 159.41 15.01 Favored 'General case' 0 C--N 1.321 -0.647 0 CA-C-N 116.003 -0.544 . . . . 0.0 110.11 177.351 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 104' ' ' MET . . . . . . . . . . . . . 4.0 mpp? -66.16 -12.13 53.85 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.353 -0.84 . . . . 0.0 112.022 -174.484 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 7.7 p-10 -92.01 17.91 8.69 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-O 121.141 0.496 . . . . 0.0 110.821 177.598 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 77.28 -11.56 16.6 Favored Glycine 0 N--CA 1.452 -0.259 0 CA-C-N 115.866 -0.606 . . . . 0.0 114.189 178.102 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 14.5 t -78.64 152.87 31.49 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-N 117.185 0.492 . . . . 0.0 110.005 179.251 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 35.2 tt0 -126.78 103.16 7.38 Favored 'General case' 0 C--N 1.315 -0.934 0 N-CA-C 108.867 -0.79 . . . . 0.0 108.867 -179.337 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 109' ' ' MET . . . . . . . . . . . . . 3.1 mpp? -100.34 134.91 20.42 Favored Pre-proline 0 C--N 1.32 -0.674 0 CA-C-N 116.349 -0.387 . . . . 0.0 111.323 -175.564 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 33.5 Cg_endo -67.53 135.73 37.17 Favored 'Trans proline' 0 N--CA 1.455 -0.739 0 C-N-CA 121.911 1.74 . . . . 0.0 109.638 167.847 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . -134.66 126.04 3.98 Favored Glycine 0 N--CA 1.443 -0.886 0 N-CA-C 111.11 -0.796 . . . . 0.0 111.11 -170.59 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 112' ' ' VAL . . . . . 0.451 HG23 HG12 ' A' ' 98' ' ' ILE . 32.0 t -76.57 131.07 35.55 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.655 0 N-CA-C 109.423 -0.584 . . . . 0.0 109.423 179.876 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 113' ' ' ILE . . . . . 0.543 HD12 ' HB2' ' A' ' 93' ' ' PRO . 1.9 mt -82.66 109.97 17.2 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.058 0 N-CA-C 107.826 -1.176 . . . . 0.0 107.826 173.174 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 114' ' ' ARG . . . . . 0.559 ' HE ' HG23 ' A' ' 122' ' ' THR . 2.3 tmm_? -64.89 -49.06 71.94 Favored 'General case' 0 C--N 1.315 -0.892 0 CA-C-N 115.569 -0.741 . . . . 0.0 110.272 -173.515 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 115' ' ' GLU . . . . . 0.408 ' HB2' ' HD2' ' A' ' 114' ' ' ARG . 9.4 tt0 -159.86 155.6 25.96 Favored 'General case' 0 C--N 1.326 -0.446 0 C-N-CA 121.156 -0.218 . . . . 0.0 110.419 -178.875 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 116' ' ' ILE . . . . . 0.497 HG12 ' CG1' ' A' ' 95' ' ' ILE . 31.9 mm -106.85 110.75 32.81 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.405 0 N-CA-C 109.001 -0.74 . . . . 0.0 109.001 175.901 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 117' ' ' ASN . . . . . 0.439 ' HB2' ' O ' ' A' ' 120' ' ' SER . 0.9 OUTLIER -98.83 157.69 16.13 Favored 'General case' 0 C--N 1.313 -0.981 0 CA-C-N 115.947 -0.569 . . . . 0.0 109.6 -178.04 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 118' ' ' GLY . . . . . 0.49 ' O ' ' HD2' ' A' ' 84' ' ' ARG . . . -56.27 -44.66 89.27 Favored Glycine 0 C--O 1.226 -0.392 0 C-N-CA 120.452 -0.88 . . . . 0.0 113.196 -171.47 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 119' ' ' ASP . . . . . 0.401 ' CG ' HH12 ' A' ' 85' ' ' ARG . 13.9 t70 -113.03 -9.86 13.53 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-O 121.169 0.509 . . . . 0.0 110.73 179.131 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 120' ' ' SER . . . . . 0.439 ' O ' ' HB2' ' A' ' 117' ' ' ASN . 21.6 t -126.54 157.63 38.28 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-O 121.533 0.682 . . . . 0.0 111.845 -168.79 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 121' ' ' ILE . . . . . . . . . . . . . 28.0 mm -120.49 150.41 23.25 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.761 0 CA-C-N 115.512 -0.767 . . . . 0.0 109.076 176.498 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 122' ' ' THR . . . . . 0.559 HG23 ' HE ' ' A' ' 114' ' ' ARG . 14.6 m -127.38 127.01 43.48 Favored 'General case' 0 C--N 1.312 -1.03 0 N-CA-C 107.615 -1.254 . . . . 0.0 107.615 179.667 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 2.8 t -127.74 127.14 68.05 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.839 0 N-CA-C 109.022 -0.733 . . . . 0.0 109.022 -171.01 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -114.24 96.11 5.63 Favored 'General case' 0 C--N 1.305 -1.326 0 CA-C-N 114.62 -1.173 . . . . 0.0 108.672 -177.34 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 125' ' ' PHE . . . . . 0.638 ' HB2' ' CB ' ' A' ' 78' ' ' LEU . 27.7 m-85 -82.5 103.8 12.31 Favored 'General case' 0 N--CA 1.431 -1.399 0 N-CA-C 105.821 -1.918 . . . . 0.0 105.821 175.107 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 126' ' ' ASN . . . . . 0.476 ' HA ' ' HB2' ' A' ' 75' ' ' SER . 0.1 OUTLIER . . . . . 0 C--N 1.295 -1.772 0 CA-C-N 113.884 -1.507 . . . . 0.0 112.916 -168.362 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 133' ' ' THR . . . . . . . . . . . . . 18.9 m . . . . . 0 N--CA 1.448 -0.566 0 N-CA-C 108.991 -0.744 . . . . 0.0 108.991 . . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 134' ' ' VAL . . . . . 0.426 ' HB ' HD23 ' A' ' 17' ' ' LEU . 15.7 m -115.05 167.94 7.2 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.64 0 CA-C-O 122.017 0.913 . . . . 0.0 112.639 -172.648 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 135' ' ' HIS . . . . . . . . . . . . . 82.5 m-70 -132.47 127.87 36.2 Favored 'General case' 0 C--N 1.314 -0.955 0 CA-C-N 114.043 -1.435 . . . . 0.0 107.359 177.581 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 136' ' ' PHE . . . . . 0.484 ' CE1' HD21 ' A' ' 17' ' ' LEU . 17.8 m-85 -105.53 122.81 46.78 Favored 'General case' 0 C--N 1.313 -1.006 0 CA-C-O 121.09 0.471 . . . . 0.0 111.71 -171.574 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 137' ' ' ASP . . . . . . . . . . . . . 38.2 t70 -123.03 98.76 6.04 Favored 'General case' 0 C--N 1.315 -0.907 0 N-CA-C 107.87 -1.159 . . . . 0.0 107.87 172.806 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 138' ' ' ILE . . . . . 0.47 HG23 ' CG2' ' A' ' 13' ' ' VAL . 54.8 mt -123.81 138.29 54.02 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.562 0 CA-C-N 115.968 -0.56 . . . . 0.0 112.271 -172.139 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 139' ' ' GLU . . . . . 0.509 ' HG2' ' CE ' ' A' ' 60' ' ' LYS . 2.3 mp0 -128.53 130.55 47.59 Favored 'General case' 0 N--CA 1.452 -0.364 0 N-CA-C 108.523 -0.917 . . . . 0.0 108.523 175.034 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 140' ' ' VAL . . . . . . . . . . . . . 72.6 t -77.56 126.59 38.11 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 117.805 0.275 . . . . 0.0 110.415 -176.47 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 141' ' ' LEU . . . . . 0.403 ' HG ' ' HA ' ' A' ' 13' ' ' VAL . 38.8 mt -94.83 -48.6 5.96 Favored 'General case' 0 C--N 1.321 -0.635 0 N-CA-C 109.919 -0.4 . . . . 0.0 109.919 177.386 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 142' ' ' GLU . . . . . . . . . . . . . 10.6 mm-40 -146.73 162.37 38.66 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 115.902 -0.59 . . . . 0.0 110.597 177.127 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 143' ' ' ILE . . . . . 0.417 HD13 HG22 ' A' ' 57' ' ' VAL . 95.5 mt -131.04 122.66 52.22 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.66 0 CA-C-N 115.961 -0.563 . . . . 0.0 110.337 177.529 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 144' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -74.75 132.67 77.44 Favored Pre-proline 0 CA--C 1.513 -0.472 0 CA-C-N 116.038 -0.528 . . . . 0.0 109.741 176.115 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 145' ' ' PRO . . . . . . . . . . . . . 70.0 Cg_exo . . . . . 0 CA--C 1.512 -0.583 0 C-N-CA 123.338 2.692 . . . . 0.0 113.16 -178.282 . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 73.3 m . . . . . 0 N--CA 1.455 -0.216 0 CA-C-O 121.227 0.536 . . . . 0.0 109.797 . . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 46.1 mt-10 -86.27 -22.56 26.75 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-N 115.789 -0.641 . . . . 0.0 110.733 179.934 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 4' ' ' SER . . . . . 0.446 ' HA ' ' HA ' ' A' ' 56' ' ' LYS . 19.8 m -110.03 132.94 53.71 Favored 'General case' 0 C--N 1.32 -0.702 0 CA-C-N 115.96 -0.564 . . . . 0.0 110.918 -179.686 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . 0.677 HG13 ' O ' ' A' ' 55' ' ' LEU . 7.3 p -74.2 141.19 16.44 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.425 0 CA-C-N 115.7 -0.682 . . . . 0.0 109.774 177.507 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 6' ' ' GLN . . . . . 0.611 ' HG2' ' OG ' ' A' ' 9' ' ' SER . 2.2 pt20 -134.58 167.62 20.47 Favored 'General case' 0 C--N 1.311 -1.099 0 N-CA-C 108.805 -0.813 . . . . 0.0 108.805 175.806 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 16.2 p -56.59 131.89 50.13 Favored 'General case' 0 C--N 1.313 -0.992 0 N-CA-C 109.64 -0.504 . . . . 0.0 109.64 176.881 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 64.3 t30 76.8 29.24 0.64 Allowed 'General case' 0 CA--C 1.544 0.718 0 C-N-CA 123.698 0.799 . . . . 0.0 111.645 -178.8 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 9' ' ' SER . . . . . 0.611 ' OG ' ' HG2' ' A' ' 6' ' ' GLN . 50.2 m -103.25 167.74 9.62 Favored 'General case' 0 CA--C 1.53 0.183 0 CA-C-O 120.837 0.351 . . . . 0.0 110.849 171.304 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -118.45 115.39 24.55 Favored 'General case' 0 C--N 1.325 -0.497 0 N-CA-C 109.329 -0.619 . . . . 0.0 109.329 175.65 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 4.8 m -119.71 142.15 36.51 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.609 0 C-N-CA 119.914 -0.715 . . . . 0.0 112.308 -174.006 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 47.1 tp -88.7 138.1 31.72 Favored 'General case' 0 N--CA 1.447 -0.613 0 CA-C-N 115.298 -0.864 . . . . 0.0 108.824 174.208 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 14.4 m -144.98 157.81 13.95 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.456 0 CA-C-O 120.889 0.376 . . . . 0.0 110.876 -172.912 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 14' ' ' HIS . . . . . 0.616 ' ND1' ' HA ' ' A' ' 29' ' ' ARG . 3.0 m-70 -117.49 119.85 36.3 Favored 'General case' 0 C--N 1.319 -0.727 0 N-CA-C 107.481 -1.303 . . . . 0.0 107.481 162.137 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 15' ' ' PHE . . . . . 0.62 ' HA ' ' O ' ' A' ' 137' ' ' ASP . 46.2 p90 -139.09 142.18 38.13 Favored 'General case' 0 C--N 1.319 -0.725 0 C-N-CA 120.514 -0.474 . . . . 0.0 110.897 -175.206 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 25.0 m -119.17 121.64 40.19 Favored 'General case' 0 C--N 1.318 -0.8 0 CA-C-O 120.785 0.326 . . . . 0.0 110.203 174.3 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 17' ' ' LEU . . . . . 0.642 HD21 ' O ' ' A' ' 135' ' ' HIS . 5.7 mt -92.5 127.11 37.87 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 116.086 -0.506 . . . . 0.0 112.035 179.893 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 18' ' ' LYS . . . . . 0.422 ' O ' ' HB2' ' A' ' 135' ' ' HIS . 0.8 OUTLIER -125.17 152.43 44.49 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-N 115.35 -0.841 . . . . 0.0 110.283 179.888 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 19' ' ' LEU . . . . . 0.439 HD12 ' HB ' ' A' ' 23' ' ' THR . 95.1 mt -88.62 172.92 8.93 Favored 'General case' 0 C--N 1.316 -0.867 0 N-CA-C 109.696 -0.483 . . . . 0.0 109.696 171.345 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 18.7 t70 -53.61 -36.04 61.55 Favored 'General case' 0 N--CA 1.466 0.325 0 CA-C-O 121.029 0.442 . . . . 0.0 110.96 -179.713 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 38.5 m-20 -83.49 11.74 6.59 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 115.839 -0.619 . . . . 0.0 112.067 -177.99 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 72.69 12.16 77.86 Favored Glycine 0 N--CA 1.452 -0.293 0 C-N-CA 121.111 -0.566 . . . . 0.0 113.314 -178.455 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 23' ' ' THR . . . . . 0.439 ' HB ' HD12 ' A' ' 19' ' ' LEU . 24.6 m -73.87 128.87 36.67 Favored 'General case' 0 C--N 1.322 -0.593 0 N-CA-C 109.762 -0.459 . . . . 0.0 109.762 177.123 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 36.9 m -70.99 116.32 11.14 Favored 'General case' 0 C--N 1.32 -0.691 0 CA-C-O 121.194 0.521 . . . . 0.0 110.939 -178.129 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 25' ' ' ALA . . . . . 0.434 ' HB1' ' HB3' ' A' ' 17' ' ' LEU . . . -84.07 -49.46 8.88 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 115.637 -0.711 . . . . 0.0 109.91 178.133 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 8.2 tp10 -158.44 122.9 4.14 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.354 -0.839 . . . . 0.0 109.518 177.025 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 31.2 t -103.43 113.36 26.8 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-O 121.157 0.503 . . . . 0.0 110.219 178.732 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 28' ' ' THR . . . . . 0.635 ' O ' HG21 ' A' ' 28' ' ' THR . 58.0 m -118.96 36.71 4.35 Favored 'General case' 0 N--CA 1.441 -0.898 0 CA-C-O 122.707 1.241 . . . . 0.0 110.103 178.82 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 29' ' ' ARG . . . . . 0.616 ' HA ' ' ND1' ' A' ' 14' ' ' HIS . 52.7 ttp180 -132.06 -62.47 0.84 Allowed 'General case' 0 C--N 1.316 -0.88 0 O-C-N 121.327 -0.858 . . . . 0.0 110.431 174.613 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 2.3 p-10 -83.02 14.98 2.98 Favored 'General case' 0 N--CA 1.468 0.454 0 CA-C-O 121.099 0.476 . . . . 0.0 111.128 -179.483 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 31' ' ' ASN . . . . . 0.73 ' ND2' ' HG2' ' A' ' 33' ' ' LYS . 34.1 p-10 -88.18 -18.46 28.67 Favored 'General case' 0 C--N 1.32 -0.674 0 CA-C-N 115.877 -0.602 . . . . 0.0 110.114 175.387 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 88.03 10.88 68.4 Favored Glycine 0 N--CA 1.444 -0.777 0 CA-C-N 115.496 -0.775 . . . . 0.0 112.004 -178.883 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 33' ' ' LYS . . . . . 0.73 ' HG2' ' ND2' ' A' ' 31' ' ' ASN . 12.3 ptmt -140.87 117.55 7.68 Favored Pre-proline 0 C--N 1.327 -0.397 0 CA-C-O 121.434 0.635 . . . . 0.0 110.008 -179.943 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 78.5 Cg_endo -83.36 168.4 13.14 Favored 'Trans proline' 0 N--CA 1.453 -0.867 0 C-N-CA 122.351 2.034 . . . . 0.0 111.955 177.363 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -127.15 158.66 36.49 Favored 'General case' 0 C--N 1.319 -0.736 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.485 -177.416 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -105.11 138.04 41.94 Favored 'General case' 0 C--N 1.318 -0.783 0 CA-C-N 116.104 -0.498 . . . . 0.0 109.919 175.33 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 37' ' ' PHE . . . . . . . . . . . . . 9.9 m-30 -107.5 107.6 18.53 Favored 'General case' 0 C--N 1.318 -0.773 0 N-CA-C 109.164 -0.68 . . . . 0.0 109.164 175.867 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 16.2 tpt180 -89.24 120.2 30.39 Favored 'General case' 0 C--N 1.317 -0.839 0 CA-C-N 115.669 -0.696 . . . . 0.0 109.371 178.262 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 39' ' ' LEU . . . . . 0.477 HD12 ' HB2' ' A' ' 49' ' ' GLU . 2.0 mm? -79.03 148.42 32.5 Favored 'General case' 0 C--N 1.318 -0.764 0 CA-C-N 115.752 -0.658 . . . . 0.0 110.58 -177.468 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 100.51 39.42 3.22 Favored Glycine 0 N--CA 1.445 -0.724 0 C-N-CA 120.662 -0.78 . . . . 0.0 113.358 178.077 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 34.5 t70 66.67 7.51 5.22 Favored 'General case' 0 N--CA 1.472 0.644 0 CA-C-O 121.122 0.487 . . . . 0.0 112.16 171.431 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -55.63 -58.74 6.53 Favored 'General case' 0 C--N 1.328 -0.369 0 N-CA-C 112.052 0.39 . . . . 0.0 112.052 -177.741 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 37.1 m -143.41 9.46 1.62 Allowed 'General case' 0 C--N 1.324 -0.512 0 CA-C-O 121.073 0.463 . . . . 0.0 110.839 179.161 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 4.2 mm? -115.09 148.9 38.36 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.885 -177.195 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 14.6 m -71.55 131.81 43.78 Favored 'General case' 0 N--CA 1.445 -0.688 0 N-CA-C 108.969 -0.752 . . . . 0.0 108.969 173.53 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 54.8 mt-10 -47.66 -43.92 26.68 Favored 'General case' 0 N--CA 1.468 0.472 0 O-C-N 123.534 0.521 . . . . 0.0 112.232 -169.509 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -61.41 -45.11 97.07 Favored Glycine 0 N--CA 1.448 -0.555 0 C-N-CA 120.642 -0.789 . . . . 0.0 112.696 -177.799 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 48' ' ' LEU . . . . . 0.407 HD11 ' C ' ' A' ' 48' ' ' LEU . 3.4 tm? -60.0 -54.39 46.64 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-O 120.95 0.405 . . . . 0.0 110.865 -177.879 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 49' ' ' GLU . . . . . 0.477 ' HB2' HD12 ' A' ' 39' ' ' LEU . 9.7 pt-20 -59.29 -40.25 85.58 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-N 115.458 -0.792 . . . . 0.0 111.39 -178.195 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 50' ' ' GLN . . . . . 0.535 ' HA ' ' CD2' ' A' ' 53' ' ' LEU . 83.4 mt-30 -69.14 -7.53 37.06 Favored 'General case' 0 CA--C 1.531 0.219 0 N-CA-C 113.302 0.853 . . . . 0.0 113.302 -179.78 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 51' ' ' HIS . . . . . . . . . . . . . 9.9 m-70 -103.35 -16.71 15.55 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-O 121.192 0.52 . . . . 0.0 110.019 179.687 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 27.5 mt -104.98 8.07 34.32 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-N 115.51 -0.768 . . . . 0.0 113.057 -176.419 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 53' ' ' LEU . . . . . 0.535 ' CD2' ' HA ' ' A' ' 50' ' ' GLN . 2.0 pp -92.86 155.94 17.29 Favored 'General case' 0 C--N 1.322 -0.615 0 C-N-CA 120.462 -0.495 . . . . 0.0 110.501 174.45 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 54' ' ' GLY . . . . . 0.471 ' N ' HG12 ' A' ' 5' ' ' VAL . . . 94.21 -12.55 68.89 Favored Glycine 0 CA--C 1.532 1.126 0 N-CA-C 115.941 1.136 . . . . 0.0 115.941 176.312 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 55' ' ' LEU . . . . . 0.677 ' O ' HG13 ' A' ' 5' ' ' VAL . 1.0 OUTLIER -100.73 165.44 11.38 Favored 'General case' 0 N--CA 1.471 0.603 0 CA-C-N 119.4 1.6 . . . . 0.0 112.06 -176.062 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 56' ' ' LYS . . . . . 0.446 ' HA ' ' HA ' ' A' ' 4' ' ' SER . 16.0 tttm -96.38 157.1 16.05 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-N 115.738 -0.665 . . . . 0.0 111.372 -175.563 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 57' ' ' VAL . . . . . 0.487 HG22 HD13 ' A' ' 143' ' ' ILE . 51.1 t -59.57 142.05 15.56 Favored 'Isoleucine or valine' 0 C--O 1.234 0.262 0 N-CA-C 109.398 -0.593 . . . . 0.0 109.398 171.404 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 82.43 9.3 85.06 Favored Glycine 0 N--CA 1.445 -0.766 0 C-N-CA 120.513 -0.851 . . . . 0.0 111.716 -177.51 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 59' ' ' ASP . . . . . 0.52 ' C ' ' HG3' ' A' ' 60' ' ' LYS . 15.9 m-20 -116.32 162.33 17.67 Favored 'General case' 0 CA--C 1.509 -0.629 0 N-CA-C 109.738 -0.467 . . . . 0.0 109.738 173.667 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 60' ' ' LYS . . . . . 0.573 ' HG2' ' HG2' ' A' ' 139' ' ' GLU . 32.2 mtpt -143.14 143.55 31.85 Favored 'General case' 0 C--N 1.318 -0.795 0 CA-C-N 115.439 -0.801 . . . . 0.0 110.375 -167.477 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 6.1 t -143.32 131.92 22.43 Favored 'General case' 0 C--N 1.315 -0.908 0 CA-C-N 115.938 -0.574 . . . . 0.0 109.686 178.934 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 3.3 m -113.17 130.99 56.03 Favored 'General case' 0 N--CA 1.443 -0.801 0 N-CA-C 108.949 -0.76 . . . . 0.0 108.949 177.452 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 63' ' ' PHE . . . . . 0.413 ' O ' ' HB2' ' A' ' 136' ' ' PHE . 39.3 p90 -154.59 152.76 30.4 Favored 'General case' 0 C--N 1.32 -0.704 0 CA-C-O 120.914 0.388 . . . . 0.0 111.112 179.688 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 26.5 m -101.64 156.33 17.56 Favored 'General case' 0 C--N 1.321 -0.657 0 CA-C-N 116.015 -0.539 . . . . 0.0 109.779 175.397 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 65' ' ' LEU . . . . . 0.406 HD12 ' HA ' ' A' ' 48' ' ' LEU . 74.7 mt -141.55 144.06 34.08 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 116.377 -0.374 . . . . 0.0 110.657 -178.432 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 41.7 mt-10 -80.54 159.06 70.41 Favored Pre-proline 0 C--N 1.322 -0.593 0 CA-C-N 115.747 -0.661 . . . . 0.0 109.358 174.575 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 59.0 Cg_exo -49.88 -36.86 44.58 Favored 'Trans proline' 0 C--O 1.233 0.25 0 C-N-CA 122.454 2.103 . . . . 0.0 113.624 -176.184 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 4.3 p-10 -66.04 -15.46 63.06 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-O 120.744 0.306 . . . . 0.0 111.385 -179.052 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -111.13 -16.15 13.52 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 116.591 -0.277 . . . . 0.0 111.302 179.475 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.329 -0.323 0 CA-C-N 116.364 -0.38 . . . . 0.0 111.672 -177.23 . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 75' ' ' SER . . . . . 0.447 ' HB3' ' OD1' ' A' ' 77' ' ' ASP . 16.6 m . . . . . 0 N--CA 1.44 -0.945 0 CA-C-O 120.385 0.136 . . . . 0.0 110.992 . . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 33.8 Cg_endo -66.41 -19.39 55.37 Favored 'Trans proline' 0 C--N 1.345 0.373 0 C-N-CA 122.734 2.29 . . . . 0.0 112.222 177.183 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 77' ' ' ASP . . . . . 0.447 ' OD1' ' HB3' ' A' ' 75' ' ' SER . 8.2 p-10 -76.35 -5.9 49.18 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 121.359 0.6 . . . . 0.0 110.384 177.16 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 78' ' ' LEU . . . . . 0.408 ' HG ' ' HB2' ' A' ' 125' ' ' PHE . 0.7 OUTLIER -89.03 10.39 21.8 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-N 115.548 -0.751 . . . . 0.0 110.437 176.273 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 22.4 mt -117.24 107.46 22.35 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.635 0 N-CA-C 108.349 -0.982 . . . . 0.0 108.349 177.413 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 80' ' ' GLN . . . . . 0.559 ' O ' ' HB ' ' A' ' 123' ' ' VAL . 71.5 mt-30 -119.7 140.59 50.43 Favored 'General case' 0 C--N 1.313 -1.012 0 CA-C-N 115.895 -0.593 . . . . 0.0 111.37 -172.052 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 81' ' ' TYR . . . . . . . . . . . . . 73.6 m-85 -96.38 155.3 16.82 Favored 'General case' 0 C--N 1.313 -0.983 0 CA-C-N 115.946 -0.57 . . . . 0.0 109.524 173.331 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 82' ' ' PHE . . . . . 0.419 ' CD1' HG21 ' A' ' 123' ' ' VAL . 3.2 m-85 -148.89 167.57 25.36 Favored 'General case' 0 C--N 1.323 -0.586 0 N-CA-C 108.981 -0.748 . . . . 0.0 108.981 -160.371 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 11.6 t -99.61 128.12 45.71 Favored 'General case' 0 C--N 1.321 -0.645 0 CA-C-O 121.082 0.468 . . . . 0.0 110.102 175.533 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 84' ' ' ARG . . . . . 0.644 ' HD3' ' HA ' ' A' ' 119' ' ' ASP . 15.4 ptt180 -53.27 -20.66 4.43 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.237 -0.892 . . . . 0.0 113.151 -177.916 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 85' ' ' ARG . . . . . . . . . . . . . 5.3 mpt_? -71.14 -37.45 72.27 Favored 'General case' 0 CA--C 1.517 -0.323 0 CA-C-O 120.91 0.385 . . . . 0.0 110.785 -173.38 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 27.1 mm-40 -63.97 -33.92 76.82 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-N 115.697 -0.683 . . . . 0.0 110.598 179.941 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 87' ' ' PHE . . . . . 0.408 ' HE2' ' CE1' ' A' ' 101' ' ' PHE . 27.1 m-85 -86.69 -39.73 15.75 Favored 'General case' 0 CA--C 1.509 -0.609 0 CA-C-N 115.96 -0.564 . . . . 0.0 111.158 -178.361 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 88' ' ' MET . . . . . . . . . . . . . 56.1 ttp -60.66 -34.91 75.0 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-N 116.398 -0.365 . . . . 0.0 110.844 -177.101 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 22.1 t70 -55.13 -31.2 61.09 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 121.025 0.44 . . . . 0.0 111.265 175.631 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -100.82 7.6 43.64 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 116.021 -0.536 . . . . 0.0 110.749 178.658 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 105.27 136.79 8.75 Favored Glycine 0 N--CA 1.445 -0.745 0 N-CA-C 110.846 -0.902 . . . . 0.0 110.846 -175.226 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 44.5 mt-10 -61.15 128.69 89.83 Favored Pre-proline 0 C--N 1.322 -0.618 0 CA-C-O 121.321 0.581 . . . . 0.0 111.208 -176.485 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 93' ' ' PRO . . . . . 0.477 ' HG2' HD11 ' A' ' 116' ' ' ILE . 56.2 Cg_endo -71.76 165.46 32.48 Favored 'Trans proline' 0 N--CA 1.462 -0.329 0 C-N-CA 123.318 2.678 . . . . 0.0 112.65 -175.441 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 16.3 mt-10 -116.65 155.79 28.19 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.843 -175.344 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 95' ' ' ILE . . . . . 0.53 HG22 ' O ' ' A' ' 114' ' ' ARG . 22.3 mt -82.37 135.77 24.24 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.469 0 CA-C-N 115.886 -0.597 . . . . 0.0 110.781 -178.711 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 73.16 19.6 79.68 Favored Glycine 0 N--CA 1.45 -0.394 0 CA-C-N 115.747 -0.661 . . . . 0.0 112.582 -175.822 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -96.48 119.51 35.1 Favored 'General case' 0 N--CA 1.452 -0.339 0 CA-C-O 121.54 0.686 . . . . 0.0 112.622 -179.32 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 98' ' ' ILE . . . . . 0.555 HG12 ' HB ' ' A' ' 112' ' ' VAL . 6.3 mt -88.69 107.46 17.78 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.665 0 N-CA-C 108.179 -1.045 . . . . 0.0 108.179 174.577 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 99' ' ' MET . . . . . . . . . . . . . 4.9 mtm -127.5 144.3 51.08 Favored 'General case' 0 N--CA 1.443 -0.786 0 N-CA-C 107.625 -1.25 . . . . 0.0 107.625 -175.607 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 100' ' ' LEU . . . . . 0.44 ' HB3' ' HB3' ' A' ' 108' ' ' GLU . 4.1 mm? -75.62 105.0 6.42 Favored 'General case' 0 C--N 1.311 -1.107 0 CA-C-N 116.494 -0.321 . . . . 0.0 110.873 -176.893 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 101' ' ' PHE . . . . . 0.408 ' CE1' ' HE2' ' A' ' 87' ' ' PHE . 42.9 m-85 -92.65 109.95 21.37 Favored 'General case' 0 CA--C 1.516 -0.346 0 CA-C-O 121.692 0.758 . . . . 0.0 110.915 -178.652 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 102' ' ' THR . . . . . 0.456 ' HA ' ' HA ' ' A' ' 108' ' ' GLU . 12.1 m -63.55 112.2 2.69 Favored 'General case' 0 C--N 1.311 -1.089 0 CA-C-N 114.411 -1.268 . . . . 0.0 113.038 -179.08 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -74.49 171.06 14.45 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-N 113.2 -1.818 . . . . 0.0 112.934 -178.945 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 104' ' ' MET . . . . . 0.487 ' C ' ' H ' ' A' ' 106' ' ' GLY . 4.2 mpp? -57.01 -33.5 67.22 Favored 'General case' 0 N--CA 1.465 0.276 0 CA-C-N 115.824 -0.625 . . . . 0.0 111.641 179.111 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 9.3 p-10 -76.93 22.05 0.2 Allowed 'General case' 0 N--CA 1.468 0.427 0 CA-C-O 121.528 0.68 . . . . 0.0 110.813 177.526 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 106' ' ' GLY . . . . . 0.487 ' H ' ' C ' ' A' ' 104' ' ' MET . . . 65.95 -7.84 1.06 Allowed Glycine 0 C--N 1.333 0.415 0 CA-C-N 114.649 -1.16 . . . . 0.0 114.694 -178.321 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 23.3 t -87.22 144.62 26.74 Favored 'General case' 0 CA--C 1.502 -0.902 0 CA-C-O 121.476 0.655 . . . . 0.0 110.705 -172.117 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 108' ' ' GLU . . . . . 0.456 ' HA ' ' HA ' ' A' ' 102' ' ' THR . 2.7 mp0 -80.45 156.41 26.62 Favored 'General case' 0 C--N 1.301 -1.531 0 CA-C-N 114.852 -1.067 . . . . 0.0 109.732 177.369 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 109' ' ' MET . . . . . 0.406 ' O ' ' HA ' ' A' ' 100' ' ' LEU . 96.5 mmm -136.61 125.04 15.07 Favored Pre-proline 0 C--N 1.314 -0.97 0 N-CA-C 107.563 -1.273 . . . . 0.0 107.563 -164.648 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 31.1 Cg_endo -69.39 119.08 6.09 Favored 'Trans proline' 0 N--CA 1.453 -0.887 0 CA-C-N 120.199 1.107 . . . . 0.0 110.644 175.145 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 111' ' ' GLY . . . . . 0.43 ' HA2' ' HA ' ' A' ' 125' ' ' PHE . . . -144.58 120.81 1.47 Allowed Glycine 0 N--CA 1.443 -0.895 0 CA-C-N 115.294 -0.866 . . . . 0.0 111.015 -172.202 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 112' ' ' VAL . . . . . 0.555 ' HB ' HG12 ' A' ' 98' ' ' ILE . 7.1 p -101.89 108.11 23.05 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.856 0 CA-C-O 122.058 0.933 . . . . 0.0 110.602 -179.819 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 113' ' ' ILE . . . . . 0.601 HG23 ' O ' ' A' ' 122' ' ' THR . 25.6 mt -61.2 109.89 0.56 Allowed 'Isoleucine or valine' 0 C--N 1.314 -0.966 0 CA-C-N 114.717 -1.129 . . . . 0.0 110.271 171.717 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 114' ' ' ARG . . . . . 0.53 ' O ' HG22 ' A' ' 95' ' ' ILE . 6.4 tmm_? -77.32 -32.56 55.37 Favored 'General case' 0 C--N 1.315 -0.908 0 CA-C-N 115.13 -0.941 . . . . 0.0 111.024 -173.833 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 115' ' ' GLU . . . . . 0.527 ' HB2' ' HD2' ' A' ' 114' ' ' ARG . 5.7 tt0 -159.98 160.9 33.91 Favored 'General case' 0 C--N 1.329 -0.315 0 N-CA-C 110.289 -0.263 . . . . 0.0 110.289 178.337 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 116' ' ' ILE . . . . . 0.488 HG12 ' CG1' ' A' ' 95' ' ' ILE . 29.4 mm -107.36 107.22 22.24 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.514 0 N-CA-C 109.581 -0.525 . . . . 0.0 109.581 173.909 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 117' ' ' ASN . . . . . 0.461 HD21 ' N ' ' A' ' 117' ' ' ASN . 0.9 OUTLIER -83.1 157.1 22.97 Favored 'General case' 0 C--N 1.313 -0.987 0 N-CA-C 108.906 -0.776 . . . . 0.0 108.906 178.33 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . -57.17 -48.54 79.15 Favored Glycine 0 N--CA 1.449 -0.457 0 C-N-CA 120.382 -0.913 . . . . 0.0 112.763 -172.987 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 119' ' ' ASP . . . . . 0.644 ' HA ' ' HD3' ' A' ' 84' ' ' ARG . 1.4 m-20 -107.8 -15.26 14.6 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-O 121.088 0.471 . . . . 0.0 111.346 -178.062 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 120' ' ' SER . . . . . 0.445 ' O ' ' HB2' ' A' ' 117' ' ' ASN . 32.4 t -123.38 157.76 32.63 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-N 115.878 -0.601 . . . . 0.0 111.158 -169.508 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 121' ' ' ILE . . . . . . . . . . . . . 50.0 mm -113.68 137.27 47.39 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.523 0 CA-C-O 121.165 0.507 . . . . 0.0 110.253 175.951 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 122' ' ' THR . . . . . 0.601 ' O ' HG23 ' A' ' 113' ' ' ILE . 3.6 m -93.98 142.21 27.64 Favored 'General case' 0 C--N 1.318 -0.776 0 CA-C-N 115.167 -0.924 . . . . 0.0 110.095 178.014 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 123' ' ' VAL . . . . . 0.559 ' HB ' ' O ' ' A' ' 80' ' ' GLN . 33.9 t -147.05 107.99 0.66 Allowed 'Isoleucine or valine' 0 N--CA 1.466 0.353 0 C-N-CA 117.085 -1.846 . . . . 0.0 110.385 -165.221 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 124' ' ' ASP . . . . . 0.448 ' HB3' HG13 ' A' ' 112' ' ' VAL . 28.6 t70 -107.98 101.64 10.88 Favored 'General case' 0 C--N 1.313 -1.006 0 C-N-CA 119.397 -0.921 . . . . 0.0 112.545 174.064 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 125' ' ' PHE . . . . . 0.43 ' HA ' ' HA2' ' A' ' 111' ' ' GLY . 83.5 m-85 -81.63 6.89 13.71 Favored 'General case' 0 N--CA 1.47 0.542 0 CA-C-N 116.285 -0.416 . . . . 0.0 110.894 178.459 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 7.7 m-80 . . . . . 0 C--N 1.327 -0.41 0 CA-C-O 122.054 0.93 . . . . 0.0 111.023 179.656 . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 133' ' ' THR . . . . . . . . . . . . . 21.5 m . . . . . 0 N--CA 1.451 -0.399 0 CA-C-O 121.035 0.445 . . . . 0.0 110.942 . . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 134' ' ' VAL . . . . . . . . . . . . . 30.6 m -102.75 171.68 1.52 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.609 0 CA-C-O 121.556 0.693 . . . . 0.0 110.999 179.624 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 135' ' ' HIS . . . . . 0.642 ' O ' HD21 ' A' ' 17' ' ' LEU . 13.8 m-70 -132.66 140.56 48.21 Favored 'General case' 0 C--N 1.318 -0.768 0 N-CA-C 107.548 -1.279 . . . . 0.0 107.548 -172.236 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 136' ' ' PHE . . . . . 0.559 ' CE2' HD23 ' A' ' 17' ' ' LEU . 9.3 m-85 -125.42 122.76 37.64 Favored 'General case' 0 C--N 1.311 -1.107 0 C-N-CA 120.492 -0.483 . . . . 0.0 112.188 -169.545 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 137' ' ' ASP . . . . . 0.62 ' O ' ' HA ' ' A' ' 15' ' ' PHE . 5.0 m-20 -115.82 100.8 8.26 Favored 'General case' 0 C--N 1.322 -0.628 0 N-CA-C 108.479 -0.934 . . . . 0.0 108.479 171.156 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 138' ' ' ILE . . . . . 0.498 ' CD1' ' HB3' ' A' ' 136' ' ' PHE . 4.4 mp -110.57 129.74 65.15 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.644 0 CA-C-O 121.229 0.538 . . . . 0.0 111.936 -177.535 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 139' ' ' GLU . . . . . 0.573 ' HG2' ' HG2' ' A' ' 60' ' ' LYS . 34.2 mt-10 -122.11 109.07 14.07 Favored 'General case' 0 N--CA 1.447 -0.601 0 CA-C-N 115.244 -0.889 . . . . 0.0 109.006 172.245 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 140' ' ' VAL . . . . . . . . . . . . . 58.9 t -59.63 119.55 4.15 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.499 0 CA-C-N 115.779 -0.646 . . . . 0.0 110.933 -179.276 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 141' ' ' LEU . . . . . 0.554 HD12 ' CD2' ' A' ' 14' ' ' HIS . 37.7 mt -90.51 -49.49 6.47 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 116.372 -0.376 . . . . 0.0 110.498 179.554 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 142' ' ' GLU . . . . . . . . . . . . . 44.3 mt-10 -156.87 158.88 37.53 Favored 'General case' 0 CA--C 1.519 -0.222 0 N-CA-C 108.835 -0.802 . . . . 0.0 108.835 -177.036 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 143' ' ' ILE . . . . . 0.487 HD13 HG22 ' A' ' 57' ' ' VAL . 97.4 mt -128.35 115.45 38.08 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.837 0 CA-C-O 121.139 0.495 . . . . 0.0 111.852 179.609 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 144' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -77.95 128.59 78.51 Favored Pre-proline 0 C--O 1.235 0.318 0 CA-C-N 115.397 -0.82 . . . . 0.0 109.069 172.582 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 145' ' ' PRO . . . . . . . . . . . . . 18.3 Cg_endo . . . . . 0 C--O 1.233 0.228 0 C-N-CA 123.126 2.55 . . . . 0.0 114.183 -172.379 . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 16.5 mmt . . . . . 0 N--CA 1.483 1.187 0 CA-C-O 120.52 0.2 . . . . 0.0 111.495 . . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 2' ' ' SER . . . . . 0.438 ' HB3' ' HA ' ' A' ' 145' ' ' PRO . 6.2 p -165.02 43.34 0.08 Allowed 'General case' 0 C--N 1.326 -0.431 0 CA-C-O 121.145 0.498 . . . . 0.0 110.705 -178.745 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 3.3 mp0 -77.38 -35.44 54.45 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-O 121.653 0.74 . . . . 0.0 109.77 -179.006 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 16.1 p -133.26 157.56 45.12 Favored 'General case' 0 C--N 1.315 -0.904 0 CA-C-N 114.893 -1.049 . . . . 0.0 109.745 -179.629 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . 0.588 HG12 ' O ' ' A' ' 52' ' ' LEU . 10.2 p -71.11 139.04 20.57 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.573 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.04 -178.04 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 6' ' ' GLN . . . . . . . . . . . . . 2.9 pt20 -142.7 164.15 30.88 Favored 'General case' 0 C--N 1.314 -0.954 0 N-CA-C 108.549 -0.908 . . . . 0.0 108.549 179.149 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 83.2 p -67.41 136.32 54.53 Favored 'General case' 0 C--N 1.316 -0.886 0 C-N-CA 120.724 -0.391 . . . . 0.0 110.453 -178.154 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 66.6 t30 71.27 28.43 3.0 Favored 'General case' 0 CA--C 1.538 0.488 0 C-N-CA 123.449 0.699 . . . . 0.0 111.667 -178.697 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 49.6 m -128.54 132.99 48.29 Favored 'General case' 0 C--N 1.327 -0.374 0 O-C-N 121.623 -0.673 . . . . 0.0 110.166 174.011 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -83.2 165.78 19.16 Favored 'General case' 0 C--N 1.322 -0.63 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.765 -171.862 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 33.0 m -143.46 139.7 26.25 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.685 0 CA-C-O 120.924 0.392 . . . . 0.0 110.281 -175.585 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 12' ' ' LEU . . . . . 0.418 HD12 ' HB3' ' A' ' 142' ' ' GLU . 75.7 mt -86.0 124.07 32.03 Favored 'General case' 0 C--N 1.319 -0.752 0 N-CA-C 108.127 -1.064 . . . . 0.0 108.127 173.253 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 13' ' ' VAL . . . . . 0.504 HG22 ' N ' ' A' ' 14' ' ' HIS . 3.5 p -136.06 153.24 31.6 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.912 0 CA-C-O 122.289 1.042 . . . . 0.0 112.993 -167.348 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 14' ' ' HIS . . . . . 0.504 ' N ' HG22 ' A' ' 13' ' ' VAL . 1.9 m-70 -123.72 116.16 22.59 Favored 'General case' 0 C--N 1.313 -1.008 0 CA-C-N 113.359 -1.746 . . . . 0.0 106.58 167.654 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 15' ' ' PHE . . . . . 0.55 ' HB2' ' O ' ' A' ' 137' ' ' ASP . 16.5 p90 -142.12 168.95 18.52 Favored 'General case' 0 C--N 1.317 -0.826 0 C-N-CA 119.2 -1.0 . . . . 0.0 112.531 -172.452 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 21.5 m -145.9 142.7 29.01 Favored 'General case' 0 C--N 1.321 -0.631 0 CA-C-N 115.076 -0.965 . . . . 0.0 110.438 176.253 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 17' ' ' LEU . . . . . 0.786 ' HG ' ' CZ ' ' A' ' 71' ' ' PHE . 0.0 OUTLIER -105.68 128.43 53.66 Favored 'General case' 0 C--N 1.326 -0.424 0 N-CA-C 109.527 -0.545 . . . . 0.0 109.527 -175.621 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 18' ' ' LYS . . . . . 0.484 ' HA ' ' O ' ' A' ' 23' ' ' THR . 0.1 OUTLIER -125.56 136.85 53.75 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-O 121.663 0.744 . . . . 0.0 112.204 -174.256 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 19' ' ' LEU . . . . . 0.445 HD22 ' HB ' ' A' ' 23' ' ' THR . 3.5 mm? -78.2 174.74 10.87 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 114.96 -1.018 . . . . 0.0 109.963 172.683 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 23.9 m-20 -60.74 -27.83 68.23 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-O 120.797 0.332 . . . . 0.0 111.08 176.905 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 35.8 t70 -80.61 5.02 16.67 Favored 'General case' 0 N--CA 1.474 0.739 0 CA-C-O 122.224 1.011 . . . . 0.0 109.926 174.224 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 66.91 19.3 69.57 Favored Glycine 0 N--CA 1.451 -0.363 0 CA-C-N 114.259 -1.337 . . . . 0.0 112.478 -175.944 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 23' ' ' THR . . . . . 0.484 ' O ' ' HA ' ' A' ' 18' ' ' LYS . 17.4 m -72.55 142.7 48.46 Favored 'General case' 0 C--N 1.323 -0.544 0 N-CA-C 110.33 -0.248 . . . . 0.0 110.33 178.473 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 59.0 m -77.05 107.9 9.74 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-O 120.871 0.367 . . . . 0.0 111.026 179.32 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 25' ' ' ALA . . . . . 0.4 ' HB2' ' HB3' ' A' ' 17' ' ' LEU . . . -77.29 -35.51 55.04 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-O 121.405 0.621 . . . . 0.0 109.567 174.709 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 9.0 tp10 -160.48 142.72 12.85 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 115.033 -0.985 . . . . 0.0 108.896 -179.419 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 19.6 t -124.75 149.42 47.33 Favored 'General case' 0 C--N 1.313 -1.007 0 N-CA-C 109.09 -0.707 . . . . 0.0 109.09 175.125 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 28' ' ' THR . . . . . 0.439 ' O ' HG21 ' A' ' 28' ' ' THR . 36.6 m -148.23 44.55 1.05 Allowed 'General case' 0 N--CA 1.437 -1.113 0 CA-C-O 123.79 1.757 . . . . 0.0 106.819 172.764 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 52.9 ttp180 -151.65 -45.96 0.11 Allowed 'General case' 0 C--N 1.312 -1.052 0 CA-C-N 112.653 -2.067 . . . . 0.0 109.681 -178.784 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 91.6 m-20 -67.81 -25.73 65.73 Favored 'General case' 0 N--CA 1.464 0.272 0 CA-C-O 121.087 0.47 . . . . 0.0 110.549 177.643 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 71.8 m-20 -76.53 -12.66 60.06 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.595 -0.729 . . . . 0.0 110.65 179.898 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 83.01 -1.37 88.81 Favored Glycine 0 N--CA 1.45 -0.371 0 C-N-CA 120.989 -0.624 . . . . 0.0 111.804 -179.691 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 59.4 mttp -107.41 121.68 43.64 Favored Pre-proline 0 C--N 1.321 -0.659 0 CA-C-N 115.717 -0.242 . . . . 0.0 110.698 -177.952 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 7.8 Cg_exo -76.48 168.94 22.84 Favored 'Trans proline' 0 N--CA 1.46 -0.491 0 C-N-CA 122.938 2.426 . . . . 0.0 112.118 172.113 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -140.89 161.7 37.2 Favored 'General case' 0 C--N 1.312 -1.04 0 CA-C-N 115.097 -0.956 . . . . 0.0 109.592 179.383 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 3.8 tp -112.89 130.77 55.99 Favored 'General case' 0 N--CA 1.445 -0.722 0 N-CA-C 110.049 -0.352 . . . . 0.0 110.049 175.968 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 37' ' ' PHE . . . . . . . . . . . . . 9.4 m-30 -95.98 112.14 23.95 Favored 'General case' 0 C--N 1.318 -0.77 0 N-CA-C 110.055 -0.35 . . . . 0.0 110.055 175.411 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 38' ' ' ARG . . . . . 0.451 ' HB3' ' HB1' ' A' ' 42' ' ' ALA . 22.3 mmm180 -83.46 106.91 15.59 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-O 121.351 0.596 . . . . 0.0 110.957 -179.513 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 10.9 mp -81.84 154.18 26.01 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-N 115.104 -0.953 . . . . 0.0 110.979 178.278 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 91.79 41.11 5.11 Favored Glycine 0 N--CA 1.449 -0.455 0 C-N-CA 120.915 -0.66 . . . . 0.0 113.06 176.575 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 16.6 m-20 58.46 23.55 10.81 Favored 'General case' 0 N--CA 1.468 0.429 0 CA-C-O 120.873 0.368 . . . . 0.0 111.374 177.78 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 42' ' ' ALA . . . . . 0.451 ' HB1' ' HB3' ' A' ' 38' ' ' ARG . . . -86.48 -27.37 24.11 Favored 'General case' 0 C--N 1.323 -0.587 0 CA-C-O 121.027 0.441 . . . . 0.0 110.278 -178.162 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 40.8 m -154.31 -45.09 0.09 Allowed 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 115.821 -0.627 . . . . 0.0 109.532 175.585 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 51.5 mt -102.81 159.34 15.57 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 115.775 -0.648 . . . . 0.0 110.179 178.482 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 50.1 m -84.45 161.72 20.19 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-N 115.853 -0.612 . . . . 0.0 110.765 -177.546 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 45.2 mt-10 -57.4 -26.8 61.66 Favored 'General case' 0 N--CA 1.463 0.202 0 CA-C-N 115.858 -0.61 . . . . 0.0 111.715 -177.213 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -58.86 -36.72 88.6 Favored Glycine 0 N--CA 1.45 -0.403 0 C-N-CA 121.086 -0.578 . . . . 0.0 112.546 -175.808 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 48' ' ' LEU . . . . . 0.429 ' HA ' HD12 ' A' ' 65' ' ' LEU . 3.0 tt -76.22 -36.53 58.51 Favored 'General case' 0 CA--C 1.515 -0.387 0 CA-C-O 121.768 0.794 . . . . 0.0 110.388 -179.122 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 7.2 tt0 -66.79 -46.68 74.49 Favored 'General case' 0 C--N 1.318 -0.785 0 CA-C-N 114.273 -1.331 . . . . 0.0 108.827 -176.472 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 50' ' ' GLN . . . . . 0.477 ' HA ' HD21 ' A' ' 53' ' ' LEU . 82.9 mm-40 -62.67 -16.4 56.86 Favored 'General case' 0 C--N 1.314 -0.936 0 CA-C-N 113.504 -1.68 . . . . 0.0 112.396 -176.069 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 51' ' ' HIS . . . . . . . . . . . . . 14.1 m-70 -105.34 -3.48 22.67 Favored 'General case' 0 C--O 1.233 0.223 0 C-N-CA 120.221 -0.591 . . . . 0.0 111.663 176.21 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 52' ' ' LEU . . . . . 0.588 ' O ' HG12 ' A' ' 5' ' ' VAL . 6.1 mt -99.98 -23.66 14.85 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 116.461 -0.336 . . . . 0.0 111.866 -178.493 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 53' ' ' LEU . . . . . 0.48 ' HA ' HG13 ' A' ' 5' ' ' VAL . 0.0 OUTLIER -59.85 152.21 23.78 Favored 'General case' 0 CA--C 1.53 0.209 0 CA-C-O 121.316 0.579 . . . . 0.0 112.286 -177.124 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 94.26 -17.14 59.5 Favored Glycine 0 N--CA 1.451 -0.306 0 CA-C-N 115.296 -0.865 . . . . 0.0 113.557 175.964 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 55' ' ' LEU . . . . . 0.556 ' O ' HG11 ' A' ' 5' ' ' VAL . 16.0 tp -84.9 158.97 20.43 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-O 121.099 0.476 . . . . 0.0 110.975 177.677 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 56' ' ' LYS . . . . . 0.562 ' HD3' ' N ' ' A' ' 57' ' ' VAL . 12.8 tmtt? -120.11 162.89 18.54 Favored 'General case' 0 C--N 1.325 -0.487 0 N-CA-C 109.768 -0.456 . . . . 0.0 109.768 -176.331 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 57' ' ' VAL . . . . . 0.562 ' N ' ' HD3' ' A' ' 56' ' ' LYS . 42.1 t -57.76 147.74 6.04 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-O 120.889 0.376 . . . . 0.0 111.259 177.491 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 80.6 9.46 86.39 Favored Glycine 0 N--CA 1.451 -0.334 0 CA-C-N 115.852 -0.613 . . . . 0.0 113.575 -177.712 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 2.5 m-20 -121.53 162.55 20.36 Favored 'General case' 0 CA--C 1.513 -0.46 0 CA-C-O 121.022 0.439 . . . . 0.0 110.828 178.364 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 60' ' ' LYS . . . . . 0.536 ' HB3' ' HG2' ' A' ' 139' ' ' GLU . 1.1 ptmt -135.15 146.15 48.49 Favored 'General case' 0 C--N 1.316 -0.855 0 CA-C-N 115.576 -0.738 . . . . 0.0 109.133 179.136 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 12.1 t -142.76 143.35 32.17 Favored 'General case' 0 C--N 1.318 -0.793 0 CA-C-O 121.13 0.491 . . . . 0.0 109.754 -178.612 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 3.7 m -109.17 138.52 45.39 Favored 'General case' 0 C--N 1.311 -1.101 0 N-CA-C 108.889 -0.782 . . . . 0.0 108.889 176.668 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 63' ' ' PHE . . . . . 0.515 ' CZ ' HD13 ' A' ' 138' ' ' ILE . 31.4 p90 -158.36 158.85 35.07 Favored 'General case' 0 C--N 1.321 -0.653 0 CA-C-O 121.238 0.542 . . . . 0.0 111.42 -179.444 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 64' ' ' SER . . . . . 0.413 ' O ' ' HG ' ' A' ' 65' ' ' LEU . 26.1 t -104.73 159.42 15.8 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-N 115.197 -0.911 . . . . 0.0 109.71 -179.204 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 65' ' ' LEU . . . . . 0.479 HD13 ' O ' ' A' ' 69' ' ' ALA . 18.5 mt -161.09 151.38 17.71 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 116.302 -0.408 . . . . 0.0 110.698 -171.975 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 48.0 mt-10 -69.86 152.79 95.92 Favored Pre-proline 0 C--N 1.321 -0.662 0 CA-C-N 115.796 -0.638 . . . . 0.0 109.365 174.485 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 3.4 Cg_exo -42.45 -49.71 6.13 Favored 'Trans proline' 0 CA--C 1.532 0.406 0 C-N-CA 123.673 2.915 . . . . 0.0 113.865 -176.804 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -56.86 -31.12 64.48 Favored 'General case' 0 N--CA 1.468 0.439 0 CA-C-N 115.996 -0.547 . . . . 0.0 111.784 179.84 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 69' ' ' ALA . . . . . 0.479 ' O ' HD13 ' A' ' 65' ' ' LEU . . . -98.26 16.75 20.46 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.825 -175.67 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -131.92 -84.66 0.49 Allowed 'General case' 0 C--N 1.323 -0.559 0 N-CA-C 108.944 -0.762 . . . . 0.0 108.944 -173.24 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 71' ' ' PHE . . . . . 0.786 ' CZ ' ' HG ' ' A' ' 17' ' ' LEU . 9.1 m-85 -94.71 -3.69 48.83 Favored 'General case' 0 C--N 1.318 -0.768 0 CA-C-N 115.544 -0.753 . . . . 0.0 110.294 176.102 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 85.66 -170.7 44.41 Favored Glycine 0 N--CA 1.439 -1.109 0 CA-C-N 115.19 -0.914 . . . . 0.0 112.09 176.097 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 19.7 t -87.1 138.05 32.77 Favored Pre-proline 0 C--N 1.312 -1.057 0 N-CA-C 109.311 -0.625 . . . . 0.0 109.311 173.94 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 9.8 Cg_endo -52.91 142.77 51.54 Favored 'Trans proline' 0 C--N 1.346 0.436 0 C-N-CA 122.221 1.948 . . . . 0.0 110.275 173.661 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 75' ' ' SER . . . . . 0.4 ' HA ' ' HD2' ' A' ' 76' ' ' PRO . 54.7 m -120.94 102.51 43.99 Favored Pre-proline 0 C--N 1.322 -0.608 0 N-CA-C 112.031 0.382 . . . . 0.0 112.031 -165.574 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 76' ' ' PRO . . . . . 0.4 ' HD2' ' HA ' ' A' ' 75' ' ' SER . 36.3 Cg_endo -67.53 -14.25 41.69 Favored 'Trans proline' 0 N--CA 1.462 -0.333 0 C-N-CA 122.692 2.261 . . . . 0.0 112.043 174.996 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 23.8 t70 -64.03 -19.61 65.32 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.689 -178.801 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 78' ' ' LEU . . . . . 0.546 ' HB3' ' HB2' ' A' ' 125' ' ' PHE . 3.0 mm? -88.66 -1.12 57.91 Favored 'General case' 0 CA--C 1.513 -0.469 0 C-N-CA 120.697 -0.401 . . . . 0.0 110.775 -179.611 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 79' ' ' ILE . . . . . 0.631 HG21 ' O ' ' A' ' 123' ' ' VAL . 20.2 mt -65.4 128.51 28.32 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.594 0 CA-C-O 121.921 0.867 . . . . 0.0 111.335 -178.243 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 80' ' ' GLN . . . . . 0.567 ' O ' ' HB ' ' A' ' 123' ' ' VAL . 49.5 mt-30 -135.81 138.88 43.02 Favored 'General case' 0 C--N 1.319 -0.76 0 CA-C-N 114.14 -1.391 . . . . 0.0 108.736 -174.274 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 81' ' ' TYR . . . . . 0.437 ' CE2' HG22 ' A' ' 122' ' ' THR . 73.1 m-85 -107.17 110.3 22.33 Favored 'General case' 0 C--N 1.32 -0.691 0 C-N-CA 119.707 -0.797 . . . . 0.0 110.276 -179.117 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 48.9 m-85 -104.81 168.55 8.99 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-N 115.881 -0.599 . . . . 0.0 110.684 172.495 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 22.6 t -87.22 157.99 19.21 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-O 121.365 0.603 . . . . 0.0 111.209 -176.883 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 12.5 ptm180 -61.86 -34.74 76.54 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 115.22 -0.9 . . . . 0.0 109.825 175.961 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 85' ' ' ARG . . . . . . . . . . . . . 5.1 mpt_? -54.7 -28.08 45.22 Favored 'General case' 0 C--N 1.32 -0.7 0 CA-C-N 113.952 -1.476 . . . . 0.0 111.781 176.092 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 21.2 mm-40 -79.86 -20.2 46.48 Favored 'General case' 0 C--N 1.32 -0.689 0 CA-C-O 121.105 0.478 . . . . 0.0 111.389 179.396 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 87' ' ' PHE . . . . . . . . . . . . . 57.0 m-85 -104.22 -20.5 13.77 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 116.093 -0.503 . . . . 0.0 111.558 -176.076 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 88' ' ' MET . . . . . . . . . . . . . 22.5 ttm -56.13 -38.37 70.72 Favored 'General case' 0 C--N 1.323 -0.556 0 N-CA-C 112.307 0.484 . . . . 0.0 112.307 -173.239 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 2.3 m-20 -53.98 -27.46 31.58 Favored 'General case' 0 C--N 1.328 -0.327 0 N-CA-C 112.362 0.504 . . . . 0.0 112.362 176.709 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -110.47 14.81 22.46 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-O 120.957 0.408 . . . . 0.0 110.554 179.834 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 92.3 138.85 8.57 Favored Glycine 0 N--CA 1.448 -0.566 0 C-N-CA 120.837 -0.696 . . . . 0.0 111.973 -178.554 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 63.6 mt-10 -62.47 122.13 71.53 Favored Pre-proline 0 C--N 1.324 -0.532 0 CA-C-O 121.148 0.499 . . . . 0.0 110.906 -179.632 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 43.9 Cg_endo -72.95 168.12 25.53 Favored 'Trans proline' 0 CA--C 1.516 -0.393 0 C-N-CA 123.777 2.984 . . . . 0.0 114.123 -173.214 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 3.4 mp0 -114.07 160.03 19.35 Favored 'General case' 0 N--CA 1.444 -0.742 0 CA-C-N 114.181 -1.372 . . . . 0.0 110.54 -172.357 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 95' ' ' ILE . . . . . 0.487 HG12 HG12 ' A' ' 116' ' ' ILE . 11.3 mt -78.2 131.7 33.99 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.446 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.535 178.829 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 71.76 24.02 77.24 Favored Glycine 0 N--CA 1.445 -0.708 0 CA-C-N 115.629 -0.714 . . . . 0.0 111.963 -176.626 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -103.29 117.42 34.47 Favored 'General case' 0 N--CA 1.449 -0.502 0 CA-C-O 121.937 0.875 . . . . 0.0 110.661 179.456 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 98' ' ' ILE . . . . . 0.546 HG12 ' HB ' ' A' ' 112' ' ' VAL . 4.1 mt -97.97 120.51 47.4 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.294 0 CA-C-N 114.481 -1.236 . . . . 0.0 108.726 -176.012 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 99' ' ' MET . . . . . 0.439 ' HE1' HD12 ' A' ' 113' ' ' ILE . 8.3 mtm -133.91 149.65 51.3 Favored 'General case' 0 N--CA 1.439 -0.99 0 N-CA-C 106.922 -1.51 . . . . 0.0 106.922 -177.949 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 3.2 mm? -70.38 119.7 14.94 Favored 'General case' 0 C--N 1.311 -1.087 0 CA-C-O 122.313 1.054 . . . . 0.0 113.044 -176.417 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 101' ' ' PHE . . . . . 0.617 ' O ' ' HA ' ' A' ' 108' ' ' GLU . 20.8 m-85 -109.7 175.89 5.28 Favored 'General case' 0 C--O 1.22 -0.452 0 CA-C-N 113.05 -1.886 . . . . 0.0 111.47 -175.533 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 9.2 m -124.84 109.65 13.31 Favored 'General case' 0 N--CA 1.466 0.373 0 C-N-CA 120.492 -0.483 . . . . 0.0 111.136 -166.248 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -77.3 170.3 16.78 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-N 115.733 -0.667 . . . . 0.0 112.483 178.659 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 104' ' ' MET . . . . . 0.417 ' C ' ' H ' ' A' ' 106' ' ' GLY . 3.7 mpp? -58.93 -37.71 77.31 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 115.659 -0.7 . . . . 0.0 111.193 -179.783 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 11.1 p-10 -78.59 22.97 0.33 Allowed 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 121.381 0.61 . . . . 0.0 110.665 177.774 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 106' ' ' GLY . . . . . 0.417 ' H ' ' C ' ' A' ' 104' ' ' MET . . . 66.39 -12.04 0.5 Allowed Glycine 0 C--N 1.337 0.623 0 CA-C-N 115.178 -0.919 . . . . 0.0 114.812 -174.869 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 46.6 t -65.74 132.72 49.43 Favored 'General case' 0 CA--C 1.501 -0.912 0 CA-C-O 122.063 0.935 . . . . 0.0 110.896 -171.909 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 108' ' ' GLU . . . . . 0.617 ' HA ' ' O ' ' A' ' 101' ' ' PHE . 2.1 tt0 -90.77 104.04 16.68 Favored 'General case' 0 C--N 1.297 -1.677 0 CA-C-N 114.146 -1.388 . . . . 0.0 109.128 178.907 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 109' ' ' MET . . . . . . . . . . . . . 1.7 mtm -102.63 148.32 35.34 Favored Pre-proline 0 CA--C 1.511 -0.549 0 N-CA-C 108.096 -1.076 . . . . 0.0 108.096 -178.138 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 29.6 Cg_endo -63.85 146.14 91.34 Favored 'Trans proline' 0 N--CA 1.45 -1.046 0 C-N-CA 121.325 1.35 . . . . 0.0 110.482 172.999 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 111' ' ' GLY . . . . . 0.488 ' HA3' ' CD2' ' A' ' 101' ' ' PHE . . . -143.35 107.76 0.48 Allowed Glycine 0 N--CA 1.439 -1.138 0 N-CA-C 109.763 -1.335 . . . . 0.0 109.763 -173.359 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 112' ' ' VAL . . . . . 0.546 ' HB ' HG12 ' A' ' 98' ' ' ILE . 2.9 p -87.57 107.55 17.37 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.876 0 C-N-CA 118.798 -1.161 . . . . 0.0 109.976 -174.779 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 113' ' ' ILE . . . . . 0.439 HD12 ' HE1' ' A' ' 99' ' ' MET . 34.8 mt -62.91 108.46 0.59 Allowed 'Isoleucine or valine' 0 N--CA 1.436 -1.168 0 N-CA-C 108.531 -0.915 . . . . 0.0 108.531 170.525 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 114' ' ' ARG . . . . . 0.471 ' O ' HG23 ' A' ' 95' ' ' ILE . 6.3 tpp180 -75.37 -42.72 53.36 Favored 'General case' 0 C--N 1.308 -1.203 0 CA-C-N 113.853 -1.521 . . . . 0.0 111.06 -168.969 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 8.3 tt0 -159.57 156.78 28.65 Favored 'General case' 0 C--N 1.32 -0.694 0 N-CA-C 109.622 -0.51 . . . . 0.0 109.622 -176.381 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 116' ' ' ILE . . . . . 0.487 HG12 HG12 ' A' ' 95' ' ' ILE . 38.8 mm -111.48 115.28 49.45 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.528 0 N-CA-C 109.907 -0.405 . . . . 0.0 109.907 179.68 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 117' ' ' ASN . . . . . 0.521 HD21 ' N ' ' A' ' 117' ' ' ASN . 0.8 OUTLIER -99.51 154.69 18.04 Favored 'General case' 0 C--N 1.316 -0.858 0 N-CA-C 108.8 -0.815 . . . . 0.0 108.8 176.672 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . -62.3 -28.0 70.19 Favored Glycine 0 N--CA 1.45 -0.395 0 CA-C-N 115.929 -0.578 . . . . 0.0 113.648 -173.78 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 11.8 t70 -114.87 -17.63 11.5 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 117.004 0.402 . . . . 0.0 111.77 179.08 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 120' ' ' SER . . . . . 0.44 ' O ' ' HB2' ' A' ' 117' ' ' ASN . 14.8 t -137.59 157.8 45.74 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-O 121.179 0.514 . . . . 0.0 111.281 -169.662 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 121' ' ' ILE . . . . . . . . . . . . . 45.1 mm -110.13 132.91 57.12 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.811 0 CA-C-N 116.102 -0.499 . . . . 0.0 109.963 177.376 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 122' ' ' THR . . . . . 0.437 HG22 ' CE2' ' A' ' 81' ' ' TYR . 4.6 m -92.44 103.34 15.78 Favored 'General case' 0 N--CA 1.442 -0.848 0 CA-C-O 122.142 0.972 . . . . 0.0 109.924 178.233 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 123' ' ' VAL . . . . . 0.631 ' O ' HG21 ' A' ' 79' ' ' ILE . 18.8 t -93.86 156.51 3.09 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.005 0 CA-C-N 113.54 -1.664 . . . . 0.0 110.355 177.581 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 124' ' ' ASP . . . . . 0.585 ' HA ' HG12 ' A' ' 79' ' ' ILE . 10.8 t0 -151.06 94.08 2.01 Favored 'General case' 0 C--N 1.317 -0.827 0 CA-C-N 115.216 -0.902 . . . . 0.0 109.684 -176.596 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 125' ' ' PHE . . . . . 0.546 ' HB2' ' HB3' ' A' ' 78' ' ' LEU . 84.4 m-85 -84.68 96.83 9.34 Favored 'General case' 0 CA--C 1.51 -0.593 0 CA-C-O 122.041 0.924 . . . . 0.0 110.517 177.537 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -89.0 -177.0 5.35 Favored 'General case' 0 C--N 1.299 -1.611 0 CA-C-N 114.297 -1.32 . . . . 0.0 109.763 173.261 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 127' ' ' HIS . . . . . 0.413 ' CB ' ' HD2' ' A' ' 128' ' ' PRO . 1.4 m170 -87.41 -178.52 1.11 Allowed Pre-proline 0 C--N 1.307 -1.266 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.926 -173.209 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 128' ' ' PRO . . . . . 0.522 ' O ' ' N ' ' A' ' 130' ' ' ALA . 1.1 Cg_endo -46.06 175.76 0.01 OUTLIER 'Trans proline' 0 CA--C 1.533 0.425 0 C-N-CA 123.979 3.12 . . . . 0.0 112.338 161.588 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 129' ' ' LEU . . . . . . . . . . . . . 15.8 tp -49.45 43.74 0.0 OUTLIER 'General case' 0 N--CA 1.482 1.166 0 C-N-CA 126.483 1.913 . . . . 0.0 114.858 179.836 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 130' ' ' ALA . . . . . 0.522 ' N ' ' O ' ' A' ' 128' ' ' PRO . . . -78.02 -177.28 4.94 Favored 'General case' 0 C--N 1.318 -0.775 0 C-N-CA 123.335 0.654 . . . . 0.0 110.025 -173.632 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . 72.97 15.22 78.45 Favored Glycine 0 N--CA 1.449 -0.484 0 C-N-CA 120.761 -0.733 . . . . 0.0 113.257 -178.956 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 132' ' ' GLN . . . . . . . . . . . . . 2.7 pt20 -149.0 158.55 44.27 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 117.045 0.422 . . . . 0.0 110.295 173.803 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 133' ' ' THR . . . . . . . . . . . . . 24.0 m -80.6 127.02 31.98 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.974 -178.489 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 134' ' ' VAL . . . . . 0.431 ' HB ' ' CD1' ' A' ' 17' ' ' LEU . 2.6 m -134.2 146.29 31.57 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.362 0 N-CA-C 112.297 0.48 . . . . 0.0 112.297 -174.397 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 135' ' ' HIS . . . . . . . . . . . . . 26.1 m-70 -98.32 120.41 38.68 Favored 'General case' 0 N--CA 1.465 0.315 0 CA-C-N 116.0 -0.545 . . . . 0.0 110.618 178.734 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 136' ' ' PHE . . . . . 0.459 ' HB3' HD12 ' A' ' 17' ' ' LEU . 3.1 p90 -128.78 150.83 50.13 Favored 'General case' 0 C--N 1.321 -0.653 0 N-CA-C 113.894 1.072 . . . . 0.0 113.894 179.287 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 137' ' ' ASP . . . . . 0.55 ' O ' ' HB2' ' A' ' 15' ' ' PHE . 5.1 m-20 -100.38 140.29 34.84 Favored 'General case' 0 CA--C 1.508 -0.639 0 CA-C-N 114.139 -1.392 . . . . 0.0 107.706 174.666 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 138' ' ' ILE . . . . . 0.515 HD13 ' CZ ' ' A' ' 63' ' ' PHE . 60.2 mt -137.32 132.99 46.48 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.836 0 CA-C-O 120.761 0.315 . . . . 0.0 110.526 -179.911 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 139' ' ' GLU . . . . . 0.536 ' HG2' ' HB3' ' A' ' 60' ' ' LYS . 28.3 mt-10 -105.65 144.36 32.5 Favored 'General case' 0 CA--C 1.514 -0.439 0 CA-C-N 116.494 -0.321 . . . . 0.0 110.749 -179.3 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 140' ' ' VAL . . . . . 0.431 ' CG1' ' HA ' ' A' ' 57' ' ' VAL . 37.6 t -97.71 104.66 16.19 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.886 0 N-CA-C 108.366 -0.976 . . . . 0.0 108.366 169.415 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 41.1 mt -91.67 -51.62 5.15 Favored 'General case' 0 C--N 1.318 -0.769 0 N-CA-C 109.347 -0.612 . . . . 0.0 109.347 -178.362 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 142' ' ' GLU . . . . . 0.418 ' HB3' HD12 ' A' ' 12' ' ' LEU . 40.9 tt0 -150.95 148.61 28.62 Favored 'General case' 0 C--N 1.321 -0.654 0 CA-C-N 115.55 -0.75 . . . . 0.0 109.236 169.393 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 143' ' ' ILE . . . . . 0.499 HD13 HG22 ' A' ' 57' ' ' VAL . 74.5 mt -103.52 136.2 37.52 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.7 0 CA-C-O 120.811 0.339 . . . . 0.0 110.109 -178.152 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 144' ' ' ASP . . . . . . . . . . . . . 29.0 t70 -77.29 133.73 67.82 Favored Pre-proline 0 C--N 1.324 -0.523 0 CA-C-N 115.895 -0.593 . . . . 0.0 109.808 -177.295 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 145' ' ' PRO . . . . . 0.438 ' HA ' ' HB3' ' A' ' 2' ' ' SER . 24.4 Cg_endo -56.43 128.08 28.6 Favored 'Trans proline' 0 C--N 1.345 0.389 0 C-N-CA 123.308 2.672 . . . . 0.0 113.048 -172.575 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 146' ' ' ALA . . . . . . . . . . . . . . . -84.52 98.62 10.22 Favored 'General case' 0 C--N 1.314 -0.955 0 CA-C-N 114.967 -1.015 . . . . 0.0 109.907 178.185 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -98.61 45.94 1.0 Allowed 'General case' 0 C--N 1.32 -0.696 0 N-CA-C 108.388 -0.967 . . . . 0.0 108.388 179.628 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.448 -0.562 0 CA-C-N 115.46 -0.791 . . . . 0.0 110.902 -173.933 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 51.7 ttm . . . . . 0 N--CA 1.48 1.074 0 CA-C-O 120.791 0.329 . . . . 0.0 110.738 . . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 18.7 m -99.1 75.13 2.01 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-O 120.86 0.362 . . . . 0.0 110.516 -178.411 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 7.2 mp0 -76.31 -29.77 57.46 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 121.55 0.69 . . . . 0.0 110.051 177.681 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 20.8 t -120.97 152.56 38.4 Favored 'General case' 0 C--N 1.317 -0.834 0 CA-C-N 115.031 -0.986 . . . . 0.0 109.698 -179.98 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 69.8 t -68.72 123.39 22.05 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.443 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.36 -178.595 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 6' ' ' GLN . . . . . . . . . . . . . 5.1 pt20 -140.49 160.67 39.48 Favored 'General case' 0 C--N 1.315 -0.929 0 CA-C-N 115.206 -0.906 . . . . 0.0 109.342 -177.667 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 41.4 p -62.64 145.33 54.82 Favored 'General case' 0 C--N 1.317 -0.837 0 O-C-N 123.215 0.322 . . . . 0.0 110.824 -178.47 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 8' ' ' ASN . . . . . 0.433 ' OD1' ' HA ' ' A' ' 148' ' ' GLU . 21.3 t-20 77.24 -1.01 2.82 Favored 'General case' 0 N--CA 1.47 0.564 0 C-N-CA 123.762 0.825 . . . . 0.0 111.558 179.732 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 67.1 m -99.99 166.23 11.15 Favored 'General case' 0 C--N 1.327 -0.384 0 N-CA-C 108.983 -0.747 . . . . 0.0 108.983 172.693 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 10' ' ' ALA . . . . . 0.49 ' HB2' ' HB3' ' A' ' 144' ' ' ASP . . . -115.82 154.32 29.88 Favored 'General case' 0 C--N 1.316 -0.875 0 C-N-CA 120.598 -0.441 . . . . 0.0 110.209 178.705 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 8.6 m -129.69 133.57 64.73 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.786 0 CA-C-O 121.395 0.617 . . . . 0.0 110.575 177.776 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 12' ' ' LEU . . . . . 0.442 HD11 ' N ' ' A' ' 12' ' ' LEU . 5.9 mp -86.81 110.36 19.89 Favored 'General case' 0 C--N 1.316 -0.88 0 N-CA-C 107.173 -1.418 . . . . 0.0 107.173 172.923 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 13' ' ' VAL . . . . . 0.452 ' CG2' HG21 ' A' ' 138' ' ' ILE . 1.5 p -123.73 157.19 30.42 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.93 0 CA-C-O 121.089 0.471 . . . . 0.0 110.858 -171.963 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 14' ' ' HIS . . . . . 0.409 ' N ' HG23 ' A' ' 13' ' ' VAL . 0.0 OUTLIER -119.02 116.34 26.21 Favored 'General case' 0 C--N 1.317 -0.822 0 N-CA-C 106.376 -1.713 . . . . 0.0 106.376 174.197 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 15' ' ' PHE . . . . . 0.44 ' HB2' ' O ' ' A' ' 137' ' ' ASP . 21.2 p90 -150.81 161.69 42.17 Favored 'General case' 0 C--N 1.32 -0.695 0 C-N-CA 119.221 -0.992 . . . . 0.0 112.441 -169.448 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 13.8 m -128.58 122.99 32.25 Favored 'General case' 0 N--CA 1.448 -0.535 0 N-CA-C 109.09 -0.707 . . . . 0.0 109.09 173.101 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 7.3 tp -92.23 125.52 36.93 Favored 'General case' 0 C--N 1.319 -0.72 0 CA-C-O 121.407 0.622 . . . . 0.0 110.941 -173.505 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 18' ' ' LYS . . . . . 0.435 ' N ' ' HD3' ' A' ' 18' ' ' LYS . 0.0 OUTLIER -111.49 145.84 38.33 Favored 'General case' 0 C--N 1.321 -0.651 0 CA-C-N 114.849 -1.068 . . . . 0.0 111.247 -173.319 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 19' ' ' LEU . . . . . 0.458 ' CD2' ' HB2' ' A' ' 25' ' ' ALA . 4.0 mm? -86.69 166.43 15.33 Favored 'General case' 0 C--N 1.319 -0.74 0 N-CA-C 109.64 -0.504 . . . . 0.0 109.64 172.24 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 15.7 t70 -61.08 -33.75 73.83 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-O 121.243 0.544 . . . . 0.0 109.659 174.052 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 17.7 m-20 -80.08 9.34 5.64 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 115.46 -0.791 . . . . 0.0 111.899 -179.614 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 73.34 17.61 78.96 Favored Glycine 0 N--CA 1.453 -0.174 0 C-N-CA 121.146 -0.55 . . . . 0.0 113.004 178.439 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 9.3 m -85.69 152.54 23.0 Favored 'General case' 0 C--N 1.32 -0.694 0 N-CA-C 109.577 -0.527 . . . . 0.0 109.577 176.337 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 23.5 m -95.47 116.35 28.69 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-O 120.718 0.294 . . . . 0.0 110.828 179.038 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 25' ' ' ALA . . . . . 0.458 ' HB2' ' CD2' ' A' ' 19' ' ' LEU . . . -87.31 -50.67 6.43 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 116.258 -0.428 . . . . 0.0 111.567 -177.009 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 8.1 tp10 -145.62 129.29 17.13 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 115.78 -0.645 . . . . 0.0 109.468 -175.113 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 21.0 m -124.09 115.03 20.5 Favored 'General case' 0 C--N 1.318 -0.786 0 N-CA-C 110.474 -0.195 . . . . 0.0 110.474 -178.939 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 8.4 t -122.11 57.76 1.05 Allowed 'General case' 0 C--O 1.239 0.546 0 CA-C-O 122.653 1.216 . . . . 0.0 109.182 173.484 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 10.6 mmm180 -118.12 -71.78 0.72 Allowed 'General case' 0 C--N 1.323 -0.564 0 CA-C-N 114.152 -1.386 . . . . 0.0 110.366 173.089 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 11.0 p30 -65.49 -7.45 14.4 Favored 'General case' 0 N--CA 1.47 0.537 0 CA-C-N 116.096 -0.502 . . . . 0.0 111.765 -177.302 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -61.4 -35.31 77.15 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 115.877 -0.602 . . . . 0.0 110.62 -179.419 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 90.0 -1.36 80.35 Favored Glycine 0 N--CA 1.447 -0.584 0 N-CA-C 110.759 -0.936 . . . . 0.0 110.759 -172.22 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 65.6 mttm -128.71 138.53 33.32 Favored Pre-proline 0 C--N 1.326 -0.446 0 N-CA-C 109.06 -0.719 . . . . 0.0 109.06 179.792 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 37.0 Cg_endo -85.06 171.49 9.17 Favored 'Trans proline' 0 N--CA 1.451 -1.008 0 C-N-CA 122.933 2.422 . . . . 0.0 112.029 174.423 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -113.89 139.13 49.44 Favored 'General case' 0 C--N 1.309 -1.182 0 CA-C-N 115.019 -0.992 . . . . 0.0 109.115 -179.905 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 3.3 tm? -94.97 117.49 30.23 Favored 'General case' 0 C--N 1.316 -0.856 0 CA-C-O 121.27 0.557 . . . . 0.0 110.184 -178.629 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 37' ' ' PHE . . . . . . . . . . . . . 4.4 m-30 -98.51 107.84 20.39 Favored 'General case' 0 C--N 1.317 -0.84 0 CA-C-N 115.266 -0.879 . . . . 0.0 110.181 174.175 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 38' ' ' ARG . . . . . 0.406 ' HD2' ' HB3' ' A' ' 10' ' ' ALA . 19.2 tpt180 -92.84 109.39 20.83 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-N 116.265 -0.425 . . . . 0.0 109.858 178.95 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 14.7 mt -81.05 154.04 27.05 Favored 'General case' 0 C--N 1.321 -0.653 0 CA-C-N 115.611 -0.722 . . . . 0.0 109.77 -177.877 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 101.47 35.78 4.01 Favored Glycine 0 N--CA 1.444 -0.778 0 C-N-CA 120.754 -0.736 . . . . 0.0 112.349 -177.191 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER 62.99 14.94 7.98 Favored 'General case' 0 N--CA 1.47 0.556 0 N-CA-C 112.96 0.726 . . . . 0.0 112.96 175.515 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -62.73 -59.01 5.48 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-O 121.034 0.445 . . . . 0.0 110.663 179.92 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 16.4 t -134.53 2.86 3.26 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-O 121.303 0.573 . . . . 0.0 110.03 177.145 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 44' ' ' LEU . . . . . 0.461 HD12 ' CD2' ' A' ' 48' ' ' LEU . 78.9 mt -115.38 174.1 6.18 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-N 115.542 -0.754 . . . . 0.0 109.994 -178.09 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 12.9 t -104.65 154.91 19.36 Favored 'General case' 0 C--N 1.322 -0.608 0 N-CA-C 109.306 -0.627 . . . . 0.0 109.306 176.586 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 46' ' ' GLU . . . . . 0.539 ' O ' ' HG2' ' A' ' 50' ' ' GLN . 37.7 mt-10 -47.35 -46.17 25.37 Favored 'General case' 0 N--CA 1.466 0.335 0 O-C-N 123.605 0.565 . . . . 0.0 112.067 -175.221 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -61.24 -42.12 99.69 Favored Glycine 0 N--CA 1.446 -0.677 0 CA-C-N 115.975 -0.557 . . . . 0.0 113.581 -173.562 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 48' ' ' LEU . . . . . 0.461 ' CD2' HD12 ' A' ' 44' ' ' LEU . 2.6 tt -61.26 -48.95 79.07 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 117.325 0.563 . . . . 0.0 111.538 -176.749 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 49' ' ' GLU . . . . . 0.425 ' O ' HD12 ' A' ' 53' ' ' LEU . 11.7 pt-20 -64.5 -37.78 88.71 Favored 'General case' 0 C--N 1.325 -0.49 0 C-N-CA 120.555 -0.458 . . . . 0.0 109.907 -179.033 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 50' ' ' GLN . . . . . 0.539 ' HG2' ' O ' ' A' ' 46' ' ' GLU . 84.5 mm-40 -51.88 -29.3 19.26 Favored 'General case' 0 N--CA 1.464 0.249 0 N-CA-C 112.047 0.388 . . . . 0.0 112.047 175.475 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 51' ' ' HIS . . . . . . . . . . . . . 12.3 m-70 -97.63 -3.81 38.73 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-O 121.057 0.456 . . . . 0.0 110.973 -177.319 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 31.1 mt -102.84 -29.69 11.31 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 116.097 -0.501 . . . . 0.0 111.279 178.022 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 53' ' ' LEU . . . . . 0.425 HD12 ' O ' ' A' ' 49' ' ' GLU . 0.0 OUTLIER -59.47 139.08 57.42 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-O 121.158 0.504 . . . . 0.0 111.26 -179.465 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 93.67 -8.85 74.09 Favored Glycine 0 N--CA 1.45 -0.391 0 CA-C-N 115.743 -0.662 . . . . 0.0 112.589 -179.45 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 4.2 mm? -78.15 164.92 24.56 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-O 121.048 0.452 . . . . 0.0 110.918 176.857 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 56' ' ' LYS . . . . . 0.553 ' HZ1' ' HB2' ' A' ' 56' ' ' LYS . 0.1 OUTLIER -126.78 164.84 20.46 Favored 'General case' 0 C--N 1.321 -0.665 0 CA-C-N 116.197 -0.456 . . . . 0.0 109.874 -176.993 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 25.5 t -63.91 132.37 29.74 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 N-CA-C 109.908 -0.405 . . . . 0.0 109.908 172.377 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 79.93 9.93 86.18 Favored Glycine 0 N--CA 1.45 -0.373 0 C-N-CA 120.995 -0.621 . . . . 0.0 112.38 -176.133 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 59' ' ' ASP . . . . . 0.527 ' HB2' ' O ' ' A' ' 56' ' ' LYS . 0.4 OUTLIER -104.52 152.96 21.75 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-O 120.964 0.411 . . . . 0.0 110.634 178.732 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 60' ' ' LYS . . . . . 0.4 ' HE3' ' OE1' ' A' ' 139' ' ' GLU . 0.6 OUTLIER -112.18 132.35 54.95 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 115.671 -0.695 . . . . 0.0 110.412 -173.003 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 7.6 t -139.35 115.81 10.58 Favored 'General case' 0 C--N 1.319 -0.744 0 CA-C-O 121.562 0.696 . . . . 0.0 111.066 175.743 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 34.6 m -112.37 130.58 55.91 Favored 'General case' 0 C--N 1.318 -0.768 0 N-CA-C 108.986 -0.746 . . . . 0.0 108.986 173.492 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 28.4 p90 -148.71 146.84 28.29 Favored 'General case' 0 C--N 1.315 -0.903 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.252 -177.591 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 26.6 p -89.85 144.52 25.87 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.492 176.241 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 77.0 mt -138.55 133.1 32.14 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-O 121.356 0.598 . . . . 0.0 110.866 177.635 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 66' ' ' GLU . . . . . 0.423 ' HB2' ' OD1' ' A' ' 68' ' ' ASP . 4.3 mm-40 -88.61 161.84 40.88 Favored Pre-proline 0 C--N 1.313 -1.003 0 CA-C-N 115.157 -0.929 . . . . 0.0 108.728 174.671 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 67' ' ' PRO . . . . . 0.424 ' HB3' ' HA2' ' A' ' 131' ' ' GLY . 99.1 Cg_exo -45.53 -35.47 12.47 Favored 'Trans proline' 0 C--N 1.349 0.586 0 C-N-CA 123.055 2.503 . . . . 0.0 114.367 -174.305 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 68' ' ' ASP . . . . . 0.423 ' OD1' ' HB2' ' A' ' 66' ' ' GLU . 6.8 p-10 -59.21 -29.41 67.48 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-O 120.723 0.297 . . . . 0.0 111.417 -178.889 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -115.04 11.8 16.53 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-O 120.76 0.314 . . . . 0.0 111.045 179.589 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -146.67 108.62 4.38 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 116.302 -0.408 . . . . 0.0 110.972 -174.349 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 71' ' ' PHE . . . . . 0.501 ' CB ' ' HA ' ' A' ' 130' ' ' ALA . 27.5 m-85 72.07 -45.48 0.62 Allowed 'General case' 0 N--CA 1.466 0.369 0 CA-C-N 115.358 -0.837 . . . . 0.0 111.937 179.756 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 72' ' ' GLY . . . . . 0.566 ' O ' ' HB3' ' A' ' 130' ' ' ALA . . . 131.31 155.46 8.15 Favored Glycine 0 N--CA 1.45 -0.41 0 C-N-CA 121.041 -0.599 . . . . 0.0 112.452 177.663 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 45.2 t -80.82 125.72 79.5 Favored Pre-proline 0 C--N 1.323 -0.548 0 O-C-N 122.843 -0.21 . . . . 0.0 111.298 175.101 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 74' ' ' PRO . . . . . 0.404 ' HD3' ' CA ' ' A' ' 131' ' ' GLY . 90.2 Cg_endo -80.43 155.25 21.62 Favored 'Trans proline' 0 C--N 1.346 0.397 0 C-N-CA 122.815 2.343 . . . . 0.0 111.235 173.904 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 8.1 t -140.95 130.48 12.97 Favored Pre-proline 0 C--N 1.32 -0.687 0 CA-C-O 121.077 0.465 . . . . 0.0 110.955 -177.972 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 57.1 Cg_endo -69.92 -17.84 36.61 Favored 'Trans proline' 0 C--N 1.347 0.462 0 C-N-CA 123.27 2.647 . . . . 0.0 113.615 -176.521 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 2.6 p-10 -70.85 -11.39 60.93 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-O 120.986 0.422 . . . . 0.0 110.522 -178.785 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 4.3 mm? -70.9 -18.86 62.66 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.002 -0.545 . . . . 0.0 110.589 174.645 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 79' ' ' ILE . . . . . 0.47 HG12 ' HA ' ' A' ' 124' ' ' ASP . 9.9 mt -85.46 106.76 15.51 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.643 0 CA-C-N 115.763 -0.653 . . . . 0.0 110.447 -175.94 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 30.8 mt-30 -121.79 122.01 38.53 Favored 'General case' 0 C--N 1.319 -0.759 0 CA-C-N 115.639 -0.71 . . . . 0.0 111.248 -178.501 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 81' ' ' TYR . . . . . 0.594 ' HB3' ' HA ' ' A' ' 122' ' ' THR . 0.1 OUTLIER -108.27 114.02 27.56 Favored 'General case' 0 C--N 1.315 -0.903 0 CA-C-N 115.914 -0.584 . . . . 0.0 111.55 176.945 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -116.55 177.93 4.52 Favored 'General case' 0 C--N 1.319 -0.748 0 CA-C-O 120.626 0.251 . . . . 0.0 111.125 168.394 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 83' ' ' SER . . . . . 0.414 ' HA ' ' O ' ' A' ' 119' ' ' ASP . 8.2 t -59.27 151.58 22.91 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-O 121.572 0.701 . . . . 0.0 111.963 -170.437 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -74.36 -12.72 60.6 Favored 'General case' 0 C--N 1.333 -0.131 0 CA-C-N 115.249 -0.887 . . . . 0.0 111.34 -169.681 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 85' ' ' ARG . . . . . . . . . . . . . 7.5 mpt_? -71.49 -20.52 62.05 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 121.51 0.671 . . . . 0.0 109.905 -177.574 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 30.6 mm-40 -79.48 -12.1 59.88 Favored 'General case' 0 C--N 1.321 -0.653 0 CA-C-N 114.959 -1.019 . . . . 0.0 109.797 176.206 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 87' ' ' PHE . . . . . 0.486 ' CE1' ' HB ' ' A' ' 121' ' ' ILE . 73.7 m-85 -105.0 -46.39 4.29 Favored 'General case' 0 C--N 1.319 -0.72 0 CA-C-N 114.709 -1.132 . . . . 0.0 110.538 -175.039 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 88' ' ' MET . . . . . . . . . . . . . 64.5 ttp -58.16 -22.35 50.95 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-N 115.325 -0.852 . . . . 0.0 110.216 178.666 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 32.1 t70 -53.3 -35.67 60.37 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 115.047 -0.979 . . . . 0.0 110.838 174.033 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -116.06 11.44 15.33 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.272 -179.919 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 113.58 141.26 7.84 Favored Glycine 0 N--CA 1.448 -0.505 0 C-N-CA 120.827 -0.701 . . . . 0.0 112.117 -178.301 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 44.2 mt-10 -64.41 125.81 89.23 Favored Pre-proline 0 C--N 1.324 -0.505 0 CA-C-O 121.017 0.437 . . . . 0.0 111.416 -178.842 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 93' ' ' PRO . . . . . 0.432 ' HB2' HD12 ' A' ' 113' ' ' ILE . 53.1 Cg_endo -78.83 167.06 22.76 Favored 'Trans proline' 0 C--O 1.232 0.217 0 C-N-CA 123.591 2.86 . . . . 0.0 114.146 -174.389 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 1.1 mp0 -120.08 155.65 32.57 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 115.015 -0.993 . . . . 0.0 111.352 -173.133 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 95' ' ' ILE . . . . . 0.542 ' CG1' HG12 ' A' ' 116' ' ' ILE . 13.7 mt -82.34 131.41 33.86 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.155 0 CA-C-N 116.301 -0.409 . . . . 0.0 111.01 178.778 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 68.13 30.05 73.66 Favored Glycine 0 N--CA 1.448 -0.544 0 CA-C-N 115.815 -0.63 . . . . 0.0 111.905 179.966 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -108.45 125.32 51.64 Favored 'General case' 0 N--CA 1.445 -0.695 0 CA-C-O 120.934 0.397 . . . . 0.0 109.939 179.828 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 98' ' ' ILE . . . . . 0.472 ' HA ' ' HA ' ' A' ' 112' ' ' VAL . 35.4 mt -86.52 102.47 11.95 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.867 0 N-CA-C 108.807 -0.812 . . . . 0.0 108.807 179.601 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 99' ' ' MET . . . . . 0.485 ' O ' ' HD2' ' A' ' 101' ' ' PHE . 7.0 mtm -105.39 126.63 52.33 Favored 'General case' 0 N--CA 1.438 -1.057 0 CA-C-O 121.665 0.745 . . . . 0.0 110.545 -175.279 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 4.4 mm? -62.75 147.81 48.65 Favored 'General case' 0 C--N 1.305 -1.331 0 CA-C-N 114.28 -1.327 . . . . 0.0 109.326 171.078 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 101' ' ' PHE . . . . . 0.485 ' HD2' ' O ' ' A' ' 99' ' ' MET . 0.4 OUTLIER -148.62 167.02 26.55 Favored 'General case' 0 CA--C 1.509 -0.619 0 CA-C-N 115.021 -0.99 . . . . 0.0 108.44 -152.806 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 1.5 m -121.78 122.15 38.86 Favored 'General case' 0 C--N 1.309 -1.179 0 C-N-CA 119.773 -0.771 . . . . 0.0 110.353 176.965 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -88.12 165.25 15.24 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-N 115.791 -0.64 . . . . 0.0 110.305 -177.779 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 104' ' ' MET . . . . . . . . . . . . . 2.0 mpt? -66.23 -12.73 58.01 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.807 -0.633 . . . . 0.0 112.002 -175.014 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 8.6 p-10 -99.71 15.44 26.8 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-O 120.737 0.304 . . . . 0.0 110.982 179.765 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 79.76 -11.95 31.3 Favored Glycine 0 CA--C 1.52 0.346 0 C-N-CA 121.121 -0.562 . . . . 0.0 113.88 177.824 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 24.6 t -79.71 151.13 30.61 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-O 121.203 0.525 . . . . 0.0 110.081 179.586 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 26.3 tt0 -94.56 100.26 12.26 Favored 'General case' 0 C--N 1.313 -1.016 0 CA-C-N 115.585 -0.734 . . . . 0.0 110.009 -178.019 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 109' ' ' MET . . . . . . . . . . . . . 3.1 mtp -92.25 147.85 35.42 Favored Pre-proline 0 C--N 1.324 -0.524 0 CA-C-N 115.3 -0.864 . . . . 0.0 110.842 179.998 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 55.2 Cg_endo -72.49 154.72 55.46 Favored 'Trans proline' 0 N--CA 1.458 -0.56 0 C-N-CA 122.009 1.806 . . . . 0.0 110.871 173.374 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 111' ' ' GLY . . . . . 0.494 ' HA2' ' O ' ' A' ' 124' ' ' ASP . . . -150.21 103.48 0.25 Allowed Glycine 0 N--CA 1.445 -0.736 0 C-N-CA 120.164 -1.017 . . . . 0.0 110.853 -171.637 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 112' ' ' VAL . . . . . 0.472 ' HA ' ' HA ' ' A' ' 98' ' ' ILE . 7.7 p -97.73 113.26 31.77 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.559 0 CA-C-N 119.237 1.518 . . . . 0.0 110.689 -179.462 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 113' ' ' ILE . . . . . 0.458 ' HA ' ' O ' ' A' ' 122' ' ' THR . 39.2 mt -72.6 111.14 6.47 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.897 0 CA-C-N 114.902 -1.045 . . . . 0.0 110.059 179.941 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 114' ' ' ARG . . . . . 0.508 ' HD3' ' O ' ' A' ' 114' ' ' ARG . 8.8 tpp180 -63.81 -46.73 83.81 Favored 'General case' 0 C--N 1.322 -0.625 0 CA-C-N 114.909 -1.041 . . . . 0.0 110.864 -177.669 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 14.5 tt0 -159.25 154.43 25.27 Favored 'General case' 0 C--N 1.324 -0.531 0 C-N-CA 120.705 -0.398 . . . . 0.0 110.882 -175.751 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 116' ' ' ILE . . . . . 0.542 HG12 ' CG1' ' A' ' 95' ' ' ILE . 37.4 mm -100.57 120.63 50.3 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 N-CA-C 109.183 -0.673 . . . . 0.0 109.183 175.987 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 117' ' ' ASN . . . . . 0.424 ' HB2' ' O ' ' A' ' 120' ' ' SER . 30.2 m-80 -110.41 157.46 19.53 Favored 'General case' 0 C--N 1.315 -0.913 0 CA-C-N 115.934 -0.575 . . . . 0.0 110.171 -179.755 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . -56.21 -40.59 84.53 Favored Glycine 0 C--O 1.227 -0.343 0 C-N-CA 120.688 -0.768 . . . . 0.0 113.694 -169.528 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 119' ' ' ASP . . . . . 0.414 ' O ' ' HA ' ' A' ' 83' ' ' SER . 24.8 m-20 -113.07 -15.69 12.77 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 117.169 0.484 . . . . 0.0 112.119 179.826 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 120' ' ' SER . . . . . 0.424 ' O ' ' HB2' ' A' ' 117' ' ' ASN . 13.6 t -130.73 156.49 44.86 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-O 120.923 0.392 . . . . 0.0 111.483 -169.999 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 121' ' ' ILE . . . . . 0.517 ' O ' ' HA ' ' A' ' 81' ' ' TYR . 49.5 mm -127.46 125.59 65.95 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.778 -178.626 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 122' ' ' THR . . . . . 0.594 ' HA ' ' HB3' ' A' ' 81' ' ' TYR . 10.7 m -95.38 103.32 15.18 Favored 'General case' 0 C--N 1.329 -0.323 0 N-CA-C 112.477 0.547 . . . . 0.0 112.477 -174.246 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 5.6 t -103.78 122.06 56.02 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 N-CA-C 113.307 0.854 . . . . 0.0 113.307 177.404 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 124' ' ' ASP . . . . . 0.494 ' O ' ' HA2' ' A' ' 111' ' ' GLY . 1.3 t70 -89.04 135.41 33.57 Favored 'General case' 0 C--N 1.322 -0.587 0 CA-C-N 115.191 -0.913 . . . . 0.0 111.508 170.285 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 125' ' ' PHE . . . . . . . . . . . . . 63.2 m-85 -117.98 59.15 0.8 Allowed 'General case' 0 C--N 1.331 -0.216 0 CA-C-O 122.115 0.96 . . . . 0.0 110.381 -176.118 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 13.2 m-80 -104.39 142.4 34.65 Favored 'General case' 0 C--N 1.307 -1.266 0 CA-C-N 114.311 -1.313 . . . . 0.0 111.496 -179.439 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 127' ' ' HIS . . . . . 0.506 ' HB3' ' HD2' ' A' ' 128' ' ' PRO . 20.9 m80 -60.73 -175.2 0.08 OUTLIER Pre-proline 0 C--N 1.321 -0.645 0 CA-C-N 113.914 -1.493 . . . . 0.0 112.794 -178.162 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 128' ' ' PRO . . . . . 0.532 ' O ' ' N ' ' A' ' 130' ' ' ALA . 3.9 Cg_exo -42.82 177.47 0.0 OUTLIER 'Trans proline' 0 C--N 1.355 0.881 0 C-N-CA 125.252 3.968 . . . . 0.0 114.172 165.184 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 129' ' ' LEU . . . . . 0.506 ' HG ' ' O ' ' A' ' 129' ' ' LEU . 26.4 tp -47.6 42.45 0.0 OUTLIER 'General case' 0 N--CA 1.488 1.433 0 C-N-CA 127.621 2.368 . . . . 0.0 115.418 -176.24 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 130' ' ' ALA . . . . . 0.566 ' HB3' ' O ' ' A' ' 72' ' ' GLY . . . -86.24 173.95 9.42 Favored 'General case' 0 C--N 1.31 -1.143 0 N-CA-C 109.49 -0.559 . . . . 0.0 109.49 -176.153 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 131' ' ' GLY . . . . . 0.424 ' HA2' ' HB3' ' A' ' 67' ' ' PRO . . . 73.56 21.48 79.43 Favored Glycine 0 N--CA 1.448 -0.541 0 C-N-CA 120.637 -0.792 . . . . 0.0 113.145 178.836 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 132' ' ' GLN . . . . . . . . . . . . . 3.9 pt20 -110.31 143.67 40.18 Favored 'General case' 0 N--CA 1.444 -0.766 0 N-CA-C 109.707 -0.479 . . . . 0.0 109.707 174.965 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 133' ' ' THR . . . . . . . . . . . . . 20.5 m -88.36 111.79 22.14 Favored 'General case' 0 C--N 1.317 -0.829 0 N-CA-C 108.85 -0.796 . . . . 0.0 108.85 177.82 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 134' ' ' VAL . . . . . . . . . . . . . 1.5 m -121.99 148.78 25.37 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.595 0 CA-C-O 121.894 0.854 . . . . 0.0 112.6 -172.271 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 135' ' ' HIS . . . . . . . . . . . . . 15.0 m-70 -112.42 147.38 36.58 Favored 'General case' 0 C--N 1.316 -0.89 0 CA-C-N 114.624 -1.171 . . . . 0.0 108.508 174.028 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 136' ' ' PHE . . . . . . . . . . . . . 12.5 m-85 -123.45 124.11 42.15 Favored 'General case' 0 C--N 1.31 -1.131 0 CA-C-N 116.028 -0.533 . . . . 0.0 111.71 -166.726 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 137' ' ' ASP . . . . . 0.44 ' O ' ' HB2' ' A' ' 15' ' ' PHE . 12.9 m-20 -116.58 96.42 5.5 Favored 'General case' 0 C--N 1.324 -0.525 0 N-CA-C 108.608 -0.886 . . . . 0.0 108.608 175.784 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 138' ' ' ILE . . . . . 0.452 HG21 ' CG2' ' A' ' 13' ' ' VAL . 1.9 mp -107.65 138.57 33.28 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.55 0 N-CA-C 112.599 0.592 . . . . 0.0 112.599 -177.794 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 139' ' ' GLU . . . . . 0.4 ' OE1' ' HE3' ' A' ' 60' ' ' LYS . 31.8 mt-10 -125.59 124.71 41.83 Favored 'General case' 0 CA--C 1.507 -0.676 0 N-CA-C 108.084 -1.08 . . . . 0.0 108.084 167.885 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 140' ' ' VAL . . . . . . . . . . . . . 71.6 t -78.16 121.47 31.05 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.747 0 C-N-CA 120.704 -0.398 . . . . 0.0 110.428 -176.947 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 19.2 mt -93.1 -44.05 8.57 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-O 121.262 0.553 . . . . 0.0 110.027 178.084 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 142' ' ' GLU . . . . . . . . . . . . . 10.2 tp10 -153.67 152.22 30.56 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-N 115.465 -0.789 . . . . 0.0 109.768 -179.336 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 143' ' ' ILE . . . . . . . . . . . . . 63.0 mt -116.9 121.16 67.13 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.421 0 CA-C-O 121.007 0.432 . . . . 0.0 110.317 178.531 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 144' ' ' ASP . . . . . 0.49 ' HB3' ' HB2' ' A' ' 10' ' ' ALA . 38.6 t70 -77.37 128.5 80.22 Favored Pre-proline 0 C--N 1.322 -0.618 0 CA-C-N 115.808 -0.633 . . . . 0.0 110.154 -179.341 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 145' ' ' PRO . . . . . . . . . . . . . 73.7 Cg_exo -52.61 153.89 13.27 Favored 'Trans proline' 0 C--N 1.345 0.383 0 C-N-CA 123.29 2.66 . . . . 0.0 112.539 178.415 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 146' ' ' ALA . . . . . . . . . . . . . . . -83.73 95.71 8.49 Favored 'General case' 0 C--N 1.32 -0.716 0 CA-C-O 121.591 0.71 . . . . 0.0 111.106 -177.684 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 3.8 mm? -102.33 31.07 4.19 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-N 115.438 -0.801 . . . . 0.0 108.841 170.469 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 148' ' ' GLU . . . . . 0.433 ' HA ' ' OD1' ' A' ' 8' ' ' ASN . 41.2 mt-10 . . . . . 0 CA--C 1.527 0.083 0 CA-C-N 114.679 -1.146 . . . . 0.0 111.249 -178.733 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 26.4 ttt . . . . . 0 N--CA 1.48 1.037 0 CA-C-O 120.743 0.306 . . . . 0.0 110.189 . . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 4.8 t -109.55 118.34 36.35 Favored 'General case' 0 C--N 1.322 -0.605 0 N-CA-C 109.25 -0.648 . . . . 0.0 109.25 177.86 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 3' ' ' GLU . . . . . 0.408 ' CG ' ' HE2' ' A' ' 56' ' ' LYS . 39.2 tt0 -74.5 -34.44 63.06 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-O 121.477 0.656 . . . . 0.0 110.554 -177.132 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 24.2 m -128.12 156.82 42.24 Favored 'General case' 0 C--N 1.314 -0.939 0 CA-C-N 115.302 -0.863 . . . . 0.0 109.604 179.621 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . 0.441 HG13 ' HA ' ' A' ' 53' ' ' LEU . 7.1 p -81.96 135.94 23.97 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.532 0 CA-C-O 121.021 0.439 . . . . 0.0 110.83 -177.58 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 6' ' ' GLN . . . . . 0.574 ' HG2' ' OG ' ' A' ' 9' ' ' SER . 0.6 OUTLIER -123.21 168.49 12.37 Favored 'General case' 0 C--N 1.318 -0.792 0 CA-C-N 115.933 -0.576 . . . . 0.0 109.632 177.866 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 29.4 t -54.23 122.77 11.01 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-O 120.765 0.317 . . . . 0.0 110.493 179.052 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 2.9 t30 73.5 41.25 0.46 Allowed 'General case' 0 N--CA 1.469 0.497 0 C-N-CA 123.935 0.894 . . . . 0.0 111.132 -177.238 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 9' ' ' SER . . . . . 0.574 ' OG ' ' HG2' ' A' ' 6' ' ' GLN . 67.0 m -122.2 134.74 54.71 Favored 'General case' 0 C--N 1.325 -0.473 0 N-CA-C 108.846 -0.798 . . . . 0.0 108.846 168.288 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -84.68 147.57 26.86 Favored 'General case' 0 C--N 1.315 -0.899 0 CA-C-N 116.533 -0.303 . . . . 0.0 110.233 -176.858 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 13.5 m -133.91 142.88 40.08 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.864 0 C-N-CA 120.712 -0.395 . . . . 0.0 110.335 179.971 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 30.6 tp -86.55 123.57 31.9 Favored 'General case' 0 C--N 1.319 -0.739 0 N-CA-C 108.271 -1.011 . . . . 0.0 108.271 174.797 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 13' ' ' VAL . . . . . 0.57 HG21 ' N ' ' A' ' 14' ' ' HIS . 4.4 p -131.93 156.28 42.38 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.778 0 CA-C-O 122.27 1.033 . . . . 0.0 113.057 -172.432 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 14' ' ' HIS . . . . . 0.57 ' N ' HG21 ' A' ' 13' ' ' VAL . 2.2 m-70 -118.77 120.85 38.59 Favored 'General case' 0 C--N 1.317 -0.835 0 N-CA-C 106.059 -1.83 . . . . 0.0 106.059 169.471 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 15' ' ' PHE . . . . . 0.521 ' CD1' ' HB ' ' A' ' 28' ' ' THR . 16.2 p90 -151.08 157.87 43.33 Favored 'General case' 0 C--N 1.324 -0.537 0 C-N-CA 118.181 -1.408 . . . . 0.0 113.948 -170.336 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 22.2 m -131.06 130.43 43.23 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 114.85 -1.068 . . . . 0.0 108.598 176.904 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 17' ' ' LEU . . . . . 0.456 ' HG ' ' HB3' ' A' ' 136' ' ' PHE . 2.2 tt -121.81 118.05 28.05 Favored 'General case' 0 N--CA 1.446 -0.637 0 N-CA-C 109.435 -0.58 . . . . 0.0 109.435 -173.678 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 18' ' ' LYS . . . . . 0.632 ' HB3' ' CE1' ' A' ' 135' ' ' HIS . 2.4 tppt? -126.19 155.63 41.46 Favored 'General case' 0 C--N 1.314 -0.94 0 C-N-CA 119.988 -0.685 . . . . 0.0 111.455 -174.885 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 3.1 mm? -99.52 171.5 7.89 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-N 115.291 -0.868 . . . . 0.0 109.339 173.813 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 35.5 t70 -64.72 -25.49 67.96 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-O 121.373 0.606 . . . . 0.0 109.866 176.099 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 5.0 m-20 -77.53 2.99 14.67 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.5 -0.773 . . . . 0.0 110.843 178.501 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 73.27 9.57 77.28 Favored Glycine 0 C--N 1.33 0.245 0 C-N-CA 121.387 -0.435 . . . . 0.0 113.28 -179.913 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 26.7 m -82.27 142.26 32.25 Favored 'General case' 0 C--N 1.321 -0.644 0 N-CA-C 109.835 -0.431 . . . . 0.0 109.835 177.093 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 20.9 m -89.59 112.57 23.82 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-O 120.747 0.308 . . . . 0.0 110.335 179.316 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -72.69 -38.09 67.66 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 121.134 0.493 . . . . 0.0 110.111 178.506 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 8.4 tp10 -157.32 141.24 16.04 Favored 'General case' 0 N--CA 1.446 -0.663 0 CA-C-N 115.732 -0.667 . . . . 0.0 110.132 178.682 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 36.9 p -124.53 119.72 29.91 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-O 121.125 0.488 . . . . 0.0 110.934 -178.828 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 28' ' ' THR . . . . . 0.641 ' O ' HG23 ' A' ' 28' ' ' THR . 96.8 m -139.62 11.26 2.49 Favored 'General case' 0 CA--C 1.547 0.848 0 CA-C-O 123.269 1.509 . . . . 0.0 110.562 177.187 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 8.7 tmm_? -104.27 -52.96 2.82 Favored 'General case' 0 C--N 1.308 -1.215 0 CA-C-N 115.099 -0.955 . . . . 0.0 109.921 167.481 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 4.8 p-10 -82.52 35.0 0.44 Allowed 'General case' 0 C--N 1.326 -0.436 0 CA-C-O 121.079 0.466 . . . . 0.0 111.472 -178.87 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 4.5 m-20 -120.33 -23.27 6.24 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.334 -0.394 . . . . 0.0 111.599 -178.788 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 84.85 -11.6 59.37 Favored Glycine 0 N--CA 1.453 -0.212 0 C-N-CA 120.435 -0.888 . . . . 0.0 110.905 -174.286 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 33' ' ' LYS . . . . . 0.448 ' HD2' ' HD2' ' A' ' 34' ' ' PRO . 56.1 tptt -120.53 118.16 31.09 Favored Pre-proline 0 C--N 1.321 -0.646 0 CA-C-N 114.896 -0.652 . . . . 0.0 110.054 -177.974 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 34' ' ' PRO . . . . . 0.448 ' HD2' ' HD2' ' A' ' 33' ' ' LYS . 73.9 Cg_endo -80.28 170.77 15.8 Favored 'Trans proline' 0 N--CA 1.457 -0.672 0 C-N-CA 122.506 2.137 . . . . 0.0 111.526 174.125 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -137.02 152.26 49.9 Favored 'General case' 0 C--N 1.311 -1.091 0 CA-C-N 115.671 -0.695 . . . . 0.0 110.463 -175.58 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 2.0 tp -90.69 138.24 31.73 Favored 'General case' 0 C--N 1.317 -0.807 0 N-CA-C 109.414 -0.588 . . . . 0.0 109.414 175.038 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 37' ' ' PHE . . . . . . . . . . . . . 2.4 m-30 -104.0 106.66 17.24 Favored 'General case' 0 C--N 1.317 -0.825 0 N-CA-C 108.67 -0.863 . . . . 0.0 108.67 175.535 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 6.5 tpp180 -86.07 105.6 16.61 Favored 'General case' 0 C--N 1.323 -0.569 0 N-CA-C 109.105 -0.702 . . . . 0.0 109.105 -179.733 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 39' ' ' LEU . . . . . 0.4 HD13 ' O ' ' A' ' 9' ' ' SER . 40.0 mt -90.38 156.39 18.27 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-N 115.363 -0.835 . . . . 0.0 111.666 -175.743 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 102.49 37.85 3.17 Favored Glycine 0 N--CA 1.45 -0.407 0 CA-C-N 115.335 -0.848 . . . . 0.0 111.996 -177.884 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 31.9 t70 65.74 0.53 1.52 Allowed 'General case' 0 N--CA 1.472 0.637 0 C-N-CA 123.509 0.724 . . . . 0.0 111.893 179.739 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -65.78 -48.34 72.12 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.781 -179.779 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 23.1 m -134.42 -39.79 0.82 Allowed 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 116.066 -0.515 . . . . 0.0 110.788 178.135 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 4.6 mm? -88.79 162.72 16.05 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-O 121.038 0.447 . . . . 0.0 111.19 -178.818 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 32.2 t -86.81 153.68 21.48 Favored 'General case' 0 C--N 1.324 -0.5 0 CA-C-N 115.356 -0.838 . . . . 0.0 110.212 -178.997 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 42.3 mt-10 -52.45 -42.9 64.58 Favored 'General case' 0 C--N 1.328 -0.336 0 N-CA-C 112.309 0.485 . . . . 0.0 112.309 -173.818 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -64.96 -37.68 94.57 Favored Glycine 0 N--CA 1.447 -0.62 0 C-N-CA 120.41 -0.9 . . . . 0.0 112.777 -174.699 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 48' ' ' LEU . . . . . 0.436 ' HA ' ' CD1' ' A' ' 65' ' ' LEU . 3.4 tm? -70.09 -53.63 16.6 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 121.003 0.43 . . . . 0.0 110.093 -176.934 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 10.4 pt-20 -58.3 -40.89 83.19 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 115.712 -0.676 . . . . 0.0 112.107 -177.868 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 50' ' ' GLN . . . . . 0.504 ' HA ' ' CD2' ' A' ' 53' ' ' LEU . 90.6 mm-40 -73.74 -15.14 61.22 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-O 120.811 0.338 . . . . 0.0 111.336 -173.003 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 51' ' ' HIS . . . . . . . . . . . . . 14.6 m-70 -107.48 -9.4 15.97 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-O 120.945 0.402 . . . . 0.0 110.45 179.255 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -98.62 -30.48 12.46 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.274 179.284 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 53' ' ' LEU . . . . . 0.504 ' CD2' ' HA ' ' A' ' 50' ' ' GLN . 3.0 pp -66.76 152.08 46.2 Favored 'General case' 0 N--CA 1.452 -0.331 0 N-CA-C 109.764 -0.458 . . . . 0.0 109.764 179.565 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 93.28 3.27 65.28 Favored Glycine 0 N--CA 1.445 -0.704 0 C-N-CA 120.872 -0.68 . . . . 0.0 112.824 -175.136 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 3.8 mm? -96.01 165.28 12.33 Favored 'General case' 0 C--O 1.233 0.228 0 CA-C-N 117.395 0.598 . . . . 0.0 110.703 177.759 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 56' ' ' LYS . . . . . 0.589 ' HD3' ' N ' ' A' ' 57' ' ' VAL . 11.0 tmtt? -117.62 151.3 37.48 Favored 'General case' 0 C--N 1.324 -0.53 0 N-CA-C 109.031 -0.729 . . . . 0.0 109.031 -177.969 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 57' ' ' VAL . . . . . 0.589 ' N ' ' HD3' ' A' ' 56' ' ' LYS . 42.6 t -58.44 136.91 21.42 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-O 121.134 0.492 . . . . 0.0 111.492 176.708 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 82.75 8.97 85.23 Favored Glycine 0 N--CA 1.446 -0.645 0 CA-C-N 115.116 -0.947 . . . . 0.0 111.973 -178.985 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 59' ' ' ASP . . . . . 0.455 ' HB2' ' O ' ' A' ' 56' ' ' LYS . 1.0 OUTLIER -99.56 134.09 42.94 Favored 'General case' 0 C--N 1.323 -0.544 0 N-CA-C 108.916 -0.772 . . . . 0.0 108.916 171.772 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 6.9 mmmm -106.52 128.35 54.03 Favored 'General case' 0 C--N 1.319 -0.744 0 N-CA-C 109.248 -0.649 . . . . 0.0 109.248 -175.753 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 4.7 t -136.64 113.8 10.65 Favored 'General case' 0 C--N 1.32 -0.694 0 CA-C-O 121.837 0.827 . . . . 0.0 111.525 -176.536 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 6.1 m -100.47 131.66 46.27 Favored 'General case' 0 C--N 1.317 -0.842 0 N-CA-C 108.238 -1.023 . . . . 0.0 108.238 172.084 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 63' ' ' PHE . . . . . 0.516 ' CE2' ' HE1' ' A' ' 136' ' ' PHE . 11.3 p90 -157.92 163.98 37.34 Favored 'General case' 0 C--N 1.321 -0.661 0 C-N-CA 120.063 -0.655 . . . . 0.0 111.818 -178.072 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 26.0 t -128.75 151.81 49.13 Favored 'General case' 0 C--N 1.318 -0.785 0 CA-C-N 115.187 -0.915 . . . . 0.0 109.829 179.816 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 65' ' ' LEU . . . . . 0.436 ' CD1' ' HA ' ' A' ' 48' ' ' LEU . 39.3 mt -135.85 150.94 49.57 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-N 116.219 -0.446 . . . . 0.0 109.981 -176.882 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 48.7 mt-10 -64.1 153.88 83.94 Favored Pre-proline 0 C--N 1.33 -0.282 0 CA-C-N 116.081 -0.509 . . . . 0.0 110.527 178.779 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 80.9 Cg_exo -46.35 -52.25 7.57 Favored 'Trans proline' 0 C--O 1.233 0.257 0 C-N-CA 123.103 2.535 . . . . 0.0 113.542 -175.777 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 1.9 p-10 -66.26 -24.96 66.67 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-O 120.921 0.391 . . . . 0.0 111.053 -174.784 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -79.85 -18.55 50.49 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 115.98 -0.554 . . . . 0.0 110.922 -178.581 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -117.86 -85.84 0.64 Allowed 'General case' 0 N--CA 1.449 -0.482 0 N-CA-C 111.953 0.353 . . . . 0.0 111.953 -178.093 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 71' ' ' PHE . . . . . . . . . . . . . 9.2 m-85 -86.29 -12.31 49.86 Favored 'General case' 0 C--N 1.328 -0.345 0 N-CA-C 112.379 0.511 . . . . 0.0 112.379 -171.863 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 72' ' ' GLY . . . . . 0.478 ' C ' ' HB2' ' A' ' 130' ' ' ALA . . . 105.91 -152.59 17.13 Favored Glycine 0 N--CA 1.454 -0.158 0 C-N-CA 120.82 -0.705 . . . . 0.0 112.202 179.284 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 26.0 m -134.0 128.41 19.62 Favored Pre-proline 0 N--CA 1.449 -0.49 0 CA-C-O 121.572 0.701 . . . . 0.0 112.181 -179.019 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 74' ' ' PRO . . . . . 0.509 ' HD3' ' N ' ' A' ' 131' ' ' GLY . 61.7 Cg_endo -85.5 165.07 10.79 Favored 'Trans proline' 0 N--CA 1.458 -0.6 0 C-N-CA 124.438 3.426 . . . . 0.0 110.905 169.687 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 75' ' ' SER . . . . . 0.476 ' HB3' ' HB2' ' A' ' 78' ' ' LEU . 41.3 t -141.48 97.36 6.75 Favored Pre-proline 0 C--N 1.312 -1.061 0 N-CA-C 109.896 -0.409 . . . . 0.0 109.896 173.784 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 26.9 Cg_endo -65.44 -25.84 55.61 Favored 'Trans proline' 0 N--CA 1.459 -0.536 0 C-N-CA 121.729 1.619 . . . . 0.0 111.009 175.666 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 8.6 p-10 -77.36 -8.87 58.37 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 115.701 -0.681 . . . . 0.0 110.753 176.524 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 78' ' ' LEU . . . . . 0.51 ' CD2' ' HB2' ' A' ' 125' ' ' PHE . 4.4 tp -73.23 -23.06 60.31 Favored 'General case' 0 CA--C 1.511 -0.549 0 CA-C-O 121.596 0.712 . . . . 0.0 109.147 176.604 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 79' ' ' ILE . . . . . 0.626 HG23 ' O ' ' A' ' 123' ' ' VAL . 7.0 mt -68.3 124.24 23.43 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.724 0 CA-C-N 114.69 -1.141 . . . . 0.0 110.575 177.245 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 40.2 mt-30 -149.97 119.27 6.83 Favored 'General case' 0 CA--C 1.502 -0.885 0 CA-C-N 114.992 -1.004 . . . . 0.0 109.377 -176.184 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 81' ' ' TYR . . . . . 0.531 ' CE2' HG22 ' A' ' 122' ' ' THR . 1.8 m-85 -80.26 114.75 19.38 Favored 'General case' 0 C--N 1.307 -1.27 0 C-N-CA 118.76 -1.176 . . . . 0.0 111.902 174.97 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 23.6 m-85 -100.15 172.71 7.01 Favored 'General case' 0 C--N 1.322 -0.627 0 CA-C-N 113.782 -1.554 . . . . 0.0 110.141 172.399 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 83' ' ' SER . . . . . 0.412 ' HB3' ' HG3' ' A' ' 86' ' ' GLU . 23.2 t -63.24 159.34 18.01 Favored 'General case' 0 C--N 1.321 -0.657 0 CA-C-O 122.836 1.303 . . . . 0.0 112.485 -167.952 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 84' ' ' ARG . . . . . 0.521 ' HD3' ' HA ' ' A' ' 119' ' ' ASP . 36.5 ptt180 -77.5 -28.21 52.08 Favored 'General case' 0 C--N 1.315 -0.925 0 CA-C-N 112.604 -2.089 . . . . 0.0 108.118 -179.31 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 85' ' ' ARG . . . . . . . . . . . . . 6.6 mpt_? -71.53 -39.8 70.5 Favored 'General case' 0 CA--C 1.512 -0.5 0 CA-C-N 114.281 -1.327 . . . . 0.0 111.158 -176.99 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 86' ' ' GLU . . . . . 0.412 ' HG3' ' HB3' ' A' ' 83' ' ' SER . 41.4 mt-10 -56.02 -36.88 68.45 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 115.316 -0.857 . . . . 0.0 110.891 -175.941 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 87' ' ' PHE . . . . . 0.421 ' HB3' ' HG3' ' A' ' 93' ' ' PRO . 14.0 m-85 -93.18 -37.44 12.09 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.475 -0.329 . . . . 0.0 111.843 -179.601 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 88' ' ' MET . . . . . . . . . . . . . 58.6 ttp -58.53 -31.79 68.25 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.59 -173.382 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 33.9 t70 -57.55 -28.62 63.71 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-O 120.954 0.407 . . . . 0.0 110.912 177.443 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -102.79 -2.91 27.18 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.055 -0.52 . . . . 0.0 110.732 176.967 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 119.59 140.08 6.1 Favored Glycine 0 N--CA 1.447 -0.583 0 C-N-CA 121.035 -0.602 . . . . 0.0 112.117 -178.108 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 47.0 mt-10 -61.11 120.94 58.9 Favored Pre-proline 0 C--N 1.327 -0.398 0 CA-C-O 120.807 0.336 . . . . 0.0 110.887 178.465 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 93' ' ' PRO . . . . . 0.425 ' CB ' HD12 ' A' ' 113' ' ' ILE . 4.3 Cg_exo -71.7 167.42 26.57 Favored 'Trans proline' 0 C--N 1.344 0.312 0 C-N-CA 123.303 2.669 . . . . 0.0 112.895 -176.841 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -115.4 156.04 26.31 Favored 'General case' 0 C--N 1.321 -0.64 0 CA-C-N 115.04 -0.982 . . . . 0.0 111.045 -174.609 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 95' ' ' ILE . . . . . 0.493 HG12 HG12 ' A' ' 116' ' ' ILE . 21.6 mt -81.76 131.06 34.72 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.453 0 CA-C-N 115.909 -0.587 . . . . 0.0 110.875 -178.716 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 72.92 18.76 79.2 Favored Glycine 0 N--CA 1.449 -0.466 0 CA-C-N 115.709 -0.678 . . . . 0.0 112.422 -177.289 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 97' ' ' ALA . . . . . 0.412 ' O ' HG13 ' A' ' 113' ' ' ILE . . . -98.71 129.74 45.17 Favored 'General case' 0 C--N 1.324 -0.515 0 N-CA-C 109.674 -0.491 . . . . 0.0 109.674 177.385 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 98' ' ' ILE . . . . . 0.513 ' HA ' ' HA ' ' A' ' 112' ' ' VAL . 16.4 mt -97.79 130.08 47.04 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.725 0 N-CA-C 108.837 -0.801 . . . . 0.0 108.837 178.759 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 99' ' ' MET . . . . . . . . . . . . . 9.7 mtm -137.0 160.44 38.91 Favored 'General case' 0 N--CA 1.447 -0.594 0 N-CA-C 107.601 -1.259 . . . . 0.0 107.601 -179.721 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 2.6 mm? -69.77 103.63 2.22 Favored 'General case' 0 C--N 1.317 -0.814 0 CA-C-O 122.318 1.056 . . . . 0.0 111.046 175.307 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 101' ' ' PHE . . . . . . . . . . . . . 2.8 m-85 -94.2 171.63 8.71 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 113.151 -1.841 . . . . 0.0 112.612 -172.914 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 2.6 m -124.87 135.71 53.14 Favored 'General case' 0 C--N 1.313 -0.985 0 CA-C-N 114.439 -1.255 . . . . 0.0 109.382 -178.241 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -103.54 159.47 15.57 Favored 'General case' 0 C--N 1.32 -0.692 0 N-CA-C 109.316 -0.624 . . . . 0.0 109.316 -177.929 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 104' ' ' MET . . . . . . . . . . . . . 71.2 mtm -66.39 -12.49 57.22 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.057 -0.519 . . . . 0.0 111.798 -174.446 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 4.5 p-10 -93.59 3.96 54.7 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 120.848 0.356 . . . . 0.0 110.853 177.568 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 92.32 -10.83 73.51 Favored Glycine 0 N--CA 1.444 -0.788 0 C-N-CA 120.672 -0.775 . . . . 0.0 113.69 178.939 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 34.9 t -78.01 140.32 39.17 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-O 121.52 0.676 . . . . 0.0 111.072 -179.471 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 23.0 tt0 -94.74 98.78 11.01 Favored 'General case' 0 C--N 1.314 -0.97 0 CA-C-N 115.253 -0.885 . . . . 0.0 110.249 178.389 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 109' ' ' MET . . . . . . . . . . . . . 1.6 mtm -100.81 145.1 29.78 Favored Pre-proline 0 C--N 1.326 -0.421 0 CA-C-N 115.203 -0.908 . . . . 0.0 110.609 176.897 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 23.9 Cg_endo -66.61 116.35 4.04 Favored 'Trans proline' 0 N--CA 1.455 -0.741 0 C-N-CA 121.336 1.357 . . . . 0.0 110.631 173.227 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . -111.26 132.49 10.94 Favored Glycine 0 CA--C 1.502 -0.739 0 CA-C-N 115.518 -0.765 . . . . 0.0 112.223 -177.147 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 112' ' ' VAL . . . . . 0.513 ' HA ' ' HA ' ' A' ' 98' ' ' ILE . 3.0 p -94.62 133.22 36.29 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.739 0 N-CA-C 108.774 -0.825 . . . . 0.0 108.774 174.207 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 113' ' ' ILE . . . . . 0.425 HD12 ' CB ' ' A' ' 93' ' ' PRO . 20.3 mt -86.24 109.85 19.25 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.14 0 N-CA-C 108.201 -1.037 . . . . 0.0 108.201 -178.433 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 114' ' ' ARG . . . . . 0.486 ' O ' HG23 ' A' ' 95' ' ' ILE . 11.9 tpp180 -64.97 -46.75 80.19 Favored 'General case' 0 C--N 1.314 -0.957 0 CA-C-N 115.198 -0.91 . . . . 0.0 111.078 -174.395 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 115' ' ' GLU . . . . . 0.412 ' O ' ' HB ' ' A' ' 122' ' ' THR . 4.8 tt0 -159.7 160.05 33.66 Favored 'General case' 0 C--N 1.32 -0.71 0 C-N-CA 120.822 -0.351 . . . . 0.0 110.225 -176.324 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 116' ' ' ILE . . . . . 0.493 HG12 HG12 ' A' ' 95' ' ' ILE . 38.2 mm -114.61 121.78 67.39 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.436 0 CA-C-O 120.954 0.407 . . . . 0.0 110.36 177.99 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 117' ' ' ASN . . . . . . . . . . . . . 30.1 m-80 -112.64 154.1 26.59 Favored 'General case' 0 C--N 1.316 -0.87 0 N-CA-C 109.285 -0.635 . . . . 0.0 109.285 174.668 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . -75.94 -13.92 82.68 Favored Glycine 0 N--CA 1.449 -0.476 0 C-N-CA 120.74 -0.743 . . . . 0.0 113.021 -173.781 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 119' ' ' ASP . . . . . 0.521 ' HA ' ' HD3' ' A' ' 84' ' ' ARG . 30.2 t70 -112.82 -18.4 12.29 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-O 120.943 0.402 . . . . 0.0 111.594 -179.606 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 4.8 t -152.22 158.02 42.27 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 116.494 -0.321 . . . . 0.0 110.797 -172.997 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 121' ' ' ILE . . . . . 0.477 ' O ' ' HA ' ' A' ' 81' ' ' TYR . 47.7 mm -106.45 128.42 61.02 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.423 0 CA-C-O 121.218 0.533 . . . . 0.0 111.095 178.024 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 122' ' ' THR . . . . . 0.531 HG22 ' CE2' ' A' ' 81' ' ' TYR . 8.5 m -91.76 108.53 19.98 Favored 'General case' 0 C--N 1.321 -0.639 0 CA-C-O 122.19 0.995 . . . . 0.0 112.115 -178.429 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 123' ' ' VAL . . . . . 0.626 ' O ' HG23 ' A' ' 79' ' ' ILE . 15.5 t -99.63 157.79 3.81 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.555 0 CA-C-N 113.522 -1.672 . . . . 0.0 110.935 -177.755 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 124' ' ' ASP . . . . . 0.541 ' OD1' ' HB2' ' A' ' 126' ' ' ASN . 12.2 t0 -155.16 96.67 1.85 Allowed 'General case' 0 CA--C 1.537 0.474 0 N-CA-C 108.402 -0.962 . . . . 0.0 108.402 -176.025 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 125' ' ' PHE . . . . . 0.51 ' HB2' ' CD2' ' A' ' 78' ' ' LEU . 76.6 m-85 -90.31 23.62 2.86 Favored 'General case' 0 N--CA 1.47 0.541 0 O-C-N 120.618 -1.301 . . . . 0.0 111.478 -177.492 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 126' ' ' ASN . . . . . 0.541 ' HB2' ' OD1' ' A' ' 124' ' ' ASP . 27.1 m-80 -74.69 178.2 5.59 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 122.096 0.951 . . . . 0.0 113.446 -174.817 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 127' ' ' HIS . . . . . 0.546 ' HB3' ' HD2' ' A' ' 128' ' ' PRO . 33.7 m170 -127.59 -176.51 0.51 Allowed Pre-proline 0 CA--C 1.536 0.433 0 CA-C-N 114.214 -1.357 . . . . 0.0 110.95 -168.841 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 128' ' ' PRO . . . . . 0.546 ' HD2' ' HB3' ' A' ' 127' ' ' HIS . 2.1 Cg_endo -44.59 173.7 0.01 OUTLIER 'Trans proline' 0 C--N 1.357 0.978 0 C-N-CA 124.904 3.736 . . . . 0.0 113.805 164.976 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 129' ' ' LEU . . . . . . . . . . . . . 93.3 mt -51.44 37.07 0.0 OUTLIER 'General case' 0 N--CA 1.494 1.757 0 C-N-CA 126.532 1.933 . . . . 0.0 115.818 -176.279 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 130' ' ' ALA . . . . . 0.478 ' HB2' ' C ' ' A' ' 72' ' ' GLY . . . -76.51 -179.06 4.99 Favored 'General case' 0 C--N 1.305 -1.331 0 C-N-CA 123.585 0.754 . . . . 0.0 111.104 -179.953 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 131' ' ' GLY . . . . . 0.509 ' N ' ' HD3' ' A' ' 74' ' ' PRO . . . 70.5 20.78 77.33 Favored Glycine 0 CA--C 1.51 -0.265 0 C-N-CA 121.307 -0.473 . . . . 0.0 114.098 176.026 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 132' ' ' GLN . . . . . . . . . . . . . 19.4 pt20 -145.15 142.25 29.46 Favored 'General case' 0 C--N 1.318 -0.789 0 N-CA-C 109.256 -0.646 . . . . 0.0 109.256 175.826 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 133' ' ' THR . . . . . . . . . . . . . 1.5 m -73.03 114.25 10.98 Favored 'General case' 0 C--N 1.317 -0.843 0 CA-C-N 115.617 -0.72 . . . . 0.0 109.808 -176.424 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 134' ' ' VAL . . . . . . . . . . . . . 4.0 m -99.02 123.16 51.49 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.724 0 CA-C-O 121.447 0.641 . . . . 0.0 111.106 -175.126 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 135' ' ' HIS . . . . . 0.632 ' CE1' ' HB3' ' A' ' 18' ' ' LYS . 18.1 p80 -103.27 137.51 41.3 Favored 'General case' 0 C--N 1.318 -0.804 0 CA-C-N 115.112 -0.949 . . . . 0.0 110.189 174.152 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 136' ' ' PHE . . . . . 0.516 ' HE1' ' CE2' ' A' ' 63' ' ' PHE . 0.1 OUTLIER -134.48 138.33 44.63 Favored 'General case' 0 N--CA 1.442 -0.846 0 CA-C-O 121.55 0.69 . . . . 0.0 110.534 -175.153 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 137' ' ' ASP . . . . . 0.517 ' O ' ' HA ' ' A' ' 15' ' ' PHE . 37.6 t70 -98.93 108.07 20.66 Favored 'General case' 0 C--N 1.312 -1.062 0 CA-C-N 114.539 -1.21 . . . . 0.0 108.344 175.212 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 138' ' ' ILE . . . . . 0.493 HG22 HG22 ' A' ' 13' ' ' VAL . 62.5 mt -120.67 120.66 63.19 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.565 0 CA-C-O 121.396 0.617 . . . . 0.0 111.037 -167.851 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 30.2 mt-10 -110.8 111.32 22.4 Favored 'General case' 0 C--N 1.321 -0.671 0 CA-C-N 115.818 -0.628 . . . . 0.0 110.67 -178.703 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 140' ' ' VAL . . . . . 0.442 ' CG1' ' HA ' ' A' ' 57' ' ' VAL . 45.2 t -65.95 111.6 1.65 Allowed 'Isoleucine or valine' 0 C--O 1.234 0.266 0 CA-C-N 116.548 -0.296 . . . . 0.0 110.456 178.227 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 141' ' ' LEU . . . . . 0.475 HD12 ' CD2' ' A' ' 14' ' ' HIS . 48.0 mt -98.42 -49.74 4.56 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-O 120.746 0.307 . . . . 0.0 110.29 -179.943 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 142' ' ' GLU . . . . . . . . . . . . . 67.7 mm-40 -141.26 163.85 31.83 Favored 'General case' 0 CA--C 1.514 -0.413 0 CA-C-N 115.979 -0.555 . . . . 0.0 111.115 177.127 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 143' ' ' ILE . . . . . 0.41 ' CD1' HG23 ' A' ' 57' ' ' VAL . 94.4 mt -130.0 110.63 19.8 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.652 0 CA-C-N 115.168 -0.924 . . . . 0.0 110.381 176.605 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 144' ' ' ASP . . . . . . . . . . . . . 20.1 t70 -78.98 124.49 84.76 Favored Pre-proline 0 C--N 1.322 -0.617 0 CA-C-N 115.53 -0.759 . . . . 0.0 109.49 177.53 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 145' ' ' PRO . . . . . . . . . . . . . 41.3 Cg_endo -66.84 148.49 82.49 Favored 'Trans proline' 0 C--O 1.234 0.32 0 C-N-CA 122.585 2.19 . . . . 0.0 112.29 -175.532 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 146' ' ' ALA . . . . . . . . . . . . . . . -85.98 98.8 11.02 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 116.018 -0.537 . . . . 0.0 111.275 -176.036 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 3.2 mm? -106.79 13.11 28.29 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.248 176.897 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 39.7 mt-10 . . . . . 0 C--N 1.326 -0.447 0 N-CA-C 109.596 -0.52 . . . . 0.0 109.596 176.687 . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 13.4 tpt . . . . . 0 N--CA 1.48 1.049 0 CA-C-O 120.686 0.279 . . . . 0.0 110.311 . . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 2' ' ' SER . . . . . 0.428 ' CB ' ' HA ' ' A' ' 145' ' ' PRO . 14.6 t -76.58 82.3 3.25 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.237 -0.438 . . . . 0.0 109.84 178.136 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 3' ' ' GLU . . . . . 0.455 ' O ' ' HG3' ' A' ' 56' ' ' LYS . 32.3 mt-10 -74.5 -30.21 61.72 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 115.844 -0.616 . . . . 0.0 109.682 179.276 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 40.0 t -116.88 151.23 37.03 Favored 'General case' 0 C--N 1.318 -0.771 0 CA-C-N 114.904 -1.043 . . . . 0.0 109.389 -178.532 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 98.0 t -72.96 125.3 31.57 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.403 0 CA-C-O 121.036 0.446 . . . . 0.0 110.267 177.08 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 6' ' ' GLN . . . . . 0.63 ' HG2' ' OG ' ' A' ' 9' ' ' SER . 5.2 pt20 -119.34 166.94 12.39 Favored 'General case' 0 C--N 1.319 -0.718 0 CA-C-N 115.609 -0.723 . . . . 0.0 109.141 -179.557 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 7' ' ' SER . . . . . 0.455 ' O ' ' HB2' ' A' ' 8' ' ' ASN . 10.0 p -63.23 133.75 54.78 Favored 'General case' 0 C--N 1.316 -0.882 0 N-CA-C 109.857 -0.423 . . . . 0.0 109.857 177.832 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 8' ' ' ASN . . . . . 0.493 ' OD1' ' HA3' ' A' ' 40' ' ' GLY . 34.4 m-80 72.7 35.07 1.11 Allowed 'General case' 0 N--CA 1.471 0.596 0 O-C-N 123.755 0.659 . . . . 0.0 112.327 -176.78 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 9' ' ' SER . . . . . 0.63 ' OG ' ' HG2' ' A' ' 6' ' ' GLN . 49.6 m -92.82 167.03 12.13 Favored 'General case' 0 C--N 1.332 -0.152 0 CA-C-O 121.151 0.501 . . . . 0.0 110.785 173.006 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 10' ' ' ALA . . . . . 0.426 ' HB1' ' HB3' ' A' ' 144' ' ' ASP . . . -115.54 118.14 32.31 Favored 'General case' 0 C--N 1.319 -0.759 0 N-CA-C 108.558 -0.905 . . . . 0.0 108.558 170.808 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 4.3 m -127.5 142.75 42.75 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.729 0 C-N-CA 120.165 -0.614 . . . . 0.0 110.909 -174.05 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 12' ' ' LEU . . . . . 0.468 ' HB2' ' HB2' ' A' ' 142' ' ' GLU . 83.8 mt -93.96 133.4 37.44 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-N 115.818 -0.628 . . . . 0.0 109.346 176.566 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 17.2 m -131.68 167.11 27.07 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.941 0 CA-C-O 121.519 0.676 . . . . 0.0 112.262 -174.867 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 14' ' ' HIS . . . . . 0.545 ' CD2' HD13 ' A' ' 141' ' ' LEU . 0.3 OUTLIER -134.21 115.67 14.44 Favored 'General case' 0 C--N 1.322 -0.59 0 N-CA-C 106.433 -1.692 . . . . 0.0 106.433 166.159 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 45.4 p90 -145.8 156.14 43.38 Favored 'General case' 0 C--N 1.319 -0.726 0 C-N-CA 120.841 -0.344 . . . . 0.0 110.629 -171.084 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 60.1 m -121.63 131.47 54.13 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-O 120.884 0.373 . . . . 0.0 110.664 174.478 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 17' ' ' LEU . . . . . 0.448 ' CD2' ' HB3' ' A' ' 136' ' ' PHE . 6.3 mt -98.26 121.8 40.64 Favored 'General case' 0 C--N 1.328 -0.363 0 N-CA-C 112.662 0.616 . . . . 0.0 112.662 178.331 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 9.5 mptt -127.67 142.84 51.23 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-N 114.973 -1.012 . . . . 0.0 110.197 -179.236 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 19' ' ' LEU . . . . . 0.422 HD12 HG21 ' A' ' 134' ' ' VAL . 3.2 mm? -89.66 169.05 11.64 Favored 'General case' 0 C--N 1.325 -0.477 0 N-CA-C 109.487 -0.561 . . . . 0.0 109.487 175.918 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 1.8 p30 -67.27 -23.65 65.7 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 121.41 0.624 . . . . 0.0 109.965 177.163 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 36.3 m-20 -74.03 -0.49 16.55 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 115.139 -0.937 . . . . 0.0 111.447 175.826 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 73.8 15.47 79.51 Favored Glycine 0 N--CA 1.449 -0.442 0 C-N-CA 121.007 -0.616 . . . . 0.0 111.922 -179.124 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 27.0 m -88.34 151.79 22.37 Favored 'General case' 0 C--N 1.32 -0.68 0 N-CA-C 109.525 -0.546 . . . . 0.0 109.525 176.132 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 38.3 m -95.25 128.77 42.35 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-O 120.874 0.368 . . . . 0.0 110.969 178.167 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -91.8 -49.04 6.47 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.001 -0.545 . . . . 0.0 110.011 176.143 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 26' ' ' GLU . . . . . 0.433 ' O ' ' HB2' ' A' ' 17' ' ' LEU . 11.8 tp10 -160.9 120.29 2.63 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 115.88 -0.6 . . . . 0.0 109.872 178.352 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 46.8 m -105.31 99.08 8.7 Favored 'General case' 0 C--N 1.318 -0.777 0 C-N-CA 120.233 -0.587 . . . . 0.0 110.3 177.276 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 32.8 m -91.69 57.14 3.16 Favored 'General case' 0 C--N 1.318 -0.789 0 CA-C-O 122.171 0.986 . . . . 0.0 110.068 -178.756 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 21.2 ttt180 -146.44 -55.73 0.27 Allowed 'General case' 0 C--N 1.312 -1.043 0 CA-C-N 115.065 -0.971 . . . . 0.0 109.866 176.959 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 10.7 p30 -77.86 -1.58 32.38 Favored 'General case' 0 N--CA 1.465 0.279 0 C-N-CA 120.928 -0.309 . . . . 0.0 111.069 179.36 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 94.9 m-20 -74.35 -13.42 60.74 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-O 120.861 0.363 . . . . 0.0 110.239 175.338 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 77.81 2.38 81.31 Favored Glycine 0 N--CA 1.446 -0.648 0 N-CA-C 111.23 -0.748 . . . . 0.0 111.23 -178.114 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 35.4 mtmm -131.23 115.28 16.27 Favored Pre-proline 0 N--CA 1.449 -0.477 0 CA-C-N 115.631 -0.285 . . . . 0.0 110.497 -174.575 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 19.6 Cg_exo -69.13 166.88 25.28 Favored 'Trans proline' 0 C--O 1.233 0.265 0 C-N-CA 122.792 2.328 . . . . 0.0 112.002 173.482 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -130.85 155.52 46.57 Favored 'General case' 0 C--N 1.316 -0.891 0 CA-C-N 115.462 -0.79 . . . . 0.0 110.453 -177.767 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 3.1 tp -101.14 142.4 32.63 Favored 'General case' 0 C--N 1.316 -0.867 0 CA-C-N 115.849 -0.614 . . . . 0.0 110.348 177.825 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 37' ' ' PHE . . . . . . . . . . . . . 5.8 m-30 -109.46 108.09 18.46 Favored 'General case' 0 C--N 1.312 -1.046 0 N-CA-C 108.364 -0.976 . . . . 0.0 108.364 177.787 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -86.46 107.62 18.15 Favored 'General case' 0 C--N 1.321 -0.658 0 CA-C-O 121.129 0.49 . . . . 0.0 109.826 -179.595 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 39' ' ' LEU . . . . . 0.422 ' HG ' ' CB ' ' A' ' 49' ' ' GLU . 9.5 mp -81.77 153.02 26.71 Favored 'General case' 0 C--N 1.317 -0.837 0 CA-C-N 115.208 -0.906 . . . . 0.0 109.935 -179.928 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 40' ' ' GLY . . . . . 0.493 ' HA3' ' OD1' ' A' ' 8' ' ' ASN . . . 96.67 29.11 8.4 Favored Glycine 0 N--CA 1.447 -0.585 0 C-N-CA 120.537 -0.84 . . . . 0.0 112.171 -178.262 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 17.9 t70 60.32 15.77 5.67 Favored 'General case' 0 N--CA 1.469 0.496 0 CA-C-O 121.425 0.631 . . . . 0.0 111.122 178.341 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -79.85 -13.52 59.34 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 121.11 0.481 . . . . 0.0 110.746 -176.336 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 35.7 t -161.18 -54.36 0.05 OUTLIER 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 115.522 -0.763 . . . . 0.0 109.024 174.998 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 4.0 mm? -91.3 149.71 21.63 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 115.829 -0.623 . . . . 0.0 109.674 176.483 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 47.5 t -70.93 155.52 40.72 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-N 115.782 -0.645 . . . . 0.0 111.119 -177.292 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 46' ' ' GLU . . . . . 0.459 ' O ' ' HG2' ' A' ' 49' ' ' GLU . 28.5 tt0 -49.94 -40.27 43.02 Favored 'General case' 0 N--CA 1.45 -0.46 0 C-N-CA 122.981 0.513 . . . . 0.0 111.854 -179.856 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -56.69 -36.34 71.33 Favored Glycine 0 N--CA 1.448 -0.541 0 C-N-CA 120.567 -0.825 . . . . 0.0 112.447 -176.445 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 1.7 tt -64.26 -52.88 56.49 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 116.953 0.377 . . . . 0.0 111.745 176.57 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 49' ' ' GLU . . . . . 0.459 ' HG2' ' O ' ' A' ' 46' ' ' GLU . 13.8 pt-20 -63.91 -29.95 71.08 Favored 'General case' 0 N--CA 1.453 -0.299 0 CA-C-O 120.508 0.194 . . . . 0.0 111.02 -173.322 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 50' ' ' GLN . . . . . 0.485 ' HA ' HD23 ' A' ' 53' ' ' LEU . 16.9 mm-40 -65.67 -17.11 64.36 Favored 'General case' 0 N--CA 1.452 -0.347 0 CA-C-N 116.372 -0.376 . . . . 0.0 110.605 -173.936 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 51' ' ' HIS . . . . . . . . . . . . . 14.7 m-70 -107.27 -3.68 19.49 Favored 'General case' 0 N--CA 1.45 -0.449 0 CA-C-O 121.053 0.454 . . . . 0.0 110.022 -176.934 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 49.4 mt -103.04 -20.55 14.15 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 115.657 -0.702 . . . . 0.0 111.282 -178.865 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 53' ' ' LEU . . . . . 0.485 HD23 ' HA ' ' A' ' 50' ' ' GLN . 0.0 OUTLIER -60.59 135.91 57.9 Favored 'General case' 0 C--O 1.234 0.257 0 CA-C-O 120.875 0.369 . . . . 0.0 111.273 177.874 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 93.03 -5.96 76.01 Favored Glycine 0 N--CA 1.45 -0.399 0 CA-C-N 115.947 -0.57 . . . . 0.0 112.667 178.884 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 64.0 mt -84.47 163.54 19.37 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-O 121.208 0.528 . . . . 0.0 111.275 179.369 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 56' ' ' LYS . . . . . 0.455 ' HG3' ' O ' ' A' ' 3' ' ' GLU . 0.0 OUTLIER -127.39 169.52 13.52 Favored 'General case' 0 C--N 1.32 -0.695 0 CA-C-N 115.322 -0.854 . . . . 0.0 109.457 176.018 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 39.6 t -60.68 142.76 15.39 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.833 0 CA-C-O 121.068 0.461 . . . . 0.0 110.547 176.026 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 80.88 10.03 85.57 Favored Glycine 0 N--CA 1.448 -0.516 0 CA-C-N 115.673 -0.694 . . . . 0.0 112.659 -177.945 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 4.0 m-20 -98.92 150.52 21.84 Favored 'General case' 0 CA--C 1.511 -0.553 0 CA-C-O 121.073 0.463 . . . . 0.0 111.183 176.164 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 60' ' ' LYS . . . . . 0.45 ' H ' ' HG2' ' A' ' 60' ' ' LYS . 0.0 OUTLIER -120.88 129.55 53.55 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-N 115.189 -0.914 . . . . 0.0 109.382 -178.998 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 6.1 m -142.32 121.39 12.91 Favored 'General case' 0 N--CA 1.433 -1.298 0 CA-C-O 121.155 0.503 . . . . 0.0 110.502 -179.003 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 14.3 m -111.0 132.82 53.89 Favored 'General case' 0 C--N 1.316 -0.88 0 CA-C-N 115.754 -0.657 . . . . 0.0 109.872 177.277 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 32.0 p90 -146.7 172.79 13.07 Favored 'General case' 0 C--N 1.314 -0.972 0 CA-C-N 116.044 -0.525 . . . . 0.0 110.239 179.032 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 50.9 m -130.83 135.91 48.17 Favored 'General case' 0 C--N 1.32 -0.681 0 N-CA-C 108.783 -0.821 . . . . 0.0 108.783 -172.44 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 65' ' ' LEU . . . . . 0.421 ' HB2' ' HB1' ' A' ' 70' ' ' ALA . 61.1 mt -139.48 140.62 37.3 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-O 121.164 0.507 . . . . 0.0 111.406 -172.052 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 66' ' ' GLU . . . . . 0.418 ' HB3' ' HD2' ' A' ' 67' ' ' PRO . 44.1 mt-10 -75.54 162.12 73.74 Favored Pre-proline 0 C--N 1.326 -0.455 0 CA-C-N 115.037 -0.983 . . . . 0.0 109.842 174.597 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 67' ' ' PRO . . . . . 0.533 ' HB3' ' HA2' ' A' ' 131' ' ' GLY . 76.0 Cg_exo -42.04 -43.3 7.22 Favored 'Trans proline' 0 C--N 1.346 0.397 0 C-N-CA 123.513 2.809 . . . . 0.0 114.558 -177.837 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 6.6 p-10 -63.74 -18.77 64.39 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-O 120.782 0.325 . . . . 0.0 111.44 -177.505 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -114.35 -7.38 12.91 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 116.326 -0.397 . . . . 0.0 111.368 179.223 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 70' ' ' ALA . . . . . 0.421 ' HB1' ' HB2' ' A' ' 65' ' ' LEU . . . -144.76 124.97 13.7 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 120.542 0.211 . . . . 0.0 111.431 -176.954 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 71' ' ' PHE . . . . . . . . . . . . . 19.4 m-30 73.48 -40.93 0.48 Allowed 'General case' 0 N--CA 1.473 0.714 0 C-N-CA 123.747 0.819 . . . . 0.0 111.686 179.95 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 72' ' ' GLY . . . . . 0.56 ' O ' ' HB3' ' A' ' 130' ' ' ALA . . . 111.39 145.61 10.15 Favored Glycine 0 N--CA 1.444 -0.83 0 N-CA-C 111.481 -0.648 . . . . 0.0 111.481 -179.243 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 29.3 m -76.1 139.15 68.73 Favored Pre-proline 0 C--N 1.321 -0.671 0 CA-C-O 121.085 0.469 . . . . 0.0 111.202 175.209 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 74' ' ' PRO . . . . . 0.442 ' HD3' ' CA ' ' A' ' 131' ' ' GLY . 59.0 Cg_endo -74.7 153.49 43.41 Favored 'Trans proline' 0 N--CA 1.459 -0.555 0 C-N-CA 122.65 2.233 . . . . 0.0 110.63 176.485 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 75' ' ' SER . . . . . 0.768 ' O ' ' HG ' ' A' ' 78' ' ' LEU . 46.1 m -132.85 121.19 16.87 Favored Pre-proline 0 C--N 1.315 -0.913 0 C-N-CA 120.755 -0.378 . . . . 0.0 111.241 -174.044 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 47.6 Cg_endo -69.73 -18.3 37.21 Favored 'Trans proline' 0 N--CA 1.463 -0.284 0 C-N-CA 122.18 1.92 . . . . 0.0 111.724 176.657 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 77' ' ' ASP . . . . . 0.618 ' OD1' ' HB3' ' A' ' 75' ' ' SER . 6.4 p-10 -76.83 -13.0 60.05 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.623 -0.717 . . . . 0.0 111.352 -179.644 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 78' ' ' LEU . . . . . 0.768 ' HG ' ' O ' ' A' ' 75' ' ' SER . 4.1 pp -91.62 -4.89 54.75 Favored 'General case' 0 CA--C 1.515 -0.396 0 C-N-CA 119.652 -0.819 . . . . 0.0 110.392 177.739 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 43.7 mt -80.31 138.51 19.67 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.611 0 N-CA-C 109.886 -0.413 . . . . 0.0 109.886 169.074 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 3.7 mp0 -142.2 142.64 32.68 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-N 116.122 -0.49 . . . . 0.0 109.84 -177.847 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 81' ' ' TYR . . . . . . . . . . . . . 43.0 m-85 -113.76 111.71 22.23 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-O 121.182 0.515 . . . . 0.0 109.983 -177.593 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 56.1 m-85 -109.73 171.17 7.6 Favored 'General case' 0 C--N 1.317 -0.814 0 CA-C-N 115.365 -0.834 . . . . 0.0 109.961 177.388 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 25.8 t -81.56 154.27 26.31 Favored 'General case' 0 C--N 1.321 -0.655 0 CA-C-O 121.368 0.604 . . . . 0.0 110.15 178.749 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 84' ' ' ARG . . . . . 0.496 ' HG3' ' HD2' ' A' ' 85' ' ' ARG . 13.0 ptm180 -68.89 -29.47 67.76 Favored 'General case' 0 C--N 1.32 -0.687 0 CA-C-N 115.383 -0.826 . . . . 0.0 109.649 178.108 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 85' ' ' ARG . . . . . 0.496 ' HD2' ' HG3' ' A' ' 84' ' ' ARG . 5.2 mpt_? -64.05 -34.06 77.16 Favored 'General case' 0 C--N 1.321 -0.667 0 CA-C-N 114.201 -1.363 . . . . 0.0 109.981 177.448 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 46.4 mt-10 -75.67 -10.8 59.75 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 115.757 -0.656 . . . . 0.0 110.565 178.119 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 87' ' ' PHE . . . . . 0.484 ' CE2' HG21 ' A' ' 121' ' ' ILE . 3.8 m-85 -103.3 -22.79 13.65 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 115.596 -0.729 . . . . 0.0 110.41 -179.748 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 88' ' ' MET . . . . . . . . . . . . . 46.4 ttm -60.14 -13.19 10.84 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 121.928 0.871 . . . . 0.0 109.679 172.375 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 25.0 t70 -61.09 -31.95 71.63 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-N 114.12 -1.4 . . . . 0.0 109.689 175.153 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -122.61 15.88 10.31 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 115.557 -0.747 . . . . 0.0 110.708 178.162 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 96.97 139.99 11.01 Favored Glycine 0 N--CA 1.45 -0.397 0 C-N-CA 120.6 -0.81 . . . . 0.0 111.925 -176.379 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 47.1 mt-10 -68.32 124.38 89.68 Favored Pre-proline 0 C--N 1.325 -0.494 0 CA-C-O 121.446 0.641 . . . . 0.0 111.48 -174.834 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 93' ' ' PRO . . . . . 0.511 ' HB2' ' CD1' ' A' ' 113' ' ' ILE . 83.8 Cg_endo -78.35 169.08 20.63 Favored 'Trans proline' 0 C--O 1.235 0.36 0 C-N-CA 124.669 3.579 . . . . 0.0 114.933 -169.373 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 94' ' ' GLU . . . . . 0.602 ' O ' HD13 ' A' ' 113' ' ' ILE . 1.4 mp0 -116.7 164.31 14.83 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 114.214 -1.357 . . . . 0.0 110.74 -174.616 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 95' ' ' ILE . . . . . 0.513 HG12 HG12 ' A' ' 116' ' ' ILE . 17.5 mt -82.78 133.96 27.97 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.377 0 CA-C-O 120.919 0.39 . . . . 0.0 110.909 179.35 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 70.69 29.89 69.07 Favored Glycine 0 N--CA 1.449 -0.447 0 CA-C-N 115.83 -0.623 . . . . 0.0 111.973 -179.194 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 97' ' ' ALA . . . . . 0.666 ' O ' HG13 ' A' ' 113' ' ' ILE . . . -106.42 140.0 40.02 Favored 'General case' 0 C--N 1.324 -0.52 0 N-CA-C 109.865 -0.42 . . . . 0.0 109.865 -179.777 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 98' ' ' ILE . . . . . 0.486 ' HA ' ' O ' ' A' ' 111' ' ' GLY . 72.5 mt -88.06 108.26 18.37 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.812 0 N-CA-C 109.972 -0.381 . . . . 0.0 109.972 -179.98 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 99' ' ' MET . . . . . 0.548 ' HB2' ' CE2' ' A' ' 101' ' ' PHE . 89.9 mtp -99.08 126.15 44.75 Favored 'General case' 0 N--CA 1.442 -0.835 0 CA-C-N 116.301 -0.409 . . . . 0.0 111.069 179.444 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 4.3 mm? -67.42 147.35 52.99 Favored 'General case' 0 C--N 1.307 -1.241 0 N-CA-C 108.327 -0.99 . . . . 0.0 108.327 163.2 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 101' ' ' PHE . . . . . 0.612 ' HB2' ' O ' ' A' ' 109' ' ' MET . 2.5 m-85 -149.49 169.78 20.12 Favored 'General case' 0 CA--C 1.51 -0.594 0 CA-C-N 116.001 -0.545 . . . . 0.0 109.925 -155.101 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 3.9 m -126.64 129.26 48.15 Favored 'General case' 0 C--N 1.31 -1.128 0 N-CA-C 108.913 -0.773 . . . . 0.0 108.913 170.663 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -97.4 154.89 17.17 Favored 'General case' 0 C--N 1.316 -0.853 0 N-CA-C 109.05 -0.722 . . . . 0.0 109.05 -175.878 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 104' ' ' MET . . . . . . . . . . . . . 4.7 mpp? -65.24 -12.77 54.95 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.945 -174.219 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 9.8 p-10 -95.21 6.86 47.88 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-O 120.728 0.299 . . . . 0.0 110.928 177.219 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 89.55 -10.95 71.62 Favored Glycine 0 N--CA 1.452 -0.272 0 C-N-CA 121.213 -0.518 . . . . 0.0 113.217 174.67 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 43.1 t -79.94 143.15 34.44 Favored 'General case' 0 C--N 1.32 -0.677 0 CA-C-O 121.37 0.605 . . . . 0.0 109.748 178.721 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 23.3 tt0 -92.18 99.03 11.9 Favored 'General case' 0 C--N 1.309 -1.175 0 CA-C-O 121.956 0.884 . . . . 0.0 109.443 179.28 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 109' ' ' MET . . . . . 0.612 ' O ' ' HB2' ' A' ' 101' ' ' PHE . 71.3 mtp -96.13 135.54 22.62 Favored Pre-proline 0 C--N 1.319 -0.73 0 CA-C-N 113.965 -1.471 . . . . 0.0 111.689 -178.964 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 30.3 Cg_endo -68.9 159.4 54.01 Favored 'Trans proline' 0 N--CA 1.456 -0.709 0 C-N-CA 121.92 1.746 . . . . 0.0 110.011 168.198 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 111' ' ' GLY . . . . . 0.486 ' O ' ' HA ' ' A' ' 98' ' ' ILE . . . -147.15 149.04 21.12 Favored Glycine 0 C--N 1.314 -0.639 0 C-N-CA 119.945 -1.121 . . . . 0.0 110.993 -172.849 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 2.7 p -118.9 111.26 32.82 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.618 0 CA-C-N 118.311 1.056 . . . . 0.0 110.305 170.917 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 113' ' ' ILE . . . . . 0.666 HG13 ' O ' ' A' ' 97' ' ' ALA . 0.5 OUTLIER -62.88 112.03 0.99 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.469 0 CA-C-N 115.729 -0.669 . . . . 0.0 110.175 175.223 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 114' ' ' ARG . . . . . 0.54 ' HD2' ' HB2' ' A' ' 115' ' ' GLU . 5.6 tmm_? -71.22 -43.36 67.51 Favored 'General case' 0 C--N 1.316 -0.883 0 CA-C-N 115.874 -0.603 . . . . 0.0 110.679 -176.983 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 115' ' ' GLU . . . . . 0.54 ' HB2' ' HD2' ' A' ' 114' ' ' ARG . 13.8 tt0 -159.42 154.76 25.46 Favored 'General case' 0 C--N 1.329 -0.313 0 N-CA-C 110.317 -0.253 . . . . 0.0 110.317 -179.871 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 116' ' ' ILE . . . . . 0.513 HG12 HG12 ' A' ' 95' ' ' ILE . 38.0 mm -98.55 112.42 30.62 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.501 0 N-CA-C 109.04 -0.726 . . . . 0.0 109.04 174.23 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 117' ' ' ASN . . . . . 0.492 HD21 ' N ' ' A' ' 117' ' ' ASN . 0.9 OUTLIER -88.18 159.68 18.07 Favored 'General case' 0 C--N 1.311 -1.094 0 N-CA-C 108.724 -0.843 . . . . 0.0 108.724 177.289 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . -55.26 -47.16 76.44 Favored Glycine 0 N--CA 1.45 -0.372 0 C-N-CA 120.518 -0.848 . . . . 0.0 113.129 -169.438 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 119' ' ' ASP . . . . . 0.442 ' O ' ' HG2' ' A' ' 84' ' ' ARG . 4.4 p-10 -114.78 -11.1 12.32 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 117.125 0.463 . . . . 0.0 111.343 175.171 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 120' ' ' SER . . . . . 0.426 ' O ' ' HB2' ' A' ' 117' ' ' ASN . 9.0 t -115.97 158.26 23.34 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-O 121.222 0.534 . . . . 0.0 111.656 -171.812 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 121' ' ' ILE . . . . . 0.484 HG21 ' CE2' ' A' ' 87' ' ' PHE . 46.7 mm -117.21 128.69 74.5 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.52 0 CA-C-N 116.112 -0.495 . . . . 0.0 110.436 177.263 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 18.7 m -93.47 102.55 14.77 Favored 'General case' 0 C--N 1.32 -0.686 0 CA-C-O 121.594 0.711 . . . . 0.0 110.907 177.97 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 42.9 t -104.4 108.16 24.1 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.385 0 CA-C-N 114.66 -1.155 . . . . 0.0 112.92 -179.983 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 124' ' ' ASP . . . . . 0.467 ' C ' ' H ' ' A' ' 126' ' ' ASN . 1.3 m-20 -98.04 106.57 18.88 Favored 'General case' 0 C--N 1.318 -0.762 0 CA-C-N 114.689 -1.141 . . . . 0.0 110.386 170.121 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 125' ' ' PHE . . . . . 0.518 ' CD2' ' HE3' ' A' ' 109' ' ' MET . 81.5 m-85 -75.07 18.9 0.16 Allowed 'General case' 0 N--CA 1.465 0.29 0 O-C-N 121.898 -0.501 . . . . 0.0 111.284 171.242 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 126' ' ' ASN . . . . . 0.467 ' H ' ' C ' ' A' ' 124' ' ' ASP . 11.4 m-80 -60.48 147.22 41.94 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.818 -0.628 . . . . 0.0 110.622 176.285 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 127' ' ' HIS . . . . . 0.607 ' HB3' ' HD2' ' A' ' 128' ' ' PRO . 56.9 m80 -107.22 -170.58 0.2 Allowed Pre-proline 0 C--N 1.319 -0.742 0 CA-C-N 115.074 -0.966 . . . . 0.0 111.395 -165.324 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 128' ' ' PRO . . . . . 0.607 ' HD2' ' HB3' ' A' ' 127' ' ' HIS . 2.7 Cg_exo -41.53 174.11 0.0 OUTLIER 'Trans proline' 0 C--N 1.358 1.034 0 C-N-CA 124.696 3.597 . . . . 0.0 113.85 162.09 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 129' ' ' LEU . . . . . . . . . . . . . 9.9 tp -50.5 38.32 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.619 0 C-N-CA 126.902 2.081 . . . . 0.0 116.32 -172.667 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 130' ' ' ALA . . . . . 0.56 ' HB3' ' O ' ' A' ' 72' ' ' GLY . . . -76.2 161.2 29.0 Favored 'General case' 0 C--N 1.308 -1.201 0 N-CA-C 108.567 -0.901 . . . . 0.0 108.567 178.191 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 131' ' ' GLY . . . . . 0.533 ' HA2' ' HB3' ' A' ' 67' ' ' PRO . . . 76.72 22.69 71.64 Favored Glycine 0 N--CA 1.449 -0.474 0 C-N-CA 120.0 -1.095 . . . . 0.0 113.032 -177.27 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 132' ' ' GLN . . . . . . . . . . . . . 2.6 tt0 -139.27 139.58 37.41 Favored 'General case' 0 N--CA 1.445 -0.702 0 N-CA-C 109.986 -0.376 . . . . 0.0 109.986 169.865 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 133' ' ' THR . . . . . . . . . . . . . 21.9 m -68.66 126.98 31.4 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 115.81 -0.632 . . . . 0.0 110.507 179.99 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 134' ' ' VAL . . . . . 0.474 HG12 ' CE1' ' A' ' 136' ' ' PHE . 14.5 p -128.92 163.6 33.45 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.594 0 CA-C-O 121.093 0.473 . . . . 0.0 111.366 -174.709 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 135' ' ' HIS . . . . . . . . . . . . . 72.2 m-70 -123.19 115.82 22.39 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 115.803 -0.635 . . . . 0.0 109.633 -176.027 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 136' ' ' PHE . . . . . 0.482 ' CD1' ' N ' ' A' ' 136' ' ' PHE . 0.1 OUTLIER -125.42 138.26 54.01 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-O 121.112 0.482 . . . . 0.0 111.993 -176.463 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 137' ' ' ASP . . . . . . . . . . . . . 5.9 m-20 -103.73 107.11 17.83 Favored 'General case' 0 N--CA 1.468 0.436 0 CA-C-N 115.263 -0.88 . . . . 0.0 110.444 -178.846 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 138' ' ' ILE . . . . . . . . . . . . . 4.5 mp -96.95 138.89 20.74 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.492 0 CA-C-O 120.806 0.336 . . . . 0.0 111.77 -174.523 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 18.0 mt-10 -127.32 127.74 44.79 Favored 'General case' 0 CA--C 1.515 -0.379 0 N-CA-C 108.416 -0.957 . . . . 0.0 108.416 168.302 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 140' ' ' VAL . . . . . . . . . . . . . 91.3 t -78.95 111.25 15.58 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-O 120.925 0.393 . . . . 0.0 110.31 -178.078 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 141' ' ' LEU . . . . . 0.545 HD13 ' CD2' ' A' ' 14' ' ' HIS . 44.4 mt -85.38 -42.86 14.16 Favored 'General case' 0 C--N 1.316 -0.882 0 CA-C-O 121.371 0.605 . . . . 0.0 110.393 -179.855 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 142' ' ' GLU . . . . . 0.468 ' HB2' ' HB2' ' A' ' 12' ' ' LEU . 6.7 mm-40 -151.1 156.55 41.28 Favored 'General case' 0 C--N 1.321 -0.673 0 CA-C-N 115.135 -0.939 . . . . 0.0 111.271 -177.96 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 143' ' ' ILE . . . . . . . . . . . . . 78.7 mt -126.68 109.69 21.53 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.766 0 CA-C-N 115.619 -0.719 . . . . 0.0 109.876 178.773 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 144' ' ' ASP . . . . . 0.426 ' HB3' ' HB1' ' A' ' 10' ' ' ALA . 33.0 t70 -78.68 125.07 84.93 Favored Pre-proline 0 C--N 1.324 -0.512 0 N-CA-C 109.222 -0.659 . . . . 0.0 109.222 175.0 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 145' ' ' PRO . . . . . 0.428 ' HA ' ' CB ' ' A' ' 2' ' ' SER . 48.6 Cg_endo -64.94 125.86 15.49 Favored 'Trans proline' 0 N--CA 1.461 -0.419 0 C-N-CA 122.537 2.158 . . . . 0.0 112.411 -175.688 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 146' ' ' ALA . . . . . . . . . . . . . . . -85.58 130.67 34.52 Favored 'General case' 0 C--N 1.313 -1.019 0 CA-C-N 115.252 -0.885 . . . . 0.0 110.229 179.066 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 3.2 mm? -82.44 44.88 0.91 Allowed 'General case' 0 N--CA 1.442 -0.845 0 CA-C-O 121.299 0.571 . . . . 0.0 111.364 -178.232 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 9.2 mm-40 . . . . . 0 C--N 1.324 -0.523 0 CA-C-N 115.486 -0.779 . . . . 0.0 109.641 175.734 . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 15.1 tpt . . . . . 0 N--CA 1.478 0.942 0 N-CA-C 110.134 -0.321 . . . . 0.0 110.134 . . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 14.3 p 42.55 70.25 0.31 Allowed 'General case' 0 N--CA 1.467 0.394 0 O-C-N 124.313 1.008 . . . . 0.0 112.396 176.271 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 3' ' ' GLU . . . . . 0.44 ' HG2' ' HD2' ' A' ' 56' ' ' LYS . 29.4 tt0 -99.05 -26.37 14.25 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 115.748 -0.66 . . . . 0.0 110.626 179.539 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 4' ' ' SER . . . . . 0.538 ' OG ' ' HE2' ' A' ' 56' ' ' LYS . 14.6 m -101.71 136.16 42.02 Favored 'General case' 0 C--N 1.318 -0.772 0 CA-C-N 115.543 -0.753 . . . . 0.0 111.034 -174.315 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 6.1 p -81.13 148.88 5.2 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.665 0 CA-C-O 121.453 0.644 . . . . 0.0 110.426 179.571 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 6' ' ' GLN . . . . . 0.671 ' HG2' ' OG ' ' A' ' 9' ' ' SER . 4.5 pt20 -140.53 166.16 25.48 Favored 'General case' 0 C--N 1.311 -1.067 0 CA-C-N 114.918 -1.037 . . . . 0.0 109.298 174.461 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 75.7 p -65.26 132.19 48.42 Favored 'General case' 0 N--CA 1.441 -0.916 0 N-CA-C 108.701 -0.851 . . . . 0.0 108.701 175.814 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 8' ' ' ASN . . . . . 0.427 ' ND2' ' HB2' ' A' ' 148' ' ' GLU . 10.4 t30 75.08 38.06 0.45 Allowed 'General case' 0 CA--C 1.539 0.551 0 O-C-N 123.682 0.614 . . . . 0.0 110.95 -177.95 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 9' ' ' SER . . . . . 0.671 ' OG ' ' HG2' ' A' ' 6' ' ' GLN . 51.0 m -93.77 166.85 12.0 Favored 'General case' 0 CA--C 1.521 -0.167 0 CA-C-O 121.308 0.575 . . . . 0.0 110.821 172.462 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 10' ' ' ALA . . . . . 0.402 ' HB1' HD21 ' A' ' 36' ' ' LEU . . . -109.43 111.32 22.8 Favored 'General case' 0 N--CA 1.444 -0.769 0 N-CA-C 108.544 -0.91 . . . . 0.0 108.544 169.992 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 3.8 m -116.52 135.54 56.45 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.682 0 C-N-CA 119.767 -0.773 . . . . 0.0 111.351 -179.378 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 18.0 tp -86.36 128.43 34.93 Favored 'General case' 0 N--CA 1.447 -0.608 0 N-CA-C 108.914 -0.772 . . . . 0.0 108.914 177.837 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 13' ' ' VAL . . . . . 0.56 HG23 ' N ' ' A' ' 14' ' ' HIS . 3.8 p -131.92 158.67 43.33 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.987 0 CA-C-O 122.23 1.014 . . . . 0.0 112.618 -174.561 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 14' ' ' HIS . . . . . 0.566 ' ND1' ' HA ' ' A' ' 29' ' ' ARG . 0.2 OUTLIER -122.94 110.28 15.19 Favored 'General case' 0 C--N 1.313 -1.001 0 CA-C-N 113.443 -1.708 . . . . 0.0 106.996 167.919 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 15' ' ' PHE . . . . . 0.475 ' HA ' ' O ' ' A' ' 137' ' ' ASP . 12.8 p90 -133.64 166.02 23.56 Favored 'General case' 0 C--N 1.324 -0.532 0 C-N-CA 119.223 -0.991 . . . . 0.0 113.673 -174.621 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 22.3 m -140.98 142.09 34.33 Favored 'General case' 0 N--CA 1.444 -0.744 0 CA-C-N 113.952 -1.476 . . . . 0.0 107.914 174.913 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 17' ' ' LEU . . . . . 0.481 ' CD2' ' HB ' ' A' ' 134' ' ' VAL . 0.5 OUTLIER -126.86 112.62 15.54 Favored 'General case' 0 C--N 1.32 -0.716 0 N-CA-C 110.327 -0.249 . . . . 0.0 110.327 -173.624 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -118.85 152.53 36.09 Favored 'General case' 0 C--N 1.315 -0.913 0 CA-C-O 120.93 0.395 . . . . 0.0 111.392 -178.393 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 19' ' ' LEU . . . . . 0.442 HD23 ' HB1' ' A' ' 25' ' ' ALA . 3.4 mm? -103.82 170.47 7.91 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 115.844 -0.616 . . . . 0.0 109.627 174.372 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 2.2 m-20 -68.9 -18.92 64.19 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-O 120.952 0.406 . . . . 0.0 110.959 178.809 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 25.3 t70 -83.37 3.64 30.85 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 121.314 0.578 . . . . 0.0 110.279 175.32 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 74.26 9.88 81.3 Favored Glycine 0 N--CA 1.451 -0.305 0 CA-C-N 115.94 -0.573 . . . . 0.0 112.645 -175.958 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 23' ' ' THR . . . . . 0.436 ' HB ' HD21 ' A' ' 19' ' ' LEU . 12.1 m -72.55 141.07 48.46 Favored 'General case' 0 C--N 1.324 -0.53 0 N-CA-C 109.728 -0.471 . . . . 0.0 109.728 175.746 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 54.4 m -94.17 109.88 21.64 Favored 'General case' 0 C--N 1.319 -0.736 0 N-CA-C 109.854 -0.425 . . . . 0.0 109.854 174.658 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 25' ' ' ALA . . . . . 0.442 ' HB1' HD23 ' A' ' 19' ' ' LEU . . . -69.76 -40.41 76.14 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.975 -0.557 . . . . 0.0 110.027 179.692 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 10.2 tp10 -160.98 139.33 9.79 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 115.406 -0.815 . . . . 0.0 109.656 177.465 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 27' ' ' SER . . . . . 0.405 ' C ' ' HG1' ' A' ' 28' ' ' THR . 16.6 p -125.77 132.41 52.31 Favored 'General case' 0 C--N 1.317 -0.824 0 CA-C-O 120.838 0.352 . . . . 0.0 110.364 175.678 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 28' ' ' THR . . . . . 0.417 ' HB ' ' CE1' ' A' ' 15' ' ' PHE . 79.3 m -152.42 65.77 0.82 Allowed 'General case' 0 N--CA 1.441 -0.894 0 CA-C-O 122.116 0.96 . . . . 0.0 109.617 178.221 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 29' ' ' ARG . . . . . 0.566 ' HA ' ' ND1' ' A' ' 14' ' ' HIS . 26.9 ttt180 -154.11 -52.27 0.1 Allowed 'General case' 0 C--N 1.319 -0.733 0 N-CA-C 108.712 -0.847 . . . . 0.0 108.712 178.206 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 9.9 p30 -76.93 -4.24 42.9 Favored 'General case' 0 N--CA 1.464 0.228 0 CA-C-N 115.855 -0.611 . . . . 0.0 110.214 176.356 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 1.5 m-20 -69.46 -21.11 63.74 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 115.46 -0.791 . . . . 0.0 110.739 -178.958 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 85.3 4.1 86.51 Favored Glycine 0 N--CA 1.445 -0.711 0 C-N-CA 120.589 -0.815 . . . . 0.0 111.33 -173.723 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 56.5 mtpt -138.26 131.47 16.45 Favored Pre-proline 0 N--CA 1.452 -0.354 0 N-CA-C 109.995 -0.372 . . . . 0.0 109.995 179.14 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 91.8 Cg_endo -82.98 168.15 13.86 Favored 'Trans proline' 0 N--CA 1.453 -0.858 0 C-N-CA 122.393 2.062 . . . . 0.0 111.492 170.711 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -129.44 153.8 47.58 Favored 'General case' 0 C--N 1.319 -0.752 0 CA-C-N 116.256 -0.429 . . . . 0.0 109.942 -178.549 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 36' ' ' LEU . . . . . 0.402 HD21 ' HB1' ' A' ' 10' ' ' ALA . 4.6 tp -98.0 132.03 43.91 Favored 'General case' 0 C--N 1.315 -0.91 0 N-CA-C 109.967 -0.382 . . . . 0.0 109.967 176.87 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 37' ' ' PHE . . . . . 0.477 ' CD2' HD22 ' A' ' 44' ' ' LEU . 5.2 m-30 -95.79 107.33 19.55 Favored 'General case' 0 C--N 1.318 -0.802 0 N-CA-C 109.477 -0.564 . . . . 0.0 109.477 174.868 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 38' ' ' ARG . . . . . 0.423 ' HD2' ' CD ' ' A' ' 148' ' ' GLU . 4.9 tpp180 -84.96 107.32 17.04 Favored 'General case' 0 N--CA 1.45 -0.468 0 CA-C-N 115.536 -0.756 . . . . 0.0 109.901 -178.269 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 63.4 mt -81.89 156.12 24.96 Favored 'General case' 0 C--N 1.32 -0.69 0 CA-C-N 115.807 -0.633 . . . . 0.0 111.156 -179.422 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 103.74 40.46 2.33 Favored Glycine 0 N--CA 1.446 -0.635 0 CA-C-N 115.724 -0.671 . . . . 0.0 111.592 -175.368 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 49.3 m-20 57.09 21.78 6.75 Favored 'General case' 0 N--CA 1.47 0.544 0 C-N-CA 123.16 0.584 . . . . 0.0 112.265 177.4 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -67.51 -40.24 85.15 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-O 121.03 0.443 . . . . 0.0 111.145 -178.852 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 41.8 m -154.17 -37.96 0.09 Allowed 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 116.034 -0.53 . . . . 0.0 110.832 -179.722 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 44' ' ' LEU . . . . . 0.477 HD22 ' CD2' ' A' ' 37' ' ' PHE . 6.7 mp -70.79 145.04 50.63 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 121.088 0.471 . . . . 0.0 110.969 -177.039 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 12.6 m -72.87 163.95 27.36 Favored 'General case' 0 C--N 1.322 -0.629 0 CA-C-N 115.373 -0.83 . . . . 0.0 110.228 175.628 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 41.7 mt-10 -51.59 -46.63 63.57 Favored 'General case' 0 C--N 1.329 -0.313 0 N-CA-C 112.72 0.637 . . . . 0.0 112.72 -173.753 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -63.75 -50.41 61.65 Favored Glycine 0 N--CA 1.448 -0.516 0 C-N-CA 119.572 -1.299 . . . . 0.0 112.539 -172.592 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 48' ' ' LEU . . . . . 0.412 HD12 HD23 ' A' ' 44' ' ' LEU . 0.0 OUTLIER -44.64 -50.88 9.59 Favored 'General case' 0 CA--C 1.517 -0.324 0 N-CA-C 113.803 1.038 . . . . 0.0 113.803 171.482 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 49' ' ' GLU . . . . . 0.499 ' O ' HD22 ' A' ' 53' ' ' LEU . 10.5 tt0 -70.8 -33.25 70.53 Favored 'General case' 0 C--N 1.312 -1.054 0 CA-C-O 120.987 0.422 . . . . 0.0 110.819 -169.369 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 19.3 mm-40 -87.08 -13.88 43.01 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-N 115.834 -0.621 . . . . 0.0 111.552 -172.827 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 51' ' ' HIS . . . . . . . . . . . . . 11.7 m-70 -100.39 -4.38 29.14 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-O 121.046 0.451 . . . . 0.0 110.545 -175.269 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 52' ' ' LEU . . . . . 0.408 HD23 ' HA ' ' A' ' 52' ' ' LEU . 11.5 mt -102.25 -14.01 17.16 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-N 115.763 -0.653 . . . . 0.0 111.757 -179.598 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 53' ' ' LEU . . . . . 0.499 HD22 ' O ' ' A' ' 49' ' ' GLU . 0.1 OUTLIER -65.43 151.49 46.2 Favored 'General case' 0 N--CA 1.451 -0.399 0 CA-C-O 120.881 0.372 . . . . 0.0 110.264 171.539 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 93.26 -16.99 59.29 Favored Glycine 0 CA--C 1.519 0.317 0 C-N-CA 121.226 -0.512 . . . . 0.0 112.85 -179.02 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 55' ' ' LEU . . . . . 0.535 HD22 ' HB3' ' A' ' 59' ' ' ASP . 7.2 mp -82.28 165.41 20.42 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-O 121.646 0.736 . . . . 0.0 112.493 -179.954 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 56' ' ' LYS . . . . . 0.538 ' HE2' ' OG ' ' A' ' 4' ' ' SER . 28.5 mmtp -119.41 170.25 9.3 Favored 'General case' 0 N--CA 1.444 -0.738 0 CA-C-N 114.963 -1.017 . . . . 0.0 110.268 175.016 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 57' ' ' VAL . . . . . 0.439 ' HA ' ' CG1' ' A' ' 140' ' ' VAL . 71.5 t -62.46 134.51 27.71 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.764 0 CA-C-N 115.696 -0.684 . . . . 0.0 109.973 173.91 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 80.82 21.95 62.55 Favored Glycine 0 N--CA 1.445 -0.732 0 C-N-CA 120.943 -0.646 . . . . 0.0 112.423 -179.67 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 59' ' ' ASP . . . . . 0.535 ' HB3' HD22 ' A' ' 55' ' ' LEU . 4.9 t70 -92.67 162.92 13.96 Favored 'General case' 0 C--N 1.323 -0.57 0 N-CA-C 108.823 -0.806 . . . . 0.0 108.823 175.441 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 2.5 mmmt -137.11 122.05 18.91 Favored 'General case' 0 C--N 1.318 -0.772 0 N-CA-C 107.716 -1.216 . . . . 0.0 107.716 -179.273 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 9.5 t -135.91 136.15 40.25 Favored 'General case' 0 C--N 1.321 -0.65 0 CA-C-O 122.039 0.923 . . . . 0.0 112.22 179.047 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 10.9 m -114.03 133.25 55.64 Favored 'General case' 0 N--CA 1.437 -1.118 0 CA-C-N 115.162 -0.926 . . . . 0.0 108.845 172.419 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 17.6 p90 -153.47 158.34 41.2 Favored 'General case' 0 C--N 1.316 -0.867 0 CA-C-O 120.963 0.411 . . . . 0.0 110.215 -178.575 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 46.2 m -129.43 132.97 47.1 Favored 'General case' 0 C--N 1.312 -1.057 0 N-CA-C 108.398 -0.964 . . . . 0.0 108.398 175.425 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 78.2 mt -100.44 146.83 26.55 Favored 'General case' 0 C--N 1.318 -0.762 0 CA-C-O 120.885 0.374 . . . . 0.0 110.386 -178.985 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 43.1 mt-10 -65.45 145.9 99.01 Favored Pre-proline 0 C--N 1.317 -0.846 0 N-CA-C 108.631 -0.877 . . . . 0.0 108.631 173.282 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 96.2 Cg_exo -41.76 -52.98 3.59 Favored 'Trans proline' 0 CA--C 1.531 0.345 0 C-N-CA 123.501 2.8 . . . . 0.0 114.5 -170.718 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 29.1 t70 -64.93 -24.62 67.58 Favored 'General case' 0 N--CA 1.466 0.363 0 CA-C-O 120.828 0.347 . . . . 0.0 111.675 -174.804 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -83.26 -10.94 58.25 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-O 120.77 0.319 . . . . 0.0 111.21 -178.605 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -119.58 -86.6 0.65 Allowed 'General case' 0 C--N 1.327 -0.403 0 N-CA-C 112.054 0.39 . . . . 0.0 112.054 -178.897 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 71' ' ' PHE . . . . . . . . . . . . . 3.2 m-85 -87.83 -21.55 24.98 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-O 120.968 0.413 . . . . 0.0 111.231 -174.847 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 72' ' ' GLY . . . . . 0.547 ' C ' ' HB1' ' A' ' 130' ' ' ALA . . . 115.31 -142.25 17.49 Favored Glycine 0 N--CA 1.445 -0.714 0 C-N-CA 120.775 -0.726 . . . . 0.0 111.59 -178.162 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 8.1 p -159.4 130.61 3.86 Favored Pre-proline 0 C--N 1.319 -0.728 0 O-C-N 122.434 -0.451 . . . . 0.0 110.627 -176.445 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 74' ' ' PRO . . . . . 0.631 ' CD ' ' HA3' ' A' ' 131' ' ' GLY . 93.7 Cg_endo -80.67 144.26 15.5 Favored 'Trans proline' 0 N--CA 1.453 -0.856 0 C-N-CA 123.174 2.583 . . . . 0.0 110.925 175.144 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 75' ' ' SER . . . . . 0.551 ' O ' ' HB2' ' A' ' 78' ' ' LEU . 28.5 t -128.23 139.44 35.45 Favored Pre-proline 0 C--N 1.311 -1.08 0 CA-C-N 116.467 -0.333 . . . . 0.0 110.383 -177.158 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 29.3 Cg_endo -65.93 -17.36 55.5 Favored 'Trans proline' 0 N--CA 1.461 -0.386 0 C-N-CA 122.493 2.129 . . . . 0.0 110.933 172.322 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 17.0 t70 -65.06 -26.81 68.4 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-O 121.798 0.808 . . . . 0.0 109.179 172.194 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 78' ' ' LEU . . . . . 0.551 ' HB2' ' O ' ' A' ' 75' ' ' SER . 0.5 OUTLIER -80.86 6.0 14.41 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 114.763 -1.108 . . . . 0.0 110.933 179.126 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 26.2 mt -126.66 99.1 5.26 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.874 0 N-CA-C 108.455 -0.943 . . . . 0.0 108.455 173.991 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 34.4 mt-30 -113.75 160.33 18.78 Favored 'General case' 0 C--N 1.309 -1.175 0 C-N-CA 119.021 -1.071 . . . . 0.0 112.527 174.357 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 81' ' ' TYR . . . . . 0.558 ' CE2' HG23 ' A' ' 122' ' ' THR . 66.6 m-85 -121.2 114.31 21.23 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.906 -0.588 . . . . 0.0 109.919 -179.796 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 49.6 m-85 -115.18 169.8 8.85 Favored 'General case' 0 C--N 1.316 -0.855 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.608 179.281 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 21.0 t -81.02 159.31 24.86 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-O 120.964 0.412 . . . . 0.0 110.97 -177.659 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 84' ' ' ARG . . . . . 0.576 ' HD2' ' O ' ' A' ' 118' ' ' GLY . 4.9 mtp180 -62.58 -36.89 84.15 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 122.1 0.952 . . . . 0.0 110.109 179.542 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 85' ' ' ARG . . . . . . . . . . . . . 8.5 mpt_? -63.14 -28.72 70.26 Favored 'General case' 0 C--N 1.319 -0.759 0 CA-C-N 113.794 -1.548 . . . . 0.0 111.447 -171.51 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 26.0 mm-40 -80.54 -10.34 59.74 Favored 'General case' 0 C--N 1.32 -0.707 0 CA-C-N 115.892 -0.595 . . . . 0.0 110.743 178.613 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 87' ' ' PHE . . . . . . . . . . . . . 17.0 m-85 -104.17 -36.6 7.62 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-N 115.712 -0.676 . . . . 0.0 110.501 -179.222 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 88' ' ' MET . . . . . . . . . . . . . 57.3 ttp -59.33 -23.41 62.46 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 121.776 0.798 . . . . 0.0 109.576 173.556 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 24.7 t70 -53.27 -34.35 56.9 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 114.246 -1.343 . . . . 0.0 110.46 173.073 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -122.57 16.73 10.4 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 115.644 -0.707 . . . . 0.0 111.501 -179.689 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 101.45 136.88 9.48 Favored Glycine 0 C--N 1.33 0.241 0 C-N-CA 120.629 -0.795 . . . . 0.0 112.415 -178.396 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 36.1 mt-10 -61.97 125.87 86.09 Favored Pre-proline 0 C--N 1.328 -0.333 0 CA-C-O 120.995 0.426 . . . . 0.0 111.494 -176.483 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 93' ' ' PRO . . . . . 0.525 ' HB2' HD13 ' A' ' 113' ' ' ILE . 57.7 Cg_endo -78.5 167.03 23.34 Favored 'Trans proline' 0 N--CA 1.459 -0.544 0 C-N-CA 123.266 2.644 . . . . 0.0 113.407 -173.436 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 94' ' ' GLU . . . . . 0.449 ' O ' HD11 ' A' ' 113' ' ' ILE . 24.7 mt-10 -118.32 164.34 15.36 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 115.982 -0.553 . . . . 0.0 110.6 -178.605 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 95' ' ' ILE . . . . . 0.487 HG12 HG12 ' A' ' 116' ' ' ILE . 12.9 mt -81.95 132.05 32.39 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.376 0 CA-C-O 120.594 0.235 . . . . 0.0 110.444 179.083 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 70.64 35.48 67.26 Favored Glycine 0 N--CA 1.448 -0.553 0 C-N-CA 121.185 -0.531 . . . . 0.0 111.785 -178.918 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 97' ' ' ALA . . . . . 0.543 ' O ' HG13 ' A' ' 113' ' ' ILE . . . -109.52 143.38 39.26 Favored 'General case' 0 C--N 1.322 -0.606 0 N-CA-C 109.744 -0.465 . . . . 0.0 109.744 -179.059 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 98' ' ' ILE . . . . . 0.495 ' HA ' ' O ' ' A' ' 111' ' ' GLY . 41.2 mt -94.48 107.9 20.0 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.115 0 CA-C-O 120.936 0.398 . . . . 0.0 110.479 -178.114 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 99' ' ' MET . . . . . 0.41 ' SD ' ' CD1' ' A' ' 113' ' ' ILE . 92.3 mtp -102.48 123.43 46.21 Favored 'General case' 0 N--CA 1.441 -0.925 0 CA-C-O 121.377 0.608 . . . . 0.0 111.404 -177.152 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 4.4 mm? -65.59 143.85 57.35 Favored 'General case' 0 C--N 1.302 -1.477 0 CA-C-N 114.655 -1.157 . . . . 0.0 108.451 166.13 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 101' ' ' PHE . . . . . 0.4 ' CE2' ' HB2' ' A' ' 99' ' ' MET . 1.8 m-85 -149.85 167.95 25.11 Favored 'General case' 0 CA--C 1.511 -0.528 0 N-CA-C 108.062 -1.088 . . . . 0.0 108.062 -157.907 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 1.5 m -122.95 126.63 47.59 Favored 'General case' 0 C--N 1.312 -1.055 0 C-N-CA 119.774 -0.77 . . . . 0.0 110.592 179.23 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 103' ' ' ALA . . . . . 0.539 ' HB3' ' SD ' ' A' ' 109' ' ' MET . . . -95.59 167.34 11.36 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 115.915 -0.584 . . . . 0.0 110.61 -178.019 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 104' ' ' MET . . . . . . . . . . . . . 66.8 mtt -66.35 -12.93 59.56 Favored 'General case' 0 N--CA 1.464 0.259 0 CA-C-N 115.648 -0.705 . . . . 0.0 112.544 -173.117 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 5.4 p-10 -100.27 12.56 36.8 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-O 120.553 0.216 . . . . 0.0 111.383 -178.184 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 82.33 -2.56 84.56 Favored Glycine 0 N--CA 1.45 -0.383 0 C-N-CA 120.602 -0.809 . . . . 0.0 113.168 179.59 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 42.7 t -84.9 146.66 27.17 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-O 121.216 0.531 . . . . 0.0 110.266 178.683 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 28.9 tt0 -94.51 99.0 11.25 Favored 'General case' 0 C--N 1.314 -0.964 0 CA-C-N 115.319 -0.855 . . . . 0.0 108.905 178.355 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 109' ' ' MET . . . . . 0.539 ' SD ' ' HB3' ' A' ' 103' ' ' ALA . 14.6 ptm -88.66 135.09 32.74 Favored Pre-proline 0 C--N 1.325 -0.46 0 CA-C-N 115.426 -0.806 . . . . 0.0 111.065 -178.9 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 29.1 Cg_endo -65.55 153.81 76.52 Favored 'Trans proline' 0 N--CA 1.451 -0.983 0 C-N-CA 121.817 1.678 . . . . 0.0 110.065 171.425 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 111' ' ' GLY . . . . . 0.495 ' O ' ' HA ' ' A' ' 98' ' ' ILE . . . -147.21 152.78 24.88 Favored Glycine 0 N--CA 1.434 -1.486 0 N-CA-C 108.632 -1.787 . . . . 0.0 108.632 -170.313 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 112' ' ' VAL . . . . . 0.474 ' O ' ' HB3' ' A' ' 124' ' ' ASP . 0.7 OUTLIER -126.53 114.59 38.65 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.335 0 CA-C-N 118.613 1.206 . . . . 0.0 110.397 172.369 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 113' ' ' ILE . . . . . 0.543 HG13 ' O ' ' A' ' 97' ' ' ALA . 0.6 OUTLIER -61.89 110.37 0.65 Allowed 'Isoleucine or valine' 0 C--N 1.317 -0.813 0 N-CA-C 109.022 -0.733 . . . . 0.0 109.022 174.314 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 114' ' ' ARG . . . . . . . . . . . . . 12.5 tpp180 -65.02 -52.57 55.26 Favored 'General case' 0 C--N 1.315 -0.927 0 CA-C-N 115.292 -0.867 . . . . 0.0 110.882 -177.695 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 10.8 tt0 -159.91 153.01 21.82 Favored 'General case' 0 C--N 1.321 -0.665 0 C-N-CA 120.887 -0.325 . . . . 0.0 110.329 -174.358 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 116' ' ' ILE . . . . . 0.487 HG12 HG12 ' A' ' 95' ' ' ILE . 43.6 mm -100.29 114.41 38.86 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.486 0 N-CA-C 109.646 -0.501 . . . . 0.0 109.646 176.231 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 117' ' ' ASN . . . . . 0.47 HD21 ' N ' ' A' ' 117' ' ' ASN . 0.9 OUTLIER -94.11 157.51 16.04 Favored 'General case' 0 C--N 1.317 -0.835 0 N-CA-C 109.266 -0.642 . . . . 0.0 109.266 177.901 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 118' ' ' GLY . . . . . 0.576 ' O ' ' HD2' ' A' ' 84' ' ' ARG . . . -56.94 -45.55 91.92 Favored Glycine 0 N--CA 1.451 -0.361 0 C-N-CA 120.537 -0.84 . . . . 0.0 112.91 -172.96 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 30.1 t70 -112.4 -10.66 13.74 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-O 121.107 0.479 . . . . 0.0 111.248 -179.107 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 120' ' ' SER . . . . . 0.459 ' O ' ' HB2' ' A' ' 117' ' ' ASN . 35.2 t -125.88 157.29 38.04 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.205 -171.893 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 121' ' ' ILE . . . . . . . . . . . . . 50.2 mm -114.31 123.12 69.67 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.567 0 CA-C-O 121.183 0.516 . . . . 0.0 110.054 175.808 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 122' ' ' THR . . . . . 0.558 HG23 ' CE2' ' A' ' 81' ' ' TYR . 24.0 m -94.56 102.2 14.11 Favored 'General case' 0 C--N 1.316 -0.85 0 CA-C-N 115.457 -0.792 . . . . 0.0 110.671 179.027 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 8.2 t -88.18 160.27 2.9 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.55 0 CA-C-N 115.267 -0.879 . . . . 0.0 111.853 174.765 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 124' ' ' ASP . . . . . 0.474 ' HB3' ' O ' ' A' ' 112' ' ' VAL . 27.0 t70 -145.91 145.9 30.88 Favored 'General case' 0 C--N 1.317 -0.808 0 CA-C-N 114.355 -1.293 . . . . 0.0 109.203 176.806 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 125' ' ' PHE . . . . . 0.456 ' CB ' ' HG ' ' A' ' 78' ' ' LEU . 98.1 m-85 -132.8 9.91 4.25 Favored 'General case' 0 C--N 1.312 -1.037 0 N-CA-C 108.534 -0.913 . . . . 0.0 108.534 179.87 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 126' ' ' ASN . . . . . 0.408 ' HB2' ' OD2' ' A' ' 124' ' ' ASP . 7.2 m-80 -59.02 120.65 9.5 Favored 'General case' 0 CA--C 1.516 -0.345 0 CA-C-N 113.996 -1.456 . . . . 0.0 111.691 -176.541 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 127' ' ' HIS . . . . . 0.572 ' HB3' ' HD2' ' A' ' 128' ' ' PRO . 16.3 m-70 -74.51 -175.55 0.45 Allowed Pre-proline 0 C--N 1.322 -0.604 0 CA-C-N 113.819 -1.537 . . . . 0.0 111.524 -177.603 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 128' ' ' PRO . . . . . 0.572 ' HD2' ' HB3' ' A' ' 127' ' ' HIS . 4.1 Cg_exo -43.23 172.28 0.01 OUTLIER 'Trans proline' 0 C--N 1.351 0.677 0 C-N-CA 124.735 3.623 . . . . 0.0 114.476 168.034 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 129' ' ' LEU . . . . . 0.49 ' HG ' ' NE2' ' A' ' 132' ' ' GLN . 13.0 tp -52.23 36.85 0.0 OUTLIER 'General case' 0 N--CA 1.488 1.443 0 C-N-CA 127.396 2.278 . . . . 0.0 115.248 -173.665 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 130' ' ' ALA . . . . . 0.547 ' HB1' ' C ' ' A' ' 72' ' ' GLY . . . -80.09 175.7 10.41 Favored 'General case' 0 C--N 1.316 -0.886 0 C-N-CA 123.761 0.824 . . . . 0.0 112.203 -173.266 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 131' ' ' GLY . . . . . 0.631 ' HA3' ' CD ' ' A' ' 74' ' ' PRO . . . 76.3 29.15 58.78 Favored Glycine 0 CA--C 1.508 -0.36 0 CA-C-N 115.625 -0.716 . . . . 0.0 113.063 173.589 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 132' ' ' GLN . . . . . 0.49 ' NE2' ' HG ' ' A' ' 129' ' ' LEU . 12.7 pt20 -148.15 148.42 30.55 Favored 'General case' 0 N--CA 1.436 -1.141 0 N-CA-C 108.434 -0.95 . . . . 0.0 108.434 168.928 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 133' ' ' THR . . . . . . . . . . . . . 28.2 m -70.87 127.77 33.75 Favored 'General case' 0 C--N 1.314 -0.941 0 CA-C-N 116.108 -0.496 . . . . 0.0 109.86 -176.87 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 134' ' ' VAL . . . . . 0.481 ' HB ' ' CD2' ' A' ' 17' ' ' LEU . 16.8 m -98.95 149.96 5.24 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.688 0 CA-C-O 121.127 0.489 . . . . 0.0 110.216 -178.122 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 135' ' ' HIS . . . . . . . . . . . . . 95.2 m-70 -115.53 111.75 21.18 Favored 'General case' 0 C--N 1.314 -0.959 0 CA-C-N 115.161 -0.927 . . . . 0.0 109.577 -172.931 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 136' ' ' PHE . . . . . 0.434 ' CZ ' HD13 ' A' ' 17' ' ' LEU . 3.1 m-85 -107.92 124.1 49.61 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 115.373 -0.831 . . . . 0.0 111.116 -173.163 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 137' ' ' ASP . . . . . 0.475 ' O ' ' HA ' ' A' ' 15' ' ' PHE . 3.7 m-20 -110.38 100.85 9.63 Favored 'General case' 0 C--N 1.317 -0.815 0 N-CA-C 109.034 -0.728 . . . . 0.0 109.034 170.758 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 138' ' ' ILE . . . . . 0.548 HG21 ' CG2' ' A' ' 13' ' ' VAL . 54.2 mt -116.02 122.62 69.99 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.37 0 N-CA-C 112.701 0.63 . . . . 0.0 112.701 -171.905 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 80.4 mt-10 -110.52 137.95 47.54 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-N 115.838 -0.619 . . . . 0.0 110.076 173.491 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 140' ' ' VAL . . . . . 0.439 ' CG1' ' HA ' ' A' ' 57' ' ' VAL . 92.9 t -82.09 105.47 11.99 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.591 0 N-CA-C 108.473 -0.936 . . . . 0.0 108.473 177.435 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 39.1 mt -79.49 -44.45 21.22 Favored 'General case' 0 CA--C 1.508 -0.673 0 N-CA-C 109.839 -0.43 . . . . 0.0 109.839 -179.362 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 142' ' ' GLU . . . . . . . . . . . . . 14.5 pt-20 -169.32 158.12 7.93 Favored 'General case' 0 C--N 1.323 -0.549 0 N-CA-C 108.812 -0.81 . . . . 0.0 108.812 176.698 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 143' ' ' ILE . . . . . 0.433 HD11 HG22 ' A' ' 57' ' ' VAL . 82.3 mt -113.38 110.83 33.59 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.647 0 CA-C-O 121.231 0.538 . . . . 0.0 110.347 -179.444 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 144' ' ' ASP . . . . . . . . . . . . . 38.3 t70 -79.75 133.67 58.49 Favored Pre-proline 0 C--N 1.326 -0.423 0 CA-C-N 115.305 -0.861 . . . . 0.0 110.546 179.886 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 145' ' ' PRO . . . . . . . . . . . . . 90.1 Cg_exo -46.57 139.35 13.42 Favored 'Trans proline' 0 C--N 1.35 0.617 0 C-N-CA 123.236 2.624 . . . . 0.0 112.538 177.581 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 146' ' ' ALA . . . . . . . . . . . . . . . -83.35 96.94 8.67 Favored 'General case' 0 C--N 1.319 -0.752 0 CA-C-O 121.217 0.532 . . . . 0.0 111.143 -174.603 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 3.6 mm? -104.7 13.51 31.33 Favored 'General case' 0 N--CA 1.449 -0.505 0 CA-C-N 115.407 -0.815 . . . . 0.0 109.948 174.054 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 148' ' ' GLU . . . . . 0.427 ' HB2' ' ND2' ' A' ' 8' ' ' ASN . 63.1 mm-40 . . . . . 0 C--N 1.328 -0.358 0 CA-C-N 115.505 -0.771 . . . . 0.0 111.883 -175.317 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 86.5 mmm . . . . . 0 N--CA 1.484 1.27 0 CA-C-O 120.718 0.294 . . . . 0.0 111.226 . . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 2' ' ' SER . . . . . 0.619 ' O ' ' HB ' ' A' ' 143' ' ' ILE . 33.2 t -97.2 135.34 39.28 Favored 'General case' 0 C--N 1.323 -0.553 0 N-CA-C 108.73 -0.841 . . . . 0.0 108.73 174.654 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 42.5 tt0 -84.41 -26.21 28.47 Favored 'General case' 0 C--N 1.321 -0.666 0 CA-C-O 121.216 0.531 . . . . 0.0 110.073 179.416 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 7.0 m -104.64 141.72 35.93 Favored 'General case' 0 C--N 1.318 -0.762 0 CA-C-N 115.443 -0.798 . . . . 0.0 110.711 -177.884 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 9.4 p -82.07 149.95 4.61 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.416 0 CA-C-N 116.052 -0.522 . . . . 0.0 111.075 -176.647 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 6' ' ' GLN . . . . . 0.44 ' CG ' ' HB2' ' A' ' 9' ' ' SER . 3.3 pt20 -143.74 157.77 44.15 Favored 'General case' 0 C--N 1.321 -0.656 0 CA-C-N 115.644 -0.707 . . . . 0.0 110.387 178.673 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 7' ' ' SER . . . . . 0.44 ' O ' ' HB2' ' A' ' 8' ' ' ASN . 5.1 p -76.02 144.12 41.03 Favored 'General case' 0 C--N 1.319 -0.724 0 CA-C-N 116.209 -0.451 . . . . 0.0 109.994 178.533 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 8' ' ' ASN . . . . . 0.484 ' N ' HD21 ' A' ' 8' ' ' ASN . 0.8 OUTLIER 71.6 13.7 6.31 Favored 'General case' 0 N--CA 1.466 0.358 0 CA-C-N 115.405 -0.816 . . . . 0.0 111.815 -178.4 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 9' ' ' SER . . . . . 0.44 ' HB2' ' CG ' ' A' ' 6' ' ' GLN . 18.2 t -82.44 166.91 18.97 Favored 'General case' 0 C--N 1.328 -0.359 0 N-CA-C 109.879 -0.415 . . . . 0.0 109.879 175.518 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 10' ' ' ALA . . . . . 0.653 ' O ' ' HB2' ' A' ' 144' ' ' ASP . . . -110.5 111.93 23.51 Favored 'General case' 0 C--N 1.318 -0.78 0 N-CA-C 109.241 -0.651 . . . . 0.0 109.241 172.638 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 16.5 m -114.61 144.72 21.56 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.789 0 C-N-CA 120.231 -0.588 . . . . 0.0 111.106 -172.67 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 12' ' ' LEU . . . . . 0.44 ' HB2' ' HB2' ' A' ' 142' ' ' GLU . 9.7 mp -87.0 128.29 35.08 Favored 'General case' 0 C--N 1.325 -0.485 0 N-CA-C 109.393 -0.595 . . . . 0.0 109.393 176.423 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 22.3 m -119.72 155.88 22.37 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.928 0 CA-C-O 121.971 0.891 . . . . 0.0 112.905 -173.094 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 14' ' ' HIS . . . . . 0.521 ' CD2' HD13 ' A' ' 141' ' ' LEU . 0.2 OUTLIER -127.82 111.61 13.83 Favored 'General case' 0 C--N 1.315 -0.924 0 CA-C-N 114.044 -1.435 . . . . 0.0 107.456 162.932 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 15' ' ' PHE . . . . . 0.572 ' HA ' ' O ' ' A' ' 137' ' ' ASP . 33.9 p90 -139.07 171.25 14.59 Favored 'General case' 0 C--N 1.321 -0.654 0 N-CA-C 114.198 1.184 . . . . 0.0 114.198 -174.299 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 89.1 m -141.9 140.13 32.76 Favored 'General case' 0 C--N 1.314 -0.955 0 CA-C-N 113.092 -1.867 . . . . 0.0 106.662 175.205 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 17' ' ' LEU . . . . . 0.464 ' CD2' HG21 ' A' ' 134' ' ' VAL . 0.5 OUTLIER -127.22 108.32 10.77 Favored 'General case' 0 C--N 1.316 -0.85 0 C-N-CA 120.973 -0.291 . . . . 0.0 110.654 -171.163 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 9.7 mptt -116.48 160.49 20.52 Favored 'General case' 0 C--N 1.321 -0.653 0 CA-C-O 121.313 0.578 . . . . 0.0 111.643 -174.601 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 19' ' ' LEU . . . . . 0.452 HD13 HG23 ' A' ' 134' ' ' VAL . 3.1 mm? -106.25 171.58 7.27 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 115.022 -0.99 . . . . 0.0 109.644 173.447 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 18.5 t70 -58.07 -30.66 66.37 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-O 121.197 0.522 . . . . 0.0 110.258 175.793 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 10.1 m-20 -77.85 6.69 7.1 Favored 'General case' 0 N--CA 1.465 0.298 0 CA-C-N 115.736 -0.666 . . . . 0.0 111.351 178.858 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 70.18 9.29 63.51 Favored Glycine 0 N--CA 1.453 -0.21 0 C-N-CA 121.294 -0.479 . . . . 0.0 113.261 -179.337 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 14.2 m -79.13 148.35 32.39 Favored 'General case' 0 C--N 1.322 -0.62 0 N-CA-C 109.891 -0.411 . . . . 0.0 109.891 178.422 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 18.2 m -95.16 116.52 28.84 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-O 120.987 0.422 . . . . 0.0 110.965 179.931 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -78.42 -39.36 39.01 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 116.0 -0.545 . . . . 0.0 109.825 176.827 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 8.0 tp10 -157.25 143.0 17.56 Favored 'General case' 0 N--CA 1.451 -0.394 0 CA-C-N 115.823 -0.626 . . . . 0.0 109.957 176.134 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 29.0 p -125.28 121.56 34.39 Favored 'General case' 0 C--N 1.316 -0.852 0 CA-C-N 116.295 -0.411 . . . . 0.0 110.402 178.327 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 50.5 m -136.99 61.24 1.63 Allowed 'General case' 0 N--CA 1.442 -0.856 0 CA-C-O 122.371 1.082 . . . . 0.0 109.816 174.81 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 4.7 tmm_? -151.75 -61.15 0.17 Allowed 'General case' 0 C--N 1.319 -0.755 0 CA-C-N 114.824 -1.08 . . . . 0.0 109.39 -177.861 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 6.2 p30 -68.94 -11.72 60.93 Favored 'General case' 0 N--CA 1.465 0.321 0 CA-C-O 121.121 0.486 . . . . 0.0 110.337 179.645 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 1.3 m-20 -66.49 -36.72 83.42 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 115.412 -0.813 . . . . 0.0 110.702 -179.76 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 98.6 -3.86 59.48 Favored Glycine 0 N--CA 1.448 -0.502 0 CA-C-N 115.655 -0.702 . . . . 0.0 111.614 -175.228 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 60.2 mtpt -126.7 132.29 24.25 Favored Pre-proline 0 C--N 1.328 -0.367 0 N-CA-C 110.143 -0.317 . . . . 0.0 110.143 179.795 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 42.6 Cg_endo -83.9 171.55 10.48 Favored 'Trans proline' 0 N--CA 1.456 -0.724 0 C-N-CA 123.207 2.605 . . . . 0.0 112.24 174.563 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -129.84 163.09 27.04 Favored 'General case' 0 C--N 1.316 -0.889 0 CA-C-N 115.927 -0.579 . . . . 0.0 109.623 -176.641 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 36' ' ' LEU . . . . . 0.461 HD22 ' HB1' ' A' ' 10' ' ' ALA . 0.9 OUTLIER -105.85 122.53 46.29 Favored 'General case' 0 C--N 1.315 -0.916 0 C-N-CA 120.757 -0.377 . . . . 0.0 110.571 177.003 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 37' ' ' PHE . . . . . . . . . . . . . 6.0 m-30 -93.44 107.57 19.39 Favored 'General case' 0 C--N 1.316 -0.891 0 CA-C-N 115.966 -0.561 . . . . 0.0 109.762 172.113 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 18.9 tpt180 -85.87 106.86 17.38 Favored 'General case' 0 N--CA 1.445 -0.701 0 N-CA-C 109.194 -0.669 . . . . 0.0 109.194 178.26 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 39' ' ' LEU . . . . . 0.432 HD22 ' HB3' ' A' ' 49' ' ' GLU . 15.9 mt -82.15 156.06 24.68 Favored 'General case' 0 C--N 1.317 -0.842 0 CA-C-N 115.215 -0.902 . . . . 0.0 110.498 -176.276 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 101.77 32.27 5.13 Favored Glycine 0 C--N 1.319 -0.415 0 C-N-CA 121.177 -0.535 . . . . 0.0 112.838 -177.32 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 41' ' ' ASP . . . . . 0.496 ' HA ' ' O ' ' A' ' 44' ' ' LEU . 14.7 t70 60.28 23.39 12.83 Favored 'General case' 0 N--CA 1.471 0.601 0 CA-C-O 121.507 0.67 . . . . 0.0 111.436 176.762 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -84.24 -5.37 59.25 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-O 121.05 0.452 . . . . 0.0 110.909 179.298 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 26.5 p -166.32 -49.17 0.03 OUTLIER 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 115.78 -0.645 . . . . 0.0 110.292 179.787 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 44' ' ' LEU . . . . . 0.496 ' O ' ' HA ' ' A' ' 41' ' ' ASP . 40.9 mt -106.42 171.1 7.54 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 115.992 -0.549 . . . . 0.0 110.413 179.259 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 21.0 t -76.79 153.37 34.99 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 116.005 -0.543 . . . . 0.0 109.605 178.727 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 46' ' ' GLU . . . . . 0.478 ' O ' ' HG2' ' A' ' 49' ' ' GLU . 44.8 mt-10 -63.7 -24.54 67.82 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 115.902 -0.59 . . . . 0.0 111.545 -176.597 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -57.97 -35.01 74.07 Favored Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 120.916 -0.659 . . . . 0.0 112.32 175.528 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -60.03 -51.91 67.63 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 121.089 0.471 . . . . 0.0 109.912 177.423 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 49' ' ' GLU . . . . . 0.645 ' O ' HD11 ' A' ' 53' ' ' LEU . 14.8 pt-20 -68.15 -51.07 50.14 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 115.9 -0.591 . . . . 0.0 111.19 -174.627 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 50' ' ' GLN . . . . . 0.48 ' HA ' HD21 ' A' ' 53' ' ' LEU . 85.3 mm-40 -56.03 -15.14 3.14 Favored 'General case' 0 C--N 1.329 -0.308 0 N-CA-C 113.75 1.018 . . . . 0.0 113.75 -176.278 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 51' ' ' HIS . . . . . . . . . . . . . 11.6 m170 -106.15 -13.8 15.33 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-O 121.074 0.464 . . . . 0.0 110.716 -177.024 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 18.3 mt -88.16 -14.65 38.12 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-N 115.632 -0.713 . . . . 0.0 109.832 172.427 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 53' ' ' LEU . . . . . 0.645 HD11 ' O ' ' A' ' 49' ' ' GLU . 5.8 mp -61.05 150.38 33.98 Favored 'General case' 0 N--CA 1.445 -0.697 0 CA-C-N 115.554 -0.748 . . . . 0.0 110.596 170.541 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 93.3 -14.67 64.74 Favored Glycine 0 N--CA 1.447 -0.581 0 C-N-CA 121.014 -0.612 . . . . 0.0 111.988 -175.23 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 6.9 mp -85.24 165.84 17.02 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-O 121.726 0.774 . . . . 0.0 112.048 177.632 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 56' ' ' LYS . . . . . 0.434 ' O ' ' HB2' ' A' ' 59' ' ' ASP . 24.2 tptt -128.75 166.92 18.05 Favored 'General case' 0 C--N 1.318 -0.8 0 N-CA-C 107.829 -1.175 . . . . 0.0 107.829 178.16 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 57' ' ' VAL . . . . . 0.47 HG23 HD11 ' A' ' 143' ' ' ILE . 12.6 t -60.52 131.83 25.55 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.52 0 CA-C-O 121.014 0.435 . . . . 0.0 110.816 176.465 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 81.59 10.25 84.62 Favored Glycine 0 N--CA 1.451 -0.364 0 CA-C-N 115.482 -0.781 . . . . 0.0 113.071 -177.519 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 59' ' ' ASP . . . . . 0.434 ' HB2' ' O ' ' A' ' 56' ' ' LYS . 1.0 OUTLIER -93.85 138.13 32.34 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.93 0.395 . . . . 0.0 110.28 176.545 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 60' ' ' LYS . . . . . 0.412 ' HE3' ' OE2' ' A' ' 139' ' ' GLU . 3.4 mmmm -110.48 131.53 54.97 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 116.034 -0.53 . . . . 0.0 109.573 -176.256 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 7.5 t -141.29 145.16 35.16 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-O 121.659 0.742 . . . . 0.0 111.839 -179.908 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 17.4 m -118.0 143.04 46.73 Favored 'General case' 0 C--N 1.313 -0.988 0 N-CA-C 108.609 -0.885 . . . . 0.0 108.609 171.143 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 21.3 p90 -161.15 163.95 30.92 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-O 120.958 0.409 . . . . 0.0 111.107 -177.01 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 41.7 t -132.48 136.9 46.99 Favored 'General case' 0 C--N 1.32 -0.686 0 CA-C-N 115.778 -0.646 . . . . 0.0 109.317 179.815 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 87.6 mt -120.74 146.19 46.74 Favored 'General case' 0 C--N 1.313 -1.011 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.034 -178.352 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 14.5 mm-40 -64.44 152.99 87.82 Favored Pre-proline 0 N--CA 1.442 -0.828 0 CA-C-N 115.364 -0.835 . . . . 0.0 109.995 173.198 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 67' ' ' PRO . . . . . 0.49 ' HB3' ' N ' ' A' ' 132' ' ' GLN . 1.9 Cg_endo -42.61 -55.19 2.78 Favored 'Trans proline' 0 N--CA 1.464 -0.264 0 C-N-CA 123.797 2.998 . . . . 0.0 114.924 -171.513 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 7.0 p-10 -72.21 -14.76 61.87 Favored 'General case' 0 N--CA 1.465 0.304 0 CA-C-O 121.075 0.464 . . . . 0.0 111.502 -174.107 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -90.3 -8.79 50.01 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.676 179.175 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -126.25 -86.11 0.61 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.142 -0.481 . . . . 0.0 111.864 -179.202 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 71' ' ' PHE . . . . . . . . . . . . . 8.9 m-30 -79.88 -33.12 40.24 Favored 'General case' 0 N--CA 1.463 0.186 0 CA-C-N 116.285 -0.416 . . . . 0.0 111.967 -173.561 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 132.67 -149.98 19.63 Favored Glycine 0 N--CA 1.447 -0.577 0 C-N-CA 120.668 -0.777 . . . . 0.0 112.034 -177.901 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 3.0 p -158.04 128.42 3.49 Favored Pre-proline 0 C--N 1.32 -0.694 0 N-CA-C 109.94 -0.392 . . . . 0.0 109.94 -174.23 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 74' ' ' PRO . . . . . 0.515 ' HD3' ' HA3' ' A' ' 131' ' ' GLY . 35.7 Cg_endo -64.58 126.4 16.75 Favored 'Trans proline' 0 C--O 1.232 0.215 0 C-N-CA 123.281 2.654 . . . . 0.0 112.352 -177.45 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 39.6 t -97.87 125.09 45.56 Favored Pre-proline 0 C--N 1.322 -0.627 0 CA-C-N 115.981 -0.554 . . . . 0.0 110.743 -179.828 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 39.1 Cg_endo -69.49 -18.93 38.01 Favored 'Trans proline' 0 N--CA 1.464 -0.236 0 C-N-CA 122.789 2.326 . . . . 0.0 111.813 174.891 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 7.3 m-20 -76.19 -15.22 60.09 Favored 'General case' 0 CA--C 1.519 -0.231 0 CA-C-O 121.359 0.6 . . . . 0.0 109.838 176.742 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 78' ' ' LEU . . . . . 0.511 ' HG ' ' HB2' ' A' ' 125' ' ' PHE . 6.2 mp -87.01 8.17 24.51 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 115.407 -0.815 . . . . 0.0 109.89 175.966 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 49.8 mt -118.86 109.41 26.74 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.681 0 N-CA-C 108.203 -1.036 . . . . 0.0 108.203 172.686 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 74.7 mt-30 -131.43 136.37 47.93 Favored 'General case' 0 C--N 1.311 -1.086 0 CA-C-N 115.259 -0.882 . . . . 0.0 110.054 -169.523 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 81' ' ' TYR . . . . . . . . . . . . . 46.3 m-85 -107.02 112.73 25.82 Favored 'General case' 0 C--N 1.321 -0.638 0 C-N-CA 120.125 -0.63 . . . . 0.0 110.252 -179.885 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 60.0 m-85 -103.78 170.47 7.91 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-O 121.548 0.689 . . . . 0.0 112.822 178.868 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 9.7 m -79.1 139.98 37.94 Favored 'General case' 0 N--CA 1.445 -0.724 0 CA-C-N 114.745 -1.116 . . . . 0.0 111.288 174.634 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 84' ' ' ARG . . . . . 0.411 ' HD2' ' O ' ' A' ' 118' ' ' GLY . 10.8 ptm180 -68.57 -17.22 64.09 Favored 'General case' 0 C--N 1.325 -0.469 0 N-CA-C 113.714 1.005 . . . . 0.0 113.714 -175.186 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 85' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -74.04 -34.13 63.98 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-O 121.134 0.492 . . . . 0.0 109.879 -174.713 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 45.1 mt-10 -64.6 -16.37 62.6 Favored 'General case' 0 N--CA 1.465 0.3 0 CA-C-N 115.177 -0.919 . . . . 0.0 110.77 -179.936 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 87' ' ' PHE . . . . . . . . . . . . . 54.8 m-85 -102.5 -23.12 13.93 Favored 'General case' 0 C--N 1.319 -0.72 0 CA-C-N 115.185 -0.916 . . . . 0.0 110.135 -177.464 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 88' ' ' MET . . . . . . . . . . . . . 56.0 ttm -62.0 -35.56 78.89 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 115.94 -0.573 . . . . 0.0 110.836 -178.419 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 23.1 t70 -58.18 -25.86 62.07 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 121.144 0.497 . . . . 0.0 111.304 178.888 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -111.13 16.51 21.03 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-N 115.938 -0.573 . . . . 0.0 110.668 177.765 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 90.65 143.99 11.66 Favored Glycine 0 N--CA 1.447 -0.629 0 C-N-CA 120.762 -0.732 . . . . 0.0 111.637 -178.225 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 44.3 mt-10 -60.42 127.28 86.33 Favored Pre-proline 0 C--N 1.323 -0.545 0 CA-C-O 121.02 0.438 . . . . 0.0 110.848 -177.633 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 18.1 Cg_endo -71.11 164.91 34.12 Favored 'Trans proline' 0 N--CA 1.457 -0.627 0 C-N-CA 122.85 2.367 . . . . 0.0 112.313 -175.282 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 23.0 mt-10 -118.07 160.8 20.89 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 116.332 -0.395 . . . . 0.0 110.392 -177.603 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 95' ' ' ILE . . . . . 0.455 HG22 ' HA ' ' A' ' 115' ' ' GLU . 9.6 mt -82.33 131.67 33.23 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.51 0 CA-C-O 120.969 0.414 . . . . 0.0 110.607 -178.333 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 71.35 34.8 63.73 Favored Glycine 0 N--CA 1.444 -0.783 0 CA-C-N 115.706 -0.679 . . . . 0.0 111.518 -176.849 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -110.14 115.58 29.98 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 121.659 0.742 . . . . 0.0 112.553 -177.555 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 98' ' ' ILE . . . . . 0.61 ' HA ' ' HA ' ' A' ' 112' ' ' VAL . 5.5 mt -82.03 123.3 37.99 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.017 0 CA-C-N 114.826 -1.079 . . . . 0.0 108.504 175.926 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 99' ' ' MET . . . . . . . . . . . . . 10.0 mtm -136.64 152.78 50.81 Favored 'General case' 0 N--CA 1.443 -0.797 0 N-CA-C 106.37 -1.715 . . . . 0.0 106.37 179.811 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 3.2 mm? -71.54 102.85 2.81 Favored 'General case' 0 C--N 1.313 -1.003 0 CA-C-O 122.273 1.035 . . . . 0.0 111.856 -178.795 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 101' ' ' PHE . . . . . . . . . . . . . 8.2 m-30 -94.78 172.65 8.04 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 113.033 -1.894 . . . . 0.0 111.826 -179.512 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 5.3 m -118.56 130.14 55.73 Favored 'General case' 0 C--N 1.316 -0.887 0 CA-C-N 114.947 -1.024 . . . . 0.0 108.972 -178.716 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 103' ' ' ALA . . . . . 0.63 ' HB3' ' SD ' ' A' ' 109' ' ' MET . . . -94.57 158.47 15.52 Favored 'General case' 0 C--N 1.322 -0.605 0 N-CA-C 109.329 -0.619 . . . . 0.0 109.329 -177.889 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 104' ' ' MET . . . . . . . . . . . . . 2.0 mpt? -66.54 -12.65 58.7 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 115.732 -0.667 . . . . 0.0 111.953 -174.988 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 5.0 p-10 -97.63 11.27 37.55 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-O 120.893 0.378 . . . . 0.0 110.989 179.227 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 87.9 -12.22 64.53 Favored Glycine 0 N--CA 1.45 -0.392 0 C-N-CA 121.249 -0.5 . . . . 0.0 113.505 175.499 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 48.9 m -76.76 142.49 40.39 Favored 'General case' 0 C--N 1.317 -0.81 0 CA-C-N 116.816 0.308 . . . . 0.0 110.308 177.499 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 30.1 tt0 -93.65 100.57 12.79 Favored 'General case' 0 C--N 1.318 -0.778 0 CA-C-O 121.675 0.75 . . . . 0.0 109.536 178.473 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 109' ' ' MET . . . . . 0.63 ' SD ' ' HB3' ' A' ' 103' ' ' ALA . 16.0 ptm -100.3 139.58 20.79 Favored Pre-proline 0 C--N 1.323 -0.573 0 CA-C-N 114.889 -1.051 . . . . 0.0 111.262 -177.289 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 17.7 Cg_exo -64.6 143.37 81.15 Favored 'Trans proline' 0 N--CA 1.451 -1.02 0 C-N-CA 121.88 1.72 . . . . 0.0 110.061 171.874 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . -144.69 108.26 0.48 Allowed Glycine 0 N--CA 1.438 -1.212 0 N-CA-C 109.876 -1.29 . . . . 0.0 109.876 -171.512 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 112' ' ' VAL . . . . . 0.61 ' HA ' ' HA ' ' A' ' 98' ' ' ILE . 1.3 p -84.11 110.38 18.64 Favored 'Isoleucine or valine' 0 CA--C 1.51 -0.582 0 C-N-CA 119.202 -0.999 . . . . 0.0 110.879 -178.647 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 113' ' ' ILE . . . . . . . . . . . . . 45.9 mt -60.41 110.11 0.52 Allowed 'Isoleucine or valine' 0 N--CA 1.438 -1.071 0 CA-C-N 114.22 -1.355 . . . . 0.0 108.536 170.726 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 114' ' ' ARG . . . . . 0.443 ' O ' HG22 ' A' ' 95' ' ' ILE . 1.3 tmt_? -79.2 -27.55 42.56 Favored 'General case' 0 C--N 1.309 -1.188 0 CA-C-N 114.162 -1.381 . . . . 0.0 110.899 -168.214 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 115' ' ' GLU . . . . . 0.598 ' N ' ' HB ' ' A' ' 122' ' ' THR . 8.2 tt0 -160.28 159.93 31.96 Favored 'General case' 0 C--N 1.325 -0.484 0 N-CA-C 112.456 0.539 . . . . 0.0 112.456 -179.046 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 116' ' ' ILE . . . . . 0.429 HG12 HG12 ' A' ' 95' ' ' ILE . 33.4 mm -118.39 130.3 73.45 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.605 0 CA-C-N 114.981 -1.009 . . . . 0.0 109.444 174.218 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 117' ' ' ASN . . . . . 0.405 ' HB2' ' O ' ' A' ' 120' ' ' SER . 19.8 m-80 -122.21 159.3 27.57 Favored 'General case' 0 C--N 1.309 -1.192 0 CA-C-N 115.51 -0.768 . . . . 0.0 109.27 -179.782 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 118' ' ' GLY . . . . . 0.411 ' O ' ' HD2' ' A' ' 84' ' ' ARG . . . -55.28 -45.59 82.47 Favored Glycine 0 N--CA 1.452 -0.297 0 C-N-CA 120.653 -0.784 . . . . 0.0 112.896 -170.624 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 3.3 p-10 -114.17 -12.08 12.56 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 117.03 0.415 . . . . 0.0 111.032 173.534 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 120' ' ' SER . . . . . 0.405 ' O ' ' HB2' ' A' ' 117' ' ' ASN . 21.9 t -113.77 159.79 19.38 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-O 122.047 0.927 . . . . 0.0 112.122 -169.196 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 121' ' ' ILE . . . . . 0.469 ' CG2' ' H ' ' A' ' 122' ' ' THR . 45.1 mm -118.98 159.68 19.4 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.863 0 CA-C-N 114.292 -1.322 . . . . 0.0 109.52 -177.289 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 122' ' ' THR . . . . . 0.598 ' HB ' ' N ' ' A' ' 115' ' ' GLU . 8.8 m -139.18 139.14 37.47 Favored 'General case' 0 N--CA 1.448 -0.533 0 N-CA-C 106.844 -1.539 . . . . 0.0 106.844 -170.78 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 55.6 t -140.46 154.57 22.46 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.67 0 C-N-CA 117.555 -1.658 . . . . 0.0 109.872 -164.119 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 124' ' ' ASP . . . . . 0.418 ' HB3' HG11 ' A' ' 112' ' ' VAL . 35.6 t70 -154.7 94.9 1.72 Allowed 'General case' 0 C--N 1.309 -1.176 0 CA-C-N 115.593 -0.73 . . . . 0.0 109.684 176.671 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 125' ' ' PHE . . . . . 0.511 ' HB2' ' HG ' ' A' ' 78' ' ' LEU . 97.4 m-85 -82.01 3.37 26.88 Favored 'General case' 0 C--N 1.324 -0.534 0 O-C-N 120.724 -1.235 . . . . 0.0 110.376 173.699 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 37.0 m-80 -57.48 136.2 56.66 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-O 122.478 1.132 . . . . 0.0 111.951 -177.92 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 127' ' ' HIS . . . . . 0.618 ' HB3' ' HD2' ' A' ' 128' ' ' PRO . 33.8 m170 -84.96 -170.9 0.27 Allowed Pre-proline 0 C--N 1.319 -0.747 0 CA-C-N 112.962 -1.926 . . . . 0.0 111.095 -168.788 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 128' ' ' PRO . . . . . 0.618 ' HD2' ' HB3' ' A' ' 127' ' ' HIS . 6.0 Cg_exo -41.83 172.64 0.01 OUTLIER 'Trans proline' 0 C--N 1.354 0.844 0 C-N-CA 124.482 3.455 . . . . 0.0 114.101 165.086 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 129' ' ' LEU . . . . . 0.463 ' HG ' ' O ' ' A' ' 129' ' ' LEU . 22.1 tp -51.68 34.76 0.0 OUTLIER 'General case' 0 N--CA 1.485 1.28 0 C-N-CA 126.91 2.084 . . . . 0.0 115.843 -173.829 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 130' ' ' ALA . . . . . 0.417 ' H ' ' C ' ' A' ' 128' ' ' PRO . . . -70.48 164.46 24.66 Favored 'General case' 0 C--N 1.315 -0.906 0 C-N-CA 122.83 0.452 . . . . 0.0 110.15 175.259 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 131' ' ' GLY . . . . . 0.515 ' HA3' ' HD3' ' A' ' 74' ' ' PRO . . . 76.46 28.37 59.8 Favored Glycine 0 N--CA 1.45 -0.389 0 C-N-CA 120.621 -0.799 . . . . 0.0 112.069 -178.439 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 132' ' ' GLN . . . . . 0.49 ' N ' ' HB3' ' A' ' 67' ' ' PRO . 14.3 tt0 -148.05 141.55 25.39 Favored 'General case' 0 N--CA 1.441 -0.89 0 N-CA-C 108.897 -0.779 . . . . 0.0 108.897 171.505 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 133' ' ' THR . . . . . . . . . . . . . 59.5 m -67.39 125.35 25.83 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.672 -178.061 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 134' ' ' VAL . . . . . 0.464 HG21 ' CD2' ' A' ' 17' ' ' LEU . 2.7 p -116.96 166.78 10.91 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.501 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.803 -173.227 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 135' ' ' HIS . . . . . . . . . . . . . 81.8 m-70 -131.0 124.48 31.05 Favored 'General case' 0 C--N 1.322 -0.587 0 CA-C-N 115.848 -0.614 . . . . 0.0 111.089 -171.278 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 136' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -131.54 150.98 51.96 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 121.478 0.656 . . . . 0.0 111.907 -179.966 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 137' ' ' ASP . . . . . 0.572 ' O ' ' HA ' ' A' ' 15' ' ' PHE . 3.3 m-20 -115.89 101.18 8.56 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-N 114.706 -1.133 . . . . 0.0 108.604 174.244 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 138' ' ' ILE . . . . . . . . . . . . . 47.6 mt -116.65 130.51 71.38 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.532 0 CA-C-O 121.203 0.525 . . . . 0.0 111.789 -172.23 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 139' ' ' GLU . . . . . 0.412 ' OE2' ' HE3' ' A' ' 60' ' ' LYS . 11.7 pt-20 -118.45 142.8 47.21 Favored 'General case' 0 C--N 1.321 -0.642 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.103 178.064 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 140' ' ' VAL . . . . . 0.442 ' CG1' ' HA ' ' A' ' 57' ' ' VAL . 78.7 t -79.09 108.33 12.55 Favored 'Isoleucine or valine' 0 C--O 1.234 0.263 0 CA-C-O 121.068 0.461 . . . . 0.0 111.116 -179.199 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 141' ' ' LEU . . . . . 0.521 HD13 ' CD2' ' A' ' 14' ' ' HIS . 48.7 mt -90.45 -33.02 16.15 Favored 'General case' 0 C--N 1.321 -0.652 0 CA-C-O 121.632 0.729 . . . . 0.0 110.324 177.291 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 142' ' ' GLU . . . . . 0.44 ' HB2' ' HB2' ' A' ' 12' ' ' LEU . 0.0 OUTLIER -164.49 148.23 9.28 Favored 'General case' 0 C--N 1.316 -0.885 0 CA-C-N 114.083 -1.417 . . . . 0.0 111.811 -176.879 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 143' ' ' ILE . . . . . 0.619 ' HB ' ' O ' ' A' ' 2' ' ' SER . 78.3 mt -125.16 127.92 72.53 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.538 0 CA-C-N 115.455 -0.793 . . . . 0.0 109.91 178.834 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 144' ' ' ASP . . . . . 0.653 ' HB2' ' O ' ' A' ' 10' ' ' ALA . 31.4 t70 -62.15 137.52 95.76 Favored Pre-proline 0 C--N 1.326 -0.448 0 CA-C-N 115.82 -0.627 . . . . 0.0 110.715 -178.246 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 145' ' ' PRO . . . . . . . . . . . . . 25.3 Cg_endo -61.47 156.43 46.77 Favored 'Trans proline' 0 N--CA 1.463 -0.32 0 C-N-CA 122.823 2.349 . . . . 0.0 111.627 178.334 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 146' ' ' ALA . . . . . . . . . . . . . . . -82.6 97.72 8.63 Favored 'General case' 0 C--N 1.317 -0.809 0 CA-C-O 120.977 0.417 . . . . 0.0 110.625 -176.388 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 4.1 mm? -90.19 41.79 1.07 Allowed 'General case' 0 C--N 1.325 -0.488 0 CA-C-O 121.477 0.656 . . . . 0.0 110.511 178.494 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 18.0 mm-40 . . . . . 0 C--N 1.323 -0.555 0 CA-C-N 115.127 -0.942 . . . . 0.0 110.467 178.272 . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 34.2 ttm . . . . . 0 N--CA 1.481 1.09 0 CA-C-O 120.953 0.406 . . . . 0.0 110.201 . . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 69.0 m -88.95 87.31 7.18 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-O 121.221 0.534 . . . . 0.0 111.005 -177.993 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 33.4 mt-10 -80.33 -25.74 39.13 Favored 'General case' 0 C--N 1.323 -0.585 0 N-CA-C 108.442 -0.947 . . . . 0.0 108.442 172.851 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 23.6 t -117.47 132.8 56.49 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-N 114.027 -1.442 . . . . 0.0 109.004 175.048 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . 0.555 HG11 ' O ' ' A' ' 55' ' ' LEU . 8.9 p -76.9 142.77 13.85 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.494 0 CA-C-O 121.244 0.545 . . . . 0.0 110.428 -179.376 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 6' ' ' GLN . . . . . 0.445 ' HG2' ' HB2' ' A' ' 9' ' ' SER . 4.2 pt20 -127.39 168.3 15.03 Favored 'General case' 0 C--N 1.314 -0.963 0 CA-C-N 115.477 -0.783 . . . . 0.0 109.176 179.933 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 31.3 p -55.9 130.2 42.73 Favored 'General case' 0 C--N 1.317 -0.819 0 N-CA-C 109.955 -0.387 . . . . 0.0 109.955 174.946 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 66.7 t30 69.04 40.29 1.62 Allowed 'General case' 0 N--CA 1.47 0.549 0 CA-C-O 121.392 0.615 . . . . 0.0 110.914 -176.339 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 9' ' ' SER . . . . . 0.445 ' HB2' ' HG2' ' A' ' 6' ' ' GLN . 18.3 t -133.71 125.97 29.73 Favored 'General case' 0 C--N 1.327 -0.409 0 N-CA-C 108.638 -0.875 . . . . 0.0 108.638 173.311 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -83.27 148.67 27.25 Favored 'General case' 0 C--N 1.319 -0.755 0 CA-C-N 116.587 -0.279 . . . . 0.0 110.707 -171.233 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 8.0 m -123.92 140.15 48.23 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.687 0 CA-C-O 121.436 0.636 . . . . 0.0 111.322 179.249 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 12' ' ' LEU . . . . . 0.493 ' N ' HD13 ' A' ' 12' ' ' LEU . 5.1 mp -88.98 112.85 23.84 Favored 'General case' 0 C--N 1.315 -0.929 0 N-CA-C 107.584 -1.265 . . . . 0.0 107.584 173.667 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 13' ' ' VAL . . . . . 0.516 ' CG2' HG21 ' A' ' 138' ' ' ILE . 1.4 p -125.46 157.03 34.93 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.952 0 CA-C-O 121.185 0.517 . . . . 0.0 110.576 -171.462 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 14' ' ' HIS . . . . . 0.625 ' CE1' ' HA ' ' A' ' 29' ' ' ARG . 43.5 t60 -130.72 113.62 14.37 Favored 'General case' 0 C--N 1.316 -0.871 0 N-CA-C 106.12 -1.807 . . . . 0.0 106.12 176.502 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 15' ' ' PHE . . . . . 0.485 ' H ' ' HB ' ' A' ' 28' ' ' THR . 48.6 p90 -141.9 -179.07 5.99 Favored 'General case' 0 C--N 1.317 -0.81 0 CA-C-O 122.363 1.078 . . . . 0.0 113.329 -163.756 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 60.1 m -143.97 113.24 6.9 Favored 'General case' 0 C--N 1.318 -0.782 0 CA-C-N 113.721 -1.582 . . . . 0.0 108.336 -176.11 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 1.1 tt -100.89 120.96 40.92 Favored 'General case' 0 C--N 1.321 -0.657 0 CA-C-N 115.923 -0.58 . . . . 0.0 112.153 -176.916 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 10.0 mptt -120.18 142.76 48.68 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-N 115.339 -0.846 . . . . 0.0 110.714 -179.248 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 19' ' ' LEU . . . . . 0.462 ' CD2' ' HB3' ' A' ' 25' ' ' ALA . 3.6 mm? -84.58 173.69 10.59 Favored 'General case' 0 C--N 1.322 -0.599 0 N-CA-C 109.11 -0.7 . . . . 0.0 109.11 170.711 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 50.5 m-20 -57.2 -33.66 67.72 Favored 'General case' 0 C--N 1.327 -0.408 0 C-N-CA 120.786 -0.366 . . . . 0.0 110.631 177.057 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 23.3 t70 -78.16 4.08 13.46 Favored 'General case' 0 CA--C 1.535 0.398 0 CA-C-O 121.338 0.59 . . . . 0.0 111.201 178.957 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 73.57 9.41 78.23 Favored Glycine 0 CA--C 1.516 0.15 0 CA-C-N 116.137 -0.483 . . . . 0.0 113.264 -179.047 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 8.1 m -71.19 141.38 50.67 Favored 'General case' 0 C--N 1.323 -0.583 0 N-CA-C 109.529 -0.545 . . . . 0.0 109.529 174.776 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 7.3 m -88.8 112.25 22.99 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-O 120.923 0.392 . . . . 0.0 110.567 -178.665 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 25' ' ' ALA . . . . . 0.462 ' HB3' ' CD2' ' A' ' 19' ' ' LEU . . . -80.41 -38.38 30.33 Favored 'General case' 0 CA--C 1.516 -0.332 0 CA-C-N 116.009 -0.542 . . . . 0.0 111.033 -178.708 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 23.8 tt0 -154.24 121.14 5.59 Favored 'General case' 0 C--N 1.321 -0.668 0 CA-C-N 115.543 -0.753 . . . . 0.0 109.645 -176.735 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 14.9 p -114.08 101.65 9.43 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-O 121.677 0.751 . . . . 0.0 111.679 -178.09 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 28' ' ' THR . . . . . 0.485 ' HB ' ' H ' ' A' ' 15' ' ' PHE . 80.3 m -91.14 81.05 5.59 Favored 'General case' 0 N--CA 1.431 -1.393 0 N-CA-C 106.468 -1.678 . . . . 0.0 106.468 171.475 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 29' ' ' ARG . . . . . 0.625 ' HA ' ' CE1' ' A' ' 14' ' ' HIS . 43.0 ttt180 -174.07 -70.85 0.01 OUTLIER 'General case' 0 C--N 1.305 -1.354 0 CA-C-N 112.735 -2.03 . . . . 0.0 110.32 -162.54 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 73.2 m-20 -65.51 -29.12 69.72 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 121.1 0.476 . . . . 0.0 111.2 -176.968 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 93.6 m-20 -67.9 -22.06 65.1 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 115.82 -0.627 . . . . 0.0 111.391 179.915 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 78.08 12.71 84.1 Favored Glycine 0 N--CA 1.449 -0.466 0 C-N-CA 120.719 -0.753 . . . . 0.0 111.509 -178.895 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 66.9 mttm -133.34 128.48 20.31 Favored Pre-proline 0 C--N 1.324 -0.54 0 CA-C-N 115.455 -0.372 . . . . 0.0 110.156 -176.801 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 34' ' ' PRO . . . . . 0.42 ' HA ' ' CG2' ' A' ' 28' ' ' THR . 93.9 Cg_endo -80.17 154.58 22.18 Favored 'Trans proline' 0 N--CA 1.45 -1.038 0 C-N-CA 121.914 1.743 . . . . 0.0 111.112 174.231 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -113.59 150.53 32.95 Favored 'General case' 0 C--N 1.319 -0.749 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.211 -173.027 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 10.9 tp -94.51 126.94 40.11 Favored 'General case' 0 C--N 1.318 -0.797 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.574 178.547 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 37' ' ' PHE . . . . . . . . . . . . . 4.4 m-30 -94.97 107.43 19.46 Favored 'General case' 0 C--N 1.315 -0.907 0 CA-C-N 115.924 -0.58 . . . . 0.0 109.678 171.96 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 16.1 mmm180 -81.71 108.0 14.9 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 115.615 -0.72 . . . . 0.0 111.341 -178.311 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 39' ' ' LEU . . . . . 0.435 ' HG ' ' CB ' ' A' ' 49' ' ' GLU . 10.7 mp -81.77 154.55 25.91 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-N 114.897 -1.047 . . . . 0.0 110.567 177.466 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 101.35 34.23 4.56 Favored Glycine 0 N--CA 1.449 -0.481 0 C-N-CA 120.718 -0.753 . . . . 0.0 112.823 177.107 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 20.6 t70 65.68 6.05 3.66 Favored 'General case' 0 N--CA 1.471 0.619 0 CA-C-O 121.148 0.499 . . . . 0.0 111.994 176.676 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -68.7 -59.3 3.21 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-O 121.068 0.461 . . . . 0.0 111.127 -175.858 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 22.2 m -116.85 -31.21 5.51 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-O 121.306 0.574 . . . . 0.0 110.353 177.979 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 44' ' ' LEU . . . . . 0.402 HD12 HD13 ' A' ' 48' ' ' LEU . 49.9 mt -108.8 157.8 18.24 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-N 115.651 -0.704 . . . . 0.0 110.456 -175.291 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 49.1 m -89.07 171.27 9.96 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 115.825 -0.625 . . . . 0.0 111.018 179.654 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 46' ' ' GLU . . . . . 0.445 ' O ' ' HG3' ' A' ' 50' ' ' GLN . 59.0 mm-40 -47.89 -49.12 30.76 Favored 'General case' 0 C--N 1.33 -0.247 0 O-C-N 123.856 0.723 . . . . 0.0 112.201 -176.01 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . 0.449 ' HA3' ' HB1' ' A' ' 69' ' ' ALA . . . -58.73 -45.61 94.58 Favored Glycine 0 CA--C 1.519 0.303 0 C-N-CA 120.881 -0.676 . . . . 0.0 113.379 -175.155 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 48' ' ' LEU . . . . . 0.402 HD13 HD12 ' A' ' 44' ' ' LEU . 0.3 OUTLIER -60.12 -52.91 63.33 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 117.039 0.42 . . . . 0.0 110.324 -178.889 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 49' ' ' GLU . . . . . 0.435 ' CB ' ' HG ' ' A' ' 39' ' ' LEU . 7.6 pt-20 -68.06 -31.9 71.87 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 116.376 -0.375 . . . . 0.0 111.994 -172.212 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 50' ' ' GLN . . . . . 0.603 ' HA ' ' CD2' ' A' ' 53' ' ' LEU . 84.5 mt-30 -80.7 -8.39 59.63 Favored 'General case' 0 N--CA 1.452 -0.354 0 N-CA-C 111.814 0.302 . . . . 0.0 111.814 -170.642 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 51' ' ' HIS . . . . . . . . . . . . . 21.8 m-70 -108.81 -5.14 16.38 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-O 121.215 0.531 . . . . 0.0 110.18 -178.501 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 18.1 mt -103.72 -30.25 10.54 Favored 'General case' 0 C--N 1.32 -0.691 0 CA-C-N 115.684 -0.689 . . . . 0.0 111.601 177.216 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 53' ' ' LEU . . . . . 0.603 ' CD2' ' HA ' ' A' ' 50' ' ' GLN . 2.5 pp -67.57 151.34 47.49 Favored 'General case' 0 C--O 1.234 0.24 0 C-N-CA 120.991 -0.284 . . . . 0.0 110.584 -177.215 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 93.7 -5.15 73.17 Favored Glycine 0 CA--C 1.522 0.53 0 C-N-CA 120.996 -0.621 . . . . 0.0 113.049 -177.418 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 55' ' ' LEU . . . . . 0.555 ' O ' HG11 ' A' ' 5' ' ' VAL . 72.3 mt -92.51 164.66 13.37 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 117.082 0.441 . . . . 0.0 111.008 179.084 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 56' ' ' LYS . . . . . 0.445 ' O ' ' HB2' ' A' ' 59' ' ' ASP . 2.8 mptp? -111.59 169.87 8.52 Favored 'General case' 0 C--N 1.32 -0.717 0 CA-C-O 121.466 0.651 . . . . 0.0 109.345 175.583 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 57' ' ' VAL . . . . . 0.43 ' HA ' ' CG1' ' A' ' 140' ' ' VAL . 52.5 t -63.1 138.73 22.43 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.331 0 CA-C-N 114.954 -1.021 . . . . 0.0 110.027 174.086 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 81.49 10.95 83.82 Favored Glycine 0 N--CA 1.446 -0.651 0 C-N-CA 120.858 -0.687 . . . . 0.0 112.419 -177.35 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 59' ' ' ASP . . . . . 0.445 ' HB2' ' O ' ' A' ' 56' ' ' LYS . 3.3 m-20 -92.48 139.65 30.37 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-O 120.801 0.334 . . . . 0.0 110.306 175.317 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 6.8 mmmt -111.78 127.97 55.96 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 115.839 -0.619 . . . . 0.0 109.34 -177.767 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 11.3 t -142.43 141.28 32.19 Favored 'General case' 0 C--N 1.317 -0.836 0 CA-C-O 121.281 0.562 . . . . 0.0 111.103 -179.178 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 5.0 m -127.73 131.36 49.71 Favored 'General case' 0 C--N 1.316 -0.878 0 N-CA-C 109.049 -0.723 . . . . 0.0 109.049 174.789 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 63' ' ' PHE . . . . . 0.529 ' CE2' ' HE1' ' A' ' 136' ' ' PHE . 41.2 p90 -152.2 172.59 16.15 Favored 'General case' 0 C--N 1.319 -0.75 0 CA-C-O 120.648 0.261 . . . . 0.0 110.576 179.061 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 38.3 t -132.04 143.8 50.31 Favored 'General case' 0 C--N 1.319 -0.735 0 N-CA-C 108.743 -0.836 . . . . 0.0 108.743 -172.16 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 57.2 mt -139.48 139.18 36.92 Favored 'General case' 0 C--N 1.319 -0.758 0 CA-C-O 121.12 0.486 . . . . 0.0 111.501 -176.728 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 66' ' ' GLU . . . . . 0.447 ' CD ' ' H ' ' A' ' 66' ' ' GLU . 13.5 mp0 -64.84 148.36 97.44 Favored Pre-proline 0 N--CA 1.44 -0.928 0 CA-C-N 115.009 -0.996 . . . . 0.0 109.373 170.571 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 73.7 Cg_exo -50.44 -23.78 11.05 Favored 'Trans proline' 0 C--N 1.346 0.434 0 C-N-CA 124.024 3.15 . . . . 0.0 114.662 -174.697 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 32.8 t70 -66.8 -26.2 66.83 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-O 121.149 0.5 . . . . 0.0 110.697 177.867 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 69' ' ' ALA . . . . . 0.449 ' HB1' ' HA3' ' A' ' 47' ' ' GLY . . . -108.21 -6.34 16.43 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 115.954 -0.567 . . . . 0.0 111.524 -178.067 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 70' ' ' ALA . . . . . 0.439 ' O ' ' HB2' ' A' ' 71' ' ' PHE . . . -149.19 128.73 13.1 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.664 -0.244 . . . . 0.0 111.154 -176.009 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 71' ' ' PHE . . . . . 0.439 ' HB2' ' O ' ' A' ' 70' ' ' ALA . 3.3 m-85 74.37 -47.96 0.64 Allowed 'General case' 0 N--CA 1.47 0.569 0 O-C-N 123.778 0.674 . . . . 0.0 111.943 179.526 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 72' ' ' GLY . . . . . 0.526 ' O ' ' HB1' ' A' ' 130' ' ' ALA . . . 115.86 141.16 7.2 Favored Glycine 0 N--CA 1.447 -0.582 0 C-N-CA 120.845 -0.693 . . . . 0.0 112.51 177.663 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 46.5 t -75.02 121.38 85.14 Favored Pre-proline 0 C--N 1.322 -0.625 0 CA-C-O 120.868 0.366 . . . . 0.0 110.903 173.509 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 53.0 Cg_exo -56.92 146.62 78.52 Favored 'Trans proline' 0 C--N 1.347 0.456 0 C-N-CA 123.732 2.955 . . . . 0.0 112.627 178.168 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 32.2 t -111.16 101.94 51.59 Favored Pre-proline 0 N--CA 1.446 -0.642 0 CA-C-N 116.081 -0.509 . . . . 0.0 110.276 -178.904 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 39.5 Cg_endo -69.11 -24.47 32.61 Favored 'Trans proline' 0 N--CA 1.465 -0.173 0 C-N-CA 122.074 1.849 . . . . 0.0 111.245 175.463 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 5.8 p-10 -77.26 -9.09 58.59 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 115.869 -0.605 . . . . 0.0 110.781 177.314 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 78' ' ' LEU . . . . . 0.52 ' HG ' ' HB2' ' A' ' 125' ' ' PHE . 5.0 tp -69.42 -20.99 63.78 Favored 'General case' 0 N--CA 1.453 -0.298 0 CA-C-O 121.645 0.736 . . . . 0.0 109.249 175.388 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 79' ' ' ILE . . . . . 0.451 HG23 ' O ' ' A' ' 123' ' ' VAL . 65.2 mt -70.21 132.17 33.48 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.555 0 CA-C-N 114.473 -1.239 . . . . 0.0 110.396 178.653 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 42.6 mt-30 -152.8 118.24 5.27 Favored 'General case' 0 CA--C 1.509 -0.605 0 CA-C-N 116.099 -0.501 . . . . 0.0 109.983 -176.992 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 81' ' ' TYR . . . . . 0.422 ' HA ' ' O ' ' A' ' 121' ' ' ILE . 0.6 OUTLIER -83.51 121.71 27.57 Favored 'General case' 0 C--N 1.317 -0.846 0 N-CA-C 114.193 1.183 . . . . 0.0 114.193 -179.936 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 82' ' ' PHE . . . . . 0.433 ' HZ ' ' SD ' ' A' ' 104' ' ' MET . 7.5 m-85 -102.99 171.14 7.55 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 113.887 -1.506 . . . . 0.0 110.486 175.015 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 8.5 t -74.48 136.52 42.25 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-O 121.368 0.604 . . . . 0.0 110.904 -178.669 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 84' ' ' ARG . . . . . 0.583 ' HA ' ' CG1' ' A' ' 121' ' ' ILE . 12.1 ptm180 -61.36 -17.28 53.2 Favored 'General case' 0 C--N 1.326 -0.448 0 N-CA-C 113.734 1.013 . . . . 0.0 113.734 -178.187 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 85' ' ' ARG . . . . . 0.472 ' HD2' ' N ' ' A' ' 85' ' ' ARG . 6.7 mpt_? -73.92 -32.3 63.48 Favored 'General case' 0 C--N 1.321 -0.643 0 CA-C-O 121.203 0.525 . . . . 0.0 109.716 -176.396 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 32.7 mt-10 -63.28 -21.71 66.42 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 115.175 -0.921 . . . . 0.0 111.044 -179.102 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 87' ' ' PHE . . . . . . . . . . . . . 52.5 m-85 -96.83 -20.48 18.15 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 115.831 -0.622 . . . . 0.0 110.916 -178.308 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 88' ' ' MET . . . . . . . . . . . . . 55.7 ttm -60.91 -27.14 67.97 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 115.682 -0.69 . . . . 0.0 111.544 -175.915 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 60.8 m-20 -53.33 -34.57 58.01 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 116.426 -0.352 . . . . 0.0 111.538 177.022 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -109.79 16.58 21.95 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-O 121.014 0.435 . . . . 0.0 110.495 179.315 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 93.95 155.26 31.65 Favored Glycine 0 N--CA 1.448 -0.549 0 C-N-CA 121.088 -0.577 . . . . 0.0 111.734 -177.212 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 11.6 tt0 -64.73 127.86 92.97 Favored Pre-proline 0 N--CA 1.431 -1.402 0 CA-C-O 121.0 0.428 . . . . 0.0 109.945 -179.799 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 93' ' ' PRO . . . . . 0.486 ' CB ' HD11 ' A' ' 113' ' ' ILE . 31.8 Cg_endo -65.5 165.65 22.08 Favored 'Trans proline' 0 C--O 1.233 0.271 0 C-N-CA 123.398 2.732 . . . . 0.0 113.923 -176.196 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 94' ' ' GLU . . . . . 0.445 ' O ' ' HB ' ' A' ' 113' ' ' ILE . 14.2 mt-10 -114.22 154.53 27.74 Favored 'General case' 0 C--N 1.333 -0.145 0 CA-C-N 115.651 -0.704 . . . . 0.0 110.69 -177.385 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 95' ' ' ILE . . . . . 0.56 ' CG1' HG12 ' A' ' 116' ' ' ILE . 20.2 mt -82.27 129.66 37.1 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.386 0 CA-C-O 121.047 0.451 . . . . 0.0 111.576 -178.168 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 71.76 27.09 71.46 Favored Glycine 0 N--CA 1.45 -0.406 0 CA-C-N 115.49 -0.777 . . . . 0.0 113.208 179.076 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -109.52 129.02 55.59 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-O 120.634 0.254 . . . . 0.0 110.691 177.062 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 98' ' ' ILE . . . . . 0.623 ' HA ' ' HA ' ' A' ' 112' ' ' VAL . 4.1 mt -89.01 133.07 32.18 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.561 0 N-CA-C 108.68 -0.859 . . . . 0.0 108.68 177.02 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 99' ' ' MET . . . . . . . . . . . . . 10.3 mtm -136.64 157.59 46.42 Favored 'General case' 0 N--CA 1.444 -0.764 0 N-CA-C 106.648 -1.612 . . . . 0.0 106.648 177.194 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 100' ' ' LEU . . . . . 0.462 HD13 ' HG2' ' A' ' 108' ' ' GLU . 1.3 mm? -71.56 103.36 2.97 Favored 'General case' 0 C--N 1.313 -1.01 0 CA-C-O 122.438 1.113 . . . . 0.0 110.772 174.457 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 101' ' ' PHE . . . . . . . . . . . . . 2.7 m-85 -90.19 170.1 10.58 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-N 113.215 -1.811 . . . . 0.0 112.455 -174.144 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 1.6 m -126.37 140.52 52.44 Favored 'General case' 0 C--N 1.317 -0.829 0 CA-C-N 114.234 -1.348 . . . . 0.0 109.781 178.432 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -96.23 163.91 12.89 Favored 'General case' 0 C--N 1.321 -0.657 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.491 -179.598 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 104' ' ' MET . . . . . 0.433 ' SD ' ' HZ ' ' A' ' 82' ' ' PHE . 4.3 mpp? -66.73 -19.57 65.78 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 115.813 -0.63 . . . . 0.0 110.969 -179.272 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 6.2 p-10 -93.94 16.26 14.81 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.926 0.393 . . . . 0.0 111.458 -179.25 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 85.23 -11.15 61.45 Favored Glycine 0 N--CA 1.451 -0.364 0 C-N-CA 121.148 -0.548 . . . . 0.0 113.254 174.484 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 68.2 m -78.36 149.42 33.4 Favored 'General case' 0 C--N 1.316 -0.87 0 CA-C-O 121.18 0.514 . . . . 0.0 110.974 -179.652 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 108' ' ' GLU . . . . . 0.462 ' HG2' HD13 ' A' ' 100' ' ' LEU . 40.1 tt0 -91.21 146.57 23.72 Favored 'General case' 0 C--N 1.312 -1.043 0 CA-C-N 115.519 -0.764 . . . . 0.0 108.979 175.929 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 109' ' ' MET . . . . . . . . . . . . . 88.9 mmm -138.41 151.17 68.74 Favored Pre-proline 0 C--O 1.231 0.12 0 N-CA-C 106.016 -1.846 . . . . 0.0 106.016 -164.073 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 4.9 Cg_endo -81.63 113.24 2.53 Favored 'Trans proline' 0 N--CA 1.446 -1.285 0 CA-C-N 121.428 1.546 . . . . 0.0 109.671 162.962 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 111' ' ' GLY . . . . . 0.434 ' HA2' ' O ' ' A' ' 124' ' ' ASP . . . -121.39 126.21 6.45 Favored Glycine 0 N--CA 1.436 -1.354 0 C-N-CA 120.251 -0.975 . . . . 0.0 112.299 179.2 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 112' ' ' VAL . . . . . 0.623 ' HA ' ' HA ' ' A' ' 98' ' ' ILE . 0.2 OUTLIER -105.1 140.18 23.88 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.142 0 N-CA-C 108.587 -0.894 . . . . 0.0 108.587 174.023 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 113' ' ' ILE . . . . . 0.486 HD11 ' CB ' ' A' ' 93' ' ' PRO . 10.3 mt -89.2 108.61 19.3 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.374 0 N-CA-C 107.826 -1.175 . . . . 0.0 107.826 -174.194 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 114' ' ' ARG . . . . . 0.469 ' O ' HG22 ' A' ' 95' ' ' ILE . 10.9 tpp180 -64.88 -47.53 77.53 Favored 'General case' 0 C--N 1.317 -0.839 0 CA-C-N 115.284 -0.871 . . . . 0.0 111.513 -171.179 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 115' ' ' GLU . . . . . 0.458 ' N ' ' HB ' ' A' ' 122' ' ' THR . 8.6 tt0 -161.63 162.48 30.01 Favored 'General case' 0 C--N 1.317 -0.833 0 N-CA-C 109.445 -0.576 . . . . 0.0 109.445 -175.28 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 116' ' ' ILE . . . . . 0.56 HG12 ' CG1' ' A' ' 95' ' ' ILE . 28.7 mm -111.82 112.53 40.93 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.427 0 CA-C-O 121.174 0.511 . . . . 0.0 110.129 177.356 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 117' ' ' ASN . . . . . 0.462 HD21 ' N ' ' A' ' 117' ' ' ASN . 0.9 OUTLIER -96.31 158.93 15.21 Favored 'General case' 0 C--N 1.315 -0.896 0 CA-C-N 115.557 -0.747 . . . . 0.0 110.056 179.06 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . -57.18 -45.75 92.29 Favored Glycine 0 N--CA 1.452 -0.294 0 C-N-CA 120.612 -0.804 . . . . 0.0 113.304 -172.476 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 119' ' ' ASP . . . . . 0.421 ' O ' ' HG2' ' A' ' 84' ' ' ARG . 10.3 m-20 -113.39 -15.8 12.57 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-O 120.784 0.326 . . . . 0.0 111.53 178.397 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 120' ' ' SER . . . . . 0.453 ' O ' ' HB2' ' A' ' 117' ' ' ASN . 16.0 t -116.86 157.74 25.13 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-O 120.814 0.34 . . . . 0.0 111.09 -172.312 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 121' ' ' ILE . . . . . 0.583 ' CG1' ' HA ' ' A' ' 84' ' ' ARG . 38.8 mm -112.21 128.18 68.98 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.576 0 CA-C-O 121.746 0.784 . . . . 0.0 110.837 174.491 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 122' ' ' THR . . . . . 0.458 ' HB ' ' N ' ' A' ' 115' ' ' GLU . 0.6 OUTLIER -90.88 141.11 29.17 Favored 'General case' 0 C--N 1.307 -1.278 0 CA-C-N 114.338 -1.301 . . . . 0.0 109.382 178.236 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 123' ' ' VAL . . . . . 0.451 ' O ' HG23 ' A' ' 79' ' ' ILE . 43.8 t -138.39 158.93 31.91 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.41 0 N-CA-C 109.055 -0.72 . . . . 0.0 109.055 -156.522 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 124' ' ' ASP . . . . . 0.555 ' HB3' HG13 ' A' ' 112' ' ' VAL . 46.1 t0 -148.83 148.74 30.26 Favored 'General case' 0 C--N 1.305 -1.357 0 CA-C-N 116.058 -0.519 . . . . 0.0 110.256 174.781 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 125' ' ' PHE . . . . . 0.52 ' HB2' ' HG ' ' A' ' 78' ' ' LEU . 84.4 m-85 -135.97 3.71 2.95 Favored 'General case' 0 C--N 1.318 -0.804 0 CA-C-N 115.246 -0.888 . . . . 0.0 109.707 176.041 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 29.4 m-80 -58.39 134.66 56.81 Favored 'General case' 0 N--CA 1.449 -0.495 0 CA-C-N 114.685 -1.143 . . . . 0.0 110.571 176.103 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 127' ' ' HIS . . . . . 0.624 ' HB3' ' HD2' ' A' ' 128' ' ' PRO . 41.6 m80 -80.81 -173.32 0.41 Allowed Pre-proline 0 C--N 1.318 -0.79 0 CA-C-N 113.89 -1.504 . . . . 0.0 111.822 -168.203 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 128' ' ' PRO . . . . . 0.624 ' HD2' ' HB3' ' A' ' 127' ' ' HIS . 5.8 Cg_exo -41.51 174.77 0.0 OUTLIER 'Trans proline' 0 C--N 1.357 0.99 0 C-N-CA 124.843 3.696 . . . . 0.0 114.287 166.519 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 129' ' ' LEU . . . . . . . . . . . . . 5.5 tp -48.85 41.43 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.528 0 C-N-CA 127.895 2.478 . . . . 0.0 115.848 -171.695 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 130' ' ' ALA . . . . . 0.527 ' N ' ' O ' ' A' ' 128' ' ' PRO . . . -85.99 173.56 9.83 Favored 'General case' 0 C--N 1.306 -1.286 0 C-N-CA 123.057 0.543 . . . . 0.0 110.065 -174.873 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . 74.79 34.23 53.72 Favored Glycine 0 N--CA 1.45 -0.403 0 C-N-CA 120.765 -0.731 . . . . 0.0 112.679 177.948 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 132' ' ' GLN . . . . . . . . . . . . . 5.7 pt20 -148.76 157.61 43.57 Favored 'General case' 0 C--N 1.326 -0.427 0 N-CA-C 109.488 -0.56 . . . . 0.0 109.488 172.793 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 133' ' ' THR . . . . . . . . . . . . . 14.5 m -71.06 112.36 7.15 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-O 120.904 0.383 . . . . 0.0 110.552 -175.696 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 134' ' ' VAL . . . . . . . . . . . . . 4.6 m -101.98 142.81 15.72 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.599 0 CA-C-O 121.236 0.541 . . . . 0.0 111.576 -176.483 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 135' ' ' HIS . . . . . . . . . . . . . 69.5 m-70 -124.87 113.24 17.61 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 115.328 -0.851 . . . . 0.0 109.076 -178.794 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 136' ' ' PHE . . . . . 0.529 ' HE1' ' CE2' ' A' ' 63' ' ' PHE . 0.1 OUTLIER -117.96 132.2 56.42 Favored 'General case' 0 C--N 1.316 -0.862 0 CA-C-O 121.103 0.478 . . . . 0.0 111.295 -175.787 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 137' ' ' ASP . . . . . . . . . . . . . 14.4 t70 -99.23 102.61 14.31 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-N 115.18 -0.918 . . . . 0.0 108.56 177.427 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 138' ' ' ILE . . . . . 0.516 HG21 ' CG2' ' A' ' 13' ' ' VAL . 40.6 mt -103.27 132.78 48.81 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.644 0 N-CA-C 112.716 0.635 . . . . 0.0 112.716 -166.912 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 24.0 mt-10 -125.7 114.46 18.68 Favored 'General case' 0 N--CA 1.45 -0.439 0 CA-C-N 115.24 -0.891 . . . . 0.0 109.131 178.781 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 140' ' ' VAL . . . . . 0.43 ' CG1' ' HA ' ' A' ' 57' ' ' VAL . 65.2 t -70.55 122.16 21.8 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.417 0 CA-C-N 117.824 0.284 . . . . 0.0 110.86 -179.498 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 141' ' ' LEU . . . . . 0.486 HD12 ' CB ' ' A' ' 14' ' ' HIS . 13.8 mt -100.76 -33.12 10.38 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-O 121.672 0.748 . . . . 0.0 110.426 178.739 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 142' ' ' GLU . . . . . 0.427 ' HB3' ' HB2' ' A' ' 12' ' ' LEU . 32.8 tt0 -163.88 151.59 12.64 Favored 'General case' 0 C--N 1.314 -0.971 0 CA-C-N 114.405 -1.27 . . . . 0.0 109.858 -178.334 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 143' ' ' ILE . . . . . . . . . . . . . 85.3 mt -122.1 113.82 40.28 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.397 0 CA-C-O 120.961 0.41 . . . . 0.0 110.932 -178.473 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 144' ' ' ASP . . . . . . . . . . . . . 37.4 t70 -79.15 126.17 82.19 Favored Pre-proline 0 C--N 1.323 -0.55 0 CA-C-N 115.807 -0.633 . . . . 0.0 110.291 177.998 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 145' ' ' PRO . . . . . . . . . . . . . 41.5 Cg_endo -66.2 169.9 12.9 Favored 'Trans proline' 0 C--O 1.234 0.311 0 C-N-CA 123.016 2.477 . . . . 0.0 113.294 -175.864 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 146' ' ' ALA . . . . . . . . . . . . . . . -82.21 102.04 10.86 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-O 121.444 0.64 . . . . 0.0 109.551 177.814 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -149.3 68.0 1.03 Allowed 'General case' 0 C--N 1.317 -0.836 0 N-CA-C 106.932 -1.507 . . . . 0.0 106.932 -175.324 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 39.2 mm-40 . . . . . 0 C--N 1.314 -0.937 0 CA-C-N 114.402 -1.272 . . . . 0.0 111.738 -172.246 . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 27.1 ttt . . . . . 0 N--CA 1.481 1.078 0 CA-C-O 120.245 0.069 . . . . 0.0 110.903 . . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 18.9 p 49.59 70.01 0.53 Allowed 'General case' 0 N--CA 1.469 0.51 0 C-N-CA 123.284 0.633 . . . . 0.0 112.464 177.014 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 47.7 mt-10 -75.79 -33.24 60.13 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-O 121.215 0.531 . . . . 0.0 110.734 176.311 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 12.6 p -114.37 149.12 36.61 Favored 'General case' 0 C--N 1.319 -0.749 0 CA-C-N 115.558 -0.746 . . . . 0.0 110.647 -177.894 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . 0.483 HG13 ' O ' ' A' ' 55' ' ' LEU . 7.4 p -73.68 144.83 12.2 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.395 0 CA-C-N 115.61 -0.723 . . . . 0.0 110.598 -178.281 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 6' ' ' GLN . . . . . . . . . . . . . 3.4 pt20 -136.99 166.31 23.96 Favored 'General case' 0 N--CA 1.444 -0.727 0 N-CA-C 108.488 -0.93 . . . . 0.0 108.488 -179.592 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 34.2 p -63.93 138.68 58.58 Favored 'General case' 0 C--N 1.317 -0.812 0 CA-C-O 120.735 0.303 . . . . 0.0 110.94 -176.531 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 15.5 t30 70.92 15.59 6.72 Favored 'General case' 0 CA--C 1.542 0.641 0 CA-C-N 115.491 -0.777 . . . . 0.0 111.643 177.928 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 9' ' ' SER . . . . . 0.627 ' O ' HD22 ' A' ' 39' ' ' LEU . 8.8 t -108.15 134.36 51.11 Favored 'General case' 0 N--CA 1.451 -0.411 0 N-CA-C 108.079 -1.082 . . . . 0.0 108.079 177.276 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -82.19 149.07 28.11 Favored 'General case' 0 C--N 1.322 -0.599 0 N-CA-C 109.69 -0.485 . . . . 0.0 109.69 -174.02 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 6.3 m -134.33 145.05 33.51 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.755 0 C-N-CA 120.281 -0.568 . . . . 0.0 111.35 -175.869 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 12' ' ' LEU . . . . . 0.42 HD22 ' HB2' ' A' ' 142' ' ' GLU . 6.6 mp -91.74 119.36 31.51 Favored 'General case' 0 C--N 1.326 -0.456 0 N-CA-C 108.809 -0.811 . . . . 0.0 108.809 177.909 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 13' ' ' VAL . . . . . 0.45 HG23 ' N ' ' A' ' 14' ' ' HIS . 2.4 p -132.37 154.48 40.07 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.68 0 CA-C-O 122.146 0.974 . . . . 0.0 113.219 -172.12 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 14' ' ' HIS . . . . . 0.45 ' N ' HG23 ' A' ' 13' ' ' VAL . 0.2 OUTLIER -117.2 117.7 30.28 Favored 'General case' 0 C--N 1.32 -0.704 0 N-CA-C 106.225 -1.769 . . . . 0.0 106.225 170.936 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 32.1 p90 -148.27 157.35 43.44 Favored 'General case' 0 C--N 1.327 -0.396 0 C-N-CA 118.671 -1.212 . . . . 0.0 113.785 -167.523 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 85.9 m -128.88 118.77 23.25 Favored 'General case' 0 C--N 1.321 -0.653 0 CA-C-N 115.006 -0.997 . . . . 0.0 109.813 174.617 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 17' ' ' LEU . . . . . 0.502 HD21 ' CE2' ' A' ' 136' ' ' PHE . 1.4 mt -95.17 112.91 24.56 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-O 121.034 0.445 . . . . 0.0 111.163 179.045 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 10.2 mptt -109.05 128.01 54.61 Favored 'General case' 0 C--N 1.314 -0.945 0 CA-C-N 115.735 -0.666 . . . . 0.0 110.826 -179.251 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 19.8 tp -85.42 161.53 19.39 Favored 'General case' 0 N--CA 1.438 -1.069 0 CA-C-N 115.677 -0.692 . . . . 0.0 109.199 175.775 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 29.2 t70 -62.77 -24.69 67.85 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 121.431 0.634 . . . . 0.0 110.25 178.603 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 27.1 t70 -70.25 -3.66 18.12 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 115.162 -0.927 . . . . 0.0 111.385 177.646 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 74.81 9.08 82.99 Favored Glycine 0 C--N 1.332 0.333 0 C-N-CA 121.508 -0.377 . . . . 0.0 112.425 -175.593 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 52.7 m -91.45 140.28 29.9 Favored 'General case' 0 C--N 1.319 -0.745 0 CA-C-N 115.309 -0.446 . . . . 0.0 110.06 175.779 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 41.7 m -79.68 108.24 13.08 Favored 'General case' 0 C--N 1.318 -0.784 0 N-CA-C 110.05 -0.352 . . . . 0.0 110.05 177.197 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -69.86 -34.77 74.05 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.88 -0.6 . . . . 0.0 110.527 -177.969 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 44.2 tt0 -159.83 128.35 4.96 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 115.857 -0.611 . . . . 0.0 109.697 177.356 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 18.4 p -109.58 130.48 55.51 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-N 116.534 -0.303 . . . . 0.0 110.835 -178.289 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 28' ' ' THR . . . . . 0.684 ' O ' HG23 ' A' ' 28' ' ' THR . 62.2 m -148.59 14.48 0.96 Allowed 'General case' 0 CA--C 1.546 0.798 0 CA-C-O 122.831 1.301 . . . . 0.0 110.854 174.75 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 16.0 tpt180 -92.94 -68.99 0.77 Allowed 'General case' 0 C--N 1.307 -1.257 0 O-C-N 121.19 -0.944 . . . . 0.0 111.018 168.523 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 7.8 p30 -69.47 -10.61 58.77 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.407 -0.36 . . . . 0.0 111.452 -172.754 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 2.2 m-20 -58.37 -31.08 67.3 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.981 177.631 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 91.09 -13.39 66.37 Favored Glycine 0 N--CA 1.447 -0.593 0 C-N-CA 120.621 -0.8 . . . . 0.0 111.404 -175.813 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 75.4 mmtt -120.23 124.47 27.74 Favored Pre-proline 0 C--N 1.324 -0.533 0 N-CA-C 109.587 -0.524 . . . . 0.0 109.587 179.871 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 71.6 Cg_endo -76.53 168.85 22.98 Favored 'Trans proline' 0 N--CA 1.457 -0.659 0 C-N-CA 122.38 2.053 . . . . 0.0 111.889 176.438 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -131.75 149.86 52.34 Favored 'General case' 0 C--N 1.319 -0.719 0 CA-C-N 116.391 -0.368 . . . . 0.0 110.43 -177.234 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 4.9 tp -88.71 137.32 32.42 Favored 'General case' 0 C--N 1.318 -0.801 0 N-CA-C 109.769 -0.456 . . . . 0.0 109.769 174.711 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 37' ' ' PHE . . . . . . . . . . . . . 6.4 m-30 -98.37 119.89 37.84 Favored 'General case' 0 C--N 1.316 -0.862 0 N-CA-C 108.548 -0.908 . . . . 0.0 108.548 172.5 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 24.6 tpt180 -90.33 104.88 17.41 Favored 'General case' 0 N--CA 1.442 -0.832 0 N-CA-C 108.955 -0.757 . . . . 0.0 108.955 177.92 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 39' ' ' LEU . . . . . 0.627 HD22 ' O ' ' A' ' 9' ' ' SER . 2.2 mm? -89.97 156.26 18.54 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-N 115.455 -0.793 . . . . 0.0 111.137 -178.767 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 101.09 29.48 6.4 Favored Glycine 0 N--CA 1.445 -0.713 0 C-N-CA 120.723 -0.751 . . . . 0.0 112.103 -175.19 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 38.8 t70 68.87 3.42 3.97 Favored 'General case' 0 N--CA 1.472 0.627 0 CA-C-O 121.34 0.59 . . . . 0.0 111.823 175.357 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -74.53 -7.52 53.35 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-N 116.055 -0.52 . . . . 0.0 112.113 -179.305 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 32.7 t -163.68 -60.64 0.04 OUTLIER 'General case' 0 C--N 1.323 -0.556 0 N-CA-C 109.476 -0.564 . . . . 0.0 109.476 176.056 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 7.8 mp -90.01 161.46 15.85 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-N 115.87 -0.604 . . . . 0.0 110.502 178.096 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 46.9 t -77.99 145.87 35.75 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-N 115.438 -0.801 . . . . 0.0 109.752 178.273 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 46' ' ' GLU . . . . . 0.608 ' O ' ' HG2' ' A' ' 50' ' ' GLN . 12.1 tt0 -58.68 -16.69 17.44 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 115.078 -0.964 . . . . 0.0 112.004 -176.987 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -69.29 -32.06 71.99 Favored Glycine 0 N--CA 1.446 -0.634 0 C-N-CA 120.69 -0.766 . . . . 0.0 111.942 -177.812 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 1.6 tt -69.07 -53.0 22.64 Favored 'General case' 0 N--CA 1.45 -0.445 0 CA-C-O 120.672 0.272 . . . . 0.0 110.834 -178.298 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 49' ' ' GLU . . . . . 0.604 ' O ' HD21 ' A' ' 53' ' ' LEU . 14.2 pt-20 -58.04 -32.32 67.87 Favored 'General case' 0 N--CA 1.453 -0.305 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.61 179.497 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 50' ' ' GLN . . . . . 0.608 ' HG2' ' O ' ' A' ' 46' ' ' GLU . 69.9 mm-40 -57.32 -26.75 61.42 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 120.775 0.321 . . . . 0.0 110.904 -177.841 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 51' ' ' HIS . . . . . . . . . . . . . 12.1 m-70 -99.76 -14.02 19.03 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 116.397 -0.365 . . . . 0.0 111.03 -179.222 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 25.6 mt -95.76 -30.76 13.54 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 116.406 -0.361 . . . . 0.0 111.914 -177.401 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 53' ' ' LEU . . . . . 0.604 HD21 ' O ' ' A' ' 49' ' ' GLU . 0.0 OUTLIER -57.59 143.59 40.56 Favored 'General case' 0 C--O 1.234 0.26 0 CA-C-O 120.874 0.369 . . . . 0.0 111.246 -176.862 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 93.56 -2.7 70.75 Favored Glycine 0 N--CA 1.443 -0.845 0 C-N-CA 120.879 -0.677 . . . . 0.0 113.452 177.972 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 55' ' ' LEU . . . . . 0.483 ' O ' HG13 ' A' ' 5' ' ' VAL . 24.8 tp -94.41 164.22 13.1 Favored 'General case' 0 N--CA 1.453 -0.311 0 CA-C-N 118.052 0.926 . . . . 0.0 109.159 178.549 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 56' ' ' LYS . . . . . 0.667 ' HD2' ' N ' ' A' ' 57' ' ' VAL . 0.9 OUTLIER -117.15 157.79 25.34 Favored 'General case' 0 C--N 1.32 -0.708 0 N-CA-C 109.89 -0.411 . . . . 0.0 109.89 -174.803 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 57' ' ' VAL . . . . . 0.667 ' N ' ' HD2' ' A' ' 56' ' ' LYS . 8.8 t -57.61 141.74 14.23 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.243 0 CA-C-O 121.078 0.465 . . . . 0.0 111.357 177.954 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 82.87 10.12 83.5 Favored Glycine 0 N--CA 1.447 -0.576 0 CA-C-N 115.734 -0.666 . . . . 0.0 112.338 -178.859 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 8.5 m-20 -116.41 152.76 33.33 Favored 'General case' 0 C--N 1.324 -0.53 0 N-CA-C 109.543 -0.54 . . . . 0.0 109.543 174.291 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 60' ' ' LYS . . . . . 0.493 ' HE3' ' HG2' ' A' ' 139' ' ' GLU . 0.6 OUTLIER -131.73 149.38 52.5 Favored 'General case' 0 C--N 1.316 -0.877 0 CA-C-O 121.519 0.676 . . . . 0.0 111.76 -175.364 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 9.3 t -143.53 130.86 20.91 Favored 'General case' 0 C--N 1.314 -0.961 0 CA-C-N 114.714 -1.13 . . . . 0.0 110.884 -178.36 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 4.1 m -107.1 131.53 54.01 Favored 'General case' 0 N--CA 1.44 -0.944 0 N-CA-C 107.866 -1.161 . . . . 0.0 107.866 171.134 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 63' ' ' PHE . . . . . 0.43 ' HE1' ' CG1' ' A' ' 138' ' ' ILE . 1.5 p90 -158.24 153.46 25.65 Favored 'General case' 0 C--N 1.321 -0.631 0 CA-C-O 121.021 0.439 . . . . 0.0 110.937 -171.195 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 16.4 m -104.85 148.96 26.09 Favored 'General case' 0 C--N 1.319 -0.748 0 CA-C-N 115.727 -0.669 . . . . 0.0 110.644 -179.713 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 65' ' ' LEU . . . . . 0.451 ' O ' HG22 ' A' ' 133' ' ' THR . 82.8 mt -138.82 142.39 38.68 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.557 -0.292 . . . . 0.0 110.722 -176.039 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 66' ' ' GLU . . . . . 0.425 ' H ' ' CD ' ' A' ' 66' ' ' GLU . 1.6 mp0 -64.76 154.11 86.23 Favored Pre-proline 0 C--N 1.329 -0.311 0 CA-C-N 115.921 -0.581 . . . . 0.0 109.741 174.299 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 67' ' ' PRO . . . . . 0.513 ' HB3' ' N ' ' A' ' 132' ' ' GLN . 10.8 Cg_endo -56.65 -48.55 18.26 Favored 'Trans proline' 0 C--O 1.219 -0.431 0 C-N-CA 121.869 1.712 . . . . 0.0 113.563 -176.355 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 23.5 t70 -64.01 -21.99 66.74 Favored 'General case' 0 C--N 1.324 -0.511 0 O-C-N 121.515 -0.741 . . . . 0.0 110.072 178.534 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -86.35 -28.76 23.46 Favored 'General case' 0 N--CA 1.451 -0.406 0 CA-C-N 115.982 -0.554 . . . . 0.0 111.216 179.09 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 70' ' ' ALA . . . . . 0.518 ' O ' ' HB2' ' A' ' 71' ' ' PHE . . . -136.85 127.56 27.16 Favored 'General case' 0 N--CA 1.454 -0.262 0 N-CA-C 109.776 -0.453 . . . . 0.0 109.776 176.578 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 71' ' ' PHE . . . . . 0.518 ' HB2' ' O ' ' A' ' 70' ' ' ALA . 2.2 m-30 84.11 -44.29 0.09 Allowed 'General case' 0 N--CA 1.473 0.677 0 O-C-N 124.016 0.822 . . . . 0.0 109.102 -172.755 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 102.54 -114.23 4.84 Favored Glycine 0 N--CA 1.443 -0.863 0 CA-C-O 121.998 0.777 . . . . 0.0 114.792 166.427 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -150.92 163.96 21.94 Favored Pre-proline 0 C--N 1.31 -1.113 0 CA-C-N 113.772 -1.214 . . . . 0.0 110.562 -165.489 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 74' ' ' PRO . . . . . 0.537 ' HA ' ' HB3' ' A' ' 126' ' ' ASN . 60.7 Cg_exo -43.49 132.97 7.19 Favored 'Trans proline' 0 C--N 1.347 0.462 0 C-N-CA 123.659 2.906 . . . . 0.0 114.3 -178.749 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 75' ' ' SER . . . . . 0.572 ' HB3' ' OD1' ' A' ' 77' ' ' ASP . 30.8 m -137.06 123.42 13.5 Favored Pre-proline 0 C--N 1.329 -0.312 0 CA-C-N 115.325 -0.852 . . . . 0.0 110.993 179.892 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 76' ' ' PRO . . . . . 0.401 ' HA ' HG13 ' A' ' 79' ' ' ILE . 53.1 Cg_endo -70.16 -17.28 35.87 Favored 'Trans proline' 0 CA--C 1.529 0.274 0 C-N-CA 123.199 2.599 . . . . 0.0 113.571 -178.118 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 77' ' ' ASP . . . . . 0.572 ' OD1' ' HB3' ' A' ' 75' ' ' SER . 5.2 p-10 -69.27 -4.75 19.2 Favored 'General case' 0 C--N 1.329 -0.325 0 N-CA-C 112.829 0.678 . . . . 0.0 112.829 -173.331 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 78' ' ' LEU . . . . . 0.625 ' HB2' ' O ' ' A' ' 125' ' ' PHE . 83.1 mt -112.57 -5.1 14.03 Favored 'General case' 0 C--N 1.324 -0.523 0 C-N-CA 120.742 -0.383 . . . . 0.0 110.963 176.399 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 79' ' ' ILE . . . . . 0.401 HG13 ' HA ' ' A' ' 76' ' ' PRO . 15.2 mt -77.39 104.81 5.64 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.736 0 C-N-CA 120.345 -0.542 . . . . 0.0 109.705 -173.695 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 73.0 mt-30 -108.95 164.06 12.75 Favored 'General case' 0 C--N 1.314 -0.937 0 CA-C-N 115.671 -0.695 . . . . 0.0 111.824 -172.806 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 81' ' ' TYR . . . . . . . . . . . . . 11.3 m-85 -129.48 115.67 17.82 Favored 'General case' 0 N--CA 1.444 -0.766 0 N-CA-C 107.514 -1.291 . . . . 0.0 107.514 -172.78 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 73.4 m-85 -111.24 168.29 9.63 Favored 'General case' 0 C--N 1.317 -0.844 0 CA-C-O 120.763 0.316 . . . . 0.0 110.863 -174.661 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 12.2 t -73.86 145.24 45.02 Favored 'General case' 0 C--N 1.323 -0.577 0 N-CA-C 108.849 -0.797 . . . . 0.0 108.849 176.692 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 84' ' ' ARG . . . . . 0.6 ' HD3' ' HA ' ' A' ' 119' ' ' ASP . 28.9 ptt180 -73.64 -29.72 62.51 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-O 121.576 0.703 . . . . 0.0 109.609 -173.895 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 85' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -64.7 -38.94 92.7 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 114.597 -1.183 . . . . 0.0 113.391 -171.015 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 86' ' ' GLU . . . . . 0.444 ' O ' ' HB3' ' A' ' 89' ' ' ASP . 44.1 mm-40 -60.65 -48.88 79.82 Favored 'General case' 0 C--N 1.317 -0.836 0 CA-C-O 122.269 1.033 . . . . 0.0 108.687 174.259 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 87' ' ' PHE . . . . . . . . . . . . . 55.6 m-85 -59.0 -31.85 69.18 Favored 'General case' 0 C--N 1.318 -0.783 0 CA-C-N 113.701 -1.591 . . . . 0.0 112.91 175.264 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 88' ' ' MET . . . . . . . . . . . . . 60.3 ttp -68.18 -41.45 81.43 Favored 'General case' 0 C--N 1.315 -0.898 0 CA-C-O 122.13 0.967 . . . . 0.0 109.521 174.025 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 89' ' ' ASP . . . . . 0.444 ' HB3' ' O ' ' A' ' 86' ' ' GLU . 19.3 t70 -55.17 -23.07 19.82 Favored 'General case' 0 C--N 1.321 -0.673 0 CA-C-N 113.387 -1.733 . . . . 0.0 110.164 176.029 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -112.86 8.63 18.75 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 115.646 -0.706 . . . . 0.0 111.799 178.938 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 92.08 137.61 7.85 Favored Glycine 0 C--N 1.331 0.265 0 C-N-CA 120.482 -0.866 . . . . 0.0 111.989 -177.453 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 8.8 tt0 -61.91 122.07 69.47 Favored Pre-proline 0 N--CA 1.442 -0.848 0 CA-C-O 121.116 0.484 . . . . 0.0 111.306 -172.271 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 93' ' ' PRO . . . . . 0.437 ' HB2' HD11 ' A' ' 113' ' ' ILE . 38.1 Cg_endo -77.75 165.96 26.03 Favored 'Trans proline' 0 N--CA 1.46 -0.497 0 C-N-CA 122.935 2.423 . . . . 0.0 112.875 -177.525 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 94' ' ' GLU . . . . . 0.509 ' O ' HD12 ' A' ' 113' ' ' ILE . 27.0 mt-10 -115.94 154.13 30.35 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.018 -0.537 . . . . 0.0 111.131 -176.135 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 95' ' ' ILE . . . . . 0.519 ' CG1' HG12 ' A' ' 116' ' ' ILE . 32.6 mt -77.17 134.16 29.24 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.384 0 CA-C-N 116.446 -0.343 . . . . 0.0 110.099 179.168 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 72.26 19.47 78.7 Favored Glycine 0 N--CA 1.449 -0.481 0 C-N-CA 121.032 -0.604 . . . . 0.0 112.407 -176.997 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 97' ' ' ALA . . . . . 0.452 ' O ' HG13 ' A' ' 113' ' ' ILE . . . -99.71 166.86 10.91 Favored 'General case' 0 C--N 1.323 -0.562 0 N-CA-C 109.562 -0.533 . . . . 0.0 109.562 175.27 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 38.8 mt -125.79 126.11 69.49 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.727 0 CA-C-O 120.876 0.37 . . . . 0.0 110.533 -175.598 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 99' ' ' MET . . . . . 0.439 ' SD ' HD13 ' A' ' 113' ' ' ILE . 2.7 mtp -124.72 161.58 26.06 Favored 'General case' 0 C--N 1.324 -0.527 0 N-CA-C 107.898 -1.149 . . . . 0.0 107.898 -179.922 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 3.9 mm? -77.24 153.62 33.82 Favored 'General case' 0 C--N 1.323 -0.587 0 CA-C-N 118.806 0.73 . . . . 0.0 111.078 167.635 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 101' ' ' PHE . . . . . 0.585 ' CE2' HG11 ' A' ' 123' ' ' VAL . 65.5 m-85 -149.42 155.52 40.57 Favored 'General case' 0 C--N 1.319 -0.761 0 CA-C-N 114.702 -1.136 . . . . 0.0 107.986 -170.334 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 3.1 m -121.11 111.44 17.45 Favored 'General case' 0 C--N 1.314 -0.958 0 C-N-CA 119.793 -0.763 . . . . 0.0 110.154 -178.348 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -77.78 166.25 23.18 Favored 'General case' 0 N--CA 1.448 -0.56 0 CA-C-N 115.4 -0.818 . . . . 0.0 110.868 -177.183 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 104' ' ' MET . . . . . . . . . . . . . 60.1 mtt -67.37 -14.32 62.81 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.128 -0.942 . . . . 0.0 111.901 -173.669 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 8.2 p-10 -96.51 11.38 35.27 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 116.551 -0.295 . . . . 0.0 111.383 -177.784 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 88.06 -11.33 67.52 Favored Glycine 0 N--CA 1.447 -0.602 0 C-N-CA 120.42 -0.895 . . . . 0.0 113.289 179.448 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 33.3 t -79.36 149.74 31.61 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-O 121.227 0.537 . . . . 0.0 110.692 -179.327 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 108' ' ' GLU . . . . . 0.422 ' HA ' ' O ' ' A' ' 101' ' ' PHE . 44.5 tt0 -120.51 104.11 9.71 Favored 'General case' 0 C--N 1.317 -0.845 0 CA-C-N 115.615 -0.72 . . . . 0.0 109.381 179.801 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 109' ' ' MET . . . . . 0.449 ' SD ' ' HD2' ' A' ' 125' ' ' PHE . 13.7 ptp -111.44 145.14 31.97 Favored Pre-proline 0 C--N 1.322 -0.614 0 CA-C-N 116.535 -0.302 . . . . 0.0 110.621 -175.579 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 12.2 Cg_exo -70.1 120.6 7.31 Favored 'Trans proline' 0 N--CA 1.462 -0.368 0 C-N-CA 122.475 2.117 . . . . 0.0 110.663 171.5 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . -117.41 153.88 17.01 Favored Glycine 0 C--N 1.321 -0.29 0 C-N-CA 120.752 -0.737 . . . . 0.0 112.447 -176.562 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER -100.77 121.29 51.39 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.426 0 CA-C-O 121.064 0.459 . . . . 0.0 110.249 -176.392 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 113' ' ' ILE . . . . . 0.509 HD12 ' O ' ' A' ' 94' ' ' GLU . 1.0 OUTLIER -67.05 111.22 1.85 Allowed 'Isoleucine or valine' 0 C--N 1.316 -0.85 0 CA-C-N 115.762 -0.654 . . . . 0.0 109.386 176.709 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 114' ' ' ARG . . . . . . . . . . . . . 13.2 tpp180 -63.29 -52.36 62.31 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 115.349 -0.841 . . . . 0.0 110.744 -178.085 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 5.2 tt0 -159.48 148.45 18.03 Favored 'General case' 0 C--N 1.32 -0.699 0 N-CA-C 110.11 -0.33 . . . . 0.0 110.11 -177.79 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 116' ' ' ILE . . . . . 0.519 HG12 ' CG1' ' A' ' 95' ' ' ILE . 45.9 mm -96.12 111.2 25.88 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.533 0 N-CA-C 108.879 -0.786 . . . . 0.0 108.879 176.197 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 117' ' ' ASN . . . . . . . . . . . . . 37.6 m-80 -101.47 155.8 17.85 Favored 'General case' 0 C--N 1.313 -1.012 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.057 -179.111 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . -57.22 -38.84 88.48 Favored Glycine 0 N--CA 1.448 -0.52 0 C-N-CA 120.453 -0.88 . . . . 0.0 112.925 -170.842 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 119' ' ' ASP . . . . . 0.6 ' HA ' ' HD3' ' A' ' 84' ' ' ARG . 4.7 p-10 -109.75 -12.55 14.61 Favored 'General case' 0 C--N 1.324 -0.516 0 N-CA-C 111.977 0.362 . . . . 0.0 111.977 -174.66 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 20.3 t -146.12 155.99 43.13 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 121.065 0.459 . . . . 0.0 111.899 -168.603 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 121' ' ' ILE . . . . . 0.416 HD13 ' HG2' ' A' ' 93' ' ' PRO . 35.1 mm -119.43 120.25 63.04 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 115.896 -0.593 . . . . 0.0 110.178 178.705 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 89.8 m -106.14 119.48 39.34 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 116.568 -0.287 . . . . 0.0 111.052 -177.504 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 123' ' ' VAL . . . . . 0.585 HG11 ' CE2' ' A' ' 101' ' ' PHE . 38.8 t -117.69 118.26 57.8 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.316 0 CA-C-O 119.482 -0.295 . . . . 0.0 110.539 179.049 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 9.4 p-10 -95.32 96.34 9.08 Favored 'General case' 0 N--CA 1.452 -0.345 0 N-CA-C 114.131 1.159 . . . . 0.0 114.131 -179.906 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 125' ' ' PHE . . . . . 0.625 ' O ' ' HB2' ' A' ' 78' ' ' LEU . 12.0 m-85 -68.78 98.0 0.87 Allowed 'General case' 0 N--CA 1.447 -0.616 0 N-CA-C 109.303 -0.629 . . . . 0.0 109.303 165.912 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 126' ' ' ASN . . . . . 0.537 ' HB3' ' HA ' ' A' ' 74' ' ' PRO . 1.2 m-80 -79.3 88.2 4.96 Favored 'General case' 0 C--N 1.3 -1.585 0 CA-C-O 121.092 0.473 . . . . 0.0 110.934 177.237 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 127' ' ' HIS . . . . . 0.435 ' CD2' ' HD2' ' A' ' 128' ' ' PRO . 0.3 OUTLIER 60.76 -171.73 0.02 OUTLIER Pre-proline 0 C--O 1.236 0.386 0 CA-C-N 114.865 -1.061 . . . . 0.0 109.854 -173.077 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 128' ' ' PRO . . . . . 0.486 ' C ' ' H ' ' A' ' 130' ' ' ALA . 72.2 Cg_exo -46.5 177.72 0.01 OUTLIER 'Trans proline' 0 CA--C 1.533 0.454 0 C-N-CA 123.174 2.583 . . . . 0.0 110.816 156.048 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 129' ' ' LEU . . . . . 0.615 ' O ' ' HG2' ' A' ' 132' ' ' GLN . 3.9 mm? -51.42 37.23 0.0 OUTLIER 'General case' 0 N--CA 1.488 1.473 0 N-CA-C 114.998 1.481 . . . . 0.0 114.998 -178.794 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 130' ' ' ALA . . . . . 0.486 ' H ' ' C ' ' A' ' 128' ' ' PRO . . . -54.0 179.97 0.02 OUTLIER 'General case' 0 C--O 1.237 0.436 0 C-N-CA 124.254 1.022 . . . . 0.0 111.49 174.544 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . 67.19 3.52 24.58 Favored Glycine 0 CA--C 1.527 0.785 0 C-N-CA 120.494 -0.86 . . . . 0.0 114.035 -172.894 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 132' ' ' GLN . . . . . 0.615 ' HG2' ' O ' ' A' ' 129' ' ' LEU . 6.3 pt20 -149.18 153.42 37.64 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 117.687 0.744 . . . . 0.0 110.201 176.02 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 133' ' ' THR . . . . . 0.451 HG22 ' O ' ' A' ' 65' ' ' LEU . 59.6 m -72.51 136.38 45.88 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 116.001 -0.545 . . . . 0.0 111.13 -178.735 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 134' ' ' VAL . . . . . . . . . . . . . 20.3 m -120.73 151.34 23.62 Favored 'Isoleucine or valine' 0 C--O 1.233 0.22 0 CA-C-O 121.526 0.679 . . . . 0.0 111.697 177.957 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 135' ' ' HIS . . . . . 0.46 ' O ' HD22 ' A' ' 17' ' ' LEU . 86.2 m-70 -90.58 134.94 34.02 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-N 114.728 -1.124 . . . . 0.0 110.375 174.225 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 136' ' ' PHE . . . . . 0.502 ' CE2' HD21 ' A' ' 17' ' ' LEU . 2.5 m-85 -120.94 125.68 48.04 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 116.252 -0.431 . . . . 0.0 111.113 -177.385 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 137' ' ' ASP . . . . . . . . . . . . . 36.0 t70 -113.11 109.52 18.93 Favored 'General case' 0 C--N 1.315 -0.911 0 N-CA-C 108.513 -0.921 . . . . 0.0 108.513 169.028 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 138' ' ' ILE . . . . . 0.43 ' CG1' ' HE1' ' A' ' 63' ' ' PHE . 43.1 mm -119.19 121.33 66.38 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.452 0 O-C-N 123.098 0.249 . . . . 0.0 111.262 -169.773 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 139' ' ' GLU . . . . . 0.493 ' HG2' ' HE3' ' A' ' 60' ' ' LYS . 33.3 mt-10 -107.73 115.55 30.35 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 120.59 0.233 . . . . 0.0 111.201 173.356 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 140' ' ' VAL . . . . . 0.4 ' CG1' ' HA ' ' A' ' 57' ' ' VAL . 38.8 t -71.12 107.47 2.31 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.568 0 CA-C-N 116.299 -0.409 . . . . 0.0 110.177 175.533 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 141' ' ' LEU . . . . . 0.405 HD11 ' CD2' ' A' ' 14' ' ' HIS . 40.1 mt -94.59 -49.64 5.55 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-O 120.885 0.374 . . . . 0.0 110.097 179.821 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 142' ' ' GLU . . . . . 0.42 ' HB2' HD22 ' A' ' 12' ' ' LEU . 37.1 mt-10 -143.7 163.15 34.11 Favored 'General case' 0 CA--C 1.513 -0.476 0 CA-C-N 115.847 -0.615 . . . . 0.0 109.88 172.38 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 143' ' ' ILE . . . . . 0.45 HD11 ' N ' ' A' ' 5' ' ' VAL . 94.8 mt -123.49 110.07 25.03 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.901 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.539 178.484 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 144' ' ' ASP . . . . . . . . . . . . . 27.1 t70 -78.57 111.89 22.58 Favored Pre-proline 0 C--N 1.325 -0.469 0 CA-C-N 115.487 -0.779 . . . . 0.0 110.058 178.408 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 145' ' ' PRO . . . . . . . . . . . . . 52.5 Cg_endo -67.86 145.52 68.8 Favored 'Trans proline' 0 N--CA 1.459 -0.514 0 C-N-CA 122.186 1.924 . . . . 0.0 111.831 -177.207 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 146' ' ' ALA . . . . . . . . . . . . . . . -83.39 102.86 12.32 Favored 'General case' 0 C--N 1.318 -0.781 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.139 178.299 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 3.9 mm? -83.03 52.14 2.11 Favored 'General case' 0 C--N 1.319 -0.756 0 CA-C-O 121.42 0.628 . . . . 0.0 111.025 -178.085 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 71.6 mt-10 . . . . . 0 C--N 1.32 -0.713 0 CA-C-N 115.338 -0.847 . . . . 0.0 110.461 179.263 . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 66.0 mtt . . . . . 0 N--CA 1.479 0.987 0 CA-C-O 120.551 0.215 . . . . 0.0 110.88 . . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 35.5 m -113.83 108.2 16.76 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-O 121.216 0.532 . . . . 0.0 110.603 -179.897 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 3' ' ' GLU . . . . . 0.466 ' HG2' ' HE2' ' A' ' 56' ' ' LYS . 36.0 tt0 -99.54 -27.99 13.44 Favored 'General case' 0 C--N 1.319 -0.721 0 CA-C-N 115.533 -0.758 . . . . 0.0 110.525 -177.584 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 8.5 p -124.94 158.27 33.99 Favored 'General case' 0 C--N 1.318 -0.782 0 CA-C-N 115.415 -0.811 . . . . 0.0 109.998 178.489 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . 0.472 HG23 ' N ' ' A' ' 55' ' ' LEU . 3.7 m -83.22 151.89 3.95 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.41 0 CA-C-O 121.294 0.568 . . . . 0.0 111.032 -175.341 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 6' ' ' GLN . . . . . 0.614 ' HG2' ' OG ' ' A' ' 9' ' ' SER . 1.4 pt20 -141.88 168.42 19.81 Favored 'General case' 0 C--N 1.314 -0.948 0 CA-C-N 115.223 -0.899 . . . . 0.0 108.86 176.164 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 51.5 p -53.47 122.08 8.98 Favored 'General case' 0 C--N 1.318 -0.768 0 N-CA-C 109.928 -0.397 . . . . 0.0 109.928 176.073 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 8' ' ' ASN . . . . . 0.422 ' HA ' ' O ' ' A' ' 39' ' ' LEU . 3.6 t-20 80.53 41.43 0.06 Allowed 'General case' 0 N--CA 1.475 0.809 0 O-C-N 124.036 0.835 . . . . 0.0 111.507 178.332 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 9' ' ' SER . . . . . 0.614 ' OG ' ' HG2' ' A' ' 6' ' ' GLN . 47.8 m -103.86 160.77 14.51 Favored 'General case' 0 C--N 1.332 -0.16 0 O-C-N 121.994 -0.441 . . . . 0.0 111.039 174.17 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 10' ' ' ALA . . . . . 0.441 ' HB1' HD22 ' A' ' 36' ' ' LEU . . . -109.49 131.93 54.61 Favored 'General case' 0 C--N 1.322 -0.606 0 N-CA-C 108.779 -0.823 . . . . 0.0 108.779 171.964 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 11' ' ' VAL . . . . . 0.471 ' O ' ' HA ' ' A' ' 36' ' ' LEU . 6.4 m -138.8 136.88 43.15 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.435 0 C-N-CA 120.501 -0.48 . . . . 0.0 111.437 -174.305 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 89.3 mt -86.42 128.61 34.97 Favored 'General case' 0 C--N 1.324 -0.51 0 N-CA-C 108.251 -1.018 . . . . 0.0 108.251 173.238 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 13' ' ' VAL . . . . . 0.47 ' CG2' HG23 ' A' ' 138' ' ' ILE . 1.6 p -141.65 157.53 21.17 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.86 0 CA-C-O 121.117 0.485 . . . . 0.0 110.747 -173.196 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 14' ' ' HIS . . . . . 0.488 ' ND1' ' HA ' ' A' ' 29' ' ' ARG . 0.5 OUTLIER -124.98 116.42 22.13 Favored 'General case' 0 C--N 1.318 -0.802 0 N-CA-C 106.396 -1.705 . . . . 0.0 106.396 170.545 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 15' ' ' PHE . . . . . 0.456 ' CE1' ' HB ' ' A' ' 28' ' ' THR . 18.2 p90 -146.0 158.8 43.87 Favored 'General case' 0 C--N 1.316 -0.852 0 C-N-CA 120.427 -0.509 . . . . 0.0 110.77 -169.019 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 87.8 m -130.32 130.16 44.12 Favored 'General case' 0 C--N 1.318 -0.775 0 N-CA-C 109.859 -0.423 . . . . 0.0 109.859 174.434 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 17' ' ' LEU . . . . . 0.484 HD21 ' CE1' ' A' ' 136' ' ' PHE . 9.5 mt -95.77 138.8 32.91 Favored 'General case' 0 N--CA 1.445 -0.683 0 CA-C-O 121.714 0.769 . . . . 0.0 111.659 -179.008 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 4.3 mptp? -122.31 147.47 46.2 Favored 'General case' 0 C--N 1.314 -0.95 0 CA-C-N 114.314 -1.312 . . . . 0.0 110.031 -176.24 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 4.1 mm? -83.43 169.13 15.88 Favored 'General case' 0 C--N 1.312 -1.041 0 N-CA-C 108.716 -0.846 . . . . 0.0 108.716 170.755 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 29.3 t70 -68.88 -25.42 64.61 Favored 'General case' 0 C--N 1.318 -0.804 0 CA-C-O 121.323 0.583 . . . . 0.0 109.607 177.717 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 15.4 t70 -80.07 0.95 29.77 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.339 -0.846 . . . . 0.0 110.426 176.001 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 76.22 25.38 66.32 Favored Glycine 0 N--CA 1.45 -0.402 0 CA-C-N 116.175 -0.466 . . . . 0.0 113.155 178.64 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 14.1 m -90.11 154.73 19.56 Favored 'General case' 0 C--N 1.322 -0.607 0 N-CA-C 109.307 -0.627 . . . . 0.0 109.307 171.954 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 59.7 m -90.43 118.26 29.77 Favored 'General case' 0 C--N 1.32 -0.679 0 O-C-N 121.749 -0.594 . . . . 0.0 110.538 177.33 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -84.11 -48.85 9.43 Favored 'General case' 0 CA--C 1.516 -0.33 0 CA-C-O 121.498 0.666 . . . . 0.0 110.269 179.337 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 9.2 tp10 -151.41 119.95 6.47 Favored 'General case' 0 C--N 1.318 -0.774 0 CA-C-N 114.842 -1.072 . . . . 0.0 109.068 -179.498 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 12.8 t -111.72 101.14 9.53 Favored 'General case' 0 C--N 1.315 -0.921 0 C-N-CA 120.033 -0.667 . . . . 0.0 110.259 177.512 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 28' ' ' THR . . . . . 0.456 ' HB ' ' CE1' ' A' ' 15' ' ' PHE . 31.0 m -97.64 51.4 1.07 Allowed 'General case' 0 C--N 1.313 -0.984 0 CA-C-O 122.706 1.241 . . . . 0.0 109.302 175.978 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 29' ' ' ARG . . . . . 0.488 ' HA ' ' ND1' ' A' ' 14' ' ' HIS . 29.6 ttp180 -143.56 -67.94 0.34 Allowed 'General case' 0 C--N 1.314 -0.954 0 CA-C-N 114.785 -1.098 . . . . 0.0 110.618 -177.059 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 2.2 p-10 -80.69 33.8 0.32 Allowed 'General case' 0 N--CA 1.467 0.385 0 N-CA-C 111.972 0.36 . . . . 0.0 111.972 -177.805 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 92.4 m-20 -119.21 -7.82 10.23 Favored 'General case' 0 C--N 1.325 -0.472 0 N-CA-C 109.829 -0.434 . . . . 0.0 109.829 173.082 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 79.73 6.25 89.11 Favored Glycine 0 N--CA 1.447 -0.592 0 C-N-CA 121.055 -0.593 . . . . 0.0 111.635 -177.342 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 50.0 mmtm -114.28 112.91 46.29 Favored Pre-proline 0 C--N 1.325 -0.474 0 CA-C-N 115.885 -0.158 . . . . 0.0 110.7 -178.263 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 6.2 Cg_exo -79.3 169.82 18.34 Favored 'Trans proline' 0 N--CA 1.46 -0.454 0 C-N-CA 122.88 2.386 . . . . 0.0 112.434 172.45 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -144.55 158.79 43.6 Favored 'General case' 0 C--N 1.315 -0.926 0 CA-C-N 115.061 -0.972 . . . . 0.0 109.698 179.009 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 36' ' ' LEU . . . . . 0.471 ' HA ' ' O ' ' A' ' 11' ' ' VAL . 0.7 OUTLIER -108.63 134.54 51.23 Favored 'General case' 0 N--CA 1.445 -0.677 0 CA-C-O 120.749 0.309 . . . . 0.0 110.333 177.202 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 37' ' ' PHE . . . . . . . . . . . . . 4.7 m-30 -96.4 130.71 43.46 Favored 'General case' 0 C--N 1.318 -0.766 0 CA-C-N 116.05 -0.523 . . . . 0.0 109.911 174.187 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 2.1 tpp180 -111.59 107.98 17.31 Favored 'General case' 0 C--N 1.321 -0.649 0 CA-C-N 116.076 -0.511 . . . . 0.0 109.76 -177.443 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 39' ' ' LEU . . . . . 0.547 ' HG ' ' O ' ' A' ' 9' ' ' SER . 6.6 mt -83.71 154.87 23.4 Favored 'General case' 0 C--N 1.319 -0.739 0 CA-C-N 116.201 -0.454 . . . . 0.0 109.894 -178.092 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 40' ' ' GLY . . . . . 0.43 ' H ' ' CD ' ' A' ' 49' ' ' GLU . . . 100.41 33.66 5.04 Favored Glycine 0 C--N 1.312 -0.782 0 CA-C-N 115.807 -0.633 . . . . 0.0 112.494 -179.125 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 6.5 m-20 63.58 8.36 3.59 Favored 'General case' 0 N--CA 1.473 0.709 0 N-CA-C 112.538 0.569 . . . . 0.0 112.538 178.237 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -67.37 -31.39 71.6 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-O 120.803 0.335 . . . . 0.0 111.657 -176.773 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 11.9 p -137.31 -65.85 0.53 Allowed 'General case' 0 C--N 1.321 -0.638 0 CA-C-N 116.453 -0.339 . . . . 0.0 111.048 -178.931 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 7.5 mp -85.89 -178.74 6.66 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.392 -179.432 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 31.0 m -95.86 164.05 12.9 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-N 116.317 -0.401 . . . . 0.0 111.539 -176.603 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 46' ' ' GLU . . . . . 0.452 ' O ' ' HG2' ' A' ' 50' ' ' GLN . 41.6 mt-10 -52.38 -41.11 62.85 Favored 'General case' 0 N--CA 1.465 0.289 0 N-CA-C 112.876 0.695 . . . . 0.0 112.876 -172.576 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -61.9 -41.82 99.68 Favored Glycine 0 N--CA 1.449 -0.453 0 C-N-CA 120.571 -0.823 . . . . 0.0 112.284 -170.134 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 48' ' ' LEU . . . . . 0.428 ' C ' HD12 ' A' ' 48' ' ' LEU . 3.2 tm? -61.02 -53.6 55.24 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-O 120.495 0.188 . . . . 0.0 111.144 -179.426 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 49' ' ' GLU . . . . . 0.689 ' O ' HD12 ' A' ' 53' ' ' LEU . 9.7 pt-20 -68.77 -37.4 79.31 Favored 'General case' 0 C--N 1.325 -0.46 0 N-CA-C 111.621 0.23 . . . . 0.0 111.621 -173.633 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 50' ' ' GLN . . . . . 0.475 ' HA ' HD23 ' A' ' 53' ' ' LEU . 33.1 mm-40 -66.15 -12.47 56.01 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 120.845 0.355 . . . . 0.0 111.353 -176.42 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 51' ' ' HIS . . . . . . . . . . . . . 12.1 m-70 -103.38 -4.0 24.74 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 121.213 0.53 . . . . 0.0 110.485 177.629 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 52' ' ' LEU . . . . . 0.459 ' O ' HG21 ' A' ' 5' ' ' VAL . 12.0 mt -102.51 -11.72 18.33 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-N 115.762 -0.653 . . . . 0.0 111.16 177.76 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 53' ' ' LEU . . . . . 0.689 HD12 ' O ' ' A' ' 49' ' ' GLU . 1.1 mp -58.78 136.6 57.81 Favored 'General case' 0 N--CA 1.449 -0.511 0 CA-C-O 121.125 0.488 . . . . 0.0 111.47 177.805 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 94.39 -4.57 70.16 Favored Glycine 0 N--CA 1.447 -0.572 0 CA-C-N 115.592 -0.731 . . . . 0.0 113.091 -179.677 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 55' ' ' LEU . . . . . 0.472 ' N ' HG23 ' A' ' 5' ' ' VAL . 3.0 mm? -71.97 164.8 25.46 Favored 'General case' 0 CA--C 1.521 -0.15 0 CA-C-N 117.391 0.595 . . . . 0.0 110.935 177.876 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 56' ' ' LYS . . . . . 0.597 ' HD3' ' N ' ' A' ' 57' ' ' VAL . 12.3 tmtt? -140.73 154.99 46.55 Favored 'General case' 0 C--N 1.32 -0.699 0 N-CA-C 108.703 -0.851 . . . . 0.0 108.703 -175.031 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 57' ' ' VAL . . . . . 0.597 ' N ' ' HD3' ' A' ' 56' ' ' LYS . 29.8 t -59.66 125.65 16.09 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-O 121.261 0.553 . . . . 0.0 111.386 179.714 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 80.95 19.74 66.82 Favored Glycine 0 N--CA 1.447 -0.627 0 CA-C-N 115.521 -0.763 . . . . 0.0 112.399 -177.398 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 59' ' ' ASP . . . . . 0.482 ' OD1' ' HB3' ' A' ' 56' ' ' LYS . 1.6 m-20 -110.55 150.16 29.34 Favored 'General case' 0 C--N 1.321 -0.631 0 CA-C-O 121.021 0.439 . . . . 0.0 110.452 176.01 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 60' ' ' LYS . . . . . 0.509 ' CE ' ' HG2' ' A' ' 139' ' ' GLU . 0.3 OUTLIER -115.48 133.11 56.34 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-N 115.51 -0.768 . . . . 0.0 109.926 -171.424 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 13.0 t -143.3 134.67 26.08 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-O 121.557 0.694 . . . . 0.0 111.306 178.643 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 5.9 m -123.78 132.49 53.81 Favored 'General case' 0 C--N 1.319 -0.741 0 CA-C-N 115.686 -0.688 . . . . 0.0 109.176 176.293 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 31.7 p90 -152.52 149.19 28.26 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-O 121.013 0.435 . . . . 0.0 111.346 -178.101 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 14.9 m -96.6 156.06 16.5 Favored 'General case' 0 C--N 1.321 -0.647 0 CA-C-N 116.089 -0.505 . . . . 0.0 109.863 177.832 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 31.7 mt -150.67 134.82 16.91 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-O 120.996 0.427 . . . . 0.0 110.749 -177.155 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 22.4 mm-40 -70.71 150.21 95.32 Favored Pre-proline 0 C--N 1.322 -0.587 0 N-CA-C 108.922 -0.77 . . . . 0.0 108.922 173.674 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 67' ' ' PRO . . . . . 0.41 ' HB3' ' N ' ' A' ' 132' ' ' GLN . 5.1 Cg_endo -48.38 -49.04 15.3 Favored 'Trans proline' 0 C--N 1.345 0.344 0 C-N-CA 122.383 2.056 . . . . 0.0 112.515 -175.742 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 22.9 t70 -62.92 -32.09 73.31 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-O 120.823 0.344 . . . . 0.0 111.123 -179.524 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -95.24 13.26 26.1 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-O 121.086 0.47 . . . . 0.0 111.082 -178.244 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -121.25 -84.74 0.66 Allowed 'General case' 0 C--N 1.323 -0.586 0 CA-C-O 121.247 0.546 . . . . 0.0 109.775 179.09 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 71' ' ' PHE . . . . . 0.412 ' HB2' ' HA ' ' A' ' 130' ' ' ALA . 2.4 m-85 -92.82 -17.42 24.13 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-N 115.616 -0.72 . . . . 0.0 109.776 176.947 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 72' ' ' GLY . . . . . 0.534 ' O ' ' HB1' ' A' ' 130' ' ' ALA . . . 97.32 -171.85 27.16 Favored Glycine 0 N--CA 1.45 -0.426 0 N-CA-C 110.68 -0.968 . . . . 0.0 110.68 -173.87 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 73' ' ' VAL . . . . . 0.591 ' N ' ' HD3' ' A' ' 74' ' ' PRO . 1.6 m -150.19 60.44 4.27 Favored Pre-proline 0 C--N 1.33 -0.252 0 CA-C-N 117.703 0.751 . . . . 0.0 110.774 171.359 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 74' ' ' PRO . . . . . 0.591 ' HD3' ' N ' ' A' ' 73' ' ' VAL . 19.7 Cg_endo -95.09 113.09 0.16 Allowed 'Trans proline' 0 N--CA 1.44 -1.625 0 C-N-CA 121.752 1.635 . . . . 0.0 114.529 173.97 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 75' ' ' SER . . . . . 0.512 ' HB2' ' O ' ' A' ' 125' ' ' PHE . 34.7 m -152.45 63.28 4.93 Favored Pre-proline 0 N--CA 1.441 -0.892 0 N-CA-C 107.475 -1.306 . . . . 0.0 107.475 145.494 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 3.4 Cg_exo -73.49 -48.6 0.24 Allowed 'Trans proline' 0 CA--C 1.518 -0.317 0 C-N-CA 122.315 2.01 . . . . 0.0 113.014 -171.296 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 9.1 p-10 -69.71 -4.18 18.57 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-N 115.149 -0.932 . . . . 0.0 111.199 -177.597 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 78' ' ' LEU . . . . . 0.638 ' CB ' ' HB2' ' A' ' 125' ' ' PHE . 1.3 mm? -92.74 3.13 56.19 Favored 'General case' 0 C--N 1.325 -0.484 0 N-CA-C 109.6 -0.518 . . . . 0.0 109.6 178.323 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 68.5 mt -97.5 109.5 23.52 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.808 0 CA-C-O 121.544 0.688 . . . . 0.0 110.068 -173.97 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 39.0 mt-30 -129.1 135.43 48.89 Favored 'General case' 0 C--N 1.317 -0.83 0 CA-C-N 114.702 -1.136 . . . . 0.0 111.79 -168.149 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 81' ' ' TYR . . . . . . . . . . . . . 2.6 m-85 -90.63 114.98 27.38 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 121.554 0.692 . . . . 0.0 111.596 173.566 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 82' ' ' PHE . . . . . 0.437 ' CB ' ' HE1' ' A' ' 87' ' ' PHE . 25.3 m-85 -102.53 170.68 7.89 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 114.745 -1.116 . . . . 0.0 112.01 175.194 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 22.2 t -89.67 155.67 19.08 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 115.721 -0.672 . . . . 0.0 109.847 176.981 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 84' ' ' ARG . . . . . 0.49 ' HD2' ' O ' ' A' ' 118' ' ' GLY . 11.9 ptm180 -66.44 -21.49 66.2 Favored 'General case' 0 C--O 1.227 -0.114 0 N-CA-C 112.143 0.423 . . . . 0.0 112.143 -178.356 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 85' ' ' ARG . . . . . 0.401 HH12 ' CG ' ' A' ' 119' ' ' ASP . 7.5 mpt_? -71.83 -39.42 69.79 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 121.192 0.52 . . . . 0.0 110.357 -175.538 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 31.4 mt-10 -64.64 -30.38 71.4 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 115.06 -0.973 . . . . 0.0 110.406 -174.966 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 87' ' ' PHE . . . . . 0.437 ' HE1' ' CB ' ' A' ' 82' ' ' PHE . 4.3 m-85 -89.65 -46.05 8.91 Favored 'General case' 0 CA--C 1.512 -0.504 0 CA-C-N 115.584 -0.735 . . . . 0.0 111.091 179.291 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 88' ' ' MET . . . . . 0.467 ' HE2' ' NH2' ' A' ' 84' ' ' ARG . 53.3 ttm -61.75 -26.05 67.83 Favored 'General case' 0 C--N 1.321 -0.665 0 CA-C-N 115.497 -0.774 . . . . 0.0 111.045 -175.345 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 23.0 t70 -55.46 -33.24 63.46 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 121.178 0.513 . . . . 0.0 110.59 174.061 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -109.93 11.44 24.12 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-N 115.64 -0.709 . . . . 0.0 111.257 179.304 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 111.75 138.19 7.42 Favored Glycine 0 N--CA 1.449 -0.453 0 C-N-CA 120.771 -0.728 . . . . 0.0 112.282 -179.197 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 92' ' ' GLU . . . . . 0.426 ' HA ' ' HD3' ' A' ' 93' ' ' PRO . 42.3 mt-10 -62.22 128.32 90.89 Favored Pre-proline 0 C--N 1.324 -0.516 0 CA-C-O 120.882 0.372 . . . . 0.0 111.402 -177.073 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 93' ' ' PRO . . . . . 0.543 ' HB2' HD12 ' A' ' 113' ' ' ILE . 17.7 Cg_endo -78.06 165.36 26.19 Favored 'Trans proline' 0 N--CA 1.459 -0.552 0 C-N-CA 122.745 2.297 . . . . 0.0 112.612 -177.518 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 30.9 mt-10 -116.95 146.88 42.72 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.497 -0.32 . . . . 0.0 111.054 -178.452 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 95' ' ' ILE . . . . . 0.497 ' CG1' HG12 ' A' ' 116' ' ' ILE . 16.6 mt -71.16 130.73 35.0 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.424 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.688 179.31 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 71.9 16.32 76.41 Favored Glycine 0 N--CA 1.446 -0.694 0 CA-C-N 115.813 -0.631 . . . . 0.0 113.059 179.367 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 97' ' ' ALA . . . . . 0.464 ' O ' HG13 ' A' ' 113' ' ' ILE . . . -100.85 161.77 13.37 Favored 'General case' 0 C--N 1.327 -0.389 0 N-CA-C 108.962 -0.755 . . . . 0.0 108.962 174.217 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 98' ' ' ILE . . . . . 0.451 HG12 HG23 ' A' ' 112' ' ' VAL . 59.1 mt -107.53 143.92 17.24 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.872 0 N-CA-C 110.066 -0.346 . . . . 0.0 110.066 179.417 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 99' ' ' MET . . . . . 0.482 ' SD ' HD11 ' A' ' 113' ' ' ILE . 82.8 mtp -128.36 163.34 25.04 Favored 'General case' 0 N--CA 1.448 -0.542 0 N-CA-C 107.958 -1.127 . . . . 0.0 107.958 179.347 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 3.5 mm? -100.62 137.1 39.48 Favored 'General case' 0 C--N 1.309 -1.184 0 N-CA-C 109.991 -0.374 . . . . 0.0 109.991 174.139 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 101' ' ' PHE . . . . . 0.456 ' CE2' ' HB2' ' A' ' 99' ' ' MET . 50.9 m-85 -143.55 136.35 27.48 Favored 'General case' 0 C--N 1.319 -0.725 0 N-CA-C 108.998 -0.742 . . . . 0.0 108.998 -174.55 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 17.2 m -96.53 131.78 42.79 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-O 120.97 0.414 . . . . 0.0 110.55 178.825 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -95.46 159.41 15.01 Favored 'General case' 0 C--N 1.321 -0.647 0 CA-C-N 116.003 -0.544 . . . . 0.0 110.11 177.351 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 104' ' ' MET . . . . . . . . . . . . . 4.0 mpp? -66.16 -12.13 53.85 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.353 -0.84 . . . . 0.0 112.022 -174.484 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 7.7 p-10 -92.01 17.91 8.69 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-O 121.141 0.496 . . . . 0.0 110.821 177.598 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 77.28 -11.56 16.6 Favored Glycine 0 N--CA 1.452 -0.259 0 CA-C-N 115.866 -0.606 . . . . 0.0 114.189 178.102 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 14.5 t -78.64 152.87 31.49 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-N 117.185 0.492 . . . . 0.0 110.005 179.251 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 35.2 tt0 -126.78 103.16 7.38 Favored 'General case' 0 C--N 1.315 -0.934 0 N-CA-C 108.867 -0.79 . . . . 0.0 108.867 -179.337 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 109' ' ' MET . . . . . . . . . . . . . 3.1 mpp? -100.34 134.91 20.42 Favored Pre-proline 0 C--N 1.32 -0.674 0 CA-C-N 116.349 -0.387 . . . . 0.0 111.323 -175.564 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 33.5 Cg_endo -67.53 135.73 37.17 Favored 'Trans proline' 0 N--CA 1.455 -0.739 0 C-N-CA 121.911 1.74 . . . . 0.0 109.638 167.847 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . -134.66 126.04 3.98 Favored Glycine 0 N--CA 1.443 -0.886 0 N-CA-C 111.11 -0.796 . . . . 0.0 111.11 -170.59 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 112' ' ' VAL . . . . . 0.451 HG23 HG12 ' A' ' 98' ' ' ILE . 32.0 t -76.57 131.07 35.55 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.655 0 N-CA-C 109.423 -0.584 . . . . 0.0 109.423 179.876 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 113' ' ' ILE . . . . . 0.543 HD12 ' HB2' ' A' ' 93' ' ' PRO . 1.9 mt -82.66 109.97 17.2 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.058 0 N-CA-C 107.826 -1.176 . . . . 0.0 107.826 173.174 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 114' ' ' ARG . . . . . 0.559 ' HE ' HG23 ' A' ' 122' ' ' THR . 2.3 tmm_? -64.89 -49.06 71.94 Favored 'General case' 0 C--N 1.315 -0.892 0 CA-C-N 115.569 -0.741 . . . . 0.0 110.272 -173.515 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 115' ' ' GLU . . . . . 0.408 ' HB2' ' HD2' ' A' ' 114' ' ' ARG . 9.4 tt0 -159.86 155.6 25.96 Favored 'General case' 0 C--N 1.326 -0.446 0 C-N-CA 121.156 -0.218 . . . . 0.0 110.419 -178.875 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 116' ' ' ILE . . . . . 0.497 HG12 ' CG1' ' A' ' 95' ' ' ILE . 31.9 mm -106.85 110.75 32.81 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.405 0 N-CA-C 109.001 -0.74 . . . . 0.0 109.001 175.901 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 117' ' ' ASN . . . . . 0.439 ' HB2' ' O ' ' A' ' 120' ' ' SER . 0.9 OUTLIER -98.83 157.69 16.13 Favored 'General case' 0 C--N 1.313 -0.981 0 CA-C-N 115.947 -0.569 . . . . 0.0 109.6 -178.04 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 118' ' ' GLY . . . . . 0.49 ' O ' ' HD2' ' A' ' 84' ' ' ARG . . . -56.27 -44.66 89.27 Favored Glycine 0 C--O 1.226 -0.392 0 C-N-CA 120.452 -0.88 . . . . 0.0 113.196 -171.47 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 119' ' ' ASP . . . . . 0.401 ' CG ' HH12 ' A' ' 85' ' ' ARG . 13.9 t70 -113.03 -9.86 13.53 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-O 121.169 0.509 . . . . 0.0 110.73 179.131 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 120' ' ' SER . . . . . 0.439 ' O ' ' HB2' ' A' ' 117' ' ' ASN . 21.6 t -126.54 157.63 38.28 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-O 121.533 0.682 . . . . 0.0 111.845 -168.79 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 121' ' ' ILE . . . . . . . . . . . . . 28.0 mm -120.49 150.41 23.25 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.761 0 CA-C-N 115.512 -0.767 . . . . 0.0 109.076 176.498 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 122' ' ' THR . . . . . 0.559 HG23 ' HE ' ' A' ' 114' ' ' ARG . 14.6 m -127.38 127.01 43.48 Favored 'General case' 0 C--N 1.312 -1.03 0 N-CA-C 107.615 -1.254 . . . . 0.0 107.615 179.667 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 2.8 t -127.74 127.14 68.05 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.839 0 N-CA-C 109.022 -0.733 . . . . 0.0 109.022 -171.01 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -114.24 96.11 5.63 Favored 'General case' 0 C--N 1.305 -1.326 0 CA-C-N 114.62 -1.173 . . . . 0.0 108.672 -177.34 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 125' ' ' PHE . . . . . 0.638 ' HB2' ' CB ' ' A' ' 78' ' ' LEU . 27.7 m-85 -82.5 103.8 12.31 Favored 'General case' 0 N--CA 1.431 -1.399 0 N-CA-C 105.821 -1.918 . . . . 0.0 105.821 175.107 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 126' ' ' ASN . . . . . 0.476 ' HA ' ' HB2' ' A' ' 75' ' ' SER . 0.1 OUTLIER -122.69 122.95 40.0 Favored 'General case' 0 C--N 1.295 -1.772 0 CA-C-N 113.884 -1.507 . . . . 0.0 112.916 -168.362 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 127' ' ' HIS . . . . . . . . . . . . . 4.2 p-80 70.68 124.81 0.03 OUTLIER Pre-proline 0 C--N 1.315 -0.907 0 N-CA-C 116.647 2.092 . . . . 0.0 116.647 156.587 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 128' ' ' PRO . . . . . 0.687 ' C ' ' H ' ' A' ' 130' ' ' ALA . 74.7 Cg_exo -51.42 -174.37 0.01 OUTLIER 'Trans proline' 0 C--O 1.222 -0.319 0 C-N-CA 124.963 3.776 . . . . 0.0 108.983 141.698 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 129' ' ' LEU . . . . . 0.529 ' HG ' ' NE2' ' A' ' 132' ' ' GLN . 17.1 tp -51.11 27.21 0.0 OUTLIER 'General case' 0 CA--C 1.572 1.807 0 N-CA-C 113.915 1.08 . . . . 0.0 113.915 174.042 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 130' ' ' ALA . . . . . 0.687 ' H ' ' C ' ' A' ' 128' ' ' PRO . . . -95.94 -176.27 3.65 Favored 'General case' 0 N--CA 1.45 -0.469 0 C-N-CA 124.832 1.253 . . . . 0.0 108.855 170.889 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 131' ' ' GLY . . . . . 0.479 ' HA2' ' CG1' ' A' ' 73' ' ' VAL . . . 65.59 26.41 71.93 Favored Glycine 0 N--CA 1.458 0.153 0 C-N-CA 120.689 -0.767 . . . . 0.0 114.129 174.855 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 132' ' ' GLN . . . . . 0.529 ' NE2' ' HG ' ' A' ' 129' ' ' LEU . 23.3 pt20 -123.55 141.69 51.76 Favored 'General case' 0 C--N 1.315 -0.918 0 N-CA-C 109.33 -0.619 . . . . 0.0 109.33 176.568 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 133' ' ' THR . . . . . . . . . . . . . 18.9 m -79.86 111.87 16.6 Favored 'General case' 0 C--N 1.319 -0.748 0 N-CA-C 108.991 -0.744 . . . . 0.0 108.991 178.365 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 134' ' ' VAL . . . . . 0.426 ' HB ' HD23 ' A' ' 17' ' ' LEU . 15.7 m -115.05 167.94 7.2 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.64 0 CA-C-O 122.017 0.913 . . . . 0.0 112.639 -172.648 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 135' ' ' HIS . . . . . . . . . . . . . 82.5 m-70 -132.47 127.87 36.2 Favored 'General case' 0 C--N 1.314 -0.955 0 CA-C-N 114.043 -1.435 . . . . 0.0 107.359 177.581 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 136' ' ' PHE . . . . . 0.484 ' CE1' HD21 ' A' ' 17' ' ' LEU . 17.8 m-85 -105.53 122.81 46.78 Favored 'General case' 0 C--N 1.313 -1.006 0 CA-C-O 121.09 0.471 . . . . 0.0 111.71 -171.574 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 137' ' ' ASP . . . . . . . . . . . . . 38.2 t70 -123.03 98.76 6.04 Favored 'General case' 0 C--N 1.315 -0.907 0 N-CA-C 107.87 -1.159 . . . . 0.0 107.87 172.806 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 138' ' ' ILE . . . . . 0.47 HG23 ' CG2' ' A' ' 13' ' ' VAL . 54.8 mt -123.81 138.29 54.02 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.562 0 CA-C-N 115.968 -0.56 . . . . 0.0 112.271 -172.139 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 139' ' ' GLU . . . . . 0.509 ' HG2' ' CE ' ' A' ' 60' ' ' LYS . 2.3 mp0 -128.53 130.55 47.59 Favored 'General case' 0 N--CA 1.452 -0.364 0 N-CA-C 108.523 -0.917 . . . . 0.0 108.523 175.034 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 140' ' ' VAL . . . . . . . . . . . . . 72.6 t -77.56 126.59 38.11 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 117.805 0.275 . . . . 0.0 110.415 -176.47 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 141' ' ' LEU . . . . . 0.403 ' HG ' ' HA ' ' A' ' 13' ' ' VAL . 38.8 mt -94.83 -48.6 5.96 Favored 'General case' 0 C--N 1.321 -0.635 0 N-CA-C 109.919 -0.4 . . . . 0.0 109.919 177.386 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 142' ' ' GLU . . . . . . . . . . . . . 10.6 mm-40 -146.73 162.37 38.66 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 115.902 -0.59 . . . . 0.0 110.597 177.127 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 143' ' ' ILE . . . . . 0.417 HD13 HG22 ' A' ' 57' ' ' VAL . 95.5 mt -131.04 122.66 52.22 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.66 0 CA-C-N 115.961 -0.563 . . . . 0.0 110.337 177.529 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 144' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -74.75 132.67 77.44 Favored Pre-proline 0 CA--C 1.513 -0.472 0 CA-C-N 116.038 -0.528 . . . . 0.0 109.741 176.115 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 145' ' ' PRO . . . . . . . . . . . . . 70.0 Cg_exo -45.9 117.97 2.1 Favored 'Trans proline' 0 CA--C 1.512 -0.583 0 C-N-CA 123.338 2.692 . . . . 0.0 113.16 -178.282 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 146' ' ' ALA . . . . . . . . . . . . . . . -93.37 104.42 16.58 Favored 'General case' 0 C--N 1.31 -1.113 0 CA-C-N 114.604 -1.18 . . . . 0.0 109.378 179.209 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 2.8 mm? -88.64 1.59 54.74 Favored 'General case' 0 C--N 1.319 -0.725 0 CA-C-N 115.889 -0.596 . . . . 0.0 109.721 179.712 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 42.0 mt-10 . . . . . 0 CA--C 1.518 -0.256 0 CA-C-N 114.791 -1.095 . . . . 0.0 109.324 -177.238 . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.481 1.11 0 CA-C-O 121.1 0.476 . . . . 0.0 109.82 . . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 73.3 m -156.01 82.78 1.01 Allowed 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 115.944 -0.571 . . . . 0.0 109.797 175.87 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 46.1 mt-10 -86.27 -22.56 26.75 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-N 115.789 -0.641 . . . . 0.0 110.733 179.934 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 4' ' ' SER . . . . . 0.446 ' HA ' ' HA ' ' A' ' 56' ' ' LYS . 19.8 m -110.03 132.94 53.71 Favored 'General case' 0 C--N 1.32 -0.702 0 CA-C-N 115.96 -0.564 . . . . 0.0 110.918 -179.686 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . 0.677 HG13 ' O ' ' A' ' 55' ' ' LEU . 7.3 p -74.2 141.19 16.44 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.425 0 CA-C-N 115.7 -0.682 . . . . 0.0 109.774 177.507 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 6' ' ' GLN . . . . . 0.611 ' HG2' ' OG ' ' A' ' 9' ' ' SER . 2.2 pt20 -134.58 167.62 20.47 Favored 'General case' 0 C--N 1.311 -1.099 0 N-CA-C 108.805 -0.813 . . . . 0.0 108.805 175.806 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 16.2 p -56.59 131.89 50.13 Favored 'General case' 0 C--N 1.313 -0.992 0 N-CA-C 109.64 -0.504 . . . . 0.0 109.64 176.881 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 64.3 t30 76.8 29.24 0.64 Allowed 'General case' 0 CA--C 1.544 0.718 0 C-N-CA 123.698 0.799 . . . . 0.0 111.645 -178.8 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 9' ' ' SER . . . . . 0.611 ' OG ' ' HG2' ' A' ' 6' ' ' GLN . 50.2 m -103.25 167.74 9.62 Favored 'General case' 0 CA--C 1.53 0.183 0 CA-C-O 120.837 0.351 . . . . 0.0 110.849 171.304 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -118.45 115.39 24.55 Favored 'General case' 0 C--N 1.325 -0.497 0 N-CA-C 109.329 -0.619 . . . . 0.0 109.329 175.65 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 4.8 m -119.71 142.15 36.51 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.609 0 C-N-CA 119.914 -0.715 . . . . 0.0 112.308 -174.006 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 47.1 tp -88.7 138.1 31.72 Favored 'General case' 0 N--CA 1.447 -0.613 0 CA-C-N 115.298 -0.864 . . . . 0.0 108.824 174.208 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 14.4 m -144.98 157.81 13.95 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.456 0 CA-C-O 120.889 0.376 . . . . 0.0 110.876 -172.912 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 14' ' ' HIS . . . . . 0.616 ' ND1' ' HA ' ' A' ' 29' ' ' ARG . 3.0 m-70 -117.49 119.85 36.3 Favored 'General case' 0 C--N 1.319 -0.727 0 N-CA-C 107.481 -1.303 . . . . 0.0 107.481 162.137 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 15' ' ' PHE . . . . . 0.62 ' HA ' ' O ' ' A' ' 137' ' ' ASP . 46.2 p90 -139.09 142.18 38.13 Favored 'General case' 0 C--N 1.319 -0.725 0 C-N-CA 120.514 -0.474 . . . . 0.0 110.897 -175.206 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 25.0 m -119.17 121.64 40.19 Favored 'General case' 0 C--N 1.318 -0.8 0 CA-C-O 120.785 0.326 . . . . 0.0 110.203 174.3 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 17' ' ' LEU . . . . . 0.642 HD21 ' O ' ' A' ' 135' ' ' HIS . 5.7 mt -92.5 127.11 37.87 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 116.086 -0.506 . . . . 0.0 112.035 179.893 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 18' ' ' LYS . . . . . 0.422 ' O ' ' HB2' ' A' ' 135' ' ' HIS . 0.8 OUTLIER -125.17 152.43 44.49 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-N 115.35 -0.841 . . . . 0.0 110.283 179.888 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 19' ' ' LEU . . . . . 0.439 HD12 ' HB ' ' A' ' 23' ' ' THR . 95.1 mt -88.62 172.92 8.93 Favored 'General case' 0 C--N 1.316 -0.867 0 N-CA-C 109.696 -0.483 . . . . 0.0 109.696 171.345 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 18.7 t70 -53.61 -36.04 61.55 Favored 'General case' 0 N--CA 1.466 0.325 0 CA-C-O 121.029 0.442 . . . . 0.0 110.96 -179.713 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 38.5 m-20 -83.49 11.74 6.59 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 115.839 -0.619 . . . . 0.0 112.067 -177.99 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 72.69 12.16 77.86 Favored Glycine 0 N--CA 1.452 -0.293 0 C-N-CA 121.111 -0.566 . . . . 0.0 113.314 -178.455 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 23' ' ' THR . . . . . 0.439 ' HB ' HD12 ' A' ' 19' ' ' LEU . 24.6 m -73.87 128.87 36.67 Favored 'General case' 0 C--N 1.322 -0.593 0 N-CA-C 109.762 -0.459 . . . . 0.0 109.762 177.123 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 36.9 m -70.99 116.32 11.14 Favored 'General case' 0 C--N 1.32 -0.691 0 CA-C-O 121.194 0.521 . . . . 0.0 110.939 -178.129 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 25' ' ' ALA . . . . . 0.434 ' HB1' ' HB3' ' A' ' 17' ' ' LEU . . . -84.07 -49.46 8.88 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 115.637 -0.711 . . . . 0.0 109.91 178.133 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 8.2 tp10 -158.44 122.9 4.14 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.354 -0.839 . . . . 0.0 109.518 177.025 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 31.2 t -103.43 113.36 26.8 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-O 121.157 0.503 . . . . 0.0 110.219 178.732 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 28' ' ' THR . . . . . 0.635 ' O ' HG21 ' A' ' 28' ' ' THR . 58.0 m -118.96 36.71 4.35 Favored 'General case' 0 N--CA 1.441 -0.898 0 CA-C-O 122.707 1.241 . . . . 0.0 110.103 178.82 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 29' ' ' ARG . . . . . 0.616 ' HA ' ' ND1' ' A' ' 14' ' ' HIS . 52.7 ttp180 -132.06 -62.47 0.84 Allowed 'General case' 0 C--N 1.316 -0.88 0 O-C-N 121.327 -0.858 . . . . 0.0 110.431 174.613 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 2.3 p-10 -83.02 14.98 2.98 Favored 'General case' 0 N--CA 1.468 0.454 0 CA-C-O 121.099 0.476 . . . . 0.0 111.128 -179.483 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 31' ' ' ASN . . . . . 0.73 ' ND2' ' HG2' ' A' ' 33' ' ' LYS . 34.1 p-10 -88.18 -18.46 28.67 Favored 'General case' 0 C--N 1.32 -0.674 0 CA-C-N 115.877 -0.602 . . . . 0.0 110.114 175.387 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 88.03 10.88 68.4 Favored Glycine 0 N--CA 1.444 -0.777 0 CA-C-N 115.496 -0.775 . . . . 0.0 112.004 -178.883 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 33' ' ' LYS . . . . . 0.73 ' HG2' ' ND2' ' A' ' 31' ' ' ASN . 12.3 ptmt -140.87 117.55 7.68 Favored Pre-proline 0 C--N 1.327 -0.397 0 CA-C-O 121.434 0.635 . . . . 0.0 110.008 -179.943 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 78.5 Cg_endo -83.36 168.4 13.14 Favored 'Trans proline' 0 N--CA 1.453 -0.867 0 C-N-CA 122.351 2.034 . . . . 0.0 111.955 177.363 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -127.15 158.66 36.49 Favored 'General case' 0 C--N 1.319 -0.736 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.485 -177.416 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -105.11 138.04 41.94 Favored 'General case' 0 C--N 1.318 -0.783 0 CA-C-N 116.104 -0.498 . . . . 0.0 109.919 175.33 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 37' ' ' PHE . . . . . . . . . . . . . 9.9 m-30 -107.5 107.6 18.53 Favored 'General case' 0 C--N 1.318 -0.773 0 N-CA-C 109.164 -0.68 . . . . 0.0 109.164 175.867 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 16.2 tpt180 -89.24 120.2 30.39 Favored 'General case' 0 C--N 1.317 -0.839 0 CA-C-N 115.669 -0.696 . . . . 0.0 109.371 178.262 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 39' ' ' LEU . . . . . 0.477 HD12 ' HB2' ' A' ' 49' ' ' GLU . 2.0 mm? -79.03 148.42 32.5 Favored 'General case' 0 C--N 1.318 -0.764 0 CA-C-N 115.752 -0.658 . . . . 0.0 110.58 -177.468 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 100.51 39.42 3.22 Favored Glycine 0 N--CA 1.445 -0.724 0 C-N-CA 120.662 -0.78 . . . . 0.0 113.358 178.077 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 34.5 t70 66.67 7.51 5.22 Favored 'General case' 0 N--CA 1.472 0.644 0 CA-C-O 121.122 0.487 . . . . 0.0 112.16 171.431 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -55.63 -58.74 6.53 Favored 'General case' 0 C--N 1.328 -0.369 0 N-CA-C 112.052 0.39 . . . . 0.0 112.052 -177.741 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 37.1 m -143.41 9.46 1.62 Allowed 'General case' 0 C--N 1.324 -0.512 0 CA-C-O 121.073 0.463 . . . . 0.0 110.839 179.161 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 4.2 mm? -115.09 148.9 38.36 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.885 -177.195 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 14.6 m -71.55 131.81 43.78 Favored 'General case' 0 N--CA 1.445 -0.688 0 N-CA-C 108.969 -0.752 . . . . 0.0 108.969 173.53 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 54.8 mt-10 -47.66 -43.92 26.68 Favored 'General case' 0 N--CA 1.468 0.472 0 O-C-N 123.534 0.521 . . . . 0.0 112.232 -169.509 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -61.41 -45.11 97.07 Favored Glycine 0 N--CA 1.448 -0.555 0 C-N-CA 120.642 -0.789 . . . . 0.0 112.696 -177.799 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 48' ' ' LEU . . . . . 0.407 HD11 ' C ' ' A' ' 48' ' ' LEU . 3.4 tm? -60.0 -54.39 46.64 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-O 120.95 0.405 . . . . 0.0 110.865 -177.879 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 49' ' ' GLU . . . . . 0.477 ' HB2' HD12 ' A' ' 39' ' ' LEU . 9.7 pt-20 -59.29 -40.25 85.58 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-N 115.458 -0.792 . . . . 0.0 111.39 -178.195 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 50' ' ' GLN . . . . . 0.535 ' HA ' ' CD2' ' A' ' 53' ' ' LEU . 83.4 mt-30 -69.14 -7.53 37.06 Favored 'General case' 0 CA--C 1.531 0.219 0 N-CA-C 113.302 0.853 . . . . 0.0 113.302 -179.78 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 51' ' ' HIS . . . . . . . . . . . . . 9.9 m-70 -103.35 -16.71 15.55 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-O 121.192 0.52 . . . . 0.0 110.019 179.687 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 27.5 mt -104.98 8.07 34.32 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-N 115.51 -0.768 . . . . 0.0 113.057 -176.419 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 53' ' ' LEU . . . . . 0.535 ' CD2' ' HA ' ' A' ' 50' ' ' GLN . 2.0 pp -92.86 155.94 17.29 Favored 'General case' 0 C--N 1.322 -0.615 0 C-N-CA 120.462 -0.495 . . . . 0.0 110.501 174.45 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 54' ' ' GLY . . . . . 0.471 ' N ' HG12 ' A' ' 5' ' ' VAL . . . 94.21 -12.55 68.89 Favored Glycine 0 CA--C 1.532 1.126 0 N-CA-C 115.941 1.136 . . . . 0.0 115.941 176.312 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 55' ' ' LEU . . . . . 0.677 ' O ' HG13 ' A' ' 5' ' ' VAL . 1.0 OUTLIER -100.73 165.44 11.38 Favored 'General case' 0 N--CA 1.471 0.603 0 CA-C-N 119.4 1.6 . . . . 0.0 112.06 -176.062 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 56' ' ' LYS . . . . . 0.446 ' HA ' ' HA ' ' A' ' 4' ' ' SER . 16.0 tttm -96.38 157.1 16.05 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-N 115.738 -0.665 . . . . 0.0 111.372 -175.563 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 57' ' ' VAL . . . . . 0.487 HG22 HD13 ' A' ' 143' ' ' ILE . 51.1 t -59.57 142.05 15.56 Favored 'Isoleucine or valine' 0 C--O 1.234 0.262 0 N-CA-C 109.398 -0.593 . . . . 0.0 109.398 171.404 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 82.43 9.3 85.06 Favored Glycine 0 N--CA 1.445 -0.766 0 C-N-CA 120.513 -0.851 . . . . 0.0 111.716 -177.51 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 59' ' ' ASP . . . . . 0.52 ' C ' ' HG3' ' A' ' 60' ' ' LYS . 15.9 m-20 -116.32 162.33 17.67 Favored 'General case' 0 CA--C 1.509 -0.629 0 N-CA-C 109.738 -0.467 . . . . 0.0 109.738 173.667 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 60' ' ' LYS . . . . . 0.573 ' HG2' ' HG2' ' A' ' 139' ' ' GLU . 32.2 mtpt -143.14 143.55 31.85 Favored 'General case' 0 C--N 1.318 -0.795 0 CA-C-N 115.439 -0.801 . . . . 0.0 110.375 -167.477 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 6.1 t -143.32 131.92 22.43 Favored 'General case' 0 C--N 1.315 -0.908 0 CA-C-N 115.938 -0.574 . . . . 0.0 109.686 178.934 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 3.3 m -113.17 130.99 56.03 Favored 'General case' 0 N--CA 1.443 -0.801 0 N-CA-C 108.949 -0.76 . . . . 0.0 108.949 177.452 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 63' ' ' PHE . . . . . 0.413 ' O ' ' HB2' ' A' ' 136' ' ' PHE . 39.3 p90 -154.59 152.76 30.4 Favored 'General case' 0 C--N 1.32 -0.704 0 CA-C-O 120.914 0.388 . . . . 0.0 111.112 179.688 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 26.5 m -101.64 156.33 17.56 Favored 'General case' 0 C--N 1.321 -0.657 0 CA-C-N 116.015 -0.539 . . . . 0.0 109.779 175.397 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 65' ' ' LEU . . . . . 0.406 HD12 ' HA ' ' A' ' 48' ' ' LEU . 74.7 mt -141.55 144.06 34.08 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 116.377 -0.374 . . . . 0.0 110.657 -178.432 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 41.7 mt-10 -80.54 159.06 70.41 Favored Pre-proline 0 C--N 1.322 -0.593 0 CA-C-N 115.747 -0.661 . . . . 0.0 109.358 174.575 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 59.0 Cg_exo -49.88 -36.86 44.58 Favored 'Trans proline' 0 C--O 1.233 0.25 0 C-N-CA 122.454 2.103 . . . . 0.0 113.624 -176.184 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 4.3 p-10 -66.04 -15.46 63.06 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-O 120.744 0.306 . . . . 0.0 111.385 -179.052 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -111.13 -16.15 13.52 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 116.591 -0.277 . . . . 0.0 111.302 179.475 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 70' ' ' ALA . . . . . 0.489 ' O ' ' HB2' ' A' ' 71' ' ' PHE . . . -143.67 129.68 19.57 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.364 -0.38 . . . . 0.0 111.672 -177.23 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 71' ' ' PHE . . . . . 0.489 ' HB2' ' O ' ' A' ' 70' ' ' ALA . 3.3 m-30 76.31 -44.96 0.5 Allowed 'General case' 0 N--CA 1.472 0.65 0 C-N-CA 123.341 0.656 . . . . 0.0 111.785 176.837 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 114.14 146.28 9.26 Favored Glycine 0 N--CA 1.445 -0.721 0 C-N-CA 120.95 -0.643 . . . . 0.0 112.176 178.905 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 16.8 m -76.14 148.47 81.2 Favored Pre-proline 0 C--N 1.322 -0.595 0 CA-C-O 120.886 0.374 . . . . 0.0 111.119 176.002 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 74.3 Cg_endo -75.83 133.77 15.74 Favored 'Trans proline' 0 C--N 1.347 0.492 0 C-N-CA 122.929 2.42 . . . . 0.0 113.121 -173.856 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 75' ' ' SER . . . . . 0.447 ' HB3' ' OD1' ' A' ' 77' ' ' ASP . 16.6 m -91.93 114.16 61.2 Favored Pre-proline 0 N--CA 1.44 -0.945 0 CA-C-N 115.949 -0.569 . . . . 0.0 110.992 -179.086 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 33.8 Cg_endo -66.41 -19.39 55.37 Favored 'Trans proline' 0 C--N 1.345 0.373 0 C-N-CA 122.734 2.29 . . . . 0.0 112.222 177.183 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 77' ' ' ASP . . . . . 0.447 ' OD1' ' HB3' ' A' ' 75' ' ' SER . 8.2 p-10 -76.35 -5.9 49.18 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 121.359 0.6 . . . . 0.0 110.384 177.16 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 78' ' ' LEU . . . . . 0.408 ' HG ' ' HB2' ' A' ' 125' ' ' PHE . 0.7 OUTLIER -89.03 10.39 21.8 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-N 115.548 -0.751 . . . . 0.0 110.437 176.273 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 22.4 mt -117.24 107.46 22.35 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.635 0 N-CA-C 108.349 -0.982 . . . . 0.0 108.349 177.413 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 80' ' ' GLN . . . . . 0.559 ' O ' ' HB ' ' A' ' 123' ' ' VAL . 71.5 mt-30 -119.7 140.59 50.43 Favored 'General case' 0 C--N 1.313 -1.012 0 CA-C-N 115.895 -0.593 . . . . 0.0 111.37 -172.052 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 81' ' ' TYR . . . . . . . . . . . . . 73.6 m-85 -96.38 155.3 16.82 Favored 'General case' 0 C--N 1.313 -0.983 0 CA-C-N 115.946 -0.57 . . . . 0.0 109.524 173.331 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 82' ' ' PHE . . . . . 0.419 ' CD1' HG21 ' A' ' 123' ' ' VAL . 3.2 m-85 -148.89 167.57 25.36 Favored 'General case' 0 C--N 1.323 -0.586 0 N-CA-C 108.981 -0.748 . . . . 0.0 108.981 -160.371 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 11.6 t -99.61 128.12 45.71 Favored 'General case' 0 C--N 1.321 -0.645 0 CA-C-O 121.082 0.468 . . . . 0.0 110.102 175.533 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 84' ' ' ARG . . . . . 0.644 ' HD3' ' HA ' ' A' ' 119' ' ' ASP . 15.4 ptt180 -53.27 -20.66 4.43 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.237 -0.892 . . . . 0.0 113.151 -177.916 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 85' ' ' ARG . . . . . . . . . . . . . 5.3 mpt_? -71.14 -37.45 72.27 Favored 'General case' 0 CA--C 1.517 -0.323 0 CA-C-O 120.91 0.385 . . . . 0.0 110.785 -173.38 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 27.1 mm-40 -63.97 -33.92 76.82 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-N 115.697 -0.683 . . . . 0.0 110.598 179.941 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 87' ' ' PHE . . . . . 0.408 ' HE2' ' CE1' ' A' ' 101' ' ' PHE . 27.1 m-85 -86.69 -39.73 15.75 Favored 'General case' 0 CA--C 1.509 -0.609 0 CA-C-N 115.96 -0.564 . . . . 0.0 111.158 -178.361 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 88' ' ' MET . . . . . . . . . . . . . 56.1 ttp -60.66 -34.91 75.0 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-N 116.398 -0.365 . . . . 0.0 110.844 -177.101 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 22.1 t70 -55.13 -31.2 61.09 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 121.025 0.44 . . . . 0.0 111.265 175.631 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -100.82 7.6 43.64 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 116.021 -0.536 . . . . 0.0 110.749 178.658 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 105.27 136.79 8.75 Favored Glycine 0 N--CA 1.445 -0.745 0 N-CA-C 110.846 -0.902 . . . . 0.0 110.846 -175.226 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 44.5 mt-10 -61.15 128.69 89.83 Favored Pre-proline 0 C--N 1.322 -0.618 0 CA-C-O 121.321 0.581 . . . . 0.0 111.208 -176.485 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 93' ' ' PRO . . . . . 0.477 ' HG2' HD11 ' A' ' 116' ' ' ILE . 56.2 Cg_endo -71.76 165.46 32.48 Favored 'Trans proline' 0 N--CA 1.462 -0.329 0 C-N-CA 123.318 2.678 . . . . 0.0 112.65 -175.441 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 16.3 mt-10 -116.65 155.79 28.19 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.843 -175.344 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 95' ' ' ILE . . . . . 0.53 HG22 ' O ' ' A' ' 114' ' ' ARG . 22.3 mt -82.37 135.77 24.24 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.469 0 CA-C-N 115.886 -0.597 . . . . 0.0 110.781 -178.711 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 73.16 19.6 79.68 Favored Glycine 0 N--CA 1.45 -0.394 0 CA-C-N 115.747 -0.661 . . . . 0.0 112.582 -175.822 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -96.48 119.51 35.1 Favored 'General case' 0 N--CA 1.452 -0.339 0 CA-C-O 121.54 0.686 . . . . 0.0 112.622 -179.32 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 98' ' ' ILE . . . . . 0.555 HG12 ' HB ' ' A' ' 112' ' ' VAL . 6.3 mt -88.69 107.46 17.78 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.665 0 N-CA-C 108.179 -1.045 . . . . 0.0 108.179 174.577 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 99' ' ' MET . . . . . . . . . . . . . 4.9 mtm -127.5 144.3 51.08 Favored 'General case' 0 N--CA 1.443 -0.786 0 N-CA-C 107.625 -1.25 . . . . 0.0 107.625 -175.607 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 100' ' ' LEU . . . . . 0.44 ' HB3' ' HB3' ' A' ' 108' ' ' GLU . 4.1 mm? -75.62 105.0 6.42 Favored 'General case' 0 C--N 1.311 -1.107 0 CA-C-N 116.494 -0.321 . . . . 0.0 110.873 -176.893 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 101' ' ' PHE . . . . . 0.408 ' CE1' ' HE2' ' A' ' 87' ' ' PHE . 42.9 m-85 -92.65 109.95 21.37 Favored 'General case' 0 CA--C 1.516 -0.346 0 CA-C-O 121.692 0.758 . . . . 0.0 110.915 -178.652 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 102' ' ' THR . . . . . 0.456 ' HA ' ' HA ' ' A' ' 108' ' ' GLU . 12.1 m -63.55 112.2 2.69 Favored 'General case' 0 C--N 1.311 -1.089 0 CA-C-N 114.411 -1.268 . . . . 0.0 113.038 -179.08 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -74.49 171.06 14.45 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-N 113.2 -1.818 . . . . 0.0 112.934 -178.945 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 104' ' ' MET . . . . . 0.487 ' C ' ' H ' ' A' ' 106' ' ' GLY . 4.2 mpp? -57.01 -33.5 67.22 Favored 'General case' 0 N--CA 1.465 0.276 0 CA-C-N 115.824 -0.625 . . . . 0.0 111.641 179.111 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 9.3 p-10 -76.93 22.05 0.2 Allowed 'General case' 0 N--CA 1.468 0.427 0 CA-C-O 121.528 0.68 . . . . 0.0 110.813 177.526 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 106' ' ' GLY . . . . . 0.487 ' H ' ' C ' ' A' ' 104' ' ' MET . . . 65.95 -7.84 1.06 Allowed Glycine 0 C--N 1.333 0.415 0 CA-C-N 114.649 -1.16 . . . . 0.0 114.694 -178.321 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 23.3 t -87.22 144.62 26.74 Favored 'General case' 0 CA--C 1.502 -0.902 0 CA-C-O 121.476 0.655 . . . . 0.0 110.705 -172.117 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 108' ' ' GLU . . . . . 0.456 ' HA ' ' HA ' ' A' ' 102' ' ' THR . 2.7 mp0 -80.45 156.41 26.62 Favored 'General case' 0 C--N 1.301 -1.531 0 CA-C-N 114.852 -1.067 . . . . 0.0 109.732 177.369 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 109' ' ' MET . . . . . 0.406 ' O ' ' HA ' ' A' ' 100' ' ' LEU . 96.5 mmm -136.61 125.04 15.07 Favored Pre-proline 0 C--N 1.314 -0.97 0 N-CA-C 107.563 -1.273 . . . . 0.0 107.563 -164.648 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 31.1 Cg_endo -69.39 119.08 6.09 Favored 'Trans proline' 0 N--CA 1.453 -0.887 0 CA-C-N 120.199 1.107 . . . . 0.0 110.644 175.145 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 111' ' ' GLY . . . . . 0.43 ' HA2' ' HA ' ' A' ' 125' ' ' PHE . . . -144.58 120.81 1.47 Allowed Glycine 0 N--CA 1.443 -0.895 0 CA-C-N 115.294 -0.866 . . . . 0.0 111.015 -172.202 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 112' ' ' VAL . . . . . 0.555 ' HB ' HG12 ' A' ' 98' ' ' ILE . 7.1 p -101.89 108.11 23.05 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.856 0 CA-C-O 122.058 0.933 . . . . 0.0 110.602 -179.819 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 113' ' ' ILE . . . . . 0.601 HG23 ' O ' ' A' ' 122' ' ' THR . 25.6 mt -61.2 109.89 0.56 Allowed 'Isoleucine or valine' 0 C--N 1.314 -0.966 0 CA-C-N 114.717 -1.129 . . . . 0.0 110.271 171.717 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 114' ' ' ARG . . . . . 0.53 ' O ' HG22 ' A' ' 95' ' ' ILE . 6.4 tmm_? -77.32 -32.56 55.37 Favored 'General case' 0 C--N 1.315 -0.908 0 CA-C-N 115.13 -0.941 . . . . 0.0 111.024 -173.833 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 115' ' ' GLU . . . . . 0.527 ' HB2' ' HD2' ' A' ' 114' ' ' ARG . 5.7 tt0 -159.98 160.9 33.91 Favored 'General case' 0 C--N 1.329 -0.315 0 N-CA-C 110.289 -0.263 . . . . 0.0 110.289 178.337 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 116' ' ' ILE . . . . . 0.488 HG12 ' CG1' ' A' ' 95' ' ' ILE . 29.4 mm -107.36 107.22 22.24 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.514 0 N-CA-C 109.581 -0.525 . . . . 0.0 109.581 173.909 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 117' ' ' ASN . . . . . 0.461 HD21 ' N ' ' A' ' 117' ' ' ASN . 0.9 OUTLIER -83.1 157.1 22.97 Favored 'General case' 0 C--N 1.313 -0.987 0 N-CA-C 108.906 -0.776 . . . . 0.0 108.906 178.33 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . -57.17 -48.54 79.15 Favored Glycine 0 N--CA 1.449 -0.457 0 C-N-CA 120.382 -0.913 . . . . 0.0 112.763 -172.987 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 119' ' ' ASP . . . . . 0.644 ' HA ' ' HD3' ' A' ' 84' ' ' ARG . 1.4 m-20 -107.8 -15.26 14.6 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-O 121.088 0.471 . . . . 0.0 111.346 -178.062 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 120' ' ' SER . . . . . 0.445 ' O ' ' HB2' ' A' ' 117' ' ' ASN . 32.4 t -123.38 157.76 32.63 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-N 115.878 -0.601 . . . . 0.0 111.158 -169.508 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 121' ' ' ILE . . . . . . . . . . . . . 50.0 mm -113.68 137.27 47.39 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.523 0 CA-C-O 121.165 0.507 . . . . 0.0 110.253 175.951 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 122' ' ' THR . . . . . 0.601 ' O ' HG23 ' A' ' 113' ' ' ILE . 3.6 m -93.98 142.21 27.64 Favored 'General case' 0 C--N 1.318 -0.776 0 CA-C-N 115.167 -0.924 . . . . 0.0 110.095 178.014 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 123' ' ' VAL . . . . . 0.559 ' HB ' ' O ' ' A' ' 80' ' ' GLN . 33.9 t -147.05 107.99 0.66 Allowed 'Isoleucine or valine' 0 N--CA 1.466 0.353 0 C-N-CA 117.085 -1.846 . . . . 0.0 110.385 -165.221 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 124' ' ' ASP . . . . . 0.448 ' HB3' HG13 ' A' ' 112' ' ' VAL . 28.6 t70 -107.98 101.64 10.88 Favored 'General case' 0 C--N 1.313 -1.006 0 C-N-CA 119.397 -0.921 . . . . 0.0 112.545 174.064 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 125' ' ' PHE . . . . . 0.43 ' HA ' ' HA2' ' A' ' 111' ' ' GLY . 83.5 m-85 -81.63 6.89 13.71 Favored 'General case' 0 N--CA 1.47 0.542 0 CA-C-N 116.285 -0.416 . . . . 0.0 110.894 178.459 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 7.7 m-80 -57.51 137.74 55.93 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-O 122.054 0.93 . . . . 0.0 111.023 179.656 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 127' ' ' HIS . . . . . 0.515 ' HB3' ' HD2' ' A' ' 128' ' ' PRO . 22.8 m170 -72.39 -174.23 0.29 Allowed Pre-proline 0 C--N 1.321 -0.632 0 CA-C-N 113.654 -1.612 . . . . 0.0 112.576 -168.481 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 128' ' ' PRO . . . . . 0.515 ' HD2' ' HB3' ' A' ' 127' ' ' HIS . 4.5 Cg_exo -42.13 174.92 0.0 OUTLIER 'Trans proline' 0 C--N 1.354 0.845 0 C-N-CA 124.671 3.58 . . . . 0.0 113.412 161.733 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 129' ' ' LEU . . . . . . . . . . . . . 3.6 tp -49.37 40.64 0.0 OUTLIER 'General case' 0 N--CA 1.488 1.428 0 C-N-CA 127.455 2.302 . . . . 0.0 116.097 -172.339 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 130' ' ' ALA . . . . . 0.507 ' N ' ' O ' ' A' ' 128' ' ' PRO . . . -88.11 175.17 7.85 Favored 'General case' 0 C--N 1.31 -1.122 0 N-CA-C 109.369 -0.604 . . . . 0.0 109.369 -178.897 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . 71.18 26.93 72.72 Favored Glycine 0 N--CA 1.449 -0.491 0 C-N-CA 120.473 -0.87 . . . . 0.0 113.287 178.27 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 132' ' ' GLN . . . . . . . . . . . . . 4.0 pt20 -148.03 157.22 43.4 Favored 'General case' 0 C--N 1.328 -0.358 0 N-CA-C 110.192 -0.299 . . . . 0.0 110.192 176.038 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 133' ' ' THR . . . . . . . . . . . . . 21.5 m -72.11 113.04 8.72 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 116.101 -0.499 . . . . 0.0 110.942 -176.183 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 134' ' ' VAL . . . . . . . . . . . . . 30.6 m -102.75 171.68 1.52 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.609 0 CA-C-O 121.556 0.693 . . . . 0.0 110.999 179.624 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 135' ' ' HIS . . . . . 0.642 ' O ' HD21 ' A' ' 17' ' ' LEU . 13.8 m-70 -132.66 140.56 48.21 Favored 'General case' 0 C--N 1.318 -0.768 0 N-CA-C 107.548 -1.279 . . . . 0.0 107.548 -172.236 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 136' ' ' PHE . . . . . 0.559 ' CE2' HD23 ' A' ' 17' ' ' LEU . 9.3 m-85 -125.42 122.76 37.64 Favored 'General case' 0 C--N 1.311 -1.107 0 C-N-CA 120.492 -0.483 . . . . 0.0 112.188 -169.545 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 137' ' ' ASP . . . . . 0.62 ' O ' ' HA ' ' A' ' 15' ' ' PHE . 5.0 m-20 -115.82 100.8 8.26 Favored 'General case' 0 C--N 1.322 -0.628 0 N-CA-C 108.479 -0.934 . . . . 0.0 108.479 171.156 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 138' ' ' ILE . . . . . 0.498 ' CD1' ' HB3' ' A' ' 136' ' ' PHE . 4.4 mp -110.57 129.74 65.15 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.644 0 CA-C-O 121.229 0.538 . . . . 0.0 111.936 -177.535 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 139' ' ' GLU . . . . . 0.573 ' HG2' ' HG2' ' A' ' 60' ' ' LYS . 34.2 mt-10 -122.11 109.07 14.07 Favored 'General case' 0 N--CA 1.447 -0.601 0 CA-C-N 115.244 -0.889 . . . . 0.0 109.006 172.245 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 140' ' ' VAL . . . . . . . . . . . . . 58.9 t -59.63 119.55 4.15 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.499 0 CA-C-N 115.779 -0.646 . . . . 0.0 110.933 -179.276 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 141' ' ' LEU . . . . . 0.554 HD12 ' CD2' ' A' ' 14' ' ' HIS . 37.7 mt -90.51 -49.49 6.47 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 116.372 -0.376 . . . . 0.0 110.498 179.554 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 142' ' ' GLU . . . . . . . . . . . . . 44.3 mt-10 -156.87 158.88 37.53 Favored 'General case' 0 CA--C 1.519 -0.222 0 N-CA-C 108.835 -0.802 . . . . 0.0 108.835 -177.036 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 143' ' ' ILE . . . . . 0.487 HD13 HG22 ' A' ' 57' ' ' VAL . 97.4 mt -128.35 115.45 38.08 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.837 0 CA-C-O 121.139 0.495 . . . . 0.0 111.852 179.609 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 144' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -77.95 128.59 78.51 Favored Pre-proline 0 C--O 1.235 0.318 0 CA-C-N 115.397 -0.82 . . . . 0.0 109.069 172.582 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 145' ' ' PRO . . . . . . . . . . . . . 18.3 Cg_endo -60.35 152.77 64.69 Favored 'Trans proline' 0 C--O 1.233 0.228 0 C-N-CA 123.126 2.55 . . . . 0.0 114.183 -172.379 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 146' ' ' ALA . . . . . . . . . . . . . . . -98.73 136.83 38.21 Favored 'General case' 0 C--N 1.318 -0.768 0 CA-C-N 114.479 -1.237 . . . . 0.0 108.684 172.763 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 3.7 mm? -81.46 15.08 2.18 Favored 'General case' 0 C--N 1.32 -0.682 0 N-CA-C 111.81 0.3 . . . . 0.0 111.81 -172.857 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 8.3 pt-20 . . . . . 0 C--N 1.324 -0.536 0 CA-C-N 116.54 -0.3 . . . . 0.0 111.072 176.624 . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 2' ' ' SER . . . . . 0.487 ' HB3' ' HA ' ' A' ' 145' ' ' PRO . 6.2 p . . . . . 0 N--CA 1.455 -0.183 0 CA-C-O 121.145 0.498 . . . . 0.0 110.705 . . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 3.3 mp0 -77.38 -35.44 54.45 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-O 121.653 0.74 . . . . 0.0 109.77 -179.006 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 16.1 p -133.26 157.56 45.12 Favored 'General case' 0 C--N 1.315 -0.904 0 CA-C-N 114.893 -1.049 . . . . 0.0 109.745 -179.629 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 5' ' ' VAL . . . . . 0.67 HG13 ' HA ' ' A' ' 53' ' ' LEU . 10.2 p -71.11 139.04 20.57 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.573 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.04 -178.04 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 6' ' ' GLN . . . . . . . . . . . . . 2.9 pt20 -142.7 164.15 30.88 Favored 'General case' 0 C--N 1.314 -0.954 0 N-CA-C 108.549 -0.908 . . . . 0.0 108.549 179.149 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 83.2 p -67.41 136.32 54.53 Favored 'General case' 0 C--N 1.316 -0.886 0 C-N-CA 120.724 -0.391 . . . . 0.0 110.453 -178.154 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 66.6 t30 71.27 28.43 3.0 Favored 'General case' 0 CA--C 1.538 0.488 0 C-N-CA 123.449 0.699 . . . . 0.0 111.667 -178.697 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 49.6 m -128.54 132.99 48.29 Favored 'General case' 0 C--N 1.327 -0.374 0 O-C-N 121.623 -0.673 . . . . 0.0 110.166 174.011 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -83.2 165.78 19.16 Favored 'General case' 0 C--N 1.322 -0.63 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.765 -171.862 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 33.0 m -143.46 139.7 26.25 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.685 0 CA-C-O 120.924 0.392 . . . . 0.0 110.281 -175.585 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 12' ' ' LEU . . . . . 0.519 HD12 ' HB3' ' A' ' 142' ' ' GLU . 75.7 mt -86.0 124.07 32.03 Favored 'General case' 0 C--N 1.319 -0.752 0 N-CA-C 108.127 -1.064 . . . . 0.0 108.127 173.253 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 13' ' ' VAL . . . . . 0.621 HG21 HG23 ' A' ' 138' ' ' ILE . 3.5 p -136.06 153.24 31.6 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.912 0 CA-C-O 122.289 1.042 . . . . 0.0 112.993 -167.348 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 14' ' ' HIS . . . . . . . . . . . . . 1.9 m-70 -123.72 116.16 22.59 Favored 'General case' 0 C--N 1.313 -1.008 0 CA-C-N 113.359 -1.746 . . . . 0.0 106.58 167.654 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 15' ' ' PHE . . . . . 0.57 ' HB2' ' O ' ' A' ' 137' ' ' ASP . 16.5 p90 -142.12 168.95 18.52 Favored 'General case' 0 C--N 1.317 -0.826 0 C-N-CA 119.2 -1.0 . . . . 0.0 112.531 -172.452 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 21.5 m -145.9 142.7 29.01 Favored 'General case' 0 C--N 1.321 -0.631 0 CA-C-N 115.076 -0.965 . . . . 0.0 110.438 176.253 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 17' ' ' LEU . . . . . 0.499 HD13 ' HB3' ' A' ' 136' ' ' PHE . 0.0 OUTLIER -105.68 128.43 53.66 Favored 'General case' 0 C--N 1.326 -0.424 0 N-CA-C 109.527 -0.545 . . . . 0.0 109.527 -175.621 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 18' ' ' LYS . . . . . 0.502 ' HA ' ' O ' ' A' ' 23' ' ' THR . 0.1 OUTLIER -125.56 136.85 53.75 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-O 121.663 0.744 . . . . 0.0 112.204 -174.256 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 19' ' ' LEU . . . . . 0.478 HD23 ' HB ' ' A' ' 23' ' ' THR . 3.5 mm? -78.2 174.74 10.87 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 114.96 -1.018 . . . . 0.0 109.963 172.683 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 23.9 m-20 -60.74 -27.83 68.23 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-O 120.797 0.332 . . . . 0.0 111.08 176.905 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 35.8 t70 -80.61 5.02 16.67 Favored 'General case' 0 N--CA 1.474 0.739 0 CA-C-O 122.224 1.011 . . . . 0.0 109.926 174.224 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 66.91 19.3 69.57 Favored Glycine 0 N--CA 1.451 -0.363 0 CA-C-N 114.259 -1.337 . . . . 0.0 112.478 -175.944 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 23' ' ' THR . . . . . 0.502 ' O ' ' HA ' ' A' ' 18' ' ' LYS . 17.4 m -72.55 142.7 48.46 Favored 'General case' 0 C--N 1.323 -0.544 0 N-CA-C 110.33 -0.248 . . . . 0.0 110.33 178.473 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 59.0 m -77.05 107.9 9.74 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-O 120.871 0.367 . . . . 0.0 111.026 179.32 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 25' ' ' ALA . . . . . 0.422 ' HB3' ' HB3' ' A' ' 17' ' ' LEU . . . -77.29 -35.51 55.04 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-O 121.405 0.621 . . . . 0.0 109.567 174.709 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 9.0 tp10 -160.48 142.72 12.85 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 115.033 -0.985 . . . . 0.0 108.896 -179.419 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 19.6 t -124.75 149.42 47.33 Favored 'General case' 0 C--N 1.313 -1.007 0 N-CA-C 109.09 -0.707 . . . . 0.0 109.09 175.125 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 28' ' ' THR . . . . . 0.461 HG21 ' HB2' ' A' ' 35' ' ' ALA . 36.6 m -148.23 44.55 1.05 Allowed 'General case' 0 N--CA 1.437 -1.113 0 CA-C-O 123.79 1.757 . . . . 0.0 106.819 172.764 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 52.9 ttp180 -151.65 -45.96 0.11 Allowed 'General case' 0 C--N 1.312 -1.052 0 CA-C-N 112.653 -2.067 . . . . 0.0 109.681 -178.784 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 91.6 m-20 -67.81 -25.73 65.73 Favored 'General case' 0 N--CA 1.464 0.272 0 CA-C-O 121.087 0.47 . . . . 0.0 110.549 177.643 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 71.8 m-20 -76.53 -12.66 60.06 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.595 -0.729 . . . . 0.0 110.65 179.898 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 83.01 -1.37 88.81 Favored Glycine 0 N--CA 1.45 -0.371 0 C-N-CA 120.989 -0.624 . . . . 0.0 111.804 -179.691 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 59.4 mttp -107.41 121.68 43.64 Favored Pre-proline 0 C--N 1.321 -0.659 0 CA-C-N 115.717 -0.242 . . . . 0.0 110.698 -177.952 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 7.8 Cg_exo -76.48 168.94 22.84 Favored 'Trans proline' 0 N--CA 1.46 -0.491 0 C-N-CA 122.938 2.426 . . . . 0.0 112.118 172.113 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 35' ' ' ALA . . . . . 0.461 ' HB2' HG21 ' A' ' 28' ' ' THR . . . -140.89 161.7 37.2 Favored 'General case' 0 C--N 1.312 -1.04 0 CA-C-N 115.097 -0.956 . . . . 0.0 109.592 179.383 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 3.8 tp -112.89 130.77 55.99 Favored 'General case' 0 N--CA 1.445 -0.722 0 N-CA-C 110.049 -0.352 . . . . 0.0 110.049 175.968 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 37' ' ' PHE . . . . . . . . . . . . . 9.4 m-30 -95.98 112.14 23.95 Favored 'General case' 0 C--N 1.318 -0.77 0 N-CA-C 110.055 -0.35 . . . . 0.0 110.055 175.411 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 38' ' ' ARG . . . . . 0.567 ' HB3' ' HB3' ' A' ' 42' ' ' ALA . 22.3 mmm180 -83.46 106.91 15.59 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-O 121.351 0.596 . . . . 0.0 110.957 -179.513 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 10.9 mp -81.84 154.18 26.01 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-N 115.104 -0.953 . . . . 0.0 110.979 178.278 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 91.79 41.11 5.11 Favored Glycine 0 N--CA 1.449 -0.455 0 C-N-CA 120.915 -0.66 . . . . 0.0 113.06 176.575 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 16.6 m-20 58.46 23.55 10.81 Favored 'General case' 0 N--CA 1.468 0.429 0 CA-C-O 120.873 0.368 . . . . 0.0 111.374 177.78 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 42' ' ' ALA . . . . . 0.567 ' HB3' ' HB3' ' A' ' 38' ' ' ARG . . . -86.48 -27.37 24.11 Favored 'General case' 0 C--N 1.323 -0.587 0 CA-C-O 121.027 0.441 . . . . 0.0 110.278 -178.162 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 40.8 m -154.31 -45.09 0.09 Allowed 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 115.821 -0.627 . . . . 0.0 109.532 175.585 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 51.5 mt -102.81 159.34 15.57 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 115.775 -0.648 . . . . 0.0 110.179 178.482 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 50.1 m -84.45 161.72 20.19 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-N 115.853 -0.612 . . . . 0.0 110.765 -177.546 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 45.2 mt-10 -57.4 -26.8 61.66 Favored 'General case' 0 N--CA 1.463 0.202 0 CA-C-N 115.858 -0.61 . . . . 0.0 111.715 -177.213 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -58.86 -36.72 88.6 Favored Glycine 0 N--CA 1.45 -0.403 0 C-N-CA 121.086 -0.578 . . . . 0.0 112.546 -175.808 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 3.0 tt -76.22 -36.53 58.51 Favored 'General case' 0 CA--C 1.515 -0.387 0 CA-C-O 121.768 0.794 . . . . 0.0 110.388 -179.122 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 7.2 tt0 -66.79 -46.68 74.49 Favored 'General case' 0 C--N 1.318 -0.785 0 CA-C-N 114.273 -1.331 . . . . 0.0 108.827 -176.472 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 50' ' ' GLN . . . . . 0.518 ' HA ' HD22 ' A' ' 53' ' ' LEU . 82.9 mm-40 -62.67 -16.4 56.86 Favored 'General case' 0 C--N 1.314 -0.936 0 CA-C-N 113.504 -1.68 . . . . 0.0 112.396 -176.069 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 51' ' ' HIS . . . . . . . . . . . . . 14.1 m-70 -105.34 -3.48 22.67 Favored 'General case' 0 C--O 1.233 0.223 0 C-N-CA 120.221 -0.591 . . . . 0.0 111.663 176.21 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 52' ' ' LEU . . . . . 0.563 ' O ' HG11 ' A' ' 5' ' ' VAL . 6.1 mt -99.98 -23.66 14.85 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 116.461 -0.336 . . . . 0.0 111.866 -178.493 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 53' ' ' LEU . . . . . 0.67 ' HA ' HG13 ' A' ' 5' ' ' VAL . 0.0 OUTLIER -59.85 152.21 23.78 Favored 'General case' 0 CA--C 1.53 0.209 0 CA-C-O 121.316 0.579 . . . . 0.0 112.286 -177.124 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 94.26 -17.14 59.5 Favored Glycine 0 N--CA 1.451 -0.306 0 CA-C-N 115.296 -0.865 . . . . 0.0 113.557 175.964 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 55' ' ' LEU . . . . . 0.532 ' O ' HG12 ' A' ' 5' ' ' VAL . 16.0 tp -84.9 158.97 20.43 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-O 121.099 0.476 . . . . 0.0 110.975 177.677 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 56' ' ' LYS . . . . . 0.563 ' HD3' ' N ' ' A' ' 57' ' ' VAL . 12.8 tmtt? -120.11 162.89 18.54 Favored 'General case' 0 C--N 1.325 -0.487 0 N-CA-C 109.768 -0.456 . . . . 0.0 109.768 -176.331 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 57' ' ' VAL . . . . . 0.563 ' N ' ' HD3' ' A' ' 56' ' ' LYS . 42.1 t -57.76 147.74 6.04 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-O 120.889 0.376 . . . . 0.0 111.259 177.491 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 80.6 9.46 86.39 Favored Glycine 0 N--CA 1.451 -0.334 0 CA-C-N 115.852 -0.613 . . . . 0.0 113.575 -177.712 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 2.5 m-20 -121.53 162.55 20.36 Favored 'General case' 0 CA--C 1.513 -0.46 0 CA-C-O 121.022 0.439 . . . . 0.0 110.828 178.364 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 60' ' ' LYS . . . . . 0.593 ' HB3' ' HG2' ' A' ' 139' ' ' GLU . 1.1 ptmt -135.15 146.15 48.49 Favored 'General case' 0 C--N 1.316 -0.855 0 CA-C-N 115.576 -0.738 . . . . 0.0 109.133 179.136 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 12.1 t -142.76 143.35 32.17 Favored 'General case' 0 C--N 1.318 -0.793 0 CA-C-O 121.13 0.491 . . . . 0.0 109.754 -178.612 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 3.7 m -109.17 138.52 45.39 Favored 'General case' 0 C--N 1.311 -1.101 0 N-CA-C 108.889 -0.782 . . . . 0.0 108.889 176.668 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 63' ' ' PHE . . . . . 0.544 ' CZ ' HD12 ' A' ' 138' ' ' ILE . 31.4 p90 -158.36 158.85 35.07 Favored 'General case' 0 C--N 1.321 -0.653 0 CA-C-O 121.238 0.542 . . . . 0.0 111.42 -179.444 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 64' ' ' SER . . . . . 0.425 ' O ' ' HG ' ' A' ' 65' ' ' LEU . 26.1 t -104.73 159.42 15.8 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-N 115.197 -0.911 . . . . 0.0 109.71 -179.204 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 65' ' ' LEU . . . . . 0.479 HD12 ' CZ ' ' A' ' 136' ' ' PHE . 18.5 mt -161.09 151.38 17.71 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 116.302 -0.408 . . . . 0.0 110.698 -171.975 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 48.0 mt-10 -69.86 152.79 95.92 Favored Pre-proline 0 C--N 1.321 -0.662 0 CA-C-N 115.796 -0.638 . . . . 0.0 109.365 174.485 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 3.4 Cg_exo -42.45 -49.71 6.13 Favored 'Trans proline' 0 CA--C 1.532 0.406 0 C-N-CA 123.673 2.915 . . . . 0.0 113.865 -176.804 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -56.86 -31.12 64.48 Favored 'General case' 0 N--CA 1.468 0.439 0 CA-C-N 115.996 -0.547 . . . . 0.0 111.784 179.84 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 69' ' ' ALA . . . . . 0.415 ' O ' HD13 ' A' ' 65' ' ' LEU . . . -98.26 16.75 20.46 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.825 -175.67 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.323 -0.559 0 N-CA-C 108.944 -0.762 . . . . 0.0 108.944 -173.24 . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 75' ' ' SER . . . . . 0.471 ' HB2' HD23 ' A' ' 78' ' ' LEU . 54.7 m . . . . . 0 N--CA 1.447 -0.591 0 N-CA-C 112.031 0.382 . . . . 0.0 112.031 . . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 76' ' ' PRO . . . . . 0.453 ' HD2' ' HA ' ' A' ' 75' ' ' SER . 36.3 Cg_endo -67.53 -14.25 41.69 Favored 'Trans proline' 0 N--CA 1.462 -0.333 0 C-N-CA 122.692 2.261 . . . . 0.0 112.043 174.996 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 23.8 t70 -64.03 -19.61 65.32 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.689 -178.801 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 78' ' ' LEU . . . . . 0.6 ' HB3' ' HB2' ' A' ' 125' ' ' PHE . 3.0 mm? -88.66 -1.12 57.91 Favored 'General case' 0 CA--C 1.513 -0.469 0 C-N-CA 120.697 -0.401 . . . . 0.0 110.775 -179.611 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 79' ' ' ILE . . . . . 0.64 HG23 ' O ' ' A' ' 123' ' ' VAL . 20.2 mt -65.4 128.51 28.32 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.594 0 CA-C-O 121.921 0.867 . . . . 0.0 111.335 -178.243 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 80' ' ' GLN . . . . . 0.573 ' O ' ' HB ' ' A' ' 123' ' ' VAL . 49.5 mt-30 -135.81 138.88 43.02 Favored 'General case' 0 C--N 1.319 -0.76 0 CA-C-N 114.14 -1.391 . . . . 0.0 108.736 -174.274 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 81' ' ' TYR . . . . . 0.447 ' CE2' HG23 ' A' ' 122' ' ' THR . 73.1 m-85 -107.17 110.3 22.33 Favored 'General case' 0 C--N 1.32 -0.691 0 C-N-CA 119.707 -0.797 . . . . 0.0 110.276 -179.117 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 48.9 m-85 -104.81 168.55 8.99 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-N 115.881 -0.599 . . . . 0.0 110.684 172.495 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 22.6 t -87.22 157.99 19.21 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-O 121.365 0.603 . . . . 0.0 111.209 -176.883 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 84' ' ' ARG . . . . . 0.402 ' HG3' ' HD2' ' A' ' 85' ' ' ARG . 12.5 ptm180 -61.86 -34.74 76.54 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 115.22 -0.9 . . . . 0.0 109.825 175.961 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 85' ' ' ARG . . . . . 0.402 ' HD2' ' HG3' ' A' ' 84' ' ' ARG . 5.1 mpt_? -54.7 -28.08 45.22 Favored 'General case' 0 C--N 1.32 -0.7 0 CA-C-N 113.952 -1.476 . . . . 0.0 111.781 176.092 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 21.2 mm-40 -79.86 -20.2 46.48 Favored 'General case' 0 C--N 1.32 -0.689 0 CA-C-O 121.105 0.478 . . . . 0.0 111.389 179.396 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 87' ' ' PHE . . . . . . . . . . . . . 57.0 m-85 -104.22 -20.5 13.77 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 116.093 -0.503 . . . . 0.0 111.558 -176.076 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 88' ' ' MET . . . . . . . . . . . . . 22.5 ttm -56.13 -38.37 70.72 Favored 'General case' 0 C--N 1.323 -0.556 0 N-CA-C 112.307 0.484 . . . . 0.0 112.307 -173.239 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 2.3 m-20 -53.98 -27.46 31.58 Favored 'General case' 0 C--N 1.328 -0.327 0 N-CA-C 112.362 0.504 . . . . 0.0 112.362 176.709 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -110.47 14.81 22.46 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-O 120.957 0.408 . . . . 0.0 110.554 179.834 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 92.3 138.85 8.57 Favored Glycine 0 N--CA 1.448 -0.566 0 C-N-CA 120.837 -0.696 . . . . 0.0 111.973 -178.554 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 63.6 mt-10 -62.47 122.13 71.53 Favored Pre-proline 0 C--N 1.324 -0.532 0 CA-C-O 121.148 0.499 . . . . 0.0 110.906 -179.632 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 93' ' ' PRO . . . . . 0.5 ' HG2' HD12 ' A' ' 121' ' ' ILE . 43.9 Cg_endo -72.95 168.12 25.53 Favored 'Trans proline' 0 CA--C 1.516 -0.393 0 C-N-CA 123.777 2.984 . . . . 0.0 114.123 -173.214 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 94' ' ' GLU . . . . . 0.414 ' HB2' ' HB2' ' A' ' 97' ' ' ALA . 3.4 mp0 -114.07 160.03 19.35 Favored 'General case' 0 N--CA 1.444 -0.742 0 CA-C-N 114.181 -1.372 . . . . 0.0 110.54 -172.357 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 95' ' ' ILE . . . . . 0.533 HG12 HG12 ' A' ' 116' ' ' ILE . 11.3 mt -78.2 131.7 33.99 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.446 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.535 178.829 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 71.76 24.02 77.24 Favored Glycine 0 N--CA 1.445 -0.708 0 CA-C-N 115.629 -0.714 . . . . 0.0 111.963 -176.626 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 97' ' ' ALA . . . . . 0.414 ' HB2' ' HB2' ' A' ' 94' ' ' GLU . . . -103.29 117.42 34.47 Favored 'General case' 0 N--CA 1.449 -0.502 0 CA-C-O 121.937 0.875 . . . . 0.0 110.661 179.456 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 98' ' ' ILE . . . . . 0.565 ' HA ' ' HA ' ' A' ' 112' ' ' VAL . 4.1 mt -97.97 120.51 47.4 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.294 0 CA-C-N 114.481 -1.236 . . . . 0.0 108.726 -176.012 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 99' ' ' MET . . . . . . . . . . . . . 8.3 mtm -133.91 149.65 51.3 Favored 'General case' 0 N--CA 1.439 -0.99 0 N-CA-C 106.922 -1.51 . . . . 0.0 106.922 -177.949 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 3.2 mm? -70.38 119.7 14.94 Favored 'General case' 0 C--N 1.311 -1.087 0 CA-C-O 122.313 1.054 . . . . 0.0 113.044 -176.417 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 101' ' ' PHE . . . . . 0.647 ' O ' ' HA ' ' A' ' 108' ' ' GLU . 20.8 m-85 -109.7 175.89 5.28 Favored 'General case' 0 C--O 1.22 -0.452 0 CA-C-N 113.05 -1.886 . . . . 0.0 111.47 -175.533 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 9.2 m -124.84 109.65 13.31 Favored 'General case' 0 N--CA 1.466 0.373 0 C-N-CA 120.492 -0.483 . . . . 0.0 111.136 -166.248 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -77.3 170.3 16.78 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-N 115.733 -0.667 . . . . 0.0 112.483 178.659 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 104' ' ' MET . . . . . 0.421 ' C ' ' H ' ' A' ' 106' ' ' GLY . 3.7 mpp? -58.93 -37.71 77.31 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 115.659 -0.7 . . . . 0.0 111.193 -179.783 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 11.1 p-10 -78.59 22.97 0.33 Allowed 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 121.381 0.61 . . . . 0.0 110.665 177.774 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 106' ' ' GLY . . . . . 0.421 ' H ' ' C ' ' A' ' 104' ' ' MET . . . 66.39 -12.04 0.5 Allowed Glycine 0 C--N 1.337 0.623 0 CA-C-N 115.178 -0.919 . . . . 0.0 114.812 -174.869 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 46.6 t -65.74 132.72 49.43 Favored 'General case' 0 CA--C 1.501 -0.912 0 CA-C-O 122.063 0.935 . . . . 0.0 110.896 -171.909 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 108' ' ' GLU . . . . . 0.647 ' HA ' ' O ' ' A' ' 101' ' ' PHE . 2.1 tt0 -90.77 104.04 16.68 Favored 'General case' 0 C--N 1.297 -1.677 0 CA-C-N 114.146 -1.388 . . . . 0.0 109.128 178.907 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 109' ' ' MET . . . . . . . . . . . . . 1.7 mtm -102.63 148.32 35.34 Favored Pre-proline 0 CA--C 1.511 -0.549 0 N-CA-C 108.096 -1.076 . . . . 0.0 108.096 -178.138 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 29.6 Cg_endo -63.85 146.14 91.34 Favored 'Trans proline' 0 N--CA 1.45 -1.046 0 C-N-CA 121.325 1.35 . . . . 0.0 110.482 172.999 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 111' ' ' GLY . . . . . 0.493 ' HA3' ' CD2' ' A' ' 101' ' ' PHE . . . -143.35 107.76 0.48 Allowed Glycine 0 N--CA 1.439 -1.138 0 N-CA-C 109.763 -1.335 . . . . 0.0 109.763 -173.359 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 112' ' ' VAL . . . . . 0.84 HG13 ' HB3' ' A' ' 124' ' ' ASP . 2.9 p -87.57 107.55 17.37 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.876 0 C-N-CA 118.798 -1.161 . . . . 0.0 109.976 -174.779 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 113' ' ' ILE . . . . . . . . . . . . . 34.8 mt -62.91 108.46 0.59 Allowed 'Isoleucine or valine' 0 N--CA 1.436 -1.168 0 N-CA-C 108.531 -0.915 . . . . 0.0 108.531 170.525 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 114' ' ' ARG . . . . . 0.419 ' O ' HG23 ' A' ' 95' ' ' ILE . 6.3 tpp180 -75.37 -42.72 53.36 Favored 'General case' 0 C--N 1.308 -1.203 0 CA-C-N 113.853 -1.521 . . . . 0.0 111.06 -168.969 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 115' ' ' GLU . . . . . 0.5 ' HA ' HG23 ' A' ' 95' ' ' ILE . 8.3 tt0 -159.57 156.78 28.65 Favored 'General case' 0 C--N 1.32 -0.694 0 N-CA-C 109.622 -0.51 . . . . 0.0 109.622 -176.381 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 116' ' ' ILE . . . . . 0.533 HG12 HG12 ' A' ' 95' ' ' ILE . 38.8 mm -111.48 115.28 49.45 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.528 0 N-CA-C 109.907 -0.405 . . . . 0.0 109.907 179.68 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 117' ' ' ASN . . . . . 0.448 ' HB2' ' O ' ' A' ' 120' ' ' SER . 3.7 m-20 -99.51 154.69 18.04 Favored 'General case' 0 C--N 1.316 -0.858 0 N-CA-C 108.8 -0.815 . . . . 0.0 108.8 176.672 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . -62.3 -28.0 70.19 Favored Glycine 0 N--CA 1.45 -0.395 0 CA-C-N 115.929 -0.578 . . . . 0.0 113.648 -173.78 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 11.8 t70 -114.87 -17.63 11.5 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 117.004 0.402 . . . . 0.0 111.77 179.08 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 120' ' ' SER . . . . . 0.448 ' O ' ' HB2' ' A' ' 117' ' ' ASN . 14.8 t -137.59 157.8 45.74 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-O 121.179 0.514 . . . . 0.0 111.281 -169.662 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 121' ' ' ILE . . . . . 0.5 HD12 ' HG2' ' A' ' 93' ' ' PRO . 45.1 mm -110.13 132.91 57.12 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.811 0 CA-C-N 116.102 -0.499 . . . . 0.0 109.963 177.376 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 122' ' ' THR . . . . . 0.447 HG23 ' CE2' ' A' ' 81' ' ' TYR . 4.6 m -92.44 103.34 15.78 Favored 'General case' 0 N--CA 1.442 -0.848 0 CA-C-O 122.142 0.972 . . . . 0.0 109.924 178.233 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 123' ' ' VAL . . . . . 0.64 ' O ' HG23 ' A' ' 79' ' ' ILE . 18.8 t -93.86 156.51 3.09 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.005 0 CA-C-N 113.54 -1.664 . . . . 0.0 110.355 177.581 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 124' ' ' ASP . . . . . 0.84 ' HB3' HG13 ' A' ' 112' ' ' VAL . 10.8 t0 -151.06 94.08 2.01 Favored 'General case' 0 C--N 1.317 -0.827 0 CA-C-N 115.216 -0.902 . . . . 0.0 109.684 -176.596 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 125' ' ' PHE . . . . . 0.6 ' HB2' ' HB3' ' A' ' 78' ' ' LEU . 84.4 m-85 -84.68 96.83 9.34 Favored 'General case' 0 CA--C 1.51 -0.593 0 CA-C-O 122.041 0.924 . . . . 0.0 110.517 177.537 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 7.1 m-20 . . . . . 0 C--N 1.299 -1.611 0 CA-C-N 114.297 -1.32 . . . . 0.0 109.763 173.261 . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 133' ' ' THR . . . . . . . . . . . . . 24.0 m . . . . . 0 N--CA 1.455 -0.181 0 CA-C-O 120.82 0.343 . . . . 0.0 110.974 . . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 134' ' ' VAL . . . . . 0.436 ' HB ' ' CD1' ' A' ' 17' ' ' LEU . 2.6 m -134.2 146.29 31.57 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.362 0 N-CA-C 112.297 0.48 . . . . 0.0 112.297 -174.397 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 135' ' ' HIS . . . . . . . . . . . . . 26.1 m-70 -98.32 120.41 38.68 Favored 'General case' 0 N--CA 1.465 0.315 0 CA-C-N 116.0 -0.545 . . . . 0.0 110.618 178.734 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 136' ' ' PHE . . . . . 0.499 ' HB3' HD13 ' A' ' 17' ' ' LEU . 3.1 p90 -128.78 150.83 50.13 Favored 'General case' 0 C--N 1.321 -0.653 0 N-CA-C 113.894 1.072 . . . . 0.0 113.894 179.287 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 137' ' ' ASP . . . . . 0.57 ' O ' ' HB2' ' A' ' 15' ' ' PHE . 5.1 m-20 -100.38 140.29 34.84 Favored 'General case' 0 CA--C 1.508 -0.639 0 CA-C-N 114.139 -1.392 . . . . 0.0 107.706 174.666 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 138' ' ' ILE . . . . . 0.621 HG23 HG21 ' A' ' 13' ' ' VAL . 60.2 mt -137.32 132.99 46.48 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.836 0 CA-C-O 120.761 0.315 . . . . 0.0 110.526 -179.911 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 139' ' ' GLU . . . . . 0.593 ' HG2' ' HB3' ' A' ' 60' ' ' LYS . 28.3 mt-10 -105.65 144.36 32.5 Favored 'General case' 0 CA--C 1.514 -0.439 0 CA-C-N 116.494 -0.321 . . . . 0.0 110.749 -179.3 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 140' ' ' VAL . . . . . 0.441 ' CG1' ' HA ' ' A' ' 57' ' ' VAL . 37.6 t -97.71 104.66 16.19 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.886 0 N-CA-C 108.366 -0.976 . . . . 0.0 108.366 169.415 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 41.1 mt -91.67 -51.62 5.15 Favored 'General case' 0 C--N 1.318 -0.769 0 N-CA-C 109.347 -0.612 . . . . 0.0 109.347 -178.362 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 142' ' ' GLU . . . . . 0.519 ' HB3' HD12 ' A' ' 12' ' ' LEU . 40.9 tt0 -150.95 148.61 28.62 Favored 'General case' 0 C--N 1.321 -0.654 0 CA-C-N 115.55 -0.75 . . . . 0.0 109.236 169.393 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 143' ' ' ILE . . . . . 0.536 HD12 HG23 ' A' ' 57' ' ' VAL . 74.5 mt -103.52 136.2 37.52 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.7 0 CA-C-O 120.811 0.339 . . . . 0.0 110.109 -178.152 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 144' ' ' ASP . . . . . . . . . . . . . 29.0 t70 -77.29 133.73 67.82 Favored Pre-proline 0 C--N 1.324 -0.523 0 CA-C-N 115.895 -0.593 . . . . 0.0 109.808 -177.295 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 145' ' ' PRO . . . . . 0.487 ' HA ' ' HB3' ' A' ' 2' ' ' SER . 24.4 Cg_endo . . . . . 0 C--N 1.345 0.389 0 C-N-CA 123.308 2.672 . . . . 0.0 113.048 -172.575 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 18.7 m . . . . . 0 N--CA 1.453 -0.324 0 CA-C-O 120.86 0.362 . . . . 0.0 110.516 . . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 7.2 mp0 -76.31 -29.77 57.46 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 121.55 0.69 . . . . 0.0 110.051 177.681 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 20.8 t -120.97 152.56 38.4 Favored 'General case' 0 C--N 1.317 -0.834 0 CA-C-N 115.031 -0.986 . . . . 0.0 109.698 -179.98 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 69.8 t -68.72 123.39 22.05 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.443 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.36 -178.595 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 6' ' ' GLN . . . . . . . . . . . . . 5.1 pt20 -140.49 160.67 39.48 Favored 'General case' 0 C--N 1.315 -0.929 0 CA-C-N 115.206 -0.906 . . . . 0.0 109.342 -177.667 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 41.4 p -62.64 145.33 54.82 Favored 'General case' 0 C--N 1.317 -0.837 0 O-C-N 123.215 0.322 . . . . 0.0 110.824 -178.47 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 21.3 t-20 77.24 -1.01 2.82 Favored 'General case' 0 N--CA 1.47 0.564 0 C-N-CA 123.762 0.825 . . . . 0.0 111.558 179.732 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 67.1 m -99.99 166.23 11.15 Favored 'General case' 0 C--N 1.327 -0.384 0 N-CA-C 108.983 -0.747 . . . . 0.0 108.983 172.693 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 10' ' ' ALA . . . . . 0.707 ' HB2' ' HD2' ' A' ' 38' ' ' ARG . . . -115.82 154.32 29.88 Favored 'General case' 0 C--N 1.316 -0.875 0 C-N-CA 120.598 -0.441 . . . . 0.0 110.209 178.705 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 8.6 m -129.69 133.57 64.73 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.786 0 CA-C-O 121.395 0.617 . . . . 0.0 110.575 177.776 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 12' ' ' LEU . . . . . 0.433 ' N ' HD12 ' A' ' 12' ' ' LEU . 5.9 mp -86.81 110.36 19.89 Favored 'General case' 0 C--N 1.316 -0.88 0 N-CA-C 107.173 -1.418 . . . . 0.0 107.173 172.923 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 13' ' ' VAL . . . . . 0.479 HG21 HG23 ' A' ' 138' ' ' ILE . 1.5 p -123.73 157.19 30.42 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.93 0 CA-C-O 121.089 0.471 . . . . 0.0 110.858 -171.963 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 14' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -119.02 116.34 26.21 Favored 'General case' 0 C--N 1.317 -0.822 0 N-CA-C 106.376 -1.713 . . . . 0.0 106.376 174.197 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 15' ' ' PHE . . . . . 0.517 ' H ' HG23 ' A' ' 28' ' ' THR . 21.2 p90 -150.81 161.69 42.17 Favored 'General case' 0 C--N 1.32 -0.695 0 C-N-CA 119.221 -0.992 . . . . 0.0 112.441 -169.448 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 13.8 m -128.58 122.99 32.25 Favored 'General case' 0 N--CA 1.448 -0.535 0 N-CA-C 109.09 -0.707 . . . . 0.0 109.09 173.101 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 17' ' ' LEU . . . . . 0.51 HD11 ' HB ' ' A' ' 134' ' ' VAL . 7.3 tp -92.23 125.52 36.93 Favored 'General case' 0 C--N 1.319 -0.72 0 CA-C-O 121.407 0.622 . . . . 0.0 110.941 -173.505 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 18' ' ' LYS . . . . . 0.445 ' HD3' ' N ' ' A' ' 18' ' ' LYS . 0.0 OUTLIER -111.49 145.84 38.33 Favored 'General case' 0 C--N 1.321 -0.651 0 CA-C-N 114.849 -1.068 . . . . 0.0 111.247 -173.319 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 19' ' ' LEU . . . . . 0.466 ' CD2' ' HB2' ' A' ' 25' ' ' ALA . 4.0 mm? -86.69 166.43 15.33 Favored 'General case' 0 C--N 1.319 -0.74 0 N-CA-C 109.64 -0.504 . . . . 0.0 109.64 172.24 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 15.7 t70 -61.08 -33.75 73.83 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-O 121.243 0.544 . . . . 0.0 109.659 174.052 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 17.7 m-20 -80.08 9.34 5.64 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 115.46 -0.791 . . . . 0.0 111.899 -179.614 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 73.34 17.61 78.96 Favored Glycine 0 N--CA 1.453 -0.174 0 C-N-CA 121.146 -0.55 . . . . 0.0 113.004 178.439 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 9.3 m -85.69 152.54 23.0 Favored 'General case' 0 C--N 1.32 -0.694 0 N-CA-C 109.577 -0.527 . . . . 0.0 109.577 176.337 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 23.5 m -95.47 116.35 28.69 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-O 120.718 0.294 . . . . 0.0 110.828 179.038 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 25' ' ' ALA . . . . . 0.466 ' HB2' ' CD2' ' A' ' 19' ' ' LEU . . . -87.31 -50.67 6.43 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 116.258 -0.428 . . . . 0.0 111.567 -177.009 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 8.1 tp10 -145.62 129.29 17.13 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 115.78 -0.645 . . . . 0.0 109.468 -175.113 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 21.0 m -124.09 115.03 20.5 Favored 'General case' 0 C--N 1.318 -0.786 0 N-CA-C 110.474 -0.195 . . . . 0.0 110.474 -178.939 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 28' ' ' THR . . . . . 0.517 HG23 ' H ' ' A' ' 15' ' ' PHE . 8.4 t -122.11 57.76 1.05 Allowed 'General case' 0 C--O 1.239 0.546 0 CA-C-O 122.653 1.216 . . . . 0.0 109.182 173.484 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 10.6 mmm180 -118.12 -71.78 0.72 Allowed 'General case' 0 C--N 1.323 -0.564 0 CA-C-N 114.152 -1.386 . . . . 0.0 110.366 173.089 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 11.0 p30 -65.49 -7.45 14.4 Favored 'General case' 0 N--CA 1.47 0.537 0 CA-C-N 116.096 -0.502 . . . . 0.0 111.765 -177.302 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -61.4 -35.31 77.15 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 115.877 -0.602 . . . . 0.0 110.62 -179.419 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 90.0 -1.36 80.35 Favored Glycine 0 N--CA 1.447 -0.584 0 N-CA-C 110.759 -0.936 . . . . 0.0 110.759 -172.22 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 65.6 mttm -128.71 138.53 33.32 Favored Pre-proline 0 C--N 1.326 -0.446 0 N-CA-C 109.06 -0.719 . . . . 0.0 109.06 179.792 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 37.0 Cg_endo -85.06 171.49 9.17 Favored 'Trans proline' 0 N--CA 1.451 -1.008 0 C-N-CA 122.933 2.422 . . . . 0.0 112.029 174.423 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -113.89 139.13 49.44 Favored 'General case' 0 C--N 1.309 -1.182 0 CA-C-N 115.019 -0.992 . . . . 0.0 109.115 -179.905 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 36' ' ' LEU . . . . . 0.413 HD21 ' HB1' ' A' ' 10' ' ' ALA . 3.3 tm? -94.97 117.49 30.23 Favored 'General case' 0 C--N 1.316 -0.856 0 CA-C-O 121.27 0.557 . . . . 0.0 110.184 -178.629 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 37' ' ' PHE . . . . . . . . . . . . . 4.4 m-30 -98.51 107.84 20.39 Favored 'General case' 0 C--N 1.317 -0.84 0 CA-C-N 115.266 -0.879 . . . . 0.0 110.181 174.175 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 38' ' ' ARG . . . . . 0.707 ' HD2' ' HB2' ' A' ' 10' ' ' ALA . 19.2 tpt180 -92.84 109.39 20.83 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-N 116.265 -0.425 . . . . 0.0 109.858 178.95 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 39' ' ' LEU . . . . . 0.438 HD22 ' CB ' ' A' ' 49' ' ' GLU . 14.7 mt -81.05 154.04 27.05 Favored 'General case' 0 C--N 1.321 -0.653 0 CA-C-N 115.611 -0.722 . . . . 0.0 109.77 -177.877 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 101.47 35.78 4.01 Favored Glycine 0 N--CA 1.444 -0.778 0 C-N-CA 120.754 -0.736 . . . . 0.0 112.349 -177.191 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER 62.99 14.94 7.98 Favored 'General case' 0 N--CA 1.47 0.556 0 N-CA-C 112.96 0.726 . . . . 0.0 112.96 175.515 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -62.73 -59.01 5.48 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-O 121.034 0.445 . . . . 0.0 110.663 179.92 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 16.4 t -134.53 2.86 3.26 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-O 121.303 0.573 . . . . 0.0 110.03 177.145 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 44' ' ' LEU . . . . . 0.555 HD13 HD22 ' A' ' 48' ' ' LEU . 78.9 mt -115.38 174.1 6.18 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-N 115.542 -0.754 . . . . 0.0 109.994 -178.09 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 12.9 t -104.65 154.91 19.36 Favored 'General case' 0 C--N 1.322 -0.608 0 N-CA-C 109.306 -0.627 . . . . 0.0 109.306 176.586 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 46' ' ' GLU . . . . . 0.556 ' O ' ' HG2' ' A' ' 50' ' ' GLN . 37.7 mt-10 -47.35 -46.17 25.37 Favored 'General case' 0 N--CA 1.466 0.335 0 O-C-N 123.605 0.565 . . . . 0.0 112.067 -175.221 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -61.24 -42.12 99.69 Favored Glycine 0 N--CA 1.446 -0.677 0 CA-C-N 115.975 -0.557 . . . . 0.0 113.581 -173.562 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 48' ' ' LEU . . . . . 0.555 HD22 HD13 ' A' ' 44' ' ' LEU . 2.6 tt -61.26 -48.95 79.07 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 117.325 0.563 . . . . 0.0 111.538 -176.749 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 49' ' ' GLU . . . . . 0.465 ' O ' HD13 ' A' ' 53' ' ' LEU . 11.7 pt-20 -64.5 -37.78 88.71 Favored 'General case' 0 C--N 1.325 -0.49 0 C-N-CA 120.555 -0.458 . . . . 0.0 109.907 -179.033 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 50' ' ' GLN . . . . . 0.556 ' HG2' ' O ' ' A' ' 46' ' ' GLU . 84.5 mm-40 -51.88 -29.3 19.26 Favored 'General case' 0 N--CA 1.464 0.249 0 N-CA-C 112.047 0.388 . . . . 0.0 112.047 175.475 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 51' ' ' HIS . . . . . . . . . . . . . 3.8 m80 -97.63 -3.81 38.73 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-O 121.057 0.456 . . . . 0.0 110.973 -177.319 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 31.1 mt -102.84 -29.69 11.31 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 116.097 -0.501 . . . . 0.0 111.279 178.022 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 53' ' ' LEU . . . . . 0.465 HD13 ' O ' ' A' ' 49' ' ' GLU . 0.0 OUTLIER -59.47 139.08 57.42 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-O 121.158 0.504 . . . . 0.0 111.26 -179.465 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 93.67 -8.85 74.09 Favored Glycine 0 N--CA 1.45 -0.391 0 CA-C-N 115.743 -0.662 . . . . 0.0 112.589 -179.45 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 55' ' ' LEU . . . . . 0.424 HD12 ' HB3' ' A' ' 59' ' ' ASP . 4.2 mm? -78.15 164.92 24.56 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-O 121.048 0.452 . . . . 0.0 110.918 176.857 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 56' ' ' LYS . . . . . 0.542 ' O ' ' HB2' ' A' ' 59' ' ' ASP . 0.1 OUTLIER -126.78 164.84 20.46 Favored 'General case' 0 C--N 1.321 -0.665 0 CA-C-N 116.197 -0.456 . . . . 0.0 109.874 -176.993 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 25.5 t -63.91 132.37 29.74 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 N-CA-C 109.908 -0.405 . . . . 0.0 109.908 172.377 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 79.93 9.93 86.18 Favored Glycine 0 N--CA 1.45 -0.373 0 C-N-CA 120.995 -0.621 . . . . 0.0 112.38 -176.133 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 59' ' ' ASP . . . . . 0.542 ' HB2' ' O ' ' A' ' 56' ' ' LYS . 0.4 OUTLIER -104.52 152.96 21.75 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-O 120.964 0.411 . . . . 0.0 110.634 178.732 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 60' ' ' LYS . . . . . 0.416 ' HE3' ' OE1' ' A' ' 139' ' ' GLU . 0.6 OUTLIER -112.18 132.35 54.95 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 115.671 -0.695 . . . . 0.0 110.412 -173.003 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 61' ' ' THR . . . . . 0.404 ' HB ' HD11 ' A' ' 55' ' ' LEU . 7.6 t -139.35 115.81 10.58 Favored 'General case' 0 C--N 1.319 -0.744 0 CA-C-O 121.562 0.696 . . . . 0.0 111.066 175.743 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 62' ' ' THR . . . . . 0.459 HG23 ' O ' ' A' ' 136' ' ' PHE . 34.6 m -112.37 130.58 55.91 Favored 'General case' 0 C--N 1.318 -0.768 0 N-CA-C 108.986 -0.746 . . . . 0.0 108.986 173.492 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 28.4 p90 -148.71 146.84 28.29 Favored 'General case' 0 C--N 1.315 -0.903 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.252 -177.591 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 26.6 p -89.85 144.52 25.87 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.492 176.241 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 65' ' ' LEU . . . . . 0.41 HD11 ' HA ' ' A' ' 48' ' ' LEU . 77.0 mt -138.55 133.1 32.14 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-O 121.356 0.598 . . . . 0.0 110.866 177.635 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 66' ' ' GLU . . . . . 0.435 ' HB2' ' OD1' ' A' ' 68' ' ' ASP . 4.3 mm-40 -88.61 161.84 40.88 Favored Pre-proline 0 C--N 1.313 -1.003 0 CA-C-N 115.157 -0.929 . . . . 0.0 108.728 174.671 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 99.1 Cg_exo -45.53 -35.47 12.47 Favored 'Trans proline' 0 C--N 1.349 0.586 0 C-N-CA 123.055 2.503 . . . . 0.0 114.367 -174.305 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 68' ' ' ASP . . . . . 0.435 ' OD1' ' HB2' ' A' ' 66' ' ' GLU . 6.8 p-10 -59.21 -29.41 67.48 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-O 120.723 0.297 . . . . 0.0 111.417 -178.889 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -115.04 11.8 16.53 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-O 120.76 0.314 . . . . 0.0 111.045 179.589 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.326 -0.453 0 CA-C-N 116.302 -0.408 . . . . 0.0 110.972 -174.349 . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 75' ' ' SER . . . . . 0.405 ' HB3' HD23 ' A' ' 78' ' ' LEU . 8.1 t . . . . . 0 N--CA 1.452 -0.335 0 CA-C-O 121.077 0.465 . . . . 0.0 110.955 . . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 57.1 Cg_endo -69.92 -17.84 36.61 Favored 'Trans proline' 0 C--N 1.347 0.462 0 C-N-CA 123.27 2.647 . . . . 0.0 113.615 -176.521 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 2.6 p-10 -70.85 -11.39 60.93 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-O 120.986 0.422 . . . . 0.0 110.522 -178.785 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 78' ' ' LEU . . . . . 0.405 HD23 ' HB3' ' A' ' 75' ' ' SER . 4.3 mm? -70.9 -18.86 62.66 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.002 -0.545 . . . . 0.0 110.589 174.645 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 79' ' ' ILE . . . . . 0.471 HG12 ' HA ' ' A' ' 124' ' ' ASP . 9.9 mt -85.46 106.76 15.51 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.643 0 CA-C-N 115.763 -0.653 . . . . 0.0 110.447 -175.94 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 30.8 mt-30 -121.79 122.01 38.53 Favored 'General case' 0 C--N 1.319 -0.759 0 CA-C-N 115.639 -0.71 . . . . 0.0 111.248 -178.501 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 81' ' ' TYR . . . . . 0.658 ' CD1' HG23 ' A' ' 122' ' ' THR . 0.1 OUTLIER -108.27 114.02 27.56 Favored 'General case' 0 C--N 1.315 -0.903 0 CA-C-N 115.914 -0.584 . . . . 0.0 111.55 176.945 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -116.55 177.93 4.52 Favored 'General case' 0 C--N 1.319 -0.748 0 CA-C-O 120.626 0.251 . . . . 0.0 111.125 168.394 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 83' ' ' SER . . . . . 0.419 ' HA ' ' O ' ' A' ' 119' ' ' ASP . 8.2 t -59.27 151.58 22.91 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-O 121.572 0.701 . . . . 0.0 111.963 -170.437 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -74.36 -12.72 60.6 Favored 'General case' 0 C--N 1.333 -0.131 0 CA-C-N 115.249 -0.887 . . . . 0.0 111.34 -169.681 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 85' ' ' ARG . . . . . . . . . . . . . 7.5 mpt_? -71.49 -20.52 62.05 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 121.51 0.671 . . . . 0.0 109.905 -177.574 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 30.6 mm-40 -79.48 -12.1 59.88 Favored 'General case' 0 C--N 1.321 -0.653 0 CA-C-N 114.959 -1.019 . . . . 0.0 109.797 176.206 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 87' ' ' PHE . . . . . 0.496 ' CE1' ' HB ' ' A' ' 121' ' ' ILE . 73.7 m-85 -105.0 -46.39 4.29 Favored 'General case' 0 C--N 1.319 -0.72 0 CA-C-N 114.709 -1.132 . . . . 0.0 110.538 -175.039 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 88' ' ' MET . . . . . . . . . . . . . 64.5 ttp -58.16 -22.35 50.95 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-N 115.325 -0.852 . . . . 0.0 110.216 178.666 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 32.1 t70 -53.3 -35.67 60.37 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 115.047 -0.979 . . . . 0.0 110.838 174.033 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -116.06 11.44 15.33 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.272 -179.919 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 113.58 141.26 7.84 Favored Glycine 0 N--CA 1.448 -0.505 0 C-N-CA 120.827 -0.701 . . . . 0.0 112.117 -178.301 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 44.2 mt-10 -64.41 125.81 89.23 Favored Pre-proline 0 C--N 1.324 -0.505 0 CA-C-O 121.017 0.437 . . . . 0.0 111.416 -178.842 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 93' ' ' PRO . . . . . 0.445 ' HB2' HD13 ' A' ' 113' ' ' ILE . 53.1 Cg_endo -78.83 167.06 22.76 Favored 'Trans proline' 0 C--O 1.232 0.217 0 C-N-CA 123.591 2.86 . . . . 0.0 114.146 -174.389 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 1.1 mp0 -120.08 155.65 32.57 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 115.015 -0.993 . . . . 0.0 111.352 -173.133 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 95' ' ' ILE . . . . . 0.568 HG12 HG12 ' A' ' 116' ' ' ILE . 13.7 mt -82.34 131.41 33.86 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.155 0 CA-C-N 116.301 -0.409 . . . . 0.0 111.01 178.778 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 68.13 30.05 73.66 Favored Glycine 0 N--CA 1.448 -0.544 0 CA-C-N 115.815 -0.63 . . . . 0.0 111.905 179.966 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -108.45 125.32 51.64 Favored 'General case' 0 N--CA 1.445 -0.695 0 CA-C-O 120.934 0.397 . . . . 0.0 109.939 179.828 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 98' ' ' ILE . . . . . 0.516 ' HA ' ' HA ' ' A' ' 112' ' ' VAL . 35.4 mt -86.52 102.47 11.95 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.867 0 N-CA-C 108.807 -0.812 . . . . 0.0 108.807 179.601 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 99' ' ' MET . . . . . 0.487 ' O ' ' HD2' ' A' ' 101' ' ' PHE . 7.0 mtm -105.39 126.63 52.33 Favored 'General case' 0 N--CA 1.438 -1.057 0 CA-C-O 121.665 0.745 . . . . 0.0 110.545 -175.279 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 4.4 mm? -62.75 147.81 48.65 Favored 'General case' 0 C--N 1.305 -1.331 0 CA-C-N 114.28 -1.327 . . . . 0.0 109.326 171.078 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 101' ' ' PHE . . . . . 0.487 ' HD2' ' O ' ' A' ' 99' ' ' MET . 0.4 OUTLIER -148.62 167.02 26.55 Favored 'General case' 0 CA--C 1.509 -0.619 0 CA-C-N 115.021 -0.99 . . . . 0.0 108.44 -152.806 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 1.5 m -121.78 122.15 38.86 Favored 'General case' 0 C--N 1.309 -1.179 0 C-N-CA 119.773 -0.771 . . . . 0.0 110.353 176.965 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -88.12 165.25 15.24 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-N 115.791 -0.64 . . . . 0.0 110.305 -177.779 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 104' ' ' MET . . . . . . . . . . . . . 2.0 mpt? -66.23 -12.73 58.01 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.807 -0.633 . . . . 0.0 112.002 -175.014 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 8.6 p-10 -99.71 15.44 26.8 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-O 120.737 0.304 . . . . 0.0 110.982 179.765 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 79.76 -11.95 31.3 Favored Glycine 0 CA--C 1.52 0.346 0 C-N-CA 121.121 -0.562 . . . . 0.0 113.88 177.824 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 24.6 t -79.71 151.13 30.61 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-O 121.203 0.525 . . . . 0.0 110.081 179.586 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 26.3 tt0 -94.56 100.26 12.26 Favored 'General case' 0 C--N 1.313 -1.016 0 CA-C-N 115.585 -0.734 . . . . 0.0 110.009 -178.019 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 109' ' ' MET . . . . . . . . . . . . . 3.1 mtp -92.25 147.85 35.42 Favored Pre-proline 0 C--N 1.324 -0.524 0 CA-C-N 115.3 -0.864 . . . . 0.0 110.842 179.998 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 55.2 Cg_endo -72.49 154.72 55.46 Favored 'Trans proline' 0 N--CA 1.458 -0.56 0 C-N-CA 122.009 1.806 . . . . 0.0 110.871 173.374 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 111' ' ' GLY . . . . . 0.502 ' HA2' ' O ' ' A' ' 124' ' ' ASP . . . -150.21 103.48 0.25 Allowed Glycine 0 N--CA 1.445 -0.736 0 C-N-CA 120.164 -1.017 . . . . 0.0 110.853 -171.637 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 112' ' ' VAL . . . . . 0.516 ' HA ' ' HA ' ' A' ' 98' ' ' ILE . 7.7 p -97.73 113.26 31.77 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.559 0 CA-C-N 119.237 1.518 . . . . 0.0 110.689 -179.462 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 113' ' ' ILE . . . . . 0.466 ' HA ' ' O ' ' A' ' 122' ' ' THR . 39.2 mt -72.6 111.14 6.47 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.897 0 CA-C-N 114.902 -1.045 . . . . 0.0 110.059 179.941 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 114' ' ' ARG . . . . . 0.514 ' HD3' ' O ' ' A' ' 114' ' ' ARG . 8.8 tpp180 -63.81 -46.73 83.81 Favored 'General case' 0 C--N 1.322 -0.625 0 CA-C-N 114.909 -1.041 . . . . 0.0 110.864 -177.669 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 115' ' ' GLU . . . . . 0.526 ' HA ' HG23 ' A' ' 95' ' ' ILE . 14.5 tt0 -159.25 154.43 25.27 Favored 'General case' 0 C--N 1.324 -0.531 0 C-N-CA 120.705 -0.398 . . . . 0.0 110.882 -175.751 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 116' ' ' ILE . . . . . 0.568 HG12 HG12 ' A' ' 95' ' ' ILE . 37.4 mm -100.57 120.63 50.3 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 N-CA-C 109.183 -0.673 . . . . 0.0 109.183 175.987 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 117' ' ' ASN . . . . . 0.432 ' HB2' ' O ' ' A' ' 120' ' ' SER . 30.2 m-80 -110.41 157.46 19.53 Favored 'General case' 0 C--N 1.315 -0.913 0 CA-C-N 115.934 -0.575 . . . . 0.0 110.171 -179.755 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . -56.21 -40.59 84.53 Favored Glycine 0 C--O 1.227 -0.343 0 C-N-CA 120.688 -0.768 . . . . 0.0 113.694 -169.528 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 119' ' ' ASP . . . . . 0.419 ' O ' ' HA ' ' A' ' 83' ' ' SER . 24.8 m-20 -113.07 -15.69 12.77 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 117.169 0.484 . . . . 0.0 112.119 179.826 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 120' ' ' SER . . . . . 0.432 ' O ' ' HB2' ' A' ' 117' ' ' ASN . 13.6 t -130.73 156.49 44.86 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-O 120.923 0.392 . . . . 0.0 111.483 -169.999 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 121' ' ' ILE . . . . . 0.506 HD12 HD12 ' A' ' 116' ' ' ILE . 49.5 mm -127.46 125.59 65.95 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.778 -178.626 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 122' ' ' THR . . . . . 0.658 HG23 ' CD1' ' A' ' 81' ' ' TYR . 10.7 m -95.38 103.32 15.18 Favored 'General case' 0 C--N 1.329 -0.323 0 N-CA-C 112.477 0.547 . . . . 0.0 112.477 -174.246 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 5.6 t -103.78 122.06 56.02 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 N-CA-C 113.307 0.854 . . . . 0.0 113.307 177.404 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 124' ' ' ASP . . . . . 0.502 ' O ' ' HA2' ' A' ' 111' ' ' GLY . 1.3 t70 -89.04 135.41 33.57 Favored 'General case' 0 C--N 1.322 -0.587 0 CA-C-N 115.191 -0.913 . . . . 0.0 111.508 170.285 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 125' ' ' PHE . . . . . . . . . . . . . 63.2 m-85 -117.98 59.15 0.8 Allowed 'General case' 0 C--N 1.331 -0.216 0 CA-C-O 122.115 0.96 . . . . 0.0 110.381 -176.118 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 7.4 m120 . . . . . 0 C--N 1.307 -1.266 0 CA-C-N 114.311 -1.313 . . . . 0.0 111.496 -179.439 . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 133' ' ' THR . . . . . . . . . . . . . 20.5 m . . . . . 0 N--CA 1.443 -0.82 0 N-CA-C 108.85 -0.796 . . . . 0.0 108.85 . . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 134' ' ' VAL . . . . . 0.51 ' HB ' HD11 ' A' ' 17' ' ' LEU . 1.5 m -121.99 148.78 25.37 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.595 0 CA-C-O 121.894 0.854 . . . . 0.0 112.6 -172.271 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 135' ' ' HIS . . . . . 0.41 ' O ' HD12 ' A' ' 17' ' ' LEU . 15.0 m-70 -112.42 147.38 36.58 Favored 'General case' 0 C--N 1.316 -0.89 0 CA-C-N 114.624 -1.171 . . . . 0.0 108.508 174.028 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 136' ' ' PHE . . . . . 0.459 ' O ' HG23 ' A' ' 62' ' ' THR . 12.5 m-85 -123.45 124.11 42.15 Favored 'General case' 0 C--N 1.31 -1.131 0 CA-C-N 116.028 -0.533 . . . . 0.0 111.71 -166.726 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 137' ' ' ASP . . . . . 0.466 ' O ' ' HB2' ' A' ' 15' ' ' PHE . 12.9 m-20 -116.58 96.42 5.5 Favored 'General case' 0 C--N 1.324 -0.525 0 N-CA-C 108.608 -0.886 . . . . 0.0 108.608 175.784 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 138' ' ' ILE . . . . . 0.479 HG23 HG21 ' A' ' 13' ' ' VAL . 1.9 mp -107.65 138.57 33.28 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.55 0 N-CA-C 112.599 0.592 . . . . 0.0 112.599 -177.794 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 139' ' ' GLU . . . . . 0.416 ' OE1' ' HE3' ' A' ' 60' ' ' LYS . 31.8 mt-10 -125.59 124.71 41.83 Favored 'General case' 0 CA--C 1.507 -0.676 0 N-CA-C 108.084 -1.08 . . . . 0.0 108.084 167.885 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 140' ' ' VAL . . . . . . . . . . . . . 71.6 t -78.16 121.47 31.05 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.747 0 C-N-CA 120.704 -0.398 . . . . 0.0 110.428 -176.947 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 19.2 mt -93.1 -44.05 8.57 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-O 121.262 0.553 . . . . 0.0 110.027 178.084 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 142' ' ' GLU . . . . . . . . . . . . . 10.2 tp10 -153.67 152.22 30.56 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-N 115.465 -0.789 . . . . 0.0 109.768 -179.336 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 143' ' ' ILE . . . . . . . . . . . . . 63.0 mt -116.9 121.16 67.13 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.421 0 CA-C-O 121.007 0.432 . . . . 0.0 110.317 178.531 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 144' ' ' ASP . . . . . 0.646 ' HB3' ' HB3' ' A' ' 10' ' ' ALA . 38.6 t70 -77.37 128.5 80.22 Favored Pre-proline 0 C--N 1.322 -0.618 0 CA-C-N 115.808 -0.633 . . . . 0.0 110.154 -179.341 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 145' ' ' PRO . . . . . . . . . . . . . 73.7 Cg_exo . . . . . 0 C--N 1.345 0.383 0 C-N-CA 123.29 2.66 . . . . 0.0 112.539 178.415 . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 4.8 t . . . . . 0 N--CA 1.451 -0.388 0 N-CA-C 109.25 -0.648 . . . . 0.0 109.25 . . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 3' ' ' GLU . . . . . 0.436 ' CG ' ' HE2' ' A' ' 56' ' ' LYS . 39.2 tt0 -74.5 -34.44 63.06 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-O 121.477 0.656 . . . . 0.0 110.554 -177.132 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 24.2 m -128.12 156.82 42.24 Favored 'General case' 0 C--N 1.314 -0.939 0 CA-C-N 115.302 -0.863 . . . . 0.0 109.604 179.621 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 5' ' ' VAL . . . . . 0.561 HG13 ' HA ' ' A' ' 53' ' ' LEU . 7.1 p -81.96 135.94 23.97 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.532 0 CA-C-O 121.021 0.439 . . . . 0.0 110.83 -177.58 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 6' ' ' GLN . . . . . 0.594 ' HG2' ' OG ' ' A' ' 9' ' ' SER . 7.4 pt20 -123.21 168.49 12.37 Favored 'General case' 0 C--N 1.318 -0.792 0 CA-C-N 115.933 -0.576 . . . . 0.0 109.632 177.866 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 29.4 t -54.23 122.77 11.01 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-O 120.765 0.317 . . . . 0.0 110.493 179.052 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 2.9 t30 73.5 41.25 0.46 Allowed 'General case' 0 N--CA 1.469 0.497 0 C-N-CA 123.935 0.894 . . . . 0.0 111.132 -177.238 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 9' ' ' SER . . . . . 0.594 ' OG ' ' HG2' ' A' ' 6' ' ' GLN . 67.0 m -122.2 134.74 54.71 Favored 'General case' 0 C--N 1.325 -0.473 0 N-CA-C 108.846 -0.798 . . . . 0.0 108.846 168.288 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 10' ' ' ALA . . . . . 0.502 ' HB2' ' HD3' ' A' ' 38' ' ' ARG . . . -84.68 147.57 26.86 Favored 'General case' 0 C--N 1.315 -0.899 0 CA-C-N 116.533 -0.303 . . . . 0.0 110.233 -176.858 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 13.5 m -133.91 142.88 40.08 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.864 0 C-N-CA 120.712 -0.395 . . . . 0.0 110.335 179.971 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 30.6 tp -86.55 123.57 31.9 Favored 'General case' 0 C--N 1.319 -0.739 0 N-CA-C 108.271 -1.011 . . . . 0.0 108.271 174.797 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 13' ' ' VAL . . . . . 0.706 HG21 HG23 ' A' ' 138' ' ' ILE . 4.4 p -131.93 156.28 42.38 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.778 0 CA-C-O 122.27 1.033 . . . . 0.0 113.057 -172.432 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 14' ' ' HIS . . . . . 0.497 ' CD2' HD11 ' A' ' 141' ' ' LEU . 2.2 m-70 -118.77 120.85 38.59 Favored 'General case' 0 C--N 1.317 -0.835 0 N-CA-C 106.059 -1.83 . . . . 0.0 106.059 169.471 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 15' ' ' PHE . . . . . 0.519 ' CD1' ' HB ' ' A' ' 28' ' ' THR . 16.2 p90 -151.08 157.87 43.33 Favored 'General case' 0 C--N 1.324 -0.537 0 C-N-CA 118.181 -1.408 . . . . 0.0 113.948 -170.336 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 22.2 m -131.06 130.43 43.23 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 114.85 -1.068 . . . . 0.0 108.598 176.904 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 17' ' ' LEU . . . . . 0.799 HD21 ' HB ' ' A' ' 134' ' ' VAL . 2.2 tt -121.81 118.05 28.05 Favored 'General case' 0 N--CA 1.446 -0.637 0 N-CA-C 109.435 -0.58 . . . . 0.0 109.435 -173.678 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 18' ' ' LYS . . . . . 0.651 ' HB3' ' CE1' ' A' ' 135' ' ' HIS . 2.4 tppt? -126.19 155.63 41.46 Favored 'General case' 0 C--N 1.314 -0.94 0 C-N-CA 119.988 -0.685 . . . . 0.0 111.455 -174.885 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 3.1 mm? -99.52 171.5 7.89 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-N 115.291 -0.868 . . . . 0.0 109.339 173.813 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 35.5 t70 -64.72 -25.49 67.96 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-O 121.373 0.606 . . . . 0.0 109.866 176.099 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 5.0 m-20 -77.53 2.99 14.67 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.5 -0.773 . . . . 0.0 110.843 178.501 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 73.27 9.57 77.28 Favored Glycine 0 C--N 1.33 0.245 0 C-N-CA 121.387 -0.435 . . . . 0.0 113.28 -179.913 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 26.7 m -82.27 142.26 32.25 Favored 'General case' 0 C--N 1.321 -0.644 0 N-CA-C 109.835 -0.431 . . . . 0.0 109.835 177.093 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 20.9 m -89.59 112.57 23.82 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-O 120.747 0.308 . . . . 0.0 110.335 179.316 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 25' ' ' ALA . . . . . 0.714 ' HB3' HD22 ' A' ' 17' ' ' LEU . . . -72.69 -38.09 67.66 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 121.134 0.493 . . . . 0.0 110.111 178.506 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 8.4 tp10 -157.32 141.24 16.04 Favored 'General case' 0 N--CA 1.446 -0.663 0 CA-C-N 115.732 -0.667 . . . . 0.0 110.132 178.682 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 36.9 p -124.53 119.72 29.91 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-O 121.125 0.488 . . . . 0.0 110.934 -178.828 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 28' ' ' THR . . . . . 0.584 ' O ' HG22 ' A' ' 28' ' ' THR . 96.8 m -139.62 11.26 2.49 Favored 'General case' 0 CA--C 1.547 0.848 0 CA-C-O 123.269 1.509 . . . . 0.0 110.562 177.187 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 29' ' ' ARG . . . . . 0.407 ' NH1' ' HB3' ' A' ' 30' ' ' ASN . 8.7 tmm_? -104.27 -52.96 2.82 Favored 'General case' 0 C--N 1.308 -1.215 0 CA-C-N 115.099 -0.955 . . . . 0.0 109.921 167.481 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 30' ' ' ASN . . . . . 0.407 ' HB3' ' NH1' ' A' ' 29' ' ' ARG . 4.8 p-10 -82.52 35.0 0.44 Allowed 'General case' 0 C--N 1.326 -0.436 0 CA-C-O 121.079 0.466 . . . . 0.0 111.472 -178.87 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 4.5 m-20 -120.33 -23.27 6.24 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.334 -0.394 . . . . 0.0 111.599 -178.788 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 84.85 -11.6 59.37 Favored Glycine 0 N--CA 1.453 -0.212 0 C-N-CA 120.435 -0.888 . . . . 0.0 110.905 -174.286 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 33' ' ' LYS . . . . . 0.458 ' HD2' ' HD2' ' A' ' 34' ' ' PRO . 56.1 tptt -120.53 118.16 31.09 Favored Pre-proline 0 C--N 1.321 -0.646 0 CA-C-N 114.896 -0.652 . . . . 0.0 110.054 -177.974 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 34' ' ' PRO . . . . . 0.458 ' HD2' ' HD2' ' A' ' 33' ' ' LYS . 73.9 Cg_endo -80.28 170.77 15.8 Favored 'Trans proline' 0 N--CA 1.457 -0.672 0 C-N-CA 122.506 2.137 . . . . 0.0 111.526 174.125 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -137.02 152.26 49.9 Favored 'General case' 0 C--N 1.311 -1.091 0 CA-C-N 115.671 -0.695 . . . . 0.0 110.463 -175.58 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 2.0 tp -90.69 138.24 31.73 Favored 'General case' 0 C--N 1.317 -0.807 0 N-CA-C 109.414 -0.588 . . . . 0.0 109.414 175.038 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 37' ' ' PHE . . . . . . . . . . . . . 2.4 m-30 -104.0 106.66 17.24 Favored 'General case' 0 C--N 1.317 -0.825 0 N-CA-C 108.67 -0.863 . . . . 0.0 108.67 175.535 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 38' ' ' ARG . . . . . 0.502 ' HD3' ' HB2' ' A' ' 10' ' ' ALA . 6.5 tpp180 -86.07 105.6 16.61 Favored 'General case' 0 C--N 1.323 -0.569 0 N-CA-C 109.105 -0.702 . . . . 0.0 109.105 -179.733 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 40.0 mt -90.38 156.39 18.27 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-N 115.363 -0.835 . . . . 0.0 111.666 -175.743 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 102.49 37.85 3.17 Favored Glycine 0 N--CA 1.45 -0.407 0 CA-C-N 115.335 -0.848 . . . . 0.0 111.996 -177.884 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 31.9 t70 65.74 0.53 1.52 Allowed 'General case' 0 N--CA 1.472 0.637 0 C-N-CA 123.509 0.724 . . . . 0.0 111.893 179.739 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -65.78 -48.34 72.12 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.781 -179.779 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 23.1 m -134.42 -39.79 0.82 Allowed 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 116.066 -0.515 . . . . 0.0 110.788 178.135 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 4.6 mm? -88.79 162.72 16.05 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-O 121.038 0.447 . . . . 0.0 111.19 -178.818 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 32.2 t -86.81 153.68 21.48 Favored 'General case' 0 C--N 1.324 -0.5 0 CA-C-N 115.356 -0.838 . . . . 0.0 110.212 -178.997 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 42.3 mt-10 -52.45 -42.9 64.58 Favored 'General case' 0 C--N 1.328 -0.336 0 N-CA-C 112.309 0.485 . . . . 0.0 112.309 -173.818 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -64.96 -37.68 94.57 Favored Glycine 0 N--CA 1.447 -0.62 0 C-N-CA 120.41 -0.9 . . . . 0.0 112.777 -174.699 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 48' ' ' LEU . . . . . 0.482 HD11 HD12 ' A' ' 52' ' ' LEU . 3.4 tm? -70.09 -53.63 16.6 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 121.003 0.43 . . . . 0.0 110.093 -176.934 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 10.4 pt-20 -58.3 -40.89 83.19 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 115.712 -0.676 . . . . 0.0 112.107 -177.868 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 50' ' ' GLN . . . . . 0.516 ' HA ' ' CD2' ' A' ' 53' ' ' LEU . 90.6 mm-40 -73.74 -15.14 61.22 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-O 120.811 0.338 . . . . 0.0 111.336 -173.003 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 51' ' ' HIS . . . . . . . . . . . . . 14.6 m-70 -107.48 -9.4 15.97 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-O 120.945 0.402 . . . . 0.0 110.45 179.255 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 52' ' ' LEU . . . . . 0.482 HD12 HD11 ' A' ' 48' ' ' LEU . 0.4 OUTLIER -98.62 -30.48 12.46 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.274 179.284 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 53' ' ' LEU . . . . . 0.561 ' HA ' HG13 ' A' ' 5' ' ' VAL . 3.0 pp -66.76 152.08 46.2 Favored 'General case' 0 N--CA 1.452 -0.331 0 N-CA-C 109.764 -0.458 . . . . 0.0 109.764 179.565 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 93.28 3.27 65.28 Favored Glycine 0 N--CA 1.445 -0.704 0 C-N-CA 120.872 -0.68 . . . . 0.0 112.824 -175.136 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 55' ' ' LEU . . . . . 0.415 ' O ' HG12 ' A' ' 5' ' ' VAL . 3.8 mm? -96.01 165.28 12.33 Favored 'General case' 0 C--O 1.233 0.228 0 CA-C-N 117.395 0.598 . . . . 0.0 110.703 177.759 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 56' ' ' LYS . . . . . 0.601 ' HD3' ' N ' ' A' ' 57' ' ' VAL . 11.0 tmtt? -117.62 151.3 37.48 Favored 'General case' 0 C--N 1.324 -0.53 0 N-CA-C 109.031 -0.729 . . . . 0.0 109.031 -177.969 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 57' ' ' VAL . . . . . 0.601 ' N ' ' HD3' ' A' ' 56' ' ' LYS . 42.6 t -58.44 136.91 21.42 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-O 121.134 0.492 . . . . 0.0 111.492 176.708 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 82.75 8.97 85.23 Favored Glycine 0 N--CA 1.446 -0.645 0 CA-C-N 115.116 -0.947 . . . . 0.0 111.973 -178.985 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 59' ' ' ASP . . . . . 0.452 ' HB2' ' O ' ' A' ' 56' ' ' LYS . 1.0 OUTLIER -99.56 134.09 42.94 Favored 'General case' 0 C--N 1.323 -0.544 0 N-CA-C 108.916 -0.772 . . . . 0.0 108.916 171.772 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 6.9 mmmm -106.52 128.35 54.03 Favored 'General case' 0 C--N 1.319 -0.744 0 N-CA-C 109.248 -0.649 . . . . 0.0 109.248 -175.753 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 4.7 t -136.64 113.8 10.65 Favored 'General case' 0 C--N 1.32 -0.694 0 CA-C-O 121.837 0.827 . . . . 0.0 111.525 -176.536 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 62' ' ' THR . . . . . 0.434 HG23 ' HA ' ' A' ' 137' ' ' ASP . 6.1 m -100.47 131.66 46.27 Favored 'General case' 0 C--N 1.317 -0.842 0 N-CA-C 108.238 -1.023 . . . . 0.0 108.238 172.084 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 63' ' ' PHE . . . . . 0.513 ' CE2' ' HE1' ' A' ' 136' ' ' PHE . 11.3 p90 -157.92 163.98 37.34 Favored 'General case' 0 C--N 1.321 -0.661 0 C-N-CA 120.063 -0.655 . . . . 0.0 111.818 -178.072 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 26.0 t -128.75 151.81 49.13 Favored 'General case' 0 C--N 1.318 -0.785 0 CA-C-N 115.187 -0.915 . . . . 0.0 109.829 179.816 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 65' ' ' LEU . . . . . 0.421 ' CD1' ' HA ' ' A' ' 48' ' ' LEU . 39.3 mt -135.85 150.94 49.57 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-N 116.219 -0.446 . . . . 0.0 109.981 -176.882 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 48.7 mt-10 -64.1 153.88 83.94 Favored Pre-proline 0 C--N 1.33 -0.282 0 CA-C-N 116.081 -0.509 . . . . 0.0 110.527 178.779 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 80.9 Cg_exo -46.35 -52.25 7.57 Favored 'Trans proline' 0 C--O 1.233 0.257 0 C-N-CA 123.103 2.535 . . . . 0.0 113.542 -175.777 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 1.9 p-10 -66.26 -24.96 66.67 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-O 120.921 0.391 . . . . 0.0 111.053 -174.784 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -79.85 -18.55 50.49 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 115.98 -0.554 . . . . 0.0 110.922 -178.581 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.449 -0.482 0 N-CA-C 111.953 0.353 . . . . 0.0 111.953 -178.093 . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 75' ' ' SER . . . . . 0.59 ' HB3' HD22 ' A' ' 78' ' ' LEU . 41.3 t . . . . . 0 N--CA 1.44 -0.959 0 N-CA-C 109.896 -0.409 . . . . 0.0 109.896 . . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 26.9 Cg_endo -65.44 -25.84 55.61 Favored 'Trans proline' 0 N--CA 1.459 -0.536 0 C-N-CA 121.729 1.619 . . . . 0.0 111.009 175.666 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 8.6 p-10 -77.36 -8.87 58.37 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 115.701 -0.681 . . . . 0.0 110.753 176.524 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 78' ' ' LEU . . . . . 0.59 HD22 ' HB3' ' A' ' 75' ' ' SER . 4.4 tp -73.23 -23.06 60.31 Favored 'General case' 0 CA--C 1.511 -0.549 0 CA-C-O 121.596 0.712 . . . . 0.0 109.147 176.604 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 79' ' ' ILE . . . . . 0.632 HG23 ' O ' ' A' ' 123' ' ' VAL . 7.0 mt -68.3 124.24 23.43 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.724 0 CA-C-N 114.69 -1.141 . . . . 0.0 110.575 177.245 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 40.2 mt-30 -149.97 119.27 6.83 Favored 'General case' 0 CA--C 1.502 -0.885 0 CA-C-N 114.992 -1.004 . . . . 0.0 109.377 -176.184 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 81' ' ' TYR . . . . . 0.592 ' CE2' HG23 ' A' ' 122' ' ' THR . 1.8 m-85 -80.26 114.75 19.38 Favored 'General case' 0 C--N 1.307 -1.27 0 C-N-CA 118.76 -1.176 . . . . 0.0 111.902 174.97 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 23.6 m-85 -100.15 172.71 7.01 Favored 'General case' 0 C--N 1.322 -0.627 0 CA-C-N 113.782 -1.554 . . . . 0.0 110.141 172.399 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 83' ' ' SER . . . . . 0.436 ' HB3' ' HG3' ' A' ' 86' ' ' GLU . 23.2 t -63.24 159.34 18.01 Favored 'General case' 0 C--N 1.321 -0.657 0 CA-C-O 122.836 1.303 . . . . 0.0 112.485 -167.952 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 84' ' ' ARG . . . . . 0.574 ' HD3' ' HA ' ' A' ' 119' ' ' ASP . 36.5 ptt180 -77.5 -28.21 52.08 Favored 'General case' 0 C--N 1.315 -0.925 0 CA-C-N 112.604 -2.089 . . . . 0.0 108.118 -179.31 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 85' ' ' ARG . . . . . . . . . . . . . 6.6 mpt_? -71.53 -39.8 70.5 Favored 'General case' 0 CA--C 1.512 -0.5 0 CA-C-N 114.281 -1.327 . . . . 0.0 111.158 -176.99 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 86' ' ' GLU . . . . . 0.436 ' HG3' ' HB3' ' A' ' 83' ' ' SER . 41.4 mt-10 -56.02 -36.88 68.45 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 115.316 -0.857 . . . . 0.0 110.891 -175.941 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 87' ' ' PHE . . . . . 0.443 ' HB3' ' HG3' ' A' ' 93' ' ' PRO . 14.0 m-85 -93.18 -37.44 12.09 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.475 -0.329 . . . . 0.0 111.843 -179.601 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 88' ' ' MET . . . . . . . . . . . . . 58.6 ttp -58.53 -31.79 68.25 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.59 -173.382 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 33.9 t70 -57.55 -28.62 63.71 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-O 120.954 0.407 . . . . 0.0 110.912 177.443 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -102.79 -2.91 27.18 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.055 -0.52 . . . . 0.0 110.732 176.967 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 119.59 140.08 6.1 Favored Glycine 0 N--CA 1.447 -0.583 0 C-N-CA 121.035 -0.602 . . . . 0.0 112.117 -178.108 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 47.0 mt-10 -61.11 120.94 58.9 Favored Pre-proline 0 C--N 1.327 -0.398 0 CA-C-O 120.807 0.336 . . . . 0.0 110.887 178.465 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 93' ' ' PRO . . . . . 0.447 ' HG2' HD12 ' A' ' 121' ' ' ILE . 4.3 Cg_exo -71.7 167.42 26.57 Favored 'Trans proline' 0 C--N 1.344 0.312 0 C-N-CA 123.303 2.669 . . . . 0.0 112.895 -176.841 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -115.4 156.04 26.31 Favored 'General case' 0 C--N 1.321 -0.64 0 CA-C-N 115.04 -0.982 . . . . 0.0 111.045 -174.609 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 95' ' ' ILE . . . . . 0.528 HG12 HG12 ' A' ' 116' ' ' ILE . 21.6 mt -81.76 131.06 34.72 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.453 0 CA-C-N 115.909 -0.587 . . . . 0.0 110.875 -178.716 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 72.92 18.76 79.2 Favored Glycine 0 N--CA 1.449 -0.466 0 CA-C-N 115.709 -0.678 . . . . 0.0 112.422 -177.289 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 97' ' ' ALA . . . . . 0.411 ' O ' HG13 ' A' ' 113' ' ' ILE . . . -98.71 129.74 45.17 Favored 'General case' 0 C--N 1.324 -0.515 0 N-CA-C 109.674 -0.491 . . . . 0.0 109.674 177.385 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 98' ' ' ILE . . . . . 0.555 ' HA ' ' HA ' ' A' ' 112' ' ' VAL . 16.4 mt -97.79 130.08 47.04 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.725 0 N-CA-C 108.837 -0.801 . . . . 0.0 108.837 178.759 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 99' ' ' MET . . . . . . . . . . . . . 9.7 mtm -137.0 160.44 38.91 Favored 'General case' 0 N--CA 1.447 -0.594 0 N-CA-C 107.601 -1.259 . . . . 0.0 107.601 -179.721 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 2.6 mm? -69.77 103.63 2.22 Favored 'General case' 0 C--N 1.317 -0.814 0 CA-C-O 122.318 1.056 . . . . 0.0 111.046 175.307 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 101' ' ' PHE . . . . . . . . . . . . . 2.8 m-85 -94.2 171.63 8.71 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 113.151 -1.841 . . . . 0.0 112.612 -172.914 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 2.6 m -124.87 135.71 53.14 Favored 'General case' 0 C--N 1.313 -0.985 0 CA-C-N 114.439 -1.255 . . . . 0.0 109.382 -178.241 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -103.54 159.47 15.57 Favored 'General case' 0 C--N 1.32 -0.692 0 N-CA-C 109.316 -0.624 . . . . 0.0 109.316 -177.929 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 104' ' ' MET . . . . . . . . . . . . . 71.2 mtm -66.39 -12.49 57.22 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.057 -0.519 . . . . 0.0 111.798 -174.446 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 4.5 p-10 -93.59 3.96 54.7 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 120.848 0.356 . . . . 0.0 110.853 177.568 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 92.32 -10.83 73.51 Favored Glycine 0 N--CA 1.444 -0.788 0 C-N-CA 120.672 -0.775 . . . . 0.0 113.69 178.939 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 34.9 t -78.01 140.32 39.17 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-O 121.52 0.676 . . . . 0.0 111.072 -179.471 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 23.0 tt0 -94.74 98.78 11.01 Favored 'General case' 0 C--N 1.314 -0.97 0 CA-C-N 115.253 -0.885 . . . . 0.0 110.249 178.389 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 109' ' ' MET . . . . . . . . . . . . . 1.6 mtm -100.81 145.1 29.78 Favored Pre-proline 0 C--N 1.326 -0.421 0 CA-C-N 115.203 -0.908 . . . . 0.0 110.609 176.897 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 23.9 Cg_endo -66.61 116.35 4.04 Favored 'Trans proline' 0 N--CA 1.455 -0.741 0 C-N-CA 121.336 1.357 . . . . 0.0 110.631 173.227 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . -111.26 132.49 10.94 Favored Glycine 0 CA--C 1.502 -0.739 0 CA-C-N 115.518 -0.765 . . . . 0.0 112.223 -177.147 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 112' ' ' VAL . . . . . 0.555 ' HA ' ' HA ' ' A' ' 98' ' ' ILE . 3.0 p -94.62 133.22 36.29 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.739 0 N-CA-C 108.774 -0.825 . . . . 0.0 108.774 174.207 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 113' ' ' ILE . . . . . 0.444 HD13 ' CB ' ' A' ' 93' ' ' PRO . 20.3 mt -86.24 109.85 19.25 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.14 0 N-CA-C 108.201 -1.037 . . . . 0.0 108.201 -178.433 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 114' ' ' ARG . . . . . 0.474 ' O ' HG23 ' A' ' 95' ' ' ILE . 11.9 tpp180 -64.97 -46.75 80.19 Favored 'General case' 0 C--N 1.314 -0.957 0 CA-C-N 115.198 -0.91 . . . . 0.0 111.078 -174.395 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 115' ' ' GLU . . . . . 0.442 ' HA ' HG23 ' A' ' 95' ' ' ILE . 4.8 tt0 -159.7 160.05 33.66 Favored 'General case' 0 C--N 1.32 -0.71 0 C-N-CA 120.822 -0.351 . . . . 0.0 110.225 -176.324 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 116' ' ' ILE . . . . . 0.528 HG12 HG12 ' A' ' 95' ' ' ILE . 38.2 mm -114.61 121.78 67.39 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.436 0 CA-C-O 120.954 0.407 . . . . 0.0 110.36 177.99 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 117' ' ' ASN . . . . . . . . . . . . . 30.1 m-80 -112.64 154.1 26.59 Favored 'General case' 0 C--N 1.316 -0.87 0 N-CA-C 109.285 -0.635 . . . . 0.0 109.285 174.668 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . -75.94 -13.92 82.68 Favored Glycine 0 N--CA 1.449 -0.476 0 C-N-CA 120.74 -0.743 . . . . 0.0 113.021 -173.781 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 119' ' ' ASP . . . . . 0.574 ' HA ' ' HD3' ' A' ' 84' ' ' ARG . 30.2 t70 -112.82 -18.4 12.29 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-O 120.943 0.402 . . . . 0.0 111.594 -179.606 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 4.8 t -152.22 158.02 42.27 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 116.494 -0.321 . . . . 0.0 110.797 -172.997 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 121' ' ' ILE . . . . . 0.466 ' O ' ' HA ' ' A' ' 81' ' ' TYR . 47.7 mm -106.45 128.42 61.02 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.423 0 CA-C-O 121.218 0.533 . . . . 0.0 111.095 178.024 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 122' ' ' THR . . . . . 0.592 HG23 ' CE2' ' A' ' 81' ' ' TYR . 8.5 m -91.76 108.53 19.98 Favored 'General case' 0 C--N 1.321 -0.639 0 CA-C-O 122.19 0.995 . . . . 0.0 112.115 -178.429 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 123' ' ' VAL . . . . . 0.632 ' O ' HG23 ' A' ' 79' ' ' ILE . 15.5 t -99.63 157.79 3.81 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.555 0 CA-C-N 113.522 -1.672 . . . . 0.0 110.935 -177.755 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 124' ' ' ASP . . . . . 0.536 ' OD1' ' HB2' ' A' ' 126' ' ' ASN . 12.2 t0 -155.16 96.67 1.85 Allowed 'General case' 0 CA--C 1.537 0.474 0 N-CA-C 108.402 -0.962 . . . . 0.0 108.402 -176.025 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 125' ' ' PHE . . . . . 0.541 ' HB2' ' CD2' ' A' ' 78' ' ' LEU . 76.6 m-85 -90.31 23.62 2.86 Favored 'General case' 0 N--CA 1.47 0.541 0 O-C-N 120.618 -1.301 . . . . 0.0 111.478 -177.492 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 126' ' ' ASN . . . . . 0.536 ' HB2' ' OD1' ' A' ' 124' ' ' ASP . 27.1 m-80 . . . . . 0 C--N 1.328 -0.345 0 CA-C-O 122.096 0.951 . . . . 0.0 113.446 -174.817 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 133' ' ' THR . . . . . . . . . . . . . 1.5 m . . . . . 0 N--CA 1.444 -0.769 0 N-CA-C 109.808 -0.441 . . . . 0.0 109.808 . . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 134' ' ' VAL . . . . . 0.799 ' HB ' HD21 ' A' ' 17' ' ' LEU . 4.0 m -99.02 123.16 51.49 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.724 0 CA-C-O 121.447 0.641 . . . . 0.0 111.106 -175.126 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 135' ' ' HIS . . . . . 0.651 ' CE1' ' HB3' ' A' ' 18' ' ' LYS . 18.1 p80 -103.27 137.51 41.3 Favored 'General case' 0 C--N 1.318 -0.804 0 CA-C-N 115.112 -0.949 . . . . 0.0 110.189 174.152 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 136' ' ' PHE . . . . . 0.513 ' HE1' ' CE2' ' A' ' 63' ' ' PHE . 0.1 OUTLIER -134.48 138.33 44.63 Favored 'General case' 0 N--CA 1.442 -0.846 0 CA-C-O 121.55 0.69 . . . . 0.0 110.534 -175.153 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 137' ' ' ASP . . . . . 0.505 ' O ' ' HA ' ' A' ' 15' ' ' PHE . 37.6 t70 -98.93 108.07 20.66 Favored 'General case' 0 C--N 1.312 -1.062 0 CA-C-N 114.539 -1.21 . . . . 0.0 108.344 175.212 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 138' ' ' ILE . . . . . 0.706 HG23 HG21 ' A' ' 13' ' ' VAL . 62.5 mt -120.67 120.66 63.19 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.565 0 CA-C-O 121.396 0.617 . . . . 0.0 111.037 -167.851 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 30.2 mt-10 -110.8 111.32 22.4 Favored 'General case' 0 C--N 1.321 -0.671 0 CA-C-N 115.818 -0.628 . . . . 0.0 110.67 -178.703 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 140' ' ' VAL . . . . . 0.461 ' CG1' ' HA ' ' A' ' 57' ' ' VAL . 45.2 t -65.95 111.6 1.65 Allowed 'Isoleucine or valine' 0 C--O 1.234 0.266 0 CA-C-N 116.548 -0.296 . . . . 0.0 110.456 178.227 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 141' ' ' LEU . . . . . 0.497 HD11 ' CD2' ' A' ' 14' ' ' HIS . 48.0 mt -98.42 -49.74 4.56 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-O 120.746 0.307 . . . . 0.0 110.29 -179.943 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 142' ' ' GLU . . . . . . . . . . . . . 67.7 mm-40 -141.26 163.85 31.83 Favored 'General case' 0 CA--C 1.514 -0.413 0 CA-C-N 115.979 -0.555 . . . . 0.0 111.115 177.127 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 143' ' ' ILE . . . . . 0.52 HD12 HG23 ' A' ' 57' ' ' VAL . 94.4 mt -130.0 110.63 19.8 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.652 0 CA-C-N 115.168 -0.924 . . . . 0.0 110.381 176.605 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 144' ' ' ASP . . . . . 0.402 ' HB3' ' HB3' ' A' ' 10' ' ' ALA . 20.1 t70 -78.98 124.49 84.76 Favored Pre-proline 0 C--N 1.322 -0.617 0 CA-C-N 115.53 -0.759 . . . . 0.0 109.49 177.53 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 145' ' ' PRO . . . . . . . . . . . . . 41.3 Cg_endo . . . . . 0 C--O 1.234 0.32 0 C-N-CA 122.585 2.19 . . . . 0.0 112.29 -175.532 . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 2' ' ' SER . . . . . 0.407 ' CB ' ' HA ' ' A' ' 145' ' ' PRO . 14.6 t . . . . . 0 N--CA 1.452 -0.325 0 N-CA-C 109.84 -0.43 . . . . 0.0 109.84 . . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 3' ' ' GLU . . . . . 0.46 ' O ' ' HG3' ' A' ' 56' ' ' LYS . 32.3 mt-10 -74.5 -30.21 61.72 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 115.844 -0.616 . . . . 0.0 109.682 179.276 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 40.0 t -116.88 151.23 37.03 Favored 'General case' 0 C--N 1.318 -0.771 0 CA-C-N 114.904 -1.043 . . . . 0.0 109.389 -178.532 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 98.0 t -72.96 125.3 31.57 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.403 0 CA-C-O 121.036 0.446 . . . . 0.0 110.267 177.08 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 6' ' ' GLN . . . . . 0.651 ' HG2' ' OG ' ' A' ' 9' ' ' SER . 9.8 pt20 -119.34 166.94 12.39 Favored 'General case' 0 C--N 1.319 -0.718 0 CA-C-N 115.609 -0.723 . . . . 0.0 109.141 -179.557 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 7' ' ' SER . . . . . 0.452 ' O ' ' HB2' ' A' ' 8' ' ' ASN . 10.0 p -63.23 133.75 54.78 Favored 'General case' 0 C--N 1.316 -0.882 0 N-CA-C 109.857 -0.423 . . . . 0.0 109.857 177.832 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 8' ' ' ASN . . . . . 0.514 ' OD1' ' HA3' ' A' ' 40' ' ' GLY . 34.4 m-80 72.7 35.07 1.11 Allowed 'General case' 0 N--CA 1.471 0.596 0 O-C-N 123.755 0.659 . . . . 0.0 112.327 -176.78 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 9' ' ' SER . . . . . 0.651 ' OG ' ' HG2' ' A' ' 6' ' ' GLN . 49.6 m -92.82 167.03 12.13 Favored 'General case' 0 C--N 1.332 -0.152 0 CA-C-O 121.151 0.501 . . . . 0.0 110.785 173.006 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 10' ' ' ALA . . . . . 0.493 ' HB3' ' HB3' ' A' ' 144' ' ' ASP . . . -115.54 118.14 32.31 Favored 'General case' 0 C--N 1.319 -0.759 0 N-CA-C 108.558 -0.905 . . . . 0.0 108.558 170.808 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 4.3 m -127.5 142.75 42.75 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.729 0 C-N-CA 120.165 -0.614 . . . . 0.0 110.909 -174.05 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 12' ' ' LEU . . . . . 0.502 ' HB2' ' HB2' ' A' ' 142' ' ' GLU . 83.8 mt -93.96 133.4 37.44 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-N 115.818 -0.628 . . . . 0.0 109.346 176.566 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 17.2 m -131.68 167.11 27.07 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.941 0 CA-C-O 121.519 0.676 . . . . 0.0 112.262 -174.867 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 14' ' ' HIS . . . . . 0.566 ' CD2' HD11 ' A' ' 141' ' ' LEU . 0.3 OUTLIER -134.21 115.67 14.44 Favored 'General case' 0 C--N 1.322 -0.59 0 N-CA-C 106.433 -1.692 . . . . 0.0 106.433 166.159 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 45.4 p90 -145.8 156.14 43.38 Favored 'General case' 0 C--N 1.319 -0.726 0 C-N-CA 120.841 -0.344 . . . . 0.0 110.629 -171.084 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 60.1 m -121.63 131.47 54.13 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-O 120.884 0.373 . . . . 0.0 110.664 174.478 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 17' ' ' LEU . . . . . 0.446 ' CD2' ' HB3' ' A' ' 136' ' ' PHE . 6.3 mt -98.26 121.8 40.64 Favored 'General case' 0 C--N 1.328 -0.363 0 N-CA-C 112.662 0.616 . . . . 0.0 112.662 178.331 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 9.5 mptt -127.67 142.84 51.23 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-N 114.973 -1.012 . . . . 0.0 110.197 -179.236 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 19' ' ' LEU . . . . . 0.519 HD13 HG23 ' A' ' 134' ' ' VAL . 3.2 mm? -89.66 169.05 11.64 Favored 'General case' 0 C--N 1.325 -0.477 0 N-CA-C 109.487 -0.561 . . . . 0.0 109.487 175.918 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 1.8 p30 -67.27 -23.65 65.7 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 121.41 0.624 . . . . 0.0 109.965 177.163 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 36.3 m-20 -74.03 -0.49 16.55 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 115.139 -0.937 . . . . 0.0 111.447 175.826 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 73.8 15.47 79.51 Favored Glycine 0 N--CA 1.449 -0.442 0 C-N-CA 121.007 -0.616 . . . . 0.0 111.922 -179.124 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 27.0 m -88.34 151.79 22.37 Favored 'General case' 0 C--N 1.32 -0.68 0 N-CA-C 109.525 -0.546 . . . . 0.0 109.525 176.132 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 38.3 m -95.25 128.77 42.35 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-O 120.874 0.368 . . . . 0.0 110.969 178.167 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -91.8 -49.04 6.47 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.001 -0.545 . . . . 0.0 110.011 176.143 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 26' ' ' GLU . . . . . 0.436 ' O ' ' HB2' ' A' ' 17' ' ' LEU . 11.8 tp10 -160.9 120.29 2.63 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 115.88 -0.6 . . . . 0.0 109.872 178.352 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 46.8 m -105.31 99.08 8.7 Favored 'General case' 0 C--N 1.318 -0.777 0 C-N-CA 120.233 -0.587 . . . . 0.0 110.3 177.276 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 28' ' ' THR . . . . . 0.408 ' O ' HG22 ' A' ' 28' ' ' THR . 32.8 m -91.69 57.14 3.16 Favored 'General case' 0 C--N 1.318 -0.789 0 CA-C-O 122.171 0.986 . . . . 0.0 110.068 -178.756 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 21.2 ttt180 -146.44 -55.73 0.27 Allowed 'General case' 0 C--N 1.312 -1.043 0 CA-C-N 115.065 -0.971 . . . . 0.0 109.866 176.959 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 2.0 p-10 -77.86 -1.58 32.38 Favored 'General case' 0 N--CA 1.465 0.279 0 C-N-CA 120.928 -0.309 . . . . 0.0 111.069 179.36 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 94.9 m-20 -74.35 -13.42 60.74 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-O 120.861 0.363 . . . . 0.0 110.239 175.338 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 77.81 2.38 81.31 Favored Glycine 0 N--CA 1.446 -0.648 0 N-CA-C 111.23 -0.748 . . . . 0.0 111.23 -178.114 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 35.4 mtmm -131.23 115.28 16.27 Favored Pre-proline 0 N--CA 1.449 -0.477 0 CA-C-N 115.631 -0.285 . . . . 0.0 110.497 -174.575 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 19.6 Cg_exo -69.13 166.88 25.28 Favored 'Trans proline' 0 C--O 1.233 0.265 0 C-N-CA 122.792 2.328 . . . . 0.0 112.002 173.482 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -130.85 155.52 46.57 Favored 'General case' 0 C--N 1.316 -0.891 0 CA-C-N 115.462 -0.79 . . . . 0.0 110.453 -177.767 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 3.1 tp -101.14 142.4 32.63 Favored 'General case' 0 C--N 1.316 -0.867 0 CA-C-N 115.849 -0.614 . . . . 0.0 110.348 177.825 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 37' ' ' PHE . . . . . . . . . . . . . 5.8 m-30 -109.46 108.09 18.46 Favored 'General case' 0 C--N 1.312 -1.046 0 N-CA-C 108.364 -0.976 . . . . 0.0 108.364 177.787 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -86.46 107.62 18.15 Favored 'General case' 0 C--N 1.321 -0.658 0 CA-C-O 121.129 0.49 . . . . 0.0 109.826 -179.595 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 39' ' ' LEU . . . . . 0.422 ' HG ' ' CB ' ' A' ' 49' ' ' GLU . 9.5 mp -81.77 153.02 26.71 Favored 'General case' 0 C--N 1.317 -0.837 0 CA-C-N 115.208 -0.906 . . . . 0.0 109.935 -179.928 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 40' ' ' GLY . . . . . 0.514 ' HA3' ' OD1' ' A' ' 8' ' ' ASN . . . 96.67 29.11 8.4 Favored Glycine 0 N--CA 1.447 -0.585 0 C-N-CA 120.537 -0.84 . . . . 0.0 112.171 -178.262 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 17.9 t70 60.32 15.77 5.67 Favored 'General case' 0 N--CA 1.469 0.496 0 CA-C-O 121.425 0.631 . . . . 0.0 111.122 178.341 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -79.85 -13.52 59.34 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 121.11 0.481 . . . . 0.0 110.746 -176.336 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 35.7 t -161.18 -54.36 0.05 OUTLIER 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 115.522 -0.763 . . . . 0.0 109.024 174.998 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 4.0 mm? -91.3 149.71 21.63 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 115.829 -0.623 . . . . 0.0 109.674 176.483 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 47.5 t -70.93 155.52 40.72 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-N 115.782 -0.645 . . . . 0.0 111.119 -177.292 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 46' ' ' GLU . . . . . 0.483 ' O ' ' HG2' ' A' ' 49' ' ' GLU . 28.5 tt0 -49.94 -40.27 43.02 Favored 'General case' 0 N--CA 1.45 -0.46 0 C-N-CA 122.981 0.513 . . . . 0.0 111.854 -179.856 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 47' ' ' GLY . . . . . 0.417 ' HA3' ' HB1' ' A' ' 69' ' ' ALA . . . -56.69 -36.34 71.33 Favored Glycine 0 N--CA 1.448 -0.541 0 C-N-CA 120.567 -0.825 . . . . 0.0 112.447 -176.445 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 1.7 tt -64.26 -52.88 56.49 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 116.953 0.377 . . . . 0.0 111.745 176.57 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 49' ' ' GLU . . . . . 0.491 ' O ' HD13 ' A' ' 53' ' ' LEU . 13.8 pt-20 -63.91 -29.95 71.08 Favored 'General case' 0 N--CA 1.453 -0.299 0 CA-C-O 120.508 0.194 . . . . 0.0 111.02 -173.322 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 50' ' ' GLN . . . . . 0.527 ' HA ' HD22 ' A' ' 53' ' ' LEU . 16.9 mm-40 -65.67 -17.11 64.36 Favored 'General case' 0 N--CA 1.452 -0.347 0 CA-C-N 116.372 -0.376 . . . . 0.0 110.605 -173.936 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 51' ' ' HIS . . . . . . . . . . . . . 10.7 m80 -107.27 -3.68 19.49 Favored 'General case' 0 N--CA 1.45 -0.449 0 CA-C-O 121.053 0.454 . . . . 0.0 110.022 -176.934 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 49.4 mt -103.04 -20.55 14.15 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 115.657 -0.702 . . . . 0.0 111.282 -178.865 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 53' ' ' LEU . . . . . 0.527 HD22 ' HA ' ' A' ' 50' ' ' GLN . 0.0 OUTLIER -60.59 135.91 57.9 Favored 'General case' 0 C--O 1.234 0.257 0 CA-C-O 120.875 0.369 . . . . 0.0 111.273 177.874 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 93.03 -5.96 76.01 Favored Glycine 0 N--CA 1.45 -0.399 0 CA-C-N 115.947 -0.57 . . . . 0.0 112.667 178.884 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 64.0 mt -84.47 163.54 19.37 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-O 121.208 0.528 . . . . 0.0 111.275 179.369 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 56' ' ' LYS . . . . . 0.46 ' HG3' ' O ' ' A' ' 3' ' ' GLU . 0.0 OUTLIER -127.39 169.52 13.52 Favored 'General case' 0 C--N 1.32 -0.695 0 CA-C-N 115.322 -0.854 . . . . 0.0 109.457 176.018 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 39.6 t -60.68 142.76 15.39 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.833 0 CA-C-O 121.068 0.461 . . . . 0.0 110.547 176.026 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 80.88 10.03 85.57 Favored Glycine 0 N--CA 1.448 -0.516 0 CA-C-N 115.673 -0.694 . . . . 0.0 112.659 -177.945 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 4.0 m-20 -98.92 150.52 21.84 Favored 'General case' 0 CA--C 1.511 -0.553 0 CA-C-O 121.073 0.463 . . . . 0.0 111.183 176.164 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 60' ' ' LYS . . . . . 0.471 ' H ' ' HG2' ' A' ' 60' ' ' LYS . 0.0 OUTLIER -120.88 129.55 53.55 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-N 115.189 -0.914 . . . . 0.0 109.382 -178.998 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 6.1 m -142.32 121.39 12.91 Favored 'General case' 0 N--CA 1.433 -1.298 0 CA-C-O 121.155 0.503 . . . . 0.0 110.502 -179.003 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 14.3 m -111.0 132.82 53.89 Favored 'General case' 0 C--N 1.316 -0.88 0 CA-C-N 115.754 -0.657 . . . . 0.0 109.872 177.277 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 32.0 p90 -146.7 172.79 13.07 Favored 'General case' 0 C--N 1.314 -0.972 0 CA-C-N 116.044 -0.525 . . . . 0.0 110.239 179.032 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 50.9 m -130.83 135.91 48.17 Favored 'General case' 0 C--N 1.32 -0.681 0 N-CA-C 108.783 -0.821 . . . . 0.0 108.783 -172.44 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 65' ' ' LEU . . . . . 0.453 ' HB2' ' HB2' ' A' ' 70' ' ' ALA . 61.1 mt -139.48 140.62 37.3 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-O 121.164 0.507 . . . . 0.0 111.406 -172.052 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 66' ' ' GLU . . . . . 0.431 ' HB3' ' HD2' ' A' ' 67' ' ' PRO . 44.1 mt-10 -75.54 162.12 73.74 Favored Pre-proline 0 C--N 1.326 -0.455 0 CA-C-N 115.037 -0.983 . . . . 0.0 109.842 174.597 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 67' ' ' PRO . . . . . 0.431 ' HD2' ' HB3' ' A' ' 66' ' ' GLU . 76.0 Cg_exo -42.04 -43.3 7.22 Favored 'Trans proline' 0 C--N 1.346 0.397 0 C-N-CA 123.513 2.809 . . . . 0.0 114.558 -177.837 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 6.6 p-10 -63.74 -18.77 64.39 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-O 120.782 0.325 . . . . 0.0 111.44 -177.505 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 69' ' ' ALA . . . . . 0.417 ' HB1' ' HA3' ' A' ' 47' ' ' GLY . . . -114.35 -7.38 12.91 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 116.326 -0.397 . . . . 0.0 111.368 179.223 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 70' ' ' ALA . . . . . 0.453 ' HB2' ' HB2' ' A' ' 65' ' ' LEU . . . . . . . . 0 C--N 1.33 -0.253 0 CA-C-O 120.542 0.211 . . . . 0.0 111.431 -176.954 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 75' ' ' SER . . . . . 0.777 ' O ' ' HG ' ' A' ' 78' ' ' LEU . 46.1 m . . . . . 0 N--CA 1.445 -0.683 0 CA-C-O 120.758 0.313 . . . . 0.0 111.241 . . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 47.6 Cg_endo -69.73 -18.3 37.21 Favored 'Trans proline' 0 N--CA 1.463 -0.284 0 C-N-CA 122.18 1.92 . . . . 0.0 111.724 176.657 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 77' ' ' ASP . . . . . 0.631 ' OD1' ' HB3' ' A' ' 75' ' ' SER . 6.4 p-10 -76.83 -13.0 60.05 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.623 -0.717 . . . . 0.0 111.352 -179.644 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 78' ' ' LEU . . . . . 0.777 ' HG ' ' O ' ' A' ' 75' ' ' SER . 4.1 pp -91.62 -4.89 54.75 Favored 'General case' 0 CA--C 1.515 -0.396 0 C-N-CA 119.652 -0.819 . . . . 0.0 110.392 177.739 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 43.7 mt -80.31 138.51 19.67 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.611 0 N-CA-C 109.886 -0.413 . . . . 0.0 109.886 169.074 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 3.7 mp0 -142.2 142.64 32.68 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-N 116.122 -0.49 . . . . 0.0 109.84 -177.847 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 81' ' ' TYR . . . . . 0.409 ' CE2' HG23 ' A' ' 122' ' ' THR . 43.0 m-85 -113.76 111.71 22.23 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-O 121.182 0.515 . . . . 0.0 109.983 -177.593 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 56.1 m-85 -109.73 171.17 7.6 Favored 'General case' 0 C--N 1.317 -0.814 0 CA-C-N 115.365 -0.834 . . . . 0.0 109.961 177.388 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 25.8 t -81.56 154.27 26.31 Favored 'General case' 0 C--N 1.321 -0.655 0 CA-C-O 121.368 0.604 . . . . 0.0 110.15 178.749 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 84' ' ' ARG . . . . . 0.519 ' HG3' ' HD2' ' A' ' 85' ' ' ARG . 13.0 ptm180 -68.89 -29.47 67.76 Favored 'General case' 0 C--N 1.32 -0.687 0 CA-C-N 115.383 -0.826 . . . . 0.0 109.649 178.108 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 85' ' ' ARG . . . . . 0.519 ' HD2' ' HG3' ' A' ' 84' ' ' ARG . 5.2 mpt_? -64.05 -34.06 77.16 Favored 'General case' 0 C--N 1.321 -0.667 0 CA-C-N 114.201 -1.363 . . . . 0.0 109.981 177.448 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 46.4 mt-10 -75.67 -10.8 59.75 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 115.757 -0.656 . . . . 0.0 110.565 178.119 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 87' ' ' PHE . . . . . 0.488 ' CE2' HG21 ' A' ' 121' ' ' ILE . 3.8 m-85 -103.3 -22.79 13.65 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 115.596 -0.729 . . . . 0.0 110.41 -179.748 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 88' ' ' MET . . . . . . . . . . . . . 46.4 ttm -60.14 -13.19 10.84 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 121.928 0.871 . . . . 0.0 109.679 172.375 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 25.0 t70 -61.09 -31.95 71.63 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-N 114.12 -1.4 . . . . 0.0 109.689 175.153 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -122.61 15.88 10.31 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 115.557 -0.747 . . . . 0.0 110.708 178.162 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 96.97 139.99 11.01 Favored Glycine 0 N--CA 1.45 -0.397 0 C-N-CA 120.6 -0.81 . . . . 0.0 111.925 -176.379 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 47.1 mt-10 -68.32 124.38 89.68 Favored Pre-proline 0 C--N 1.325 -0.494 0 CA-C-O 121.446 0.641 . . . . 0.0 111.48 -174.834 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 93' ' ' PRO . . . . . 0.54 ' HB2' HD13 ' A' ' 113' ' ' ILE . 83.8 Cg_endo -78.35 169.08 20.63 Favored 'Trans proline' 0 C--O 1.235 0.36 0 C-N-CA 124.669 3.579 . . . . 0.0 114.933 -169.373 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 94' ' ' GLU . . . . . 0.564 ' O ' HD12 ' A' ' 113' ' ' ILE . 1.4 mp0 -116.7 164.31 14.83 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 114.214 -1.357 . . . . 0.0 110.74 -174.616 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 95' ' ' ILE . . . . . 0.643 HG23 ' HA ' ' A' ' 115' ' ' GLU . 17.5 mt -82.78 133.96 27.97 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.377 0 CA-C-O 120.919 0.39 . . . . 0.0 110.909 179.35 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 70.69 29.89 69.07 Favored Glycine 0 N--CA 1.449 -0.447 0 CA-C-N 115.83 -0.623 . . . . 0.0 111.973 -179.194 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 97' ' ' ALA . . . . . 0.685 ' O ' HG13 ' A' ' 113' ' ' ILE . . . -106.42 140.0 40.02 Favored 'General case' 0 C--N 1.324 -0.52 0 N-CA-C 109.865 -0.42 . . . . 0.0 109.865 -179.777 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 98' ' ' ILE . . . . . 0.492 ' HA ' ' O ' ' A' ' 111' ' ' GLY . 72.5 mt -88.06 108.26 18.37 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.812 0 N-CA-C 109.972 -0.381 . . . . 0.0 109.972 -179.98 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 99' ' ' MET . . . . . 0.562 ' HB2' ' CE2' ' A' ' 101' ' ' PHE . 89.9 mtp -99.08 126.15 44.75 Favored 'General case' 0 N--CA 1.442 -0.835 0 CA-C-N 116.301 -0.409 . . . . 0.0 111.069 179.444 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 100' ' ' LEU . . . . . 0.447 ' HA ' HD13 ' A' ' 100' ' ' LEU . 4.3 mm? -67.42 147.35 52.99 Favored 'General case' 0 C--N 1.307 -1.241 0 N-CA-C 108.327 -0.99 . . . . 0.0 108.327 163.2 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 101' ' ' PHE . . . . . 0.632 ' HB2' ' O ' ' A' ' 109' ' ' MET . 2.5 m-85 -149.49 169.78 20.12 Favored 'General case' 0 CA--C 1.51 -0.594 0 CA-C-N 116.001 -0.545 . . . . 0.0 109.925 -155.101 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 3.9 m -126.64 129.26 48.15 Favored 'General case' 0 C--N 1.31 -1.128 0 N-CA-C 108.913 -0.773 . . . . 0.0 108.913 170.663 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -97.4 154.89 17.17 Favored 'General case' 0 C--N 1.316 -0.853 0 N-CA-C 109.05 -0.722 . . . . 0.0 109.05 -175.878 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 104' ' ' MET . . . . . . . . . . . . . 4.7 mpp? -65.24 -12.77 54.95 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.945 -174.219 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 9.8 p-10 -95.21 6.86 47.88 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-O 120.728 0.299 . . . . 0.0 110.928 177.219 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 89.55 -10.95 71.62 Favored Glycine 0 N--CA 1.452 -0.272 0 C-N-CA 121.213 -0.518 . . . . 0.0 113.217 174.67 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 43.1 t -79.94 143.15 34.44 Favored 'General case' 0 C--N 1.32 -0.677 0 CA-C-O 121.37 0.605 . . . . 0.0 109.748 178.721 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 23.3 tt0 -92.18 99.03 11.9 Favored 'General case' 0 C--N 1.309 -1.175 0 CA-C-O 121.956 0.884 . . . . 0.0 109.443 179.28 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 109' ' ' MET . . . . . 0.632 ' O ' ' HB2' ' A' ' 101' ' ' PHE . 71.3 mtp -96.13 135.54 22.62 Favored Pre-proline 0 C--N 1.319 -0.73 0 CA-C-N 113.965 -1.471 . . . . 0.0 111.689 -178.964 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 30.3 Cg_endo -68.9 159.4 54.01 Favored 'Trans proline' 0 N--CA 1.456 -0.709 0 C-N-CA 121.92 1.746 . . . . 0.0 110.011 168.198 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 111' ' ' GLY . . . . . 0.492 ' O ' ' HA ' ' A' ' 98' ' ' ILE . . . -147.15 149.04 21.12 Favored Glycine 0 C--N 1.314 -0.639 0 C-N-CA 119.945 -1.121 . . . . 0.0 110.993 -172.849 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 2.7 p -118.9 111.26 32.82 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.618 0 CA-C-N 118.311 1.056 . . . . 0.0 110.305 170.917 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 113' ' ' ILE . . . . . 0.685 HG13 ' O ' ' A' ' 97' ' ' ALA . 0.5 OUTLIER -62.88 112.03 0.99 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.469 0 CA-C-N 115.729 -0.669 . . . . 0.0 110.175 175.223 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 114' ' ' ARG . . . . . 0.573 ' HD2' ' HB2' ' A' ' 115' ' ' GLU . 5.6 tmm_? -71.22 -43.36 67.51 Favored 'General case' 0 C--N 1.316 -0.883 0 CA-C-N 115.874 -0.603 . . . . 0.0 110.679 -176.983 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 115' ' ' GLU . . . . . 0.643 ' HA ' HG23 ' A' ' 95' ' ' ILE . 13.8 tt0 -159.42 154.76 25.46 Favored 'General case' 0 C--N 1.329 -0.313 0 N-CA-C 110.317 -0.253 . . . . 0.0 110.317 -179.871 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 116' ' ' ILE . . . . . 0.56 HG12 HG12 ' A' ' 95' ' ' ILE . 38.0 mm -98.55 112.42 30.62 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.501 0 N-CA-C 109.04 -0.726 . . . . 0.0 109.04 174.23 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 117' ' ' ASN . . . . . 0.434 ' HB2' ' O ' ' A' ' 120' ' ' SER . 5.4 m-20 -88.18 159.68 18.07 Favored 'General case' 0 C--N 1.311 -1.094 0 N-CA-C 108.724 -0.843 . . . . 0.0 108.724 177.289 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . -55.26 -47.16 76.44 Favored Glycine 0 N--CA 1.45 -0.372 0 C-N-CA 120.518 -0.848 . . . . 0.0 113.129 -169.438 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 119' ' ' ASP . . . . . 0.444 ' O ' ' HG2' ' A' ' 84' ' ' ARG . 4.4 p-10 -114.78 -11.1 12.32 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 117.125 0.463 . . . . 0.0 111.343 175.171 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 120' ' ' SER . . . . . 0.434 ' O ' ' HB2' ' A' ' 117' ' ' ASN . 9.0 t -115.97 158.26 23.34 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-O 121.222 0.534 . . . . 0.0 111.656 -171.812 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 121' ' ' ILE . . . . . 0.488 HG21 ' CE2' ' A' ' 87' ' ' PHE . 46.7 mm -117.21 128.69 74.5 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.52 0 CA-C-N 116.112 -0.495 . . . . 0.0 110.436 177.263 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 122' ' ' THR . . . . . 0.409 HG23 ' CE2' ' A' ' 81' ' ' TYR . 18.7 m -93.47 102.55 14.77 Favored 'General case' 0 C--N 1.32 -0.686 0 CA-C-O 121.594 0.711 . . . . 0.0 110.907 177.97 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 42.9 t -104.4 108.16 24.1 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.385 0 CA-C-N 114.66 -1.155 . . . . 0.0 112.92 -179.983 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 124' ' ' ASP . . . . . 0.443 ' C ' ' H ' ' A' ' 126' ' ' ASN . 1.3 m-20 -98.04 106.57 18.88 Favored 'General case' 0 C--N 1.318 -0.762 0 CA-C-N 114.689 -1.141 . . . . 0.0 110.386 170.121 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 125' ' ' PHE . . . . . 0.582 ' HB2' HD13 ' A' ' 78' ' ' LEU . 81.5 m-85 -75.07 18.9 0.16 Allowed 'General case' 0 N--CA 1.465 0.29 0 O-C-N 121.898 -0.501 . . . . 0.0 111.284 171.242 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 126' ' ' ASN . . . . . 0.443 ' H ' ' C ' ' A' ' 124' ' ' ASP . 11.4 m-80 . . . . . 0 C--N 1.328 -0.368 0 CA-C-N 115.818 -0.628 . . . . 0.0 110.622 176.285 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 133' ' ' THR . . . . . . . . . . . . . 21.9 m . . . . . 0 C--O 1.232 0.154 0 N-CA-C 110.507 -0.182 . . . . 0.0 110.507 . . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 134' ' ' VAL . . . . . 0.519 HG23 HD13 ' A' ' 19' ' ' LEU . 14.5 p -128.92 163.6 33.45 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.594 0 CA-C-O 121.093 0.473 . . . . 0.0 111.366 -174.709 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 135' ' ' HIS . . . . . 0.42 ' N ' HG22 ' A' ' 134' ' ' VAL . 72.2 m-70 -123.19 115.82 22.39 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 115.803 -0.635 . . . . 0.0 109.633 -176.027 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 136' ' ' PHE . . . . . 0.488 ' CE1' HG13 ' A' ' 134' ' ' VAL . 0.1 OUTLIER -125.42 138.26 54.01 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-O 121.112 0.482 . . . . 0.0 111.993 -176.463 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 137' ' ' ASP . . . . . . . . . . . . . 5.9 m-20 -103.73 107.11 17.83 Favored 'General case' 0 N--CA 1.468 0.436 0 CA-C-N 115.263 -0.88 . . . . 0.0 110.444 -178.846 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 138' ' ' ILE . . . . . 0.473 HD11 ' HD2' ' A' ' 136' ' ' PHE . 4.5 mp -96.95 138.89 20.74 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.492 0 CA-C-O 120.806 0.336 . . . . 0.0 111.77 -174.523 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 18.0 mt-10 -127.32 127.74 44.79 Favored 'General case' 0 CA--C 1.515 -0.379 0 N-CA-C 108.416 -0.957 . . . . 0.0 108.416 168.302 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 140' ' ' VAL . . . . . . . . . . . . . 91.3 t -78.95 111.25 15.58 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-O 120.925 0.393 . . . . 0.0 110.31 -178.078 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 141' ' ' LEU . . . . . 0.566 HD11 ' CD2' ' A' ' 14' ' ' HIS . 44.4 mt -85.38 -42.86 14.16 Favored 'General case' 0 C--N 1.316 -0.882 0 CA-C-O 121.371 0.605 . . . . 0.0 110.393 -179.855 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 142' ' ' GLU . . . . . 0.502 ' HB2' ' HB2' ' A' ' 12' ' ' LEU . 6.7 mm-40 -151.1 156.55 41.28 Favored 'General case' 0 C--N 1.321 -0.673 0 CA-C-N 115.135 -0.939 . . . . 0.0 111.271 -177.96 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 143' ' ' ILE . . . . . . . . . . . . . 78.7 mt -126.68 109.69 21.53 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.766 0 CA-C-N 115.619 -0.719 . . . . 0.0 109.876 178.773 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 144' ' ' ASP . . . . . 0.493 ' HB3' ' HB3' ' A' ' 10' ' ' ALA . 33.0 t70 -78.68 125.07 84.93 Favored Pre-proline 0 C--N 1.324 -0.512 0 N-CA-C 109.222 -0.659 . . . . 0.0 109.222 175.0 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 145' ' ' PRO . . . . . 0.407 ' HA ' ' CB ' ' A' ' 2' ' ' SER . 48.6 Cg_endo . . . . . 0 N--CA 1.461 -0.419 0 C-N-CA 122.537 2.158 . . . . 0.0 112.411 -175.688 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 14.3 p . . . . . 0 N--CA 1.467 0.394 0 CA-C-O 121.487 0.66 . . . . 0.0 112.396 . . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 3' ' ' GLU . . . . . 0.459 ' HG2' ' HD2' ' A' ' 56' ' ' LYS . 29.4 tt0 -99.05 -26.37 14.25 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 115.748 -0.66 . . . . 0.0 110.626 179.539 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 4' ' ' SER . . . . . 0.547 ' OG ' ' HE2' ' A' ' 56' ' ' LYS . 14.6 m -101.71 136.16 42.02 Favored 'General case' 0 C--N 1.318 -0.772 0 CA-C-N 115.543 -0.753 . . . . 0.0 111.034 -174.315 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 6.1 p -81.13 148.88 5.2 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.665 0 CA-C-O 121.453 0.644 . . . . 0.0 110.426 179.571 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 6' ' ' GLN . . . . . 0.688 ' HG2' ' OG ' ' A' ' 9' ' ' SER . 4.5 pt20 -140.53 166.16 25.48 Favored 'General case' 0 C--N 1.311 -1.067 0 CA-C-N 114.918 -1.037 . . . . 0.0 109.298 174.461 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 75.7 p -65.26 132.19 48.42 Favored 'General case' 0 N--CA 1.441 -0.916 0 N-CA-C 108.701 -0.851 . . . . 0.0 108.701 175.814 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 10.4 t30 75.08 38.06 0.45 Allowed 'General case' 0 CA--C 1.539 0.551 0 O-C-N 123.682 0.614 . . . . 0.0 110.95 -177.95 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 9' ' ' SER . . . . . 0.688 ' OG ' ' HG2' ' A' ' 6' ' ' GLN . 51.0 m -93.77 166.85 12.0 Favored 'General case' 0 CA--C 1.521 -0.167 0 CA-C-O 121.308 0.575 . . . . 0.0 110.821 172.462 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 10' ' ' ALA . . . . . 0.672 ' HB1' HD21 ' A' ' 36' ' ' LEU . . . -109.43 111.32 22.8 Favored 'General case' 0 N--CA 1.444 -0.769 0 N-CA-C 108.544 -0.91 . . . . 0.0 108.544 169.992 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 3.8 m -116.52 135.54 56.45 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.682 0 C-N-CA 119.767 -0.773 . . . . 0.0 111.351 -179.378 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 18.0 tp -86.36 128.43 34.93 Favored 'General case' 0 N--CA 1.447 -0.608 0 N-CA-C 108.914 -0.772 . . . . 0.0 108.914 177.837 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 13' ' ' VAL . . . . . 0.638 HG21 HG23 ' A' ' 138' ' ' ILE . 3.8 p -131.92 158.67 43.33 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.987 0 CA-C-O 122.23 1.014 . . . . 0.0 112.618 -174.561 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 14' ' ' HIS . . . . . 0.584 ' ND1' ' HA ' ' A' ' 29' ' ' ARG . 0.2 OUTLIER -122.94 110.28 15.19 Favored 'General case' 0 C--N 1.313 -1.001 0 CA-C-N 113.443 -1.708 . . . . 0.0 106.996 167.919 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 15' ' ' PHE . . . . . 0.453 ' HA ' ' O ' ' A' ' 137' ' ' ASP . 12.8 p90 -133.64 166.02 23.56 Favored 'General case' 0 C--N 1.324 -0.532 0 C-N-CA 119.223 -0.991 . . . . 0.0 113.673 -174.621 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 22.3 m -140.98 142.09 34.33 Favored 'General case' 0 N--CA 1.444 -0.744 0 CA-C-N 113.952 -1.476 . . . . 0.0 107.914 174.913 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 17' ' ' LEU . . . . . 0.537 HD11 ' CZ ' ' A' ' 136' ' ' PHE . 0.5 OUTLIER -126.86 112.62 15.54 Favored 'General case' 0 C--N 1.32 -0.716 0 N-CA-C 110.327 -0.249 . . . . 0.0 110.327 -173.624 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -118.85 152.53 36.09 Favored 'General case' 0 C--N 1.315 -0.913 0 CA-C-O 120.93 0.395 . . . . 0.0 111.392 -178.393 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 19' ' ' LEU . . . . . 0.603 HD21 ' HB2' ' A' ' 25' ' ' ALA . 3.4 mm? -103.82 170.47 7.91 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 115.844 -0.616 . . . . 0.0 109.627 174.372 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 2.2 m-20 -68.9 -18.92 64.19 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-O 120.952 0.406 . . . . 0.0 110.959 178.809 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 25.3 t70 -83.37 3.64 30.85 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 121.314 0.578 . . . . 0.0 110.279 175.32 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 74.26 9.88 81.3 Favored Glycine 0 N--CA 1.451 -0.305 0 CA-C-N 115.94 -0.573 . . . . 0.0 112.645 -175.958 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 23' ' ' THR . . . . . 0.466 ' HB ' HD23 ' A' ' 19' ' ' LEU . 12.1 m -72.55 141.07 48.46 Favored 'General case' 0 C--N 1.324 -0.53 0 N-CA-C 109.728 -0.471 . . . . 0.0 109.728 175.746 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 54.4 m -94.17 109.88 21.64 Favored 'General case' 0 C--N 1.319 -0.736 0 N-CA-C 109.854 -0.425 . . . . 0.0 109.854 174.658 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 25' ' ' ALA . . . . . 0.603 ' HB2' HD21 ' A' ' 19' ' ' LEU . . . -69.76 -40.41 76.14 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.975 -0.557 . . . . 0.0 110.027 179.692 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 10.2 tp10 -160.98 139.33 9.79 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 115.406 -0.815 . . . . 0.0 109.656 177.465 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 16.6 p -125.77 132.41 52.31 Favored 'General case' 0 C--N 1.317 -0.824 0 CA-C-O 120.838 0.352 . . . . 0.0 110.364 175.678 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 28' ' ' THR . . . . . 0.538 HG21 ' HB2' ' A' ' 35' ' ' ALA . 79.3 m -152.42 65.77 0.82 Allowed 'General case' 0 N--CA 1.441 -0.894 0 CA-C-O 122.116 0.96 . . . . 0.0 109.617 178.221 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 29' ' ' ARG . . . . . 0.584 ' HA ' ' ND1' ' A' ' 14' ' ' HIS . 26.9 ttt180 -154.11 -52.27 0.1 Allowed 'General case' 0 C--N 1.319 -0.733 0 N-CA-C 108.712 -0.847 . . . . 0.0 108.712 178.206 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 9.9 p30 -76.93 -4.24 42.9 Favored 'General case' 0 N--CA 1.464 0.228 0 CA-C-N 115.855 -0.611 . . . . 0.0 110.214 176.356 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 1.5 m-20 -69.46 -21.11 63.74 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 115.46 -0.791 . . . . 0.0 110.739 -178.958 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 85.3 4.1 86.51 Favored Glycine 0 N--CA 1.445 -0.711 0 C-N-CA 120.589 -0.815 . . . . 0.0 111.33 -173.723 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 56.5 mtpt -138.26 131.47 16.45 Favored Pre-proline 0 N--CA 1.452 -0.354 0 N-CA-C 109.995 -0.372 . . . . 0.0 109.995 179.14 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 91.8 Cg_endo -82.98 168.15 13.86 Favored 'Trans proline' 0 N--CA 1.453 -0.858 0 C-N-CA 122.393 2.062 . . . . 0.0 111.492 170.711 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 35' ' ' ALA . . . . . 0.538 ' HB2' HG21 ' A' ' 28' ' ' THR . . . -129.44 153.8 47.58 Favored 'General case' 0 C--N 1.319 -0.752 0 CA-C-N 116.256 -0.429 . . . . 0.0 109.942 -178.549 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 36' ' ' LEU . . . . . 0.672 HD21 ' HB1' ' A' ' 10' ' ' ALA . 4.6 tp -98.0 132.03 43.91 Favored 'General case' 0 C--N 1.315 -0.91 0 N-CA-C 109.967 -0.382 . . . . 0.0 109.967 176.87 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 37' ' ' PHE . . . . . 0.415 ' CD2' HD21 ' A' ' 44' ' ' LEU . 5.2 m-30 -95.79 107.33 19.55 Favored 'General case' 0 C--N 1.318 -0.802 0 N-CA-C 109.477 -0.564 . . . . 0.0 109.477 174.868 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 4.9 tpp180 -84.96 107.32 17.04 Favored 'General case' 0 N--CA 1.45 -0.468 0 CA-C-N 115.536 -0.756 . . . . 0.0 109.901 -178.269 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 63.4 mt -81.89 156.12 24.96 Favored 'General case' 0 C--N 1.32 -0.69 0 CA-C-N 115.807 -0.633 . . . . 0.0 111.156 -179.422 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 103.74 40.46 2.33 Favored Glycine 0 N--CA 1.446 -0.635 0 CA-C-N 115.724 -0.671 . . . . 0.0 111.592 -175.368 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 49.3 m-20 57.09 21.78 6.75 Favored 'General case' 0 N--CA 1.47 0.544 0 C-N-CA 123.16 0.584 . . . . 0.0 112.265 177.4 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -67.51 -40.24 85.15 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-O 121.03 0.443 . . . . 0.0 111.145 -178.852 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 41.8 m -154.17 -37.96 0.09 Allowed 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 116.034 -0.53 . . . . 0.0 110.832 -179.722 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 44' ' ' LEU . . . . . 0.453 HD23 HD12 ' A' ' 48' ' ' LEU . 6.7 mp -70.79 145.04 50.63 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 121.088 0.471 . . . . 0.0 110.969 -177.039 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 12.6 m -72.87 163.95 27.36 Favored 'General case' 0 C--N 1.322 -0.629 0 CA-C-N 115.373 -0.83 . . . . 0.0 110.228 175.628 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 41.7 mt-10 -51.59 -46.63 63.57 Favored 'General case' 0 C--N 1.329 -0.313 0 N-CA-C 112.72 0.637 . . . . 0.0 112.72 -173.753 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -63.75 -50.41 61.65 Favored Glycine 0 N--CA 1.448 -0.516 0 C-N-CA 119.572 -1.299 . . . . 0.0 112.539 -172.592 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 48' ' ' LEU . . . . . 0.453 HD12 HD23 ' A' ' 44' ' ' LEU . 0.0 OUTLIER -44.64 -50.88 9.59 Favored 'General case' 0 CA--C 1.517 -0.324 0 N-CA-C 113.803 1.038 . . . . 0.0 113.803 171.482 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 10.5 tt0 -70.8 -33.25 70.53 Favored 'General case' 0 C--N 1.312 -1.054 0 CA-C-O 120.987 0.422 . . . . 0.0 110.819 -169.369 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 50' ' ' GLN . . . . . 0.473 ' HA ' HD22 ' A' ' 53' ' ' LEU . 19.3 mm-40 -87.08 -13.88 43.01 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-N 115.834 -0.621 . . . . 0.0 111.552 -172.827 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 51' ' ' HIS . . . . . . . . . . . . . 11.7 m-70 -100.39 -4.38 29.14 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-O 121.046 0.451 . . . . 0.0 110.545 -175.269 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 11.5 mt -102.25 -14.01 17.16 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-N 115.763 -0.653 . . . . 0.0 111.757 -179.598 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 53' ' ' LEU . . . . . 0.473 HD22 ' HA ' ' A' ' 50' ' ' GLN . 0.1 OUTLIER -65.43 151.49 46.2 Favored 'General case' 0 N--CA 1.451 -0.399 0 CA-C-O 120.881 0.372 . . . . 0.0 110.264 171.539 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 93.26 -16.99 59.29 Favored Glycine 0 CA--C 1.519 0.317 0 C-N-CA 121.226 -0.512 . . . . 0.0 112.85 -179.02 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 55' ' ' LEU . . . . . 0.553 HD23 ' HB3' ' A' ' 59' ' ' ASP . 7.2 mp -82.28 165.41 20.42 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-O 121.646 0.736 . . . . 0.0 112.493 -179.954 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 56' ' ' LYS . . . . . 0.547 ' HE2' ' OG ' ' A' ' 4' ' ' SER . 28.5 mmtp -119.41 170.25 9.3 Favored 'General case' 0 N--CA 1.444 -0.738 0 CA-C-N 114.963 -1.017 . . . . 0.0 110.268 175.016 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 57' ' ' VAL . . . . . 0.5 HG23 HD12 ' A' ' 143' ' ' ILE . 71.5 t -62.46 134.51 27.71 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.764 0 CA-C-N 115.696 -0.684 . . . . 0.0 109.973 173.91 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 80.82 21.95 62.55 Favored Glycine 0 N--CA 1.445 -0.732 0 C-N-CA 120.943 -0.646 . . . . 0.0 112.423 -179.67 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 59' ' ' ASP . . . . . 0.553 ' HB3' HD23 ' A' ' 55' ' ' LEU . 4.9 t70 -92.67 162.92 13.96 Favored 'General case' 0 C--N 1.323 -0.57 0 N-CA-C 108.823 -0.806 . . . . 0.0 108.823 175.441 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 2.5 mmmt -137.11 122.05 18.91 Favored 'General case' 0 C--N 1.318 -0.772 0 N-CA-C 107.716 -1.216 . . . . 0.0 107.716 -179.273 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 9.5 t -135.91 136.15 40.25 Favored 'General case' 0 C--N 1.321 -0.65 0 CA-C-O 122.039 0.923 . . . . 0.0 112.22 179.047 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 10.9 m -114.03 133.25 55.64 Favored 'General case' 0 N--CA 1.437 -1.118 0 CA-C-N 115.162 -0.926 . . . . 0.0 108.845 172.419 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 17.6 p90 -153.47 158.34 41.2 Favored 'General case' 0 C--N 1.316 -0.867 0 CA-C-O 120.963 0.411 . . . . 0.0 110.215 -178.575 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 46.2 m -129.43 132.97 47.1 Favored 'General case' 0 C--N 1.312 -1.057 0 N-CA-C 108.398 -0.964 . . . . 0.0 108.398 175.425 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 78.2 mt -100.44 146.83 26.55 Favored 'General case' 0 C--N 1.318 -0.762 0 CA-C-O 120.885 0.374 . . . . 0.0 110.386 -178.985 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 43.1 mt-10 -65.45 145.9 99.01 Favored Pre-proline 0 C--N 1.317 -0.846 0 N-CA-C 108.631 -0.877 . . . . 0.0 108.631 173.282 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 96.2 Cg_exo -41.76 -52.98 3.59 Favored 'Trans proline' 0 CA--C 1.531 0.345 0 C-N-CA 123.501 2.8 . . . . 0.0 114.5 -170.718 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 29.1 t70 -64.93 -24.62 67.58 Favored 'General case' 0 N--CA 1.466 0.363 0 CA-C-O 120.828 0.347 . . . . 0.0 111.675 -174.804 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -83.26 -10.94 58.25 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-O 120.77 0.319 . . . . 0.0 111.21 -178.605 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.327 -0.403 0 N-CA-C 112.054 0.39 . . . . 0.0 112.054 -178.897 . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 75' ' ' SER . . . . . 0.559 ' O ' ' HB2' ' A' ' 78' ' ' LEU . 28.5 t . . . . . 0 N--CA 1.446 -0.674 0 CA-C-O 120.588 0.232 . . . . 0.0 110.383 . . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 29.3 Cg_endo -65.93 -17.36 55.5 Favored 'Trans proline' 0 N--CA 1.461 -0.386 0 C-N-CA 122.493 2.129 . . . . 0.0 110.933 172.322 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 17.0 t70 -65.06 -26.81 68.4 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-O 121.798 0.808 . . . . 0.0 109.179 172.194 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 78' ' ' LEU . . . . . 0.559 ' HB2' ' O ' ' A' ' 75' ' ' SER . 0.5 OUTLIER -80.86 6.0 14.41 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 114.763 -1.108 . . . . 0.0 110.933 179.126 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 26.2 mt -126.66 99.1 5.26 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.874 0 N-CA-C 108.455 -0.943 . . . . 0.0 108.455 173.991 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 34.4 mt-30 -113.75 160.33 18.78 Favored 'General case' 0 C--N 1.309 -1.175 0 C-N-CA 119.021 -1.071 . . . . 0.0 112.527 174.357 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 81' ' ' TYR . . . . . 0.531 ' CE2' HG23 ' A' ' 122' ' ' THR . 66.6 m-85 -121.2 114.31 21.23 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.906 -0.588 . . . . 0.0 109.919 -179.796 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 49.6 m-85 -115.18 169.8 8.85 Favored 'General case' 0 C--N 1.316 -0.855 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.608 179.281 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 21.0 t -81.02 159.31 24.86 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-O 120.964 0.412 . . . . 0.0 110.97 -177.659 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 84' ' ' ARG . . . . . 0.591 ' HD2' ' O ' ' A' ' 118' ' ' GLY . 4.9 mtp180 -62.58 -36.89 84.15 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 122.1 0.952 . . . . 0.0 110.109 179.542 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 85' ' ' ARG . . . . . . . . . . . . . 8.5 mpt_? -63.14 -28.72 70.26 Favored 'General case' 0 C--N 1.319 -0.759 0 CA-C-N 113.794 -1.548 . . . . 0.0 111.447 -171.51 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 26.0 mm-40 -80.54 -10.34 59.74 Favored 'General case' 0 C--N 1.32 -0.707 0 CA-C-N 115.892 -0.595 . . . . 0.0 110.743 178.613 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 87' ' ' PHE . . . . . . . . . . . . . 17.0 m-85 -104.17 -36.6 7.62 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-N 115.712 -0.676 . . . . 0.0 110.501 -179.222 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 88' ' ' MET . . . . . . . . . . . . . 57.3 ttp -59.33 -23.41 62.46 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 121.776 0.798 . . . . 0.0 109.576 173.556 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 24.7 t70 -53.27 -34.35 56.9 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 114.246 -1.343 . . . . 0.0 110.46 173.073 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -122.57 16.73 10.4 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 115.644 -0.707 . . . . 0.0 111.501 -179.689 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 101.45 136.88 9.48 Favored Glycine 0 C--N 1.33 0.241 0 C-N-CA 120.629 -0.795 . . . . 0.0 112.415 -178.396 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 36.1 mt-10 -61.97 125.87 86.09 Favored Pre-proline 0 C--N 1.328 -0.333 0 CA-C-O 120.995 0.426 . . . . 0.0 111.494 -176.483 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 93' ' ' PRO . . . . . 0.666 ' HB2' HD13 ' A' ' 113' ' ' ILE . 57.7 Cg_endo -78.5 167.03 23.34 Favored 'Trans proline' 0 N--CA 1.459 -0.544 0 C-N-CA 123.266 2.644 . . . . 0.0 113.407 -173.436 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 94' ' ' GLU . . . . . 0.42 ' O ' HD12 ' A' ' 113' ' ' ILE . 24.7 mt-10 -118.32 164.34 15.36 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 115.982 -0.553 . . . . 0.0 110.6 -178.605 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 95' ' ' ILE . . . . . 0.531 HG12 HG12 ' A' ' 116' ' ' ILE . 12.9 mt -81.95 132.05 32.39 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.376 0 CA-C-O 120.594 0.235 . . . . 0.0 110.444 179.083 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 70.64 35.48 67.26 Favored Glycine 0 N--CA 1.448 -0.553 0 C-N-CA 121.185 -0.531 . . . . 0.0 111.785 -178.918 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 97' ' ' ALA . . . . . 0.561 ' O ' HG13 ' A' ' 113' ' ' ILE . . . -109.52 143.38 39.26 Favored 'General case' 0 C--N 1.322 -0.606 0 N-CA-C 109.744 -0.465 . . . . 0.0 109.744 -179.059 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 98' ' ' ILE . . . . . 0.51 ' HA ' ' O ' ' A' ' 111' ' ' GLY . 41.2 mt -94.48 107.9 20.0 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.115 0 CA-C-O 120.936 0.398 . . . . 0.0 110.479 -178.114 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 99' ' ' MET . . . . . 0.43 ' SD ' HD11 ' A' ' 113' ' ' ILE . 92.3 mtp -102.48 123.43 46.21 Favored 'General case' 0 N--CA 1.441 -0.925 0 CA-C-O 121.377 0.608 . . . . 0.0 111.404 -177.152 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 100' ' ' LEU . . . . . 0.444 HD13 ' HA ' ' A' ' 100' ' ' LEU . 4.4 mm? -65.59 143.85 57.35 Favored 'General case' 0 C--N 1.302 -1.477 0 CA-C-N 114.655 -1.157 . . . . 0.0 108.451 166.13 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 101' ' ' PHE . . . . . 0.417 ' CE2' ' HB2' ' A' ' 99' ' ' MET . 1.8 m-85 -149.85 167.95 25.11 Favored 'General case' 0 CA--C 1.511 -0.528 0 N-CA-C 108.062 -1.088 . . . . 0.0 108.062 -157.907 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 1.5 m -122.95 126.63 47.59 Favored 'General case' 0 C--N 1.312 -1.055 0 C-N-CA 119.774 -0.77 . . . . 0.0 110.592 179.23 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 103' ' ' ALA . . . . . 0.543 ' HB2' ' SD ' ' A' ' 109' ' ' MET . . . -95.59 167.34 11.36 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 115.915 -0.584 . . . . 0.0 110.61 -178.019 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 104' ' ' MET . . . . . . . . . . . . . 66.8 mtt -66.35 -12.93 59.56 Favored 'General case' 0 N--CA 1.464 0.259 0 CA-C-N 115.648 -0.705 . . . . 0.0 112.544 -173.117 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 5.4 p-10 -100.27 12.56 36.8 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-O 120.553 0.216 . . . . 0.0 111.383 -178.184 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 82.33 -2.56 84.56 Favored Glycine 0 N--CA 1.45 -0.383 0 C-N-CA 120.602 -0.809 . . . . 0.0 113.168 179.59 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 42.7 t -84.9 146.66 27.17 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-O 121.216 0.531 . . . . 0.0 110.266 178.683 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 28.9 tt0 -94.51 99.0 11.25 Favored 'General case' 0 C--N 1.314 -0.964 0 CA-C-N 115.319 -0.855 . . . . 0.0 108.905 178.355 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 109' ' ' MET . . . . . 0.543 ' SD ' ' HB2' ' A' ' 103' ' ' ALA . 14.6 ptm -88.66 135.09 32.74 Favored Pre-proline 0 C--N 1.325 -0.46 0 CA-C-N 115.426 -0.806 . . . . 0.0 111.065 -178.9 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 29.1 Cg_endo -65.55 153.81 76.52 Favored 'Trans proline' 0 N--CA 1.451 -0.983 0 C-N-CA 121.817 1.678 . . . . 0.0 110.065 171.425 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 111' ' ' GLY . . . . . 0.51 ' O ' ' HA ' ' A' ' 98' ' ' ILE . . . -147.21 152.78 24.88 Favored Glycine 0 N--CA 1.434 -1.486 0 N-CA-C 108.632 -1.787 . . . . 0.0 108.632 -170.313 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 112' ' ' VAL . . . . . 0.488 ' O ' ' HB3' ' A' ' 124' ' ' ASP . 0.7 OUTLIER -126.53 114.59 38.65 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.335 0 CA-C-N 118.613 1.206 . . . . 0.0 110.397 172.369 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 113' ' ' ILE . . . . . 0.666 HD13 ' HB2' ' A' ' 93' ' ' PRO . 0.6 OUTLIER -61.89 110.37 0.65 Allowed 'Isoleucine or valine' 0 C--N 1.317 -0.813 0 N-CA-C 109.022 -0.733 . . . . 0.0 109.022 174.314 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 114' ' ' ARG . . . . . 0.439 ' HB3' HG22 ' A' ' 122' ' ' THR . 12.5 tpp180 -65.02 -52.57 55.26 Favored 'General case' 0 C--N 1.315 -0.927 0 CA-C-N 115.292 -0.867 . . . . 0.0 110.882 -177.695 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 115' ' ' GLU . . . . . 0.502 ' HA ' HG23 ' A' ' 95' ' ' ILE . 10.8 tt0 -159.91 153.01 21.82 Favored 'General case' 0 C--N 1.321 -0.665 0 C-N-CA 120.887 -0.325 . . . . 0.0 110.329 -174.358 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 116' ' ' ILE . . . . . 0.531 HG12 HG12 ' A' ' 95' ' ' ILE . 43.6 mm -100.29 114.41 38.86 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.486 0 N-CA-C 109.646 -0.501 . . . . 0.0 109.646 176.231 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 117' ' ' ASN . . . . . 0.468 ' HB2' ' O ' ' A' ' 120' ' ' SER . 5.4 m-20 -94.11 157.51 16.04 Favored 'General case' 0 C--N 1.317 -0.835 0 N-CA-C 109.266 -0.642 . . . . 0.0 109.266 177.901 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 118' ' ' GLY . . . . . 0.591 ' O ' ' HD2' ' A' ' 84' ' ' ARG . . . -56.94 -45.55 91.92 Favored Glycine 0 N--CA 1.451 -0.361 0 C-N-CA 120.537 -0.84 . . . . 0.0 112.91 -172.96 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 30.1 t70 -112.4 -10.66 13.74 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-O 121.107 0.479 . . . . 0.0 111.248 -179.107 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 120' ' ' SER . . . . . 0.468 ' O ' ' HB2' ' A' ' 117' ' ' ASN . 35.2 t -125.88 157.29 38.04 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.205 -171.893 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 121' ' ' ILE . . . . . . . . . . . . . 50.2 mm -114.31 123.12 69.67 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.567 0 CA-C-O 121.183 0.516 . . . . 0.0 110.054 175.808 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 122' ' ' THR . . . . . 0.531 HG23 ' CE2' ' A' ' 81' ' ' TYR . 24.0 m -94.56 102.2 14.11 Favored 'General case' 0 C--N 1.316 -0.85 0 CA-C-N 115.457 -0.792 . . . . 0.0 110.671 179.027 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 123' ' ' VAL . . . . . 0.45 HG12 ' N ' ' A' ' 124' ' ' ASP . 8.2 t -88.18 160.27 2.9 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.55 0 CA-C-N 115.267 -0.879 . . . . 0.0 111.853 174.765 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 124' ' ' ASP . . . . . 0.488 ' HB3' ' O ' ' A' ' 112' ' ' VAL . 27.0 t70 -145.91 145.9 30.88 Favored 'General case' 0 C--N 1.317 -0.808 0 CA-C-N 114.355 -1.293 . . . . 0.0 109.203 176.806 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 125' ' ' PHE . . . . . 0.492 ' HB2' ' HG ' ' A' ' 78' ' ' LEU . 98.1 m-85 -132.8 9.91 4.25 Favored 'General case' 0 C--N 1.312 -1.037 0 N-CA-C 108.534 -0.913 . . . . 0.0 108.534 179.87 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 126' ' ' ASN . . . . . 0.414 ' HB2' ' OD2' ' A' ' 124' ' ' ASP . 7.2 m-80 . . . . . 0 CA--C 1.516 -0.345 0 CA-C-N 113.996 -1.456 . . . . 0.0 111.691 -176.541 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 133' ' ' THR . . . . . . . . . . . . . 28.2 m . . . . . 0 N--CA 1.446 -0.674 0 N-CA-C 109.86 -0.422 . . . . 0.0 109.86 . . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 134' ' ' VAL . . . . . 0.505 ' HB ' HD21 ' A' ' 17' ' ' LEU . 16.8 m -98.95 149.96 5.24 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.688 0 CA-C-O 121.127 0.489 . . . . 0.0 110.216 -178.122 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 135' ' ' HIS . . . . . . . . . . . . . 95.2 m-70 -115.53 111.75 21.18 Favored 'General case' 0 C--N 1.314 -0.959 0 CA-C-N 115.161 -0.927 . . . . 0.0 109.577 -172.931 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 136' ' ' PHE . . . . . 0.537 ' CZ ' HD11 ' A' ' 17' ' ' LEU . 3.1 m-85 -107.92 124.1 49.61 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 115.373 -0.831 . . . . 0.0 111.116 -173.163 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 137' ' ' ASP . . . . . 0.453 ' O ' ' HA ' ' A' ' 15' ' ' PHE . 3.7 m-20 -110.38 100.85 9.63 Favored 'General case' 0 C--N 1.317 -0.815 0 N-CA-C 109.034 -0.728 . . . . 0.0 109.034 170.758 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 138' ' ' ILE . . . . . 0.638 HG23 HG21 ' A' ' 13' ' ' VAL . 54.2 mt -116.02 122.62 69.99 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.37 0 N-CA-C 112.701 0.63 . . . . 0.0 112.701 -171.905 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 80.4 mt-10 -110.52 137.95 47.54 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-N 115.838 -0.619 . . . . 0.0 110.076 173.491 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 140' ' ' VAL . . . . . 0.488 HG11 ' HA ' ' A' ' 57' ' ' VAL . 92.9 t -82.09 105.47 11.99 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.591 0 N-CA-C 108.473 -0.936 . . . . 0.0 108.473 177.435 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 39.1 mt -79.49 -44.45 21.22 Favored 'General case' 0 CA--C 1.508 -0.673 0 N-CA-C 109.839 -0.43 . . . . 0.0 109.839 -179.362 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 142' ' ' GLU . . . . . . . . . . . . . 14.5 pt-20 -169.32 158.12 7.93 Favored 'General case' 0 C--N 1.323 -0.549 0 N-CA-C 108.812 -0.81 . . . . 0.0 108.812 176.698 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 143' ' ' ILE . . . . . 0.5 HD12 HG23 ' A' ' 57' ' ' VAL . 82.3 mt -113.38 110.83 33.59 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.647 0 CA-C-O 121.231 0.538 . . . . 0.0 110.347 -179.444 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 144' ' ' ASP . . . . . . . . . . . . . 38.3 t70 -79.75 133.67 58.49 Favored Pre-proline 0 C--N 1.326 -0.423 0 CA-C-N 115.305 -0.861 . . . . 0.0 110.546 179.886 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 145' ' ' PRO . . . . . . . . . . . . . 90.1 Cg_exo . . . . . 0 C--N 1.35 0.617 0 C-N-CA 123.236 2.624 . . . . 0.0 112.538 177.581 . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 2' ' ' SER . . . . . 0.628 ' O ' ' HB ' ' A' ' 143' ' ' ILE . 33.2 t . . . . . 0 N--CA 1.45 -0.438 0 N-CA-C 108.73 -0.841 . . . . 0.0 108.73 . . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 42.5 tt0 -84.41 -26.21 28.47 Favored 'General case' 0 C--N 1.321 -0.666 0 CA-C-O 121.216 0.531 . . . . 0.0 110.073 179.416 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 7.0 m -104.64 141.72 35.93 Favored 'General case' 0 C--N 1.318 -0.762 0 CA-C-N 115.443 -0.798 . . . . 0.0 110.711 -177.884 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 9.4 p -82.07 149.95 4.61 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.416 0 CA-C-N 116.052 -0.522 . . . . 0.0 111.075 -176.647 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 6' ' ' GLN . . . . . 0.448 ' CG ' ' HB2' ' A' ' 9' ' ' SER . 3.3 pt20 -143.74 157.77 44.15 Favored 'General case' 0 C--N 1.321 -0.656 0 CA-C-N 115.644 -0.707 . . . . 0.0 110.387 178.673 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 7' ' ' SER . . . . . 0.438 ' O ' ' HB2' ' A' ' 8' ' ' ASN . 5.1 p -76.02 144.12 41.03 Favored 'General case' 0 C--N 1.319 -0.724 0 CA-C-N 116.209 -0.451 . . . . 0.0 109.994 178.533 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 8' ' ' ASN . . . . . 0.438 ' HB2' ' O ' ' A' ' 7' ' ' SER . 4.6 m-20 71.6 13.7 6.31 Favored 'General case' 0 N--CA 1.466 0.358 0 CA-C-N 115.405 -0.816 . . . . 0.0 111.815 -178.4 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 9' ' ' SER . . . . . 0.448 ' HB2' ' CG ' ' A' ' 6' ' ' GLN . 18.2 t -82.44 166.91 18.97 Favored 'General case' 0 C--N 1.328 -0.359 0 N-CA-C 109.879 -0.415 . . . . 0.0 109.879 175.518 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 10' ' ' ALA . . . . . 0.67 ' O ' ' HB2' ' A' ' 144' ' ' ASP . . . -110.5 111.93 23.51 Favored 'General case' 0 C--N 1.318 -0.78 0 N-CA-C 109.241 -0.651 . . . . 0.0 109.241 172.638 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 16.5 m -114.61 144.72 21.56 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.789 0 C-N-CA 120.231 -0.588 . . . . 0.0 111.106 -172.67 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 12' ' ' LEU . . . . . 0.478 ' HB2' ' HB2' ' A' ' 142' ' ' GLU . 9.7 mp -87.0 128.29 35.08 Favored 'General case' 0 C--N 1.325 -0.485 0 N-CA-C 109.393 -0.595 . . . . 0.0 109.393 176.423 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 22.3 m -119.72 155.88 22.37 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.928 0 CA-C-O 121.971 0.891 . . . . 0.0 112.905 -173.094 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 14' ' ' HIS . . . . . 0.521 ' CD2' HD11 ' A' ' 141' ' ' LEU . 0.2 OUTLIER -127.82 111.61 13.83 Favored 'General case' 0 C--N 1.315 -0.924 0 CA-C-N 114.044 -1.435 . . . . 0.0 107.456 162.932 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 15' ' ' PHE . . . . . 0.552 ' HA ' ' O ' ' A' ' 137' ' ' ASP . 33.9 p90 -139.07 171.25 14.59 Favored 'General case' 0 C--N 1.321 -0.654 0 N-CA-C 114.198 1.184 . . . . 0.0 114.198 -174.299 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 89.1 m -141.9 140.13 32.76 Favored 'General case' 0 C--N 1.314 -0.955 0 CA-C-N 113.092 -1.867 . . . . 0.0 106.662 175.205 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 17' ' ' LEU . . . . . 0.4 ' HG ' ' HB3' ' A' ' 136' ' ' PHE . 0.5 OUTLIER -127.22 108.32 10.77 Favored 'General case' 0 C--N 1.316 -0.85 0 C-N-CA 120.973 -0.291 . . . . 0.0 110.654 -171.163 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 9.7 mptt -116.48 160.49 20.52 Favored 'General case' 0 C--N 1.321 -0.653 0 CA-C-O 121.313 0.578 . . . . 0.0 111.643 -174.601 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 19' ' ' LEU . . . . . 0.451 HD13 HG23 ' A' ' 134' ' ' VAL . 3.1 mm? -106.25 171.58 7.27 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 115.022 -0.99 . . . . 0.0 109.644 173.447 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 18.5 t70 -58.07 -30.66 66.37 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-O 121.197 0.522 . . . . 0.0 110.258 175.793 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 10.1 m-20 -77.85 6.69 7.1 Favored 'General case' 0 N--CA 1.465 0.298 0 CA-C-N 115.736 -0.666 . . . . 0.0 111.351 178.858 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 70.18 9.29 63.51 Favored Glycine 0 N--CA 1.453 -0.21 0 C-N-CA 121.294 -0.479 . . . . 0.0 113.261 -179.337 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 14.2 m -79.13 148.35 32.39 Favored 'General case' 0 C--N 1.322 -0.62 0 N-CA-C 109.891 -0.411 . . . . 0.0 109.891 178.422 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 18.2 m -95.16 116.52 28.84 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-O 120.987 0.422 . . . . 0.0 110.965 179.931 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -78.42 -39.36 39.01 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 116.0 -0.545 . . . . 0.0 109.825 176.827 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 8.0 tp10 -157.25 143.0 17.56 Favored 'General case' 0 N--CA 1.451 -0.394 0 CA-C-N 115.823 -0.626 . . . . 0.0 109.957 176.134 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 29.0 p -125.28 121.56 34.39 Favored 'General case' 0 C--N 1.316 -0.852 0 CA-C-N 116.295 -0.411 . . . . 0.0 110.402 178.327 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 50.5 m -136.99 61.24 1.63 Allowed 'General case' 0 N--CA 1.442 -0.856 0 CA-C-O 122.371 1.082 . . . . 0.0 109.816 174.81 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 4.7 tmm_? -151.75 -61.15 0.17 Allowed 'General case' 0 C--N 1.319 -0.755 0 CA-C-N 114.824 -1.08 . . . . 0.0 109.39 -177.861 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 6.2 p30 -68.94 -11.72 60.93 Favored 'General case' 0 N--CA 1.465 0.321 0 CA-C-O 121.121 0.486 . . . . 0.0 110.337 179.645 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 1.3 m-20 -66.49 -36.72 83.42 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 115.412 -0.813 . . . . 0.0 110.702 -179.76 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 98.6 -3.86 59.48 Favored Glycine 0 N--CA 1.448 -0.502 0 CA-C-N 115.655 -0.702 . . . . 0.0 111.614 -175.228 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 60.2 mtpt -126.7 132.29 24.25 Favored Pre-proline 0 C--N 1.328 -0.367 0 N-CA-C 110.143 -0.317 . . . . 0.0 110.143 179.795 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 42.6 Cg_endo -83.9 171.55 10.48 Favored 'Trans proline' 0 N--CA 1.456 -0.724 0 C-N-CA 123.207 2.605 . . . . 0.0 112.24 174.563 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -129.84 163.09 27.04 Favored 'General case' 0 C--N 1.316 -0.889 0 CA-C-N 115.927 -0.579 . . . . 0.0 109.623 -176.641 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 36' ' ' LEU . . . . . 0.523 HD21 ' HB1' ' A' ' 10' ' ' ALA . 0.9 OUTLIER -105.85 122.53 46.29 Favored 'General case' 0 C--N 1.315 -0.916 0 C-N-CA 120.757 -0.377 . . . . 0.0 110.571 177.003 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 37' ' ' PHE . . . . . . . . . . . . . 6.0 m-30 -93.44 107.57 19.39 Favored 'General case' 0 C--N 1.316 -0.891 0 CA-C-N 115.966 -0.561 . . . . 0.0 109.762 172.113 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 18.9 tpt180 -85.87 106.86 17.38 Favored 'General case' 0 N--CA 1.445 -0.701 0 N-CA-C 109.194 -0.669 . . . . 0.0 109.194 178.26 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 39' ' ' LEU . . . . . 0.516 HD22 ' HB3' ' A' ' 49' ' ' GLU . 15.9 mt -82.15 156.06 24.68 Favored 'General case' 0 C--N 1.317 -0.842 0 CA-C-N 115.215 -0.902 . . . . 0.0 110.498 -176.276 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 101.77 32.27 5.13 Favored Glycine 0 C--N 1.319 -0.415 0 C-N-CA 121.177 -0.535 . . . . 0.0 112.838 -177.32 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 41' ' ' ASP . . . . . 0.507 ' HA ' ' O ' ' A' ' 44' ' ' LEU . 14.7 t70 60.28 23.39 12.83 Favored 'General case' 0 N--CA 1.471 0.601 0 CA-C-O 121.507 0.67 . . . . 0.0 111.436 176.762 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -84.24 -5.37 59.25 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-O 121.05 0.452 . . . . 0.0 110.909 179.298 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 26.5 p -166.32 -49.17 0.03 OUTLIER 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 115.78 -0.645 . . . . 0.0 110.292 179.787 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 44' ' ' LEU . . . . . 0.507 ' O ' ' HA ' ' A' ' 41' ' ' ASP . 40.9 mt -106.42 171.1 7.54 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 115.992 -0.549 . . . . 0.0 110.413 179.259 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 21.0 t -76.79 153.37 34.99 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 116.005 -0.543 . . . . 0.0 109.605 178.727 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 46' ' ' GLU . . . . . 0.502 ' O ' ' HG2' ' A' ' 49' ' ' GLU . 44.8 mt-10 -63.7 -24.54 67.82 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 115.902 -0.59 . . . . 0.0 111.545 -176.597 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -57.97 -35.01 74.07 Favored Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 120.916 -0.659 . . . . 0.0 112.32 175.528 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 48' ' ' LEU . . . . . 0.445 ' HG ' HD13 ' A' ' 44' ' ' LEU . 0.6 OUTLIER -60.03 -51.91 67.63 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 121.089 0.471 . . . . 0.0 109.912 177.423 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 49' ' ' GLU . . . . . 0.652 ' O ' HD13 ' A' ' 53' ' ' LEU . 14.8 pt-20 -68.15 -51.07 50.14 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 115.9 -0.591 . . . . 0.0 111.19 -174.627 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 50' ' ' GLN . . . . . 0.535 ' HA ' HD22 ' A' ' 53' ' ' LEU . 85.3 mm-40 -56.03 -15.14 3.14 Favored 'General case' 0 C--N 1.329 -0.308 0 N-CA-C 113.75 1.018 . . . . 0.0 113.75 -176.278 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 51' ' ' HIS . . . . . . . . . . . . . 11.6 m170 -106.15 -13.8 15.33 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-O 121.074 0.464 . . . . 0.0 110.716 -177.024 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 18.3 mt -88.16 -14.65 38.12 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-N 115.632 -0.713 . . . . 0.0 109.832 172.427 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 53' ' ' LEU . . . . . 0.652 HD13 ' O ' ' A' ' 49' ' ' GLU . 5.8 mp -61.05 150.38 33.98 Favored 'General case' 0 N--CA 1.445 -0.697 0 CA-C-N 115.554 -0.748 . . . . 0.0 110.596 170.541 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 93.3 -14.67 64.74 Favored Glycine 0 N--CA 1.447 -0.581 0 C-N-CA 121.014 -0.612 . . . . 0.0 111.988 -175.23 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 6.9 mp -85.24 165.84 17.02 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-O 121.726 0.774 . . . . 0.0 112.048 177.632 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 56' ' ' LYS . . . . . 0.429 ' O ' ' HB2' ' A' ' 59' ' ' ASP . 24.2 tptt -128.75 166.92 18.05 Favored 'General case' 0 C--N 1.318 -0.8 0 N-CA-C 107.829 -1.175 . . . . 0.0 107.829 178.16 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 57' ' ' VAL . . . . . 0.552 HG23 HD12 ' A' ' 143' ' ' ILE . 12.6 t -60.52 131.83 25.55 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.52 0 CA-C-O 121.014 0.435 . . . . 0.0 110.816 176.465 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 81.59 10.25 84.62 Favored Glycine 0 N--CA 1.451 -0.364 0 CA-C-N 115.482 -0.781 . . . . 0.0 113.071 -177.519 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 59' ' ' ASP . . . . . 0.429 ' HB2' ' O ' ' A' ' 56' ' ' LYS . 1.0 OUTLIER -93.85 138.13 32.34 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.93 0.395 . . . . 0.0 110.28 176.545 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 60' ' ' LYS . . . . . 0.421 ' HE3' ' OE2' ' A' ' 139' ' ' GLU . 3.4 mmmm -110.48 131.53 54.97 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 116.034 -0.53 . . . . 0.0 109.573 -176.256 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 7.5 t -141.29 145.16 35.16 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-O 121.659 0.742 . . . . 0.0 111.839 -179.908 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 17.4 m -118.0 143.04 46.73 Favored 'General case' 0 C--N 1.313 -0.988 0 N-CA-C 108.609 -0.885 . . . . 0.0 108.609 171.143 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 21.3 p90 -161.15 163.95 30.92 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-O 120.958 0.409 . . . . 0.0 111.107 -177.01 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 41.7 t -132.48 136.9 46.99 Favored 'General case' 0 C--N 1.32 -0.686 0 CA-C-N 115.778 -0.646 . . . . 0.0 109.317 179.815 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 65' ' ' LEU . . . . . 0.409 HD11 ' HA ' ' A' ' 48' ' ' LEU . 87.6 mt -120.74 146.19 46.74 Favored 'General case' 0 C--N 1.313 -1.011 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.034 -178.352 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 14.5 mm-40 -64.44 152.99 87.82 Favored Pre-proline 0 N--CA 1.442 -0.828 0 CA-C-N 115.364 -0.835 . . . . 0.0 109.995 173.198 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 1.9 Cg_endo -42.61 -55.19 2.78 Favored 'Trans proline' 0 N--CA 1.464 -0.264 0 C-N-CA 123.797 2.998 . . . . 0.0 114.924 -171.513 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 7.0 p-10 -72.21 -14.76 61.87 Favored 'General case' 0 N--CA 1.465 0.304 0 CA-C-O 121.075 0.464 . . . . 0.0 111.502 -174.107 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -90.3 -8.79 50.01 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.676 179.175 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.329 -0.313 0 CA-C-N 116.142 -0.481 . . . . 0.0 111.864 -179.202 . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 39.6 t . . . . . 0 N--CA 1.449 -0.499 0 CA-C-O 120.97 0.414 . . . . 0.0 110.743 . . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 39.1 Cg_endo -69.49 -18.93 38.01 Favored 'Trans proline' 0 N--CA 1.464 -0.236 0 C-N-CA 122.789 2.326 . . . . 0.0 111.813 174.891 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 7.3 m-20 -76.19 -15.22 60.09 Favored 'General case' 0 CA--C 1.519 -0.231 0 CA-C-O 121.359 0.6 . . . . 0.0 109.838 176.742 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 78' ' ' LEU . . . . . 0.553 ' HG ' ' HB2' ' A' ' 125' ' ' PHE . 6.2 mp -87.01 8.17 24.51 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 115.407 -0.815 . . . . 0.0 109.89 175.966 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 49.8 mt -118.86 109.41 26.74 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.681 0 N-CA-C 108.203 -1.036 . . . . 0.0 108.203 172.686 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 74.7 mt-30 -131.43 136.37 47.93 Favored 'General case' 0 C--N 1.311 -1.086 0 CA-C-N 115.259 -0.882 . . . . 0.0 110.054 -169.523 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 81' ' ' TYR . . . . . . . . . . . . . 46.3 m-85 -107.02 112.73 25.82 Favored 'General case' 0 C--N 1.321 -0.638 0 C-N-CA 120.125 -0.63 . . . . 0.0 110.252 -179.885 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 60.0 m-85 -103.78 170.47 7.91 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-O 121.548 0.689 . . . . 0.0 112.822 178.868 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 9.7 m -79.1 139.98 37.94 Favored 'General case' 0 N--CA 1.445 -0.724 0 CA-C-N 114.745 -1.116 . . . . 0.0 111.288 174.634 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 84' ' ' ARG . . . . . 0.434 ' HD2' ' O ' ' A' ' 118' ' ' GLY . 10.8 ptm180 -68.57 -17.22 64.09 Favored 'General case' 0 C--N 1.325 -0.469 0 N-CA-C 113.714 1.005 . . . . 0.0 113.714 -175.186 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 85' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -74.04 -34.13 63.98 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-O 121.134 0.492 . . . . 0.0 109.879 -174.713 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 45.1 mt-10 -64.6 -16.37 62.6 Favored 'General case' 0 N--CA 1.465 0.3 0 CA-C-N 115.177 -0.919 . . . . 0.0 110.77 -179.936 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 87' ' ' PHE . . . . . . . . . . . . . 54.8 m-85 -102.5 -23.12 13.93 Favored 'General case' 0 C--N 1.319 -0.72 0 CA-C-N 115.185 -0.916 . . . . 0.0 110.135 -177.464 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 88' ' ' MET . . . . . . . . . . . . . 56.0 ttm -62.0 -35.56 78.89 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 115.94 -0.573 . . . . 0.0 110.836 -178.419 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 23.1 t70 -58.18 -25.86 62.07 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 121.144 0.497 . . . . 0.0 111.304 178.888 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -111.13 16.51 21.03 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-N 115.938 -0.573 . . . . 0.0 110.668 177.765 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 90.65 143.99 11.66 Favored Glycine 0 N--CA 1.447 -0.629 0 C-N-CA 120.762 -0.732 . . . . 0.0 111.637 -178.225 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 44.3 mt-10 -60.42 127.28 86.33 Favored Pre-proline 0 C--N 1.323 -0.545 0 CA-C-O 121.02 0.438 . . . . 0.0 110.848 -177.633 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 18.1 Cg_endo -71.11 164.91 34.12 Favored 'Trans proline' 0 N--CA 1.457 -0.627 0 C-N-CA 122.85 2.367 . . . . 0.0 112.313 -175.282 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 23.0 mt-10 -118.07 160.8 20.89 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 116.332 -0.395 . . . . 0.0 110.392 -177.603 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 95' ' ' ILE . . . . . 0.502 HG23 ' HA ' ' A' ' 115' ' ' GLU . 9.6 mt -82.33 131.67 33.23 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.51 0 CA-C-O 120.969 0.414 . . . . 0.0 110.607 -178.333 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 71.35 34.8 63.73 Favored Glycine 0 N--CA 1.444 -0.783 0 CA-C-N 115.706 -0.679 . . . . 0.0 111.518 -176.849 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -110.14 115.58 29.98 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 121.659 0.742 . . . . 0.0 112.553 -177.555 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 98' ' ' ILE . . . . . 0.667 ' HA ' ' HA ' ' A' ' 112' ' ' VAL . 5.5 mt -82.03 123.3 37.99 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.017 0 CA-C-N 114.826 -1.079 . . . . 0.0 108.504 175.926 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 99' ' ' MET . . . . . . . . . . . . . 10.0 mtm -136.64 152.78 50.81 Favored 'General case' 0 N--CA 1.443 -0.797 0 N-CA-C 106.37 -1.715 . . . . 0.0 106.37 179.811 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 3.2 mm? -71.54 102.85 2.81 Favored 'General case' 0 C--N 1.313 -1.003 0 CA-C-O 122.273 1.035 . . . . 0.0 111.856 -178.795 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 101' ' ' PHE . . . . . . . . . . . . . 8.2 m-30 -94.78 172.65 8.04 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 113.033 -1.894 . . . . 0.0 111.826 -179.512 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 5.3 m -118.56 130.14 55.73 Favored 'General case' 0 C--N 1.316 -0.887 0 CA-C-N 114.947 -1.024 . . . . 0.0 108.972 -178.716 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 103' ' ' ALA . . . . . 0.612 ' HB2' ' SD ' ' A' ' 109' ' ' MET . . . -94.57 158.47 15.52 Favored 'General case' 0 C--N 1.322 -0.605 0 N-CA-C 109.329 -0.619 . . . . 0.0 109.329 -177.889 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 104' ' ' MET . . . . . . . . . . . . . 2.0 mpt? -66.54 -12.65 58.7 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 115.732 -0.667 . . . . 0.0 111.953 -174.988 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 5.0 p-10 -97.63 11.27 37.55 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-O 120.893 0.378 . . . . 0.0 110.989 179.227 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 87.9 -12.22 64.53 Favored Glycine 0 N--CA 1.45 -0.392 0 C-N-CA 121.249 -0.5 . . . . 0.0 113.505 175.499 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 48.9 m -76.76 142.49 40.39 Favored 'General case' 0 C--N 1.317 -0.81 0 CA-C-N 116.816 0.308 . . . . 0.0 110.308 177.499 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 30.1 tt0 -93.65 100.57 12.79 Favored 'General case' 0 C--N 1.318 -0.778 0 CA-C-O 121.675 0.75 . . . . 0.0 109.536 178.473 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 109' ' ' MET . . . . . 0.612 ' SD ' ' HB2' ' A' ' 103' ' ' ALA . 16.0 ptm -100.3 139.58 20.79 Favored Pre-proline 0 C--N 1.323 -0.573 0 CA-C-N 114.889 -1.051 . . . . 0.0 111.262 -177.289 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 17.7 Cg_exo -64.6 143.37 81.15 Favored 'Trans proline' 0 N--CA 1.451 -1.02 0 C-N-CA 121.88 1.72 . . . . 0.0 110.061 171.874 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . -144.69 108.26 0.48 Allowed Glycine 0 N--CA 1.438 -1.212 0 N-CA-C 109.876 -1.29 . . . . 0.0 109.876 -171.512 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 112' ' ' VAL . . . . . 0.667 ' HA ' ' HA ' ' A' ' 98' ' ' ILE . 1.3 p -84.11 110.38 18.64 Favored 'Isoleucine or valine' 0 CA--C 1.51 -0.582 0 C-N-CA 119.202 -0.999 . . . . 0.0 110.879 -178.647 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 113' ' ' ILE . . . . . . . . . . . . . 45.9 mt -60.41 110.11 0.52 Allowed 'Isoleucine or valine' 0 N--CA 1.438 -1.071 0 CA-C-N 114.22 -1.355 . . . . 0.0 108.536 170.726 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 114' ' ' ARG . . . . . 0.444 ' O ' HG23 ' A' ' 95' ' ' ILE . 1.3 tmt_? -79.2 -27.55 42.56 Favored 'General case' 0 C--N 1.309 -1.188 0 CA-C-N 114.162 -1.381 . . . . 0.0 110.899 -168.214 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 115' ' ' GLU . . . . . 0.612 ' N ' ' HB ' ' A' ' 122' ' ' THR . 8.2 tt0 -160.28 159.93 31.96 Favored 'General case' 0 C--N 1.325 -0.484 0 N-CA-C 112.456 0.539 . . . . 0.0 112.456 -179.046 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 116' ' ' ILE . . . . . 0.471 HG12 HG12 ' A' ' 95' ' ' ILE . 33.4 mm -118.39 130.3 73.45 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.605 0 CA-C-N 114.981 -1.009 . . . . 0.0 109.444 174.218 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 117' ' ' ASN . . . . . 0.41 ' HB2' ' O ' ' A' ' 120' ' ' SER . 19.8 m-80 -122.21 159.3 27.57 Favored 'General case' 0 C--N 1.309 -1.192 0 CA-C-N 115.51 -0.768 . . . . 0.0 109.27 -179.782 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 118' ' ' GLY . . . . . 0.434 ' O ' ' HD2' ' A' ' 84' ' ' ARG . . . -55.28 -45.59 82.47 Favored Glycine 0 N--CA 1.452 -0.297 0 C-N-CA 120.653 -0.784 . . . . 0.0 112.896 -170.624 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 3.3 p-10 -114.17 -12.08 12.56 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 117.03 0.415 . . . . 0.0 111.032 173.534 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 120' ' ' SER . . . . . 0.41 ' O ' ' HB2' ' A' ' 117' ' ' ASN . 21.9 t -113.77 159.79 19.38 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-O 122.047 0.927 . . . . 0.0 112.122 -169.196 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 121' ' ' ILE . . . . . . . . . . . . . 45.1 mm -118.98 159.68 19.4 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.863 0 CA-C-N 114.292 -1.322 . . . . 0.0 109.52 -177.289 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 122' ' ' THR . . . . . 0.612 ' HB ' ' N ' ' A' ' 115' ' ' GLU . 8.8 m -139.18 139.14 37.47 Favored 'General case' 0 N--CA 1.448 -0.533 0 N-CA-C 106.844 -1.539 . . . . 0.0 106.844 -170.78 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 123' ' ' VAL . . . . . 0.4 HG12 ' N ' ' A' ' 124' ' ' ASP . 55.6 t -140.46 154.57 22.46 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.67 0 C-N-CA 117.555 -1.658 . . . . 0.0 109.872 -164.119 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 124' ' ' ASP . . . . . 0.441 ' HB3' HG13 ' A' ' 112' ' ' VAL . 35.6 t70 -154.7 94.9 1.72 Allowed 'General case' 0 C--N 1.309 -1.176 0 CA-C-N 115.593 -0.73 . . . . 0.0 109.684 176.671 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 125' ' ' PHE . . . . . 0.553 ' HB2' ' HG ' ' A' ' 78' ' ' LEU . 97.4 m-85 -82.01 3.37 26.88 Favored 'General case' 0 C--N 1.324 -0.534 0 O-C-N 120.724 -1.235 . . . . 0.0 110.376 173.699 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 37.0 m-80 . . . . . 0 C--N 1.325 -0.496 0 CA-C-O 122.478 1.132 . . . . 0.0 111.951 -177.92 . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 133' ' ' THR . . . . . . . . . . . . . 59.5 m . . . . . 0 CA--C 1.529 0.161 0 CA-C-O 120.85 0.357 . . . . 0.0 110.672 . . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 134' ' ' VAL . . . . . 0.451 HG23 HD13 ' A' ' 19' ' ' LEU . 2.7 p -116.96 166.78 10.91 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.501 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.803 -173.227 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 135' ' ' HIS . . . . . 0.441 ' H ' HG22 ' A' ' 134' ' ' VAL . 81.8 m-70 -131.0 124.48 31.05 Favored 'General case' 0 C--N 1.322 -0.587 0 CA-C-N 115.848 -0.614 . . . . 0.0 111.089 -171.278 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 136' ' ' PHE . . . . . 0.4 ' HB3' ' HG ' ' A' ' 17' ' ' LEU . 0.1 OUTLIER -131.54 150.98 51.96 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 121.478 0.656 . . . . 0.0 111.907 -179.966 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 137' ' ' ASP . . . . . 0.552 ' O ' ' HA ' ' A' ' 15' ' ' PHE . 3.3 m-20 -115.89 101.18 8.56 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-N 114.706 -1.133 . . . . 0.0 108.604 174.244 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 138' ' ' ILE . . . . . . . . . . . . . 47.6 mt -116.65 130.51 71.38 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.532 0 CA-C-O 121.203 0.525 . . . . 0.0 111.789 -172.23 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 139' ' ' GLU . . . . . 0.421 ' OE2' ' HE3' ' A' ' 60' ' ' LYS . 11.7 pt-20 -118.45 142.8 47.21 Favored 'General case' 0 C--N 1.321 -0.642 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.103 178.064 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 140' ' ' VAL . . . . . 0.453 ' CG1' ' HA ' ' A' ' 57' ' ' VAL . 78.7 t -79.09 108.33 12.55 Favored 'Isoleucine or valine' 0 C--O 1.234 0.263 0 CA-C-O 121.068 0.461 . . . . 0.0 111.116 -179.199 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 141' ' ' LEU . . . . . 0.521 HD11 ' CD2' ' A' ' 14' ' ' HIS . 48.7 mt -90.45 -33.02 16.15 Favored 'General case' 0 C--N 1.321 -0.652 0 CA-C-O 121.632 0.729 . . . . 0.0 110.324 177.291 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 142' ' ' GLU . . . . . 0.478 ' HB2' ' HB2' ' A' ' 12' ' ' LEU . 0.0 OUTLIER -164.49 148.23 9.28 Favored 'General case' 0 C--N 1.316 -0.885 0 CA-C-N 114.083 -1.417 . . . . 0.0 111.811 -176.879 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 143' ' ' ILE . . . . . 0.628 ' HB ' ' O ' ' A' ' 2' ' ' SER . 78.3 mt -125.16 127.92 72.53 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.538 0 CA-C-N 115.455 -0.793 . . . . 0.0 109.91 178.834 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 144' ' ' ASP . . . . . 0.67 ' HB2' ' O ' ' A' ' 10' ' ' ALA . 31.4 t70 -62.15 137.52 95.76 Favored Pre-proline 0 C--N 1.326 -0.448 0 CA-C-N 115.82 -0.627 . . . . 0.0 110.715 -178.246 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 145' ' ' PRO . . . . . . . . . . . . . 25.3 Cg_endo . . . . . 0 N--CA 1.463 -0.32 0 C-N-CA 122.823 2.349 . . . . 0.0 111.627 178.334 . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 69.0 m . . . . . 0 N--CA 1.451 -0.415 0 CA-C-O 121.221 0.534 . . . . 0.0 111.005 . . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 33.4 mt-10 -80.33 -25.74 39.13 Favored 'General case' 0 C--N 1.323 -0.585 0 N-CA-C 108.442 -0.947 . . . . 0.0 108.442 172.851 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 23.6 t -117.47 132.8 56.49 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-N 114.027 -1.442 . . . . 0.0 109.004 175.048 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 5' ' ' VAL . . . . . 0.583 HG12 ' O ' ' A' ' 55' ' ' LEU . 8.9 p -76.9 142.77 13.85 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.494 0 CA-C-O 121.244 0.545 . . . . 0.0 110.428 -179.376 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 6' ' ' GLN . . . . . 0.5 ' HG2' ' HB2' ' A' ' 9' ' ' SER . 4.2 pt20 -127.39 168.3 15.03 Favored 'General case' 0 C--N 1.314 -0.963 0 CA-C-N 115.477 -0.783 . . . . 0.0 109.176 179.933 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 31.3 p -55.9 130.2 42.73 Favored 'General case' 0 C--N 1.317 -0.819 0 N-CA-C 109.955 -0.387 . . . . 0.0 109.955 174.946 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 66.7 t30 69.04 40.29 1.62 Allowed 'General case' 0 N--CA 1.47 0.549 0 CA-C-O 121.392 0.615 . . . . 0.0 110.914 -176.339 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 9' ' ' SER . . . . . 0.5 ' HB2' ' HG2' ' A' ' 6' ' ' GLN . 18.3 t -133.71 125.97 29.73 Favored 'General case' 0 C--N 1.327 -0.409 0 N-CA-C 108.638 -0.875 . . . . 0.0 108.638 173.311 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -83.27 148.67 27.25 Favored 'General case' 0 C--N 1.319 -0.755 0 CA-C-N 116.587 -0.279 . . . . 0.0 110.707 -171.233 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 8.0 m -123.92 140.15 48.23 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.687 0 CA-C-O 121.436 0.636 . . . . 0.0 111.322 179.249 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 12' ' ' LEU . . . . . 0.476 ' N ' HD12 ' A' ' 12' ' ' LEU . 5.1 mp -88.98 112.85 23.84 Favored 'General case' 0 C--N 1.315 -0.929 0 N-CA-C 107.584 -1.265 . . . . 0.0 107.584 173.667 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 13' ' ' VAL . . . . . 0.694 HG21 HG23 ' A' ' 138' ' ' ILE . 1.4 p -125.46 157.03 34.93 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.952 0 CA-C-O 121.185 0.517 . . . . 0.0 110.576 -171.462 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 14' ' ' HIS . . . . . 0.555 ' HB2' HD11 ' A' ' 141' ' ' LEU . 30.0 t-80 -130.72 113.62 14.37 Favored 'General case' 0 C--N 1.316 -0.871 0 N-CA-C 106.12 -1.807 . . . . 0.0 106.12 176.502 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 15' ' ' PHE . . . . . 0.573 ' H ' ' HB ' ' A' ' 28' ' ' THR . 48.6 p90 -141.9 -179.07 5.99 Favored 'General case' 0 C--N 1.317 -0.81 0 CA-C-O 122.363 1.078 . . . . 0.0 113.329 -163.756 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 60.1 m -143.97 113.24 6.9 Favored 'General case' 0 C--N 1.318 -0.782 0 CA-C-N 113.721 -1.582 . . . . 0.0 108.336 -176.11 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 17' ' ' LEU . . . . . 0.89 HD21 ' HB ' ' A' ' 134' ' ' VAL . 1.1 tt -100.89 120.96 40.92 Favored 'General case' 0 C--N 1.321 -0.657 0 CA-C-N 115.923 -0.58 . . . . 0.0 112.153 -176.916 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 10.0 mptt -120.18 142.76 48.68 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-N 115.339 -0.846 . . . . 0.0 110.714 -179.248 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 19' ' ' LEU . . . . . 0.614 HD21 ' HB2' ' A' ' 25' ' ' ALA . 3.6 mm? -84.58 173.69 10.59 Favored 'General case' 0 C--N 1.322 -0.599 0 N-CA-C 109.11 -0.7 . . . . 0.0 109.11 170.711 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 50.5 m-20 -57.2 -33.66 67.72 Favored 'General case' 0 C--N 1.327 -0.408 0 C-N-CA 120.786 -0.366 . . . . 0.0 110.631 177.057 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 23.3 t70 -78.16 4.08 13.46 Favored 'General case' 0 CA--C 1.535 0.398 0 CA-C-O 121.338 0.59 . . . . 0.0 111.201 178.957 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 73.57 9.41 78.23 Favored Glycine 0 CA--C 1.516 0.15 0 CA-C-N 116.137 -0.483 . . . . 0.0 113.264 -179.047 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 8.1 m -71.19 141.38 50.67 Favored 'General case' 0 C--N 1.323 -0.583 0 N-CA-C 109.529 -0.545 . . . . 0.0 109.529 174.776 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 7.3 m -88.8 112.25 22.99 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-O 120.923 0.392 . . . . 0.0 110.567 -178.665 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 25' ' ' ALA . . . . . 0.79 ' HB3' HD22 ' A' ' 17' ' ' LEU . . . -80.41 -38.38 30.33 Favored 'General case' 0 CA--C 1.516 -0.332 0 CA-C-N 116.009 -0.542 . . . . 0.0 111.033 -178.708 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 23.8 tt0 -154.24 121.14 5.59 Favored 'General case' 0 C--N 1.321 -0.668 0 CA-C-N 115.543 -0.753 . . . . 0.0 109.645 -176.735 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 14.9 p -114.08 101.65 9.43 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-O 121.677 0.751 . . . . 0.0 111.679 -178.09 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 28' ' ' THR . . . . . 0.573 ' HB ' ' H ' ' A' ' 15' ' ' PHE . 80.3 m -91.14 81.05 5.59 Favored 'General case' 0 N--CA 1.431 -1.393 0 N-CA-C 106.468 -1.678 . . . . 0.0 106.468 171.475 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 29' ' ' ARG . . . . . 0.437 ' HA ' ' NE2' ' A' ' 14' ' ' HIS . 43.0 ttt180 -174.07 -70.85 0.01 OUTLIER 'General case' 0 C--N 1.305 -1.354 0 CA-C-N 112.735 -2.03 . . . . 0.0 110.32 -162.54 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 73.2 m-20 -65.51 -29.12 69.72 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 121.1 0.476 . . . . 0.0 111.2 -176.968 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 93.6 m-20 -67.9 -22.06 65.1 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 115.82 -0.627 . . . . 0.0 111.391 179.915 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 78.08 12.71 84.1 Favored Glycine 0 N--CA 1.449 -0.466 0 C-N-CA 120.719 -0.753 . . . . 0.0 111.509 -178.895 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 66.9 mttm -133.34 128.48 20.31 Favored Pre-proline 0 C--N 1.324 -0.54 0 CA-C-N 115.455 -0.372 . . . . 0.0 110.156 -176.801 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 34' ' ' PRO . . . . . 0.461 ' HA ' ' CG2' ' A' ' 28' ' ' THR . 93.9 Cg_endo -80.17 154.58 22.18 Favored 'Trans proline' 0 N--CA 1.45 -1.038 0 C-N-CA 121.914 1.743 . . . . 0.0 111.112 174.231 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -113.59 150.53 32.95 Favored 'General case' 0 C--N 1.319 -0.749 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.211 -173.027 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 10.9 tp -94.51 126.94 40.11 Favored 'General case' 0 C--N 1.318 -0.797 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.574 178.547 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 37' ' ' PHE . . . . . . . . . . . . . 4.4 m-30 -94.97 107.43 19.46 Favored 'General case' 0 C--N 1.315 -0.907 0 CA-C-N 115.924 -0.58 . . . . 0.0 109.678 171.96 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 16.1 mmm180 -81.71 108.0 14.9 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 115.615 -0.72 . . . . 0.0 111.341 -178.311 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 39' ' ' LEU . . . . . 0.448 ' HG ' ' CB ' ' A' ' 49' ' ' GLU . 10.7 mp -81.77 154.55 25.91 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-N 114.897 -1.047 . . . . 0.0 110.567 177.466 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 101.35 34.23 4.56 Favored Glycine 0 N--CA 1.449 -0.481 0 C-N-CA 120.718 -0.753 . . . . 0.0 112.823 177.107 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 20.6 t70 65.68 6.05 3.66 Favored 'General case' 0 N--CA 1.471 0.619 0 CA-C-O 121.148 0.499 . . . . 0.0 111.994 176.676 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -68.7 -59.3 3.21 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-O 121.068 0.461 . . . . 0.0 111.127 -175.858 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 22.2 m -116.85 -31.21 5.51 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-O 121.306 0.574 . . . . 0.0 110.353 177.979 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 44' ' ' LEU . . . . . 0.47 HD13 HD12 ' A' ' 48' ' ' LEU . 49.9 mt -108.8 157.8 18.24 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-N 115.651 -0.704 . . . . 0.0 110.456 -175.291 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 49.1 m -89.07 171.27 9.96 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 115.825 -0.625 . . . . 0.0 111.018 179.654 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 46' ' ' GLU . . . . . 0.437 ' O ' ' HG3' ' A' ' 50' ' ' GLN . 59.0 mm-40 -47.89 -49.12 30.76 Favored 'General case' 0 C--N 1.33 -0.247 0 O-C-N 123.856 0.723 . . . . 0.0 112.201 -176.01 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 47' ' ' GLY . . . . . 0.482 ' HA3' ' HB1' ' A' ' 69' ' ' ALA . . . -58.73 -45.61 94.58 Favored Glycine 0 CA--C 1.519 0.303 0 C-N-CA 120.881 -0.676 . . . . 0.0 113.379 -175.155 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 48' ' ' LEU . . . . . 0.47 HD12 HD13 ' A' ' 44' ' ' LEU . 0.3 OUTLIER -60.12 -52.91 63.33 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 117.039 0.42 . . . . 0.0 110.324 -178.889 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 49' ' ' GLU . . . . . 0.448 ' CB ' ' HG ' ' A' ' 39' ' ' LEU . 7.6 pt-20 -68.06 -31.9 71.87 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 116.376 -0.375 . . . . 0.0 111.994 -172.212 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 50' ' ' GLN . . . . . 0.616 ' HA ' ' CD2' ' A' ' 53' ' ' LEU . 84.5 mt-30 -80.7 -8.39 59.63 Favored 'General case' 0 N--CA 1.452 -0.354 0 N-CA-C 111.814 0.302 . . . . 0.0 111.814 -170.642 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 51' ' ' HIS . . . . . . . . . . . . . 21.8 m-70 -108.81 -5.14 16.38 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-O 121.215 0.531 . . . . 0.0 110.18 -178.501 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 18.1 mt -103.72 -30.25 10.54 Favored 'General case' 0 C--N 1.32 -0.691 0 CA-C-N 115.684 -0.689 . . . . 0.0 111.601 177.216 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 53' ' ' LEU . . . . . 0.616 ' CD2' ' HA ' ' A' ' 50' ' ' GLN . 2.5 pp -67.57 151.34 47.49 Favored 'General case' 0 C--O 1.234 0.24 0 C-N-CA 120.991 -0.284 . . . . 0.0 110.584 -177.215 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 93.7 -5.15 73.17 Favored Glycine 0 CA--C 1.522 0.53 0 C-N-CA 120.996 -0.621 . . . . 0.0 113.049 -177.418 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 55' ' ' LEU . . . . . 0.583 ' O ' HG12 ' A' ' 5' ' ' VAL . 72.3 mt -92.51 164.66 13.37 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 117.082 0.441 . . . . 0.0 111.008 179.084 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 56' ' ' LYS . . . . . 0.442 ' O ' ' HB2' ' A' ' 59' ' ' ASP . 2.8 mptp? -111.59 169.87 8.52 Favored 'General case' 0 C--N 1.32 -0.717 0 CA-C-O 121.466 0.651 . . . . 0.0 109.345 175.583 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 57' ' ' VAL . . . . . 0.44 ' HA ' ' CG1' ' A' ' 140' ' ' VAL . 52.5 t -63.1 138.73 22.43 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.331 0 CA-C-N 114.954 -1.021 . . . . 0.0 110.027 174.086 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 81.49 10.95 83.82 Favored Glycine 0 N--CA 1.446 -0.651 0 C-N-CA 120.858 -0.687 . . . . 0.0 112.419 -177.35 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 59' ' ' ASP . . . . . 0.442 ' HB2' ' O ' ' A' ' 56' ' ' LYS . 3.3 m-20 -92.48 139.65 30.37 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-O 120.801 0.334 . . . . 0.0 110.306 175.317 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 6.8 mmmt -111.78 127.97 55.96 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 115.839 -0.619 . . . . 0.0 109.34 -177.767 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 11.3 t -142.43 141.28 32.19 Favored 'General case' 0 C--N 1.317 -0.836 0 CA-C-O 121.281 0.562 . . . . 0.0 111.103 -179.178 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 5.0 m -127.73 131.36 49.71 Favored 'General case' 0 C--N 1.316 -0.878 0 N-CA-C 109.049 -0.723 . . . . 0.0 109.049 174.789 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 63' ' ' PHE . . . . . 0.529 ' CE2' ' HE1' ' A' ' 136' ' ' PHE . 41.2 p90 -152.2 172.59 16.15 Favored 'General case' 0 C--N 1.319 -0.75 0 CA-C-O 120.648 0.261 . . . . 0.0 110.576 179.061 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 38.3 t -132.04 143.8 50.31 Favored 'General case' 0 C--N 1.319 -0.735 0 N-CA-C 108.743 -0.836 . . . . 0.0 108.743 -172.16 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 65' ' ' LEU . . . . . 0.422 HD11 ' HA ' ' A' ' 48' ' ' LEU . 57.2 mt -139.48 139.18 36.92 Favored 'General case' 0 C--N 1.319 -0.758 0 CA-C-O 121.12 0.486 . . . . 0.0 111.501 -176.728 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 66' ' ' GLU . . . . . 0.475 ' H ' ' CD ' ' A' ' 66' ' ' GLU . 13.5 mp0 -64.84 148.36 97.44 Favored Pre-proline 0 N--CA 1.44 -0.928 0 CA-C-N 115.009 -0.996 . . . . 0.0 109.373 170.571 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 67' ' ' PRO . . . . . 0.405 ' HA ' ' O ' ' A' ' 70' ' ' ALA . 73.7 Cg_exo -50.44 -23.78 11.05 Favored 'Trans proline' 0 C--N 1.346 0.434 0 C-N-CA 124.024 3.15 . . . . 0.0 114.662 -174.697 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 32.8 t70 -66.8 -26.2 66.83 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-O 121.149 0.5 . . . . 0.0 110.697 177.867 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 69' ' ' ALA . . . . . 0.482 ' HB1' ' HA3' ' A' ' 47' ' ' GLY . . . -108.21 -6.34 16.43 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 115.954 -0.567 . . . . 0.0 111.524 -178.067 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 70' ' ' ALA . . . . . 0.405 ' O ' ' HA ' ' A' ' 67' ' ' PRO . . . . . . . . 0 C--N 1.327 -0.374 0 CA-C-N 116.664 -0.244 . . . . 0.0 111.154 -176.009 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 32.2 t . . . . . 0 N--CA 1.446 -0.642 0 CA-C-O 120.671 0.272 . . . . 0.0 110.276 . . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 39.5 Cg_endo -69.11 -24.47 32.61 Favored 'Trans proline' 0 N--CA 1.465 -0.173 0 C-N-CA 122.074 1.849 . . . . 0.0 111.245 175.463 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 5.8 p-10 -77.26 -9.09 58.59 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 115.869 -0.605 . . . . 0.0 110.781 177.314 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 78' ' ' LEU . . . . . 0.537 ' HG ' ' HB2' ' A' ' 125' ' ' PHE . 5.0 tp -69.42 -20.99 63.78 Favored 'General case' 0 N--CA 1.453 -0.298 0 CA-C-O 121.645 0.736 . . . . 0.0 109.249 175.388 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 79' ' ' ILE . . . . . 0.471 HG23 ' O ' ' A' ' 123' ' ' VAL . 65.2 mt -70.21 132.17 33.48 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.555 0 CA-C-N 114.473 -1.239 . . . . 0.0 110.396 178.653 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 42.6 mt-30 -152.8 118.24 5.27 Favored 'General case' 0 CA--C 1.509 -0.605 0 CA-C-N 116.099 -0.501 . . . . 0.0 109.983 -176.992 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 81' ' ' TYR . . . . . . . . . . . . . 0.6 OUTLIER -83.51 121.71 27.57 Favored 'General case' 0 C--N 1.317 -0.846 0 N-CA-C 114.193 1.183 . . . . 0.0 114.193 -179.936 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 82' ' ' PHE . . . . . 0.431 ' HZ ' ' SD ' ' A' ' 104' ' ' MET . 7.5 m-85 -102.99 171.14 7.55 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 113.887 -1.506 . . . . 0.0 110.486 175.015 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 8.5 t -74.48 136.52 42.25 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-O 121.368 0.604 . . . . 0.0 110.904 -178.669 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 84' ' ' ARG . . . . . 0.573 ' HA ' ' CG1' ' A' ' 121' ' ' ILE . 12.1 ptm180 -61.36 -17.28 53.2 Favored 'General case' 0 C--N 1.326 -0.448 0 N-CA-C 113.734 1.013 . . . . 0.0 113.734 -178.187 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 85' ' ' ARG . . . . . 0.476 ' HD2' ' N ' ' A' ' 85' ' ' ARG . 6.7 mpt_? -73.92 -32.3 63.48 Favored 'General case' 0 C--N 1.321 -0.643 0 CA-C-O 121.203 0.525 . . . . 0.0 109.716 -176.396 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 32.7 mt-10 -63.28 -21.71 66.42 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 115.175 -0.921 . . . . 0.0 111.044 -179.102 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 87' ' ' PHE . . . . . . . . . . . . . 52.5 m-85 -96.83 -20.48 18.15 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 115.831 -0.622 . . . . 0.0 110.916 -178.308 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 88' ' ' MET . . . . . . . . . . . . . 55.7 ttm -60.91 -27.14 67.97 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 115.682 -0.69 . . . . 0.0 111.544 -175.915 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 60.8 m-20 -53.33 -34.57 58.01 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 116.426 -0.352 . . . . 0.0 111.538 177.022 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -109.79 16.58 21.95 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-O 121.014 0.435 . . . . 0.0 110.495 179.315 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 93.95 155.26 31.65 Favored Glycine 0 N--CA 1.448 -0.549 0 C-N-CA 121.088 -0.577 . . . . 0.0 111.734 -177.212 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 11.6 tt0 -64.73 127.86 92.97 Favored Pre-proline 0 N--CA 1.431 -1.402 0 CA-C-O 121.0 0.428 . . . . 0.0 109.945 -179.799 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 93' ' ' PRO . . . . . 0.53 ' CB ' HD13 ' A' ' 113' ' ' ILE . 31.8 Cg_endo -65.5 165.65 22.08 Favored 'Trans proline' 0 C--O 1.233 0.271 0 C-N-CA 123.398 2.732 . . . . 0.0 113.923 -176.196 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 94' ' ' GLU . . . . . 0.464 ' O ' ' HB ' ' A' ' 113' ' ' ILE . 14.2 mt-10 -114.22 154.53 27.74 Favored 'General case' 0 C--N 1.333 -0.145 0 CA-C-N 115.651 -0.704 . . . . 0.0 110.69 -177.385 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 95' ' ' ILE . . . . . 0.577 ' CG1' HG12 ' A' ' 116' ' ' ILE . 20.2 mt -82.27 129.66 37.1 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.386 0 CA-C-O 121.047 0.451 . . . . 0.0 111.576 -178.168 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 71.76 27.09 71.46 Favored Glycine 0 N--CA 1.45 -0.406 0 CA-C-N 115.49 -0.777 . . . . 0.0 113.208 179.076 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -109.52 129.02 55.59 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-O 120.634 0.254 . . . . 0.0 110.691 177.062 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 98' ' ' ILE . . . . . 0.697 ' HA ' ' HA ' ' A' ' 112' ' ' VAL . 4.1 mt -89.01 133.07 32.18 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.561 0 N-CA-C 108.68 -0.859 . . . . 0.0 108.68 177.02 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 99' ' ' MET . . . . . . . . . . . . . 10.3 mtm -136.64 157.59 46.42 Favored 'General case' 0 N--CA 1.444 -0.764 0 N-CA-C 106.648 -1.612 . . . . 0.0 106.648 177.194 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 100' ' ' LEU . . . . . 0.465 HD12 ' HG2' ' A' ' 108' ' ' GLU . 1.3 mm? -71.56 103.36 2.97 Favored 'General case' 0 C--N 1.313 -1.01 0 CA-C-O 122.438 1.113 . . . . 0.0 110.772 174.457 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 101' ' ' PHE . . . . . . . . . . . . . 2.7 m-85 -90.19 170.1 10.58 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-N 113.215 -1.811 . . . . 0.0 112.455 -174.144 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 1.6 m -126.37 140.52 52.44 Favored 'General case' 0 C--N 1.317 -0.829 0 CA-C-N 114.234 -1.348 . . . . 0.0 109.781 178.432 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 103' ' ' ALA . . . . . 0.417 ' HB2' ' HG3' ' A' ' 109' ' ' MET . . . -96.23 163.91 12.89 Favored 'General case' 0 C--N 1.321 -0.657 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.491 -179.598 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 104' ' ' MET . . . . . 0.431 ' SD ' ' HZ ' ' A' ' 82' ' ' PHE . 4.3 mpp? -66.73 -19.57 65.78 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 115.813 -0.63 . . . . 0.0 110.969 -179.272 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 6.2 p-10 -93.94 16.26 14.81 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.926 0.393 . . . . 0.0 111.458 -179.25 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 85.23 -11.15 61.45 Favored Glycine 0 N--CA 1.451 -0.364 0 C-N-CA 121.148 -0.548 . . . . 0.0 113.254 174.484 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 68.2 m -78.36 149.42 33.4 Favored 'General case' 0 C--N 1.316 -0.87 0 CA-C-O 121.18 0.514 . . . . 0.0 110.974 -179.652 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 108' ' ' GLU . . . . . 0.465 ' HG2' HD12 ' A' ' 100' ' ' LEU . 40.1 tt0 -91.21 146.57 23.72 Favored 'General case' 0 C--N 1.312 -1.043 0 CA-C-N 115.519 -0.764 . . . . 0.0 108.979 175.929 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 109' ' ' MET . . . . . 0.417 ' HG3' ' HB2' ' A' ' 103' ' ' ALA . 88.9 mmm -138.41 151.17 68.74 Favored Pre-proline 0 C--O 1.231 0.12 0 N-CA-C 106.016 -1.846 . . . . 0.0 106.016 -164.073 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 4.9 Cg_endo -81.63 113.24 2.53 Favored 'Trans proline' 0 N--CA 1.446 -1.285 0 CA-C-N 121.428 1.546 . . . . 0.0 109.671 162.962 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 111' ' ' GLY . . . . . 0.444 ' HA2' ' O ' ' A' ' 124' ' ' ASP . . . -121.39 126.21 6.45 Favored Glycine 0 N--CA 1.436 -1.354 0 C-N-CA 120.251 -0.975 . . . . 0.0 112.299 179.2 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 112' ' ' VAL . . . . . 0.697 ' HA ' ' HA ' ' A' ' 98' ' ' ILE . 0.2 OUTLIER -105.1 140.18 23.88 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.142 0 N-CA-C 108.587 -0.894 . . . . 0.0 108.587 174.023 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 113' ' ' ILE . . . . . 0.53 HD13 ' CB ' ' A' ' 93' ' ' PRO . 10.3 mt -89.2 108.61 19.3 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.374 0 N-CA-C 107.826 -1.175 . . . . 0.0 107.826 -174.194 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 114' ' ' ARG . . . . . 0.465 ' O ' HG23 ' A' ' 95' ' ' ILE . 10.9 tpp180 -64.88 -47.53 77.53 Favored 'General case' 0 C--N 1.317 -0.839 0 CA-C-N 115.284 -0.871 . . . . 0.0 111.513 -171.179 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 115' ' ' GLU . . . . . 0.474 ' H ' ' HB ' ' A' ' 122' ' ' THR . 8.6 tt0 -161.63 162.48 30.01 Favored 'General case' 0 C--N 1.317 -0.833 0 N-CA-C 109.445 -0.576 . . . . 0.0 109.445 -175.28 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 116' ' ' ILE . . . . . 0.577 HG12 ' CG1' ' A' ' 95' ' ' ILE . 28.7 mm -111.82 112.53 40.93 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.427 0 CA-C-O 121.174 0.511 . . . . 0.0 110.129 177.356 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 117' ' ' ASN . . . . . 0.465 ' HB2' ' O ' ' A' ' 120' ' ' SER . 5.4 m-20 -96.31 158.93 15.21 Favored 'General case' 0 C--N 1.315 -0.896 0 CA-C-N 115.557 -0.747 . . . . 0.0 110.056 179.06 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . -57.18 -45.75 92.29 Favored Glycine 0 N--CA 1.452 -0.294 0 C-N-CA 120.612 -0.804 . . . . 0.0 113.304 -172.476 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 119' ' ' ASP . . . . . 0.424 ' O ' ' HG2' ' A' ' 84' ' ' ARG . 10.3 m-20 -113.39 -15.8 12.57 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-O 120.784 0.326 . . . . 0.0 111.53 178.397 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 120' ' ' SER . . . . . 0.465 ' O ' ' HB2' ' A' ' 117' ' ' ASN . 16.0 t -116.86 157.74 25.13 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-O 120.814 0.34 . . . . 0.0 111.09 -172.312 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 121' ' ' ILE . . . . . 0.573 ' CG1' ' HA ' ' A' ' 84' ' ' ARG . 38.8 mm -112.21 128.18 68.98 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.576 0 CA-C-O 121.746 0.784 . . . . 0.0 110.837 174.491 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 122' ' ' THR . . . . . 0.474 ' HB ' ' H ' ' A' ' 115' ' ' GLU . 0.6 OUTLIER -90.88 141.11 29.17 Favored 'General case' 0 C--N 1.307 -1.278 0 CA-C-N 114.338 -1.301 . . . . 0.0 109.382 178.236 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 123' ' ' VAL . . . . . 0.471 ' O ' HG23 ' A' ' 79' ' ' ILE . 43.8 t -138.39 158.93 31.91 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.41 0 N-CA-C 109.055 -0.72 . . . . 0.0 109.055 -156.522 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 124' ' ' ASP . . . . . 0.572 ' HB3' HG13 ' A' ' 112' ' ' VAL . 46.1 t0 -148.83 148.74 30.26 Favored 'General case' 0 C--N 1.305 -1.357 0 CA-C-N 116.058 -0.519 . . . . 0.0 110.256 174.781 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 125' ' ' PHE . . . . . 0.537 ' HB2' ' HG ' ' A' ' 78' ' ' LEU . 84.4 m-85 -135.97 3.71 2.95 Favored 'General case' 0 C--N 1.318 -0.804 0 CA-C-N 115.246 -0.888 . . . . 0.0 109.707 176.041 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 29.4 m-80 . . . . . 0 N--CA 1.449 -0.495 0 CA-C-N 114.685 -1.143 . . . . 0.0 110.571 176.103 . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 133' ' ' THR . . . . . . . . . . . . . 14.5 m . . . . . 0 N--CA 1.451 -0.39 0 CA-C-O 120.904 0.383 . . . . 0.0 110.552 . . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 134' ' ' VAL . . . . . 0.89 ' HB ' HD21 ' A' ' 17' ' ' LEU . 4.6 m -101.98 142.81 15.72 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.599 0 CA-C-O 121.236 0.541 . . . . 0.0 111.576 -176.483 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 135' ' ' HIS . . . . . . . . . . . . . 69.5 m-70 -124.87 113.24 17.61 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 115.328 -0.851 . . . . 0.0 109.076 -178.794 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 136' ' ' PHE . . . . . 0.529 ' HE1' ' CE2' ' A' ' 63' ' ' PHE . 0.1 OUTLIER -117.96 132.2 56.42 Favored 'General case' 0 C--N 1.316 -0.862 0 CA-C-O 121.103 0.478 . . . . 0.0 111.295 -175.787 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 137' ' ' ASP . . . . . . . . . . . . . 14.4 t70 -99.23 102.61 14.31 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-N 115.18 -0.918 . . . . 0.0 108.56 177.427 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 138' ' ' ILE . . . . . 0.694 HG23 HG21 ' A' ' 13' ' ' VAL . 40.6 mt -103.27 132.78 48.81 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.644 0 N-CA-C 112.716 0.635 . . . . 0.0 112.716 -166.912 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 24.0 mt-10 -125.7 114.46 18.68 Favored 'General case' 0 N--CA 1.45 -0.439 0 CA-C-N 115.24 -0.891 . . . . 0.0 109.131 178.781 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 140' ' ' VAL . . . . . 0.44 ' CG1' ' HA ' ' A' ' 57' ' ' VAL . 65.2 t -70.55 122.16 21.8 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.417 0 CA-C-N 117.824 0.284 . . . . 0.0 110.86 -179.498 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 141' ' ' LEU . . . . . 0.555 HD11 ' HB2' ' A' ' 14' ' ' HIS . 13.8 mt -100.76 -33.12 10.38 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-O 121.672 0.748 . . . . 0.0 110.426 178.739 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 142' ' ' GLU . . . . . 0.451 ' HB3' ' HB2' ' A' ' 12' ' ' LEU . 32.8 tt0 -163.88 151.59 12.64 Favored 'General case' 0 C--N 1.314 -0.971 0 CA-C-N 114.405 -1.27 . . . . 0.0 109.858 -178.334 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 143' ' ' ILE . . . . . . . . . . . . . 85.3 mt -122.1 113.82 40.28 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.397 0 CA-C-O 120.961 0.41 . . . . 0.0 110.932 -178.473 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 144' ' ' ASP . . . . . . . . . . . . . 37.4 t70 -79.15 126.17 82.19 Favored Pre-proline 0 C--N 1.323 -0.55 0 CA-C-N 115.807 -0.633 . . . . 0.0 110.291 177.998 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 145' ' ' PRO . . . . . . . . . . . . . 41.5 Cg_endo . . . . . 0 C--O 1.234 0.311 0 C-N-CA 123.016 2.477 . . . . 0.0 113.294 -175.864 . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 18.9 p . . . . . 0 N--CA 1.469 0.51 0 N-CA-C 112.464 0.542 . . . . 0.0 112.464 . . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 47.7 mt-10 -75.79 -33.24 60.13 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-O 121.215 0.531 . . . . 0.0 110.734 176.311 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 12.6 p -114.37 149.12 36.61 Favored 'General case' 0 C--N 1.319 -0.749 0 CA-C-N 115.558 -0.746 . . . . 0.0 110.647 -177.894 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 5' ' ' VAL . . . . . 0.525 HG13 ' HA ' ' A' ' 53' ' ' LEU . 7.4 p -73.68 144.83 12.2 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.395 0 CA-C-N 115.61 -0.723 . . . . 0.0 110.598 -178.281 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 6' ' ' GLN . . . . . . . . . . . . . 3.4 pt20 -136.99 166.31 23.96 Favored 'General case' 0 N--CA 1.444 -0.727 0 N-CA-C 108.488 -0.93 . . . . 0.0 108.488 -179.592 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 34.2 p -63.93 138.68 58.58 Favored 'General case' 0 C--N 1.317 -0.812 0 CA-C-O 120.735 0.303 . . . . 0.0 110.94 -176.531 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 15.5 t30 70.92 15.59 6.72 Favored 'General case' 0 CA--C 1.542 0.641 0 CA-C-N 115.491 -0.777 . . . . 0.0 111.643 177.928 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 9' ' ' SER . . . . . 0.631 ' O ' HD23 ' A' ' 39' ' ' LEU . 8.8 t -108.15 134.36 51.11 Favored 'General case' 0 N--CA 1.451 -0.411 0 N-CA-C 108.079 -1.082 . . . . 0.0 108.079 177.276 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -82.19 149.07 28.11 Favored 'General case' 0 C--N 1.322 -0.599 0 N-CA-C 109.69 -0.485 . . . . 0.0 109.69 -174.02 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 6.3 m -134.33 145.05 33.51 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.755 0 C-N-CA 120.281 -0.568 . . . . 0.0 111.35 -175.869 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 12' ' ' LEU . . . . . 0.449 HD22 ' HB2' ' A' ' 142' ' ' GLU . 6.6 mp -91.74 119.36 31.51 Favored 'General case' 0 C--N 1.326 -0.456 0 N-CA-C 108.809 -0.811 . . . . 0.0 108.809 177.909 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 13' ' ' VAL . . . . . 0.547 HG21 HG23 ' A' ' 138' ' ' ILE . 2.4 p -132.37 154.48 40.07 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.68 0 CA-C-O 122.146 0.974 . . . . 0.0 113.219 -172.12 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 14' ' ' HIS . . . . . 0.429 ' CD2' HD11 ' A' ' 141' ' ' LEU . 0.2 OUTLIER -117.2 117.7 30.28 Favored 'General case' 0 C--N 1.32 -0.704 0 N-CA-C 106.225 -1.769 . . . . 0.0 106.225 170.936 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 15' ' ' PHE . . . . . 0.42 ' HB2' ' O ' ' A' ' 137' ' ' ASP . 32.1 p90 -148.27 157.35 43.44 Favored 'General case' 0 C--N 1.327 -0.396 0 C-N-CA 118.671 -1.212 . . . . 0.0 113.785 -167.523 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 16' ' ' THR . . . . . 0.447 HG22 ' HD3' ' A' ' 18' ' ' LYS . 85.9 m -128.88 118.77 23.25 Favored 'General case' 0 C--N 1.321 -0.653 0 CA-C-N 115.006 -0.997 . . . . 0.0 109.813 174.617 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 17' ' ' LEU . . . . . 0.509 HD21 ' CE2' ' A' ' 136' ' ' PHE . 1.4 mt -95.17 112.91 24.56 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-O 121.034 0.445 . . . . 0.0 111.163 179.045 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 18' ' ' LYS . . . . . 0.447 ' HD3' HG22 ' A' ' 16' ' ' THR . 10.2 mptt -109.05 128.01 54.61 Favored 'General case' 0 C--N 1.314 -0.945 0 CA-C-N 115.735 -0.666 . . . . 0.0 110.826 -179.251 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 19.8 tp -85.42 161.53 19.39 Favored 'General case' 0 N--CA 1.438 -1.069 0 CA-C-N 115.677 -0.692 . . . . 0.0 109.199 175.775 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 29.2 t70 -62.77 -24.69 67.85 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 121.431 0.634 . . . . 0.0 110.25 178.603 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 27.1 t70 -70.25 -3.66 18.12 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 115.162 -0.927 . . . . 0.0 111.385 177.646 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 74.81 9.08 82.99 Favored Glycine 0 C--N 1.332 0.333 0 C-N-CA 121.508 -0.377 . . . . 0.0 112.425 -175.593 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 52.7 m -91.45 140.28 29.9 Favored 'General case' 0 C--N 1.319 -0.745 0 CA-C-N 115.309 -0.446 . . . . 0.0 110.06 175.779 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 41.7 m -79.68 108.24 13.08 Favored 'General case' 0 C--N 1.318 -0.784 0 N-CA-C 110.05 -0.352 . . . . 0.0 110.05 177.197 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -69.86 -34.77 74.05 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.88 -0.6 . . . . 0.0 110.527 -177.969 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 44.2 tt0 -159.83 128.35 4.96 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 115.857 -0.611 . . . . 0.0 109.697 177.356 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 18.4 p -109.58 130.48 55.51 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-N 116.534 -0.303 . . . . 0.0 110.835 -178.289 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 28' ' ' THR . . . . . 0.611 ' O ' HG22 ' A' ' 28' ' ' THR . 62.2 m -148.59 14.48 0.96 Allowed 'General case' 0 CA--C 1.546 0.798 0 CA-C-O 122.831 1.301 . . . . 0.0 110.854 174.75 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 16.0 tpt180 -92.94 -68.99 0.77 Allowed 'General case' 0 C--N 1.307 -1.257 0 O-C-N 121.19 -0.944 . . . . 0.0 111.018 168.523 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 7.8 p30 -69.47 -10.61 58.77 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.407 -0.36 . . . . 0.0 111.452 -172.754 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 2.2 m-20 -58.37 -31.08 67.3 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.981 177.631 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 91.09 -13.39 66.37 Favored Glycine 0 N--CA 1.447 -0.593 0 C-N-CA 120.621 -0.8 . . . . 0.0 111.404 -175.813 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 75.4 mmtt -120.23 124.47 27.74 Favored Pre-proline 0 C--N 1.324 -0.533 0 N-CA-C 109.587 -0.524 . . . . 0.0 109.587 179.871 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 71.6 Cg_endo -76.53 168.85 22.98 Favored 'Trans proline' 0 N--CA 1.457 -0.659 0 C-N-CA 122.38 2.053 . . . . 0.0 111.889 176.438 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -131.75 149.86 52.34 Favored 'General case' 0 C--N 1.319 -0.719 0 CA-C-N 116.391 -0.368 . . . . 0.0 110.43 -177.234 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 4.9 tp -88.71 137.32 32.42 Favored 'General case' 0 C--N 1.318 -0.801 0 N-CA-C 109.769 -0.456 . . . . 0.0 109.769 174.711 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 37' ' ' PHE . . . . . . . . . . . . . 6.4 m-30 -98.37 119.89 37.84 Favored 'General case' 0 C--N 1.316 -0.862 0 N-CA-C 108.548 -0.908 . . . . 0.0 108.548 172.5 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 38' ' ' ARG . . . . . 0.437 ' HG3' ' HB3' ' A' ' 42' ' ' ALA . 24.6 tpt180 -90.33 104.88 17.41 Favored 'General case' 0 N--CA 1.442 -0.832 0 N-CA-C 108.955 -0.757 . . . . 0.0 108.955 177.92 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 39' ' ' LEU . . . . . 0.631 HD23 ' O ' ' A' ' 9' ' ' SER . 2.2 mm? -89.97 156.26 18.54 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-N 115.455 -0.793 . . . . 0.0 111.137 -178.767 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 101.09 29.48 6.4 Favored Glycine 0 N--CA 1.445 -0.713 0 C-N-CA 120.723 -0.751 . . . . 0.0 112.103 -175.19 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 38.8 t70 68.87 3.42 3.97 Favored 'General case' 0 N--CA 1.472 0.627 0 CA-C-O 121.34 0.59 . . . . 0.0 111.823 175.357 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 42' ' ' ALA . . . . . 0.437 ' HB3' ' HG3' ' A' ' 38' ' ' ARG . . . -74.53 -7.52 53.35 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-N 116.055 -0.52 . . . . 0.0 112.113 -179.305 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 32.7 t -163.68 -60.64 0.04 OUTLIER 'General case' 0 C--N 1.323 -0.556 0 N-CA-C 109.476 -0.564 . . . . 0.0 109.476 176.056 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 7.8 mp -90.01 161.46 15.85 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-N 115.87 -0.604 . . . . 0.0 110.502 178.096 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 46.9 t -77.99 145.87 35.75 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-N 115.438 -0.801 . . . . 0.0 109.752 178.273 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 46' ' ' GLU . . . . . 0.62 ' O ' ' HG2' ' A' ' 50' ' ' GLN . 12.1 tt0 -58.68 -16.69 17.44 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 115.078 -0.964 . . . . 0.0 112.004 -176.987 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -69.29 -32.06 71.99 Favored Glycine 0 N--CA 1.446 -0.634 0 C-N-CA 120.69 -0.766 . . . . 0.0 111.942 -177.812 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 1.6 tt -69.07 -53.0 22.64 Favored 'General case' 0 N--CA 1.45 -0.445 0 CA-C-O 120.672 0.272 . . . . 0.0 110.834 -178.298 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 49' ' ' GLU . . . . . 0.58 ' O ' HD22 ' A' ' 53' ' ' LEU . 14.2 pt-20 -58.04 -32.32 67.87 Favored 'General case' 0 N--CA 1.453 -0.305 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.61 179.497 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 50' ' ' GLN . . . . . 0.62 ' HG2' ' O ' ' A' ' 46' ' ' GLU . 69.9 mm-40 -57.32 -26.75 61.42 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 120.775 0.321 . . . . 0.0 110.904 -177.841 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 51' ' ' HIS . . . . . . . . . . . . . 12.1 m-70 -99.76 -14.02 19.03 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 116.397 -0.365 . . . . 0.0 111.03 -179.222 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 25.6 mt -95.76 -30.76 13.54 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 116.406 -0.361 . . . . 0.0 111.914 -177.401 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 53' ' ' LEU . . . . . 0.58 HD22 ' O ' ' A' ' 49' ' ' GLU . 0.0 OUTLIER -57.59 143.59 40.56 Favored 'General case' 0 C--O 1.234 0.26 0 CA-C-O 120.874 0.369 . . . . 0.0 111.246 -176.862 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 93.56 -2.7 70.75 Favored Glycine 0 N--CA 1.443 -0.845 0 C-N-CA 120.879 -0.677 . . . . 0.0 113.452 177.972 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 55' ' ' LEU . . . . . 0.501 ' O ' HG12 ' A' ' 5' ' ' VAL . 24.8 tp -94.41 164.22 13.1 Favored 'General case' 0 N--CA 1.453 -0.311 0 CA-C-N 118.052 0.926 . . . . 0.0 109.159 178.549 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 56' ' ' LYS . . . . . 0.665 ' HD2' ' N ' ' A' ' 57' ' ' VAL . 0.9 OUTLIER -117.15 157.79 25.34 Favored 'General case' 0 C--N 1.32 -0.708 0 N-CA-C 109.89 -0.411 . . . . 0.0 109.89 -174.803 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 57' ' ' VAL . . . . . 0.665 ' N ' ' HD2' ' A' ' 56' ' ' LYS . 8.8 t -57.61 141.74 14.23 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.243 0 CA-C-O 121.078 0.465 . . . . 0.0 111.357 177.954 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 82.87 10.12 83.5 Favored Glycine 0 N--CA 1.447 -0.576 0 CA-C-N 115.734 -0.666 . . . . 0.0 112.338 -178.859 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 8.5 m-20 -116.41 152.76 33.33 Favored 'General case' 0 C--N 1.324 -0.53 0 N-CA-C 109.543 -0.54 . . . . 0.0 109.543 174.291 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 60' ' ' LYS . . . . . 0.525 ' HE3' ' HG2' ' A' ' 139' ' ' GLU . 0.6 OUTLIER -131.73 149.38 52.5 Favored 'General case' 0 C--N 1.316 -0.877 0 CA-C-O 121.519 0.676 . . . . 0.0 111.76 -175.364 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 9.3 t -143.53 130.86 20.91 Favored 'General case' 0 C--N 1.314 -0.961 0 CA-C-N 114.714 -1.13 . . . . 0.0 110.884 -178.36 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 4.1 m -107.1 131.53 54.01 Favored 'General case' 0 N--CA 1.44 -0.944 0 N-CA-C 107.866 -1.161 . . . . 0.0 107.866 171.134 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 63' ' ' PHE . . . . . 0.43 ' HE1' ' CG1' ' A' ' 138' ' ' ILE . 1.5 p90 -158.24 153.46 25.65 Favored 'General case' 0 C--N 1.321 -0.631 0 CA-C-O 121.021 0.439 . . . . 0.0 110.937 -171.195 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 16.4 m -104.85 148.96 26.09 Favored 'General case' 0 C--N 1.319 -0.748 0 CA-C-N 115.727 -0.669 . . . . 0.0 110.644 -179.713 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 65' ' ' LEU . . . . . 0.451 ' O ' HG23 ' A' ' 133' ' ' THR . 82.8 mt -138.82 142.39 38.68 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.557 -0.292 . . . . 0.0 110.722 -176.039 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 66' ' ' GLU . . . . . 0.49 ' H ' ' CD ' ' A' ' 66' ' ' GLU . 1.6 mp0 -64.76 154.11 86.23 Favored Pre-proline 0 C--N 1.329 -0.311 0 CA-C-N 115.921 -0.581 . . . . 0.0 109.741 174.299 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 10.8 Cg_endo -56.65 -48.55 18.26 Favored 'Trans proline' 0 C--O 1.219 -0.431 0 C-N-CA 121.869 1.712 . . . . 0.0 113.563 -176.355 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 23.5 t70 -64.01 -21.99 66.74 Favored 'General case' 0 C--N 1.324 -0.511 0 O-C-N 121.515 -0.741 . . . . 0.0 110.072 178.534 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -86.35 -28.76 23.46 Favored 'General case' 0 N--CA 1.451 -0.406 0 CA-C-N 115.982 -0.554 . . . . 0.0 111.216 179.09 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.454 -0.262 0 N-CA-C 109.776 -0.453 . . . . 0.0 109.776 176.578 . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 75' ' ' SER . . . . . 0.578 ' HB3' ' OD1' ' A' ' 77' ' ' ASP . 30.8 m . . . . . 0 C--O 1.232 0.156 0 CA-C-O 120.774 0.321 . . . . 0.0 110.993 . . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 76' ' ' PRO . . . . . 0.473 ' HA ' HG13 ' A' ' 79' ' ' ILE . 53.1 Cg_endo -70.16 -17.28 35.87 Favored 'Trans proline' 0 CA--C 1.529 0.274 0 C-N-CA 123.199 2.599 . . . . 0.0 113.571 -178.118 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 77' ' ' ASP . . . . . 0.578 ' OD1' ' HB3' ' A' ' 75' ' ' SER . 5.2 p-10 -69.27 -4.75 19.2 Favored 'General case' 0 C--N 1.329 -0.325 0 N-CA-C 112.829 0.678 . . . . 0.0 112.829 -173.331 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 78' ' ' LEU . . . . . 0.635 ' HB2' ' O ' ' A' ' 125' ' ' PHE . 83.1 mt -112.57 -5.1 14.03 Favored 'General case' 0 C--N 1.324 -0.523 0 C-N-CA 120.742 -0.383 . . . . 0.0 110.963 176.399 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 79' ' ' ILE . . . . . 0.473 HG13 ' HA ' ' A' ' 76' ' ' PRO . 15.2 mt -77.39 104.81 5.64 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.736 0 C-N-CA 120.345 -0.542 . . . . 0.0 109.705 -173.695 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 73.0 mt-30 -108.95 164.06 12.75 Favored 'General case' 0 C--N 1.314 -0.937 0 CA-C-N 115.671 -0.695 . . . . 0.0 111.824 -172.806 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 81' ' ' TYR . . . . . . . . . . . . . 11.3 m-85 -129.48 115.67 17.82 Favored 'General case' 0 N--CA 1.444 -0.766 0 N-CA-C 107.514 -1.291 . . . . 0.0 107.514 -172.78 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 73.4 m-85 -111.24 168.29 9.63 Favored 'General case' 0 C--N 1.317 -0.844 0 CA-C-O 120.763 0.316 . . . . 0.0 110.863 -174.661 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 12.2 t -73.86 145.24 45.02 Favored 'General case' 0 C--N 1.323 -0.577 0 N-CA-C 108.849 -0.797 . . . . 0.0 108.849 176.692 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 84' ' ' ARG . . . . . 0.649 ' HD3' ' HA ' ' A' ' 119' ' ' ASP . 28.9 ptt180 -73.64 -29.72 62.51 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-O 121.576 0.703 . . . . 0.0 109.609 -173.895 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 85' ' ' ARG . . . . . 0.446 ' HD2' ' H ' ' A' ' 85' ' ' ARG . 0.8 OUTLIER -64.7 -38.94 92.7 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 114.597 -1.183 . . . . 0.0 113.391 -171.015 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 86' ' ' GLU . . . . . 0.461 ' O ' ' HB3' ' A' ' 89' ' ' ASP . 44.1 mm-40 -60.65 -48.88 79.82 Favored 'General case' 0 C--N 1.317 -0.836 0 CA-C-O 122.269 1.033 . . . . 0.0 108.687 174.259 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 87' ' ' PHE . . . . . . . . . . . . . 55.6 m-85 -59.0 -31.85 69.18 Favored 'General case' 0 C--N 1.318 -0.783 0 CA-C-N 113.701 -1.591 . . . . 0.0 112.91 175.264 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 88' ' ' MET . . . . . . . . . . . . . 60.3 ttp -68.18 -41.45 81.43 Favored 'General case' 0 C--N 1.315 -0.898 0 CA-C-O 122.13 0.967 . . . . 0.0 109.521 174.025 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 89' ' ' ASP . . . . . 0.461 ' HB3' ' O ' ' A' ' 86' ' ' GLU . 19.3 t70 -55.17 -23.07 19.82 Favored 'General case' 0 C--N 1.321 -0.673 0 CA-C-N 113.387 -1.733 . . . . 0.0 110.164 176.029 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -112.86 8.63 18.75 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 115.646 -0.706 . . . . 0.0 111.799 178.938 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 92.08 137.61 7.85 Favored Glycine 0 C--N 1.331 0.265 0 C-N-CA 120.482 -0.866 . . . . 0.0 111.989 -177.453 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 8.8 tt0 -61.91 122.07 69.47 Favored Pre-proline 0 N--CA 1.442 -0.848 0 CA-C-O 121.116 0.484 . . . . 0.0 111.306 -172.271 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 93' ' ' PRO . . . . . 0.482 ' HG2' HD12 ' A' ' 121' ' ' ILE . 38.1 Cg_endo -77.75 165.96 26.03 Favored 'Trans proline' 0 N--CA 1.46 -0.497 0 C-N-CA 122.935 2.423 . . . . 0.0 112.875 -177.525 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 94' ' ' GLU . . . . . 0.521 ' O ' HD12 ' A' ' 113' ' ' ILE . 27.0 mt-10 -115.94 154.13 30.35 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.018 -0.537 . . . . 0.0 111.131 -176.135 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 95' ' ' ILE . . . . . 0.543 HG12 HG12 ' A' ' 116' ' ' ILE . 32.6 mt -77.17 134.16 29.24 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.384 0 CA-C-N 116.446 -0.343 . . . . 0.0 110.099 179.168 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 72.26 19.47 78.7 Favored Glycine 0 N--CA 1.449 -0.481 0 C-N-CA 121.032 -0.604 . . . . 0.0 112.407 -176.997 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 97' ' ' ALA . . . . . 0.466 ' O ' HG13 ' A' ' 113' ' ' ILE . . . -99.71 166.86 10.91 Favored 'General case' 0 C--N 1.323 -0.562 0 N-CA-C 109.562 -0.533 . . . . 0.0 109.562 175.27 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 38.8 mt -125.79 126.11 69.49 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.727 0 CA-C-O 120.876 0.37 . . . . 0.0 110.533 -175.598 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 99' ' ' MET . . . . . 0.421 ' SD ' HD11 ' A' ' 113' ' ' ILE . 2.7 mtp -124.72 161.58 26.06 Favored 'General case' 0 C--N 1.324 -0.527 0 N-CA-C 107.898 -1.149 . . . . 0.0 107.898 -179.922 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 100' ' ' LEU . . . . . 0.423 HD13 ' HA ' ' A' ' 100' ' ' LEU . 3.9 mm? -77.24 153.62 33.82 Favored 'General case' 0 C--N 1.323 -0.587 0 CA-C-N 118.806 0.73 . . . . 0.0 111.078 167.635 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 101' ' ' PHE . . . . . 0.6 ' CE2' HG11 ' A' ' 123' ' ' VAL . 65.5 m-85 -149.42 155.52 40.57 Favored 'General case' 0 C--N 1.319 -0.761 0 CA-C-N 114.702 -1.136 . . . . 0.0 107.986 -170.334 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 3.1 m -121.11 111.44 17.45 Favored 'General case' 0 C--N 1.314 -0.958 0 C-N-CA 119.793 -0.763 . . . . 0.0 110.154 -178.348 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -77.78 166.25 23.18 Favored 'General case' 0 N--CA 1.448 -0.56 0 CA-C-N 115.4 -0.818 . . . . 0.0 110.868 -177.183 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 104' ' ' MET . . . . . . . . . . . . . 60.1 mtt -67.37 -14.32 62.81 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.128 -0.942 . . . . 0.0 111.901 -173.669 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 8.2 p-10 -96.51 11.38 35.27 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 116.551 -0.295 . . . . 0.0 111.383 -177.784 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 88.06 -11.33 67.52 Favored Glycine 0 N--CA 1.447 -0.602 0 C-N-CA 120.42 -0.895 . . . . 0.0 113.289 179.448 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 33.3 t -79.36 149.74 31.61 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-O 121.227 0.537 . . . . 0.0 110.692 -179.327 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 108' ' ' GLU . . . . . 0.448 ' HA ' ' O ' ' A' ' 101' ' ' PHE . 44.5 tt0 -120.51 104.11 9.71 Favored 'General case' 0 C--N 1.317 -0.845 0 CA-C-N 115.615 -0.72 . . . . 0.0 109.381 179.801 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 109' ' ' MET . . . . . 0.438 ' SD ' ' HD2' ' A' ' 125' ' ' PHE . 13.7 ptp -111.44 145.14 31.97 Favored Pre-proline 0 C--N 1.322 -0.614 0 CA-C-N 116.535 -0.302 . . . . 0.0 110.621 -175.579 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 12.2 Cg_exo -70.1 120.6 7.31 Favored 'Trans proline' 0 N--CA 1.462 -0.368 0 C-N-CA 122.475 2.117 . . . . 0.0 110.663 171.5 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . -117.41 153.88 17.01 Favored Glycine 0 C--N 1.321 -0.29 0 C-N-CA 120.752 -0.737 . . . . 0.0 112.447 -176.562 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER -100.77 121.29 51.39 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.426 0 CA-C-O 121.064 0.459 . . . . 0.0 110.249 -176.392 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 113' ' ' ILE . . . . . 0.521 HD12 ' O ' ' A' ' 94' ' ' GLU . 1.0 OUTLIER -67.05 111.22 1.85 Allowed 'Isoleucine or valine' 0 C--N 1.316 -0.85 0 CA-C-N 115.762 -0.654 . . . . 0.0 109.386 176.709 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 114' ' ' ARG . . . . . . . . . . . . . 13.2 tpp180 -63.29 -52.36 62.31 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 115.349 -0.841 . . . . 0.0 110.744 -178.085 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 5.2 tt0 -159.48 148.45 18.03 Favored 'General case' 0 C--N 1.32 -0.699 0 N-CA-C 110.11 -0.33 . . . . 0.0 110.11 -177.79 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 116' ' ' ILE . . . . . 0.543 HG12 HG12 ' A' ' 95' ' ' ILE . 45.9 mm -96.12 111.2 25.88 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.533 0 N-CA-C 108.879 -0.786 . . . . 0.0 108.879 176.197 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 117' ' ' ASN . . . . . . . . . . . . . 37.6 m-80 -101.47 155.8 17.85 Favored 'General case' 0 C--N 1.313 -1.012 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.057 -179.111 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . -57.22 -38.84 88.48 Favored Glycine 0 N--CA 1.448 -0.52 0 C-N-CA 120.453 -0.88 . . . . 0.0 112.925 -170.842 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 119' ' ' ASP . . . . . 0.649 ' HA ' ' HD3' ' A' ' 84' ' ' ARG . 4.7 p-10 -109.75 -12.55 14.61 Favored 'General case' 0 C--N 1.324 -0.516 0 N-CA-C 111.977 0.362 . . . . 0.0 111.977 -174.66 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 20.3 t -146.12 155.99 43.13 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 121.065 0.459 . . . . 0.0 111.899 -168.603 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 121' ' ' ILE . . . . . 0.482 HD12 ' HG2' ' A' ' 93' ' ' PRO . 35.1 mm -119.43 120.25 63.04 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 115.896 -0.593 . . . . 0.0 110.178 178.705 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 89.8 m -106.14 119.48 39.34 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 116.568 -0.287 . . . . 0.0 111.052 -177.504 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 123' ' ' VAL . . . . . 0.6 HG11 ' CE2' ' A' ' 101' ' ' PHE . 38.8 t -117.69 118.26 57.8 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.316 0 CA-C-O 119.482 -0.295 . . . . 0.0 110.539 179.049 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 9.4 p-10 -95.32 96.34 9.08 Favored 'General case' 0 N--CA 1.452 -0.345 0 N-CA-C 114.131 1.159 . . . . 0.0 114.131 -179.906 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 125' ' ' PHE . . . . . 0.635 ' O ' ' HB2' ' A' ' 78' ' ' LEU . 12.0 m-85 -68.78 98.0 0.87 Allowed 'General case' 0 N--CA 1.447 -0.616 0 N-CA-C 109.303 -0.629 . . . . 0.0 109.303 165.912 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 13.6 m-20 . . . . . 0 C--N 1.3 -1.585 0 CA-C-O 121.092 0.473 . . . . 0.0 110.934 177.237 . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 133' ' ' THR . . . . . 0.451 HG23 ' O ' ' A' ' 65' ' ' LEU . 59.6 m . . . . . 0 C--O 1.234 0.242 0 CA-C-O 120.451 0.167 . . . . 0.0 111.13 . . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 134' ' ' VAL . . . . . . . . . . . . . 20.3 m -120.73 151.34 23.62 Favored 'Isoleucine or valine' 0 C--O 1.233 0.22 0 CA-C-O 121.526 0.679 . . . . 0.0 111.697 177.957 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 135' ' ' HIS . . . . . 0.477 ' O ' HD23 ' A' ' 17' ' ' LEU . 86.2 m-70 -90.58 134.94 34.02 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-N 114.728 -1.124 . . . . 0.0 110.375 174.225 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 136' ' ' PHE . . . . . 0.509 ' CE2' HD21 ' A' ' 17' ' ' LEU . 2.5 m-85 -120.94 125.68 48.04 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 116.252 -0.431 . . . . 0.0 111.113 -177.385 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 137' ' ' ASP . . . . . 0.42 ' O ' ' HB2' ' A' ' 15' ' ' PHE . 36.0 t70 -113.11 109.52 18.93 Favored 'General case' 0 C--N 1.315 -0.911 0 N-CA-C 108.513 -0.921 . . . . 0.0 108.513 169.028 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 138' ' ' ILE . . . . . 0.547 HG23 HG21 ' A' ' 13' ' ' VAL . 43.1 mm -119.19 121.33 66.38 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.452 0 O-C-N 123.098 0.249 . . . . 0.0 111.262 -169.773 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 139' ' ' GLU . . . . . 0.525 ' HG2' ' HE3' ' A' ' 60' ' ' LYS . 33.3 mt-10 -107.73 115.55 30.35 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 120.59 0.233 . . . . 0.0 111.201 173.356 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 140' ' ' VAL . . . . . 0.412 ' CG1' ' HA ' ' A' ' 57' ' ' VAL . 38.8 t -71.12 107.47 2.31 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.568 0 CA-C-N 116.299 -0.409 . . . . 0.0 110.177 175.533 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 141' ' ' LEU . . . . . 0.429 HD11 ' CD2' ' A' ' 14' ' ' HIS . 40.1 mt -94.59 -49.64 5.55 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-O 120.885 0.374 . . . . 0.0 110.097 179.821 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 142' ' ' GLU . . . . . 0.449 ' HB2' HD22 ' A' ' 12' ' ' LEU . 37.1 mt-10 -143.7 163.15 34.11 Favored 'General case' 0 CA--C 1.513 -0.476 0 CA-C-N 115.847 -0.615 . . . . 0.0 109.88 172.38 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 143' ' ' ILE . . . . . 0.443 HD13 ' N ' ' A' ' 5' ' ' VAL . 94.8 mt -123.49 110.07 25.03 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.901 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.539 178.484 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 144' ' ' ASP . . . . . . . . . . . . . 27.1 t70 -78.57 111.89 22.58 Favored Pre-proline 0 C--N 1.325 -0.469 0 CA-C-N 115.487 -0.779 . . . . 0.0 110.058 178.408 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 145' ' ' PRO . . . . . . . . . . . . . 52.5 Cg_endo . . . . . 0 N--CA 1.459 -0.514 0 C-N-CA 122.186 1.924 . . . . 0.0 111.831 -177.207 . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 2' ' ' SER . . . . . 0.407 ' OG ' ' HA ' ' A' ' 145' ' ' PRO . 35.5 m . . . . . 0 N--CA 1.453 -0.307 0 CA-C-O 121.216 0.532 . . . . 0.0 110.603 . . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 3' ' ' GLU . . . . . 0.508 ' HG2' ' HE2' ' A' ' 56' ' ' LYS . 36.0 tt0 -99.54 -27.99 13.44 Favored 'General case' 0 C--N 1.319 -0.721 0 CA-C-N 115.533 -0.758 . . . . 0.0 110.525 -177.584 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 4' ' ' SER . . . . . 0.42 ' HA ' ' HA ' ' A' ' 56' ' ' LYS . 8.5 p -124.94 158.27 33.99 Favored 'General case' 0 C--N 1.318 -0.782 0 CA-C-N 115.415 -0.811 . . . . 0.0 109.998 178.489 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 5' ' ' VAL . . . . . 0.519 HG22 ' N ' ' A' ' 55' ' ' LEU . 3.7 m -83.22 151.89 3.95 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.41 0 CA-C-O 121.294 0.568 . . . . 0.0 111.032 -175.341 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 6' ' ' GLN . . . . . 0.625 ' HG2' ' OG ' ' A' ' 9' ' ' SER . 1.4 pt20 -141.88 168.42 19.81 Favored 'General case' 0 C--N 1.314 -0.948 0 CA-C-N 115.223 -0.899 . . . . 0.0 108.86 176.164 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 51.5 p -53.47 122.08 8.98 Favored 'General case' 0 C--N 1.318 -0.768 0 N-CA-C 109.928 -0.397 . . . . 0.0 109.928 176.073 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 8' ' ' ASN . . . . . 0.438 ' HA ' ' O ' ' A' ' 39' ' ' LEU . 3.6 t-20 80.53 41.43 0.06 Allowed 'General case' 0 N--CA 1.475 0.809 0 O-C-N 124.036 0.835 . . . . 0.0 111.507 178.332 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 9' ' ' SER . . . . . 0.625 ' OG ' ' HG2' ' A' ' 6' ' ' GLN . 47.8 m -103.86 160.77 14.51 Favored 'General case' 0 C--N 1.332 -0.16 0 O-C-N 121.994 -0.441 . . . . 0.0 111.039 174.17 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 10' ' ' ALA . . . . . 0.713 ' HB1' HD21 ' A' ' 36' ' ' LEU . . . -109.49 131.93 54.61 Favored 'General case' 0 C--N 1.322 -0.606 0 N-CA-C 108.779 -0.823 . . . . 0.0 108.779 171.964 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 11' ' ' VAL . . . . . 0.475 ' O ' ' HA ' ' A' ' 36' ' ' LEU . 6.4 m -138.8 136.88 43.15 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.435 0 C-N-CA 120.501 -0.48 . . . . 0.0 111.437 -174.305 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 89.3 mt -86.42 128.61 34.97 Favored 'General case' 0 C--N 1.324 -0.51 0 N-CA-C 108.251 -1.018 . . . . 0.0 108.251 173.238 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 13' ' ' VAL . . . . . 0.736 HG21 HG23 ' A' ' 138' ' ' ILE . 1.6 p -141.65 157.53 21.17 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.86 0 CA-C-O 121.117 0.485 . . . . 0.0 110.747 -173.196 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 14' ' ' HIS . . . . . 0.495 ' ND1' ' HA ' ' A' ' 29' ' ' ARG . 0.5 OUTLIER -124.98 116.42 22.13 Favored 'General case' 0 C--N 1.318 -0.802 0 N-CA-C 106.396 -1.705 . . . . 0.0 106.396 170.545 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 15' ' ' PHE . . . . . 0.461 ' CE1' ' HB ' ' A' ' 28' ' ' THR . 18.2 p90 -146.0 158.8 43.87 Favored 'General case' 0 C--N 1.316 -0.852 0 C-N-CA 120.427 -0.509 . . . . 0.0 110.77 -169.019 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 87.8 m -130.32 130.16 44.12 Favored 'General case' 0 C--N 1.318 -0.775 0 N-CA-C 109.859 -0.423 . . . . 0.0 109.859 174.434 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 17' ' ' LEU . . . . . 0.5 HD21 ' CE1' ' A' ' 136' ' ' PHE . 9.5 mt -95.77 138.8 32.91 Favored 'General case' 0 N--CA 1.445 -0.683 0 CA-C-O 121.714 0.769 . . . . 0.0 111.659 -179.008 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 4.3 mptp? -122.31 147.47 46.2 Favored 'General case' 0 C--N 1.314 -0.95 0 CA-C-N 114.314 -1.312 . . . . 0.0 110.031 -176.24 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 19' ' ' LEU . . . . . 0.404 HD13 ' HA ' ' A' ' 19' ' ' LEU . 4.1 mm? -83.43 169.13 15.88 Favored 'General case' 0 C--N 1.312 -1.041 0 N-CA-C 108.716 -0.846 . . . . 0.0 108.716 170.755 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 29.3 t70 -68.88 -25.42 64.61 Favored 'General case' 0 C--N 1.318 -0.804 0 CA-C-O 121.323 0.583 . . . . 0.0 109.607 177.717 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 15.4 t70 -80.07 0.95 29.77 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.339 -0.846 . . . . 0.0 110.426 176.001 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 76.22 25.38 66.32 Favored Glycine 0 N--CA 1.45 -0.402 0 CA-C-N 116.175 -0.466 . . . . 0.0 113.155 178.64 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 14.1 m -90.11 154.73 19.56 Favored 'General case' 0 C--N 1.322 -0.607 0 N-CA-C 109.307 -0.627 . . . . 0.0 109.307 171.954 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 59.7 m -90.43 118.26 29.77 Favored 'General case' 0 C--N 1.32 -0.679 0 O-C-N 121.749 -0.594 . . . . 0.0 110.538 177.33 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 25' ' ' ALA . . . . . 0.401 ' HB2' ' CD2' ' A' ' 19' ' ' LEU . . . -84.11 -48.85 9.43 Favored 'General case' 0 CA--C 1.516 -0.33 0 CA-C-O 121.498 0.666 . . . . 0.0 110.269 179.337 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 9.2 tp10 -151.41 119.95 6.47 Favored 'General case' 0 C--N 1.318 -0.774 0 CA-C-N 114.842 -1.072 . . . . 0.0 109.068 -179.498 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 12.8 t -111.72 101.14 9.53 Favored 'General case' 0 C--N 1.315 -0.921 0 C-N-CA 120.033 -0.667 . . . . 0.0 110.259 177.512 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 28' ' ' THR . . . . . 0.461 ' HB ' ' CE1' ' A' ' 15' ' ' PHE . 31.0 m -97.64 51.4 1.07 Allowed 'General case' 0 C--N 1.313 -0.984 0 CA-C-O 122.706 1.241 . . . . 0.0 109.302 175.978 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 29' ' ' ARG . . . . . 0.495 ' HA ' ' ND1' ' A' ' 14' ' ' HIS . 29.6 ttp180 -143.56 -67.94 0.34 Allowed 'General case' 0 C--N 1.314 -0.954 0 CA-C-N 114.785 -1.098 . . . . 0.0 110.618 -177.059 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 2.2 p-10 -80.69 33.8 0.32 Allowed 'General case' 0 N--CA 1.467 0.385 0 N-CA-C 111.972 0.36 . . . . 0.0 111.972 -177.805 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 92.4 m-20 -119.21 -7.82 10.23 Favored 'General case' 0 C--N 1.325 -0.472 0 N-CA-C 109.829 -0.434 . . . . 0.0 109.829 173.082 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 79.73 6.25 89.11 Favored Glycine 0 N--CA 1.447 -0.592 0 C-N-CA 121.055 -0.593 . . . . 0.0 111.635 -177.342 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 50.0 mmtm -114.28 112.91 46.29 Favored Pre-proline 0 C--N 1.325 -0.474 0 CA-C-N 115.885 -0.158 . . . . 0.0 110.7 -178.263 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 6.2 Cg_exo -79.3 169.82 18.34 Favored 'Trans proline' 0 N--CA 1.46 -0.454 0 C-N-CA 122.88 2.386 . . . . 0.0 112.434 172.45 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 35' ' ' ALA . . . . . 0.41 ' CB ' HG21 ' A' ' 28' ' ' THR . . . -144.55 158.79 43.6 Favored 'General case' 0 C--N 1.315 -0.926 0 CA-C-N 115.061 -0.972 . . . . 0.0 109.698 179.009 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 36' ' ' LEU . . . . . 0.713 HD21 ' HB1' ' A' ' 10' ' ' ALA . 0.7 OUTLIER -108.63 134.54 51.23 Favored 'General case' 0 N--CA 1.445 -0.677 0 CA-C-O 120.749 0.309 . . . . 0.0 110.333 177.202 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 37' ' ' PHE . . . . . . . . . . . . . 4.7 m-30 -96.4 130.71 43.46 Favored 'General case' 0 C--N 1.318 -0.766 0 CA-C-N 116.05 -0.523 . . . . 0.0 109.911 174.187 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 2.1 tpp180 -111.59 107.98 17.31 Favored 'General case' 0 C--N 1.321 -0.649 0 CA-C-N 116.076 -0.511 . . . . 0.0 109.76 -177.443 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 39' ' ' LEU . . . . . 0.566 ' HG ' ' O ' ' A' ' 9' ' ' SER . 6.6 mt -83.71 154.87 23.4 Favored 'General case' 0 C--N 1.319 -0.739 0 CA-C-N 116.201 -0.454 . . . . 0.0 109.894 -178.092 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 40' ' ' GLY . . . . . 0.465 ' H ' ' CD ' ' A' ' 49' ' ' GLU . . . 100.41 33.66 5.04 Favored Glycine 0 C--N 1.312 -0.782 0 CA-C-N 115.807 -0.633 . . . . 0.0 112.494 -179.125 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 6.5 m-20 63.58 8.36 3.59 Favored 'General case' 0 N--CA 1.473 0.709 0 N-CA-C 112.538 0.569 . . . . 0.0 112.538 178.237 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -67.37 -31.39 71.6 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-O 120.803 0.335 . . . . 0.0 111.657 -176.773 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 11.9 p -137.31 -65.85 0.53 Allowed 'General case' 0 C--N 1.321 -0.638 0 CA-C-N 116.453 -0.339 . . . . 0.0 111.048 -178.931 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 7.5 mp -85.89 -178.74 6.66 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.392 -179.432 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 31.0 m -95.86 164.05 12.9 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-N 116.317 -0.401 . . . . 0.0 111.539 -176.603 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 46' ' ' GLU . . . . . 0.47 ' O ' ' HG2' ' A' ' 50' ' ' GLN . 41.6 mt-10 -52.38 -41.11 62.85 Favored 'General case' 0 N--CA 1.465 0.289 0 N-CA-C 112.876 0.695 . . . . 0.0 112.876 -172.576 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -61.9 -41.82 99.68 Favored Glycine 0 N--CA 1.449 -0.453 0 C-N-CA 120.571 -0.823 . . . . 0.0 112.284 -170.134 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 48' ' ' LEU . . . . . 0.445 HD13 ' C ' ' A' ' 48' ' ' LEU . 3.2 tm? -61.02 -53.6 55.24 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-O 120.495 0.188 . . . . 0.0 111.144 -179.426 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 49' ' ' GLU . . . . . 0.697 ' O ' HD13 ' A' ' 53' ' ' LEU . 9.7 pt-20 -68.77 -37.4 79.31 Favored 'General case' 0 C--N 1.325 -0.46 0 N-CA-C 111.621 0.23 . . . . 0.0 111.621 -173.633 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 50' ' ' GLN . . . . . 0.541 ' HA ' HD22 ' A' ' 53' ' ' LEU . 17.1 mm100 -66.15 -12.47 56.01 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 120.845 0.355 . . . . 0.0 111.353 -176.42 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 51' ' ' HIS . . . . . . . . . . . . . 12.1 m-70 -103.38 -4.0 24.74 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 121.213 0.53 . . . . 0.0 110.485 177.629 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 52' ' ' LEU . . . . . 0.466 ' O ' HG21 ' A' ' 5' ' ' VAL . 12.0 mt -102.51 -11.72 18.33 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-N 115.762 -0.653 . . . . 0.0 111.16 177.76 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 53' ' ' LEU . . . . . 0.697 HD13 ' O ' ' A' ' 49' ' ' GLU . 1.1 mp -58.78 136.6 57.81 Favored 'General case' 0 N--CA 1.449 -0.511 0 CA-C-O 121.125 0.488 . . . . 0.0 111.47 177.805 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 94.39 -4.57 70.16 Favored Glycine 0 N--CA 1.447 -0.572 0 CA-C-N 115.592 -0.731 . . . . 0.0 113.091 -179.677 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 55' ' ' LEU . . . . . 0.519 ' N ' HG22 ' A' ' 5' ' ' VAL . 3.0 mm? -71.97 164.8 25.46 Favored 'General case' 0 CA--C 1.521 -0.15 0 CA-C-N 117.391 0.595 . . . . 0.0 110.935 177.876 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 56' ' ' LYS . . . . . 0.604 ' HD3' ' N ' ' A' ' 57' ' ' VAL . 12.3 tmtt? -140.73 154.99 46.55 Favored 'General case' 0 C--N 1.32 -0.699 0 N-CA-C 108.703 -0.851 . . . . 0.0 108.703 -175.031 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 57' ' ' VAL . . . . . 0.604 ' N ' ' HD3' ' A' ' 56' ' ' LYS . 29.8 t -59.66 125.65 16.09 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-O 121.261 0.553 . . . . 0.0 111.386 179.714 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 80.95 19.74 66.82 Favored Glycine 0 N--CA 1.447 -0.627 0 CA-C-N 115.521 -0.763 . . . . 0.0 112.399 -177.398 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 59' ' ' ASP . . . . . 0.487 ' OD1' ' HB3' ' A' ' 56' ' ' LYS . 1.6 m-20 -110.55 150.16 29.34 Favored 'General case' 0 C--N 1.321 -0.631 0 CA-C-O 121.021 0.439 . . . . 0.0 110.452 176.01 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 60' ' ' LYS . . . . . 0.531 ' CE ' ' HG2' ' A' ' 139' ' ' GLU . 0.3 OUTLIER -115.48 133.11 56.34 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-N 115.51 -0.768 . . . . 0.0 109.926 -171.424 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 13.0 t -143.3 134.67 26.08 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-O 121.557 0.694 . . . . 0.0 111.306 178.643 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 5.9 m -123.78 132.49 53.81 Favored 'General case' 0 C--N 1.319 -0.741 0 CA-C-N 115.686 -0.688 . . . . 0.0 109.176 176.293 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 31.7 p90 -152.52 149.19 28.26 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-O 121.013 0.435 . . . . 0.0 111.346 -178.101 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 14.9 m -96.6 156.06 16.5 Favored 'General case' 0 C--N 1.321 -0.647 0 CA-C-N 116.089 -0.505 . . . . 0.0 109.863 177.832 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 31.7 mt -150.67 134.82 16.91 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-O 120.996 0.427 . . . . 0.0 110.749 -177.155 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 22.4 mm-40 -70.71 150.21 95.32 Favored Pre-proline 0 C--N 1.322 -0.587 0 N-CA-C 108.922 -0.77 . . . . 0.0 108.922 173.674 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 5.1 Cg_endo -48.38 -49.04 15.3 Favored 'Trans proline' 0 C--N 1.345 0.344 0 C-N-CA 122.383 2.056 . . . . 0.0 112.515 -175.742 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 22.9 t70 -62.92 -32.09 73.31 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-O 120.823 0.344 . . . . 0.0 111.123 -179.524 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -95.24 13.26 26.1 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-O 121.086 0.47 . . . . 0.0 111.082 -178.244 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.323 -0.586 0 CA-C-O 121.247 0.546 . . . . 0.0 109.775 179.09 . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 75' ' ' SER . . . . . 0.548 ' CA ' HD23 ' A' ' 78' ' ' LEU . 34.7 m . . . . . 0 N--CA 1.441 -0.892 0 N-CA-C 107.475 -1.306 . . . . 0.0 107.475 . . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 3.4 Cg_exo -73.49 -48.6 0.24 Allowed 'Trans proline' 0 CA--C 1.518 -0.317 0 C-N-CA 122.315 2.01 . . . . 0.0 113.014 -171.296 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 9.1 p-10 -69.71 -4.18 18.57 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-N 115.149 -0.932 . . . . 0.0 111.199 -177.597 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 78' ' ' LEU . . . . . 0.708 ' HB3' ' HB2' ' A' ' 125' ' ' PHE . 1.3 mm? -92.74 3.13 56.19 Favored 'General case' 0 C--N 1.325 -0.484 0 N-CA-C 109.6 -0.518 . . . . 0.0 109.6 178.323 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 68.5 mt -97.5 109.5 23.52 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.808 0 CA-C-O 121.544 0.688 . . . . 0.0 110.068 -173.97 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 39.0 mt-30 -129.1 135.43 48.89 Favored 'General case' 0 C--N 1.317 -0.83 0 CA-C-N 114.702 -1.136 . . . . 0.0 111.79 -168.149 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 81' ' ' TYR . . . . . 0.419 ' CE1' HG23 ' A' ' 122' ' ' THR . 2.6 m-85 -90.63 114.98 27.38 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 121.554 0.692 . . . . 0.0 111.596 173.566 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 82' ' ' PHE . . . . . 0.438 ' CB ' ' HE1' ' A' ' 87' ' ' PHE . 25.3 m-85 -102.53 170.68 7.89 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 114.745 -1.116 . . . . 0.0 112.01 175.194 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 22.2 t -89.67 155.67 19.08 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 115.721 -0.672 . . . . 0.0 109.847 176.981 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 84' ' ' ARG . . . . . 0.501 ' HD2' ' O ' ' A' ' 118' ' ' GLY . 11.9 ptm180 -66.44 -21.49 66.2 Favored 'General case' 0 C--O 1.227 -0.114 0 N-CA-C 112.143 0.423 . . . . 0.0 112.143 -178.356 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 85' ' ' ARG . . . . . 0.404 HH12 ' CG ' ' A' ' 119' ' ' ASP . 7.5 mpt_? -71.83 -39.42 69.79 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 121.192 0.52 . . . . 0.0 110.357 -175.538 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 31.4 mt-10 -64.64 -30.38 71.4 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 115.06 -0.973 . . . . 0.0 110.406 -174.966 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 87' ' ' PHE . . . . . 0.438 ' HE1' ' CB ' ' A' ' 82' ' ' PHE . 4.3 m-85 -89.65 -46.05 8.91 Favored 'General case' 0 CA--C 1.512 -0.504 0 CA-C-N 115.584 -0.735 . . . . 0.0 111.091 179.291 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 88' ' ' MET . . . . . . . . . . . . . 53.3 ttm -61.75 -26.05 67.83 Favored 'General case' 0 C--N 1.321 -0.665 0 CA-C-N 115.497 -0.774 . . . . 0.0 111.045 -175.345 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 23.0 t70 -55.46 -33.24 63.46 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 121.178 0.513 . . . . 0.0 110.59 174.061 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -109.93 11.44 24.12 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-N 115.64 -0.709 . . . . 0.0 111.257 179.304 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 111.75 138.19 7.42 Favored Glycine 0 N--CA 1.449 -0.453 0 C-N-CA 120.771 -0.728 . . . . 0.0 112.282 -179.197 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 92' ' ' GLU . . . . . 0.463 ' HA ' ' HD3' ' A' ' 93' ' ' PRO . 42.3 mt-10 -62.22 128.32 90.89 Favored Pre-proline 0 C--N 1.324 -0.516 0 CA-C-O 120.882 0.372 . . . . 0.0 111.402 -177.073 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 93' ' ' PRO . . . . . 0.599 ' HB2' HD13 ' A' ' 113' ' ' ILE . 17.7 Cg_endo -78.06 165.36 26.19 Favored 'Trans proline' 0 N--CA 1.459 -0.552 0 C-N-CA 122.745 2.297 . . . . 0.0 112.612 -177.518 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 30.9 mt-10 -116.95 146.88 42.72 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.497 -0.32 . . . . 0.0 111.054 -178.452 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 95' ' ' ILE . . . . . 0.532 HG12 HG12 ' A' ' 116' ' ' ILE . 16.6 mt -71.16 130.73 35.0 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.424 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.688 179.31 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 71.9 16.32 76.41 Favored Glycine 0 N--CA 1.446 -0.694 0 CA-C-N 115.813 -0.631 . . . . 0.0 113.059 179.367 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 97' ' ' ALA . . . . . 0.48 ' O ' HG13 ' A' ' 113' ' ' ILE . . . -100.85 161.77 13.37 Favored 'General case' 0 C--N 1.327 -0.389 0 N-CA-C 108.962 -0.755 . . . . 0.0 108.962 174.217 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 98' ' ' ILE . . . . . 0.498 HG12 HG22 ' A' ' 112' ' ' VAL . 59.1 mt -107.53 143.92 17.24 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.872 0 N-CA-C 110.066 -0.346 . . . . 0.0 110.066 179.417 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 99' ' ' MET . . . . . 0.5 ' SD ' HD11 ' A' ' 113' ' ' ILE . 82.8 mtp -128.36 163.34 25.04 Favored 'General case' 0 N--CA 1.448 -0.542 0 N-CA-C 107.958 -1.127 . . . . 0.0 107.958 179.347 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 3.5 mm? -100.62 137.1 39.48 Favored 'General case' 0 C--N 1.309 -1.184 0 N-CA-C 109.991 -0.374 . . . . 0.0 109.991 174.139 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 101' ' ' PHE . . . . . 0.471 ' CE2' ' HB2' ' A' ' 99' ' ' MET . 50.9 m-85 -143.55 136.35 27.48 Favored 'General case' 0 C--N 1.319 -0.725 0 N-CA-C 108.998 -0.742 . . . . 0.0 108.998 -174.55 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 17.2 m -96.53 131.78 42.79 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-O 120.97 0.414 . . . . 0.0 110.55 178.825 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -95.46 159.41 15.01 Favored 'General case' 0 C--N 1.321 -0.647 0 CA-C-N 116.003 -0.544 . . . . 0.0 110.11 177.351 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 104' ' ' MET . . . . . . . . . . . . . 4.0 mpp? -66.16 -12.13 53.85 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.353 -0.84 . . . . 0.0 112.022 -174.484 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 7.7 p-10 -92.01 17.91 8.69 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-O 121.141 0.496 . . . . 0.0 110.821 177.598 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 77.28 -11.56 16.6 Favored Glycine 0 N--CA 1.452 -0.259 0 CA-C-N 115.866 -0.606 . . . . 0.0 114.189 178.102 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 14.5 t -78.64 152.87 31.49 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-N 117.185 0.492 . . . . 0.0 110.005 179.251 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 35.2 tt0 -126.78 103.16 7.38 Favored 'General case' 0 C--N 1.315 -0.934 0 N-CA-C 108.867 -0.79 . . . . 0.0 108.867 -179.337 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 109' ' ' MET . . . . . . . . . . . . . 3.1 mpp? -100.34 134.91 20.42 Favored Pre-proline 0 C--N 1.32 -0.674 0 CA-C-N 116.349 -0.387 . . . . 0.0 111.323 -175.564 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 33.5 Cg_endo -67.53 135.73 37.17 Favored 'Trans proline' 0 N--CA 1.455 -0.739 0 C-N-CA 121.911 1.74 . . . . 0.0 109.638 167.847 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . -134.66 126.04 3.98 Favored Glycine 0 N--CA 1.443 -0.886 0 N-CA-C 111.11 -0.796 . . . . 0.0 111.11 -170.59 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 112' ' ' VAL . . . . . 0.498 HG22 HG12 ' A' ' 98' ' ' ILE . 32.0 t -76.57 131.07 35.55 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.655 0 N-CA-C 109.423 -0.584 . . . . 0.0 109.423 179.876 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 113' ' ' ILE . . . . . 0.599 HD13 ' HB2' ' A' ' 93' ' ' PRO . 1.9 mt -82.66 109.97 17.2 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.058 0 N-CA-C 107.826 -1.176 . . . . 0.0 107.826 173.174 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 114' ' ' ARG . . . . . 0.689 ' HE ' HG21 ' A' ' 122' ' ' THR . 2.3 tmm_? -64.89 -49.06 71.94 Favored 'General case' 0 C--N 1.315 -0.892 0 CA-C-N 115.569 -0.741 . . . . 0.0 110.272 -173.515 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 115' ' ' GLU . . . . . 0.416 ' HB2' ' HD2' ' A' ' 114' ' ' ARG . 9.4 tt0 -159.86 155.6 25.96 Favored 'General case' 0 C--N 1.326 -0.446 0 C-N-CA 121.156 -0.218 . . . . 0.0 110.419 -178.875 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 116' ' ' ILE . . . . . 0.532 HG12 HG12 ' A' ' 95' ' ' ILE . 31.9 mm -106.85 110.75 32.81 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.405 0 N-CA-C 109.001 -0.74 . . . . 0.0 109.001 175.901 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 117' ' ' ASN . . . . . 0.447 ' HB2' ' O ' ' A' ' 120' ' ' SER . 7.5 m-20 -98.83 157.69 16.13 Favored 'General case' 0 C--N 1.313 -0.981 0 CA-C-N 115.947 -0.569 . . . . 0.0 109.6 -178.04 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 118' ' ' GLY . . . . . 0.501 ' O ' ' HD2' ' A' ' 84' ' ' ARG . . . -56.27 -44.66 89.27 Favored Glycine 0 C--O 1.226 -0.392 0 C-N-CA 120.452 -0.88 . . . . 0.0 113.196 -171.47 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 119' ' ' ASP . . . . . 0.432 ' HA ' ' HD3' ' A' ' 84' ' ' ARG . 13.9 t70 -113.03 -9.86 13.53 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-O 121.169 0.509 . . . . 0.0 110.73 179.131 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 120' ' ' SER . . . . . 0.447 ' O ' ' HB2' ' A' ' 117' ' ' ASN . 21.6 t -126.54 157.63 38.28 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-O 121.533 0.682 . . . . 0.0 111.845 -168.79 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 121' ' ' ILE . . . . . . . . . . . . . 28.0 mm -120.49 150.41 23.25 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.761 0 CA-C-N 115.512 -0.767 . . . . 0.0 109.076 176.498 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 122' ' ' THR . . . . . 0.689 HG21 ' HE ' ' A' ' 114' ' ' ARG . 14.6 m -127.38 127.01 43.48 Favored 'General case' 0 C--N 1.312 -1.03 0 N-CA-C 107.615 -1.254 . . . . 0.0 107.615 179.667 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 2.8 t -127.74 127.14 68.05 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.839 0 N-CA-C 109.022 -0.733 . . . . 0.0 109.022 -171.01 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -114.24 96.11 5.63 Favored 'General case' 0 C--N 1.305 -1.326 0 CA-C-N 114.62 -1.173 . . . . 0.0 108.672 -177.34 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 125' ' ' PHE . . . . . 0.708 ' HB2' ' HB3' ' A' ' 78' ' ' LEU . 27.7 m-85 -82.5 103.8 12.31 Favored 'General case' 0 N--CA 1.431 -1.399 0 N-CA-C 105.821 -1.918 . . . . 0.0 105.821 175.107 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 126' ' ' ASN . . . . . 0.491 ' HA ' ' HB2' ' A' ' 75' ' ' SER . 1.0 OUTLIER . . . . . 0 C--N 1.295 -1.772 0 CA-C-N 113.884 -1.507 . . . . 0.0 112.916 -168.362 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 133' ' ' THR . . . . . . . . . . . . . 18.9 m . . . . . 0 N--CA 1.448 -0.566 0 N-CA-C 108.991 -0.744 . . . . 0.0 108.991 . . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 134' ' ' VAL . . . . . 0.444 ' HB ' HD22 ' A' ' 17' ' ' LEU . 15.7 m -115.05 167.94 7.2 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.64 0 CA-C-O 122.017 0.913 . . . . 0.0 112.639 -172.648 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 135' ' ' HIS . . . . . . . . . . . . . 82.5 m-70 -132.47 127.87 36.2 Favored 'General case' 0 C--N 1.314 -0.955 0 CA-C-N 114.043 -1.435 . . . . 0.0 107.359 177.581 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 136' ' ' PHE . . . . . 0.5 ' CE1' HD21 ' A' ' 17' ' ' LEU . 17.8 m-85 -105.53 122.81 46.78 Favored 'General case' 0 C--N 1.313 -1.006 0 CA-C-O 121.09 0.471 . . . . 0.0 111.71 -171.574 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 137' ' ' ASP . . . . . . . . . . . . . 38.2 t70 -123.03 98.76 6.04 Favored 'General case' 0 C--N 1.315 -0.907 0 N-CA-C 107.87 -1.159 . . . . 0.0 107.87 172.806 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 138' ' ' ILE . . . . . 0.736 HG23 HG21 ' A' ' 13' ' ' VAL . 54.8 mt -123.81 138.29 54.02 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.562 0 CA-C-N 115.968 -0.56 . . . . 0.0 112.271 -172.139 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 139' ' ' GLU . . . . . 0.531 ' HG2' ' CE ' ' A' ' 60' ' ' LYS . 2.3 mp0 -128.53 130.55 47.59 Favored 'General case' 0 N--CA 1.452 -0.364 0 N-CA-C 108.523 -0.917 . . . . 0.0 108.523 175.034 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 140' ' ' VAL . . . . . . . . . . . . . 72.6 t -77.56 126.59 38.11 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 117.805 0.275 . . . . 0.0 110.415 -176.47 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 141' ' ' LEU . . . . . 0.425 ' HG ' ' HA ' ' A' ' 13' ' ' VAL . 38.8 mt -94.83 -48.6 5.96 Favored 'General case' 0 C--N 1.321 -0.635 0 N-CA-C 109.919 -0.4 . . . . 0.0 109.919 177.386 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 142' ' ' GLU . . . . . . . . . . . . . 10.6 mm-40 -146.73 162.37 38.66 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 115.902 -0.59 . . . . 0.0 110.597 177.127 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 143' ' ' ILE . . . . . 0.478 HD12 HG23 ' A' ' 57' ' ' VAL . 95.5 mt -131.04 122.66 52.22 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.66 0 CA-C-N 115.961 -0.563 . . . . 0.0 110.337 177.529 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 144' ' ' ASP . . . . . 0.513 ' HB2' ' HB3' ' A' ' 10' ' ' ALA . 1.2 m-20 -74.75 132.67 77.44 Favored Pre-proline 0 CA--C 1.513 -0.472 0 CA-C-N 116.038 -0.528 . . . . 0.0 109.741 176.115 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 145' ' ' PRO . . . . . 0.407 ' HA ' ' OG ' ' A' ' 2' ' ' SER . 70.0 Cg_exo . . . . . 0 CA--C 1.512 -0.583 0 C-N-CA 123.338 2.692 . . . . 0.0 113.16 -178.282 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 73.3 m . . . . . 0 N--CA 1.455 -0.216 0 CA-C-O 121.227 0.536 . . . . 0.0 109.797 . . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 46.1 mt-10 -86.27 -22.56 26.75 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-N 115.789 -0.641 . . . . 0.0 110.733 179.934 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 4' ' ' SER . . . . . 0.457 ' HA ' ' HA ' ' A' ' 56' ' ' LYS . 19.8 m -110.03 132.94 53.71 Favored 'General case' 0 C--N 1.32 -0.702 0 CA-C-N 115.96 -0.564 . . . . 0.0 110.918 -179.686 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 5' ' ' VAL . . . . . 0.683 HG12 ' O ' ' A' ' 55' ' ' LEU . 7.3 p -74.2 141.19 16.44 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.425 0 CA-C-N 115.7 -0.682 . . . . 0.0 109.774 177.507 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 6' ' ' GLN . . . . . 0.628 ' HG2' ' OG ' ' A' ' 9' ' ' SER . 2.2 pt20 -134.58 167.62 20.47 Favored 'General case' 0 C--N 1.311 -1.099 0 N-CA-C 108.805 -0.813 . . . . 0.0 108.805 175.806 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 16.2 p -56.59 131.89 50.13 Favored 'General case' 0 C--N 1.313 -0.992 0 N-CA-C 109.64 -0.504 . . . . 0.0 109.64 176.881 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 8' ' ' ASN . . . . . 0.452 ' H ' ' HB3' ' A' ' 39' ' ' LEU . 64.3 t30 76.8 29.24 0.64 Allowed 'General case' 0 CA--C 1.544 0.718 0 C-N-CA 123.698 0.799 . . . . 0.0 111.645 -178.8 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 9' ' ' SER . . . . . 0.628 ' OG ' ' HG2' ' A' ' 6' ' ' GLN . 50.2 m -103.25 167.74 9.62 Favored 'General case' 0 CA--C 1.53 0.183 0 CA-C-O 120.837 0.351 . . . . 0.0 110.849 171.304 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -118.45 115.39 24.55 Favored 'General case' 0 C--N 1.325 -0.497 0 N-CA-C 109.329 -0.619 . . . . 0.0 109.329 175.65 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 4.8 m -119.71 142.15 36.51 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.609 0 C-N-CA 119.914 -0.715 . . . . 0.0 112.308 -174.006 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 12' ' ' LEU . . . . . 0.401 ' HG ' HD12 ' A' ' 141' ' ' LEU . 47.1 tp -88.7 138.1 31.72 Favored 'General case' 0 N--CA 1.447 -0.613 0 CA-C-N 115.298 -0.864 . . . . 0.0 108.824 174.208 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 14.4 m -144.98 157.81 13.95 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.456 0 CA-C-O 120.889 0.376 . . . . 0.0 110.876 -172.912 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 14' ' ' HIS . . . . . 0.627 ' ND1' ' HA ' ' A' ' 29' ' ' ARG . 3.0 m-70 -117.49 119.85 36.3 Favored 'General case' 0 C--N 1.319 -0.727 0 N-CA-C 107.481 -1.303 . . . . 0.0 107.481 162.137 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 15' ' ' PHE . . . . . 0.632 ' HA ' ' O ' ' A' ' 137' ' ' ASP . 46.2 p90 -139.09 142.18 38.13 Favored 'General case' 0 C--N 1.319 -0.725 0 C-N-CA 120.514 -0.474 . . . . 0.0 110.897 -175.206 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 25.0 m -119.17 121.64 40.19 Favored 'General case' 0 C--N 1.318 -0.8 0 CA-C-O 120.785 0.326 . . . . 0.0 110.203 174.3 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 17' ' ' LEU . . . . . 0.659 HD23 ' O ' ' A' ' 135' ' ' HIS . 5.7 mt -92.5 127.11 37.87 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 116.086 -0.506 . . . . 0.0 112.035 179.893 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 18' ' ' LYS . . . . . 0.417 ' O ' ' HB2' ' A' ' 135' ' ' HIS . 0.8 OUTLIER -125.17 152.43 44.49 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-N 115.35 -0.841 . . . . 0.0 110.283 179.888 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 19' ' ' LEU . . . . . 0.466 HD12 ' HB ' ' A' ' 23' ' ' THR . 95.1 mt -88.62 172.92 8.93 Favored 'General case' 0 C--N 1.316 -0.867 0 N-CA-C 109.696 -0.483 . . . . 0.0 109.696 171.345 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 18.7 t70 -53.61 -36.04 61.55 Favored 'General case' 0 N--CA 1.466 0.325 0 CA-C-O 121.029 0.442 . . . . 0.0 110.96 -179.713 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 38.5 m-20 -83.49 11.74 6.59 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 115.839 -0.619 . . . . 0.0 112.067 -177.99 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 72.69 12.16 77.86 Favored Glycine 0 N--CA 1.452 -0.293 0 C-N-CA 121.111 -0.566 . . . . 0.0 113.314 -178.455 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 23' ' ' THR . . . . . 0.466 ' HB ' HD12 ' A' ' 19' ' ' LEU . 24.6 m -73.87 128.87 36.67 Favored 'General case' 0 C--N 1.322 -0.593 0 N-CA-C 109.762 -0.459 . . . . 0.0 109.762 177.123 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 36.9 m -70.99 116.32 11.14 Favored 'General case' 0 C--N 1.32 -0.691 0 CA-C-O 121.194 0.521 . . . . 0.0 110.939 -178.129 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 25' ' ' ALA . . . . . 0.475 ' HB3' ' HB3' ' A' ' 17' ' ' LEU . . . -84.07 -49.46 8.88 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 115.637 -0.711 . . . . 0.0 109.91 178.133 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 8.2 tp10 -158.44 122.9 4.14 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.354 -0.839 . . . . 0.0 109.518 177.025 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 31.2 t -103.43 113.36 26.8 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-O 121.157 0.503 . . . . 0.0 110.219 178.732 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 28' ' ' THR . . . . . 0.606 ' O ' HG22 ' A' ' 28' ' ' THR . 58.0 m -118.96 36.71 4.35 Favored 'General case' 0 N--CA 1.441 -0.898 0 CA-C-O 122.707 1.241 . . . . 0.0 110.103 178.82 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 29' ' ' ARG . . . . . 0.627 ' HA ' ' ND1' ' A' ' 14' ' ' HIS . 52.7 ttp180 -132.06 -62.47 0.84 Allowed 'General case' 0 C--N 1.316 -0.88 0 O-C-N 121.327 -0.858 . . . . 0.0 110.431 174.613 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 2.3 p-10 -83.02 14.98 2.98 Favored 'General case' 0 N--CA 1.468 0.454 0 CA-C-O 121.099 0.476 . . . . 0.0 111.128 -179.483 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 31' ' ' ASN . . . . . 0.752 ' ND2' ' HG2' ' A' ' 33' ' ' LYS . 34.1 p-10 -88.18 -18.46 28.67 Favored 'General case' 0 C--N 1.32 -0.674 0 CA-C-N 115.877 -0.602 . . . . 0.0 110.114 175.387 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 88.03 10.88 68.4 Favored Glycine 0 N--CA 1.444 -0.777 0 CA-C-N 115.496 -0.775 . . . . 0.0 112.004 -178.883 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 33' ' ' LYS . . . . . 0.752 ' HG2' ' ND2' ' A' ' 31' ' ' ASN . 12.3 ptmt -140.87 117.55 7.68 Favored Pre-proline 0 C--N 1.327 -0.397 0 CA-C-O 121.434 0.635 . . . . 0.0 110.008 -179.943 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 78.5 Cg_endo -83.36 168.4 13.14 Favored 'Trans proline' 0 N--CA 1.453 -0.867 0 C-N-CA 122.351 2.034 . . . . 0.0 111.955 177.363 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -127.15 158.66 36.49 Favored 'General case' 0 C--N 1.319 -0.736 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.485 -177.416 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -105.11 138.04 41.94 Favored 'General case' 0 C--N 1.318 -0.783 0 CA-C-N 116.104 -0.498 . . . . 0.0 109.919 175.33 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 37' ' ' PHE . . . . . . . . . . . . . 9.9 m-30 -107.5 107.6 18.53 Favored 'General case' 0 C--N 1.318 -0.773 0 N-CA-C 109.164 -0.68 . . . . 0.0 109.164 175.867 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 16.2 tpt180 -89.24 120.2 30.39 Favored 'General case' 0 C--N 1.317 -0.839 0 CA-C-N 115.669 -0.696 . . . . 0.0 109.371 178.262 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 39' ' ' LEU . . . . . 0.713 HD13 ' HB2' ' A' ' 49' ' ' GLU . 2.0 mm? -79.03 148.42 32.5 Favored 'General case' 0 C--N 1.318 -0.764 0 CA-C-N 115.752 -0.658 . . . . 0.0 110.58 -177.468 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 100.51 39.42 3.22 Favored Glycine 0 N--CA 1.445 -0.724 0 C-N-CA 120.662 -0.78 . . . . 0.0 113.358 178.077 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 34.5 t70 66.67 7.51 5.22 Favored 'General case' 0 N--CA 1.472 0.644 0 CA-C-O 121.122 0.487 . . . . 0.0 112.16 171.431 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -55.63 -58.74 6.53 Favored 'General case' 0 C--N 1.328 -0.369 0 N-CA-C 112.052 0.39 . . . . 0.0 112.052 -177.741 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 37.1 m -143.41 9.46 1.62 Allowed 'General case' 0 C--N 1.324 -0.512 0 CA-C-O 121.073 0.463 . . . . 0.0 110.839 179.161 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 44' ' ' LEU . . . . . 0.436 HD13 ' HA ' ' A' ' 44' ' ' LEU . 4.2 mm? -115.09 148.9 38.36 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.885 -177.195 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 14.6 m -71.55 131.81 43.78 Favored 'General case' 0 N--CA 1.445 -0.688 0 N-CA-C 108.969 -0.752 . . . . 0.0 108.969 173.53 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 54.8 mt-10 -47.66 -43.92 26.68 Favored 'General case' 0 N--CA 1.468 0.472 0 O-C-N 123.534 0.521 . . . . 0.0 112.232 -169.509 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -61.41 -45.11 97.07 Favored Glycine 0 N--CA 1.448 -0.555 0 C-N-CA 120.642 -0.789 . . . . 0.0 112.696 -177.799 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 48' ' ' LEU . . . . . 0.403 HD13 ' C ' ' A' ' 48' ' ' LEU . 3.4 tm? -60.0 -54.39 46.64 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-O 120.95 0.405 . . . . 0.0 110.865 -177.879 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 49' ' ' GLU . . . . . 0.713 ' HB2' HD13 ' A' ' 39' ' ' LEU . 9.7 pt-20 -59.29 -40.25 85.58 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-N 115.458 -0.792 . . . . 0.0 111.39 -178.195 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 50' ' ' GLN . . . . . 0.702 ' HA ' HD23 ' A' ' 53' ' ' LEU . 83.4 mt-30 -69.14 -7.53 37.06 Favored 'General case' 0 CA--C 1.531 0.219 0 N-CA-C 113.302 0.853 . . . . 0.0 113.302 -179.78 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 51' ' ' HIS . . . . . . . . . . . . . 12.6 m80 -103.35 -16.71 15.55 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-O 121.192 0.52 . . . . 0.0 110.019 179.687 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 52' ' ' LEU . . . . . 0.426 HD11 HG12 ' A' ' 138' ' ' ILE . 27.5 mt -104.98 8.07 34.32 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-N 115.51 -0.768 . . . . 0.0 113.057 -176.419 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 53' ' ' LEU . . . . . 0.702 HD23 ' HA ' ' A' ' 50' ' ' GLN . 2.0 pp -92.86 155.94 17.29 Favored 'General case' 0 C--N 1.322 -0.615 0 C-N-CA 120.462 -0.495 . . . . 0.0 110.501 174.45 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 54' ' ' GLY . . . . . 0.485 ' N ' HG13 ' A' ' 5' ' ' VAL . . . 94.21 -12.55 68.89 Favored Glycine 0 CA--C 1.532 1.126 0 N-CA-C 115.941 1.136 . . . . 0.0 115.941 176.312 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 55' ' ' LEU . . . . . 0.683 ' O ' HG12 ' A' ' 5' ' ' VAL . 1.0 OUTLIER -100.73 165.44 11.38 Favored 'General case' 0 N--CA 1.471 0.603 0 CA-C-N 119.4 1.6 . . . . 0.0 112.06 -176.062 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 56' ' ' LYS . . . . . 0.457 ' HA ' ' HA ' ' A' ' 4' ' ' SER . 16.0 tttm -96.38 157.1 16.05 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-N 115.738 -0.665 . . . . 0.0 111.372 -175.563 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 57' ' ' VAL . . . . . 0.621 HG23 HD12 ' A' ' 143' ' ' ILE . 51.1 t -59.57 142.05 15.56 Favored 'Isoleucine or valine' 0 C--O 1.234 0.262 0 N-CA-C 109.398 -0.593 . . . . 0.0 109.398 171.404 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 82.43 9.3 85.06 Favored Glycine 0 N--CA 1.445 -0.766 0 C-N-CA 120.513 -0.851 . . . . 0.0 111.716 -177.51 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 59' ' ' ASP . . . . . 0.523 ' C ' ' HG3' ' A' ' 60' ' ' LYS . 15.9 m-20 -116.32 162.33 17.67 Favored 'General case' 0 CA--C 1.509 -0.629 0 N-CA-C 109.738 -0.467 . . . . 0.0 109.738 173.667 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 60' ' ' LYS . . . . . 0.585 ' HG2' ' HG2' ' A' ' 139' ' ' GLU . 32.2 mtpt -143.14 143.55 31.85 Favored 'General case' 0 C--N 1.318 -0.795 0 CA-C-N 115.439 -0.801 . . . . 0.0 110.375 -167.477 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 6.1 t -143.32 131.92 22.43 Favored 'General case' 0 C--N 1.315 -0.908 0 CA-C-N 115.938 -0.574 . . . . 0.0 109.686 178.934 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 3.3 m -113.17 130.99 56.03 Favored 'General case' 0 N--CA 1.443 -0.801 0 N-CA-C 108.949 -0.76 . . . . 0.0 108.949 177.452 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 63' ' ' PHE . . . . . 0.426 ' O ' ' HB2' ' A' ' 136' ' ' PHE . 39.3 p90 -154.59 152.76 30.4 Favored 'General case' 0 C--N 1.32 -0.704 0 CA-C-O 120.914 0.388 . . . . 0.0 111.112 179.688 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 26.5 m -101.64 156.33 17.56 Favored 'General case' 0 C--N 1.321 -0.657 0 CA-C-N 116.015 -0.539 . . . . 0.0 109.779 175.397 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 74.7 mt -141.55 144.06 34.08 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 116.377 -0.374 . . . . 0.0 110.657 -178.432 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 41.7 mt-10 -80.54 159.06 70.41 Favored Pre-proline 0 C--N 1.322 -0.593 0 CA-C-N 115.747 -0.661 . . . . 0.0 109.358 174.575 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 59.0 Cg_exo -49.88 -36.86 44.58 Favored 'Trans proline' 0 C--O 1.233 0.25 0 C-N-CA 122.454 2.103 . . . . 0.0 113.624 -176.184 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 4.3 p-10 -66.04 -15.46 63.06 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-O 120.744 0.306 . . . . 0.0 111.385 -179.052 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -111.13 -16.15 13.52 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 116.591 -0.277 . . . . 0.0 111.302 179.475 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.329 -0.323 0 CA-C-N 116.364 -0.38 . . . . 0.0 111.672 -177.23 . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 75' ' ' SER . . . . . 0.47 ' HB3' ' OD1' ' A' ' 77' ' ' ASP . 16.6 m . . . . . 0 N--CA 1.44 -0.945 0 CA-C-O 120.385 0.136 . . . . 0.0 110.992 . . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 76' ' ' PRO . . . . . 0.438 ' HD2' ' HA ' ' A' ' 75' ' ' SER . 33.8 Cg_endo -66.41 -19.39 55.37 Favored 'Trans proline' 0 C--N 1.345 0.373 0 C-N-CA 122.734 2.29 . . . . 0.0 112.222 177.183 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 77' ' ' ASP . . . . . 0.47 ' OD1' ' HB3' ' A' ' 75' ' ' SER . 8.2 p-10 -76.35 -5.9 49.18 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 121.359 0.6 . . . . 0.0 110.384 177.16 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 78' ' ' LEU . . . . . 0.458 ' HG ' ' HB2' ' A' ' 125' ' ' PHE . 0.7 OUTLIER -89.03 10.39 21.8 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-N 115.548 -0.751 . . . . 0.0 110.437 176.273 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 22.4 mt -117.24 107.46 22.35 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.635 0 N-CA-C 108.349 -0.982 . . . . 0.0 108.349 177.413 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 80' ' ' GLN . . . . . 0.588 ' O ' ' HB ' ' A' ' 123' ' ' VAL . 71.5 mt-30 -119.7 140.59 50.43 Favored 'General case' 0 C--N 1.313 -1.012 0 CA-C-N 115.895 -0.593 . . . . 0.0 111.37 -172.052 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 81' ' ' TYR . . . . . . . . . . . . . 73.6 m-85 -96.38 155.3 16.82 Favored 'General case' 0 C--N 1.313 -0.983 0 CA-C-N 115.946 -0.57 . . . . 0.0 109.524 173.331 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 82' ' ' PHE . . . . . 0.457 ' CD1' HG21 ' A' ' 123' ' ' VAL . 3.2 m-85 -148.89 167.57 25.36 Favored 'General case' 0 C--N 1.323 -0.586 0 N-CA-C 108.981 -0.748 . . . . 0.0 108.981 -160.371 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 11.6 t -99.61 128.12 45.71 Favored 'General case' 0 C--N 1.321 -0.645 0 CA-C-O 121.082 0.468 . . . . 0.0 110.102 175.533 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 84' ' ' ARG . . . . . 0.689 ' HD3' ' HA ' ' A' ' 119' ' ' ASP . 15.4 ptt180 -53.27 -20.66 4.43 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.237 -0.892 . . . . 0.0 113.151 -177.916 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 85' ' ' ARG . . . . . . . . . . . . . 5.3 mpt_? -71.14 -37.45 72.27 Favored 'General case' 0 CA--C 1.517 -0.323 0 CA-C-O 120.91 0.385 . . . . 0.0 110.785 -173.38 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 27.1 mm-40 -63.97 -33.92 76.82 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-N 115.697 -0.683 . . . . 0.0 110.598 179.941 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 87' ' ' PHE . . . . . 0.409 ' HE2' ' CE1' ' A' ' 101' ' ' PHE . 27.1 m-85 -86.69 -39.73 15.75 Favored 'General case' 0 CA--C 1.509 -0.609 0 CA-C-N 115.96 -0.564 . . . . 0.0 111.158 -178.361 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 88' ' ' MET . . . . . . . . . . . . . 56.1 ttp -60.66 -34.91 75.0 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-N 116.398 -0.365 . . . . 0.0 110.844 -177.101 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 22.1 t70 -55.13 -31.2 61.09 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 121.025 0.44 . . . . 0.0 111.265 175.631 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -100.82 7.6 43.64 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 116.021 -0.536 . . . . 0.0 110.749 178.658 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 105.27 136.79 8.75 Favored Glycine 0 N--CA 1.445 -0.745 0 N-CA-C 110.846 -0.902 . . . . 0.0 110.846 -175.226 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 44.5 mt-10 -61.15 128.69 89.83 Favored Pre-proline 0 C--N 1.322 -0.618 0 CA-C-O 121.321 0.581 . . . . 0.0 111.208 -176.485 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 93' ' ' PRO . . . . . 0.61 ' HG2' HD12 ' A' ' 116' ' ' ILE . 56.2 Cg_endo -71.76 165.46 32.48 Favored 'Trans proline' 0 N--CA 1.462 -0.329 0 C-N-CA 123.318 2.678 . . . . 0.0 112.65 -175.441 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 16.3 mt-10 -116.65 155.79 28.19 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.843 -175.344 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 95' ' ' ILE . . . . . 0.514 HG23 ' O ' ' A' ' 114' ' ' ARG . 22.3 mt -82.37 135.77 24.24 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.469 0 CA-C-N 115.886 -0.597 . . . . 0.0 110.781 -178.711 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 73.16 19.6 79.68 Favored Glycine 0 N--CA 1.45 -0.394 0 CA-C-N 115.747 -0.661 . . . . 0.0 112.582 -175.822 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -96.48 119.51 35.1 Favored 'General case' 0 N--CA 1.452 -0.339 0 CA-C-O 121.54 0.686 . . . . 0.0 112.622 -179.32 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 98' ' ' ILE . . . . . 0.618 ' HA ' ' HA ' ' A' ' 112' ' ' VAL . 6.3 mt -88.69 107.46 17.78 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.665 0 N-CA-C 108.179 -1.045 . . . . 0.0 108.179 174.577 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 99' ' ' MET . . . . . . . . . . . . . 4.9 mtm -127.5 144.3 51.08 Favored 'General case' 0 N--CA 1.443 -0.786 0 N-CA-C 107.625 -1.25 . . . . 0.0 107.625 -175.607 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 100' ' ' LEU . . . . . 0.459 ' HB3' ' HB3' ' A' ' 108' ' ' GLU . 4.1 mm? -75.62 105.0 6.42 Favored 'General case' 0 C--N 1.311 -1.107 0 CA-C-N 116.494 -0.321 . . . . 0.0 110.873 -176.893 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 101' ' ' PHE . . . . . 0.409 ' CE1' ' HE2' ' A' ' 87' ' ' PHE . 42.9 m-85 -92.65 109.95 21.37 Favored 'General case' 0 CA--C 1.516 -0.346 0 CA-C-O 121.692 0.758 . . . . 0.0 110.915 -178.652 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 102' ' ' THR . . . . . 0.485 ' HA ' ' HA ' ' A' ' 108' ' ' GLU . 12.1 m -63.55 112.2 2.69 Favored 'General case' 0 C--N 1.311 -1.089 0 CA-C-N 114.411 -1.268 . . . . 0.0 113.038 -179.08 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -74.49 171.06 14.45 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-N 113.2 -1.818 . . . . 0.0 112.934 -178.945 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 104' ' ' MET . . . . . 0.446 ' C ' ' H ' ' A' ' 106' ' ' GLY . 4.2 mpp? -57.01 -33.5 67.22 Favored 'General case' 0 N--CA 1.465 0.276 0 CA-C-N 115.824 -0.625 . . . . 0.0 111.641 179.111 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 9.3 p-10 -76.93 22.05 0.2 Allowed 'General case' 0 N--CA 1.468 0.427 0 CA-C-O 121.528 0.68 . . . . 0.0 110.813 177.526 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 106' ' ' GLY . . . . . 0.446 ' H ' ' C ' ' A' ' 104' ' ' MET . . . 65.95 -7.84 1.06 Allowed Glycine 0 C--N 1.333 0.415 0 CA-C-N 114.649 -1.16 . . . . 0.0 114.694 -178.321 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 23.3 t -87.22 144.62 26.74 Favored 'General case' 0 CA--C 1.502 -0.902 0 CA-C-O 121.476 0.655 . . . . 0.0 110.705 -172.117 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 108' ' ' GLU . . . . . 0.485 ' HA ' ' HA ' ' A' ' 102' ' ' THR . 2.7 mp0 -80.45 156.41 26.62 Favored 'General case' 0 C--N 1.301 -1.531 0 CA-C-N 114.852 -1.067 . . . . 0.0 109.732 177.369 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 109' ' ' MET . . . . . 0.414 ' O ' ' HA ' ' A' ' 100' ' ' LEU . 96.5 mmm -136.61 125.04 15.07 Favored Pre-proline 0 C--N 1.314 -0.97 0 N-CA-C 107.563 -1.273 . . . . 0.0 107.563 -164.648 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 31.1 Cg_endo -69.39 119.08 6.09 Favored 'Trans proline' 0 N--CA 1.453 -0.887 0 CA-C-N 120.199 1.107 . . . . 0.0 110.644 175.145 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 111' ' ' GLY . . . . . 0.471 ' HA2' ' HA ' ' A' ' 125' ' ' PHE . . . -144.58 120.81 1.47 Allowed Glycine 0 N--CA 1.443 -0.895 0 CA-C-N 115.294 -0.866 . . . . 0.0 111.015 -172.202 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 112' ' ' VAL . . . . . 0.618 ' HA ' ' HA ' ' A' ' 98' ' ' ILE . 7.1 p -101.89 108.11 23.05 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.856 0 CA-C-O 122.058 0.933 . . . . 0.0 110.602 -179.819 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 113' ' ' ILE . . . . . 0.591 HG23 ' O ' ' A' ' 122' ' ' THR . 25.6 mt -61.2 109.89 0.56 Allowed 'Isoleucine or valine' 0 C--N 1.314 -0.966 0 CA-C-N 114.717 -1.129 . . . . 0.0 110.271 171.717 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 114' ' ' ARG . . . . . 0.565 ' HD2' ' HB2' ' A' ' 115' ' ' GLU . 6.4 tmm_? -77.32 -32.56 55.37 Favored 'General case' 0 C--N 1.315 -0.908 0 CA-C-N 115.13 -0.941 . . . . 0.0 111.024 -173.833 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 115' ' ' GLU . . . . . 0.565 ' HB2' ' HD2' ' A' ' 114' ' ' ARG . 5.7 tt0 -159.98 160.9 33.91 Favored 'General case' 0 C--N 1.329 -0.315 0 N-CA-C 110.289 -0.263 . . . . 0.0 110.289 178.337 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 116' ' ' ILE . . . . . 0.61 HD12 ' HG2' ' A' ' 93' ' ' PRO . 29.4 mm -107.36 107.22 22.24 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.514 0 N-CA-C 109.581 -0.525 . . . . 0.0 109.581 173.909 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 117' ' ' ASN . . . . . 0.455 ' HB2' ' O ' ' A' ' 120' ' ' SER . 5.6 m-20 -83.1 157.1 22.97 Favored 'General case' 0 C--N 1.313 -0.987 0 N-CA-C 108.906 -0.776 . . . . 0.0 108.906 178.33 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . -57.17 -48.54 79.15 Favored Glycine 0 N--CA 1.449 -0.457 0 C-N-CA 120.382 -0.913 . . . . 0.0 112.763 -172.987 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 119' ' ' ASP . . . . . 0.689 ' HA ' ' HD3' ' A' ' 84' ' ' ARG . 1.4 m-20 -107.8 -15.26 14.6 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-O 121.088 0.471 . . . . 0.0 111.346 -178.062 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 120' ' ' SER . . . . . 0.455 ' O ' ' HB2' ' A' ' 117' ' ' ASN . 32.4 t -123.38 157.76 32.63 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-N 115.878 -0.601 . . . . 0.0 111.158 -169.508 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 121' ' ' ILE . . . . . . . . . . . . . 50.0 mm -113.68 137.27 47.39 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.523 0 CA-C-O 121.165 0.507 . . . . 0.0 110.253 175.951 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 122' ' ' THR . . . . . 0.591 ' O ' HG23 ' A' ' 113' ' ' ILE . 3.6 m -93.98 142.21 27.64 Favored 'General case' 0 C--N 1.318 -0.776 0 CA-C-N 115.167 -0.924 . . . . 0.0 110.095 178.014 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 123' ' ' VAL . . . . . 0.588 ' HB ' ' O ' ' A' ' 80' ' ' GLN . 33.9 t -147.05 107.99 0.66 Allowed 'Isoleucine or valine' 0 N--CA 1.466 0.353 0 C-N-CA 117.085 -1.846 . . . . 0.0 110.385 -165.221 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 124' ' ' ASP . . . . . 0.546 ' HB3' HG13 ' A' ' 112' ' ' VAL . 28.6 t70 -107.98 101.64 10.88 Favored 'General case' 0 C--N 1.313 -1.006 0 C-N-CA 119.397 -0.921 . . . . 0.0 112.545 174.064 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 125' ' ' PHE . . . . . 0.471 ' HA ' ' HA2' ' A' ' 111' ' ' GLY . 83.5 m-85 -81.63 6.89 13.71 Favored 'General case' 0 N--CA 1.47 0.542 0 CA-C-N 116.285 -0.416 . . . . 0.0 110.894 178.459 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 7.7 m-80 . . . . . 0 C--N 1.327 -0.41 0 CA-C-O 122.054 0.93 . . . . 0.0 111.023 179.656 . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 133' ' ' THR . . . . . . . . . . . . . 21.5 m . . . . . 0 N--CA 1.451 -0.399 0 CA-C-O 121.035 0.445 . . . . 0.0 110.942 . . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 134' ' ' VAL . . . . . 0.429 ' HB ' HD22 ' A' ' 17' ' ' LEU . 30.6 m -102.75 171.68 1.52 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.609 0 CA-C-O 121.556 0.693 . . . . 0.0 110.999 179.624 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 135' ' ' HIS . . . . . 0.659 ' O ' HD23 ' A' ' 17' ' ' LEU . 13.8 m-70 -132.66 140.56 48.21 Favored 'General case' 0 C--N 1.318 -0.768 0 N-CA-C 107.548 -1.279 . . . . 0.0 107.548 -172.236 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 136' ' ' PHE . . . . . 0.573 ' CZ ' HD21 ' A' ' 17' ' ' LEU . 9.3 m-85 -125.42 122.76 37.64 Favored 'General case' 0 C--N 1.311 -1.107 0 C-N-CA 120.492 -0.483 . . . . 0.0 112.188 -169.545 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 137' ' ' ASP . . . . . 0.632 ' O ' ' HA ' ' A' ' 15' ' ' PHE . 5.0 m-20 -115.82 100.8 8.26 Favored 'General case' 0 C--N 1.322 -0.628 0 N-CA-C 108.479 -0.934 . . . . 0.0 108.479 171.156 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 138' ' ' ILE . . . . . 0.5 ' CD1' ' HB3' ' A' ' 136' ' ' PHE . 4.4 mp -110.57 129.74 65.15 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.644 0 CA-C-O 121.229 0.538 . . . . 0.0 111.936 -177.535 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 139' ' ' GLU . . . . . 0.585 ' HG2' ' HG2' ' A' ' 60' ' ' LYS . 34.2 mt-10 -122.11 109.07 14.07 Favored 'General case' 0 N--CA 1.447 -0.601 0 CA-C-N 115.244 -0.889 . . . . 0.0 109.006 172.245 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 140' ' ' VAL . . . . . . . . . . . . . 58.9 t -59.63 119.55 4.15 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.499 0 CA-C-N 115.779 -0.646 . . . . 0.0 110.933 -179.276 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 141' ' ' LEU . . . . . 0.527 HD11 ' CD2' ' A' ' 14' ' ' HIS . 37.7 mt -90.51 -49.49 6.47 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 116.372 -0.376 . . . . 0.0 110.498 179.554 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 142' ' ' GLU . . . . . . . . . . . . . 44.3 mt-10 -156.87 158.88 37.53 Favored 'General case' 0 CA--C 1.519 -0.222 0 N-CA-C 108.835 -0.802 . . . . 0.0 108.835 -177.036 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 143' ' ' ILE . . . . . 0.621 HD12 HG23 ' A' ' 57' ' ' VAL . 97.4 mt -128.35 115.45 38.08 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.837 0 CA-C-O 121.139 0.495 . . . . 0.0 111.852 179.609 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 144' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -77.95 128.59 78.51 Favored Pre-proline 0 C--O 1.235 0.318 0 CA-C-N 115.397 -0.82 . . . . 0.0 109.069 172.582 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 145' ' ' PRO . . . . . . . . . . . . . 18.3 Cg_endo . . . . . 0 C--O 1.233 0.228 0 C-N-CA 123.126 2.55 . . . . 0.0 114.183 -172.379 . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 16.5 mmt . . . . . 0 N--CA 1.483 1.187 0 CA-C-O 120.52 0.2 . . . . 0.0 111.495 . . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 2' ' ' SER . . . . . 0.487 ' HB3' ' HA ' ' A' ' 145' ' ' PRO . 6.2 p -165.02 43.34 0.08 Allowed 'General case' 0 C--N 1.326 -0.431 0 CA-C-O 121.145 0.498 . . . . 0.0 110.705 -178.745 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 3.3 mp0 -77.38 -35.44 54.45 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-O 121.653 0.74 . . . . 0.0 109.77 -179.006 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 16.1 p -133.26 157.56 45.12 Favored 'General case' 0 C--N 1.315 -0.904 0 CA-C-N 114.893 -1.049 . . . . 0.0 109.745 -179.629 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 5' ' ' VAL . . . . . 0.67 HG13 ' HA ' ' A' ' 53' ' ' LEU . 10.2 p -71.11 139.04 20.57 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.573 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.04 -178.04 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 6' ' ' GLN . . . . . . . . . . . . . 2.9 pt20 -142.7 164.15 30.88 Favored 'General case' 0 C--N 1.314 -0.954 0 N-CA-C 108.549 -0.908 . . . . 0.0 108.549 179.149 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 83.2 p -67.41 136.32 54.53 Favored 'General case' 0 C--N 1.316 -0.886 0 C-N-CA 120.724 -0.391 . . . . 0.0 110.453 -178.154 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 66.6 t30 71.27 28.43 3.0 Favored 'General case' 0 CA--C 1.538 0.488 0 C-N-CA 123.449 0.699 . . . . 0.0 111.667 -178.697 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 49.6 m -128.54 132.99 48.29 Favored 'General case' 0 C--N 1.327 -0.374 0 O-C-N 121.623 -0.673 . . . . 0.0 110.166 174.011 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -83.2 165.78 19.16 Favored 'General case' 0 C--N 1.322 -0.63 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.765 -171.862 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 33.0 m -143.46 139.7 26.25 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.685 0 CA-C-O 120.924 0.392 . . . . 0.0 110.281 -175.585 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 12' ' ' LEU . . . . . 0.519 HD12 ' HB3' ' A' ' 142' ' ' GLU . 75.7 mt -86.0 124.07 32.03 Favored 'General case' 0 C--N 1.319 -0.752 0 N-CA-C 108.127 -1.064 . . . . 0.0 108.127 173.253 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 13' ' ' VAL . . . . . 0.621 HG21 HG23 ' A' ' 138' ' ' ILE . 3.5 p -136.06 153.24 31.6 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.912 0 CA-C-O 122.289 1.042 . . . . 0.0 112.993 -167.348 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 14' ' ' HIS . . . . . . . . . . . . . 1.9 m-70 -123.72 116.16 22.59 Favored 'General case' 0 C--N 1.313 -1.008 0 CA-C-N 113.359 -1.746 . . . . 0.0 106.58 167.654 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 15' ' ' PHE . . . . . 0.57 ' HB2' ' O ' ' A' ' 137' ' ' ASP . 16.5 p90 -142.12 168.95 18.52 Favored 'General case' 0 C--N 1.317 -0.826 0 C-N-CA 119.2 -1.0 . . . . 0.0 112.531 -172.452 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 21.5 m -145.9 142.7 29.01 Favored 'General case' 0 C--N 1.321 -0.631 0 CA-C-N 115.076 -0.965 . . . . 0.0 110.438 176.253 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 17' ' ' LEU . . . . . 0.791 ' HG ' ' CZ ' ' A' ' 71' ' ' PHE . 0.0 OUTLIER -105.68 128.43 53.66 Favored 'General case' 0 C--N 1.326 -0.424 0 N-CA-C 109.527 -0.545 . . . . 0.0 109.527 -175.621 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 18' ' ' LYS . . . . . 0.502 ' HA ' ' O ' ' A' ' 23' ' ' THR . 0.1 OUTLIER -125.56 136.85 53.75 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-O 121.663 0.744 . . . . 0.0 112.204 -174.256 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 19' ' ' LEU . . . . . 0.478 HD23 ' HB ' ' A' ' 23' ' ' THR . 3.5 mm? -78.2 174.74 10.87 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 114.96 -1.018 . . . . 0.0 109.963 172.683 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 23.9 m-20 -60.74 -27.83 68.23 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-O 120.797 0.332 . . . . 0.0 111.08 176.905 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 35.8 t70 -80.61 5.02 16.67 Favored 'General case' 0 N--CA 1.474 0.739 0 CA-C-O 122.224 1.011 . . . . 0.0 109.926 174.224 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 66.91 19.3 69.57 Favored Glycine 0 N--CA 1.451 -0.363 0 CA-C-N 114.259 -1.337 . . . . 0.0 112.478 -175.944 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 23' ' ' THR . . . . . 0.502 ' O ' ' HA ' ' A' ' 18' ' ' LYS . 17.4 m -72.55 142.7 48.46 Favored 'General case' 0 C--N 1.323 -0.544 0 N-CA-C 110.33 -0.248 . . . . 0.0 110.33 178.473 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 59.0 m -77.05 107.9 9.74 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-O 120.871 0.367 . . . . 0.0 111.026 179.32 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 25' ' ' ALA . . . . . 0.422 ' HB3' ' HB3' ' A' ' 17' ' ' LEU . . . -77.29 -35.51 55.04 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-O 121.405 0.621 . . . . 0.0 109.567 174.709 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 9.0 tp10 -160.48 142.72 12.85 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 115.033 -0.985 . . . . 0.0 108.896 -179.419 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 19.6 t -124.75 149.42 47.33 Favored 'General case' 0 C--N 1.313 -1.007 0 N-CA-C 109.09 -0.707 . . . . 0.0 109.09 175.125 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 28' ' ' THR . . . . . 0.461 HG21 ' HB2' ' A' ' 35' ' ' ALA . 36.6 m -148.23 44.55 1.05 Allowed 'General case' 0 N--CA 1.437 -1.113 0 CA-C-O 123.79 1.757 . . . . 0.0 106.819 172.764 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 52.9 ttp180 -151.65 -45.96 0.11 Allowed 'General case' 0 C--N 1.312 -1.052 0 CA-C-N 112.653 -2.067 . . . . 0.0 109.681 -178.784 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 91.6 m-20 -67.81 -25.73 65.73 Favored 'General case' 0 N--CA 1.464 0.272 0 CA-C-O 121.087 0.47 . . . . 0.0 110.549 177.643 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 71.8 m-20 -76.53 -12.66 60.06 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.595 -0.729 . . . . 0.0 110.65 179.898 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 83.01 -1.37 88.81 Favored Glycine 0 N--CA 1.45 -0.371 0 C-N-CA 120.989 -0.624 . . . . 0.0 111.804 -179.691 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 59.4 mttp -107.41 121.68 43.64 Favored Pre-proline 0 C--N 1.321 -0.659 0 CA-C-N 115.717 -0.242 . . . . 0.0 110.698 -177.952 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 7.8 Cg_exo -76.48 168.94 22.84 Favored 'Trans proline' 0 N--CA 1.46 -0.491 0 C-N-CA 122.938 2.426 . . . . 0.0 112.118 172.113 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 35' ' ' ALA . . . . . 0.461 ' HB2' HG21 ' A' ' 28' ' ' THR . . . -140.89 161.7 37.2 Favored 'General case' 0 C--N 1.312 -1.04 0 CA-C-N 115.097 -0.956 . . . . 0.0 109.592 179.383 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 3.8 tp -112.89 130.77 55.99 Favored 'General case' 0 N--CA 1.445 -0.722 0 N-CA-C 110.049 -0.352 . . . . 0.0 110.049 175.968 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 37' ' ' PHE . . . . . . . . . . . . . 9.4 m-30 -95.98 112.14 23.95 Favored 'General case' 0 C--N 1.318 -0.77 0 N-CA-C 110.055 -0.35 . . . . 0.0 110.055 175.411 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 38' ' ' ARG . . . . . 0.567 ' HB3' ' HB3' ' A' ' 42' ' ' ALA . 22.3 mmm180 -83.46 106.91 15.59 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-O 121.351 0.596 . . . . 0.0 110.957 -179.513 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 10.9 mp -81.84 154.18 26.01 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-N 115.104 -0.953 . . . . 0.0 110.979 178.278 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 91.79 41.11 5.11 Favored Glycine 0 N--CA 1.449 -0.455 0 C-N-CA 120.915 -0.66 . . . . 0.0 113.06 176.575 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 16.6 m-20 58.46 23.55 10.81 Favored 'General case' 0 N--CA 1.468 0.429 0 CA-C-O 120.873 0.368 . . . . 0.0 111.374 177.78 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 42' ' ' ALA . . . . . 0.567 ' HB3' ' HB3' ' A' ' 38' ' ' ARG . . . -86.48 -27.37 24.11 Favored 'General case' 0 C--N 1.323 -0.587 0 CA-C-O 121.027 0.441 . . . . 0.0 110.278 -178.162 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 40.8 m -154.31 -45.09 0.09 Allowed 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 115.821 -0.627 . . . . 0.0 109.532 175.585 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 51.5 mt -102.81 159.34 15.57 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 115.775 -0.648 . . . . 0.0 110.179 178.482 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 50.1 m -84.45 161.72 20.19 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-N 115.853 -0.612 . . . . 0.0 110.765 -177.546 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 45.2 mt-10 -57.4 -26.8 61.66 Favored 'General case' 0 N--CA 1.463 0.202 0 CA-C-N 115.858 -0.61 . . . . 0.0 111.715 -177.213 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -58.86 -36.72 88.6 Favored Glycine 0 N--CA 1.45 -0.403 0 C-N-CA 121.086 -0.578 . . . . 0.0 112.546 -175.808 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 3.0 tt -76.22 -36.53 58.51 Favored 'General case' 0 CA--C 1.515 -0.387 0 CA-C-O 121.768 0.794 . . . . 0.0 110.388 -179.122 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 7.2 tt0 -66.79 -46.68 74.49 Favored 'General case' 0 C--N 1.318 -0.785 0 CA-C-N 114.273 -1.331 . . . . 0.0 108.827 -176.472 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 50' ' ' GLN . . . . . 0.518 ' HA ' HD22 ' A' ' 53' ' ' LEU . 82.9 mm-40 -62.67 -16.4 56.86 Favored 'General case' 0 C--N 1.314 -0.936 0 CA-C-N 113.504 -1.68 . . . . 0.0 112.396 -176.069 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 51' ' ' HIS . . . . . . . . . . . . . 14.1 m-70 -105.34 -3.48 22.67 Favored 'General case' 0 C--O 1.233 0.223 0 C-N-CA 120.221 -0.591 . . . . 0.0 111.663 176.21 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 52' ' ' LEU . . . . . 0.563 ' O ' HG11 ' A' ' 5' ' ' VAL . 6.1 mt -99.98 -23.66 14.85 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 116.461 -0.336 . . . . 0.0 111.866 -178.493 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 53' ' ' LEU . . . . . 0.67 ' HA ' HG13 ' A' ' 5' ' ' VAL . 0.0 OUTLIER -59.85 152.21 23.78 Favored 'General case' 0 CA--C 1.53 0.209 0 CA-C-O 121.316 0.579 . . . . 0.0 112.286 -177.124 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 94.26 -17.14 59.5 Favored Glycine 0 N--CA 1.451 -0.306 0 CA-C-N 115.296 -0.865 . . . . 0.0 113.557 175.964 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 55' ' ' LEU . . . . . 0.532 ' O ' HG12 ' A' ' 5' ' ' VAL . 16.0 tp -84.9 158.97 20.43 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-O 121.099 0.476 . . . . 0.0 110.975 177.677 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 56' ' ' LYS . . . . . 0.563 ' HD3' ' N ' ' A' ' 57' ' ' VAL . 12.8 tmtt? -120.11 162.89 18.54 Favored 'General case' 0 C--N 1.325 -0.487 0 N-CA-C 109.768 -0.456 . . . . 0.0 109.768 -176.331 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 57' ' ' VAL . . . . . 0.563 ' N ' ' HD3' ' A' ' 56' ' ' LYS . 42.1 t -57.76 147.74 6.04 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-O 120.889 0.376 . . . . 0.0 111.259 177.491 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 80.6 9.46 86.39 Favored Glycine 0 N--CA 1.451 -0.334 0 CA-C-N 115.852 -0.613 . . . . 0.0 113.575 -177.712 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 2.5 m-20 -121.53 162.55 20.36 Favored 'General case' 0 CA--C 1.513 -0.46 0 CA-C-O 121.022 0.439 . . . . 0.0 110.828 178.364 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 60' ' ' LYS . . . . . 0.593 ' HB3' ' HG2' ' A' ' 139' ' ' GLU . 1.1 ptmt -135.15 146.15 48.49 Favored 'General case' 0 C--N 1.316 -0.855 0 CA-C-N 115.576 -0.738 . . . . 0.0 109.133 179.136 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 12.1 t -142.76 143.35 32.17 Favored 'General case' 0 C--N 1.318 -0.793 0 CA-C-O 121.13 0.491 . . . . 0.0 109.754 -178.612 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 3.7 m -109.17 138.52 45.39 Favored 'General case' 0 C--N 1.311 -1.101 0 N-CA-C 108.889 -0.782 . . . . 0.0 108.889 176.668 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 63' ' ' PHE . . . . . 0.544 ' CZ ' HD12 ' A' ' 138' ' ' ILE . 31.4 p90 -158.36 158.85 35.07 Favored 'General case' 0 C--N 1.321 -0.653 0 CA-C-O 121.238 0.542 . . . . 0.0 111.42 -179.444 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 64' ' ' SER . . . . . 0.425 ' O ' ' HG ' ' A' ' 65' ' ' LEU . 26.1 t -104.73 159.42 15.8 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-N 115.197 -0.911 . . . . 0.0 109.71 -179.204 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 65' ' ' LEU . . . . . 0.479 HD12 ' CZ ' ' A' ' 136' ' ' PHE . 18.5 mt -161.09 151.38 17.71 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 116.302 -0.408 . . . . 0.0 110.698 -171.975 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 48.0 mt-10 -69.86 152.79 95.92 Favored Pre-proline 0 C--N 1.321 -0.662 0 CA-C-N 115.796 -0.638 . . . . 0.0 109.365 174.485 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 3.4 Cg_exo -42.45 -49.71 6.13 Favored 'Trans proline' 0 CA--C 1.532 0.406 0 C-N-CA 123.673 2.915 . . . . 0.0 113.865 -176.804 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -56.86 -31.12 64.48 Favored 'General case' 0 N--CA 1.468 0.439 0 CA-C-N 115.996 -0.547 . . . . 0.0 111.784 179.84 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 69' ' ' ALA . . . . . 0.415 ' O ' HD13 ' A' ' 65' ' ' LEU . . . -98.26 16.75 20.46 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.825 -175.67 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -131.92 -84.66 0.49 Allowed 'General case' 0 C--N 1.323 -0.559 0 N-CA-C 108.944 -0.762 . . . . 0.0 108.944 -173.24 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 71' ' ' PHE . . . . . 0.791 ' CZ ' ' HG ' ' A' ' 17' ' ' LEU . 9.1 m-85 -94.71 -3.69 48.83 Favored 'General case' 0 C--N 1.318 -0.768 0 CA-C-N 115.544 -0.753 . . . . 0.0 110.294 176.102 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 85.66 -170.7 44.41 Favored Glycine 0 N--CA 1.439 -1.109 0 CA-C-N 115.19 -0.914 . . . . 0.0 112.09 176.097 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 19.7 t -87.1 138.05 32.77 Favored Pre-proline 0 C--N 1.312 -1.057 0 N-CA-C 109.311 -0.625 . . . . 0.0 109.311 173.94 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 9.8 Cg_endo -52.91 142.77 51.54 Favored 'Trans proline' 0 C--N 1.346 0.436 0 C-N-CA 122.221 1.948 . . . . 0.0 110.275 173.661 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 75' ' ' SER . . . . . 0.471 ' HB2' HD23 ' A' ' 78' ' ' LEU . 54.7 m -120.94 102.51 43.99 Favored Pre-proline 0 C--N 1.322 -0.608 0 N-CA-C 112.031 0.382 . . . . 0.0 112.031 -165.574 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 76' ' ' PRO . . . . . 0.453 ' HD2' ' HA ' ' A' ' 75' ' ' SER . 36.3 Cg_endo -67.53 -14.25 41.69 Favored 'Trans proline' 0 N--CA 1.462 -0.333 0 C-N-CA 122.692 2.261 . . . . 0.0 112.043 174.996 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 23.8 t70 -64.03 -19.61 65.32 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.689 -178.801 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 78' ' ' LEU . . . . . 0.6 ' HB3' ' HB2' ' A' ' 125' ' ' PHE . 3.0 mm? -88.66 -1.12 57.91 Favored 'General case' 0 CA--C 1.513 -0.469 0 C-N-CA 120.697 -0.401 . . . . 0.0 110.775 -179.611 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 79' ' ' ILE . . . . . 0.64 HG23 ' O ' ' A' ' 123' ' ' VAL . 20.2 mt -65.4 128.51 28.32 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.594 0 CA-C-O 121.921 0.867 . . . . 0.0 111.335 -178.243 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 80' ' ' GLN . . . . . 0.573 ' O ' ' HB ' ' A' ' 123' ' ' VAL . 49.5 mt-30 -135.81 138.88 43.02 Favored 'General case' 0 C--N 1.319 -0.76 0 CA-C-N 114.14 -1.391 . . . . 0.0 108.736 -174.274 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 81' ' ' TYR . . . . . 0.447 ' CE2' HG23 ' A' ' 122' ' ' THR . 73.1 m-85 -107.17 110.3 22.33 Favored 'General case' 0 C--N 1.32 -0.691 0 C-N-CA 119.707 -0.797 . . . . 0.0 110.276 -179.117 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 48.9 m-85 -104.81 168.55 8.99 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-N 115.881 -0.599 . . . . 0.0 110.684 172.495 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 22.6 t -87.22 157.99 19.21 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-O 121.365 0.603 . . . . 0.0 111.209 -176.883 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 84' ' ' ARG . . . . . 0.402 ' HG3' ' HD2' ' A' ' 85' ' ' ARG . 12.5 ptm180 -61.86 -34.74 76.54 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 115.22 -0.9 . . . . 0.0 109.825 175.961 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 85' ' ' ARG . . . . . 0.402 ' HD2' ' HG3' ' A' ' 84' ' ' ARG . 5.1 mpt_? -54.7 -28.08 45.22 Favored 'General case' 0 C--N 1.32 -0.7 0 CA-C-N 113.952 -1.476 . . . . 0.0 111.781 176.092 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 21.2 mm-40 -79.86 -20.2 46.48 Favored 'General case' 0 C--N 1.32 -0.689 0 CA-C-O 121.105 0.478 . . . . 0.0 111.389 179.396 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 87' ' ' PHE . . . . . . . . . . . . . 57.0 m-85 -104.22 -20.5 13.77 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 116.093 -0.503 . . . . 0.0 111.558 -176.076 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 88' ' ' MET . . . . . . . . . . . . . 22.5 ttm -56.13 -38.37 70.72 Favored 'General case' 0 C--N 1.323 -0.556 0 N-CA-C 112.307 0.484 . . . . 0.0 112.307 -173.239 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 2.3 m-20 -53.98 -27.46 31.58 Favored 'General case' 0 C--N 1.328 -0.327 0 N-CA-C 112.362 0.504 . . . . 0.0 112.362 176.709 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -110.47 14.81 22.46 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-O 120.957 0.408 . . . . 0.0 110.554 179.834 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 92.3 138.85 8.57 Favored Glycine 0 N--CA 1.448 -0.566 0 C-N-CA 120.837 -0.696 . . . . 0.0 111.973 -178.554 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 63.6 mt-10 -62.47 122.13 71.53 Favored Pre-proline 0 C--N 1.324 -0.532 0 CA-C-O 121.148 0.499 . . . . 0.0 110.906 -179.632 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 93' ' ' PRO . . . . . 0.5 ' HG2' HD12 ' A' ' 121' ' ' ILE . 43.9 Cg_endo -72.95 168.12 25.53 Favored 'Trans proline' 0 CA--C 1.516 -0.393 0 C-N-CA 123.777 2.984 . . . . 0.0 114.123 -173.214 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 94' ' ' GLU . . . . . 0.414 ' HB2' ' HB2' ' A' ' 97' ' ' ALA . 3.4 mp0 -114.07 160.03 19.35 Favored 'General case' 0 N--CA 1.444 -0.742 0 CA-C-N 114.181 -1.372 . . . . 0.0 110.54 -172.357 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 95' ' ' ILE . . . . . 0.533 HG12 HG12 ' A' ' 116' ' ' ILE . 11.3 mt -78.2 131.7 33.99 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.446 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.535 178.829 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 71.76 24.02 77.24 Favored Glycine 0 N--CA 1.445 -0.708 0 CA-C-N 115.629 -0.714 . . . . 0.0 111.963 -176.626 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 97' ' ' ALA . . . . . 0.414 ' HB2' ' HB2' ' A' ' 94' ' ' GLU . . . -103.29 117.42 34.47 Favored 'General case' 0 N--CA 1.449 -0.502 0 CA-C-O 121.937 0.875 . . . . 0.0 110.661 179.456 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 98' ' ' ILE . . . . . 0.565 ' HA ' ' HA ' ' A' ' 112' ' ' VAL . 4.1 mt -97.97 120.51 47.4 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.294 0 CA-C-N 114.481 -1.236 . . . . 0.0 108.726 -176.012 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 99' ' ' MET . . . . . . . . . . . . . 8.3 mtm -133.91 149.65 51.3 Favored 'General case' 0 N--CA 1.439 -0.99 0 N-CA-C 106.922 -1.51 . . . . 0.0 106.922 -177.949 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 3.2 mm? -70.38 119.7 14.94 Favored 'General case' 0 C--N 1.311 -1.087 0 CA-C-O 122.313 1.054 . . . . 0.0 113.044 -176.417 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 101' ' ' PHE . . . . . 0.647 ' O ' ' HA ' ' A' ' 108' ' ' GLU . 20.8 m-85 -109.7 175.89 5.28 Favored 'General case' 0 C--O 1.22 -0.452 0 CA-C-N 113.05 -1.886 . . . . 0.0 111.47 -175.533 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 9.2 m -124.84 109.65 13.31 Favored 'General case' 0 N--CA 1.466 0.373 0 C-N-CA 120.492 -0.483 . . . . 0.0 111.136 -166.248 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -77.3 170.3 16.78 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-N 115.733 -0.667 . . . . 0.0 112.483 178.659 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 104' ' ' MET . . . . . 0.421 ' C ' ' H ' ' A' ' 106' ' ' GLY . 3.7 mpp? -58.93 -37.71 77.31 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 115.659 -0.7 . . . . 0.0 111.193 -179.783 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 11.1 p-10 -78.59 22.97 0.33 Allowed 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 121.381 0.61 . . . . 0.0 110.665 177.774 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 106' ' ' GLY . . . . . 0.421 ' H ' ' C ' ' A' ' 104' ' ' MET . . . 66.39 -12.04 0.5 Allowed Glycine 0 C--N 1.337 0.623 0 CA-C-N 115.178 -0.919 . . . . 0.0 114.812 -174.869 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 46.6 t -65.74 132.72 49.43 Favored 'General case' 0 CA--C 1.501 -0.912 0 CA-C-O 122.063 0.935 . . . . 0.0 110.896 -171.909 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 108' ' ' GLU . . . . . 0.647 ' HA ' ' O ' ' A' ' 101' ' ' PHE . 2.1 tt0 -90.77 104.04 16.68 Favored 'General case' 0 C--N 1.297 -1.677 0 CA-C-N 114.146 -1.388 . . . . 0.0 109.128 178.907 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 109' ' ' MET . . . . . . . . . . . . . 1.7 mtm -102.63 148.32 35.34 Favored Pre-proline 0 CA--C 1.511 -0.549 0 N-CA-C 108.096 -1.076 . . . . 0.0 108.096 -178.138 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 29.6 Cg_endo -63.85 146.14 91.34 Favored 'Trans proline' 0 N--CA 1.45 -1.046 0 C-N-CA 121.325 1.35 . . . . 0.0 110.482 172.999 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 111' ' ' GLY . . . . . 0.493 ' HA3' ' CD2' ' A' ' 101' ' ' PHE . . . -143.35 107.76 0.48 Allowed Glycine 0 N--CA 1.439 -1.138 0 N-CA-C 109.763 -1.335 . . . . 0.0 109.763 -173.359 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 112' ' ' VAL . . . . . 0.84 HG13 ' HB3' ' A' ' 124' ' ' ASP . 2.9 p -87.57 107.55 17.37 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.876 0 C-N-CA 118.798 -1.161 . . . . 0.0 109.976 -174.779 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 113' ' ' ILE . . . . . . . . . . . . . 34.8 mt -62.91 108.46 0.59 Allowed 'Isoleucine or valine' 0 N--CA 1.436 -1.168 0 N-CA-C 108.531 -0.915 . . . . 0.0 108.531 170.525 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 114' ' ' ARG . . . . . 0.419 ' O ' HG23 ' A' ' 95' ' ' ILE . 6.3 tpp180 -75.37 -42.72 53.36 Favored 'General case' 0 C--N 1.308 -1.203 0 CA-C-N 113.853 -1.521 . . . . 0.0 111.06 -168.969 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 115' ' ' GLU . . . . . 0.5 ' HA ' HG23 ' A' ' 95' ' ' ILE . 8.3 tt0 -159.57 156.78 28.65 Favored 'General case' 0 C--N 1.32 -0.694 0 N-CA-C 109.622 -0.51 . . . . 0.0 109.622 -176.381 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 116' ' ' ILE . . . . . 0.533 HG12 HG12 ' A' ' 95' ' ' ILE . 38.8 mm -111.48 115.28 49.45 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.528 0 N-CA-C 109.907 -0.405 . . . . 0.0 109.907 179.68 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 117' ' ' ASN . . . . . 0.448 ' HB2' ' O ' ' A' ' 120' ' ' SER . 3.7 m-20 -99.51 154.69 18.04 Favored 'General case' 0 C--N 1.316 -0.858 0 N-CA-C 108.8 -0.815 . . . . 0.0 108.8 176.672 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . -62.3 -28.0 70.19 Favored Glycine 0 N--CA 1.45 -0.395 0 CA-C-N 115.929 -0.578 . . . . 0.0 113.648 -173.78 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 11.8 t70 -114.87 -17.63 11.5 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 117.004 0.402 . . . . 0.0 111.77 179.08 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 120' ' ' SER . . . . . 0.448 ' O ' ' HB2' ' A' ' 117' ' ' ASN . 14.8 t -137.59 157.8 45.74 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-O 121.179 0.514 . . . . 0.0 111.281 -169.662 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 121' ' ' ILE . . . . . 0.5 HD12 ' HG2' ' A' ' 93' ' ' PRO . 45.1 mm -110.13 132.91 57.12 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.811 0 CA-C-N 116.102 -0.499 . . . . 0.0 109.963 177.376 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 122' ' ' THR . . . . . 0.447 HG23 ' CE2' ' A' ' 81' ' ' TYR . 4.6 m -92.44 103.34 15.78 Favored 'General case' 0 N--CA 1.442 -0.848 0 CA-C-O 122.142 0.972 . . . . 0.0 109.924 178.233 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 123' ' ' VAL . . . . . 0.64 ' O ' HG23 ' A' ' 79' ' ' ILE . 18.8 t -93.86 156.51 3.09 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.005 0 CA-C-N 113.54 -1.664 . . . . 0.0 110.355 177.581 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 124' ' ' ASP . . . . . 0.84 ' HB3' HG13 ' A' ' 112' ' ' VAL . 10.8 t0 -151.06 94.08 2.01 Favored 'General case' 0 C--N 1.317 -0.827 0 CA-C-N 115.216 -0.902 . . . . 0.0 109.684 -176.596 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 125' ' ' PHE . . . . . 0.6 ' HB2' ' HB3' ' A' ' 78' ' ' LEU . 84.4 m-85 -84.68 96.83 9.34 Favored 'General case' 0 CA--C 1.51 -0.593 0 CA-C-O 122.041 0.924 . . . . 0.0 110.517 177.537 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 7.1 m-20 -89.0 -177.0 5.35 Favored 'General case' 0 C--N 1.299 -1.611 0 CA-C-N 114.297 -1.32 . . . . 0.0 109.763 173.261 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 127' ' ' HIS . . . . . . . . . . . . . 1.4 m170 -87.41 -178.52 1.11 Allowed Pre-proline 0 C--N 1.307 -1.266 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.926 -173.209 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 128' ' ' PRO . . . . . 0.448 ' O ' ' N ' ' A' ' 130' ' ' ALA . 1.1 Cg_endo -46.06 175.76 0.01 OUTLIER 'Trans proline' 0 CA--C 1.533 0.425 0 C-N-CA 123.979 3.12 . . . . 0.0 112.338 161.588 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 129' ' ' LEU . . . . . . . . . . . . . 15.8 tp -49.45 43.74 0.0 OUTLIER 'General case' 0 N--CA 1.482 1.166 0 C-N-CA 126.483 1.913 . . . . 0.0 114.858 179.836 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 130' ' ' ALA . . . . . 0.448 ' N ' ' O ' ' A' ' 128' ' ' PRO . . . -78.02 -177.28 4.94 Favored 'General case' 0 C--N 1.318 -0.775 0 C-N-CA 123.335 0.654 . . . . 0.0 110.025 -173.632 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . 72.97 15.22 78.45 Favored Glycine 0 N--CA 1.449 -0.484 0 C-N-CA 120.761 -0.733 . . . . 0.0 113.257 -178.956 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 132' ' ' GLN . . . . . . . . . . . . . 2.7 pt20 -149.0 158.55 44.27 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 117.045 0.422 . . . . 0.0 110.295 173.803 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 133' ' ' THR . . . . . . . . . . . . . 24.0 m -80.6 127.02 31.98 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.974 -178.489 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 134' ' ' VAL . . . . . 0.436 ' HB ' ' CD1' ' A' ' 17' ' ' LEU . 2.6 m -134.2 146.29 31.57 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.362 0 N-CA-C 112.297 0.48 . . . . 0.0 112.297 -174.397 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 135' ' ' HIS . . . . . . . . . . . . . 26.1 m-70 -98.32 120.41 38.68 Favored 'General case' 0 N--CA 1.465 0.315 0 CA-C-N 116.0 -0.545 . . . . 0.0 110.618 178.734 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 136' ' ' PHE . . . . . 0.499 ' HB3' HD13 ' A' ' 17' ' ' LEU . 3.1 p90 -128.78 150.83 50.13 Favored 'General case' 0 C--N 1.321 -0.653 0 N-CA-C 113.894 1.072 . . . . 0.0 113.894 179.287 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 137' ' ' ASP . . . . . 0.57 ' O ' ' HB2' ' A' ' 15' ' ' PHE . 5.1 m-20 -100.38 140.29 34.84 Favored 'General case' 0 CA--C 1.508 -0.639 0 CA-C-N 114.139 -1.392 . . . . 0.0 107.706 174.666 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 138' ' ' ILE . . . . . 0.621 HG23 HG21 ' A' ' 13' ' ' VAL . 60.2 mt -137.32 132.99 46.48 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.836 0 CA-C-O 120.761 0.315 . . . . 0.0 110.526 -179.911 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 139' ' ' GLU . . . . . 0.593 ' HG2' ' HB3' ' A' ' 60' ' ' LYS . 28.3 mt-10 -105.65 144.36 32.5 Favored 'General case' 0 CA--C 1.514 -0.439 0 CA-C-N 116.494 -0.321 . . . . 0.0 110.749 -179.3 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 140' ' ' VAL . . . . . 0.441 ' CG1' ' HA ' ' A' ' 57' ' ' VAL . 37.6 t -97.71 104.66 16.19 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.886 0 N-CA-C 108.366 -0.976 . . . . 0.0 108.366 169.415 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 41.1 mt -91.67 -51.62 5.15 Favored 'General case' 0 C--N 1.318 -0.769 0 N-CA-C 109.347 -0.612 . . . . 0.0 109.347 -178.362 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 142' ' ' GLU . . . . . 0.519 ' HB3' HD12 ' A' ' 12' ' ' LEU . 40.9 tt0 -150.95 148.61 28.62 Favored 'General case' 0 C--N 1.321 -0.654 0 CA-C-N 115.55 -0.75 . . . . 0.0 109.236 169.393 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 143' ' ' ILE . . . . . 0.536 HD12 HG23 ' A' ' 57' ' ' VAL . 74.5 mt -103.52 136.2 37.52 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.7 0 CA-C-O 120.811 0.339 . . . . 0.0 110.109 -178.152 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 144' ' ' ASP . . . . . . . . . . . . . 29.0 t70 -77.29 133.73 67.82 Favored Pre-proline 0 C--N 1.324 -0.523 0 CA-C-N 115.895 -0.593 . . . . 0.0 109.808 -177.295 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 145' ' ' PRO . . . . . 0.487 ' HA ' ' HB3' ' A' ' 2' ' ' SER . 24.4 Cg_endo -56.43 128.08 28.6 Favored 'Trans proline' 0 C--N 1.345 0.389 0 C-N-CA 123.308 2.672 . . . . 0.0 113.048 -172.575 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 146' ' ' ALA . . . . . . . . . . . . . . . -84.52 98.62 10.22 Favored 'General case' 0 C--N 1.314 -0.955 0 CA-C-N 114.967 -1.015 . . . . 0.0 109.907 178.185 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -98.61 45.94 1.0 Allowed 'General case' 0 C--N 1.32 -0.696 0 N-CA-C 108.388 -0.967 . . . . 0.0 108.388 179.628 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.448 -0.562 0 CA-C-N 115.46 -0.791 . . . . 0.0 110.902 -173.933 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 51.7 ttm . . . . . 0 N--CA 1.48 1.074 0 CA-C-O 120.791 0.329 . . . . 0.0 110.738 . . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 18.7 m -99.1 75.13 2.01 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-O 120.86 0.362 . . . . 0.0 110.516 -178.411 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 7.2 mp0 -76.31 -29.77 57.46 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 121.55 0.69 . . . . 0.0 110.051 177.681 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 20.8 t -120.97 152.56 38.4 Favored 'General case' 0 C--N 1.317 -0.834 0 CA-C-N 115.031 -0.986 . . . . 0.0 109.698 -179.98 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 69.8 t -68.72 123.39 22.05 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.443 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.36 -178.595 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 6' ' ' GLN . . . . . . . . . . . . . 5.1 pt20 -140.49 160.67 39.48 Favored 'General case' 0 C--N 1.315 -0.929 0 CA-C-N 115.206 -0.906 . . . . 0.0 109.342 -177.667 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 41.4 p -62.64 145.33 54.82 Favored 'General case' 0 C--N 1.317 -0.837 0 O-C-N 123.215 0.322 . . . . 0.0 110.824 -178.47 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 8' ' ' ASN . . . . . 0.438 ' OD1' ' HA ' ' A' ' 148' ' ' GLU . 21.3 t-20 77.24 -1.01 2.82 Favored 'General case' 0 N--CA 1.47 0.564 0 C-N-CA 123.762 0.825 . . . . 0.0 111.558 179.732 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 67.1 m -99.99 166.23 11.15 Favored 'General case' 0 C--N 1.327 -0.384 0 N-CA-C 108.983 -0.747 . . . . 0.0 108.983 172.693 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 10' ' ' ALA . . . . . 0.707 ' HB2' ' HD2' ' A' ' 38' ' ' ARG . . . -115.82 154.32 29.88 Favored 'General case' 0 C--N 1.316 -0.875 0 C-N-CA 120.598 -0.441 . . . . 0.0 110.209 178.705 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 8.6 m -129.69 133.57 64.73 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.786 0 CA-C-O 121.395 0.617 . . . . 0.0 110.575 177.776 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 12' ' ' LEU . . . . . 0.433 ' N ' HD12 ' A' ' 12' ' ' LEU . 5.9 mp -86.81 110.36 19.89 Favored 'General case' 0 C--N 1.316 -0.88 0 N-CA-C 107.173 -1.418 . . . . 0.0 107.173 172.923 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 13' ' ' VAL . . . . . 0.479 HG21 HG23 ' A' ' 138' ' ' ILE . 1.5 p -123.73 157.19 30.42 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.93 0 CA-C-O 121.089 0.471 . . . . 0.0 110.858 -171.963 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 14' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -119.02 116.34 26.21 Favored 'General case' 0 C--N 1.317 -0.822 0 N-CA-C 106.376 -1.713 . . . . 0.0 106.376 174.197 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 15' ' ' PHE . . . . . 0.517 ' H ' HG23 ' A' ' 28' ' ' THR . 21.2 p90 -150.81 161.69 42.17 Favored 'General case' 0 C--N 1.32 -0.695 0 C-N-CA 119.221 -0.992 . . . . 0.0 112.441 -169.448 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 13.8 m -128.58 122.99 32.25 Favored 'General case' 0 N--CA 1.448 -0.535 0 N-CA-C 109.09 -0.707 . . . . 0.0 109.09 173.101 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 17' ' ' LEU . . . . . 0.51 HD11 ' HB ' ' A' ' 134' ' ' VAL . 7.3 tp -92.23 125.52 36.93 Favored 'General case' 0 C--N 1.319 -0.72 0 CA-C-O 121.407 0.622 . . . . 0.0 110.941 -173.505 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 18' ' ' LYS . . . . . 0.445 ' HD3' ' N ' ' A' ' 18' ' ' LYS . 0.0 OUTLIER -111.49 145.84 38.33 Favored 'General case' 0 C--N 1.321 -0.651 0 CA-C-N 114.849 -1.068 . . . . 0.0 111.247 -173.319 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 19' ' ' LEU . . . . . 0.466 ' CD2' ' HB2' ' A' ' 25' ' ' ALA . 4.0 mm? -86.69 166.43 15.33 Favored 'General case' 0 C--N 1.319 -0.74 0 N-CA-C 109.64 -0.504 . . . . 0.0 109.64 172.24 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 15.7 t70 -61.08 -33.75 73.83 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-O 121.243 0.544 . . . . 0.0 109.659 174.052 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 17.7 m-20 -80.08 9.34 5.64 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 115.46 -0.791 . . . . 0.0 111.899 -179.614 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 73.34 17.61 78.96 Favored Glycine 0 N--CA 1.453 -0.174 0 C-N-CA 121.146 -0.55 . . . . 0.0 113.004 178.439 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 9.3 m -85.69 152.54 23.0 Favored 'General case' 0 C--N 1.32 -0.694 0 N-CA-C 109.577 -0.527 . . . . 0.0 109.577 176.337 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 23.5 m -95.47 116.35 28.69 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-O 120.718 0.294 . . . . 0.0 110.828 179.038 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 25' ' ' ALA . . . . . 0.466 ' HB2' ' CD2' ' A' ' 19' ' ' LEU . . . -87.31 -50.67 6.43 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 116.258 -0.428 . . . . 0.0 111.567 -177.009 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 8.1 tp10 -145.62 129.29 17.13 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 115.78 -0.645 . . . . 0.0 109.468 -175.113 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 21.0 m -124.09 115.03 20.5 Favored 'General case' 0 C--N 1.318 -0.786 0 N-CA-C 110.474 -0.195 . . . . 0.0 110.474 -178.939 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 28' ' ' THR . . . . . 0.517 HG23 ' H ' ' A' ' 15' ' ' PHE . 8.4 t -122.11 57.76 1.05 Allowed 'General case' 0 C--O 1.239 0.546 0 CA-C-O 122.653 1.216 . . . . 0.0 109.182 173.484 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 10.6 mmm180 -118.12 -71.78 0.72 Allowed 'General case' 0 C--N 1.323 -0.564 0 CA-C-N 114.152 -1.386 . . . . 0.0 110.366 173.089 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 11.0 p30 -65.49 -7.45 14.4 Favored 'General case' 0 N--CA 1.47 0.537 0 CA-C-N 116.096 -0.502 . . . . 0.0 111.765 -177.302 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -61.4 -35.31 77.15 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 115.877 -0.602 . . . . 0.0 110.62 -179.419 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 90.0 -1.36 80.35 Favored Glycine 0 N--CA 1.447 -0.584 0 N-CA-C 110.759 -0.936 . . . . 0.0 110.759 -172.22 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 65.6 mttm -128.71 138.53 33.32 Favored Pre-proline 0 C--N 1.326 -0.446 0 N-CA-C 109.06 -0.719 . . . . 0.0 109.06 179.792 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 37.0 Cg_endo -85.06 171.49 9.17 Favored 'Trans proline' 0 N--CA 1.451 -1.008 0 C-N-CA 122.933 2.422 . . . . 0.0 112.029 174.423 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -113.89 139.13 49.44 Favored 'General case' 0 C--N 1.309 -1.182 0 CA-C-N 115.019 -0.992 . . . . 0.0 109.115 -179.905 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 36' ' ' LEU . . . . . 0.413 HD21 ' HB1' ' A' ' 10' ' ' ALA . 3.3 tm? -94.97 117.49 30.23 Favored 'General case' 0 C--N 1.316 -0.856 0 CA-C-O 121.27 0.557 . . . . 0.0 110.184 -178.629 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 37' ' ' PHE . . . . . . . . . . . . . 4.4 m-30 -98.51 107.84 20.39 Favored 'General case' 0 C--N 1.317 -0.84 0 CA-C-N 115.266 -0.879 . . . . 0.0 110.181 174.175 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 38' ' ' ARG . . . . . 0.707 ' HD2' ' HB2' ' A' ' 10' ' ' ALA . 19.2 tpt180 -92.84 109.39 20.83 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-N 116.265 -0.425 . . . . 0.0 109.858 178.95 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 39' ' ' LEU . . . . . 0.438 HD22 ' CB ' ' A' ' 49' ' ' GLU . 14.7 mt -81.05 154.04 27.05 Favored 'General case' 0 C--N 1.321 -0.653 0 CA-C-N 115.611 -0.722 . . . . 0.0 109.77 -177.877 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 101.47 35.78 4.01 Favored Glycine 0 N--CA 1.444 -0.778 0 C-N-CA 120.754 -0.736 . . . . 0.0 112.349 -177.191 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER 62.99 14.94 7.98 Favored 'General case' 0 N--CA 1.47 0.556 0 N-CA-C 112.96 0.726 . . . . 0.0 112.96 175.515 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -62.73 -59.01 5.48 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-O 121.034 0.445 . . . . 0.0 110.663 179.92 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 16.4 t -134.53 2.86 3.26 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-O 121.303 0.573 . . . . 0.0 110.03 177.145 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 44' ' ' LEU . . . . . 0.555 HD13 HD22 ' A' ' 48' ' ' LEU . 78.9 mt -115.38 174.1 6.18 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-N 115.542 -0.754 . . . . 0.0 109.994 -178.09 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 12.9 t -104.65 154.91 19.36 Favored 'General case' 0 C--N 1.322 -0.608 0 N-CA-C 109.306 -0.627 . . . . 0.0 109.306 176.586 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 46' ' ' GLU . . . . . 0.556 ' O ' ' HG2' ' A' ' 50' ' ' GLN . 37.7 mt-10 -47.35 -46.17 25.37 Favored 'General case' 0 N--CA 1.466 0.335 0 O-C-N 123.605 0.565 . . . . 0.0 112.067 -175.221 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -61.24 -42.12 99.69 Favored Glycine 0 N--CA 1.446 -0.677 0 CA-C-N 115.975 -0.557 . . . . 0.0 113.581 -173.562 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 48' ' ' LEU . . . . . 0.555 HD22 HD13 ' A' ' 44' ' ' LEU . 2.6 tt -61.26 -48.95 79.07 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 117.325 0.563 . . . . 0.0 111.538 -176.749 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 49' ' ' GLU . . . . . 0.465 ' O ' HD13 ' A' ' 53' ' ' LEU . 11.7 pt-20 -64.5 -37.78 88.71 Favored 'General case' 0 C--N 1.325 -0.49 0 C-N-CA 120.555 -0.458 . . . . 0.0 109.907 -179.033 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 50' ' ' GLN . . . . . 0.556 ' HG2' ' O ' ' A' ' 46' ' ' GLU . 84.5 mm-40 -51.88 -29.3 19.26 Favored 'General case' 0 N--CA 1.464 0.249 0 N-CA-C 112.047 0.388 . . . . 0.0 112.047 175.475 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 51' ' ' HIS . . . . . . . . . . . . . 3.8 m80 -97.63 -3.81 38.73 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-O 121.057 0.456 . . . . 0.0 110.973 -177.319 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 31.1 mt -102.84 -29.69 11.31 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 116.097 -0.501 . . . . 0.0 111.279 178.022 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 53' ' ' LEU . . . . . 0.465 HD13 ' O ' ' A' ' 49' ' ' GLU . 0.0 OUTLIER -59.47 139.08 57.42 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-O 121.158 0.504 . . . . 0.0 111.26 -179.465 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 93.67 -8.85 74.09 Favored Glycine 0 N--CA 1.45 -0.391 0 CA-C-N 115.743 -0.662 . . . . 0.0 112.589 -179.45 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 55' ' ' LEU . . . . . 0.424 HD12 ' HB3' ' A' ' 59' ' ' ASP . 4.2 mm? -78.15 164.92 24.56 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-O 121.048 0.452 . . . . 0.0 110.918 176.857 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 56' ' ' LYS . . . . . 0.542 ' O ' ' HB2' ' A' ' 59' ' ' ASP . 0.1 OUTLIER -126.78 164.84 20.46 Favored 'General case' 0 C--N 1.321 -0.665 0 CA-C-N 116.197 -0.456 . . . . 0.0 109.874 -176.993 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 25.5 t -63.91 132.37 29.74 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 N-CA-C 109.908 -0.405 . . . . 0.0 109.908 172.377 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 79.93 9.93 86.18 Favored Glycine 0 N--CA 1.45 -0.373 0 C-N-CA 120.995 -0.621 . . . . 0.0 112.38 -176.133 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 59' ' ' ASP . . . . . 0.542 ' HB2' ' O ' ' A' ' 56' ' ' LYS . 0.4 OUTLIER -104.52 152.96 21.75 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-O 120.964 0.411 . . . . 0.0 110.634 178.732 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 60' ' ' LYS . . . . . 0.416 ' HE3' ' OE1' ' A' ' 139' ' ' GLU . 0.6 OUTLIER -112.18 132.35 54.95 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 115.671 -0.695 . . . . 0.0 110.412 -173.003 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 61' ' ' THR . . . . . 0.404 ' HB ' HD11 ' A' ' 55' ' ' LEU . 7.6 t -139.35 115.81 10.58 Favored 'General case' 0 C--N 1.319 -0.744 0 CA-C-O 121.562 0.696 . . . . 0.0 111.066 175.743 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 62' ' ' THR . . . . . 0.459 HG23 ' O ' ' A' ' 136' ' ' PHE . 34.6 m -112.37 130.58 55.91 Favored 'General case' 0 C--N 1.318 -0.768 0 N-CA-C 108.986 -0.746 . . . . 0.0 108.986 173.492 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 28.4 p90 -148.71 146.84 28.29 Favored 'General case' 0 C--N 1.315 -0.903 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.252 -177.591 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 26.6 p -89.85 144.52 25.87 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.492 176.241 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 65' ' ' LEU . . . . . 0.41 HD11 ' HA ' ' A' ' 48' ' ' LEU . 77.0 mt -138.55 133.1 32.14 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-O 121.356 0.598 . . . . 0.0 110.866 177.635 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 66' ' ' GLU . . . . . 0.435 ' HB2' ' OD1' ' A' ' 68' ' ' ASP . 4.3 mm-40 -88.61 161.84 40.88 Favored Pre-proline 0 C--N 1.313 -1.003 0 CA-C-N 115.157 -0.929 . . . . 0.0 108.728 174.671 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 67' ' ' PRO . . . . . 0.449 ' HB3' ' HA2' ' A' ' 131' ' ' GLY . 99.1 Cg_exo -45.53 -35.47 12.47 Favored 'Trans proline' 0 C--N 1.349 0.586 0 C-N-CA 123.055 2.503 . . . . 0.0 114.367 -174.305 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 68' ' ' ASP . . . . . 0.435 ' OD1' ' HB2' ' A' ' 66' ' ' GLU . 6.8 p-10 -59.21 -29.41 67.48 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-O 120.723 0.297 . . . . 0.0 111.417 -178.889 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -115.04 11.8 16.53 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-O 120.76 0.314 . . . . 0.0 111.045 179.589 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -146.67 108.62 4.38 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 116.302 -0.408 . . . . 0.0 110.972 -174.349 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 71' ' ' PHE . . . . . 0.506 ' CB ' ' HA ' ' A' ' 130' ' ' ALA . 27.5 m-85 72.07 -45.48 0.62 Allowed 'General case' 0 N--CA 1.466 0.369 0 CA-C-N 115.358 -0.837 . . . . 0.0 111.937 179.756 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 72' ' ' GLY . . . . . 0.594 ' O ' ' HB1' ' A' ' 130' ' ' ALA . . . 131.31 155.46 8.15 Favored Glycine 0 N--CA 1.45 -0.41 0 C-N-CA 121.041 -0.599 . . . . 0.0 112.452 177.663 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 45.2 t -80.82 125.72 79.5 Favored Pre-proline 0 C--N 1.323 -0.548 0 O-C-N 122.843 -0.21 . . . . 0.0 111.298 175.101 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 74' ' ' PRO . . . . . 0.415 ' HD3' ' CA ' ' A' ' 131' ' ' GLY . 90.2 Cg_endo -80.43 155.25 21.62 Favored 'Trans proline' 0 C--N 1.346 0.397 0 C-N-CA 122.815 2.343 . . . . 0.0 111.235 173.904 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 75' ' ' SER . . . . . 0.44 ' H ' HD22 ' A' ' 126' ' ' ASN . 8.1 t -140.95 130.48 12.97 Favored Pre-proline 0 C--N 1.32 -0.687 0 CA-C-O 121.077 0.465 . . . . 0.0 110.955 -177.972 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 57.1 Cg_endo -69.92 -17.84 36.61 Favored 'Trans proline' 0 C--N 1.347 0.462 0 C-N-CA 123.27 2.647 . . . . 0.0 113.615 -176.521 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 2.6 p-10 -70.85 -11.39 60.93 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-O 120.986 0.422 . . . . 0.0 110.522 -178.785 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 78' ' ' LEU . . . . . 0.405 HD23 ' HB3' ' A' ' 75' ' ' SER . 4.3 mm? -70.9 -18.86 62.66 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.002 -0.545 . . . . 0.0 110.589 174.645 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 79' ' ' ILE . . . . . 0.471 HG12 ' HA ' ' A' ' 124' ' ' ASP . 9.9 mt -85.46 106.76 15.51 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.643 0 CA-C-N 115.763 -0.653 . . . . 0.0 110.447 -175.94 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 30.8 mt-30 -121.79 122.01 38.53 Favored 'General case' 0 C--N 1.319 -0.759 0 CA-C-N 115.639 -0.71 . . . . 0.0 111.248 -178.501 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 81' ' ' TYR . . . . . 0.658 ' CD1' HG23 ' A' ' 122' ' ' THR . 0.1 OUTLIER -108.27 114.02 27.56 Favored 'General case' 0 C--N 1.315 -0.903 0 CA-C-N 115.914 -0.584 . . . . 0.0 111.55 176.945 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -116.55 177.93 4.52 Favored 'General case' 0 C--N 1.319 -0.748 0 CA-C-O 120.626 0.251 . . . . 0.0 111.125 168.394 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 83' ' ' SER . . . . . 0.419 ' HA ' ' O ' ' A' ' 119' ' ' ASP . 8.2 t -59.27 151.58 22.91 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-O 121.572 0.701 . . . . 0.0 111.963 -170.437 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -74.36 -12.72 60.6 Favored 'General case' 0 C--N 1.333 -0.131 0 CA-C-N 115.249 -0.887 . . . . 0.0 111.34 -169.681 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 85' ' ' ARG . . . . . . . . . . . . . 7.5 mpt_? -71.49 -20.52 62.05 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 121.51 0.671 . . . . 0.0 109.905 -177.574 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 30.6 mm-40 -79.48 -12.1 59.88 Favored 'General case' 0 C--N 1.321 -0.653 0 CA-C-N 114.959 -1.019 . . . . 0.0 109.797 176.206 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 87' ' ' PHE . . . . . 0.496 ' CE1' ' HB ' ' A' ' 121' ' ' ILE . 73.7 m-85 -105.0 -46.39 4.29 Favored 'General case' 0 C--N 1.319 -0.72 0 CA-C-N 114.709 -1.132 . . . . 0.0 110.538 -175.039 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 88' ' ' MET . . . . . . . . . . . . . 64.5 ttp -58.16 -22.35 50.95 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-N 115.325 -0.852 . . . . 0.0 110.216 178.666 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 32.1 t70 -53.3 -35.67 60.37 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 115.047 -0.979 . . . . 0.0 110.838 174.033 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -116.06 11.44 15.33 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.272 -179.919 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 113.58 141.26 7.84 Favored Glycine 0 N--CA 1.448 -0.505 0 C-N-CA 120.827 -0.701 . . . . 0.0 112.117 -178.301 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 44.2 mt-10 -64.41 125.81 89.23 Favored Pre-proline 0 C--N 1.324 -0.505 0 CA-C-O 121.017 0.437 . . . . 0.0 111.416 -178.842 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 93' ' ' PRO . . . . . 0.445 ' HB2' HD13 ' A' ' 113' ' ' ILE . 53.1 Cg_endo -78.83 167.06 22.76 Favored 'Trans proline' 0 C--O 1.232 0.217 0 C-N-CA 123.591 2.86 . . . . 0.0 114.146 -174.389 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 1.1 mp0 -120.08 155.65 32.57 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 115.015 -0.993 . . . . 0.0 111.352 -173.133 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 95' ' ' ILE . . . . . 0.568 HG12 HG12 ' A' ' 116' ' ' ILE . 13.7 mt -82.34 131.41 33.86 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.155 0 CA-C-N 116.301 -0.409 . . . . 0.0 111.01 178.778 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 68.13 30.05 73.66 Favored Glycine 0 N--CA 1.448 -0.544 0 CA-C-N 115.815 -0.63 . . . . 0.0 111.905 179.966 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -108.45 125.32 51.64 Favored 'General case' 0 N--CA 1.445 -0.695 0 CA-C-O 120.934 0.397 . . . . 0.0 109.939 179.828 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 98' ' ' ILE . . . . . 0.516 ' HA ' ' HA ' ' A' ' 112' ' ' VAL . 35.4 mt -86.52 102.47 11.95 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.867 0 N-CA-C 108.807 -0.812 . . . . 0.0 108.807 179.601 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 99' ' ' MET . . . . . 0.487 ' O ' ' HD2' ' A' ' 101' ' ' PHE . 7.0 mtm -105.39 126.63 52.33 Favored 'General case' 0 N--CA 1.438 -1.057 0 CA-C-O 121.665 0.745 . . . . 0.0 110.545 -175.279 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 4.4 mm? -62.75 147.81 48.65 Favored 'General case' 0 C--N 1.305 -1.331 0 CA-C-N 114.28 -1.327 . . . . 0.0 109.326 171.078 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 101' ' ' PHE . . . . . 0.487 ' HD2' ' O ' ' A' ' 99' ' ' MET . 0.4 OUTLIER -148.62 167.02 26.55 Favored 'General case' 0 CA--C 1.509 -0.619 0 CA-C-N 115.021 -0.99 . . . . 0.0 108.44 -152.806 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 1.5 m -121.78 122.15 38.86 Favored 'General case' 0 C--N 1.309 -1.179 0 C-N-CA 119.773 -0.771 . . . . 0.0 110.353 176.965 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -88.12 165.25 15.24 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-N 115.791 -0.64 . . . . 0.0 110.305 -177.779 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 104' ' ' MET . . . . . . . . . . . . . 2.0 mpt? -66.23 -12.73 58.01 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.807 -0.633 . . . . 0.0 112.002 -175.014 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 8.6 p-10 -99.71 15.44 26.8 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-O 120.737 0.304 . . . . 0.0 110.982 179.765 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 79.76 -11.95 31.3 Favored Glycine 0 CA--C 1.52 0.346 0 C-N-CA 121.121 -0.562 . . . . 0.0 113.88 177.824 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 24.6 t -79.71 151.13 30.61 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-O 121.203 0.525 . . . . 0.0 110.081 179.586 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 26.3 tt0 -94.56 100.26 12.26 Favored 'General case' 0 C--N 1.313 -1.016 0 CA-C-N 115.585 -0.734 . . . . 0.0 110.009 -178.019 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 109' ' ' MET . . . . . . . . . . . . . 3.1 mtp -92.25 147.85 35.42 Favored Pre-proline 0 C--N 1.324 -0.524 0 CA-C-N 115.3 -0.864 . . . . 0.0 110.842 179.998 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 55.2 Cg_endo -72.49 154.72 55.46 Favored 'Trans proline' 0 N--CA 1.458 -0.56 0 C-N-CA 122.009 1.806 . . . . 0.0 110.871 173.374 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 111' ' ' GLY . . . . . 0.502 ' HA2' ' O ' ' A' ' 124' ' ' ASP . . . -150.21 103.48 0.25 Allowed Glycine 0 N--CA 1.445 -0.736 0 C-N-CA 120.164 -1.017 . . . . 0.0 110.853 -171.637 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 112' ' ' VAL . . . . . 0.516 ' HA ' ' HA ' ' A' ' 98' ' ' ILE . 7.7 p -97.73 113.26 31.77 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.559 0 CA-C-N 119.237 1.518 . . . . 0.0 110.689 -179.462 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 113' ' ' ILE . . . . . 0.466 ' HA ' ' O ' ' A' ' 122' ' ' THR . 39.2 mt -72.6 111.14 6.47 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.897 0 CA-C-N 114.902 -1.045 . . . . 0.0 110.059 179.941 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 114' ' ' ARG . . . . . 0.514 ' HD3' ' O ' ' A' ' 114' ' ' ARG . 8.8 tpp180 -63.81 -46.73 83.81 Favored 'General case' 0 C--N 1.322 -0.625 0 CA-C-N 114.909 -1.041 . . . . 0.0 110.864 -177.669 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 115' ' ' GLU . . . . . 0.526 ' HA ' HG23 ' A' ' 95' ' ' ILE . 14.5 tt0 -159.25 154.43 25.27 Favored 'General case' 0 C--N 1.324 -0.531 0 C-N-CA 120.705 -0.398 . . . . 0.0 110.882 -175.751 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 116' ' ' ILE . . . . . 0.568 HG12 HG12 ' A' ' 95' ' ' ILE . 37.4 mm -100.57 120.63 50.3 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 N-CA-C 109.183 -0.673 . . . . 0.0 109.183 175.987 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 117' ' ' ASN . . . . . 0.432 ' HB2' ' O ' ' A' ' 120' ' ' SER . 30.2 m-80 -110.41 157.46 19.53 Favored 'General case' 0 C--N 1.315 -0.913 0 CA-C-N 115.934 -0.575 . . . . 0.0 110.171 -179.755 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . -56.21 -40.59 84.53 Favored Glycine 0 C--O 1.227 -0.343 0 C-N-CA 120.688 -0.768 . . . . 0.0 113.694 -169.528 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 119' ' ' ASP . . . . . 0.419 ' O ' ' HA ' ' A' ' 83' ' ' SER . 24.8 m-20 -113.07 -15.69 12.77 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 117.169 0.484 . . . . 0.0 112.119 179.826 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 120' ' ' SER . . . . . 0.432 ' O ' ' HB2' ' A' ' 117' ' ' ASN . 13.6 t -130.73 156.49 44.86 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-O 120.923 0.392 . . . . 0.0 111.483 -169.999 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 121' ' ' ILE . . . . . 0.506 HD12 HD12 ' A' ' 116' ' ' ILE . 49.5 mm -127.46 125.59 65.95 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.778 -178.626 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 122' ' ' THR . . . . . 0.658 HG23 ' CD1' ' A' ' 81' ' ' TYR . 10.7 m -95.38 103.32 15.18 Favored 'General case' 0 C--N 1.329 -0.323 0 N-CA-C 112.477 0.547 . . . . 0.0 112.477 -174.246 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 5.6 t -103.78 122.06 56.02 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 N-CA-C 113.307 0.854 . . . . 0.0 113.307 177.404 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 124' ' ' ASP . . . . . 0.502 ' O ' ' HA2' ' A' ' 111' ' ' GLY . 1.3 t70 -89.04 135.41 33.57 Favored 'General case' 0 C--N 1.322 -0.587 0 CA-C-N 115.191 -0.913 . . . . 0.0 111.508 170.285 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 125' ' ' PHE . . . . . . . . . . . . . 63.2 m-85 -117.98 59.15 0.8 Allowed 'General case' 0 C--N 1.331 -0.216 0 CA-C-O 122.115 0.96 . . . . 0.0 110.381 -176.118 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 126' ' ' ASN . . . . . 0.44 HD22 ' H ' ' A' ' 75' ' ' SER . 7.4 m120 -104.39 142.4 34.65 Favored 'General case' 0 C--N 1.307 -1.266 0 CA-C-N 114.311 -1.313 . . . . 0.0 111.496 -179.439 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 127' ' ' HIS . . . . . 0.492 ' HB3' ' HD2' ' A' ' 128' ' ' PRO . 20.9 m80 -60.73 -175.2 0.08 OUTLIER Pre-proline 0 C--N 1.321 -0.645 0 CA-C-N 113.914 -1.493 . . . . 0.0 112.794 -178.162 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 128' ' ' PRO . . . . . 0.492 ' HD2' ' HB3' ' A' ' 127' ' ' HIS . 3.9 Cg_exo -42.82 177.47 0.0 OUTLIER 'Trans proline' 0 C--N 1.355 0.881 0 C-N-CA 125.252 3.968 . . . . 0.0 114.172 165.184 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 129' ' ' LEU . . . . . 0.514 ' O ' ' HG ' ' A' ' 129' ' ' LEU . 26.4 tp -47.6 42.45 0.0 OUTLIER 'General case' 0 N--CA 1.488 1.433 0 C-N-CA 127.621 2.368 . . . . 0.0 115.418 -176.24 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 130' ' ' ALA . . . . . 0.594 ' HB1' ' O ' ' A' ' 72' ' ' GLY . . . -86.24 173.95 9.42 Favored 'General case' 0 C--N 1.31 -1.143 0 N-CA-C 109.49 -0.559 . . . . 0.0 109.49 -176.153 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 131' ' ' GLY . . . . . 0.449 ' HA2' ' HB3' ' A' ' 67' ' ' PRO . . . 73.56 21.48 79.43 Favored Glycine 0 N--CA 1.448 -0.541 0 C-N-CA 120.637 -0.792 . . . . 0.0 113.145 178.836 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 132' ' ' GLN . . . . . . . . . . . . . 10.0 pt20 -110.31 143.67 40.18 Favored 'General case' 0 N--CA 1.444 -0.766 0 N-CA-C 109.707 -0.479 . . . . 0.0 109.707 174.965 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 133' ' ' THR . . . . . . . . . . . . . 20.5 m -88.36 111.79 22.14 Favored 'General case' 0 C--N 1.317 -0.829 0 N-CA-C 108.85 -0.796 . . . . 0.0 108.85 177.82 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 134' ' ' VAL . . . . . 0.51 ' HB ' HD11 ' A' ' 17' ' ' LEU . 1.5 m -121.99 148.78 25.37 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.595 0 CA-C-O 121.894 0.854 . . . . 0.0 112.6 -172.271 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 135' ' ' HIS . . . . . 0.41 ' O ' HD12 ' A' ' 17' ' ' LEU . 15.0 m-70 -112.42 147.38 36.58 Favored 'General case' 0 C--N 1.316 -0.89 0 CA-C-N 114.624 -1.171 . . . . 0.0 108.508 174.028 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 136' ' ' PHE . . . . . 0.459 ' O ' HG23 ' A' ' 62' ' ' THR . 12.5 m-85 -123.45 124.11 42.15 Favored 'General case' 0 C--N 1.31 -1.131 0 CA-C-N 116.028 -0.533 . . . . 0.0 111.71 -166.726 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 137' ' ' ASP . . . . . 0.466 ' O ' ' HB2' ' A' ' 15' ' ' PHE . 12.9 m-20 -116.58 96.42 5.5 Favored 'General case' 0 C--N 1.324 -0.525 0 N-CA-C 108.608 -0.886 . . . . 0.0 108.608 175.784 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 138' ' ' ILE . . . . . 0.479 HG23 HG21 ' A' ' 13' ' ' VAL . 1.9 mp -107.65 138.57 33.28 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.55 0 N-CA-C 112.599 0.592 . . . . 0.0 112.599 -177.794 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 139' ' ' GLU . . . . . 0.416 ' OE1' ' HE3' ' A' ' 60' ' ' LYS . 31.8 mt-10 -125.59 124.71 41.83 Favored 'General case' 0 CA--C 1.507 -0.676 0 N-CA-C 108.084 -1.08 . . . . 0.0 108.084 167.885 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 140' ' ' VAL . . . . . . . . . . . . . 71.6 t -78.16 121.47 31.05 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.747 0 C-N-CA 120.704 -0.398 . . . . 0.0 110.428 -176.947 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 19.2 mt -93.1 -44.05 8.57 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-O 121.262 0.553 . . . . 0.0 110.027 178.084 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 142' ' ' GLU . . . . . . . . . . . . . 10.2 tp10 -153.67 152.22 30.56 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-N 115.465 -0.789 . . . . 0.0 109.768 -179.336 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 143' ' ' ILE . . . . . . . . . . . . . 63.0 mt -116.9 121.16 67.13 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.421 0 CA-C-O 121.007 0.432 . . . . 0.0 110.317 178.531 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 144' ' ' ASP . . . . . 0.646 ' HB3' ' HB3' ' A' ' 10' ' ' ALA . 38.6 t70 -77.37 128.5 80.22 Favored Pre-proline 0 C--N 1.322 -0.618 0 CA-C-N 115.808 -0.633 . . . . 0.0 110.154 -179.341 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 145' ' ' PRO . . . . . . . . . . . . . 73.7 Cg_exo -52.61 153.89 13.27 Favored 'Trans proline' 0 C--N 1.345 0.383 0 C-N-CA 123.29 2.66 . . . . 0.0 112.539 178.415 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 146' ' ' ALA . . . . . . . . . . . . . . . -83.73 95.71 8.49 Favored 'General case' 0 C--N 1.32 -0.716 0 CA-C-O 121.591 0.71 . . . . 0.0 111.106 -177.684 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 3.8 mm? -102.33 31.07 4.19 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-N 115.438 -0.801 . . . . 0.0 108.841 170.469 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 148' ' ' GLU . . . . . 0.438 ' HA ' ' OD1' ' A' ' 8' ' ' ASN . 41.2 mt-10 . . . . . 0 CA--C 1.527 0.083 0 CA-C-N 114.679 -1.146 . . . . 0.0 111.249 -178.733 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 26.4 ttt . . . . . 0 N--CA 1.48 1.037 0 CA-C-O 120.743 0.306 . . . . 0.0 110.189 . . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 4.8 t -109.55 118.34 36.35 Favored 'General case' 0 C--N 1.322 -0.605 0 N-CA-C 109.25 -0.648 . . . . 0.0 109.25 177.86 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 3' ' ' GLU . . . . . 0.436 ' CG ' ' HE2' ' A' ' 56' ' ' LYS . 39.2 tt0 -74.5 -34.44 63.06 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-O 121.477 0.656 . . . . 0.0 110.554 -177.132 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 24.2 m -128.12 156.82 42.24 Favored 'General case' 0 C--N 1.314 -0.939 0 CA-C-N 115.302 -0.863 . . . . 0.0 109.604 179.621 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 5' ' ' VAL . . . . . 0.561 HG13 ' HA ' ' A' ' 53' ' ' LEU . 7.1 p -81.96 135.94 23.97 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.532 0 CA-C-O 121.021 0.439 . . . . 0.0 110.83 -177.58 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 6' ' ' GLN . . . . . 0.594 ' HG2' ' OG ' ' A' ' 9' ' ' SER . 7.4 pt20 -123.21 168.49 12.37 Favored 'General case' 0 C--N 1.318 -0.792 0 CA-C-N 115.933 -0.576 . . . . 0.0 109.632 177.866 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 29.4 t -54.23 122.77 11.01 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-O 120.765 0.317 . . . . 0.0 110.493 179.052 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 2.9 t30 73.5 41.25 0.46 Allowed 'General case' 0 N--CA 1.469 0.497 0 C-N-CA 123.935 0.894 . . . . 0.0 111.132 -177.238 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 9' ' ' SER . . . . . 0.594 ' OG ' ' HG2' ' A' ' 6' ' ' GLN . 67.0 m -122.2 134.74 54.71 Favored 'General case' 0 C--N 1.325 -0.473 0 N-CA-C 108.846 -0.798 . . . . 0.0 108.846 168.288 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 10' ' ' ALA . . . . . 0.502 ' HB2' ' HD3' ' A' ' 38' ' ' ARG . . . -84.68 147.57 26.86 Favored 'General case' 0 C--N 1.315 -0.899 0 CA-C-N 116.533 -0.303 . . . . 0.0 110.233 -176.858 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 13.5 m -133.91 142.88 40.08 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.864 0 C-N-CA 120.712 -0.395 . . . . 0.0 110.335 179.971 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 30.6 tp -86.55 123.57 31.9 Favored 'General case' 0 C--N 1.319 -0.739 0 N-CA-C 108.271 -1.011 . . . . 0.0 108.271 174.797 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 13' ' ' VAL . . . . . 0.706 HG21 HG23 ' A' ' 138' ' ' ILE . 4.4 p -131.93 156.28 42.38 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.778 0 CA-C-O 122.27 1.033 . . . . 0.0 113.057 -172.432 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 14' ' ' HIS . . . . . 0.497 ' CD2' HD11 ' A' ' 141' ' ' LEU . 2.2 m-70 -118.77 120.85 38.59 Favored 'General case' 0 C--N 1.317 -0.835 0 N-CA-C 106.059 -1.83 . . . . 0.0 106.059 169.471 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 15' ' ' PHE . . . . . 0.519 ' CD1' ' HB ' ' A' ' 28' ' ' THR . 16.2 p90 -151.08 157.87 43.33 Favored 'General case' 0 C--N 1.324 -0.537 0 C-N-CA 118.181 -1.408 . . . . 0.0 113.948 -170.336 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 22.2 m -131.06 130.43 43.23 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 114.85 -1.068 . . . . 0.0 108.598 176.904 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 17' ' ' LEU . . . . . 0.799 HD21 ' HB ' ' A' ' 134' ' ' VAL . 2.2 tt -121.81 118.05 28.05 Favored 'General case' 0 N--CA 1.446 -0.637 0 N-CA-C 109.435 -0.58 . . . . 0.0 109.435 -173.678 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 18' ' ' LYS . . . . . 0.651 ' HB3' ' CE1' ' A' ' 135' ' ' HIS . 2.4 tppt? -126.19 155.63 41.46 Favored 'General case' 0 C--N 1.314 -0.94 0 C-N-CA 119.988 -0.685 . . . . 0.0 111.455 -174.885 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 3.1 mm? -99.52 171.5 7.89 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-N 115.291 -0.868 . . . . 0.0 109.339 173.813 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 35.5 t70 -64.72 -25.49 67.96 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-O 121.373 0.606 . . . . 0.0 109.866 176.099 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 5.0 m-20 -77.53 2.99 14.67 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.5 -0.773 . . . . 0.0 110.843 178.501 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 73.27 9.57 77.28 Favored Glycine 0 C--N 1.33 0.245 0 C-N-CA 121.387 -0.435 . . . . 0.0 113.28 -179.913 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 26.7 m -82.27 142.26 32.25 Favored 'General case' 0 C--N 1.321 -0.644 0 N-CA-C 109.835 -0.431 . . . . 0.0 109.835 177.093 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 20.9 m -89.59 112.57 23.82 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-O 120.747 0.308 . . . . 0.0 110.335 179.316 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 25' ' ' ALA . . . . . 0.714 ' HB3' HD22 ' A' ' 17' ' ' LEU . . . -72.69 -38.09 67.66 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 121.134 0.493 . . . . 0.0 110.111 178.506 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 8.4 tp10 -157.32 141.24 16.04 Favored 'General case' 0 N--CA 1.446 -0.663 0 CA-C-N 115.732 -0.667 . . . . 0.0 110.132 178.682 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 36.9 p -124.53 119.72 29.91 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-O 121.125 0.488 . . . . 0.0 110.934 -178.828 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 28' ' ' THR . . . . . 0.584 ' O ' HG22 ' A' ' 28' ' ' THR . 96.8 m -139.62 11.26 2.49 Favored 'General case' 0 CA--C 1.547 0.848 0 CA-C-O 123.269 1.509 . . . . 0.0 110.562 177.187 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 29' ' ' ARG . . . . . 0.407 ' NH1' ' HB3' ' A' ' 30' ' ' ASN . 8.7 tmm_? -104.27 -52.96 2.82 Favored 'General case' 0 C--N 1.308 -1.215 0 CA-C-N 115.099 -0.955 . . . . 0.0 109.921 167.481 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 30' ' ' ASN . . . . . 0.407 ' HB3' ' NH1' ' A' ' 29' ' ' ARG . 4.8 p-10 -82.52 35.0 0.44 Allowed 'General case' 0 C--N 1.326 -0.436 0 CA-C-O 121.079 0.466 . . . . 0.0 111.472 -178.87 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 4.5 m-20 -120.33 -23.27 6.24 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.334 -0.394 . . . . 0.0 111.599 -178.788 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 84.85 -11.6 59.37 Favored Glycine 0 N--CA 1.453 -0.212 0 C-N-CA 120.435 -0.888 . . . . 0.0 110.905 -174.286 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 33' ' ' LYS . . . . . 0.458 ' HD2' ' HD2' ' A' ' 34' ' ' PRO . 56.1 tptt -120.53 118.16 31.09 Favored Pre-proline 0 C--N 1.321 -0.646 0 CA-C-N 114.896 -0.652 . . . . 0.0 110.054 -177.974 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 34' ' ' PRO . . . . . 0.458 ' HD2' ' HD2' ' A' ' 33' ' ' LYS . 73.9 Cg_endo -80.28 170.77 15.8 Favored 'Trans proline' 0 N--CA 1.457 -0.672 0 C-N-CA 122.506 2.137 . . . . 0.0 111.526 174.125 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -137.02 152.26 49.9 Favored 'General case' 0 C--N 1.311 -1.091 0 CA-C-N 115.671 -0.695 . . . . 0.0 110.463 -175.58 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 2.0 tp -90.69 138.24 31.73 Favored 'General case' 0 C--N 1.317 -0.807 0 N-CA-C 109.414 -0.588 . . . . 0.0 109.414 175.038 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 37' ' ' PHE . . . . . . . . . . . . . 2.4 m-30 -104.0 106.66 17.24 Favored 'General case' 0 C--N 1.317 -0.825 0 N-CA-C 108.67 -0.863 . . . . 0.0 108.67 175.535 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 38' ' ' ARG . . . . . 0.502 ' HD3' ' HB2' ' A' ' 10' ' ' ALA . 6.5 tpp180 -86.07 105.6 16.61 Favored 'General case' 0 C--N 1.323 -0.569 0 N-CA-C 109.105 -0.702 . . . . 0.0 109.105 -179.733 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 40.0 mt -90.38 156.39 18.27 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-N 115.363 -0.835 . . . . 0.0 111.666 -175.743 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 102.49 37.85 3.17 Favored Glycine 0 N--CA 1.45 -0.407 0 CA-C-N 115.335 -0.848 . . . . 0.0 111.996 -177.884 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 31.9 t70 65.74 0.53 1.52 Allowed 'General case' 0 N--CA 1.472 0.637 0 C-N-CA 123.509 0.724 . . . . 0.0 111.893 179.739 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -65.78 -48.34 72.12 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.781 -179.779 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 23.1 m -134.42 -39.79 0.82 Allowed 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 116.066 -0.515 . . . . 0.0 110.788 178.135 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 4.6 mm? -88.79 162.72 16.05 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-O 121.038 0.447 . . . . 0.0 111.19 -178.818 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 32.2 t -86.81 153.68 21.48 Favored 'General case' 0 C--N 1.324 -0.5 0 CA-C-N 115.356 -0.838 . . . . 0.0 110.212 -178.997 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 42.3 mt-10 -52.45 -42.9 64.58 Favored 'General case' 0 C--N 1.328 -0.336 0 N-CA-C 112.309 0.485 . . . . 0.0 112.309 -173.818 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -64.96 -37.68 94.57 Favored Glycine 0 N--CA 1.447 -0.62 0 C-N-CA 120.41 -0.9 . . . . 0.0 112.777 -174.699 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 48' ' ' LEU . . . . . 0.482 HD11 HD12 ' A' ' 52' ' ' LEU . 3.4 tm? -70.09 -53.63 16.6 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 121.003 0.43 . . . . 0.0 110.093 -176.934 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 10.4 pt-20 -58.3 -40.89 83.19 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 115.712 -0.676 . . . . 0.0 112.107 -177.868 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 50' ' ' GLN . . . . . 0.516 ' HA ' ' CD2' ' A' ' 53' ' ' LEU . 90.6 mm-40 -73.74 -15.14 61.22 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-O 120.811 0.338 . . . . 0.0 111.336 -173.003 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 51' ' ' HIS . . . . . . . . . . . . . 14.6 m-70 -107.48 -9.4 15.97 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-O 120.945 0.402 . . . . 0.0 110.45 179.255 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 52' ' ' LEU . . . . . 0.482 HD12 HD11 ' A' ' 48' ' ' LEU . 0.4 OUTLIER -98.62 -30.48 12.46 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.274 179.284 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 53' ' ' LEU . . . . . 0.561 ' HA ' HG13 ' A' ' 5' ' ' VAL . 3.0 pp -66.76 152.08 46.2 Favored 'General case' 0 N--CA 1.452 -0.331 0 N-CA-C 109.764 -0.458 . . . . 0.0 109.764 179.565 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 93.28 3.27 65.28 Favored Glycine 0 N--CA 1.445 -0.704 0 C-N-CA 120.872 -0.68 . . . . 0.0 112.824 -175.136 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 55' ' ' LEU . . . . . 0.415 ' O ' HG12 ' A' ' 5' ' ' VAL . 3.8 mm? -96.01 165.28 12.33 Favored 'General case' 0 C--O 1.233 0.228 0 CA-C-N 117.395 0.598 . . . . 0.0 110.703 177.759 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 56' ' ' LYS . . . . . 0.601 ' HD3' ' N ' ' A' ' 57' ' ' VAL . 11.0 tmtt? -117.62 151.3 37.48 Favored 'General case' 0 C--N 1.324 -0.53 0 N-CA-C 109.031 -0.729 . . . . 0.0 109.031 -177.969 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 57' ' ' VAL . . . . . 0.601 ' N ' ' HD3' ' A' ' 56' ' ' LYS . 42.6 t -58.44 136.91 21.42 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-O 121.134 0.492 . . . . 0.0 111.492 176.708 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 82.75 8.97 85.23 Favored Glycine 0 N--CA 1.446 -0.645 0 CA-C-N 115.116 -0.947 . . . . 0.0 111.973 -178.985 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 59' ' ' ASP . . . . . 0.452 ' HB2' ' O ' ' A' ' 56' ' ' LYS . 1.0 OUTLIER -99.56 134.09 42.94 Favored 'General case' 0 C--N 1.323 -0.544 0 N-CA-C 108.916 -0.772 . . . . 0.0 108.916 171.772 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 6.9 mmmm -106.52 128.35 54.03 Favored 'General case' 0 C--N 1.319 -0.744 0 N-CA-C 109.248 -0.649 . . . . 0.0 109.248 -175.753 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 4.7 t -136.64 113.8 10.65 Favored 'General case' 0 C--N 1.32 -0.694 0 CA-C-O 121.837 0.827 . . . . 0.0 111.525 -176.536 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 62' ' ' THR . . . . . 0.434 HG23 ' HA ' ' A' ' 137' ' ' ASP . 6.1 m -100.47 131.66 46.27 Favored 'General case' 0 C--N 1.317 -0.842 0 N-CA-C 108.238 -1.023 . . . . 0.0 108.238 172.084 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 63' ' ' PHE . . . . . 0.513 ' CE2' ' HE1' ' A' ' 136' ' ' PHE . 11.3 p90 -157.92 163.98 37.34 Favored 'General case' 0 C--N 1.321 -0.661 0 C-N-CA 120.063 -0.655 . . . . 0.0 111.818 -178.072 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 26.0 t -128.75 151.81 49.13 Favored 'General case' 0 C--N 1.318 -0.785 0 CA-C-N 115.187 -0.915 . . . . 0.0 109.829 179.816 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 65' ' ' LEU . . . . . 0.421 ' CD1' ' HA ' ' A' ' 48' ' ' LEU . 39.3 mt -135.85 150.94 49.57 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-N 116.219 -0.446 . . . . 0.0 109.981 -176.882 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 48.7 mt-10 -64.1 153.88 83.94 Favored Pre-proline 0 C--N 1.33 -0.282 0 CA-C-N 116.081 -0.509 . . . . 0.0 110.527 178.779 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 80.9 Cg_exo -46.35 -52.25 7.57 Favored 'Trans proline' 0 C--O 1.233 0.257 0 C-N-CA 123.103 2.535 . . . . 0.0 113.542 -175.777 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 1.9 p-10 -66.26 -24.96 66.67 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-O 120.921 0.391 . . . . 0.0 111.053 -174.784 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -79.85 -18.55 50.49 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 115.98 -0.554 . . . . 0.0 110.922 -178.581 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -117.86 -85.84 0.64 Allowed 'General case' 0 N--CA 1.449 -0.482 0 N-CA-C 111.953 0.353 . . . . 0.0 111.953 -178.093 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 71' ' ' PHE . . . . . . . . . . . . . 9.2 m-85 -86.29 -12.31 49.86 Favored 'General case' 0 C--N 1.328 -0.345 0 N-CA-C 112.379 0.511 . . . . 0.0 112.379 -171.863 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 72' ' ' GLY . . . . . 0.465 ' C ' ' HB1' ' A' ' 130' ' ' ALA . . . 105.91 -152.59 17.13 Favored Glycine 0 N--CA 1.454 -0.158 0 C-N-CA 120.82 -0.705 . . . . 0.0 112.202 179.284 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 26.0 m -134.0 128.41 19.62 Favored Pre-proline 0 N--CA 1.449 -0.49 0 CA-C-O 121.572 0.701 . . . . 0.0 112.181 -179.019 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 74' ' ' PRO . . . . . 0.523 ' HD3' ' N ' ' A' ' 131' ' ' GLY . 61.7 Cg_endo -85.5 165.07 10.79 Favored 'Trans proline' 0 N--CA 1.458 -0.6 0 C-N-CA 124.438 3.426 . . . . 0.0 110.905 169.687 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 75' ' ' SER . . . . . 0.59 ' HB3' HD22 ' A' ' 78' ' ' LEU . 41.3 t -141.48 97.36 6.75 Favored Pre-proline 0 C--N 1.312 -1.061 0 N-CA-C 109.896 -0.409 . . . . 0.0 109.896 173.784 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 26.9 Cg_endo -65.44 -25.84 55.61 Favored 'Trans proline' 0 N--CA 1.459 -0.536 0 C-N-CA 121.729 1.619 . . . . 0.0 111.009 175.666 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 8.6 p-10 -77.36 -8.87 58.37 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 115.701 -0.681 . . . . 0.0 110.753 176.524 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 78' ' ' LEU . . . . . 0.59 HD22 ' HB3' ' A' ' 75' ' ' SER . 4.4 tp -73.23 -23.06 60.31 Favored 'General case' 0 CA--C 1.511 -0.549 0 CA-C-O 121.596 0.712 . . . . 0.0 109.147 176.604 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 79' ' ' ILE . . . . . 0.632 HG23 ' O ' ' A' ' 123' ' ' VAL . 7.0 mt -68.3 124.24 23.43 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.724 0 CA-C-N 114.69 -1.141 . . . . 0.0 110.575 177.245 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 40.2 mt-30 -149.97 119.27 6.83 Favored 'General case' 0 CA--C 1.502 -0.885 0 CA-C-N 114.992 -1.004 . . . . 0.0 109.377 -176.184 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 81' ' ' TYR . . . . . 0.592 ' CE2' HG23 ' A' ' 122' ' ' THR . 1.8 m-85 -80.26 114.75 19.38 Favored 'General case' 0 C--N 1.307 -1.27 0 C-N-CA 118.76 -1.176 . . . . 0.0 111.902 174.97 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 23.6 m-85 -100.15 172.71 7.01 Favored 'General case' 0 C--N 1.322 -0.627 0 CA-C-N 113.782 -1.554 . . . . 0.0 110.141 172.399 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 83' ' ' SER . . . . . 0.436 ' HB3' ' HG3' ' A' ' 86' ' ' GLU . 23.2 t -63.24 159.34 18.01 Favored 'General case' 0 C--N 1.321 -0.657 0 CA-C-O 122.836 1.303 . . . . 0.0 112.485 -167.952 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 84' ' ' ARG . . . . . 0.574 ' HD3' ' HA ' ' A' ' 119' ' ' ASP . 36.5 ptt180 -77.5 -28.21 52.08 Favored 'General case' 0 C--N 1.315 -0.925 0 CA-C-N 112.604 -2.089 . . . . 0.0 108.118 -179.31 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 85' ' ' ARG . . . . . . . . . . . . . 6.6 mpt_? -71.53 -39.8 70.5 Favored 'General case' 0 CA--C 1.512 -0.5 0 CA-C-N 114.281 -1.327 . . . . 0.0 111.158 -176.99 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 86' ' ' GLU . . . . . 0.436 ' HG3' ' HB3' ' A' ' 83' ' ' SER . 41.4 mt-10 -56.02 -36.88 68.45 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 115.316 -0.857 . . . . 0.0 110.891 -175.941 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 87' ' ' PHE . . . . . 0.443 ' HB3' ' HG3' ' A' ' 93' ' ' PRO . 14.0 m-85 -93.18 -37.44 12.09 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.475 -0.329 . . . . 0.0 111.843 -179.601 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 88' ' ' MET . . . . . . . . . . . . . 58.6 ttp -58.53 -31.79 68.25 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.59 -173.382 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 33.9 t70 -57.55 -28.62 63.71 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-O 120.954 0.407 . . . . 0.0 110.912 177.443 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -102.79 -2.91 27.18 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.055 -0.52 . . . . 0.0 110.732 176.967 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 119.59 140.08 6.1 Favored Glycine 0 N--CA 1.447 -0.583 0 C-N-CA 121.035 -0.602 . . . . 0.0 112.117 -178.108 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 47.0 mt-10 -61.11 120.94 58.9 Favored Pre-proline 0 C--N 1.327 -0.398 0 CA-C-O 120.807 0.336 . . . . 0.0 110.887 178.465 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 93' ' ' PRO . . . . . 0.447 ' HG2' HD12 ' A' ' 121' ' ' ILE . 4.3 Cg_exo -71.7 167.42 26.57 Favored 'Trans proline' 0 C--N 1.344 0.312 0 C-N-CA 123.303 2.669 . . . . 0.0 112.895 -176.841 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -115.4 156.04 26.31 Favored 'General case' 0 C--N 1.321 -0.64 0 CA-C-N 115.04 -0.982 . . . . 0.0 111.045 -174.609 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 95' ' ' ILE . . . . . 0.528 HG12 HG12 ' A' ' 116' ' ' ILE . 21.6 mt -81.76 131.06 34.72 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.453 0 CA-C-N 115.909 -0.587 . . . . 0.0 110.875 -178.716 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 72.92 18.76 79.2 Favored Glycine 0 N--CA 1.449 -0.466 0 CA-C-N 115.709 -0.678 . . . . 0.0 112.422 -177.289 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 97' ' ' ALA . . . . . 0.411 ' O ' HG13 ' A' ' 113' ' ' ILE . . . -98.71 129.74 45.17 Favored 'General case' 0 C--N 1.324 -0.515 0 N-CA-C 109.674 -0.491 . . . . 0.0 109.674 177.385 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 98' ' ' ILE . . . . . 0.555 ' HA ' ' HA ' ' A' ' 112' ' ' VAL . 16.4 mt -97.79 130.08 47.04 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.725 0 N-CA-C 108.837 -0.801 . . . . 0.0 108.837 178.759 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 99' ' ' MET . . . . . . . . . . . . . 9.7 mtm -137.0 160.44 38.91 Favored 'General case' 0 N--CA 1.447 -0.594 0 N-CA-C 107.601 -1.259 . . . . 0.0 107.601 -179.721 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 2.6 mm? -69.77 103.63 2.22 Favored 'General case' 0 C--N 1.317 -0.814 0 CA-C-O 122.318 1.056 . . . . 0.0 111.046 175.307 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 101' ' ' PHE . . . . . . . . . . . . . 2.8 m-85 -94.2 171.63 8.71 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 113.151 -1.841 . . . . 0.0 112.612 -172.914 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 2.6 m -124.87 135.71 53.14 Favored 'General case' 0 C--N 1.313 -0.985 0 CA-C-N 114.439 -1.255 . . . . 0.0 109.382 -178.241 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -103.54 159.47 15.57 Favored 'General case' 0 C--N 1.32 -0.692 0 N-CA-C 109.316 -0.624 . . . . 0.0 109.316 -177.929 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 104' ' ' MET . . . . . . . . . . . . . 71.2 mtm -66.39 -12.49 57.22 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.057 -0.519 . . . . 0.0 111.798 -174.446 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 4.5 p-10 -93.59 3.96 54.7 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 120.848 0.356 . . . . 0.0 110.853 177.568 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 92.32 -10.83 73.51 Favored Glycine 0 N--CA 1.444 -0.788 0 C-N-CA 120.672 -0.775 . . . . 0.0 113.69 178.939 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 34.9 t -78.01 140.32 39.17 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-O 121.52 0.676 . . . . 0.0 111.072 -179.471 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 23.0 tt0 -94.74 98.78 11.01 Favored 'General case' 0 C--N 1.314 -0.97 0 CA-C-N 115.253 -0.885 . . . . 0.0 110.249 178.389 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 109' ' ' MET . . . . . . . . . . . . . 1.6 mtm -100.81 145.1 29.78 Favored Pre-proline 0 C--N 1.326 -0.421 0 CA-C-N 115.203 -0.908 . . . . 0.0 110.609 176.897 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 23.9 Cg_endo -66.61 116.35 4.04 Favored 'Trans proline' 0 N--CA 1.455 -0.741 0 C-N-CA 121.336 1.357 . . . . 0.0 110.631 173.227 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . -111.26 132.49 10.94 Favored Glycine 0 CA--C 1.502 -0.739 0 CA-C-N 115.518 -0.765 . . . . 0.0 112.223 -177.147 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 112' ' ' VAL . . . . . 0.555 ' HA ' ' HA ' ' A' ' 98' ' ' ILE . 3.0 p -94.62 133.22 36.29 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.739 0 N-CA-C 108.774 -0.825 . . . . 0.0 108.774 174.207 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 113' ' ' ILE . . . . . 0.444 HD13 ' CB ' ' A' ' 93' ' ' PRO . 20.3 mt -86.24 109.85 19.25 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.14 0 N-CA-C 108.201 -1.037 . . . . 0.0 108.201 -178.433 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 114' ' ' ARG . . . . . 0.474 ' O ' HG23 ' A' ' 95' ' ' ILE . 11.9 tpp180 -64.97 -46.75 80.19 Favored 'General case' 0 C--N 1.314 -0.957 0 CA-C-N 115.198 -0.91 . . . . 0.0 111.078 -174.395 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 115' ' ' GLU . . . . . 0.442 ' HA ' HG23 ' A' ' 95' ' ' ILE . 4.8 tt0 -159.7 160.05 33.66 Favored 'General case' 0 C--N 1.32 -0.71 0 C-N-CA 120.822 -0.351 . . . . 0.0 110.225 -176.324 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 116' ' ' ILE . . . . . 0.528 HG12 HG12 ' A' ' 95' ' ' ILE . 38.2 mm -114.61 121.78 67.39 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.436 0 CA-C-O 120.954 0.407 . . . . 0.0 110.36 177.99 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 117' ' ' ASN . . . . . . . . . . . . . 30.1 m-80 -112.64 154.1 26.59 Favored 'General case' 0 C--N 1.316 -0.87 0 N-CA-C 109.285 -0.635 . . . . 0.0 109.285 174.668 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . -75.94 -13.92 82.68 Favored Glycine 0 N--CA 1.449 -0.476 0 C-N-CA 120.74 -0.743 . . . . 0.0 113.021 -173.781 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 119' ' ' ASP . . . . . 0.574 ' HA ' ' HD3' ' A' ' 84' ' ' ARG . 30.2 t70 -112.82 -18.4 12.29 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-O 120.943 0.402 . . . . 0.0 111.594 -179.606 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 4.8 t -152.22 158.02 42.27 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 116.494 -0.321 . . . . 0.0 110.797 -172.997 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 121' ' ' ILE . . . . . 0.466 ' O ' ' HA ' ' A' ' 81' ' ' TYR . 47.7 mm -106.45 128.42 61.02 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.423 0 CA-C-O 121.218 0.533 . . . . 0.0 111.095 178.024 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 122' ' ' THR . . . . . 0.592 HG23 ' CE2' ' A' ' 81' ' ' TYR . 8.5 m -91.76 108.53 19.98 Favored 'General case' 0 C--N 1.321 -0.639 0 CA-C-O 122.19 0.995 . . . . 0.0 112.115 -178.429 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 123' ' ' VAL . . . . . 0.632 ' O ' HG23 ' A' ' 79' ' ' ILE . 15.5 t -99.63 157.79 3.81 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.555 0 CA-C-N 113.522 -1.672 . . . . 0.0 110.935 -177.755 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 124' ' ' ASP . . . . . 0.536 ' OD1' ' HB2' ' A' ' 126' ' ' ASN . 12.2 t0 -155.16 96.67 1.85 Allowed 'General case' 0 CA--C 1.537 0.474 0 N-CA-C 108.402 -0.962 . . . . 0.0 108.402 -176.025 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 125' ' ' PHE . . . . . 0.541 ' HB2' ' CD2' ' A' ' 78' ' ' LEU . 76.6 m-85 -90.31 23.62 2.86 Favored 'General case' 0 N--CA 1.47 0.541 0 O-C-N 120.618 -1.301 . . . . 0.0 111.478 -177.492 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 126' ' ' ASN . . . . . 0.536 ' HB2' ' OD1' ' A' ' 124' ' ' ASP . 27.1 m-80 -74.69 178.2 5.59 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 122.096 0.951 . . . . 0.0 113.446 -174.817 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 127' ' ' HIS . . . . . 0.531 ' HB3' ' HD2' ' A' ' 128' ' ' PRO . 33.7 m170 -127.59 -176.51 0.51 Allowed Pre-proline 0 CA--C 1.536 0.433 0 CA-C-N 114.214 -1.357 . . . . 0.0 110.95 -168.841 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 128' ' ' PRO . . . . . 0.531 ' HD2' ' HB3' ' A' ' 127' ' ' HIS . 2.1 Cg_endo -44.59 173.7 0.01 OUTLIER 'Trans proline' 0 C--N 1.357 0.978 0 C-N-CA 124.904 3.736 . . . . 0.0 113.805 164.976 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 129' ' ' LEU . . . . . . . . . . . . . 93.3 mt -51.44 37.07 0.0 OUTLIER 'General case' 0 N--CA 1.494 1.757 0 C-N-CA 126.532 1.933 . . . . 0.0 115.818 -176.279 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 130' ' ' ALA . . . . . 0.465 ' HB1' ' C ' ' A' ' 72' ' ' GLY . . . -76.51 -179.06 4.99 Favored 'General case' 0 C--N 1.305 -1.331 0 C-N-CA 123.585 0.754 . . . . 0.0 111.104 -179.953 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 131' ' ' GLY . . . . . 0.523 ' N ' ' HD3' ' A' ' 74' ' ' PRO . . . 70.5 20.78 77.33 Favored Glycine 0 CA--C 1.51 -0.265 0 C-N-CA 121.307 -0.473 . . . . 0.0 114.098 176.026 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 132' ' ' GLN . . . . . . . . . . . . . 19.4 pt20 -145.15 142.25 29.46 Favored 'General case' 0 C--N 1.318 -0.789 0 N-CA-C 109.256 -0.646 . . . . 0.0 109.256 175.826 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 133' ' ' THR . . . . . . . . . . . . . 1.5 m -73.03 114.25 10.98 Favored 'General case' 0 C--N 1.317 -0.843 0 CA-C-N 115.617 -0.72 . . . . 0.0 109.808 -176.424 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 134' ' ' VAL . . . . . 0.799 ' HB ' HD21 ' A' ' 17' ' ' LEU . 4.0 m -99.02 123.16 51.49 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.724 0 CA-C-O 121.447 0.641 . . . . 0.0 111.106 -175.126 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 135' ' ' HIS . . . . . 0.651 ' CE1' ' HB3' ' A' ' 18' ' ' LYS . 18.1 p80 -103.27 137.51 41.3 Favored 'General case' 0 C--N 1.318 -0.804 0 CA-C-N 115.112 -0.949 . . . . 0.0 110.189 174.152 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 136' ' ' PHE . . . . . 0.513 ' HE1' ' CE2' ' A' ' 63' ' ' PHE . 0.1 OUTLIER -134.48 138.33 44.63 Favored 'General case' 0 N--CA 1.442 -0.846 0 CA-C-O 121.55 0.69 . . . . 0.0 110.534 -175.153 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 137' ' ' ASP . . . . . 0.505 ' O ' ' HA ' ' A' ' 15' ' ' PHE . 37.6 t70 -98.93 108.07 20.66 Favored 'General case' 0 C--N 1.312 -1.062 0 CA-C-N 114.539 -1.21 . . . . 0.0 108.344 175.212 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 138' ' ' ILE . . . . . 0.706 HG23 HG21 ' A' ' 13' ' ' VAL . 62.5 mt -120.67 120.66 63.19 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.565 0 CA-C-O 121.396 0.617 . . . . 0.0 111.037 -167.851 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 30.2 mt-10 -110.8 111.32 22.4 Favored 'General case' 0 C--N 1.321 -0.671 0 CA-C-N 115.818 -0.628 . . . . 0.0 110.67 -178.703 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 140' ' ' VAL . . . . . 0.461 ' CG1' ' HA ' ' A' ' 57' ' ' VAL . 45.2 t -65.95 111.6 1.65 Allowed 'Isoleucine or valine' 0 C--O 1.234 0.266 0 CA-C-N 116.548 -0.296 . . . . 0.0 110.456 178.227 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 141' ' ' LEU . . . . . 0.497 HD11 ' CD2' ' A' ' 14' ' ' HIS . 48.0 mt -98.42 -49.74 4.56 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-O 120.746 0.307 . . . . 0.0 110.29 -179.943 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 142' ' ' GLU . . . . . . . . . . . . . 67.7 mm-40 -141.26 163.85 31.83 Favored 'General case' 0 CA--C 1.514 -0.413 0 CA-C-N 115.979 -0.555 . . . . 0.0 111.115 177.127 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 143' ' ' ILE . . . . . 0.52 HD12 HG23 ' A' ' 57' ' ' VAL . 94.4 mt -130.0 110.63 19.8 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.652 0 CA-C-N 115.168 -0.924 . . . . 0.0 110.381 176.605 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 144' ' ' ASP . . . . . 0.402 ' HB3' ' HB3' ' A' ' 10' ' ' ALA . 20.1 t70 -78.98 124.49 84.76 Favored Pre-proline 0 C--N 1.322 -0.617 0 CA-C-N 115.53 -0.759 . . . . 0.0 109.49 177.53 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 145' ' ' PRO . . . . . . . . . . . . . 41.3 Cg_endo -66.84 148.49 82.49 Favored 'Trans proline' 0 C--O 1.234 0.32 0 C-N-CA 122.585 2.19 . . . . 0.0 112.29 -175.532 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 146' ' ' ALA . . . . . . . . . . . . . . . -85.98 98.8 11.02 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 116.018 -0.537 . . . . 0.0 111.275 -176.036 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 147' ' ' LEU . . . . . 0.402 HD13 ' HA ' ' A' ' 147' ' ' LEU . 3.2 mm? -106.79 13.11 28.29 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.248 176.897 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 39.7 mt-10 . . . . . 0 C--N 1.326 -0.447 0 N-CA-C 109.596 -0.52 . . . . 0.0 109.596 176.687 . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 13.4 tpt . . . . . 0 N--CA 1.48 1.049 0 CA-C-O 120.686 0.279 . . . . 0.0 110.311 . . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 2' ' ' SER . . . . . 0.407 ' CB ' ' HA ' ' A' ' 145' ' ' PRO . 14.6 t -76.58 82.3 3.25 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.237 -0.438 . . . . 0.0 109.84 178.136 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 3' ' ' GLU . . . . . 0.46 ' O ' ' HG3' ' A' ' 56' ' ' LYS . 32.3 mt-10 -74.5 -30.21 61.72 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 115.844 -0.616 . . . . 0.0 109.682 179.276 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 40.0 t -116.88 151.23 37.03 Favored 'General case' 0 C--N 1.318 -0.771 0 CA-C-N 114.904 -1.043 . . . . 0.0 109.389 -178.532 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 98.0 t -72.96 125.3 31.57 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.403 0 CA-C-O 121.036 0.446 . . . . 0.0 110.267 177.08 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 6' ' ' GLN . . . . . 0.651 ' HG2' ' OG ' ' A' ' 9' ' ' SER . 9.8 pt20 -119.34 166.94 12.39 Favored 'General case' 0 C--N 1.319 -0.718 0 CA-C-N 115.609 -0.723 . . . . 0.0 109.141 -179.557 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 7' ' ' SER . . . . . 0.452 ' O ' ' HB2' ' A' ' 8' ' ' ASN . 10.0 p -63.23 133.75 54.78 Favored 'General case' 0 C--N 1.316 -0.882 0 N-CA-C 109.857 -0.423 . . . . 0.0 109.857 177.832 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 8' ' ' ASN . . . . . 0.514 ' OD1' ' HA3' ' A' ' 40' ' ' GLY . 34.4 m-80 72.7 35.07 1.11 Allowed 'General case' 0 N--CA 1.471 0.596 0 O-C-N 123.755 0.659 . . . . 0.0 112.327 -176.78 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 9' ' ' SER . . . . . 0.651 ' OG ' ' HG2' ' A' ' 6' ' ' GLN . 49.6 m -92.82 167.03 12.13 Favored 'General case' 0 C--N 1.332 -0.152 0 CA-C-O 121.151 0.501 . . . . 0.0 110.785 173.006 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 10' ' ' ALA . . . . . 0.493 ' HB3' ' HB3' ' A' ' 144' ' ' ASP . . . -115.54 118.14 32.31 Favored 'General case' 0 C--N 1.319 -0.759 0 N-CA-C 108.558 -0.905 . . . . 0.0 108.558 170.808 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 4.3 m -127.5 142.75 42.75 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.729 0 C-N-CA 120.165 -0.614 . . . . 0.0 110.909 -174.05 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 12' ' ' LEU . . . . . 0.502 ' HB2' ' HB2' ' A' ' 142' ' ' GLU . 83.8 mt -93.96 133.4 37.44 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-N 115.818 -0.628 . . . . 0.0 109.346 176.566 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 17.2 m -131.68 167.11 27.07 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.941 0 CA-C-O 121.519 0.676 . . . . 0.0 112.262 -174.867 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 14' ' ' HIS . . . . . 0.566 ' CD2' HD11 ' A' ' 141' ' ' LEU . 0.3 OUTLIER -134.21 115.67 14.44 Favored 'General case' 0 C--N 1.322 -0.59 0 N-CA-C 106.433 -1.692 . . . . 0.0 106.433 166.159 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 45.4 p90 -145.8 156.14 43.38 Favored 'General case' 0 C--N 1.319 -0.726 0 C-N-CA 120.841 -0.344 . . . . 0.0 110.629 -171.084 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 60.1 m -121.63 131.47 54.13 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-O 120.884 0.373 . . . . 0.0 110.664 174.478 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 17' ' ' LEU . . . . . 0.446 ' CD2' ' HB3' ' A' ' 136' ' ' PHE . 6.3 mt -98.26 121.8 40.64 Favored 'General case' 0 C--N 1.328 -0.363 0 N-CA-C 112.662 0.616 . . . . 0.0 112.662 178.331 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 9.5 mptt -127.67 142.84 51.23 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-N 114.973 -1.012 . . . . 0.0 110.197 -179.236 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 19' ' ' LEU . . . . . 0.519 HD13 HG23 ' A' ' 134' ' ' VAL . 3.2 mm? -89.66 169.05 11.64 Favored 'General case' 0 C--N 1.325 -0.477 0 N-CA-C 109.487 -0.561 . . . . 0.0 109.487 175.918 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 1.8 p30 -67.27 -23.65 65.7 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 121.41 0.624 . . . . 0.0 109.965 177.163 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 36.3 m-20 -74.03 -0.49 16.55 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 115.139 -0.937 . . . . 0.0 111.447 175.826 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 73.8 15.47 79.51 Favored Glycine 0 N--CA 1.449 -0.442 0 C-N-CA 121.007 -0.616 . . . . 0.0 111.922 -179.124 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 27.0 m -88.34 151.79 22.37 Favored 'General case' 0 C--N 1.32 -0.68 0 N-CA-C 109.525 -0.546 . . . . 0.0 109.525 176.132 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 38.3 m -95.25 128.77 42.35 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-O 120.874 0.368 . . . . 0.0 110.969 178.167 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -91.8 -49.04 6.47 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.001 -0.545 . . . . 0.0 110.011 176.143 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 26' ' ' GLU . . . . . 0.436 ' O ' ' HB2' ' A' ' 17' ' ' LEU . 11.8 tp10 -160.9 120.29 2.63 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 115.88 -0.6 . . . . 0.0 109.872 178.352 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 46.8 m -105.31 99.08 8.7 Favored 'General case' 0 C--N 1.318 -0.777 0 C-N-CA 120.233 -0.587 . . . . 0.0 110.3 177.276 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 28' ' ' THR . . . . . 0.408 ' O ' HG22 ' A' ' 28' ' ' THR . 32.8 m -91.69 57.14 3.16 Favored 'General case' 0 C--N 1.318 -0.789 0 CA-C-O 122.171 0.986 . . . . 0.0 110.068 -178.756 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 21.2 ttt180 -146.44 -55.73 0.27 Allowed 'General case' 0 C--N 1.312 -1.043 0 CA-C-N 115.065 -0.971 . . . . 0.0 109.866 176.959 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 2.0 p-10 -77.86 -1.58 32.38 Favored 'General case' 0 N--CA 1.465 0.279 0 C-N-CA 120.928 -0.309 . . . . 0.0 111.069 179.36 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 94.9 m-20 -74.35 -13.42 60.74 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-O 120.861 0.363 . . . . 0.0 110.239 175.338 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 77.81 2.38 81.31 Favored Glycine 0 N--CA 1.446 -0.648 0 N-CA-C 111.23 -0.748 . . . . 0.0 111.23 -178.114 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 35.4 mtmm -131.23 115.28 16.27 Favored Pre-proline 0 N--CA 1.449 -0.477 0 CA-C-N 115.631 -0.285 . . . . 0.0 110.497 -174.575 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 19.6 Cg_exo -69.13 166.88 25.28 Favored 'Trans proline' 0 C--O 1.233 0.265 0 C-N-CA 122.792 2.328 . . . . 0.0 112.002 173.482 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -130.85 155.52 46.57 Favored 'General case' 0 C--N 1.316 -0.891 0 CA-C-N 115.462 -0.79 . . . . 0.0 110.453 -177.767 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 3.1 tp -101.14 142.4 32.63 Favored 'General case' 0 C--N 1.316 -0.867 0 CA-C-N 115.849 -0.614 . . . . 0.0 110.348 177.825 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 37' ' ' PHE . . . . . . . . . . . . . 5.8 m-30 -109.46 108.09 18.46 Favored 'General case' 0 C--N 1.312 -1.046 0 N-CA-C 108.364 -0.976 . . . . 0.0 108.364 177.787 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -86.46 107.62 18.15 Favored 'General case' 0 C--N 1.321 -0.658 0 CA-C-O 121.129 0.49 . . . . 0.0 109.826 -179.595 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 39' ' ' LEU . . . . . 0.422 ' HG ' ' CB ' ' A' ' 49' ' ' GLU . 9.5 mp -81.77 153.02 26.71 Favored 'General case' 0 C--N 1.317 -0.837 0 CA-C-N 115.208 -0.906 . . . . 0.0 109.935 -179.928 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 40' ' ' GLY . . . . . 0.514 ' HA3' ' OD1' ' A' ' 8' ' ' ASN . . . 96.67 29.11 8.4 Favored Glycine 0 N--CA 1.447 -0.585 0 C-N-CA 120.537 -0.84 . . . . 0.0 112.171 -178.262 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 17.9 t70 60.32 15.77 5.67 Favored 'General case' 0 N--CA 1.469 0.496 0 CA-C-O 121.425 0.631 . . . . 0.0 111.122 178.341 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -79.85 -13.52 59.34 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 121.11 0.481 . . . . 0.0 110.746 -176.336 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 35.7 t -161.18 -54.36 0.05 OUTLIER 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 115.522 -0.763 . . . . 0.0 109.024 174.998 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 4.0 mm? -91.3 149.71 21.63 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 115.829 -0.623 . . . . 0.0 109.674 176.483 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 47.5 t -70.93 155.52 40.72 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-N 115.782 -0.645 . . . . 0.0 111.119 -177.292 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 46' ' ' GLU . . . . . 0.483 ' O ' ' HG2' ' A' ' 49' ' ' GLU . 28.5 tt0 -49.94 -40.27 43.02 Favored 'General case' 0 N--CA 1.45 -0.46 0 C-N-CA 122.981 0.513 . . . . 0.0 111.854 -179.856 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 47' ' ' GLY . . . . . 0.417 ' HA3' ' HB1' ' A' ' 69' ' ' ALA . . . -56.69 -36.34 71.33 Favored Glycine 0 N--CA 1.448 -0.541 0 C-N-CA 120.567 -0.825 . . . . 0.0 112.447 -176.445 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 1.7 tt -64.26 -52.88 56.49 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 116.953 0.377 . . . . 0.0 111.745 176.57 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 49' ' ' GLU . . . . . 0.491 ' O ' HD13 ' A' ' 53' ' ' LEU . 13.8 pt-20 -63.91 -29.95 71.08 Favored 'General case' 0 N--CA 1.453 -0.299 0 CA-C-O 120.508 0.194 . . . . 0.0 111.02 -173.322 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 50' ' ' GLN . . . . . 0.527 ' HA ' HD22 ' A' ' 53' ' ' LEU . 16.9 mm-40 -65.67 -17.11 64.36 Favored 'General case' 0 N--CA 1.452 -0.347 0 CA-C-N 116.372 -0.376 . . . . 0.0 110.605 -173.936 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 51' ' ' HIS . . . . . . . . . . . . . 10.7 m80 -107.27 -3.68 19.49 Favored 'General case' 0 N--CA 1.45 -0.449 0 CA-C-O 121.053 0.454 . . . . 0.0 110.022 -176.934 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 49.4 mt -103.04 -20.55 14.15 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 115.657 -0.702 . . . . 0.0 111.282 -178.865 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 53' ' ' LEU . . . . . 0.527 HD22 ' HA ' ' A' ' 50' ' ' GLN . 0.0 OUTLIER -60.59 135.91 57.9 Favored 'General case' 0 C--O 1.234 0.257 0 CA-C-O 120.875 0.369 . . . . 0.0 111.273 177.874 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 93.03 -5.96 76.01 Favored Glycine 0 N--CA 1.45 -0.399 0 CA-C-N 115.947 -0.57 . . . . 0.0 112.667 178.884 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 64.0 mt -84.47 163.54 19.37 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-O 121.208 0.528 . . . . 0.0 111.275 179.369 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 56' ' ' LYS . . . . . 0.46 ' HG3' ' O ' ' A' ' 3' ' ' GLU . 0.0 OUTLIER -127.39 169.52 13.52 Favored 'General case' 0 C--N 1.32 -0.695 0 CA-C-N 115.322 -0.854 . . . . 0.0 109.457 176.018 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 39.6 t -60.68 142.76 15.39 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.833 0 CA-C-O 121.068 0.461 . . . . 0.0 110.547 176.026 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 80.88 10.03 85.57 Favored Glycine 0 N--CA 1.448 -0.516 0 CA-C-N 115.673 -0.694 . . . . 0.0 112.659 -177.945 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 4.0 m-20 -98.92 150.52 21.84 Favored 'General case' 0 CA--C 1.511 -0.553 0 CA-C-O 121.073 0.463 . . . . 0.0 111.183 176.164 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 60' ' ' LYS . . . . . 0.471 ' H ' ' HG2' ' A' ' 60' ' ' LYS . 0.0 OUTLIER -120.88 129.55 53.55 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-N 115.189 -0.914 . . . . 0.0 109.382 -178.998 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 6.1 m -142.32 121.39 12.91 Favored 'General case' 0 N--CA 1.433 -1.298 0 CA-C-O 121.155 0.503 . . . . 0.0 110.502 -179.003 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 14.3 m -111.0 132.82 53.89 Favored 'General case' 0 C--N 1.316 -0.88 0 CA-C-N 115.754 -0.657 . . . . 0.0 109.872 177.277 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 32.0 p90 -146.7 172.79 13.07 Favored 'General case' 0 C--N 1.314 -0.972 0 CA-C-N 116.044 -0.525 . . . . 0.0 110.239 179.032 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 50.9 m -130.83 135.91 48.17 Favored 'General case' 0 C--N 1.32 -0.681 0 N-CA-C 108.783 -0.821 . . . . 0.0 108.783 -172.44 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 65' ' ' LEU . . . . . 0.453 ' HB2' ' HB2' ' A' ' 70' ' ' ALA . 61.1 mt -139.48 140.62 37.3 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-O 121.164 0.507 . . . . 0.0 111.406 -172.052 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 66' ' ' GLU . . . . . 0.431 ' HB3' ' HD2' ' A' ' 67' ' ' PRO . 44.1 mt-10 -75.54 162.12 73.74 Favored Pre-proline 0 C--N 1.326 -0.455 0 CA-C-N 115.037 -0.983 . . . . 0.0 109.842 174.597 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 67' ' ' PRO . . . . . 0.571 ' HB3' ' HA2' ' A' ' 131' ' ' GLY . 76.0 Cg_exo -42.04 -43.3 7.22 Favored 'Trans proline' 0 C--N 1.346 0.397 0 C-N-CA 123.513 2.809 . . . . 0.0 114.558 -177.837 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 6.6 p-10 -63.74 -18.77 64.39 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-O 120.782 0.325 . . . . 0.0 111.44 -177.505 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 69' ' ' ALA . . . . . 0.417 ' HB1' ' HA3' ' A' ' 47' ' ' GLY . . . -114.35 -7.38 12.91 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 116.326 -0.397 . . . . 0.0 111.368 179.223 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 70' ' ' ALA . . . . . 0.453 ' HB2' ' HB2' ' A' ' 65' ' ' LEU . . . -144.76 124.97 13.7 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 120.542 0.211 . . . . 0.0 111.431 -176.954 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 71' ' ' PHE . . . . . . . . . . . . . 19.4 m-30 73.48 -40.93 0.48 Allowed 'General case' 0 N--CA 1.473 0.714 0 C-N-CA 123.747 0.819 . . . . 0.0 111.686 179.95 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 72' ' ' GLY . . . . . 0.587 ' O ' ' HB1' ' A' ' 130' ' ' ALA . . . 111.39 145.61 10.15 Favored Glycine 0 N--CA 1.444 -0.83 0 N-CA-C 111.481 -0.648 . . . . 0.0 111.481 -179.243 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 73' ' ' VAL . . . . . 0.425 HG12 ' HB2' ' A' ' 67' ' ' PRO . 29.3 m -76.1 139.15 68.73 Favored Pre-proline 0 C--N 1.321 -0.671 0 CA-C-O 121.085 0.469 . . . . 0.0 111.202 175.209 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 74' ' ' PRO . . . . . 0.462 ' HD3' ' CA ' ' A' ' 131' ' ' GLY . 59.0 Cg_endo -74.7 153.49 43.41 Favored 'Trans proline' 0 N--CA 1.459 -0.555 0 C-N-CA 122.65 2.233 . . . . 0.0 110.63 176.485 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 75' ' ' SER . . . . . 0.777 ' O ' ' HG ' ' A' ' 78' ' ' LEU . 46.1 m -132.85 121.19 16.87 Favored Pre-proline 0 C--N 1.315 -0.913 0 C-N-CA 120.755 -0.378 . . . . 0.0 111.241 -174.044 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 47.6 Cg_endo -69.73 -18.3 37.21 Favored 'Trans proline' 0 N--CA 1.463 -0.284 0 C-N-CA 122.18 1.92 . . . . 0.0 111.724 176.657 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 77' ' ' ASP . . . . . 0.631 ' OD1' ' HB3' ' A' ' 75' ' ' SER . 6.4 p-10 -76.83 -13.0 60.05 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.623 -0.717 . . . . 0.0 111.352 -179.644 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 78' ' ' LEU . . . . . 0.777 ' HG ' ' O ' ' A' ' 75' ' ' SER . 4.1 pp -91.62 -4.89 54.75 Favored 'General case' 0 CA--C 1.515 -0.396 0 C-N-CA 119.652 -0.819 . . . . 0.0 110.392 177.739 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 43.7 mt -80.31 138.51 19.67 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.611 0 N-CA-C 109.886 -0.413 . . . . 0.0 109.886 169.074 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 3.7 mp0 -142.2 142.64 32.68 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-N 116.122 -0.49 . . . . 0.0 109.84 -177.847 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 81' ' ' TYR . . . . . 0.409 ' CE2' HG23 ' A' ' 122' ' ' THR . 43.0 m-85 -113.76 111.71 22.23 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-O 121.182 0.515 . . . . 0.0 109.983 -177.593 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 56.1 m-85 -109.73 171.17 7.6 Favored 'General case' 0 C--N 1.317 -0.814 0 CA-C-N 115.365 -0.834 . . . . 0.0 109.961 177.388 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 25.8 t -81.56 154.27 26.31 Favored 'General case' 0 C--N 1.321 -0.655 0 CA-C-O 121.368 0.604 . . . . 0.0 110.15 178.749 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 84' ' ' ARG . . . . . 0.519 ' HG3' ' HD2' ' A' ' 85' ' ' ARG . 13.0 ptm180 -68.89 -29.47 67.76 Favored 'General case' 0 C--N 1.32 -0.687 0 CA-C-N 115.383 -0.826 . . . . 0.0 109.649 178.108 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 85' ' ' ARG . . . . . 0.519 ' HD2' ' HG3' ' A' ' 84' ' ' ARG . 5.2 mpt_? -64.05 -34.06 77.16 Favored 'General case' 0 C--N 1.321 -0.667 0 CA-C-N 114.201 -1.363 . . . . 0.0 109.981 177.448 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 46.4 mt-10 -75.67 -10.8 59.75 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 115.757 -0.656 . . . . 0.0 110.565 178.119 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 87' ' ' PHE . . . . . 0.488 ' CE2' HG21 ' A' ' 121' ' ' ILE . 3.8 m-85 -103.3 -22.79 13.65 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 115.596 -0.729 . . . . 0.0 110.41 -179.748 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 88' ' ' MET . . . . . . . . . . . . . 46.4 ttm -60.14 -13.19 10.84 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 121.928 0.871 . . . . 0.0 109.679 172.375 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 25.0 t70 -61.09 -31.95 71.63 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-N 114.12 -1.4 . . . . 0.0 109.689 175.153 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -122.61 15.88 10.31 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 115.557 -0.747 . . . . 0.0 110.708 178.162 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 96.97 139.99 11.01 Favored Glycine 0 N--CA 1.45 -0.397 0 C-N-CA 120.6 -0.81 . . . . 0.0 111.925 -176.379 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 47.1 mt-10 -68.32 124.38 89.68 Favored Pre-proline 0 C--N 1.325 -0.494 0 CA-C-O 121.446 0.641 . . . . 0.0 111.48 -174.834 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 93' ' ' PRO . . . . . 0.54 ' HB2' HD13 ' A' ' 113' ' ' ILE . 83.8 Cg_endo -78.35 169.08 20.63 Favored 'Trans proline' 0 C--O 1.235 0.36 0 C-N-CA 124.669 3.579 . . . . 0.0 114.933 -169.373 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 94' ' ' GLU . . . . . 0.564 ' O ' HD12 ' A' ' 113' ' ' ILE . 1.4 mp0 -116.7 164.31 14.83 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 114.214 -1.357 . . . . 0.0 110.74 -174.616 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 95' ' ' ILE . . . . . 0.643 HG23 ' HA ' ' A' ' 115' ' ' GLU . 17.5 mt -82.78 133.96 27.97 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.377 0 CA-C-O 120.919 0.39 . . . . 0.0 110.909 179.35 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 70.69 29.89 69.07 Favored Glycine 0 N--CA 1.449 -0.447 0 CA-C-N 115.83 -0.623 . . . . 0.0 111.973 -179.194 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 97' ' ' ALA . . . . . 0.685 ' O ' HG13 ' A' ' 113' ' ' ILE . . . -106.42 140.0 40.02 Favored 'General case' 0 C--N 1.324 -0.52 0 N-CA-C 109.865 -0.42 . . . . 0.0 109.865 -179.777 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 98' ' ' ILE . . . . . 0.492 ' HA ' ' O ' ' A' ' 111' ' ' GLY . 72.5 mt -88.06 108.26 18.37 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.812 0 N-CA-C 109.972 -0.381 . . . . 0.0 109.972 -179.98 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 99' ' ' MET . . . . . 0.562 ' HB2' ' CE2' ' A' ' 101' ' ' PHE . 89.9 mtp -99.08 126.15 44.75 Favored 'General case' 0 N--CA 1.442 -0.835 0 CA-C-N 116.301 -0.409 . . . . 0.0 111.069 179.444 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 100' ' ' LEU . . . . . 0.447 ' HA ' HD13 ' A' ' 100' ' ' LEU . 4.3 mm? -67.42 147.35 52.99 Favored 'General case' 0 C--N 1.307 -1.241 0 N-CA-C 108.327 -0.99 . . . . 0.0 108.327 163.2 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 101' ' ' PHE . . . . . 0.632 ' HB2' ' O ' ' A' ' 109' ' ' MET . 2.5 m-85 -149.49 169.78 20.12 Favored 'General case' 0 CA--C 1.51 -0.594 0 CA-C-N 116.001 -0.545 . . . . 0.0 109.925 -155.101 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 3.9 m -126.64 129.26 48.15 Favored 'General case' 0 C--N 1.31 -1.128 0 N-CA-C 108.913 -0.773 . . . . 0.0 108.913 170.663 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -97.4 154.89 17.17 Favored 'General case' 0 C--N 1.316 -0.853 0 N-CA-C 109.05 -0.722 . . . . 0.0 109.05 -175.878 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 104' ' ' MET . . . . . . . . . . . . . 4.7 mpp? -65.24 -12.77 54.95 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.945 -174.219 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 9.8 p-10 -95.21 6.86 47.88 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-O 120.728 0.299 . . . . 0.0 110.928 177.219 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 89.55 -10.95 71.62 Favored Glycine 0 N--CA 1.452 -0.272 0 C-N-CA 121.213 -0.518 . . . . 0.0 113.217 174.67 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 43.1 t -79.94 143.15 34.44 Favored 'General case' 0 C--N 1.32 -0.677 0 CA-C-O 121.37 0.605 . . . . 0.0 109.748 178.721 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 23.3 tt0 -92.18 99.03 11.9 Favored 'General case' 0 C--N 1.309 -1.175 0 CA-C-O 121.956 0.884 . . . . 0.0 109.443 179.28 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 109' ' ' MET . . . . . 0.632 ' O ' ' HB2' ' A' ' 101' ' ' PHE . 71.3 mtp -96.13 135.54 22.62 Favored Pre-proline 0 C--N 1.319 -0.73 0 CA-C-N 113.965 -1.471 . . . . 0.0 111.689 -178.964 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 30.3 Cg_endo -68.9 159.4 54.01 Favored 'Trans proline' 0 N--CA 1.456 -0.709 0 C-N-CA 121.92 1.746 . . . . 0.0 110.011 168.198 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 111' ' ' GLY . . . . . 0.492 ' O ' ' HA ' ' A' ' 98' ' ' ILE . . . -147.15 149.04 21.12 Favored Glycine 0 C--N 1.314 -0.639 0 C-N-CA 119.945 -1.121 . . . . 0.0 110.993 -172.849 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 2.7 p -118.9 111.26 32.82 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.618 0 CA-C-N 118.311 1.056 . . . . 0.0 110.305 170.917 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 113' ' ' ILE . . . . . 0.685 HG13 ' O ' ' A' ' 97' ' ' ALA . 0.5 OUTLIER -62.88 112.03 0.99 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.469 0 CA-C-N 115.729 -0.669 . . . . 0.0 110.175 175.223 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 114' ' ' ARG . . . . . 0.573 ' HD2' ' HB2' ' A' ' 115' ' ' GLU . 5.6 tmm_? -71.22 -43.36 67.51 Favored 'General case' 0 C--N 1.316 -0.883 0 CA-C-N 115.874 -0.603 . . . . 0.0 110.679 -176.983 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 115' ' ' GLU . . . . . 0.643 ' HA ' HG23 ' A' ' 95' ' ' ILE . 13.8 tt0 -159.42 154.76 25.46 Favored 'General case' 0 C--N 1.329 -0.313 0 N-CA-C 110.317 -0.253 . . . . 0.0 110.317 -179.871 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 116' ' ' ILE . . . . . 0.56 HG12 HG12 ' A' ' 95' ' ' ILE . 38.0 mm -98.55 112.42 30.62 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.501 0 N-CA-C 109.04 -0.726 . . . . 0.0 109.04 174.23 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 117' ' ' ASN . . . . . 0.434 ' HB2' ' O ' ' A' ' 120' ' ' SER . 5.4 m-20 -88.18 159.68 18.07 Favored 'General case' 0 C--N 1.311 -1.094 0 N-CA-C 108.724 -0.843 . . . . 0.0 108.724 177.289 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . -55.26 -47.16 76.44 Favored Glycine 0 N--CA 1.45 -0.372 0 C-N-CA 120.518 -0.848 . . . . 0.0 113.129 -169.438 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 119' ' ' ASP . . . . . 0.444 ' O ' ' HG2' ' A' ' 84' ' ' ARG . 4.4 p-10 -114.78 -11.1 12.32 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 117.125 0.463 . . . . 0.0 111.343 175.171 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 120' ' ' SER . . . . . 0.434 ' O ' ' HB2' ' A' ' 117' ' ' ASN . 9.0 t -115.97 158.26 23.34 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-O 121.222 0.534 . . . . 0.0 111.656 -171.812 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 121' ' ' ILE . . . . . 0.488 HG21 ' CE2' ' A' ' 87' ' ' PHE . 46.7 mm -117.21 128.69 74.5 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.52 0 CA-C-N 116.112 -0.495 . . . . 0.0 110.436 177.263 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 122' ' ' THR . . . . . 0.409 HG23 ' CE2' ' A' ' 81' ' ' TYR . 18.7 m -93.47 102.55 14.77 Favored 'General case' 0 C--N 1.32 -0.686 0 CA-C-O 121.594 0.711 . . . . 0.0 110.907 177.97 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 42.9 t -104.4 108.16 24.1 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.385 0 CA-C-N 114.66 -1.155 . . . . 0.0 112.92 -179.983 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 124' ' ' ASP . . . . . 0.443 ' C ' ' H ' ' A' ' 126' ' ' ASN . 1.3 m-20 -98.04 106.57 18.88 Favored 'General case' 0 C--N 1.318 -0.762 0 CA-C-N 114.689 -1.141 . . . . 0.0 110.386 170.121 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 125' ' ' PHE . . . . . 0.582 ' HB2' HD13 ' A' ' 78' ' ' LEU . 81.5 m-85 -75.07 18.9 0.16 Allowed 'General case' 0 N--CA 1.465 0.29 0 O-C-N 121.898 -0.501 . . . . 0.0 111.284 171.242 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 126' ' ' ASN . . . . . 0.443 ' H ' ' C ' ' A' ' 124' ' ' ASP . 11.4 m-80 -60.48 147.22 41.94 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.818 -0.628 . . . . 0.0 110.622 176.285 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 127' ' ' HIS . . . . . 0.611 ' HB3' ' HD2' ' A' ' 128' ' ' PRO . 56.9 m80 -107.22 -170.58 0.2 Allowed Pre-proline 0 C--N 1.319 -0.742 0 CA-C-N 115.074 -0.966 . . . . 0.0 111.395 -165.324 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 128' ' ' PRO . . . . . 0.611 ' HD2' ' HB3' ' A' ' 127' ' ' HIS . 2.7 Cg_exo -41.53 174.11 0.0 OUTLIER 'Trans proline' 0 C--N 1.358 1.034 0 C-N-CA 124.696 3.597 . . . . 0.0 113.85 162.09 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 129' ' ' LEU . . . . . . . . . . . . . 9.9 tp -50.5 38.32 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.619 0 C-N-CA 126.902 2.081 . . . . 0.0 116.32 -172.667 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 130' ' ' ALA . . . . . 0.587 ' HB1' ' O ' ' A' ' 72' ' ' GLY . . . -76.2 161.2 29.0 Favored 'General case' 0 C--N 1.308 -1.201 0 N-CA-C 108.567 -0.901 . . . . 0.0 108.567 178.191 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 131' ' ' GLY . . . . . 0.571 ' HA2' ' HB3' ' A' ' 67' ' ' PRO . . . 76.72 22.69 71.64 Favored Glycine 0 N--CA 1.449 -0.474 0 C-N-CA 120.0 -1.095 . . . . 0.0 113.032 -177.27 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 132' ' ' GLN . . . . . . . . . . . . . 13.4 tt0 -139.27 139.58 37.41 Favored 'General case' 0 N--CA 1.445 -0.702 0 N-CA-C 109.986 -0.376 . . . . 0.0 109.986 169.865 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 133' ' ' THR . . . . . . . . . . . . . 21.9 m -68.66 126.98 31.4 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 115.81 -0.632 . . . . 0.0 110.507 179.99 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 134' ' ' VAL . . . . . 0.519 HG23 HD13 ' A' ' 19' ' ' LEU . 14.5 p -128.92 163.6 33.45 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.594 0 CA-C-O 121.093 0.473 . . . . 0.0 111.366 -174.709 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 135' ' ' HIS . . . . . 0.42 ' N ' HG22 ' A' ' 134' ' ' VAL . 72.2 m-70 -123.19 115.82 22.39 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 115.803 -0.635 . . . . 0.0 109.633 -176.027 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 136' ' ' PHE . . . . . 0.488 ' CE1' HG13 ' A' ' 134' ' ' VAL . 0.1 OUTLIER -125.42 138.26 54.01 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-O 121.112 0.482 . . . . 0.0 111.993 -176.463 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 137' ' ' ASP . . . . . . . . . . . . . 5.9 m-20 -103.73 107.11 17.83 Favored 'General case' 0 N--CA 1.468 0.436 0 CA-C-N 115.263 -0.88 . . . . 0.0 110.444 -178.846 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 138' ' ' ILE . . . . . 0.473 HD11 ' HD2' ' A' ' 136' ' ' PHE . 4.5 mp -96.95 138.89 20.74 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.492 0 CA-C-O 120.806 0.336 . . . . 0.0 111.77 -174.523 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 18.0 mt-10 -127.32 127.74 44.79 Favored 'General case' 0 CA--C 1.515 -0.379 0 N-CA-C 108.416 -0.957 . . . . 0.0 108.416 168.302 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 140' ' ' VAL . . . . . . . . . . . . . 91.3 t -78.95 111.25 15.58 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-O 120.925 0.393 . . . . 0.0 110.31 -178.078 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 141' ' ' LEU . . . . . 0.566 HD11 ' CD2' ' A' ' 14' ' ' HIS . 44.4 mt -85.38 -42.86 14.16 Favored 'General case' 0 C--N 1.316 -0.882 0 CA-C-O 121.371 0.605 . . . . 0.0 110.393 -179.855 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 142' ' ' GLU . . . . . 0.502 ' HB2' ' HB2' ' A' ' 12' ' ' LEU . 6.7 mm-40 -151.1 156.55 41.28 Favored 'General case' 0 C--N 1.321 -0.673 0 CA-C-N 115.135 -0.939 . . . . 0.0 111.271 -177.96 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 143' ' ' ILE . . . . . . . . . . . . . 78.7 mt -126.68 109.69 21.53 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.766 0 CA-C-N 115.619 -0.719 . . . . 0.0 109.876 178.773 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 144' ' ' ASP . . . . . 0.493 ' HB3' ' HB3' ' A' ' 10' ' ' ALA . 33.0 t70 -78.68 125.07 84.93 Favored Pre-proline 0 C--N 1.324 -0.512 0 N-CA-C 109.222 -0.659 . . . . 0.0 109.222 175.0 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 145' ' ' PRO . . . . . 0.407 ' HA ' ' CB ' ' A' ' 2' ' ' SER . 48.6 Cg_endo -64.94 125.86 15.49 Favored 'Trans proline' 0 N--CA 1.461 -0.419 0 C-N-CA 122.537 2.158 . . . . 0.0 112.411 -175.688 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 146' ' ' ALA . . . . . . . . . . . . . . . -85.58 130.67 34.52 Favored 'General case' 0 C--N 1.313 -1.019 0 CA-C-N 115.252 -0.885 . . . . 0.0 110.229 179.066 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 147' ' ' LEU . . . . . 0.413 HD13 ' HA ' ' A' ' 147' ' ' LEU . 3.2 mm? -82.44 44.88 0.91 Allowed 'General case' 0 N--CA 1.442 -0.845 0 CA-C-O 121.299 0.571 . . . . 0.0 111.364 -178.232 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 9.2 mm-40 . . . . . 0 C--N 1.324 -0.523 0 CA-C-N 115.486 -0.779 . . . . 0.0 109.641 175.734 . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 15.1 tpt . . . . . 0 N--CA 1.478 0.942 0 N-CA-C 110.134 -0.321 . . . . 0.0 110.134 . . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 14.3 p 42.55 70.25 0.31 Allowed 'General case' 0 N--CA 1.467 0.394 0 O-C-N 124.313 1.008 . . . . 0.0 112.396 176.271 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 3' ' ' GLU . . . . . 0.459 ' HG2' ' HD2' ' A' ' 56' ' ' LYS . 29.4 tt0 -99.05 -26.37 14.25 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 115.748 -0.66 . . . . 0.0 110.626 179.539 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 4' ' ' SER . . . . . 0.547 ' OG ' ' HE2' ' A' ' 56' ' ' LYS . 14.6 m -101.71 136.16 42.02 Favored 'General case' 0 C--N 1.318 -0.772 0 CA-C-N 115.543 -0.753 . . . . 0.0 111.034 -174.315 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 6.1 p -81.13 148.88 5.2 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.665 0 CA-C-O 121.453 0.644 . . . . 0.0 110.426 179.571 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 6' ' ' GLN . . . . . 0.688 ' HG2' ' OG ' ' A' ' 9' ' ' SER . 4.5 pt20 -140.53 166.16 25.48 Favored 'General case' 0 C--N 1.311 -1.067 0 CA-C-N 114.918 -1.037 . . . . 0.0 109.298 174.461 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 75.7 p -65.26 132.19 48.42 Favored 'General case' 0 N--CA 1.441 -0.916 0 N-CA-C 108.701 -0.851 . . . . 0.0 108.701 175.814 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 8' ' ' ASN . . . . . 0.446 ' ND2' ' HB2' ' A' ' 148' ' ' GLU . 10.4 t30 75.08 38.06 0.45 Allowed 'General case' 0 CA--C 1.539 0.551 0 O-C-N 123.682 0.614 . . . . 0.0 110.95 -177.95 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 9' ' ' SER . . . . . 0.688 ' OG ' ' HG2' ' A' ' 6' ' ' GLN . 51.0 m -93.77 166.85 12.0 Favored 'General case' 0 CA--C 1.521 -0.167 0 CA-C-O 121.308 0.575 . . . . 0.0 110.821 172.462 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 10' ' ' ALA . . . . . 0.672 ' HB1' HD21 ' A' ' 36' ' ' LEU . . . -109.43 111.32 22.8 Favored 'General case' 0 N--CA 1.444 -0.769 0 N-CA-C 108.544 -0.91 . . . . 0.0 108.544 169.992 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 3.8 m -116.52 135.54 56.45 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.682 0 C-N-CA 119.767 -0.773 . . . . 0.0 111.351 -179.378 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 18.0 tp -86.36 128.43 34.93 Favored 'General case' 0 N--CA 1.447 -0.608 0 N-CA-C 108.914 -0.772 . . . . 0.0 108.914 177.837 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 13' ' ' VAL . . . . . 0.638 HG21 HG23 ' A' ' 138' ' ' ILE . 3.8 p -131.92 158.67 43.33 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.987 0 CA-C-O 122.23 1.014 . . . . 0.0 112.618 -174.561 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 14' ' ' HIS . . . . . 0.584 ' ND1' ' HA ' ' A' ' 29' ' ' ARG . 0.2 OUTLIER -122.94 110.28 15.19 Favored 'General case' 0 C--N 1.313 -1.001 0 CA-C-N 113.443 -1.708 . . . . 0.0 106.996 167.919 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 15' ' ' PHE . . . . . 0.453 ' HA ' ' O ' ' A' ' 137' ' ' ASP . 12.8 p90 -133.64 166.02 23.56 Favored 'General case' 0 C--N 1.324 -0.532 0 C-N-CA 119.223 -0.991 . . . . 0.0 113.673 -174.621 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 22.3 m -140.98 142.09 34.33 Favored 'General case' 0 N--CA 1.444 -0.744 0 CA-C-N 113.952 -1.476 . . . . 0.0 107.914 174.913 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 17' ' ' LEU . . . . . 0.537 HD11 ' CZ ' ' A' ' 136' ' ' PHE . 0.5 OUTLIER -126.86 112.62 15.54 Favored 'General case' 0 C--N 1.32 -0.716 0 N-CA-C 110.327 -0.249 . . . . 0.0 110.327 -173.624 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -118.85 152.53 36.09 Favored 'General case' 0 C--N 1.315 -0.913 0 CA-C-O 120.93 0.395 . . . . 0.0 111.392 -178.393 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 19' ' ' LEU . . . . . 0.603 HD21 ' HB2' ' A' ' 25' ' ' ALA . 3.4 mm? -103.82 170.47 7.91 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 115.844 -0.616 . . . . 0.0 109.627 174.372 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 2.2 m-20 -68.9 -18.92 64.19 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-O 120.952 0.406 . . . . 0.0 110.959 178.809 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 25.3 t70 -83.37 3.64 30.85 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 121.314 0.578 . . . . 0.0 110.279 175.32 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 74.26 9.88 81.3 Favored Glycine 0 N--CA 1.451 -0.305 0 CA-C-N 115.94 -0.573 . . . . 0.0 112.645 -175.958 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 23' ' ' THR . . . . . 0.466 ' HB ' HD23 ' A' ' 19' ' ' LEU . 12.1 m -72.55 141.07 48.46 Favored 'General case' 0 C--N 1.324 -0.53 0 N-CA-C 109.728 -0.471 . . . . 0.0 109.728 175.746 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 54.4 m -94.17 109.88 21.64 Favored 'General case' 0 C--N 1.319 -0.736 0 N-CA-C 109.854 -0.425 . . . . 0.0 109.854 174.658 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 25' ' ' ALA . . . . . 0.603 ' HB2' HD21 ' A' ' 19' ' ' LEU . . . -69.76 -40.41 76.14 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.975 -0.557 . . . . 0.0 110.027 179.692 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 10.2 tp10 -160.98 139.33 9.79 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 115.406 -0.815 . . . . 0.0 109.656 177.465 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 16.6 p -125.77 132.41 52.31 Favored 'General case' 0 C--N 1.317 -0.824 0 CA-C-O 120.838 0.352 . . . . 0.0 110.364 175.678 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 28' ' ' THR . . . . . 0.538 HG21 ' HB2' ' A' ' 35' ' ' ALA . 79.3 m -152.42 65.77 0.82 Allowed 'General case' 0 N--CA 1.441 -0.894 0 CA-C-O 122.116 0.96 . . . . 0.0 109.617 178.221 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 29' ' ' ARG . . . . . 0.584 ' HA ' ' ND1' ' A' ' 14' ' ' HIS . 26.9 ttt180 -154.11 -52.27 0.1 Allowed 'General case' 0 C--N 1.319 -0.733 0 N-CA-C 108.712 -0.847 . . . . 0.0 108.712 178.206 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 9.9 p30 -76.93 -4.24 42.9 Favored 'General case' 0 N--CA 1.464 0.228 0 CA-C-N 115.855 -0.611 . . . . 0.0 110.214 176.356 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 1.5 m-20 -69.46 -21.11 63.74 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 115.46 -0.791 . . . . 0.0 110.739 -178.958 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 85.3 4.1 86.51 Favored Glycine 0 N--CA 1.445 -0.711 0 C-N-CA 120.589 -0.815 . . . . 0.0 111.33 -173.723 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 56.5 mtpt -138.26 131.47 16.45 Favored Pre-proline 0 N--CA 1.452 -0.354 0 N-CA-C 109.995 -0.372 . . . . 0.0 109.995 179.14 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 91.8 Cg_endo -82.98 168.15 13.86 Favored 'Trans proline' 0 N--CA 1.453 -0.858 0 C-N-CA 122.393 2.062 . . . . 0.0 111.492 170.711 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 35' ' ' ALA . . . . . 0.538 ' HB2' HG21 ' A' ' 28' ' ' THR . . . -129.44 153.8 47.58 Favored 'General case' 0 C--N 1.319 -0.752 0 CA-C-N 116.256 -0.429 . . . . 0.0 109.942 -178.549 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 36' ' ' LEU . . . . . 0.672 HD21 ' HB1' ' A' ' 10' ' ' ALA . 4.6 tp -98.0 132.03 43.91 Favored 'General case' 0 C--N 1.315 -0.91 0 N-CA-C 109.967 -0.382 . . . . 0.0 109.967 176.87 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 37' ' ' PHE . . . . . 0.415 ' CD2' HD21 ' A' ' 44' ' ' LEU . 5.2 m-30 -95.79 107.33 19.55 Favored 'General case' 0 C--N 1.318 -0.802 0 N-CA-C 109.477 -0.564 . . . . 0.0 109.477 174.868 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 38' ' ' ARG . . . . . 0.434 ' HD2' ' CD ' ' A' ' 148' ' ' GLU . 4.9 tpp180 -84.96 107.32 17.04 Favored 'General case' 0 N--CA 1.45 -0.468 0 CA-C-N 115.536 -0.756 . . . . 0.0 109.901 -178.269 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 63.4 mt -81.89 156.12 24.96 Favored 'General case' 0 C--N 1.32 -0.69 0 CA-C-N 115.807 -0.633 . . . . 0.0 111.156 -179.422 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 103.74 40.46 2.33 Favored Glycine 0 N--CA 1.446 -0.635 0 CA-C-N 115.724 -0.671 . . . . 0.0 111.592 -175.368 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 49.3 m-20 57.09 21.78 6.75 Favored 'General case' 0 N--CA 1.47 0.544 0 C-N-CA 123.16 0.584 . . . . 0.0 112.265 177.4 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -67.51 -40.24 85.15 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-O 121.03 0.443 . . . . 0.0 111.145 -178.852 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 41.8 m -154.17 -37.96 0.09 Allowed 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 116.034 -0.53 . . . . 0.0 110.832 -179.722 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 44' ' ' LEU . . . . . 0.453 HD23 HD12 ' A' ' 48' ' ' LEU . 6.7 mp -70.79 145.04 50.63 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 121.088 0.471 . . . . 0.0 110.969 -177.039 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 12.6 m -72.87 163.95 27.36 Favored 'General case' 0 C--N 1.322 -0.629 0 CA-C-N 115.373 -0.83 . . . . 0.0 110.228 175.628 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 41.7 mt-10 -51.59 -46.63 63.57 Favored 'General case' 0 C--N 1.329 -0.313 0 N-CA-C 112.72 0.637 . . . . 0.0 112.72 -173.753 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -63.75 -50.41 61.65 Favored Glycine 0 N--CA 1.448 -0.516 0 C-N-CA 119.572 -1.299 . . . . 0.0 112.539 -172.592 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 48' ' ' LEU . . . . . 0.453 HD12 HD23 ' A' ' 44' ' ' LEU . 0.0 OUTLIER -44.64 -50.88 9.59 Favored 'General case' 0 CA--C 1.517 -0.324 0 N-CA-C 113.803 1.038 . . . . 0.0 113.803 171.482 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 10.5 tt0 -70.8 -33.25 70.53 Favored 'General case' 0 C--N 1.312 -1.054 0 CA-C-O 120.987 0.422 . . . . 0.0 110.819 -169.369 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 50' ' ' GLN . . . . . 0.473 ' HA ' HD22 ' A' ' 53' ' ' LEU . 19.3 mm-40 -87.08 -13.88 43.01 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-N 115.834 -0.621 . . . . 0.0 111.552 -172.827 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 51' ' ' HIS . . . . . . . . . . . . . 11.7 m-70 -100.39 -4.38 29.14 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-O 121.046 0.451 . . . . 0.0 110.545 -175.269 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 11.5 mt -102.25 -14.01 17.16 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-N 115.763 -0.653 . . . . 0.0 111.757 -179.598 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 53' ' ' LEU . . . . . 0.473 HD22 ' HA ' ' A' ' 50' ' ' GLN . 0.1 OUTLIER -65.43 151.49 46.2 Favored 'General case' 0 N--CA 1.451 -0.399 0 CA-C-O 120.881 0.372 . . . . 0.0 110.264 171.539 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 93.26 -16.99 59.29 Favored Glycine 0 CA--C 1.519 0.317 0 C-N-CA 121.226 -0.512 . . . . 0.0 112.85 -179.02 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 55' ' ' LEU . . . . . 0.553 HD23 ' HB3' ' A' ' 59' ' ' ASP . 7.2 mp -82.28 165.41 20.42 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-O 121.646 0.736 . . . . 0.0 112.493 -179.954 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 56' ' ' LYS . . . . . 0.547 ' HE2' ' OG ' ' A' ' 4' ' ' SER . 28.5 mmtp -119.41 170.25 9.3 Favored 'General case' 0 N--CA 1.444 -0.738 0 CA-C-N 114.963 -1.017 . . . . 0.0 110.268 175.016 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 57' ' ' VAL . . . . . 0.5 HG23 HD12 ' A' ' 143' ' ' ILE . 71.5 t -62.46 134.51 27.71 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.764 0 CA-C-N 115.696 -0.684 . . . . 0.0 109.973 173.91 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 80.82 21.95 62.55 Favored Glycine 0 N--CA 1.445 -0.732 0 C-N-CA 120.943 -0.646 . . . . 0.0 112.423 -179.67 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 59' ' ' ASP . . . . . 0.553 ' HB3' HD23 ' A' ' 55' ' ' LEU . 4.9 t70 -92.67 162.92 13.96 Favored 'General case' 0 C--N 1.323 -0.57 0 N-CA-C 108.823 -0.806 . . . . 0.0 108.823 175.441 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 2.5 mmmt -137.11 122.05 18.91 Favored 'General case' 0 C--N 1.318 -0.772 0 N-CA-C 107.716 -1.216 . . . . 0.0 107.716 -179.273 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 9.5 t -135.91 136.15 40.25 Favored 'General case' 0 C--N 1.321 -0.65 0 CA-C-O 122.039 0.923 . . . . 0.0 112.22 179.047 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 10.9 m -114.03 133.25 55.64 Favored 'General case' 0 N--CA 1.437 -1.118 0 CA-C-N 115.162 -0.926 . . . . 0.0 108.845 172.419 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 17.6 p90 -153.47 158.34 41.2 Favored 'General case' 0 C--N 1.316 -0.867 0 CA-C-O 120.963 0.411 . . . . 0.0 110.215 -178.575 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 46.2 m -129.43 132.97 47.1 Favored 'General case' 0 C--N 1.312 -1.057 0 N-CA-C 108.398 -0.964 . . . . 0.0 108.398 175.425 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 78.2 mt -100.44 146.83 26.55 Favored 'General case' 0 C--N 1.318 -0.762 0 CA-C-O 120.885 0.374 . . . . 0.0 110.386 -178.985 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 43.1 mt-10 -65.45 145.9 99.01 Favored Pre-proline 0 C--N 1.317 -0.846 0 N-CA-C 108.631 -0.877 . . . . 0.0 108.631 173.282 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 96.2 Cg_exo -41.76 -52.98 3.59 Favored 'Trans proline' 0 CA--C 1.531 0.345 0 C-N-CA 123.501 2.8 . . . . 0.0 114.5 -170.718 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 29.1 t70 -64.93 -24.62 67.58 Favored 'General case' 0 N--CA 1.466 0.363 0 CA-C-O 120.828 0.347 . . . . 0.0 111.675 -174.804 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -83.26 -10.94 58.25 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-O 120.77 0.319 . . . . 0.0 111.21 -178.605 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -119.58 -86.6 0.65 Allowed 'General case' 0 C--N 1.327 -0.403 0 N-CA-C 112.054 0.39 . . . . 0.0 112.054 -178.897 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 71' ' ' PHE . . . . . . . . . . . . . 3.2 m-85 -87.83 -21.55 24.98 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-O 120.968 0.413 . . . . 0.0 111.231 -174.847 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 72' ' ' GLY . . . . . 0.549 ' C ' ' HB1' ' A' ' 130' ' ' ALA . . . 115.31 -142.25 17.49 Favored Glycine 0 N--CA 1.445 -0.714 0 C-N-CA 120.775 -0.726 . . . . 0.0 111.59 -178.162 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 8.1 p -159.4 130.61 3.86 Favored Pre-proline 0 C--N 1.319 -0.728 0 O-C-N 122.434 -0.451 . . . . 0.0 110.627 -176.445 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 74' ' ' PRO . . . . . 0.647 ' CD ' ' HA3' ' A' ' 131' ' ' GLY . 93.7 Cg_endo -80.67 144.26 15.5 Favored 'Trans proline' 0 N--CA 1.453 -0.856 0 C-N-CA 123.174 2.583 . . . . 0.0 110.925 175.144 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 75' ' ' SER . . . . . 0.559 ' O ' ' HB2' ' A' ' 78' ' ' LEU . 28.5 t -128.23 139.44 35.45 Favored Pre-proline 0 C--N 1.311 -1.08 0 CA-C-N 116.467 -0.333 . . . . 0.0 110.383 -177.158 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 29.3 Cg_endo -65.93 -17.36 55.5 Favored 'Trans proline' 0 N--CA 1.461 -0.386 0 C-N-CA 122.493 2.129 . . . . 0.0 110.933 172.322 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 17.0 t70 -65.06 -26.81 68.4 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-O 121.798 0.808 . . . . 0.0 109.179 172.194 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 78' ' ' LEU . . . . . 0.559 ' HB2' ' O ' ' A' ' 75' ' ' SER . 0.5 OUTLIER -80.86 6.0 14.41 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 114.763 -1.108 . . . . 0.0 110.933 179.126 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 26.2 mt -126.66 99.1 5.26 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.874 0 N-CA-C 108.455 -0.943 . . . . 0.0 108.455 173.991 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 34.4 mt-30 -113.75 160.33 18.78 Favored 'General case' 0 C--N 1.309 -1.175 0 C-N-CA 119.021 -1.071 . . . . 0.0 112.527 174.357 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 81' ' ' TYR . . . . . 0.531 ' CE2' HG23 ' A' ' 122' ' ' THR . 66.6 m-85 -121.2 114.31 21.23 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.906 -0.588 . . . . 0.0 109.919 -179.796 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 49.6 m-85 -115.18 169.8 8.85 Favored 'General case' 0 C--N 1.316 -0.855 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.608 179.281 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 21.0 t -81.02 159.31 24.86 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-O 120.964 0.412 . . . . 0.0 110.97 -177.659 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 84' ' ' ARG . . . . . 0.591 ' HD2' ' O ' ' A' ' 118' ' ' GLY . 4.9 mtp180 -62.58 -36.89 84.15 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 122.1 0.952 . . . . 0.0 110.109 179.542 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 85' ' ' ARG . . . . . . . . . . . . . 8.5 mpt_? -63.14 -28.72 70.26 Favored 'General case' 0 C--N 1.319 -0.759 0 CA-C-N 113.794 -1.548 . . . . 0.0 111.447 -171.51 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 26.0 mm-40 -80.54 -10.34 59.74 Favored 'General case' 0 C--N 1.32 -0.707 0 CA-C-N 115.892 -0.595 . . . . 0.0 110.743 178.613 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 87' ' ' PHE . . . . . . . . . . . . . 17.0 m-85 -104.17 -36.6 7.62 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-N 115.712 -0.676 . . . . 0.0 110.501 -179.222 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 88' ' ' MET . . . . . . . . . . . . . 57.3 ttp -59.33 -23.41 62.46 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 121.776 0.798 . . . . 0.0 109.576 173.556 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 24.7 t70 -53.27 -34.35 56.9 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 114.246 -1.343 . . . . 0.0 110.46 173.073 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -122.57 16.73 10.4 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 115.644 -0.707 . . . . 0.0 111.501 -179.689 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 101.45 136.88 9.48 Favored Glycine 0 C--N 1.33 0.241 0 C-N-CA 120.629 -0.795 . . . . 0.0 112.415 -178.396 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 36.1 mt-10 -61.97 125.87 86.09 Favored Pre-proline 0 C--N 1.328 -0.333 0 CA-C-O 120.995 0.426 . . . . 0.0 111.494 -176.483 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 93' ' ' PRO . . . . . 0.666 ' HB2' HD13 ' A' ' 113' ' ' ILE . 57.7 Cg_endo -78.5 167.03 23.34 Favored 'Trans proline' 0 N--CA 1.459 -0.544 0 C-N-CA 123.266 2.644 . . . . 0.0 113.407 -173.436 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 94' ' ' GLU . . . . . 0.42 ' O ' HD12 ' A' ' 113' ' ' ILE . 24.7 mt-10 -118.32 164.34 15.36 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 115.982 -0.553 . . . . 0.0 110.6 -178.605 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 95' ' ' ILE . . . . . 0.531 HG12 HG12 ' A' ' 116' ' ' ILE . 12.9 mt -81.95 132.05 32.39 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.376 0 CA-C-O 120.594 0.235 . . . . 0.0 110.444 179.083 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 70.64 35.48 67.26 Favored Glycine 0 N--CA 1.448 -0.553 0 C-N-CA 121.185 -0.531 . . . . 0.0 111.785 -178.918 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 97' ' ' ALA . . . . . 0.561 ' O ' HG13 ' A' ' 113' ' ' ILE . . . -109.52 143.38 39.26 Favored 'General case' 0 C--N 1.322 -0.606 0 N-CA-C 109.744 -0.465 . . . . 0.0 109.744 -179.059 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 98' ' ' ILE . . . . . 0.51 ' HA ' ' O ' ' A' ' 111' ' ' GLY . 41.2 mt -94.48 107.9 20.0 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.115 0 CA-C-O 120.936 0.398 . . . . 0.0 110.479 -178.114 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 99' ' ' MET . . . . . 0.43 ' SD ' HD11 ' A' ' 113' ' ' ILE . 92.3 mtp -102.48 123.43 46.21 Favored 'General case' 0 N--CA 1.441 -0.925 0 CA-C-O 121.377 0.608 . . . . 0.0 111.404 -177.152 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 100' ' ' LEU . . . . . 0.444 HD13 ' HA ' ' A' ' 100' ' ' LEU . 4.4 mm? -65.59 143.85 57.35 Favored 'General case' 0 C--N 1.302 -1.477 0 CA-C-N 114.655 -1.157 . . . . 0.0 108.451 166.13 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 101' ' ' PHE . . . . . 0.417 ' CE2' ' HB2' ' A' ' 99' ' ' MET . 1.8 m-85 -149.85 167.95 25.11 Favored 'General case' 0 CA--C 1.511 -0.528 0 N-CA-C 108.062 -1.088 . . . . 0.0 108.062 -157.907 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 1.5 m -122.95 126.63 47.59 Favored 'General case' 0 C--N 1.312 -1.055 0 C-N-CA 119.774 -0.77 . . . . 0.0 110.592 179.23 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 103' ' ' ALA . . . . . 0.543 ' HB2' ' SD ' ' A' ' 109' ' ' MET . . . -95.59 167.34 11.36 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 115.915 -0.584 . . . . 0.0 110.61 -178.019 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 104' ' ' MET . . . . . . . . . . . . . 66.8 mtt -66.35 -12.93 59.56 Favored 'General case' 0 N--CA 1.464 0.259 0 CA-C-N 115.648 -0.705 . . . . 0.0 112.544 -173.117 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 5.4 p-10 -100.27 12.56 36.8 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-O 120.553 0.216 . . . . 0.0 111.383 -178.184 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 82.33 -2.56 84.56 Favored Glycine 0 N--CA 1.45 -0.383 0 C-N-CA 120.602 -0.809 . . . . 0.0 113.168 179.59 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 42.7 t -84.9 146.66 27.17 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-O 121.216 0.531 . . . . 0.0 110.266 178.683 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 28.9 tt0 -94.51 99.0 11.25 Favored 'General case' 0 C--N 1.314 -0.964 0 CA-C-N 115.319 -0.855 . . . . 0.0 108.905 178.355 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 109' ' ' MET . . . . . 0.543 ' SD ' ' HB2' ' A' ' 103' ' ' ALA . 14.6 ptm -88.66 135.09 32.74 Favored Pre-proline 0 C--N 1.325 -0.46 0 CA-C-N 115.426 -0.806 . . . . 0.0 111.065 -178.9 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 29.1 Cg_endo -65.55 153.81 76.52 Favored 'Trans proline' 0 N--CA 1.451 -0.983 0 C-N-CA 121.817 1.678 . . . . 0.0 110.065 171.425 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 111' ' ' GLY . . . . . 0.51 ' O ' ' HA ' ' A' ' 98' ' ' ILE . . . -147.21 152.78 24.88 Favored Glycine 0 N--CA 1.434 -1.486 0 N-CA-C 108.632 -1.787 . . . . 0.0 108.632 -170.313 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 112' ' ' VAL . . . . . 0.488 ' O ' ' HB3' ' A' ' 124' ' ' ASP . 0.7 OUTLIER -126.53 114.59 38.65 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.335 0 CA-C-N 118.613 1.206 . . . . 0.0 110.397 172.369 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 113' ' ' ILE . . . . . 0.666 HD13 ' HB2' ' A' ' 93' ' ' PRO . 0.6 OUTLIER -61.89 110.37 0.65 Allowed 'Isoleucine or valine' 0 C--N 1.317 -0.813 0 N-CA-C 109.022 -0.733 . . . . 0.0 109.022 174.314 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 114' ' ' ARG . . . . . 0.439 ' HB3' HG22 ' A' ' 122' ' ' THR . 12.5 tpp180 -65.02 -52.57 55.26 Favored 'General case' 0 C--N 1.315 -0.927 0 CA-C-N 115.292 -0.867 . . . . 0.0 110.882 -177.695 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 115' ' ' GLU . . . . . 0.502 ' HA ' HG23 ' A' ' 95' ' ' ILE . 10.8 tt0 -159.91 153.01 21.82 Favored 'General case' 0 C--N 1.321 -0.665 0 C-N-CA 120.887 -0.325 . . . . 0.0 110.329 -174.358 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 116' ' ' ILE . . . . . 0.531 HG12 HG12 ' A' ' 95' ' ' ILE . 43.6 mm -100.29 114.41 38.86 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.486 0 N-CA-C 109.646 -0.501 . . . . 0.0 109.646 176.231 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 117' ' ' ASN . . . . . 0.468 ' HB2' ' O ' ' A' ' 120' ' ' SER . 5.4 m-20 -94.11 157.51 16.04 Favored 'General case' 0 C--N 1.317 -0.835 0 N-CA-C 109.266 -0.642 . . . . 0.0 109.266 177.901 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 118' ' ' GLY . . . . . 0.591 ' O ' ' HD2' ' A' ' 84' ' ' ARG . . . -56.94 -45.55 91.92 Favored Glycine 0 N--CA 1.451 -0.361 0 C-N-CA 120.537 -0.84 . . . . 0.0 112.91 -172.96 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 30.1 t70 -112.4 -10.66 13.74 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-O 121.107 0.479 . . . . 0.0 111.248 -179.107 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 120' ' ' SER . . . . . 0.468 ' O ' ' HB2' ' A' ' 117' ' ' ASN . 35.2 t -125.88 157.29 38.04 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.205 -171.893 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 121' ' ' ILE . . . . . . . . . . . . . 50.2 mm -114.31 123.12 69.67 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.567 0 CA-C-O 121.183 0.516 . . . . 0.0 110.054 175.808 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 122' ' ' THR . . . . . 0.531 HG23 ' CE2' ' A' ' 81' ' ' TYR . 24.0 m -94.56 102.2 14.11 Favored 'General case' 0 C--N 1.316 -0.85 0 CA-C-N 115.457 -0.792 . . . . 0.0 110.671 179.027 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 123' ' ' VAL . . . . . 0.45 HG12 ' N ' ' A' ' 124' ' ' ASP . 8.2 t -88.18 160.27 2.9 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.55 0 CA-C-N 115.267 -0.879 . . . . 0.0 111.853 174.765 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 124' ' ' ASP . . . . . 0.488 ' HB3' ' O ' ' A' ' 112' ' ' VAL . 27.0 t70 -145.91 145.9 30.88 Favored 'General case' 0 C--N 1.317 -0.808 0 CA-C-N 114.355 -1.293 . . . . 0.0 109.203 176.806 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 125' ' ' PHE . . . . . 0.492 ' HB2' ' HG ' ' A' ' 78' ' ' LEU . 98.1 m-85 -132.8 9.91 4.25 Favored 'General case' 0 C--N 1.312 -1.037 0 N-CA-C 108.534 -0.913 . . . . 0.0 108.534 179.87 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 126' ' ' ASN . . . . . 0.414 ' HB2' ' OD2' ' A' ' 124' ' ' ASP . 7.2 m-80 -59.02 120.65 9.5 Favored 'General case' 0 CA--C 1.516 -0.345 0 CA-C-N 113.996 -1.456 . . . . 0.0 111.691 -176.541 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 127' ' ' HIS . . . . . 0.56 ' HB3' ' HD2' ' A' ' 128' ' ' PRO . 16.3 m-70 -74.51 -175.55 0.45 Allowed Pre-proline 0 C--N 1.322 -0.604 0 CA-C-N 113.819 -1.537 . . . . 0.0 111.524 -177.603 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 128' ' ' PRO . . . . . 0.56 ' HD2' ' HB3' ' A' ' 127' ' ' HIS . 4.1 Cg_exo -43.23 172.28 0.01 OUTLIER 'Trans proline' 0 C--N 1.351 0.677 0 C-N-CA 124.735 3.623 . . . . 0.0 114.476 168.034 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 129' ' ' LEU . . . . . . . . . . . . . 13.0 tp -52.23 36.85 0.0 OUTLIER 'General case' 0 N--CA 1.488 1.443 0 C-N-CA 127.396 2.278 . . . . 0.0 115.248 -173.665 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 130' ' ' ALA . . . . . 0.549 ' HB1' ' C ' ' A' ' 72' ' ' GLY . . . -80.09 175.7 10.41 Favored 'General case' 0 C--N 1.316 -0.886 0 C-N-CA 123.761 0.824 . . . . 0.0 112.203 -173.266 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 131' ' ' GLY . . . . . 0.647 ' HA3' ' CD ' ' A' ' 74' ' ' PRO . . . 76.3 29.15 58.78 Favored Glycine 0 CA--C 1.508 -0.36 0 CA-C-N 115.625 -0.716 . . . . 0.0 113.063 173.589 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 132' ' ' GLN . . . . . . . . . . . . . 4.0 pt20 -148.15 148.42 30.55 Favored 'General case' 0 N--CA 1.436 -1.141 0 N-CA-C 108.434 -0.95 . . . . 0.0 108.434 168.928 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 133' ' ' THR . . . . . . . . . . . . . 28.2 m -70.87 127.77 33.75 Favored 'General case' 0 C--N 1.314 -0.941 0 CA-C-N 116.108 -0.496 . . . . 0.0 109.86 -176.87 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 134' ' ' VAL . . . . . 0.505 ' HB ' HD21 ' A' ' 17' ' ' LEU . 16.8 m -98.95 149.96 5.24 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.688 0 CA-C-O 121.127 0.489 . . . . 0.0 110.216 -178.122 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 135' ' ' HIS . . . . . . . . . . . . . 95.2 m-70 -115.53 111.75 21.18 Favored 'General case' 0 C--N 1.314 -0.959 0 CA-C-N 115.161 -0.927 . . . . 0.0 109.577 -172.931 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 136' ' ' PHE . . . . . 0.537 ' CZ ' HD11 ' A' ' 17' ' ' LEU . 3.1 m-85 -107.92 124.1 49.61 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 115.373 -0.831 . . . . 0.0 111.116 -173.163 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 137' ' ' ASP . . . . . 0.453 ' O ' ' HA ' ' A' ' 15' ' ' PHE . 3.7 m-20 -110.38 100.85 9.63 Favored 'General case' 0 C--N 1.317 -0.815 0 N-CA-C 109.034 -0.728 . . . . 0.0 109.034 170.758 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 138' ' ' ILE . . . . . 0.638 HG23 HG21 ' A' ' 13' ' ' VAL . 54.2 mt -116.02 122.62 69.99 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.37 0 N-CA-C 112.701 0.63 . . . . 0.0 112.701 -171.905 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 80.4 mt-10 -110.52 137.95 47.54 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-N 115.838 -0.619 . . . . 0.0 110.076 173.491 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 140' ' ' VAL . . . . . 0.488 HG11 ' HA ' ' A' ' 57' ' ' VAL . 92.9 t -82.09 105.47 11.99 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.591 0 N-CA-C 108.473 -0.936 . . . . 0.0 108.473 177.435 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 39.1 mt -79.49 -44.45 21.22 Favored 'General case' 0 CA--C 1.508 -0.673 0 N-CA-C 109.839 -0.43 . . . . 0.0 109.839 -179.362 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 142' ' ' GLU . . . . . . . . . . . . . 14.5 pt-20 -169.32 158.12 7.93 Favored 'General case' 0 C--N 1.323 -0.549 0 N-CA-C 108.812 -0.81 . . . . 0.0 108.812 176.698 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 143' ' ' ILE . . . . . 0.5 HD12 HG23 ' A' ' 57' ' ' VAL . 82.3 mt -113.38 110.83 33.59 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.647 0 CA-C-O 121.231 0.538 . . . . 0.0 110.347 -179.444 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 144' ' ' ASP . . . . . . . . . . . . . 38.3 t70 -79.75 133.67 58.49 Favored Pre-proline 0 C--N 1.326 -0.423 0 CA-C-N 115.305 -0.861 . . . . 0.0 110.546 179.886 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 145' ' ' PRO . . . . . . . . . . . . . 90.1 Cg_exo -46.57 139.35 13.42 Favored 'Trans proline' 0 C--N 1.35 0.617 0 C-N-CA 123.236 2.624 . . . . 0.0 112.538 177.581 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 146' ' ' ALA . . . . . . . . . . . . . . . -83.35 96.94 8.67 Favored 'General case' 0 C--N 1.319 -0.752 0 CA-C-O 121.217 0.532 . . . . 0.0 111.143 -174.603 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 147' ' ' LEU . . . . . 0.407 HD13 ' HA ' ' A' ' 147' ' ' LEU . 3.6 mm? -104.7 13.51 31.33 Favored 'General case' 0 N--CA 1.449 -0.505 0 CA-C-N 115.407 -0.815 . . . . 0.0 109.948 174.054 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 148' ' ' GLU . . . . . 0.446 ' HB2' ' ND2' ' A' ' 8' ' ' ASN . 63.1 mm-40 . . . . . 0 C--N 1.328 -0.358 0 CA-C-N 115.505 -0.771 . . . . 0.0 111.883 -175.317 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 86.5 mmm . . . . . 0 N--CA 1.484 1.27 0 CA-C-O 120.718 0.294 . . . . 0.0 111.226 . . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 2' ' ' SER . . . . . 0.628 ' O ' ' HB ' ' A' ' 143' ' ' ILE . 33.2 t -97.2 135.34 39.28 Favored 'General case' 0 C--N 1.323 -0.553 0 N-CA-C 108.73 -0.841 . . . . 0.0 108.73 174.654 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 42.5 tt0 -84.41 -26.21 28.47 Favored 'General case' 0 C--N 1.321 -0.666 0 CA-C-O 121.216 0.531 . . . . 0.0 110.073 179.416 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 7.0 m -104.64 141.72 35.93 Favored 'General case' 0 C--N 1.318 -0.762 0 CA-C-N 115.443 -0.798 . . . . 0.0 110.711 -177.884 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 9.4 p -82.07 149.95 4.61 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.416 0 CA-C-N 116.052 -0.522 . . . . 0.0 111.075 -176.647 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 6' ' ' GLN . . . . . 0.448 ' CG ' ' HB2' ' A' ' 9' ' ' SER . 3.3 pt20 -143.74 157.77 44.15 Favored 'General case' 0 C--N 1.321 -0.656 0 CA-C-N 115.644 -0.707 . . . . 0.0 110.387 178.673 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 7' ' ' SER . . . . . 0.438 ' O ' ' HB2' ' A' ' 8' ' ' ASN . 5.1 p -76.02 144.12 41.03 Favored 'General case' 0 C--N 1.319 -0.724 0 CA-C-N 116.209 -0.451 . . . . 0.0 109.994 178.533 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 8' ' ' ASN . . . . . 0.438 ' HB2' ' O ' ' A' ' 7' ' ' SER . 4.6 m-20 71.6 13.7 6.31 Favored 'General case' 0 N--CA 1.466 0.358 0 CA-C-N 115.405 -0.816 . . . . 0.0 111.815 -178.4 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 9' ' ' SER . . . . . 0.448 ' HB2' ' CG ' ' A' ' 6' ' ' GLN . 18.2 t -82.44 166.91 18.97 Favored 'General case' 0 C--N 1.328 -0.359 0 N-CA-C 109.879 -0.415 . . . . 0.0 109.879 175.518 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 10' ' ' ALA . . . . . 0.67 ' O ' ' HB2' ' A' ' 144' ' ' ASP . . . -110.5 111.93 23.51 Favored 'General case' 0 C--N 1.318 -0.78 0 N-CA-C 109.241 -0.651 . . . . 0.0 109.241 172.638 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 16.5 m -114.61 144.72 21.56 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.789 0 C-N-CA 120.231 -0.588 . . . . 0.0 111.106 -172.67 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 12' ' ' LEU . . . . . 0.478 ' HB2' ' HB2' ' A' ' 142' ' ' GLU . 9.7 mp -87.0 128.29 35.08 Favored 'General case' 0 C--N 1.325 -0.485 0 N-CA-C 109.393 -0.595 . . . . 0.0 109.393 176.423 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 22.3 m -119.72 155.88 22.37 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.928 0 CA-C-O 121.971 0.891 . . . . 0.0 112.905 -173.094 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 14' ' ' HIS . . . . . 0.521 ' CD2' HD11 ' A' ' 141' ' ' LEU . 0.2 OUTLIER -127.82 111.61 13.83 Favored 'General case' 0 C--N 1.315 -0.924 0 CA-C-N 114.044 -1.435 . . . . 0.0 107.456 162.932 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 15' ' ' PHE . . . . . 0.552 ' HA ' ' O ' ' A' ' 137' ' ' ASP . 33.9 p90 -139.07 171.25 14.59 Favored 'General case' 0 C--N 1.321 -0.654 0 N-CA-C 114.198 1.184 . . . . 0.0 114.198 -174.299 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 89.1 m -141.9 140.13 32.76 Favored 'General case' 0 C--N 1.314 -0.955 0 CA-C-N 113.092 -1.867 . . . . 0.0 106.662 175.205 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 17' ' ' LEU . . . . . 0.4 ' HG ' ' HB3' ' A' ' 136' ' ' PHE . 0.5 OUTLIER -127.22 108.32 10.77 Favored 'General case' 0 C--N 1.316 -0.85 0 C-N-CA 120.973 -0.291 . . . . 0.0 110.654 -171.163 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 9.7 mptt -116.48 160.49 20.52 Favored 'General case' 0 C--N 1.321 -0.653 0 CA-C-O 121.313 0.578 . . . . 0.0 111.643 -174.601 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 19' ' ' LEU . . . . . 0.451 HD13 HG23 ' A' ' 134' ' ' VAL . 3.1 mm? -106.25 171.58 7.27 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 115.022 -0.99 . . . . 0.0 109.644 173.447 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 18.5 t70 -58.07 -30.66 66.37 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-O 121.197 0.522 . . . . 0.0 110.258 175.793 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 10.1 m-20 -77.85 6.69 7.1 Favored 'General case' 0 N--CA 1.465 0.298 0 CA-C-N 115.736 -0.666 . . . . 0.0 111.351 178.858 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 70.18 9.29 63.51 Favored Glycine 0 N--CA 1.453 -0.21 0 C-N-CA 121.294 -0.479 . . . . 0.0 113.261 -179.337 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 14.2 m -79.13 148.35 32.39 Favored 'General case' 0 C--N 1.322 -0.62 0 N-CA-C 109.891 -0.411 . . . . 0.0 109.891 178.422 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 18.2 m -95.16 116.52 28.84 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-O 120.987 0.422 . . . . 0.0 110.965 179.931 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -78.42 -39.36 39.01 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 116.0 -0.545 . . . . 0.0 109.825 176.827 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 8.0 tp10 -157.25 143.0 17.56 Favored 'General case' 0 N--CA 1.451 -0.394 0 CA-C-N 115.823 -0.626 . . . . 0.0 109.957 176.134 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 29.0 p -125.28 121.56 34.39 Favored 'General case' 0 C--N 1.316 -0.852 0 CA-C-N 116.295 -0.411 . . . . 0.0 110.402 178.327 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 50.5 m -136.99 61.24 1.63 Allowed 'General case' 0 N--CA 1.442 -0.856 0 CA-C-O 122.371 1.082 . . . . 0.0 109.816 174.81 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 4.7 tmm_? -151.75 -61.15 0.17 Allowed 'General case' 0 C--N 1.319 -0.755 0 CA-C-N 114.824 -1.08 . . . . 0.0 109.39 -177.861 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 6.2 p30 -68.94 -11.72 60.93 Favored 'General case' 0 N--CA 1.465 0.321 0 CA-C-O 121.121 0.486 . . . . 0.0 110.337 179.645 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 1.3 m-20 -66.49 -36.72 83.42 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 115.412 -0.813 . . . . 0.0 110.702 -179.76 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 98.6 -3.86 59.48 Favored Glycine 0 N--CA 1.448 -0.502 0 CA-C-N 115.655 -0.702 . . . . 0.0 111.614 -175.228 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 60.2 mtpt -126.7 132.29 24.25 Favored Pre-proline 0 C--N 1.328 -0.367 0 N-CA-C 110.143 -0.317 . . . . 0.0 110.143 179.795 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 42.6 Cg_endo -83.9 171.55 10.48 Favored 'Trans proline' 0 N--CA 1.456 -0.724 0 C-N-CA 123.207 2.605 . . . . 0.0 112.24 174.563 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -129.84 163.09 27.04 Favored 'General case' 0 C--N 1.316 -0.889 0 CA-C-N 115.927 -0.579 . . . . 0.0 109.623 -176.641 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 36' ' ' LEU . . . . . 0.523 HD21 ' HB1' ' A' ' 10' ' ' ALA . 0.9 OUTLIER -105.85 122.53 46.29 Favored 'General case' 0 C--N 1.315 -0.916 0 C-N-CA 120.757 -0.377 . . . . 0.0 110.571 177.003 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 37' ' ' PHE . . . . . . . . . . . . . 6.0 m-30 -93.44 107.57 19.39 Favored 'General case' 0 C--N 1.316 -0.891 0 CA-C-N 115.966 -0.561 . . . . 0.0 109.762 172.113 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 18.9 tpt180 -85.87 106.86 17.38 Favored 'General case' 0 N--CA 1.445 -0.701 0 N-CA-C 109.194 -0.669 . . . . 0.0 109.194 178.26 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 39' ' ' LEU . . . . . 0.516 HD22 ' HB3' ' A' ' 49' ' ' GLU . 15.9 mt -82.15 156.06 24.68 Favored 'General case' 0 C--N 1.317 -0.842 0 CA-C-N 115.215 -0.902 . . . . 0.0 110.498 -176.276 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 101.77 32.27 5.13 Favored Glycine 0 C--N 1.319 -0.415 0 C-N-CA 121.177 -0.535 . . . . 0.0 112.838 -177.32 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 41' ' ' ASP . . . . . 0.507 ' HA ' ' O ' ' A' ' 44' ' ' LEU . 14.7 t70 60.28 23.39 12.83 Favored 'General case' 0 N--CA 1.471 0.601 0 CA-C-O 121.507 0.67 . . . . 0.0 111.436 176.762 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -84.24 -5.37 59.25 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-O 121.05 0.452 . . . . 0.0 110.909 179.298 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 26.5 p -166.32 -49.17 0.03 OUTLIER 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 115.78 -0.645 . . . . 0.0 110.292 179.787 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 44' ' ' LEU . . . . . 0.507 ' O ' ' HA ' ' A' ' 41' ' ' ASP . 40.9 mt -106.42 171.1 7.54 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 115.992 -0.549 . . . . 0.0 110.413 179.259 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 21.0 t -76.79 153.37 34.99 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 116.005 -0.543 . . . . 0.0 109.605 178.727 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 46' ' ' GLU . . . . . 0.502 ' O ' ' HG2' ' A' ' 49' ' ' GLU . 44.8 mt-10 -63.7 -24.54 67.82 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 115.902 -0.59 . . . . 0.0 111.545 -176.597 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -57.97 -35.01 74.07 Favored Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 120.916 -0.659 . . . . 0.0 112.32 175.528 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 48' ' ' LEU . . . . . 0.445 ' HG ' HD13 ' A' ' 44' ' ' LEU . 0.6 OUTLIER -60.03 -51.91 67.63 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 121.089 0.471 . . . . 0.0 109.912 177.423 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 49' ' ' GLU . . . . . 0.652 ' O ' HD13 ' A' ' 53' ' ' LEU . 14.8 pt-20 -68.15 -51.07 50.14 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 115.9 -0.591 . . . . 0.0 111.19 -174.627 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 50' ' ' GLN . . . . . 0.535 ' HA ' HD22 ' A' ' 53' ' ' LEU . 85.3 mm-40 -56.03 -15.14 3.14 Favored 'General case' 0 C--N 1.329 -0.308 0 N-CA-C 113.75 1.018 . . . . 0.0 113.75 -176.278 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 51' ' ' HIS . . . . . . . . . . . . . 11.6 m170 -106.15 -13.8 15.33 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-O 121.074 0.464 . . . . 0.0 110.716 -177.024 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 18.3 mt -88.16 -14.65 38.12 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-N 115.632 -0.713 . . . . 0.0 109.832 172.427 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 53' ' ' LEU . . . . . 0.652 HD13 ' O ' ' A' ' 49' ' ' GLU . 5.8 mp -61.05 150.38 33.98 Favored 'General case' 0 N--CA 1.445 -0.697 0 CA-C-N 115.554 -0.748 . . . . 0.0 110.596 170.541 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 93.3 -14.67 64.74 Favored Glycine 0 N--CA 1.447 -0.581 0 C-N-CA 121.014 -0.612 . . . . 0.0 111.988 -175.23 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 6.9 mp -85.24 165.84 17.02 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-O 121.726 0.774 . . . . 0.0 112.048 177.632 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 56' ' ' LYS . . . . . 0.429 ' O ' ' HB2' ' A' ' 59' ' ' ASP . 24.2 tptt -128.75 166.92 18.05 Favored 'General case' 0 C--N 1.318 -0.8 0 N-CA-C 107.829 -1.175 . . . . 0.0 107.829 178.16 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 57' ' ' VAL . . . . . 0.552 HG23 HD12 ' A' ' 143' ' ' ILE . 12.6 t -60.52 131.83 25.55 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.52 0 CA-C-O 121.014 0.435 . . . . 0.0 110.816 176.465 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 81.59 10.25 84.62 Favored Glycine 0 N--CA 1.451 -0.364 0 CA-C-N 115.482 -0.781 . . . . 0.0 113.071 -177.519 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 59' ' ' ASP . . . . . 0.429 ' HB2' ' O ' ' A' ' 56' ' ' LYS . 1.0 OUTLIER -93.85 138.13 32.34 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.93 0.395 . . . . 0.0 110.28 176.545 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 60' ' ' LYS . . . . . 0.421 ' HE3' ' OE2' ' A' ' 139' ' ' GLU . 3.4 mmmm -110.48 131.53 54.97 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 116.034 -0.53 . . . . 0.0 109.573 -176.256 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 7.5 t -141.29 145.16 35.16 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-O 121.659 0.742 . . . . 0.0 111.839 -179.908 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 17.4 m -118.0 143.04 46.73 Favored 'General case' 0 C--N 1.313 -0.988 0 N-CA-C 108.609 -0.885 . . . . 0.0 108.609 171.143 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 21.3 p90 -161.15 163.95 30.92 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-O 120.958 0.409 . . . . 0.0 111.107 -177.01 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 41.7 t -132.48 136.9 46.99 Favored 'General case' 0 C--N 1.32 -0.686 0 CA-C-N 115.778 -0.646 . . . . 0.0 109.317 179.815 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 65' ' ' LEU . . . . . 0.409 HD11 ' HA ' ' A' ' 48' ' ' LEU . 87.6 mt -120.74 146.19 46.74 Favored 'General case' 0 C--N 1.313 -1.011 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.034 -178.352 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 14.5 mm-40 -64.44 152.99 87.82 Favored Pre-proline 0 N--CA 1.442 -0.828 0 CA-C-N 115.364 -0.835 . . . . 0.0 109.995 173.198 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 67' ' ' PRO . . . . . 0.499 ' HB3' ' N ' ' A' ' 132' ' ' GLN . 1.9 Cg_endo -42.61 -55.19 2.78 Favored 'Trans proline' 0 N--CA 1.464 -0.264 0 C-N-CA 123.797 2.998 . . . . 0.0 114.924 -171.513 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 7.0 p-10 -72.21 -14.76 61.87 Favored 'General case' 0 N--CA 1.465 0.304 0 CA-C-O 121.075 0.464 . . . . 0.0 111.502 -174.107 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -90.3 -8.79 50.01 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.676 179.175 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -126.25 -86.11 0.61 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.142 -0.481 . . . . 0.0 111.864 -179.202 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 71' ' ' PHE . . . . . . . . . . . . . 8.9 m-30 -79.88 -33.12 40.24 Favored 'General case' 0 N--CA 1.463 0.186 0 CA-C-N 116.285 -0.416 . . . . 0.0 111.967 -173.561 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 132.67 -149.98 19.63 Favored Glycine 0 N--CA 1.447 -0.577 0 C-N-CA 120.668 -0.777 . . . . 0.0 112.034 -177.901 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 3.0 p -158.04 128.42 3.49 Favored Pre-proline 0 C--N 1.32 -0.694 0 N-CA-C 109.94 -0.392 . . . . 0.0 109.94 -174.23 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 74' ' ' PRO . . . . . 0.56 ' HD3' ' HA3' ' A' ' 131' ' ' GLY . 35.7 Cg_endo -64.58 126.4 16.75 Favored 'Trans proline' 0 C--O 1.232 0.215 0 C-N-CA 123.281 2.654 . . . . 0.0 112.352 -177.45 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 39.6 t -97.87 125.09 45.56 Favored Pre-proline 0 C--N 1.322 -0.627 0 CA-C-N 115.981 -0.554 . . . . 0.0 110.743 -179.828 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 39.1 Cg_endo -69.49 -18.93 38.01 Favored 'Trans proline' 0 N--CA 1.464 -0.236 0 C-N-CA 122.789 2.326 . . . . 0.0 111.813 174.891 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 7.3 m-20 -76.19 -15.22 60.09 Favored 'General case' 0 CA--C 1.519 -0.231 0 CA-C-O 121.359 0.6 . . . . 0.0 109.838 176.742 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 78' ' ' LEU . . . . . 0.553 ' HG ' ' HB2' ' A' ' 125' ' ' PHE . 6.2 mp -87.01 8.17 24.51 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 115.407 -0.815 . . . . 0.0 109.89 175.966 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 49.8 mt -118.86 109.41 26.74 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.681 0 N-CA-C 108.203 -1.036 . . . . 0.0 108.203 172.686 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 74.7 mt-30 -131.43 136.37 47.93 Favored 'General case' 0 C--N 1.311 -1.086 0 CA-C-N 115.259 -0.882 . . . . 0.0 110.054 -169.523 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 81' ' ' TYR . . . . . . . . . . . . . 46.3 m-85 -107.02 112.73 25.82 Favored 'General case' 0 C--N 1.321 -0.638 0 C-N-CA 120.125 -0.63 . . . . 0.0 110.252 -179.885 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 60.0 m-85 -103.78 170.47 7.91 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-O 121.548 0.689 . . . . 0.0 112.822 178.868 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 9.7 m -79.1 139.98 37.94 Favored 'General case' 0 N--CA 1.445 -0.724 0 CA-C-N 114.745 -1.116 . . . . 0.0 111.288 174.634 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 84' ' ' ARG . . . . . 0.434 ' HD2' ' O ' ' A' ' 118' ' ' GLY . 10.8 ptm180 -68.57 -17.22 64.09 Favored 'General case' 0 C--N 1.325 -0.469 0 N-CA-C 113.714 1.005 . . . . 0.0 113.714 -175.186 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 85' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -74.04 -34.13 63.98 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-O 121.134 0.492 . . . . 0.0 109.879 -174.713 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 45.1 mt-10 -64.6 -16.37 62.6 Favored 'General case' 0 N--CA 1.465 0.3 0 CA-C-N 115.177 -0.919 . . . . 0.0 110.77 -179.936 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 87' ' ' PHE . . . . . . . . . . . . . 54.8 m-85 -102.5 -23.12 13.93 Favored 'General case' 0 C--N 1.319 -0.72 0 CA-C-N 115.185 -0.916 . . . . 0.0 110.135 -177.464 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 88' ' ' MET . . . . . . . . . . . . . 56.0 ttm -62.0 -35.56 78.89 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 115.94 -0.573 . . . . 0.0 110.836 -178.419 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 23.1 t70 -58.18 -25.86 62.07 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 121.144 0.497 . . . . 0.0 111.304 178.888 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -111.13 16.51 21.03 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-N 115.938 -0.573 . . . . 0.0 110.668 177.765 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 90.65 143.99 11.66 Favored Glycine 0 N--CA 1.447 -0.629 0 C-N-CA 120.762 -0.732 . . . . 0.0 111.637 -178.225 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 44.3 mt-10 -60.42 127.28 86.33 Favored Pre-proline 0 C--N 1.323 -0.545 0 CA-C-O 121.02 0.438 . . . . 0.0 110.848 -177.633 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 18.1 Cg_endo -71.11 164.91 34.12 Favored 'Trans proline' 0 N--CA 1.457 -0.627 0 C-N-CA 122.85 2.367 . . . . 0.0 112.313 -175.282 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 23.0 mt-10 -118.07 160.8 20.89 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 116.332 -0.395 . . . . 0.0 110.392 -177.603 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 95' ' ' ILE . . . . . 0.502 HG23 ' HA ' ' A' ' 115' ' ' GLU . 9.6 mt -82.33 131.67 33.23 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.51 0 CA-C-O 120.969 0.414 . . . . 0.0 110.607 -178.333 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 71.35 34.8 63.73 Favored Glycine 0 N--CA 1.444 -0.783 0 CA-C-N 115.706 -0.679 . . . . 0.0 111.518 -176.849 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -110.14 115.58 29.98 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 121.659 0.742 . . . . 0.0 112.553 -177.555 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 98' ' ' ILE . . . . . 0.667 ' HA ' ' HA ' ' A' ' 112' ' ' VAL . 5.5 mt -82.03 123.3 37.99 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.017 0 CA-C-N 114.826 -1.079 . . . . 0.0 108.504 175.926 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 99' ' ' MET . . . . . . . . . . . . . 10.0 mtm -136.64 152.78 50.81 Favored 'General case' 0 N--CA 1.443 -0.797 0 N-CA-C 106.37 -1.715 . . . . 0.0 106.37 179.811 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 3.2 mm? -71.54 102.85 2.81 Favored 'General case' 0 C--N 1.313 -1.003 0 CA-C-O 122.273 1.035 . . . . 0.0 111.856 -178.795 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 101' ' ' PHE . . . . . . . . . . . . . 8.2 m-30 -94.78 172.65 8.04 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 113.033 -1.894 . . . . 0.0 111.826 -179.512 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 5.3 m -118.56 130.14 55.73 Favored 'General case' 0 C--N 1.316 -0.887 0 CA-C-N 114.947 -1.024 . . . . 0.0 108.972 -178.716 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 103' ' ' ALA . . . . . 0.612 ' HB2' ' SD ' ' A' ' 109' ' ' MET . . . -94.57 158.47 15.52 Favored 'General case' 0 C--N 1.322 -0.605 0 N-CA-C 109.329 -0.619 . . . . 0.0 109.329 -177.889 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 104' ' ' MET . . . . . . . . . . . . . 2.0 mpt? -66.54 -12.65 58.7 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 115.732 -0.667 . . . . 0.0 111.953 -174.988 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 5.0 p-10 -97.63 11.27 37.55 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-O 120.893 0.378 . . . . 0.0 110.989 179.227 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 87.9 -12.22 64.53 Favored Glycine 0 N--CA 1.45 -0.392 0 C-N-CA 121.249 -0.5 . . . . 0.0 113.505 175.499 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 48.9 m -76.76 142.49 40.39 Favored 'General case' 0 C--N 1.317 -0.81 0 CA-C-N 116.816 0.308 . . . . 0.0 110.308 177.499 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 30.1 tt0 -93.65 100.57 12.79 Favored 'General case' 0 C--N 1.318 -0.778 0 CA-C-O 121.675 0.75 . . . . 0.0 109.536 178.473 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 109' ' ' MET . . . . . 0.612 ' SD ' ' HB2' ' A' ' 103' ' ' ALA . 16.0 ptm -100.3 139.58 20.79 Favored Pre-proline 0 C--N 1.323 -0.573 0 CA-C-N 114.889 -1.051 . . . . 0.0 111.262 -177.289 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 17.7 Cg_exo -64.6 143.37 81.15 Favored 'Trans proline' 0 N--CA 1.451 -1.02 0 C-N-CA 121.88 1.72 . . . . 0.0 110.061 171.874 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . -144.69 108.26 0.48 Allowed Glycine 0 N--CA 1.438 -1.212 0 N-CA-C 109.876 -1.29 . . . . 0.0 109.876 -171.512 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 112' ' ' VAL . . . . . 0.667 ' HA ' ' HA ' ' A' ' 98' ' ' ILE . 1.3 p -84.11 110.38 18.64 Favored 'Isoleucine or valine' 0 CA--C 1.51 -0.582 0 C-N-CA 119.202 -0.999 . . . . 0.0 110.879 -178.647 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 113' ' ' ILE . . . . . . . . . . . . . 45.9 mt -60.41 110.11 0.52 Allowed 'Isoleucine or valine' 0 N--CA 1.438 -1.071 0 CA-C-N 114.22 -1.355 . . . . 0.0 108.536 170.726 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 114' ' ' ARG . . . . . 0.444 ' O ' HG23 ' A' ' 95' ' ' ILE . 1.3 tmt_? -79.2 -27.55 42.56 Favored 'General case' 0 C--N 1.309 -1.188 0 CA-C-N 114.162 -1.381 . . . . 0.0 110.899 -168.214 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 115' ' ' GLU . . . . . 0.612 ' N ' ' HB ' ' A' ' 122' ' ' THR . 8.2 tt0 -160.28 159.93 31.96 Favored 'General case' 0 C--N 1.325 -0.484 0 N-CA-C 112.456 0.539 . . . . 0.0 112.456 -179.046 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 116' ' ' ILE . . . . . 0.471 HG12 HG12 ' A' ' 95' ' ' ILE . 33.4 mm -118.39 130.3 73.45 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.605 0 CA-C-N 114.981 -1.009 . . . . 0.0 109.444 174.218 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 117' ' ' ASN . . . . . 0.41 ' HB2' ' O ' ' A' ' 120' ' ' SER . 19.8 m-80 -122.21 159.3 27.57 Favored 'General case' 0 C--N 1.309 -1.192 0 CA-C-N 115.51 -0.768 . . . . 0.0 109.27 -179.782 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 118' ' ' GLY . . . . . 0.434 ' O ' ' HD2' ' A' ' 84' ' ' ARG . . . -55.28 -45.59 82.47 Favored Glycine 0 N--CA 1.452 -0.297 0 C-N-CA 120.653 -0.784 . . . . 0.0 112.896 -170.624 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 3.3 p-10 -114.17 -12.08 12.56 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 117.03 0.415 . . . . 0.0 111.032 173.534 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 120' ' ' SER . . . . . 0.41 ' O ' ' HB2' ' A' ' 117' ' ' ASN . 21.9 t -113.77 159.79 19.38 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-O 122.047 0.927 . . . . 0.0 112.122 -169.196 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 121' ' ' ILE . . . . . . . . . . . . . 45.1 mm -118.98 159.68 19.4 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.863 0 CA-C-N 114.292 -1.322 . . . . 0.0 109.52 -177.289 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 122' ' ' THR . . . . . 0.612 ' HB ' ' N ' ' A' ' 115' ' ' GLU . 8.8 m -139.18 139.14 37.47 Favored 'General case' 0 N--CA 1.448 -0.533 0 N-CA-C 106.844 -1.539 . . . . 0.0 106.844 -170.78 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 123' ' ' VAL . . . . . 0.4 HG12 ' N ' ' A' ' 124' ' ' ASP . 55.6 t -140.46 154.57 22.46 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.67 0 C-N-CA 117.555 -1.658 . . . . 0.0 109.872 -164.119 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 124' ' ' ASP . . . . . 0.441 ' HB3' HG13 ' A' ' 112' ' ' VAL . 35.6 t70 -154.7 94.9 1.72 Allowed 'General case' 0 C--N 1.309 -1.176 0 CA-C-N 115.593 -0.73 . . . . 0.0 109.684 176.671 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 125' ' ' PHE . . . . . 0.553 ' HB2' ' HG ' ' A' ' 78' ' ' LEU . 97.4 m-85 -82.01 3.37 26.88 Favored 'General case' 0 C--N 1.324 -0.534 0 O-C-N 120.724 -1.235 . . . . 0.0 110.376 173.699 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 37.0 m-80 -57.48 136.2 56.66 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-O 122.478 1.132 . . . . 0.0 111.951 -177.92 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 127' ' ' HIS . . . . . 0.637 ' HB3' ' HD2' ' A' ' 128' ' ' PRO . 33.8 m170 -84.96 -170.9 0.27 Allowed Pre-proline 0 C--N 1.319 -0.747 0 CA-C-N 112.962 -1.926 . . . . 0.0 111.095 -168.788 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 128' ' ' PRO . . . . . 0.637 ' HD2' ' HB3' ' A' ' 127' ' ' HIS . 6.0 Cg_exo -41.83 172.64 0.01 OUTLIER 'Trans proline' 0 C--N 1.354 0.844 0 C-N-CA 124.482 3.455 . . . . 0.0 114.101 165.086 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 129' ' ' LEU . . . . . 0.473 ' O ' ' HG ' ' A' ' 129' ' ' LEU . 22.1 tp -51.68 34.76 0.0 OUTLIER 'General case' 0 N--CA 1.485 1.28 0 C-N-CA 126.91 2.084 . . . . 0.0 115.843 -173.829 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 130' ' ' ALA . . . . . 0.403 ' N ' ' O ' ' A' ' 128' ' ' PRO . . . -70.48 164.46 24.66 Favored 'General case' 0 C--N 1.315 -0.906 0 C-N-CA 122.83 0.452 . . . . 0.0 110.15 175.259 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 131' ' ' GLY . . . . . 0.56 ' HA3' ' HD3' ' A' ' 74' ' ' PRO . . . 76.46 28.37 59.8 Favored Glycine 0 N--CA 1.45 -0.389 0 C-N-CA 120.621 -0.799 . . . . 0.0 112.069 -178.439 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 132' ' ' GLN . . . . . 0.499 ' N ' ' HB3' ' A' ' 67' ' ' PRO . 14.9 tt0 -148.05 141.55 25.39 Favored 'General case' 0 N--CA 1.441 -0.89 0 N-CA-C 108.897 -0.779 . . . . 0.0 108.897 171.505 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 133' ' ' THR . . . . . . . . . . . . . 59.5 m -67.39 125.35 25.83 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.672 -178.061 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 134' ' ' VAL . . . . . 0.451 HG23 HD13 ' A' ' 19' ' ' LEU . 2.7 p -116.96 166.78 10.91 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.501 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.803 -173.227 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 135' ' ' HIS . . . . . 0.441 ' H ' HG22 ' A' ' 134' ' ' VAL . 81.8 m-70 -131.0 124.48 31.05 Favored 'General case' 0 C--N 1.322 -0.587 0 CA-C-N 115.848 -0.614 . . . . 0.0 111.089 -171.278 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 136' ' ' PHE . . . . . 0.4 ' HB3' ' HG ' ' A' ' 17' ' ' LEU . 0.1 OUTLIER -131.54 150.98 51.96 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 121.478 0.656 . . . . 0.0 111.907 -179.966 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 137' ' ' ASP . . . . . 0.552 ' O ' ' HA ' ' A' ' 15' ' ' PHE . 3.3 m-20 -115.89 101.18 8.56 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-N 114.706 -1.133 . . . . 0.0 108.604 174.244 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 138' ' ' ILE . . . . . . . . . . . . . 47.6 mt -116.65 130.51 71.38 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.532 0 CA-C-O 121.203 0.525 . . . . 0.0 111.789 -172.23 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 139' ' ' GLU . . . . . 0.421 ' OE2' ' HE3' ' A' ' 60' ' ' LYS . 11.7 pt-20 -118.45 142.8 47.21 Favored 'General case' 0 C--N 1.321 -0.642 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.103 178.064 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 140' ' ' VAL . . . . . 0.453 ' CG1' ' HA ' ' A' ' 57' ' ' VAL . 78.7 t -79.09 108.33 12.55 Favored 'Isoleucine or valine' 0 C--O 1.234 0.263 0 CA-C-O 121.068 0.461 . . . . 0.0 111.116 -179.199 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 141' ' ' LEU . . . . . 0.521 HD11 ' CD2' ' A' ' 14' ' ' HIS . 48.7 mt -90.45 -33.02 16.15 Favored 'General case' 0 C--N 1.321 -0.652 0 CA-C-O 121.632 0.729 . . . . 0.0 110.324 177.291 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 142' ' ' GLU . . . . . 0.478 ' HB2' ' HB2' ' A' ' 12' ' ' LEU . 0.0 OUTLIER -164.49 148.23 9.28 Favored 'General case' 0 C--N 1.316 -0.885 0 CA-C-N 114.083 -1.417 . . . . 0.0 111.811 -176.879 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 143' ' ' ILE . . . . . 0.628 ' HB ' ' O ' ' A' ' 2' ' ' SER . 78.3 mt -125.16 127.92 72.53 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.538 0 CA-C-N 115.455 -0.793 . . . . 0.0 109.91 178.834 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 144' ' ' ASP . . . . . 0.67 ' HB2' ' O ' ' A' ' 10' ' ' ALA . 31.4 t70 -62.15 137.52 95.76 Favored Pre-proline 0 C--N 1.326 -0.448 0 CA-C-N 115.82 -0.627 . . . . 0.0 110.715 -178.246 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 145' ' ' PRO . . . . . . . . . . . . . 25.3 Cg_endo -61.47 156.43 46.77 Favored 'Trans proline' 0 N--CA 1.463 -0.32 0 C-N-CA 122.823 2.349 . . . . 0.0 111.627 178.334 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 146' ' ' ALA . . . . . . . . . . . . . . . -82.6 97.72 8.63 Favored 'General case' 0 C--N 1.317 -0.809 0 CA-C-O 120.977 0.417 . . . . 0.0 110.625 -176.388 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 4.1 mm? -90.19 41.79 1.07 Allowed 'General case' 0 C--N 1.325 -0.488 0 CA-C-O 121.477 0.656 . . . . 0.0 110.511 178.494 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 18.0 mm-40 . . . . . 0 C--N 1.323 -0.555 0 CA-C-N 115.127 -0.942 . . . . 0.0 110.467 178.272 . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 34.2 ttm . . . . . 0 N--CA 1.481 1.09 0 CA-C-O 120.953 0.406 . . . . 0.0 110.201 . . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 69.0 m -88.95 87.31 7.18 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-O 121.221 0.534 . . . . 0.0 111.005 -177.993 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 33.4 mt-10 -80.33 -25.74 39.13 Favored 'General case' 0 C--N 1.323 -0.585 0 N-CA-C 108.442 -0.947 . . . . 0.0 108.442 172.851 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 23.6 t -117.47 132.8 56.49 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-N 114.027 -1.442 . . . . 0.0 109.004 175.048 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 5' ' ' VAL . . . . . 0.583 HG12 ' O ' ' A' ' 55' ' ' LEU . 8.9 p -76.9 142.77 13.85 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.494 0 CA-C-O 121.244 0.545 . . . . 0.0 110.428 -179.376 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 6' ' ' GLN . . . . . 0.5 ' HG2' ' HB2' ' A' ' 9' ' ' SER . 4.2 pt20 -127.39 168.3 15.03 Favored 'General case' 0 C--N 1.314 -0.963 0 CA-C-N 115.477 -0.783 . . . . 0.0 109.176 179.933 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 31.3 p -55.9 130.2 42.73 Favored 'General case' 0 C--N 1.317 -0.819 0 N-CA-C 109.955 -0.387 . . . . 0.0 109.955 174.946 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 66.7 t30 69.04 40.29 1.62 Allowed 'General case' 0 N--CA 1.47 0.549 0 CA-C-O 121.392 0.615 . . . . 0.0 110.914 -176.339 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 9' ' ' SER . . . . . 0.5 ' HB2' ' HG2' ' A' ' 6' ' ' GLN . 18.3 t -133.71 125.97 29.73 Favored 'General case' 0 C--N 1.327 -0.409 0 N-CA-C 108.638 -0.875 . . . . 0.0 108.638 173.311 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -83.27 148.67 27.25 Favored 'General case' 0 C--N 1.319 -0.755 0 CA-C-N 116.587 -0.279 . . . . 0.0 110.707 -171.233 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 8.0 m -123.92 140.15 48.23 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.687 0 CA-C-O 121.436 0.636 . . . . 0.0 111.322 179.249 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 12' ' ' LEU . . . . . 0.476 ' N ' HD12 ' A' ' 12' ' ' LEU . 5.1 mp -88.98 112.85 23.84 Favored 'General case' 0 C--N 1.315 -0.929 0 N-CA-C 107.584 -1.265 . . . . 0.0 107.584 173.667 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 13' ' ' VAL . . . . . 0.694 HG21 HG23 ' A' ' 138' ' ' ILE . 1.4 p -125.46 157.03 34.93 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.952 0 CA-C-O 121.185 0.517 . . . . 0.0 110.576 -171.462 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 14' ' ' HIS . . . . . 0.555 ' HB2' HD11 ' A' ' 141' ' ' LEU . 30.0 t-80 -130.72 113.62 14.37 Favored 'General case' 0 C--N 1.316 -0.871 0 N-CA-C 106.12 -1.807 . . . . 0.0 106.12 176.502 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 15' ' ' PHE . . . . . 0.573 ' H ' ' HB ' ' A' ' 28' ' ' THR . 48.6 p90 -141.9 -179.07 5.99 Favored 'General case' 0 C--N 1.317 -0.81 0 CA-C-O 122.363 1.078 . . . . 0.0 113.329 -163.756 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 60.1 m -143.97 113.24 6.9 Favored 'General case' 0 C--N 1.318 -0.782 0 CA-C-N 113.721 -1.582 . . . . 0.0 108.336 -176.11 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 17' ' ' LEU . . . . . 0.89 HD21 ' HB ' ' A' ' 134' ' ' VAL . 1.1 tt -100.89 120.96 40.92 Favored 'General case' 0 C--N 1.321 -0.657 0 CA-C-N 115.923 -0.58 . . . . 0.0 112.153 -176.916 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 10.0 mptt -120.18 142.76 48.68 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-N 115.339 -0.846 . . . . 0.0 110.714 -179.248 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 19' ' ' LEU . . . . . 0.614 HD21 ' HB2' ' A' ' 25' ' ' ALA . 3.6 mm? -84.58 173.69 10.59 Favored 'General case' 0 C--N 1.322 -0.599 0 N-CA-C 109.11 -0.7 . . . . 0.0 109.11 170.711 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 50.5 m-20 -57.2 -33.66 67.72 Favored 'General case' 0 C--N 1.327 -0.408 0 C-N-CA 120.786 -0.366 . . . . 0.0 110.631 177.057 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 23.3 t70 -78.16 4.08 13.46 Favored 'General case' 0 CA--C 1.535 0.398 0 CA-C-O 121.338 0.59 . . . . 0.0 111.201 178.957 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 73.57 9.41 78.23 Favored Glycine 0 CA--C 1.516 0.15 0 CA-C-N 116.137 -0.483 . . . . 0.0 113.264 -179.047 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 8.1 m -71.19 141.38 50.67 Favored 'General case' 0 C--N 1.323 -0.583 0 N-CA-C 109.529 -0.545 . . . . 0.0 109.529 174.776 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 7.3 m -88.8 112.25 22.99 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-O 120.923 0.392 . . . . 0.0 110.567 -178.665 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 25' ' ' ALA . . . . . 0.79 ' HB3' HD22 ' A' ' 17' ' ' LEU . . . -80.41 -38.38 30.33 Favored 'General case' 0 CA--C 1.516 -0.332 0 CA-C-N 116.009 -0.542 . . . . 0.0 111.033 -178.708 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 23.8 tt0 -154.24 121.14 5.59 Favored 'General case' 0 C--N 1.321 -0.668 0 CA-C-N 115.543 -0.753 . . . . 0.0 109.645 -176.735 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 14.9 p -114.08 101.65 9.43 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-O 121.677 0.751 . . . . 0.0 111.679 -178.09 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 28' ' ' THR . . . . . 0.573 ' HB ' ' H ' ' A' ' 15' ' ' PHE . 80.3 m -91.14 81.05 5.59 Favored 'General case' 0 N--CA 1.431 -1.393 0 N-CA-C 106.468 -1.678 . . . . 0.0 106.468 171.475 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 29' ' ' ARG . . . . . 0.437 ' HA ' ' NE2' ' A' ' 14' ' ' HIS . 43.0 ttt180 -174.07 -70.85 0.01 OUTLIER 'General case' 0 C--N 1.305 -1.354 0 CA-C-N 112.735 -2.03 . . . . 0.0 110.32 -162.54 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 73.2 m-20 -65.51 -29.12 69.72 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 121.1 0.476 . . . . 0.0 111.2 -176.968 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 93.6 m-20 -67.9 -22.06 65.1 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 115.82 -0.627 . . . . 0.0 111.391 179.915 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 78.08 12.71 84.1 Favored Glycine 0 N--CA 1.449 -0.466 0 C-N-CA 120.719 -0.753 . . . . 0.0 111.509 -178.895 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 66.9 mttm -133.34 128.48 20.31 Favored Pre-proline 0 C--N 1.324 -0.54 0 CA-C-N 115.455 -0.372 . . . . 0.0 110.156 -176.801 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 34' ' ' PRO . . . . . 0.461 ' HA ' ' CG2' ' A' ' 28' ' ' THR . 93.9 Cg_endo -80.17 154.58 22.18 Favored 'Trans proline' 0 N--CA 1.45 -1.038 0 C-N-CA 121.914 1.743 . . . . 0.0 111.112 174.231 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -113.59 150.53 32.95 Favored 'General case' 0 C--N 1.319 -0.749 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.211 -173.027 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 10.9 tp -94.51 126.94 40.11 Favored 'General case' 0 C--N 1.318 -0.797 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.574 178.547 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 37' ' ' PHE . . . . . . . . . . . . . 4.4 m-30 -94.97 107.43 19.46 Favored 'General case' 0 C--N 1.315 -0.907 0 CA-C-N 115.924 -0.58 . . . . 0.0 109.678 171.96 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 16.1 mmm180 -81.71 108.0 14.9 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 115.615 -0.72 . . . . 0.0 111.341 -178.311 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 39' ' ' LEU . . . . . 0.448 ' HG ' ' CB ' ' A' ' 49' ' ' GLU . 10.7 mp -81.77 154.55 25.91 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-N 114.897 -1.047 . . . . 0.0 110.567 177.466 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 101.35 34.23 4.56 Favored Glycine 0 N--CA 1.449 -0.481 0 C-N-CA 120.718 -0.753 . . . . 0.0 112.823 177.107 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 20.6 t70 65.68 6.05 3.66 Favored 'General case' 0 N--CA 1.471 0.619 0 CA-C-O 121.148 0.499 . . . . 0.0 111.994 176.676 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -68.7 -59.3 3.21 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-O 121.068 0.461 . . . . 0.0 111.127 -175.858 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 22.2 m -116.85 -31.21 5.51 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-O 121.306 0.574 . . . . 0.0 110.353 177.979 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 44' ' ' LEU . . . . . 0.47 HD13 HD12 ' A' ' 48' ' ' LEU . 49.9 mt -108.8 157.8 18.24 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-N 115.651 -0.704 . . . . 0.0 110.456 -175.291 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 49.1 m -89.07 171.27 9.96 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 115.825 -0.625 . . . . 0.0 111.018 179.654 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 46' ' ' GLU . . . . . 0.437 ' O ' ' HG3' ' A' ' 50' ' ' GLN . 59.0 mm-40 -47.89 -49.12 30.76 Favored 'General case' 0 C--N 1.33 -0.247 0 O-C-N 123.856 0.723 . . . . 0.0 112.201 -176.01 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 47' ' ' GLY . . . . . 0.482 ' HA3' ' HB1' ' A' ' 69' ' ' ALA . . . -58.73 -45.61 94.58 Favored Glycine 0 CA--C 1.519 0.303 0 C-N-CA 120.881 -0.676 . . . . 0.0 113.379 -175.155 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 48' ' ' LEU . . . . . 0.47 HD12 HD13 ' A' ' 44' ' ' LEU . 0.3 OUTLIER -60.12 -52.91 63.33 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 117.039 0.42 . . . . 0.0 110.324 -178.889 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 49' ' ' GLU . . . . . 0.448 ' CB ' ' HG ' ' A' ' 39' ' ' LEU . 7.6 pt-20 -68.06 -31.9 71.87 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 116.376 -0.375 . . . . 0.0 111.994 -172.212 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 50' ' ' GLN . . . . . 0.616 ' HA ' ' CD2' ' A' ' 53' ' ' LEU . 84.5 mt-30 -80.7 -8.39 59.63 Favored 'General case' 0 N--CA 1.452 -0.354 0 N-CA-C 111.814 0.302 . . . . 0.0 111.814 -170.642 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 51' ' ' HIS . . . . . . . . . . . . . 21.8 m-70 -108.81 -5.14 16.38 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-O 121.215 0.531 . . . . 0.0 110.18 -178.501 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 18.1 mt -103.72 -30.25 10.54 Favored 'General case' 0 C--N 1.32 -0.691 0 CA-C-N 115.684 -0.689 . . . . 0.0 111.601 177.216 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 53' ' ' LEU . . . . . 0.616 ' CD2' ' HA ' ' A' ' 50' ' ' GLN . 2.5 pp -67.57 151.34 47.49 Favored 'General case' 0 C--O 1.234 0.24 0 C-N-CA 120.991 -0.284 . . . . 0.0 110.584 -177.215 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 93.7 -5.15 73.17 Favored Glycine 0 CA--C 1.522 0.53 0 C-N-CA 120.996 -0.621 . . . . 0.0 113.049 -177.418 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 55' ' ' LEU . . . . . 0.583 ' O ' HG12 ' A' ' 5' ' ' VAL . 72.3 mt -92.51 164.66 13.37 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 117.082 0.441 . . . . 0.0 111.008 179.084 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 56' ' ' LYS . . . . . 0.442 ' O ' ' HB2' ' A' ' 59' ' ' ASP . 2.8 mptp? -111.59 169.87 8.52 Favored 'General case' 0 C--N 1.32 -0.717 0 CA-C-O 121.466 0.651 . . . . 0.0 109.345 175.583 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 57' ' ' VAL . . . . . 0.44 ' HA ' ' CG1' ' A' ' 140' ' ' VAL . 52.5 t -63.1 138.73 22.43 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.331 0 CA-C-N 114.954 -1.021 . . . . 0.0 110.027 174.086 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 81.49 10.95 83.82 Favored Glycine 0 N--CA 1.446 -0.651 0 C-N-CA 120.858 -0.687 . . . . 0.0 112.419 -177.35 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 59' ' ' ASP . . . . . 0.442 ' HB2' ' O ' ' A' ' 56' ' ' LYS . 3.3 m-20 -92.48 139.65 30.37 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-O 120.801 0.334 . . . . 0.0 110.306 175.317 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 6.8 mmmt -111.78 127.97 55.96 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 115.839 -0.619 . . . . 0.0 109.34 -177.767 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 11.3 t -142.43 141.28 32.19 Favored 'General case' 0 C--N 1.317 -0.836 0 CA-C-O 121.281 0.562 . . . . 0.0 111.103 -179.178 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 5.0 m -127.73 131.36 49.71 Favored 'General case' 0 C--N 1.316 -0.878 0 N-CA-C 109.049 -0.723 . . . . 0.0 109.049 174.789 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 63' ' ' PHE . . . . . 0.529 ' CE2' ' HE1' ' A' ' 136' ' ' PHE . 41.2 p90 -152.2 172.59 16.15 Favored 'General case' 0 C--N 1.319 -0.75 0 CA-C-O 120.648 0.261 . . . . 0.0 110.576 179.061 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 38.3 t -132.04 143.8 50.31 Favored 'General case' 0 C--N 1.319 -0.735 0 N-CA-C 108.743 -0.836 . . . . 0.0 108.743 -172.16 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 65' ' ' LEU . . . . . 0.422 HD11 ' HA ' ' A' ' 48' ' ' LEU . 57.2 mt -139.48 139.18 36.92 Favored 'General case' 0 C--N 1.319 -0.758 0 CA-C-O 121.12 0.486 . . . . 0.0 111.501 -176.728 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 66' ' ' GLU . . . . . 0.475 ' H ' ' CD ' ' A' ' 66' ' ' GLU . 13.5 mp0 -64.84 148.36 97.44 Favored Pre-proline 0 N--CA 1.44 -0.928 0 CA-C-N 115.009 -0.996 . . . . 0.0 109.373 170.571 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 67' ' ' PRO . . . . . 0.427 ' HB3' ' HA2' ' A' ' 131' ' ' GLY . 73.7 Cg_exo -50.44 -23.78 11.05 Favored 'Trans proline' 0 C--N 1.346 0.434 0 C-N-CA 124.024 3.15 . . . . 0.0 114.662 -174.697 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 32.8 t70 -66.8 -26.2 66.83 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-O 121.149 0.5 . . . . 0.0 110.697 177.867 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 69' ' ' ALA . . . . . 0.482 ' HB1' ' HA3' ' A' ' 47' ' ' GLY . . . -108.21 -6.34 16.43 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 115.954 -0.567 . . . . 0.0 111.524 -178.067 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 70' ' ' ALA . . . . . 0.446 ' O ' ' HB2' ' A' ' 71' ' ' PHE . . . -149.19 128.73 13.1 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.664 -0.244 . . . . 0.0 111.154 -176.009 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 71' ' ' PHE . . . . . 0.446 ' HB2' ' O ' ' A' ' 70' ' ' ALA . 3.3 m-85 74.37 -47.96 0.64 Allowed 'General case' 0 N--CA 1.47 0.569 0 O-C-N 123.778 0.674 . . . . 0.0 111.943 179.526 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 72' ' ' GLY . . . . . 0.569 ' O ' ' HB1' ' A' ' 130' ' ' ALA . . . 115.86 141.16 7.2 Favored Glycine 0 N--CA 1.447 -0.582 0 C-N-CA 120.845 -0.693 . . . . 0.0 112.51 177.663 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 73' ' ' VAL . . . . . 0.401 ' HA ' ' HD3' ' A' ' 74' ' ' PRO . 46.5 t -75.02 121.38 85.14 Favored Pre-proline 0 C--N 1.322 -0.625 0 CA-C-O 120.868 0.366 . . . . 0.0 110.903 173.509 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 74' ' ' PRO . . . . . 0.401 ' HD3' ' HA ' ' A' ' 73' ' ' VAL . 53.0 Cg_exo -56.92 146.62 78.52 Favored 'Trans proline' 0 C--N 1.347 0.456 0 C-N-CA 123.732 2.955 . . . . 0.0 112.627 178.168 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 32.2 t -111.16 101.94 51.59 Favored Pre-proline 0 N--CA 1.446 -0.642 0 CA-C-N 116.081 -0.509 . . . . 0.0 110.276 -178.904 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 39.5 Cg_endo -69.11 -24.47 32.61 Favored 'Trans proline' 0 N--CA 1.465 -0.173 0 C-N-CA 122.074 1.849 . . . . 0.0 111.245 175.463 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 5.8 p-10 -77.26 -9.09 58.59 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 115.869 -0.605 . . . . 0.0 110.781 177.314 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 78' ' ' LEU . . . . . 0.537 ' HG ' ' HB2' ' A' ' 125' ' ' PHE . 5.0 tp -69.42 -20.99 63.78 Favored 'General case' 0 N--CA 1.453 -0.298 0 CA-C-O 121.645 0.736 . . . . 0.0 109.249 175.388 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 79' ' ' ILE . . . . . 0.471 HG23 ' O ' ' A' ' 123' ' ' VAL . 65.2 mt -70.21 132.17 33.48 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.555 0 CA-C-N 114.473 -1.239 . . . . 0.0 110.396 178.653 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 42.6 mt-30 -152.8 118.24 5.27 Favored 'General case' 0 CA--C 1.509 -0.605 0 CA-C-N 116.099 -0.501 . . . . 0.0 109.983 -176.992 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 81' ' ' TYR . . . . . . . . . . . . . 0.6 OUTLIER -83.51 121.71 27.57 Favored 'General case' 0 C--N 1.317 -0.846 0 N-CA-C 114.193 1.183 . . . . 0.0 114.193 -179.936 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 82' ' ' PHE . . . . . 0.431 ' HZ ' ' SD ' ' A' ' 104' ' ' MET . 7.5 m-85 -102.99 171.14 7.55 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 113.887 -1.506 . . . . 0.0 110.486 175.015 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 8.5 t -74.48 136.52 42.25 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-O 121.368 0.604 . . . . 0.0 110.904 -178.669 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 84' ' ' ARG . . . . . 0.573 ' HA ' ' CG1' ' A' ' 121' ' ' ILE . 12.1 ptm180 -61.36 -17.28 53.2 Favored 'General case' 0 C--N 1.326 -0.448 0 N-CA-C 113.734 1.013 . . . . 0.0 113.734 -178.187 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 85' ' ' ARG . . . . . 0.476 ' HD2' ' N ' ' A' ' 85' ' ' ARG . 6.7 mpt_? -73.92 -32.3 63.48 Favored 'General case' 0 C--N 1.321 -0.643 0 CA-C-O 121.203 0.525 . . . . 0.0 109.716 -176.396 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 32.7 mt-10 -63.28 -21.71 66.42 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 115.175 -0.921 . . . . 0.0 111.044 -179.102 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 87' ' ' PHE . . . . . . . . . . . . . 52.5 m-85 -96.83 -20.48 18.15 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 115.831 -0.622 . . . . 0.0 110.916 -178.308 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 88' ' ' MET . . . . . . . . . . . . . 55.7 ttm -60.91 -27.14 67.97 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 115.682 -0.69 . . . . 0.0 111.544 -175.915 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 60.8 m-20 -53.33 -34.57 58.01 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 116.426 -0.352 . . . . 0.0 111.538 177.022 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -109.79 16.58 21.95 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-O 121.014 0.435 . . . . 0.0 110.495 179.315 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 93.95 155.26 31.65 Favored Glycine 0 N--CA 1.448 -0.549 0 C-N-CA 121.088 -0.577 . . . . 0.0 111.734 -177.212 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 11.6 tt0 -64.73 127.86 92.97 Favored Pre-proline 0 N--CA 1.431 -1.402 0 CA-C-O 121.0 0.428 . . . . 0.0 109.945 -179.799 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 93' ' ' PRO . . . . . 0.53 ' CB ' HD13 ' A' ' 113' ' ' ILE . 31.8 Cg_endo -65.5 165.65 22.08 Favored 'Trans proline' 0 C--O 1.233 0.271 0 C-N-CA 123.398 2.732 . . . . 0.0 113.923 -176.196 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 94' ' ' GLU . . . . . 0.464 ' O ' ' HB ' ' A' ' 113' ' ' ILE . 14.2 mt-10 -114.22 154.53 27.74 Favored 'General case' 0 C--N 1.333 -0.145 0 CA-C-N 115.651 -0.704 . . . . 0.0 110.69 -177.385 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 95' ' ' ILE . . . . . 0.577 ' CG1' HG12 ' A' ' 116' ' ' ILE . 20.2 mt -82.27 129.66 37.1 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.386 0 CA-C-O 121.047 0.451 . . . . 0.0 111.576 -178.168 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 71.76 27.09 71.46 Favored Glycine 0 N--CA 1.45 -0.406 0 CA-C-N 115.49 -0.777 . . . . 0.0 113.208 179.076 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -109.52 129.02 55.59 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-O 120.634 0.254 . . . . 0.0 110.691 177.062 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 98' ' ' ILE . . . . . 0.697 ' HA ' ' HA ' ' A' ' 112' ' ' VAL . 4.1 mt -89.01 133.07 32.18 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.561 0 N-CA-C 108.68 -0.859 . . . . 0.0 108.68 177.02 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 99' ' ' MET . . . . . . . . . . . . . 10.3 mtm -136.64 157.59 46.42 Favored 'General case' 0 N--CA 1.444 -0.764 0 N-CA-C 106.648 -1.612 . . . . 0.0 106.648 177.194 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 100' ' ' LEU . . . . . 0.465 HD12 ' HG2' ' A' ' 108' ' ' GLU . 1.3 mm? -71.56 103.36 2.97 Favored 'General case' 0 C--N 1.313 -1.01 0 CA-C-O 122.438 1.113 . . . . 0.0 110.772 174.457 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 101' ' ' PHE . . . . . . . . . . . . . 2.7 m-85 -90.19 170.1 10.58 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-N 113.215 -1.811 . . . . 0.0 112.455 -174.144 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 1.6 m -126.37 140.52 52.44 Favored 'General case' 0 C--N 1.317 -0.829 0 CA-C-N 114.234 -1.348 . . . . 0.0 109.781 178.432 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 103' ' ' ALA . . . . . 0.417 ' HB2' ' HG3' ' A' ' 109' ' ' MET . . . -96.23 163.91 12.89 Favored 'General case' 0 C--N 1.321 -0.657 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.491 -179.598 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 104' ' ' MET . . . . . 0.431 ' SD ' ' HZ ' ' A' ' 82' ' ' PHE . 4.3 mpp? -66.73 -19.57 65.78 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 115.813 -0.63 . . . . 0.0 110.969 -179.272 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 6.2 p-10 -93.94 16.26 14.81 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.926 0.393 . . . . 0.0 111.458 -179.25 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 85.23 -11.15 61.45 Favored Glycine 0 N--CA 1.451 -0.364 0 C-N-CA 121.148 -0.548 . . . . 0.0 113.254 174.484 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 68.2 m -78.36 149.42 33.4 Favored 'General case' 0 C--N 1.316 -0.87 0 CA-C-O 121.18 0.514 . . . . 0.0 110.974 -179.652 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 108' ' ' GLU . . . . . 0.465 ' HG2' HD12 ' A' ' 100' ' ' LEU . 40.1 tt0 -91.21 146.57 23.72 Favored 'General case' 0 C--N 1.312 -1.043 0 CA-C-N 115.519 -0.764 . . . . 0.0 108.979 175.929 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 109' ' ' MET . . . . . 0.417 ' HG3' ' HB2' ' A' ' 103' ' ' ALA . 88.9 mmm -138.41 151.17 68.74 Favored Pre-proline 0 C--O 1.231 0.12 0 N-CA-C 106.016 -1.846 . . . . 0.0 106.016 -164.073 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 4.9 Cg_endo -81.63 113.24 2.53 Favored 'Trans proline' 0 N--CA 1.446 -1.285 0 CA-C-N 121.428 1.546 . . . . 0.0 109.671 162.962 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 111' ' ' GLY . . . . . 0.444 ' HA2' ' O ' ' A' ' 124' ' ' ASP . . . -121.39 126.21 6.45 Favored Glycine 0 N--CA 1.436 -1.354 0 C-N-CA 120.251 -0.975 . . . . 0.0 112.299 179.2 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 112' ' ' VAL . . . . . 0.697 ' HA ' ' HA ' ' A' ' 98' ' ' ILE . 0.2 OUTLIER -105.1 140.18 23.88 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.142 0 N-CA-C 108.587 -0.894 . . . . 0.0 108.587 174.023 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 113' ' ' ILE . . . . . 0.53 HD13 ' CB ' ' A' ' 93' ' ' PRO . 10.3 mt -89.2 108.61 19.3 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.374 0 N-CA-C 107.826 -1.175 . . . . 0.0 107.826 -174.194 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 114' ' ' ARG . . . . . 0.465 ' O ' HG23 ' A' ' 95' ' ' ILE . 10.9 tpp180 -64.88 -47.53 77.53 Favored 'General case' 0 C--N 1.317 -0.839 0 CA-C-N 115.284 -0.871 . . . . 0.0 111.513 -171.179 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 115' ' ' GLU . . . . . 0.474 ' H ' ' HB ' ' A' ' 122' ' ' THR . 8.6 tt0 -161.63 162.48 30.01 Favored 'General case' 0 C--N 1.317 -0.833 0 N-CA-C 109.445 -0.576 . . . . 0.0 109.445 -175.28 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 116' ' ' ILE . . . . . 0.577 HG12 ' CG1' ' A' ' 95' ' ' ILE . 28.7 mm -111.82 112.53 40.93 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.427 0 CA-C-O 121.174 0.511 . . . . 0.0 110.129 177.356 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 117' ' ' ASN . . . . . 0.465 ' HB2' ' O ' ' A' ' 120' ' ' SER . 5.4 m-20 -96.31 158.93 15.21 Favored 'General case' 0 C--N 1.315 -0.896 0 CA-C-N 115.557 -0.747 . . . . 0.0 110.056 179.06 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . -57.18 -45.75 92.29 Favored Glycine 0 N--CA 1.452 -0.294 0 C-N-CA 120.612 -0.804 . . . . 0.0 113.304 -172.476 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 119' ' ' ASP . . . . . 0.424 ' O ' ' HG2' ' A' ' 84' ' ' ARG . 10.3 m-20 -113.39 -15.8 12.57 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-O 120.784 0.326 . . . . 0.0 111.53 178.397 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 120' ' ' SER . . . . . 0.465 ' O ' ' HB2' ' A' ' 117' ' ' ASN . 16.0 t -116.86 157.74 25.13 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-O 120.814 0.34 . . . . 0.0 111.09 -172.312 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 121' ' ' ILE . . . . . 0.573 ' CG1' ' HA ' ' A' ' 84' ' ' ARG . 38.8 mm -112.21 128.18 68.98 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.576 0 CA-C-O 121.746 0.784 . . . . 0.0 110.837 174.491 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 122' ' ' THR . . . . . 0.474 ' HB ' ' H ' ' A' ' 115' ' ' GLU . 0.6 OUTLIER -90.88 141.11 29.17 Favored 'General case' 0 C--N 1.307 -1.278 0 CA-C-N 114.338 -1.301 . . . . 0.0 109.382 178.236 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 123' ' ' VAL . . . . . 0.471 ' O ' HG23 ' A' ' 79' ' ' ILE . 43.8 t -138.39 158.93 31.91 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.41 0 N-CA-C 109.055 -0.72 . . . . 0.0 109.055 -156.522 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 124' ' ' ASP . . . . . 0.572 ' HB3' HG13 ' A' ' 112' ' ' VAL . 46.1 t0 -148.83 148.74 30.26 Favored 'General case' 0 C--N 1.305 -1.357 0 CA-C-N 116.058 -0.519 . . . . 0.0 110.256 174.781 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 125' ' ' PHE . . . . . 0.537 ' HB2' ' HG ' ' A' ' 78' ' ' LEU . 84.4 m-85 -135.97 3.71 2.95 Favored 'General case' 0 C--N 1.318 -0.804 0 CA-C-N 115.246 -0.888 . . . . 0.0 109.707 176.041 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 29.4 m-80 -58.39 134.66 56.81 Favored 'General case' 0 N--CA 1.449 -0.495 0 CA-C-N 114.685 -1.143 . . . . 0.0 110.571 176.103 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 127' ' ' HIS . . . . . 0.628 ' HB3' ' HD2' ' A' ' 128' ' ' PRO . 41.6 m80 -80.81 -173.32 0.41 Allowed Pre-proline 0 C--N 1.318 -0.79 0 CA-C-N 113.89 -1.504 . . . . 0.0 111.822 -168.203 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 128' ' ' PRO . . . . . 0.628 ' HD2' ' HB3' ' A' ' 127' ' ' HIS . 5.8 Cg_exo -41.51 174.77 0.0 OUTLIER 'Trans proline' 0 C--N 1.357 0.99 0 C-N-CA 124.843 3.696 . . . . 0.0 114.287 166.519 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 129' ' ' LEU . . . . . . . . . . . . . 5.5 tp -48.85 41.43 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.528 0 C-N-CA 127.895 2.478 . . . . 0.0 115.848 -171.695 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 130' ' ' ALA . . . . . 0.569 ' HB1' ' O ' ' A' ' 72' ' ' GLY . . . -85.99 173.56 9.83 Favored 'General case' 0 C--N 1.306 -1.286 0 C-N-CA 123.057 0.543 . . . . 0.0 110.065 -174.873 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 131' ' ' GLY . . . . . 0.427 ' HA2' ' HB3' ' A' ' 67' ' ' PRO . . . 74.79 34.23 53.72 Favored Glycine 0 N--CA 1.45 -0.403 0 C-N-CA 120.765 -0.731 . . . . 0.0 112.679 177.948 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 132' ' ' GLN . . . . . . . . . . . . . 5.7 pt20 -148.76 157.61 43.57 Favored 'General case' 0 C--N 1.326 -0.427 0 N-CA-C 109.488 -0.56 . . . . 0.0 109.488 172.793 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 133' ' ' THR . . . . . . . . . . . . . 14.5 m -71.06 112.36 7.15 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-O 120.904 0.383 . . . . 0.0 110.552 -175.696 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 134' ' ' VAL . . . . . 0.89 ' HB ' HD21 ' A' ' 17' ' ' LEU . 4.6 m -101.98 142.81 15.72 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.599 0 CA-C-O 121.236 0.541 . . . . 0.0 111.576 -176.483 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 135' ' ' HIS . . . . . . . . . . . . . 69.5 m-70 -124.87 113.24 17.61 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 115.328 -0.851 . . . . 0.0 109.076 -178.794 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 136' ' ' PHE . . . . . 0.529 ' HE1' ' CE2' ' A' ' 63' ' ' PHE . 0.1 OUTLIER -117.96 132.2 56.42 Favored 'General case' 0 C--N 1.316 -0.862 0 CA-C-O 121.103 0.478 . . . . 0.0 111.295 -175.787 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 137' ' ' ASP . . . . . . . . . . . . . 14.4 t70 -99.23 102.61 14.31 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-N 115.18 -0.918 . . . . 0.0 108.56 177.427 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 138' ' ' ILE . . . . . 0.694 HG23 HG21 ' A' ' 13' ' ' VAL . 40.6 mt -103.27 132.78 48.81 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.644 0 N-CA-C 112.716 0.635 . . . . 0.0 112.716 -166.912 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 24.0 mt-10 -125.7 114.46 18.68 Favored 'General case' 0 N--CA 1.45 -0.439 0 CA-C-N 115.24 -0.891 . . . . 0.0 109.131 178.781 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 140' ' ' VAL . . . . . 0.44 ' CG1' ' HA ' ' A' ' 57' ' ' VAL . 65.2 t -70.55 122.16 21.8 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.417 0 CA-C-N 117.824 0.284 . . . . 0.0 110.86 -179.498 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 141' ' ' LEU . . . . . 0.555 HD11 ' HB2' ' A' ' 14' ' ' HIS . 13.8 mt -100.76 -33.12 10.38 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-O 121.672 0.748 . . . . 0.0 110.426 178.739 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 142' ' ' GLU . . . . . 0.451 ' HB3' ' HB2' ' A' ' 12' ' ' LEU . 32.8 tt0 -163.88 151.59 12.64 Favored 'General case' 0 C--N 1.314 -0.971 0 CA-C-N 114.405 -1.27 . . . . 0.0 109.858 -178.334 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 143' ' ' ILE . . . . . . . . . . . . . 85.3 mt -122.1 113.82 40.28 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.397 0 CA-C-O 120.961 0.41 . . . . 0.0 110.932 -178.473 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 144' ' ' ASP . . . . . . . . . . . . . 37.4 t70 -79.15 126.17 82.19 Favored Pre-proline 0 C--N 1.323 -0.55 0 CA-C-N 115.807 -0.633 . . . . 0.0 110.291 177.998 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 145' ' ' PRO . . . . . . . . . . . . . 41.5 Cg_endo -66.2 169.9 12.9 Favored 'Trans proline' 0 C--O 1.234 0.311 0 C-N-CA 123.016 2.477 . . . . 0.0 113.294 -175.864 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 146' ' ' ALA . . . . . . . . . . . . . . . -82.21 102.04 10.86 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-O 121.444 0.64 . . . . 0.0 109.551 177.814 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -149.3 68.0 1.03 Allowed 'General case' 0 C--N 1.317 -0.836 0 N-CA-C 106.932 -1.507 . . . . 0.0 106.932 -175.324 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 39.2 mm-40 . . . . . 0 C--N 1.314 -0.937 0 CA-C-N 114.402 -1.272 . . . . 0.0 111.738 -172.246 . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 27.1 ttt . . . . . 0 N--CA 1.481 1.078 0 CA-C-O 120.245 0.069 . . . . 0.0 110.903 . . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 18.9 p 49.59 70.01 0.53 Allowed 'General case' 0 N--CA 1.469 0.51 0 C-N-CA 123.284 0.633 . . . . 0.0 112.464 177.014 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 47.7 mt-10 -75.79 -33.24 60.13 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-O 121.215 0.531 . . . . 0.0 110.734 176.311 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 12.6 p -114.37 149.12 36.61 Favored 'General case' 0 C--N 1.319 -0.749 0 CA-C-N 115.558 -0.746 . . . . 0.0 110.647 -177.894 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 5' ' ' VAL . . . . . 0.525 HG13 ' HA ' ' A' ' 53' ' ' LEU . 7.4 p -73.68 144.83 12.2 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.395 0 CA-C-N 115.61 -0.723 . . . . 0.0 110.598 -178.281 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 6' ' ' GLN . . . . . . . . . . . . . 3.4 pt20 -136.99 166.31 23.96 Favored 'General case' 0 N--CA 1.444 -0.727 0 N-CA-C 108.488 -0.93 . . . . 0.0 108.488 -179.592 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 34.2 p -63.93 138.68 58.58 Favored 'General case' 0 C--N 1.317 -0.812 0 CA-C-O 120.735 0.303 . . . . 0.0 110.94 -176.531 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 15.5 t30 70.92 15.59 6.72 Favored 'General case' 0 CA--C 1.542 0.641 0 CA-C-N 115.491 -0.777 . . . . 0.0 111.643 177.928 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 9' ' ' SER . . . . . 0.631 ' O ' HD23 ' A' ' 39' ' ' LEU . 8.8 t -108.15 134.36 51.11 Favored 'General case' 0 N--CA 1.451 -0.411 0 N-CA-C 108.079 -1.082 . . . . 0.0 108.079 177.276 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -82.19 149.07 28.11 Favored 'General case' 0 C--N 1.322 -0.599 0 N-CA-C 109.69 -0.485 . . . . 0.0 109.69 -174.02 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 6.3 m -134.33 145.05 33.51 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.755 0 C-N-CA 120.281 -0.568 . . . . 0.0 111.35 -175.869 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 12' ' ' LEU . . . . . 0.449 HD22 ' HB2' ' A' ' 142' ' ' GLU . 6.6 mp -91.74 119.36 31.51 Favored 'General case' 0 C--N 1.326 -0.456 0 N-CA-C 108.809 -0.811 . . . . 0.0 108.809 177.909 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 13' ' ' VAL . . . . . 0.547 HG21 HG23 ' A' ' 138' ' ' ILE . 2.4 p -132.37 154.48 40.07 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.68 0 CA-C-O 122.146 0.974 . . . . 0.0 113.219 -172.12 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 14' ' ' HIS . . . . . 0.429 ' CD2' HD11 ' A' ' 141' ' ' LEU . 0.2 OUTLIER -117.2 117.7 30.28 Favored 'General case' 0 C--N 1.32 -0.704 0 N-CA-C 106.225 -1.769 . . . . 0.0 106.225 170.936 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 15' ' ' PHE . . . . . 0.42 ' HB2' ' O ' ' A' ' 137' ' ' ASP . 32.1 p90 -148.27 157.35 43.44 Favored 'General case' 0 C--N 1.327 -0.396 0 C-N-CA 118.671 -1.212 . . . . 0.0 113.785 -167.523 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 16' ' ' THR . . . . . 0.447 HG22 ' HD3' ' A' ' 18' ' ' LYS . 85.9 m -128.88 118.77 23.25 Favored 'General case' 0 C--N 1.321 -0.653 0 CA-C-N 115.006 -0.997 . . . . 0.0 109.813 174.617 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 17' ' ' LEU . . . . . 0.509 HD21 ' CE2' ' A' ' 136' ' ' PHE . 1.4 mt -95.17 112.91 24.56 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-O 121.034 0.445 . . . . 0.0 111.163 179.045 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 18' ' ' LYS . . . . . 0.447 ' HD3' HG22 ' A' ' 16' ' ' THR . 10.2 mptt -109.05 128.01 54.61 Favored 'General case' 0 C--N 1.314 -0.945 0 CA-C-N 115.735 -0.666 . . . . 0.0 110.826 -179.251 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 19.8 tp -85.42 161.53 19.39 Favored 'General case' 0 N--CA 1.438 -1.069 0 CA-C-N 115.677 -0.692 . . . . 0.0 109.199 175.775 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 29.2 t70 -62.77 -24.69 67.85 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 121.431 0.634 . . . . 0.0 110.25 178.603 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 27.1 t70 -70.25 -3.66 18.12 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 115.162 -0.927 . . . . 0.0 111.385 177.646 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 74.81 9.08 82.99 Favored Glycine 0 C--N 1.332 0.333 0 C-N-CA 121.508 -0.377 . . . . 0.0 112.425 -175.593 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 52.7 m -91.45 140.28 29.9 Favored 'General case' 0 C--N 1.319 -0.745 0 CA-C-N 115.309 -0.446 . . . . 0.0 110.06 175.779 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 41.7 m -79.68 108.24 13.08 Favored 'General case' 0 C--N 1.318 -0.784 0 N-CA-C 110.05 -0.352 . . . . 0.0 110.05 177.197 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -69.86 -34.77 74.05 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.88 -0.6 . . . . 0.0 110.527 -177.969 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 44.2 tt0 -159.83 128.35 4.96 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 115.857 -0.611 . . . . 0.0 109.697 177.356 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 18.4 p -109.58 130.48 55.51 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-N 116.534 -0.303 . . . . 0.0 110.835 -178.289 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 28' ' ' THR . . . . . 0.611 ' O ' HG22 ' A' ' 28' ' ' THR . 62.2 m -148.59 14.48 0.96 Allowed 'General case' 0 CA--C 1.546 0.798 0 CA-C-O 122.831 1.301 . . . . 0.0 110.854 174.75 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 16.0 tpt180 -92.94 -68.99 0.77 Allowed 'General case' 0 C--N 1.307 -1.257 0 O-C-N 121.19 -0.944 . . . . 0.0 111.018 168.523 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 7.8 p30 -69.47 -10.61 58.77 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.407 -0.36 . . . . 0.0 111.452 -172.754 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 2.2 m-20 -58.37 -31.08 67.3 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.981 177.631 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 91.09 -13.39 66.37 Favored Glycine 0 N--CA 1.447 -0.593 0 C-N-CA 120.621 -0.8 . . . . 0.0 111.404 -175.813 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 75.4 mmtt -120.23 124.47 27.74 Favored Pre-proline 0 C--N 1.324 -0.533 0 N-CA-C 109.587 -0.524 . . . . 0.0 109.587 179.871 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 71.6 Cg_endo -76.53 168.85 22.98 Favored 'Trans proline' 0 N--CA 1.457 -0.659 0 C-N-CA 122.38 2.053 . . . . 0.0 111.889 176.438 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -131.75 149.86 52.34 Favored 'General case' 0 C--N 1.319 -0.719 0 CA-C-N 116.391 -0.368 . . . . 0.0 110.43 -177.234 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 4.9 tp -88.71 137.32 32.42 Favored 'General case' 0 C--N 1.318 -0.801 0 N-CA-C 109.769 -0.456 . . . . 0.0 109.769 174.711 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 37' ' ' PHE . . . . . . . . . . . . . 6.4 m-30 -98.37 119.89 37.84 Favored 'General case' 0 C--N 1.316 -0.862 0 N-CA-C 108.548 -0.908 . . . . 0.0 108.548 172.5 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 38' ' ' ARG . . . . . 0.437 ' HG3' ' HB3' ' A' ' 42' ' ' ALA . 24.6 tpt180 -90.33 104.88 17.41 Favored 'General case' 0 N--CA 1.442 -0.832 0 N-CA-C 108.955 -0.757 . . . . 0.0 108.955 177.92 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 39' ' ' LEU . . . . . 0.631 HD23 ' O ' ' A' ' 9' ' ' SER . 2.2 mm? -89.97 156.26 18.54 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-N 115.455 -0.793 . . . . 0.0 111.137 -178.767 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 101.09 29.48 6.4 Favored Glycine 0 N--CA 1.445 -0.713 0 C-N-CA 120.723 -0.751 . . . . 0.0 112.103 -175.19 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 38.8 t70 68.87 3.42 3.97 Favored 'General case' 0 N--CA 1.472 0.627 0 CA-C-O 121.34 0.59 . . . . 0.0 111.823 175.357 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 42' ' ' ALA . . . . . 0.437 ' HB3' ' HG3' ' A' ' 38' ' ' ARG . . . -74.53 -7.52 53.35 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-N 116.055 -0.52 . . . . 0.0 112.113 -179.305 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 32.7 t -163.68 -60.64 0.04 OUTLIER 'General case' 0 C--N 1.323 -0.556 0 N-CA-C 109.476 -0.564 . . . . 0.0 109.476 176.056 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 7.8 mp -90.01 161.46 15.85 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-N 115.87 -0.604 . . . . 0.0 110.502 178.096 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 46.9 t -77.99 145.87 35.75 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-N 115.438 -0.801 . . . . 0.0 109.752 178.273 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 46' ' ' GLU . . . . . 0.62 ' O ' ' HG2' ' A' ' 50' ' ' GLN . 12.1 tt0 -58.68 -16.69 17.44 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 115.078 -0.964 . . . . 0.0 112.004 -176.987 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -69.29 -32.06 71.99 Favored Glycine 0 N--CA 1.446 -0.634 0 C-N-CA 120.69 -0.766 . . . . 0.0 111.942 -177.812 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 1.6 tt -69.07 -53.0 22.64 Favored 'General case' 0 N--CA 1.45 -0.445 0 CA-C-O 120.672 0.272 . . . . 0.0 110.834 -178.298 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 49' ' ' GLU . . . . . 0.58 ' O ' HD22 ' A' ' 53' ' ' LEU . 14.2 pt-20 -58.04 -32.32 67.87 Favored 'General case' 0 N--CA 1.453 -0.305 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.61 179.497 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 50' ' ' GLN . . . . . 0.62 ' HG2' ' O ' ' A' ' 46' ' ' GLU . 69.9 mm-40 -57.32 -26.75 61.42 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 120.775 0.321 . . . . 0.0 110.904 -177.841 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 51' ' ' HIS . . . . . . . . . . . . . 12.1 m-70 -99.76 -14.02 19.03 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 116.397 -0.365 . . . . 0.0 111.03 -179.222 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 25.6 mt -95.76 -30.76 13.54 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 116.406 -0.361 . . . . 0.0 111.914 -177.401 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 53' ' ' LEU . . . . . 0.58 HD22 ' O ' ' A' ' 49' ' ' GLU . 0.0 OUTLIER -57.59 143.59 40.56 Favored 'General case' 0 C--O 1.234 0.26 0 CA-C-O 120.874 0.369 . . . . 0.0 111.246 -176.862 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 93.56 -2.7 70.75 Favored Glycine 0 N--CA 1.443 -0.845 0 C-N-CA 120.879 -0.677 . . . . 0.0 113.452 177.972 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 55' ' ' LEU . . . . . 0.501 ' O ' HG12 ' A' ' 5' ' ' VAL . 24.8 tp -94.41 164.22 13.1 Favored 'General case' 0 N--CA 1.453 -0.311 0 CA-C-N 118.052 0.926 . . . . 0.0 109.159 178.549 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 56' ' ' LYS . . . . . 0.665 ' HD2' ' N ' ' A' ' 57' ' ' VAL . 0.9 OUTLIER -117.15 157.79 25.34 Favored 'General case' 0 C--N 1.32 -0.708 0 N-CA-C 109.89 -0.411 . . . . 0.0 109.89 -174.803 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 57' ' ' VAL . . . . . 0.665 ' N ' ' HD2' ' A' ' 56' ' ' LYS . 8.8 t -57.61 141.74 14.23 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.243 0 CA-C-O 121.078 0.465 . . . . 0.0 111.357 177.954 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 82.87 10.12 83.5 Favored Glycine 0 N--CA 1.447 -0.576 0 CA-C-N 115.734 -0.666 . . . . 0.0 112.338 -178.859 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 8.5 m-20 -116.41 152.76 33.33 Favored 'General case' 0 C--N 1.324 -0.53 0 N-CA-C 109.543 -0.54 . . . . 0.0 109.543 174.291 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 60' ' ' LYS . . . . . 0.525 ' HE3' ' HG2' ' A' ' 139' ' ' GLU . 0.6 OUTLIER -131.73 149.38 52.5 Favored 'General case' 0 C--N 1.316 -0.877 0 CA-C-O 121.519 0.676 . . . . 0.0 111.76 -175.364 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 9.3 t -143.53 130.86 20.91 Favored 'General case' 0 C--N 1.314 -0.961 0 CA-C-N 114.714 -1.13 . . . . 0.0 110.884 -178.36 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 4.1 m -107.1 131.53 54.01 Favored 'General case' 0 N--CA 1.44 -0.944 0 N-CA-C 107.866 -1.161 . . . . 0.0 107.866 171.134 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 63' ' ' PHE . . . . . 0.43 ' HE1' ' CG1' ' A' ' 138' ' ' ILE . 1.5 p90 -158.24 153.46 25.65 Favored 'General case' 0 C--N 1.321 -0.631 0 CA-C-O 121.021 0.439 . . . . 0.0 110.937 -171.195 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 16.4 m -104.85 148.96 26.09 Favored 'General case' 0 C--N 1.319 -0.748 0 CA-C-N 115.727 -0.669 . . . . 0.0 110.644 -179.713 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 65' ' ' LEU . . . . . 0.451 ' O ' HG23 ' A' ' 133' ' ' THR . 82.8 mt -138.82 142.39 38.68 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.557 -0.292 . . . . 0.0 110.722 -176.039 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 66' ' ' GLU . . . . . 0.49 ' H ' ' CD ' ' A' ' 66' ' ' GLU . 1.6 mp0 -64.76 154.11 86.23 Favored Pre-proline 0 C--N 1.329 -0.311 0 CA-C-N 115.921 -0.581 . . . . 0.0 109.741 174.299 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 67' ' ' PRO . . . . . 0.538 ' HB3' ' N ' ' A' ' 132' ' ' GLN . 10.8 Cg_endo -56.65 -48.55 18.26 Favored 'Trans proline' 0 C--O 1.219 -0.431 0 C-N-CA 121.869 1.712 . . . . 0.0 113.563 -176.355 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 23.5 t70 -64.01 -21.99 66.74 Favored 'General case' 0 C--N 1.324 -0.511 0 O-C-N 121.515 -0.741 . . . . 0.0 110.072 178.534 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -86.35 -28.76 23.46 Favored 'General case' 0 N--CA 1.451 -0.406 0 CA-C-N 115.982 -0.554 . . . . 0.0 111.216 179.09 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 70' ' ' ALA . . . . . 0.509 ' O ' ' HB2' ' A' ' 71' ' ' PHE . . . -136.85 127.56 27.16 Favored 'General case' 0 N--CA 1.454 -0.262 0 N-CA-C 109.776 -0.453 . . . . 0.0 109.776 176.578 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 71' ' ' PHE . . . . . 0.509 ' HB2' ' O ' ' A' ' 70' ' ' ALA . 2.2 m-30 84.11 -44.29 0.09 Allowed 'General case' 0 N--CA 1.473 0.677 0 O-C-N 124.016 0.822 . . . . 0.0 109.102 -172.755 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 102.54 -114.23 4.84 Favored Glycine 0 N--CA 1.443 -0.863 0 CA-C-O 121.998 0.777 . . . . 0.0 114.792 166.427 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -150.92 163.96 21.94 Favored Pre-proline 0 C--N 1.31 -1.113 0 CA-C-N 113.772 -1.214 . . . . 0.0 110.562 -165.489 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 74' ' ' PRO . . . . . 0.521 ' HA ' ' HB3' ' A' ' 126' ' ' ASN . 60.7 Cg_exo -43.49 132.97 7.19 Favored 'Trans proline' 0 C--N 1.347 0.462 0 C-N-CA 123.659 2.906 . . . . 0.0 114.3 -178.749 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 75' ' ' SER . . . . . 0.578 ' HB3' ' OD1' ' A' ' 77' ' ' ASP . 30.8 m -137.06 123.42 13.5 Favored Pre-proline 0 C--N 1.329 -0.312 0 CA-C-N 115.325 -0.852 . . . . 0.0 110.993 179.892 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 76' ' ' PRO . . . . . 0.473 ' HA ' HG13 ' A' ' 79' ' ' ILE . 53.1 Cg_endo -70.16 -17.28 35.87 Favored 'Trans proline' 0 CA--C 1.529 0.274 0 C-N-CA 123.199 2.599 . . . . 0.0 113.571 -178.118 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 77' ' ' ASP . . . . . 0.578 ' OD1' ' HB3' ' A' ' 75' ' ' SER . 5.2 p-10 -69.27 -4.75 19.2 Favored 'General case' 0 C--N 1.329 -0.325 0 N-CA-C 112.829 0.678 . . . . 0.0 112.829 -173.331 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 78' ' ' LEU . . . . . 0.635 ' HB2' ' O ' ' A' ' 125' ' ' PHE . 83.1 mt -112.57 -5.1 14.03 Favored 'General case' 0 C--N 1.324 -0.523 0 C-N-CA 120.742 -0.383 . . . . 0.0 110.963 176.399 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 79' ' ' ILE . . . . . 0.473 HG13 ' HA ' ' A' ' 76' ' ' PRO . 15.2 mt -77.39 104.81 5.64 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.736 0 C-N-CA 120.345 -0.542 . . . . 0.0 109.705 -173.695 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 73.0 mt-30 -108.95 164.06 12.75 Favored 'General case' 0 C--N 1.314 -0.937 0 CA-C-N 115.671 -0.695 . . . . 0.0 111.824 -172.806 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 81' ' ' TYR . . . . . . . . . . . . . 11.3 m-85 -129.48 115.67 17.82 Favored 'General case' 0 N--CA 1.444 -0.766 0 N-CA-C 107.514 -1.291 . . . . 0.0 107.514 -172.78 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 73.4 m-85 -111.24 168.29 9.63 Favored 'General case' 0 C--N 1.317 -0.844 0 CA-C-O 120.763 0.316 . . . . 0.0 110.863 -174.661 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 12.2 t -73.86 145.24 45.02 Favored 'General case' 0 C--N 1.323 -0.577 0 N-CA-C 108.849 -0.797 . . . . 0.0 108.849 176.692 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 84' ' ' ARG . . . . . 0.649 ' HD3' ' HA ' ' A' ' 119' ' ' ASP . 28.9 ptt180 -73.64 -29.72 62.51 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-O 121.576 0.703 . . . . 0.0 109.609 -173.895 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 85' ' ' ARG . . . . . 0.446 ' HD2' ' H ' ' A' ' 85' ' ' ARG . 0.8 OUTLIER -64.7 -38.94 92.7 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 114.597 -1.183 . . . . 0.0 113.391 -171.015 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 86' ' ' GLU . . . . . 0.461 ' O ' ' HB3' ' A' ' 89' ' ' ASP . 44.1 mm-40 -60.65 -48.88 79.82 Favored 'General case' 0 C--N 1.317 -0.836 0 CA-C-O 122.269 1.033 . . . . 0.0 108.687 174.259 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 87' ' ' PHE . . . . . . . . . . . . . 55.6 m-85 -59.0 -31.85 69.18 Favored 'General case' 0 C--N 1.318 -0.783 0 CA-C-N 113.701 -1.591 . . . . 0.0 112.91 175.264 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 88' ' ' MET . . . . . . . . . . . . . 60.3 ttp -68.18 -41.45 81.43 Favored 'General case' 0 C--N 1.315 -0.898 0 CA-C-O 122.13 0.967 . . . . 0.0 109.521 174.025 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 89' ' ' ASP . . . . . 0.461 ' HB3' ' O ' ' A' ' 86' ' ' GLU . 19.3 t70 -55.17 -23.07 19.82 Favored 'General case' 0 C--N 1.321 -0.673 0 CA-C-N 113.387 -1.733 . . . . 0.0 110.164 176.029 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -112.86 8.63 18.75 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 115.646 -0.706 . . . . 0.0 111.799 178.938 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 92.08 137.61 7.85 Favored Glycine 0 C--N 1.331 0.265 0 C-N-CA 120.482 -0.866 . . . . 0.0 111.989 -177.453 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 8.8 tt0 -61.91 122.07 69.47 Favored Pre-proline 0 N--CA 1.442 -0.848 0 CA-C-O 121.116 0.484 . . . . 0.0 111.306 -172.271 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 93' ' ' PRO . . . . . 0.482 ' HG2' HD12 ' A' ' 121' ' ' ILE . 38.1 Cg_endo -77.75 165.96 26.03 Favored 'Trans proline' 0 N--CA 1.46 -0.497 0 C-N-CA 122.935 2.423 . . . . 0.0 112.875 -177.525 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 94' ' ' GLU . . . . . 0.521 ' O ' HD12 ' A' ' 113' ' ' ILE . 27.0 mt-10 -115.94 154.13 30.35 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.018 -0.537 . . . . 0.0 111.131 -176.135 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 95' ' ' ILE . . . . . 0.543 HG12 HG12 ' A' ' 116' ' ' ILE . 32.6 mt -77.17 134.16 29.24 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.384 0 CA-C-N 116.446 -0.343 . . . . 0.0 110.099 179.168 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 72.26 19.47 78.7 Favored Glycine 0 N--CA 1.449 -0.481 0 C-N-CA 121.032 -0.604 . . . . 0.0 112.407 -176.997 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 97' ' ' ALA . . . . . 0.466 ' O ' HG13 ' A' ' 113' ' ' ILE . . . -99.71 166.86 10.91 Favored 'General case' 0 C--N 1.323 -0.562 0 N-CA-C 109.562 -0.533 . . . . 0.0 109.562 175.27 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 38.8 mt -125.79 126.11 69.49 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.727 0 CA-C-O 120.876 0.37 . . . . 0.0 110.533 -175.598 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 99' ' ' MET . . . . . 0.421 ' SD ' HD11 ' A' ' 113' ' ' ILE . 2.7 mtp -124.72 161.58 26.06 Favored 'General case' 0 C--N 1.324 -0.527 0 N-CA-C 107.898 -1.149 . . . . 0.0 107.898 -179.922 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 100' ' ' LEU . . . . . 0.423 HD13 ' HA ' ' A' ' 100' ' ' LEU . 3.9 mm? -77.24 153.62 33.82 Favored 'General case' 0 C--N 1.323 -0.587 0 CA-C-N 118.806 0.73 . . . . 0.0 111.078 167.635 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 101' ' ' PHE . . . . . 0.6 ' CE2' HG11 ' A' ' 123' ' ' VAL . 65.5 m-85 -149.42 155.52 40.57 Favored 'General case' 0 C--N 1.319 -0.761 0 CA-C-N 114.702 -1.136 . . . . 0.0 107.986 -170.334 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 3.1 m -121.11 111.44 17.45 Favored 'General case' 0 C--N 1.314 -0.958 0 C-N-CA 119.793 -0.763 . . . . 0.0 110.154 -178.348 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -77.78 166.25 23.18 Favored 'General case' 0 N--CA 1.448 -0.56 0 CA-C-N 115.4 -0.818 . . . . 0.0 110.868 -177.183 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 104' ' ' MET . . . . . . . . . . . . . 60.1 mtt -67.37 -14.32 62.81 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.128 -0.942 . . . . 0.0 111.901 -173.669 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 8.2 p-10 -96.51 11.38 35.27 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 116.551 -0.295 . . . . 0.0 111.383 -177.784 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 88.06 -11.33 67.52 Favored Glycine 0 N--CA 1.447 -0.602 0 C-N-CA 120.42 -0.895 . . . . 0.0 113.289 179.448 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 33.3 t -79.36 149.74 31.61 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-O 121.227 0.537 . . . . 0.0 110.692 -179.327 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 108' ' ' GLU . . . . . 0.448 ' HA ' ' O ' ' A' ' 101' ' ' PHE . 44.5 tt0 -120.51 104.11 9.71 Favored 'General case' 0 C--N 1.317 -0.845 0 CA-C-N 115.615 -0.72 . . . . 0.0 109.381 179.801 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 109' ' ' MET . . . . . 0.438 ' SD ' ' HD2' ' A' ' 125' ' ' PHE . 13.7 ptp -111.44 145.14 31.97 Favored Pre-proline 0 C--N 1.322 -0.614 0 CA-C-N 116.535 -0.302 . . . . 0.0 110.621 -175.579 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 110' ' ' PRO . . . . . 0.431 ' HD2' HD11 ' A' ' 129' ' ' LEU . 12.2 Cg_exo -70.1 120.6 7.31 Favored 'Trans proline' 0 N--CA 1.462 -0.368 0 C-N-CA 122.475 2.117 . . . . 0.0 110.663 171.5 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . -117.41 153.88 17.01 Favored Glycine 0 C--N 1.321 -0.29 0 C-N-CA 120.752 -0.737 . . . . 0.0 112.447 -176.562 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER -100.77 121.29 51.39 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.426 0 CA-C-O 121.064 0.459 . . . . 0.0 110.249 -176.392 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 113' ' ' ILE . . . . . 0.521 HD12 ' O ' ' A' ' 94' ' ' GLU . 1.0 OUTLIER -67.05 111.22 1.85 Allowed 'Isoleucine or valine' 0 C--N 1.316 -0.85 0 CA-C-N 115.762 -0.654 . . . . 0.0 109.386 176.709 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 114' ' ' ARG . . . . . . . . . . . . . 13.2 tpp180 -63.29 -52.36 62.31 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 115.349 -0.841 . . . . 0.0 110.744 -178.085 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 5.2 tt0 -159.48 148.45 18.03 Favored 'General case' 0 C--N 1.32 -0.699 0 N-CA-C 110.11 -0.33 . . . . 0.0 110.11 -177.79 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 116' ' ' ILE . . . . . 0.543 HG12 HG12 ' A' ' 95' ' ' ILE . 45.9 mm -96.12 111.2 25.88 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.533 0 N-CA-C 108.879 -0.786 . . . . 0.0 108.879 176.197 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 117' ' ' ASN . . . . . . . . . . . . . 37.6 m-80 -101.47 155.8 17.85 Favored 'General case' 0 C--N 1.313 -1.012 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.057 -179.111 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . -57.22 -38.84 88.48 Favored Glycine 0 N--CA 1.448 -0.52 0 C-N-CA 120.453 -0.88 . . . . 0.0 112.925 -170.842 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 119' ' ' ASP . . . . . 0.649 ' HA ' ' HD3' ' A' ' 84' ' ' ARG . 4.7 p-10 -109.75 -12.55 14.61 Favored 'General case' 0 C--N 1.324 -0.516 0 N-CA-C 111.977 0.362 . . . . 0.0 111.977 -174.66 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 20.3 t -146.12 155.99 43.13 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 121.065 0.459 . . . . 0.0 111.899 -168.603 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 121' ' ' ILE . . . . . 0.482 HD12 ' HG2' ' A' ' 93' ' ' PRO . 35.1 mm -119.43 120.25 63.04 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 115.896 -0.593 . . . . 0.0 110.178 178.705 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 89.8 m -106.14 119.48 39.34 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 116.568 -0.287 . . . . 0.0 111.052 -177.504 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 123' ' ' VAL . . . . . 0.6 HG11 ' CE2' ' A' ' 101' ' ' PHE . 38.8 t -117.69 118.26 57.8 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.316 0 CA-C-O 119.482 -0.295 . . . . 0.0 110.539 179.049 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 9.4 p-10 -95.32 96.34 9.08 Favored 'General case' 0 N--CA 1.452 -0.345 0 N-CA-C 114.131 1.159 . . . . 0.0 114.131 -179.906 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 125' ' ' PHE . . . . . 0.635 ' O ' ' HB2' ' A' ' 78' ' ' LEU . 12.0 m-85 -68.78 98.0 0.87 Allowed 'General case' 0 N--CA 1.447 -0.616 0 N-CA-C 109.303 -0.629 . . . . 0.0 109.303 165.912 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 126' ' ' ASN . . . . . 0.521 ' HB3' ' HA ' ' A' ' 74' ' ' PRO . 13.6 m-20 -79.3 88.2 4.96 Favored 'General case' 0 C--N 1.3 -1.585 0 CA-C-O 121.092 0.473 . . . . 0.0 110.934 177.237 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 127' ' ' HIS . . . . . 0.469 ' CD2' ' HD2' ' A' ' 128' ' ' PRO . 0.3 OUTLIER 60.76 -171.73 0.02 OUTLIER Pre-proline 0 C--O 1.236 0.386 0 CA-C-N 114.865 -1.061 . . . . 0.0 109.854 -173.077 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 128' ' ' PRO . . . . . 0.483 ' HB2' ' CD2' ' A' ' 71' ' ' PHE . 72.2 Cg_exo -46.5 177.72 0.01 OUTLIER 'Trans proline' 0 CA--C 1.533 0.454 0 C-N-CA 123.174 2.583 . . . . 0.0 110.816 156.048 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 129' ' ' LEU . . . . . 0.628 ' O ' ' HG2' ' A' ' 132' ' ' GLN . 3.9 mm? -51.42 37.23 0.0 OUTLIER 'General case' 0 N--CA 1.488 1.473 0 N-CA-C 114.998 1.481 . . . . 0.0 114.998 -178.794 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 130' ' ' ALA . . . . . 0.474 ' N ' ' O ' ' A' ' 128' ' ' PRO . . . -54.0 179.97 0.02 OUTLIER 'General case' 0 C--O 1.237 0.436 0 C-N-CA 124.254 1.022 . . . . 0.0 111.49 174.544 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . 67.19 3.52 24.58 Favored Glycine 0 CA--C 1.527 0.785 0 C-N-CA 120.494 -0.86 . . . . 0.0 114.035 -172.894 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 132' ' ' GLN . . . . . 0.628 ' HG2' ' O ' ' A' ' 129' ' ' LEU . 6.3 pt20 -149.18 153.42 37.64 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 117.687 0.744 . . . . 0.0 110.201 176.02 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 133' ' ' THR . . . . . 0.451 HG23 ' O ' ' A' ' 65' ' ' LEU . 59.6 m -72.51 136.38 45.88 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 116.001 -0.545 . . . . 0.0 111.13 -178.735 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 134' ' ' VAL . . . . . 0.425 HG11 ' CE2' ' A' ' 71' ' ' PHE . 20.3 m -120.73 151.34 23.62 Favored 'Isoleucine or valine' 0 C--O 1.233 0.22 0 CA-C-O 121.526 0.679 . . . . 0.0 111.697 177.957 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 135' ' ' HIS . . . . . 0.477 ' O ' HD23 ' A' ' 17' ' ' LEU . 86.2 m-70 -90.58 134.94 34.02 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-N 114.728 -1.124 . . . . 0.0 110.375 174.225 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 136' ' ' PHE . . . . . 0.509 ' CE2' HD21 ' A' ' 17' ' ' LEU . 2.5 m-85 -120.94 125.68 48.04 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 116.252 -0.431 . . . . 0.0 111.113 -177.385 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 137' ' ' ASP . . . . . 0.42 ' O ' ' HB2' ' A' ' 15' ' ' PHE . 36.0 t70 -113.11 109.52 18.93 Favored 'General case' 0 C--N 1.315 -0.911 0 N-CA-C 108.513 -0.921 . . . . 0.0 108.513 169.028 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 138' ' ' ILE . . . . . 0.547 HG23 HG21 ' A' ' 13' ' ' VAL . 43.1 mm -119.19 121.33 66.38 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.452 0 O-C-N 123.098 0.249 . . . . 0.0 111.262 -169.773 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 139' ' ' GLU . . . . . 0.525 ' HG2' ' HE3' ' A' ' 60' ' ' LYS . 33.3 mt-10 -107.73 115.55 30.35 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 120.59 0.233 . . . . 0.0 111.201 173.356 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 140' ' ' VAL . . . . . 0.412 ' CG1' ' HA ' ' A' ' 57' ' ' VAL . 38.8 t -71.12 107.47 2.31 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.568 0 CA-C-N 116.299 -0.409 . . . . 0.0 110.177 175.533 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 141' ' ' LEU . . . . . 0.429 HD11 ' CD2' ' A' ' 14' ' ' HIS . 40.1 mt -94.59 -49.64 5.55 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-O 120.885 0.374 . . . . 0.0 110.097 179.821 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 142' ' ' GLU . . . . . 0.449 ' HB2' HD22 ' A' ' 12' ' ' LEU . 37.1 mt-10 -143.7 163.15 34.11 Favored 'General case' 0 CA--C 1.513 -0.476 0 CA-C-N 115.847 -0.615 . . . . 0.0 109.88 172.38 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 143' ' ' ILE . . . . . 0.443 HD13 ' N ' ' A' ' 5' ' ' VAL . 94.8 mt -123.49 110.07 25.03 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.901 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.539 178.484 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 144' ' ' ASP . . . . . . . . . . . . . 27.1 t70 -78.57 111.89 22.58 Favored Pre-proline 0 C--N 1.325 -0.469 0 CA-C-N 115.487 -0.779 . . . . 0.0 110.058 178.408 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 145' ' ' PRO . . . . . . . . . . . . . 52.5 Cg_endo -67.86 145.52 68.8 Favored 'Trans proline' 0 N--CA 1.459 -0.514 0 C-N-CA 122.186 1.924 . . . . 0.0 111.831 -177.207 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 146' ' ' ALA . . . . . . . . . . . . . . . -83.39 102.86 12.32 Favored 'General case' 0 C--N 1.318 -0.781 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.139 178.299 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 147' ' ' LEU . . . . . 0.409 HD13 ' HA ' ' A' ' 147' ' ' LEU . 3.9 mm? -83.03 52.14 2.11 Favored 'General case' 0 C--N 1.319 -0.756 0 CA-C-O 121.42 0.628 . . . . 0.0 111.025 -178.085 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 71.6 mt-10 . . . . . 0 C--N 1.32 -0.713 0 CA-C-N 115.338 -0.847 . . . . 0.0 110.461 179.263 . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 66.0 mtt . . . . . 0 N--CA 1.479 0.987 0 CA-C-O 120.551 0.215 . . . . 0.0 110.88 . . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 2' ' ' SER . . . . . 0.407 ' OG ' ' HA ' ' A' ' 145' ' ' PRO . 35.5 m -113.83 108.2 16.76 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-O 121.216 0.532 . . . . 0.0 110.603 -179.897 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 3' ' ' GLU . . . . . 0.508 ' HG2' ' HE2' ' A' ' 56' ' ' LYS . 36.0 tt0 -99.54 -27.99 13.44 Favored 'General case' 0 C--N 1.319 -0.721 0 CA-C-N 115.533 -0.758 . . . . 0.0 110.525 -177.584 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 4' ' ' SER . . . . . 0.42 ' HA ' ' HA ' ' A' ' 56' ' ' LYS . 8.5 p -124.94 158.27 33.99 Favored 'General case' 0 C--N 1.318 -0.782 0 CA-C-N 115.415 -0.811 . . . . 0.0 109.998 178.489 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 5' ' ' VAL . . . . . 0.519 HG22 ' N ' ' A' ' 55' ' ' LEU . 3.7 m -83.22 151.89 3.95 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.41 0 CA-C-O 121.294 0.568 . . . . 0.0 111.032 -175.341 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 6' ' ' GLN . . . . . 0.625 ' HG2' ' OG ' ' A' ' 9' ' ' SER . 1.4 pt20 -141.88 168.42 19.81 Favored 'General case' 0 C--N 1.314 -0.948 0 CA-C-N 115.223 -0.899 . . . . 0.0 108.86 176.164 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 51.5 p -53.47 122.08 8.98 Favored 'General case' 0 C--N 1.318 -0.768 0 N-CA-C 109.928 -0.397 . . . . 0.0 109.928 176.073 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 8' ' ' ASN . . . . . 0.438 ' HA ' ' O ' ' A' ' 39' ' ' LEU . 3.6 t-20 80.53 41.43 0.06 Allowed 'General case' 0 N--CA 1.475 0.809 0 O-C-N 124.036 0.835 . . . . 0.0 111.507 178.332 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 9' ' ' SER . . . . . 0.625 ' OG ' ' HG2' ' A' ' 6' ' ' GLN . 47.8 m -103.86 160.77 14.51 Favored 'General case' 0 C--N 1.332 -0.16 0 O-C-N 121.994 -0.441 . . . . 0.0 111.039 174.17 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 10' ' ' ALA . . . . . 0.713 ' HB1' HD21 ' A' ' 36' ' ' LEU . . . -109.49 131.93 54.61 Favored 'General case' 0 C--N 1.322 -0.606 0 N-CA-C 108.779 -0.823 . . . . 0.0 108.779 171.964 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 11' ' ' VAL . . . . . 0.475 ' O ' ' HA ' ' A' ' 36' ' ' LEU . 6.4 m -138.8 136.88 43.15 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.435 0 C-N-CA 120.501 -0.48 . . . . 0.0 111.437 -174.305 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 89.3 mt -86.42 128.61 34.97 Favored 'General case' 0 C--N 1.324 -0.51 0 N-CA-C 108.251 -1.018 . . . . 0.0 108.251 173.238 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 13' ' ' VAL . . . . . 0.736 HG21 HG23 ' A' ' 138' ' ' ILE . 1.6 p -141.65 157.53 21.17 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.86 0 CA-C-O 121.117 0.485 . . . . 0.0 110.747 -173.196 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 14' ' ' HIS . . . . . 0.495 ' ND1' ' HA ' ' A' ' 29' ' ' ARG . 0.5 OUTLIER -124.98 116.42 22.13 Favored 'General case' 0 C--N 1.318 -0.802 0 N-CA-C 106.396 -1.705 . . . . 0.0 106.396 170.545 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 15' ' ' PHE . . . . . 0.461 ' CE1' ' HB ' ' A' ' 28' ' ' THR . 18.2 p90 -146.0 158.8 43.87 Favored 'General case' 0 C--N 1.316 -0.852 0 C-N-CA 120.427 -0.509 . . . . 0.0 110.77 -169.019 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 87.8 m -130.32 130.16 44.12 Favored 'General case' 0 C--N 1.318 -0.775 0 N-CA-C 109.859 -0.423 . . . . 0.0 109.859 174.434 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 17' ' ' LEU . . . . . 0.5 HD21 ' CE1' ' A' ' 136' ' ' PHE . 9.5 mt -95.77 138.8 32.91 Favored 'General case' 0 N--CA 1.445 -0.683 0 CA-C-O 121.714 0.769 . . . . 0.0 111.659 -179.008 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 4.3 mptp? -122.31 147.47 46.2 Favored 'General case' 0 C--N 1.314 -0.95 0 CA-C-N 114.314 -1.312 . . . . 0.0 110.031 -176.24 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 19' ' ' LEU . . . . . 0.404 HD13 ' HA ' ' A' ' 19' ' ' LEU . 4.1 mm? -83.43 169.13 15.88 Favored 'General case' 0 C--N 1.312 -1.041 0 N-CA-C 108.716 -0.846 . . . . 0.0 108.716 170.755 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 29.3 t70 -68.88 -25.42 64.61 Favored 'General case' 0 C--N 1.318 -0.804 0 CA-C-O 121.323 0.583 . . . . 0.0 109.607 177.717 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 15.4 t70 -80.07 0.95 29.77 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.339 -0.846 . . . . 0.0 110.426 176.001 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 76.22 25.38 66.32 Favored Glycine 0 N--CA 1.45 -0.402 0 CA-C-N 116.175 -0.466 . . . . 0.0 113.155 178.64 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 14.1 m -90.11 154.73 19.56 Favored 'General case' 0 C--N 1.322 -0.607 0 N-CA-C 109.307 -0.627 . . . . 0.0 109.307 171.954 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 59.7 m -90.43 118.26 29.77 Favored 'General case' 0 C--N 1.32 -0.679 0 O-C-N 121.749 -0.594 . . . . 0.0 110.538 177.33 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 25' ' ' ALA . . . . . 0.401 ' HB2' ' CD2' ' A' ' 19' ' ' LEU . . . -84.11 -48.85 9.43 Favored 'General case' 0 CA--C 1.516 -0.33 0 CA-C-O 121.498 0.666 . . . . 0.0 110.269 179.337 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 9.2 tp10 -151.41 119.95 6.47 Favored 'General case' 0 C--N 1.318 -0.774 0 CA-C-N 114.842 -1.072 . . . . 0.0 109.068 -179.498 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 12.8 t -111.72 101.14 9.53 Favored 'General case' 0 C--N 1.315 -0.921 0 C-N-CA 120.033 -0.667 . . . . 0.0 110.259 177.512 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 28' ' ' THR . . . . . 0.461 ' HB ' ' CE1' ' A' ' 15' ' ' PHE . 31.0 m -97.64 51.4 1.07 Allowed 'General case' 0 C--N 1.313 -0.984 0 CA-C-O 122.706 1.241 . . . . 0.0 109.302 175.978 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 29' ' ' ARG . . . . . 0.495 ' HA ' ' ND1' ' A' ' 14' ' ' HIS . 29.6 ttp180 -143.56 -67.94 0.34 Allowed 'General case' 0 C--N 1.314 -0.954 0 CA-C-N 114.785 -1.098 . . . . 0.0 110.618 -177.059 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 2.2 p-10 -80.69 33.8 0.32 Allowed 'General case' 0 N--CA 1.467 0.385 0 N-CA-C 111.972 0.36 . . . . 0.0 111.972 -177.805 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 92.4 m-20 -119.21 -7.82 10.23 Favored 'General case' 0 C--N 1.325 -0.472 0 N-CA-C 109.829 -0.434 . . . . 0.0 109.829 173.082 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 79.73 6.25 89.11 Favored Glycine 0 N--CA 1.447 -0.592 0 C-N-CA 121.055 -0.593 . . . . 0.0 111.635 -177.342 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 50.0 mmtm -114.28 112.91 46.29 Favored Pre-proline 0 C--N 1.325 -0.474 0 CA-C-N 115.885 -0.158 . . . . 0.0 110.7 -178.263 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 6.2 Cg_exo -79.3 169.82 18.34 Favored 'Trans proline' 0 N--CA 1.46 -0.454 0 C-N-CA 122.88 2.386 . . . . 0.0 112.434 172.45 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 35' ' ' ALA . . . . . 0.41 ' CB ' HG21 ' A' ' 28' ' ' THR . . . -144.55 158.79 43.6 Favored 'General case' 0 C--N 1.315 -0.926 0 CA-C-N 115.061 -0.972 . . . . 0.0 109.698 179.009 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 36' ' ' LEU . . . . . 0.713 HD21 ' HB1' ' A' ' 10' ' ' ALA . 0.7 OUTLIER -108.63 134.54 51.23 Favored 'General case' 0 N--CA 1.445 -0.677 0 CA-C-O 120.749 0.309 . . . . 0.0 110.333 177.202 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 37' ' ' PHE . . . . . . . . . . . . . 4.7 m-30 -96.4 130.71 43.46 Favored 'General case' 0 C--N 1.318 -0.766 0 CA-C-N 116.05 -0.523 . . . . 0.0 109.911 174.187 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 2.1 tpp180 -111.59 107.98 17.31 Favored 'General case' 0 C--N 1.321 -0.649 0 CA-C-N 116.076 -0.511 . . . . 0.0 109.76 -177.443 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 39' ' ' LEU . . . . . 0.566 ' HG ' ' O ' ' A' ' 9' ' ' SER . 6.6 mt -83.71 154.87 23.4 Favored 'General case' 0 C--N 1.319 -0.739 0 CA-C-N 116.201 -0.454 . . . . 0.0 109.894 -178.092 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 40' ' ' GLY . . . . . 0.465 ' H ' ' CD ' ' A' ' 49' ' ' GLU . . . 100.41 33.66 5.04 Favored Glycine 0 C--N 1.312 -0.782 0 CA-C-N 115.807 -0.633 . . . . 0.0 112.494 -179.125 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 6.5 m-20 63.58 8.36 3.59 Favored 'General case' 0 N--CA 1.473 0.709 0 N-CA-C 112.538 0.569 . . . . 0.0 112.538 178.237 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -67.37 -31.39 71.6 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-O 120.803 0.335 . . . . 0.0 111.657 -176.773 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 11.9 p -137.31 -65.85 0.53 Allowed 'General case' 0 C--N 1.321 -0.638 0 CA-C-N 116.453 -0.339 . . . . 0.0 111.048 -178.931 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 7.5 mp -85.89 -178.74 6.66 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.392 -179.432 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 31.0 m -95.86 164.05 12.9 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-N 116.317 -0.401 . . . . 0.0 111.539 -176.603 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 46' ' ' GLU . . . . . 0.47 ' O ' ' HG2' ' A' ' 50' ' ' GLN . 41.6 mt-10 -52.38 -41.11 62.85 Favored 'General case' 0 N--CA 1.465 0.289 0 N-CA-C 112.876 0.695 . . . . 0.0 112.876 -172.576 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -61.9 -41.82 99.68 Favored Glycine 0 N--CA 1.449 -0.453 0 C-N-CA 120.571 -0.823 . . . . 0.0 112.284 -170.134 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 48' ' ' LEU . . . . . 0.445 HD13 ' C ' ' A' ' 48' ' ' LEU . 3.2 tm? -61.02 -53.6 55.24 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-O 120.495 0.188 . . . . 0.0 111.144 -179.426 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 49' ' ' GLU . . . . . 0.697 ' O ' HD13 ' A' ' 53' ' ' LEU . 9.7 pt-20 -68.77 -37.4 79.31 Favored 'General case' 0 C--N 1.325 -0.46 0 N-CA-C 111.621 0.23 . . . . 0.0 111.621 -173.633 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 50' ' ' GLN . . . . . 0.541 ' HA ' HD22 ' A' ' 53' ' ' LEU . 17.1 mm100 -66.15 -12.47 56.01 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 120.845 0.355 . . . . 0.0 111.353 -176.42 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 51' ' ' HIS . . . . . . . . . . . . . 12.1 m-70 -103.38 -4.0 24.74 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 121.213 0.53 . . . . 0.0 110.485 177.629 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 52' ' ' LEU . . . . . 0.466 ' O ' HG21 ' A' ' 5' ' ' VAL . 12.0 mt -102.51 -11.72 18.33 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-N 115.762 -0.653 . . . . 0.0 111.16 177.76 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 53' ' ' LEU . . . . . 0.697 HD13 ' O ' ' A' ' 49' ' ' GLU . 1.1 mp -58.78 136.6 57.81 Favored 'General case' 0 N--CA 1.449 -0.511 0 CA-C-O 121.125 0.488 . . . . 0.0 111.47 177.805 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 94.39 -4.57 70.16 Favored Glycine 0 N--CA 1.447 -0.572 0 CA-C-N 115.592 -0.731 . . . . 0.0 113.091 -179.677 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 55' ' ' LEU . . . . . 0.519 ' N ' HG22 ' A' ' 5' ' ' VAL . 3.0 mm? -71.97 164.8 25.46 Favored 'General case' 0 CA--C 1.521 -0.15 0 CA-C-N 117.391 0.595 . . . . 0.0 110.935 177.876 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 56' ' ' LYS . . . . . 0.604 ' HD3' ' N ' ' A' ' 57' ' ' VAL . 12.3 tmtt? -140.73 154.99 46.55 Favored 'General case' 0 C--N 1.32 -0.699 0 N-CA-C 108.703 -0.851 . . . . 0.0 108.703 -175.031 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 57' ' ' VAL . . . . . 0.604 ' N ' ' HD3' ' A' ' 56' ' ' LYS . 29.8 t -59.66 125.65 16.09 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-O 121.261 0.553 . . . . 0.0 111.386 179.714 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 80.95 19.74 66.82 Favored Glycine 0 N--CA 1.447 -0.627 0 CA-C-N 115.521 -0.763 . . . . 0.0 112.399 -177.398 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 59' ' ' ASP . . . . . 0.487 ' OD1' ' HB3' ' A' ' 56' ' ' LYS . 1.6 m-20 -110.55 150.16 29.34 Favored 'General case' 0 C--N 1.321 -0.631 0 CA-C-O 121.021 0.439 . . . . 0.0 110.452 176.01 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 60' ' ' LYS . . . . . 0.531 ' CE ' ' HG2' ' A' ' 139' ' ' GLU . 0.3 OUTLIER -115.48 133.11 56.34 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-N 115.51 -0.768 . . . . 0.0 109.926 -171.424 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 13.0 t -143.3 134.67 26.08 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-O 121.557 0.694 . . . . 0.0 111.306 178.643 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 5.9 m -123.78 132.49 53.81 Favored 'General case' 0 C--N 1.319 -0.741 0 CA-C-N 115.686 -0.688 . . . . 0.0 109.176 176.293 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 31.7 p90 -152.52 149.19 28.26 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-O 121.013 0.435 . . . . 0.0 111.346 -178.101 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 14.9 m -96.6 156.06 16.5 Favored 'General case' 0 C--N 1.321 -0.647 0 CA-C-N 116.089 -0.505 . . . . 0.0 109.863 177.832 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 31.7 mt -150.67 134.82 16.91 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-O 120.996 0.427 . . . . 0.0 110.749 -177.155 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 22.4 mm-40 -70.71 150.21 95.32 Favored Pre-proline 0 C--N 1.322 -0.587 0 N-CA-C 108.922 -0.77 . . . . 0.0 108.922 173.674 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 67' ' ' PRO . . . . . 0.424 ' HB3' ' N ' ' A' ' 132' ' ' GLN . 5.1 Cg_endo -48.38 -49.04 15.3 Favored 'Trans proline' 0 C--N 1.345 0.344 0 C-N-CA 122.383 2.056 . . . . 0.0 112.515 -175.742 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 22.9 t70 -62.92 -32.09 73.31 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-O 120.823 0.344 . . . . 0.0 111.123 -179.524 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -95.24 13.26 26.1 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-O 121.086 0.47 . . . . 0.0 111.082 -178.244 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -121.25 -84.74 0.66 Allowed 'General case' 0 C--N 1.323 -0.586 0 CA-C-O 121.247 0.546 . . . . 0.0 109.775 179.09 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 71' ' ' PHE . . . . . 0.442 ' HB2' ' HA ' ' A' ' 130' ' ' ALA . 2.4 m-85 -92.82 -17.42 24.13 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-N 115.616 -0.72 . . . . 0.0 109.776 176.947 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 72' ' ' GLY . . . . . 0.538 ' O ' ' HB1' ' A' ' 130' ' ' ALA . . . 97.32 -171.85 27.16 Favored Glycine 0 N--CA 1.45 -0.426 0 N-CA-C 110.68 -0.968 . . . . 0.0 110.68 -173.87 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 73' ' ' VAL . . . . . 0.582 ' N ' ' HD3' ' A' ' 74' ' ' PRO . 1.6 m -150.19 60.44 4.27 Favored Pre-proline 0 C--N 1.33 -0.252 0 CA-C-N 117.703 0.751 . . . . 0.0 110.774 171.359 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 74' ' ' PRO . . . . . 0.582 ' HD3' ' N ' ' A' ' 73' ' ' VAL . 19.7 Cg_endo -95.09 113.09 0.16 Allowed 'Trans proline' 0 N--CA 1.44 -1.625 0 C-N-CA 121.752 1.635 . . . . 0.0 114.529 173.97 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 75' ' ' SER . . . . . 0.548 ' CA ' HD23 ' A' ' 78' ' ' LEU . 34.7 m -152.45 63.28 4.93 Favored Pre-proline 0 N--CA 1.441 -0.892 0 N-CA-C 107.475 -1.306 . . . . 0.0 107.475 145.494 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 3.4 Cg_exo -73.49 -48.6 0.24 Allowed 'Trans proline' 0 CA--C 1.518 -0.317 0 C-N-CA 122.315 2.01 . . . . 0.0 113.014 -171.296 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 9.1 p-10 -69.71 -4.18 18.57 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-N 115.149 -0.932 . . . . 0.0 111.199 -177.597 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 78' ' ' LEU . . . . . 0.708 ' HB3' ' HB2' ' A' ' 125' ' ' PHE . 1.3 mm? -92.74 3.13 56.19 Favored 'General case' 0 C--N 1.325 -0.484 0 N-CA-C 109.6 -0.518 . . . . 0.0 109.6 178.323 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 68.5 mt -97.5 109.5 23.52 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.808 0 CA-C-O 121.544 0.688 . . . . 0.0 110.068 -173.97 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 39.0 mt-30 -129.1 135.43 48.89 Favored 'General case' 0 C--N 1.317 -0.83 0 CA-C-N 114.702 -1.136 . . . . 0.0 111.79 -168.149 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 81' ' ' TYR . . . . . 0.419 ' CE1' HG23 ' A' ' 122' ' ' THR . 2.6 m-85 -90.63 114.98 27.38 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 121.554 0.692 . . . . 0.0 111.596 173.566 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 82' ' ' PHE . . . . . 0.438 ' CB ' ' HE1' ' A' ' 87' ' ' PHE . 25.3 m-85 -102.53 170.68 7.89 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 114.745 -1.116 . . . . 0.0 112.01 175.194 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 22.2 t -89.67 155.67 19.08 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 115.721 -0.672 . . . . 0.0 109.847 176.981 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 84' ' ' ARG . . . . . 0.501 ' HD2' ' O ' ' A' ' 118' ' ' GLY . 11.9 ptm180 -66.44 -21.49 66.2 Favored 'General case' 0 C--O 1.227 -0.114 0 N-CA-C 112.143 0.423 . . . . 0.0 112.143 -178.356 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 85' ' ' ARG . . . . . 0.404 HH12 ' CG ' ' A' ' 119' ' ' ASP . 7.5 mpt_? -71.83 -39.42 69.79 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 121.192 0.52 . . . . 0.0 110.357 -175.538 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 31.4 mt-10 -64.64 -30.38 71.4 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 115.06 -0.973 . . . . 0.0 110.406 -174.966 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 87' ' ' PHE . . . . . 0.438 ' HE1' ' CB ' ' A' ' 82' ' ' PHE . 4.3 m-85 -89.65 -46.05 8.91 Favored 'General case' 0 CA--C 1.512 -0.504 0 CA-C-N 115.584 -0.735 . . . . 0.0 111.091 179.291 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 88' ' ' MET . . . . . . . . . . . . . 53.3 ttm -61.75 -26.05 67.83 Favored 'General case' 0 C--N 1.321 -0.665 0 CA-C-N 115.497 -0.774 . . . . 0.0 111.045 -175.345 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 23.0 t70 -55.46 -33.24 63.46 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 121.178 0.513 . . . . 0.0 110.59 174.061 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -109.93 11.44 24.12 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-N 115.64 -0.709 . . . . 0.0 111.257 179.304 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 111.75 138.19 7.42 Favored Glycine 0 N--CA 1.449 -0.453 0 C-N-CA 120.771 -0.728 . . . . 0.0 112.282 -179.197 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 92' ' ' GLU . . . . . 0.463 ' HA ' ' HD3' ' A' ' 93' ' ' PRO . 42.3 mt-10 -62.22 128.32 90.89 Favored Pre-proline 0 C--N 1.324 -0.516 0 CA-C-O 120.882 0.372 . . . . 0.0 111.402 -177.073 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 93' ' ' PRO . . . . . 0.599 ' HB2' HD13 ' A' ' 113' ' ' ILE . 17.7 Cg_endo -78.06 165.36 26.19 Favored 'Trans proline' 0 N--CA 1.459 -0.552 0 C-N-CA 122.745 2.297 . . . . 0.0 112.612 -177.518 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 30.9 mt-10 -116.95 146.88 42.72 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.497 -0.32 . . . . 0.0 111.054 -178.452 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 95' ' ' ILE . . . . . 0.532 HG12 HG12 ' A' ' 116' ' ' ILE . 16.6 mt -71.16 130.73 35.0 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.424 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.688 179.31 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 71.9 16.32 76.41 Favored Glycine 0 N--CA 1.446 -0.694 0 CA-C-N 115.813 -0.631 . . . . 0.0 113.059 179.367 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 97' ' ' ALA . . . . . 0.48 ' O ' HG13 ' A' ' 113' ' ' ILE . . . -100.85 161.77 13.37 Favored 'General case' 0 C--N 1.327 -0.389 0 N-CA-C 108.962 -0.755 . . . . 0.0 108.962 174.217 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 98' ' ' ILE . . . . . 0.498 HG12 HG22 ' A' ' 112' ' ' VAL . 59.1 mt -107.53 143.92 17.24 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.872 0 N-CA-C 110.066 -0.346 . . . . 0.0 110.066 179.417 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 99' ' ' MET . . . . . 0.5 ' SD ' HD11 ' A' ' 113' ' ' ILE . 82.8 mtp -128.36 163.34 25.04 Favored 'General case' 0 N--CA 1.448 -0.542 0 N-CA-C 107.958 -1.127 . . . . 0.0 107.958 179.347 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 3.5 mm? -100.62 137.1 39.48 Favored 'General case' 0 C--N 1.309 -1.184 0 N-CA-C 109.991 -0.374 . . . . 0.0 109.991 174.139 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 101' ' ' PHE . . . . . 0.471 ' CE2' ' HB2' ' A' ' 99' ' ' MET . 50.9 m-85 -143.55 136.35 27.48 Favored 'General case' 0 C--N 1.319 -0.725 0 N-CA-C 108.998 -0.742 . . . . 0.0 108.998 -174.55 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 17.2 m -96.53 131.78 42.79 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-O 120.97 0.414 . . . . 0.0 110.55 178.825 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -95.46 159.41 15.01 Favored 'General case' 0 C--N 1.321 -0.647 0 CA-C-N 116.003 -0.544 . . . . 0.0 110.11 177.351 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 104' ' ' MET . . . . . . . . . . . . . 4.0 mpp? -66.16 -12.13 53.85 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.353 -0.84 . . . . 0.0 112.022 -174.484 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 7.7 p-10 -92.01 17.91 8.69 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-O 121.141 0.496 . . . . 0.0 110.821 177.598 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 77.28 -11.56 16.6 Favored Glycine 0 N--CA 1.452 -0.259 0 CA-C-N 115.866 -0.606 . . . . 0.0 114.189 178.102 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 14.5 t -78.64 152.87 31.49 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-N 117.185 0.492 . . . . 0.0 110.005 179.251 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 35.2 tt0 -126.78 103.16 7.38 Favored 'General case' 0 C--N 1.315 -0.934 0 N-CA-C 108.867 -0.79 . . . . 0.0 108.867 -179.337 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 109' ' ' MET . . . . . . . . . . . . . 3.1 mpp? -100.34 134.91 20.42 Favored Pre-proline 0 C--N 1.32 -0.674 0 CA-C-N 116.349 -0.387 . . . . 0.0 111.323 -175.564 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 33.5 Cg_endo -67.53 135.73 37.17 Favored 'Trans proline' 0 N--CA 1.455 -0.739 0 C-N-CA 121.911 1.74 . . . . 0.0 109.638 167.847 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . -134.66 126.04 3.98 Favored Glycine 0 N--CA 1.443 -0.886 0 N-CA-C 111.11 -0.796 . . . . 0.0 111.11 -170.59 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 112' ' ' VAL . . . . . 0.498 HG22 HG12 ' A' ' 98' ' ' ILE . 32.0 t -76.57 131.07 35.55 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.655 0 N-CA-C 109.423 -0.584 . . . . 0.0 109.423 179.876 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 113' ' ' ILE . . . . . 0.599 HD13 ' HB2' ' A' ' 93' ' ' PRO . 1.9 mt -82.66 109.97 17.2 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.058 0 N-CA-C 107.826 -1.176 . . . . 0.0 107.826 173.174 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 114' ' ' ARG . . . . . 0.689 ' HE ' HG21 ' A' ' 122' ' ' THR . 2.3 tmm_? -64.89 -49.06 71.94 Favored 'General case' 0 C--N 1.315 -0.892 0 CA-C-N 115.569 -0.741 . . . . 0.0 110.272 -173.515 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 115' ' ' GLU . . . . . 0.416 ' HB2' ' HD2' ' A' ' 114' ' ' ARG . 9.4 tt0 -159.86 155.6 25.96 Favored 'General case' 0 C--N 1.326 -0.446 0 C-N-CA 121.156 -0.218 . . . . 0.0 110.419 -178.875 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 116' ' ' ILE . . . . . 0.532 HG12 HG12 ' A' ' 95' ' ' ILE . 31.9 mm -106.85 110.75 32.81 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.405 0 N-CA-C 109.001 -0.74 . . . . 0.0 109.001 175.901 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 117' ' ' ASN . . . . . 0.447 ' HB2' ' O ' ' A' ' 120' ' ' SER . 7.5 m-20 -98.83 157.69 16.13 Favored 'General case' 0 C--N 1.313 -0.981 0 CA-C-N 115.947 -0.569 . . . . 0.0 109.6 -178.04 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 118' ' ' GLY . . . . . 0.501 ' O ' ' HD2' ' A' ' 84' ' ' ARG . . . -56.27 -44.66 89.27 Favored Glycine 0 C--O 1.226 -0.392 0 C-N-CA 120.452 -0.88 . . . . 0.0 113.196 -171.47 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 119' ' ' ASP . . . . . 0.432 ' HA ' ' HD3' ' A' ' 84' ' ' ARG . 13.9 t70 -113.03 -9.86 13.53 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-O 121.169 0.509 . . . . 0.0 110.73 179.131 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 120' ' ' SER . . . . . 0.447 ' O ' ' HB2' ' A' ' 117' ' ' ASN . 21.6 t -126.54 157.63 38.28 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-O 121.533 0.682 . . . . 0.0 111.845 -168.79 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 121' ' ' ILE . . . . . . . . . . . . . 28.0 mm -120.49 150.41 23.25 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.761 0 CA-C-N 115.512 -0.767 . . . . 0.0 109.076 176.498 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 122' ' ' THR . . . . . 0.689 HG21 ' HE ' ' A' ' 114' ' ' ARG . 14.6 m -127.38 127.01 43.48 Favored 'General case' 0 C--N 1.312 -1.03 0 N-CA-C 107.615 -1.254 . . . . 0.0 107.615 179.667 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 2.8 t -127.74 127.14 68.05 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.839 0 N-CA-C 109.022 -0.733 . . . . 0.0 109.022 -171.01 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -114.24 96.11 5.63 Favored 'General case' 0 C--N 1.305 -1.326 0 CA-C-N 114.62 -1.173 . . . . 0.0 108.672 -177.34 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 125' ' ' PHE . . . . . 0.708 ' HB2' ' HB3' ' A' ' 78' ' ' LEU . 27.7 m-85 -82.5 103.8 12.31 Favored 'General case' 0 N--CA 1.431 -1.399 0 N-CA-C 105.821 -1.918 . . . . 0.0 105.821 175.107 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 126' ' ' ASN . . . . . 0.491 ' HA ' ' HB2' ' A' ' 75' ' ' SER . 1.0 OUTLIER -122.69 122.95 40.0 Favored 'General case' 0 C--N 1.295 -1.772 0 CA-C-N 113.884 -1.507 . . . . 0.0 112.916 -168.362 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 127' ' ' HIS . . . . . 0.417 ' HA ' ' HD2' ' A' ' 128' ' ' PRO . 10.0 p80 70.68 124.81 0.03 OUTLIER Pre-proline 0 C--N 1.315 -0.907 0 N-CA-C 116.647 2.092 . . . . 0.0 116.647 156.587 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 128' ' ' PRO . . . . . 0.658 ' C ' ' H ' ' A' ' 130' ' ' ALA . 74.7 Cg_exo -51.42 -174.37 0.01 OUTLIER 'Trans proline' 0 C--O 1.222 -0.319 0 C-N-CA 124.963 3.776 . . . . 0.0 108.983 141.698 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 129' ' ' LEU . . . . . 0.53 ' HG ' ' NE2' ' A' ' 132' ' ' GLN . 17.1 tp -51.11 27.21 0.0 OUTLIER 'General case' 0 CA--C 1.572 1.807 0 N-CA-C 113.915 1.08 . . . . 0.0 113.915 174.042 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 130' ' ' ALA . . . . . 0.658 ' H ' ' C ' ' A' ' 128' ' ' PRO . . . -95.94 -176.27 3.65 Favored 'General case' 0 N--CA 1.45 -0.469 0 C-N-CA 124.832 1.253 . . . . 0.0 108.855 170.889 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 131' ' ' GLY . . . . . 0.533 ' HA2' HG12 ' A' ' 73' ' ' VAL . . . 65.59 26.41 71.93 Favored Glycine 0 N--CA 1.458 0.153 0 C-N-CA 120.689 -0.767 . . . . 0.0 114.129 174.855 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 132' ' ' GLN . . . . . 0.53 ' NE2' ' HG ' ' A' ' 129' ' ' LEU . 23.3 pt20 -123.55 141.69 51.76 Favored 'General case' 0 C--N 1.315 -0.918 0 N-CA-C 109.33 -0.619 . . . . 0.0 109.33 176.568 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 133' ' ' THR . . . . . . . . . . . . . 18.9 m -79.86 111.87 16.6 Favored 'General case' 0 C--N 1.319 -0.748 0 N-CA-C 108.991 -0.744 . . . . 0.0 108.991 178.365 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 134' ' ' VAL . . . . . 0.444 ' HB ' HD22 ' A' ' 17' ' ' LEU . 15.7 m -115.05 167.94 7.2 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.64 0 CA-C-O 122.017 0.913 . . . . 0.0 112.639 -172.648 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 135' ' ' HIS . . . . . . . . . . . . . 82.5 m-70 -132.47 127.87 36.2 Favored 'General case' 0 C--N 1.314 -0.955 0 CA-C-N 114.043 -1.435 . . . . 0.0 107.359 177.581 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 136' ' ' PHE . . . . . 0.5 ' CE1' HD21 ' A' ' 17' ' ' LEU . 17.8 m-85 -105.53 122.81 46.78 Favored 'General case' 0 C--N 1.313 -1.006 0 CA-C-O 121.09 0.471 . . . . 0.0 111.71 -171.574 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 137' ' ' ASP . . . . . . . . . . . . . 38.2 t70 -123.03 98.76 6.04 Favored 'General case' 0 C--N 1.315 -0.907 0 N-CA-C 107.87 -1.159 . . . . 0.0 107.87 172.806 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 138' ' ' ILE . . . . . 0.736 HG23 HG21 ' A' ' 13' ' ' VAL . 54.8 mt -123.81 138.29 54.02 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.562 0 CA-C-N 115.968 -0.56 . . . . 0.0 112.271 -172.139 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 139' ' ' GLU . . . . . 0.531 ' HG2' ' CE ' ' A' ' 60' ' ' LYS . 2.3 mp0 -128.53 130.55 47.59 Favored 'General case' 0 N--CA 1.452 -0.364 0 N-CA-C 108.523 -0.917 . . . . 0.0 108.523 175.034 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 140' ' ' VAL . . . . . . . . . . . . . 72.6 t -77.56 126.59 38.11 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 117.805 0.275 . . . . 0.0 110.415 -176.47 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 141' ' ' LEU . . . . . 0.425 ' HG ' ' HA ' ' A' ' 13' ' ' VAL . 38.8 mt -94.83 -48.6 5.96 Favored 'General case' 0 C--N 1.321 -0.635 0 N-CA-C 109.919 -0.4 . . . . 0.0 109.919 177.386 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 142' ' ' GLU . . . . . . . . . . . . . 10.6 mm-40 -146.73 162.37 38.66 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 115.902 -0.59 . . . . 0.0 110.597 177.127 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 143' ' ' ILE . . . . . 0.478 HD12 HG23 ' A' ' 57' ' ' VAL . 95.5 mt -131.04 122.66 52.22 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.66 0 CA-C-N 115.961 -0.563 . . . . 0.0 110.337 177.529 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 144' ' ' ASP . . . . . 0.513 ' HB2' ' HB3' ' A' ' 10' ' ' ALA . 1.2 m-20 -74.75 132.67 77.44 Favored Pre-proline 0 CA--C 1.513 -0.472 0 CA-C-N 116.038 -0.528 . . . . 0.0 109.741 176.115 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 145' ' ' PRO . . . . . 0.407 ' HA ' ' OG ' ' A' ' 2' ' ' SER . 70.0 Cg_exo -45.9 117.97 2.1 Favored 'Trans proline' 0 CA--C 1.512 -0.583 0 C-N-CA 123.338 2.692 . . . . 0.0 113.16 -178.282 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 146' ' ' ALA . . . . . . . . . . . . . . . -93.37 104.42 16.58 Favored 'General case' 0 C--N 1.31 -1.113 0 CA-C-N 114.604 -1.18 . . . . 0.0 109.378 179.209 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 2.8 mm? -88.64 1.59 54.74 Favored 'General case' 0 C--N 1.319 -0.725 0 CA-C-N 115.889 -0.596 . . . . 0.0 109.721 179.712 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 42.0 mt-10 . . . . . 0 CA--C 1.518 -0.256 0 CA-C-N 114.791 -1.095 . . . . 0.0 109.324 -177.238 . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.481 1.11 0 CA-C-O 121.1 0.476 . . . . 0.0 109.82 . . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 73.3 m -156.01 82.78 1.01 Allowed 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 115.944 -0.571 . . . . 0.0 109.797 175.87 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 46.1 mt-10 -86.27 -22.56 26.75 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-N 115.789 -0.641 . . . . 0.0 110.733 179.934 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 4' ' ' SER . . . . . 0.457 ' HA ' ' HA ' ' A' ' 56' ' ' LYS . 19.8 m -110.03 132.94 53.71 Favored 'General case' 0 C--N 1.32 -0.702 0 CA-C-N 115.96 -0.564 . . . . 0.0 110.918 -179.686 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 5' ' ' VAL . . . . . 0.683 HG12 ' O ' ' A' ' 55' ' ' LEU . 7.3 p -74.2 141.19 16.44 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.425 0 CA-C-N 115.7 -0.682 . . . . 0.0 109.774 177.507 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 6' ' ' GLN . . . . . 0.628 ' HG2' ' OG ' ' A' ' 9' ' ' SER . 2.2 pt20 -134.58 167.62 20.47 Favored 'General case' 0 C--N 1.311 -1.099 0 N-CA-C 108.805 -0.813 . . . . 0.0 108.805 175.806 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 16.2 p -56.59 131.89 50.13 Favored 'General case' 0 C--N 1.313 -0.992 0 N-CA-C 109.64 -0.504 . . . . 0.0 109.64 176.881 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 8' ' ' ASN . . . . . 0.452 ' H ' ' HB3' ' A' ' 39' ' ' LEU . 64.3 t30 76.8 29.24 0.64 Allowed 'General case' 0 CA--C 1.544 0.718 0 C-N-CA 123.698 0.799 . . . . 0.0 111.645 -178.8 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 9' ' ' SER . . . . . 0.628 ' OG ' ' HG2' ' A' ' 6' ' ' GLN . 50.2 m -103.25 167.74 9.62 Favored 'General case' 0 CA--C 1.53 0.183 0 CA-C-O 120.837 0.351 . . . . 0.0 110.849 171.304 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -118.45 115.39 24.55 Favored 'General case' 0 C--N 1.325 -0.497 0 N-CA-C 109.329 -0.619 . . . . 0.0 109.329 175.65 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 4.8 m -119.71 142.15 36.51 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.609 0 C-N-CA 119.914 -0.715 . . . . 0.0 112.308 -174.006 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 12' ' ' LEU . . . . . 0.401 ' HG ' HD12 ' A' ' 141' ' ' LEU . 47.1 tp -88.7 138.1 31.72 Favored 'General case' 0 N--CA 1.447 -0.613 0 CA-C-N 115.298 -0.864 . . . . 0.0 108.824 174.208 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 14.4 m -144.98 157.81 13.95 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.456 0 CA-C-O 120.889 0.376 . . . . 0.0 110.876 -172.912 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 14' ' ' HIS . . . . . 0.627 ' ND1' ' HA ' ' A' ' 29' ' ' ARG . 3.0 m-70 -117.49 119.85 36.3 Favored 'General case' 0 C--N 1.319 -0.727 0 N-CA-C 107.481 -1.303 . . . . 0.0 107.481 162.137 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 15' ' ' PHE . . . . . 0.632 ' HA ' ' O ' ' A' ' 137' ' ' ASP . 46.2 p90 -139.09 142.18 38.13 Favored 'General case' 0 C--N 1.319 -0.725 0 C-N-CA 120.514 -0.474 . . . . 0.0 110.897 -175.206 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 25.0 m -119.17 121.64 40.19 Favored 'General case' 0 C--N 1.318 -0.8 0 CA-C-O 120.785 0.326 . . . . 0.0 110.203 174.3 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 17' ' ' LEU . . . . . 0.659 HD23 ' O ' ' A' ' 135' ' ' HIS . 5.7 mt -92.5 127.11 37.87 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 116.086 -0.506 . . . . 0.0 112.035 179.893 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 18' ' ' LYS . . . . . 0.417 ' O ' ' HB2' ' A' ' 135' ' ' HIS . 0.8 OUTLIER -125.17 152.43 44.49 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-N 115.35 -0.841 . . . . 0.0 110.283 179.888 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 19' ' ' LEU . . . . . 0.466 HD12 ' HB ' ' A' ' 23' ' ' THR . 95.1 mt -88.62 172.92 8.93 Favored 'General case' 0 C--N 1.316 -0.867 0 N-CA-C 109.696 -0.483 . . . . 0.0 109.696 171.345 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 18.7 t70 -53.61 -36.04 61.55 Favored 'General case' 0 N--CA 1.466 0.325 0 CA-C-O 121.029 0.442 . . . . 0.0 110.96 -179.713 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 38.5 m-20 -83.49 11.74 6.59 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 115.839 -0.619 . . . . 0.0 112.067 -177.99 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 72.69 12.16 77.86 Favored Glycine 0 N--CA 1.452 -0.293 0 C-N-CA 121.111 -0.566 . . . . 0.0 113.314 -178.455 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 23' ' ' THR . . . . . 0.466 ' HB ' HD12 ' A' ' 19' ' ' LEU . 24.6 m -73.87 128.87 36.67 Favored 'General case' 0 C--N 1.322 -0.593 0 N-CA-C 109.762 -0.459 . . . . 0.0 109.762 177.123 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 36.9 m -70.99 116.32 11.14 Favored 'General case' 0 C--N 1.32 -0.691 0 CA-C-O 121.194 0.521 . . . . 0.0 110.939 -178.129 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 25' ' ' ALA . . . . . 0.475 ' HB3' ' HB3' ' A' ' 17' ' ' LEU . . . -84.07 -49.46 8.88 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 115.637 -0.711 . . . . 0.0 109.91 178.133 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 8.2 tp10 -158.44 122.9 4.14 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.354 -0.839 . . . . 0.0 109.518 177.025 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 31.2 t -103.43 113.36 26.8 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-O 121.157 0.503 . . . . 0.0 110.219 178.732 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 28' ' ' THR . . . . . 0.606 ' O ' HG22 ' A' ' 28' ' ' THR . 58.0 m -118.96 36.71 4.35 Favored 'General case' 0 N--CA 1.441 -0.898 0 CA-C-O 122.707 1.241 . . . . 0.0 110.103 178.82 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 29' ' ' ARG . . . . . 0.627 ' HA ' ' ND1' ' A' ' 14' ' ' HIS . 52.7 ttp180 -132.06 -62.47 0.84 Allowed 'General case' 0 C--N 1.316 -0.88 0 O-C-N 121.327 -0.858 . . . . 0.0 110.431 174.613 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 2.3 p-10 -83.02 14.98 2.98 Favored 'General case' 0 N--CA 1.468 0.454 0 CA-C-O 121.099 0.476 . . . . 0.0 111.128 -179.483 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 31' ' ' ASN . . . . . 0.752 ' ND2' ' HG2' ' A' ' 33' ' ' LYS . 34.1 p-10 -88.18 -18.46 28.67 Favored 'General case' 0 C--N 1.32 -0.674 0 CA-C-N 115.877 -0.602 . . . . 0.0 110.114 175.387 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 88.03 10.88 68.4 Favored Glycine 0 N--CA 1.444 -0.777 0 CA-C-N 115.496 -0.775 . . . . 0.0 112.004 -178.883 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 33' ' ' LYS . . . . . 0.752 ' HG2' ' ND2' ' A' ' 31' ' ' ASN . 12.3 ptmt -140.87 117.55 7.68 Favored Pre-proline 0 C--N 1.327 -0.397 0 CA-C-O 121.434 0.635 . . . . 0.0 110.008 -179.943 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 78.5 Cg_endo -83.36 168.4 13.14 Favored 'Trans proline' 0 N--CA 1.453 -0.867 0 C-N-CA 122.351 2.034 . . . . 0.0 111.955 177.363 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -127.15 158.66 36.49 Favored 'General case' 0 C--N 1.319 -0.736 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.485 -177.416 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -105.11 138.04 41.94 Favored 'General case' 0 C--N 1.318 -0.783 0 CA-C-N 116.104 -0.498 . . . . 0.0 109.919 175.33 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 37' ' ' PHE . . . . . . . . . . . . . 9.9 m-30 -107.5 107.6 18.53 Favored 'General case' 0 C--N 1.318 -0.773 0 N-CA-C 109.164 -0.68 . . . . 0.0 109.164 175.867 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 16.2 tpt180 -89.24 120.2 30.39 Favored 'General case' 0 C--N 1.317 -0.839 0 CA-C-N 115.669 -0.696 . . . . 0.0 109.371 178.262 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 39' ' ' LEU . . . . . 0.713 HD13 ' HB2' ' A' ' 49' ' ' GLU . 2.0 mm? -79.03 148.42 32.5 Favored 'General case' 0 C--N 1.318 -0.764 0 CA-C-N 115.752 -0.658 . . . . 0.0 110.58 -177.468 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 100.51 39.42 3.22 Favored Glycine 0 N--CA 1.445 -0.724 0 C-N-CA 120.662 -0.78 . . . . 0.0 113.358 178.077 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 34.5 t70 66.67 7.51 5.22 Favored 'General case' 0 N--CA 1.472 0.644 0 CA-C-O 121.122 0.487 . . . . 0.0 112.16 171.431 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -55.63 -58.74 6.53 Favored 'General case' 0 C--N 1.328 -0.369 0 N-CA-C 112.052 0.39 . . . . 0.0 112.052 -177.741 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 37.1 m -143.41 9.46 1.62 Allowed 'General case' 0 C--N 1.324 -0.512 0 CA-C-O 121.073 0.463 . . . . 0.0 110.839 179.161 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 44' ' ' LEU . . . . . 0.436 HD13 ' HA ' ' A' ' 44' ' ' LEU . 4.2 mm? -115.09 148.9 38.36 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.885 -177.195 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 14.6 m -71.55 131.81 43.78 Favored 'General case' 0 N--CA 1.445 -0.688 0 N-CA-C 108.969 -0.752 . . . . 0.0 108.969 173.53 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 54.8 mt-10 -47.66 -43.92 26.68 Favored 'General case' 0 N--CA 1.468 0.472 0 O-C-N 123.534 0.521 . . . . 0.0 112.232 -169.509 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -61.41 -45.11 97.07 Favored Glycine 0 N--CA 1.448 -0.555 0 C-N-CA 120.642 -0.789 . . . . 0.0 112.696 -177.799 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 48' ' ' LEU . . . . . 0.403 HD13 ' C ' ' A' ' 48' ' ' LEU . 3.4 tm? -60.0 -54.39 46.64 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-O 120.95 0.405 . . . . 0.0 110.865 -177.879 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 49' ' ' GLU . . . . . 0.713 ' HB2' HD13 ' A' ' 39' ' ' LEU . 9.7 pt-20 -59.29 -40.25 85.58 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-N 115.458 -0.792 . . . . 0.0 111.39 -178.195 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 50' ' ' GLN . . . . . 0.702 ' HA ' HD23 ' A' ' 53' ' ' LEU . 83.4 mt-30 -69.14 -7.53 37.06 Favored 'General case' 0 CA--C 1.531 0.219 0 N-CA-C 113.302 0.853 . . . . 0.0 113.302 -179.78 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 51' ' ' HIS . . . . . . . . . . . . . 12.6 m80 -103.35 -16.71 15.55 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-O 121.192 0.52 . . . . 0.0 110.019 179.687 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 52' ' ' LEU . . . . . 0.426 HD11 HG12 ' A' ' 138' ' ' ILE . 27.5 mt -104.98 8.07 34.32 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-N 115.51 -0.768 . . . . 0.0 113.057 -176.419 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 53' ' ' LEU . . . . . 0.702 HD23 ' HA ' ' A' ' 50' ' ' GLN . 2.0 pp -92.86 155.94 17.29 Favored 'General case' 0 C--N 1.322 -0.615 0 C-N-CA 120.462 -0.495 . . . . 0.0 110.501 174.45 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 54' ' ' GLY . . . . . 0.485 ' N ' HG13 ' A' ' 5' ' ' VAL . . . 94.21 -12.55 68.89 Favored Glycine 0 CA--C 1.532 1.126 0 N-CA-C 115.941 1.136 . . . . 0.0 115.941 176.312 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 55' ' ' LEU . . . . . 0.683 ' O ' HG12 ' A' ' 5' ' ' VAL . 1.0 OUTLIER -100.73 165.44 11.38 Favored 'General case' 0 N--CA 1.471 0.603 0 CA-C-N 119.4 1.6 . . . . 0.0 112.06 -176.062 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 56' ' ' LYS . . . . . 0.457 ' HA ' ' HA ' ' A' ' 4' ' ' SER . 16.0 tttm -96.38 157.1 16.05 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-N 115.738 -0.665 . . . . 0.0 111.372 -175.563 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 57' ' ' VAL . . . . . 0.621 HG23 HD12 ' A' ' 143' ' ' ILE . 51.1 t -59.57 142.05 15.56 Favored 'Isoleucine or valine' 0 C--O 1.234 0.262 0 N-CA-C 109.398 -0.593 . . . . 0.0 109.398 171.404 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 82.43 9.3 85.06 Favored Glycine 0 N--CA 1.445 -0.766 0 C-N-CA 120.513 -0.851 . . . . 0.0 111.716 -177.51 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 59' ' ' ASP . . . . . 0.523 ' C ' ' HG3' ' A' ' 60' ' ' LYS . 15.9 m-20 -116.32 162.33 17.67 Favored 'General case' 0 CA--C 1.509 -0.629 0 N-CA-C 109.738 -0.467 . . . . 0.0 109.738 173.667 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 60' ' ' LYS . . . . . 0.585 ' HG2' ' HG2' ' A' ' 139' ' ' GLU . 32.2 mtpt -143.14 143.55 31.85 Favored 'General case' 0 C--N 1.318 -0.795 0 CA-C-N 115.439 -0.801 . . . . 0.0 110.375 -167.477 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 6.1 t -143.32 131.92 22.43 Favored 'General case' 0 C--N 1.315 -0.908 0 CA-C-N 115.938 -0.574 . . . . 0.0 109.686 178.934 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 3.3 m -113.17 130.99 56.03 Favored 'General case' 0 N--CA 1.443 -0.801 0 N-CA-C 108.949 -0.76 . . . . 0.0 108.949 177.452 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 63' ' ' PHE . . . . . 0.426 ' O ' ' HB2' ' A' ' 136' ' ' PHE . 39.3 p90 -154.59 152.76 30.4 Favored 'General case' 0 C--N 1.32 -0.704 0 CA-C-O 120.914 0.388 . . . . 0.0 111.112 179.688 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 26.5 m -101.64 156.33 17.56 Favored 'General case' 0 C--N 1.321 -0.657 0 CA-C-N 116.015 -0.539 . . . . 0.0 109.779 175.397 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 74.7 mt -141.55 144.06 34.08 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 116.377 -0.374 . . . . 0.0 110.657 -178.432 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 41.7 mt-10 -80.54 159.06 70.41 Favored Pre-proline 0 C--N 1.322 -0.593 0 CA-C-N 115.747 -0.661 . . . . 0.0 109.358 174.575 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 67' ' ' PRO . . . . . 0.404 ' HB3' ' HA2' ' A' ' 131' ' ' GLY . 59.0 Cg_exo -49.88 -36.86 44.58 Favored 'Trans proline' 0 C--O 1.233 0.25 0 C-N-CA 122.454 2.103 . . . . 0.0 113.624 -176.184 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 4.3 p-10 -66.04 -15.46 63.06 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-O 120.744 0.306 . . . . 0.0 111.385 -179.052 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -111.13 -16.15 13.52 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 116.591 -0.277 . . . . 0.0 111.302 179.475 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 70' ' ' ALA . . . . . 0.492 ' O ' ' HB2' ' A' ' 71' ' ' PHE . . . -143.67 129.68 19.57 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.364 -0.38 . . . . 0.0 111.672 -177.23 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 71' ' ' PHE . . . . . 0.492 ' HB2' ' O ' ' A' ' 70' ' ' ALA . 3.3 m-30 76.31 -44.96 0.5 Allowed 'General case' 0 N--CA 1.472 0.65 0 C-N-CA 123.341 0.656 . . . . 0.0 111.785 176.837 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 114.14 146.28 9.26 Favored Glycine 0 N--CA 1.445 -0.721 0 C-N-CA 120.95 -0.643 . . . . 0.0 112.176 178.905 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 16.8 m -76.14 148.47 81.2 Favored Pre-proline 0 C--N 1.322 -0.595 0 CA-C-O 120.886 0.374 . . . . 0.0 111.119 176.002 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 74.3 Cg_endo -75.83 133.77 15.74 Favored 'Trans proline' 0 C--N 1.347 0.492 0 C-N-CA 122.929 2.42 . . . . 0.0 113.121 -173.856 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 75' ' ' SER . . . . . 0.47 ' HB3' ' OD1' ' A' ' 77' ' ' ASP . 16.6 m -91.93 114.16 61.2 Favored Pre-proline 0 N--CA 1.44 -0.945 0 CA-C-N 115.949 -0.569 . . . . 0.0 110.992 -179.086 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 76' ' ' PRO . . . . . 0.438 ' HD2' ' HA ' ' A' ' 75' ' ' SER . 33.8 Cg_endo -66.41 -19.39 55.37 Favored 'Trans proline' 0 C--N 1.345 0.373 0 C-N-CA 122.734 2.29 . . . . 0.0 112.222 177.183 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 77' ' ' ASP . . . . . 0.47 ' OD1' ' HB3' ' A' ' 75' ' ' SER . 8.2 p-10 -76.35 -5.9 49.18 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 121.359 0.6 . . . . 0.0 110.384 177.16 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 78' ' ' LEU . . . . . 0.458 ' HG ' ' HB2' ' A' ' 125' ' ' PHE . 0.7 OUTLIER -89.03 10.39 21.8 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-N 115.548 -0.751 . . . . 0.0 110.437 176.273 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 22.4 mt -117.24 107.46 22.35 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.635 0 N-CA-C 108.349 -0.982 . . . . 0.0 108.349 177.413 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 80' ' ' GLN . . . . . 0.588 ' O ' ' HB ' ' A' ' 123' ' ' VAL . 71.5 mt-30 -119.7 140.59 50.43 Favored 'General case' 0 C--N 1.313 -1.012 0 CA-C-N 115.895 -0.593 . . . . 0.0 111.37 -172.052 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 81' ' ' TYR . . . . . . . . . . . . . 73.6 m-85 -96.38 155.3 16.82 Favored 'General case' 0 C--N 1.313 -0.983 0 CA-C-N 115.946 -0.57 . . . . 0.0 109.524 173.331 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 82' ' ' PHE . . . . . 0.457 ' CD1' HG21 ' A' ' 123' ' ' VAL . 3.2 m-85 -148.89 167.57 25.36 Favored 'General case' 0 C--N 1.323 -0.586 0 N-CA-C 108.981 -0.748 . . . . 0.0 108.981 -160.371 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 11.6 t -99.61 128.12 45.71 Favored 'General case' 0 C--N 1.321 -0.645 0 CA-C-O 121.082 0.468 . . . . 0.0 110.102 175.533 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 84' ' ' ARG . . . . . 0.689 ' HD3' ' HA ' ' A' ' 119' ' ' ASP . 15.4 ptt180 -53.27 -20.66 4.43 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.237 -0.892 . . . . 0.0 113.151 -177.916 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 85' ' ' ARG . . . . . . . . . . . . . 5.3 mpt_? -71.14 -37.45 72.27 Favored 'General case' 0 CA--C 1.517 -0.323 0 CA-C-O 120.91 0.385 . . . . 0.0 110.785 -173.38 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 27.1 mm-40 -63.97 -33.92 76.82 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-N 115.697 -0.683 . . . . 0.0 110.598 179.941 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 87' ' ' PHE . . . . . 0.409 ' HE2' ' CE1' ' A' ' 101' ' ' PHE . 27.1 m-85 -86.69 -39.73 15.75 Favored 'General case' 0 CA--C 1.509 -0.609 0 CA-C-N 115.96 -0.564 . . . . 0.0 111.158 -178.361 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 88' ' ' MET . . . . . . . . . . . . . 56.1 ttp -60.66 -34.91 75.0 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-N 116.398 -0.365 . . . . 0.0 110.844 -177.101 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 22.1 t70 -55.13 -31.2 61.09 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 121.025 0.44 . . . . 0.0 111.265 175.631 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -100.82 7.6 43.64 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 116.021 -0.536 . . . . 0.0 110.749 178.658 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 105.27 136.79 8.75 Favored Glycine 0 N--CA 1.445 -0.745 0 N-CA-C 110.846 -0.902 . . . . 0.0 110.846 -175.226 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 44.5 mt-10 -61.15 128.69 89.83 Favored Pre-proline 0 C--N 1.322 -0.618 0 CA-C-O 121.321 0.581 . . . . 0.0 111.208 -176.485 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 93' ' ' PRO . . . . . 0.61 ' HG2' HD12 ' A' ' 116' ' ' ILE . 56.2 Cg_endo -71.76 165.46 32.48 Favored 'Trans proline' 0 N--CA 1.462 -0.329 0 C-N-CA 123.318 2.678 . . . . 0.0 112.65 -175.441 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 16.3 mt-10 -116.65 155.79 28.19 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.843 -175.344 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 95' ' ' ILE . . . . . 0.514 HG23 ' O ' ' A' ' 114' ' ' ARG . 22.3 mt -82.37 135.77 24.24 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.469 0 CA-C-N 115.886 -0.597 . . . . 0.0 110.781 -178.711 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 73.16 19.6 79.68 Favored Glycine 0 N--CA 1.45 -0.394 0 CA-C-N 115.747 -0.661 . . . . 0.0 112.582 -175.822 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -96.48 119.51 35.1 Favored 'General case' 0 N--CA 1.452 -0.339 0 CA-C-O 121.54 0.686 . . . . 0.0 112.622 -179.32 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 98' ' ' ILE . . . . . 0.618 ' HA ' ' HA ' ' A' ' 112' ' ' VAL . 6.3 mt -88.69 107.46 17.78 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.665 0 N-CA-C 108.179 -1.045 . . . . 0.0 108.179 174.577 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 99' ' ' MET . . . . . . . . . . . . . 4.9 mtm -127.5 144.3 51.08 Favored 'General case' 0 N--CA 1.443 -0.786 0 N-CA-C 107.625 -1.25 . . . . 0.0 107.625 -175.607 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 100' ' ' LEU . . . . . 0.459 ' HB3' ' HB3' ' A' ' 108' ' ' GLU . 4.1 mm? -75.62 105.0 6.42 Favored 'General case' 0 C--N 1.311 -1.107 0 CA-C-N 116.494 -0.321 . . . . 0.0 110.873 -176.893 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 101' ' ' PHE . . . . . 0.409 ' CE1' ' HE2' ' A' ' 87' ' ' PHE . 42.9 m-85 -92.65 109.95 21.37 Favored 'General case' 0 CA--C 1.516 -0.346 0 CA-C-O 121.692 0.758 . . . . 0.0 110.915 -178.652 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 102' ' ' THR . . . . . 0.485 ' HA ' ' HA ' ' A' ' 108' ' ' GLU . 12.1 m -63.55 112.2 2.69 Favored 'General case' 0 C--N 1.311 -1.089 0 CA-C-N 114.411 -1.268 . . . . 0.0 113.038 -179.08 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -74.49 171.06 14.45 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-N 113.2 -1.818 . . . . 0.0 112.934 -178.945 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 104' ' ' MET . . . . . 0.446 ' C ' ' H ' ' A' ' 106' ' ' GLY . 4.2 mpp? -57.01 -33.5 67.22 Favored 'General case' 0 N--CA 1.465 0.276 0 CA-C-N 115.824 -0.625 . . . . 0.0 111.641 179.111 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 9.3 p-10 -76.93 22.05 0.2 Allowed 'General case' 0 N--CA 1.468 0.427 0 CA-C-O 121.528 0.68 . . . . 0.0 110.813 177.526 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 106' ' ' GLY . . . . . 0.446 ' H ' ' C ' ' A' ' 104' ' ' MET . . . 65.95 -7.84 1.06 Allowed Glycine 0 C--N 1.333 0.415 0 CA-C-N 114.649 -1.16 . . . . 0.0 114.694 -178.321 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 23.3 t -87.22 144.62 26.74 Favored 'General case' 0 CA--C 1.502 -0.902 0 CA-C-O 121.476 0.655 . . . . 0.0 110.705 -172.117 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 108' ' ' GLU . . . . . 0.485 ' HA ' ' HA ' ' A' ' 102' ' ' THR . 2.7 mp0 -80.45 156.41 26.62 Favored 'General case' 0 C--N 1.301 -1.531 0 CA-C-N 114.852 -1.067 . . . . 0.0 109.732 177.369 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 109' ' ' MET . . . . . 0.414 ' O ' ' HA ' ' A' ' 100' ' ' LEU . 96.5 mmm -136.61 125.04 15.07 Favored Pre-proline 0 C--N 1.314 -0.97 0 N-CA-C 107.563 -1.273 . . . . 0.0 107.563 -164.648 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 31.1 Cg_endo -69.39 119.08 6.09 Favored 'Trans proline' 0 N--CA 1.453 -0.887 0 CA-C-N 120.199 1.107 . . . . 0.0 110.644 175.145 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 111' ' ' GLY . . . . . 0.471 ' HA2' ' HA ' ' A' ' 125' ' ' PHE . . . -144.58 120.81 1.47 Allowed Glycine 0 N--CA 1.443 -0.895 0 CA-C-N 115.294 -0.866 . . . . 0.0 111.015 -172.202 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 112' ' ' VAL . . . . . 0.618 ' HA ' ' HA ' ' A' ' 98' ' ' ILE . 7.1 p -101.89 108.11 23.05 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.856 0 CA-C-O 122.058 0.933 . . . . 0.0 110.602 -179.819 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 113' ' ' ILE . . . . . 0.591 HG23 ' O ' ' A' ' 122' ' ' THR . 25.6 mt -61.2 109.89 0.56 Allowed 'Isoleucine or valine' 0 C--N 1.314 -0.966 0 CA-C-N 114.717 -1.129 . . . . 0.0 110.271 171.717 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 114' ' ' ARG . . . . . 0.565 ' HD2' ' HB2' ' A' ' 115' ' ' GLU . 6.4 tmm_? -77.32 -32.56 55.37 Favored 'General case' 0 C--N 1.315 -0.908 0 CA-C-N 115.13 -0.941 . . . . 0.0 111.024 -173.833 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 115' ' ' GLU . . . . . 0.565 ' HB2' ' HD2' ' A' ' 114' ' ' ARG . 5.7 tt0 -159.98 160.9 33.91 Favored 'General case' 0 C--N 1.329 -0.315 0 N-CA-C 110.289 -0.263 . . . . 0.0 110.289 178.337 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 116' ' ' ILE . . . . . 0.61 HD12 ' HG2' ' A' ' 93' ' ' PRO . 29.4 mm -107.36 107.22 22.24 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.514 0 N-CA-C 109.581 -0.525 . . . . 0.0 109.581 173.909 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 117' ' ' ASN . . . . . 0.455 ' HB2' ' O ' ' A' ' 120' ' ' SER . 5.6 m-20 -83.1 157.1 22.97 Favored 'General case' 0 C--N 1.313 -0.987 0 N-CA-C 108.906 -0.776 . . . . 0.0 108.906 178.33 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . -57.17 -48.54 79.15 Favored Glycine 0 N--CA 1.449 -0.457 0 C-N-CA 120.382 -0.913 . . . . 0.0 112.763 -172.987 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 119' ' ' ASP . . . . . 0.689 ' HA ' ' HD3' ' A' ' 84' ' ' ARG . 1.4 m-20 -107.8 -15.26 14.6 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-O 121.088 0.471 . . . . 0.0 111.346 -178.062 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 120' ' ' SER . . . . . 0.455 ' O ' ' HB2' ' A' ' 117' ' ' ASN . 32.4 t -123.38 157.76 32.63 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-N 115.878 -0.601 . . . . 0.0 111.158 -169.508 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 121' ' ' ILE . . . . . . . . . . . . . 50.0 mm -113.68 137.27 47.39 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.523 0 CA-C-O 121.165 0.507 . . . . 0.0 110.253 175.951 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 122' ' ' THR . . . . . 0.591 ' O ' HG23 ' A' ' 113' ' ' ILE . 3.6 m -93.98 142.21 27.64 Favored 'General case' 0 C--N 1.318 -0.776 0 CA-C-N 115.167 -0.924 . . . . 0.0 110.095 178.014 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 123' ' ' VAL . . . . . 0.588 ' HB ' ' O ' ' A' ' 80' ' ' GLN . 33.9 t -147.05 107.99 0.66 Allowed 'Isoleucine or valine' 0 N--CA 1.466 0.353 0 C-N-CA 117.085 -1.846 . . . . 0.0 110.385 -165.221 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 124' ' ' ASP . . . . . 0.546 ' HB3' HG13 ' A' ' 112' ' ' VAL . 28.6 t70 -107.98 101.64 10.88 Favored 'General case' 0 C--N 1.313 -1.006 0 C-N-CA 119.397 -0.921 . . . . 0.0 112.545 174.064 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 125' ' ' PHE . . . . . 0.471 ' HA ' ' HA2' ' A' ' 111' ' ' GLY . 83.5 m-85 -81.63 6.89 13.71 Favored 'General case' 0 N--CA 1.47 0.542 0 CA-C-N 116.285 -0.416 . . . . 0.0 110.894 178.459 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 7.7 m-80 -57.51 137.74 55.93 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-O 122.054 0.93 . . . . 0.0 111.023 179.656 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 127' ' ' HIS . . . . . 0.497 ' HB3' ' HD2' ' A' ' 128' ' ' PRO . 22.8 m170 -72.39 -174.23 0.29 Allowed Pre-proline 0 C--N 1.321 -0.632 0 CA-C-N 113.654 -1.612 . . . . 0.0 112.576 -168.481 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 128' ' ' PRO . . . . . 0.507 ' O ' ' N ' ' A' ' 130' ' ' ALA . 4.5 Cg_exo -42.13 174.92 0.0 OUTLIER 'Trans proline' 0 C--N 1.354 0.845 0 C-N-CA 124.671 3.58 . . . . 0.0 113.412 161.733 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 129' ' ' LEU . . . . . 0.44 HD21 HD11 ' A' ' 19' ' ' LEU . 3.6 tp -49.37 40.64 0.0 OUTLIER 'General case' 0 N--CA 1.488 1.428 0 C-N-CA 127.455 2.302 . . . . 0.0 116.097 -172.339 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 130' ' ' ALA . . . . . 0.507 ' N ' ' O ' ' A' ' 128' ' ' PRO . . . -88.11 175.17 7.85 Favored 'General case' 0 C--N 1.31 -1.122 0 N-CA-C 109.369 -0.604 . . . . 0.0 109.369 -178.897 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 131' ' ' GLY . . . . . 0.404 ' HA2' ' HB3' ' A' ' 67' ' ' PRO . . . 71.18 26.93 72.72 Favored Glycine 0 N--CA 1.449 -0.491 0 C-N-CA 120.473 -0.87 . . . . 0.0 113.287 178.27 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 132' ' ' GLN . . . . . . . . . . . . . 4.0 pt20 -148.03 157.22 43.4 Favored 'General case' 0 C--N 1.328 -0.358 0 N-CA-C 110.192 -0.299 . . . . 0.0 110.192 176.038 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 133' ' ' THR . . . . . . . . . . . . . 21.5 m -72.11 113.04 8.72 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 116.101 -0.499 . . . . 0.0 110.942 -176.183 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 134' ' ' VAL . . . . . 0.429 ' HB ' HD22 ' A' ' 17' ' ' LEU . 30.6 m -102.75 171.68 1.52 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.609 0 CA-C-O 121.556 0.693 . . . . 0.0 110.999 179.624 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 135' ' ' HIS . . . . . 0.659 ' O ' HD23 ' A' ' 17' ' ' LEU . 13.8 m-70 -132.66 140.56 48.21 Favored 'General case' 0 C--N 1.318 -0.768 0 N-CA-C 107.548 -1.279 . . . . 0.0 107.548 -172.236 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 136' ' ' PHE . . . . . 0.573 ' CZ ' HD21 ' A' ' 17' ' ' LEU . 9.3 m-85 -125.42 122.76 37.64 Favored 'General case' 0 C--N 1.311 -1.107 0 C-N-CA 120.492 -0.483 . . . . 0.0 112.188 -169.545 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 137' ' ' ASP . . . . . 0.632 ' O ' ' HA ' ' A' ' 15' ' ' PHE . 5.0 m-20 -115.82 100.8 8.26 Favored 'General case' 0 C--N 1.322 -0.628 0 N-CA-C 108.479 -0.934 . . . . 0.0 108.479 171.156 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 138' ' ' ILE . . . . . 0.5 ' CD1' ' HB3' ' A' ' 136' ' ' PHE . 4.4 mp -110.57 129.74 65.15 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.644 0 CA-C-O 121.229 0.538 . . . . 0.0 111.936 -177.535 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 139' ' ' GLU . . . . . 0.585 ' HG2' ' HG2' ' A' ' 60' ' ' LYS . 34.2 mt-10 -122.11 109.07 14.07 Favored 'General case' 0 N--CA 1.447 -0.601 0 CA-C-N 115.244 -0.889 . . . . 0.0 109.006 172.245 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 140' ' ' VAL . . . . . . . . . . . . . 58.9 t -59.63 119.55 4.15 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.499 0 CA-C-N 115.779 -0.646 . . . . 0.0 110.933 -179.276 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 141' ' ' LEU . . . . . 0.527 HD11 ' CD2' ' A' ' 14' ' ' HIS . 37.7 mt -90.51 -49.49 6.47 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 116.372 -0.376 . . . . 0.0 110.498 179.554 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 142' ' ' GLU . . . . . . . . . . . . . 44.3 mt-10 -156.87 158.88 37.53 Favored 'General case' 0 CA--C 1.519 -0.222 0 N-CA-C 108.835 -0.802 . . . . 0.0 108.835 -177.036 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 143' ' ' ILE . . . . . 0.621 HD12 HG23 ' A' ' 57' ' ' VAL . 97.4 mt -128.35 115.45 38.08 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.837 0 CA-C-O 121.139 0.495 . . . . 0.0 111.852 179.609 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 144' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -77.95 128.59 78.51 Favored Pre-proline 0 C--O 1.235 0.318 0 CA-C-N 115.397 -0.82 . . . . 0.0 109.069 172.582 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 145' ' ' PRO . . . . . . . . . . . . . 18.3 Cg_endo -60.35 152.77 64.69 Favored 'Trans proline' 0 C--O 1.233 0.228 0 C-N-CA 123.126 2.55 . . . . 0.0 114.183 -172.379 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 146' ' ' ALA . . . . . . . . . . . . . . . -98.73 136.83 38.21 Favored 'General case' 0 C--N 1.318 -0.768 0 CA-C-N 114.479 -1.237 . . . . 0.0 108.684 172.763 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 147' ' ' LEU . . . . . 0.404 HD13 ' HA ' ' A' ' 147' ' ' LEU . 3.7 mm? -81.46 15.08 2.18 Favored 'General case' 0 C--N 1.32 -0.682 0 N-CA-C 111.81 0.3 . . . . 0.0 111.81 -172.857 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 8.3 pt-20 . . . . . 0 C--N 1.324 -0.536 0 CA-C-N 116.54 -0.3 . . . . 0.0 111.072 176.624 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 2' ' ' SER . . . . . 0.487 ' HB3' ' HA ' ' A' ' 145' ' ' PRO . 6.2 p . . . . . 0 N--CA 1.455 -0.183 0 CA-C-O 121.145 0.498 . . . . 0.0 110.705 . . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 3.3 mp0 -77.38 -35.44 54.45 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-O 121.653 0.74 . . . . 0.0 109.77 -179.006 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 16.1 p -133.26 157.56 45.12 Favored 'General case' 0 C--N 1.315 -0.904 0 CA-C-N 114.893 -1.049 . . . . 0.0 109.745 -179.629 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . 0.67 HG13 ' HA ' ' A' ' 53' ' ' LEU . 10.2 p -71.11 139.04 20.57 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.573 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.04 -178.04 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 6' ' ' GLN . . . . . . . . . . . . . 2.9 pt20 -142.7 164.15 30.88 Favored 'General case' 0 C--N 1.314 -0.954 0 N-CA-C 108.549 -0.908 . . . . 0.0 108.549 179.149 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 83.2 p -67.41 136.32 54.53 Favored 'General case' 0 C--N 1.316 -0.886 0 C-N-CA 120.724 -0.391 . . . . 0.0 110.453 -178.154 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 66.6 t30 71.27 28.43 3.0 Favored 'General case' 0 CA--C 1.538 0.488 0 C-N-CA 123.449 0.699 . . . . 0.0 111.667 -178.697 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 49.6 m -128.54 132.99 48.29 Favored 'General case' 0 C--N 1.327 -0.374 0 O-C-N 121.623 -0.673 . . . . 0.0 110.166 174.011 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -83.2 165.78 19.16 Favored 'General case' 0 C--N 1.322 -0.63 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.765 -171.862 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 33.0 m -143.46 139.7 26.25 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.685 0 CA-C-O 120.924 0.392 . . . . 0.0 110.281 -175.585 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 12' ' ' LEU . . . . . 0.519 HD12 ' HB3' ' A' ' 142' ' ' GLU . 75.7 mt -86.0 124.07 32.03 Favored 'General case' 0 C--N 1.319 -0.752 0 N-CA-C 108.127 -1.064 . . . . 0.0 108.127 173.253 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 13' ' ' VAL . . . . . 0.621 HG21 HG23 ' A' ' 138' ' ' ILE . 3.5 p -136.06 153.24 31.6 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.912 0 CA-C-O 122.289 1.042 . . . . 0.0 112.993 -167.348 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 14' ' ' HIS . . . . . . . . . . . . . 1.9 m-70 -123.72 116.16 22.59 Favored 'General case' 0 C--N 1.313 -1.008 0 CA-C-N 113.359 -1.746 . . . . 0.0 106.58 167.654 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 15' ' ' PHE . . . . . 0.57 ' HB2' ' O ' ' A' ' 137' ' ' ASP . 16.5 p90 -142.12 168.95 18.52 Favored 'General case' 0 C--N 1.317 -0.826 0 C-N-CA 119.2 -1.0 . . . . 0.0 112.531 -172.452 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 21.5 m -145.9 142.7 29.01 Favored 'General case' 0 C--N 1.321 -0.631 0 CA-C-N 115.076 -0.965 . . . . 0.0 110.438 176.253 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 17' ' ' LEU . . . . . 0.499 HD13 ' HB3' ' A' ' 136' ' ' PHE . 0.0 OUTLIER -105.68 128.43 53.66 Favored 'General case' 0 C--N 1.326 -0.424 0 N-CA-C 109.527 -0.545 . . . . 0.0 109.527 -175.621 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 18' ' ' LYS . . . . . 0.502 ' HA ' ' O ' ' A' ' 23' ' ' THR . 0.1 OUTLIER -125.56 136.85 53.75 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-O 121.663 0.744 . . . . 0.0 112.204 -174.256 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 19' ' ' LEU . . . . . 0.478 HD23 ' HB ' ' A' ' 23' ' ' THR . 3.5 mm? -78.2 174.74 10.87 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 114.96 -1.018 . . . . 0.0 109.963 172.683 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 23.9 m-20 -60.74 -27.83 68.23 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-O 120.797 0.332 . . . . 0.0 111.08 176.905 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 35.8 t70 -80.61 5.02 16.67 Favored 'General case' 0 N--CA 1.474 0.739 0 CA-C-O 122.224 1.011 . . . . 0.0 109.926 174.224 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 66.91 19.3 69.57 Favored Glycine 0 N--CA 1.451 -0.363 0 CA-C-N 114.259 -1.337 . . . . 0.0 112.478 -175.944 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 23' ' ' THR . . . . . 0.502 ' O ' ' HA ' ' A' ' 18' ' ' LYS . 17.4 m -72.55 142.7 48.46 Favored 'General case' 0 C--N 1.323 -0.544 0 N-CA-C 110.33 -0.248 . . . . 0.0 110.33 178.473 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 59.0 m -77.05 107.9 9.74 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-O 120.871 0.367 . . . . 0.0 111.026 179.32 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 25' ' ' ALA . . . . . 0.422 ' HB3' ' HB3' ' A' ' 17' ' ' LEU . . . -77.29 -35.51 55.04 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-O 121.405 0.621 . . . . 0.0 109.567 174.709 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 9.0 tp10 -160.48 142.72 12.85 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 115.033 -0.985 . . . . 0.0 108.896 -179.419 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 19.6 t -124.75 149.42 47.33 Favored 'General case' 0 C--N 1.313 -1.007 0 N-CA-C 109.09 -0.707 . . . . 0.0 109.09 175.125 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 28' ' ' THR . . . . . 0.461 HG21 ' HB2' ' A' ' 35' ' ' ALA . 36.6 m -148.23 44.55 1.05 Allowed 'General case' 0 N--CA 1.437 -1.113 0 CA-C-O 123.79 1.757 . . . . 0.0 106.819 172.764 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 52.9 ttp180 -151.65 -45.96 0.11 Allowed 'General case' 0 C--N 1.312 -1.052 0 CA-C-N 112.653 -2.067 . . . . 0.0 109.681 -178.784 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 91.6 m-20 -67.81 -25.73 65.73 Favored 'General case' 0 N--CA 1.464 0.272 0 CA-C-O 121.087 0.47 . . . . 0.0 110.549 177.643 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 71.8 m-20 -76.53 -12.66 60.06 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.595 -0.729 . . . . 0.0 110.65 179.898 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 83.01 -1.37 88.81 Favored Glycine 0 N--CA 1.45 -0.371 0 C-N-CA 120.989 -0.624 . . . . 0.0 111.804 -179.691 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 59.4 mttp -107.41 121.68 43.64 Favored Pre-proline 0 C--N 1.321 -0.659 0 CA-C-N 115.717 -0.242 . . . . 0.0 110.698 -177.952 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 7.8 Cg_exo -76.48 168.94 22.84 Favored 'Trans proline' 0 N--CA 1.46 -0.491 0 C-N-CA 122.938 2.426 . . . . 0.0 112.118 172.113 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 35' ' ' ALA . . . . . 0.461 ' HB2' HG21 ' A' ' 28' ' ' THR . . . -140.89 161.7 37.2 Favored 'General case' 0 C--N 1.312 -1.04 0 CA-C-N 115.097 -0.956 . . . . 0.0 109.592 179.383 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 3.8 tp -112.89 130.77 55.99 Favored 'General case' 0 N--CA 1.445 -0.722 0 N-CA-C 110.049 -0.352 . . . . 0.0 110.049 175.968 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 37' ' ' PHE . . . . . . . . . . . . . 9.4 m-30 -95.98 112.14 23.95 Favored 'General case' 0 C--N 1.318 -0.77 0 N-CA-C 110.055 -0.35 . . . . 0.0 110.055 175.411 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 38' ' ' ARG . . . . . 0.567 ' HB3' ' HB3' ' A' ' 42' ' ' ALA . 22.3 mmm180 -83.46 106.91 15.59 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-O 121.351 0.596 . . . . 0.0 110.957 -179.513 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 10.9 mp -81.84 154.18 26.01 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-N 115.104 -0.953 . . . . 0.0 110.979 178.278 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 91.79 41.11 5.11 Favored Glycine 0 N--CA 1.449 -0.455 0 C-N-CA 120.915 -0.66 . . . . 0.0 113.06 176.575 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 16.6 m-20 58.46 23.55 10.81 Favored 'General case' 0 N--CA 1.468 0.429 0 CA-C-O 120.873 0.368 . . . . 0.0 111.374 177.78 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 42' ' ' ALA . . . . . 0.567 ' HB3' ' HB3' ' A' ' 38' ' ' ARG . . . -86.48 -27.37 24.11 Favored 'General case' 0 C--N 1.323 -0.587 0 CA-C-O 121.027 0.441 . . . . 0.0 110.278 -178.162 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 40.8 m -154.31 -45.09 0.09 Allowed 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 115.821 -0.627 . . . . 0.0 109.532 175.585 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 51.5 mt -102.81 159.34 15.57 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 115.775 -0.648 . . . . 0.0 110.179 178.482 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 50.1 m -84.45 161.72 20.19 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-N 115.853 -0.612 . . . . 0.0 110.765 -177.546 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 45.2 mt-10 -57.4 -26.8 61.66 Favored 'General case' 0 N--CA 1.463 0.202 0 CA-C-N 115.858 -0.61 . . . . 0.0 111.715 -177.213 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -58.86 -36.72 88.6 Favored Glycine 0 N--CA 1.45 -0.403 0 C-N-CA 121.086 -0.578 . . . . 0.0 112.546 -175.808 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 3.0 tt -76.22 -36.53 58.51 Favored 'General case' 0 CA--C 1.515 -0.387 0 CA-C-O 121.768 0.794 . . . . 0.0 110.388 -179.122 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 7.2 tt0 -66.79 -46.68 74.49 Favored 'General case' 0 C--N 1.318 -0.785 0 CA-C-N 114.273 -1.331 . . . . 0.0 108.827 -176.472 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 50' ' ' GLN . . . . . 0.518 ' HA ' HD22 ' A' ' 53' ' ' LEU . 82.9 mm-40 -62.67 -16.4 56.86 Favored 'General case' 0 C--N 1.314 -0.936 0 CA-C-N 113.504 -1.68 . . . . 0.0 112.396 -176.069 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 51' ' ' HIS . . . . . . . . . . . . . 14.1 m-70 -105.34 -3.48 22.67 Favored 'General case' 0 C--O 1.233 0.223 0 C-N-CA 120.221 -0.591 . . . . 0.0 111.663 176.21 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 52' ' ' LEU . . . . . 0.563 ' O ' HG11 ' A' ' 5' ' ' VAL . 6.1 mt -99.98 -23.66 14.85 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 116.461 -0.336 . . . . 0.0 111.866 -178.493 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 53' ' ' LEU . . . . . 0.67 ' HA ' HG13 ' A' ' 5' ' ' VAL . 0.0 OUTLIER -59.85 152.21 23.78 Favored 'General case' 0 CA--C 1.53 0.209 0 CA-C-O 121.316 0.579 . . . . 0.0 112.286 -177.124 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 94.26 -17.14 59.5 Favored Glycine 0 N--CA 1.451 -0.306 0 CA-C-N 115.296 -0.865 . . . . 0.0 113.557 175.964 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 55' ' ' LEU . . . . . 0.532 ' O ' HG12 ' A' ' 5' ' ' VAL . 16.0 tp -84.9 158.97 20.43 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-O 121.099 0.476 . . . . 0.0 110.975 177.677 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 56' ' ' LYS . . . . . 0.563 ' HD3' ' N ' ' A' ' 57' ' ' VAL . 12.8 tmtt? -120.11 162.89 18.54 Favored 'General case' 0 C--N 1.325 -0.487 0 N-CA-C 109.768 -0.456 . . . . 0.0 109.768 -176.331 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 57' ' ' VAL . . . . . 0.563 ' N ' ' HD3' ' A' ' 56' ' ' LYS . 42.1 t -57.76 147.74 6.04 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-O 120.889 0.376 . . . . 0.0 111.259 177.491 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 80.6 9.46 86.39 Favored Glycine 0 N--CA 1.451 -0.334 0 CA-C-N 115.852 -0.613 . . . . 0.0 113.575 -177.712 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 2.5 m-20 -121.53 162.55 20.36 Favored 'General case' 0 CA--C 1.513 -0.46 0 CA-C-O 121.022 0.439 . . . . 0.0 110.828 178.364 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 60' ' ' LYS . . . . . 0.593 ' HB3' ' HG2' ' A' ' 139' ' ' GLU . 1.1 ptmt -135.15 146.15 48.49 Favored 'General case' 0 C--N 1.316 -0.855 0 CA-C-N 115.576 -0.738 . . . . 0.0 109.133 179.136 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 12.1 t -142.76 143.35 32.17 Favored 'General case' 0 C--N 1.318 -0.793 0 CA-C-O 121.13 0.491 . . . . 0.0 109.754 -178.612 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 3.7 m -109.17 138.52 45.39 Favored 'General case' 0 C--N 1.311 -1.101 0 N-CA-C 108.889 -0.782 . . . . 0.0 108.889 176.668 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 63' ' ' PHE . . . . . 0.544 ' CZ ' HD12 ' A' ' 138' ' ' ILE . 31.4 p90 -158.36 158.85 35.07 Favored 'General case' 0 C--N 1.321 -0.653 0 CA-C-O 121.238 0.542 . . . . 0.0 111.42 -179.444 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 64' ' ' SER . . . . . 0.425 ' O ' ' HG ' ' A' ' 65' ' ' LEU . 26.1 t -104.73 159.42 15.8 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-N 115.197 -0.911 . . . . 0.0 109.71 -179.204 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 65' ' ' LEU . . . . . 0.479 HD12 ' CZ ' ' A' ' 136' ' ' PHE . 18.5 mt -161.09 151.38 17.71 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 116.302 -0.408 . . . . 0.0 110.698 -171.975 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 48.0 mt-10 -69.86 152.79 95.92 Favored Pre-proline 0 C--N 1.321 -0.662 0 CA-C-N 115.796 -0.638 . . . . 0.0 109.365 174.485 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 3.4 Cg_exo -42.45 -49.71 6.13 Favored 'Trans proline' 0 CA--C 1.532 0.406 0 C-N-CA 123.673 2.915 . . . . 0.0 113.865 -176.804 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -56.86 -31.12 64.48 Favored 'General case' 0 N--CA 1.468 0.439 0 CA-C-N 115.996 -0.547 . . . . 0.0 111.784 179.84 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 69' ' ' ALA . . . . . 0.415 ' O ' HD13 ' A' ' 65' ' ' LEU . . . -98.26 16.75 20.46 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.825 -175.67 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.323 -0.559 0 N-CA-C 108.944 -0.762 . . . . 0.0 108.944 -173.24 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 75' ' ' SER . . . . . 0.471 ' HB2' HD23 ' A' ' 78' ' ' LEU . 54.7 m . . . . . 0 N--CA 1.447 -0.591 0 N-CA-C 112.031 0.382 . . . . 0.0 112.031 . . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 76' ' ' PRO . . . . . 0.453 ' HD2' ' HA ' ' A' ' 75' ' ' SER . 36.3 Cg_endo -67.53 -14.25 41.69 Favored 'Trans proline' 0 N--CA 1.462 -0.333 0 C-N-CA 122.692 2.261 . . . . 0.0 112.043 174.996 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 23.8 t70 -64.03 -19.61 65.32 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.689 -178.801 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 78' ' ' LEU . . . . . 0.6 ' HB3' ' HB2' ' A' ' 125' ' ' PHE . 3.0 mm? -88.66 -1.12 57.91 Favored 'General case' 0 CA--C 1.513 -0.469 0 C-N-CA 120.697 -0.401 . . . . 0.0 110.775 -179.611 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 79' ' ' ILE . . . . . 0.64 HG23 ' O ' ' A' ' 123' ' ' VAL . 20.2 mt -65.4 128.51 28.32 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.594 0 CA-C-O 121.921 0.867 . . . . 0.0 111.335 -178.243 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 80' ' ' GLN . . . . . 0.573 ' O ' ' HB ' ' A' ' 123' ' ' VAL . 49.5 mt-30 -135.81 138.88 43.02 Favored 'General case' 0 C--N 1.319 -0.76 0 CA-C-N 114.14 -1.391 . . . . 0.0 108.736 -174.274 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 81' ' ' TYR . . . . . 0.447 ' CE2' HG23 ' A' ' 122' ' ' THR . 73.1 m-85 -107.17 110.3 22.33 Favored 'General case' 0 C--N 1.32 -0.691 0 C-N-CA 119.707 -0.797 . . . . 0.0 110.276 -179.117 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 48.9 m-85 -104.81 168.55 8.99 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-N 115.881 -0.599 . . . . 0.0 110.684 172.495 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 22.6 t -87.22 157.99 19.21 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-O 121.365 0.603 . . . . 0.0 111.209 -176.883 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 84' ' ' ARG . . . . . 0.402 ' HG3' ' HD2' ' A' ' 85' ' ' ARG . 12.5 ptm180 -61.86 -34.74 76.54 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 115.22 -0.9 . . . . 0.0 109.825 175.961 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 85' ' ' ARG . . . . . 0.402 ' HD2' ' HG3' ' A' ' 84' ' ' ARG . 5.1 mpt_? -54.7 -28.08 45.22 Favored 'General case' 0 C--N 1.32 -0.7 0 CA-C-N 113.952 -1.476 . . . . 0.0 111.781 176.092 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 21.2 mm-40 -79.86 -20.2 46.48 Favored 'General case' 0 C--N 1.32 -0.689 0 CA-C-O 121.105 0.478 . . . . 0.0 111.389 179.396 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 87' ' ' PHE . . . . . . . . . . . . . 57.0 m-85 -104.22 -20.5 13.77 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 116.093 -0.503 . . . . 0.0 111.558 -176.076 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 88' ' ' MET . . . . . . . . . . . . . 22.5 ttm -56.13 -38.37 70.72 Favored 'General case' 0 C--N 1.323 -0.556 0 N-CA-C 112.307 0.484 . . . . 0.0 112.307 -173.239 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 2.3 m-20 -53.98 -27.46 31.58 Favored 'General case' 0 C--N 1.328 -0.327 0 N-CA-C 112.362 0.504 . . . . 0.0 112.362 176.709 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -110.47 14.81 22.46 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-O 120.957 0.408 . . . . 0.0 110.554 179.834 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 92.3 138.85 8.57 Favored Glycine 0 N--CA 1.448 -0.566 0 C-N-CA 120.837 -0.696 . . . . 0.0 111.973 -178.554 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 63.6 mt-10 -62.47 122.13 71.53 Favored Pre-proline 0 C--N 1.324 -0.532 0 CA-C-O 121.148 0.499 . . . . 0.0 110.906 -179.632 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 93' ' ' PRO . . . . . 0.5 ' HG2' HD12 ' A' ' 121' ' ' ILE . 43.9 Cg_endo -72.95 168.12 25.53 Favored 'Trans proline' 0 CA--C 1.516 -0.393 0 C-N-CA 123.777 2.984 . . . . 0.0 114.123 -173.214 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 94' ' ' GLU . . . . . 0.414 ' HB2' ' HB2' ' A' ' 97' ' ' ALA . 3.4 mp0 -114.07 160.03 19.35 Favored 'General case' 0 N--CA 1.444 -0.742 0 CA-C-N 114.181 -1.372 . . . . 0.0 110.54 -172.357 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 95' ' ' ILE . . . . . 0.533 HG12 HG12 ' A' ' 116' ' ' ILE . 11.3 mt -78.2 131.7 33.99 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.446 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.535 178.829 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 71.76 24.02 77.24 Favored Glycine 0 N--CA 1.445 -0.708 0 CA-C-N 115.629 -0.714 . . . . 0.0 111.963 -176.626 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 97' ' ' ALA . . . . . 0.414 ' HB2' ' HB2' ' A' ' 94' ' ' GLU . . . -103.29 117.42 34.47 Favored 'General case' 0 N--CA 1.449 -0.502 0 CA-C-O 121.937 0.875 . . . . 0.0 110.661 179.456 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 98' ' ' ILE . . . . . 0.565 ' HA ' ' HA ' ' A' ' 112' ' ' VAL . 4.1 mt -97.97 120.51 47.4 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.294 0 CA-C-N 114.481 -1.236 . . . . 0.0 108.726 -176.012 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 99' ' ' MET . . . . . . . . . . . . . 8.3 mtm -133.91 149.65 51.3 Favored 'General case' 0 N--CA 1.439 -0.99 0 N-CA-C 106.922 -1.51 . . . . 0.0 106.922 -177.949 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 3.2 mm? -70.38 119.7 14.94 Favored 'General case' 0 C--N 1.311 -1.087 0 CA-C-O 122.313 1.054 . . . . 0.0 113.044 -176.417 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 101' ' ' PHE . . . . . 0.647 ' O ' ' HA ' ' A' ' 108' ' ' GLU . 20.8 m-85 -109.7 175.89 5.28 Favored 'General case' 0 C--O 1.22 -0.452 0 CA-C-N 113.05 -1.886 . . . . 0.0 111.47 -175.533 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 9.2 m -124.84 109.65 13.31 Favored 'General case' 0 N--CA 1.466 0.373 0 C-N-CA 120.492 -0.483 . . . . 0.0 111.136 -166.248 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -77.3 170.3 16.78 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-N 115.733 -0.667 . . . . 0.0 112.483 178.659 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 104' ' ' MET . . . . . 0.421 ' C ' ' H ' ' A' ' 106' ' ' GLY . 3.7 mpp? -58.93 -37.71 77.31 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 115.659 -0.7 . . . . 0.0 111.193 -179.783 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 11.1 p-10 -78.59 22.97 0.33 Allowed 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 121.381 0.61 . . . . 0.0 110.665 177.774 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 106' ' ' GLY . . . . . 0.421 ' H ' ' C ' ' A' ' 104' ' ' MET . . . 66.39 -12.04 0.5 Allowed Glycine 0 C--N 1.337 0.623 0 CA-C-N 115.178 -0.919 . . . . 0.0 114.812 -174.869 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 46.6 t -65.74 132.72 49.43 Favored 'General case' 0 CA--C 1.501 -0.912 0 CA-C-O 122.063 0.935 . . . . 0.0 110.896 -171.909 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 108' ' ' GLU . . . . . 0.647 ' HA ' ' O ' ' A' ' 101' ' ' PHE . 2.1 tt0 -90.77 104.04 16.68 Favored 'General case' 0 C--N 1.297 -1.677 0 CA-C-N 114.146 -1.388 . . . . 0.0 109.128 178.907 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 109' ' ' MET . . . . . . . . . . . . . 1.7 mtm -102.63 148.32 35.34 Favored Pre-proline 0 CA--C 1.511 -0.549 0 N-CA-C 108.096 -1.076 . . . . 0.0 108.096 -178.138 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 29.6 Cg_endo -63.85 146.14 91.34 Favored 'Trans proline' 0 N--CA 1.45 -1.046 0 C-N-CA 121.325 1.35 . . . . 0.0 110.482 172.999 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 111' ' ' GLY . . . . . 0.493 ' HA3' ' CD2' ' A' ' 101' ' ' PHE . . . -143.35 107.76 0.48 Allowed Glycine 0 N--CA 1.439 -1.138 0 N-CA-C 109.763 -1.335 . . . . 0.0 109.763 -173.359 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 112' ' ' VAL . . . . . 0.84 HG13 ' HB3' ' A' ' 124' ' ' ASP . 2.9 p -87.57 107.55 17.37 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.876 0 C-N-CA 118.798 -1.161 . . . . 0.0 109.976 -174.779 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 113' ' ' ILE . . . . . . . . . . . . . 34.8 mt -62.91 108.46 0.59 Allowed 'Isoleucine or valine' 0 N--CA 1.436 -1.168 0 N-CA-C 108.531 -0.915 . . . . 0.0 108.531 170.525 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 114' ' ' ARG . . . . . 0.419 ' O ' HG23 ' A' ' 95' ' ' ILE . 6.3 tpp180 -75.37 -42.72 53.36 Favored 'General case' 0 C--N 1.308 -1.203 0 CA-C-N 113.853 -1.521 . . . . 0.0 111.06 -168.969 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 115' ' ' GLU . . . . . 0.5 ' HA ' HG23 ' A' ' 95' ' ' ILE . 8.3 tt0 -159.57 156.78 28.65 Favored 'General case' 0 C--N 1.32 -0.694 0 N-CA-C 109.622 -0.51 . . . . 0.0 109.622 -176.381 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 116' ' ' ILE . . . . . 0.533 HG12 HG12 ' A' ' 95' ' ' ILE . 38.8 mm -111.48 115.28 49.45 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.528 0 N-CA-C 109.907 -0.405 . . . . 0.0 109.907 179.68 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 117' ' ' ASN . . . . . 0.525 HD22 ' N ' ' A' ' 117' ' ' ASN . 0.8 OUTLIER -99.51 154.69 18.04 Favored 'General case' 0 C--N 1.316 -0.858 0 N-CA-C 108.8 -0.815 . . . . 0.0 108.8 176.672 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . -62.3 -28.0 70.19 Favored Glycine 0 N--CA 1.45 -0.395 0 CA-C-N 115.929 -0.578 . . . . 0.0 113.648 -173.78 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 11.8 t70 -114.87 -17.63 11.5 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 117.004 0.402 . . . . 0.0 111.77 179.08 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 120' ' ' SER . . . . . 0.448 ' O ' ' HB2' ' A' ' 117' ' ' ASN . 14.8 t -137.59 157.8 45.74 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-O 121.179 0.514 . . . . 0.0 111.281 -169.662 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 121' ' ' ILE . . . . . 0.5 HD12 ' HG2' ' A' ' 93' ' ' PRO . 45.1 mm -110.13 132.91 57.12 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.811 0 CA-C-N 116.102 -0.499 . . . . 0.0 109.963 177.376 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 122' ' ' THR . . . . . 0.447 HG23 ' CE2' ' A' ' 81' ' ' TYR . 4.6 m -92.44 103.34 15.78 Favored 'General case' 0 N--CA 1.442 -0.848 0 CA-C-O 122.142 0.972 . . . . 0.0 109.924 178.233 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 123' ' ' VAL . . . . . 0.64 ' O ' HG23 ' A' ' 79' ' ' ILE . 18.8 t -93.86 156.51 3.09 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.005 0 CA-C-N 113.54 -1.664 . . . . 0.0 110.355 177.581 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 124' ' ' ASP . . . . . 0.84 ' HB3' HG13 ' A' ' 112' ' ' VAL . 10.8 t0 -151.06 94.08 2.01 Favored 'General case' 0 C--N 1.317 -0.827 0 CA-C-N 115.216 -0.902 . . . . 0.0 109.684 -176.596 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 125' ' ' PHE . . . . . 0.6 ' HB2' ' HB3' ' A' ' 78' ' ' LEU . 84.4 m-85 -84.68 96.83 9.34 Favored 'General case' 0 CA--C 1.51 -0.593 0 CA-C-O 122.041 0.924 . . . . 0.0 110.517 177.537 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER . . . . . 0 C--N 1.299 -1.611 0 CA-C-N 114.297 -1.32 . . . . 0.0 109.763 173.261 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 133' ' ' THR . . . . . . . . . . . . . 24.0 m . . . . . 0 N--CA 1.455 -0.181 0 CA-C-O 120.82 0.343 . . . . 0.0 110.974 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 134' ' ' VAL . . . . . 0.436 ' HB ' ' CD1' ' A' ' 17' ' ' LEU . 2.6 m -134.2 146.29 31.57 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.362 0 N-CA-C 112.297 0.48 . . . . 0.0 112.297 -174.397 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 135' ' ' HIS . . . . . . . . . . . . . 26.1 m-70 -98.32 120.41 38.68 Favored 'General case' 0 N--CA 1.465 0.315 0 CA-C-N 116.0 -0.545 . . . . 0.0 110.618 178.734 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 136' ' ' PHE . . . . . 0.499 ' HB3' HD13 ' A' ' 17' ' ' LEU . 3.1 p90 -128.78 150.83 50.13 Favored 'General case' 0 C--N 1.321 -0.653 0 N-CA-C 113.894 1.072 . . . . 0.0 113.894 179.287 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 137' ' ' ASP . . . . . 0.57 ' O ' ' HB2' ' A' ' 15' ' ' PHE . 5.1 m-20 -100.38 140.29 34.84 Favored 'General case' 0 CA--C 1.508 -0.639 0 CA-C-N 114.139 -1.392 . . . . 0.0 107.706 174.666 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 138' ' ' ILE . . . . . 0.621 HG23 HG21 ' A' ' 13' ' ' VAL . 60.2 mt -137.32 132.99 46.48 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.836 0 CA-C-O 120.761 0.315 . . . . 0.0 110.526 -179.911 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 139' ' ' GLU . . . . . 0.593 ' HG2' ' HB3' ' A' ' 60' ' ' LYS . 28.3 mt-10 -105.65 144.36 32.5 Favored 'General case' 0 CA--C 1.514 -0.439 0 CA-C-N 116.494 -0.321 . . . . 0.0 110.749 -179.3 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 140' ' ' VAL . . . . . 0.441 ' CG1' ' HA ' ' A' ' 57' ' ' VAL . 37.6 t -97.71 104.66 16.19 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.886 0 N-CA-C 108.366 -0.976 . . . . 0.0 108.366 169.415 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 41.1 mt -91.67 -51.62 5.15 Favored 'General case' 0 C--N 1.318 -0.769 0 N-CA-C 109.347 -0.612 . . . . 0.0 109.347 -178.362 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 142' ' ' GLU . . . . . 0.519 ' HB3' HD12 ' A' ' 12' ' ' LEU . 40.9 tt0 -150.95 148.61 28.62 Favored 'General case' 0 C--N 1.321 -0.654 0 CA-C-N 115.55 -0.75 . . . . 0.0 109.236 169.393 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 143' ' ' ILE . . . . . 0.536 HD12 HG23 ' A' ' 57' ' ' VAL . 74.5 mt -103.52 136.2 37.52 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.7 0 CA-C-O 120.811 0.339 . . . . 0.0 110.109 -178.152 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 144' ' ' ASP . . . . . . . . . . . . . 29.0 t70 -77.29 133.73 67.82 Favored Pre-proline 0 C--N 1.324 -0.523 0 CA-C-N 115.895 -0.593 . . . . 0.0 109.808 -177.295 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 145' ' ' PRO . . . . . 0.487 ' HA ' ' HB3' ' A' ' 2' ' ' SER . 24.4 Cg_endo . . . . . 0 C--N 1.345 0.389 0 C-N-CA 123.308 2.672 . . . . 0.0 113.048 -172.575 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 18.7 m . . . . . 0 N--CA 1.453 -0.324 0 CA-C-O 120.86 0.362 . . . . 0.0 110.516 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 7.2 mp0 -76.31 -29.77 57.46 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 121.55 0.69 . . . . 0.0 110.051 177.681 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 20.8 t -120.97 152.56 38.4 Favored 'General case' 0 C--N 1.317 -0.834 0 CA-C-N 115.031 -0.986 . . . . 0.0 109.698 -179.98 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 69.8 t -68.72 123.39 22.05 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.443 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.36 -178.595 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 6' ' ' GLN . . . . . . . . . . . . . 5.1 pt20 -140.49 160.67 39.48 Favored 'General case' 0 C--N 1.315 -0.929 0 CA-C-N 115.206 -0.906 . . . . 0.0 109.342 -177.667 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 41.4 p -62.64 145.33 54.82 Favored 'General case' 0 C--N 1.317 -0.837 0 O-C-N 123.215 0.322 . . . . 0.0 110.824 -178.47 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 21.3 t-20 77.24 -1.01 2.82 Favored 'General case' 0 N--CA 1.47 0.564 0 C-N-CA 123.762 0.825 . . . . 0.0 111.558 179.732 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 67.1 m -99.99 166.23 11.15 Favored 'General case' 0 C--N 1.327 -0.384 0 N-CA-C 108.983 -0.747 . . . . 0.0 108.983 172.693 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 10' ' ' ALA . . . . . 0.707 ' HB2' ' HD2' ' A' ' 38' ' ' ARG . . . -115.82 154.32 29.88 Favored 'General case' 0 C--N 1.316 -0.875 0 C-N-CA 120.598 -0.441 . . . . 0.0 110.209 178.705 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 8.6 m -129.69 133.57 64.73 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.786 0 CA-C-O 121.395 0.617 . . . . 0.0 110.575 177.776 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 12' ' ' LEU . . . . . 0.433 ' N ' HD12 ' A' ' 12' ' ' LEU . 5.9 mp -86.81 110.36 19.89 Favored 'General case' 0 C--N 1.316 -0.88 0 N-CA-C 107.173 -1.418 . . . . 0.0 107.173 172.923 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 13' ' ' VAL . . . . . 0.479 HG21 HG23 ' A' ' 138' ' ' ILE . 1.5 p -123.73 157.19 30.42 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.93 0 CA-C-O 121.089 0.471 . . . . 0.0 110.858 -171.963 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 14' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -119.02 116.34 26.21 Favored 'General case' 0 C--N 1.317 -0.822 0 N-CA-C 106.376 -1.713 . . . . 0.0 106.376 174.197 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 15' ' ' PHE . . . . . 0.517 ' H ' HG23 ' A' ' 28' ' ' THR . 21.2 p90 -150.81 161.69 42.17 Favored 'General case' 0 C--N 1.32 -0.695 0 C-N-CA 119.221 -0.992 . . . . 0.0 112.441 -169.448 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 13.8 m -128.58 122.99 32.25 Favored 'General case' 0 N--CA 1.448 -0.535 0 N-CA-C 109.09 -0.707 . . . . 0.0 109.09 173.101 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 17' ' ' LEU . . . . . 0.51 HD11 ' HB ' ' A' ' 134' ' ' VAL . 7.3 tp -92.23 125.52 36.93 Favored 'General case' 0 C--N 1.319 -0.72 0 CA-C-O 121.407 0.622 . . . . 0.0 110.941 -173.505 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 18' ' ' LYS . . . . . 0.445 ' HD3' ' N ' ' A' ' 18' ' ' LYS . 0.0 OUTLIER -111.49 145.84 38.33 Favored 'General case' 0 C--N 1.321 -0.651 0 CA-C-N 114.849 -1.068 . . . . 0.0 111.247 -173.319 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 19' ' ' LEU . . . . . 0.466 ' CD2' ' HB2' ' A' ' 25' ' ' ALA . 4.0 mm? -86.69 166.43 15.33 Favored 'General case' 0 C--N 1.319 -0.74 0 N-CA-C 109.64 -0.504 . . . . 0.0 109.64 172.24 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 15.7 t70 -61.08 -33.75 73.83 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-O 121.243 0.544 . . . . 0.0 109.659 174.052 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 17.7 m-20 -80.08 9.34 5.64 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 115.46 -0.791 . . . . 0.0 111.899 -179.614 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 73.34 17.61 78.96 Favored Glycine 0 N--CA 1.453 -0.174 0 C-N-CA 121.146 -0.55 . . . . 0.0 113.004 178.439 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 9.3 m -85.69 152.54 23.0 Favored 'General case' 0 C--N 1.32 -0.694 0 N-CA-C 109.577 -0.527 . . . . 0.0 109.577 176.337 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 23.5 m -95.47 116.35 28.69 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-O 120.718 0.294 . . . . 0.0 110.828 179.038 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 25' ' ' ALA . . . . . 0.466 ' HB2' ' CD2' ' A' ' 19' ' ' LEU . . . -87.31 -50.67 6.43 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 116.258 -0.428 . . . . 0.0 111.567 -177.009 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 8.1 tp10 -145.62 129.29 17.13 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 115.78 -0.645 . . . . 0.0 109.468 -175.113 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 21.0 m -124.09 115.03 20.5 Favored 'General case' 0 C--N 1.318 -0.786 0 N-CA-C 110.474 -0.195 . . . . 0.0 110.474 -178.939 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 28' ' ' THR . . . . . 0.517 HG23 ' H ' ' A' ' 15' ' ' PHE . 8.4 t -122.11 57.76 1.05 Allowed 'General case' 0 C--O 1.239 0.546 0 CA-C-O 122.653 1.216 . . . . 0.0 109.182 173.484 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 10.6 mmm180 -118.12 -71.78 0.72 Allowed 'General case' 0 C--N 1.323 -0.564 0 CA-C-N 114.152 -1.386 . . . . 0.0 110.366 173.089 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 11.0 p30 -65.49 -7.45 14.4 Favored 'General case' 0 N--CA 1.47 0.537 0 CA-C-N 116.096 -0.502 . . . . 0.0 111.765 -177.302 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -61.4 -35.31 77.15 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 115.877 -0.602 . . . . 0.0 110.62 -179.419 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 90.0 -1.36 80.35 Favored Glycine 0 N--CA 1.447 -0.584 0 N-CA-C 110.759 -0.936 . . . . 0.0 110.759 -172.22 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 65.6 mttm -128.71 138.53 33.32 Favored Pre-proline 0 C--N 1.326 -0.446 0 N-CA-C 109.06 -0.719 . . . . 0.0 109.06 179.792 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 37.0 Cg_endo -85.06 171.49 9.17 Favored 'Trans proline' 0 N--CA 1.451 -1.008 0 C-N-CA 122.933 2.422 . . . . 0.0 112.029 174.423 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -113.89 139.13 49.44 Favored 'General case' 0 C--N 1.309 -1.182 0 CA-C-N 115.019 -0.992 . . . . 0.0 109.115 -179.905 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 36' ' ' LEU . . . . . 0.413 HD21 ' HB1' ' A' ' 10' ' ' ALA . 3.3 tm? -94.97 117.49 30.23 Favored 'General case' 0 C--N 1.316 -0.856 0 CA-C-O 121.27 0.557 . . . . 0.0 110.184 -178.629 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 37' ' ' PHE . . . . . . . . . . . . . 4.4 m-30 -98.51 107.84 20.39 Favored 'General case' 0 C--N 1.317 -0.84 0 CA-C-N 115.266 -0.879 . . . . 0.0 110.181 174.175 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 38' ' ' ARG . . . . . 0.707 ' HD2' ' HB2' ' A' ' 10' ' ' ALA . 19.2 tpt180 -92.84 109.39 20.83 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-N 116.265 -0.425 . . . . 0.0 109.858 178.95 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 39' ' ' LEU . . . . . 0.438 HD22 ' CB ' ' A' ' 49' ' ' GLU . 14.7 mt -81.05 154.04 27.05 Favored 'General case' 0 C--N 1.321 -0.653 0 CA-C-N 115.611 -0.722 . . . . 0.0 109.77 -177.877 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 101.47 35.78 4.01 Favored Glycine 0 N--CA 1.444 -0.778 0 C-N-CA 120.754 -0.736 . . . . 0.0 112.349 -177.191 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER 62.99 14.94 7.98 Favored 'General case' 0 N--CA 1.47 0.556 0 N-CA-C 112.96 0.726 . . . . 0.0 112.96 175.515 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -62.73 -59.01 5.48 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-O 121.034 0.445 . . . . 0.0 110.663 179.92 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 16.4 t -134.53 2.86 3.26 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-O 121.303 0.573 . . . . 0.0 110.03 177.145 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 44' ' ' LEU . . . . . 0.555 HD13 HD22 ' A' ' 48' ' ' LEU . 78.9 mt -115.38 174.1 6.18 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-N 115.542 -0.754 . . . . 0.0 109.994 -178.09 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 12.9 t -104.65 154.91 19.36 Favored 'General case' 0 C--N 1.322 -0.608 0 N-CA-C 109.306 -0.627 . . . . 0.0 109.306 176.586 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 46' ' ' GLU . . . . . 0.556 ' O ' ' HG2' ' A' ' 50' ' ' GLN . 37.7 mt-10 -47.35 -46.17 25.37 Favored 'General case' 0 N--CA 1.466 0.335 0 O-C-N 123.605 0.565 . . . . 0.0 112.067 -175.221 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -61.24 -42.12 99.69 Favored Glycine 0 N--CA 1.446 -0.677 0 CA-C-N 115.975 -0.557 . . . . 0.0 113.581 -173.562 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 48' ' ' LEU . . . . . 0.555 HD22 HD13 ' A' ' 44' ' ' LEU . 2.6 tt -61.26 -48.95 79.07 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 117.325 0.563 . . . . 0.0 111.538 -176.749 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 49' ' ' GLU . . . . . 0.465 ' O ' HD13 ' A' ' 53' ' ' LEU . 11.7 pt-20 -64.5 -37.78 88.71 Favored 'General case' 0 C--N 1.325 -0.49 0 C-N-CA 120.555 -0.458 . . . . 0.0 109.907 -179.033 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 50' ' ' GLN . . . . . 0.556 ' HG2' ' O ' ' A' ' 46' ' ' GLU . 84.5 mm-40 -51.88 -29.3 19.26 Favored 'General case' 0 N--CA 1.464 0.249 0 N-CA-C 112.047 0.388 . . . . 0.0 112.047 175.475 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 51' ' ' HIS . . . . . . . . . . . . . 12.3 m-70 -97.63 -3.81 38.73 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-O 121.057 0.456 . . . . 0.0 110.973 -177.319 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 31.1 mt -102.84 -29.69 11.31 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 116.097 -0.501 . . . . 0.0 111.279 178.022 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 53' ' ' LEU . . . . . 0.465 HD13 ' O ' ' A' ' 49' ' ' GLU . 0.0 OUTLIER -59.47 139.08 57.42 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-O 121.158 0.504 . . . . 0.0 111.26 -179.465 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 93.67 -8.85 74.09 Favored Glycine 0 N--CA 1.45 -0.391 0 CA-C-N 115.743 -0.662 . . . . 0.0 112.589 -179.45 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 55' ' ' LEU . . . . . 0.424 HD12 ' HB3' ' A' ' 59' ' ' ASP . 4.2 mm? -78.15 164.92 24.56 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-O 121.048 0.452 . . . . 0.0 110.918 176.857 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 56' ' ' LYS . . . . . 0.542 ' O ' ' HB2' ' A' ' 59' ' ' ASP . 0.1 OUTLIER -126.78 164.84 20.46 Favored 'General case' 0 C--N 1.321 -0.665 0 CA-C-N 116.197 -0.456 . . . . 0.0 109.874 -176.993 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 25.5 t -63.91 132.37 29.74 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 N-CA-C 109.908 -0.405 . . . . 0.0 109.908 172.377 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 79.93 9.93 86.18 Favored Glycine 0 N--CA 1.45 -0.373 0 C-N-CA 120.995 -0.621 . . . . 0.0 112.38 -176.133 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 59' ' ' ASP . . . . . 0.542 ' HB2' ' O ' ' A' ' 56' ' ' LYS . 0.4 OUTLIER -104.52 152.96 21.75 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-O 120.964 0.411 . . . . 0.0 110.634 178.732 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 60' ' ' LYS . . . . . 0.416 ' HE3' ' OE1' ' A' ' 139' ' ' GLU . 0.6 OUTLIER -112.18 132.35 54.95 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 115.671 -0.695 . . . . 0.0 110.412 -173.003 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 61' ' ' THR . . . . . 0.404 ' HB ' HD11 ' A' ' 55' ' ' LEU . 7.6 t -139.35 115.81 10.58 Favored 'General case' 0 C--N 1.319 -0.744 0 CA-C-O 121.562 0.696 . . . . 0.0 111.066 175.743 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 62' ' ' THR . . . . . 0.459 HG23 ' O ' ' A' ' 136' ' ' PHE . 34.6 m -112.37 130.58 55.91 Favored 'General case' 0 C--N 1.318 -0.768 0 N-CA-C 108.986 -0.746 . . . . 0.0 108.986 173.492 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 28.4 p90 -148.71 146.84 28.29 Favored 'General case' 0 C--N 1.315 -0.903 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.252 -177.591 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 26.6 p -89.85 144.52 25.87 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.492 176.241 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 65' ' ' LEU . . . . . 0.41 HD11 ' HA ' ' A' ' 48' ' ' LEU . 77.0 mt -138.55 133.1 32.14 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-O 121.356 0.598 . . . . 0.0 110.866 177.635 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 66' ' ' GLU . . . . . 0.435 ' HB2' ' OD1' ' A' ' 68' ' ' ASP . 4.3 mm-40 -88.61 161.84 40.88 Favored Pre-proline 0 C--N 1.313 -1.003 0 CA-C-N 115.157 -0.929 . . . . 0.0 108.728 174.671 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 99.1 Cg_exo -45.53 -35.47 12.47 Favored 'Trans proline' 0 C--N 1.349 0.586 0 C-N-CA 123.055 2.503 . . . . 0.0 114.367 -174.305 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 68' ' ' ASP . . . . . 0.435 ' OD1' ' HB2' ' A' ' 66' ' ' GLU . 6.8 p-10 -59.21 -29.41 67.48 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-O 120.723 0.297 . . . . 0.0 111.417 -178.889 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -115.04 11.8 16.53 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-O 120.76 0.314 . . . . 0.0 111.045 179.589 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.326 -0.453 0 CA-C-N 116.302 -0.408 . . . . 0.0 110.972 -174.349 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 75' ' ' SER . . . . . 0.405 ' HB3' HD23 ' A' ' 78' ' ' LEU . 8.1 t . . . . . 0 N--CA 1.452 -0.335 0 CA-C-O 121.077 0.465 . . . . 0.0 110.955 . . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 57.1 Cg_endo -69.92 -17.84 36.61 Favored 'Trans proline' 0 C--N 1.347 0.462 0 C-N-CA 123.27 2.647 . . . . 0.0 113.615 -176.521 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 2.6 p-10 -70.85 -11.39 60.93 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-O 120.986 0.422 . . . . 0.0 110.522 -178.785 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 78' ' ' LEU . . . . . 0.405 HD23 ' HB3' ' A' ' 75' ' ' SER . 4.3 mm? -70.9 -18.86 62.66 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.002 -0.545 . . . . 0.0 110.589 174.645 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 79' ' ' ILE . . . . . 0.471 HG12 ' HA ' ' A' ' 124' ' ' ASP . 9.9 mt -85.46 106.76 15.51 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.643 0 CA-C-N 115.763 -0.653 . . . . 0.0 110.447 -175.94 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 30.8 mt-30 -121.79 122.01 38.53 Favored 'General case' 0 C--N 1.319 -0.759 0 CA-C-N 115.639 -0.71 . . . . 0.0 111.248 -178.501 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 81' ' ' TYR . . . . . 0.658 ' CD1' HG23 ' A' ' 122' ' ' THR . 0.1 OUTLIER -108.27 114.02 27.56 Favored 'General case' 0 C--N 1.315 -0.903 0 CA-C-N 115.914 -0.584 . . . . 0.0 111.55 176.945 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -116.55 177.93 4.52 Favored 'General case' 0 C--N 1.319 -0.748 0 CA-C-O 120.626 0.251 . . . . 0.0 111.125 168.394 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 83' ' ' SER . . . . . 0.419 ' HA ' ' O ' ' A' ' 119' ' ' ASP . 8.2 t -59.27 151.58 22.91 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-O 121.572 0.701 . . . . 0.0 111.963 -170.437 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -74.36 -12.72 60.6 Favored 'General case' 0 C--N 1.333 -0.131 0 CA-C-N 115.249 -0.887 . . . . 0.0 111.34 -169.681 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 85' ' ' ARG . . . . . . . . . . . . . 7.5 mpt_? -71.49 -20.52 62.05 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 121.51 0.671 . . . . 0.0 109.905 -177.574 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 30.6 mm-40 -79.48 -12.1 59.88 Favored 'General case' 0 C--N 1.321 -0.653 0 CA-C-N 114.959 -1.019 . . . . 0.0 109.797 176.206 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 87' ' ' PHE . . . . . 0.496 ' CE1' ' HB ' ' A' ' 121' ' ' ILE . 73.7 m-85 -105.0 -46.39 4.29 Favored 'General case' 0 C--N 1.319 -0.72 0 CA-C-N 114.709 -1.132 . . . . 0.0 110.538 -175.039 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 88' ' ' MET . . . . . . . . . . . . . 64.5 ttp -58.16 -22.35 50.95 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-N 115.325 -0.852 . . . . 0.0 110.216 178.666 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 32.1 t70 -53.3 -35.67 60.37 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 115.047 -0.979 . . . . 0.0 110.838 174.033 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -116.06 11.44 15.33 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.272 -179.919 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 113.58 141.26 7.84 Favored Glycine 0 N--CA 1.448 -0.505 0 C-N-CA 120.827 -0.701 . . . . 0.0 112.117 -178.301 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 44.2 mt-10 -64.41 125.81 89.23 Favored Pre-proline 0 C--N 1.324 -0.505 0 CA-C-O 121.017 0.437 . . . . 0.0 111.416 -178.842 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 93' ' ' PRO . . . . . 0.445 ' HB2' HD13 ' A' ' 113' ' ' ILE . 53.1 Cg_endo -78.83 167.06 22.76 Favored 'Trans proline' 0 C--O 1.232 0.217 0 C-N-CA 123.591 2.86 . . . . 0.0 114.146 -174.389 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 1.1 mp0 -120.08 155.65 32.57 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 115.015 -0.993 . . . . 0.0 111.352 -173.133 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 95' ' ' ILE . . . . . 0.568 HG12 HG12 ' A' ' 116' ' ' ILE . 13.7 mt -82.34 131.41 33.86 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.155 0 CA-C-N 116.301 -0.409 . . . . 0.0 111.01 178.778 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 68.13 30.05 73.66 Favored Glycine 0 N--CA 1.448 -0.544 0 CA-C-N 115.815 -0.63 . . . . 0.0 111.905 179.966 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -108.45 125.32 51.64 Favored 'General case' 0 N--CA 1.445 -0.695 0 CA-C-O 120.934 0.397 . . . . 0.0 109.939 179.828 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 98' ' ' ILE . . . . . 0.516 ' HA ' ' HA ' ' A' ' 112' ' ' VAL . 35.4 mt -86.52 102.47 11.95 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.867 0 N-CA-C 108.807 -0.812 . . . . 0.0 108.807 179.601 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 99' ' ' MET . . . . . 0.487 ' O ' ' HD2' ' A' ' 101' ' ' PHE . 7.0 mtm -105.39 126.63 52.33 Favored 'General case' 0 N--CA 1.438 -1.057 0 CA-C-O 121.665 0.745 . . . . 0.0 110.545 -175.279 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 4.4 mm? -62.75 147.81 48.65 Favored 'General case' 0 C--N 1.305 -1.331 0 CA-C-N 114.28 -1.327 . . . . 0.0 109.326 171.078 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 101' ' ' PHE . . . . . 0.487 ' HD2' ' O ' ' A' ' 99' ' ' MET . 0.4 OUTLIER -148.62 167.02 26.55 Favored 'General case' 0 CA--C 1.509 -0.619 0 CA-C-N 115.021 -0.99 . . . . 0.0 108.44 -152.806 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 1.5 m -121.78 122.15 38.86 Favored 'General case' 0 C--N 1.309 -1.179 0 C-N-CA 119.773 -0.771 . . . . 0.0 110.353 176.965 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -88.12 165.25 15.24 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-N 115.791 -0.64 . . . . 0.0 110.305 -177.779 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 104' ' ' MET . . . . . . . . . . . . . 2.0 mpt? -66.23 -12.73 58.01 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.807 -0.633 . . . . 0.0 112.002 -175.014 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 8.6 p-10 -99.71 15.44 26.8 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-O 120.737 0.304 . . . . 0.0 110.982 179.765 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 79.76 -11.95 31.3 Favored Glycine 0 CA--C 1.52 0.346 0 C-N-CA 121.121 -0.562 . . . . 0.0 113.88 177.824 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 24.6 t -79.71 151.13 30.61 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-O 121.203 0.525 . . . . 0.0 110.081 179.586 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 26.3 tt0 -94.56 100.26 12.26 Favored 'General case' 0 C--N 1.313 -1.016 0 CA-C-N 115.585 -0.734 . . . . 0.0 110.009 -178.019 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 109' ' ' MET . . . . . . . . . . . . . 3.1 mtp -92.25 147.85 35.42 Favored Pre-proline 0 C--N 1.324 -0.524 0 CA-C-N 115.3 -0.864 . . . . 0.0 110.842 179.998 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 55.2 Cg_endo -72.49 154.72 55.46 Favored 'Trans proline' 0 N--CA 1.458 -0.56 0 C-N-CA 122.009 1.806 . . . . 0.0 110.871 173.374 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 111' ' ' GLY . . . . . 0.502 ' HA2' ' O ' ' A' ' 124' ' ' ASP . . . -150.21 103.48 0.25 Allowed Glycine 0 N--CA 1.445 -0.736 0 C-N-CA 120.164 -1.017 . . . . 0.0 110.853 -171.637 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 112' ' ' VAL . . . . . 0.516 ' HA ' ' HA ' ' A' ' 98' ' ' ILE . 7.7 p -97.73 113.26 31.77 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.559 0 CA-C-N 119.237 1.518 . . . . 0.0 110.689 -179.462 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 113' ' ' ILE . . . . . 0.466 ' HA ' ' O ' ' A' ' 122' ' ' THR . 39.2 mt -72.6 111.14 6.47 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.897 0 CA-C-N 114.902 -1.045 . . . . 0.0 110.059 179.941 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 114' ' ' ARG . . . . . 0.514 ' HD3' ' O ' ' A' ' 114' ' ' ARG . 8.8 tpp180 -63.81 -46.73 83.81 Favored 'General case' 0 C--N 1.322 -0.625 0 CA-C-N 114.909 -1.041 . . . . 0.0 110.864 -177.669 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 115' ' ' GLU . . . . . 0.526 ' HA ' HG23 ' A' ' 95' ' ' ILE . 14.5 tt0 -159.25 154.43 25.27 Favored 'General case' 0 C--N 1.324 -0.531 0 C-N-CA 120.705 -0.398 . . . . 0.0 110.882 -175.751 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 116' ' ' ILE . . . . . 0.568 HG12 HG12 ' A' ' 95' ' ' ILE . 37.4 mm -100.57 120.63 50.3 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 N-CA-C 109.183 -0.673 . . . . 0.0 109.183 175.987 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 117' ' ' ASN . . . . . 0.432 ' HB2' ' O ' ' A' ' 120' ' ' SER . 30.2 m-80 -110.41 157.46 19.53 Favored 'General case' 0 C--N 1.315 -0.913 0 CA-C-N 115.934 -0.575 . . . . 0.0 110.171 -179.755 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . -56.21 -40.59 84.53 Favored Glycine 0 C--O 1.227 -0.343 0 C-N-CA 120.688 -0.768 . . . . 0.0 113.694 -169.528 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 119' ' ' ASP . . . . . 0.419 ' O ' ' HA ' ' A' ' 83' ' ' SER . 24.8 m-20 -113.07 -15.69 12.77 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 117.169 0.484 . . . . 0.0 112.119 179.826 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 120' ' ' SER . . . . . 0.432 ' O ' ' HB2' ' A' ' 117' ' ' ASN . 13.6 t -130.73 156.49 44.86 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-O 120.923 0.392 . . . . 0.0 111.483 -169.999 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 121' ' ' ILE . . . . . 0.506 HD12 HD12 ' A' ' 116' ' ' ILE . 49.5 mm -127.46 125.59 65.95 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.778 -178.626 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 122' ' ' THR . . . . . 0.658 HG23 ' CD1' ' A' ' 81' ' ' TYR . 10.7 m -95.38 103.32 15.18 Favored 'General case' 0 C--N 1.329 -0.323 0 N-CA-C 112.477 0.547 . . . . 0.0 112.477 -174.246 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 5.6 t -103.78 122.06 56.02 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 N-CA-C 113.307 0.854 . . . . 0.0 113.307 177.404 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 124' ' ' ASP . . . . . 0.502 ' O ' ' HA2' ' A' ' 111' ' ' GLY . 1.3 t70 -89.04 135.41 33.57 Favored 'General case' 0 C--N 1.322 -0.587 0 CA-C-N 115.191 -0.913 . . . . 0.0 111.508 170.285 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 125' ' ' PHE . . . . . . . . . . . . . 63.2 m-85 -117.98 59.15 0.8 Allowed 'General case' 0 C--N 1.331 -0.216 0 CA-C-O 122.115 0.96 . . . . 0.0 110.381 -176.118 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 126' ' ' ASN . . . . . 0.41 HD22 ' CG ' ' A' ' 124' ' ' ASP . 13.2 m-80 . . . . . 0 C--N 1.307 -1.266 0 CA-C-N 114.311 -1.313 . . . . 0.0 111.496 -179.439 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 133' ' ' THR . . . . . . . . . . . . . 20.5 m . . . . . 0 N--CA 1.443 -0.82 0 N-CA-C 108.85 -0.796 . . . . 0.0 108.85 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 134' ' ' VAL . . . . . 0.51 ' HB ' HD11 ' A' ' 17' ' ' LEU . 1.5 m -121.99 148.78 25.37 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.595 0 CA-C-O 121.894 0.854 . . . . 0.0 112.6 -172.271 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 135' ' ' HIS . . . . . 0.41 ' O ' HD12 ' A' ' 17' ' ' LEU . 15.0 m-70 -112.42 147.38 36.58 Favored 'General case' 0 C--N 1.316 -0.89 0 CA-C-N 114.624 -1.171 . . . . 0.0 108.508 174.028 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 136' ' ' PHE . . . . . 0.459 ' O ' HG23 ' A' ' 62' ' ' THR . 12.5 m-85 -123.45 124.11 42.15 Favored 'General case' 0 C--N 1.31 -1.131 0 CA-C-N 116.028 -0.533 . . . . 0.0 111.71 -166.726 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 137' ' ' ASP . . . . . 0.466 ' O ' ' HB2' ' A' ' 15' ' ' PHE . 12.9 m-20 -116.58 96.42 5.5 Favored 'General case' 0 C--N 1.324 -0.525 0 N-CA-C 108.608 -0.886 . . . . 0.0 108.608 175.784 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 138' ' ' ILE . . . . . 0.479 HG23 HG21 ' A' ' 13' ' ' VAL . 1.9 mp -107.65 138.57 33.28 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.55 0 N-CA-C 112.599 0.592 . . . . 0.0 112.599 -177.794 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 139' ' ' GLU . . . . . 0.416 ' OE1' ' HE3' ' A' ' 60' ' ' LYS . 31.8 mt-10 -125.59 124.71 41.83 Favored 'General case' 0 CA--C 1.507 -0.676 0 N-CA-C 108.084 -1.08 . . . . 0.0 108.084 167.885 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 140' ' ' VAL . . . . . . . . . . . . . 71.6 t -78.16 121.47 31.05 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.747 0 C-N-CA 120.704 -0.398 . . . . 0.0 110.428 -176.947 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 19.2 mt -93.1 -44.05 8.57 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-O 121.262 0.553 . . . . 0.0 110.027 178.084 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 142' ' ' GLU . . . . . . . . . . . . . 10.2 tp10 -153.67 152.22 30.56 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-N 115.465 -0.789 . . . . 0.0 109.768 -179.336 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 143' ' ' ILE . . . . . . . . . . . . . 63.0 mt -116.9 121.16 67.13 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.421 0 CA-C-O 121.007 0.432 . . . . 0.0 110.317 178.531 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 144' ' ' ASP . . . . . 0.646 ' HB3' ' HB3' ' A' ' 10' ' ' ALA . 38.6 t70 -77.37 128.5 80.22 Favored Pre-proline 0 C--N 1.322 -0.618 0 CA-C-N 115.808 -0.633 . . . . 0.0 110.154 -179.341 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 145' ' ' PRO . . . . . . . . . . . . . 73.7 Cg_exo . . . . . 0 C--N 1.345 0.383 0 C-N-CA 123.29 2.66 . . . . 0.0 112.539 178.415 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 4.8 t . . . . . 0 N--CA 1.451 -0.388 0 N-CA-C 109.25 -0.648 . . . . 0.0 109.25 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 3' ' ' GLU . . . . . 0.436 ' CG ' ' HE2' ' A' ' 56' ' ' LYS . 39.2 tt0 -74.5 -34.44 63.06 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-O 121.477 0.656 . . . . 0.0 110.554 -177.132 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 24.2 m -128.12 156.82 42.24 Favored 'General case' 0 C--N 1.314 -0.939 0 CA-C-N 115.302 -0.863 . . . . 0.0 109.604 179.621 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . 0.561 HG13 ' HA ' ' A' ' 53' ' ' LEU . 7.1 p -81.96 135.94 23.97 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.532 0 CA-C-O 121.021 0.439 . . . . 0.0 110.83 -177.58 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 6' ' ' GLN . . . . . 0.594 ' HG2' ' OG ' ' A' ' 9' ' ' SER . 0.6 OUTLIER -123.21 168.49 12.37 Favored 'General case' 0 C--N 1.318 -0.792 0 CA-C-N 115.933 -0.576 . . . . 0.0 109.632 177.866 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 29.4 t -54.23 122.77 11.01 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-O 120.765 0.317 . . . . 0.0 110.493 179.052 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 2.9 t30 73.5 41.25 0.46 Allowed 'General case' 0 N--CA 1.469 0.497 0 C-N-CA 123.935 0.894 . . . . 0.0 111.132 -177.238 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 9' ' ' SER . . . . . 0.594 ' OG ' ' HG2' ' A' ' 6' ' ' GLN . 67.0 m -122.2 134.74 54.71 Favored 'General case' 0 C--N 1.325 -0.473 0 N-CA-C 108.846 -0.798 . . . . 0.0 108.846 168.288 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 10' ' ' ALA . . . . . 0.502 ' HB2' ' HD3' ' A' ' 38' ' ' ARG . . . -84.68 147.57 26.86 Favored 'General case' 0 C--N 1.315 -0.899 0 CA-C-N 116.533 -0.303 . . . . 0.0 110.233 -176.858 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 13.5 m -133.91 142.88 40.08 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.864 0 C-N-CA 120.712 -0.395 . . . . 0.0 110.335 179.971 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 30.6 tp -86.55 123.57 31.9 Favored 'General case' 0 C--N 1.319 -0.739 0 N-CA-C 108.271 -1.011 . . . . 0.0 108.271 174.797 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 13' ' ' VAL . . . . . 0.706 HG21 HG23 ' A' ' 138' ' ' ILE . 4.4 p -131.93 156.28 42.38 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.778 0 CA-C-O 122.27 1.033 . . . . 0.0 113.057 -172.432 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 14' ' ' HIS . . . . . 0.497 ' CD2' HD11 ' A' ' 141' ' ' LEU . 2.2 m-70 -118.77 120.85 38.59 Favored 'General case' 0 C--N 1.317 -0.835 0 N-CA-C 106.059 -1.83 . . . . 0.0 106.059 169.471 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 15' ' ' PHE . . . . . 0.519 ' CD1' ' HB ' ' A' ' 28' ' ' THR . 16.2 p90 -151.08 157.87 43.33 Favored 'General case' 0 C--N 1.324 -0.537 0 C-N-CA 118.181 -1.408 . . . . 0.0 113.948 -170.336 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 22.2 m -131.06 130.43 43.23 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 114.85 -1.068 . . . . 0.0 108.598 176.904 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 17' ' ' LEU . . . . . 0.799 HD21 ' HB ' ' A' ' 134' ' ' VAL . 2.2 tt -121.81 118.05 28.05 Favored 'General case' 0 N--CA 1.446 -0.637 0 N-CA-C 109.435 -0.58 . . . . 0.0 109.435 -173.678 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 18' ' ' LYS . . . . . 0.651 ' HB3' ' CE1' ' A' ' 135' ' ' HIS . 2.4 tppt? -126.19 155.63 41.46 Favored 'General case' 0 C--N 1.314 -0.94 0 C-N-CA 119.988 -0.685 . . . . 0.0 111.455 -174.885 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 3.1 mm? -99.52 171.5 7.89 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-N 115.291 -0.868 . . . . 0.0 109.339 173.813 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 35.5 t70 -64.72 -25.49 67.96 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-O 121.373 0.606 . . . . 0.0 109.866 176.099 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 5.0 m-20 -77.53 2.99 14.67 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.5 -0.773 . . . . 0.0 110.843 178.501 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 73.27 9.57 77.28 Favored Glycine 0 C--N 1.33 0.245 0 C-N-CA 121.387 -0.435 . . . . 0.0 113.28 -179.913 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 26.7 m -82.27 142.26 32.25 Favored 'General case' 0 C--N 1.321 -0.644 0 N-CA-C 109.835 -0.431 . . . . 0.0 109.835 177.093 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 20.9 m -89.59 112.57 23.82 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-O 120.747 0.308 . . . . 0.0 110.335 179.316 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 25' ' ' ALA . . . . . 0.714 ' HB3' HD22 ' A' ' 17' ' ' LEU . . . -72.69 -38.09 67.66 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 121.134 0.493 . . . . 0.0 110.111 178.506 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 8.4 tp10 -157.32 141.24 16.04 Favored 'General case' 0 N--CA 1.446 -0.663 0 CA-C-N 115.732 -0.667 . . . . 0.0 110.132 178.682 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 36.9 p -124.53 119.72 29.91 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-O 121.125 0.488 . . . . 0.0 110.934 -178.828 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 28' ' ' THR . . . . . 0.584 ' O ' HG22 ' A' ' 28' ' ' THR . 96.8 m -139.62 11.26 2.49 Favored 'General case' 0 CA--C 1.547 0.848 0 CA-C-O 123.269 1.509 . . . . 0.0 110.562 177.187 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 29' ' ' ARG . . . . . 0.407 ' NH1' ' HB3' ' A' ' 30' ' ' ASN . 8.7 tmm_? -104.27 -52.96 2.82 Favored 'General case' 0 C--N 1.308 -1.215 0 CA-C-N 115.099 -0.955 . . . . 0.0 109.921 167.481 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 30' ' ' ASN . . . . . 0.407 ' HB3' ' NH1' ' A' ' 29' ' ' ARG . 4.8 p-10 -82.52 35.0 0.44 Allowed 'General case' 0 C--N 1.326 -0.436 0 CA-C-O 121.079 0.466 . . . . 0.0 111.472 -178.87 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 4.5 m-20 -120.33 -23.27 6.24 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.334 -0.394 . . . . 0.0 111.599 -178.788 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 84.85 -11.6 59.37 Favored Glycine 0 N--CA 1.453 -0.212 0 C-N-CA 120.435 -0.888 . . . . 0.0 110.905 -174.286 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 33' ' ' LYS . . . . . 0.458 ' HD2' ' HD2' ' A' ' 34' ' ' PRO . 56.1 tptt -120.53 118.16 31.09 Favored Pre-proline 0 C--N 1.321 -0.646 0 CA-C-N 114.896 -0.652 . . . . 0.0 110.054 -177.974 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 34' ' ' PRO . . . . . 0.458 ' HD2' ' HD2' ' A' ' 33' ' ' LYS . 73.9 Cg_endo -80.28 170.77 15.8 Favored 'Trans proline' 0 N--CA 1.457 -0.672 0 C-N-CA 122.506 2.137 . . . . 0.0 111.526 174.125 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -137.02 152.26 49.9 Favored 'General case' 0 C--N 1.311 -1.091 0 CA-C-N 115.671 -0.695 . . . . 0.0 110.463 -175.58 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 2.0 tp -90.69 138.24 31.73 Favored 'General case' 0 C--N 1.317 -0.807 0 N-CA-C 109.414 -0.588 . . . . 0.0 109.414 175.038 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 37' ' ' PHE . . . . . . . . . . . . . 2.4 m-30 -104.0 106.66 17.24 Favored 'General case' 0 C--N 1.317 -0.825 0 N-CA-C 108.67 -0.863 . . . . 0.0 108.67 175.535 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 38' ' ' ARG . . . . . 0.502 ' HD3' ' HB2' ' A' ' 10' ' ' ALA . 6.5 tpp180 -86.07 105.6 16.61 Favored 'General case' 0 C--N 1.323 -0.569 0 N-CA-C 109.105 -0.702 . . . . 0.0 109.105 -179.733 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 40.0 mt -90.38 156.39 18.27 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-N 115.363 -0.835 . . . . 0.0 111.666 -175.743 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 102.49 37.85 3.17 Favored Glycine 0 N--CA 1.45 -0.407 0 CA-C-N 115.335 -0.848 . . . . 0.0 111.996 -177.884 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 31.9 t70 65.74 0.53 1.52 Allowed 'General case' 0 N--CA 1.472 0.637 0 C-N-CA 123.509 0.724 . . . . 0.0 111.893 179.739 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -65.78 -48.34 72.12 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.781 -179.779 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 23.1 m -134.42 -39.79 0.82 Allowed 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 116.066 -0.515 . . . . 0.0 110.788 178.135 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 4.6 mm? -88.79 162.72 16.05 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-O 121.038 0.447 . . . . 0.0 111.19 -178.818 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 32.2 t -86.81 153.68 21.48 Favored 'General case' 0 C--N 1.324 -0.5 0 CA-C-N 115.356 -0.838 . . . . 0.0 110.212 -178.997 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 42.3 mt-10 -52.45 -42.9 64.58 Favored 'General case' 0 C--N 1.328 -0.336 0 N-CA-C 112.309 0.485 . . . . 0.0 112.309 -173.818 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -64.96 -37.68 94.57 Favored Glycine 0 N--CA 1.447 -0.62 0 C-N-CA 120.41 -0.9 . . . . 0.0 112.777 -174.699 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 48' ' ' LEU . . . . . 0.482 HD11 HD12 ' A' ' 52' ' ' LEU . 3.4 tm? -70.09 -53.63 16.6 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 121.003 0.43 . . . . 0.0 110.093 -176.934 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 10.4 pt-20 -58.3 -40.89 83.19 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 115.712 -0.676 . . . . 0.0 112.107 -177.868 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 50' ' ' GLN . . . . . 0.516 ' HA ' ' CD2' ' A' ' 53' ' ' LEU . 90.6 mm-40 -73.74 -15.14 61.22 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-O 120.811 0.338 . . . . 0.0 111.336 -173.003 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 51' ' ' HIS . . . . . . . . . . . . . 14.6 m-70 -107.48 -9.4 15.97 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-O 120.945 0.402 . . . . 0.0 110.45 179.255 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 52' ' ' LEU . . . . . 0.482 HD12 HD11 ' A' ' 48' ' ' LEU . 0.4 OUTLIER -98.62 -30.48 12.46 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.274 179.284 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 53' ' ' LEU . . . . . 0.561 ' HA ' HG13 ' A' ' 5' ' ' VAL . 3.0 pp -66.76 152.08 46.2 Favored 'General case' 0 N--CA 1.452 -0.331 0 N-CA-C 109.764 -0.458 . . . . 0.0 109.764 179.565 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 93.28 3.27 65.28 Favored Glycine 0 N--CA 1.445 -0.704 0 C-N-CA 120.872 -0.68 . . . . 0.0 112.824 -175.136 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 55' ' ' LEU . . . . . 0.415 ' O ' HG12 ' A' ' 5' ' ' VAL . 3.8 mm? -96.01 165.28 12.33 Favored 'General case' 0 C--O 1.233 0.228 0 CA-C-N 117.395 0.598 . . . . 0.0 110.703 177.759 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 56' ' ' LYS . . . . . 0.601 ' HD3' ' N ' ' A' ' 57' ' ' VAL . 11.0 tmtt? -117.62 151.3 37.48 Favored 'General case' 0 C--N 1.324 -0.53 0 N-CA-C 109.031 -0.729 . . . . 0.0 109.031 -177.969 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 57' ' ' VAL . . . . . 0.601 ' N ' ' HD3' ' A' ' 56' ' ' LYS . 42.6 t -58.44 136.91 21.42 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-O 121.134 0.492 . . . . 0.0 111.492 176.708 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 82.75 8.97 85.23 Favored Glycine 0 N--CA 1.446 -0.645 0 CA-C-N 115.116 -0.947 . . . . 0.0 111.973 -178.985 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 59' ' ' ASP . . . . . 0.452 ' HB2' ' O ' ' A' ' 56' ' ' LYS . 1.0 OUTLIER -99.56 134.09 42.94 Favored 'General case' 0 C--N 1.323 -0.544 0 N-CA-C 108.916 -0.772 . . . . 0.0 108.916 171.772 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 6.9 mmmm -106.52 128.35 54.03 Favored 'General case' 0 C--N 1.319 -0.744 0 N-CA-C 109.248 -0.649 . . . . 0.0 109.248 -175.753 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 4.7 t -136.64 113.8 10.65 Favored 'General case' 0 C--N 1.32 -0.694 0 CA-C-O 121.837 0.827 . . . . 0.0 111.525 -176.536 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 62' ' ' THR . . . . . 0.434 HG23 ' HA ' ' A' ' 137' ' ' ASP . 6.1 m -100.47 131.66 46.27 Favored 'General case' 0 C--N 1.317 -0.842 0 N-CA-C 108.238 -1.023 . . . . 0.0 108.238 172.084 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 63' ' ' PHE . . . . . 0.513 ' CE2' ' HE1' ' A' ' 136' ' ' PHE . 11.3 p90 -157.92 163.98 37.34 Favored 'General case' 0 C--N 1.321 -0.661 0 C-N-CA 120.063 -0.655 . . . . 0.0 111.818 -178.072 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 26.0 t -128.75 151.81 49.13 Favored 'General case' 0 C--N 1.318 -0.785 0 CA-C-N 115.187 -0.915 . . . . 0.0 109.829 179.816 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 65' ' ' LEU . . . . . 0.421 ' CD1' ' HA ' ' A' ' 48' ' ' LEU . 39.3 mt -135.85 150.94 49.57 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-N 116.219 -0.446 . . . . 0.0 109.981 -176.882 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 48.7 mt-10 -64.1 153.88 83.94 Favored Pre-proline 0 C--N 1.33 -0.282 0 CA-C-N 116.081 -0.509 . . . . 0.0 110.527 178.779 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 80.9 Cg_exo -46.35 -52.25 7.57 Favored 'Trans proline' 0 C--O 1.233 0.257 0 C-N-CA 123.103 2.535 . . . . 0.0 113.542 -175.777 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 1.9 p-10 -66.26 -24.96 66.67 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-O 120.921 0.391 . . . . 0.0 111.053 -174.784 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -79.85 -18.55 50.49 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 115.98 -0.554 . . . . 0.0 110.922 -178.581 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.449 -0.482 0 N-CA-C 111.953 0.353 . . . . 0.0 111.953 -178.093 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 75' ' ' SER . . . . . 0.59 ' HB3' HD22 ' A' ' 78' ' ' LEU . 41.3 t . . . . . 0 N--CA 1.44 -0.959 0 N-CA-C 109.896 -0.409 . . . . 0.0 109.896 . . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 26.9 Cg_endo -65.44 -25.84 55.61 Favored 'Trans proline' 0 N--CA 1.459 -0.536 0 C-N-CA 121.729 1.619 . . . . 0.0 111.009 175.666 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 8.6 p-10 -77.36 -8.87 58.37 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 115.701 -0.681 . . . . 0.0 110.753 176.524 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 78' ' ' LEU . . . . . 0.59 HD22 ' HB3' ' A' ' 75' ' ' SER . 4.4 tp -73.23 -23.06 60.31 Favored 'General case' 0 CA--C 1.511 -0.549 0 CA-C-O 121.596 0.712 . . . . 0.0 109.147 176.604 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 79' ' ' ILE . . . . . 0.632 HG23 ' O ' ' A' ' 123' ' ' VAL . 7.0 mt -68.3 124.24 23.43 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.724 0 CA-C-N 114.69 -1.141 . . . . 0.0 110.575 177.245 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 40.2 mt-30 -149.97 119.27 6.83 Favored 'General case' 0 CA--C 1.502 -0.885 0 CA-C-N 114.992 -1.004 . . . . 0.0 109.377 -176.184 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 81' ' ' TYR . . . . . 0.592 ' CE2' HG23 ' A' ' 122' ' ' THR . 1.8 m-85 -80.26 114.75 19.38 Favored 'General case' 0 C--N 1.307 -1.27 0 C-N-CA 118.76 -1.176 . . . . 0.0 111.902 174.97 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 23.6 m-85 -100.15 172.71 7.01 Favored 'General case' 0 C--N 1.322 -0.627 0 CA-C-N 113.782 -1.554 . . . . 0.0 110.141 172.399 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 83' ' ' SER . . . . . 0.436 ' HB3' ' HG3' ' A' ' 86' ' ' GLU . 23.2 t -63.24 159.34 18.01 Favored 'General case' 0 C--N 1.321 -0.657 0 CA-C-O 122.836 1.303 . . . . 0.0 112.485 -167.952 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 84' ' ' ARG . . . . . 0.574 ' HD3' ' HA ' ' A' ' 119' ' ' ASP . 36.5 ptt180 -77.5 -28.21 52.08 Favored 'General case' 0 C--N 1.315 -0.925 0 CA-C-N 112.604 -2.089 . . . . 0.0 108.118 -179.31 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 85' ' ' ARG . . . . . . . . . . . . . 6.6 mpt_? -71.53 -39.8 70.5 Favored 'General case' 0 CA--C 1.512 -0.5 0 CA-C-N 114.281 -1.327 . . . . 0.0 111.158 -176.99 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 86' ' ' GLU . . . . . 0.436 ' HG3' ' HB3' ' A' ' 83' ' ' SER . 41.4 mt-10 -56.02 -36.88 68.45 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 115.316 -0.857 . . . . 0.0 110.891 -175.941 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 87' ' ' PHE . . . . . 0.443 ' HB3' ' HG3' ' A' ' 93' ' ' PRO . 14.0 m-85 -93.18 -37.44 12.09 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.475 -0.329 . . . . 0.0 111.843 -179.601 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 88' ' ' MET . . . . . . . . . . . . . 58.6 ttp -58.53 -31.79 68.25 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.59 -173.382 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 33.9 t70 -57.55 -28.62 63.71 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-O 120.954 0.407 . . . . 0.0 110.912 177.443 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -102.79 -2.91 27.18 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.055 -0.52 . . . . 0.0 110.732 176.967 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 119.59 140.08 6.1 Favored Glycine 0 N--CA 1.447 -0.583 0 C-N-CA 121.035 -0.602 . . . . 0.0 112.117 -178.108 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 47.0 mt-10 -61.11 120.94 58.9 Favored Pre-proline 0 C--N 1.327 -0.398 0 CA-C-O 120.807 0.336 . . . . 0.0 110.887 178.465 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 93' ' ' PRO . . . . . 0.447 ' HG2' HD12 ' A' ' 121' ' ' ILE . 4.3 Cg_exo -71.7 167.42 26.57 Favored 'Trans proline' 0 C--N 1.344 0.312 0 C-N-CA 123.303 2.669 . . . . 0.0 112.895 -176.841 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -115.4 156.04 26.31 Favored 'General case' 0 C--N 1.321 -0.64 0 CA-C-N 115.04 -0.982 . . . . 0.0 111.045 -174.609 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 95' ' ' ILE . . . . . 0.528 HG12 HG12 ' A' ' 116' ' ' ILE . 21.6 mt -81.76 131.06 34.72 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.453 0 CA-C-N 115.909 -0.587 . . . . 0.0 110.875 -178.716 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 72.92 18.76 79.2 Favored Glycine 0 N--CA 1.449 -0.466 0 CA-C-N 115.709 -0.678 . . . . 0.0 112.422 -177.289 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 97' ' ' ALA . . . . . 0.411 ' O ' HG13 ' A' ' 113' ' ' ILE . . . -98.71 129.74 45.17 Favored 'General case' 0 C--N 1.324 -0.515 0 N-CA-C 109.674 -0.491 . . . . 0.0 109.674 177.385 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 98' ' ' ILE . . . . . 0.555 ' HA ' ' HA ' ' A' ' 112' ' ' VAL . 16.4 mt -97.79 130.08 47.04 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.725 0 N-CA-C 108.837 -0.801 . . . . 0.0 108.837 178.759 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 99' ' ' MET . . . . . . . . . . . . . 9.7 mtm -137.0 160.44 38.91 Favored 'General case' 0 N--CA 1.447 -0.594 0 N-CA-C 107.601 -1.259 . . . . 0.0 107.601 -179.721 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 2.6 mm? -69.77 103.63 2.22 Favored 'General case' 0 C--N 1.317 -0.814 0 CA-C-O 122.318 1.056 . . . . 0.0 111.046 175.307 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 101' ' ' PHE . . . . . . . . . . . . . 2.8 m-85 -94.2 171.63 8.71 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 113.151 -1.841 . . . . 0.0 112.612 -172.914 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 2.6 m -124.87 135.71 53.14 Favored 'General case' 0 C--N 1.313 -0.985 0 CA-C-N 114.439 -1.255 . . . . 0.0 109.382 -178.241 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -103.54 159.47 15.57 Favored 'General case' 0 C--N 1.32 -0.692 0 N-CA-C 109.316 -0.624 . . . . 0.0 109.316 -177.929 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 104' ' ' MET . . . . . . . . . . . . . 71.2 mtm -66.39 -12.49 57.22 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.057 -0.519 . . . . 0.0 111.798 -174.446 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 4.5 p-10 -93.59 3.96 54.7 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 120.848 0.356 . . . . 0.0 110.853 177.568 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 92.32 -10.83 73.51 Favored Glycine 0 N--CA 1.444 -0.788 0 C-N-CA 120.672 -0.775 . . . . 0.0 113.69 178.939 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 34.9 t -78.01 140.32 39.17 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-O 121.52 0.676 . . . . 0.0 111.072 -179.471 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 23.0 tt0 -94.74 98.78 11.01 Favored 'General case' 0 C--N 1.314 -0.97 0 CA-C-N 115.253 -0.885 . . . . 0.0 110.249 178.389 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 109' ' ' MET . . . . . . . . . . . . . 1.6 mtm -100.81 145.1 29.78 Favored Pre-proline 0 C--N 1.326 -0.421 0 CA-C-N 115.203 -0.908 . . . . 0.0 110.609 176.897 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 23.9 Cg_endo -66.61 116.35 4.04 Favored 'Trans proline' 0 N--CA 1.455 -0.741 0 C-N-CA 121.336 1.357 . . . . 0.0 110.631 173.227 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . -111.26 132.49 10.94 Favored Glycine 0 CA--C 1.502 -0.739 0 CA-C-N 115.518 -0.765 . . . . 0.0 112.223 -177.147 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 112' ' ' VAL . . . . . 0.555 ' HA ' ' HA ' ' A' ' 98' ' ' ILE . 3.0 p -94.62 133.22 36.29 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.739 0 N-CA-C 108.774 -0.825 . . . . 0.0 108.774 174.207 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 113' ' ' ILE . . . . . 0.444 HD13 ' CB ' ' A' ' 93' ' ' PRO . 20.3 mt -86.24 109.85 19.25 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.14 0 N-CA-C 108.201 -1.037 . . . . 0.0 108.201 -178.433 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 114' ' ' ARG . . . . . 0.474 ' O ' HG23 ' A' ' 95' ' ' ILE . 11.9 tpp180 -64.97 -46.75 80.19 Favored 'General case' 0 C--N 1.314 -0.957 0 CA-C-N 115.198 -0.91 . . . . 0.0 111.078 -174.395 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 115' ' ' GLU . . . . . 0.442 ' HA ' HG23 ' A' ' 95' ' ' ILE . 4.8 tt0 -159.7 160.05 33.66 Favored 'General case' 0 C--N 1.32 -0.71 0 C-N-CA 120.822 -0.351 . . . . 0.0 110.225 -176.324 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 116' ' ' ILE . . . . . 0.528 HG12 HG12 ' A' ' 95' ' ' ILE . 38.2 mm -114.61 121.78 67.39 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.436 0 CA-C-O 120.954 0.407 . . . . 0.0 110.36 177.99 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 117' ' ' ASN . . . . . . . . . . . . . 30.1 m-80 -112.64 154.1 26.59 Favored 'General case' 0 C--N 1.316 -0.87 0 N-CA-C 109.285 -0.635 . . . . 0.0 109.285 174.668 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . -75.94 -13.92 82.68 Favored Glycine 0 N--CA 1.449 -0.476 0 C-N-CA 120.74 -0.743 . . . . 0.0 113.021 -173.781 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 119' ' ' ASP . . . . . 0.574 ' HA ' ' HD3' ' A' ' 84' ' ' ARG . 30.2 t70 -112.82 -18.4 12.29 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-O 120.943 0.402 . . . . 0.0 111.594 -179.606 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 4.8 t -152.22 158.02 42.27 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 116.494 -0.321 . . . . 0.0 110.797 -172.997 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 121' ' ' ILE . . . . . 0.466 ' O ' ' HA ' ' A' ' 81' ' ' TYR . 47.7 mm -106.45 128.42 61.02 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.423 0 CA-C-O 121.218 0.533 . . . . 0.0 111.095 178.024 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 122' ' ' THR . . . . . 0.592 HG23 ' CE2' ' A' ' 81' ' ' TYR . 8.5 m -91.76 108.53 19.98 Favored 'General case' 0 C--N 1.321 -0.639 0 CA-C-O 122.19 0.995 . . . . 0.0 112.115 -178.429 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 123' ' ' VAL . . . . . 0.632 ' O ' HG23 ' A' ' 79' ' ' ILE . 15.5 t -99.63 157.79 3.81 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.555 0 CA-C-N 113.522 -1.672 . . . . 0.0 110.935 -177.755 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 124' ' ' ASP . . . . . 0.536 ' OD1' ' HB2' ' A' ' 126' ' ' ASN . 12.2 t0 -155.16 96.67 1.85 Allowed 'General case' 0 CA--C 1.537 0.474 0 N-CA-C 108.402 -0.962 . . . . 0.0 108.402 -176.025 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 125' ' ' PHE . . . . . 0.541 ' HB2' ' CD2' ' A' ' 78' ' ' LEU . 76.6 m-85 -90.31 23.62 2.86 Favored 'General case' 0 N--CA 1.47 0.541 0 O-C-N 120.618 -1.301 . . . . 0.0 111.478 -177.492 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 126' ' ' ASN . . . . . 0.536 ' HB2' ' OD1' ' A' ' 124' ' ' ASP . 27.1 m-80 . . . . . 0 C--N 1.328 -0.345 0 CA-C-O 122.096 0.951 . . . . 0.0 113.446 -174.817 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 133' ' ' THR . . . . . . . . . . . . . 1.5 m . . . . . 0 N--CA 1.444 -0.769 0 N-CA-C 109.808 -0.441 . . . . 0.0 109.808 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 134' ' ' VAL . . . . . 0.799 ' HB ' HD21 ' A' ' 17' ' ' LEU . 4.0 m -99.02 123.16 51.49 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.724 0 CA-C-O 121.447 0.641 . . . . 0.0 111.106 -175.126 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 135' ' ' HIS . . . . . 0.651 ' CE1' ' HB3' ' A' ' 18' ' ' LYS . 18.1 p80 -103.27 137.51 41.3 Favored 'General case' 0 C--N 1.318 -0.804 0 CA-C-N 115.112 -0.949 . . . . 0.0 110.189 174.152 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 136' ' ' PHE . . . . . 0.513 ' HE1' ' CE2' ' A' ' 63' ' ' PHE . 0.1 OUTLIER -134.48 138.33 44.63 Favored 'General case' 0 N--CA 1.442 -0.846 0 CA-C-O 121.55 0.69 . . . . 0.0 110.534 -175.153 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 137' ' ' ASP . . . . . 0.505 ' O ' ' HA ' ' A' ' 15' ' ' PHE . 37.6 t70 -98.93 108.07 20.66 Favored 'General case' 0 C--N 1.312 -1.062 0 CA-C-N 114.539 -1.21 . . . . 0.0 108.344 175.212 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 138' ' ' ILE . . . . . 0.706 HG23 HG21 ' A' ' 13' ' ' VAL . 62.5 mt -120.67 120.66 63.19 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.565 0 CA-C-O 121.396 0.617 . . . . 0.0 111.037 -167.851 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 30.2 mt-10 -110.8 111.32 22.4 Favored 'General case' 0 C--N 1.321 -0.671 0 CA-C-N 115.818 -0.628 . . . . 0.0 110.67 -178.703 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 140' ' ' VAL . . . . . 0.461 ' CG1' ' HA ' ' A' ' 57' ' ' VAL . 45.2 t -65.95 111.6 1.65 Allowed 'Isoleucine or valine' 0 C--O 1.234 0.266 0 CA-C-N 116.548 -0.296 . . . . 0.0 110.456 178.227 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 141' ' ' LEU . . . . . 0.497 HD11 ' CD2' ' A' ' 14' ' ' HIS . 48.0 mt -98.42 -49.74 4.56 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-O 120.746 0.307 . . . . 0.0 110.29 -179.943 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 142' ' ' GLU . . . . . . . . . . . . . 67.7 mm-40 -141.26 163.85 31.83 Favored 'General case' 0 CA--C 1.514 -0.413 0 CA-C-N 115.979 -0.555 . . . . 0.0 111.115 177.127 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 143' ' ' ILE . . . . . 0.52 HD12 HG23 ' A' ' 57' ' ' VAL . 94.4 mt -130.0 110.63 19.8 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.652 0 CA-C-N 115.168 -0.924 . . . . 0.0 110.381 176.605 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 144' ' ' ASP . . . . . 0.402 ' HB3' ' HB3' ' A' ' 10' ' ' ALA . 20.1 t70 -78.98 124.49 84.76 Favored Pre-proline 0 C--N 1.322 -0.617 0 CA-C-N 115.53 -0.759 . . . . 0.0 109.49 177.53 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 145' ' ' PRO . . . . . . . . . . . . . 41.3 Cg_endo . . . . . 0 C--O 1.234 0.32 0 C-N-CA 122.585 2.19 . . . . 0.0 112.29 -175.532 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 2' ' ' SER . . . . . 0.407 ' CB ' ' HA ' ' A' ' 145' ' ' PRO . 14.6 t . . . . . 0 N--CA 1.452 -0.325 0 N-CA-C 109.84 -0.43 . . . . 0.0 109.84 . . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 3' ' ' GLU . . . . . 0.46 ' O ' ' HG3' ' A' ' 56' ' ' LYS . 32.3 mt-10 -74.5 -30.21 61.72 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 115.844 -0.616 . . . . 0.0 109.682 179.276 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 40.0 t -116.88 151.23 37.03 Favored 'General case' 0 C--N 1.318 -0.771 0 CA-C-N 114.904 -1.043 . . . . 0.0 109.389 -178.532 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 98.0 t -72.96 125.3 31.57 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.403 0 CA-C-O 121.036 0.446 . . . . 0.0 110.267 177.08 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 6' ' ' GLN . . . . . 0.651 ' HG2' ' OG ' ' A' ' 9' ' ' SER . 5.2 pt20 -119.34 166.94 12.39 Favored 'General case' 0 C--N 1.319 -0.718 0 CA-C-N 115.609 -0.723 . . . . 0.0 109.141 -179.557 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 7' ' ' SER . . . . . 0.452 ' O ' ' HB2' ' A' ' 8' ' ' ASN . 10.0 p -63.23 133.75 54.78 Favored 'General case' 0 C--N 1.316 -0.882 0 N-CA-C 109.857 -0.423 . . . . 0.0 109.857 177.832 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 8' ' ' ASN . . . . . 0.514 ' OD1' ' HA3' ' A' ' 40' ' ' GLY . 34.4 m-80 72.7 35.07 1.11 Allowed 'General case' 0 N--CA 1.471 0.596 0 O-C-N 123.755 0.659 . . . . 0.0 112.327 -176.78 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 9' ' ' SER . . . . . 0.651 ' OG ' ' HG2' ' A' ' 6' ' ' GLN . 49.6 m -92.82 167.03 12.13 Favored 'General case' 0 C--N 1.332 -0.152 0 CA-C-O 121.151 0.501 . . . . 0.0 110.785 173.006 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 10' ' ' ALA . . . . . 0.493 ' HB3' ' HB3' ' A' ' 144' ' ' ASP . . . -115.54 118.14 32.31 Favored 'General case' 0 C--N 1.319 -0.759 0 N-CA-C 108.558 -0.905 . . . . 0.0 108.558 170.808 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 4.3 m -127.5 142.75 42.75 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.729 0 C-N-CA 120.165 -0.614 . . . . 0.0 110.909 -174.05 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 12' ' ' LEU . . . . . 0.502 ' HB2' ' HB2' ' A' ' 142' ' ' GLU . 83.8 mt -93.96 133.4 37.44 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-N 115.818 -0.628 . . . . 0.0 109.346 176.566 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 17.2 m -131.68 167.11 27.07 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.941 0 CA-C-O 121.519 0.676 . . . . 0.0 112.262 -174.867 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 14' ' ' HIS . . . . . 0.566 ' CD2' HD11 ' A' ' 141' ' ' LEU . 0.3 OUTLIER -134.21 115.67 14.44 Favored 'General case' 0 C--N 1.322 -0.59 0 N-CA-C 106.433 -1.692 . . . . 0.0 106.433 166.159 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 45.4 p90 -145.8 156.14 43.38 Favored 'General case' 0 C--N 1.319 -0.726 0 C-N-CA 120.841 -0.344 . . . . 0.0 110.629 -171.084 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 60.1 m -121.63 131.47 54.13 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-O 120.884 0.373 . . . . 0.0 110.664 174.478 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 17' ' ' LEU . . . . . 0.446 ' CD2' ' HB3' ' A' ' 136' ' ' PHE . 6.3 mt -98.26 121.8 40.64 Favored 'General case' 0 C--N 1.328 -0.363 0 N-CA-C 112.662 0.616 . . . . 0.0 112.662 178.331 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 9.5 mptt -127.67 142.84 51.23 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-N 114.973 -1.012 . . . . 0.0 110.197 -179.236 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 19' ' ' LEU . . . . . 0.519 HD13 HG23 ' A' ' 134' ' ' VAL . 3.2 mm? -89.66 169.05 11.64 Favored 'General case' 0 C--N 1.325 -0.477 0 N-CA-C 109.487 -0.561 . . . . 0.0 109.487 175.918 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 1.8 p30 -67.27 -23.65 65.7 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 121.41 0.624 . . . . 0.0 109.965 177.163 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 36.3 m-20 -74.03 -0.49 16.55 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 115.139 -0.937 . . . . 0.0 111.447 175.826 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 73.8 15.47 79.51 Favored Glycine 0 N--CA 1.449 -0.442 0 C-N-CA 121.007 -0.616 . . . . 0.0 111.922 -179.124 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 27.0 m -88.34 151.79 22.37 Favored 'General case' 0 C--N 1.32 -0.68 0 N-CA-C 109.525 -0.546 . . . . 0.0 109.525 176.132 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 38.3 m -95.25 128.77 42.35 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-O 120.874 0.368 . . . . 0.0 110.969 178.167 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -91.8 -49.04 6.47 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.001 -0.545 . . . . 0.0 110.011 176.143 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 26' ' ' GLU . . . . . 0.436 ' O ' ' HB2' ' A' ' 17' ' ' LEU . 11.8 tp10 -160.9 120.29 2.63 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 115.88 -0.6 . . . . 0.0 109.872 178.352 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 46.8 m -105.31 99.08 8.7 Favored 'General case' 0 C--N 1.318 -0.777 0 C-N-CA 120.233 -0.587 . . . . 0.0 110.3 177.276 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 28' ' ' THR . . . . . 0.408 ' O ' HG22 ' A' ' 28' ' ' THR . 32.8 m -91.69 57.14 3.16 Favored 'General case' 0 C--N 1.318 -0.789 0 CA-C-O 122.171 0.986 . . . . 0.0 110.068 -178.756 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 21.2 ttt180 -146.44 -55.73 0.27 Allowed 'General case' 0 C--N 1.312 -1.043 0 CA-C-N 115.065 -0.971 . . . . 0.0 109.866 176.959 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 10.7 p30 -77.86 -1.58 32.38 Favored 'General case' 0 N--CA 1.465 0.279 0 C-N-CA 120.928 -0.309 . . . . 0.0 111.069 179.36 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 94.9 m-20 -74.35 -13.42 60.74 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-O 120.861 0.363 . . . . 0.0 110.239 175.338 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 77.81 2.38 81.31 Favored Glycine 0 N--CA 1.446 -0.648 0 N-CA-C 111.23 -0.748 . . . . 0.0 111.23 -178.114 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 35.4 mtmm -131.23 115.28 16.27 Favored Pre-proline 0 N--CA 1.449 -0.477 0 CA-C-N 115.631 -0.285 . . . . 0.0 110.497 -174.575 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 19.6 Cg_exo -69.13 166.88 25.28 Favored 'Trans proline' 0 C--O 1.233 0.265 0 C-N-CA 122.792 2.328 . . . . 0.0 112.002 173.482 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -130.85 155.52 46.57 Favored 'General case' 0 C--N 1.316 -0.891 0 CA-C-N 115.462 -0.79 . . . . 0.0 110.453 -177.767 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 3.1 tp -101.14 142.4 32.63 Favored 'General case' 0 C--N 1.316 -0.867 0 CA-C-N 115.849 -0.614 . . . . 0.0 110.348 177.825 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 37' ' ' PHE . . . . . . . . . . . . . 5.8 m-30 -109.46 108.09 18.46 Favored 'General case' 0 C--N 1.312 -1.046 0 N-CA-C 108.364 -0.976 . . . . 0.0 108.364 177.787 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -86.46 107.62 18.15 Favored 'General case' 0 C--N 1.321 -0.658 0 CA-C-O 121.129 0.49 . . . . 0.0 109.826 -179.595 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 39' ' ' LEU . . . . . 0.422 ' HG ' ' CB ' ' A' ' 49' ' ' GLU . 9.5 mp -81.77 153.02 26.71 Favored 'General case' 0 C--N 1.317 -0.837 0 CA-C-N 115.208 -0.906 . . . . 0.0 109.935 -179.928 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 40' ' ' GLY . . . . . 0.514 ' HA3' ' OD1' ' A' ' 8' ' ' ASN . . . 96.67 29.11 8.4 Favored Glycine 0 N--CA 1.447 -0.585 0 C-N-CA 120.537 -0.84 . . . . 0.0 112.171 -178.262 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 17.9 t70 60.32 15.77 5.67 Favored 'General case' 0 N--CA 1.469 0.496 0 CA-C-O 121.425 0.631 . . . . 0.0 111.122 178.341 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -79.85 -13.52 59.34 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 121.11 0.481 . . . . 0.0 110.746 -176.336 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 35.7 t -161.18 -54.36 0.05 OUTLIER 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 115.522 -0.763 . . . . 0.0 109.024 174.998 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 4.0 mm? -91.3 149.71 21.63 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 115.829 -0.623 . . . . 0.0 109.674 176.483 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 47.5 t -70.93 155.52 40.72 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-N 115.782 -0.645 . . . . 0.0 111.119 -177.292 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 46' ' ' GLU . . . . . 0.483 ' O ' ' HG2' ' A' ' 49' ' ' GLU . 28.5 tt0 -49.94 -40.27 43.02 Favored 'General case' 0 N--CA 1.45 -0.46 0 C-N-CA 122.981 0.513 . . . . 0.0 111.854 -179.856 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . 0.417 ' HA3' ' HB1' ' A' ' 69' ' ' ALA . . . -56.69 -36.34 71.33 Favored Glycine 0 N--CA 1.448 -0.541 0 C-N-CA 120.567 -0.825 . . . . 0.0 112.447 -176.445 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 1.7 tt -64.26 -52.88 56.49 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 116.953 0.377 . . . . 0.0 111.745 176.57 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 49' ' ' GLU . . . . . 0.491 ' O ' HD13 ' A' ' 53' ' ' LEU . 13.8 pt-20 -63.91 -29.95 71.08 Favored 'General case' 0 N--CA 1.453 -0.299 0 CA-C-O 120.508 0.194 . . . . 0.0 111.02 -173.322 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 50' ' ' GLN . . . . . 0.527 ' HA ' HD22 ' A' ' 53' ' ' LEU . 16.9 mm-40 -65.67 -17.11 64.36 Favored 'General case' 0 N--CA 1.452 -0.347 0 CA-C-N 116.372 -0.376 . . . . 0.0 110.605 -173.936 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 51' ' ' HIS . . . . . . . . . . . . . 14.7 m-70 -107.27 -3.68 19.49 Favored 'General case' 0 N--CA 1.45 -0.449 0 CA-C-O 121.053 0.454 . . . . 0.0 110.022 -176.934 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 49.4 mt -103.04 -20.55 14.15 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 115.657 -0.702 . . . . 0.0 111.282 -178.865 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 53' ' ' LEU . . . . . 0.527 HD22 ' HA ' ' A' ' 50' ' ' GLN . 0.0 OUTLIER -60.59 135.91 57.9 Favored 'General case' 0 C--O 1.234 0.257 0 CA-C-O 120.875 0.369 . . . . 0.0 111.273 177.874 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 93.03 -5.96 76.01 Favored Glycine 0 N--CA 1.45 -0.399 0 CA-C-N 115.947 -0.57 . . . . 0.0 112.667 178.884 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 64.0 mt -84.47 163.54 19.37 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-O 121.208 0.528 . . . . 0.0 111.275 179.369 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 56' ' ' LYS . . . . . 0.46 ' HG3' ' O ' ' A' ' 3' ' ' GLU . 0.0 OUTLIER -127.39 169.52 13.52 Favored 'General case' 0 C--N 1.32 -0.695 0 CA-C-N 115.322 -0.854 . . . . 0.0 109.457 176.018 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 39.6 t -60.68 142.76 15.39 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.833 0 CA-C-O 121.068 0.461 . . . . 0.0 110.547 176.026 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 80.88 10.03 85.57 Favored Glycine 0 N--CA 1.448 -0.516 0 CA-C-N 115.673 -0.694 . . . . 0.0 112.659 -177.945 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 4.0 m-20 -98.92 150.52 21.84 Favored 'General case' 0 CA--C 1.511 -0.553 0 CA-C-O 121.073 0.463 . . . . 0.0 111.183 176.164 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 60' ' ' LYS . . . . . 0.471 ' H ' ' HG2' ' A' ' 60' ' ' LYS . 0.0 OUTLIER -120.88 129.55 53.55 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-N 115.189 -0.914 . . . . 0.0 109.382 -178.998 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 6.1 m -142.32 121.39 12.91 Favored 'General case' 0 N--CA 1.433 -1.298 0 CA-C-O 121.155 0.503 . . . . 0.0 110.502 -179.003 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 14.3 m -111.0 132.82 53.89 Favored 'General case' 0 C--N 1.316 -0.88 0 CA-C-N 115.754 -0.657 . . . . 0.0 109.872 177.277 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 32.0 p90 -146.7 172.79 13.07 Favored 'General case' 0 C--N 1.314 -0.972 0 CA-C-N 116.044 -0.525 . . . . 0.0 110.239 179.032 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 50.9 m -130.83 135.91 48.17 Favored 'General case' 0 C--N 1.32 -0.681 0 N-CA-C 108.783 -0.821 . . . . 0.0 108.783 -172.44 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 65' ' ' LEU . . . . . 0.453 ' HB2' ' HB2' ' A' ' 70' ' ' ALA . 61.1 mt -139.48 140.62 37.3 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-O 121.164 0.507 . . . . 0.0 111.406 -172.052 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 66' ' ' GLU . . . . . 0.431 ' HB3' ' HD2' ' A' ' 67' ' ' PRO . 44.1 mt-10 -75.54 162.12 73.74 Favored Pre-proline 0 C--N 1.326 -0.455 0 CA-C-N 115.037 -0.983 . . . . 0.0 109.842 174.597 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 67' ' ' PRO . . . . . 0.431 ' HD2' ' HB3' ' A' ' 66' ' ' GLU . 76.0 Cg_exo -42.04 -43.3 7.22 Favored 'Trans proline' 0 C--N 1.346 0.397 0 C-N-CA 123.513 2.809 . . . . 0.0 114.558 -177.837 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 6.6 p-10 -63.74 -18.77 64.39 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-O 120.782 0.325 . . . . 0.0 111.44 -177.505 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 69' ' ' ALA . . . . . 0.417 ' HB1' ' HA3' ' A' ' 47' ' ' GLY . . . -114.35 -7.38 12.91 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 116.326 -0.397 . . . . 0.0 111.368 179.223 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 70' ' ' ALA . . . . . 0.453 ' HB2' ' HB2' ' A' ' 65' ' ' LEU . . . . . . . . 0 C--N 1.33 -0.253 0 CA-C-O 120.542 0.211 . . . . 0.0 111.431 -176.954 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 75' ' ' SER . . . . . 0.777 ' O ' ' HG ' ' A' ' 78' ' ' LEU . 46.1 m . . . . . 0 N--CA 1.445 -0.683 0 CA-C-O 120.758 0.313 . . . . 0.0 111.241 . . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 47.6 Cg_endo -69.73 -18.3 37.21 Favored 'Trans proline' 0 N--CA 1.463 -0.284 0 C-N-CA 122.18 1.92 . . . . 0.0 111.724 176.657 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 77' ' ' ASP . . . . . 0.631 ' OD1' ' HB3' ' A' ' 75' ' ' SER . 6.4 p-10 -76.83 -13.0 60.05 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.623 -0.717 . . . . 0.0 111.352 -179.644 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 78' ' ' LEU . . . . . 0.777 ' HG ' ' O ' ' A' ' 75' ' ' SER . 4.1 pp -91.62 -4.89 54.75 Favored 'General case' 0 CA--C 1.515 -0.396 0 C-N-CA 119.652 -0.819 . . . . 0.0 110.392 177.739 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 43.7 mt -80.31 138.51 19.67 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.611 0 N-CA-C 109.886 -0.413 . . . . 0.0 109.886 169.074 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 3.7 mp0 -142.2 142.64 32.68 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-N 116.122 -0.49 . . . . 0.0 109.84 -177.847 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 81' ' ' TYR . . . . . 0.409 ' CE2' HG23 ' A' ' 122' ' ' THR . 43.0 m-85 -113.76 111.71 22.23 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-O 121.182 0.515 . . . . 0.0 109.983 -177.593 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 56.1 m-85 -109.73 171.17 7.6 Favored 'General case' 0 C--N 1.317 -0.814 0 CA-C-N 115.365 -0.834 . . . . 0.0 109.961 177.388 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 25.8 t -81.56 154.27 26.31 Favored 'General case' 0 C--N 1.321 -0.655 0 CA-C-O 121.368 0.604 . . . . 0.0 110.15 178.749 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 84' ' ' ARG . . . . . 0.519 ' HG3' ' HD2' ' A' ' 85' ' ' ARG . 13.0 ptm180 -68.89 -29.47 67.76 Favored 'General case' 0 C--N 1.32 -0.687 0 CA-C-N 115.383 -0.826 . . . . 0.0 109.649 178.108 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 85' ' ' ARG . . . . . 0.519 ' HD2' ' HG3' ' A' ' 84' ' ' ARG . 5.2 mpt_? -64.05 -34.06 77.16 Favored 'General case' 0 C--N 1.321 -0.667 0 CA-C-N 114.201 -1.363 . . . . 0.0 109.981 177.448 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 46.4 mt-10 -75.67 -10.8 59.75 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 115.757 -0.656 . . . . 0.0 110.565 178.119 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 87' ' ' PHE . . . . . 0.488 ' CE2' HG21 ' A' ' 121' ' ' ILE . 3.8 m-85 -103.3 -22.79 13.65 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 115.596 -0.729 . . . . 0.0 110.41 -179.748 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 88' ' ' MET . . . . . . . . . . . . . 46.4 ttm -60.14 -13.19 10.84 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 121.928 0.871 . . . . 0.0 109.679 172.375 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 25.0 t70 -61.09 -31.95 71.63 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-N 114.12 -1.4 . . . . 0.0 109.689 175.153 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -122.61 15.88 10.31 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 115.557 -0.747 . . . . 0.0 110.708 178.162 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 96.97 139.99 11.01 Favored Glycine 0 N--CA 1.45 -0.397 0 C-N-CA 120.6 -0.81 . . . . 0.0 111.925 -176.379 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 47.1 mt-10 -68.32 124.38 89.68 Favored Pre-proline 0 C--N 1.325 -0.494 0 CA-C-O 121.446 0.641 . . . . 0.0 111.48 -174.834 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 93' ' ' PRO . . . . . 0.54 ' HB2' HD13 ' A' ' 113' ' ' ILE . 83.8 Cg_endo -78.35 169.08 20.63 Favored 'Trans proline' 0 C--O 1.235 0.36 0 C-N-CA 124.669 3.579 . . . . 0.0 114.933 -169.373 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 94' ' ' GLU . . . . . 0.564 ' O ' HD12 ' A' ' 113' ' ' ILE . 1.4 mp0 -116.7 164.31 14.83 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 114.214 -1.357 . . . . 0.0 110.74 -174.616 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 95' ' ' ILE . . . . . 0.643 HG23 ' HA ' ' A' ' 115' ' ' GLU . 17.5 mt -82.78 133.96 27.97 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.377 0 CA-C-O 120.919 0.39 . . . . 0.0 110.909 179.35 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 70.69 29.89 69.07 Favored Glycine 0 N--CA 1.449 -0.447 0 CA-C-N 115.83 -0.623 . . . . 0.0 111.973 -179.194 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 97' ' ' ALA . . . . . 0.685 ' O ' HG13 ' A' ' 113' ' ' ILE . . . -106.42 140.0 40.02 Favored 'General case' 0 C--N 1.324 -0.52 0 N-CA-C 109.865 -0.42 . . . . 0.0 109.865 -179.777 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 98' ' ' ILE . . . . . 0.492 ' HA ' ' O ' ' A' ' 111' ' ' GLY . 72.5 mt -88.06 108.26 18.37 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.812 0 N-CA-C 109.972 -0.381 . . . . 0.0 109.972 -179.98 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 99' ' ' MET . . . . . 0.562 ' HB2' ' CE2' ' A' ' 101' ' ' PHE . 89.9 mtp -99.08 126.15 44.75 Favored 'General case' 0 N--CA 1.442 -0.835 0 CA-C-N 116.301 -0.409 . . . . 0.0 111.069 179.444 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 100' ' ' LEU . . . . . 0.447 ' HA ' HD13 ' A' ' 100' ' ' LEU . 4.3 mm? -67.42 147.35 52.99 Favored 'General case' 0 C--N 1.307 -1.241 0 N-CA-C 108.327 -0.99 . . . . 0.0 108.327 163.2 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 101' ' ' PHE . . . . . 0.632 ' HB2' ' O ' ' A' ' 109' ' ' MET . 2.5 m-85 -149.49 169.78 20.12 Favored 'General case' 0 CA--C 1.51 -0.594 0 CA-C-N 116.001 -0.545 . . . . 0.0 109.925 -155.101 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 3.9 m -126.64 129.26 48.15 Favored 'General case' 0 C--N 1.31 -1.128 0 N-CA-C 108.913 -0.773 . . . . 0.0 108.913 170.663 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -97.4 154.89 17.17 Favored 'General case' 0 C--N 1.316 -0.853 0 N-CA-C 109.05 -0.722 . . . . 0.0 109.05 -175.878 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 104' ' ' MET . . . . . . . . . . . . . 4.7 mpp? -65.24 -12.77 54.95 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.945 -174.219 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 9.8 p-10 -95.21 6.86 47.88 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-O 120.728 0.299 . . . . 0.0 110.928 177.219 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 89.55 -10.95 71.62 Favored Glycine 0 N--CA 1.452 -0.272 0 C-N-CA 121.213 -0.518 . . . . 0.0 113.217 174.67 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 43.1 t -79.94 143.15 34.44 Favored 'General case' 0 C--N 1.32 -0.677 0 CA-C-O 121.37 0.605 . . . . 0.0 109.748 178.721 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 23.3 tt0 -92.18 99.03 11.9 Favored 'General case' 0 C--N 1.309 -1.175 0 CA-C-O 121.956 0.884 . . . . 0.0 109.443 179.28 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 109' ' ' MET . . . . . 0.632 ' O ' ' HB2' ' A' ' 101' ' ' PHE . 71.3 mtp -96.13 135.54 22.62 Favored Pre-proline 0 C--N 1.319 -0.73 0 CA-C-N 113.965 -1.471 . . . . 0.0 111.689 -178.964 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 30.3 Cg_endo -68.9 159.4 54.01 Favored 'Trans proline' 0 N--CA 1.456 -0.709 0 C-N-CA 121.92 1.746 . . . . 0.0 110.011 168.198 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 111' ' ' GLY . . . . . 0.492 ' O ' ' HA ' ' A' ' 98' ' ' ILE . . . -147.15 149.04 21.12 Favored Glycine 0 C--N 1.314 -0.639 0 C-N-CA 119.945 -1.121 . . . . 0.0 110.993 -172.849 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 2.7 p -118.9 111.26 32.82 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.618 0 CA-C-N 118.311 1.056 . . . . 0.0 110.305 170.917 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 113' ' ' ILE . . . . . 0.685 HG13 ' O ' ' A' ' 97' ' ' ALA . 0.5 OUTLIER -62.88 112.03 0.99 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.469 0 CA-C-N 115.729 -0.669 . . . . 0.0 110.175 175.223 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 114' ' ' ARG . . . . . 0.573 ' HD2' ' HB2' ' A' ' 115' ' ' GLU . 5.6 tmm_? -71.22 -43.36 67.51 Favored 'General case' 0 C--N 1.316 -0.883 0 CA-C-N 115.874 -0.603 . . . . 0.0 110.679 -176.983 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 115' ' ' GLU . . . . . 0.643 ' HA ' HG23 ' A' ' 95' ' ' ILE . 13.8 tt0 -159.42 154.76 25.46 Favored 'General case' 0 C--N 1.329 -0.313 0 N-CA-C 110.317 -0.253 . . . . 0.0 110.317 -179.871 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 116' ' ' ILE . . . . . 0.56 HG12 HG12 ' A' ' 95' ' ' ILE . 38.0 mm -98.55 112.42 30.62 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.501 0 N-CA-C 109.04 -0.726 . . . . 0.0 109.04 174.23 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 117' ' ' ASN . . . . . 0.494 HD22 ' N ' ' A' ' 117' ' ' ASN . 0.9 OUTLIER -88.18 159.68 18.07 Favored 'General case' 0 C--N 1.311 -1.094 0 N-CA-C 108.724 -0.843 . . . . 0.0 108.724 177.289 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . -55.26 -47.16 76.44 Favored Glycine 0 N--CA 1.45 -0.372 0 C-N-CA 120.518 -0.848 . . . . 0.0 113.129 -169.438 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 119' ' ' ASP . . . . . 0.444 ' O ' ' HG2' ' A' ' 84' ' ' ARG . 4.4 p-10 -114.78 -11.1 12.32 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 117.125 0.463 . . . . 0.0 111.343 175.171 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 120' ' ' SER . . . . . 0.434 ' O ' ' HB2' ' A' ' 117' ' ' ASN . 9.0 t -115.97 158.26 23.34 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-O 121.222 0.534 . . . . 0.0 111.656 -171.812 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 121' ' ' ILE . . . . . 0.488 HG21 ' CE2' ' A' ' 87' ' ' PHE . 46.7 mm -117.21 128.69 74.5 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.52 0 CA-C-N 116.112 -0.495 . . . . 0.0 110.436 177.263 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 122' ' ' THR . . . . . 0.409 HG23 ' CE2' ' A' ' 81' ' ' TYR . 18.7 m -93.47 102.55 14.77 Favored 'General case' 0 C--N 1.32 -0.686 0 CA-C-O 121.594 0.711 . . . . 0.0 110.907 177.97 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 42.9 t -104.4 108.16 24.1 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.385 0 CA-C-N 114.66 -1.155 . . . . 0.0 112.92 -179.983 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 124' ' ' ASP . . . . . 0.443 ' C ' ' H ' ' A' ' 126' ' ' ASN . 1.3 m-20 -98.04 106.57 18.88 Favored 'General case' 0 C--N 1.318 -0.762 0 CA-C-N 114.689 -1.141 . . . . 0.0 110.386 170.121 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 125' ' ' PHE . . . . . 0.582 ' HB2' HD13 ' A' ' 78' ' ' LEU . 81.5 m-85 -75.07 18.9 0.16 Allowed 'General case' 0 N--CA 1.465 0.29 0 O-C-N 121.898 -0.501 . . . . 0.0 111.284 171.242 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 126' ' ' ASN . . . . . 0.443 ' H ' ' C ' ' A' ' 124' ' ' ASP . 11.4 m-80 . . . . . 0 C--N 1.328 -0.368 0 CA-C-N 115.818 -0.628 . . . . 0.0 110.622 176.285 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 133' ' ' THR . . . . . . . . . . . . . 21.9 m . . . . . 0 C--O 1.232 0.154 0 N-CA-C 110.507 -0.182 . . . . 0.0 110.507 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 134' ' ' VAL . . . . . 0.519 HG23 HD13 ' A' ' 19' ' ' LEU . 14.5 p -128.92 163.6 33.45 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.594 0 CA-C-O 121.093 0.473 . . . . 0.0 111.366 -174.709 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 135' ' ' HIS . . . . . 0.42 ' N ' HG22 ' A' ' 134' ' ' VAL . 72.2 m-70 -123.19 115.82 22.39 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 115.803 -0.635 . . . . 0.0 109.633 -176.027 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 136' ' ' PHE . . . . . 0.488 ' CE1' HG13 ' A' ' 134' ' ' VAL . 0.1 OUTLIER -125.42 138.26 54.01 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-O 121.112 0.482 . . . . 0.0 111.993 -176.463 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 137' ' ' ASP . . . . . . . . . . . . . 5.9 m-20 -103.73 107.11 17.83 Favored 'General case' 0 N--CA 1.468 0.436 0 CA-C-N 115.263 -0.88 . . . . 0.0 110.444 -178.846 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 138' ' ' ILE . . . . . 0.473 HD11 ' HD2' ' A' ' 136' ' ' PHE . 4.5 mp -96.95 138.89 20.74 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.492 0 CA-C-O 120.806 0.336 . . . . 0.0 111.77 -174.523 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 18.0 mt-10 -127.32 127.74 44.79 Favored 'General case' 0 CA--C 1.515 -0.379 0 N-CA-C 108.416 -0.957 . . . . 0.0 108.416 168.302 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 140' ' ' VAL . . . . . . . . . . . . . 91.3 t -78.95 111.25 15.58 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-O 120.925 0.393 . . . . 0.0 110.31 -178.078 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 141' ' ' LEU . . . . . 0.566 HD11 ' CD2' ' A' ' 14' ' ' HIS . 44.4 mt -85.38 -42.86 14.16 Favored 'General case' 0 C--N 1.316 -0.882 0 CA-C-O 121.371 0.605 . . . . 0.0 110.393 -179.855 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 142' ' ' GLU . . . . . 0.502 ' HB2' ' HB2' ' A' ' 12' ' ' LEU . 6.7 mm-40 -151.1 156.55 41.28 Favored 'General case' 0 C--N 1.321 -0.673 0 CA-C-N 115.135 -0.939 . . . . 0.0 111.271 -177.96 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 143' ' ' ILE . . . . . . . . . . . . . 78.7 mt -126.68 109.69 21.53 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.766 0 CA-C-N 115.619 -0.719 . . . . 0.0 109.876 178.773 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 144' ' ' ASP . . . . . 0.493 ' HB3' ' HB3' ' A' ' 10' ' ' ALA . 33.0 t70 -78.68 125.07 84.93 Favored Pre-proline 0 C--N 1.324 -0.512 0 N-CA-C 109.222 -0.659 . . . . 0.0 109.222 175.0 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 145' ' ' PRO . . . . . 0.407 ' HA ' ' CB ' ' A' ' 2' ' ' SER . 48.6 Cg_endo . . . . . 0 N--CA 1.461 -0.419 0 C-N-CA 122.537 2.158 . . . . 0.0 112.411 -175.688 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 14.3 p . . . . . 0 N--CA 1.467 0.394 0 CA-C-O 121.487 0.66 . . . . 0.0 112.396 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 3' ' ' GLU . . . . . 0.459 ' HG2' ' HD2' ' A' ' 56' ' ' LYS . 29.4 tt0 -99.05 -26.37 14.25 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 115.748 -0.66 . . . . 0.0 110.626 179.539 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 4' ' ' SER . . . . . 0.547 ' OG ' ' HE2' ' A' ' 56' ' ' LYS . 14.6 m -101.71 136.16 42.02 Favored 'General case' 0 C--N 1.318 -0.772 0 CA-C-N 115.543 -0.753 . . . . 0.0 111.034 -174.315 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 6.1 p -81.13 148.88 5.2 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.665 0 CA-C-O 121.453 0.644 . . . . 0.0 110.426 179.571 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 6' ' ' GLN . . . . . 0.688 ' HG2' ' OG ' ' A' ' 9' ' ' SER . 4.5 pt20 -140.53 166.16 25.48 Favored 'General case' 0 C--N 1.311 -1.067 0 CA-C-N 114.918 -1.037 . . . . 0.0 109.298 174.461 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 75.7 p -65.26 132.19 48.42 Favored 'General case' 0 N--CA 1.441 -0.916 0 N-CA-C 108.701 -0.851 . . . . 0.0 108.701 175.814 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 10.4 t30 75.08 38.06 0.45 Allowed 'General case' 0 CA--C 1.539 0.551 0 O-C-N 123.682 0.614 . . . . 0.0 110.95 -177.95 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 9' ' ' SER . . . . . 0.688 ' OG ' ' HG2' ' A' ' 6' ' ' GLN . 51.0 m -93.77 166.85 12.0 Favored 'General case' 0 CA--C 1.521 -0.167 0 CA-C-O 121.308 0.575 . . . . 0.0 110.821 172.462 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 10' ' ' ALA . . . . . 0.672 ' HB1' HD21 ' A' ' 36' ' ' LEU . . . -109.43 111.32 22.8 Favored 'General case' 0 N--CA 1.444 -0.769 0 N-CA-C 108.544 -0.91 . . . . 0.0 108.544 169.992 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 3.8 m -116.52 135.54 56.45 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.682 0 C-N-CA 119.767 -0.773 . . . . 0.0 111.351 -179.378 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 18.0 tp -86.36 128.43 34.93 Favored 'General case' 0 N--CA 1.447 -0.608 0 N-CA-C 108.914 -0.772 . . . . 0.0 108.914 177.837 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 13' ' ' VAL . . . . . 0.638 HG21 HG23 ' A' ' 138' ' ' ILE . 3.8 p -131.92 158.67 43.33 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.987 0 CA-C-O 122.23 1.014 . . . . 0.0 112.618 -174.561 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 14' ' ' HIS . . . . . 0.584 ' ND1' ' HA ' ' A' ' 29' ' ' ARG . 0.2 OUTLIER -122.94 110.28 15.19 Favored 'General case' 0 C--N 1.313 -1.001 0 CA-C-N 113.443 -1.708 . . . . 0.0 106.996 167.919 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 15' ' ' PHE . . . . . 0.453 ' HA ' ' O ' ' A' ' 137' ' ' ASP . 12.8 p90 -133.64 166.02 23.56 Favored 'General case' 0 C--N 1.324 -0.532 0 C-N-CA 119.223 -0.991 . . . . 0.0 113.673 -174.621 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 22.3 m -140.98 142.09 34.33 Favored 'General case' 0 N--CA 1.444 -0.744 0 CA-C-N 113.952 -1.476 . . . . 0.0 107.914 174.913 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 17' ' ' LEU . . . . . 0.537 HD11 ' CZ ' ' A' ' 136' ' ' PHE . 0.5 OUTLIER -126.86 112.62 15.54 Favored 'General case' 0 C--N 1.32 -0.716 0 N-CA-C 110.327 -0.249 . . . . 0.0 110.327 -173.624 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -118.85 152.53 36.09 Favored 'General case' 0 C--N 1.315 -0.913 0 CA-C-O 120.93 0.395 . . . . 0.0 111.392 -178.393 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 19' ' ' LEU . . . . . 0.603 HD21 ' HB2' ' A' ' 25' ' ' ALA . 3.4 mm? -103.82 170.47 7.91 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 115.844 -0.616 . . . . 0.0 109.627 174.372 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 2.2 m-20 -68.9 -18.92 64.19 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-O 120.952 0.406 . . . . 0.0 110.959 178.809 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 25.3 t70 -83.37 3.64 30.85 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 121.314 0.578 . . . . 0.0 110.279 175.32 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 74.26 9.88 81.3 Favored Glycine 0 N--CA 1.451 -0.305 0 CA-C-N 115.94 -0.573 . . . . 0.0 112.645 -175.958 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 23' ' ' THR . . . . . 0.466 ' HB ' HD23 ' A' ' 19' ' ' LEU . 12.1 m -72.55 141.07 48.46 Favored 'General case' 0 C--N 1.324 -0.53 0 N-CA-C 109.728 -0.471 . . . . 0.0 109.728 175.746 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 54.4 m -94.17 109.88 21.64 Favored 'General case' 0 C--N 1.319 -0.736 0 N-CA-C 109.854 -0.425 . . . . 0.0 109.854 174.658 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 25' ' ' ALA . . . . . 0.603 ' HB2' HD21 ' A' ' 19' ' ' LEU . . . -69.76 -40.41 76.14 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.975 -0.557 . . . . 0.0 110.027 179.692 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 10.2 tp10 -160.98 139.33 9.79 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 115.406 -0.815 . . . . 0.0 109.656 177.465 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 16.6 p -125.77 132.41 52.31 Favored 'General case' 0 C--N 1.317 -0.824 0 CA-C-O 120.838 0.352 . . . . 0.0 110.364 175.678 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 28' ' ' THR . . . . . 0.538 HG21 ' HB2' ' A' ' 35' ' ' ALA . 79.3 m -152.42 65.77 0.82 Allowed 'General case' 0 N--CA 1.441 -0.894 0 CA-C-O 122.116 0.96 . . . . 0.0 109.617 178.221 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 29' ' ' ARG . . . . . 0.584 ' HA ' ' ND1' ' A' ' 14' ' ' HIS . 26.9 ttt180 -154.11 -52.27 0.1 Allowed 'General case' 0 C--N 1.319 -0.733 0 N-CA-C 108.712 -0.847 . . . . 0.0 108.712 178.206 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 9.9 p30 -76.93 -4.24 42.9 Favored 'General case' 0 N--CA 1.464 0.228 0 CA-C-N 115.855 -0.611 . . . . 0.0 110.214 176.356 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 1.5 m-20 -69.46 -21.11 63.74 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 115.46 -0.791 . . . . 0.0 110.739 -178.958 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 85.3 4.1 86.51 Favored Glycine 0 N--CA 1.445 -0.711 0 C-N-CA 120.589 -0.815 . . . . 0.0 111.33 -173.723 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 56.5 mtpt -138.26 131.47 16.45 Favored Pre-proline 0 N--CA 1.452 -0.354 0 N-CA-C 109.995 -0.372 . . . . 0.0 109.995 179.14 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 91.8 Cg_endo -82.98 168.15 13.86 Favored 'Trans proline' 0 N--CA 1.453 -0.858 0 C-N-CA 122.393 2.062 . . . . 0.0 111.492 170.711 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 35' ' ' ALA . . . . . 0.538 ' HB2' HG21 ' A' ' 28' ' ' THR . . . -129.44 153.8 47.58 Favored 'General case' 0 C--N 1.319 -0.752 0 CA-C-N 116.256 -0.429 . . . . 0.0 109.942 -178.549 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 36' ' ' LEU . . . . . 0.672 HD21 ' HB1' ' A' ' 10' ' ' ALA . 4.6 tp -98.0 132.03 43.91 Favored 'General case' 0 C--N 1.315 -0.91 0 N-CA-C 109.967 -0.382 . . . . 0.0 109.967 176.87 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 37' ' ' PHE . . . . . 0.415 ' CD2' HD21 ' A' ' 44' ' ' LEU . 5.2 m-30 -95.79 107.33 19.55 Favored 'General case' 0 C--N 1.318 -0.802 0 N-CA-C 109.477 -0.564 . . . . 0.0 109.477 174.868 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 4.9 tpp180 -84.96 107.32 17.04 Favored 'General case' 0 N--CA 1.45 -0.468 0 CA-C-N 115.536 -0.756 . . . . 0.0 109.901 -178.269 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 63.4 mt -81.89 156.12 24.96 Favored 'General case' 0 C--N 1.32 -0.69 0 CA-C-N 115.807 -0.633 . . . . 0.0 111.156 -179.422 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 103.74 40.46 2.33 Favored Glycine 0 N--CA 1.446 -0.635 0 CA-C-N 115.724 -0.671 . . . . 0.0 111.592 -175.368 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 49.3 m-20 57.09 21.78 6.75 Favored 'General case' 0 N--CA 1.47 0.544 0 C-N-CA 123.16 0.584 . . . . 0.0 112.265 177.4 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -67.51 -40.24 85.15 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-O 121.03 0.443 . . . . 0.0 111.145 -178.852 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 41.8 m -154.17 -37.96 0.09 Allowed 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 116.034 -0.53 . . . . 0.0 110.832 -179.722 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 44' ' ' LEU . . . . . 0.453 HD23 HD12 ' A' ' 48' ' ' LEU . 6.7 mp -70.79 145.04 50.63 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 121.088 0.471 . . . . 0.0 110.969 -177.039 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 12.6 m -72.87 163.95 27.36 Favored 'General case' 0 C--N 1.322 -0.629 0 CA-C-N 115.373 -0.83 . . . . 0.0 110.228 175.628 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 41.7 mt-10 -51.59 -46.63 63.57 Favored 'General case' 0 C--N 1.329 -0.313 0 N-CA-C 112.72 0.637 . . . . 0.0 112.72 -173.753 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -63.75 -50.41 61.65 Favored Glycine 0 N--CA 1.448 -0.516 0 C-N-CA 119.572 -1.299 . . . . 0.0 112.539 -172.592 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 48' ' ' LEU . . . . . 0.453 HD12 HD23 ' A' ' 44' ' ' LEU . 0.0 OUTLIER -44.64 -50.88 9.59 Favored 'General case' 0 CA--C 1.517 -0.324 0 N-CA-C 113.803 1.038 . . . . 0.0 113.803 171.482 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 10.5 tt0 -70.8 -33.25 70.53 Favored 'General case' 0 C--N 1.312 -1.054 0 CA-C-O 120.987 0.422 . . . . 0.0 110.819 -169.369 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 50' ' ' GLN . . . . . 0.473 ' HA ' HD22 ' A' ' 53' ' ' LEU . 19.3 mm-40 -87.08 -13.88 43.01 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-N 115.834 -0.621 . . . . 0.0 111.552 -172.827 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 51' ' ' HIS . . . . . . . . . . . . . 11.7 m-70 -100.39 -4.38 29.14 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-O 121.046 0.451 . . . . 0.0 110.545 -175.269 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 11.5 mt -102.25 -14.01 17.16 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-N 115.763 -0.653 . . . . 0.0 111.757 -179.598 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 53' ' ' LEU . . . . . 0.473 HD22 ' HA ' ' A' ' 50' ' ' GLN . 0.1 OUTLIER -65.43 151.49 46.2 Favored 'General case' 0 N--CA 1.451 -0.399 0 CA-C-O 120.881 0.372 . . . . 0.0 110.264 171.539 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 93.26 -16.99 59.29 Favored Glycine 0 CA--C 1.519 0.317 0 C-N-CA 121.226 -0.512 . . . . 0.0 112.85 -179.02 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 55' ' ' LEU . . . . . 0.553 HD23 ' HB3' ' A' ' 59' ' ' ASP . 7.2 mp -82.28 165.41 20.42 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-O 121.646 0.736 . . . . 0.0 112.493 -179.954 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 56' ' ' LYS . . . . . 0.547 ' HE2' ' OG ' ' A' ' 4' ' ' SER . 28.5 mmtp -119.41 170.25 9.3 Favored 'General case' 0 N--CA 1.444 -0.738 0 CA-C-N 114.963 -1.017 . . . . 0.0 110.268 175.016 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 57' ' ' VAL . . . . . 0.5 HG23 HD12 ' A' ' 143' ' ' ILE . 71.5 t -62.46 134.51 27.71 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.764 0 CA-C-N 115.696 -0.684 . . . . 0.0 109.973 173.91 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 80.82 21.95 62.55 Favored Glycine 0 N--CA 1.445 -0.732 0 C-N-CA 120.943 -0.646 . . . . 0.0 112.423 -179.67 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 59' ' ' ASP . . . . . 0.553 ' HB3' HD23 ' A' ' 55' ' ' LEU . 4.9 t70 -92.67 162.92 13.96 Favored 'General case' 0 C--N 1.323 -0.57 0 N-CA-C 108.823 -0.806 . . . . 0.0 108.823 175.441 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 2.5 mmmt -137.11 122.05 18.91 Favored 'General case' 0 C--N 1.318 -0.772 0 N-CA-C 107.716 -1.216 . . . . 0.0 107.716 -179.273 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 9.5 t -135.91 136.15 40.25 Favored 'General case' 0 C--N 1.321 -0.65 0 CA-C-O 122.039 0.923 . . . . 0.0 112.22 179.047 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 10.9 m -114.03 133.25 55.64 Favored 'General case' 0 N--CA 1.437 -1.118 0 CA-C-N 115.162 -0.926 . . . . 0.0 108.845 172.419 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 17.6 p90 -153.47 158.34 41.2 Favored 'General case' 0 C--N 1.316 -0.867 0 CA-C-O 120.963 0.411 . . . . 0.0 110.215 -178.575 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 46.2 m -129.43 132.97 47.1 Favored 'General case' 0 C--N 1.312 -1.057 0 N-CA-C 108.398 -0.964 . . . . 0.0 108.398 175.425 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 78.2 mt -100.44 146.83 26.55 Favored 'General case' 0 C--N 1.318 -0.762 0 CA-C-O 120.885 0.374 . . . . 0.0 110.386 -178.985 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 43.1 mt-10 -65.45 145.9 99.01 Favored Pre-proline 0 C--N 1.317 -0.846 0 N-CA-C 108.631 -0.877 . . . . 0.0 108.631 173.282 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 96.2 Cg_exo -41.76 -52.98 3.59 Favored 'Trans proline' 0 CA--C 1.531 0.345 0 C-N-CA 123.501 2.8 . . . . 0.0 114.5 -170.718 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 29.1 t70 -64.93 -24.62 67.58 Favored 'General case' 0 N--CA 1.466 0.363 0 CA-C-O 120.828 0.347 . . . . 0.0 111.675 -174.804 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -83.26 -10.94 58.25 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-O 120.77 0.319 . . . . 0.0 111.21 -178.605 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.327 -0.403 0 N-CA-C 112.054 0.39 . . . . 0.0 112.054 -178.897 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 75' ' ' SER . . . . . 0.559 ' O ' ' HB2' ' A' ' 78' ' ' LEU . 28.5 t . . . . . 0 N--CA 1.446 -0.674 0 CA-C-O 120.588 0.232 . . . . 0.0 110.383 . . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 29.3 Cg_endo -65.93 -17.36 55.5 Favored 'Trans proline' 0 N--CA 1.461 -0.386 0 C-N-CA 122.493 2.129 . . . . 0.0 110.933 172.322 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 17.0 t70 -65.06 -26.81 68.4 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-O 121.798 0.808 . . . . 0.0 109.179 172.194 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 78' ' ' LEU . . . . . 0.559 ' HB2' ' O ' ' A' ' 75' ' ' SER . 0.5 OUTLIER -80.86 6.0 14.41 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 114.763 -1.108 . . . . 0.0 110.933 179.126 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 26.2 mt -126.66 99.1 5.26 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.874 0 N-CA-C 108.455 -0.943 . . . . 0.0 108.455 173.991 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 34.4 mt-30 -113.75 160.33 18.78 Favored 'General case' 0 C--N 1.309 -1.175 0 C-N-CA 119.021 -1.071 . . . . 0.0 112.527 174.357 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 81' ' ' TYR . . . . . 0.531 ' CE2' HG23 ' A' ' 122' ' ' THR . 66.6 m-85 -121.2 114.31 21.23 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.906 -0.588 . . . . 0.0 109.919 -179.796 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 49.6 m-85 -115.18 169.8 8.85 Favored 'General case' 0 C--N 1.316 -0.855 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.608 179.281 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 21.0 t -81.02 159.31 24.86 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-O 120.964 0.412 . . . . 0.0 110.97 -177.659 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 84' ' ' ARG . . . . . 0.591 ' HD2' ' O ' ' A' ' 118' ' ' GLY . 4.9 mtp180 -62.58 -36.89 84.15 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 122.1 0.952 . . . . 0.0 110.109 179.542 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 85' ' ' ARG . . . . . . . . . . . . . 8.5 mpt_? -63.14 -28.72 70.26 Favored 'General case' 0 C--N 1.319 -0.759 0 CA-C-N 113.794 -1.548 . . . . 0.0 111.447 -171.51 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 26.0 mm-40 -80.54 -10.34 59.74 Favored 'General case' 0 C--N 1.32 -0.707 0 CA-C-N 115.892 -0.595 . . . . 0.0 110.743 178.613 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 87' ' ' PHE . . . . . . . . . . . . . 17.0 m-85 -104.17 -36.6 7.62 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-N 115.712 -0.676 . . . . 0.0 110.501 -179.222 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 88' ' ' MET . . . . . . . . . . . . . 57.3 ttp -59.33 -23.41 62.46 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 121.776 0.798 . . . . 0.0 109.576 173.556 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 24.7 t70 -53.27 -34.35 56.9 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 114.246 -1.343 . . . . 0.0 110.46 173.073 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -122.57 16.73 10.4 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 115.644 -0.707 . . . . 0.0 111.501 -179.689 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 101.45 136.88 9.48 Favored Glycine 0 C--N 1.33 0.241 0 C-N-CA 120.629 -0.795 . . . . 0.0 112.415 -178.396 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 36.1 mt-10 -61.97 125.87 86.09 Favored Pre-proline 0 C--N 1.328 -0.333 0 CA-C-O 120.995 0.426 . . . . 0.0 111.494 -176.483 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 93' ' ' PRO . . . . . 0.666 ' HB2' HD13 ' A' ' 113' ' ' ILE . 57.7 Cg_endo -78.5 167.03 23.34 Favored 'Trans proline' 0 N--CA 1.459 -0.544 0 C-N-CA 123.266 2.644 . . . . 0.0 113.407 -173.436 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 94' ' ' GLU . . . . . 0.42 ' O ' HD12 ' A' ' 113' ' ' ILE . 24.7 mt-10 -118.32 164.34 15.36 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 115.982 -0.553 . . . . 0.0 110.6 -178.605 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 95' ' ' ILE . . . . . 0.531 HG12 HG12 ' A' ' 116' ' ' ILE . 12.9 mt -81.95 132.05 32.39 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.376 0 CA-C-O 120.594 0.235 . . . . 0.0 110.444 179.083 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 70.64 35.48 67.26 Favored Glycine 0 N--CA 1.448 -0.553 0 C-N-CA 121.185 -0.531 . . . . 0.0 111.785 -178.918 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 97' ' ' ALA . . . . . 0.561 ' O ' HG13 ' A' ' 113' ' ' ILE . . . -109.52 143.38 39.26 Favored 'General case' 0 C--N 1.322 -0.606 0 N-CA-C 109.744 -0.465 . . . . 0.0 109.744 -179.059 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 98' ' ' ILE . . . . . 0.51 ' HA ' ' O ' ' A' ' 111' ' ' GLY . 41.2 mt -94.48 107.9 20.0 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.115 0 CA-C-O 120.936 0.398 . . . . 0.0 110.479 -178.114 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 99' ' ' MET . . . . . 0.43 ' SD ' HD11 ' A' ' 113' ' ' ILE . 92.3 mtp -102.48 123.43 46.21 Favored 'General case' 0 N--CA 1.441 -0.925 0 CA-C-O 121.377 0.608 . . . . 0.0 111.404 -177.152 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 100' ' ' LEU . . . . . 0.444 HD13 ' HA ' ' A' ' 100' ' ' LEU . 4.4 mm? -65.59 143.85 57.35 Favored 'General case' 0 C--N 1.302 -1.477 0 CA-C-N 114.655 -1.157 . . . . 0.0 108.451 166.13 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 101' ' ' PHE . . . . . 0.417 ' CE2' ' HB2' ' A' ' 99' ' ' MET . 1.8 m-85 -149.85 167.95 25.11 Favored 'General case' 0 CA--C 1.511 -0.528 0 N-CA-C 108.062 -1.088 . . . . 0.0 108.062 -157.907 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 1.5 m -122.95 126.63 47.59 Favored 'General case' 0 C--N 1.312 -1.055 0 C-N-CA 119.774 -0.77 . . . . 0.0 110.592 179.23 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 103' ' ' ALA . . . . . 0.543 ' HB2' ' SD ' ' A' ' 109' ' ' MET . . . -95.59 167.34 11.36 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 115.915 -0.584 . . . . 0.0 110.61 -178.019 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 104' ' ' MET . . . . . . . . . . . . . 66.8 mtt -66.35 -12.93 59.56 Favored 'General case' 0 N--CA 1.464 0.259 0 CA-C-N 115.648 -0.705 . . . . 0.0 112.544 -173.117 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 5.4 p-10 -100.27 12.56 36.8 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-O 120.553 0.216 . . . . 0.0 111.383 -178.184 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 82.33 -2.56 84.56 Favored Glycine 0 N--CA 1.45 -0.383 0 C-N-CA 120.602 -0.809 . . . . 0.0 113.168 179.59 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 42.7 t -84.9 146.66 27.17 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-O 121.216 0.531 . . . . 0.0 110.266 178.683 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 28.9 tt0 -94.51 99.0 11.25 Favored 'General case' 0 C--N 1.314 -0.964 0 CA-C-N 115.319 -0.855 . . . . 0.0 108.905 178.355 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 109' ' ' MET . . . . . 0.543 ' SD ' ' HB2' ' A' ' 103' ' ' ALA . 14.6 ptm -88.66 135.09 32.74 Favored Pre-proline 0 C--N 1.325 -0.46 0 CA-C-N 115.426 -0.806 . . . . 0.0 111.065 -178.9 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 29.1 Cg_endo -65.55 153.81 76.52 Favored 'Trans proline' 0 N--CA 1.451 -0.983 0 C-N-CA 121.817 1.678 . . . . 0.0 110.065 171.425 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 111' ' ' GLY . . . . . 0.51 ' O ' ' HA ' ' A' ' 98' ' ' ILE . . . -147.21 152.78 24.88 Favored Glycine 0 N--CA 1.434 -1.486 0 N-CA-C 108.632 -1.787 . . . . 0.0 108.632 -170.313 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 112' ' ' VAL . . . . . 0.488 ' O ' ' HB3' ' A' ' 124' ' ' ASP . 0.7 OUTLIER -126.53 114.59 38.65 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.335 0 CA-C-N 118.613 1.206 . . . . 0.0 110.397 172.369 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 113' ' ' ILE . . . . . 0.666 HD13 ' HB2' ' A' ' 93' ' ' PRO . 0.6 OUTLIER -61.89 110.37 0.65 Allowed 'Isoleucine or valine' 0 C--N 1.317 -0.813 0 N-CA-C 109.022 -0.733 . . . . 0.0 109.022 174.314 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 114' ' ' ARG . . . . . 0.439 ' HB3' HG22 ' A' ' 122' ' ' THR . 12.5 tpp180 -65.02 -52.57 55.26 Favored 'General case' 0 C--N 1.315 -0.927 0 CA-C-N 115.292 -0.867 . . . . 0.0 110.882 -177.695 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 115' ' ' GLU . . . . . 0.502 ' HA ' HG23 ' A' ' 95' ' ' ILE . 10.8 tt0 -159.91 153.01 21.82 Favored 'General case' 0 C--N 1.321 -0.665 0 C-N-CA 120.887 -0.325 . . . . 0.0 110.329 -174.358 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 116' ' ' ILE . . . . . 0.531 HG12 HG12 ' A' ' 95' ' ' ILE . 43.6 mm -100.29 114.41 38.86 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.486 0 N-CA-C 109.646 -0.501 . . . . 0.0 109.646 176.231 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 117' ' ' ASN . . . . . 0.475 HD22 ' N ' ' A' ' 117' ' ' ASN . 0.9 OUTLIER -94.11 157.51 16.04 Favored 'General case' 0 C--N 1.317 -0.835 0 N-CA-C 109.266 -0.642 . . . . 0.0 109.266 177.901 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 118' ' ' GLY . . . . . 0.591 ' O ' ' HD2' ' A' ' 84' ' ' ARG . . . -56.94 -45.55 91.92 Favored Glycine 0 N--CA 1.451 -0.361 0 C-N-CA 120.537 -0.84 . . . . 0.0 112.91 -172.96 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 30.1 t70 -112.4 -10.66 13.74 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-O 121.107 0.479 . . . . 0.0 111.248 -179.107 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 120' ' ' SER . . . . . 0.468 ' O ' ' HB2' ' A' ' 117' ' ' ASN . 35.2 t -125.88 157.29 38.04 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.205 -171.893 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 121' ' ' ILE . . . . . . . . . . . . . 50.2 mm -114.31 123.12 69.67 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.567 0 CA-C-O 121.183 0.516 . . . . 0.0 110.054 175.808 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 122' ' ' THR . . . . . 0.531 HG23 ' CE2' ' A' ' 81' ' ' TYR . 24.0 m -94.56 102.2 14.11 Favored 'General case' 0 C--N 1.316 -0.85 0 CA-C-N 115.457 -0.792 . . . . 0.0 110.671 179.027 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 123' ' ' VAL . . . . . 0.45 HG12 ' N ' ' A' ' 124' ' ' ASP . 8.2 t -88.18 160.27 2.9 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.55 0 CA-C-N 115.267 -0.879 . . . . 0.0 111.853 174.765 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 124' ' ' ASP . . . . . 0.488 ' HB3' ' O ' ' A' ' 112' ' ' VAL . 27.0 t70 -145.91 145.9 30.88 Favored 'General case' 0 C--N 1.317 -0.808 0 CA-C-N 114.355 -1.293 . . . . 0.0 109.203 176.806 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 125' ' ' PHE . . . . . 0.492 ' HB2' ' HG ' ' A' ' 78' ' ' LEU . 98.1 m-85 -132.8 9.91 4.25 Favored 'General case' 0 C--N 1.312 -1.037 0 N-CA-C 108.534 -0.913 . . . . 0.0 108.534 179.87 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 126' ' ' ASN . . . . . 0.414 ' HB2' ' OD2' ' A' ' 124' ' ' ASP . 7.2 m-80 . . . . . 0 CA--C 1.516 -0.345 0 CA-C-N 113.996 -1.456 . . . . 0.0 111.691 -176.541 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 133' ' ' THR . . . . . . . . . . . . . 28.2 m . . . . . 0 N--CA 1.446 -0.674 0 N-CA-C 109.86 -0.422 . . . . 0.0 109.86 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 134' ' ' VAL . . . . . 0.505 ' HB ' HD21 ' A' ' 17' ' ' LEU . 16.8 m -98.95 149.96 5.24 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.688 0 CA-C-O 121.127 0.489 . . . . 0.0 110.216 -178.122 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 135' ' ' HIS . . . . . . . . . . . . . 95.2 m-70 -115.53 111.75 21.18 Favored 'General case' 0 C--N 1.314 -0.959 0 CA-C-N 115.161 -0.927 . . . . 0.0 109.577 -172.931 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 136' ' ' PHE . . . . . 0.537 ' CZ ' HD11 ' A' ' 17' ' ' LEU . 3.1 m-85 -107.92 124.1 49.61 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 115.373 -0.831 . . . . 0.0 111.116 -173.163 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 137' ' ' ASP . . . . . 0.453 ' O ' ' HA ' ' A' ' 15' ' ' PHE . 3.7 m-20 -110.38 100.85 9.63 Favored 'General case' 0 C--N 1.317 -0.815 0 N-CA-C 109.034 -0.728 . . . . 0.0 109.034 170.758 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 138' ' ' ILE . . . . . 0.638 HG23 HG21 ' A' ' 13' ' ' VAL . 54.2 mt -116.02 122.62 69.99 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.37 0 N-CA-C 112.701 0.63 . . . . 0.0 112.701 -171.905 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 80.4 mt-10 -110.52 137.95 47.54 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-N 115.838 -0.619 . . . . 0.0 110.076 173.491 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 140' ' ' VAL . . . . . 0.488 HG11 ' HA ' ' A' ' 57' ' ' VAL . 92.9 t -82.09 105.47 11.99 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.591 0 N-CA-C 108.473 -0.936 . . . . 0.0 108.473 177.435 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 39.1 mt -79.49 -44.45 21.22 Favored 'General case' 0 CA--C 1.508 -0.673 0 N-CA-C 109.839 -0.43 . . . . 0.0 109.839 -179.362 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 142' ' ' GLU . . . . . . . . . . . . . 14.5 pt-20 -169.32 158.12 7.93 Favored 'General case' 0 C--N 1.323 -0.549 0 N-CA-C 108.812 -0.81 . . . . 0.0 108.812 176.698 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 143' ' ' ILE . . . . . 0.5 HD12 HG23 ' A' ' 57' ' ' VAL . 82.3 mt -113.38 110.83 33.59 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.647 0 CA-C-O 121.231 0.538 . . . . 0.0 110.347 -179.444 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 144' ' ' ASP . . . . . . . . . . . . . 38.3 t70 -79.75 133.67 58.49 Favored Pre-proline 0 C--N 1.326 -0.423 0 CA-C-N 115.305 -0.861 . . . . 0.0 110.546 179.886 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 145' ' ' PRO . . . . . . . . . . . . . 90.1 Cg_exo . . . . . 0 C--N 1.35 0.617 0 C-N-CA 123.236 2.624 . . . . 0.0 112.538 177.581 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 2' ' ' SER . . . . . 0.628 ' O ' ' HB ' ' A' ' 143' ' ' ILE . 33.2 t . . . . . 0 N--CA 1.45 -0.438 0 N-CA-C 108.73 -0.841 . . . . 0.0 108.73 . . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 42.5 tt0 -84.41 -26.21 28.47 Favored 'General case' 0 C--N 1.321 -0.666 0 CA-C-O 121.216 0.531 . . . . 0.0 110.073 179.416 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 7.0 m -104.64 141.72 35.93 Favored 'General case' 0 C--N 1.318 -0.762 0 CA-C-N 115.443 -0.798 . . . . 0.0 110.711 -177.884 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 9.4 p -82.07 149.95 4.61 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.416 0 CA-C-N 116.052 -0.522 . . . . 0.0 111.075 -176.647 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 6' ' ' GLN . . . . . 0.448 ' CG ' ' HB2' ' A' ' 9' ' ' SER . 3.3 pt20 -143.74 157.77 44.15 Favored 'General case' 0 C--N 1.321 -0.656 0 CA-C-N 115.644 -0.707 . . . . 0.0 110.387 178.673 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 7' ' ' SER . . . . . 0.438 ' O ' ' HB2' ' A' ' 8' ' ' ASN . 5.1 p -76.02 144.12 41.03 Favored 'General case' 0 C--N 1.319 -0.724 0 CA-C-N 116.209 -0.451 . . . . 0.0 109.994 178.533 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 8' ' ' ASN . . . . . 0.485 HD22 ' N ' ' A' ' 8' ' ' ASN . 0.8 OUTLIER 71.6 13.7 6.31 Favored 'General case' 0 N--CA 1.466 0.358 0 CA-C-N 115.405 -0.816 . . . . 0.0 111.815 -178.4 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 9' ' ' SER . . . . . 0.448 ' HB2' ' CG ' ' A' ' 6' ' ' GLN . 18.2 t -82.44 166.91 18.97 Favored 'General case' 0 C--N 1.328 -0.359 0 N-CA-C 109.879 -0.415 . . . . 0.0 109.879 175.518 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 10' ' ' ALA . . . . . 0.67 ' O ' ' HB2' ' A' ' 144' ' ' ASP . . . -110.5 111.93 23.51 Favored 'General case' 0 C--N 1.318 -0.78 0 N-CA-C 109.241 -0.651 . . . . 0.0 109.241 172.638 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 16.5 m -114.61 144.72 21.56 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.789 0 C-N-CA 120.231 -0.588 . . . . 0.0 111.106 -172.67 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 12' ' ' LEU . . . . . 0.478 ' HB2' ' HB2' ' A' ' 142' ' ' GLU . 9.7 mp -87.0 128.29 35.08 Favored 'General case' 0 C--N 1.325 -0.485 0 N-CA-C 109.393 -0.595 . . . . 0.0 109.393 176.423 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 22.3 m -119.72 155.88 22.37 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.928 0 CA-C-O 121.971 0.891 . . . . 0.0 112.905 -173.094 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 14' ' ' HIS . . . . . 0.521 ' CD2' HD11 ' A' ' 141' ' ' LEU . 0.2 OUTLIER -127.82 111.61 13.83 Favored 'General case' 0 C--N 1.315 -0.924 0 CA-C-N 114.044 -1.435 . . . . 0.0 107.456 162.932 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 15' ' ' PHE . . . . . 0.552 ' HA ' ' O ' ' A' ' 137' ' ' ASP . 33.9 p90 -139.07 171.25 14.59 Favored 'General case' 0 C--N 1.321 -0.654 0 N-CA-C 114.198 1.184 . . . . 0.0 114.198 -174.299 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 89.1 m -141.9 140.13 32.76 Favored 'General case' 0 C--N 1.314 -0.955 0 CA-C-N 113.092 -1.867 . . . . 0.0 106.662 175.205 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 17' ' ' LEU . . . . . 0.4 ' HG ' ' HB3' ' A' ' 136' ' ' PHE . 0.5 OUTLIER -127.22 108.32 10.77 Favored 'General case' 0 C--N 1.316 -0.85 0 C-N-CA 120.973 -0.291 . . . . 0.0 110.654 -171.163 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 9.7 mptt -116.48 160.49 20.52 Favored 'General case' 0 C--N 1.321 -0.653 0 CA-C-O 121.313 0.578 . . . . 0.0 111.643 -174.601 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 19' ' ' LEU . . . . . 0.451 HD13 HG23 ' A' ' 134' ' ' VAL . 3.1 mm? -106.25 171.58 7.27 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 115.022 -0.99 . . . . 0.0 109.644 173.447 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 18.5 t70 -58.07 -30.66 66.37 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-O 121.197 0.522 . . . . 0.0 110.258 175.793 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 10.1 m-20 -77.85 6.69 7.1 Favored 'General case' 0 N--CA 1.465 0.298 0 CA-C-N 115.736 -0.666 . . . . 0.0 111.351 178.858 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 70.18 9.29 63.51 Favored Glycine 0 N--CA 1.453 -0.21 0 C-N-CA 121.294 -0.479 . . . . 0.0 113.261 -179.337 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 14.2 m -79.13 148.35 32.39 Favored 'General case' 0 C--N 1.322 -0.62 0 N-CA-C 109.891 -0.411 . . . . 0.0 109.891 178.422 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 18.2 m -95.16 116.52 28.84 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-O 120.987 0.422 . . . . 0.0 110.965 179.931 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -78.42 -39.36 39.01 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 116.0 -0.545 . . . . 0.0 109.825 176.827 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 8.0 tp10 -157.25 143.0 17.56 Favored 'General case' 0 N--CA 1.451 -0.394 0 CA-C-N 115.823 -0.626 . . . . 0.0 109.957 176.134 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 29.0 p -125.28 121.56 34.39 Favored 'General case' 0 C--N 1.316 -0.852 0 CA-C-N 116.295 -0.411 . . . . 0.0 110.402 178.327 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 50.5 m -136.99 61.24 1.63 Allowed 'General case' 0 N--CA 1.442 -0.856 0 CA-C-O 122.371 1.082 . . . . 0.0 109.816 174.81 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 4.7 tmm_? -151.75 -61.15 0.17 Allowed 'General case' 0 C--N 1.319 -0.755 0 CA-C-N 114.824 -1.08 . . . . 0.0 109.39 -177.861 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 6.2 p30 -68.94 -11.72 60.93 Favored 'General case' 0 N--CA 1.465 0.321 0 CA-C-O 121.121 0.486 . . . . 0.0 110.337 179.645 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 1.3 m-20 -66.49 -36.72 83.42 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 115.412 -0.813 . . . . 0.0 110.702 -179.76 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 98.6 -3.86 59.48 Favored Glycine 0 N--CA 1.448 -0.502 0 CA-C-N 115.655 -0.702 . . . . 0.0 111.614 -175.228 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 60.2 mtpt -126.7 132.29 24.25 Favored Pre-proline 0 C--N 1.328 -0.367 0 N-CA-C 110.143 -0.317 . . . . 0.0 110.143 179.795 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 42.6 Cg_endo -83.9 171.55 10.48 Favored 'Trans proline' 0 N--CA 1.456 -0.724 0 C-N-CA 123.207 2.605 . . . . 0.0 112.24 174.563 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -129.84 163.09 27.04 Favored 'General case' 0 C--N 1.316 -0.889 0 CA-C-N 115.927 -0.579 . . . . 0.0 109.623 -176.641 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 36' ' ' LEU . . . . . 0.523 HD21 ' HB1' ' A' ' 10' ' ' ALA . 0.9 OUTLIER -105.85 122.53 46.29 Favored 'General case' 0 C--N 1.315 -0.916 0 C-N-CA 120.757 -0.377 . . . . 0.0 110.571 177.003 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 37' ' ' PHE . . . . . . . . . . . . . 6.0 m-30 -93.44 107.57 19.39 Favored 'General case' 0 C--N 1.316 -0.891 0 CA-C-N 115.966 -0.561 . . . . 0.0 109.762 172.113 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 18.9 tpt180 -85.87 106.86 17.38 Favored 'General case' 0 N--CA 1.445 -0.701 0 N-CA-C 109.194 -0.669 . . . . 0.0 109.194 178.26 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 39' ' ' LEU . . . . . 0.516 HD22 ' HB3' ' A' ' 49' ' ' GLU . 15.9 mt -82.15 156.06 24.68 Favored 'General case' 0 C--N 1.317 -0.842 0 CA-C-N 115.215 -0.902 . . . . 0.0 110.498 -176.276 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 101.77 32.27 5.13 Favored Glycine 0 C--N 1.319 -0.415 0 C-N-CA 121.177 -0.535 . . . . 0.0 112.838 -177.32 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 41' ' ' ASP . . . . . 0.507 ' HA ' ' O ' ' A' ' 44' ' ' LEU . 14.7 t70 60.28 23.39 12.83 Favored 'General case' 0 N--CA 1.471 0.601 0 CA-C-O 121.507 0.67 . . . . 0.0 111.436 176.762 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -84.24 -5.37 59.25 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-O 121.05 0.452 . . . . 0.0 110.909 179.298 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 26.5 p -166.32 -49.17 0.03 OUTLIER 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 115.78 -0.645 . . . . 0.0 110.292 179.787 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 44' ' ' LEU . . . . . 0.507 ' O ' ' HA ' ' A' ' 41' ' ' ASP . 40.9 mt -106.42 171.1 7.54 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 115.992 -0.549 . . . . 0.0 110.413 179.259 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 21.0 t -76.79 153.37 34.99 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 116.005 -0.543 . . . . 0.0 109.605 178.727 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 46' ' ' GLU . . . . . 0.502 ' O ' ' HG2' ' A' ' 49' ' ' GLU . 44.8 mt-10 -63.7 -24.54 67.82 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 115.902 -0.59 . . . . 0.0 111.545 -176.597 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -57.97 -35.01 74.07 Favored Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 120.916 -0.659 . . . . 0.0 112.32 175.528 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 48' ' ' LEU . . . . . 0.445 ' HG ' HD13 ' A' ' 44' ' ' LEU . 0.6 OUTLIER -60.03 -51.91 67.63 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 121.089 0.471 . . . . 0.0 109.912 177.423 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 49' ' ' GLU . . . . . 0.652 ' O ' HD13 ' A' ' 53' ' ' LEU . 14.8 pt-20 -68.15 -51.07 50.14 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 115.9 -0.591 . . . . 0.0 111.19 -174.627 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 50' ' ' GLN . . . . . 0.535 ' HA ' HD22 ' A' ' 53' ' ' LEU . 85.3 mm-40 -56.03 -15.14 3.14 Favored 'General case' 0 C--N 1.329 -0.308 0 N-CA-C 113.75 1.018 . . . . 0.0 113.75 -176.278 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 51' ' ' HIS . . . . . . . . . . . . . 11.6 m170 -106.15 -13.8 15.33 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-O 121.074 0.464 . . . . 0.0 110.716 -177.024 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 18.3 mt -88.16 -14.65 38.12 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-N 115.632 -0.713 . . . . 0.0 109.832 172.427 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 53' ' ' LEU . . . . . 0.652 HD13 ' O ' ' A' ' 49' ' ' GLU . 5.8 mp -61.05 150.38 33.98 Favored 'General case' 0 N--CA 1.445 -0.697 0 CA-C-N 115.554 -0.748 . . . . 0.0 110.596 170.541 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 93.3 -14.67 64.74 Favored Glycine 0 N--CA 1.447 -0.581 0 C-N-CA 121.014 -0.612 . . . . 0.0 111.988 -175.23 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 6.9 mp -85.24 165.84 17.02 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-O 121.726 0.774 . . . . 0.0 112.048 177.632 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 56' ' ' LYS . . . . . 0.429 ' O ' ' HB2' ' A' ' 59' ' ' ASP . 24.2 tptt -128.75 166.92 18.05 Favored 'General case' 0 C--N 1.318 -0.8 0 N-CA-C 107.829 -1.175 . . . . 0.0 107.829 178.16 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 57' ' ' VAL . . . . . 0.552 HG23 HD12 ' A' ' 143' ' ' ILE . 12.6 t -60.52 131.83 25.55 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.52 0 CA-C-O 121.014 0.435 . . . . 0.0 110.816 176.465 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 81.59 10.25 84.62 Favored Glycine 0 N--CA 1.451 -0.364 0 CA-C-N 115.482 -0.781 . . . . 0.0 113.071 -177.519 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 59' ' ' ASP . . . . . 0.429 ' HB2' ' O ' ' A' ' 56' ' ' LYS . 1.0 OUTLIER -93.85 138.13 32.34 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.93 0.395 . . . . 0.0 110.28 176.545 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 60' ' ' LYS . . . . . 0.421 ' HE3' ' OE2' ' A' ' 139' ' ' GLU . 3.4 mmmm -110.48 131.53 54.97 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 116.034 -0.53 . . . . 0.0 109.573 -176.256 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 7.5 t -141.29 145.16 35.16 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-O 121.659 0.742 . . . . 0.0 111.839 -179.908 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 17.4 m -118.0 143.04 46.73 Favored 'General case' 0 C--N 1.313 -0.988 0 N-CA-C 108.609 -0.885 . . . . 0.0 108.609 171.143 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 21.3 p90 -161.15 163.95 30.92 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-O 120.958 0.409 . . . . 0.0 111.107 -177.01 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 41.7 t -132.48 136.9 46.99 Favored 'General case' 0 C--N 1.32 -0.686 0 CA-C-N 115.778 -0.646 . . . . 0.0 109.317 179.815 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 65' ' ' LEU . . . . . 0.409 HD11 ' HA ' ' A' ' 48' ' ' LEU . 87.6 mt -120.74 146.19 46.74 Favored 'General case' 0 C--N 1.313 -1.011 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.034 -178.352 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 14.5 mm-40 -64.44 152.99 87.82 Favored Pre-proline 0 N--CA 1.442 -0.828 0 CA-C-N 115.364 -0.835 . . . . 0.0 109.995 173.198 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 1.9 Cg_endo -42.61 -55.19 2.78 Favored 'Trans proline' 0 N--CA 1.464 -0.264 0 C-N-CA 123.797 2.998 . . . . 0.0 114.924 -171.513 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 7.0 p-10 -72.21 -14.76 61.87 Favored 'General case' 0 N--CA 1.465 0.304 0 CA-C-O 121.075 0.464 . . . . 0.0 111.502 -174.107 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -90.3 -8.79 50.01 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.676 179.175 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.329 -0.313 0 CA-C-N 116.142 -0.481 . . . . 0.0 111.864 -179.202 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 39.6 t . . . . . 0 N--CA 1.449 -0.499 0 CA-C-O 120.97 0.414 . . . . 0.0 110.743 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 39.1 Cg_endo -69.49 -18.93 38.01 Favored 'Trans proline' 0 N--CA 1.464 -0.236 0 C-N-CA 122.789 2.326 . . . . 0.0 111.813 174.891 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 7.3 m-20 -76.19 -15.22 60.09 Favored 'General case' 0 CA--C 1.519 -0.231 0 CA-C-O 121.359 0.6 . . . . 0.0 109.838 176.742 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 78' ' ' LEU . . . . . 0.553 ' HG ' ' HB2' ' A' ' 125' ' ' PHE . 6.2 mp -87.01 8.17 24.51 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 115.407 -0.815 . . . . 0.0 109.89 175.966 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 49.8 mt -118.86 109.41 26.74 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.681 0 N-CA-C 108.203 -1.036 . . . . 0.0 108.203 172.686 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 74.7 mt-30 -131.43 136.37 47.93 Favored 'General case' 0 C--N 1.311 -1.086 0 CA-C-N 115.259 -0.882 . . . . 0.0 110.054 -169.523 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 81' ' ' TYR . . . . . . . . . . . . . 46.3 m-85 -107.02 112.73 25.82 Favored 'General case' 0 C--N 1.321 -0.638 0 C-N-CA 120.125 -0.63 . . . . 0.0 110.252 -179.885 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 60.0 m-85 -103.78 170.47 7.91 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-O 121.548 0.689 . . . . 0.0 112.822 178.868 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 9.7 m -79.1 139.98 37.94 Favored 'General case' 0 N--CA 1.445 -0.724 0 CA-C-N 114.745 -1.116 . . . . 0.0 111.288 174.634 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 84' ' ' ARG . . . . . 0.434 ' HD2' ' O ' ' A' ' 118' ' ' GLY . 10.8 ptm180 -68.57 -17.22 64.09 Favored 'General case' 0 C--N 1.325 -0.469 0 N-CA-C 113.714 1.005 . . . . 0.0 113.714 -175.186 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 85' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -74.04 -34.13 63.98 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-O 121.134 0.492 . . . . 0.0 109.879 -174.713 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 45.1 mt-10 -64.6 -16.37 62.6 Favored 'General case' 0 N--CA 1.465 0.3 0 CA-C-N 115.177 -0.919 . . . . 0.0 110.77 -179.936 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 87' ' ' PHE . . . . . . . . . . . . . 54.8 m-85 -102.5 -23.12 13.93 Favored 'General case' 0 C--N 1.319 -0.72 0 CA-C-N 115.185 -0.916 . . . . 0.0 110.135 -177.464 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 88' ' ' MET . . . . . . . . . . . . . 56.0 ttm -62.0 -35.56 78.89 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 115.94 -0.573 . . . . 0.0 110.836 -178.419 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 23.1 t70 -58.18 -25.86 62.07 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 121.144 0.497 . . . . 0.0 111.304 178.888 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -111.13 16.51 21.03 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-N 115.938 -0.573 . . . . 0.0 110.668 177.765 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 90.65 143.99 11.66 Favored Glycine 0 N--CA 1.447 -0.629 0 C-N-CA 120.762 -0.732 . . . . 0.0 111.637 -178.225 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 44.3 mt-10 -60.42 127.28 86.33 Favored Pre-proline 0 C--N 1.323 -0.545 0 CA-C-O 121.02 0.438 . . . . 0.0 110.848 -177.633 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 18.1 Cg_endo -71.11 164.91 34.12 Favored 'Trans proline' 0 N--CA 1.457 -0.627 0 C-N-CA 122.85 2.367 . . . . 0.0 112.313 -175.282 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 23.0 mt-10 -118.07 160.8 20.89 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 116.332 -0.395 . . . . 0.0 110.392 -177.603 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 95' ' ' ILE . . . . . 0.502 HG23 ' HA ' ' A' ' 115' ' ' GLU . 9.6 mt -82.33 131.67 33.23 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.51 0 CA-C-O 120.969 0.414 . . . . 0.0 110.607 -178.333 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 71.35 34.8 63.73 Favored Glycine 0 N--CA 1.444 -0.783 0 CA-C-N 115.706 -0.679 . . . . 0.0 111.518 -176.849 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -110.14 115.58 29.98 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 121.659 0.742 . . . . 0.0 112.553 -177.555 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 98' ' ' ILE . . . . . 0.667 ' HA ' ' HA ' ' A' ' 112' ' ' VAL . 5.5 mt -82.03 123.3 37.99 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.017 0 CA-C-N 114.826 -1.079 . . . . 0.0 108.504 175.926 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 99' ' ' MET . . . . . . . . . . . . . 10.0 mtm -136.64 152.78 50.81 Favored 'General case' 0 N--CA 1.443 -0.797 0 N-CA-C 106.37 -1.715 . . . . 0.0 106.37 179.811 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 3.2 mm? -71.54 102.85 2.81 Favored 'General case' 0 C--N 1.313 -1.003 0 CA-C-O 122.273 1.035 . . . . 0.0 111.856 -178.795 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 101' ' ' PHE . . . . . . . . . . . . . 8.2 m-30 -94.78 172.65 8.04 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 113.033 -1.894 . . . . 0.0 111.826 -179.512 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 5.3 m -118.56 130.14 55.73 Favored 'General case' 0 C--N 1.316 -0.887 0 CA-C-N 114.947 -1.024 . . . . 0.0 108.972 -178.716 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 103' ' ' ALA . . . . . 0.612 ' HB2' ' SD ' ' A' ' 109' ' ' MET . . . -94.57 158.47 15.52 Favored 'General case' 0 C--N 1.322 -0.605 0 N-CA-C 109.329 -0.619 . . . . 0.0 109.329 -177.889 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 104' ' ' MET . . . . . . . . . . . . . 2.0 mpt? -66.54 -12.65 58.7 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 115.732 -0.667 . . . . 0.0 111.953 -174.988 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 5.0 p-10 -97.63 11.27 37.55 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-O 120.893 0.378 . . . . 0.0 110.989 179.227 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 87.9 -12.22 64.53 Favored Glycine 0 N--CA 1.45 -0.392 0 C-N-CA 121.249 -0.5 . . . . 0.0 113.505 175.499 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 48.9 m -76.76 142.49 40.39 Favored 'General case' 0 C--N 1.317 -0.81 0 CA-C-N 116.816 0.308 . . . . 0.0 110.308 177.499 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 30.1 tt0 -93.65 100.57 12.79 Favored 'General case' 0 C--N 1.318 -0.778 0 CA-C-O 121.675 0.75 . . . . 0.0 109.536 178.473 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 109' ' ' MET . . . . . 0.612 ' SD ' ' HB2' ' A' ' 103' ' ' ALA . 16.0 ptm -100.3 139.58 20.79 Favored Pre-proline 0 C--N 1.323 -0.573 0 CA-C-N 114.889 -1.051 . . . . 0.0 111.262 -177.289 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 17.7 Cg_exo -64.6 143.37 81.15 Favored 'Trans proline' 0 N--CA 1.451 -1.02 0 C-N-CA 121.88 1.72 . . . . 0.0 110.061 171.874 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . -144.69 108.26 0.48 Allowed Glycine 0 N--CA 1.438 -1.212 0 N-CA-C 109.876 -1.29 . . . . 0.0 109.876 -171.512 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 112' ' ' VAL . . . . . 0.667 ' HA ' ' HA ' ' A' ' 98' ' ' ILE . 1.3 p -84.11 110.38 18.64 Favored 'Isoleucine or valine' 0 CA--C 1.51 -0.582 0 C-N-CA 119.202 -0.999 . . . . 0.0 110.879 -178.647 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 113' ' ' ILE . . . . . . . . . . . . . 45.9 mt -60.41 110.11 0.52 Allowed 'Isoleucine or valine' 0 N--CA 1.438 -1.071 0 CA-C-N 114.22 -1.355 . . . . 0.0 108.536 170.726 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 114' ' ' ARG . . . . . 0.444 ' O ' HG23 ' A' ' 95' ' ' ILE . 1.3 tmt_? -79.2 -27.55 42.56 Favored 'General case' 0 C--N 1.309 -1.188 0 CA-C-N 114.162 -1.381 . . . . 0.0 110.899 -168.214 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 115' ' ' GLU . . . . . 0.612 ' N ' ' HB ' ' A' ' 122' ' ' THR . 8.2 tt0 -160.28 159.93 31.96 Favored 'General case' 0 C--N 1.325 -0.484 0 N-CA-C 112.456 0.539 . . . . 0.0 112.456 -179.046 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 116' ' ' ILE . . . . . 0.471 HG12 HG12 ' A' ' 95' ' ' ILE . 33.4 mm -118.39 130.3 73.45 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.605 0 CA-C-N 114.981 -1.009 . . . . 0.0 109.444 174.218 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 117' ' ' ASN . . . . . 0.41 ' HB2' ' O ' ' A' ' 120' ' ' SER . 19.8 m-80 -122.21 159.3 27.57 Favored 'General case' 0 C--N 1.309 -1.192 0 CA-C-N 115.51 -0.768 . . . . 0.0 109.27 -179.782 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 118' ' ' GLY . . . . . 0.434 ' O ' ' HD2' ' A' ' 84' ' ' ARG . . . -55.28 -45.59 82.47 Favored Glycine 0 N--CA 1.452 -0.297 0 C-N-CA 120.653 -0.784 . . . . 0.0 112.896 -170.624 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 3.3 p-10 -114.17 -12.08 12.56 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 117.03 0.415 . . . . 0.0 111.032 173.534 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 120' ' ' SER . . . . . 0.41 ' O ' ' HB2' ' A' ' 117' ' ' ASN . 21.9 t -113.77 159.79 19.38 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-O 122.047 0.927 . . . . 0.0 112.122 -169.196 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 121' ' ' ILE . . . . . . . . . . . . . 45.1 mm -118.98 159.68 19.4 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.863 0 CA-C-N 114.292 -1.322 . . . . 0.0 109.52 -177.289 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 122' ' ' THR . . . . . 0.612 ' HB ' ' N ' ' A' ' 115' ' ' GLU . 8.8 m -139.18 139.14 37.47 Favored 'General case' 0 N--CA 1.448 -0.533 0 N-CA-C 106.844 -1.539 . . . . 0.0 106.844 -170.78 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 123' ' ' VAL . . . . . 0.4 HG12 ' N ' ' A' ' 124' ' ' ASP . 55.6 t -140.46 154.57 22.46 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.67 0 C-N-CA 117.555 -1.658 . . . . 0.0 109.872 -164.119 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 124' ' ' ASP . . . . . 0.441 ' HB3' HG13 ' A' ' 112' ' ' VAL . 35.6 t70 -154.7 94.9 1.72 Allowed 'General case' 0 C--N 1.309 -1.176 0 CA-C-N 115.593 -0.73 . . . . 0.0 109.684 176.671 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 125' ' ' PHE . . . . . 0.553 ' HB2' ' HG ' ' A' ' 78' ' ' LEU . 97.4 m-85 -82.01 3.37 26.88 Favored 'General case' 0 C--N 1.324 -0.534 0 O-C-N 120.724 -1.235 . . . . 0.0 110.376 173.699 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 37.0 m-80 . . . . . 0 C--N 1.325 -0.496 0 CA-C-O 122.478 1.132 . . . . 0.0 111.951 -177.92 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 133' ' ' THR . . . . . . . . . . . . . 59.5 m . . . . . 0 CA--C 1.529 0.161 0 CA-C-O 120.85 0.357 . . . . 0.0 110.672 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 134' ' ' VAL . . . . . 0.451 HG23 HD13 ' A' ' 19' ' ' LEU . 2.7 p -116.96 166.78 10.91 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.501 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.803 -173.227 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 135' ' ' HIS . . . . . 0.441 ' H ' HG22 ' A' ' 134' ' ' VAL . 81.8 m-70 -131.0 124.48 31.05 Favored 'General case' 0 C--N 1.322 -0.587 0 CA-C-N 115.848 -0.614 . . . . 0.0 111.089 -171.278 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 136' ' ' PHE . . . . . 0.4 ' HB3' ' HG ' ' A' ' 17' ' ' LEU . 0.1 OUTLIER -131.54 150.98 51.96 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 121.478 0.656 . . . . 0.0 111.907 -179.966 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 137' ' ' ASP . . . . . 0.552 ' O ' ' HA ' ' A' ' 15' ' ' PHE . 3.3 m-20 -115.89 101.18 8.56 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-N 114.706 -1.133 . . . . 0.0 108.604 174.244 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 138' ' ' ILE . . . . . . . . . . . . . 47.6 mt -116.65 130.51 71.38 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.532 0 CA-C-O 121.203 0.525 . . . . 0.0 111.789 -172.23 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 139' ' ' GLU . . . . . 0.421 ' OE2' ' HE3' ' A' ' 60' ' ' LYS . 11.7 pt-20 -118.45 142.8 47.21 Favored 'General case' 0 C--N 1.321 -0.642 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.103 178.064 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 140' ' ' VAL . . . . . 0.453 ' CG1' ' HA ' ' A' ' 57' ' ' VAL . 78.7 t -79.09 108.33 12.55 Favored 'Isoleucine or valine' 0 C--O 1.234 0.263 0 CA-C-O 121.068 0.461 . . . . 0.0 111.116 -179.199 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 141' ' ' LEU . . . . . 0.521 HD11 ' CD2' ' A' ' 14' ' ' HIS . 48.7 mt -90.45 -33.02 16.15 Favored 'General case' 0 C--N 1.321 -0.652 0 CA-C-O 121.632 0.729 . . . . 0.0 110.324 177.291 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 142' ' ' GLU . . . . . 0.478 ' HB2' ' HB2' ' A' ' 12' ' ' LEU . 0.0 OUTLIER -164.49 148.23 9.28 Favored 'General case' 0 C--N 1.316 -0.885 0 CA-C-N 114.083 -1.417 . . . . 0.0 111.811 -176.879 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 143' ' ' ILE . . . . . 0.628 ' HB ' ' O ' ' A' ' 2' ' ' SER . 78.3 mt -125.16 127.92 72.53 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.538 0 CA-C-N 115.455 -0.793 . . . . 0.0 109.91 178.834 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 144' ' ' ASP . . . . . 0.67 ' HB2' ' O ' ' A' ' 10' ' ' ALA . 31.4 t70 -62.15 137.52 95.76 Favored Pre-proline 0 C--N 1.326 -0.448 0 CA-C-N 115.82 -0.627 . . . . 0.0 110.715 -178.246 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 145' ' ' PRO . . . . . . . . . . . . . 25.3 Cg_endo . . . . . 0 N--CA 1.463 -0.32 0 C-N-CA 122.823 2.349 . . . . 0.0 111.627 178.334 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 69.0 m . . . . . 0 N--CA 1.451 -0.415 0 CA-C-O 121.221 0.534 . . . . 0.0 111.005 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 33.4 mt-10 -80.33 -25.74 39.13 Favored 'General case' 0 C--N 1.323 -0.585 0 N-CA-C 108.442 -0.947 . . . . 0.0 108.442 172.851 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 23.6 t -117.47 132.8 56.49 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-N 114.027 -1.442 . . . . 0.0 109.004 175.048 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . 0.583 HG12 ' O ' ' A' ' 55' ' ' LEU . 8.9 p -76.9 142.77 13.85 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.494 0 CA-C-O 121.244 0.545 . . . . 0.0 110.428 -179.376 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 6' ' ' GLN . . . . . 0.5 ' HG2' ' HB2' ' A' ' 9' ' ' SER . 4.2 pt20 -127.39 168.3 15.03 Favored 'General case' 0 C--N 1.314 -0.963 0 CA-C-N 115.477 -0.783 . . . . 0.0 109.176 179.933 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 31.3 p -55.9 130.2 42.73 Favored 'General case' 0 C--N 1.317 -0.819 0 N-CA-C 109.955 -0.387 . . . . 0.0 109.955 174.946 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 66.7 t30 69.04 40.29 1.62 Allowed 'General case' 0 N--CA 1.47 0.549 0 CA-C-O 121.392 0.615 . . . . 0.0 110.914 -176.339 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 9' ' ' SER . . . . . 0.5 ' HB2' ' HG2' ' A' ' 6' ' ' GLN . 18.3 t -133.71 125.97 29.73 Favored 'General case' 0 C--N 1.327 -0.409 0 N-CA-C 108.638 -0.875 . . . . 0.0 108.638 173.311 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -83.27 148.67 27.25 Favored 'General case' 0 C--N 1.319 -0.755 0 CA-C-N 116.587 -0.279 . . . . 0.0 110.707 -171.233 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 8.0 m -123.92 140.15 48.23 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.687 0 CA-C-O 121.436 0.636 . . . . 0.0 111.322 179.249 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 12' ' ' LEU . . . . . 0.476 ' N ' HD12 ' A' ' 12' ' ' LEU . 5.1 mp -88.98 112.85 23.84 Favored 'General case' 0 C--N 1.315 -0.929 0 N-CA-C 107.584 -1.265 . . . . 0.0 107.584 173.667 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 13' ' ' VAL . . . . . 0.694 HG21 HG23 ' A' ' 138' ' ' ILE . 1.4 p -125.46 157.03 34.93 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.952 0 CA-C-O 121.185 0.517 . . . . 0.0 110.576 -171.462 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 14' ' ' HIS . . . . . 0.635 ' CE1' ' HA ' ' A' ' 29' ' ' ARG . 43.5 t60 -130.72 113.62 14.37 Favored 'General case' 0 C--N 1.316 -0.871 0 N-CA-C 106.12 -1.807 . . . . 0.0 106.12 176.502 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 15' ' ' PHE . . . . . 0.573 ' H ' ' HB ' ' A' ' 28' ' ' THR . 48.6 p90 -141.9 -179.07 5.99 Favored 'General case' 0 C--N 1.317 -0.81 0 CA-C-O 122.363 1.078 . . . . 0.0 113.329 -163.756 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 60.1 m -143.97 113.24 6.9 Favored 'General case' 0 C--N 1.318 -0.782 0 CA-C-N 113.721 -1.582 . . . . 0.0 108.336 -176.11 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 17' ' ' LEU . . . . . 0.89 HD21 ' HB ' ' A' ' 134' ' ' VAL . 1.1 tt -100.89 120.96 40.92 Favored 'General case' 0 C--N 1.321 -0.657 0 CA-C-N 115.923 -0.58 . . . . 0.0 112.153 -176.916 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 10.0 mptt -120.18 142.76 48.68 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-N 115.339 -0.846 . . . . 0.0 110.714 -179.248 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 19' ' ' LEU . . . . . 0.614 HD21 ' HB2' ' A' ' 25' ' ' ALA . 3.6 mm? -84.58 173.69 10.59 Favored 'General case' 0 C--N 1.322 -0.599 0 N-CA-C 109.11 -0.7 . . . . 0.0 109.11 170.711 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 50.5 m-20 -57.2 -33.66 67.72 Favored 'General case' 0 C--N 1.327 -0.408 0 C-N-CA 120.786 -0.366 . . . . 0.0 110.631 177.057 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 23.3 t70 -78.16 4.08 13.46 Favored 'General case' 0 CA--C 1.535 0.398 0 CA-C-O 121.338 0.59 . . . . 0.0 111.201 178.957 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 73.57 9.41 78.23 Favored Glycine 0 CA--C 1.516 0.15 0 CA-C-N 116.137 -0.483 . . . . 0.0 113.264 -179.047 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 8.1 m -71.19 141.38 50.67 Favored 'General case' 0 C--N 1.323 -0.583 0 N-CA-C 109.529 -0.545 . . . . 0.0 109.529 174.776 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 7.3 m -88.8 112.25 22.99 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-O 120.923 0.392 . . . . 0.0 110.567 -178.665 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 25' ' ' ALA . . . . . 0.79 ' HB3' HD22 ' A' ' 17' ' ' LEU . . . -80.41 -38.38 30.33 Favored 'General case' 0 CA--C 1.516 -0.332 0 CA-C-N 116.009 -0.542 . . . . 0.0 111.033 -178.708 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 23.8 tt0 -154.24 121.14 5.59 Favored 'General case' 0 C--N 1.321 -0.668 0 CA-C-N 115.543 -0.753 . . . . 0.0 109.645 -176.735 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 14.9 p -114.08 101.65 9.43 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-O 121.677 0.751 . . . . 0.0 111.679 -178.09 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 28' ' ' THR . . . . . 0.573 ' HB ' ' H ' ' A' ' 15' ' ' PHE . 80.3 m -91.14 81.05 5.59 Favored 'General case' 0 N--CA 1.431 -1.393 0 N-CA-C 106.468 -1.678 . . . . 0.0 106.468 171.475 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 29' ' ' ARG . . . . . 0.635 ' HA ' ' CE1' ' A' ' 14' ' ' HIS . 43.0 ttt180 -174.07 -70.85 0.01 OUTLIER 'General case' 0 C--N 1.305 -1.354 0 CA-C-N 112.735 -2.03 . . . . 0.0 110.32 -162.54 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 73.2 m-20 -65.51 -29.12 69.72 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 121.1 0.476 . . . . 0.0 111.2 -176.968 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 93.6 m-20 -67.9 -22.06 65.1 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 115.82 -0.627 . . . . 0.0 111.391 179.915 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 78.08 12.71 84.1 Favored Glycine 0 N--CA 1.449 -0.466 0 C-N-CA 120.719 -0.753 . . . . 0.0 111.509 -178.895 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 66.9 mttm -133.34 128.48 20.31 Favored Pre-proline 0 C--N 1.324 -0.54 0 CA-C-N 115.455 -0.372 . . . . 0.0 110.156 -176.801 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 34' ' ' PRO . . . . . 0.461 ' HA ' ' CG2' ' A' ' 28' ' ' THR . 93.9 Cg_endo -80.17 154.58 22.18 Favored 'Trans proline' 0 N--CA 1.45 -1.038 0 C-N-CA 121.914 1.743 . . . . 0.0 111.112 174.231 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -113.59 150.53 32.95 Favored 'General case' 0 C--N 1.319 -0.749 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.211 -173.027 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 10.9 tp -94.51 126.94 40.11 Favored 'General case' 0 C--N 1.318 -0.797 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.574 178.547 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 37' ' ' PHE . . . . . . . . . . . . . 4.4 m-30 -94.97 107.43 19.46 Favored 'General case' 0 C--N 1.315 -0.907 0 CA-C-N 115.924 -0.58 . . . . 0.0 109.678 171.96 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 16.1 mmm180 -81.71 108.0 14.9 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 115.615 -0.72 . . . . 0.0 111.341 -178.311 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 39' ' ' LEU . . . . . 0.448 ' HG ' ' CB ' ' A' ' 49' ' ' GLU . 10.7 mp -81.77 154.55 25.91 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-N 114.897 -1.047 . . . . 0.0 110.567 177.466 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 101.35 34.23 4.56 Favored Glycine 0 N--CA 1.449 -0.481 0 C-N-CA 120.718 -0.753 . . . . 0.0 112.823 177.107 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 20.6 t70 65.68 6.05 3.66 Favored 'General case' 0 N--CA 1.471 0.619 0 CA-C-O 121.148 0.499 . . . . 0.0 111.994 176.676 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -68.7 -59.3 3.21 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-O 121.068 0.461 . . . . 0.0 111.127 -175.858 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 22.2 m -116.85 -31.21 5.51 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-O 121.306 0.574 . . . . 0.0 110.353 177.979 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 44' ' ' LEU . . . . . 0.47 HD13 HD12 ' A' ' 48' ' ' LEU . 49.9 mt -108.8 157.8 18.24 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-N 115.651 -0.704 . . . . 0.0 110.456 -175.291 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 49.1 m -89.07 171.27 9.96 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 115.825 -0.625 . . . . 0.0 111.018 179.654 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 46' ' ' GLU . . . . . 0.437 ' O ' ' HG3' ' A' ' 50' ' ' GLN . 59.0 mm-40 -47.89 -49.12 30.76 Favored 'General case' 0 C--N 1.33 -0.247 0 O-C-N 123.856 0.723 . . . . 0.0 112.201 -176.01 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . 0.482 ' HA3' ' HB1' ' A' ' 69' ' ' ALA . . . -58.73 -45.61 94.58 Favored Glycine 0 CA--C 1.519 0.303 0 C-N-CA 120.881 -0.676 . . . . 0.0 113.379 -175.155 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 48' ' ' LEU . . . . . 0.47 HD12 HD13 ' A' ' 44' ' ' LEU . 0.3 OUTLIER -60.12 -52.91 63.33 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 117.039 0.42 . . . . 0.0 110.324 -178.889 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 49' ' ' GLU . . . . . 0.448 ' CB ' ' HG ' ' A' ' 39' ' ' LEU . 7.6 pt-20 -68.06 -31.9 71.87 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 116.376 -0.375 . . . . 0.0 111.994 -172.212 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 50' ' ' GLN . . . . . 0.616 ' HA ' ' CD2' ' A' ' 53' ' ' LEU . 84.5 mt-30 -80.7 -8.39 59.63 Favored 'General case' 0 N--CA 1.452 -0.354 0 N-CA-C 111.814 0.302 . . . . 0.0 111.814 -170.642 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 51' ' ' HIS . . . . . . . . . . . . . 21.8 m-70 -108.81 -5.14 16.38 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-O 121.215 0.531 . . . . 0.0 110.18 -178.501 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 18.1 mt -103.72 -30.25 10.54 Favored 'General case' 0 C--N 1.32 -0.691 0 CA-C-N 115.684 -0.689 . . . . 0.0 111.601 177.216 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 53' ' ' LEU . . . . . 0.616 ' CD2' ' HA ' ' A' ' 50' ' ' GLN . 2.5 pp -67.57 151.34 47.49 Favored 'General case' 0 C--O 1.234 0.24 0 C-N-CA 120.991 -0.284 . . . . 0.0 110.584 -177.215 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 93.7 -5.15 73.17 Favored Glycine 0 CA--C 1.522 0.53 0 C-N-CA 120.996 -0.621 . . . . 0.0 113.049 -177.418 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 55' ' ' LEU . . . . . 0.583 ' O ' HG12 ' A' ' 5' ' ' VAL . 72.3 mt -92.51 164.66 13.37 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 117.082 0.441 . . . . 0.0 111.008 179.084 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 56' ' ' LYS . . . . . 0.442 ' O ' ' HB2' ' A' ' 59' ' ' ASP . 2.8 mptp? -111.59 169.87 8.52 Favored 'General case' 0 C--N 1.32 -0.717 0 CA-C-O 121.466 0.651 . . . . 0.0 109.345 175.583 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 57' ' ' VAL . . . . . 0.44 ' HA ' ' CG1' ' A' ' 140' ' ' VAL . 52.5 t -63.1 138.73 22.43 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.331 0 CA-C-N 114.954 -1.021 . . . . 0.0 110.027 174.086 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 81.49 10.95 83.82 Favored Glycine 0 N--CA 1.446 -0.651 0 C-N-CA 120.858 -0.687 . . . . 0.0 112.419 -177.35 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 59' ' ' ASP . . . . . 0.442 ' HB2' ' O ' ' A' ' 56' ' ' LYS . 3.3 m-20 -92.48 139.65 30.37 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-O 120.801 0.334 . . . . 0.0 110.306 175.317 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 6.8 mmmt -111.78 127.97 55.96 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 115.839 -0.619 . . . . 0.0 109.34 -177.767 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 11.3 t -142.43 141.28 32.19 Favored 'General case' 0 C--N 1.317 -0.836 0 CA-C-O 121.281 0.562 . . . . 0.0 111.103 -179.178 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 5.0 m -127.73 131.36 49.71 Favored 'General case' 0 C--N 1.316 -0.878 0 N-CA-C 109.049 -0.723 . . . . 0.0 109.049 174.789 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 63' ' ' PHE . . . . . 0.529 ' CE2' ' HE1' ' A' ' 136' ' ' PHE . 41.2 p90 -152.2 172.59 16.15 Favored 'General case' 0 C--N 1.319 -0.75 0 CA-C-O 120.648 0.261 . . . . 0.0 110.576 179.061 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 38.3 t -132.04 143.8 50.31 Favored 'General case' 0 C--N 1.319 -0.735 0 N-CA-C 108.743 -0.836 . . . . 0.0 108.743 -172.16 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 65' ' ' LEU . . . . . 0.422 HD11 ' HA ' ' A' ' 48' ' ' LEU . 57.2 mt -139.48 139.18 36.92 Favored 'General case' 0 C--N 1.319 -0.758 0 CA-C-O 121.12 0.486 . . . . 0.0 111.501 -176.728 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 66' ' ' GLU . . . . . 0.475 ' H ' ' CD ' ' A' ' 66' ' ' GLU . 13.5 mp0 -64.84 148.36 97.44 Favored Pre-proline 0 N--CA 1.44 -0.928 0 CA-C-N 115.009 -0.996 . . . . 0.0 109.373 170.571 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 67' ' ' PRO . . . . . 0.405 ' HA ' ' O ' ' A' ' 70' ' ' ALA . 73.7 Cg_exo -50.44 -23.78 11.05 Favored 'Trans proline' 0 C--N 1.346 0.434 0 C-N-CA 124.024 3.15 . . . . 0.0 114.662 -174.697 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 32.8 t70 -66.8 -26.2 66.83 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-O 121.149 0.5 . . . . 0.0 110.697 177.867 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 69' ' ' ALA . . . . . 0.482 ' HB1' ' HA3' ' A' ' 47' ' ' GLY . . . -108.21 -6.34 16.43 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 115.954 -0.567 . . . . 0.0 111.524 -178.067 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 70' ' ' ALA . . . . . 0.405 ' O ' ' HA ' ' A' ' 67' ' ' PRO . . . . . . . . 0 C--N 1.327 -0.374 0 CA-C-N 116.664 -0.244 . . . . 0.0 111.154 -176.009 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 32.2 t . . . . . 0 N--CA 1.446 -0.642 0 CA-C-O 120.671 0.272 . . . . 0.0 110.276 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 39.5 Cg_endo -69.11 -24.47 32.61 Favored 'Trans proline' 0 N--CA 1.465 -0.173 0 C-N-CA 122.074 1.849 . . . . 0.0 111.245 175.463 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 5.8 p-10 -77.26 -9.09 58.59 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 115.869 -0.605 . . . . 0.0 110.781 177.314 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 78' ' ' LEU . . . . . 0.537 ' HG ' ' HB2' ' A' ' 125' ' ' PHE . 5.0 tp -69.42 -20.99 63.78 Favored 'General case' 0 N--CA 1.453 -0.298 0 CA-C-O 121.645 0.736 . . . . 0.0 109.249 175.388 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 79' ' ' ILE . . . . . 0.471 HG23 ' O ' ' A' ' 123' ' ' VAL . 65.2 mt -70.21 132.17 33.48 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.555 0 CA-C-N 114.473 -1.239 . . . . 0.0 110.396 178.653 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 42.6 mt-30 -152.8 118.24 5.27 Favored 'General case' 0 CA--C 1.509 -0.605 0 CA-C-N 116.099 -0.501 . . . . 0.0 109.983 -176.992 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 81' ' ' TYR . . . . . . . . . . . . . 0.6 OUTLIER -83.51 121.71 27.57 Favored 'General case' 0 C--N 1.317 -0.846 0 N-CA-C 114.193 1.183 . . . . 0.0 114.193 -179.936 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 82' ' ' PHE . . . . . 0.431 ' HZ ' ' SD ' ' A' ' 104' ' ' MET . 7.5 m-85 -102.99 171.14 7.55 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 113.887 -1.506 . . . . 0.0 110.486 175.015 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 8.5 t -74.48 136.52 42.25 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-O 121.368 0.604 . . . . 0.0 110.904 -178.669 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 84' ' ' ARG . . . . . 0.573 ' HA ' ' CG1' ' A' ' 121' ' ' ILE . 12.1 ptm180 -61.36 -17.28 53.2 Favored 'General case' 0 C--N 1.326 -0.448 0 N-CA-C 113.734 1.013 . . . . 0.0 113.734 -178.187 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 85' ' ' ARG . . . . . 0.476 ' HD2' ' N ' ' A' ' 85' ' ' ARG . 6.7 mpt_? -73.92 -32.3 63.48 Favored 'General case' 0 C--N 1.321 -0.643 0 CA-C-O 121.203 0.525 . . . . 0.0 109.716 -176.396 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 32.7 mt-10 -63.28 -21.71 66.42 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 115.175 -0.921 . . . . 0.0 111.044 -179.102 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 87' ' ' PHE . . . . . . . . . . . . . 52.5 m-85 -96.83 -20.48 18.15 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 115.831 -0.622 . . . . 0.0 110.916 -178.308 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 88' ' ' MET . . . . . . . . . . . . . 55.7 ttm -60.91 -27.14 67.97 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 115.682 -0.69 . . . . 0.0 111.544 -175.915 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 60.8 m-20 -53.33 -34.57 58.01 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 116.426 -0.352 . . . . 0.0 111.538 177.022 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -109.79 16.58 21.95 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-O 121.014 0.435 . . . . 0.0 110.495 179.315 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 93.95 155.26 31.65 Favored Glycine 0 N--CA 1.448 -0.549 0 C-N-CA 121.088 -0.577 . . . . 0.0 111.734 -177.212 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 11.6 tt0 -64.73 127.86 92.97 Favored Pre-proline 0 N--CA 1.431 -1.402 0 CA-C-O 121.0 0.428 . . . . 0.0 109.945 -179.799 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 93' ' ' PRO . . . . . 0.53 ' CB ' HD13 ' A' ' 113' ' ' ILE . 31.8 Cg_endo -65.5 165.65 22.08 Favored 'Trans proline' 0 C--O 1.233 0.271 0 C-N-CA 123.398 2.732 . . . . 0.0 113.923 -176.196 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 94' ' ' GLU . . . . . 0.464 ' O ' ' HB ' ' A' ' 113' ' ' ILE . 14.2 mt-10 -114.22 154.53 27.74 Favored 'General case' 0 C--N 1.333 -0.145 0 CA-C-N 115.651 -0.704 . . . . 0.0 110.69 -177.385 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 95' ' ' ILE . . . . . 0.577 ' CG1' HG12 ' A' ' 116' ' ' ILE . 20.2 mt -82.27 129.66 37.1 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.386 0 CA-C-O 121.047 0.451 . . . . 0.0 111.576 -178.168 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 71.76 27.09 71.46 Favored Glycine 0 N--CA 1.45 -0.406 0 CA-C-N 115.49 -0.777 . . . . 0.0 113.208 179.076 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -109.52 129.02 55.59 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-O 120.634 0.254 . . . . 0.0 110.691 177.062 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 98' ' ' ILE . . . . . 0.697 ' HA ' ' HA ' ' A' ' 112' ' ' VAL . 4.1 mt -89.01 133.07 32.18 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.561 0 N-CA-C 108.68 -0.859 . . . . 0.0 108.68 177.02 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 99' ' ' MET . . . . . . . . . . . . . 10.3 mtm -136.64 157.59 46.42 Favored 'General case' 0 N--CA 1.444 -0.764 0 N-CA-C 106.648 -1.612 . . . . 0.0 106.648 177.194 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 100' ' ' LEU . . . . . 0.465 HD12 ' HG2' ' A' ' 108' ' ' GLU . 1.3 mm? -71.56 103.36 2.97 Favored 'General case' 0 C--N 1.313 -1.01 0 CA-C-O 122.438 1.113 . . . . 0.0 110.772 174.457 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 101' ' ' PHE . . . . . . . . . . . . . 2.7 m-85 -90.19 170.1 10.58 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-N 113.215 -1.811 . . . . 0.0 112.455 -174.144 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 1.6 m -126.37 140.52 52.44 Favored 'General case' 0 C--N 1.317 -0.829 0 CA-C-N 114.234 -1.348 . . . . 0.0 109.781 178.432 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 103' ' ' ALA . . . . . 0.417 ' HB2' ' HG3' ' A' ' 109' ' ' MET . . . -96.23 163.91 12.89 Favored 'General case' 0 C--N 1.321 -0.657 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.491 -179.598 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 104' ' ' MET . . . . . 0.431 ' SD ' ' HZ ' ' A' ' 82' ' ' PHE . 4.3 mpp? -66.73 -19.57 65.78 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 115.813 -0.63 . . . . 0.0 110.969 -179.272 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 6.2 p-10 -93.94 16.26 14.81 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.926 0.393 . . . . 0.0 111.458 -179.25 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 85.23 -11.15 61.45 Favored Glycine 0 N--CA 1.451 -0.364 0 C-N-CA 121.148 -0.548 . . . . 0.0 113.254 174.484 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 68.2 m -78.36 149.42 33.4 Favored 'General case' 0 C--N 1.316 -0.87 0 CA-C-O 121.18 0.514 . . . . 0.0 110.974 -179.652 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 108' ' ' GLU . . . . . 0.465 ' HG2' HD12 ' A' ' 100' ' ' LEU . 40.1 tt0 -91.21 146.57 23.72 Favored 'General case' 0 C--N 1.312 -1.043 0 CA-C-N 115.519 -0.764 . . . . 0.0 108.979 175.929 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 109' ' ' MET . . . . . 0.417 ' HG3' ' HB2' ' A' ' 103' ' ' ALA . 88.9 mmm -138.41 151.17 68.74 Favored Pre-proline 0 C--O 1.231 0.12 0 N-CA-C 106.016 -1.846 . . . . 0.0 106.016 -164.073 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 4.9 Cg_endo -81.63 113.24 2.53 Favored 'Trans proline' 0 N--CA 1.446 -1.285 0 CA-C-N 121.428 1.546 . . . . 0.0 109.671 162.962 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 111' ' ' GLY . . . . . 0.444 ' HA2' ' O ' ' A' ' 124' ' ' ASP . . . -121.39 126.21 6.45 Favored Glycine 0 N--CA 1.436 -1.354 0 C-N-CA 120.251 -0.975 . . . . 0.0 112.299 179.2 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 112' ' ' VAL . . . . . 0.697 ' HA ' ' HA ' ' A' ' 98' ' ' ILE . 0.2 OUTLIER -105.1 140.18 23.88 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.142 0 N-CA-C 108.587 -0.894 . . . . 0.0 108.587 174.023 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 113' ' ' ILE . . . . . 0.53 HD13 ' CB ' ' A' ' 93' ' ' PRO . 10.3 mt -89.2 108.61 19.3 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.374 0 N-CA-C 107.826 -1.175 . . . . 0.0 107.826 -174.194 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 114' ' ' ARG . . . . . 0.465 ' O ' HG23 ' A' ' 95' ' ' ILE . 10.9 tpp180 -64.88 -47.53 77.53 Favored 'General case' 0 C--N 1.317 -0.839 0 CA-C-N 115.284 -0.871 . . . . 0.0 111.513 -171.179 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 115' ' ' GLU . . . . . 0.474 ' H ' ' HB ' ' A' ' 122' ' ' THR . 8.6 tt0 -161.63 162.48 30.01 Favored 'General case' 0 C--N 1.317 -0.833 0 N-CA-C 109.445 -0.576 . . . . 0.0 109.445 -175.28 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 116' ' ' ILE . . . . . 0.577 HG12 ' CG1' ' A' ' 95' ' ' ILE . 28.7 mm -111.82 112.53 40.93 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.427 0 CA-C-O 121.174 0.511 . . . . 0.0 110.129 177.356 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 117' ' ' ASN . . . . . 0.466 HD22 ' N ' ' A' ' 117' ' ' ASN . 0.9 OUTLIER -96.31 158.93 15.21 Favored 'General case' 0 C--N 1.315 -0.896 0 CA-C-N 115.557 -0.747 . . . . 0.0 110.056 179.06 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . -57.18 -45.75 92.29 Favored Glycine 0 N--CA 1.452 -0.294 0 C-N-CA 120.612 -0.804 . . . . 0.0 113.304 -172.476 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 119' ' ' ASP . . . . . 0.424 ' O ' ' HG2' ' A' ' 84' ' ' ARG . 10.3 m-20 -113.39 -15.8 12.57 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-O 120.784 0.326 . . . . 0.0 111.53 178.397 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 120' ' ' SER . . . . . 0.465 ' O ' ' HB2' ' A' ' 117' ' ' ASN . 16.0 t -116.86 157.74 25.13 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-O 120.814 0.34 . . . . 0.0 111.09 -172.312 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 121' ' ' ILE . . . . . 0.573 ' CG1' ' HA ' ' A' ' 84' ' ' ARG . 38.8 mm -112.21 128.18 68.98 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.576 0 CA-C-O 121.746 0.784 . . . . 0.0 110.837 174.491 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 122' ' ' THR . . . . . 0.474 ' HB ' ' H ' ' A' ' 115' ' ' GLU . 0.6 OUTLIER -90.88 141.11 29.17 Favored 'General case' 0 C--N 1.307 -1.278 0 CA-C-N 114.338 -1.301 . . . . 0.0 109.382 178.236 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 123' ' ' VAL . . . . . 0.471 ' O ' HG23 ' A' ' 79' ' ' ILE . 43.8 t -138.39 158.93 31.91 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.41 0 N-CA-C 109.055 -0.72 . . . . 0.0 109.055 -156.522 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 124' ' ' ASP . . . . . 0.572 ' HB3' HG13 ' A' ' 112' ' ' VAL . 46.1 t0 -148.83 148.74 30.26 Favored 'General case' 0 C--N 1.305 -1.357 0 CA-C-N 116.058 -0.519 . . . . 0.0 110.256 174.781 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 125' ' ' PHE . . . . . 0.537 ' HB2' ' HG ' ' A' ' 78' ' ' LEU . 84.4 m-85 -135.97 3.71 2.95 Favored 'General case' 0 C--N 1.318 -0.804 0 CA-C-N 115.246 -0.888 . . . . 0.0 109.707 176.041 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 29.4 m-80 . . . . . 0 N--CA 1.449 -0.495 0 CA-C-N 114.685 -1.143 . . . . 0.0 110.571 176.103 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 133' ' ' THR . . . . . . . . . . . . . 14.5 m . . . . . 0 N--CA 1.451 -0.39 0 CA-C-O 120.904 0.383 . . . . 0.0 110.552 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 134' ' ' VAL . . . . . 0.89 ' HB ' HD21 ' A' ' 17' ' ' LEU . 4.6 m -101.98 142.81 15.72 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.599 0 CA-C-O 121.236 0.541 . . . . 0.0 111.576 -176.483 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 135' ' ' HIS . . . . . . . . . . . . . 69.5 m-70 -124.87 113.24 17.61 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 115.328 -0.851 . . . . 0.0 109.076 -178.794 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 136' ' ' PHE . . . . . 0.529 ' HE1' ' CE2' ' A' ' 63' ' ' PHE . 0.1 OUTLIER -117.96 132.2 56.42 Favored 'General case' 0 C--N 1.316 -0.862 0 CA-C-O 121.103 0.478 . . . . 0.0 111.295 -175.787 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 137' ' ' ASP . . . . . . . . . . . . . 14.4 t70 -99.23 102.61 14.31 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-N 115.18 -0.918 . . . . 0.0 108.56 177.427 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 138' ' ' ILE . . . . . 0.694 HG23 HG21 ' A' ' 13' ' ' VAL . 40.6 mt -103.27 132.78 48.81 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.644 0 N-CA-C 112.716 0.635 . . . . 0.0 112.716 -166.912 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 24.0 mt-10 -125.7 114.46 18.68 Favored 'General case' 0 N--CA 1.45 -0.439 0 CA-C-N 115.24 -0.891 . . . . 0.0 109.131 178.781 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 140' ' ' VAL . . . . . 0.44 ' CG1' ' HA ' ' A' ' 57' ' ' VAL . 65.2 t -70.55 122.16 21.8 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.417 0 CA-C-N 117.824 0.284 . . . . 0.0 110.86 -179.498 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 141' ' ' LEU . . . . . 0.555 HD11 ' HB2' ' A' ' 14' ' ' HIS . 13.8 mt -100.76 -33.12 10.38 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-O 121.672 0.748 . . . . 0.0 110.426 178.739 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 142' ' ' GLU . . . . . 0.451 ' HB3' ' HB2' ' A' ' 12' ' ' LEU . 32.8 tt0 -163.88 151.59 12.64 Favored 'General case' 0 C--N 1.314 -0.971 0 CA-C-N 114.405 -1.27 . . . . 0.0 109.858 -178.334 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 143' ' ' ILE . . . . . . . . . . . . . 85.3 mt -122.1 113.82 40.28 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.397 0 CA-C-O 120.961 0.41 . . . . 0.0 110.932 -178.473 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 144' ' ' ASP . . . . . . . . . . . . . 37.4 t70 -79.15 126.17 82.19 Favored Pre-proline 0 C--N 1.323 -0.55 0 CA-C-N 115.807 -0.633 . . . . 0.0 110.291 177.998 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 145' ' ' PRO . . . . . . . . . . . . . 41.5 Cg_endo . . . . . 0 C--O 1.234 0.311 0 C-N-CA 123.016 2.477 . . . . 0.0 113.294 -175.864 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 18.9 p . . . . . 0 N--CA 1.469 0.51 0 N-CA-C 112.464 0.542 . . . . 0.0 112.464 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 47.7 mt-10 -75.79 -33.24 60.13 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-O 121.215 0.531 . . . . 0.0 110.734 176.311 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 12.6 p -114.37 149.12 36.61 Favored 'General case' 0 C--N 1.319 -0.749 0 CA-C-N 115.558 -0.746 . . . . 0.0 110.647 -177.894 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . 0.525 HG13 ' HA ' ' A' ' 53' ' ' LEU . 7.4 p -73.68 144.83 12.2 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.395 0 CA-C-N 115.61 -0.723 . . . . 0.0 110.598 -178.281 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 6' ' ' GLN . . . . . . . . . . . . . 3.4 pt20 -136.99 166.31 23.96 Favored 'General case' 0 N--CA 1.444 -0.727 0 N-CA-C 108.488 -0.93 . . . . 0.0 108.488 -179.592 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 34.2 p -63.93 138.68 58.58 Favored 'General case' 0 C--N 1.317 -0.812 0 CA-C-O 120.735 0.303 . . . . 0.0 110.94 -176.531 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 15.5 t30 70.92 15.59 6.72 Favored 'General case' 0 CA--C 1.542 0.641 0 CA-C-N 115.491 -0.777 . . . . 0.0 111.643 177.928 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 9' ' ' SER . . . . . 0.631 ' O ' HD23 ' A' ' 39' ' ' LEU . 8.8 t -108.15 134.36 51.11 Favored 'General case' 0 N--CA 1.451 -0.411 0 N-CA-C 108.079 -1.082 . . . . 0.0 108.079 177.276 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -82.19 149.07 28.11 Favored 'General case' 0 C--N 1.322 -0.599 0 N-CA-C 109.69 -0.485 . . . . 0.0 109.69 -174.02 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 6.3 m -134.33 145.05 33.51 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.755 0 C-N-CA 120.281 -0.568 . . . . 0.0 111.35 -175.869 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 12' ' ' LEU . . . . . 0.449 HD22 ' HB2' ' A' ' 142' ' ' GLU . 6.6 mp -91.74 119.36 31.51 Favored 'General case' 0 C--N 1.326 -0.456 0 N-CA-C 108.809 -0.811 . . . . 0.0 108.809 177.909 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 13' ' ' VAL . . . . . 0.547 HG21 HG23 ' A' ' 138' ' ' ILE . 2.4 p -132.37 154.48 40.07 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.68 0 CA-C-O 122.146 0.974 . . . . 0.0 113.219 -172.12 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 14' ' ' HIS . . . . . 0.429 ' CD2' HD11 ' A' ' 141' ' ' LEU . 0.2 OUTLIER -117.2 117.7 30.28 Favored 'General case' 0 C--N 1.32 -0.704 0 N-CA-C 106.225 -1.769 . . . . 0.0 106.225 170.936 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 15' ' ' PHE . . . . . 0.42 ' HB2' ' O ' ' A' ' 137' ' ' ASP . 32.1 p90 -148.27 157.35 43.44 Favored 'General case' 0 C--N 1.327 -0.396 0 C-N-CA 118.671 -1.212 . . . . 0.0 113.785 -167.523 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 16' ' ' THR . . . . . 0.447 HG22 ' HD3' ' A' ' 18' ' ' LYS . 85.9 m -128.88 118.77 23.25 Favored 'General case' 0 C--N 1.321 -0.653 0 CA-C-N 115.006 -0.997 . . . . 0.0 109.813 174.617 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 17' ' ' LEU . . . . . 0.509 HD21 ' CE2' ' A' ' 136' ' ' PHE . 1.4 mt -95.17 112.91 24.56 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-O 121.034 0.445 . . . . 0.0 111.163 179.045 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 18' ' ' LYS . . . . . 0.447 ' HD3' HG22 ' A' ' 16' ' ' THR . 10.2 mptt -109.05 128.01 54.61 Favored 'General case' 0 C--N 1.314 -0.945 0 CA-C-N 115.735 -0.666 . . . . 0.0 110.826 -179.251 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 19.8 tp -85.42 161.53 19.39 Favored 'General case' 0 N--CA 1.438 -1.069 0 CA-C-N 115.677 -0.692 . . . . 0.0 109.199 175.775 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 29.2 t70 -62.77 -24.69 67.85 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 121.431 0.634 . . . . 0.0 110.25 178.603 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 27.1 t70 -70.25 -3.66 18.12 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 115.162 -0.927 . . . . 0.0 111.385 177.646 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 74.81 9.08 82.99 Favored Glycine 0 C--N 1.332 0.333 0 C-N-CA 121.508 -0.377 . . . . 0.0 112.425 -175.593 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 52.7 m -91.45 140.28 29.9 Favored 'General case' 0 C--N 1.319 -0.745 0 CA-C-N 115.309 -0.446 . . . . 0.0 110.06 175.779 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 41.7 m -79.68 108.24 13.08 Favored 'General case' 0 C--N 1.318 -0.784 0 N-CA-C 110.05 -0.352 . . . . 0.0 110.05 177.197 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -69.86 -34.77 74.05 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.88 -0.6 . . . . 0.0 110.527 -177.969 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 44.2 tt0 -159.83 128.35 4.96 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 115.857 -0.611 . . . . 0.0 109.697 177.356 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 18.4 p -109.58 130.48 55.51 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-N 116.534 -0.303 . . . . 0.0 110.835 -178.289 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 28' ' ' THR . . . . . 0.611 ' O ' HG22 ' A' ' 28' ' ' THR . 62.2 m -148.59 14.48 0.96 Allowed 'General case' 0 CA--C 1.546 0.798 0 CA-C-O 122.831 1.301 . . . . 0.0 110.854 174.75 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 16.0 tpt180 -92.94 -68.99 0.77 Allowed 'General case' 0 C--N 1.307 -1.257 0 O-C-N 121.19 -0.944 . . . . 0.0 111.018 168.523 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 7.8 p30 -69.47 -10.61 58.77 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.407 -0.36 . . . . 0.0 111.452 -172.754 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 2.2 m-20 -58.37 -31.08 67.3 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.981 177.631 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 91.09 -13.39 66.37 Favored Glycine 0 N--CA 1.447 -0.593 0 C-N-CA 120.621 -0.8 . . . . 0.0 111.404 -175.813 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 75.4 mmtt -120.23 124.47 27.74 Favored Pre-proline 0 C--N 1.324 -0.533 0 N-CA-C 109.587 -0.524 . . . . 0.0 109.587 179.871 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 71.6 Cg_endo -76.53 168.85 22.98 Favored 'Trans proline' 0 N--CA 1.457 -0.659 0 C-N-CA 122.38 2.053 . . . . 0.0 111.889 176.438 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -131.75 149.86 52.34 Favored 'General case' 0 C--N 1.319 -0.719 0 CA-C-N 116.391 -0.368 . . . . 0.0 110.43 -177.234 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 4.9 tp -88.71 137.32 32.42 Favored 'General case' 0 C--N 1.318 -0.801 0 N-CA-C 109.769 -0.456 . . . . 0.0 109.769 174.711 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 37' ' ' PHE . . . . . . . . . . . . . 6.4 m-30 -98.37 119.89 37.84 Favored 'General case' 0 C--N 1.316 -0.862 0 N-CA-C 108.548 -0.908 . . . . 0.0 108.548 172.5 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 38' ' ' ARG . . . . . 0.437 ' HG3' ' HB3' ' A' ' 42' ' ' ALA . 24.6 tpt180 -90.33 104.88 17.41 Favored 'General case' 0 N--CA 1.442 -0.832 0 N-CA-C 108.955 -0.757 . . . . 0.0 108.955 177.92 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 39' ' ' LEU . . . . . 0.631 HD23 ' O ' ' A' ' 9' ' ' SER . 2.2 mm? -89.97 156.26 18.54 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-N 115.455 -0.793 . . . . 0.0 111.137 -178.767 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 101.09 29.48 6.4 Favored Glycine 0 N--CA 1.445 -0.713 0 C-N-CA 120.723 -0.751 . . . . 0.0 112.103 -175.19 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 38.8 t70 68.87 3.42 3.97 Favored 'General case' 0 N--CA 1.472 0.627 0 CA-C-O 121.34 0.59 . . . . 0.0 111.823 175.357 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 42' ' ' ALA . . . . . 0.437 ' HB3' ' HG3' ' A' ' 38' ' ' ARG . . . -74.53 -7.52 53.35 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-N 116.055 -0.52 . . . . 0.0 112.113 -179.305 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 32.7 t -163.68 -60.64 0.04 OUTLIER 'General case' 0 C--N 1.323 -0.556 0 N-CA-C 109.476 -0.564 . . . . 0.0 109.476 176.056 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 7.8 mp -90.01 161.46 15.85 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-N 115.87 -0.604 . . . . 0.0 110.502 178.096 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 46.9 t -77.99 145.87 35.75 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-N 115.438 -0.801 . . . . 0.0 109.752 178.273 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 46' ' ' GLU . . . . . 0.62 ' O ' ' HG2' ' A' ' 50' ' ' GLN . 12.1 tt0 -58.68 -16.69 17.44 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 115.078 -0.964 . . . . 0.0 112.004 -176.987 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -69.29 -32.06 71.99 Favored Glycine 0 N--CA 1.446 -0.634 0 C-N-CA 120.69 -0.766 . . . . 0.0 111.942 -177.812 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 1.6 tt -69.07 -53.0 22.64 Favored 'General case' 0 N--CA 1.45 -0.445 0 CA-C-O 120.672 0.272 . . . . 0.0 110.834 -178.298 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 49' ' ' GLU . . . . . 0.58 ' O ' HD22 ' A' ' 53' ' ' LEU . 14.2 pt-20 -58.04 -32.32 67.87 Favored 'General case' 0 N--CA 1.453 -0.305 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.61 179.497 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 50' ' ' GLN . . . . . 0.62 ' HG2' ' O ' ' A' ' 46' ' ' GLU . 69.9 mm-40 -57.32 -26.75 61.42 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 120.775 0.321 . . . . 0.0 110.904 -177.841 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 51' ' ' HIS . . . . . . . . . . . . . 12.1 m-70 -99.76 -14.02 19.03 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 116.397 -0.365 . . . . 0.0 111.03 -179.222 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 25.6 mt -95.76 -30.76 13.54 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 116.406 -0.361 . . . . 0.0 111.914 -177.401 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 53' ' ' LEU . . . . . 0.58 HD22 ' O ' ' A' ' 49' ' ' GLU . 0.0 OUTLIER -57.59 143.59 40.56 Favored 'General case' 0 C--O 1.234 0.26 0 CA-C-O 120.874 0.369 . . . . 0.0 111.246 -176.862 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 93.56 -2.7 70.75 Favored Glycine 0 N--CA 1.443 -0.845 0 C-N-CA 120.879 -0.677 . . . . 0.0 113.452 177.972 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 55' ' ' LEU . . . . . 0.501 ' O ' HG12 ' A' ' 5' ' ' VAL . 24.8 tp -94.41 164.22 13.1 Favored 'General case' 0 N--CA 1.453 -0.311 0 CA-C-N 118.052 0.926 . . . . 0.0 109.159 178.549 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 56' ' ' LYS . . . . . 0.665 ' HD2' ' N ' ' A' ' 57' ' ' VAL . 0.9 OUTLIER -117.15 157.79 25.34 Favored 'General case' 0 C--N 1.32 -0.708 0 N-CA-C 109.89 -0.411 . . . . 0.0 109.89 -174.803 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 57' ' ' VAL . . . . . 0.665 ' N ' ' HD2' ' A' ' 56' ' ' LYS . 8.8 t -57.61 141.74 14.23 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.243 0 CA-C-O 121.078 0.465 . . . . 0.0 111.357 177.954 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 82.87 10.12 83.5 Favored Glycine 0 N--CA 1.447 -0.576 0 CA-C-N 115.734 -0.666 . . . . 0.0 112.338 -178.859 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 8.5 m-20 -116.41 152.76 33.33 Favored 'General case' 0 C--N 1.324 -0.53 0 N-CA-C 109.543 -0.54 . . . . 0.0 109.543 174.291 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 60' ' ' LYS . . . . . 0.525 ' HE3' ' HG2' ' A' ' 139' ' ' GLU . 0.6 OUTLIER -131.73 149.38 52.5 Favored 'General case' 0 C--N 1.316 -0.877 0 CA-C-O 121.519 0.676 . . . . 0.0 111.76 -175.364 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 9.3 t -143.53 130.86 20.91 Favored 'General case' 0 C--N 1.314 -0.961 0 CA-C-N 114.714 -1.13 . . . . 0.0 110.884 -178.36 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 4.1 m -107.1 131.53 54.01 Favored 'General case' 0 N--CA 1.44 -0.944 0 N-CA-C 107.866 -1.161 . . . . 0.0 107.866 171.134 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 63' ' ' PHE . . . . . 0.43 ' HE1' ' CG1' ' A' ' 138' ' ' ILE . 1.5 p90 -158.24 153.46 25.65 Favored 'General case' 0 C--N 1.321 -0.631 0 CA-C-O 121.021 0.439 . . . . 0.0 110.937 -171.195 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 16.4 m -104.85 148.96 26.09 Favored 'General case' 0 C--N 1.319 -0.748 0 CA-C-N 115.727 -0.669 . . . . 0.0 110.644 -179.713 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 65' ' ' LEU . . . . . 0.451 ' O ' HG23 ' A' ' 133' ' ' THR . 82.8 mt -138.82 142.39 38.68 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.557 -0.292 . . . . 0.0 110.722 -176.039 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 66' ' ' GLU . . . . . 0.49 ' H ' ' CD ' ' A' ' 66' ' ' GLU . 1.6 mp0 -64.76 154.11 86.23 Favored Pre-proline 0 C--N 1.329 -0.311 0 CA-C-N 115.921 -0.581 . . . . 0.0 109.741 174.299 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 10.8 Cg_endo -56.65 -48.55 18.26 Favored 'Trans proline' 0 C--O 1.219 -0.431 0 C-N-CA 121.869 1.712 . . . . 0.0 113.563 -176.355 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 23.5 t70 -64.01 -21.99 66.74 Favored 'General case' 0 C--N 1.324 -0.511 0 O-C-N 121.515 -0.741 . . . . 0.0 110.072 178.534 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -86.35 -28.76 23.46 Favored 'General case' 0 N--CA 1.451 -0.406 0 CA-C-N 115.982 -0.554 . . . . 0.0 111.216 179.09 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.454 -0.262 0 N-CA-C 109.776 -0.453 . . . . 0.0 109.776 176.578 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 75' ' ' SER . . . . . 0.578 ' HB3' ' OD1' ' A' ' 77' ' ' ASP . 30.8 m . . . . . 0 C--O 1.232 0.156 0 CA-C-O 120.774 0.321 . . . . 0.0 110.993 . . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 76' ' ' PRO . . . . . 0.473 ' HA ' HG13 ' A' ' 79' ' ' ILE . 53.1 Cg_endo -70.16 -17.28 35.87 Favored 'Trans proline' 0 CA--C 1.529 0.274 0 C-N-CA 123.199 2.599 . . . . 0.0 113.571 -178.118 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 77' ' ' ASP . . . . . 0.578 ' OD1' ' HB3' ' A' ' 75' ' ' SER . 5.2 p-10 -69.27 -4.75 19.2 Favored 'General case' 0 C--N 1.329 -0.325 0 N-CA-C 112.829 0.678 . . . . 0.0 112.829 -173.331 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 78' ' ' LEU . . . . . 0.635 ' HB2' ' O ' ' A' ' 125' ' ' PHE . 83.1 mt -112.57 -5.1 14.03 Favored 'General case' 0 C--N 1.324 -0.523 0 C-N-CA 120.742 -0.383 . . . . 0.0 110.963 176.399 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 79' ' ' ILE . . . . . 0.473 HG13 ' HA ' ' A' ' 76' ' ' PRO . 15.2 mt -77.39 104.81 5.64 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.736 0 C-N-CA 120.345 -0.542 . . . . 0.0 109.705 -173.695 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 73.0 mt-30 -108.95 164.06 12.75 Favored 'General case' 0 C--N 1.314 -0.937 0 CA-C-N 115.671 -0.695 . . . . 0.0 111.824 -172.806 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 81' ' ' TYR . . . . . . . . . . . . . 11.3 m-85 -129.48 115.67 17.82 Favored 'General case' 0 N--CA 1.444 -0.766 0 N-CA-C 107.514 -1.291 . . . . 0.0 107.514 -172.78 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 73.4 m-85 -111.24 168.29 9.63 Favored 'General case' 0 C--N 1.317 -0.844 0 CA-C-O 120.763 0.316 . . . . 0.0 110.863 -174.661 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 12.2 t -73.86 145.24 45.02 Favored 'General case' 0 C--N 1.323 -0.577 0 N-CA-C 108.849 -0.797 . . . . 0.0 108.849 176.692 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 84' ' ' ARG . . . . . 0.649 ' HD3' ' HA ' ' A' ' 119' ' ' ASP . 28.9 ptt180 -73.64 -29.72 62.51 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-O 121.576 0.703 . . . . 0.0 109.609 -173.895 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 85' ' ' ARG . . . . . 0.446 ' HD2' ' H ' ' A' ' 85' ' ' ARG . 0.8 OUTLIER -64.7 -38.94 92.7 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 114.597 -1.183 . . . . 0.0 113.391 -171.015 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 86' ' ' GLU . . . . . 0.461 ' O ' ' HB3' ' A' ' 89' ' ' ASP . 44.1 mm-40 -60.65 -48.88 79.82 Favored 'General case' 0 C--N 1.317 -0.836 0 CA-C-O 122.269 1.033 . . . . 0.0 108.687 174.259 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 87' ' ' PHE . . . . . . . . . . . . . 55.6 m-85 -59.0 -31.85 69.18 Favored 'General case' 0 C--N 1.318 -0.783 0 CA-C-N 113.701 -1.591 . . . . 0.0 112.91 175.264 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 88' ' ' MET . . . . . . . . . . . . . 60.3 ttp -68.18 -41.45 81.43 Favored 'General case' 0 C--N 1.315 -0.898 0 CA-C-O 122.13 0.967 . . . . 0.0 109.521 174.025 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 89' ' ' ASP . . . . . 0.461 ' HB3' ' O ' ' A' ' 86' ' ' GLU . 19.3 t70 -55.17 -23.07 19.82 Favored 'General case' 0 C--N 1.321 -0.673 0 CA-C-N 113.387 -1.733 . . . . 0.0 110.164 176.029 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -112.86 8.63 18.75 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 115.646 -0.706 . . . . 0.0 111.799 178.938 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 92.08 137.61 7.85 Favored Glycine 0 C--N 1.331 0.265 0 C-N-CA 120.482 -0.866 . . . . 0.0 111.989 -177.453 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 8.8 tt0 -61.91 122.07 69.47 Favored Pre-proline 0 N--CA 1.442 -0.848 0 CA-C-O 121.116 0.484 . . . . 0.0 111.306 -172.271 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 93' ' ' PRO . . . . . 0.482 ' HG2' HD12 ' A' ' 121' ' ' ILE . 38.1 Cg_endo -77.75 165.96 26.03 Favored 'Trans proline' 0 N--CA 1.46 -0.497 0 C-N-CA 122.935 2.423 . . . . 0.0 112.875 -177.525 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 94' ' ' GLU . . . . . 0.521 ' O ' HD12 ' A' ' 113' ' ' ILE . 27.0 mt-10 -115.94 154.13 30.35 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.018 -0.537 . . . . 0.0 111.131 -176.135 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 95' ' ' ILE . . . . . 0.543 HG12 HG12 ' A' ' 116' ' ' ILE . 32.6 mt -77.17 134.16 29.24 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.384 0 CA-C-N 116.446 -0.343 . . . . 0.0 110.099 179.168 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 72.26 19.47 78.7 Favored Glycine 0 N--CA 1.449 -0.481 0 C-N-CA 121.032 -0.604 . . . . 0.0 112.407 -176.997 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 97' ' ' ALA . . . . . 0.466 ' O ' HG13 ' A' ' 113' ' ' ILE . . . -99.71 166.86 10.91 Favored 'General case' 0 C--N 1.323 -0.562 0 N-CA-C 109.562 -0.533 . . . . 0.0 109.562 175.27 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 38.8 mt -125.79 126.11 69.49 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.727 0 CA-C-O 120.876 0.37 . . . . 0.0 110.533 -175.598 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 99' ' ' MET . . . . . 0.421 ' SD ' HD11 ' A' ' 113' ' ' ILE . 2.7 mtp -124.72 161.58 26.06 Favored 'General case' 0 C--N 1.324 -0.527 0 N-CA-C 107.898 -1.149 . . . . 0.0 107.898 -179.922 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 100' ' ' LEU . . . . . 0.423 HD13 ' HA ' ' A' ' 100' ' ' LEU . 3.9 mm? -77.24 153.62 33.82 Favored 'General case' 0 C--N 1.323 -0.587 0 CA-C-N 118.806 0.73 . . . . 0.0 111.078 167.635 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 101' ' ' PHE . . . . . 0.6 ' CE2' HG11 ' A' ' 123' ' ' VAL . 65.5 m-85 -149.42 155.52 40.57 Favored 'General case' 0 C--N 1.319 -0.761 0 CA-C-N 114.702 -1.136 . . . . 0.0 107.986 -170.334 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 3.1 m -121.11 111.44 17.45 Favored 'General case' 0 C--N 1.314 -0.958 0 C-N-CA 119.793 -0.763 . . . . 0.0 110.154 -178.348 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -77.78 166.25 23.18 Favored 'General case' 0 N--CA 1.448 -0.56 0 CA-C-N 115.4 -0.818 . . . . 0.0 110.868 -177.183 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 104' ' ' MET . . . . . . . . . . . . . 60.1 mtt -67.37 -14.32 62.81 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.128 -0.942 . . . . 0.0 111.901 -173.669 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 8.2 p-10 -96.51 11.38 35.27 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 116.551 -0.295 . . . . 0.0 111.383 -177.784 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 88.06 -11.33 67.52 Favored Glycine 0 N--CA 1.447 -0.602 0 C-N-CA 120.42 -0.895 . . . . 0.0 113.289 179.448 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 33.3 t -79.36 149.74 31.61 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-O 121.227 0.537 . . . . 0.0 110.692 -179.327 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 108' ' ' GLU . . . . . 0.448 ' HA ' ' O ' ' A' ' 101' ' ' PHE . 44.5 tt0 -120.51 104.11 9.71 Favored 'General case' 0 C--N 1.317 -0.845 0 CA-C-N 115.615 -0.72 . . . . 0.0 109.381 179.801 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 109' ' ' MET . . . . . 0.438 ' SD ' ' HD2' ' A' ' 125' ' ' PHE . 13.7 ptp -111.44 145.14 31.97 Favored Pre-proline 0 C--N 1.322 -0.614 0 CA-C-N 116.535 -0.302 . . . . 0.0 110.621 -175.579 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 12.2 Cg_exo -70.1 120.6 7.31 Favored 'Trans proline' 0 N--CA 1.462 -0.368 0 C-N-CA 122.475 2.117 . . . . 0.0 110.663 171.5 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . -117.41 153.88 17.01 Favored Glycine 0 C--N 1.321 -0.29 0 C-N-CA 120.752 -0.737 . . . . 0.0 112.447 -176.562 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER -100.77 121.29 51.39 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.426 0 CA-C-O 121.064 0.459 . . . . 0.0 110.249 -176.392 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 113' ' ' ILE . . . . . 0.521 HD12 ' O ' ' A' ' 94' ' ' GLU . 1.0 OUTLIER -67.05 111.22 1.85 Allowed 'Isoleucine or valine' 0 C--N 1.316 -0.85 0 CA-C-N 115.762 -0.654 . . . . 0.0 109.386 176.709 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 114' ' ' ARG . . . . . . . . . . . . . 13.2 tpp180 -63.29 -52.36 62.31 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 115.349 -0.841 . . . . 0.0 110.744 -178.085 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 5.2 tt0 -159.48 148.45 18.03 Favored 'General case' 0 C--N 1.32 -0.699 0 N-CA-C 110.11 -0.33 . . . . 0.0 110.11 -177.79 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 116' ' ' ILE . . . . . 0.543 HG12 HG12 ' A' ' 95' ' ' ILE . 45.9 mm -96.12 111.2 25.88 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.533 0 N-CA-C 108.879 -0.786 . . . . 0.0 108.879 176.197 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 117' ' ' ASN . . . . . . . . . . . . . 37.6 m-80 -101.47 155.8 17.85 Favored 'General case' 0 C--N 1.313 -1.012 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.057 -179.111 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . -57.22 -38.84 88.48 Favored Glycine 0 N--CA 1.448 -0.52 0 C-N-CA 120.453 -0.88 . . . . 0.0 112.925 -170.842 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 119' ' ' ASP . . . . . 0.649 ' HA ' ' HD3' ' A' ' 84' ' ' ARG . 4.7 p-10 -109.75 -12.55 14.61 Favored 'General case' 0 C--N 1.324 -0.516 0 N-CA-C 111.977 0.362 . . . . 0.0 111.977 -174.66 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 20.3 t -146.12 155.99 43.13 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 121.065 0.459 . . . . 0.0 111.899 -168.603 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 121' ' ' ILE . . . . . 0.482 HD12 ' HG2' ' A' ' 93' ' ' PRO . 35.1 mm -119.43 120.25 63.04 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 115.896 -0.593 . . . . 0.0 110.178 178.705 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 89.8 m -106.14 119.48 39.34 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 116.568 -0.287 . . . . 0.0 111.052 -177.504 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 123' ' ' VAL . . . . . 0.6 HG11 ' CE2' ' A' ' 101' ' ' PHE . 38.8 t -117.69 118.26 57.8 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.316 0 CA-C-O 119.482 -0.295 . . . . 0.0 110.539 179.049 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 9.4 p-10 -95.32 96.34 9.08 Favored 'General case' 0 N--CA 1.452 -0.345 0 N-CA-C 114.131 1.159 . . . . 0.0 114.131 -179.906 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 125' ' ' PHE . . . . . 0.635 ' O ' ' HB2' ' A' ' 78' ' ' LEU . 12.0 m-85 -68.78 98.0 0.87 Allowed 'General case' 0 N--CA 1.447 -0.616 0 N-CA-C 109.303 -0.629 . . . . 0.0 109.303 165.912 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 126' ' ' ASN . . . . . 0.42 ' N ' HD22 ' A' ' 126' ' ' ASN . 1.2 m-80 . . . . . 0 C--N 1.3 -1.585 0 CA-C-O 121.092 0.473 . . . . 0.0 110.934 177.237 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 133' ' ' THR . . . . . 0.451 HG23 ' O ' ' A' ' 65' ' ' LEU . 59.6 m . . . . . 0 C--O 1.234 0.242 0 CA-C-O 120.451 0.167 . . . . 0.0 111.13 . . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 134' ' ' VAL . . . . . . . . . . . . . 20.3 m -120.73 151.34 23.62 Favored 'Isoleucine or valine' 0 C--O 1.233 0.22 0 CA-C-O 121.526 0.679 . . . . 0.0 111.697 177.957 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 135' ' ' HIS . . . . . 0.477 ' O ' HD23 ' A' ' 17' ' ' LEU . 86.2 m-70 -90.58 134.94 34.02 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-N 114.728 -1.124 . . . . 0.0 110.375 174.225 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 136' ' ' PHE . . . . . 0.509 ' CE2' HD21 ' A' ' 17' ' ' LEU . 2.5 m-85 -120.94 125.68 48.04 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 116.252 -0.431 . . . . 0.0 111.113 -177.385 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 137' ' ' ASP . . . . . 0.42 ' O ' ' HB2' ' A' ' 15' ' ' PHE . 36.0 t70 -113.11 109.52 18.93 Favored 'General case' 0 C--N 1.315 -0.911 0 N-CA-C 108.513 -0.921 . . . . 0.0 108.513 169.028 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 138' ' ' ILE . . . . . 0.547 HG23 HG21 ' A' ' 13' ' ' VAL . 43.1 mm -119.19 121.33 66.38 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.452 0 O-C-N 123.098 0.249 . . . . 0.0 111.262 -169.773 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 139' ' ' GLU . . . . . 0.525 ' HG2' ' HE3' ' A' ' 60' ' ' LYS . 33.3 mt-10 -107.73 115.55 30.35 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 120.59 0.233 . . . . 0.0 111.201 173.356 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 140' ' ' VAL . . . . . 0.412 ' CG1' ' HA ' ' A' ' 57' ' ' VAL . 38.8 t -71.12 107.47 2.31 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.568 0 CA-C-N 116.299 -0.409 . . . . 0.0 110.177 175.533 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 141' ' ' LEU . . . . . 0.429 HD11 ' CD2' ' A' ' 14' ' ' HIS . 40.1 mt -94.59 -49.64 5.55 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-O 120.885 0.374 . . . . 0.0 110.097 179.821 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 142' ' ' GLU . . . . . 0.449 ' HB2' HD22 ' A' ' 12' ' ' LEU . 37.1 mt-10 -143.7 163.15 34.11 Favored 'General case' 0 CA--C 1.513 -0.476 0 CA-C-N 115.847 -0.615 . . . . 0.0 109.88 172.38 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 143' ' ' ILE . . . . . 0.443 HD13 ' N ' ' A' ' 5' ' ' VAL . 94.8 mt -123.49 110.07 25.03 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.901 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.539 178.484 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 144' ' ' ASP . . . . . . . . . . . . . 27.1 t70 -78.57 111.89 22.58 Favored Pre-proline 0 C--N 1.325 -0.469 0 CA-C-N 115.487 -0.779 . . . . 0.0 110.058 178.408 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 145' ' ' PRO . . . . . . . . . . . . . 52.5 Cg_endo . . . . . 0 N--CA 1.459 -0.514 0 C-N-CA 122.186 1.924 . . . . 0.0 111.831 -177.207 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 2' ' ' SER . . . . . 0.407 ' OG ' ' HA ' ' A' ' 145' ' ' PRO . 35.5 m . . . . . 0 N--CA 1.453 -0.307 0 CA-C-O 121.216 0.532 . . . . 0.0 110.603 . . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 3' ' ' GLU . . . . . 0.508 ' HG2' ' HE2' ' A' ' 56' ' ' LYS . 36.0 tt0 -99.54 -27.99 13.44 Favored 'General case' 0 C--N 1.319 -0.721 0 CA-C-N 115.533 -0.758 . . . . 0.0 110.525 -177.584 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 4' ' ' SER . . . . . 0.42 ' HA ' ' HA ' ' A' ' 56' ' ' LYS . 8.5 p -124.94 158.27 33.99 Favored 'General case' 0 C--N 1.318 -0.782 0 CA-C-N 115.415 -0.811 . . . . 0.0 109.998 178.489 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . 0.519 HG22 ' N ' ' A' ' 55' ' ' LEU . 3.7 m -83.22 151.89 3.95 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.41 0 CA-C-O 121.294 0.568 . . . . 0.0 111.032 -175.341 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 6' ' ' GLN . . . . . 0.625 ' HG2' ' OG ' ' A' ' 9' ' ' SER . 1.4 pt20 -141.88 168.42 19.81 Favored 'General case' 0 C--N 1.314 -0.948 0 CA-C-N 115.223 -0.899 . . . . 0.0 108.86 176.164 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 51.5 p -53.47 122.08 8.98 Favored 'General case' 0 C--N 1.318 -0.768 0 N-CA-C 109.928 -0.397 . . . . 0.0 109.928 176.073 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 8' ' ' ASN . . . . . 0.438 ' HA ' ' O ' ' A' ' 39' ' ' LEU . 3.6 t-20 80.53 41.43 0.06 Allowed 'General case' 0 N--CA 1.475 0.809 0 O-C-N 124.036 0.835 . . . . 0.0 111.507 178.332 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 9' ' ' SER . . . . . 0.625 ' OG ' ' HG2' ' A' ' 6' ' ' GLN . 47.8 m -103.86 160.77 14.51 Favored 'General case' 0 C--N 1.332 -0.16 0 O-C-N 121.994 -0.441 . . . . 0.0 111.039 174.17 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 10' ' ' ALA . . . . . 0.713 ' HB1' HD21 ' A' ' 36' ' ' LEU . . . -109.49 131.93 54.61 Favored 'General case' 0 C--N 1.322 -0.606 0 N-CA-C 108.779 -0.823 . . . . 0.0 108.779 171.964 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 11' ' ' VAL . . . . . 0.475 ' O ' ' HA ' ' A' ' 36' ' ' LEU . 6.4 m -138.8 136.88 43.15 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.435 0 C-N-CA 120.501 -0.48 . . . . 0.0 111.437 -174.305 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 89.3 mt -86.42 128.61 34.97 Favored 'General case' 0 C--N 1.324 -0.51 0 N-CA-C 108.251 -1.018 . . . . 0.0 108.251 173.238 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 13' ' ' VAL . . . . . 0.736 HG21 HG23 ' A' ' 138' ' ' ILE . 1.6 p -141.65 157.53 21.17 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.86 0 CA-C-O 121.117 0.485 . . . . 0.0 110.747 -173.196 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 14' ' ' HIS . . . . . 0.495 ' ND1' ' HA ' ' A' ' 29' ' ' ARG . 0.5 OUTLIER -124.98 116.42 22.13 Favored 'General case' 0 C--N 1.318 -0.802 0 N-CA-C 106.396 -1.705 . . . . 0.0 106.396 170.545 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 15' ' ' PHE . . . . . 0.461 ' CE1' ' HB ' ' A' ' 28' ' ' THR . 18.2 p90 -146.0 158.8 43.87 Favored 'General case' 0 C--N 1.316 -0.852 0 C-N-CA 120.427 -0.509 . . . . 0.0 110.77 -169.019 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 87.8 m -130.32 130.16 44.12 Favored 'General case' 0 C--N 1.318 -0.775 0 N-CA-C 109.859 -0.423 . . . . 0.0 109.859 174.434 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 17' ' ' LEU . . . . . 0.5 HD21 ' CE1' ' A' ' 136' ' ' PHE . 9.5 mt -95.77 138.8 32.91 Favored 'General case' 0 N--CA 1.445 -0.683 0 CA-C-O 121.714 0.769 . . . . 0.0 111.659 -179.008 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 4.3 mptp? -122.31 147.47 46.2 Favored 'General case' 0 C--N 1.314 -0.95 0 CA-C-N 114.314 -1.312 . . . . 0.0 110.031 -176.24 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 19' ' ' LEU . . . . . 0.404 HD13 ' HA ' ' A' ' 19' ' ' LEU . 4.1 mm? -83.43 169.13 15.88 Favored 'General case' 0 C--N 1.312 -1.041 0 N-CA-C 108.716 -0.846 . . . . 0.0 108.716 170.755 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 29.3 t70 -68.88 -25.42 64.61 Favored 'General case' 0 C--N 1.318 -0.804 0 CA-C-O 121.323 0.583 . . . . 0.0 109.607 177.717 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 15.4 t70 -80.07 0.95 29.77 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.339 -0.846 . . . . 0.0 110.426 176.001 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 76.22 25.38 66.32 Favored Glycine 0 N--CA 1.45 -0.402 0 CA-C-N 116.175 -0.466 . . . . 0.0 113.155 178.64 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 14.1 m -90.11 154.73 19.56 Favored 'General case' 0 C--N 1.322 -0.607 0 N-CA-C 109.307 -0.627 . . . . 0.0 109.307 171.954 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 59.7 m -90.43 118.26 29.77 Favored 'General case' 0 C--N 1.32 -0.679 0 O-C-N 121.749 -0.594 . . . . 0.0 110.538 177.33 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 25' ' ' ALA . . . . . 0.401 ' HB2' ' CD2' ' A' ' 19' ' ' LEU . . . -84.11 -48.85 9.43 Favored 'General case' 0 CA--C 1.516 -0.33 0 CA-C-O 121.498 0.666 . . . . 0.0 110.269 179.337 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 9.2 tp10 -151.41 119.95 6.47 Favored 'General case' 0 C--N 1.318 -0.774 0 CA-C-N 114.842 -1.072 . . . . 0.0 109.068 -179.498 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 12.8 t -111.72 101.14 9.53 Favored 'General case' 0 C--N 1.315 -0.921 0 C-N-CA 120.033 -0.667 . . . . 0.0 110.259 177.512 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 28' ' ' THR . . . . . 0.461 ' HB ' ' CE1' ' A' ' 15' ' ' PHE . 31.0 m -97.64 51.4 1.07 Allowed 'General case' 0 C--N 1.313 -0.984 0 CA-C-O 122.706 1.241 . . . . 0.0 109.302 175.978 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 29' ' ' ARG . . . . . 0.495 ' HA ' ' ND1' ' A' ' 14' ' ' HIS . 29.6 ttp180 -143.56 -67.94 0.34 Allowed 'General case' 0 C--N 1.314 -0.954 0 CA-C-N 114.785 -1.098 . . . . 0.0 110.618 -177.059 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 2.2 p-10 -80.69 33.8 0.32 Allowed 'General case' 0 N--CA 1.467 0.385 0 N-CA-C 111.972 0.36 . . . . 0.0 111.972 -177.805 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 92.4 m-20 -119.21 -7.82 10.23 Favored 'General case' 0 C--N 1.325 -0.472 0 N-CA-C 109.829 -0.434 . . . . 0.0 109.829 173.082 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 79.73 6.25 89.11 Favored Glycine 0 N--CA 1.447 -0.592 0 C-N-CA 121.055 -0.593 . . . . 0.0 111.635 -177.342 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 50.0 mmtm -114.28 112.91 46.29 Favored Pre-proline 0 C--N 1.325 -0.474 0 CA-C-N 115.885 -0.158 . . . . 0.0 110.7 -178.263 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 6.2 Cg_exo -79.3 169.82 18.34 Favored 'Trans proline' 0 N--CA 1.46 -0.454 0 C-N-CA 122.88 2.386 . . . . 0.0 112.434 172.45 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 35' ' ' ALA . . . . . 0.41 ' CB ' HG21 ' A' ' 28' ' ' THR . . . -144.55 158.79 43.6 Favored 'General case' 0 C--N 1.315 -0.926 0 CA-C-N 115.061 -0.972 . . . . 0.0 109.698 179.009 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 36' ' ' LEU . . . . . 0.713 HD21 ' HB1' ' A' ' 10' ' ' ALA . 0.7 OUTLIER -108.63 134.54 51.23 Favored 'General case' 0 N--CA 1.445 -0.677 0 CA-C-O 120.749 0.309 . . . . 0.0 110.333 177.202 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 37' ' ' PHE . . . . . . . . . . . . . 4.7 m-30 -96.4 130.71 43.46 Favored 'General case' 0 C--N 1.318 -0.766 0 CA-C-N 116.05 -0.523 . . . . 0.0 109.911 174.187 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 2.1 tpp180 -111.59 107.98 17.31 Favored 'General case' 0 C--N 1.321 -0.649 0 CA-C-N 116.076 -0.511 . . . . 0.0 109.76 -177.443 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 39' ' ' LEU . . . . . 0.566 ' HG ' ' O ' ' A' ' 9' ' ' SER . 6.6 mt -83.71 154.87 23.4 Favored 'General case' 0 C--N 1.319 -0.739 0 CA-C-N 116.201 -0.454 . . . . 0.0 109.894 -178.092 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 40' ' ' GLY . . . . . 0.465 ' H ' ' CD ' ' A' ' 49' ' ' GLU . . . 100.41 33.66 5.04 Favored Glycine 0 C--N 1.312 -0.782 0 CA-C-N 115.807 -0.633 . . . . 0.0 112.494 -179.125 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 6.5 m-20 63.58 8.36 3.59 Favored 'General case' 0 N--CA 1.473 0.709 0 N-CA-C 112.538 0.569 . . . . 0.0 112.538 178.237 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -67.37 -31.39 71.6 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-O 120.803 0.335 . . . . 0.0 111.657 -176.773 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 11.9 p -137.31 -65.85 0.53 Allowed 'General case' 0 C--N 1.321 -0.638 0 CA-C-N 116.453 -0.339 . . . . 0.0 111.048 -178.931 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 7.5 mp -85.89 -178.74 6.66 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.392 -179.432 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 31.0 m -95.86 164.05 12.9 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-N 116.317 -0.401 . . . . 0.0 111.539 -176.603 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 46' ' ' GLU . . . . . 0.47 ' O ' ' HG2' ' A' ' 50' ' ' GLN . 41.6 mt-10 -52.38 -41.11 62.85 Favored 'General case' 0 N--CA 1.465 0.289 0 N-CA-C 112.876 0.695 . . . . 0.0 112.876 -172.576 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -61.9 -41.82 99.68 Favored Glycine 0 N--CA 1.449 -0.453 0 C-N-CA 120.571 -0.823 . . . . 0.0 112.284 -170.134 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 48' ' ' LEU . . . . . 0.445 HD13 ' C ' ' A' ' 48' ' ' LEU . 3.2 tm? -61.02 -53.6 55.24 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-O 120.495 0.188 . . . . 0.0 111.144 -179.426 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 49' ' ' GLU . . . . . 0.697 ' O ' HD13 ' A' ' 53' ' ' LEU . 9.7 pt-20 -68.77 -37.4 79.31 Favored 'General case' 0 C--N 1.325 -0.46 0 N-CA-C 111.621 0.23 . . . . 0.0 111.621 -173.633 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 50' ' ' GLN . . . . . 0.541 ' HA ' HD22 ' A' ' 53' ' ' LEU . 33.1 mm-40 -66.15 -12.47 56.01 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 120.845 0.355 . . . . 0.0 111.353 -176.42 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 51' ' ' HIS . . . . . . . . . . . . . 12.1 m-70 -103.38 -4.0 24.74 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 121.213 0.53 . . . . 0.0 110.485 177.629 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 52' ' ' LEU . . . . . 0.466 ' O ' HG21 ' A' ' 5' ' ' VAL . 12.0 mt -102.51 -11.72 18.33 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-N 115.762 -0.653 . . . . 0.0 111.16 177.76 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 53' ' ' LEU . . . . . 0.697 HD13 ' O ' ' A' ' 49' ' ' GLU . 1.1 mp -58.78 136.6 57.81 Favored 'General case' 0 N--CA 1.449 -0.511 0 CA-C-O 121.125 0.488 . . . . 0.0 111.47 177.805 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 94.39 -4.57 70.16 Favored Glycine 0 N--CA 1.447 -0.572 0 CA-C-N 115.592 -0.731 . . . . 0.0 113.091 -179.677 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 55' ' ' LEU . . . . . 0.519 ' N ' HG22 ' A' ' 5' ' ' VAL . 3.0 mm? -71.97 164.8 25.46 Favored 'General case' 0 CA--C 1.521 -0.15 0 CA-C-N 117.391 0.595 . . . . 0.0 110.935 177.876 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 56' ' ' LYS . . . . . 0.604 ' HD3' ' N ' ' A' ' 57' ' ' VAL . 12.3 tmtt? -140.73 154.99 46.55 Favored 'General case' 0 C--N 1.32 -0.699 0 N-CA-C 108.703 -0.851 . . . . 0.0 108.703 -175.031 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 57' ' ' VAL . . . . . 0.604 ' N ' ' HD3' ' A' ' 56' ' ' LYS . 29.8 t -59.66 125.65 16.09 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-O 121.261 0.553 . . . . 0.0 111.386 179.714 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 80.95 19.74 66.82 Favored Glycine 0 N--CA 1.447 -0.627 0 CA-C-N 115.521 -0.763 . . . . 0.0 112.399 -177.398 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 59' ' ' ASP . . . . . 0.487 ' OD1' ' HB3' ' A' ' 56' ' ' LYS . 1.6 m-20 -110.55 150.16 29.34 Favored 'General case' 0 C--N 1.321 -0.631 0 CA-C-O 121.021 0.439 . . . . 0.0 110.452 176.01 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 60' ' ' LYS . . . . . 0.531 ' CE ' ' HG2' ' A' ' 139' ' ' GLU . 0.3 OUTLIER -115.48 133.11 56.34 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-N 115.51 -0.768 . . . . 0.0 109.926 -171.424 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 13.0 t -143.3 134.67 26.08 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-O 121.557 0.694 . . . . 0.0 111.306 178.643 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 5.9 m -123.78 132.49 53.81 Favored 'General case' 0 C--N 1.319 -0.741 0 CA-C-N 115.686 -0.688 . . . . 0.0 109.176 176.293 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 31.7 p90 -152.52 149.19 28.26 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-O 121.013 0.435 . . . . 0.0 111.346 -178.101 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 14.9 m -96.6 156.06 16.5 Favored 'General case' 0 C--N 1.321 -0.647 0 CA-C-N 116.089 -0.505 . . . . 0.0 109.863 177.832 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 31.7 mt -150.67 134.82 16.91 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-O 120.996 0.427 . . . . 0.0 110.749 -177.155 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 22.4 mm-40 -70.71 150.21 95.32 Favored Pre-proline 0 C--N 1.322 -0.587 0 N-CA-C 108.922 -0.77 . . . . 0.0 108.922 173.674 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 5.1 Cg_endo -48.38 -49.04 15.3 Favored 'Trans proline' 0 C--N 1.345 0.344 0 C-N-CA 122.383 2.056 . . . . 0.0 112.515 -175.742 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 22.9 t70 -62.92 -32.09 73.31 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-O 120.823 0.344 . . . . 0.0 111.123 -179.524 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -95.24 13.26 26.1 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-O 121.086 0.47 . . . . 0.0 111.082 -178.244 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.323 -0.586 0 CA-C-O 121.247 0.546 . . . . 0.0 109.775 179.09 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 75' ' ' SER . . . . . 0.548 ' CA ' HD23 ' A' ' 78' ' ' LEU . 34.7 m . . . . . 0 N--CA 1.441 -0.892 0 N-CA-C 107.475 -1.306 . . . . 0.0 107.475 . . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 3.4 Cg_exo -73.49 -48.6 0.24 Allowed 'Trans proline' 0 CA--C 1.518 -0.317 0 C-N-CA 122.315 2.01 . . . . 0.0 113.014 -171.296 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 9.1 p-10 -69.71 -4.18 18.57 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-N 115.149 -0.932 . . . . 0.0 111.199 -177.597 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 78' ' ' LEU . . . . . 0.708 ' HB3' ' HB2' ' A' ' 125' ' ' PHE . 1.3 mm? -92.74 3.13 56.19 Favored 'General case' 0 C--N 1.325 -0.484 0 N-CA-C 109.6 -0.518 . . . . 0.0 109.6 178.323 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 68.5 mt -97.5 109.5 23.52 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.808 0 CA-C-O 121.544 0.688 . . . . 0.0 110.068 -173.97 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 39.0 mt-30 -129.1 135.43 48.89 Favored 'General case' 0 C--N 1.317 -0.83 0 CA-C-N 114.702 -1.136 . . . . 0.0 111.79 -168.149 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 81' ' ' TYR . . . . . 0.419 ' CE1' HG23 ' A' ' 122' ' ' THR . 2.6 m-85 -90.63 114.98 27.38 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 121.554 0.692 . . . . 0.0 111.596 173.566 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 82' ' ' PHE . . . . . 0.438 ' CB ' ' HE1' ' A' ' 87' ' ' PHE . 25.3 m-85 -102.53 170.68 7.89 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 114.745 -1.116 . . . . 0.0 112.01 175.194 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 22.2 t -89.67 155.67 19.08 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 115.721 -0.672 . . . . 0.0 109.847 176.981 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 84' ' ' ARG . . . . . 0.501 ' HD2' ' O ' ' A' ' 118' ' ' GLY . 11.9 ptm180 -66.44 -21.49 66.2 Favored 'General case' 0 C--O 1.227 -0.114 0 N-CA-C 112.143 0.423 . . . . 0.0 112.143 -178.356 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 85' ' ' ARG . . . . . 0.404 HH12 ' CG ' ' A' ' 119' ' ' ASP . 7.5 mpt_? -71.83 -39.42 69.79 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 121.192 0.52 . . . . 0.0 110.357 -175.538 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 31.4 mt-10 -64.64 -30.38 71.4 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 115.06 -0.973 . . . . 0.0 110.406 -174.966 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 87' ' ' PHE . . . . . 0.438 ' HE1' ' CB ' ' A' ' 82' ' ' PHE . 4.3 m-85 -89.65 -46.05 8.91 Favored 'General case' 0 CA--C 1.512 -0.504 0 CA-C-N 115.584 -0.735 . . . . 0.0 111.091 179.291 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 88' ' ' MET . . . . . . . . . . . . . 53.3 ttm -61.75 -26.05 67.83 Favored 'General case' 0 C--N 1.321 -0.665 0 CA-C-N 115.497 -0.774 . . . . 0.0 111.045 -175.345 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 23.0 t70 -55.46 -33.24 63.46 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 121.178 0.513 . . . . 0.0 110.59 174.061 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -109.93 11.44 24.12 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-N 115.64 -0.709 . . . . 0.0 111.257 179.304 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 111.75 138.19 7.42 Favored Glycine 0 N--CA 1.449 -0.453 0 C-N-CA 120.771 -0.728 . . . . 0.0 112.282 -179.197 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 92' ' ' GLU . . . . . 0.463 ' HA ' ' HD3' ' A' ' 93' ' ' PRO . 42.3 mt-10 -62.22 128.32 90.89 Favored Pre-proline 0 C--N 1.324 -0.516 0 CA-C-O 120.882 0.372 . . . . 0.0 111.402 -177.073 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 93' ' ' PRO . . . . . 0.599 ' HB2' HD13 ' A' ' 113' ' ' ILE . 17.7 Cg_endo -78.06 165.36 26.19 Favored 'Trans proline' 0 N--CA 1.459 -0.552 0 C-N-CA 122.745 2.297 . . . . 0.0 112.612 -177.518 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 30.9 mt-10 -116.95 146.88 42.72 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.497 -0.32 . . . . 0.0 111.054 -178.452 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 95' ' ' ILE . . . . . 0.532 HG12 HG12 ' A' ' 116' ' ' ILE . 16.6 mt -71.16 130.73 35.0 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.424 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.688 179.31 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 71.9 16.32 76.41 Favored Glycine 0 N--CA 1.446 -0.694 0 CA-C-N 115.813 -0.631 . . . . 0.0 113.059 179.367 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 97' ' ' ALA . . . . . 0.48 ' O ' HG13 ' A' ' 113' ' ' ILE . . . -100.85 161.77 13.37 Favored 'General case' 0 C--N 1.327 -0.389 0 N-CA-C 108.962 -0.755 . . . . 0.0 108.962 174.217 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 98' ' ' ILE . . . . . 0.498 HG12 HG22 ' A' ' 112' ' ' VAL . 59.1 mt -107.53 143.92 17.24 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.872 0 N-CA-C 110.066 -0.346 . . . . 0.0 110.066 179.417 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 99' ' ' MET . . . . . 0.5 ' SD ' HD11 ' A' ' 113' ' ' ILE . 82.8 mtp -128.36 163.34 25.04 Favored 'General case' 0 N--CA 1.448 -0.542 0 N-CA-C 107.958 -1.127 . . . . 0.0 107.958 179.347 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 3.5 mm? -100.62 137.1 39.48 Favored 'General case' 0 C--N 1.309 -1.184 0 N-CA-C 109.991 -0.374 . . . . 0.0 109.991 174.139 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 101' ' ' PHE . . . . . 0.471 ' CE2' ' HB2' ' A' ' 99' ' ' MET . 50.9 m-85 -143.55 136.35 27.48 Favored 'General case' 0 C--N 1.319 -0.725 0 N-CA-C 108.998 -0.742 . . . . 0.0 108.998 -174.55 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 17.2 m -96.53 131.78 42.79 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-O 120.97 0.414 . . . . 0.0 110.55 178.825 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -95.46 159.41 15.01 Favored 'General case' 0 C--N 1.321 -0.647 0 CA-C-N 116.003 -0.544 . . . . 0.0 110.11 177.351 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 104' ' ' MET . . . . . . . . . . . . . 4.0 mpp? -66.16 -12.13 53.85 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.353 -0.84 . . . . 0.0 112.022 -174.484 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 7.7 p-10 -92.01 17.91 8.69 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-O 121.141 0.496 . . . . 0.0 110.821 177.598 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 77.28 -11.56 16.6 Favored Glycine 0 N--CA 1.452 -0.259 0 CA-C-N 115.866 -0.606 . . . . 0.0 114.189 178.102 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 14.5 t -78.64 152.87 31.49 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-N 117.185 0.492 . . . . 0.0 110.005 179.251 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 35.2 tt0 -126.78 103.16 7.38 Favored 'General case' 0 C--N 1.315 -0.934 0 N-CA-C 108.867 -0.79 . . . . 0.0 108.867 -179.337 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 109' ' ' MET . . . . . . . . . . . . . 3.1 mpp? -100.34 134.91 20.42 Favored Pre-proline 0 C--N 1.32 -0.674 0 CA-C-N 116.349 -0.387 . . . . 0.0 111.323 -175.564 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 33.5 Cg_endo -67.53 135.73 37.17 Favored 'Trans proline' 0 N--CA 1.455 -0.739 0 C-N-CA 121.911 1.74 . . . . 0.0 109.638 167.847 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . -134.66 126.04 3.98 Favored Glycine 0 N--CA 1.443 -0.886 0 N-CA-C 111.11 -0.796 . . . . 0.0 111.11 -170.59 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 112' ' ' VAL . . . . . 0.498 HG22 HG12 ' A' ' 98' ' ' ILE . 32.0 t -76.57 131.07 35.55 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.655 0 N-CA-C 109.423 -0.584 . . . . 0.0 109.423 179.876 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 113' ' ' ILE . . . . . 0.599 HD13 ' HB2' ' A' ' 93' ' ' PRO . 1.9 mt -82.66 109.97 17.2 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.058 0 N-CA-C 107.826 -1.176 . . . . 0.0 107.826 173.174 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 114' ' ' ARG . . . . . 0.689 ' HE ' HG21 ' A' ' 122' ' ' THR . 2.3 tmm_? -64.89 -49.06 71.94 Favored 'General case' 0 C--N 1.315 -0.892 0 CA-C-N 115.569 -0.741 . . . . 0.0 110.272 -173.515 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 115' ' ' GLU . . . . . 0.416 ' HB2' ' HD2' ' A' ' 114' ' ' ARG . 9.4 tt0 -159.86 155.6 25.96 Favored 'General case' 0 C--N 1.326 -0.446 0 C-N-CA 121.156 -0.218 . . . . 0.0 110.419 -178.875 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 116' ' ' ILE . . . . . 0.532 HG12 HG12 ' A' ' 95' ' ' ILE . 31.9 mm -106.85 110.75 32.81 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.405 0 N-CA-C 109.001 -0.74 . . . . 0.0 109.001 175.901 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 117' ' ' ASN . . . . . 0.447 ' HB2' ' O ' ' A' ' 120' ' ' SER . 0.9 OUTLIER -98.83 157.69 16.13 Favored 'General case' 0 C--N 1.313 -0.981 0 CA-C-N 115.947 -0.569 . . . . 0.0 109.6 -178.04 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 118' ' ' GLY . . . . . 0.501 ' O ' ' HD2' ' A' ' 84' ' ' ARG . . . -56.27 -44.66 89.27 Favored Glycine 0 C--O 1.226 -0.392 0 C-N-CA 120.452 -0.88 . . . . 0.0 113.196 -171.47 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 119' ' ' ASP . . . . . 0.432 ' HA ' ' HD3' ' A' ' 84' ' ' ARG . 13.9 t70 -113.03 -9.86 13.53 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-O 121.169 0.509 . . . . 0.0 110.73 179.131 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 120' ' ' SER . . . . . 0.447 ' O ' ' HB2' ' A' ' 117' ' ' ASN . 21.6 t -126.54 157.63 38.28 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-O 121.533 0.682 . . . . 0.0 111.845 -168.79 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 121' ' ' ILE . . . . . . . . . . . . . 28.0 mm -120.49 150.41 23.25 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.761 0 CA-C-N 115.512 -0.767 . . . . 0.0 109.076 176.498 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 122' ' ' THR . . . . . 0.689 HG21 ' HE ' ' A' ' 114' ' ' ARG . 14.6 m -127.38 127.01 43.48 Favored 'General case' 0 C--N 1.312 -1.03 0 N-CA-C 107.615 -1.254 . . . . 0.0 107.615 179.667 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 2.8 t -127.74 127.14 68.05 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.839 0 N-CA-C 109.022 -0.733 . . . . 0.0 109.022 -171.01 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -114.24 96.11 5.63 Favored 'General case' 0 C--N 1.305 -1.326 0 CA-C-N 114.62 -1.173 . . . . 0.0 108.672 -177.34 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 125' ' ' PHE . . . . . 0.708 ' HB2' ' HB3' ' A' ' 78' ' ' LEU . 27.7 m-85 -82.5 103.8 12.31 Favored 'General case' 0 N--CA 1.431 -1.399 0 N-CA-C 105.821 -1.918 . . . . 0.0 105.821 175.107 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 126' ' ' ASN . . . . . 0.491 ' HA ' ' HB2' ' A' ' 75' ' ' SER . 0.1 OUTLIER . . . . . 0 C--N 1.295 -1.772 0 CA-C-N 113.884 -1.507 . . . . 0.0 112.916 -168.362 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 133' ' ' THR . . . . . . . . . . . . . 18.9 m . . . . . 0 N--CA 1.448 -0.566 0 N-CA-C 108.991 -0.744 . . . . 0.0 108.991 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 134' ' ' VAL . . . . . 0.444 ' HB ' HD22 ' A' ' 17' ' ' LEU . 15.7 m -115.05 167.94 7.2 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.64 0 CA-C-O 122.017 0.913 . . . . 0.0 112.639 -172.648 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 135' ' ' HIS . . . . . . . . . . . . . 82.5 m-70 -132.47 127.87 36.2 Favored 'General case' 0 C--N 1.314 -0.955 0 CA-C-N 114.043 -1.435 . . . . 0.0 107.359 177.581 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 136' ' ' PHE . . . . . 0.5 ' CE1' HD21 ' A' ' 17' ' ' LEU . 17.8 m-85 -105.53 122.81 46.78 Favored 'General case' 0 C--N 1.313 -1.006 0 CA-C-O 121.09 0.471 . . . . 0.0 111.71 -171.574 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 137' ' ' ASP . . . . . . . . . . . . . 38.2 t70 -123.03 98.76 6.04 Favored 'General case' 0 C--N 1.315 -0.907 0 N-CA-C 107.87 -1.159 . . . . 0.0 107.87 172.806 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 138' ' ' ILE . . . . . 0.736 HG23 HG21 ' A' ' 13' ' ' VAL . 54.8 mt -123.81 138.29 54.02 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.562 0 CA-C-N 115.968 -0.56 . . . . 0.0 112.271 -172.139 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 139' ' ' GLU . . . . . 0.531 ' HG2' ' CE ' ' A' ' 60' ' ' LYS . 2.3 mp0 -128.53 130.55 47.59 Favored 'General case' 0 N--CA 1.452 -0.364 0 N-CA-C 108.523 -0.917 . . . . 0.0 108.523 175.034 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 140' ' ' VAL . . . . . . . . . . . . . 72.6 t -77.56 126.59 38.11 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 117.805 0.275 . . . . 0.0 110.415 -176.47 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 141' ' ' LEU . . . . . 0.425 ' HG ' ' HA ' ' A' ' 13' ' ' VAL . 38.8 mt -94.83 -48.6 5.96 Favored 'General case' 0 C--N 1.321 -0.635 0 N-CA-C 109.919 -0.4 . . . . 0.0 109.919 177.386 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 142' ' ' GLU . . . . . . . . . . . . . 10.6 mm-40 -146.73 162.37 38.66 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 115.902 -0.59 . . . . 0.0 110.597 177.127 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 143' ' ' ILE . . . . . 0.478 HD12 HG23 ' A' ' 57' ' ' VAL . 95.5 mt -131.04 122.66 52.22 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.66 0 CA-C-N 115.961 -0.563 . . . . 0.0 110.337 177.529 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 144' ' ' ASP . . . . . 0.513 ' HB2' ' HB3' ' A' ' 10' ' ' ALA . 1.2 m-20 -74.75 132.67 77.44 Favored Pre-proline 0 CA--C 1.513 -0.472 0 CA-C-N 116.038 -0.528 . . . . 0.0 109.741 176.115 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 145' ' ' PRO . . . . . 0.407 ' HA ' ' OG ' ' A' ' 2' ' ' SER . 70.0 Cg_exo . . . . . 0 CA--C 1.512 -0.583 0 C-N-CA 123.338 2.692 . . . . 0.0 113.16 -178.282 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 73.3 m . . . . . 0 N--CA 1.455 -0.216 0 CA-C-O 121.227 0.536 . . . . 0.0 109.797 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 46.1 mt-10 -86.27 -22.56 26.75 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-N 115.789 -0.641 . . . . 0.0 110.733 179.934 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 4' ' ' SER . . . . . 0.457 ' HA ' ' HA ' ' A' ' 56' ' ' LYS . 19.8 m -110.03 132.94 53.71 Favored 'General case' 0 C--N 1.32 -0.702 0 CA-C-N 115.96 -0.564 . . . . 0.0 110.918 -179.686 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . 0.683 HG12 ' O ' ' A' ' 55' ' ' LEU . 7.3 p -74.2 141.19 16.44 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.425 0 CA-C-N 115.7 -0.682 . . . . 0.0 109.774 177.507 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 6' ' ' GLN . . . . . 0.628 ' HG2' ' OG ' ' A' ' 9' ' ' SER . 2.2 pt20 -134.58 167.62 20.47 Favored 'General case' 0 C--N 1.311 -1.099 0 N-CA-C 108.805 -0.813 . . . . 0.0 108.805 175.806 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 16.2 p -56.59 131.89 50.13 Favored 'General case' 0 C--N 1.313 -0.992 0 N-CA-C 109.64 -0.504 . . . . 0.0 109.64 176.881 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 8' ' ' ASN . . . . . 0.452 ' H ' ' HB3' ' A' ' 39' ' ' LEU . 64.3 t30 76.8 29.24 0.64 Allowed 'General case' 0 CA--C 1.544 0.718 0 C-N-CA 123.698 0.799 . . . . 0.0 111.645 -178.8 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 9' ' ' SER . . . . . 0.628 ' OG ' ' HG2' ' A' ' 6' ' ' GLN . 50.2 m -103.25 167.74 9.62 Favored 'General case' 0 CA--C 1.53 0.183 0 CA-C-O 120.837 0.351 . . . . 0.0 110.849 171.304 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -118.45 115.39 24.55 Favored 'General case' 0 C--N 1.325 -0.497 0 N-CA-C 109.329 -0.619 . . . . 0.0 109.329 175.65 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 4.8 m -119.71 142.15 36.51 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.609 0 C-N-CA 119.914 -0.715 . . . . 0.0 112.308 -174.006 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 12' ' ' LEU . . . . . 0.401 ' HG ' HD12 ' A' ' 141' ' ' LEU . 47.1 tp -88.7 138.1 31.72 Favored 'General case' 0 N--CA 1.447 -0.613 0 CA-C-N 115.298 -0.864 . . . . 0.0 108.824 174.208 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 14.4 m -144.98 157.81 13.95 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.456 0 CA-C-O 120.889 0.376 . . . . 0.0 110.876 -172.912 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 14' ' ' HIS . . . . . 0.627 ' ND1' ' HA ' ' A' ' 29' ' ' ARG . 3.0 m-70 -117.49 119.85 36.3 Favored 'General case' 0 C--N 1.319 -0.727 0 N-CA-C 107.481 -1.303 . . . . 0.0 107.481 162.137 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 15' ' ' PHE . . . . . 0.632 ' HA ' ' O ' ' A' ' 137' ' ' ASP . 46.2 p90 -139.09 142.18 38.13 Favored 'General case' 0 C--N 1.319 -0.725 0 C-N-CA 120.514 -0.474 . . . . 0.0 110.897 -175.206 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 25.0 m -119.17 121.64 40.19 Favored 'General case' 0 C--N 1.318 -0.8 0 CA-C-O 120.785 0.326 . . . . 0.0 110.203 174.3 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 17' ' ' LEU . . . . . 0.659 HD23 ' O ' ' A' ' 135' ' ' HIS . 5.7 mt -92.5 127.11 37.87 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 116.086 -0.506 . . . . 0.0 112.035 179.893 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 18' ' ' LYS . . . . . 0.417 ' O ' ' HB2' ' A' ' 135' ' ' HIS . 0.8 OUTLIER -125.17 152.43 44.49 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-N 115.35 -0.841 . . . . 0.0 110.283 179.888 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 19' ' ' LEU . . . . . 0.466 HD12 ' HB ' ' A' ' 23' ' ' THR . 95.1 mt -88.62 172.92 8.93 Favored 'General case' 0 C--N 1.316 -0.867 0 N-CA-C 109.696 -0.483 . . . . 0.0 109.696 171.345 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 18.7 t70 -53.61 -36.04 61.55 Favored 'General case' 0 N--CA 1.466 0.325 0 CA-C-O 121.029 0.442 . . . . 0.0 110.96 -179.713 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 38.5 m-20 -83.49 11.74 6.59 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 115.839 -0.619 . . . . 0.0 112.067 -177.99 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 72.69 12.16 77.86 Favored Glycine 0 N--CA 1.452 -0.293 0 C-N-CA 121.111 -0.566 . . . . 0.0 113.314 -178.455 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 23' ' ' THR . . . . . 0.466 ' HB ' HD12 ' A' ' 19' ' ' LEU . 24.6 m -73.87 128.87 36.67 Favored 'General case' 0 C--N 1.322 -0.593 0 N-CA-C 109.762 -0.459 . . . . 0.0 109.762 177.123 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 36.9 m -70.99 116.32 11.14 Favored 'General case' 0 C--N 1.32 -0.691 0 CA-C-O 121.194 0.521 . . . . 0.0 110.939 -178.129 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 25' ' ' ALA . . . . . 0.475 ' HB3' ' HB3' ' A' ' 17' ' ' LEU . . . -84.07 -49.46 8.88 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 115.637 -0.711 . . . . 0.0 109.91 178.133 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 8.2 tp10 -158.44 122.9 4.14 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.354 -0.839 . . . . 0.0 109.518 177.025 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 31.2 t -103.43 113.36 26.8 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-O 121.157 0.503 . . . . 0.0 110.219 178.732 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 28' ' ' THR . . . . . 0.606 ' O ' HG22 ' A' ' 28' ' ' THR . 58.0 m -118.96 36.71 4.35 Favored 'General case' 0 N--CA 1.441 -0.898 0 CA-C-O 122.707 1.241 . . . . 0.0 110.103 178.82 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 29' ' ' ARG . . . . . 0.627 ' HA ' ' ND1' ' A' ' 14' ' ' HIS . 52.7 ttp180 -132.06 -62.47 0.84 Allowed 'General case' 0 C--N 1.316 -0.88 0 O-C-N 121.327 -0.858 . . . . 0.0 110.431 174.613 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 2.3 p-10 -83.02 14.98 2.98 Favored 'General case' 0 N--CA 1.468 0.454 0 CA-C-O 121.099 0.476 . . . . 0.0 111.128 -179.483 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 31' ' ' ASN . . . . . 0.752 ' ND2' ' HG2' ' A' ' 33' ' ' LYS . 34.1 p-10 -88.18 -18.46 28.67 Favored 'General case' 0 C--N 1.32 -0.674 0 CA-C-N 115.877 -0.602 . . . . 0.0 110.114 175.387 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 88.03 10.88 68.4 Favored Glycine 0 N--CA 1.444 -0.777 0 CA-C-N 115.496 -0.775 . . . . 0.0 112.004 -178.883 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 33' ' ' LYS . . . . . 0.752 ' HG2' ' ND2' ' A' ' 31' ' ' ASN . 12.3 ptmt -140.87 117.55 7.68 Favored Pre-proline 0 C--N 1.327 -0.397 0 CA-C-O 121.434 0.635 . . . . 0.0 110.008 -179.943 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 78.5 Cg_endo -83.36 168.4 13.14 Favored 'Trans proline' 0 N--CA 1.453 -0.867 0 C-N-CA 122.351 2.034 . . . . 0.0 111.955 177.363 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -127.15 158.66 36.49 Favored 'General case' 0 C--N 1.319 -0.736 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.485 -177.416 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -105.11 138.04 41.94 Favored 'General case' 0 C--N 1.318 -0.783 0 CA-C-N 116.104 -0.498 . . . . 0.0 109.919 175.33 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 37' ' ' PHE . . . . . . . . . . . . . 9.9 m-30 -107.5 107.6 18.53 Favored 'General case' 0 C--N 1.318 -0.773 0 N-CA-C 109.164 -0.68 . . . . 0.0 109.164 175.867 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 16.2 tpt180 -89.24 120.2 30.39 Favored 'General case' 0 C--N 1.317 -0.839 0 CA-C-N 115.669 -0.696 . . . . 0.0 109.371 178.262 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 39' ' ' LEU . . . . . 0.713 HD13 ' HB2' ' A' ' 49' ' ' GLU . 2.0 mm? -79.03 148.42 32.5 Favored 'General case' 0 C--N 1.318 -0.764 0 CA-C-N 115.752 -0.658 . . . . 0.0 110.58 -177.468 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 100.51 39.42 3.22 Favored Glycine 0 N--CA 1.445 -0.724 0 C-N-CA 120.662 -0.78 . . . . 0.0 113.358 178.077 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 34.5 t70 66.67 7.51 5.22 Favored 'General case' 0 N--CA 1.472 0.644 0 CA-C-O 121.122 0.487 . . . . 0.0 112.16 171.431 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -55.63 -58.74 6.53 Favored 'General case' 0 C--N 1.328 -0.369 0 N-CA-C 112.052 0.39 . . . . 0.0 112.052 -177.741 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 37.1 m -143.41 9.46 1.62 Allowed 'General case' 0 C--N 1.324 -0.512 0 CA-C-O 121.073 0.463 . . . . 0.0 110.839 179.161 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 44' ' ' LEU . . . . . 0.436 HD13 ' HA ' ' A' ' 44' ' ' LEU . 4.2 mm? -115.09 148.9 38.36 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.885 -177.195 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 14.6 m -71.55 131.81 43.78 Favored 'General case' 0 N--CA 1.445 -0.688 0 N-CA-C 108.969 -0.752 . . . . 0.0 108.969 173.53 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 54.8 mt-10 -47.66 -43.92 26.68 Favored 'General case' 0 N--CA 1.468 0.472 0 O-C-N 123.534 0.521 . . . . 0.0 112.232 -169.509 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -61.41 -45.11 97.07 Favored Glycine 0 N--CA 1.448 -0.555 0 C-N-CA 120.642 -0.789 . . . . 0.0 112.696 -177.799 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 48' ' ' LEU . . . . . 0.403 HD13 ' C ' ' A' ' 48' ' ' LEU . 3.4 tm? -60.0 -54.39 46.64 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-O 120.95 0.405 . . . . 0.0 110.865 -177.879 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 49' ' ' GLU . . . . . 0.713 ' HB2' HD13 ' A' ' 39' ' ' LEU . 9.7 pt-20 -59.29 -40.25 85.58 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-N 115.458 -0.792 . . . . 0.0 111.39 -178.195 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 50' ' ' GLN . . . . . 0.702 ' HA ' HD23 ' A' ' 53' ' ' LEU . 83.4 mt-30 -69.14 -7.53 37.06 Favored 'General case' 0 CA--C 1.531 0.219 0 N-CA-C 113.302 0.853 . . . . 0.0 113.302 -179.78 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 51' ' ' HIS . . . . . . . . . . . . . 9.9 m-70 -103.35 -16.71 15.55 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-O 121.192 0.52 . . . . 0.0 110.019 179.687 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 52' ' ' LEU . . . . . 0.426 HD11 HG12 ' A' ' 138' ' ' ILE . 27.5 mt -104.98 8.07 34.32 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-N 115.51 -0.768 . . . . 0.0 113.057 -176.419 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 53' ' ' LEU . . . . . 0.702 HD23 ' HA ' ' A' ' 50' ' ' GLN . 2.0 pp -92.86 155.94 17.29 Favored 'General case' 0 C--N 1.322 -0.615 0 C-N-CA 120.462 -0.495 . . . . 0.0 110.501 174.45 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 54' ' ' GLY . . . . . 0.485 ' N ' HG13 ' A' ' 5' ' ' VAL . . . 94.21 -12.55 68.89 Favored Glycine 0 CA--C 1.532 1.126 0 N-CA-C 115.941 1.136 . . . . 0.0 115.941 176.312 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 55' ' ' LEU . . . . . 0.683 ' O ' HG12 ' A' ' 5' ' ' VAL . 1.0 OUTLIER -100.73 165.44 11.38 Favored 'General case' 0 N--CA 1.471 0.603 0 CA-C-N 119.4 1.6 . . . . 0.0 112.06 -176.062 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 56' ' ' LYS . . . . . 0.457 ' HA ' ' HA ' ' A' ' 4' ' ' SER . 16.0 tttm -96.38 157.1 16.05 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-N 115.738 -0.665 . . . . 0.0 111.372 -175.563 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 57' ' ' VAL . . . . . 0.621 HG23 HD12 ' A' ' 143' ' ' ILE . 51.1 t -59.57 142.05 15.56 Favored 'Isoleucine or valine' 0 C--O 1.234 0.262 0 N-CA-C 109.398 -0.593 . . . . 0.0 109.398 171.404 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 82.43 9.3 85.06 Favored Glycine 0 N--CA 1.445 -0.766 0 C-N-CA 120.513 -0.851 . . . . 0.0 111.716 -177.51 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 59' ' ' ASP . . . . . 0.523 ' C ' ' HG3' ' A' ' 60' ' ' LYS . 15.9 m-20 -116.32 162.33 17.67 Favored 'General case' 0 CA--C 1.509 -0.629 0 N-CA-C 109.738 -0.467 . . . . 0.0 109.738 173.667 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 60' ' ' LYS . . . . . 0.585 ' HG2' ' HG2' ' A' ' 139' ' ' GLU . 32.2 mtpt -143.14 143.55 31.85 Favored 'General case' 0 C--N 1.318 -0.795 0 CA-C-N 115.439 -0.801 . . . . 0.0 110.375 -167.477 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 6.1 t -143.32 131.92 22.43 Favored 'General case' 0 C--N 1.315 -0.908 0 CA-C-N 115.938 -0.574 . . . . 0.0 109.686 178.934 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 3.3 m -113.17 130.99 56.03 Favored 'General case' 0 N--CA 1.443 -0.801 0 N-CA-C 108.949 -0.76 . . . . 0.0 108.949 177.452 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 63' ' ' PHE . . . . . 0.426 ' O ' ' HB2' ' A' ' 136' ' ' PHE . 39.3 p90 -154.59 152.76 30.4 Favored 'General case' 0 C--N 1.32 -0.704 0 CA-C-O 120.914 0.388 . . . . 0.0 111.112 179.688 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 26.5 m -101.64 156.33 17.56 Favored 'General case' 0 C--N 1.321 -0.657 0 CA-C-N 116.015 -0.539 . . . . 0.0 109.779 175.397 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 74.7 mt -141.55 144.06 34.08 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 116.377 -0.374 . . . . 0.0 110.657 -178.432 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 41.7 mt-10 -80.54 159.06 70.41 Favored Pre-proline 0 C--N 1.322 -0.593 0 CA-C-N 115.747 -0.661 . . . . 0.0 109.358 174.575 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 59.0 Cg_exo -49.88 -36.86 44.58 Favored 'Trans proline' 0 C--O 1.233 0.25 0 C-N-CA 122.454 2.103 . . . . 0.0 113.624 -176.184 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 4.3 p-10 -66.04 -15.46 63.06 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-O 120.744 0.306 . . . . 0.0 111.385 -179.052 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -111.13 -16.15 13.52 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 116.591 -0.277 . . . . 0.0 111.302 179.475 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.329 -0.323 0 CA-C-N 116.364 -0.38 . . . . 0.0 111.672 -177.23 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 75' ' ' SER . . . . . 0.47 ' HB3' ' OD1' ' A' ' 77' ' ' ASP . 16.6 m . . . . . 0 N--CA 1.44 -0.945 0 CA-C-O 120.385 0.136 . . . . 0.0 110.992 . . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 76' ' ' PRO . . . . . 0.438 ' HD2' ' HA ' ' A' ' 75' ' ' SER . 33.8 Cg_endo -66.41 -19.39 55.37 Favored 'Trans proline' 0 C--N 1.345 0.373 0 C-N-CA 122.734 2.29 . . . . 0.0 112.222 177.183 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 77' ' ' ASP . . . . . 0.47 ' OD1' ' HB3' ' A' ' 75' ' ' SER . 8.2 p-10 -76.35 -5.9 49.18 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 121.359 0.6 . . . . 0.0 110.384 177.16 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 78' ' ' LEU . . . . . 0.458 ' HG ' ' HB2' ' A' ' 125' ' ' PHE . 0.7 OUTLIER -89.03 10.39 21.8 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-N 115.548 -0.751 . . . . 0.0 110.437 176.273 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 22.4 mt -117.24 107.46 22.35 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.635 0 N-CA-C 108.349 -0.982 . . . . 0.0 108.349 177.413 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 80' ' ' GLN . . . . . 0.588 ' O ' ' HB ' ' A' ' 123' ' ' VAL . 71.5 mt-30 -119.7 140.59 50.43 Favored 'General case' 0 C--N 1.313 -1.012 0 CA-C-N 115.895 -0.593 . . . . 0.0 111.37 -172.052 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 81' ' ' TYR . . . . . . . . . . . . . 73.6 m-85 -96.38 155.3 16.82 Favored 'General case' 0 C--N 1.313 -0.983 0 CA-C-N 115.946 -0.57 . . . . 0.0 109.524 173.331 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 82' ' ' PHE . . . . . 0.457 ' CD1' HG21 ' A' ' 123' ' ' VAL . 3.2 m-85 -148.89 167.57 25.36 Favored 'General case' 0 C--N 1.323 -0.586 0 N-CA-C 108.981 -0.748 . . . . 0.0 108.981 -160.371 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 11.6 t -99.61 128.12 45.71 Favored 'General case' 0 C--N 1.321 -0.645 0 CA-C-O 121.082 0.468 . . . . 0.0 110.102 175.533 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 84' ' ' ARG . . . . . 0.689 ' HD3' ' HA ' ' A' ' 119' ' ' ASP . 15.4 ptt180 -53.27 -20.66 4.43 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.237 -0.892 . . . . 0.0 113.151 -177.916 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 85' ' ' ARG . . . . . . . . . . . . . 5.3 mpt_? -71.14 -37.45 72.27 Favored 'General case' 0 CA--C 1.517 -0.323 0 CA-C-O 120.91 0.385 . . . . 0.0 110.785 -173.38 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 27.1 mm-40 -63.97 -33.92 76.82 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-N 115.697 -0.683 . . . . 0.0 110.598 179.941 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 87' ' ' PHE . . . . . 0.409 ' HE2' ' CE1' ' A' ' 101' ' ' PHE . 27.1 m-85 -86.69 -39.73 15.75 Favored 'General case' 0 CA--C 1.509 -0.609 0 CA-C-N 115.96 -0.564 . . . . 0.0 111.158 -178.361 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 88' ' ' MET . . . . . . . . . . . . . 56.1 ttp -60.66 -34.91 75.0 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-N 116.398 -0.365 . . . . 0.0 110.844 -177.101 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 22.1 t70 -55.13 -31.2 61.09 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 121.025 0.44 . . . . 0.0 111.265 175.631 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -100.82 7.6 43.64 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 116.021 -0.536 . . . . 0.0 110.749 178.658 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 105.27 136.79 8.75 Favored Glycine 0 N--CA 1.445 -0.745 0 N-CA-C 110.846 -0.902 . . . . 0.0 110.846 -175.226 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 44.5 mt-10 -61.15 128.69 89.83 Favored Pre-proline 0 C--N 1.322 -0.618 0 CA-C-O 121.321 0.581 . . . . 0.0 111.208 -176.485 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 93' ' ' PRO . . . . . 0.61 ' HG2' HD12 ' A' ' 116' ' ' ILE . 56.2 Cg_endo -71.76 165.46 32.48 Favored 'Trans proline' 0 N--CA 1.462 -0.329 0 C-N-CA 123.318 2.678 . . . . 0.0 112.65 -175.441 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 16.3 mt-10 -116.65 155.79 28.19 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.843 -175.344 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 95' ' ' ILE . . . . . 0.514 HG23 ' O ' ' A' ' 114' ' ' ARG . 22.3 mt -82.37 135.77 24.24 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.469 0 CA-C-N 115.886 -0.597 . . . . 0.0 110.781 -178.711 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 73.16 19.6 79.68 Favored Glycine 0 N--CA 1.45 -0.394 0 CA-C-N 115.747 -0.661 . . . . 0.0 112.582 -175.822 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -96.48 119.51 35.1 Favored 'General case' 0 N--CA 1.452 -0.339 0 CA-C-O 121.54 0.686 . . . . 0.0 112.622 -179.32 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 98' ' ' ILE . . . . . 0.618 ' HA ' ' HA ' ' A' ' 112' ' ' VAL . 6.3 mt -88.69 107.46 17.78 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.665 0 N-CA-C 108.179 -1.045 . . . . 0.0 108.179 174.577 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 99' ' ' MET . . . . . . . . . . . . . 4.9 mtm -127.5 144.3 51.08 Favored 'General case' 0 N--CA 1.443 -0.786 0 N-CA-C 107.625 -1.25 . . . . 0.0 107.625 -175.607 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 100' ' ' LEU . . . . . 0.459 ' HB3' ' HB3' ' A' ' 108' ' ' GLU . 4.1 mm? -75.62 105.0 6.42 Favored 'General case' 0 C--N 1.311 -1.107 0 CA-C-N 116.494 -0.321 . . . . 0.0 110.873 -176.893 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 101' ' ' PHE . . . . . 0.409 ' CE1' ' HE2' ' A' ' 87' ' ' PHE . 42.9 m-85 -92.65 109.95 21.37 Favored 'General case' 0 CA--C 1.516 -0.346 0 CA-C-O 121.692 0.758 . . . . 0.0 110.915 -178.652 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 102' ' ' THR . . . . . 0.485 ' HA ' ' HA ' ' A' ' 108' ' ' GLU . 12.1 m -63.55 112.2 2.69 Favored 'General case' 0 C--N 1.311 -1.089 0 CA-C-N 114.411 -1.268 . . . . 0.0 113.038 -179.08 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -74.49 171.06 14.45 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-N 113.2 -1.818 . . . . 0.0 112.934 -178.945 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 104' ' ' MET . . . . . 0.446 ' C ' ' H ' ' A' ' 106' ' ' GLY . 4.2 mpp? -57.01 -33.5 67.22 Favored 'General case' 0 N--CA 1.465 0.276 0 CA-C-N 115.824 -0.625 . . . . 0.0 111.641 179.111 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 9.3 p-10 -76.93 22.05 0.2 Allowed 'General case' 0 N--CA 1.468 0.427 0 CA-C-O 121.528 0.68 . . . . 0.0 110.813 177.526 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 106' ' ' GLY . . . . . 0.446 ' H ' ' C ' ' A' ' 104' ' ' MET . . . 65.95 -7.84 1.06 Allowed Glycine 0 C--N 1.333 0.415 0 CA-C-N 114.649 -1.16 . . . . 0.0 114.694 -178.321 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 23.3 t -87.22 144.62 26.74 Favored 'General case' 0 CA--C 1.502 -0.902 0 CA-C-O 121.476 0.655 . . . . 0.0 110.705 -172.117 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 108' ' ' GLU . . . . . 0.485 ' HA ' ' HA ' ' A' ' 102' ' ' THR . 2.7 mp0 -80.45 156.41 26.62 Favored 'General case' 0 C--N 1.301 -1.531 0 CA-C-N 114.852 -1.067 . . . . 0.0 109.732 177.369 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 109' ' ' MET . . . . . 0.414 ' O ' ' HA ' ' A' ' 100' ' ' LEU . 96.5 mmm -136.61 125.04 15.07 Favored Pre-proline 0 C--N 1.314 -0.97 0 N-CA-C 107.563 -1.273 . . . . 0.0 107.563 -164.648 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 31.1 Cg_endo -69.39 119.08 6.09 Favored 'Trans proline' 0 N--CA 1.453 -0.887 0 CA-C-N 120.199 1.107 . . . . 0.0 110.644 175.145 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 111' ' ' GLY . . . . . 0.471 ' HA2' ' HA ' ' A' ' 125' ' ' PHE . . . -144.58 120.81 1.47 Allowed Glycine 0 N--CA 1.443 -0.895 0 CA-C-N 115.294 -0.866 . . . . 0.0 111.015 -172.202 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 112' ' ' VAL . . . . . 0.618 ' HA ' ' HA ' ' A' ' 98' ' ' ILE . 7.1 p -101.89 108.11 23.05 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.856 0 CA-C-O 122.058 0.933 . . . . 0.0 110.602 -179.819 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 113' ' ' ILE . . . . . 0.591 HG23 ' O ' ' A' ' 122' ' ' THR . 25.6 mt -61.2 109.89 0.56 Allowed 'Isoleucine or valine' 0 C--N 1.314 -0.966 0 CA-C-N 114.717 -1.129 . . . . 0.0 110.271 171.717 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 114' ' ' ARG . . . . . 0.565 ' HD2' ' HB2' ' A' ' 115' ' ' GLU . 6.4 tmm_? -77.32 -32.56 55.37 Favored 'General case' 0 C--N 1.315 -0.908 0 CA-C-N 115.13 -0.941 . . . . 0.0 111.024 -173.833 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 115' ' ' GLU . . . . . 0.565 ' HB2' ' HD2' ' A' ' 114' ' ' ARG . 5.7 tt0 -159.98 160.9 33.91 Favored 'General case' 0 C--N 1.329 -0.315 0 N-CA-C 110.289 -0.263 . . . . 0.0 110.289 178.337 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 116' ' ' ILE . . . . . 0.61 HD12 ' HG2' ' A' ' 93' ' ' PRO . 29.4 mm -107.36 107.22 22.24 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.514 0 N-CA-C 109.581 -0.525 . . . . 0.0 109.581 173.909 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 117' ' ' ASN . . . . . 0.475 HD22 ' N ' ' A' ' 117' ' ' ASN . 0.9 OUTLIER -83.1 157.1 22.97 Favored 'General case' 0 C--N 1.313 -0.987 0 N-CA-C 108.906 -0.776 . . . . 0.0 108.906 178.33 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . -57.17 -48.54 79.15 Favored Glycine 0 N--CA 1.449 -0.457 0 C-N-CA 120.382 -0.913 . . . . 0.0 112.763 -172.987 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 119' ' ' ASP . . . . . 0.689 ' HA ' ' HD3' ' A' ' 84' ' ' ARG . 1.4 m-20 -107.8 -15.26 14.6 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-O 121.088 0.471 . . . . 0.0 111.346 -178.062 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 120' ' ' SER . . . . . 0.455 ' O ' ' HB2' ' A' ' 117' ' ' ASN . 32.4 t -123.38 157.76 32.63 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-N 115.878 -0.601 . . . . 0.0 111.158 -169.508 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 121' ' ' ILE . . . . . . . . . . . . . 50.0 mm -113.68 137.27 47.39 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.523 0 CA-C-O 121.165 0.507 . . . . 0.0 110.253 175.951 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 122' ' ' THR . . . . . 0.591 ' O ' HG23 ' A' ' 113' ' ' ILE . 3.6 m -93.98 142.21 27.64 Favored 'General case' 0 C--N 1.318 -0.776 0 CA-C-N 115.167 -0.924 . . . . 0.0 110.095 178.014 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 123' ' ' VAL . . . . . 0.588 ' HB ' ' O ' ' A' ' 80' ' ' GLN . 33.9 t -147.05 107.99 0.66 Allowed 'Isoleucine or valine' 0 N--CA 1.466 0.353 0 C-N-CA 117.085 -1.846 . . . . 0.0 110.385 -165.221 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 124' ' ' ASP . . . . . 0.546 ' HB3' HG13 ' A' ' 112' ' ' VAL . 28.6 t70 -107.98 101.64 10.88 Favored 'General case' 0 C--N 1.313 -1.006 0 C-N-CA 119.397 -0.921 . . . . 0.0 112.545 174.064 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 125' ' ' PHE . . . . . 0.471 ' HA ' ' HA2' ' A' ' 111' ' ' GLY . 83.5 m-85 -81.63 6.89 13.71 Favored 'General case' 0 N--CA 1.47 0.542 0 CA-C-N 116.285 -0.416 . . . . 0.0 110.894 178.459 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 7.7 m-80 . . . . . 0 C--N 1.327 -0.41 0 CA-C-O 122.054 0.93 . . . . 0.0 111.023 179.656 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 133' ' ' THR . . . . . . . . . . . . . 21.5 m . . . . . 0 N--CA 1.451 -0.399 0 CA-C-O 121.035 0.445 . . . . 0.0 110.942 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 134' ' ' VAL . . . . . 0.429 ' HB ' HD22 ' A' ' 17' ' ' LEU . 30.6 m -102.75 171.68 1.52 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.609 0 CA-C-O 121.556 0.693 . . . . 0.0 110.999 179.624 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 135' ' ' HIS . . . . . 0.659 ' O ' HD23 ' A' ' 17' ' ' LEU . 13.8 m-70 -132.66 140.56 48.21 Favored 'General case' 0 C--N 1.318 -0.768 0 N-CA-C 107.548 -1.279 . . . . 0.0 107.548 -172.236 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 136' ' ' PHE . . . . . 0.573 ' CZ ' HD21 ' A' ' 17' ' ' LEU . 9.3 m-85 -125.42 122.76 37.64 Favored 'General case' 0 C--N 1.311 -1.107 0 C-N-CA 120.492 -0.483 . . . . 0.0 112.188 -169.545 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 137' ' ' ASP . . . . . 0.632 ' O ' ' HA ' ' A' ' 15' ' ' PHE . 5.0 m-20 -115.82 100.8 8.26 Favored 'General case' 0 C--N 1.322 -0.628 0 N-CA-C 108.479 -0.934 . . . . 0.0 108.479 171.156 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 138' ' ' ILE . . . . . 0.5 ' CD1' ' HB3' ' A' ' 136' ' ' PHE . 4.4 mp -110.57 129.74 65.15 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.644 0 CA-C-O 121.229 0.538 . . . . 0.0 111.936 -177.535 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 139' ' ' GLU . . . . . 0.585 ' HG2' ' HG2' ' A' ' 60' ' ' LYS . 34.2 mt-10 -122.11 109.07 14.07 Favored 'General case' 0 N--CA 1.447 -0.601 0 CA-C-N 115.244 -0.889 . . . . 0.0 109.006 172.245 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 140' ' ' VAL . . . . . . . . . . . . . 58.9 t -59.63 119.55 4.15 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.499 0 CA-C-N 115.779 -0.646 . . . . 0.0 110.933 -179.276 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 141' ' ' LEU . . . . . 0.527 HD11 ' CD2' ' A' ' 14' ' ' HIS . 37.7 mt -90.51 -49.49 6.47 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 116.372 -0.376 . . . . 0.0 110.498 179.554 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 142' ' ' GLU . . . . . . . . . . . . . 44.3 mt-10 -156.87 158.88 37.53 Favored 'General case' 0 CA--C 1.519 -0.222 0 N-CA-C 108.835 -0.802 . . . . 0.0 108.835 -177.036 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 143' ' ' ILE . . . . . 0.621 HD12 HG23 ' A' ' 57' ' ' VAL . 97.4 mt -128.35 115.45 38.08 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.837 0 CA-C-O 121.139 0.495 . . . . 0.0 111.852 179.609 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 144' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -77.95 128.59 78.51 Favored Pre-proline 0 C--O 1.235 0.318 0 CA-C-N 115.397 -0.82 . . . . 0.0 109.069 172.582 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 145' ' ' PRO . . . . . . . . . . . . . 18.3 Cg_endo . . . . . 0 C--O 1.233 0.228 0 C-N-CA 123.126 2.55 . . . . 0.0 114.183 -172.379 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 16.5 mmt . . . . . 0 N--CA 1.483 1.187 0 CA-C-O 120.52 0.2 . . . . 0.0 111.495 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . 0.487 ' HB3' ' HA ' ' A' ' 145' ' ' PRO . 6.2 p -165.02 43.34 0.08 Allowed 'General case' 0 C--N 1.326 -0.431 0 CA-C-O 121.145 0.498 . . . . 0.0 110.705 -178.745 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 3.3 mp0 -77.38 -35.44 54.45 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-O 121.653 0.74 . . . . 0.0 109.77 -179.006 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 16.1 p -133.26 157.56 45.12 Favored 'General case' 0 C--N 1.315 -0.904 0 CA-C-N 114.893 -1.049 . . . . 0.0 109.745 -179.629 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . 0.67 HG13 ' HA ' ' A' ' 53' ' ' LEU . 10.2 p -71.11 139.04 20.57 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.573 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.04 -178.04 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 6' ' ' GLN . . . . . . . . . . . . . 2.9 pt20 -142.7 164.15 30.88 Favored 'General case' 0 C--N 1.314 -0.954 0 N-CA-C 108.549 -0.908 . . . . 0.0 108.549 179.149 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 83.2 p -67.41 136.32 54.53 Favored 'General case' 0 C--N 1.316 -0.886 0 C-N-CA 120.724 -0.391 . . . . 0.0 110.453 -178.154 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 66.6 t30 71.27 28.43 3.0 Favored 'General case' 0 CA--C 1.538 0.488 0 C-N-CA 123.449 0.699 . . . . 0.0 111.667 -178.697 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 49.6 m -128.54 132.99 48.29 Favored 'General case' 0 C--N 1.327 -0.374 0 O-C-N 121.623 -0.673 . . . . 0.0 110.166 174.011 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -83.2 165.78 19.16 Favored 'General case' 0 C--N 1.322 -0.63 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.765 -171.862 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 33.0 m -143.46 139.7 26.25 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.685 0 CA-C-O 120.924 0.392 . . . . 0.0 110.281 -175.585 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 12' ' ' LEU . . . . . 0.519 HD12 ' HB3' ' A' ' 142' ' ' GLU . 75.7 mt -86.0 124.07 32.03 Favored 'General case' 0 C--N 1.319 -0.752 0 N-CA-C 108.127 -1.064 . . . . 0.0 108.127 173.253 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 13' ' ' VAL . . . . . 0.621 HG21 HG23 ' A' ' 138' ' ' ILE . 3.5 p -136.06 153.24 31.6 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.912 0 CA-C-O 122.289 1.042 . . . . 0.0 112.993 -167.348 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 14' ' ' HIS . . . . . . . . . . . . . 1.9 m-70 -123.72 116.16 22.59 Favored 'General case' 0 C--N 1.313 -1.008 0 CA-C-N 113.359 -1.746 . . . . 0.0 106.58 167.654 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 15' ' ' PHE . . . . . 0.57 ' HB2' ' O ' ' A' ' 137' ' ' ASP . 16.5 p90 -142.12 168.95 18.52 Favored 'General case' 0 C--N 1.317 -0.826 0 C-N-CA 119.2 -1.0 . . . . 0.0 112.531 -172.452 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 21.5 m -145.9 142.7 29.01 Favored 'General case' 0 C--N 1.321 -0.631 0 CA-C-N 115.076 -0.965 . . . . 0.0 110.438 176.253 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 17' ' ' LEU . . . . . 0.791 ' HG ' ' CZ ' ' A' ' 71' ' ' PHE . 0.0 OUTLIER -105.68 128.43 53.66 Favored 'General case' 0 C--N 1.326 -0.424 0 N-CA-C 109.527 -0.545 . . . . 0.0 109.527 -175.621 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 18' ' ' LYS . . . . . 0.502 ' HA ' ' O ' ' A' ' 23' ' ' THR . 0.1 OUTLIER -125.56 136.85 53.75 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-O 121.663 0.744 . . . . 0.0 112.204 -174.256 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 19' ' ' LEU . . . . . 0.478 HD23 ' HB ' ' A' ' 23' ' ' THR . 3.5 mm? -78.2 174.74 10.87 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 114.96 -1.018 . . . . 0.0 109.963 172.683 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 23.9 m-20 -60.74 -27.83 68.23 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-O 120.797 0.332 . . . . 0.0 111.08 176.905 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 35.8 t70 -80.61 5.02 16.67 Favored 'General case' 0 N--CA 1.474 0.739 0 CA-C-O 122.224 1.011 . . . . 0.0 109.926 174.224 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 66.91 19.3 69.57 Favored Glycine 0 N--CA 1.451 -0.363 0 CA-C-N 114.259 -1.337 . . . . 0.0 112.478 -175.944 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 23' ' ' THR . . . . . 0.502 ' O ' ' HA ' ' A' ' 18' ' ' LYS . 17.4 m -72.55 142.7 48.46 Favored 'General case' 0 C--N 1.323 -0.544 0 N-CA-C 110.33 -0.248 . . . . 0.0 110.33 178.473 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 59.0 m -77.05 107.9 9.74 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-O 120.871 0.367 . . . . 0.0 111.026 179.32 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 25' ' ' ALA . . . . . 0.422 ' HB3' ' HB3' ' A' ' 17' ' ' LEU . . . -77.29 -35.51 55.04 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-O 121.405 0.621 . . . . 0.0 109.567 174.709 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 9.0 tp10 -160.48 142.72 12.85 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 115.033 -0.985 . . . . 0.0 108.896 -179.419 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 19.6 t -124.75 149.42 47.33 Favored 'General case' 0 C--N 1.313 -1.007 0 N-CA-C 109.09 -0.707 . . . . 0.0 109.09 175.125 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 28' ' ' THR . . . . . 0.461 HG21 ' HB2' ' A' ' 35' ' ' ALA . 36.6 m -148.23 44.55 1.05 Allowed 'General case' 0 N--CA 1.437 -1.113 0 CA-C-O 123.79 1.757 . . . . 0.0 106.819 172.764 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 52.9 ttp180 -151.65 -45.96 0.11 Allowed 'General case' 0 C--N 1.312 -1.052 0 CA-C-N 112.653 -2.067 . . . . 0.0 109.681 -178.784 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 91.6 m-20 -67.81 -25.73 65.73 Favored 'General case' 0 N--CA 1.464 0.272 0 CA-C-O 121.087 0.47 . . . . 0.0 110.549 177.643 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 71.8 m-20 -76.53 -12.66 60.06 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.595 -0.729 . . . . 0.0 110.65 179.898 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 83.01 -1.37 88.81 Favored Glycine 0 N--CA 1.45 -0.371 0 C-N-CA 120.989 -0.624 . . . . 0.0 111.804 -179.691 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 59.4 mttp -107.41 121.68 43.64 Favored Pre-proline 0 C--N 1.321 -0.659 0 CA-C-N 115.717 -0.242 . . . . 0.0 110.698 -177.952 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 7.8 Cg_exo -76.48 168.94 22.84 Favored 'Trans proline' 0 N--CA 1.46 -0.491 0 C-N-CA 122.938 2.426 . . . . 0.0 112.118 172.113 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 35' ' ' ALA . . . . . 0.461 ' HB2' HG21 ' A' ' 28' ' ' THR . . . -140.89 161.7 37.2 Favored 'General case' 0 C--N 1.312 -1.04 0 CA-C-N 115.097 -0.956 . . . . 0.0 109.592 179.383 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 3.8 tp -112.89 130.77 55.99 Favored 'General case' 0 N--CA 1.445 -0.722 0 N-CA-C 110.049 -0.352 . . . . 0.0 110.049 175.968 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 37' ' ' PHE . . . . . . . . . . . . . 9.4 m-30 -95.98 112.14 23.95 Favored 'General case' 0 C--N 1.318 -0.77 0 N-CA-C 110.055 -0.35 . . . . 0.0 110.055 175.411 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 38' ' ' ARG . . . . . 0.567 ' HB3' ' HB3' ' A' ' 42' ' ' ALA . 22.3 mmm180 -83.46 106.91 15.59 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-O 121.351 0.596 . . . . 0.0 110.957 -179.513 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 10.9 mp -81.84 154.18 26.01 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-N 115.104 -0.953 . . . . 0.0 110.979 178.278 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 91.79 41.11 5.11 Favored Glycine 0 N--CA 1.449 -0.455 0 C-N-CA 120.915 -0.66 . . . . 0.0 113.06 176.575 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 16.6 m-20 58.46 23.55 10.81 Favored 'General case' 0 N--CA 1.468 0.429 0 CA-C-O 120.873 0.368 . . . . 0.0 111.374 177.78 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 42' ' ' ALA . . . . . 0.567 ' HB3' ' HB3' ' A' ' 38' ' ' ARG . . . -86.48 -27.37 24.11 Favored 'General case' 0 C--N 1.323 -0.587 0 CA-C-O 121.027 0.441 . . . . 0.0 110.278 -178.162 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 40.8 m -154.31 -45.09 0.09 Allowed 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 115.821 -0.627 . . . . 0.0 109.532 175.585 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 51.5 mt -102.81 159.34 15.57 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 115.775 -0.648 . . . . 0.0 110.179 178.482 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 50.1 m -84.45 161.72 20.19 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-N 115.853 -0.612 . . . . 0.0 110.765 -177.546 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 45.2 mt-10 -57.4 -26.8 61.66 Favored 'General case' 0 N--CA 1.463 0.202 0 CA-C-N 115.858 -0.61 . . . . 0.0 111.715 -177.213 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -58.86 -36.72 88.6 Favored Glycine 0 N--CA 1.45 -0.403 0 C-N-CA 121.086 -0.578 . . . . 0.0 112.546 -175.808 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 3.0 tt -76.22 -36.53 58.51 Favored 'General case' 0 CA--C 1.515 -0.387 0 CA-C-O 121.768 0.794 . . . . 0.0 110.388 -179.122 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 7.2 tt0 -66.79 -46.68 74.49 Favored 'General case' 0 C--N 1.318 -0.785 0 CA-C-N 114.273 -1.331 . . . . 0.0 108.827 -176.472 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 50' ' ' GLN . . . . . 0.518 ' HA ' HD22 ' A' ' 53' ' ' LEU . 82.9 mm-40 -62.67 -16.4 56.86 Favored 'General case' 0 C--N 1.314 -0.936 0 CA-C-N 113.504 -1.68 . . . . 0.0 112.396 -176.069 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 51' ' ' HIS . . . . . . . . . . . . . 14.1 m-70 -105.34 -3.48 22.67 Favored 'General case' 0 C--O 1.233 0.223 0 C-N-CA 120.221 -0.591 . . . . 0.0 111.663 176.21 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 52' ' ' LEU . . . . . 0.563 ' O ' HG11 ' A' ' 5' ' ' VAL . 6.1 mt -99.98 -23.66 14.85 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 116.461 -0.336 . . . . 0.0 111.866 -178.493 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 53' ' ' LEU . . . . . 0.67 ' HA ' HG13 ' A' ' 5' ' ' VAL . 0.0 OUTLIER -59.85 152.21 23.78 Favored 'General case' 0 CA--C 1.53 0.209 0 CA-C-O 121.316 0.579 . . . . 0.0 112.286 -177.124 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 94.26 -17.14 59.5 Favored Glycine 0 N--CA 1.451 -0.306 0 CA-C-N 115.296 -0.865 . . . . 0.0 113.557 175.964 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 55' ' ' LEU . . . . . 0.532 ' O ' HG12 ' A' ' 5' ' ' VAL . 16.0 tp -84.9 158.97 20.43 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-O 121.099 0.476 . . . . 0.0 110.975 177.677 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 56' ' ' LYS . . . . . 0.563 ' HD3' ' N ' ' A' ' 57' ' ' VAL . 12.8 tmtt? -120.11 162.89 18.54 Favored 'General case' 0 C--N 1.325 -0.487 0 N-CA-C 109.768 -0.456 . . . . 0.0 109.768 -176.331 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 57' ' ' VAL . . . . . 0.563 ' N ' ' HD3' ' A' ' 56' ' ' LYS . 42.1 t -57.76 147.74 6.04 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-O 120.889 0.376 . . . . 0.0 111.259 177.491 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 80.6 9.46 86.39 Favored Glycine 0 N--CA 1.451 -0.334 0 CA-C-N 115.852 -0.613 . . . . 0.0 113.575 -177.712 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 2.5 m-20 -121.53 162.55 20.36 Favored 'General case' 0 CA--C 1.513 -0.46 0 CA-C-O 121.022 0.439 . . . . 0.0 110.828 178.364 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 60' ' ' LYS . . . . . 0.593 ' HB3' ' HG2' ' A' ' 139' ' ' GLU . 1.1 ptmt -135.15 146.15 48.49 Favored 'General case' 0 C--N 1.316 -0.855 0 CA-C-N 115.576 -0.738 . . . . 0.0 109.133 179.136 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 12.1 t -142.76 143.35 32.17 Favored 'General case' 0 C--N 1.318 -0.793 0 CA-C-O 121.13 0.491 . . . . 0.0 109.754 -178.612 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 3.7 m -109.17 138.52 45.39 Favored 'General case' 0 C--N 1.311 -1.101 0 N-CA-C 108.889 -0.782 . . . . 0.0 108.889 176.668 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 63' ' ' PHE . . . . . 0.544 ' CZ ' HD12 ' A' ' 138' ' ' ILE . 31.4 p90 -158.36 158.85 35.07 Favored 'General case' 0 C--N 1.321 -0.653 0 CA-C-O 121.238 0.542 . . . . 0.0 111.42 -179.444 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 64' ' ' SER . . . . . 0.425 ' O ' ' HG ' ' A' ' 65' ' ' LEU . 26.1 t -104.73 159.42 15.8 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-N 115.197 -0.911 . . . . 0.0 109.71 -179.204 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 65' ' ' LEU . . . . . 0.479 HD12 ' CZ ' ' A' ' 136' ' ' PHE . 18.5 mt -161.09 151.38 17.71 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 116.302 -0.408 . . . . 0.0 110.698 -171.975 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 48.0 mt-10 -69.86 152.79 95.92 Favored Pre-proline 0 C--N 1.321 -0.662 0 CA-C-N 115.796 -0.638 . . . . 0.0 109.365 174.485 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 3.4 Cg_exo -42.45 -49.71 6.13 Favored 'Trans proline' 0 CA--C 1.532 0.406 0 C-N-CA 123.673 2.915 . . . . 0.0 113.865 -176.804 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -56.86 -31.12 64.48 Favored 'General case' 0 N--CA 1.468 0.439 0 CA-C-N 115.996 -0.547 . . . . 0.0 111.784 179.84 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 69' ' ' ALA . . . . . 0.415 ' O ' HD13 ' A' ' 65' ' ' LEU . . . -98.26 16.75 20.46 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.825 -175.67 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -131.92 -84.66 0.49 Allowed 'General case' 0 C--N 1.323 -0.559 0 N-CA-C 108.944 -0.762 . . . . 0.0 108.944 -173.24 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 71' ' ' PHE . . . . . 0.791 ' CZ ' ' HG ' ' A' ' 17' ' ' LEU . 9.1 m-85 -94.71 -3.69 48.83 Favored 'General case' 0 C--N 1.318 -0.768 0 CA-C-N 115.544 -0.753 . . . . 0.0 110.294 176.102 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 85.66 -170.7 44.41 Favored Glycine 0 N--CA 1.439 -1.109 0 CA-C-N 115.19 -0.914 . . . . 0.0 112.09 176.097 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 19.7 t -87.1 138.05 32.77 Favored Pre-proline 0 C--N 1.312 -1.057 0 N-CA-C 109.311 -0.625 . . . . 0.0 109.311 173.94 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 9.8 Cg_endo -52.91 142.77 51.54 Favored 'Trans proline' 0 C--N 1.346 0.436 0 C-N-CA 122.221 1.948 . . . . 0.0 110.275 173.661 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 75' ' ' SER . . . . . 0.471 ' HB2' HD23 ' A' ' 78' ' ' LEU . 54.7 m -120.94 102.51 43.99 Favored Pre-proline 0 C--N 1.322 -0.608 0 N-CA-C 112.031 0.382 . . . . 0.0 112.031 -165.574 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 76' ' ' PRO . . . . . 0.453 ' HD2' ' HA ' ' A' ' 75' ' ' SER . 36.3 Cg_endo -67.53 -14.25 41.69 Favored 'Trans proline' 0 N--CA 1.462 -0.333 0 C-N-CA 122.692 2.261 . . . . 0.0 112.043 174.996 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 23.8 t70 -64.03 -19.61 65.32 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.689 -178.801 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 78' ' ' LEU . . . . . 0.6 ' HB3' ' HB2' ' A' ' 125' ' ' PHE . 3.0 mm? -88.66 -1.12 57.91 Favored 'General case' 0 CA--C 1.513 -0.469 0 C-N-CA 120.697 -0.401 . . . . 0.0 110.775 -179.611 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 79' ' ' ILE . . . . . 0.64 HG23 ' O ' ' A' ' 123' ' ' VAL . 20.2 mt -65.4 128.51 28.32 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.594 0 CA-C-O 121.921 0.867 . . . . 0.0 111.335 -178.243 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 80' ' ' GLN . . . . . 0.573 ' O ' ' HB ' ' A' ' 123' ' ' VAL . 49.5 mt-30 -135.81 138.88 43.02 Favored 'General case' 0 C--N 1.319 -0.76 0 CA-C-N 114.14 -1.391 . . . . 0.0 108.736 -174.274 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 81' ' ' TYR . . . . . 0.447 ' CE2' HG23 ' A' ' 122' ' ' THR . 73.1 m-85 -107.17 110.3 22.33 Favored 'General case' 0 C--N 1.32 -0.691 0 C-N-CA 119.707 -0.797 . . . . 0.0 110.276 -179.117 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 48.9 m-85 -104.81 168.55 8.99 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-N 115.881 -0.599 . . . . 0.0 110.684 172.495 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 22.6 t -87.22 157.99 19.21 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-O 121.365 0.603 . . . . 0.0 111.209 -176.883 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 84' ' ' ARG . . . . . 0.402 ' HG3' ' HD2' ' A' ' 85' ' ' ARG . 12.5 ptm180 -61.86 -34.74 76.54 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 115.22 -0.9 . . . . 0.0 109.825 175.961 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 85' ' ' ARG . . . . . 0.402 ' HD2' ' HG3' ' A' ' 84' ' ' ARG . 5.1 mpt_? -54.7 -28.08 45.22 Favored 'General case' 0 C--N 1.32 -0.7 0 CA-C-N 113.952 -1.476 . . . . 0.0 111.781 176.092 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 21.2 mm-40 -79.86 -20.2 46.48 Favored 'General case' 0 C--N 1.32 -0.689 0 CA-C-O 121.105 0.478 . . . . 0.0 111.389 179.396 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 87' ' ' PHE . . . . . . . . . . . . . 57.0 m-85 -104.22 -20.5 13.77 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 116.093 -0.503 . . . . 0.0 111.558 -176.076 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 88' ' ' MET . . . . . . . . . . . . . 22.5 ttm -56.13 -38.37 70.72 Favored 'General case' 0 C--N 1.323 -0.556 0 N-CA-C 112.307 0.484 . . . . 0.0 112.307 -173.239 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 2.3 m-20 -53.98 -27.46 31.58 Favored 'General case' 0 C--N 1.328 -0.327 0 N-CA-C 112.362 0.504 . . . . 0.0 112.362 176.709 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -110.47 14.81 22.46 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-O 120.957 0.408 . . . . 0.0 110.554 179.834 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 92.3 138.85 8.57 Favored Glycine 0 N--CA 1.448 -0.566 0 C-N-CA 120.837 -0.696 . . . . 0.0 111.973 -178.554 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 63.6 mt-10 -62.47 122.13 71.53 Favored Pre-proline 0 C--N 1.324 -0.532 0 CA-C-O 121.148 0.499 . . . . 0.0 110.906 -179.632 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 93' ' ' PRO . . . . . 0.5 ' HG2' HD12 ' A' ' 121' ' ' ILE . 43.9 Cg_endo -72.95 168.12 25.53 Favored 'Trans proline' 0 CA--C 1.516 -0.393 0 C-N-CA 123.777 2.984 . . . . 0.0 114.123 -173.214 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 94' ' ' GLU . . . . . 0.414 ' HB2' ' HB2' ' A' ' 97' ' ' ALA . 3.4 mp0 -114.07 160.03 19.35 Favored 'General case' 0 N--CA 1.444 -0.742 0 CA-C-N 114.181 -1.372 . . . . 0.0 110.54 -172.357 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 95' ' ' ILE . . . . . 0.533 HG12 HG12 ' A' ' 116' ' ' ILE . 11.3 mt -78.2 131.7 33.99 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.446 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.535 178.829 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 71.76 24.02 77.24 Favored Glycine 0 N--CA 1.445 -0.708 0 CA-C-N 115.629 -0.714 . . . . 0.0 111.963 -176.626 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 97' ' ' ALA . . . . . 0.414 ' HB2' ' HB2' ' A' ' 94' ' ' GLU . . . -103.29 117.42 34.47 Favored 'General case' 0 N--CA 1.449 -0.502 0 CA-C-O 121.937 0.875 . . . . 0.0 110.661 179.456 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 98' ' ' ILE . . . . . 0.565 ' HA ' ' HA ' ' A' ' 112' ' ' VAL . 4.1 mt -97.97 120.51 47.4 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.294 0 CA-C-N 114.481 -1.236 . . . . 0.0 108.726 -176.012 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 99' ' ' MET . . . . . . . . . . . . . 8.3 mtm -133.91 149.65 51.3 Favored 'General case' 0 N--CA 1.439 -0.99 0 N-CA-C 106.922 -1.51 . . . . 0.0 106.922 -177.949 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 3.2 mm? -70.38 119.7 14.94 Favored 'General case' 0 C--N 1.311 -1.087 0 CA-C-O 122.313 1.054 . . . . 0.0 113.044 -176.417 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 101' ' ' PHE . . . . . 0.647 ' O ' ' HA ' ' A' ' 108' ' ' GLU . 20.8 m-85 -109.7 175.89 5.28 Favored 'General case' 0 C--O 1.22 -0.452 0 CA-C-N 113.05 -1.886 . . . . 0.0 111.47 -175.533 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 9.2 m -124.84 109.65 13.31 Favored 'General case' 0 N--CA 1.466 0.373 0 C-N-CA 120.492 -0.483 . . . . 0.0 111.136 -166.248 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -77.3 170.3 16.78 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-N 115.733 -0.667 . . . . 0.0 112.483 178.659 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 104' ' ' MET . . . . . 0.421 ' C ' ' H ' ' A' ' 106' ' ' GLY . 3.7 mpp? -58.93 -37.71 77.31 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 115.659 -0.7 . . . . 0.0 111.193 -179.783 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 11.1 p-10 -78.59 22.97 0.33 Allowed 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 121.381 0.61 . . . . 0.0 110.665 177.774 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 106' ' ' GLY . . . . . 0.421 ' H ' ' C ' ' A' ' 104' ' ' MET . . . 66.39 -12.04 0.5 Allowed Glycine 0 C--N 1.337 0.623 0 CA-C-N 115.178 -0.919 . . . . 0.0 114.812 -174.869 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 46.6 t -65.74 132.72 49.43 Favored 'General case' 0 CA--C 1.501 -0.912 0 CA-C-O 122.063 0.935 . . . . 0.0 110.896 -171.909 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 108' ' ' GLU . . . . . 0.647 ' HA ' ' O ' ' A' ' 101' ' ' PHE . 2.1 tt0 -90.77 104.04 16.68 Favored 'General case' 0 C--N 1.297 -1.677 0 CA-C-N 114.146 -1.388 . . . . 0.0 109.128 178.907 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 109' ' ' MET . . . . . . . . . . . . . 1.7 mtm -102.63 148.32 35.34 Favored Pre-proline 0 CA--C 1.511 -0.549 0 N-CA-C 108.096 -1.076 . . . . 0.0 108.096 -178.138 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 29.6 Cg_endo -63.85 146.14 91.34 Favored 'Trans proline' 0 N--CA 1.45 -1.046 0 C-N-CA 121.325 1.35 . . . . 0.0 110.482 172.999 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 111' ' ' GLY . . . . . 0.493 ' HA3' ' CD2' ' A' ' 101' ' ' PHE . . . -143.35 107.76 0.48 Allowed Glycine 0 N--CA 1.439 -1.138 0 N-CA-C 109.763 -1.335 . . . . 0.0 109.763 -173.359 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 112' ' ' VAL . . . . . 0.84 HG13 ' HB3' ' A' ' 124' ' ' ASP . 2.9 p -87.57 107.55 17.37 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.876 0 C-N-CA 118.798 -1.161 . . . . 0.0 109.976 -174.779 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 113' ' ' ILE . . . . . . . . . . . . . 34.8 mt -62.91 108.46 0.59 Allowed 'Isoleucine or valine' 0 N--CA 1.436 -1.168 0 N-CA-C 108.531 -0.915 . . . . 0.0 108.531 170.525 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 114' ' ' ARG . . . . . 0.419 ' O ' HG23 ' A' ' 95' ' ' ILE . 6.3 tpp180 -75.37 -42.72 53.36 Favored 'General case' 0 C--N 1.308 -1.203 0 CA-C-N 113.853 -1.521 . . . . 0.0 111.06 -168.969 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 115' ' ' GLU . . . . . 0.5 ' HA ' HG23 ' A' ' 95' ' ' ILE . 8.3 tt0 -159.57 156.78 28.65 Favored 'General case' 0 C--N 1.32 -0.694 0 N-CA-C 109.622 -0.51 . . . . 0.0 109.622 -176.381 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 116' ' ' ILE . . . . . 0.533 HG12 HG12 ' A' ' 95' ' ' ILE . 38.8 mm -111.48 115.28 49.45 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.528 0 N-CA-C 109.907 -0.405 . . . . 0.0 109.907 179.68 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 117' ' ' ASN . . . . . 0.525 HD22 ' N ' ' A' ' 117' ' ' ASN . 0.8 OUTLIER -99.51 154.69 18.04 Favored 'General case' 0 C--N 1.316 -0.858 0 N-CA-C 108.8 -0.815 . . . . 0.0 108.8 176.672 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . -62.3 -28.0 70.19 Favored Glycine 0 N--CA 1.45 -0.395 0 CA-C-N 115.929 -0.578 . . . . 0.0 113.648 -173.78 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 11.8 t70 -114.87 -17.63 11.5 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 117.004 0.402 . . . . 0.0 111.77 179.08 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 120' ' ' SER . . . . . 0.448 ' O ' ' HB2' ' A' ' 117' ' ' ASN . 14.8 t -137.59 157.8 45.74 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-O 121.179 0.514 . . . . 0.0 111.281 -169.662 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 121' ' ' ILE . . . . . 0.5 HD12 ' HG2' ' A' ' 93' ' ' PRO . 45.1 mm -110.13 132.91 57.12 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.811 0 CA-C-N 116.102 -0.499 . . . . 0.0 109.963 177.376 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 122' ' ' THR . . . . . 0.447 HG23 ' CE2' ' A' ' 81' ' ' TYR . 4.6 m -92.44 103.34 15.78 Favored 'General case' 0 N--CA 1.442 -0.848 0 CA-C-O 122.142 0.972 . . . . 0.0 109.924 178.233 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 123' ' ' VAL . . . . . 0.64 ' O ' HG23 ' A' ' 79' ' ' ILE . 18.8 t -93.86 156.51 3.09 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.005 0 CA-C-N 113.54 -1.664 . . . . 0.0 110.355 177.581 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 124' ' ' ASP . . . . . 0.84 ' HB3' HG13 ' A' ' 112' ' ' VAL . 10.8 t0 -151.06 94.08 2.01 Favored 'General case' 0 C--N 1.317 -0.827 0 CA-C-N 115.216 -0.902 . . . . 0.0 109.684 -176.596 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 125' ' ' PHE . . . . . 0.6 ' HB2' ' HB3' ' A' ' 78' ' ' LEU . 84.4 m-85 -84.68 96.83 9.34 Favored 'General case' 0 CA--C 1.51 -0.593 0 CA-C-O 122.041 0.924 . . . . 0.0 110.517 177.537 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -89.0 -177.0 5.35 Favored 'General case' 0 C--N 1.299 -1.611 0 CA-C-N 114.297 -1.32 . . . . 0.0 109.763 173.261 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 127' ' ' HIS . . . . . . . . . . . . . 1.4 m170 -87.41 -178.52 1.11 Allowed Pre-proline 0 C--N 1.307 -1.266 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.926 -173.209 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 128' ' ' PRO . . . . . 0.448 ' O ' ' N ' ' A' ' 130' ' ' ALA . 1.1 Cg_endo -46.06 175.76 0.01 OUTLIER 'Trans proline' 0 CA--C 1.533 0.425 0 C-N-CA 123.979 3.12 . . . . 0.0 112.338 161.588 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 129' ' ' LEU . . . . . . . . . . . . . 15.8 tp -49.45 43.74 0.0 OUTLIER 'General case' 0 N--CA 1.482 1.166 0 C-N-CA 126.483 1.913 . . . . 0.0 114.858 179.836 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 130' ' ' ALA . . . . . 0.448 ' N ' ' O ' ' A' ' 128' ' ' PRO . . . -78.02 -177.28 4.94 Favored 'General case' 0 C--N 1.318 -0.775 0 C-N-CA 123.335 0.654 . . . . 0.0 110.025 -173.632 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . 72.97 15.22 78.45 Favored Glycine 0 N--CA 1.449 -0.484 0 C-N-CA 120.761 -0.733 . . . . 0.0 113.257 -178.956 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 132' ' ' GLN . . . . . . . . . . . . . 2.7 pt20 -149.0 158.55 44.27 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 117.045 0.422 . . . . 0.0 110.295 173.803 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 133' ' ' THR . . . . . . . . . . . . . 24.0 m -80.6 127.02 31.98 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.974 -178.489 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 134' ' ' VAL . . . . . 0.436 ' HB ' ' CD1' ' A' ' 17' ' ' LEU . 2.6 m -134.2 146.29 31.57 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.362 0 N-CA-C 112.297 0.48 . . . . 0.0 112.297 -174.397 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 135' ' ' HIS . . . . . . . . . . . . . 26.1 m-70 -98.32 120.41 38.68 Favored 'General case' 0 N--CA 1.465 0.315 0 CA-C-N 116.0 -0.545 . . . . 0.0 110.618 178.734 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 136' ' ' PHE . . . . . 0.499 ' HB3' HD13 ' A' ' 17' ' ' LEU . 3.1 p90 -128.78 150.83 50.13 Favored 'General case' 0 C--N 1.321 -0.653 0 N-CA-C 113.894 1.072 . . . . 0.0 113.894 179.287 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 137' ' ' ASP . . . . . 0.57 ' O ' ' HB2' ' A' ' 15' ' ' PHE . 5.1 m-20 -100.38 140.29 34.84 Favored 'General case' 0 CA--C 1.508 -0.639 0 CA-C-N 114.139 -1.392 . . . . 0.0 107.706 174.666 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 138' ' ' ILE . . . . . 0.621 HG23 HG21 ' A' ' 13' ' ' VAL . 60.2 mt -137.32 132.99 46.48 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.836 0 CA-C-O 120.761 0.315 . . . . 0.0 110.526 -179.911 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 139' ' ' GLU . . . . . 0.593 ' HG2' ' HB3' ' A' ' 60' ' ' LYS . 28.3 mt-10 -105.65 144.36 32.5 Favored 'General case' 0 CA--C 1.514 -0.439 0 CA-C-N 116.494 -0.321 . . . . 0.0 110.749 -179.3 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 140' ' ' VAL . . . . . 0.441 ' CG1' ' HA ' ' A' ' 57' ' ' VAL . 37.6 t -97.71 104.66 16.19 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.886 0 N-CA-C 108.366 -0.976 . . . . 0.0 108.366 169.415 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 41.1 mt -91.67 -51.62 5.15 Favored 'General case' 0 C--N 1.318 -0.769 0 N-CA-C 109.347 -0.612 . . . . 0.0 109.347 -178.362 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 142' ' ' GLU . . . . . 0.519 ' HB3' HD12 ' A' ' 12' ' ' LEU . 40.9 tt0 -150.95 148.61 28.62 Favored 'General case' 0 C--N 1.321 -0.654 0 CA-C-N 115.55 -0.75 . . . . 0.0 109.236 169.393 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 143' ' ' ILE . . . . . 0.536 HD12 HG23 ' A' ' 57' ' ' VAL . 74.5 mt -103.52 136.2 37.52 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.7 0 CA-C-O 120.811 0.339 . . . . 0.0 110.109 -178.152 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 144' ' ' ASP . . . . . . . . . . . . . 29.0 t70 -77.29 133.73 67.82 Favored Pre-proline 0 C--N 1.324 -0.523 0 CA-C-N 115.895 -0.593 . . . . 0.0 109.808 -177.295 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 145' ' ' PRO . . . . . 0.487 ' HA ' ' HB3' ' A' ' 2' ' ' SER . 24.4 Cg_endo -56.43 128.08 28.6 Favored 'Trans proline' 0 C--N 1.345 0.389 0 C-N-CA 123.308 2.672 . . . . 0.0 113.048 -172.575 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 146' ' ' ALA . . . . . . . . . . . . . . . -84.52 98.62 10.22 Favored 'General case' 0 C--N 1.314 -0.955 0 CA-C-N 114.967 -1.015 . . . . 0.0 109.907 178.185 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -98.61 45.94 1.0 Allowed 'General case' 0 C--N 1.32 -0.696 0 N-CA-C 108.388 -0.967 . . . . 0.0 108.388 179.628 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.448 -0.562 0 CA-C-N 115.46 -0.791 . . . . 0.0 110.902 -173.933 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 51.7 ttm . . . . . 0 N--CA 1.48 1.074 0 CA-C-O 120.791 0.329 . . . . 0.0 110.738 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 18.7 m -99.1 75.13 2.01 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-O 120.86 0.362 . . . . 0.0 110.516 -178.411 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 7.2 mp0 -76.31 -29.77 57.46 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 121.55 0.69 . . . . 0.0 110.051 177.681 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 20.8 t -120.97 152.56 38.4 Favored 'General case' 0 C--N 1.317 -0.834 0 CA-C-N 115.031 -0.986 . . . . 0.0 109.698 -179.98 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 69.8 t -68.72 123.39 22.05 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.443 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.36 -178.595 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 6' ' ' GLN . . . . . . . . . . . . . 5.1 pt20 -140.49 160.67 39.48 Favored 'General case' 0 C--N 1.315 -0.929 0 CA-C-N 115.206 -0.906 . . . . 0.0 109.342 -177.667 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 41.4 p -62.64 145.33 54.82 Favored 'General case' 0 C--N 1.317 -0.837 0 O-C-N 123.215 0.322 . . . . 0.0 110.824 -178.47 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 8' ' ' ASN . . . . . 0.438 ' OD1' ' HA ' ' A' ' 148' ' ' GLU . 21.3 t-20 77.24 -1.01 2.82 Favored 'General case' 0 N--CA 1.47 0.564 0 C-N-CA 123.762 0.825 . . . . 0.0 111.558 179.732 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 67.1 m -99.99 166.23 11.15 Favored 'General case' 0 C--N 1.327 -0.384 0 N-CA-C 108.983 -0.747 . . . . 0.0 108.983 172.693 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 10' ' ' ALA . . . . . 0.707 ' HB2' ' HD2' ' A' ' 38' ' ' ARG . . . -115.82 154.32 29.88 Favored 'General case' 0 C--N 1.316 -0.875 0 C-N-CA 120.598 -0.441 . . . . 0.0 110.209 178.705 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 8.6 m -129.69 133.57 64.73 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.786 0 CA-C-O 121.395 0.617 . . . . 0.0 110.575 177.776 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 12' ' ' LEU . . . . . 0.433 ' N ' HD12 ' A' ' 12' ' ' LEU . 5.9 mp -86.81 110.36 19.89 Favored 'General case' 0 C--N 1.316 -0.88 0 N-CA-C 107.173 -1.418 . . . . 0.0 107.173 172.923 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 13' ' ' VAL . . . . . 0.479 HG21 HG23 ' A' ' 138' ' ' ILE . 1.5 p -123.73 157.19 30.42 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.93 0 CA-C-O 121.089 0.471 . . . . 0.0 110.858 -171.963 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 14' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -119.02 116.34 26.21 Favored 'General case' 0 C--N 1.317 -0.822 0 N-CA-C 106.376 -1.713 . . . . 0.0 106.376 174.197 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 15' ' ' PHE . . . . . 0.517 ' H ' HG23 ' A' ' 28' ' ' THR . 21.2 p90 -150.81 161.69 42.17 Favored 'General case' 0 C--N 1.32 -0.695 0 C-N-CA 119.221 -0.992 . . . . 0.0 112.441 -169.448 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 13.8 m -128.58 122.99 32.25 Favored 'General case' 0 N--CA 1.448 -0.535 0 N-CA-C 109.09 -0.707 . . . . 0.0 109.09 173.101 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 17' ' ' LEU . . . . . 0.51 HD11 ' HB ' ' A' ' 134' ' ' VAL . 7.3 tp -92.23 125.52 36.93 Favored 'General case' 0 C--N 1.319 -0.72 0 CA-C-O 121.407 0.622 . . . . 0.0 110.941 -173.505 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 18' ' ' LYS . . . . . 0.445 ' HD3' ' N ' ' A' ' 18' ' ' LYS . 0.0 OUTLIER -111.49 145.84 38.33 Favored 'General case' 0 C--N 1.321 -0.651 0 CA-C-N 114.849 -1.068 . . . . 0.0 111.247 -173.319 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 19' ' ' LEU . . . . . 0.466 ' CD2' ' HB2' ' A' ' 25' ' ' ALA . 4.0 mm? -86.69 166.43 15.33 Favored 'General case' 0 C--N 1.319 -0.74 0 N-CA-C 109.64 -0.504 . . . . 0.0 109.64 172.24 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 15.7 t70 -61.08 -33.75 73.83 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-O 121.243 0.544 . . . . 0.0 109.659 174.052 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 17.7 m-20 -80.08 9.34 5.64 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 115.46 -0.791 . . . . 0.0 111.899 -179.614 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 73.34 17.61 78.96 Favored Glycine 0 N--CA 1.453 -0.174 0 C-N-CA 121.146 -0.55 . . . . 0.0 113.004 178.439 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 9.3 m -85.69 152.54 23.0 Favored 'General case' 0 C--N 1.32 -0.694 0 N-CA-C 109.577 -0.527 . . . . 0.0 109.577 176.337 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 23.5 m -95.47 116.35 28.69 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-O 120.718 0.294 . . . . 0.0 110.828 179.038 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 25' ' ' ALA . . . . . 0.466 ' HB2' ' CD2' ' A' ' 19' ' ' LEU . . . -87.31 -50.67 6.43 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 116.258 -0.428 . . . . 0.0 111.567 -177.009 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 8.1 tp10 -145.62 129.29 17.13 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 115.78 -0.645 . . . . 0.0 109.468 -175.113 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 21.0 m -124.09 115.03 20.5 Favored 'General case' 0 C--N 1.318 -0.786 0 N-CA-C 110.474 -0.195 . . . . 0.0 110.474 -178.939 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 28' ' ' THR . . . . . 0.517 HG23 ' H ' ' A' ' 15' ' ' PHE . 8.4 t -122.11 57.76 1.05 Allowed 'General case' 0 C--O 1.239 0.546 0 CA-C-O 122.653 1.216 . . . . 0.0 109.182 173.484 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 10.6 mmm180 -118.12 -71.78 0.72 Allowed 'General case' 0 C--N 1.323 -0.564 0 CA-C-N 114.152 -1.386 . . . . 0.0 110.366 173.089 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 11.0 p30 -65.49 -7.45 14.4 Favored 'General case' 0 N--CA 1.47 0.537 0 CA-C-N 116.096 -0.502 . . . . 0.0 111.765 -177.302 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -61.4 -35.31 77.15 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 115.877 -0.602 . . . . 0.0 110.62 -179.419 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 90.0 -1.36 80.35 Favored Glycine 0 N--CA 1.447 -0.584 0 N-CA-C 110.759 -0.936 . . . . 0.0 110.759 -172.22 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 65.6 mttm -128.71 138.53 33.32 Favored Pre-proline 0 C--N 1.326 -0.446 0 N-CA-C 109.06 -0.719 . . . . 0.0 109.06 179.792 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 37.0 Cg_endo -85.06 171.49 9.17 Favored 'Trans proline' 0 N--CA 1.451 -1.008 0 C-N-CA 122.933 2.422 . . . . 0.0 112.029 174.423 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -113.89 139.13 49.44 Favored 'General case' 0 C--N 1.309 -1.182 0 CA-C-N 115.019 -0.992 . . . . 0.0 109.115 -179.905 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 36' ' ' LEU . . . . . 0.413 HD21 ' HB1' ' A' ' 10' ' ' ALA . 3.3 tm? -94.97 117.49 30.23 Favored 'General case' 0 C--N 1.316 -0.856 0 CA-C-O 121.27 0.557 . . . . 0.0 110.184 -178.629 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 37' ' ' PHE . . . . . . . . . . . . . 4.4 m-30 -98.51 107.84 20.39 Favored 'General case' 0 C--N 1.317 -0.84 0 CA-C-N 115.266 -0.879 . . . . 0.0 110.181 174.175 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 38' ' ' ARG . . . . . 0.707 ' HD2' ' HB2' ' A' ' 10' ' ' ALA . 19.2 tpt180 -92.84 109.39 20.83 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-N 116.265 -0.425 . . . . 0.0 109.858 178.95 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 39' ' ' LEU . . . . . 0.438 HD22 ' CB ' ' A' ' 49' ' ' GLU . 14.7 mt -81.05 154.04 27.05 Favored 'General case' 0 C--N 1.321 -0.653 0 CA-C-N 115.611 -0.722 . . . . 0.0 109.77 -177.877 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 101.47 35.78 4.01 Favored Glycine 0 N--CA 1.444 -0.778 0 C-N-CA 120.754 -0.736 . . . . 0.0 112.349 -177.191 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER 62.99 14.94 7.98 Favored 'General case' 0 N--CA 1.47 0.556 0 N-CA-C 112.96 0.726 . . . . 0.0 112.96 175.515 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -62.73 -59.01 5.48 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-O 121.034 0.445 . . . . 0.0 110.663 179.92 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 16.4 t -134.53 2.86 3.26 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-O 121.303 0.573 . . . . 0.0 110.03 177.145 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 44' ' ' LEU . . . . . 0.555 HD13 HD22 ' A' ' 48' ' ' LEU . 78.9 mt -115.38 174.1 6.18 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-N 115.542 -0.754 . . . . 0.0 109.994 -178.09 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 12.9 t -104.65 154.91 19.36 Favored 'General case' 0 C--N 1.322 -0.608 0 N-CA-C 109.306 -0.627 . . . . 0.0 109.306 176.586 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 46' ' ' GLU . . . . . 0.556 ' O ' ' HG2' ' A' ' 50' ' ' GLN . 37.7 mt-10 -47.35 -46.17 25.37 Favored 'General case' 0 N--CA 1.466 0.335 0 O-C-N 123.605 0.565 . . . . 0.0 112.067 -175.221 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -61.24 -42.12 99.69 Favored Glycine 0 N--CA 1.446 -0.677 0 CA-C-N 115.975 -0.557 . . . . 0.0 113.581 -173.562 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 48' ' ' LEU . . . . . 0.555 HD22 HD13 ' A' ' 44' ' ' LEU . 2.6 tt -61.26 -48.95 79.07 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 117.325 0.563 . . . . 0.0 111.538 -176.749 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 49' ' ' GLU . . . . . 0.465 ' O ' HD13 ' A' ' 53' ' ' LEU . 11.7 pt-20 -64.5 -37.78 88.71 Favored 'General case' 0 C--N 1.325 -0.49 0 C-N-CA 120.555 -0.458 . . . . 0.0 109.907 -179.033 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 50' ' ' GLN . . . . . 0.556 ' HG2' ' O ' ' A' ' 46' ' ' GLU . 84.5 mm-40 -51.88 -29.3 19.26 Favored 'General case' 0 N--CA 1.464 0.249 0 N-CA-C 112.047 0.388 . . . . 0.0 112.047 175.475 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 51' ' ' HIS . . . . . . . . . . . . . 12.3 m-70 -97.63 -3.81 38.73 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-O 121.057 0.456 . . . . 0.0 110.973 -177.319 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 31.1 mt -102.84 -29.69 11.31 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 116.097 -0.501 . . . . 0.0 111.279 178.022 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 53' ' ' LEU . . . . . 0.465 HD13 ' O ' ' A' ' 49' ' ' GLU . 0.0 OUTLIER -59.47 139.08 57.42 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-O 121.158 0.504 . . . . 0.0 111.26 -179.465 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 93.67 -8.85 74.09 Favored Glycine 0 N--CA 1.45 -0.391 0 CA-C-N 115.743 -0.662 . . . . 0.0 112.589 -179.45 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 55' ' ' LEU . . . . . 0.424 HD12 ' HB3' ' A' ' 59' ' ' ASP . 4.2 mm? -78.15 164.92 24.56 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-O 121.048 0.452 . . . . 0.0 110.918 176.857 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 56' ' ' LYS . . . . . 0.542 ' O ' ' HB2' ' A' ' 59' ' ' ASP . 0.1 OUTLIER -126.78 164.84 20.46 Favored 'General case' 0 C--N 1.321 -0.665 0 CA-C-N 116.197 -0.456 . . . . 0.0 109.874 -176.993 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 25.5 t -63.91 132.37 29.74 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 N-CA-C 109.908 -0.405 . . . . 0.0 109.908 172.377 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 79.93 9.93 86.18 Favored Glycine 0 N--CA 1.45 -0.373 0 C-N-CA 120.995 -0.621 . . . . 0.0 112.38 -176.133 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 59' ' ' ASP . . . . . 0.542 ' HB2' ' O ' ' A' ' 56' ' ' LYS . 0.4 OUTLIER -104.52 152.96 21.75 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-O 120.964 0.411 . . . . 0.0 110.634 178.732 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 60' ' ' LYS . . . . . 0.416 ' HE3' ' OE1' ' A' ' 139' ' ' GLU . 0.6 OUTLIER -112.18 132.35 54.95 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 115.671 -0.695 . . . . 0.0 110.412 -173.003 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 61' ' ' THR . . . . . 0.404 ' HB ' HD11 ' A' ' 55' ' ' LEU . 7.6 t -139.35 115.81 10.58 Favored 'General case' 0 C--N 1.319 -0.744 0 CA-C-O 121.562 0.696 . . . . 0.0 111.066 175.743 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 62' ' ' THR . . . . . 0.459 HG23 ' O ' ' A' ' 136' ' ' PHE . 34.6 m -112.37 130.58 55.91 Favored 'General case' 0 C--N 1.318 -0.768 0 N-CA-C 108.986 -0.746 . . . . 0.0 108.986 173.492 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 28.4 p90 -148.71 146.84 28.29 Favored 'General case' 0 C--N 1.315 -0.903 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.252 -177.591 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 26.6 p -89.85 144.52 25.87 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.492 176.241 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 65' ' ' LEU . . . . . 0.41 HD11 ' HA ' ' A' ' 48' ' ' LEU . 77.0 mt -138.55 133.1 32.14 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-O 121.356 0.598 . . . . 0.0 110.866 177.635 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 66' ' ' GLU . . . . . 0.435 ' HB2' ' OD1' ' A' ' 68' ' ' ASP . 4.3 mm-40 -88.61 161.84 40.88 Favored Pre-proline 0 C--N 1.313 -1.003 0 CA-C-N 115.157 -0.929 . . . . 0.0 108.728 174.671 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 67' ' ' PRO . . . . . 0.449 ' HB3' ' HA2' ' A' ' 131' ' ' GLY . 99.1 Cg_exo -45.53 -35.47 12.47 Favored 'Trans proline' 0 C--N 1.349 0.586 0 C-N-CA 123.055 2.503 . . . . 0.0 114.367 -174.305 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 68' ' ' ASP . . . . . 0.435 ' OD1' ' HB2' ' A' ' 66' ' ' GLU . 6.8 p-10 -59.21 -29.41 67.48 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-O 120.723 0.297 . . . . 0.0 111.417 -178.889 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -115.04 11.8 16.53 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-O 120.76 0.314 . . . . 0.0 111.045 179.589 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -146.67 108.62 4.38 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 116.302 -0.408 . . . . 0.0 110.972 -174.349 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 71' ' ' PHE . . . . . 0.506 ' CB ' ' HA ' ' A' ' 130' ' ' ALA . 27.5 m-85 72.07 -45.48 0.62 Allowed 'General case' 0 N--CA 1.466 0.369 0 CA-C-N 115.358 -0.837 . . . . 0.0 111.937 179.756 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 72' ' ' GLY . . . . . 0.594 ' O ' ' HB1' ' A' ' 130' ' ' ALA . . . 131.31 155.46 8.15 Favored Glycine 0 N--CA 1.45 -0.41 0 C-N-CA 121.041 -0.599 . . . . 0.0 112.452 177.663 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 45.2 t -80.82 125.72 79.5 Favored Pre-proline 0 C--N 1.323 -0.548 0 O-C-N 122.843 -0.21 . . . . 0.0 111.298 175.101 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 74' ' ' PRO . . . . . 0.415 ' HD3' ' CA ' ' A' ' 131' ' ' GLY . 90.2 Cg_endo -80.43 155.25 21.62 Favored 'Trans proline' 0 C--N 1.346 0.397 0 C-N-CA 122.815 2.343 . . . . 0.0 111.235 173.904 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 75' ' ' SER . . . . . 0.405 ' HB3' HD23 ' A' ' 78' ' ' LEU . 8.1 t -140.95 130.48 12.97 Favored Pre-proline 0 C--N 1.32 -0.687 0 CA-C-O 121.077 0.465 . . . . 0.0 110.955 -177.972 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 57.1 Cg_endo -69.92 -17.84 36.61 Favored 'Trans proline' 0 C--N 1.347 0.462 0 C-N-CA 123.27 2.647 . . . . 0.0 113.615 -176.521 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 2.6 p-10 -70.85 -11.39 60.93 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-O 120.986 0.422 . . . . 0.0 110.522 -178.785 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 78' ' ' LEU . . . . . 0.405 HD23 ' HB3' ' A' ' 75' ' ' SER . 4.3 mm? -70.9 -18.86 62.66 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.002 -0.545 . . . . 0.0 110.589 174.645 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 79' ' ' ILE . . . . . 0.471 HG12 ' HA ' ' A' ' 124' ' ' ASP . 9.9 mt -85.46 106.76 15.51 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.643 0 CA-C-N 115.763 -0.653 . . . . 0.0 110.447 -175.94 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 30.8 mt-30 -121.79 122.01 38.53 Favored 'General case' 0 C--N 1.319 -0.759 0 CA-C-N 115.639 -0.71 . . . . 0.0 111.248 -178.501 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 81' ' ' TYR . . . . . 0.658 ' CD1' HG23 ' A' ' 122' ' ' THR . 0.1 OUTLIER -108.27 114.02 27.56 Favored 'General case' 0 C--N 1.315 -0.903 0 CA-C-N 115.914 -0.584 . . . . 0.0 111.55 176.945 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -116.55 177.93 4.52 Favored 'General case' 0 C--N 1.319 -0.748 0 CA-C-O 120.626 0.251 . . . . 0.0 111.125 168.394 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 83' ' ' SER . . . . . 0.419 ' HA ' ' O ' ' A' ' 119' ' ' ASP . 8.2 t -59.27 151.58 22.91 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-O 121.572 0.701 . . . . 0.0 111.963 -170.437 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -74.36 -12.72 60.6 Favored 'General case' 0 C--N 1.333 -0.131 0 CA-C-N 115.249 -0.887 . . . . 0.0 111.34 -169.681 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 85' ' ' ARG . . . . . . . . . . . . . 7.5 mpt_? -71.49 -20.52 62.05 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 121.51 0.671 . . . . 0.0 109.905 -177.574 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 30.6 mm-40 -79.48 -12.1 59.88 Favored 'General case' 0 C--N 1.321 -0.653 0 CA-C-N 114.959 -1.019 . . . . 0.0 109.797 176.206 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 87' ' ' PHE . . . . . 0.496 ' CE1' ' HB ' ' A' ' 121' ' ' ILE . 73.7 m-85 -105.0 -46.39 4.29 Favored 'General case' 0 C--N 1.319 -0.72 0 CA-C-N 114.709 -1.132 . . . . 0.0 110.538 -175.039 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 88' ' ' MET . . . . . . . . . . . . . 64.5 ttp -58.16 -22.35 50.95 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-N 115.325 -0.852 . . . . 0.0 110.216 178.666 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 32.1 t70 -53.3 -35.67 60.37 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 115.047 -0.979 . . . . 0.0 110.838 174.033 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -116.06 11.44 15.33 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.272 -179.919 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 113.58 141.26 7.84 Favored Glycine 0 N--CA 1.448 -0.505 0 C-N-CA 120.827 -0.701 . . . . 0.0 112.117 -178.301 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 44.2 mt-10 -64.41 125.81 89.23 Favored Pre-proline 0 C--N 1.324 -0.505 0 CA-C-O 121.017 0.437 . . . . 0.0 111.416 -178.842 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 93' ' ' PRO . . . . . 0.445 ' HB2' HD13 ' A' ' 113' ' ' ILE . 53.1 Cg_endo -78.83 167.06 22.76 Favored 'Trans proline' 0 C--O 1.232 0.217 0 C-N-CA 123.591 2.86 . . . . 0.0 114.146 -174.389 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 1.1 mp0 -120.08 155.65 32.57 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 115.015 -0.993 . . . . 0.0 111.352 -173.133 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 95' ' ' ILE . . . . . 0.568 HG12 HG12 ' A' ' 116' ' ' ILE . 13.7 mt -82.34 131.41 33.86 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.155 0 CA-C-N 116.301 -0.409 . . . . 0.0 111.01 178.778 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 68.13 30.05 73.66 Favored Glycine 0 N--CA 1.448 -0.544 0 CA-C-N 115.815 -0.63 . . . . 0.0 111.905 179.966 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -108.45 125.32 51.64 Favored 'General case' 0 N--CA 1.445 -0.695 0 CA-C-O 120.934 0.397 . . . . 0.0 109.939 179.828 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 98' ' ' ILE . . . . . 0.516 ' HA ' ' HA ' ' A' ' 112' ' ' VAL . 35.4 mt -86.52 102.47 11.95 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.867 0 N-CA-C 108.807 -0.812 . . . . 0.0 108.807 179.601 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 99' ' ' MET . . . . . 0.487 ' O ' ' HD2' ' A' ' 101' ' ' PHE . 7.0 mtm -105.39 126.63 52.33 Favored 'General case' 0 N--CA 1.438 -1.057 0 CA-C-O 121.665 0.745 . . . . 0.0 110.545 -175.279 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 4.4 mm? -62.75 147.81 48.65 Favored 'General case' 0 C--N 1.305 -1.331 0 CA-C-N 114.28 -1.327 . . . . 0.0 109.326 171.078 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 101' ' ' PHE . . . . . 0.487 ' HD2' ' O ' ' A' ' 99' ' ' MET . 0.4 OUTLIER -148.62 167.02 26.55 Favored 'General case' 0 CA--C 1.509 -0.619 0 CA-C-N 115.021 -0.99 . . . . 0.0 108.44 -152.806 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 1.5 m -121.78 122.15 38.86 Favored 'General case' 0 C--N 1.309 -1.179 0 C-N-CA 119.773 -0.771 . . . . 0.0 110.353 176.965 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -88.12 165.25 15.24 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-N 115.791 -0.64 . . . . 0.0 110.305 -177.779 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 104' ' ' MET . . . . . . . . . . . . . 2.0 mpt? -66.23 -12.73 58.01 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.807 -0.633 . . . . 0.0 112.002 -175.014 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 8.6 p-10 -99.71 15.44 26.8 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-O 120.737 0.304 . . . . 0.0 110.982 179.765 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 79.76 -11.95 31.3 Favored Glycine 0 CA--C 1.52 0.346 0 C-N-CA 121.121 -0.562 . . . . 0.0 113.88 177.824 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 24.6 t -79.71 151.13 30.61 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-O 121.203 0.525 . . . . 0.0 110.081 179.586 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 26.3 tt0 -94.56 100.26 12.26 Favored 'General case' 0 C--N 1.313 -1.016 0 CA-C-N 115.585 -0.734 . . . . 0.0 110.009 -178.019 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 109' ' ' MET . . . . . . . . . . . . . 3.1 mtp -92.25 147.85 35.42 Favored Pre-proline 0 C--N 1.324 -0.524 0 CA-C-N 115.3 -0.864 . . . . 0.0 110.842 179.998 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 55.2 Cg_endo -72.49 154.72 55.46 Favored 'Trans proline' 0 N--CA 1.458 -0.56 0 C-N-CA 122.009 1.806 . . . . 0.0 110.871 173.374 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 111' ' ' GLY . . . . . 0.502 ' HA2' ' O ' ' A' ' 124' ' ' ASP . . . -150.21 103.48 0.25 Allowed Glycine 0 N--CA 1.445 -0.736 0 C-N-CA 120.164 -1.017 . . . . 0.0 110.853 -171.637 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 112' ' ' VAL . . . . . 0.516 ' HA ' ' HA ' ' A' ' 98' ' ' ILE . 7.7 p -97.73 113.26 31.77 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.559 0 CA-C-N 119.237 1.518 . . . . 0.0 110.689 -179.462 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 113' ' ' ILE . . . . . 0.466 ' HA ' ' O ' ' A' ' 122' ' ' THR . 39.2 mt -72.6 111.14 6.47 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.897 0 CA-C-N 114.902 -1.045 . . . . 0.0 110.059 179.941 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 114' ' ' ARG . . . . . 0.514 ' HD3' ' O ' ' A' ' 114' ' ' ARG . 8.8 tpp180 -63.81 -46.73 83.81 Favored 'General case' 0 C--N 1.322 -0.625 0 CA-C-N 114.909 -1.041 . . . . 0.0 110.864 -177.669 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 115' ' ' GLU . . . . . 0.526 ' HA ' HG23 ' A' ' 95' ' ' ILE . 14.5 tt0 -159.25 154.43 25.27 Favored 'General case' 0 C--N 1.324 -0.531 0 C-N-CA 120.705 -0.398 . . . . 0.0 110.882 -175.751 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 116' ' ' ILE . . . . . 0.568 HG12 HG12 ' A' ' 95' ' ' ILE . 37.4 mm -100.57 120.63 50.3 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 N-CA-C 109.183 -0.673 . . . . 0.0 109.183 175.987 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 117' ' ' ASN . . . . . 0.432 ' HB2' ' O ' ' A' ' 120' ' ' SER . 30.2 m-80 -110.41 157.46 19.53 Favored 'General case' 0 C--N 1.315 -0.913 0 CA-C-N 115.934 -0.575 . . . . 0.0 110.171 -179.755 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . -56.21 -40.59 84.53 Favored Glycine 0 C--O 1.227 -0.343 0 C-N-CA 120.688 -0.768 . . . . 0.0 113.694 -169.528 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 119' ' ' ASP . . . . . 0.419 ' O ' ' HA ' ' A' ' 83' ' ' SER . 24.8 m-20 -113.07 -15.69 12.77 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 117.169 0.484 . . . . 0.0 112.119 179.826 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 120' ' ' SER . . . . . 0.432 ' O ' ' HB2' ' A' ' 117' ' ' ASN . 13.6 t -130.73 156.49 44.86 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-O 120.923 0.392 . . . . 0.0 111.483 -169.999 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 121' ' ' ILE . . . . . 0.506 HD12 HD12 ' A' ' 116' ' ' ILE . 49.5 mm -127.46 125.59 65.95 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.778 -178.626 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 122' ' ' THR . . . . . 0.658 HG23 ' CD1' ' A' ' 81' ' ' TYR . 10.7 m -95.38 103.32 15.18 Favored 'General case' 0 C--N 1.329 -0.323 0 N-CA-C 112.477 0.547 . . . . 0.0 112.477 -174.246 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 5.6 t -103.78 122.06 56.02 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 N-CA-C 113.307 0.854 . . . . 0.0 113.307 177.404 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 124' ' ' ASP . . . . . 0.502 ' O ' ' HA2' ' A' ' 111' ' ' GLY . 1.3 t70 -89.04 135.41 33.57 Favored 'General case' 0 C--N 1.322 -0.587 0 CA-C-N 115.191 -0.913 . . . . 0.0 111.508 170.285 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 125' ' ' PHE . . . . . . . . . . . . . 63.2 m-85 -117.98 59.15 0.8 Allowed 'General case' 0 C--N 1.331 -0.216 0 CA-C-O 122.115 0.96 . . . . 0.0 110.381 -176.118 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 126' ' ' ASN . . . . . 0.41 HD22 ' CG ' ' A' ' 124' ' ' ASP . 13.2 m-80 -104.39 142.4 34.65 Favored 'General case' 0 C--N 1.307 -1.266 0 CA-C-N 114.311 -1.313 . . . . 0.0 111.496 -179.439 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 127' ' ' HIS . . . . . 0.492 ' HB3' ' HD2' ' A' ' 128' ' ' PRO . 20.9 m80 -60.73 -175.2 0.08 OUTLIER Pre-proline 0 C--N 1.321 -0.645 0 CA-C-N 113.914 -1.493 . . . . 0.0 112.794 -178.162 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 128' ' ' PRO . . . . . 0.492 ' HD2' ' HB3' ' A' ' 127' ' ' HIS . 3.9 Cg_exo -42.82 177.47 0.0 OUTLIER 'Trans proline' 0 C--N 1.355 0.881 0 C-N-CA 125.252 3.968 . . . . 0.0 114.172 165.184 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 129' ' ' LEU . . . . . 0.514 ' O ' ' HG ' ' A' ' 129' ' ' LEU . 26.4 tp -47.6 42.45 0.0 OUTLIER 'General case' 0 N--CA 1.488 1.433 0 C-N-CA 127.621 2.368 . . . . 0.0 115.418 -176.24 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 130' ' ' ALA . . . . . 0.594 ' HB1' ' O ' ' A' ' 72' ' ' GLY . . . -86.24 173.95 9.42 Favored 'General case' 0 C--N 1.31 -1.143 0 N-CA-C 109.49 -0.559 . . . . 0.0 109.49 -176.153 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 131' ' ' GLY . . . . . 0.449 ' HA2' ' HB3' ' A' ' 67' ' ' PRO . . . 73.56 21.48 79.43 Favored Glycine 0 N--CA 1.448 -0.541 0 C-N-CA 120.637 -0.792 . . . . 0.0 113.145 178.836 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 132' ' ' GLN . . . . . . . . . . . . . 3.9 pt20 -110.31 143.67 40.18 Favored 'General case' 0 N--CA 1.444 -0.766 0 N-CA-C 109.707 -0.479 . . . . 0.0 109.707 174.965 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 133' ' ' THR . . . . . . . . . . . . . 20.5 m -88.36 111.79 22.14 Favored 'General case' 0 C--N 1.317 -0.829 0 N-CA-C 108.85 -0.796 . . . . 0.0 108.85 177.82 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 134' ' ' VAL . . . . . 0.51 ' HB ' HD11 ' A' ' 17' ' ' LEU . 1.5 m -121.99 148.78 25.37 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.595 0 CA-C-O 121.894 0.854 . . . . 0.0 112.6 -172.271 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 135' ' ' HIS . . . . . 0.41 ' O ' HD12 ' A' ' 17' ' ' LEU . 15.0 m-70 -112.42 147.38 36.58 Favored 'General case' 0 C--N 1.316 -0.89 0 CA-C-N 114.624 -1.171 . . . . 0.0 108.508 174.028 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 136' ' ' PHE . . . . . 0.459 ' O ' HG23 ' A' ' 62' ' ' THR . 12.5 m-85 -123.45 124.11 42.15 Favored 'General case' 0 C--N 1.31 -1.131 0 CA-C-N 116.028 -0.533 . . . . 0.0 111.71 -166.726 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 137' ' ' ASP . . . . . 0.466 ' O ' ' HB2' ' A' ' 15' ' ' PHE . 12.9 m-20 -116.58 96.42 5.5 Favored 'General case' 0 C--N 1.324 -0.525 0 N-CA-C 108.608 -0.886 . . . . 0.0 108.608 175.784 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 138' ' ' ILE . . . . . 0.479 HG23 HG21 ' A' ' 13' ' ' VAL . 1.9 mp -107.65 138.57 33.28 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.55 0 N-CA-C 112.599 0.592 . . . . 0.0 112.599 -177.794 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 139' ' ' GLU . . . . . 0.416 ' OE1' ' HE3' ' A' ' 60' ' ' LYS . 31.8 mt-10 -125.59 124.71 41.83 Favored 'General case' 0 CA--C 1.507 -0.676 0 N-CA-C 108.084 -1.08 . . . . 0.0 108.084 167.885 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 140' ' ' VAL . . . . . . . . . . . . . 71.6 t -78.16 121.47 31.05 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.747 0 C-N-CA 120.704 -0.398 . . . . 0.0 110.428 -176.947 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 19.2 mt -93.1 -44.05 8.57 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-O 121.262 0.553 . . . . 0.0 110.027 178.084 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 142' ' ' GLU . . . . . . . . . . . . . 10.2 tp10 -153.67 152.22 30.56 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-N 115.465 -0.789 . . . . 0.0 109.768 -179.336 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 143' ' ' ILE . . . . . . . . . . . . . 63.0 mt -116.9 121.16 67.13 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.421 0 CA-C-O 121.007 0.432 . . . . 0.0 110.317 178.531 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 144' ' ' ASP . . . . . 0.646 ' HB3' ' HB3' ' A' ' 10' ' ' ALA . 38.6 t70 -77.37 128.5 80.22 Favored Pre-proline 0 C--N 1.322 -0.618 0 CA-C-N 115.808 -0.633 . . . . 0.0 110.154 -179.341 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 145' ' ' PRO . . . . . . . . . . . . . 73.7 Cg_exo -52.61 153.89 13.27 Favored 'Trans proline' 0 C--N 1.345 0.383 0 C-N-CA 123.29 2.66 . . . . 0.0 112.539 178.415 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 146' ' ' ALA . . . . . . . . . . . . . . . -83.73 95.71 8.49 Favored 'General case' 0 C--N 1.32 -0.716 0 CA-C-O 121.591 0.71 . . . . 0.0 111.106 -177.684 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 3.8 mm? -102.33 31.07 4.19 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-N 115.438 -0.801 . . . . 0.0 108.841 170.469 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 148' ' ' GLU . . . . . 0.438 ' HA ' ' OD1' ' A' ' 8' ' ' ASN . 41.2 mt-10 . . . . . 0 CA--C 1.527 0.083 0 CA-C-N 114.679 -1.146 . . . . 0.0 111.249 -178.733 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 26.4 ttt . . . . . 0 N--CA 1.48 1.037 0 CA-C-O 120.743 0.306 . . . . 0.0 110.189 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 4.8 t -109.55 118.34 36.35 Favored 'General case' 0 C--N 1.322 -0.605 0 N-CA-C 109.25 -0.648 . . . . 0.0 109.25 177.86 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 3' ' ' GLU . . . . . 0.436 ' CG ' ' HE2' ' A' ' 56' ' ' LYS . 39.2 tt0 -74.5 -34.44 63.06 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-O 121.477 0.656 . . . . 0.0 110.554 -177.132 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 24.2 m -128.12 156.82 42.24 Favored 'General case' 0 C--N 1.314 -0.939 0 CA-C-N 115.302 -0.863 . . . . 0.0 109.604 179.621 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . 0.561 HG13 ' HA ' ' A' ' 53' ' ' LEU . 7.1 p -81.96 135.94 23.97 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.532 0 CA-C-O 121.021 0.439 . . . . 0.0 110.83 -177.58 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 6' ' ' GLN . . . . . 0.594 ' HG2' ' OG ' ' A' ' 9' ' ' SER . 0.6 OUTLIER -123.21 168.49 12.37 Favored 'General case' 0 C--N 1.318 -0.792 0 CA-C-N 115.933 -0.576 . . . . 0.0 109.632 177.866 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 29.4 t -54.23 122.77 11.01 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-O 120.765 0.317 . . . . 0.0 110.493 179.052 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 2.9 t30 73.5 41.25 0.46 Allowed 'General case' 0 N--CA 1.469 0.497 0 C-N-CA 123.935 0.894 . . . . 0.0 111.132 -177.238 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 9' ' ' SER . . . . . 0.594 ' OG ' ' HG2' ' A' ' 6' ' ' GLN . 67.0 m -122.2 134.74 54.71 Favored 'General case' 0 C--N 1.325 -0.473 0 N-CA-C 108.846 -0.798 . . . . 0.0 108.846 168.288 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 10' ' ' ALA . . . . . 0.502 ' HB2' ' HD3' ' A' ' 38' ' ' ARG . . . -84.68 147.57 26.86 Favored 'General case' 0 C--N 1.315 -0.899 0 CA-C-N 116.533 -0.303 . . . . 0.0 110.233 -176.858 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 13.5 m -133.91 142.88 40.08 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.864 0 C-N-CA 120.712 -0.395 . . . . 0.0 110.335 179.971 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 30.6 tp -86.55 123.57 31.9 Favored 'General case' 0 C--N 1.319 -0.739 0 N-CA-C 108.271 -1.011 . . . . 0.0 108.271 174.797 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 13' ' ' VAL . . . . . 0.706 HG21 HG23 ' A' ' 138' ' ' ILE . 4.4 p -131.93 156.28 42.38 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.778 0 CA-C-O 122.27 1.033 . . . . 0.0 113.057 -172.432 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 14' ' ' HIS . . . . . 0.497 ' CD2' HD11 ' A' ' 141' ' ' LEU . 2.2 m-70 -118.77 120.85 38.59 Favored 'General case' 0 C--N 1.317 -0.835 0 N-CA-C 106.059 -1.83 . . . . 0.0 106.059 169.471 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 15' ' ' PHE . . . . . 0.519 ' CD1' ' HB ' ' A' ' 28' ' ' THR . 16.2 p90 -151.08 157.87 43.33 Favored 'General case' 0 C--N 1.324 -0.537 0 C-N-CA 118.181 -1.408 . . . . 0.0 113.948 -170.336 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 22.2 m -131.06 130.43 43.23 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 114.85 -1.068 . . . . 0.0 108.598 176.904 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 17' ' ' LEU . . . . . 0.799 HD21 ' HB ' ' A' ' 134' ' ' VAL . 2.2 tt -121.81 118.05 28.05 Favored 'General case' 0 N--CA 1.446 -0.637 0 N-CA-C 109.435 -0.58 . . . . 0.0 109.435 -173.678 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 18' ' ' LYS . . . . . 0.651 ' HB3' ' CE1' ' A' ' 135' ' ' HIS . 2.4 tppt? -126.19 155.63 41.46 Favored 'General case' 0 C--N 1.314 -0.94 0 C-N-CA 119.988 -0.685 . . . . 0.0 111.455 -174.885 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 3.1 mm? -99.52 171.5 7.89 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-N 115.291 -0.868 . . . . 0.0 109.339 173.813 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 35.5 t70 -64.72 -25.49 67.96 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-O 121.373 0.606 . . . . 0.0 109.866 176.099 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 5.0 m-20 -77.53 2.99 14.67 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.5 -0.773 . . . . 0.0 110.843 178.501 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 73.27 9.57 77.28 Favored Glycine 0 C--N 1.33 0.245 0 C-N-CA 121.387 -0.435 . . . . 0.0 113.28 -179.913 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 26.7 m -82.27 142.26 32.25 Favored 'General case' 0 C--N 1.321 -0.644 0 N-CA-C 109.835 -0.431 . . . . 0.0 109.835 177.093 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 20.9 m -89.59 112.57 23.82 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-O 120.747 0.308 . . . . 0.0 110.335 179.316 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 25' ' ' ALA . . . . . 0.714 ' HB3' HD22 ' A' ' 17' ' ' LEU . . . -72.69 -38.09 67.66 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 121.134 0.493 . . . . 0.0 110.111 178.506 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 8.4 tp10 -157.32 141.24 16.04 Favored 'General case' 0 N--CA 1.446 -0.663 0 CA-C-N 115.732 -0.667 . . . . 0.0 110.132 178.682 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 36.9 p -124.53 119.72 29.91 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-O 121.125 0.488 . . . . 0.0 110.934 -178.828 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 28' ' ' THR . . . . . 0.584 ' O ' HG22 ' A' ' 28' ' ' THR . 96.8 m -139.62 11.26 2.49 Favored 'General case' 0 CA--C 1.547 0.848 0 CA-C-O 123.269 1.509 . . . . 0.0 110.562 177.187 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 29' ' ' ARG . . . . . 0.407 ' NH1' ' HB3' ' A' ' 30' ' ' ASN . 8.7 tmm_? -104.27 -52.96 2.82 Favored 'General case' 0 C--N 1.308 -1.215 0 CA-C-N 115.099 -0.955 . . . . 0.0 109.921 167.481 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 30' ' ' ASN . . . . . 0.407 ' HB3' ' NH1' ' A' ' 29' ' ' ARG . 4.8 p-10 -82.52 35.0 0.44 Allowed 'General case' 0 C--N 1.326 -0.436 0 CA-C-O 121.079 0.466 . . . . 0.0 111.472 -178.87 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 4.5 m-20 -120.33 -23.27 6.24 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.334 -0.394 . . . . 0.0 111.599 -178.788 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 84.85 -11.6 59.37 Favored Glycine 0 N--CA 1.453 -0.212 0 C-N-CA 120.435 -0.888 . . . . 0.0 110.905 -174.286 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 33' ' ' LYS . . . . . 0.458 ' HD2' ' HD2' ' A' ' 34' ' ' PRO . 56.1 tptt -120.53 118.16 31.09 Favored Pre-proline 0 C--N 1.321 -0.646 0 CA-C-N 114.896 -0.652 . . . . 0.0 110.054 -177.974 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 34' ' ' PRO . . . . . 0.458 ' HD2' ' HD2' ' A' ' 33' ' ' LYS . 73.9 Cg_endo -80.28 170.77 15.8 Favored 'Trans proline' 0 N--CA 1.457 -0.672 0 C-N-CA 122.506 2.137 . . . . 0.0 111.526 174.125 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -137.02 152.26 49.9 Favored 'General case' 0 C--N 1.311 -1.091 0 CA-C-N 115.671 -0.695 . . . . 0.0 110.463 -175.58 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 2.0 tp -90.69 138.24 31.73 Favored 'General case' 0 C--N 1.317 -0.807 0 N-CA-C 109.414 -0.588 . . . . 0.0 109.414 175.038 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 37' ' ' PHE . . . . . . . . . . . . . 2.4 m-30 -104.0 106.66 17.24 Favored 'General case' 0 C--N 1.317 -0.825 0 N-CA-C 108.67 -0.863 . . . . 0.0 108.67 175.535 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 38' ' ' ARG . . . . . 0.502 ' HD3' ' HB2' ' A' ' 10' ' ' ALA . 6.5 tpp180 -86.07 105.6 16.61 Favored 'General case' 0 C--N 1.323 -0.569 0 N-CA-C 109.105 -0.702 . . . . 0.0 109.105 -179.733 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 40.0 mt -90.38 156.39 18.27 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-N 115.363 -0.835 . . . . 0.0 111.666 -175.743 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 102.49 37.85 3.17 Favored Glycine 0 N--CA 1.45 -0.407 0 CA-C-N 115.335 -0.848 . . . . 0.0 111.996 -177.884 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 31.9 t70 65.74 0.53 1.52 Allowed 'General case' 0 N--CA 1.472 0.637 0 C-N-CA 123.509 0.724 . . . . 0.0 111.893 179.739 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -65.78 -48.34 72.12 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.781 -179.779 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 23.1 m -134.42 -39.79 0.82 Allowed 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 116.066 -0.515 . . . . 0.0 110.788 178.135 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 4.6 mm? -88.79 162.72 16.05 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-O 121.038 0.447 . . . . 0.0 111.19 -178.818 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 32.2 t -86.81 153.68 21.48 Favored 'General case' 0 C--N 1.324 -0.5 0 CA-C-N 115.356 -0.838 . . . . 0.0 110.212 -178.997 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 42.3 mt-10 -52.45 -42.9 64.58 Favored 'General case' 0 C--N 1.328 -0.336 0 N-CA-C 112.309 0.485 . . . . 0.0 112.309 -173.818 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -64.96 -37.68 94.57 Favored Glycine 0 N--CA 1.447 -0.62 0 C-N-CA 120.41 -0.9 . . . . 0.0 112.777 -174.699 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 48' ' ' LEU . . . . . 0.482 HD11 HD12 ' A' ' 52' ' ' LEU . 3.4 tm? -70.09 -53.63 16.6 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 121.003 0.43 . . . . 0.0 110.093 -176.934 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 10.4 pt-20 -58.3 -40.89 83.19 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 115.712 -0.676 . . . . 0.0 112.107 -177.868 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 50' ' ' GLN . . . . . 0.516 ' HA ' ' CD2' ' A' ' 53' ' ' LEU . 90.6 mm-40 -73.74 -15.14 61.22 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-O 120.811 0.338 . . . . 0.0 111.336 -173.003 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 51' ' ' HIS . . . . . . . . . . . . . 14.6 m-70 -107.48 -9.4 15.97 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-O 120.945 0.402 . . . . 0.0 110.45 179.255 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 52' ' ' LEU . . . . . 0.482 HD12 HD11 ' A' ' 48' ' ' LEU . 0.4 OUTLIER -98.62 -30.48 12.46 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.274 179.284 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 53' ' ' LEU . . . . . 0.561 ' HA ' HG13 ' A' ' 5' ' ' VAL . 3.0 pp -66.76 152.08 46.2 Favored 'General case' 0 N--CA 1.452 -0.331 0 N-CA-C 109.764 -0.458 . . . . 0.0 109.764 179.565 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 93.28 3.27 65.28 Favored Glycine 0 N--CA 1.445 -0.704 0 C-N-CA 120.872 -0.68 . . . . 0.0 112.824 -175.136 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 55' ' ' LEU . . . . . 0.415 ' O ' HG12 ' A' ' 5' ' ' VAL . 3.8 mm? -96.01 165.28 12.33 Favored 'General case' 0 C--O 1.233 0.228 0 CA-C-N 117.395 0.598 . . . . 0.0 110.703 177.759 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 56' ' ' LYS . . . . . 0.601 ' HD3' ' N ' ' A' ' 57' ' ' VAL . 11.0 tmtt? -117.62 151.3 37.48 Favored 'General case' 0 C--N 1.324 -0.53 0 N-CA-C 109.031 -0.729 . . . . 0.0 109.031 -177.969 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 57' ' ' VAL . . . . . 0.601 ' N ' ' HD3' ' A' ' 56' ' ' LYS . 42.6 t -58.44 136.91 21.42 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-O 121.134 0.492 . . . . 0.0 111.492 176.708 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 82.75 8.97 85.23 Favored Glycine 0 N--CA 1.446 -0.645 0 CA-C-N 115.116 -0.947 . . . . 0.0 111.973 -178.985 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 59' ' ' ASP . . . . . 0.452 ' HB2' ' O ' ' A' ' 56' ' ' LYS . 1.0 OUTLIER -99.56 134.09 42.94 Favored 'General case' 0 C--N 1.323 -0.544 0 N-CA-C 108.916 -0.772 . . . . 0.0 108.916 171.772 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 6.9 mmmm -106.52 128.35 54.03 Favored 'General case' 0 C--N 1.319 -0.744 0 N-CA-C 109.248 -0.649 . . . . 0.0 109.248 -175.753 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 4.7 t -136.64 113.8 10.65 Favored 'General case' 0 C--N 1.32 -0.694 0 CA-C-O 121.837 0.827 . . . . 0.0 111.525 -176.536 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 62' ' ' THR . . . . . 0.434 HG23 ' HA ' ' A' ' 137' ' ' ASP . 6.1 m -100.47 131.66 46.27 Favored 'General case' 0 C--N 1.317 -0.842 0 N-CA-C 108.238 -1.023 . . . . 0.0 108.238 172.084 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 63' ' ' PHE . . . . . 0.513 ' CE2' ' HE1' ' A' ' 136' ' ' PHE . 11.3 p90 -157.92 163.98 37.34 Favored 'General case' 0 C--N 1.321 -0.661 0 C-N-CA 120.063 -0.655 . . . . 0.0 111.818 -178.072 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 26.0 t -128.75 151.81 49.13 Favored 'General case' 0 C--N 1.318 -0.785 0 CA-C-N 115.187 -0.915 . . . . 0.0 109.829 179.816 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 65' ' ' LEU . . . . . 0.421 ' CD1' ' HA ' ' A' ' 48' ' ' LEU . 39.3 mt -135.85 150.94 49.57 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-N 116.219 -0.446 . . . . 0.0 109.981 -176.882 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 48.7 mt-10 -64.1 153.88 83.94 Favored Pre-proline 0 C--N 1.33 -0.282 0 CA-C-N 116.081 -0.509 . . . . 0.0 110.527 178.779 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 80.9 Cg_exo -46.35 -52.25 7.57 Favored 'Trans proline' 0 C--O 1.233 0.257 0 C-N-CA 123.103 2.535 . . . . 0.0 113.542 -175.777 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 1.9 p-10 -66.26 -24.96 66.67 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-O 120.921 0.391 . . . . 0.0 111.053 -174.784 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -79.85 -18.55 50.49 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 115.98 -0.554 . . . . 0.0 110.922 -178.581 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -117.86 -85.84 0.64 Allowed 'General case' 0 N--CA 1.449 -0.482 0 N-CA-C 111.953 0.353 . . . . 0.0 111.953 -178.093 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 71' ' ' PHE . . . . . . . . . . . . . 9.2 m-85 -86.29 -12.31 49.86 Favored 'General case' 0 C--N 1.328 -0.345 0 N-CA-C 112.379 0.511 . . . . 0.0 112.379 -171.863 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 72' ' ' GLY . . . . . 0.465 ' C ' ' HB1' ' A' ' 130' ' ' ALA . . . 105.91 -152.59 17.13 Favored Glycine 0 N--CA 1.454 -0.158 0 C-N-CA 120.82 -0.705 . . . . 0.0 112.202 179.284 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 26.0 m -134.0 128.41 19.62 Favored Pre-proline 0 N--CA 1.449 -0.49 0 CA-C-O 121.572 0.701 . . . . 0.0 112.181 -179.019 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 74' ' ' PRO . . . . . 0.523 ' HD3' ' N ' ' A' ' 131' ' ' GLY . 61.7 Cg_endo -85.5 165.07 10.79 Favored 'Trans proline' 0 N--CA 1.458 -0.6 0 C-N-CA 124.438 3.426 . . . . 0.0 110.905 169.687 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 75' ' ' SER . . . . . 0.59 ' HB3' HD22 ' A' ' 78' ' ' LEU . 41.3 t -141.48 97.36 6.75 Favored Pre-proline 0 C--N 1.312 -1.061 0 N-CA-C 109.896 -0.409 . . . . 0.0 109.896 173.784 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 26.9 Cg_endo -65.44 -25.84 55.61 Favored 'Trans proline' 0 N--CA 1.459 -0.536 0 C-N-CA 121.729 1.619 . . . . 0.0 111.009 175.666 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 8.6 p-10 -77.36 -8.87 58.37 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 115.701 -0.681 . . . . 0.0 110.753 176.524 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 78' ' ' LEU . . . . . 0.59 HD22 ' HB3' ' A' ' 75' ' ' SER . 4.4 tp -73.23 -23.06 60.31 Favored 'General case' 0 CA--C 1.511 -0.549 0 CA-C-O 121.596 0.712 . . . . 0.0 109.147 176.604 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 79' ' ' ILE . . . . . 0.632 HG23 ' O ' ' A' ' 123' ' ' VAL . 7.0 mt -68.3 124.24 23.43 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.724 0 CA-C-N 114.69 -1.141 . . . . 0.0 110.575 177.245 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 40.2 mt-30 -149.97 119.27 6.83 Favored 'General case' 0 CA--C 1.502 -0.885 0 CA-C-N 114.992 -1.004 . . . . 0.0 109.377 -176.184 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 81' ' ' TYR . . . . . 0.592 ' CE2' HG23 ' A' ' 122' ' ' THR . 1.8 m-85 -80.26 114.75 19.38 Favored 'General case' 0 C--N 1.307 -1.27 0 C-N-CA 118.76 -1.176 . . . . 0.0 111.902 174.97 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 23.6 m-85 -100.15 172.71 7.01 Favored 'General case' 0 C--N 1.322 -0.627 0 CA-C-N 113.782 -1.554 . . . . 0.0 110.141 172.399 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 83' ' ' SER . . . . . 0.436 ' HB3' ' HG3' ' A' ' 86' ' ' GLU . 23.2 t -63.24 159.34 18.01 Favored 'General case' 0 C--N 1.321 -0.657 0 CA-C-O 122.836 1.303 . . . . 0.0 112.485 -167.952 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 84' ' ' ARG . . . . . 0.574 ' HD3' ' HA ' ' A' ' 119' ' ' ASP . 36.5 ptt180 -77.5 -28.21 52.08 Favored 'General case' 0 C--N 1.315 -0.925 0 CA-C-N 112.604 -2.089 . . . . 0.0 108.118 -179.31 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 85' ' ' ARG . . . . . . . . . . . . . 6.6 mpt_? -71.53 -39.8 70.5 Favored 'General case' 0 CA--C 1.512 -0.5 0 CA-C-N 114.281 -1.327 . . . . 0.0 111.158 -176.99 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 86' ' ' GLU . . . . . 0.436 ' HG3' ' HB3' ' A' ' 83' ' ' SER . 41.4 mt-10 -56.02 -36.88 68.45 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 115.316 -0.857 . . . . 0.0 110.891 -175.941 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 87' ' ' PHE . . . . . 0.443 ' HB3' ' HG3' ' A' ' 93' ' ' PRO . 14.0 m-85 -93.18 -37.44 12.09 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.475 -0.329 . . . . 0.0 111.843 -179.601 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 88' ' ' MET . . . . . . . . . . . . . 58.6 ttp -58.53 -31.79 68.25 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.59 -173.382 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 33.9 t70 -57.55 -28.62 63.71 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-O 120.954 0.407 . . . . 0.0 110.912 177.443 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -102.79 -2.91 27.18 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.055 -0.52 . . . . 0.0 110.732 176.967 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 119.59 140.08 6.1 Favored Glycine 0 N--CA 1.447 -0.583 0 C-N-CA 121.035 -0.602 . . . . 0.0 112.117 -178.108 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 47.0 mt-10 -61.11 120.94 58.9 Favored Pre-proline 0 C--N 1.327 -0.398 0 CA-C-O 120.807 0.336 . . . . 0.0 110.887 178.465 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 93' ' ' PRO . . . . . 0.447 ' HG2' HD12 ' A' ' 121' ' ' ILE . 4.3 Cg_exo -71.7 167.42 26.57 Favored 'Trans proline' 0 C--N 1.344 0.312 0 C-N-CA 123.303 2.669 . . . . 0.0 112.895 -176.841 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -115.4 156.04 26.31 Favored 'General case' 0 C--N 1.321 -0.64 0 CA-C-N 115.04 -0.982 . . . . 0.0 111.045 -174.609 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 95' ' ' ILE . . . . . 0.528 HG12 HG12 ' A' ' 116' ' ' ILE . 21.6 mt -81.76 131.06 34.72 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.453 0 CA-C-N 115.909 -0.587 . . . . 0.0 110.875 -178.716 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 72.92 18.76 79.2 Favored Glycine 0 N--CA 1.449 -0.466 0 CA-C-N 115.709 -0.678 . . . . 0.0 112.422 -177.289 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 97' ' ' ALA . . . . . 0.411 ' O ' HG13 ' A' ' 113' ' ' ILE . . . -98.71 129.74 45.17 Favored 'General case' 0 C--N 1.324 -0.515 0 N-CA-C 109.674 -0.491 . . . . 0.0 109.674 177.385 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 98' ' ' ILE . . . . . 0.555 ' HA ' ' HA ' ' A' ' 112' ' ' VAL . 16.4 mt -97.79 130.08 47.04 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.725 0 N-CA-C 108.837 -0.801 . . . . 0.0 108.837 178.759 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 99' ' ' MET . . . . . . . . . . . . . 9.7 mtm -137.0 160.44 38.91 Favored 'General case' 0 N--CA 1.447 -0.594 0 N-CA-C 107.601 -1.259 . . . . 0.0 107.601 -179.721 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 2.6 mm? -69.77 103.63 2.22 Favored 'General case' 0 C--N 1.317 -0.814 0 CA-C-O 122.318 1.056 . . . . 0.0 111.046 175.307 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 101' ' ' PHE . . . . . . . . . . . . . 2.8 m-85 -94.2 171.63 8.71 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 113.151 -1.841 . . . . 0.0 112.612 -172.914 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 2.6 m -124.87 135.71 53.14 Favored 'General case' 0 C--N 1.313 -0.985 0 CA-C-N 114.439 -1.255 . . . . 0.0 109.382 -178.241 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -103.54 159.47 15.57 Favored 'General case' 0 C--N 1.32 -0.692 0 N-CA-C 109.316 -0.624 . . . . 0.0 109.316 -177.929 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 104' ' ' MET . . . . . . . . . . . . . 71.2 mtm -66.39 -12.49 57.22 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.057 -0.519 . . . . 0.0 111.798 -174.446 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 4.5 p-10 -93.59 3.96 54.7 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 120.848 0.356 . . . . 0.0 110.853 177.568 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 92.32 -10.83 73.51 Favored Glycine 0 N--CA 1.444 -0.788 0 C-N-CA 120.672 -0.775 . . . . 0.0 113.69 178.939 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 34.9 t -78.01 140.32 39.17 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-O 121.52 0.676 . . . . 0.0 111.072 -179.471 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 23.0 tt0 -94.74 98.78 11.01 Favored 'General case' 0 C--N 1.314 -0.97 0 CA-C-N 115.253 -0.885 . . . . 0.0 110.249 178.389 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 109' ' ' MET . . . . . . . . . . . . . 1.6 mtm -100.81 145.1 29.78 Favored Pre-proline 0 C--N 1.326 -0.421 0 CA-C-N 115.203 -0.908 . . . . 0.0 110.609 176.897 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 23.9 Cg_endo -66.61 116.35 4.04 Favored 'Trans proline' 0 N--CA 1.455 -0.741 0 C-N-CA 121.336 1.357 . . . . 0.0 110.631 173.227 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . -111.26 132.49 10.94 Favored Glycine 0 CA--C 1.502 -0.739 0 CA-C-N 115.518 -0.765 . . . . 0.0 112.223 -177.147 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 112' ' ' VAL . . . . . 0.555 ' HA ' ' HA ' ' A' ' 98' ' ' ILE . 3.0 p -94.62 133.22 36.29 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.739 0 N-CA-C 108.774 -0.825 . . . . 0.0 108.774 174.207 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 113' ' ' ILE . . . . . 0.444 HD13 ' CB ' ' A' ' 93' ' ' PRO . 20.3 mt -86.24 109.85 19.25 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.14 0 N-CA-C 108.201 -1.037 . . . . 0.0 108.201 -178.433 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 114' ' ' ARG . . . . . 0.474 ' O ' HG23 ' A' ' 95' ' ' ILE . 11.9 tpp180 -64.97 -46.75 80.19 Favored 'General case' 0 C--N 1.314 -0.957 0 CA-C-N 115.198 -0.91 . . . . 0.0 111.078 -174.395 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 115' ' ' GLU . . . . . 0.442 ' HA ' HG23 ' A' ' 95' ' ' ILE . 4.8 tt0 -159.7 160.05 33.66 Favored 'General case' 0 C--N 1.32 -0.71 0 C-N-CA 120.822 -0.351 . . . . 0.0 110.225 -176.324 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 116' ' ' ILE . . . . . 0.528 HG12 HG12 ' A' ' 95' ' ' ILE . 38.2 mm -114.61 121.78 67.39 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.436 0 CA-C-O 120.954 0.407 . . . . 0.0 110.36 177.99 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 117' ' ' ASN . . . . . . . . . . . . . 30.1 m-80 -112.64 154.1 26.59 Favored 'General case' 0 C--N 1.316 -0.87 0 N-CA-C 109.285 -0.635 . . . . 0.0 109.285 174.668 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . -75.94 -13.92 82.68 Favored Glycine 0 N--CA 1.449 -0.476 0 C-N-CA 120.74 -0.743 . . . . 0.0 113.021 -173.781 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 119' ' ' ASP . . . . . 0.574 ' HA ' ' HD3' ' A' ' 84' ' ' ARG . 30.2 t70 -112.82 -18.4 12.29 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-O 120.943 0.402 . . . . 0.0 111.594 -179.606 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 4.8 t -152.22 158.02 42.27 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 116.494 -0.321 . . . . 0.0 110.797 -172.997 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 121' ' ' ILE . . . . . 0.466 ' O ' ' HA ' ' A' ' 81' ' ' TYR . 47.7 mm -106.45 128.42 61.02 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.423 0 CA-C-O 121.218 0.533 . . . . 0.0 111.095 178.024 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 122' ' ' THR . . . . . 0.592 HG23 ' CE2' ' A' ' 81' ' ' TYR . 8.5 m -91.76 108.53 19.98 Favored 'General case' 0 C--N 1.321 -0.639 0 CA-C-O 122.19 0.995 . . . . 0.0 112.115 -178.429 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 123' ' ' VAL . . . . . 0.632 ' O ' HG23 ' A' ' 79' ' ' ILE . 15.5 t -99.63 157.79 3.81 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.555 0 CA-C-N 113.522 -1.672 . . . . 0.0 110.935 -177.755 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 124' ' ' ASP . . . . . 0.536 ' OD1' ' HB2' ' A' ' 126' ' ' ASN . 12.2 t0 -155.16 96.67 1.85 Allowed 'General case' 0 CA--C 1.537 0.474 0 N-CA-C 108.402 -0.962 . . . . 0.0 108.402 -176.025 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 125' ' ' PHE . . . . . 0.541 ' HB2' ' CD2' ' A' ' 78' ' ' LEU . 76.6 m-85 -90.31 23.62 2.86 Favored 'General case' 0 N--CA 1.47 0.541 0 O-C-N 120.618 -1.301 . . . . 0.0 111.478 -177.492 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 126' ' ' ASN . . . . . 0.536 ' HB2' ' OD1' ' A' ' 124' ' ' ASP . 27.1 m-80 -74.69 178.2 5.59 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 122.096 0.951 . . . . 0.0 113.446 -174.817 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 127' ' ' HIS . . . . . 0.531 ' HB3' ' HD2' ' A' ' 128' ' ' PRO . 33.7 m170 -127.59 -176.51 0.51 Allowed Pre-proline 0 CA--C 1.536 0.433 0 CA-C-N 114.214 -1.357 . . . . 0.0 110.95 -168.841 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 128' ' ' PRO . . . . . 0.531 ' HD2' ' HB3' ' A' ' 127' ' ' HIS . 2.1 Cg_endo -44.59 173.7 0.01 OUTLIER 'Trans proline' 0 C--N 1.357 0.978 0 C-N-CA 124.904 3.736 . . . . 0.0 113.805 164.976 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 129' ' ' LEU . . . . . . . . . . . . . 93.3 mt -51.44 37.07 0.0 OUTLIER 'General case' 0 N--CA 1.494 1.757 0 C-N-CA 126.532 1.933 . . . . 0.0 115.818 -176.279 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 130' ' ' ALA . . . . . 0.465 ' HB1' ' C ' ' A' ' 72' ' ' GLY . . . -76.51 -179.06 4.99 Favored 'General case' 0 C--N 1.305 -1.331 0 C-N-CA 123.585 0.754 . . . . 0.0 111.104 -179.953 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 131' ' ' GLY . . . . . 0.523 ' N ' ' HD3' ' A' ' 74' ' ' PRO . . . 70.5 20.78 77.33 Favored Glycine 0 CA--C 1.51 -0.265 0 C-N-CA 121.307 -0.473 . . . . 0.0 114.098 176.026 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 132' ' ' GLN . . . . . . . . . . . . . 19.4 pt20 -145.15 142.25 29.46 Favored 'General case' 0 C--N 1.318 -0.789 0 N-CA-C 109.256 -0.646 . . . . 0.0 109.256 175.826 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 133' ' ' THR . . . . . . . . . . . . . 1.5 m -73.03 114.25 10.98 Favored 'General case' 0 C--N 1.317 -0.843 0 CA-C-N 115.617 -0.72 . . . . 0.0 109.808 -176.424 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 134' ' ' VAL . . . . . 0.799 ' HB ' HD21 ' A' ' 17' ' ' LEU . 4.0 m -99.02 123.16 51.49 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.724 0 CA-C-O 121.447 0.641 . . . . 0.0 111.106 -175.126 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 135' ' ' HIS . . . . . 0.651 ' CE1' ' HB3' ' A' ' 18' ' ' LYS . 18.1 p80 -103.27 137.51 41.3 Favored 'General case' 0 C--N 1.318 -0.804 0 CA-C-N 115.112 -0.949 . . . . 0.0 110.189 174.152 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 136' ' ' PHE . . . . . 0.513 ' HE1' ' CE2' ' A' ' 63' ' ' PHE . 0.1 OUTLIER -134.48 138.33 44.63 Favored 'General case' 0 N--CA 1.442 -0.846 0 CA-C-O 121.55 0.69 . . . . 0.0 110.534 -175.153 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 137' ' ' ASP . . . . . 0.505 ' O ' ' HA ' ' A' ' 15' ' ' PHE . 37.6 t70 -98.93 108.07 20.66 Favored 'General case' 0 C--N 1.312 -1.062 0 CA-C-N 114.539 -1.21 . . . . 0.0 108.344 175.212 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 138' ' ' ILE . . . . . 0.706 HG23 HG21 ' A' ' 13' ' ' VAL . 62.5 mt -120.67 120.66 63.19 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.565 0 CA-C-O 121.396 0.617 . . . . 0.0 111.037 -167.851 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 30.2 mt-10 -110.8 111.32 22.4 Favored 'General case' 0 C--N 1.321 -0.671 0 CA-C-N 115.818 -0.628 . . . . 0.0 110.67 -178.703 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 140' ' ' VAL . . . . . 0.461 ' CG1' ' HA ' ' A' ' 57' ' ' VAL . 45.2 t -65.95 111.6 1.65 Allowed 'Isoleucine or valine' 0 C--O 1.234 0.266 0 CA-C-N 116.548 -0.296 . . . . 0.0 110.456 178.227 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 141' ' ' LEU . . . . . 0.497 HD11 ' CD2' ' A' ' 14' ' ' HIS . 48.0 mt -98.42 -49.74 4.56 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-O 120.746 0.307 . . . . 0.0 110.29 -179.943 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 142' ' ' GLU . . . . . . . . . . . . . 67.7 mm-40 -141.26 163.85 31.83 Favored 'General case' 0 CA--C 1.514 -0.413 0 CA-C-N 115.979 -0.555 . . . . 0.0 111.115 177.127 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 143' ' ' ILE . . . . . 0.52 HD12 HG23 ' A' ' 57' ' ' VAL . 94.4 mt -130.0 110.63 19.8 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.652 0 CA-C-N 115.168 -0.924 . . . . 0.0 110.381 176.605 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 144' ' ' ASP . . . . . 0.402 ' HB3' ' HB3' ' A' ' 10' ' ' ALA . 20.1 t70 -78.98 124.49 84.76 Favored Pre-proline 0 C--N 1.322 -0.617 0 CA-C-N 115.53 -0.759 . . . . 0.0 109.49 177.53 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 145' ' ' PRO . . . . . . . . . . . . . 41.3 Cg_endo -66.84 148.49 82.49 Favored 'Trans proline' 0 C--O 1.234 0.32 0 C-N-CA 122.585 2.19 . . . . 0.0 112.29 -175.532 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 146' ' ' ALA . . . . . . . . . . . . . . . -85.98 98.8 11.02 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 116.018 -0.537 . . . . 0.0 111.275 -176.036 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 147' ' ' LEU . . . . . 0.402 HD13 ' HA ' ' A' ' 147' ' ' LEU . 3.2 mm? -106.79 13.11 28.29 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.248 176.897 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 39.7 mt-10 . . . . . 0 C--N 1.326 -0.447 0 N-CA-C 109.596 -0.52 . . . . 0.0 109.596 176.687 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 13.4 tpt . . . . . 0 N--CA 1.48 1.049 0 CA-C-O 120.686 0.279 . . . . 0.0 110.311 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . 0.407 ' CB ' ' HA ' ' A' ' 145' ' ' PRO . 14.6 t -76.58 82.3 3.25 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.237 -0.438 . . . . 0.0 109.84 178.136 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 3' ' ' GLU . . . . . 0.46 ' O ' ' HG3' ' A' ' 56' ' ' LYS . 32.3 mt-10 -74.5 -30.21 61.72 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 115.844 -0.616 . . . . 0.0 109.682 179.276 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 40.0 t -116.88 151.23 37.03 Favored 'General case' 0 C--N 1.318 -0.771 0 CA-C-N 114.904 -1.043 . . . . 0.0 109.389 -178.532 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 98.0 t -72.96 125.3 31.57 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.403 0 CA-C-O 121.036 0.446 . . . . 0.0 110.267 177.08 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 6' ' ' GLN . . . . . 0.651 ' HG2' ' OG ' ' A' ' 9' ' ' SER . 5.2 pt20 -119.34 166.94 12.39 Favored 'General case' 0 C--N 1.319 -0.718 0 CA-C-N 115.609 -0.723 . . . . 0.0 109.141 -179.557 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 7' ' ' SER . . . . . 0.452 ' O ' ' HB2' ' A' ' 8' ' ' ASN . 10.0 p -63.23 133.75 54.78 Favored 'General case' 0 C--N 1.316 -0.882 0 N-CA-C 109.857 -0.423 . . . . 0.0 109.857 177.832 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 8' ' ' ASN . . . . . 0.514 ' OD1' ' HA3' ' A' ' 40' ' ' GLY . 34.4 m-80 72.7 35.07 1.11 Allowed 'General case' 0 N--CA 1.471 0.596 0 O-C-N 123.755 0.659 . . . . 0.0 112.327 -176.78 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 9' ' ' SER . . . . . 0.651 ' OG ' ' HG2' ' A' ' 6' ' ' GLN . 49.6 m -92.82 167.03 12.13 Favored 'General case' 0 C--N 1.332 -0.152 0 CA-C-O 121.151 0.501 . . . . 0.0 110.785 173.006 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 10' ' ' ALA . . . . . 0.493 ' HB3' ' HB3' ' A' ' 144' ' ' ASP . . . -115.54 118.14 32.31 Favored 'General case' 0 C--N 1.319 -0.759 0 N-CA-C 108.558 -0.905 . . . . 0.0 108.558 170.808 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 4.3 m -127.5 142.75 42.75 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.729 0 C-N-CA 120.165 -0.614 . . . . 0.0 110.909 -174.05 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 12' ' ' LEU . . . . . 0.502 ' HB2' ' HB2' ' A' ' 142' ' ' GLU . 83.8 mt -93.96 133.4 37.44 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-N 115.818 -0.628 . . . . 0.0 109.346 176.566 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 17.2 m -131.68 167.11 27.07 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.941 0 CA-C-O 121.519 0.676 . . . . 0.0 112.262 -174.867 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 14' ' ' HIS . . . . . 0.566 ' CD2' HD11 ' A' ' 141' ' ' LEU . 0.3 OUTLIER -134.21 115.67 14.44 Favored 'General case' 0 C--N 1.322 -0.59 0 N-CA-C 106.433 -1.692 . . . . 0.0 106.433 166.159 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 45.4 p90 -145.8 156.14 43.38 Favored 'General case' 0 C--N 1.319 -0.726 0 C-N-CA 120.841 -0.344 . . . . 0.0 110.629 -171.084 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 60.1 m -121.63 131.47 54.13 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-O 120.884 0.373 . . . . 0.0 110.664 174.478 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 17' ' ' LEU . . . . . 0.446 ' CD2' ' HB3' ' A' ' 136' ' ' PHE . 6.3 mt -98.26 121.8 40.64 Favored 'General case' 0 C--N 1.328 -0.363 0 N-CA-C 112.662 0.616 . . . . 0.0 112.662 178.331 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 9.5 mptt -127.67 142.84 51.23 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-N 114.973 -1.012 . . . . 0.0 110.197 -179.236 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 19' ' ' LEU . . . . . 0.519 HD13 HG23 ' A' ' 134' ' ' VAL . 3.2 mm? -89.66 169.05 11.64 Favored 'General case' 0 C--N 1.325 -0.477 0 N-CA-C 109.487 -0.561 . . . . 0.0 109.487 175.918 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 1.8 p30 -67.27 -23.65 65.7 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 121.41 0.624 . . . . 0.0 109.965 177.163 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 36.3 m-20 -74.03 -0.49 16.55 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 115.139 -0.937 . . . . 0.0 111.447 175.826 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 73.8 15.47 79.51 Favored Glycine 0 N--CA 1.449 -0.442 0 C-N-CA 121.007 -0.616 . . . . 0.0 111.922 -179.124 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 27.0 m -88.34 151.79 22.37 Favored 'General case' 0 C--N 1.32 -0.68 0 N-CA-C 109.525 -0.546 . . . . 0.0 109.525 176.132 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 38.3 m -95.25 128.77 42.35 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-O 120.874 0.368 . . . . 0.0 110.969 178.167 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -91.8 -49.04 6.47 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.001 -0.545 . . . . 0.0 110.011 176.143 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 26' ' ' GLU . . . . . 0.436 ' O ' ' HB2' ' A' ' 17' ' ' LEU . 11.8 tp10 -160.9 120.29 2.63 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 115.88 -0.6 . . . . 0.0 109.872 178.352 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 46.8 m -105.31 99.08 8.7 Favored 'General case' 0 C--N 1.318 -0.777 0 C-N-CA 120.233 -0.587 . . . . 0.0 110.3 177.276 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 28' ' ' THR . . . . . 0.408 ' O ' HG22 ' A' ' 28' ' ' THR . 32.8 m -91.69 57.14 3.16 Favored 'General case' 0 C--N 1.318 -0.789 0 CA-C-O 122.171 0.986 . . . . 0.0 110.068 -178.756 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 21.2 ttt180 -146.44 -55.73 0.27 Allowed 'General case' 0 C--N 1.312 -1.043 0 CA-C-N 115.065 -0.971 . . . . 0.0 109.866 176.959 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 10.7 p30 -77.86 -1.58 32.38 Favored 'General case' 0 N--CA 1.465 0.279 0 C-N-CA 120.928 -0.309 . . . . 0.0 111.069 179.36 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 94.9 m-20 -74.35 -13.42 60.74 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-O 120.861 0.363 . . . . 0.0 110.239 175.338 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 77.81 2.38 81.31 Favored Glycine 0 N--CA 1.446 -0.648 0 N-CA-C 111.23 -0.748 . . . . 0.0 111.23 -178.114 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 35.4 mtmm -131.23 115.28 16.27 Favored Pre-proline 0 N--CA 1.449 -0.477 0 CA-C-N 115.631 -0.285 . . . . 0.0 110.497 -174.575 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 19.6 Cg_exo -69.13 166.88 25.28 Favored 'Trans proline' 0 C--O 1.233 0.265 0 C-N-CA 122.792 2.328 . . . . 0.0 112.002 173.482 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -130.85 155.52 46.57 Favored 'General case' 0 C--N 1.316 -0.891 0 CA-C-N 115.462 -0.79 . . . . 0.0 110.453 -177.767 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 3.1 tp -101.14 142.4 32.63 Favored 'General case' 0 C--N 1.316 -0.867 0 CA-C-N 115.849 -0.614 . . . . 0.0 110.348 177.825 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 37' ' ' PHE . . . . . . . . . . . . . 5.8 m-30 -109.46 108.09 18.46 Favored 'General case' 0 C--N 1.312 -1.046 0 N-CA-C 108.364 -0.976 . . . . 0.0 108.364 177.787 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -86.46 107.62 18.15 Favored 'General case' 0 C--N 1.321 -0.658 0 CA-C-O 121.129 0.49 . . . . 0.0 109.826 -179.595 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 39' ' ' LEU . . . . . 0.422 ' HG ' ' CB ' ' A' ' 49' ' ' GLU . 9.5 mp -81.77 153.02 26.71 Favored 'General case' 0 C--N 1.317 -0.837 0 CA-C-N 115.208 -0.906 . . . . 0.0 109.935 -179.928 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 40' ' ' GLY . . . . . 0.514 ' HA3' ' OD1' ' A' ' 8' ' ' ASN . . . 96.67 29.11 8.4 Favored Glycine 0 N--CA 1.447 -0.585 0 C-N-CA 120.537 -0.84 . . . . 0.0 112.171 -178.262 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 17.9 t70 60.32 15.77 5.67 Favored 'General case' 0 N--CA 1.469 0.496 0 CA-C-O 121.425 0.631 . . . . 0.0 111.122 178.341 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -79.85 -13.52 59.34 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 121.11 0.481 . . . . 0.0 110.746 -176.336 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 35.7 t -161.18 -54.36 0.05 OUTLIER 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 115.522 -0.763 . . . . 0.0 109.024 174.998 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 4.0 mm? -91.3 149.71 21.63 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 115.829 -0.623 . . . . 0.0 109.674 176.483 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 47.5 t -70.93 155.52 40.72 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-N 115.782 -0.645 . . . . 0.0 111.119 -177.292 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 46' ' ' GLU . . . . . 0.483 ' O ' ' HG2' ' A' ' 49' ' ' GLU . 28.5 tt0 -49.94 -40.27 43.02 Favored 'General case' 0 N--CA 1.45 -0.46 0 C-N-CA 122.981 0.513 . . . . 0.0 111.854 -179.856 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . 0.417 ' HA3' ' HB1' ' A' ' 69' ' ' ALA . . . -56.69 -36.34 71.33 Favored Glycine 0 N--CA 1.448 -0.541 0 C-N-CA 120.567 -0.825 . . . . 0.0 112.447 -176.445 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 1.7 tt -64.26 -52.88 56.49 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 116.953 0.377 . . . . 0.0 111.745 176.57 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 49' ' ' GLU . . . . . 0.491 ' O ' HD13 ' A' ' 53' ' ' LEU . 13.8 pt-20 -63.91 -29.95 71.08 Favored 'General case' 0 N--CA 1.453 -0.299 0 CA-C-O 120.508 0.194 . . . . 0.0 111.02 -173.322 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 50' ' ' GLN . . . . . 0.527 ' HA ' HD22 ' A' ' 53' ' ' LEU . 16.9 mm-40 -65.67 -17.11 64.36 Favored 'General case' 0 N--CA 1.452 -0.347 0 CA-C-N 116.372 -0.376 . . . . 0.0 110.605 -173.936 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 51' ' ' HIS . . . . . . . . . . . . . 14.7 m-70 -107.27 -3.68 19.49 Favored 'General case' 0 N--CA 1.45 -0.449 0 CA-C-O 121.053 0.454 . . . . 0.0 110.022 -176.934 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 49.4 mt -103.04 -20.55 14.15 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 115.657 -0.702 . . . . 0.0 111.282 -178.865 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 53' ' ' LEU . . . . . 0.527 HD22 ' HA ' ' A' ' 50' ' ' GLN . 0.0 OUTLIER -60.59 135.91 57.9 Favored 'General case' 0 C--O 1.234 0.257 0 CA-C-O 120.875 0.369 . . . . 0.0 111.273 177.874 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 93.03 -5.96 76.01 Favored Glycine 0 N--CA 1.45 -0.399 0 CA-C-N 115.947 -0.57 . . . . 0.0 112.667 178.884 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 64.0 mt -84.47 163.54 19.37 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-O 121.208 0.528 . . . . 0.0 111.275 179.369 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 56' ' ' LYS . . . . . 0.46 ' HG3' ' O ' ' A' ' 3' ' ' GLU . 0.0 OUTLIER -127.39 169.52 13.52 Favored 'General case' 0 C--N 1.32 -0.695 0 CA-C-N 115.322 -0.854 . . . . 0.0 109.457 176.018 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 39.6 t -60.68 142.76 15.39 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.833 0 CA-C-O 121.068 0.461 . . . . 0.0 110.547 176.026 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 80.88 10.03 85.57 Favored Glycine 0 N--CA 1.448 -0.516 0 CA-C-N 115.673 -0.694 . . . . 0.0 112.659 -177.945 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 4.0 m-20 -98.92 150.52 21.84 Favored 'General case' 0 CA--C 1.511 -0.553 0 CA-C-O 121.073 0.463 . . . . 0.0 111.183 176.164 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 60' ' ' LYS . . . . . 0.471 ' H ' ' HG2' ' A' ' 60' ' ' LYS . 0.0 OUTLIER -120.88 129.55 53.55 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-N 115.189 -0.914 . . . . 0.0 109.382 -178.998 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 6.1 m -142.32 121.39 12.91 Favored 'General case' 0 N--CA 1.433 -1.298 0 CA-C-O 121.155 0.503 . . . . 0.0 110.502 -179.003 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 14.3 m -111.0 132.82 53.89 Favored 'General case' 0 C--N 1.316 -0.88 0 CA-C-N 115.754 -0.657 . . . . 0.0 109.872 177.277 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 32.0 p90 -146.7 172.79 13.07 Favored 'General case' 0 C--N 1.314 -0.972 0 CA-C-N 116.044 -0.525 . . . . 0.0 110.239 179.032 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 50.9 m -130.83 135.91 48.17 Favored 'General case' 0 C--N 1.32 -0.681 0 N-CA-C 108.783 -0.821 . . . . 0.0 108.783 -172.44 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 65' ' ' LEU . . . . . 0.453 ' HB2' ' HB2' ' A' ' 70' ' ' ALA . 61.1 mt -139.48 140.62 37.3 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-O 121.164 0.507 . . . . 0.0 111.406 -172.052 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 66' ' ' GLU . . . . . 0.431 ' HB3' ' HD2' ' A' ' 67' ' ' PRO . 44.1 mt-10 -75.54 162.12 73.74 Favored Pre-proline 0 C--N 1.326 -0.455 0 CA-C-N 115.037 -0.983 . . . . 0.0 109.842 174.597 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 67' ' ' PRO . . . . . 0.571 ' HB3' ' HA2' ' A' ' 131' ' ' GLY . 76.0 Cg_exo -42.04 -43.3 7.22 Favored 'Trans proline' 0 C--N 1.346 0.397 0 C-N-CA 123.513 2.809 . . . . 0.0 114.558 -177.837 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 6.6 p-10 -63.74 -18.77 64.39 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-O 120.782 0.325 . . . . 0.0 111.44 -177.505 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 69' ' ' ALA . . . . . 0.417 ' HB1' ' HA3' ' A' ' 47' ' ' GLY . . . -114.35 -7.38 12.91 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 116.326 -0.397 . . . . 0.0 111.368 179.223 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 70' ' ' ALA . . . . . 0.453 ' HB2' ' HB2' ' A' ' 65' ' ' LEU . . . -144.76 124.97 13.7 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 120.542 0.211 . . . . 0.0 111.431 -176.954 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 71' ' ' PHE . . . . . . . . . . . . . 19.4 m-30 73.48 -40.93 0.48 Allowed 'General case' 0 N--CA 1.473 0.714 0 C-N-CA 123.747 0.819 . . . . 0.0 111.686 179.95 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 72' ' ' GLY . . . . . 0.587 ' O ' ' HB1' ' A' ' 130' ' ' ALA . . . 111.39 145.61 10.15 Favored Glycine 0 N--CA 1.444 -0.83 0 N-CA-C 111.481 -0.648 . . . . 0.0 111.481 -179.243 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 73' ' ' VAL . . . . . 0.425 HG12 ' HB2' ' A' ' 67' ' ' PRO . 29.3 m -76.1 139.15 68.73 Favored Pre-proline 0 C--N 1.321 -0.671 0 CA-C-O 121.085 0.469 . . . . 0.0 111.202 175.209 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 74' ' ' PRO . . . . . 0.462 ' HD3' ' CA ' ' A' ' 131' ' ' GLY . 59.0 Cg_endo -74.7 153.49 43.41 Favored 'Trans proline' 0 N--CA 1.459 -0.555 0 C-N-CA 122.65 2.233 . . . . 0.0 110.63 176.485 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 75' ' ' SER . . . . . 0.777 ' O ' ' HG ' ' A' ' 78' ' ' LEU . 46.1 m -132.85 121.19 16.87 Favored Pre-proline 0 C--N 1.315 -0.913 0 C-N-CA 120.755 -0.378 . . . . 0.0 111.241 -174.044 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 47.6 Cg_endo -69.73 -18.3 37.21 Favored 'Trans proline' 0 N--CA 1.463 -0.284 0 C-N-CA 122.18 1.92 . . . . 0.0 111.724 176.657 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 77' ' ' ASP . . . . . 0.631 ' OD1' ' HB3' ' A' ' 75' ' ' SER . 6.4 p-10 -76.83 -13.0 60.05 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.623 -0.717 . . . . 0.0 111.352 -179.644 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 78' ' ' LEU . . . . . 0.777 ' HG ' ' O ' ' A' ' 75' ' ' SER . 4.1 pp -91.62 -4.89 54.75 Favored 'General case' 0 CA--C 1.515 -0.396 0 C-N-CA 119.652 -0.819 . . . . 0.0 110.392 177.739 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 43.7 mt -80.31 138.51 19.67 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.611 0 N-CA-C 109.886 -0.413 . . . . 0.0 109.886 169.074 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 3.7 mp0 -142.2 142.64 32.68 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-N 116.122 -0.49 . . . . 0.0 109.84 -177.847 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 81' ' ' TYR . . . . . 0.409 ' CE2' HG23 ' A' ' 122' ' ' THR . 43.0 m-85 -113.76 111.71 22.23 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-O 121.182 0.515 . . . . 0.0 109.983 -177.593 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 56.1 m-85 -109.73 171.17 7.6 Favored 'General case' 0 C--N 1.317 -0.814 0 CA-C-N 115.365 -0.834 . . . . 0.0 109.961 177.388 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 25.8 t -81.56 154.27 26.31 Favored 'General case' 0 C--N 1.321 -0.655 0 CA-C-O 121.368 0.604 . . . . 0.0 110.15 178.749 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 84' ' ' ARG . . . . . 0.519 ' HG3' ' HD2' ' A' ' 85' ' ' ARG . 13.0 ptm180 -68.89 -29.47 67.76 Favored 'General case' 0 C--N 1.32 -0.687 0 CA-C-N 115.383 -0.826 . . . . 0.0 109.649 178.108 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 85' ' ' ARG . . . . . 0.519 ' HD2' ' HG3' ' A' ' 84' ' ' ARG . 5.2 mpt_? -64.05 -34.06 77.16 Favored 'General case' 0 C--N 1.321 -0.667 0 CA-C-N 114.201 -1.363 . . . . 0.0 109.981 177.448 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 46.4 mt-10 -75.67 -10.8 59.75 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 115.757 -0.656 . . . . 0.0 110.565 178.119 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 87' ' ' PHE . . . . . 0.488 ' CE2' HG21 ' A' ' 121' ' ' ILE . 3.8 m-85 -103.3 -22.79 13.65 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 115.596 -0.729 . . . . 0.0 110.41 -179.748 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 88' ' ' MET . . . . . . . . . . . . . 46.4 ttm -60.14 -13.19 10.84 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 121.928 0.871 . . . . 0.0 109.679 172.375 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 25.0 t70 -61.09 -31.95 71.63 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-N 114.12 -1.4 . . . . 0.0 109.689 175.153 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -122.61 15.88 10.31 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 115.557 -0.747 . . . . 0.0 110.708 178.162 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 96.97 139.99 11.01 Favored Glycine 0 N--CA 1.45 -0.397 0 C-N-CA 120.6 -0.81 . . . . 0.0 111.925 -176.379 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 47.1 mt-10 -68.32 124.38 89.68 Favored Pre-proline 0 C--N 1.325 -0.494 0 CA-C-O 121.446 0.641 . . . . 0.0 111.48 -174.834 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 93' ' ' PRO . . . . . 0.54 ' HB2' HD13 ' A' ' 113' ' ' ILE . 83.8 Cg_endo -78.35 169.08 20.63 Favored 'Trans proline' 0 C--O 1.235 0.36 0 C-N-CA 124.669 3.579 . . . . 0.0 114.933 -169.373 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 94' ' ' GLU . . . . . 0.564 ' O ' HD12 ' A' ' 113' ' ' ILE . 1.4 mp0 -116.7 164.31 14.83 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 114.214 -1.357 . . . . 0.0 110.74 -174.616 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 95' ' ' ILE . . . . . 0.643 HG23 ' HA ' ' A' ' 115' ' ' GLU . 17.5 mt -82.78 133.96 27.97 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.377 0 CA-C-O 120.919 0.39 . . . . 0.0 110.909 179.35 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 70.69 29.89 69.07 Favored Glycine 0 N--CA 1.449 -0.447 0 CA-C-N 115.83 -0.623 . . . . 0.0 111.973 -179.194 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 97' ' ' ALA . . . . . 0.685 ' O ' HG13 ' A' ' 113' ' ' ILE . . . -106.42 140.0 40.02 Favored 'General case' 0 C--N 1.324 -0.52 0 N-CA-C 109.865 -0.42 . . . . 0.0 109.865 -179.777 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 98' ' ' ILE . . . . . 0.492 ' HA ' ' O ' ' A' ' 111' ' ' GLY . 72.5 mt -88.06 108.26 18.37 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.812 0 N-CA-C 109.972 -0.381 . . . . 0.0 109.972 -179.98 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 99' ' ' MET . . . . . 0.562 ' HB2' ' CE2' ' A' ' 101' ' ' PHE . 89.9 mtp -99.08 126.15 44.75 Favored 'General case' 0 N--CA 1.442 -0.835 0 CA-C-N 116.301 -0.409 . . . . 0.0 111.069 179.444 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 100' ' ' LEU . . . . . 0.447 ' HA ' HD13 ' A' ' 100' ' ' LEU . 4.3 mm? -67.42 147.35 52.99 Favored 'General case' 0 C--N 1.307 -1.241 0 N-CA-C 108.327 -0.99 . . . . 0.0 108.327 163.2 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 101' ' ' PHE . . . . . 0.632 ' HB2' ' O ' ' A' ' 109' ' ' MET . 2.5 m-85 -149.49 169.78 20.12 Favored 'General case' 0 CA--C 1.51 -0.594 0 CA-C-N 116.001 -0.545 . . . . 0.0 109.925 -155.101 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 3.9 m -126.64 129.26 48.15 Favored 'General case' 0 C--N 1.31 -1.128 0 N-CA-C 108.913 -0.773 . . . . 0.0 108.913 170.663 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -97.4 154.89 17.17 Favored 'General case' 0 C--N 1.316 -0.853 0 N-CA-C 109.05 -0.722 . . . . 0.0 109.05 -175.878 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 104' ' ' MET . . . . . . . . . . . . . 4.7 mpp? -65.24 -12.77 54.95 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.945 -174.219 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 9.8 p-10 -95.21 6.86 47.88 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-O 120.728 0.299 . . . . 0.0 110.928 177.219 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 89.55 -10.95 71.62 Favored Glycine 0 N--CA 1.452 -0.272 0 C-N-CA 121.213 -0.518 . . . . 0.0 113.217 174.67 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 43.1 t -79.94 143.15 34.44 Favored 'General case' 0 C--N 1.32 -0.677 0 CA-C-O 121.37 0.605 . . . . 0.0 109.748 178.721 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 23.3 tt0 -92.18 99.03 11.9 Favored 'General case' 0 C--N 1.309 -1.175 0 CA-C-O 121.956 0.884 . . . . 0.0 109.443 179.28 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 109' ' ' MET . . . . . 0.632 ' O ' ' HB2' ' A' ' 101' ' ' PHE . 71.3 mtp -96.13 135.54 22.62 Favored Pre-proline 0 C--N 1.319 -0.73 0 CA-C-N 113.965 -1.471 . . . . 0.0 111.689 -178.964 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 30.3 Cg_endo -68.9 159.4 54.01 Favored 'Trans proline' 0 N--CA 1.456 -0.709 0 C-N-CA 121.92 1.746 . . . . 0.0 110.011 168.198 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 111' ' ' GLY . . . . . 0.492 ' O ' ' HA ' ' A' ' 98' ' ' ILE . . . -147.15 149.04 21.12 Favored Glycine 0 C--N 1.314 -0.639 0 C-N-CA 119.945 -1.121 . . . . 0.0 110.993 -172.849 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 2.7 p -118.9 111.26 32.82 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.618 0 CA-C-N 118.311 1.056 . . . . 0.0 110.305 170.917 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 113' ' ' ILE . . . . . 0.685 HG13 ' O ' ' A' ' 97' ' ' ALA . 0.5 OUTLIER -62.88 112.03 0.99 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.469 0 CA-C-N 115.729 -0.669 . . . . 0.0 110.175 175.223 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 114' ' ' ARG . . . . . 0.573 ' HD2' ' HB2' ' A' ' 115' ' ' GLU . 5.6 tmm_? -71.22 -43.36 67.51 Favored 'General case' 0 C--N 1.316 -0.883 0 CA-C-N 115.874 -0.603 . . . . 0.0 110.679 -176.983 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 115' ' ' GLU . . . . . 0.643 ' HA ' HG23 ' A' ' 95' ' ' ILE . 13.8 tt0 -159.42 154.76 25.46 Favored 'General case' 0 C--N 1.329 -0.313 0 N-CA-C 110.317 -0.253 . . . . 0.0 110.317 -179.871 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 116' ' ' ILE . . . . . 0.56 HG12 HG12 ' A' ' 95' ' ' ILE . 38.0 mm -98.55 112.42 30.62 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.501 0 N-CA-C 109.04 -0.726 . . . . 0.0 109.04 174.23 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 117' ' ' ASN . . . . . 0.494 HD22 ' N ' ' A' ' 117' ' ' ASN . 0.9 OUTLIER -88.18 159.68 18.07 Favored 'General case' 0 C--N 1.311 -1.094 0 N-CA-C 108.724 -0.843 . . . . 0.0 108.724 177.289 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . -55.26 -47.16 76.44 Favored Glycine 0 N--CA 1.45 -0.372 0 C-N-CA 120.518 -0.848 . . . . 0.0 113.129 -169.438 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 119' ' ' ASP . . . . . 0.444 ' O ' ' HG2' ' A' ' 84' ' ' ARG . 4.4 p-10 -114.78 -11.1 12.32 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 117.125 0.463 . . . . 0.0 111.343 175.171 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 120' ' ' SER . . . . . 0.434 ' O ' ' HB2' ' A' ' 117' ' ' ASN . 9.0 t -115.97 158.26 23.34 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-O 121.222 0.534 . . . . 0.0 111.656 -171.812 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 121' ' ' ILE . . . . . 0.488 HG21 ' CE2' ' A' ' 87' ' ' PHE . 46.7 mm -117.21 128.69 74.5 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.52 0 CA-C-N 116.112 -0.495 . . . . 0.0 110.436 177.263 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 122' ' ' THR . . . . . 0.409 HG23 ' CE2' ' A' ' 81' ' ' TYR . 18.7 m -93.47 102.55 14.77 Favored 'General case' 0 C--N 1.32 -0.686 0 CA-C-O 121.594 0.711 . . . . 0.0 110.907 177.97 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 42.9 t -104.4 108.16 24.1 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.385 0 CA-C-N 114.66 -1.155 . . . . 0.0 112.92 -179.983 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 124' ' ' ASP . . . . . 0.443 ' C ' ' H ' ' A' ' 126' ' ' ASN . 1.3 m-20 -98.04 106.57 18.88 Favored 'General case' 0 C--N 1.318 -0.762 0 CA-C-N 114.689 -1.141 . . . . 0.0 110.386 170.121 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 125' ' ' PHE . . . . . 0.582 ' HB2' HD13 ' A' ' 78' ' ' LEU . 81.5 m-85 -75.07 18.9 0.16 Allowed 'General case' 0 N--CA 1.465 0.29 0 O-C-N 121.898 -0.501 . . . . 0.0 111.284 171.242 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 126' ' ' ASN . . . . . 0.443 ' H ' ' C ' ' A' ' 124' ' ' ASP . 11.4 m-80 -60.48 147.22 41.94 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.818 -0.628 . . . . 0.0 110.622 176.285 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 127' ' ' HIS . . . . . 0.611 ' HB3' ' HD2' ' A' ' 128' ' ' PRO . 56.9 m80 -107.22 -170.58 0.2 Allowed Pre-proline 0 C--N 1.319 -0.742 0 CA-C-N 115.074 -0.966 . . . . 0.0 111.395 -165.324 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 128' ' ' PRO . . . . . 0.611 ' HD2' ' HB3' ' A' ' 127' ' ' HIS . 2.7 Cg_exo -41.53 174.11 0.0 OUTLIER 'Trans proline' 0 C--N 1.358 1.034 0 C-N-CA 124.696 3.597 . . . . 0.0 113.85 162.09 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 129' ' ' LEU . . . . . . . . . . . . . 9.9 tp -50.5 38.32 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.619 0 C-N-CA 126.902 2.081 . . . . 0.0 116.32 -172.667 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 130' ' ' ALA . . . . . 0.587 ' HB1' ' O ' ' A' ' 72' ' ' GLY . . . -76.2 161.2 29.0 Favored 'General case' 0 C--N 1.308 -1.201 0 N-CA-C 108.567 -0.901 . . . . 0.0 108.567 178.191 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 131' ' ' GLY . . . . . 0.571 ' HA2' ' HB3' ' A' ' 67' ' ' PRO . . . 76.72 22.69 71.64 Favored Glycine 0 N--CA 1.449 -0.474 0 C-N-CA 120.0 -1.095 . . . . 0.0 113.032 -177.27 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 132' ' ' GLN . . . . . . . . . . . . . 2.6 tt0 -139.27 139.58 37.41 Favored 'General case' 0 N--CA 1.445 -0.702 0 N-CA-C 109.986 -0.376 . . . . 0.0 109.986 169.865 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 133' ' ' THR . . . . . . . . . . . . . 21.9 m -68.66 126.98 31.4 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 115.81 -0.632 . . . . 0.0 110.507 179.99 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 134' ' ' VAL . . . . . 0.519 HG23 HD13 ' A' ' 19' ' ' LEU . 14.5 p -128.92 163.6 33.45 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.594 0 CA-C-O 121.093 0.473 . . . . 0.0 111.366 -174.709 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 135' ' ' HIS . . . . . 0.42 ' N ' HG22 ' A' ' 134' ' ' VAL . 72.2 m-70 -123.19 115.82 22.39 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 115.803 -0.635 . . . . 0.0 109.633 -176.027 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 136' ' ' PHE . . . . . 0.488 ' CE1' HG13 ' A' ' 134' ' ' VAL . 0.1 OUTLIER -125.42 138.26 54.01 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-O 121.112 0.482 . . . . 0.0 111.993 -176.463 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 137' ' ' ASP . . . . . . . . . . . . . 5.9 m-20 -103.73 107.11 17.83 Favored 'General case' 0 N--CA 1.468 0.436 0 CA-C-N 115.263 -0.88 . . . . 0.0 110.444 -178.846 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 138' ' ' ILE . . . . . 0.473 HD11 ' HD2' ' A' ' 136' ' ' PHE . 4.5 mp -96.95 138.89 20.74 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.492 0 CA-C-O 120.806 0.336 . . . . 0.0 111.77 -174.523 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 18.0 mt-10 -127.32 127.74 44.79 Favored 'General case' 0 CA--C 1.515 -0.379 0 N-CA-C 108.416 -0.957 . . . . 0.0 108.416 168.302 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 140' ' ' VAL . . . . . . . . . . . . . 91.3 t -78.95 111.25 15.58 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-O 120.925 0.393 . . . . 0.0 110.31 -178.078 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 141' ' ' LEU . . . . . 0.566 HD11 ' CD2' ' A' ' 14' ' ' HIS . 44.4 mt -85.38 -42.86 14.16 Favored 'General case' 0 C--N 1.316 -0.882 0 CA-C-O 121.371 0.605 . . . . 0.0 110.393 -179.855 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 142' ' ' GLU . . . . . 0.502 ' HB2' ' HB2' ' A' ' 12' ' ' LEU . 6.7 mm-40 -151.1 156.55 41.28 Favored 'General case' 0 C--N 1.321 -0.673 0 CA-C-N 115.135 -0.939 . . . . 0.0 111.271 -177.96 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 143' ' ' ILE . . . . . . . . . . . . . 78.7 mt -126.68 109.69 21.53 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.766 0 CA-C-N 115.619 -0.719 . . . . 0.0 109.876 178.773 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 144' ' ' ASP . . . . . 0.493 ' HB3' ' HB3' ' A' ' 10' ' ' ALA . 33.0 t70 -78.68 125.07 84.93 Favored Pre-proline 0 C--N 1.324 -0.512 0 N-CA-C 109.222 -0.659 . . . . 0.0 109.222 175.0 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 145' ' ' PRO . . . . . 0.407 ' HA ' ' CB ' ' A' ' 2' ' ' SER . 48.6 Cg_endo -64.94 125.86 15.49 Favored 'Trans proline' 0 N--CA 1.461 -0.419 0 C-N-CA 122.537 2.158 . . . . 0.0 112.411 -175.688 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 146' ' ' ALA . . . . . . . . . . . . . . . -85.58 130.67 34.52 Favored 'General case' 0 C--N 1.313 -1.019 0 CA-C-N 115.252 -0.885 . . . . 0.0 110.229 179.066 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 147' ' ' LEU . . . . . 0.413 HD13 ' HA ' ' A' ' 147' ' ' LEU . 3.2 mm? -82.44 44.88 0.91 Allowed 'General case' 0 N--CA 1.442 -0.845 0 CA-C-O 121.299 0.571 . . . . 0.0 111.364 -178.232 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 9.2 mm-40 . . . . . 0 C--N 1.324 -0.523 0 CA-C-N 115.486 -0.779 . . . . 0.0 109.641 175.734 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 15.1 tpt . . . . . 0 N--CA 1.478 0.942 0 N-CA-C 110.134 -0.321 . . . . 0.0 110.134 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 14.3 p 42.55 70.25 0.31 Allowed 'General case' 0 N--CA 1.467 0.394 0 O-C-N 124.313 1.008 . . . . 0.0 112.396 176.271 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 3' ' ' GLU . . . . . 0.459 ' HG2' ' HD2' ' A' ' 56' ' ' LYS . 29.4 tt0 -99.05 -26.37 14.25 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 115.748 -0.66 . . . . 0.0 110.626 179.539 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 4' ' ' SER . . . . . 0.547 ' OG ' ' HE2' ' A' ' 56' ' ' LYS . 14.6 m -101.71 136.16 42.02 Favored 'General case' 0 C--N 1.318 -0.772 0 CA-C-N 115.543 -0.753 . . . . 0.0 111.034 -174.315 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 6.1 p -81.13 148.88 5.2 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.665 0 CA-C-O 121.453 0.644 . . . . 0.0 110.426 179.571 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 6' ' ' GLN . . . . . 0.688 ' HG2' ' OG ' ' A' ' 9' ' ' SER . 4.5 pt20 -140.53 166.16 25.48 Favored 'General case' 0 C--N 1.311 -1.067 0 CA-C-N 114.918 -1.037 . . . . 0.0 109.298 174.461 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 75.7 p -65.26 132.19 48.42 Favored 'General case' 0 N--CA 1.441 -0.916 0 N-CA-C 108.701 -0.851 . . . . 0.0 108.701 175.814 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 8' ' ' ASN . . . . . 0.446 ' ND2' ' HB2' ' A' ' 148' ' ' GLU . 10.4 t30 75.08 38.06 0.45 Allowed 'General case' 0 CA--C 1.539 0.551 0 O-C-N 123.682 0.614 . . . . 0.0 110.95 -177.95 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 9' ' ' SER . . . . . 0.688 ' OG ' ' HG2' ' A' ' 6' ' ' GLN . 51.0 m -93.77 166.85 12.0 Favored 'General case' 0 CA--C 1.521 -0.167 0 CA-C-O 121.308 0.575 . . . . 0.0 110.821 172.462 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 10' ' ' ALA . . . . . 0.672 ' HB1' HD21 ' A' ' 36' ' ' LEU . . . -109.43 111.32 22.8 Favored 'General case' 0 N--CA 1.444 -0.769 0 N-CA-C 108.544 -0.91 . . . . 0.0 108.544 169.992 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 3.8 m -116.52 135.54 56.45 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.682 0 C-N-CA 119.767 -0.773 . . . . 0.0 111.351 -179.378 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 18.0 tp -86.36 128.43 34.93 Favored 'General case' 0 N--CA 1.447 -0.608 0 N-CA-C 108.914 -0.772 . . . . 0.0 108.914 177.837 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 13' ' ' VAL . . . . . 0.638 HG21 HG23 ' A' ' 138' ' ' ILE . 3.8 p -131.92 158.67 43.33 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.987 0 CA-C-O 122.23 1.014 . . . . 0.0 112.618 -174.561 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 14' ' ' HIS . . . . . 0.584 ' ND1' ' HA ' ' A' ' 29' ' ' ARG . 0.2 OUTLIER -122.94 110.28 15.19 Favored 'General case' 0 C--N 1.313 -1.001 0 CA-C-N 113.443 -1.708 . . . . 0.0 106.996 167.919 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 15' ' ' PHE . . . . . 0.453 ' HA ' ' O ' ' A' ' 137' ' ' ASP . 12.8 p90 -133.64 166.02 23.56 Favored 'General case' 0 C--N 1.324 -0.532 0 C-N-CA 119.223 -0.991 . . . . 0.0 113.673 -174.621 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 22.3 m -140.98 142.09 34.33 Favored 'General case' 0 N--CA 1.444 -0.744 0 CA-C-N 113.952 -1.476 . . . . 0.0 107.914 174.913 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 17' ' ' LEU . . . . . 0.537 HD11 ' CZ ' ' A' ' 136' ' ' PHE . 0.5 OUTLIER -126.86 112.62 15.54 Favored 'General case' 0 C--N 1.32 -0.716 0 N-CA-C 110.327 -0.249 . . . . 0.0 110.327 -173.624 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -118.85 152.53 36.09 Favored 'General case' 0 C--N 1.315 -0.913 0 CA-C-O 120.93 0.395 . . . . 0.0 111.392 -178.393 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 19' ' ' LEU . . . . . 0.603 HD21 ' HB2' ' A' ' 25' ' ' ALA . 3.4 mm? -103.82 170.47 7.91 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 115.844 -0.616 . . . . 0.0 109.627 174.372 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 2.2 m-20 -68.9 -18.92 64.19 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-O 120.952 0.406 . . . . 0.0 110.959 178.809 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 25.3 t70 -83.37 3.64 30.85 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 121.314 0.578 . . . . 0.0 110.279 175.32 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 74.26 9.88 81.3 Favored Glycine 0 N--CA 1.451 -0.305 0 CA-C-N 115.94 -0.573 . . . . 0.0 112.645 -175.958 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 23' ' ' THR . . . . . 0.466 ' HB ' HD23 ' A' ' 19' ' ' LEU . 12.1 m -72.55 141.07 48.46 Favored 'General case' 0 C--N 1.324 -0.53 0 N-CA-C 109.728 -0.471 . . . . 0.0 109.728 175.746 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 54.4 m -94.17 109.88 21.64 Favored 'General case' 0 C--N 1.319 -0.736 0 N-CA-C 109.854 -0.425 . . . . 0.0 109.854 174.658 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 25' ' ' ALA . . . . . 0.603 ' HB2' HD21 ' A' ' 19' ' ' LEU . . . -69.76 -40.41 76.14 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.975 -0.557 . . . . 0.0 110.027 179.692 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 10.2 tp10 -160.98 139.33 9.79 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 115.406 -0.815 . . . . 0.0 109.656 177.465 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 16.6 p -125.77 132.41 52.31 Favored 'General case' 0 C--N 1.317 -0.824 0 CA-C-O 120.838 0.352 . . . . 0.0 110.364 175.678 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 28' ' ' THR . . . . . 0.538 HG21 ' HB2' ' A' ' 35' ' ' ALA . 79.3 m -152.42 65.77 0.82 Allowed 'General case' 0 N--CA 1.441 -0.894 0 CA-C-O 122.116 0.96 . . . . 0.0 109.617 178.221 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 29' ' ' ARG . . . . . 0.584 ' HA ' ' ND1' ' A' ' 14' ' ' HIS . 26.9 ttt180 -154.11 -52.27 0.1 Allowed 'General case' 0 C--N 1.319 -0.733 0 N-CA-C 108.712 -0.847 . . . . 0.0 108.712 178.206 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 9.9 p30 -76.93 -4.24 42.9 Favored 'General case' 0 N--CA 1.464 0.228 0 CA-C-N 115.855 -0.611 . . . . 0.0 110.214 176.356 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 1.5 m-20 -69.46 -21.11 63.74 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 115.46 -0.791 . . . . 0.0 110.739 -178.958 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 85.3 4.1 86.51 Favored Glycine 0 N--CA 1.445 -0.711 0 C-N-CA 120.589 -0.815 . . . . 0.0 111.33 -173.723 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 56.5 mtpt -138.26 131.47 16.45 Favored Pre-proline 0 N--CA 1.452 -0.354 0 N-CA-C 109.995 -0.372 . . . . 0.0 109.995 179.14 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 91.8 Cg_endo -82.98 168.15 13.86 Favored 'Trans proline' 0 N--CA 1.453 -0.858 0 C-N-CA 122.393 2.062 . . . . 0.0 111.492 170.711 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 35' ' ' ALA . . . . . 0.538 ' HB2' HG21 ' A' ' 28' ' ' THR . . . -129.44 153.8 47.58 Favored 'General case' 0 C--N 1.319 -0.752 0 CA-C-N 116.256 -0.429 . . . . 0.0 109.942 -178.549 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 36' ' ' LEU . . . . . 0.672 HD21 ' HB1' ' A' ' 10' ' ' ALA . 4.6 tp -98.0 132.03 43.91 Favored 'General case' 0 C--N 1.315 -0.91 0 N-CA-C 109.967 -0.382 . . . . 0.0 109.967 176.87 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 37' ' ' PHE . . . . . 0.415 ' CD2' HD21 ' A' ' 44' ' ' LEU . 5.2 m-30 -95.79 107.33 19.55 Favored 'General case' 0 C--N 1.318 -0.802 0 N-CA-C 109.477 -0.564 . . . . 0.0 109.477 174.868 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 38' ' ' ARG . . . . . 0.434 ' HD2' ' CD ' ' A' ' 148' ' ' GLU . 4.9 tpp180 -84.96 107.32 17.04 Favored 'General case' 0 N--CA 1.45 -0.468 0 CA-C-N 115.536 -0.756 . . . . 0.0 109.901 -178.269 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 63.4 mt -81.89 156.12 24.96 Favored 'General case' 0 C--N 1.32 -0.69 0 CA-C-N 115.807 -0.633 . . . . 0.0 111.156 -179.422 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 103.74 40.46 2.33 Favored Glycine 0 N--CA 1.446 -0.635 0 CA-C-N 115.724 -0.671 . . . . 0.0 111.592 -175.368 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 49.3 m-20 57.09 21.78 6.75 Favored 'General case' 0 N--CA 1.47 0.544 0 C-N-CA 123.16 0.584 . . . . 0.0 112.265 177.4 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -67.51 -40.24 85.15 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-O 121.03 0.443 . . . . 0.0 111.145 -178.852 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 41.8 m -154.17 -37.96 0.09 Allowed 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 116.034 -0.53 . . . . 0.0 110.832 -179.722 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 44' ' ' LEU . . . . . 0.453 HD23 HD12 ' A' ' 48' ' ' LEU . 6.7 mp -70.79 145.04 50.63 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 121.088 0.471 . . . . 0.0 110.969 -177.039 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 12.6 m -72.87 163.95 27.36 Favored 'General case' 0 C--N 1.322 -0.629 0 CA-C-N 115.373 -0.83 . . . . 0.0 110.228 175.628 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 41.7 mt-10 -51.59 -46.63 63.57 Favored 'General case' 0 C--N 1.329 -0.313 0 N-CA-C 112.72 0.637 . . . . 0.0 112.72 -173.753 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -63.75 -50.41 61.65 Favored Glycine 0 N--CA 1.448 -0.516 0 C-N-CA 119.572 -1.299 . . . . 0.0 112.539 -172.592 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 48' ' ' LEU . . . . . 0.453 HD12 HD23 ' A' ' 44' ' ' LEU . 0.0 OUTLIER -44.64 -50.88 9.59 Favored 'General case' 0 CA--C 1.517 -0.324 0 N-CA-C 113.803 1.038 . . . . 0.0 113.803 171.482 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 10.5 tt0 -70.8 -33.25 70.53 Favored 'General case' 0 C--N 1.312 -1.054 0 CA-C-O 120.987 0.422 . . . . 0.0 110.819 -169.369 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 50' ' ' GLN . . . . . 0.473 ' HA ' HD22 ' A' ' 53' ' ' LEU . 19.3 mm-40 -87.08 -13.88 43.01 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-N 115.834 -0.621 . . . . 0.0 111.552 -172.827 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 51' ' ' HIS . . . . . . . . . . . . . 11.7 m-70 -100.39 -4.38 29.14 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-O 121.046 0.451 . . . . 0.0 110.545 -175.269 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 11.5 mt -102.25 -14.01 17.16 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-N 115.763 -0.653 . . . . 0.0 111.757 -179.598 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 53' ' ' LEU . . . . . 0.473 HD22 ' HA ' ' A' ' 50' ' ' GLN . 0.1 OUTLIER -65.43 151.49 46.2 Favored 'General case' 0 N--CA 1.451 -0.399 0 CA-C-O 120.881 0.372 . . . . 0.0 110.264 171.539 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 93.26 -16.99 59.29 Favored Glycine 0 CA--C 1.519 0.317 0 C-N-CA 121.226 -0.512 . . . . 0.0 112.85 -179.02 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 55' ' ' LEU . . . . . 0.553 HD23 ' HB3' ' A' ' 59' ' ' ASP . 7.2 mp -82.28 165.41 20.42 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-O 121.646 0.736 . . . . 0.0 112.493 -179.954 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 56' ' ' LYS . . . . . 0.547 ' HE2' ' OG ' ' A' ' 4' ' ' SER . 28.5 mmtp -119.41 170.25 9.3 Favored 'General case' 0 N--CA 1.444 -0.738 0 CA-C-N 114.963 -1.017 . . . . 0.0 110.268 175.016 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 57' ' ' VAL . . . . . 0.5 HG23 HD12 ' A' ' 143' ' ' ILE . 71.5 t -62.46 134.51 27.71 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.764 0 CA-C-N 115.696 -0.684 . . . . 0.0 109.973 173.91 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 80.82 21.95 62.55 Favored Glycine 0 N--CA 1.445 -0.732 0 C-N-CA 120.943 -0.646 . . . . 0.0 112.423 -179.67 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 59' ' ' ASP . . . . . 0.553 ' HB3' HD23 ' A' ' 55' ' ' LEU . 4.9 t70 -92.67 162.92 13.96 Favored 'General case' 0 C--N 1.323 -0.57 0 N-CA-C 108.823 -0.806 . . . . 0.0 108.823 175.441 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 2.5 mmmt -137.11 122.05 18.91 Favored 'General case' 0 C--N 1.318 -0.772 0 N-CA-C 107.716 -1.216 . . . . 0.0 107.716 -179.273 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 9.5 t -135.91 136.15 40.25 Favored 'General case' 0 C--N 1.321 -0.65 0 CA-C-O 122.039 0.923 . . . . 0.0 112.22 179.047 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 10.9 m -114.03 133.25 55.64 Favored 'General case' 0 N--CA 1.437 -1.118 0 CA-C-N 115.162 -0.926 . . . . 0.0 108.845 172.419 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 17.6 p90 -153.47 158.34 41.2 Favored 'General case' 0 C--N 1.316 -0.867 0 CA-C-O 120.963 0.411 . . . . 0.0 110.215 -178.575 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 46.2 m -129.43 132.97 47.1 Favored 'General case' 0 C--N 1.312 -1.057 0 N-CA-C 108.398 -0.964 . . . . 0.0 108.398 175.425 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 78.2 mt -100.44 146.83 26.55 Favored 'General case' 0 C--N 1.318 -0.762 0 CA-C-O 120.885 0.374 . . . . 0.0 110.386 -178.985 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 43.1 mt-10 -65.45 145.9 99.01 Favored Pre-proline 0 C--N 1.317 -0.846 0 N-CA-C 108.631 -0.877 . . . . 0.0 108.631 173.282 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 96.2 Cg_exo -41.76 -52.98 3.59 Favored 'Trans proline' 0 CA--C 1.531 0.345 0 C-N-CA 123.501 2.8 . . . . 0.0 114.5 -170.718 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 29.1 t70 -64.93 -24.62 67.58 Favored 'General case' 0 N--CA 1.466 0.363 0 CA-C-O 120.828 0.347 . . . . 0.0 111.675 -174.804 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -83.26 -10.94 58.25 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-O 120.77 0.319 . . . . 0.0 111.21 -178.605 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -119.58 -86.6 0.65 Allowed 'General case' 0 C--N 1.327 -0.403 0 N-CA-C 112.054 0.39 . . . . 0.0 112.054 -178.897 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 71' ' ' PHE . . . . . . . . . . . . . 3.2 m-85 -87.83 -21.55 24.98 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-O 120.968 0.413 . . . . 0.0 111.231 -174.847 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 72' ' ' GLY . . . . . 0.549 ' C ' ' HB1' ' A' ' 130' ' ' ALA . . . 115.31 -142.25 17.49 Favored Glycine 0 N--CA 1.445 -0.714 0 C-N-CA 120.775 -0.726 . . . . 0.0 111.59 -178.162 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 8.1 p -159.4 130.61 3.86 Favored Pre-proline 0 C--N 1.319 -0.728 0 O-C-N 122.434 -0.451 . . . . 0.0 110.627 -176.445 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 74' ' ' PRO . . . . . 0.647 ' CD ' ' HA3' ' A' ' 131' ' ' GLY . 93.7 Cg_endo -80.67 144.26 15.5 Favored 'Trans proline' 0 N--CA 1.453 -0.856 0 C-N-CA 123.174 2.583 . . . . 0.0 110.925 175.144 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 75' ' ' SER . . . . . 0.559 ' O ' ' HB2' ' A' ' 78' ' ' LEU . 28.5 t -128.23 139.44 35.45 Favored Pre-proline 0 C--N 1.311 -1.08 0 CA-C-N 116.467 -0.333 . . . . 0.0 110.383 -177.158 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 29.3 Cg_endo -65.93 -17.36 55.5 Favored 'Trans proline' 0 N--CA 1.461 -0.386 0 C-N-CA 122.493 2.129 . . . . 0.0 110.933 172.322 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 17.0 t70 -65.06 -26.81 68.4 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-O 121.798 0.808 . . . . 0.0 109.179 172.194 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 78' ' ' LEU . . . . . 0.559 ' HB2' ' O ' ' A' ' 75' ' ' SER . 0.5 OUTLIER -80.86 6.0 14.41 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 114.763 -1.108 . . . . 0.0 110.933 179.126 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 26.2 mt -126.66 99.1 5.26 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.874 0 N-CA-C 108.455 -0.943 . . . . 0.0 108.455 173.991 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 34.4 mt-30 -113.75 160.33 18.78 Favored 'General case' 0 C--N 1.309 -1.175 0 C-N-CA 119.021 -1.071 . . . . 0.0 112.527 174.357 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 81' ' ' TYR . . . . . 0.531 ' CE2' HG23 ' A' ' 122' ' ' THR . 66.6 m-85 -121.2 114.31 21.23 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.906 -0.588 . . . . 0.0 109.919 -179.796 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 49.6 m-85 -115.18 169.8 8.85 Favored 'General case' 0 C--N 1.316 -0.855 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.608 179.281 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 21.0 t -81.02 159.31 24.86 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-O 120.964 0.412 . . . . 0.0 110.97 -177.659 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 84' ' ' ARG . . . . . 0.591 ' HD2' ' O ' ' A' ' 118' ' ' GLY . 4.9 mtp180 -62.58 -36.89 84.15 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 122.1 0.952 . . . . 0.0 110.109 179.542 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 85' ' ' ARG . . . . . . . . . . . . . 8.5 mpt_? -63.14 -28.72 70.26 Favored 'General case' 0 C--N 1.319 -0.759 0 CA-C-N 113.794 -1.548 . . . . 0.0 111.447 -171.51 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 26.0 mm-40 -80.54 -10.34 59.74 Favored 'General case' 0 C--N 1.32 -0.707 0 CA-C-N 115.892 -0.595 . . . . 0.0 110.743 178.613 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 87' ' ' PHE . . . . . . . . . . . . . 17.0 m-85 -104.17 -36.6 7.62 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-N 115.712 -0.676 . . . . 0.0 110.501 -179.222 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 88' ' ' MET . . . . . . . . . . . . . 57.3 ttp -59.33 -23.41 62.46 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 121.776 0.798 . . . . 0.0 109.576 173.556 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 24.7 t70 -53.27 -34.35 56.9 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 114.246 -1.343 . . . . 0.0 110.46 173.073 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -122.57 16.73 10.4 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 115.644 -0.707 . . . . 0.0 111.501 -179.689 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 101.45 136.88 9.48 Favored Glycine 0 C--N 1.33 0.241 0 C-N-CA 120.629 -0.795 . . . . 0.0 112.415 -178.396 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 36.1 mt-10 -61.97 125.87 86.09 Favored Pre-proline 0 C--N 1.328 -0.333 0 CA-C-O 120.995 0.426 . . . . 0.0 111.494 -176.483 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 93' ' ' PRO . . . . . 0.666 ' HB2' HD13 ' A' ' 113' ' ' ILE . 57.7 Cg_endo -78.5 167.03 23.34 Favored 'Trans proline' 0 N--CA 1.459 -0.544 0 C-N-CA 123.266 2.644 . . . . 0.0 113.407 -173.436 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 94' ' ' GLU . . . . . 0.42 ' O ' HD12 ' A' ' 113' ' ' ILE . 24.7 mt-10 -118.32 164.34 15.36 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 115.982 -0.553 . . . . 0.0 110.6 -178.605 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 95' ' ' ILE . . . . . 0.531 HG12 HG12 ' A' ' 116' ' ' ILE . 12.9 mt -81.95 132.05 32.39 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.376 0 CA-C-O 120.594 0.235 . . . . 0.0 110.444 179.083 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 70.64 35.48 67.26 Favored Glycine 0 N--CA 1.448 -0.553 0 C-N-CA 121.185 -0.531 . . . . 0.0 111.785 -178.918 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 97' ' ' ALA . . . . . 0.561 ' O ' HG13 ' A' ' 113' ' ' ILE . . . -109.52 143.38 39.26 Favored 'General case' 0 C--N 1.322 -0.606 0 N-CA-C 109.744 -0.465 . . . . 0.0 109.744 -179.059 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 98' ' ' ILE . . . . . 0.51 ' HA ' ' O ' ' A' ' 111' ' ' GLY . 41.2 mt -94.48 107.9 20.0 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.115 0 CA-C-O 120.936 0.398 . . . . 0.0 110.479 -178.114 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 99' ' ' MET . . . . . 0.43 ' SD ' HD11 ' A' ' 113' ' ' ILE . 92.3 mtp -102.48 123.43 46.21 Favored 'General case' 0 N--CA 1.441 -0.925 0 CA-C-O 121.377 0.608 . . . . 0.0 111.404 -177.152 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 100' ' ' LEU . . . . . 0.444 HD13 ' HA ' ' A' ' 100' ' ' LEU . 4.4 mm? -65.59 143.85 57.35 Favored 'General case' 0 C--N 1.302 -1.477 0 CA-C-N 114.655 -1.157 . . . . 0.0 108.451 166.13 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 101' ' ' PHE . . . . . 0.417 ' CE2' ' HB2' ' A' ' 99' ' ' MET . 1.8 m-85 -149.85 167.95 25.11 Favored 'General case' 0 CA--C 1.511 -0.528 0 N-CA-C 108.062 -1.088 . . . . 0.0 108.062 -157.907 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 1.5 m -122.95 126.63 47.59 Favored 'General case' 0 C--N 1.312 -1.055 0 C-N-CA 119.774 -0.77 . . . . 0.0 110.592 179.23 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 103' ' ' ALA . . . . . 0.543 ' HB2' ' SD ' ' A' ' 109' ' ' MET . . . -95.59 167.34 11.36 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 115.915 -0.584 . . . . 0.0 110.61 -178.019 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 104' ' ' MET . . . . . . . . . . . . . 66.8 mtt -66.35 -12.93 59.56 Favored 'General case' 0 N--CA 1.464 0.259 0 CA-C-N 115.648 -0.705 . . . . 0.0 112.544 -173.117 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 5.4 p-10 -100.27 12.56 36.8 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-O 120.553 0.216 . . . . 0.0 111.383 -178.184 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 82.33 -2.56 84.56 Favored Glycine 0 N--CA 1.45 -0.383 0 C-N-CA 120.602 -0.809 . . . . 0.0 113.168 179.59 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 42.7 t -84.9 146.66 27.17 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-O 121.216 0.531 . . . . 0.0 110.266 178.683 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 28.9 tt0 -94.51 99.0 11.25 Favored 'General case' 0 C--N 1.314 -0.964 0 CA-C-N 115.319 -0.855 . . . . 0.0 108.905 178.355 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 109' ' ' MET . . . . . 0.543 ' SD ' ' HB2' ' A' ' 103' ' ' ALA . 14.6 ptm -88.66 135.09 32.74 Favored Pre-proline 0 C--N 1.325 -0.46 0 CA-C-N 115.426 -0.806 . . . . 0.0 111.065 -178.9 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 29.1 Cg_endo -65.55 153.81 76.52 Favored 'Trans proline' 0 N--CA 1.451 -0.983 0 C-N-CA 121.817 1.678 . . . . 0.0 110.065 171.425 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 111' ' ' GLY . . . . . 0.51 ' O ' ' HA ' ' A' ' 98' ' ' ILE . . . -147.21 152.78 24.88 Favored Glycine 0 N--CA 1.434 -1.486 0 N-CA-C 108.632 -1.787 . . . . 0.0 108.632 -170.313 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 112' ' ' VAL . . . . . 0.488 ' O ' ' HB3' ' A' ' 124' ' ' ASP . 0.7 OUTLIER -126.53 114.59 38.65 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.335 0 CA-C-N 118.613 1.206 . . . . 0.0 110.397 172.369 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 113' ' ' ILE . . . . . 0.666 HD13 ' HB2' ' A' ' 93' ' ' PRO . 0.6 OUTLIER -61.89 110.37 0.65 Allowed 'Isoleucine or valine' 0 C--N 1.317 -0.813 0 N-CA-C 109.022 -0.733 . . . . 0.0 109.022 174.314 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 114' ' ' ARG . . . . . 0.439 ' HB3' HG22 ' A' ' 122' ' ' THR . 12.5 tpp180 -65.02 -52.57 55.26 Favored 'General case' 0 C--N 1.315 -0.927 0 CA-C-N 115.292 -0.867 . . . . 0.0 110.882 -177.695 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 115' ' ' GLU . . . . . 0.502 ' HA ' HG23 ' A' ' 95' ' ' ILE . 10.8 tt0 -159.91 153.01 21.82 Favored 'General case' 0 C--N 1.321 -0.665 0 C-N-CA 120.887 -0.325 . . . . 0.0 110.329 -174.358 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 116' ' ' ILE . . . . . 0.531 HG12 HG12 ' A' ' 95' ' ' ILE . 43.6 mm -100.29 114.41 38.86 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.486 0 N-CA-C 109.646 -0.501 . . . . 0.0 109.646 176.231 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 117' ' ' ASN . . . . . 0.475 HD22 ' N ' ' A' ' 117' ' ' ASN . 0.9 OUTLIER -94.11 157.51 16.04 Favored 'General case' 0 C--N 1.317 -0.835 0 N-CA-C 109.266 -0.642 . . . . 0.0 109.266 177.901 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 118' ' ' GLY . . . . . 0.591 ' O ' ' HD2' ' A' ' 84' ' ' ARG . . . -56.94 -45.55 91.92 Favored Glycine 0 N--CA 1.451 -0.361 0 C-N-CA 120.537 -0.84 . . . . 0.0 112.91 -172.96 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 30.1 t70 -112.4 -10.66 13.74 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-O 121.107 0.479 . . . . 0.0 111.248 -179.107 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 120' ' ' SER . . . . . 0.468 ' O ' ' HB2' ' A' ' 117' ' ' ASN . 35.2 t -125.88 157.29 38.04 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.205 -171.893 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 121' ' ' ILE . . . . . . . . . . . . . 50.2 mm -114.31 123.12 69.67 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.567 0 CA-C-O 121.183 0.516 . . . . 0.0 110.054 175.808 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 122' ' ' THR . . . . . 0.531 HG23 ' CE2' ' A' ' 81' ' ' TYR . 24.0 m -94.56 102.2 14.11 Favored 'General case' 0 C--N 1.316 -0.85 0 CA-C-N 115.457 -0.792 . . . . 0.0 110.671 179.027 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 123' ' ' VAL . . . . . 0.45 HG12 ' N ' ' A' ' 124' ' ' ASP . 8.2 t -88.18 160.27 2.9 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.55 0 CA-C-N 115.267 -0.879 . . . . 0.0 111.853 174.765 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 124' ' ' ASP . . . . . 0.488 ' HB3' ' O ' ' A' ' 112' ' ' VAL . 27.0 t70 -145.91 145.9 30.88 Favored 'General case' 0 C--N 1.317 -0.808 0 CA-C-N 114.355 -1.293 . . . . 0.0 109.203 176.806 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 125' ' ' PHE . . . . . 0.492 ' HB2' ' HG ' ' A' ' 78' ' ' LEU . 98.1 m-85 -132.8 9.91 4.25 Favored 'General case' 0 C--N 1.312 -1.037 0 N-CA-C 108.534 -0.913 . . . . 0.0 108.534 179.87 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 126' ' ' ASN . . . . . 0.414 ' HB2' ' OD2' ' A' ' 124' ' ' ASP . 7.2 m-80 -59.02 120.65 9.5 Favored 'General case' 0 CA--C 1.516 -0.345 0 CA-C-N 113.996 -1.456 . . . . 0.0 111.691 -176.541 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 127' ' ' HIS . . . . . 0.56 ' HB3' ' HD2' ' A' ' 128' ' ' PRO . 16.3 m-70 -74.51 -175.55 0.45 Allowed Pre-proline 0 C--N 1.322 -0.604 0 CA-C-N 113.819 -1.537 . . . . 0.0 111.524 -177.603 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 128' ' ' PRO . . . . . 0.56 ' HD2' ' HB3' ' A' ' 127' ' ' HIS . 4.1 Cg_exo -43.23 172.28 0.01 OUTLIER 'Trans proline' 0 C--N 1.351 0.677 0 C-N-CA 124.735 3.623 . . . . 0.0 114.476 168.034 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 129' ' ' LEU . . . . . 0.502 ' HG ' ' NE2' ' A' ' 132' ' ' GLN . 13.0 tp -52.23 36.85 0.0 OUTLIER 'General case' 0 N--CA 1.488 1.443 0 C-N-CA 127.396 2.278 . . . . 0.0 115.248 -173.665 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 130' ' ' ALA . . . . . 0.549 ' HB1' ' C ' ' A' ' 72' ' ' GLY . . . -80.09 175.7 10.41 Favored 'General case' 0 C--N 1.316 -0.886 0 C-N-CA 123.761 0.824 . . . . 0.0 112.203 -173.266 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 131' ' ' GLY . . . . . 0.647 ' HA3' ' CD ' ' A' ' 74' ' ' PRO . . . 76.3 29.15 58.78 Favored Glycine 0 CA--C 1.508 -0.36 0 CA-C-N 115.625 -0.716 . . . . 0.0 113.063 173.589 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 132' ' ' GLN . . . . . 0.502 ' NE2' ' HG ' ' A' ' 129' ' ' LEU . 12.7 pt20 -148.15 148.42 30.55 Favored 'General case' 0 N--CA 1.436 -1.141 0 N-CA-C 108.434 -0.95 . . . . 0.0 108.434 168.928 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 133' ' ' THR . . . . . . . . . . . . . 28.2 m -70.87 127.77 33.75 Favored 'General case' 0 C--N 1.314 -0.941 0 CA-C-N 116.108 -0.496 . . . . 0.0 109.86 -176.87 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 134' ' ' VAL . . . . . 0.505 ' HB ' HD21 ' A' ' 17' ' ' LEU . 16.8 m -98.95 149.96 5.24 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.688 0 CA-C-O 121.127 0.489 . . . . 0.0 110.216 -178.122 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 135' ' ' HIS . . . . . . . . . . . . . 95.2 m-70 -115.53 111.75 21.18 Favored 'General case' 0 C--N 1.314 -0.959 0 CA-C-N 115.161 -0.927 . . . . 0.0 109.577 -172.931 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 136' ' ' PHE . . . . . 0.537 ' CZ ' HD11 ' A' ' 17' ' ' LEU . 3.1 m-85 -107.92 124.1 49.61 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 115.373 -0.831 . . . . 0.0 111.116 -173.163 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 137' ' ' ASP . . . . . 0.453 ' O ' ' HA ' ' A' ' 15' ' ' PHE . 3.7 m-20 -110.38 100.85 9.63 Favored 'General case' 0 C--N 1.317 -0.815 0 N-CA-C 109.034 -0.728 . . . . 0.0 109.034 170.758 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 138' ' ' ILE . . . . . 0.638 HG23 HG21 ' A' ' 13' ' ' VAL . 54.2 mt -116.02 122.62 69.99 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.37 0 N-CA-C 112.701 0.63 . . . . 0.0 112.701 -171.905 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 80.4 mt-10 -110.52 137.95 47.54 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-N 115.838 -0.619 . . . . 0.0 110.076 173.491 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 140' ' ' VAL . . . . . 0.488 HG11 ' HA ' ' A' ' 57' ' ' VAL . 92.9 t -82.09 105.47 11.99 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.591 0 N-CA-C 108.473 -0.936 . . . . 0.0 108.473 177.435 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 39.1 mt -79.49 -44.45 21.22 Favored 'General case' 0 CA--C 1.508 -0.673 0 N-CA-C 109.839 -0.43 . . . . 0.0 109.839 -179.362 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 142' ' ' GLU . . . . . . . . . . . . . 14.5 pt-20 -169.32 158.12 7.93 Favored 'General case' 0 C--N 1.323 -0.549 0 N-CA-C 108.812 -0.81 . . . . 0.0 108.812 176.698 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 143' ' ' ILE . . . . . 0.5 HD12 HG23 ' A' ' 57' ' ' VAL . 82.3 mt -113.38 110.83 33.59 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.647 0 CA-C-O 121.231 0.538 . . . . 0.0 110.347 -179.444 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 144' ' ' ASP . . . . . . . . . . . . . 38.3 t70 -79.75 133.67 58.49 Favored Pre-proline 0 C--N 1.326 -0.423 0 CA-C-N 115.305 -0.861 . . . . 0.0 110.546 179.886 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 145' ' ' PRO . . . . . . . . . . . . . 90.1 Cg_exo -46.57 139.35 13.42 Favored 'Trans proline' 0 C--N 1.35 0.617 0 C-N-CA 123.236 2.624 . . . . 0.0 112.538 177.581 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 146' ' ' ALA . . . . . . . . . . . . . . . -83.35 96.94 8.67 Favored 'General case' 0 C--N 1.319 -0.752 0 CA-C-O 121.217 0.532 . . . . 0.0 111.143 -174.603 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 147' ' ' LEU . . . . . 0.407 HD13 ' HA ' ' A' ' 147' ' ' LEU . 3.6 mm? -104.7 13.51 31.33 Favored 'General case' 0 N--CA 1.449 -0.505 0 CA-C-N 115.407 -0.815 . . . . 0.0 109.948 174.054 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 148' ' ' GLU . . . . . 0.446 ' HB2' ' ND2' ' A' ' 8' ' ' ASN . 63.1 mm-40 . . . . . 0 C--N 1.328 -0.358 0 CA-C-N 115.505 -0.771 . . . . 0.0 111.883 -175.317 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 86.5 mmm . . . . . 0 N--CA 1.484 1.27 0 CA-C-O 120.718 0.294 . . . . 0.0 111.226 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . 0.628 ' O ' ' HB ' ' A' ' 143' ' ' ILE . 33.2 t -97.2 135.34 39.28 Favored 'General case' 0 C--N 1.323 -0.553 0 N-CA-C 108.73 -0.841 . . . . 0.0 108.73 174.654 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 42.5 tt0 -84.41 -26.21 28.47 Favored 'General case' 0 C--N 1.321 -0.666 0 CA-C-O 121.216 0.531 . . . . 0.0 110.073 179.416 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 7.0 m -104.64 141.72 35.93 Favored 'General case' 0 C--N 1.318 -0.762 0 CA-C-N 115.443 -0.798 . . . . 0.0 110.711 -177.884 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 9.4 p -82.07 149.95 4.61 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.416 0 CA-C-N 116.052 -0.522 . . . . 0.0 111.075 -176.647 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 6' ' ' GLN . . . . . 0.448 ' CG ' ' HB2' ' A' ' 9' ' ' SER . 3.3 pt20 -143.74 157.77 44.15 Favored 'General case' 0 C--N 1.321 -0.656 0 CA-C-N 115.644 -0.707 . . . . 0.0 110.387 178.673 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 7' ' ' SER . . . . . 0.438 ' O ' ' HB2' ' A' ' 8' ' ' ASN . 5.1 p -76.02 144.12 41.03 Favored 'General case' 0 C--N 1.319 -0.724 0 CA-C-N 116.209 -0.451 . . . . 0.0 109.994 178.533 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 8' ' ' ASN . . . . . 0.485 HD22 ' N ' ' A' ' 8' ' ' ASN . 0.8 OUTLIER 71.6 13.7 6.31 Favored 'General case' 0 N--CA 1.466 0.358 0 CA-C-N 115.405 -0.816 . . . . 0.0 111.815 -178.4 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 9' ' ' SER . . . . . 0.448 ' HB2' ' CG ' ' A' ' 6' ' ' GLN . 18.2 t -82.44 166.91 18.97 Favored 'General case' 0 C--N 1.328 -0.359 0 N-CA-C 109.879 -0.415 . . . . 0.0 109.879 175.518 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 10' ' ' ALA . . . . . 0.67 ' O ' ' HB2' ' A' ' 144' ' ' ASP . . . -110.5 111.93 23.51 Favored 'General case' 0 C--N 1.318 -0.78 0 N-CA-C 109.241 -0.651 . . . . 0.0 109.241 172.638 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 16.5 m -114.61 144.72 21.56 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.789 0 C-N-CA 120.231 -0.588 . . . . 0.0 111.106 -172.67 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 12' ' ' LEU . . . . . 0.478 ' HB2' ' HB2' ' A' ' 142' ' ' GLU . 9.7 mp -87.0 128.29 35.08 Favored 'General case' 0 C--N 1.325 -0.485 0 N-CA-C 109.393 -0.595 . . . . 0.0 109.393 176.423 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 22.3 m -119.72 155.88 22.37 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.928 0 CA-C-O 121.971 0.891 . . . . 0.0 112.905 -173.094 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 14' ' ' HIS . . . . . 0.521 ' CD2' HD11 ' A' ' 141' ' ' LEU . 0.2 OUTLIER -127.82 111.61 13.83 Favored 'General case' 0 C--N 1.315 -0.924 0 CA-C-N 114.044 -1.435 . . . . 0.0 107.456 162.932 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 15' ' ' PHE . . . . . 0.552 ' HA ' ' O ' ' A' ' 137' ' ' ASP . 33.9 p90 -139.07 171.25 14.59 Favored 'General case' 0 C--N 1.321 -0.654 0 N-CA-C 114.198 1.184 . . . . 0.0 114.198 -174.299 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 89.1 m -141.9 140.13 32.76 Favored 'General case' 0 C--N 1.314 -0.955 0 CA-C-N 113.092 -1.867 . . . . 0.0 106.662 175.205 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 17' ' ' LEU . . . . . 0.4 ' HG ' ' HB3' ' A' ' 136' ' ' PHE . 0.5 OUTLIER -127.22 108.32 10.77 Favored 'General case' 0 C--N 1.316 -0.85 0 C-N-CA 120.973 -0.291 . . . . 0.0 110.654 -171.163 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 9.7 mptt -116.48 160.49 20.52 Favored 'General case' 0 C--N 1.321 -0.653 0 CA-C-O 121.313 0.578 . . . . 0.0 111.643 -174.601 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 19' ' ' LEU . . . . . 0.451 HD13 HG23 ' A' ' 134' ' ' VAL . 3.1 mm? -106.25 171.58 7.27 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 115.022 -0.99 . . . . 0.0 109.644 173.447 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 18.5 t70 -58.07 -30.66 66.37 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-O 121.197 0.522 . . . . 0.0 110.258 175.793 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 10.1 m-20 -77.85 6.69 7.1 Favored 'General case' 0 N--CA 1.465 0.298 0 CA-C-N 115.736 -0.666 . . . . 0.0 111.351 178.858 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 70.18 9.29 63.51 Favored Glycine 0 N--CA 1.453 -0.21 0 C-N-CA 121.294 -0.479 . . . . 0.0 113.261 -179.337 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 14.2 m -79.13 148.35 32.39 Favored 'General case' 0 C--N 1.322 -0.62 0 N-CA-C 109.891 -0.411 . . . . 0.0 109.891 178.422 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 18.2 m -95.16 116.52 28.84 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-O 120.987 0.422 . . . . 0.0 110.965 179.931 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -78.42 -39.36 39.01 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 116.0 -0.545 . . . . 0.0 109.825 176.827 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 8.0 tp10 -157.25 143.0 17.56 Favored 'General case' 0 N--CA 1.451 -0.394 0 CA-C-N 115.823 -0.626 . . . . 0.0 109.957 176.134 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 29.0 p -125.28 121.56 34.39 Favored 'General case' 0 C--N 1.316 -0.852 0 CA-C-N 116.295 -0.411 . . . . 0.0 110.402 178.327 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 50.5 m -136.99 61.24 1.63 Allowed 'General case' 0 N--CA 1.442 -0.856 0 CA-C-O 122.371 1.082 . . . . 0.0 109.816 174.81 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 4.7 tmm_? -151.75 -61.15 0.17 Allowed 'General case' 0 C--N 1.319 -0.755 0 CA-C-N 114.824 -1.08 . . . . 0.0 109.39 -177.861 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 6.2 p30 -68.94 -11.72 60.93 Favored 'General case' 0 N--CA 1.465 0.321 0 CA-C-O 121.121 0.486 . . . . 0.0 110.337 179.645 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 1.3 m-20 -66.49 -36.72 83.42 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 115.412 -0.813 . . . . 0.0 110.702 -179.76 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 98.6 -3.86 59.48 Favored Glycine 0 N--CA 1.448 -0.502 0 CA-C-N 115.655 -0.702 . . . . 0.0 111.614 -175.228 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 60.2 mtpt -126.7 132.29 24.25 Favored Pre-proline 0 C--N 1.328 -0.367 0 N-CA-C 110.143 -0.317 . . . . 0.0 110.143 179.795 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 42.6 Cg_endo -83.9 171.55 10.48 Favored 'Trans proline' 0 N--CA 1.456 -0.724 0 C-N-CA 123.207 2.605 . . . . 0.0 112.24 174.563 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -129.84 163.09 27.04 Favored 'General case' 0 C--N 1.316 -0.889 0 CA-C-N 115.927 -0.579 . . . . 0.0 109.623 -176.641 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 36' ' ' LEU . . . . . 0.523 HD21 ' HB1' ' A' ' 10' ' ' ALA . 0.9 OUTLIER -105.85 122.53 46.29 Favored 'General case' 0 C--N 1.315 -0.916 0 C-N-CA 120.757 -0.377 . . . . 0.0 110.571 177.003 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 37' ' ' PHE . . . . . . . . . . . . . 6.0 m-30 -93.44 107.57 19.39 Favored 'General case' 0 C--N 1.316 -0.891 0 CA-C-N 115.966 -0.561 . . . . 0.0 109.762 172.113 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 18.9 tpt180 -85.87 106.86 17.38 Favored 'General case' 0 N--CA 1.445 -0.701 0 N-CA-C 109.194 -0.669 . . . . 0.0 109.194 178.26 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 39' ' ' LEU . . . . . 0.516 HD22 ' HB3' ' A' ' 49' ' ' GLU . 15.9 mt -82.15 156.06 24.68 Favored 'General case' 0 C--N 1.317 -0.842 0 CA-C-N 115.215 -0.902 . . . . 0.0 110.498 -176.276 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 101.77 32.27 5.13 Favored Glycine 0 C--N 1.319 -0.415 0 C-N-CA 121.177 -0.535 . . . . 0.0 112.838 -177.32 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 41' ' ' ASP . . . . . 0.507 ' HA ' ' O ' ' A' ' 44' ' ' LEU . 14.7 t70 60.28 23.39 12.83 Favored 'General case' 0 N--CA 1.471 0.601 0 CA-C-O 121.507 0.67 . . . . 0.0 111.436 176.762 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -84.24 -5.37 59.25 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-O 121.05 0.452 . . . . 0.0 110.909 179.298 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 26.5 p -166.32 -49.17 0.03 OUTLIER 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 115.78 -0.645 . . . . 0.0 110.292 179.787 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 44' ' ' LEU . . . . . 0.507 ' O ' ' HA ' ' A' ' 41' ' ' ASP . 40.9 mt -106.42 171.1 7.54 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 115.992 -0.549 . . . . 0.0 110.413 179.259 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 21.0 t -76.79 153.37 34.99 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 116.005 -0.543 . . . . 0.0 109.605 178.727 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 46' ' ' GLU . . . . . 0.502 ' O ' ' HG2' ' A' ' 49' ' ' GLU . 44.8 mt-10 -63.7 -24.54 67.82 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 115.902 -0.59 . . . . 0.0 111.545 -176.597 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -57.97 -35.01 74.07 Favored Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 120.916 -0.659 . . . . 0.0 112.32 175.528 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 48' ' ' LEU . . . . . 0.445 ' HG ' HD13 ' A' ' 44' ' ' LEU . 0.6 OUTLIER -60.03 -51.91 67.63 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 121.089 0.471 . . . . 0.0 109.912 177.423 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 49' ' ' GLU . . . . . 0.652 ' O ' HD13 ' A' ' 53' ' ' LEU . 14.8 pt-20 -68.15 -51.07 50.14 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 115.9 -0.591 . . . . 0.0 111.19 -174.627 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 50' ' ' GLN . . . . . 0.535 ' HA ' HD22 ' A' ' 53' ' ' LEU . 85.3 mm-40 -56.03 -15.14 3.14 Favored 'General case' 0 C--N 1.329 -0.308 0 N-CA-C 113.75 1.018 . . . . 0.0 113.75 -176.278 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 51' ' ' HIS . . . . . . . . . . . . . 11.6 m170 -106.15 -13.8 15.33 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-O 121.074 0.464 . . . . 0.0 110.716 -177.024 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 18.3 mt -88.16 -14.65 38.12 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-N 115.632 -0.713 . . . . 0.0 109.832 172.427 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 53' ' ' LEU . . . . . 0.652 HD13 ' O ' ' A' ' 49' ' ' GLU . 5.8 mp -61.05 150.38 33.98 Favored 'General case' 0 N--CA 1.445 -0.697 0 CA-C-N 115.554 -0.748 . . . . 0.0 110.596 170.541 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 93.3 -14.67 64.74 Favored Glycine 0 N--CA 1.447 -0.581 0 C-N-CA 121.014 -0.612 . . . . 0.0 111.988 -175.23 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 6.9 mp -85.24 165.84 17.02 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-O 121.726 0.774 . . . . 0.0 112.048 177.632 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 56' ' ' LYS . . . . . 0.429 ' O ' ' HB2' ' A' ' 59' ' ' ASP . 24.2 tptt -128.75 166.92 18.05 Favored 'General case' 0 C--N 1.318 -0.8 0 N-CA-C 107.829 -1.175 . . . . 0.0 107.829 178.16 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 57' ' ' VAL . . . . . 0.552 HG23 HD12 ' A' ' 143' ' ' ILE . 12.6 t -60.52 131.83 25.55 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.52 0 CA-C-O 121.014 0.435 . . . . 0.0 110.816 176.465 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 81.59 10.25 84.62 Favored Glycine 0 N--CA 1.451 -0.364 0 CA-C-N 115.482 -0.781 . . . . 0.0 113.071 -177.519 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 59' ' ' ASP . . . . . 0.429 ' HB2' ' O ' ' A' ' 56' ' ' LYS . 1.0 OUTLIER -93.85 138.13 32.34 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.93 0.395 . . . . 0.0 110.28 176.545 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 60' ' ' LYS . . . . . 0.421 ' HE3' ' OE2' ' A' ' 139' ' ' GLU . 3.4 mmmm -110.48 131.53 54.97 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 116.034 -0.53 . . . . 0.0 109.573 -176.256 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 7.5 t -141.29 145.16 35.16 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-O 121.659 0.742 . . . . 0.0 111.839 -179.908 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 17.4 m -118.0 143.04 46.73 Favored 'General case' 0 C--N 1.313 -0.988 0 N-CA-C 108.609 -0.885 . . . . 0.0 108.609 171.143 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 21.3 p90 -161.15 163.95 30.92 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-O 120.958 0.409 . . . . 0.0 111.107 -177.01 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 41.7 t -132.48 136.9 46.99 Favored 'General case' 0 C--N 1.32 -0.686 0 CA-C-N 115.778 -0.646 . . . . 0.0 109.317 179.815 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 65' ' ' LEU . . . . . 0.409 HD11 ' HA ' ' A' ' 48' ' ' LEU . 87.6 mt -120.74 146.19 46.74 Favored 'General case' 0 C--N 1.313 -1.011 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.034 -178.352 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 14.5 mm-40 -64.44 152.99 87.82 Favored Pre-proline 0 N--CA 1.442 -0.828 0 CA-C-N 115.364 -0.835 . . . . 0.0 109.995 173.198 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 67' ' ' PRO . . . . . 0.499 ' HB3' ' N ' ' A' ' 132' ' ' GLN . 1.9 Cg_endo -42.61 -55.19 2.78 Favored 'Trans proline' 0 N--CA 1.464 -0.264 0 C-N-CA 123.797 2.998 . . . . 0.0 114.924 -171.513 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 7.0 p-10 -72.21 -14.76 61.87 Favored 'General case' 0 N--CA 1.465 0.304 0 CA-C-O 121.075 0.464 . . . . 0.0 111.502 -174.107 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -90.3 -8.79 50.01 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.676 179.175 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -126.25 -86.11 0.61 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.142 -0.481 . . . . 0.0 111.864 -179.202 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 71' ' ' PHE . . . . . . . . . . . . . 8.9 m-30 -79.88 -33.12 40.24 Favored 'General case' 0 N--CA 1.463 0.186 0 CA-C-N 116.285 -0.416 . . . . 0.0 111.967 -173.561 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 132.67 -149.98 19.63 Favored Glycine 0 N--CA 1.447 -0.577 0 C-N-CA 120.668 -0.777 . . . . 0.0 112.034 -177.901 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 3.0 p -158.04 128.42 3.49 Favored Pre-proline 0 C--N 1.32 -0.694 0 N-CA-C 109.94 -0.392 . . . . 0.0 109.94 -174.23 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 74' ' ' PRO . . . . . 0.56 ' HD3' ' HA3' ' A' ' 131' ' ' GLY . 35.7 Cg_endo -64.58 126.4 16.75 Favored 'Trans proline' 0 C--O 1.232 0.215 0 C-N-CA 123.281 2.654 . . . . 0.0 112.352 -177.45 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 39.6 t -97.87 125.09 45.56 Favored Pre-proline 0 C--N 1.322 -0.627 0 CA-C-N 115.981 -0.554 . . . . 0.0 110.743 -179.828 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 39.1 Cg_endo -69.49 -18.93 38.01 Favored 'Trans proline' 0 N--CA 1.464 -0.236 0 C-N-CA 122.789 2.326 . . . . 0.0 111.813 174.891 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 7.3 m-20 -76.19 -15.22 60.09 Favored 'General case' 0 CA--C 1.519 -0.231 0 CA-C-O 121.359 0.6 . . . . 0.0 109.838 176.742 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 78' ' ' LEU . . . . . 0.553 ' HG ' ' HB2' ' A' ' 125' ' ' PHE . 6.2 mp -87.01 8.17 24.51 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 115.407 -0.815 . . . . 0.0 109.89 175.966 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 49.8 mt -118.86 109.41 26.74 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.681 0 N-CA-C 108.203 -1.036 . . . . 0.0 108.203 172.686 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 74.7 mt-30 -131.43 136.37 47.93 Favored 'General case' 0 C--N 1.311 -1.086 0 CA-C-N 115.259 -0.882 . . . . 0.0 110.054 -169.523 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 81' ' ' TYR . . . . . . . . . . . . . 46.3 m-85 -107.02 112.73 25.82 Favored 'General case' 0 C--N 1.321 -0.638 0 C-N-CA 120.125 -0.63 . . . . 0.0 110.252 -179.885 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 60.0 m-85 -103.78 170.47 7.91 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-O 121.548 0.689 . . . . 0.0 112.822 178.868 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 9.7 m -79.1 139.98 37.94 Favored 'General case' 0 N--CA 1.445 -0.724 0 CA-C-N 114.745 -1.116 . . . . 0.0 111.288 174.634 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 84' ' ' ARG . . . . . 0.434 ' HD2' ' O ' ' A' ' 118' ' ' GLY . 10.8 ptm180 -68.57 -17.22 64.09 Favored 'General case' 0 C--N 1.325 -0.469 0 N-CA-C 113.714 1.005 . . . . 0.0 113.714 -175.186 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 85' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -74.04 -34.13 63.98 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-O 121.134 0.492 . . . . 0.0 109.879 -174.713 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 45.1 mt-10 -64.6 -16.37 62.6 Favored 'General case' 0 N--CA 1.465 0.3 0 CA-C-N 115.177 -0.919 . . . . 0.0 110.77 -179.936 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 87' ' ' PHE . . . . . . . . . . . . . 54.8 m-85 -102.5 -23.12 13.93 Favored 'General case' 0 C--N 1.319 -0.72 0 CA-C-N 115.185 -0.916 . . . . 0.0 110.135 -177.464 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 88' ' ' MET . . . . . . . . . . . . . 56.0 ttm -62.0 -35.56 78.89 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 115.94 -0.573 . . . . 0.0 110.836 -178.419 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 23.1 t70 -58.18 -25.86 62.07 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 121.144 0.497 . . . . 0.0 111.304 178.888 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -111.13 16.51 21.03 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-N 115.938 -0.573 . . . . 0.0 110.668 177.765 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 90.65 143.99 11.66 Favored Glycine 0 N--CA 1.447 -0.629 0 C-N-CA 120.762 -0.732 . . . . 0.0 111.637 -178.225 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 44.3 mt-10 -60.42 127.28 86.33 Favored Pre-proline 0 C--N 1.323 -0.545 0 CA-C-O 121.02 0.438 . . . . 0.0 110.848 -177.633 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 18.1 Cg_endo -71.11 164.91 34.12 Favored 'Trans proline' 0 N--CA 1.457 -0.627 0 C-N-CA 122.85 2.367 . . . . 0.0 112.313 -175.282 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 23.0 mt-10 -118.07 160.8 20.89 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 116.332 -0.395 . . . . 0.0 110.392 -177.603 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 95' ' ' ILE . . . . . 0.502 HG23 ' HA ' ' A' ' 115' ' ' GLU . 9.6 mt -82.33 131.67 33.23 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.51 0 CA-C-O 120.969 0.414 . . . . 0.0 110.607 -178.333 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 71.35 34.8 63.73 Favored Glycine 0 N--CA 1.444 -0.783 0 CA-C-N 115.706 -0.679 . . . . 0.0 111.518 -176.849 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -110.14 115.58 29.98 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 121.659 0.742 . . . . 0.0 112.553 -177.555 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 98' ' ' ILE . . . . . 0.667 ' HA ' ' HA ' ' A' ' 112' ' ' VAL . 5.5 mt -82.03 123.3 37.99 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.017 0 CA-C-N 114.826 -1.079 . . . . 0.0 108.504 175.926 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 99' ' ' MET . . . . . . . . . . . . . 10.0 mtm -136.64 152.78 50.81 Favored 'General case' 0 N--CA 1.443 -0.797 0 N-CA-C 106.37 -1.715 . . . . 0.0 106.37 179.811 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 3.2 mm? -71.54 102.85 2.81 Favored 'General case' 0 C--N 1.313 -1.003 0 CA-C-O 122.273 1.035 . . . . 0.0 111.856 -178.795 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 101' ' ' PHE . . . . . . . . . . . . . 8.2 m-30 -94.78 172.65 8.04 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 113.033 -1.894 . . . . 0.0 111.826 -179.512 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 5.3 m -118.56 130.14 55.73 Favored 'General case' 0 C--N 1.316 -0.887 0 CA-C-N 114.947 -1.024 . . . . 0.0 108.972 -178.716 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 103' ' ' ALA . . . . . 0.612 ' HB2' ' SD ' ' A' ' 109' ' ' MET . . . -94.57 158.47 15.52 Favored 'General case' 0 C--N 1.322 -0.605 0 N-CA-C 109.329 -0.619 . . . . 0.0 109.329 -177.889 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 104' ' ' MET . . . . . . . . . . . . . 2.0 mpt? -66.54 -12.65 58.7 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 115.732 -0.667 . . . . 0.0 111.953 -174.988 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 5.0 p-10 -97.63 11.27 37.55 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-O 120.893 0.378 . . . . 0.0 110.989 179.227 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 87.9 -12.22 64.53 Favored Glycine 0 N--CA 1.45 -0.392 0 C-N-CA 121.249 -0.5 . . . . 0.0 113.505 175.499 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 48.9 m -76.76 142.49 40.39 Favored 'General case' 0 C--N 1.317 -0.81 0 CA-C-N 116.816 0.308 . . . . 0.0 110.308 177.499 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 30.1 tt0 -93.65 100.57 12.79 Favored 'General case' 0 C--N 1.318 -0.778 0 CA-C-O 121.675 0.75 . . . . 0.0 109.536 178.473 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 109' ' ' MET . . . . . 0.612 ' SD ' ' HB2' ' A' ' 103' ' ' ALA . 16.0 ptm -100.3 139.58 20.79 Favored Pre-proline 0 C--N 1.323 -0.573 0 CA-C-N 114.889 -1.051 . . . . 0.0 111.262 -177.289 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 17.7 Cg_exo -64.6 143.37 81.15 Favored 'Trans proline' 0 N--CA 1.451 -1.02 0 C-N-CA 121.88 1.72 . . . . 0.0 110.061 171.874 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . -144.69 108.26 0.48 Allowed Glycine 0 N--CA 1.438 -1.212 0 N-CA-C 109.876 -1.29 . . . . 0.0 109.876 -171.512 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 112' ' ' VAL . . . . . 0.667 ' HA ' ' HA ' ' A' ' 98' ' ' ILE . 1.3 p -84.11 110.38 18.64 Favored 'Isoleucine or valine' 0 CA--C 1.51 -0.582 0 C-N-CA 119.202 -0.999 . . . . 0.0 110.879 -178.647 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 113' ' ' ILE . . . . . . . . . . . . . 45.9 mt -60.41 110.11 0.52 Allowed 'Isoleucine or valine' 0 N--CA 1.438 -1.071 0 CA-C-N 114.22 -1.355 . . . . 0.0 108.536 170.726 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 114' ' ' ARG . . . . . 0.444 ' O ' HG23 ' A' ' 95' ' ' ILE . 1.3 tmt_? -79.2 -27.55 42.56 Favored 'General case' 0 C--N 1.309 -1.188 0 CA-C-N 114.162 -1.381 . . . . 0.0 110.899 -168.214 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 115' ' ' GLU . . . . . 0.612 ' N ' ' HB ' ' A' ' 122' ' ' THR . 8.2 tt0 -160.28 159.93 31.96 Favored 'General case' 0 C--N 1.325 -0.484 0 N-CA-C 112.456 0.539 . . . . 0.0 112.456 -179.046 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 116' ' ' ILE . . . . . 0.471 HG12 HG12 ' A' ' 95' ' ' ILE . 33.4 mm -118.39 130.3 73.45 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.605 0 CA-C-N 114.981 -1.009 . . . . 0.0 109.444 174.218 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 117' ' ' ASN . . . . . 0.41 ' HB2' ' O ' ' A' ' 120' ' ' SER . 19.8 m-80 -122.21 159.3 27.57 Favored 'General case' 0 C--N 1.309 -1.192 0 CA-C-N 115.51 -0.768 . . . . 0.0 109.27 -179.782 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 118' ' ' GLY . . . . . 0.434 ' O ' ' HD2' ' A' ' 84' ' ' ARG . . . -55.28 -45.59 82.47 Favored Glycine 0 N--CA 1.452 -0.297 0 C-N-CA 120.653 -0.784 . . . . 0.0 112.896 -170.624 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 3.3 p-10 -114.17 -12.08 12.56 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 117.03 0.415 . . . . 0.0 111.032 173.534 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 120' ' ' SER . . . . . 0.41 ' O ' ' HB2' ' A' ' 117' ' ' ASN . 21.9 t -113.77 159.79 19.38 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-O 122.047 0.927 . . . . 0.0 112.122 -169.196 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 121' ' ' ILE . . . . . . . . . . . . . 45.1 mm -118.98 159.68 19.4 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.863 0 CA-C-N 114.292 -1.322 . . . . 0.0 109.52 -177.289 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 122' ' ' THR . . . . . 0.612 ' HB ' ' N ' ' A' ' 115' ' ' GLU . 8.8 m -139.18 139.14 37.47 Favored 'General case' 0 N--CA 1.448 -0.533 0 N-CA-C 106.844 -1.539 . . . . 0.0 106.844 -170.78 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 123' ' ' VAL . . . . . 0.4 HG12 ' N ' ' A' ' 124' ' ' ASP . 55.6 t -140.46 154.57 22.46 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.67 0 C-N-CA 117.555 -1.658 . . . . 0.0 109.872 -164.119 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 124' ' ' ASP . . . . . 0.441 ' HB3' HG13 ' A' ' 112' ' ' VAL . 35.6 t70 -154.7 94.9 1.72 Allowed 'General case' 0 C--N 1.309 -1.176 0 CA-C-N 115.593 -0.73 . . . . 0.0 109.684 176.671 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 125' ' ' PHE . . . . . 0.553 ' HB2' ' HG ' ' A' ' 78' ' ' LEU . 97.4 m-85 -82.01 3.37 26.88 Favored 'General case' 0 C--N 1.324 -0.534 0 O-C-N 120.724 -1.235 . . . . 0.0 110.376 173.699 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 37.0 m-80 -57.48 136.2 56.66 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-O 122.478 1.132 . . . . 0.0 111.951 -177.92 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 127' ' ' HIS . . . . . 0.637 ' HB3' ' HD2' ' A' ' 128' ' ' PRO . 33.8 m170 -84.96 -170.9 0.27 Allowed Pre-proline 0 C--N 1.319 -0.747 0 CA-C-N 112.962 -1.926 . . . . 0.0 111.095 -168.788 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 128' ' ' PRO . . . . . 0.637 ' HD2' ' HB3' ' A' ' 127' ' ' HIS . 6.0 Cg_exo -41.83 172.64 0.01 OUTLIER 'Trans proline' 0 C--N 1.354 0.844 0 C-N-CA 124.482 3.455 . . . . 0.0 114.101 165.086 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 129' ' ' LEU . . . . . 0.473 ' O ' ' HG ' ' A' ' 129' ' ' LEU . 22.1 tp -51.68 34.76 0.0 OUTLIER 'General case' 0 N--CA 1.485 1.28 0 C-N-CA 126.91 2.084 . . . . 0.0 115.843 -173.829 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 130' ' ' ALA . . . . . 0.403 ' N ' ' O ' ' A' ' 128' ' ' PRO . . . -70.48 164.46 24.66 Favored 'General case' 0 C--N 1.315 -0.906 0 C-N-CA 122.83 0.452 . . . . 0.0 110.15 175.259 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 131' ' ' GLY . . . . . 0.56 ' HA3' ' HD3' ' A' ' 74' ' ' PRO . . . 76.46 28.37 59.8 Favored Glycine 0 N--CA 1.45 -0.389 0 C-N-CA 120.621 -0.799 . . . . 0.0 112.069 -178.439 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 132' ' ' GLN . . . . . 0.499 ' N ' ' HB3' ' A' ' 67' ' ' PRO . 14.3 tt0 -148.05 141.55 25.39 Favored 'General case' 0 N--CA 1.441 -0.89 0 N-CA-C 108.897 -0.779 . . . . 0.0 108.897 171.505 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 133' ' ' THR . . . . . . . . . . . . . 59.5 m -67.39 125.35 25.83 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.672 -178.061 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 134' ' ' VAL . . . . . 0.451 HG23 HD13 ' A' ' 19' ' ' LEU . 2.7 p -116.96 166.78 10.91 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.501 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.803 -173.227 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 135' ' ' HIS . . . . . 0.441 ' H ' HG22 ' A' ' 134' ' ' VAL . 81.8 m-70 -131.0 124.48 31.05 Favored 'General case' 0 C--N 1.322 -0.587 0 CA-C-N 115.848 -0.614 . . . . 0.0 111.089 -171.278 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 136' ' ' PHE . . . . . 0.4 ' HB3' ' HG ' ' A' ' 17' ' ' LEU . 0.1 OUTLIER -131.54 150.98 51.96 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 121.478 0.656 . . . . 0.0 111.907 -179.966 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 137' ' ' ASP . . . . . 0.552 ' O ' ' HA ' ' A' ' 15' ' ' PHE . 3.3 m-20 -115.89 101.18 8.56 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-N 114.706 -1.133 . . . . 0.0 108.604 174.244 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 138' ' ' ILE . . . . . . . . . . . . . 47.6 mt -116.65 130.51 71.38 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.532 0 CA-C-O 121.203 0.525 . . . . 0.0 111.789 -172.23 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 139' ' ' GLU . . . . . 0.421 ' OE2' ' HE3' ' A' ' 60' ' ' LYS . 11.7 pt-20 -118.45 142.8 47.21 Favored 'General case' 0 C--N 1.321 -0.642 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.103 178.064 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 140' ' ' VAL . . . . . 0.453 ' CG1' ' HA ' ' A' ' 57' ' ' VAL . 78.7 t -79.09 108.33 12.55 Favored 'Isoleucine or valine' 0 C--O 1.234 0.263 0 CA-C-O 121.068 0.461 . . . . 0.0 111.116 -179.199 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 141' ' ' LEU . . . . . 0.521 HD11 ' CD2' ' A' ' 14' ' ' HIS . 48.7 mt -90.45 -33.02 16.15 Favored 'General case' 0 C--N 1.321 -0.652 0 CA-C-O 121.632 0.729 . . . . 0.0 110.324 177.291 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 142' ' ' GLU . . . . . 0.478 ' HB2' ' HB2' ' A' ' 12' ' ' LEU . 0.0 OUTLIER -164.49 148.23 9.28 Favored 'General case' 0 C--N 1.316 -0.885 0 CA-C-N 114.083 -1.417 . . . . 0.0 111.811 -176.879 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 143' ' ' ILE . . . . . 0.628 ' HB ' ' O ' ' A' ' 2' ' ' SER . 78.3 mt -125.16 127.92 72.53 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.538 0 CA-C-N 115.455 -0.793 . . . . 0.0 109.91 178.834 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 144' ' ' ASP . . . . . 0.67 ' HB2' ' O ' ' A' ' 10' ' ' ALA . 31.4 t70 -62.15 137.52 95.76 Favored Pre-proline 0 C--N 1.326 -0.448 0 CA-C-N 115.82 -0.627 . . . . 0.0 110.715 -178.246 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 145' ' ' PRO . . . . . . . . . . . . . 25.3 Cg_endo -61.47 156.43 46.77 Favored 'Trans proline' 0 N--CA 1.463 -0.32 0 C-N-CA 122.823 2.349 . . . . 0.0 111.627 178.334 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 146' ' ' ALA . . . . . . . . . . . . . . . -82.6 97.72 8.63 Favored 'General case' 0 C--N 1.317 -0.809 0 CA-C-O 120.977 0.417 . . . . 0.0 110.625 -176.388 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 4.1 mm? -90.19 41.79 1.07 Allowed 'General case' 0 C--N 1.325 -0.488 0 CA-C-O 121.477 0.656 . . . . 0.0 110.511 178.494 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 18.0 mm-40 . . . . . 0 C--N 1.323 -0.555 0 CA-C-N 115.127 -0.942 . . . . 0.0 110.467 178.272 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 34.2 ttm . . . . . 0 N--CA 1.481 1.09 0 CA-C-O 120.953 0.406 . . . . 0.0 110.201 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 69.0 m -88.95 87.31 7.18 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-O 121.221 0.534 . . . . 0.0 111.005 -177.993 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 33.4 mt-10 -80.33 -25.74 39.13 Favored 'General case' 0 C--N 1.323 -0.585 0 N-CA-C 108.442 -0.947 . . . . 0.0 108.442 172.851 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 23.6 t -117.47 132.8 56.49 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-N 114.027 -1.442 . . . . 0.0 109.004 175.048 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . 0.583 HG12 ' O ' ' A' ' 55' ' ' LEU . 8.9 p -76.9 142.77 13.85 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.494 0 CA-C-O 121.244 0.545 . . . . 0.0 110.428 -179.376 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 6' ' ' GLN . . . . . 0.5 ' HG2' ' HB2' ' A' ' 9' ' ' SER . 4.2 pt20 -127.39 168.3 15.03 Favored 'General case' 0 C--N 1.314 -0.963 0 CA-C-N 115.477 -0.783 . . . . 0.0 109.176 179.933 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 31.3 p -55.9 130.2 42.73 Favored 'General case' 0 C--N 1.317 -0.819 0 N-CA-C 109.955 -0.387 . . . . 0.0 109.955 174.946 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 66.7 t30 69.04 40.29 1.62 Allowed 'General case' 0 N--CA 1.47 0.549 0 CA-C-O 121.392 0.615 . . . . 0.0 110.914 -176.339 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 9' ' ' SER . . . . . 0.5 ' HB2' ' HG2' ' A' ' 6' ' ' GLN . 18.3 t -133.71 125.97 29.73 Favored 'General case' 0 C--N 1.327 -0.409 0 N-CA-C 108.638 -0.875 . . . . 0.0 108.638 173.311 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -83.27 148.67 27.25 Favored 'General case' 0 C--N 1.319 -0.755 0 CA-C-N 116.587 -0.279 . . . . 0.0 110.707 -171.233 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 8.0 m -123.92 140.15 48.23 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.687 0 CA-C-O 121.436 0.636 . . . . 0.0 111.322 179.249 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 12' ' ' LEU . . . . . 0.476 ' N ' HD12 ' A' ' 12' ' ' LEU . 5.1 mp -88.98 112.85 23.84 Favored 'General case' 0 C--N 1.315 -0.929 0 N-CA-C 107.584 -1.265 . . . . 0.0 107.584 173.667 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 13' ' ' VAL . . . . . 0.694 HG21 HG23 ' A' ' 138' ' ' ILE . 1.4 p -125.46 157.03 34.93 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.952 0 CA-C-O 121.185 0.517 . . . . 0.0 110.576 -171.462 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 14' ' ' HIS . . . . . 0.635 ' CE1' ' HA ' ' A' ' 29' ' ' ARG . 43.5 t60 -130.72 113.62 14.37 Favored 'General case' 0 C--N 1.316 -0.871 0 N-CA-C 106.12 -1.807 . . . . 0.0 106.12 176.502 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 15' ' ' PHE . . . . . 0.573 ' H ' ' HB ' ' A' ' 28' ' ' THR . 48.6 p90 -141.9 -179.07 5.99 Favored 'General case' 0 C--N 1.317 -0.81 0 CA-C-O 122.363 1.078 . . . . 0.0 113.329 -163.756 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 60.1 m -143.97 113.24 6.9 Favored 'General case' 0 C--N 1.318 -0.782 0 CA-C-N 113.721 -1.582 . . . . 0.0 108.336 -176.11 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 17' ' ' LEU . . . . . 0.89 HD21 ' HB ' ' A' ' 134' ' ' VAL . 1.1 tt -100.89 120.96 40.92 Favored 'General case' 0 C--N 1.321 -0.657 0 CA-C-N 115.923 -0.58 . . . . 0.0 112.153 -176.916 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 10.0 mptt -120.18 142.76 48.68 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-N 115.339 -0.846 . . . . 0.0 110.714 -179.248 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 19' ' ' LEU . . . . . 0.614 HD21 ' HB2' ' A' ' 25' ' ' ALA . 3.6 mm? -84.58 173.69 10.59 Favored 'General case' 0 C--N 1.322 -0.599 0 N-CA-C 109.11 -0.7 . . . . 0.0 109.11 170.711 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 50.5 m-20 -57.2 -33.66 67.72 Favored 'General case' 0 C--N 1.327 -0.408 0 C-N-CA 120.786 -0.366 . . . . 0.0 110.631 177.057 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 23.3 t70 -78.16 4.08 13.46 Favored 'General case' 0 CA--C 1.535 0.398 0 CA-C-O 121.338 0.59 . . . . 0.0 111.201 178.957 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 73.57 9.41 78.23 Favored Glycine 0 CA--C 1.516 0.15 0 CA-C-N 116.137 -0.483 . . . . 0.0 113.264 -179.047 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 8.1 m -71.19 141.38 50.67 Favored 'General case' 0 C--N 1.323 -0.583 0 N-CA-C 109.529 -0.545 . . . . 0.0 109.529 174.776 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 7.3 m -88.8 112.25 22.99 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-O 120.923 0.392 . . . . 0.0 110.567 -178.665 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 25' ' ' ALA . . . . . 0.79 ' HB3' HD22 ' A' ' 17' ' ' LEU . . . -80.41 -38.38 30.33 Favored 'General case' 0 CA--C 1.516 -0.332 0 CA-C-N 116.009 -0.542 . . . . 0.0 111.033 -178.708 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 23.8 tt0 -154.24 121.14 5.59 Favored 'General case' 0 C--N 1.321 -0.668 0 CA-C-N 115.543 -0.753 . . . . 0.0 109.645 -176.735 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 14.9 p -114.08 101.65 9.43 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-O 121.677 0.751 . . . . 0.0 111.679 -178.09 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 28' ' ' THR . . . . . 0.573 ' HB ' ' H ' ' A' ' 15' ' ' PHE . 80.3 m -91.14 81.05 5.59 Favored 'General case' 0 N--CA 1.431 -1.393 0 N-CA-C 106.468 -1.678 . . . . 0.0 106.468 171.475 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 29' ' ' ARG . . . . . 0.635 ' HA ' ' CE1' ' A' ' 14' ' ' HIS . 43.0 ttt180 -174.07 -70.85 0.01 OUTLIER 'General case' 0 C--N 1.305 -1.354 0 CA-C-N 112.735 -2.03 . . . . 0.0 110.32 -162.54 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 73.2 m-20 -65.51 -29.12 69.72 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 121.1 0.476 . . . . 0.0 111.2 -176.968 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 93.6 m-20 -67.9 -22.06 65.1 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 115.82 -0.627 . . . . 0.0 111.391 179.915 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 78.08 12.71 84.1 Favored Glycine 0 N--CA 1.449 -0.466 0 C-N-CA 120.719 -0.753 . . . . 0.0 111.509 -178.895 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 66.9 mttm -133.34 128.48 20.31 Favored Pre-proline 0 C--N 1.324 -0.54 0 CA-C-N 115.455 -0.372 . . . . 0.0 110.156 -176.801 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 34' ' ' PRO . . . . . 0.461 ' HA ' ' CG2' ' A' ' 28' ' ' THR . 93.9 Cg_endo -80.17 154.58 22.18 Favored 'Trans proline' 0 N--CA 1.45 -1.038 0 C-N-CA 121.914 1.743 . . . . 0.0 111.112 174.231 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -113.59 150.53 32.95 Favored 'General case' 0 C--N 1.319 -0.749 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.211 -173.027 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 10.9 tp -94.51 126.94 40.11 Favored 'General case' 0 C--N 1.318 -0.797 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.574 178.547 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 37' ' ' PHE . . . . . . . . . . . . . 4.4 m-30 -94.97 107.43 19.46 Favored 'General case' 0 C--N 1.315 -0.907 0 CA-C-N 115.924 -0.58 . . . . 0.0 109.678 171.96 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 16.1 mmm180 -81.71 108.0 14.9 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 115.615 -0.72 . . . . 0.0 111.341 -178.311 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 39' ' ' LEU . . . . . 0.448 ' HG ' ' CB ' ' A' ' 49' ' ' GLU . 10.7 mp -81.77 154.55 25.91 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-N 114.897 -1.047 . . . . 0.0 110.567 177.466 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 101.35 34.23 4.56 Favored Glycine 0 N--CA 1.449 -0.481 0 C-N-CA 120.718 -0.753 . . . . 0.0 112.823 177.107 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 20.6 t70 65.68 6.05 3.66 Favored 'General case' 0 N--CA 1.471 0.619 0 CA-C-O 121.148 0.499 . . . . 0.0 111.994 176.676 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -68.7 -59.3 3.21 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-O 121.068 0.461 . . . . 0.0 111.127 -175.858 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 22.2 m -116.85 -31.21 5.51 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-O 121.306 0.574 . . . . 0.0 110.353 177.979 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 44' ' ' LEU . . . . . 0.47 HD13 HD12 ' A' ' 48' ' ' LEU . 49.9 mt -108.8 157.8 18.24 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-N 115.651 -0.704 . . . . 0.0 110.456 -175.291 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 49.1 m -89.07 171.27 9.96 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 115.825 -0.625 . . . . 0.0 111.018 179.654 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 46' ' ' GLU . . . . . 0.437 ' O ' ' HG3' ' A' ' 50' ' ' GLN . 59.0 mm-40 -47.89 -49.12 30.76 Favored 'General case' 0 C--N 1.33 -0.247 0 O-C-N 123.856 0.723 . . . . 0.0 112.201 -176.01 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . 0.482 ' HA3' ' HB1' ' A' ' 69' ' ' ALA . . . -58.73 -45.61 94.58 Favored Glycine 0 CA--C 1.519 0.303 0 C-N-CA 120.881 -0.676 . . . . 0.0 113.379 -175.155 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 48' ' ' LEU . . . . . 0.47 HD12 HD13 ' A' ' 44' ' ' LEU . 0.3 OUTLIER -60.12 -52.91 63.33 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 117.039 0.42 . . . . 0.0 110.324 -178.889 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 49' ' ' GLU . . . . . 0.448 ' CB ' ' HG ' ' A' ' 39' ' ' LEU . 7.6 pt-20 -68.06 -31.9 71.87 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 116.376 -0.375 . . . . 0.0 111.994 -172.212 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 50' ' ' GLN . . . . . 0.616 ' HA ' ' CD2' ' A' ' 53' ' ' LEU . 84.5 mt-30 -80.7 -8.39 59.63 Favored 'General case' 0 N--CA 1.452 -0.354 0 N-CA-C 111.814 0.302 . . . . 0.0 111.814 -170.642 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 51' ' ' HIS . . . . . . . . . . . . . 21.8 m-70 -108.81 -5.14 16.38 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-O 121.215 0.531 . . . . 0.0 110.18 -178.501 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 18.1 mt -103.72 -30.25 10.54 Favored 'General case' 0 C--N 1.32 -0.691 0 CA-C-N 115.684 -0.689 . . . . 0.0 111.601 177.216 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 53' ' ' LEU . . . . . 0.616 ' CD2' ' HA ' ' A' ' 50' ' ' GLN . 2.5 pp -67.57 151.34 47.49 Favored 'General case' 0 C--O 1.234 0.24 0 C-N-CA 120.991 -0.284 . . . . 0.0 110.584 -177.215 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 93.7 -5.15 73.17 Favored Glycine 0 CA--C 1.522 0.53 0 C-N-CA 120.996 -0.621 . . . . 0.0 113.049 -177.418 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 55' ' ' LEU . . . . . 0.583 ' O ' HG12 ' A' ' 5' ' ' VAL . 72.3 mt -92.51 164.66 13.37 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 117.082 0.441 . . . . 0.0 111.008 179.084 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 56' ' ' LYS . . . . . 0.442 ' O ' ' HB2' ' A' ' 59' ' ' ASP . 2.8 mptp? -111.59 169.87 8.52 Favored 'General case' 0 C--N 1.32 -0.717 0 CA-C-O 121.466 0.651 . . . . 0.0 109.345 175.583 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 57' ' ' VAL . . . . . 0.44 ' HA ' ' CG1' ' A' ' 140' ' ' VAL . 52.5 t -63.1 138.73 22.43 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.331 0 CA-C-N 114.954 -1.021 . . . . 0.0 110.027 174.086 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 81.49 10.95 83.82 Favored Glycine 0 N--CA 1.446 -0.651 0 C-N-CA 120.858 -0.687 . . . . 0.0 112.419 -177.35 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 59' ' ' ASP . . . . . 0.442 ' HB2' ' O ' ' A' ' 56' ' ' LYS . 3.3 m-20 -92.48 139.65 30.37 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-O 120.801 0.334 . . . . 0.0 110.306 175.317 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 6.8 mmmt -111.78 127.97 55.96 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 115.839 -0.619 . . . . 0.0 109.34 -177.767 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 11.3 t -142.43 141.28 32.19 Favored 'General case' 0 C--N 1.317 -0.836 0 CA-C-O 121.281 0.562 . . . . 0.0 111.103 -179.178 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 5.0 m -127.73 131.36 49.71 Favored 'General case' 0 C--N 1.316 -0.878 0 N-CA-C 109.049 -0.723 . . . . 0.0 109.049 174.789 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 63' ' ' PHE . . . . . 0.529 ' CE2' ' HE1' ' A' ' 136' ' ' PHE . 41.2 p90 -152.2 172.59 16.15 Favored 'General case' 0 C--N 1.319 -0.75 0 CA-C-O 120.648 0.261 . . . . 0.0 110.576 179.061 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 38.3 t -132.04 143.8 50.31 Favored 'General case' 0 C--N 1.319 -0.735 0 N-CA-C 108.743 -0.836 . . . . 0.0 108.743 -172.16 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 65' ' ' LEU . . . . . 0.422 HD11 ' HA ' ' A' ' 48' ' ' LEU . 57.2 mt -139.48 139.18 36.92 Favored 'General case' 0 C--N 1.319 -0.758 0 CA-C-O 121.12 0.486 . . . . 0.0 111.501 -176.728 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 66' ' ' GLU . . . . . 0.475 ' H ' ' CD ' ' A' ' 66' ' ' GLU . 13.5 mp0 -64.84 148.36 97.44 Favored Pre-proline 0 N--CA 1.44 -0.928 0 CA-C-N 115.009 -0.996 . . . . 0.0 109.373 170.571 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 67' ' ' PRO . . . . . 0.427 ' HB3' ' HA2' ' A' ' 131' ' ' GLY . 73.7 Cg_exo -50.44 -23.78 11.05 Favored 'Trans proline' 0 C--N 1.346 0.434 0 C-N-CA 124.024 3.15 . . . . 0.0 114.662 -174.697 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 32.8 t70 -66.8 -26.2 66.83 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-O 121.149 0.5 . . . . 0.0 110.697 177.867 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 69' ' ' ALA . . . . . 0.482 ' HB1' ' HA3' ' A' ' 47' ' ' GLY . . . -108.21 -6.34 16.43 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 115.954 -0.567 . . . . 0.0 111.524 -178.067 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 70' ' ' ALA . . . . . 0.446 ' O ' ' HB2' ' A' ' 71' ' ' PHE . . . -149.19 128.73 13.1 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.664 -0.244 . . . . 0.0 111.154 -176.009 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 71' ' ' PHE . . . . . 0.446 ' HB2' ' O ' ' A' ' 70' ' ' ALA . 3.3 m-85 74.37 -47.96 0.64 Allowed 'General case' 0 N--CA 1.47 0.569 0 O-C-N 123.778 0.674 . . . . 0.0 111.943 179.526 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 72' ' ' GLY . . . . . 0.569 ' O ' ' HB1' ' A' ' 130' ' ' ALA . . . 115.86 141.16 7.2 Favored Glycine 0 N--CA 1.447 -0.582 0 C-N-CA 120.845 -0.693 . . . . 0.0 112.51 177.663 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 73' ' ' VAL . . . . . 0.401 ' HA ' ' HD3' ' A' ' 74' ' ' PRO . 46.5 t -75.02 121.38 85.14 Favored Pre-proline 0 C--N 1.322 -0.625 0 CA-C-O 120.868 0.366 . . . . 0.0 110.903 173.509 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 74' ' ' PRO . . . . . 0.401 ' HD3' ' HA ' ' A' ' 73' ' ' VAL . 53.0 Cg_exo -56.92 146.62 78.52 Favored 'Trans proline' 0 C--N 1.347 0.456 0 C-N-CA 123.732 2.955 . . . . 0.0 112.627 178.168 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 32.2 t -111.16 101.94 51.59 Favored Pre-proline 0 N--CA 1.446 -0.642 0 CA-C-N 116.081 -0.509 . . . . 0.0 110.276 -178.904 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 39.5 Cg_endo -69.11 -24.47 32.61 Favored 'Trans proline' 0 N--CA 1.465 -0.173 0 C-N-CA 122.074 1.849 . . . . 0.0 111.245 175.463 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 5.8 p-10 -77.26 -9.09 58.59 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 115.869 -0.605 . . . . 0.0 110.781 177.314 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 78' ' ' LEU . . . . . 0.537 ' HG ' ' HB2' ' A' ' 125' ' ' PHE . 5.0 tp -69.42 -20.99 63.78 Favored 'General case' 0 N--CA 1.453 -0.298 0 CA-C-O 121.645 0.736 . . . . 0.0 109.249 175.388 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 79' ' ' ILE . . . . . 0.471 HG23 ' O ' ' A' ' 123' ' ' VAL . 65.2 mt -70.21 132.17 33.48 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.555 0 CA-C-N 114.473 -1.239 . . . . 0.0 110.396 178.653 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 42.6 mt-30 -152.8 118.24 5.27 Favored 'General case' 0 CA--C 1.509 -0.605 0 CA-C-N 116.099 -0.501 . . . . 0.0 109.983 -176.992 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 81' ' ' TYR . . . . . . . . . . . . . 0.6 OUTLIER -83.51 121.71 27.57 Favored 'General case' 0 C--N 1.317 -0.846 0 N-CA-C 114.193 1.183 . . . . 0.0 114.193 -179.936 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 82' ' ' PHE . . . . . 0.431 ' HZ ' ' SD ' ' A' ' 104' ' ' MET . 7.5 m-85 -102.99 171.14 7.55 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 113.887 -1.506 . . . . 0.0 110.486 175.015 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 8.5 t -74.48 136.52 42.25 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-O 121.368 0.604 . . . . 0.0 110.904 -178.669 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 84' ' ' ARG . . . . . 0.573 ' HA ' ' CG1' ' A' ' 121' ' ' ILE . 12.1 ptm180 -61.36 -17.28 53.2 Favored 'General case' 0 C--N 1.326 -0.448 0 N-CA-C 113.734 1.013 . . . . 0.0 113.734 -178.187 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 85' ' ' ARG . . . . . 0.476 ' HD2' ' N ' ' A' ' 85' ' ' ARG . 6.7 mpt_? -73.92 -32.3 63.48 Favored 'General case' 0 C--N 1.321 -0.643 0 CA-C-O 121.203 0.525 . . . . 0.0 109.716 -176.396 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 32.7 mt-10 -63.28 -21.71 66.42 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 115.175 -0.921 . . . . 0.0 111.044 -179.102 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 87' ' ' PHE . . . . . . . . . . . . . 52.5 m-85 -96.83 -20.48 18.15 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 115.831 -0.622 . . . . 0.0 110.916 -178.308 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 88' ' ' MET . . . . . . . . . . . . . 55.7 ttm -60.91 -27.14 67.97 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 115.682 -0.69 . . . . 0.0 111.544 -175.915 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 60.8 m-20 -53.33 -34.57 58.01 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 116.426 -0.352 . . . . 0.0 111.538 177.022 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -109.79 16.58 21.95 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-O 121.014 0.435 . . . . 0.0 110.495 179.315 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 93.95 155.26 31.65 Favored Glycine 0 N--CA 1.448 -0.549 0 C-N-CA 121.088 -0.577 . . . . 0.0 111.734 -177.212 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 11.6 tt0 -64.73 127.86 92.97 Favored Pre-proline 0 N--CA 1.431 -1.402 0 CA-C-O 121.0 0.428 . . . . 0.0 109.945 -179.799 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 93' ' ' PRO . . . . . 0.53 ' CB ' HD13 ' A' ' 113' ' ' ILE . 31.8 Cg_endo -65.5 165.65 22.08 Favored 'Trans proline' 0 C--O 1.233 0.271 0 C-N-CA 123.398 2.732 . . . . 0.0 113.923 -176.196 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 94' ' ' GLU . . . . . 0.464 ' O ' ' HB ' ' A' ' 113' ' ' ILE . 14.2 mt-10 -114.22 154.53 27.74 Favored 'General case' 0 C--N 1.333 -0.145 0 CA-C-N 115.651 -0.704 . . . . 0.0 110.69 -177.385 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 95' ' ' ILE . . . . . 0.577 ' CG1' HG12 ' A' ' 116' ' ' ILE . 20.2 mt -82.27 129.66 37.1 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.386 0 CA-C-O 121.047 0.451 . . . . 0.0 111.576 -178.168 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 71.76 27.09 71.46 Favored Glycine 0 N--CA 1.45 -0.406 0 CA-C-N 115.49 -0.777 . . . . 0.0 113.208 179.076 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -109.52 129.02 55.59 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-O 120.634 0.254 . . . . 0.0 110.691 177.062 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 98' ' ' ILE . . . . . 0.697 ' HA ' ' HA ' ' A' ' 112' ' ' VAL . 4.1 mt -89.01 133.07 32.18 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.561 0 N-CA-C 108.68 -0.859 . . . . 0.0 108.68 177.02 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 99' ' ' MET . . . . . . . . . . . . . 10.3 mtm -136.64 157.59 46.42 Favored 'General case' 0 N--CA 1.444 -0.764 0 N-CA-C 106.648 -1.612 . . . . 0.0 106.648 177.194 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 100' ' ' LEU . . . . . 0.465 HD12 ' HG2' ' A' ' 108' ' ' GLU . 1.3 mm? -71.56 103.36 2.97 Favored 'General case' 0 C--N 1.313 -1.01 0 CA-C-O 122.438 1.113 . . . . 0.0 110.772 174.457 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 101' ' ' PHE . . . . . . . . . . . . . 2.7 m-85 -90.19 170.1 10.58 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-N 113.215 -1.811 . . . . 0.0 112.455 -174.144 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 1.6 m -126.37 140.52 52.44 Favored 'General case' 0 C--N 1.317 -0.829 0 CA-C-N 114.234 -1.348 . . . . 0.0 109.781 178.432 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 103' ' ' ALA . . . . . 0.417 ' HB2' ' HG3' ' A' ' 109' ' ' MET . . . -96.23 163.91 12.89 Favored 'General case' 0 C--N 1.321 -0.657 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.491 -179.598 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 104' ' ' MET . . . . . 0.431 ' SD ' ' HZ ' ' A' ' 82' ' ' PHE . 4.3 mpp? -66.73 -19.57 65.78 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 115.813 -0.63 . . . . 0.0 110.969 -179.272 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 6.2 p-10 -93.94 16.26 14.81 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.926 0.393 . . . . 0.0 111.458 -179.25 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 85.23 -11.15 61.45 Favored Glycine 0 N--CA 1.451 -0.364 0 C-N-CA 121.148 -0.548 . . . . 0.0 113.254 174.484 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 68.2 m -78.36 149.42 33.4 Favored 'General case' 0 C--N 1.316 -0.87 0 CA-C-O 121.18 0.514 . . . . 0.0 110.974 -179.652 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 108' ' ' GLU . . . . . 0.465 ' HG2' HD12 ' A' ' 100' ' ' LEU . 40.1 tt0 -91.21 146.57 23.72 Favored 'General case' 0 C--N 1.312 -1.043 0 CA-C-N 115.519 -0.764 . . . . 0.0 108.979 175.929 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 109' ' ' MET . . . . . 0.417 ' HG3' ' HB2' ' A' ' 103' ' ' ALA . 88.9 mmm -138.41 151.17 68.74 Favored Pre-proline 0 C--O 1.231 0.12 0 N-CA-C 106.016 -1.846 . . . . 0.0 106.016 -164.073 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 4.9 Cg_endo -81.63 113.24 2.53 Favored 'Trans proline' 0 N--CA 1.446 -1.285 0 CA-C-N 121.428 1.546 . . . . 0.0 109.671 162.962 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 111' ' ' GLY . . . . . 0.444 ' HA2' ' O ' ' A' ' 124' ' ' ASP . . . -121.39 126.21 6.45 Favored Glycine 0 N--CA 1.436 -1.354 0 C-N-CA 120.251 -0.975 . . . . 0.0 112.299 179.2 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 112' ' ' VAL . . . . . 0.697 ' HA ' ' HA ' ' A' ' 98' ' ' ILE . 0.2 OUTLIER -105.1 140.18 23.88 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.142 0 N-CA-C 108.587 -0.894 . . . . 0.0 108.587 174.023 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 113' ' ' ILE . . . . . 0.53 HD13 ' CB ' ' A' ' 93' ' ' PRO . 10.3 mt -89.2 108.61 19.3 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.374 0 N-CA-C 107.826 -1.175 . . . . 0.0 107.826 -174.194 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 114' ' ' ARG . . . . . 0.465 ' O ' HG23 ' A' ' 95' ' ' ILE . 10.9 tpp180 -64.88 -47.53 77.53 Favored 'General case' 0 C--N 1.317 -0.839 0 CA-C-N 115.284 -0.871 . . . . 0.0 111.513 -171.179 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 115' ' ' GLU . . . . . 0.474 ' H ' ' HB ' ' A' ' 122' ' ' THR . 8.6 tt0 -161.63 162.48 30.01 Favored 'General case' 0 C--N 1.317 -0.833 0 N-CA-C 109.445 -0.576 . . . . 0.0 109.445 -175.28 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 116' ' ' ILE . . . . . 0.577 HG12 ' CG1' ' A' ' 95' ' ' ILE . 28.7 mm -111.82 112.53 40.93 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.427 0 CA-C-O 121.174 0.511 . . . . 0.0 110.129 177.356 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 117' ' ' ASN . . . . . 0.466 HD22 ' N ' ' A' ' 117' ' ' ASN . 0.9 OUTLIER -96.31 158.93 15.21 Favored 'General case' 0 C--N 1.315 -0.896 0 CA-C-N 115.557 -0.747 . . . . 0.0 110.056 179.06 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . -57.18 -45.75 92.29 Favored Glycine 0 N--CA 1.452 -0.294 0 C-N-CA 120.612 -0.804 . . . . 0.0 113.304 -172.476 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 119' ' ' ASP . . . . . 0.424 ' O ' ' HG2' ' A' ' 84' ' ' ARG . 10.3 m-20 -113.39 -15.8 12.57 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-O 120.784 0.326 . . . . 0.0 111.53 178.397 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 120' ' ' SER . . . . . 0.465 ' O ' ' HB2' ' A' ' 117' ' ' ASN . 16.0 t -116.86 157.74 25.13 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-O 120.814 0.34 . . . . 0.0 111.09 -172.312 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 121' ' ' ILE . . . . . 0.573 ' CG1' ' HA ' ' A' ' 84' ' ' ARG . 38.8 mm -112.21 128.18 68.98 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.576 0 CA-C-O 121.746 0.784 . . . . 0.0 110.837 174.491 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 122' ' ' THR . . . . . 0.474 ' HB ' ' H ' ' A' ' 115' ' ' GLU . 0.6 OUTLIER -90.88 141.11 29.17 Favored 'General case' 0 C--N 1.307 -1.278 0 CA-C-N 114.338 -1.301 . . . . 0.0 109.382 178.236 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 123' ' ' VAL . . . . . 0.471 ' O ' HG23 ' A' ' 79' ' ' ILE . 43.8 t -138.39 158.93 31.91 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.41 0 N-CA-C 109.055 -0.72 . . . . 0.0 109.055 -156.522 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 124' ' ' ASP . . . . . 0.572 ' HB3' HG13 ' A' ' 112' ' ' VAL . 46.1 t0 -148.83 148.74 30.26 Favored 'General case' 0 C--N 1.305 -1.357 0 CA-C-N 116.058 -0.519 . . . . 0.0 110.256 174.781 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 125' ' ' PHE . . . . . 0.537 ' HB2' ' HG ' ' A' ' 78' ' ' LEU . 84.4 m-85 -135.97 3.71 2.95 Favored 'General case' 0 C--N 1.318 -0.804 0 CA-C-N 115.246 -0.888 . . . . 0.0 109.707 176.041 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 29.4 m-80 -58.39 134.66 56.81 Favored 'General case' 0 N--CA 1.449 -0.495 0 CA-C-N 114.685 -1.143 . . . . 0.0 110.571 176.103 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 127' ' ' HIS . . . . . 0.628 ' HB3' ' HD2' ' A' ' 128' ' ' PRO . 41.6 m80 -80.81 -173.32 0.41 Allowed Pre-proline 0 C--N 1.318 -0.79 0 CA-C-N 113.89 -1.504 . . . . 0.0 111.822 -168.203 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 128' ' ' PRO . . . . . 0.628 ' HD2' ' HB3' ' A' ' 127' ' ' HIS . 5.8 Cg_exo -41.51 174.77 0.0 OUTLIER 'Trans proline' 0 C--N 1.357 0.99 0 C-N-CA 124.843 3.696 . . . . 0.0 114.287 166.519 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 129' ' ' LEU . . . . . . . . . . . . . 5.5 tp -48.85 41.43 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.528 0 C-N-CA 127.895 2.478 . . . . 0.0 115.848 -171.695 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 130' ' ' ALA . . . . . 0.569 ' HB1' ' O ' ' A' ' 72' ' ' GLY . . . -85.99 173.56 9.83 Favored 'General case' 0 C--N 1.306 -1.286 0 C-N-CA 123.057 0.543 . . . . 0.0 110.065 -174.873 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 131' ' ' GLY . . . . . 0.427 ' HA2' ' HB3' ' A' ' 67' ' ' PRO . . . 74.79 34.23 53.72 Favored Glycine 0 N--CA 1.45 -0.403 0 C-N-CA 120.765 -0.731 . . . . 0.0 112.679 177.948 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 132' ' ' GLN . . . . . . . . . . . . . 5.7 pt20 -148.76 157.61 43.57 Favored 'General case' 0 C--N 1.326 -0.427 0 N-CA-C 109.488 -0.56 . . . . 0.0 109.488 172.793 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 133' ' ' THR . . . . . . . . . . . . . 14.5 m -71.06 112.36 7.15 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-O 120.904 0.383 . . . . 0.0 110.552 -175.696 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 134' ' ' VAL . . . . . 0.89 ' HB ' HD21 ' A' ' 17' ' ' LEU . 4.6 m -101.98 142.81 15.72 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.599 0 CA-C-O 121.236 0.541 . . . . 0.0 111.576 -176.483 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 135' ' ' HIS . . . . . . . . . . . . . 69.5 m-70 -124.87 113.24 17.61 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 115.328 -0.851 . . . . 0.0 109.076 -178.794 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 136' ' ' PHE . . . . . 0.529 ' HE1' ' CE2' ' A' ' 63' ' ' PHE . 0.1 OUTLIER -117.96 132.2 56.42 Favored 'General case' 0 C--N 1.316 -0.862 0 CA-C-O 121.103 0.478 . . . . 0.0 111.295 -175.787 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 137' ' ' ASP . . . . . . . . . . . . . 14.4 t70 -99.23 102.61 14.31 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-N 115.18 -0.918 . . . . 0.0 108.56 177.427 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 138' ' ' ILE . . . . . 0.694 HG23 HG21 ' A' ' 13' ' ' VAL . 40.6 mt -103.27 132.78 48.81 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.644 0 N-CA-C 112.716 0.635 . . . . 0.0 112.716 -166.912 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 24.0 mt-10 -125.7 114.46 18.68 Favored 'General case' 0 N--CA 1.45 -0.439 0 CA-C-N 115.24 -0.891 . . . . 0.0 109.131 178.781 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 140' ' ' VAL . . . . . 0.44 ' CG1' ' HA ' ' A' ' 57' ' ' VAL . 65.2 t -70.55 122.16 21.8 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.417 0 CA-C-N 117.824 0.284 . . . . 0.0 110.86 -179.498 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 141' ' ' LEU . . . . . 0.555 HD11 ' HB2' ' A' ' 14' ' ' HIS . 13.8 mt -100.76 -33.12 10.38 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-O 121.672 0.748 . . . . 0.0 110.426 178.739 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 142' ' ' GLU . . . . . 0.451 ' HB3' ' HB2' ' A' ' 12' ' ' LEU . 32.8 tt0 -163.88 151.59 12.64 Favored 'General case' 0 C--N 1.314 -0.971 0 CA-C-N 114.405 -1.27 . . . . 0.0 109.858 -178.334 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 143' ' ' ILE . . . . . . . . . . . . . 85.3 mt -122.1 113.82 40.28 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.397 0 CA-C-O 120.961 0.41 . . . . 0.0 110.932 -178.473 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 144' ' ' ASP . . . . . . . . . . . . . 37.4 t70 -79.15 126.17 82.19 Favored Pre-proline 0 C--N 1.323 -0.55 0 CA-C-N 115.807 -0.633 . . . . 0.0 110.291 177.998 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 145' ' ' PRO . . . . . . . . . . . . . 41.5 Cg_endo -66.2 169.9 12.9 Favored 'Trans proline' 0 C--O 1.234 0.311 0 C-N-CA 123.016 2.477 . . . . 0.0 113.294 -175.864 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 146' ' ' ALA . . . . . . . . . . . . . . . -82.21 102.04 10.86 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-O 121.444 0.64 . . . . 0.0 109.551 177.814 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -149.3 68.0 1.03 Allowed 'General case' 0 C--N 1.317 -0.836 0 N-CA-C 106.932 -1.507 . . . . 0.0 106.932 -175.324 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 39.2 mm-40 . . . . . 0 C--N 1.314 -0.937 0 CA-C-N 114.402 -1.272 . . . . 0.0 111.738 -172.246 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 27.1 ttt . . . . . 0 N--CA 1.481 1.078 0 CA-C-O 120.245 0.069 . . . . 0.0 110.903 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 18.9 p 49.59 70.01 0.53 Allowed 'General case' 0 N--CA 1.469 0.51 0 C-N-CA 123.284 0.633 . . . . 0.0 112.464 177.014 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 47.7 mt-10 -75.79 -33.24 60.13 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-O 121.215 0.531 . . . . 0.0 110.734 176.311 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 12.6 p -114.37 149.12 36.61 Favored 'General case' 0 C--N 1.319 -0.749 0 CA-C-N 115.558 -0.746 . . . . 0.0 110.647 -177.894 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . 0.525 HG13 ' HA ' ' A' ' 53' ' ' LEU . 7.4 p -73.68 144.83 12.2 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.395 0 CA-C-N 115.61 -0.723 . . . . 0.0 110.598 -178.281 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 6' ' ' GLN . . . . . . . . . . . . . 3.4 pt20 -136.99 166.31 23.96 Favored 'General case' 0 N--CA 1.444 -0.727 0 N-CA-C 108.488 -0.93 . . . . 0.0 108.488 -179.592 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 34.2 p -63.93 138.68 58.58 Favored 'General case' 0 C--N 1.317 -0.812 0 CA-C-O 120.735 0.303 . . . . 0.0 110.94 -176.531 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 15.5 t30 70.92 15.59 6.72 Favored 'General case' 0 CA--C 1.542 0.641 0 CA-C-N 115.491 -0.777 . . . . 0.0 111.643 177.928 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 9' ' ' SER . . . . . 0.631 ' O ' HD23 ' A' ' 39' ' ' LEU . 8.8 t -108.15 134.36 51.11 Favored 'General case' 0 N--CA 1.451 -0.411 0 N-CA-C 108.079 -1.082 . . . . 0.0 108.079 177.276 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -82.19 149.07 28.11 Favored 'General case' 0 C--N 1.322 -0.599 0 N-CA-C 109.69 -0.485 . . . . 0.0 109.69 -174.02 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 6.3 m -134.33 145.05 33.51 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.755 0 C-N-CA 120.281 -0.568 . . . . 0.0 111.35 -175.869 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 12' ' ' LEU . . . . . 0.449 HD22 ' HB2' ' A' ' 142' ' ' GLU . 6.6 mp -91.74 119.36 31.51 Favored 'General case' 0 C--N 1.326 -0.456 0 N-CA-C 108.809 -0.811 . . . . 0.0 108.809 177.909 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 13' ' ' VAL . . . . . 0.547 HG21 HG23 ' A' ' 138' ' ' ILE . 2.4 p -132.37 154.48 40.07 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.68 0 CA-C-O 122.146 0.974 . . . . 0.0 113.219 -172.12 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 14' ' ' HIS . . . . . 0.429 ' CD2' HD11 ' A' ' 141' ' ' LEU . 0.2 OUTLIER -117.2 117.7 30.28 Favored 'General case' 0 C--N 1.32 -0.704 0 N-CA-C 106.225 -1.769 . . . . 0.0 106.225 170.936 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 15' ' ' PHE . . . . . 0.42 ' HB2' ' O ' ' A' ' 137' ' ' ASP . 32.1 p90 -148.27 157.35 43.44 Favored 'General case' 0 C--N 1.327 -0.396 0 C-N-CA 118.671 -1.212 . . . . 0.0 113.785 -167.523 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 16' ' ' THR . . . . . 0.447 HG22 ' HD3' ' A' ' 18' ' ' LYS . 85.9 m -128.88 118.77 23.25 Favored 'General case' 0 C--N 1.321 -0.653 0 CA-C-N 115.006 -0.997 . . . . 0.0 109.813 174.617 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 17' ' ' LEU . . . . . 0.509 HD21 ' CE2' ' A' ' 136' ' ' PHE . 1.4 mt -95.17 112.91 24.56 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-O 121.034 0.445 . . . . 0.0 111.163 179.045 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 18' ' ' LYS . . . . . 0.447 ' HD3' HG22 ' A' ' 16' ' ' THR . 10.2 mptt -109.05 128.01 54.61 Favored 'General case' 0 C--N 1.314 -0.945 0 CA-C-N 115.735 -0.666 . . . . 0.0 110.826 -179.251 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 19.8 tp -85.42 161.53 19.39 Favored 'General case' 0 N--CA 1.438 -1.069 0 CA-C-N 115.677 -0.692 . . . . 0.0 109.199 175.775 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 29.2 t70 -62.77 -24.69 67.85 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 121.431 0.634 . . . . 0.0 110.25 178.603 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 27.1 t70 -70.25 -3.66 18.12 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 115.162 -0.927 . . . . 0.0 111.385 177.646 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 74.81 9.08 82.99 Favored Glycine 0 C--N 1.332 0.333 0 C-N-CA 121.508 -0.377 . . . . 0.0 112.425 -175.593 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 52.7 m -91.45 140.28 29.9 Favored 'General case' 0 C--N 1.319 -0.745 0 CA-C-N 115.309 -0.446 . . . . 0.0 110.06 175.779 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 41.7 m -79.68 108.24 13.08 Favored 'General case' 0 C--N 1.318 -0.784 0 N-CA-C 110.05 -0.352 . . . . 0.0 110.05 177.197 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -69.86 -34.77 74.05 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.88 -0.6 . . . . 0.0 110.527 -177.969 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 44.2 tt0 -159.83 128.35 4.96 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 115.857 -0.611 . . . . 0.0 109.697 177.356 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 18.4 p -109.58 130.48 55.51 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-N 116.534 -0.303 . . . . 0.0 110.835 -178.289 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 28' ' ' THR . . . . . 0.611 ' O ' HG22 ' A' ' 28' ' ' THR . 62.2 m -148.59 14.48 0.96 Allowed 'General case' 0 CA--C 1.546 0.798 0 CA-C-O 122.831 1.301 . . . . 0.0 110.854 174.75 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 16.0 tpt180 -92.94 -68.99 0.77 Allowed 'General case' 0 C--N 1.307 -1.257 0 O-C-N 121.19 -0.944 . . . . 0.0 111.018 168.523 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 7.8 p30 -69.47 -10.61 58.77 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.407 -0.36 . . . . 0.0 111.452 -172.754 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 2.2 m-20 -58.37 -31.08 67.3 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.981 177.631 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 91.09 -13.39 66.37 Favored Glycine 0 N--CA 1.447 -0.593 0 C-N-CA 120.621 -0.8 . . . . 0.0 111.404 -175.813 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 75.4 mmtt -120.23 124.47 27.74 Favored Pre-proline 0 C--N 1.324 -0.533 0 N-CA-C 109.587 -0.524 . . . . 0.0 109.587 179.871 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 71.6 Cg_endo -76.53 168.85 22.98 Favored 'Trans proline' 0 N--CA 1.457 -0.659 0 C-N-CA 122.38 2.053 . . . . 0.0 111.889 176.438 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -131.75 149.86 52.34 Favored 'General case' 0 C--N 1.319 -0.719 0 CA-C-N 116.391 -0.368 . . . . 0.0 110.43 -177.234 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 4.9 tp -88.71 137.32 32.42 Favored 'General case' 0 C--N 1.318 -0.801 0 N-CA-C 109.769 -0.456 . . . . 0.0 109.769 174.711 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 37' ' ' PHE . . . . . . . . . . . . . 6.4 m-30 -98.37 119.89 37.84 Favored 'General case' 0 C--N 1.316 -0.862 0 N-CA-C 108.548 -0.908 . . . . 0.0 108.548 172.5 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 38' ' ' ARG . . . . . 0.437 ' HG3' ' HB3' ' A' ' 42' ' ' ALA . 24.6 tpt180 -90.33 104.88 17.41 Favored 'General case' 0 N--CA 1.442 -0.832 0 N-CA-C 108.955 -0.757 . . . . 0.0 108.955 177.92 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 39' ' ' LEU . . . . . 0.631 HD23 ' O ' ' A' ' 9' ' ' SER . 2.2 mm? -89.97 156.26 18.54 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-N 115.455 -0.793 . . . . 0.0 111.137 -178.767 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 101.09 29.48 6.4 Favored Glycine 0 N--CA 1.445 -0.713 0 C-N-CA 120.723 -0.751 . . . . 0.0 112.103 -175.19 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 38.8 t70 68.87 3.42 3.97 Favored 'General case' 0 N--CA 1.472 0.627 0 CA-C-O 121.34 0.59 . . . . 0.0 111.823 175.357 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 42' ' ' ALA . . . . . 0.437 ' HB3' ' HG3' ' A' ' 38' ' ' ARG . . . -74.53 -7.52 53.35 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-N 116.055 -0.52 . . . . 0.0 112.113 -179.305 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 32.7 t -163.68 -60.64 0.04 OUTLIER 'General case' 0 C--N 1.323 -0.556 0 N-CA-C 109.476 -0.564 . . . . 0.0 109.476 176.056 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 7.8 mp -90.01 161.46 15.85 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-N 115.87 -0.604 . . . . 0.0 110.502 178.096 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 46.9 t -77.99 145.87 35.75 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-N 115.438 -0.801 . . . . 0.0 109.752 178.273 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 46' ' ' GLU . . . . . 0.62 ' O ' ' HG2' ' A' ' 50' ' ' GLN . 12.1 tt0 -58.68 -16.69 17.44 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 115.078 -0.964 . . . . 0.0 112.004 -176.987 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -69.29 -32.06 71.99 Favored Glycine 0 N--CA 1.446 -0.634 0 C-N-CA 120.69 -0.766 . . . . 0.0 111.942 -177.812 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 1.6 tt -69.07 -53.0 22.64 Favored 'General case' 0 N--CA 1.45 -0.445 0 CA-C-O 120.672 0.272 . . . . 0.0 110.834 -178.298 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 49' ' ' GLU . . . . . 0.58 ' O ' HD22 ' A' ' 53' ' ' LEU . 14.2 pt-20 -58.04 -32.32 67.87 Favored 'General case' 0 N--CA 1.453 -0.305 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.61 179.497 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 50' ' ' GLN . . . . . 0.62 ' HG2' ' O ' ' A' ' 46' ' ' GLU . 69.9 mm-40 -57.32 -26.75 61.42 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 120.775 0.321 . . . . 0.0 110.904 -177.841 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 51' ' ' HIS . . . . . . . . . . . . . 12.1 m-70 -99.76 -14.02 19.03 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 116.397 -0.365 . . . . 0.0 111.03 -179.222 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 25.6 mt -95.76 -30.76 13.54 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 116.406 -0.361 . . . . 0.0 111.914 -177.401 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 53' ' ' LEU . . . . . 0.58 HD22 ' O ' ' A' ' 49' ' ' GLU . 0.0 OUTLIER -57.59 143.59 40.56 Favored 'General case' 0 C--O 1.234 0.26 0 CA-C-O 120.874 0.369 . . . . 0.0 111.246 -176.862 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 93.56 -2.7 70.75 Favored Glycine 0 N--CA 1.443 -0.845 0 C-N-CA 120.879 -0.677 . . . . 0.0 113.452 177.972 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 55' ' ' LEU . . . . . 0.501 ' O ' HG12 ' A' ' 5' ' ' VAL . 24.8 tp -94.41 164.22 13.1 Favored 'General case' 0 N--CA 1.453 -0.311 0 CA-C-N 118.052 0.926 . . . . 0.0 109.159 178.549 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 56' ' ' LYS . . . . . 0.665 ' HD2' ' N ' ' A' ' 57' ' ' VAL . 0.9 OUTLIER -117.15 157.79 25.34 Favored 'General case' 0 C--N 1.32 -0.708 0 N-CA-C 109.89 -0.411 . . . . 0.0 109.89 -174.803 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 57' ' ' VAL . . . . . 0.665 ' N ' ' HD2' ' A' ' 56' ' ' LYS . 8.8 t -57.61 141.74 14.23 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.243 0 CA-C-O 121.078 0.465 . . . . 0.0 111.357 177.954 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 82.87 10.12 83.5 Favored Glycine 0 N--CA 1.447 -0.576 0 CA-C-N 115.734 -0.666 . . . . 0.0 112.338 -178.859 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 8.5 m-20 -116.41 152.76 33.33 Favored 'General case' 0 C--N 1.324 -0.53 0 N-CA-C 109.543 -0.54 . . . . 0.0 109.543 174.291 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 60' ' ' LYS . . . . . 0.525 ' HE3' ' HG2' ' A' ' 139' ' ' GLU . 0.6 OUTLIER -131.73 149.38 52.5 Favored 'General case' 0 C--N 1.316 -0.877 0 CA-C-O 121.519 0.676 . . . . 0.0 111.76 -175.364 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 9.3 t -143.53 130.86 20.91 Favored 'General case' 0 C--N 1.314 -0.961 0 CA-C-N 114.714 -1.13 . . . . 0.0 110.884 -178.36 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 4.1 m -107.1 131.53 54.01 Favored 'General case' 0 N--CA 1.44 -0.944 0 N-CA-C 107.866 -1.161 . . . . 0.0 107.866 171.134 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 63' ' ' PHE . . . . . 0.43 ' HE1' ' CG1' ' A' ' 138' ' ' ILE . 1.5 p90 -158.24 153.46 25.65 Favored 'General case' 0 C--N 1.321 -0.631 0 CA-C-O 121.021 0.439 . . . . 0.0 110.937 -171.195 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 16.4 m -104.85 148.96 26.09 Favored 'General case' 0 C--N 1.319 -0.748 0 CA-C-N 115.727 -0.669 . . . . 0.0 110.644 -179.713 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 65' ' ' LEU . . . . . 0.451 ' O ' HG23 ' A' ' 133' ' ' THR . 82.8 mt -138.82 142.39 38.68 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.557 -0.292 . . . . 0.0 110.722 -176.039 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 66' ' ' GLU . . . . . 0.49 ' H ' ' CD ' ' A' ' 66' ' ' GLU . 1.6 mp0 -64.76 154.11 86.23 Favored Pre-proline 0 C--N 1.329 -0.311 0 CA-C-N 115.921 -0.581 . . . . 0.0 109.741 174.299 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 67' ' ' PRO . . . . . 0.538 ' HB3' ' N ' ' A' ' 132' ' ' GLN . 10.8 Cg_endo -56.65 -48.55 18.26 Favored 'Trans proline' 0 C--O 1.219 -0.431 0 C-N-CA 121.869 1.712 . . . . 0.0 113.563 -176.355 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 23.5 t70 -64.01 -21.99 66.74 Favored 'General case' 0 C--N 1.324 -0.511 0 O-C-N 121.515 -0.741 . . . . 0.0 110.072 178.534 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -86.35 -28.76 23.46 Favored 'General case' 0 N--CA 1.451 -0.406 0 CA-C-N 115.982 -0.554 . . . . 0.0 111.216 179.09 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 70' ' ' ALA . . . . . 0.509 ' O ' ' HB2' ' A' ' 71' ' ' PHE . . . -136.85 127.56 27.16 Favored 'General case' 0 N--CA 1.454 -0.262 0 N-CA-C 109.776 -0.453 . . . . 0.0 109.776 176.578 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 71' ' ' PHE . . . . . 0.509 ' HB2' ' O ' ' A' ' 70' ' ' ALA . 2.2 m-30 84.11 -44.29 0.09 Allowed 'General case' 0 N--CA 1.473 0.677 0 O-C-N 124.016 0.822 . . . . 0.0 109.102 -172.755 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 102.54 -114.23 4.84 Favored Glycine 0 N--CA 1.443 -0.863 0 CA-C-O 121.998 0.777 . . . . 0.0 114.792 166.427 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -150.92 163.96 21.94 Favored Pre-proline 0 C--N 1.31 -1.113 0 CA-C-N 113.772 -1.214 . . . . 0.0 110.562 -165.489 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 74' ' ' PRO . . . . . 0.521 ' HA ' ' HB3' ' A' ' 126' ' ' ASN . 60.7 Cg_exo -43.49 132.97 7.19 Favored 'Trans proline' 0 C--N 1.347 0.462 0 C-N-CA 123.659 2.906 . . . . 0.0 114.3 -178.749 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 75' ' ' SER . . . . . 0.578 ' HB3' ' OD1' ' A' ' 77' ' ' ASP . 30.8 m -137.06 123.42 13.5 Favored Pre-proline 0 C--N 1.329 -0.312 0 CA-C-N 115.325 -0.852 . . . . 0.0 110.993 179.892 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 76' ' ' PRO . . . . . 0.473 ' HA ' HG13 ' A' ' 79' ' ' ILE . 53.1 Cg_endo -70.16 -17.28 35.87 Favored 'Trans proline' 0 CA--C 1.529 0.274 0 C-N-CA 123.199 2.599 . . . . 0.0 113.571 -178.118 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 77' ' ' ASP . . . . . 0.578 ' OD1' ' HB3' ' A' ' 75' ' ' SER . 5.2 p-10 -69.27 -4.75 19.2 Favored 'General case' 0 C--N 1.329 -0.325 0 N-CA-C 112.829 0.678 . . . . 0.0 112.829 -173.331 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 78' ' ' LEU . . . . . 0.635 ' HB2' ' O ' ' A' ' 125' ' ' PHE . 83.1 mt -112.57 -5.1 14.03 Favored 'General case' 0 C--N 1.324 -0.523 0 C-N-CA 120.742 -0.383 . . . . 0.0 110.963 176.399 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 79' ' ' ILE . . . . . 0.473 HG13 ' HA ' ' A' ' 76' ' ' PRO . 15.2 mt -77.39 104.81 5.64 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.736 0 C-N-CA 120.345 -0.542 . . . . 0.0 109.705 -173.695 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 73.0 mt-30 -108.95 164.06 12.75 Favored 'General case' 0 C--N 1.314 -0.937 0 CA-C-N 115.671 -0.695 . . . . 0.0 111.824 -172.806 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 81' ' ' TYR . . . . . . . . . . . . . 11.3 m-85 -129.48 115.67 17.82 Favored 'General case' 0 N--CA 1.444 -0.766 0 N-CA-C 107.514 -1.291 . . . . 0.0 107.514 -172.78 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 73.4 m-85 -111.24 168.29 9.63 Favored 'General case' 0 C--N 1.317 -0.844 0 CA-C-O 120.763 0.316 . . . . 0.0 110.863 -174.661 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 12.2 t -73.86 145.24 45.02 Favored 'General case' 0 C--N 1.323 -0.577 0 N-CA-C 108.849 -0.797 . . . . 0.0 108.849 176.692 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 84' ' ' ARG . . . . . 0.649 ' HD3' ' HA ' ' A' ' 119' ' ' ASP . 28.9 ptt180 -73.64 -29.72 62.51 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-O 121.576 0.703 . . . . 0.0 109.609 -173.895 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 85' ' ' ARG . . . . . 0.446 ' HD2' ' H ' ' A' ' 85' ' ' ARG . 0.8 OUTLIER -64.7 -38.94 92.7 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 114.597 -1.183 . . . . 0.0 113.391 -171.015 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 86' ' ' GLU . . . . . 0.461 ' O ' ' HB3' ' A' ' 89' ' ' ASP . 44.1 mm-40 -60.65 -48.88 79.82 Favored 'General case' 0 C--N 1.317 -0.836 0 CA-C-O 122.269 1.033 . . . . 0.0 108.687 174.259 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 87' ' ' PHE . . . . . . . . . . . . . 55.6 m-85 -59.0 -31.85 69.18 Favored 'General case' 0 C--N 1.318 -0.783 0 CA-C-N 113.701 -1.591 . . . . 0.0 112.91 175.264 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 88' ' ' MET . . . . . . . . . . . . . 60.3 ttp -68.18 -41.45 81.43 Favored 'General case' 0 C--N 1.315 -0.898 0 CA-C-O 122.13 0.967 . . . . 0.0 109.521 174.025 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 89' ' ' ASP . . . . . 0.461 ' HB3' ' O ' ' A' ' 86' ' ' GLU . 19.3 t70 -55.17 -23.07 19.82 Favored 'General case' 0 C--N 1.321 -0.673 0 CA-C-N 113.387 -1.733 . . . . 0.0 110.164 176.029 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -112.86 8.63 18.75 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 115.646 -0.706 . . . . 0.0 111.799 178.938 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 92.08 137.61 7.85 Favored Glycine 0 C--N 1.331 0.265 0 C-N-CA 120.482 -0.866 . . . . 0.0 111.989 -177.453 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 8.8 tt0 -61.91 122.07 69.47 Favored Pre-proline 0 N--CA 1.442 -0.848 0 CA-C-O 121.116 0.484 . . . . 0.0 111.306 -172.271 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 93' ' ' PRO . . . . . 0.482 ' HG2' HD12 ' A' ' 121' ' ' ILE . 38.1 Cg_endo -77.75 165.96 26.03 Favored 'Trans proline' 0 N--CA 1.46 -0.497 0 C-N-CA 122.935 2.423 . . . . 0.0 112.875 -177.525 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 94' ' ' GLU . . . . . 0.521 ' O ' HD12 ' A' ' 113' ' ' ILE . 27.0 mt-10 -115.94 154.13 30.35 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.018 -0.537 . . . . 0.0 111.131 -176.135 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 95' ' ' ILE . . . . . 0.543 HG12 HG12 ' A' ' 116' ' ' ILE . 32.6 mt -77.17 134.16 29.24 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.384 0 CA-C-N 116.446 -0.343 . . . . 0.0 110.099 179.168 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 72.26 19.47 78.7 Favored Glycine 0 N--CA 1.449 -0.481 0 C-N-CA 121.032 -0.604 . . . . 0.0 112.407 -176.997 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 97' ' ' ALA . . . . . 0.466 ' O ' HG13 ' A' ' 113' ' ' ILE . . . -99.71 166.86 10.91 Favored 'General case' 0 C--N 1.323 -0.562 0 N-CA-C 109.562 -0.533 . . . . 0.0 109.562 175.27 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 38.8 mt -125.79 126.11 69.49 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.727 0 CA-C-O 120.876 0.37 . . . . 0.0 110.533 -175.598 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 99' ' ' MET . . . . . 0.421 ' SD ' HD11 ' A' ' 113' ' ' ILE . 2.7 mtp -124.72 161.58 26.06 Favored 'General case' 0 C--N 1.324 -0.527 0 N-CA-C 107.898 -1.149 . . . . 0.0 107.898 -179.922 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 100' ' ' LEU . . . . . 0.423 HD13 ' HA ' ' A' ' 100' ' ' LEU . 3.9 mm? -77.24 153.62 33.82 Favored 'General case' 0 C--N 1.323 -0.587 0 CA-C-N 118.806 0.73 . . . . 0.0 111.078 167.635 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 101' ' ' PHE . . . . . 0.6 ' CE2' HG11 ' A' ' 123' ' ' VAL . 65.5 m-85 -149.42 155.52 40.57 Favored 'General case' 0 C--N 1.319 -0.761 0 CA-C-N 114.702 -1.136 . . . . 0.0 107.986 -170.334 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 3.1 m -121.11 111.44 17.45 Favored 'General case' 0 C--N 1.314 -0.958 0 C-N-CA 119.793 -0.763 . . . . 0.0 110.154 -178.348 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -77.78 166.25 23.18 Favored 'General case' 0 N--CA 1.448 -0.56 0 CA-C-N 115.4 -0.818 . . . . 0.0 110.868 -177.183 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 104' ' ' MET . . . . . . . . . . . . . 60.1 mtt -67.37 -14.32 62.81 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.128 -0.942 . . . . 0.0 111.901 -173.669 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 8.2 p-10 -96.51 11.38 35.27 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 116.551 -0.295 . . . . 0.0 111.383 -177.784 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 88.06 -11.33 67.52 Favored Glycine 0 N--CA 1.447 -0.602 0 C-N-CA 120.42 -0.895 . . . . 0.0 113.289 179.448 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 33.3 t -79.36 149.74 31.61 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-O 121.227 0.537 . . . . 0.0 110.692 -179.327 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 108' ' ' GLU . . . . . 0.448 ' HA ' ' O ' ' A' ' 101' ' ' PHE . 44.5 tt0 -120.51 104.11 9.71 Favored 'General case' 0 C--N 1.317 -0.845 0 CA-C-N 115.615 -0.72 . . . . 0.0 109.381 179.801 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 109' ' ' MET . . . . . 0.438 ' SD ' ' HD2' ' A' ' 125' ' ' PHE . 13.7 ptp -111.44 145.14 31.97 Favored Pre-proline 0 C--N 1.322 -0.614 0 CA-C-N 116.535 -0.302 . . . . 0.0 110.621 -175.579 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 110' ' ' PRO . . . . . 0.431 ' HD2' HD11 ' A' ' 129' ' ' LEU . 12.2 Cg_exo -70.1 120.6 7.31 Favored 'Trans proline' 0 N--CA 1.462 -0.368 0 C-N-CA 122.475 2.117 . . . . 0.0 110.663 171.5 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . -117.41 153.88 17.01 Favored Glycine 0 C--N 1.321 -0.29 0 C-N-CA 120.752 -0.737 . . . . 0.0 112.447 -176.562 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER -100.77 121.29 51.39 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.426 0 CA-C-O 121.064 0.459 . . . . 0.0 110.249 -176.392 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 113' ' ' ILE . . . . . 0.521 HD12 ' O ' ' A' ' 94' ' ' GLU . 1.0 OUTLIER -67.05 111.22 1.85 Allowed 'Isoleucine or valine' 0 C--N 1.316 -0.85 0 CA-C-N 115.762 -0.654 . . . . 0.0 109.386 176.709 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 114' ' ' ARG . . . . . . . . . . . . . 13.2 tpp180 -63.29 -52.36 62.31 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 115.349 -0.841 . . . . 0.0 110.744 -178.085 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 5.2 tt0 -159.48 148.45 18.03 Favored 'General case' 0 C--N 1.32 -0.699 0 N-CA-C 110.11 -0.33 . . . . 0.0 110.11 -177.79 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 116' ' ' ILE . . . . . 0.543 HG12 HG12 ' A' ' 95' ' ' ILE . 45.9 mm -96.12 111.2 25.88 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.533 0 N-CA-C 108.879 -0.786 . . . . 0.0 108.879 176.197 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 117' ' ' ASN . . . . . . . . . . . . . 37.6 m-80 -101.47 155.8 17.85 Favored 'General case' 0 C--N 1.313 -1.012 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.057 -179.111 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . -57.22 -38.84 88.48 Favored Glycine 0 N--CA 1.448 -0.52 0 C-N-CA 120.453 -0.88 . . . . 0.0 112.925 -170.842 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 119' ' ' ASP . . . . . 0.649 ' HA ' ' HD3' ' A' ' 84' ' ' ARG . 4.7 p-10 -109.75 -12.55 14.61 Favored 'General case' 0 C--N 1.324 -0.516 0 N-CA-C 111.977 0.362 . . . . 0.0 111.977 -174.66 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 20.3 t -146.12 155.99 43.13 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 121.065 0.459 . . . . 0.0 111.899 -168.603 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 121' ' ' ILE . . . . . 0.482 HD12 ' HG2' ' A' ' 93' ' ' PRO . 35.1 mm -119.43 120.25 63.04 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 115.896 -0.593 . . . . 0.0 110.178 178.705 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 89.8 m -106.14 119.48 39.34 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 116.568 -0.287 . . . . 0.0 111.052 -177.504 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 123' ' ' VAL . . . . . 0.6 HG11 ' CE2' ' A' ' 101' ' ' PHE . 38.8 t -117.69 118.26 57.8 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.316 0 CA-C-O 119.482 -0.295 . . . . 0.0 110.539 179.049 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 9.4 p-10 -95.32 96.34 9.08 Favored 'General case' 0 N--CA 1.452 -0.345 0 N-CA-C 114.131 1.159 . . . . 0.0 114.131 -179.906 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 125' ' ' PHE . . . . . 0.635 ' O ' ' HB2' ' A' ' 78' ' ' LEU . 12.0 m-85 -68.78 98.0 0.87 Allowed 'General case' 0 N--CA 1.447 -0.616 0 N-CA-C 109.303 -0.629 . . . . 0.0 109.303 165.912 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 126' ' ' ASN . . . . . 0.521 ' HB3' ' HA ' ' A' ' 74' ' ' PRO . 1.2 m-80 -79.3 88.2 4.96 Favored 'General case' 0 C--N 1.3 -1.585 0 CA-C-O 121.092 0.473 . . . . 0.0 110.934 177.237 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 127' ' ' HIS . . . . . 0.469 ' CD2' ' HD2' ' A' ' 128' ' ' PRO . 0.3 OUTLIER 60.76 -171.73 0.02 OUTLIER Pre-proline 0 C--O 1.236 0.386 0 CA-C-N 114.865 -1.061 . . . . 0.0 109.854 -173.077 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 128' ' ' PRO . . . . . 0.483 ' HB2' ' CD2' ' A' ' 71' ' ' PHE . 72.2 Cg_exo -46.5 177.72 0.01 OUTLIER 'Trans proline' 0 CA--C 1.533 0.454 0 C-N-CA 123.174 2.583 . . . . 0.0 110.816 156.048 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 129' ' ' LEU . . . . . 0.628 ' O ' ' HG2' ' A' ' 132' ' ' GLN . 3.9 mm? -51.42 37.23 0.0 OUTLIER 'General case' 0 N--CA 1.488 1.473 0 N-CA-C 114.998 1.481 . . . . 0.0 114.998 -178.794 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 130' ' ' ALA . . . . . 0.474 ' N ' ' O ' ' A' ' 128' ' ' PRO . . . -54.0 179.97 0.02 OUTLIER 'General case' 0 C--O 1.237 0.436 0 C-N-CA 124.254 1.022 . . . . 0.0 111.49 174.544 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . 67.19 3.52 24.58 Favored Glycine 0 CA--C 1.527 0.785 0 C-N-CA 120.494 -0.86 . . . . 0.0 114.035 -172.894 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 132' ' ' GLN . . . . . 0.628 ' HG2' ' O ' ' A' ' 129' ' ' LEU . 6.3 pt20 -149.18 153.42 37.64 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 117.687 0.744 . . . . 0.0 110.201 176.02 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 133' ' ' THR . . . . . 0.451 HG23 ' O ' ' A' ' 65' ' ' LEU . 59.6 m -72.51 136.38 45.88 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 116.001 -0.545 . . . . 0.0 111.13 -178.735 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 134' ' ' VAL . . . . . 0.425 HG11 ' CE2' ' A' ' 71' ' ' PHE . 20.3 m -120.73 151.34 23.62 Favored 'Isoleucine or valine' 0 C--O 1.233 0.22 0 CA-C-O 121.526 0.679 . . . . 0.0 111.697 177.957 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 135' ' ' HIS . . . . . 0.477 ' O ' HD23 ' A' ' 17' ' ' LEU . 86.2 m-70 -90.58 134.94 34.02 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-N 114.728 -1.124 . . . . 0.0 110.375 174.225 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 136' ' ' PHE . . . . . 0.509 ' CE2' HD21 ' A' ' 17' ' ' LEU . 2.5 m-85 -120.94 125.68 48.04 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 116.252 -0.431 . . . . 0.0 111.113 -177.385 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 137' ' ' ASP . . . . . 0.42 ' O ' ' HB2' ' A' ' 15' ' ' PHE . 36.0 t70 -113.11 109.52 18.93 Favored 'General case' 0 C--N 1.315 -0.911 0 N-CA-C 108.513 -0.921 . . . . 0.0 108.513 169.028 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 138' ' ' ILE . . . . . 0.547 HG23 HG21 ' A' ' 13' ' ' VAL . 43.1 mm -119.19 121.33 66.38 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.452 0 O-C-N 123.098 0.249 . . . . 0.0 111.262 -169.773 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 139' ' ' GLU . . . . . 0.525 ' HG2' ' HE3' ' A' ' 60' ' ' LYS . 33.3 mt-10 -107.73 115.55 30.35 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 120.59 0.233 . . . . 0.0 111.201 173.356 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 140' ' ' VAL . . . . . 0.412 ' CG1' ' HA ' ' A' ' 57' ' ' VAL . 38.8 t -71.12 107.47 2.31 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.568 0 CA-C-N 116.299 -0.409 . . . . 0.0 110.177 175.533 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 141' ' ' LEU . . . . . 0.429 HD11 ' CD2' ' A' ' 14' ' ' HIS . 40.1 mt -94.59 -49.64 5.55 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-O 120.885 0.374 . . . . 0.0 110.097 179.821 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 142' ' ' GLU . . . . . 0.449 ' HB2' HD22 ' A' ' 12' ' ' LEU . 37.1 mt-10 -143.7 163.15 34.11 Favored 'General case' 0 CA--C 1.513 -0.476 0 CA-C-N 115.847 -0.615 . . . . 0.0 109.88 172.38 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 143' ' ' ILE . . . . . 0.443 HD13 ' N ' ' A' ' 5' ' ' VAL . 94.8 mt -123.49 110.07 25.03 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.901 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.539 178.484 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 144' ' ' ASP . . . . . . . . . . . . . 27.1 t70 -78.57 111.89 22.58 Favored Pre-proline 0 C--N 1.325 -0.469 0 CA-C-N 115.487 -0.779 . . . . 0.0 110.058 178.408 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 145' ' ' PRO . . . . . . . . . . . . . 52.5 Cg_endo -67.86 145.52 68.8 Favored 'Trans proline' 0 N--CA 1.459 -0.514 0 C-N-CA 122.186 1.924 . . . . 0.0 111.831 -177.207 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 146' ' ' ALA . . . . . . . . . . . . . . . -83.39 102.86 12.32 Favored 'General case' 0 C--N 1.318 -0.781 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.139 178.299 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 147' ' ' LEU . . . . . 0.409 HD13 ' HA ' ' A' ' 147' ' ' LEU . 3.9 mm? -83.03 52.14 2.11 Favored 'General case' 0 C--N 1.319 -0.756 0 CA-C-O 121.42 0.628 . . . . 0.0 111.025 -178.085 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 71.6 mt-10 . . . . . 0 C--N 1.32 -0.713 0 CA-C-N 115.338 -0.847 . . . . 0.0 110.461 179.263 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 66.0 mtt . . . . . 0 N--CA 1.479 0.987 0 CA-C-O 120.551 0.215 . . . . 0.0 110.88 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . 0.407 ' OG ' ' HA ' ' A' ' 145' ' ' PRO . 35.5 m -113.83 108.2 16.76 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-O 121.216 0.532 . . . . 0.0 110.603 -179.897 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 3' ' ' GLU . . . . . 0.508 ' HG2' ' HE2' ' A' ' 56' ' ' LYS . 36.0 tt0 -99.54 -27.99 13.44 Favored 'General case' 0 C--N 1.319 -0.721 0 CA-C-N 115.533 -0.758 . . . . 0.0 110.525 -177.584 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 4' ' ' SER . . . . . 0.42 ' HA ' ' HA ' ' A' ' 56' ' ' LYS . 8.5 p -124.94 158.27 33.99 Favored 'General case' 0 C--N 1.318 -0.782 0 CA-C-N 115.415 -0.811 . . . . 0.0 109.998 178.489 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . 0.519 HG22 ' N ' ' A' ' 55' ' ' LEU . 3.7 m -83.22 151.89 3.95 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.41 0 CA-C-O 121.294 0.568 . . . . 0.0 111.032 -175.341 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 6' ' ' GLN . . . . . 0.625 ' HG2' ' OG ' ' A' ' 9' ' ' SER . 1.4 pt20 -141.88 168.42 19.81 Favored 'General case' 0 C--N 1.314 -0.948 0 CA-C-N 115.223 -0.899 . . . . 0.0 108.86 176.164 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 51.5 p -53.47 122.08 8.98 Favored 'General case' 0 C--N 1.318 -0.768 0 N-CA-C 109.928 -0.397 . . . . 0.0 109.928 176.073 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 8' ' ' ASN . . . . . 0.438 ' HA ' ' O ' ' A' ' 39' ' ' LEU . 3.6 t-20 80.53 41.43 0.06 Allowed 'General case' 0 N--CA 1.475 0.809 0 O-C-N 124.036 0.835 . . . . 0.0 111.507 178.332 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 9' ' ' SER . . . . . 0.625 ' OG ' ' HG2' ' A' ' 6' ' ' GLN . 47.8 m -103.86 160.77 14.51 Favored 'General case' 0 C--N 1.332 -0.16 0 O-C-N 121.994 -0.441 . . . . 0.0 111.039 174.17 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 10' ' ' ALA . . . . . 0.713 ' HB1' HD21 ' A' ' 36' ' ' LEU . . . -109.49 131.93 54.61 Favored 'General case' 0 C--N 1.322 -0.606 0 N-CA-C 108.779 -0.823 . . . . 0.0 108.779 171.964 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 11' ' ' VAL . . . . . 0.475 ' O ' ' HA ' ' A' ' 36' ' ' LEU . 6.4 m -138.8 136.88 43.15 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.435 0 C-N-CA 120.501 -0.48 . . . . 0.0 111.437 -174.305 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 89.3 mt -86.42 128.61 34.97 Favored 'General case' 0 C--N 1.324 -0.51 0 N-CA-C 108.251 -1.018 . . . . 0.0 108.251 173.238 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 13' ' ' VAL . . . . . 0.736 HG21 HG23 ' A' ' 138' ' ' ILE . 1.6 p -141.65 157.53 21.17 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.86 0 CA-C-O 121.117 0.485 . . . . 0.0 110.747 -173.196 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 14' ' ' HIS . . . . . 0.495 ' ND1' ' HA ' ' A' ' 29' ' ' ARG . 0.5 OUTLIER -124.98 116.42 22.13 Favored 'General case' 0 C--N 1.318 -0.802 0 N-CA-C 106.396 -1.705 . . . . 0.0 106.396 170.545 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 15' ' ' PHE . . . . . 0.461 ' CE1' ' HB ' ' A' ' 28' ' ' THR . 18.2 p90 -146.0 158.8 43.87 Favored 'General case' 0 C--N 1.316 -0.852 0 C-N-CA 120.427 -0.509 . . . . 0.0 110.77 -169.019 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 87.8 m -130.32 130.16 44.12 Favored 'General case' 0 C--N 1.318 -0.775 0 N-CA-C 109.859 -0.423 . . . . 0.0 109.859 174.434 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 17' ' ' LEU . . . . . 0.5 HD21 ' CE1' ' A' ' 136' ' ' PHE . 9.5 mt -95.77 138.8 32.91 Favored 'General case' 0 N--CA 1.445 -0.683 0 CA-C-O 121.714 0.769 . . . . 0.0 111.659 -179.008 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 4.3 mptp? -122.31 147.47 46.2 Favored 'General case' 0 C--N 1.314 -0.95 0 CA-C-N 114.314 -1.312 . . . . 0.0 110.031 -176.24 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 19' ' ' LEU . . . . . 0.404 HD13 ' HA ' ' A' ' 19' ' ' LEU . 4.1 mm? -83.43 169.13 15.88 Favored 'General case' 0 C--N 1.312 -1.041 0 N-CA-C 108.716 -0.846 . . . . 0.0 108.716 170.755 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 29.3 t70 -68.88 -25.42 64.61 Favored 'General case' 0 C--N 1.318 -0.804 0 CA-C-O 121.323 0.583 . . . . 0.0 109.607 177.717 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 15.4 t70 -80.07 0.95 29.77 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.339 -0.846 . . . . 0.0 110.426 176.001 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 76.22 25.38 66.32 Favored Glycine 0 N--CA 1.45 -0.402 0 CA-C-N 116.175 -0.466 . . . . 0.0 113.155 178.64 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 14.1 m -90.11 154.73 19.56 Favored 'General case' 0 C--N 1.322 -0.607 0 N-CA-C 109.307 -0.627 . . . . 0.0 109.307 171.954 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 59.7 m -90.43 118.26 29.77 Favored 'General case' 0 C--N 1.32 -0.679 0 O-C-N 121.749 -0.594 . . . . 0.0 110.538 177.33 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 25' ' ' ALA . . . . . 0.401 ' HB2' ' CD2' ' A' ' 19' ' ' LEU . . . -84.11 -48.85 9.43 Favored 'General case' 0 CA--C 1.516 -0.33 0 CA-C-O 121.498 0.666 . . . . 0.0 110.269 179.337 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 9.2 tp10 -151.41 119.95 6.47 Favored 'General case' 0 C--N 1.318 -0.774 0 CA-C-N 114.842 -1.072 . . . . 0.0 109.068 -179.498 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 12.8 t -111.72 101.14 9.53 Favored 'General case' 0 C--N 1.315 -0.921 0 C-N-CA 120.033 -0.667 . . . . 0.0 110.259 177.512 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 28' ' ' THR . . . . . 0.461 ' HB ' ' CE1' ' A' ' 15' ' ' PHE . 31.0 m -97.64 51.4 1.07 Allowed 'General case' 0 C--N 1.313 -0.984 0 CA-C-O 122.706 1.241 . . . . 0.0 109.302 175.978 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 29' ' ' ARG . . . . . 0.495 ' HA ' ' ND1' ' A' ' 14' ' ' HIS . 29.6 ttp180 -143.56 -67.94 0.34 Allowed 'General case' 0 C--N 1.314 -0.954 0 CA-C-N 114.785 -1.098 . . . . 0.0 110.618 -177.059 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 2.2 p-10 -80.69 33.8 0.32 Allowed 'General case' 0 N--CA 1.467 0.385 0 N-CA-C 111.972 0.36 . . . . 0.0 111.972 -177.805 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 92.4 m-20 -119.21 -7.82 10.23 Favored 'General case' 0 C--N 1.325 -0.472 0 N-CA-C 109.829 -0.434 . . . . 0.0 109.829 173.082 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 79.73 6.25 89.11 Favored Glycine 0 N--CA 1.447 -0.592 0 C-N-CA 121.055 -0.593 . . . . 0.0 111.635 -177.342 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 50.0 mmtm -114.28 112.91 46.29 Favored Pre-proline 0 C--N 1.325 -0.474 0 CA-C-N 115.885 -0.158 . . . . 0.0 110.7 -178.263 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 6.2 Cg_exo -79.3 169.82 18.34 Favored 'Trans proline' 0 N--CA 1.46 -0.454 0 C-N-CA 122.88 2.386 . . . . 0.0 112.434 172.45 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 35' ' ' ALA . . . . . 0.41 ' CB ' HG21 ' A' ' 28' ' ' THR . . . -144.55 158.79 43.6 Favored 'General case' 0 C--N 1.315 -0.926 0 CA-C-N 115.061 -0.972 . . . . 0.0 109.698 179.009 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 36' ' ' LEU . . . . . 0.713 HD21 ' HB1' ' A' ' 10' ' ' ALA . 0.7 OUTLIER -108.63 134.54 51.23 Favored 'General case' 0 N--CA 1.445 -0.677 0 CA-C-O 120.749 0.309 . . . . 0.0 110.333 177.202 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 37' ' ' PHE . . . . . . . . . . . . . 4.7 m-30 -96.4 130.71 43.46 Favored 'General case' 0 C--N 1.318 -0.766 0 CA-C-N 116.05 -0.523 . . . . 0.0 109.911 174.187 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 2.1 tpp180 -111.59 107.98 17.31 Favored 'General case' 0 C--N 1.321 -0.649 0 CA-C-N 116.076 -0.511 . . . . 0.0 109.76 -177.443 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 39' ' ' LEU . . . . . 0.566 ' HG ' ' O ' ' A' ' 9' ' ' SER . 6.6 mt -83.71 154.87 23.4 Favored 'General case' 0 C--N 1.319 -0.739 0 CA-C-N 116.201 -0.454 . . . . 0.0 109.894 -178.092 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 40' ' ' GLY . . . . . 0.465 ' H ' ' CD ' ' A' ' 49' ' ' GLU . . . 100.41 33.66 5.04 Favored Glycine 0 C--N 1.312 -0.782 0 CA-C-N 115.807 -0.633 . . . . 0.0 112.494 -179.125 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 6.5 m-20 63.58 8.36 3.59 Favored 'General case' 0 N--CA 1.473 0.709 0 N-CA-C 112.538 0.569 . . . . 0.0 112.538 178.237 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -67.37 -31.39 71.6 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-O 120.803 0.335 . . . . 0.0 111.657 -176.773 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 11.9 p -137.31 -65.85 0.53 Allowed 'General case' 0 C--N 1.321 -0.638 0 CA-C-N 116.453 -0.339 . . . . 0.0 111.048 -178.931 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 7.5 mp -85.89 -178.74 6.66 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.392 -179.432 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 31.0 m -95.86 164.05 12.9 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-N 116.317 -0.401 . . . . 0.0 111.539 -176.603 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 46' ' ' GLU . . . . . 0.47 ' O ' ' HG2' ' A' ' 50' ' ' GLN . 41.6 mt-10 -52.38 -41.11 62.85 Favored 'General case' 0 N--CA 1.465 0.289 0 N-CA-C 112.876 0.695 . . . . 0.0 112.876 -172.576 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -61.9 -41.82 99.68 Favored Glycine 0 N--CA 1.449 -0.453 0 C-N-CA 120.571 -0.823 . . . . 0.0 112.284 -170.134 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 48' ' ' LEU . . . . . 0.445 HD13 ' C ' ' A' ' 48' ' ' LEU . 3.2 tm? -61.02 -53.6 55.24 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-O 120.495 0.188 . . . . 0.0 111.144 -179.426 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 49' ' ' GLU . . . . . 0.697 ' O ' HD13 ' A' ' 53' ' ' LEU . 9.7 pt-20 -68.77 -37.4 79.31 Favored 'General case' 0 C--N 1.325 -0.46 0 N-CA-C 111.621 0.23 . . . . 0.0 111.621 -173.633 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 50' ' ' GLN . . . . . 0.541 ' HA ' HD22 ' A' ' 53' ' ' LEU . 33.1 mm-40 -66.15 -12.47 56.01 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 120.845 0.355 . . . . 0.0 111.353 -176.42 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 51' ' ' HIS . . . . . . . . . . . . . 12.1 m-70 -103.38 -4.0 24.74 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 121.213 0.53 . . . . 0.0 110.485 177.629 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 52' ' ' LEU . . . . . 0.466 ' O ' HG21 ' A' ' 5' ' ' VAL . 12.0 mt -102.51 -11.72 18.33 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-N 115.762 -0.653 . . . . 0.0 111.16 177.76 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 53' ' ' LEU . . . . . 0.697 HD13 ' O ' ' A' ' 49' ' ' GLU . 1.1 mp -58.78 136.6 57.81 Favored 'General case' 0 N--CA 1.449 -0.511 0 CA-C-O 121.125 0.488 . . . . 0.0 111.47 177.805 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 94.39 -4.57 70.16 Favored Glycine 0 N--CA 1.447 -0.572 0 CA-C-N 115.592 -0.731 . . . . 0.0 113.091 -179.677 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 55' ' ' LEU . . . . . 0.519 ' N ' HG22 ' A' ' 5' ' ' VAL . 3.0 mm? -71.97 164.8 25.46 Favored 'General case' 0 CA--C 1.521 -0.15 0 CA-C-N 117.391 0.595 . . . . 0.0 110.935 177.876 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 56' ' ' LYS . . . . . 0.604 ' HD3' ' N ' ' A' ' 57' ' ' VAL . 12.3 tmtt? -140.73 154.99 46.55 Favored 'General case' 0 C--N 1.32 -0.699 0 N-CA-C 108.703 -0.851 . . . . 0.0 108.703 -175.031 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 57' ' ' VAL . . . . . 0.604 ' N ' ' HD3' ' A' ' 56' ' ' LYS . 29.8 t -59.66 125.65 16.09 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-O 121.261 0.553 . . . . 0.0 111.386 179.714 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 80.95 19.74 66.82 Favored Glycine 0 N--CA 1.447 -0.627 0 CA-C-N 115.521 -0.763 . . . . 0.0 112.399 -177.398 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 59' ' ' ASP . . . . . 0.487 ' OD1' ' HB3' ' A' ' 56' ' ' LYS . 1.6 m-20 -110.55 150.16 29.34 Favored 'General case' 0 C--N 1.321 -0.631 0 CA-C-O 121.021 0.439 . . . . 0.0 110.452 176.01 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 60' ' ' LYS . . . . . 0.531 ' CE ' ' HG2' ' A' ' 139' ' ' GLU . 0.3 OUTLIER -115.48 133.11 56.34 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-N 115.51 -0.768 . . . . 0.0 109.926 -171.424 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 13.0 t -143.3 134.67 26.08 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-O 121.557 0.694 . . . . 0.0 111.306 178.643 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 5.9 m -123.78 132.49 53.81 Favored 'General case' 0 C--N 1.319 -0.741 0 CA-C-N 115.686 -0.688 . . . . 0.0 109.176 176.293 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 31.7 p90 -152.52 149.19 28.26 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-O 121.013 0.435 . . . . 0.0 111.346 -178.101 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 14.9 m -96.6 156.06 16.5 Favored 'General case' 0 C--N 1.321 -0.647 0 CA-C-N 116.089 -0.505 . . . . 0.0 109.863 177.832 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 31.7 mt -150.67 134.82 16.91 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-O 120.996 0.427 . . . . 0.0 110.749 -177.155 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 22.4 mm-40 -70.71 150.21 95.32 Favored Pre-proline 0 C--N 1.322 -0.587 0 N-CA-C 108.922 -0.77 . . . . 0.0 108.922 173.674 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 67' ' ' PRO . . . . . 0.424 ' HB3' ' N ' ' A' ' 132' ' ' GLN . 5.1 Cg_endo -48.38 -49.04 15.3 Favored 'Trans proline' 0 C--N 1.345 0.344 0 C-N-CA 122.383 2.056 . . . . 0.0 112.515 -175.742 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 22.9 t70 -62.92 -32.09 73.31 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-O 120.823 0.344 . . . . 0.0 111.123 -179.524 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -95.24 13.26 26.1 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-O 121.086 0.47 . . . . 0.0 111.082 -178.244 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -121.25 -84.74 0.66 Allowed 'General case' 0 C--N 1.323 -0.586 0 CA-C-O 121.247 0.546 . . . . 0.0 109.775 179.09 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 71' ' ' PHE . . . . . 0.442 ' HB2' ' HA ' ' A' ' 130' ' ' ALA . 2.4 m-85 -92.82 -17.42 24.13 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-N 115.616 -0.72 . . . . 0.0 109.776 176.947 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 72' ' ' GLY . . . . . 0.538 ' O ' ' HB1' ' A' ' 130' ' ' ALA . . . 97.32 -171.85 27.16 Favored Glycine 0 N--CA 1.45 -0.426 0 N-CA-C 110.68 -0.968 . . . . 0.0 110.68 -173.87 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 73' ' ' VAL . . . . . 0.582 ' N ' ' HD3' ' A' ' 74' ' ' PRO . 1.6 m -150.19 60.44 4.27 Favored Pre-proline 0 C--N 1.33 -0.252 0 CA-C-N 117.703 0.751 . . . . 0.0 110.774 171.359 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 74' ' ' PRO . . . . . 0.582 ' HD3' ' N ' ' A' ' 73' ' ' VAL . 19.7 Cg_endo -95.09 113.09 0.16 Allowed 'Trans proline' 0 N--CA 1.44 -1.625 0 C-N-CA 121.752 1.635 . . . . 0.0 114.529 173.97 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 75' ' ' SER . . . . . 0.548 ' CA ' HD23 ' A' ' 78' ' ' LEU . 34.7 m -152.45 63.28 4.93 Favored Pre-proline 0 N--CA 1.441 -0.892 0 N-CA-C 107.475 -1.306 . . . . 0.0 107.475 145.494 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 3.4 Cg_exo -73.49 -48.6 0.24 Allowed 'Trans proline' 0 CA--C 1.518 -0.317 0 C-N-CA 122.315 2.01 . . . . 0.0 113.014 -171.296 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 9.1 p-10 -69.71 -4.18 18.57 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-N 115.149 -0.932 . . . . 0.0 111.199 -177.597 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 78' ' ' LEU . . . . . 0.708 ' HB3' ' HB2' ' A' ' 125' ' ' PHE . 1.3 mm? -92.74 3.13 56.19 Favored 'General case' 0 C--N 1.325 -0.484 0 N-CA-C 109.6 -0.518 . . . . 0.0 109.6 178.323 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 68.5 mt -97.5 109.5 23.52 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.808 0 CA-C-O 121.544 0.688 . . . . 0.0 110.068 -173.97 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 39.0 mt-30 -129.1 135.43 48.89 Favored 'General case' 0 C--N 1.317 -0.83 0 CA-C-N 114.702 -1.136 . . . . 0.0 111.79 -168.149 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 81' ' ' TYR . . . . . 0.419 ' CE1' HG23 ' A' ' 122' ' ' THR . 2.6 m-85 -90.63 114.98 27.38 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 121.554 0.692 . . . . 0.0 111.596 173.566 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 82' ' ' PHE . . . . . 0.438 ' CB ' ' HE1' ' A' ' 87' ' ' PHE . 25.3 m-85 -102.53 170.68 7.89 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 114.745 -1.116 . . . . 0.0 112.01 175.194 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 22.2 t -89.67 155.67 19.08 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 115.721 -0.672 . . . . 0.0 109.847 176.981 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 84' ' ' ARG . . . . . 0.501 ' HD2' ' O ' ' A' ' 118' ' ' GLY . 11.9 ptm180 -66.44 -21.49 66.2 Favored 'General case' 0 C--O 1.227 -0.114 0 N-CA-C 112.143 0.423 . . . . 0.0 112.143 -178.356 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 85' ' ' ARG . . . . . 0.404 HH12 ' CG ' ' A' ' 119' ' ' ASP . 7.5 mpt_? -71.83 -39.42 69.79 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 121.192 0.52 . . . . 0.0 110.357 -175.538 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 31.4 mt-10 -64.64 -30.38 71.4 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 115.06 -0.973 . . . . 0.0 110.406 -174.966 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 87' ' ' PHE . . . . . 0.438 ' HE1' ' CB ' ' A' ' 82' ' ' PHE . 4.3 m-85 -89.65 -46.05 8.91 Favored 'General case' 0 CA--C 1.512 -0.504 0 CA-C-N 115.584 -0.735 . . . . 0.0 111.091 179.291 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 88' ' ' MET . . . . . . . . . . . . . 53.3 ttm -61.75 -26.05 67.83 Favored 'General case' 0 C--N 1.321 -0.665 0 CA-C-N 115.497 -0.774 . . . . 0.0 111.045 -175.345 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 23.0 t70 -55.46 -33.24 63.46 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 121.178 0.513 . . . . 0.0 110.59 174.061 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -109.93 11.44 24.12 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-N 115.64 -0.709 . . . . 0.0 111.257 179.304 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 111.75 138.19 7.42 Favored Glycine 0 N--CA 1.449 -0.453 0 C-N-CA 120.771 -0.728 . . . . 0.0 112.282 -179.197 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 92' ' ' GLU . . . . . 0.463 ' HA ' ' HD3' ' A' ' 93' ' ' PRO . 42.3 mt-10 -62.22 128.32 90.89 Favored Pre-proline 0 C--N 1.324 -0.516 0 CA-C-O 120.882 0.372 . . . . 0.0 111.402 -177.073 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 93' ' ' PRO . . . . . 0.599 ' HB2' HD13 ' A' ' 113' ' ' ILE . 17.7 Cg_endo -78.06 165.36 26.19 Favored 'Trans proline' 0 N--CA 1.459 -0.552 0 C-N-CA 122.745 2.297 . . . . 0.0 112.612 -177.518 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 30.9 mt-10 -116.95 146.88 42.72 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.497 -0.32 . . . . 0.0 111.054 -178.452 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 95' ' ' ILE . . . . . 0.532 HG12 HG12 ' A' ' 116' ' ' ILE . 16.6 mt -71.16 130.73 35.0 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.424 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.688 179.31 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 71.9 16.32 76.41 Favored Glycine 0 N--CA 1.446 -0.694 0 CA-C-N 115.813 -0.631 . . . . 0.0 113.059 179.367 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 97' ' ' ALA . . . . . 0.48 ' O ' HG13 ' A' ' 113' ' ' ILE . . . -100.85 161.77 13.37 Favored 'General case' 0 C--N 1.327 -0.389 0 N-CA-C 108.962 -0.755 . . . . 0.0 108.962 174.217 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 98' ' ' ILE . . . . . 0.498 HG12 HG22 ' A' ' 112' ' ' VAL . 59.1 mt -107.53 143.92 17.24 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.872 0 N-CA-C 110.066 -0.346 . . . . 0.0 110.066 179.417 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 99' ' ' MET . . . . . 0.5 ' SD ' HD11 ' A' ' 113' ' ' ILE . 82.8 mtp -128.36 163.34 25.04 Favored 'General case' 0 N--CA 1.448 -0.542 0 N-CA-C 107.958 -1.127 . . . . 0.0 107.958 179.347 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 3.5 mm? -100.62 137.1 39.48 Favored 'General case' 0 C--N 1.309 -1.184 0 N-CA-C 109.991 -0.374 . . . . 0.0 109.991 174.139 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 101' ' ' PHE . . . . . 0.471 ' CE2' ' HB2' ' A' ' 99' ' ' MET . 50.9 m-85 -143.55 136.35 27.48 Favored 'General case' 0 C--N 1.319 -0.725 0 N-CA-C 108.998 -0.742 . . . . 0.0 108.998 -174.55 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 17.2 m -96.53 131.78 42.79 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-O 120.97 0.414 . . . . 0.0 110.55 178.825 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -95.46 159.41 15.01 Favored 'General case' 0 C--N 1.321 -0.647 0 CA-C-N 116.003 -0.544 . . . . 0.0 110.11 177.351 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 104' ' ' MET . . . . . . . . . . . . . 4.0 mpp? -66.16 -12.13 53.85 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.353 -0.84 . . . . 0.0 112.022 -174.484 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 7.7 p-10 -92.01 17.91 8.69 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-O 121.141 0.496 . . . . 0.0 110.821 177.598 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 77.28 -11.56 16.6 Favored Glycine 0 N--CA 1.452 -0.259 0 CA-C-N 115.866 -0.606 . . . . 0.0 114.189 178.102 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 14.5 t -78.64 152.87 31.49 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-N 117.185 0.492 . . . . 0.0 110.005 179.251 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 35.2 tt0 -126.78 103.16 7.38 Favored 'General case' 0 C--N 1.315 -0.934 0 N-CA-C 108.867 -0.79 . . . . 0.0 108.867 -179.337 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 109' ' ' MET . . . . . . . . . . . . . 3.1 mpp? -100.34 134.91 20.42 Favored Pre-proline 0 C--N 1.32 -0.674 0 CA-C-N 116.349 -0.387 . . . . 0.0 111.323 -175.564 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 33.5 Cg_endo -67.53 135.73 37.17 Favored 'Trans proline' 0 N--CA 1.455 -0.739 0 C-N-CA 121.911 1.74 . . . . 0.0 109.638 167.847 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . -134.66 126.04 3.98 Favored Glycine 0 N--CA 1.443 -0.886 0 N-CA-C 111.11 -0.796 . . . . 0.0 111.11 -170.59 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 112' ' ' VAL . . . . . 0.498 HG22 HG12 ' A' ' 98' ' ' ILE . 32.0 t -76.57 131.07 35.55 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.655 0 N-CA-C 109.423 -0.584 . . . . 0.0 109.423 179.876 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 113' ' ' ILE . . . . . 0.599 HD13 ' HB2' ' A' ' 93' ' ' PRO . 1.9 mt -82.66 109.97 17.2 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.058 0 N-CA-C 107.826 -1.176 . . . . 0.0 107.826 173.174 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 114' ' ' ARG . . . . . 0.689 ' HE ' HG21 ' A' ' 122' ' ' THR . 2.3 tmm_? -64.89 -49.06 71.94 Favored 'General case' 0 C--N 1.315 -0.892 0 CA-C-N 115.569 -0.741 . . . . 0.0 110.272 -173.515 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 115' ' ' GLU . . . . . 0.416 ' HB2' ' HD2' ' A' ' 114' ' ' ARG . 9.4 tt0 -159.86 155.6 25.96 Favored 'General case' 0 C--N 1.326 -0.446 0 C-N-CA 121.156 -0.218 . . . . 0.0 110.419 -178.875 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 116' ' ' ILE . . . . . 0.532 HG12 HG12 ' A' ' 95' ' ' ILE . 31.9 mm -106.85 110.75 32.81 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.405 0 N-CA-C 109.001 -0.74 . . . . 0.0 109.001 175.901 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 117' ' ' ASN . . . . . 0.447 ' HB2' ' O ' ' A' ' 120' ' ' SER . 0.9 OUTLIER -98.83 157.69 16.13 Favored 'General case' 0 C--N 1.313 -0.981 0 CA-C-N 115.947 -0.569 . . . . 0.0 109.6 -178.04 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 118' ' ' GLY . . . . . 0.501 ' O ' ' HD2' ' A' ' 84' ' ' ARG . . . -56.27 -44.66 89.27 Favored Glycine 0 C--O 1.226 -0.392 0 C-N-CA 120.452 -0.88 . . . . 0.0 113.196 -171.47 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 119' ' ' ASP . . . . . 0.432 ' HA ' ' HD3' ' A' ' 84' ' ' ARG . 13.9 t70 -113.03 -9.86 13.53 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-O 121.169 0.509 . . . . 0.0 110.73 179.131 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 120' ' ' SER . . . . . 0.447 ' O ' ' HB2' ' A' ' 117' ' ' ASN . 21.6 t -126.54 157.63 38.28 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-O 121.533 0.682 . . . . 0.0 111.845 -168.79 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 121' ' ' ILE . . . . . . . . . . . . . 28.0 mm -120.49 150.41 23.25 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.761 0 CA-C-N 115.512 -0.767 . . . . 0.0 109.076 176.498 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 122' ' ' THR . . . . . 0.689 HG21 ' HE ' ' A' ' 114' ' ' ARG . 14.6 m -127.38 127.01 43.48 Favored 'General case' 0 C--N 1.312 -1.03 0 N-CA-C 107.615 -1.254 . . . . 0.0 107.615 179.667 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 2.8 t -127.74 127.14 68.05 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.839 0 N-CA-C 109.022 -0.733 . . . . 0.0 109.022 -171.01 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -114.24 96.11 5.63 Favored 'General case' 0 C--N 1.305 -1.326 0 CA-C-N 114.62 -1.173 . . . . 0.0 108.672 -177.34 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 125' ' ' PHE . . . . . 0.708 ' HB2' ' HB3' ' A' ' 78' ' ' LEU . 27.7 m-85 -82.5 103.8 12.31 Favored 'General case' 0 N--CA 1.431 -1.399 0 N-CA-C 105.821 -1.918 . . . . 0.0 105.821 175.107 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 126' ' ' ASN . . . . . 0.491 ' HA ' ' HB2' ' A' ' 75' ' ' SER . 0.1 OUTLIER -122.69 122.95 40.0 Favored 'General case' 0 C--N 1.295 -1.772 0 CA-C-N 113.884 -1.507 . . . . 0.0 112.916 -168.362 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 127' ' ' HIS . . . . . 0.417 ' HA ' ' HD2' ' A' ' 128' ' ' PRO . 4.2 p-80 70.68 124.81 0.03 OUTLIER Pre-proline 0 C--N 1.315 -0.907 0 N-CA-C 116.647 2.092 . . . . 0.0 116.647 156.587 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 128' ' ' PRO . . . . . 0.658 ' C ' ' H ' ' A' ' 130' ' ' ALA . 74.7 Cg_exo -51.42 -174.37 0.01 OUTLIER 'Trans proline' 0 C--O 1.222 -0.319 0 C-N-CA 124.963 3.776 . . . . 0.0 108.983 141.698 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 129' ' ' LEU . . . . . 0.53 ' HG ' ' NE2' ' A' ' 132' ' ' GLN . 17.1 tp -51.11 27.21 0.0 OUTLIER 'General case' 0 CA--C 1.572 1.807 0 N-CA-C 113.915 1.08 . . . . 0.0 113.915 174.042 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 130' ' ' ALA . . . . . 0.658 ' H ' ' C ' ' A' ' 128' ' ' PRO . . . -95.94 -176.27 3.65 Favored 'General case' 0 N--CA 1.45 -0.469 0 C-N-CA 124.832 1.253 . . . . 0.0 108.855 170.889 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 131' ' ' GLY . . . . . 0.533 ' HA2' HG12 ' A' ' 73' ' ' VAL . . . 65.59 26.41 71.93 Favored Glycine 0 N--CA 1.458 0.153 0 C-N-CA 120.689 -0.767 . . . . 0.0 114.129 174.855 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 132' ' ' GLN . . . . . 0.53 ' NE2' ' HG ' ' A' ' 129' ' ' LEU . 23.3 pt20 -123.55 141.69 51.76 Favored 'General case' 0 C--N 1.315 -0.918 0 N-CA-C 109.33 -0.619 . . . . 0.0 109.33 176.568 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 133' ' ' THR . . . . . . . . . . . . . 18.9 m -79.86 111.87 16.6 Favored 'General case' 0 C--N 1.319 -0.748 0 N-CA-C 108.991 -0.744 . . . . 0.0 108.991 178.365 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 134' ' ' VAL . . . . . 0.444 ' HB ' HD22 ' A' ' 17' ' ' LEU . 15.7 m -115.05 167.94 7.2 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.64 0 CA-C-O 122.017 0.913 . . . . 0.0 112.639 -172.648 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 135' ' ' HIS . . . . . . . . . . . . . 82.5 m-70 -132.47 127.87 36.2 Favored 'General case' 0 C--N 1.314 -0.955 0 CA-C-N 114.043 -1.435 . . . . 0.0 107.359 177.581 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 136' ' ' PHE . . . . . 0.5 ' CE1' HD21 ' A' ' 17' ' ' LEU . 17.8 m-85 -105.53 122.81 46.78 Favored 'General case' 0 C--N 1.313 -1.006 0 CA-C-O 121.09 0.471 . . . . 0.0 111.71 -171.574 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 137' ' ' ASP . . . . . . . . . . . . . 38.2 t70 -123.03 98.76 6.04 Favored 'General case' 0 C--N 1.315 -0.907 0 N-CA-C 107.87 -1.159 . . . . 0.0 107.87 172.806 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 138' ' ' ILE . . . . . 0.736 HG23 HG21 ' A' ' 13' ' ' VAL . 54.8 mt -123.81 138.29 54.02 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.562 0 CA-C-N 115.968 -0.56 . . . . 0.0 112.271 -172.139 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 139' ' ' GLU . . . . . 0.531 ' HG2' ' CE ' ' A' ' 60' ' ' LYS . 2.3 mp0 -128.53 130.55 47.59 Favored 'General case' 0 N--CA 1.452 -0.364 0 N-CA-C 108.523 -0.917 . . . . 0.0 108.523 175.034 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 140' ' ' VAL . . . . . . . . . . . . . 72.6 t -77.56 126.59 38.11 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 117.805 0.275 . . . . 0.0 110.415 -176.47 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 141' ' ' LEU . . . . . 0.425 ' HG ' ' HA ' ' A' ' 13' ' ' VAL . 38.8 mt -94.83 -48.6 5.96 Favored 'General case' 0 C--N 1.321 -0.635 0 N-CA-C 109.919 -0.4 . . . . 0.0 109.919 177.386 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 142' ' ' GLU . . . . . . . . . . . . . 10.6 mm-40 -146.73 162.37 38.66 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 115.902 -0.59 . . . . 0.0 110.597 177.127 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 143' ' ' ILE . . . . . 0.478 HD12 HG23 ' A' ' 57' ' ' VAL . 95.5 mt -131.04 122.66 52.22 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.66 0 CA-C-N 115.961 -0.563 . . . . 0.0 110.337 177.529 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 144' ' ' ASP . . . . . 0.513 ' HB2' ' HB3' ' A' ' 10' ' ' ALA . 1.2 m-20 -74.75 132.67 77.44 Favored Pre-proline 0 CA--C 1.513 -0.472 0 CA-C-N 116.038 -0.528 . . . . 0.0 109.741 176.115 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 145' ' ' PRO . . . . . 0.407 ' HA ' ' OG ' ' A' ' 2' ' ' SER . 70.0 Cg_exo -45.9 117.97 2.1 Favored 'Trans proline' 0 CA--C 1.512 -0.583 0 C-N-CA 123.338 2.692 . . . . 0.0 113.16 -178.282 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 146' ' ' ALA . . . . . . . . . . . . . . . -93.37 104.42 16.58 Favored 'General case' 0 C--N 1.31 -1.113 0 CA-C-N 114.604 -1.18 . . . . 0.0 109.378 179.209 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 2.8 mm? -88.64 1.59 54.74 Favored 'General case' 0 C--N 1.319 -0.725 0 CA-C-N 115.889 -0.596 . . . . 0.0 109.721 179.712 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 42.0 mt-10 . . . . . 0 CA--C 1.518 -0.256 0 CA-C-N 114.791 -1.095 . . . . 0.0 109.324 -177.238 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.481 1.11 0 CA-C-O 121.1 0.476 . . . . 0.0 109.82 . . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 73.3 m -156.01 82.78 1.01 Allowed 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 115.944 -0.571 . . . . 0.0 109.797 175.87 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 46.1 mt-10 -86.27 -22.56 26.75 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-N 115.789 -0.641 . . . . 0.0 110.733 179.934 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 4' ' ' SER . . . . . 0.457 ' HA ' ' HA ' ' A' ' 56' ' ' LYS . 19.8 m -110.03 132.94 53.71 Favored 'General case' 0 C--N 1.32 -0.702 0 CA-C-N 115.96 -0.564 . . . . 0.0 110.918 -179.686 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . 0.683 HG12 ' O ' ' A' ' 55' ' ' LEU . 7.3 p -74.2 141.19 16.44 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.425 0 CA-C-N 115.7 -0.682 . . . . 0.0 109.774 177.507 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 6' ' ' GLN . . . . . 0.628 ' HG2' ' OG ' ' A' ' 9' ' ' SER . 2.2 pt20 -134.58 167.62 20.47 Favored 'General case' 0 C--N 1.311 -1.099 0 N-CA-C 108.805 -0.813 . . . . 0.0 108.805 175.806 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 16.2 p -56.59 131.89 50.13 Favored 'General case' 0 C--N 1.313 -0.992 0 N-CA-C 109.64 -0.504 . . . . 0.0 109.64 176.881 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 8' ' ' ASN . . . . . 0.452 ' H ' ' HB3' ' A' ' 39' ' ' LEU . 64.3 t30 76.8 29.24 0.64 Allowed 'General case' 0 CA--C 1.544 0.718 0 C-N-CA 123.698 0.799 . . . . 0.0 111.645 -178.8 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 9' ' ' SER . . . . . 0.628 ' OG ' ' HG2' ' A' ' 6' ' ' GLN . 50.2 m -103.25 167.74 9.62 Favored 'General case' 0 CA--C 1.53 0.183 0 CA-C-O 120.837 0.351 . . . . 0.0 110.849 171.304 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -118.45 115.39 24.55 Favored 'General case' 0 C--N 1.325 -0.497 0 N-CA-C 109.329 -0.619 . . . . 0.0 109.329 175.65 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 4.8 m -119.71 142.15 36.51 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.609 0 C-N-CA 119.914 -0.715 . . . . 0.0 112.308 -174.006 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 12' ' ' LEU . . . . . 0.401 ' HG ' HD12 ' A' ' 141' ' ' LEU . 47.1 tp -88.7 138.1 31.72 Favored 'General case' 0 N--CA 1.447 -0.613 0 CA-C-N 115.298 -0.864 . . . . 0.0 108.824 174.208 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 14.4 m -144.98 157.81 13.95 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.456 0 CA-C-O 120.889 0.376 . . . . 0.0 110.876 -172.912 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 14' ' ' HIS . . . . . 0.627 ' ND1' ' HA ' ' A' ' 29' ' ' ARG . 3.0 m-70 -117.49 119.85 36.3 Favored 'General case' 0 C--N 1.319 -0.727 0 N-CA-C 107.481 -1.303 . . . . 0.0 107.481 162.137 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 15' ' ' PHE . . . . . 0.632 ' HA ' ' O ' ' A' ' 137' ' ' ASP . 46.2 p90 -139.09 142.18 38.13 Favored 'General case' 0 C--N 1.319 -0.725 0 C-N-CA 120.514 -0.474 . . . . 0.0 110.897 -175.206 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 25.0 m -119.17 121.64 40.19 Favored 'General case' 0 C--N 1.318 -0.8 0 CA-C-O 120.785 0.326 . . . . 0.0 110.203 174.3 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 17' ' ' LEU . . . . . 0.659 HD23 ' O ' ' A' ' 135' ' ' HIS . 5.7 mt -92.5 127.11 37.87 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 116.086 -0.506 . . . . 0.0 112.035 179.893 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 18' ' ' LYS . . . . . 0.417 ' O ' ' HB2' ' A' ' 135' ' ' HIS . 0.8 OUTLIER -125.17 152.43 44.49 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-N 115.35 -0.841 . . . . 0.0 110.283 179.888 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 19' ' ' LEU . . . . . 0.466 HD12 ' HB ' ' A' ' 23' ' ' THR . 95.1 mt -88.62 172.92 8.93 Favored 'General case' 0 C--N 1.316 -0.867 0 N-CA-C 109.696 -0.483 . . . . 0.0 109.696 171.345 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 18.7 t70 -53.61 -36.04 61.55 Favored 'General case' 0 N--CA 1.466 0.325 0 CA-C-O 121.029 0.442 . . . . 0.0 110.96 -179.713 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 38.5 m-20 -83.49 11.74 6.59 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 115.839 -0.619 . . . . 0.0 112.067 -177.99 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 72.69 12.16 77.86 Favored Glycine 0 N--CA 1.452 -0.293 0 C-N-CA 121.111 -0.566 . . . . 0.0 113.314 -178.455 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 23' ' ' THR . . . . . 0.466 ' HB ' HD12 ' A' ' 19' ' ' LEU . 24.6 m -73.87 128.87 36.67 Favored 'General case' 0 C--N 1.322 -0.593 0 N-CA-C 109.762 -0.459 . . . . 0.0 109.762 177.123 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 36.9 m -70.99 116.32 11.14 Favored 'General case' 0 C--N 1.32 -0.691 0 CA-C-O 121.194 0.521 . . . . 0.0 110.939 -178.129 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 25' ' ' ALA . . . . . 0.475 ' HB3' ' HB3' ' A' ' 17' ' ' LEU . . . -84.07 -49.46 8.88 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 115.637 -0.711 . . . . 0.0 109.91 178.133 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 8.2 tp10 -158.44 122.9 4.14 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.354 -0.839 . . . . 0.0 109.518 177.025 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 31.2 t -103.43 113.36 26.8 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-O 121.157 0.503 . . . . 0.0 110.219 178.732 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 28' ' ' THR . . . . . 0.606 ' O ' HG22 ' A' ' 28' ' ' THR . 58.0 m -118.96 36.71 4.35 Favored 'General case' 0 N--CA 1.441 -0.898 0 CA-C-O 122.707 1.241 . . . . 0.0 110.103 178.82 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 29' ' ' ARG . . . . . 0.627 ' HA ' ' ND1' ' A' ' 14' ' ' HIS . 52.7 ttp180 -132.06 -62.47 0.84 Allowed 'General case' 0 C--N 1.316 -0.88 0 O-C-N 121.327 -0.858 . . . . 0.0 110.431 174.613 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 2.3 p-10 -83.02 14.98 2.98 Favored 'General case' 0 N--CA 1.468 0.454 0 CA-C-O 121.099 0.476 . . . . 0.0 111.128 -179.483 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 31' ' ' ASN . . . . . 0.752 ' ND2' ' HG2' ' A' ' 33' ' ' LYS . 34.1 p-10 -88.18 -18.46 28.67 Favored 'General case' 0 C--N 1.32 -0.674 0 CA-C-N 115.877 -0.602 . . . . 0.0 110.114 175.387 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 88.03 10.88 68.4 Favored Glycine 0 N--CA 1.444 -0.777 0 CA-C-N 115.496 -0.775 . . . . 0.0 112.004 -178.883 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 33' ' ' LYS . . . . . 0.752 ' HG2' ' ND2' ' A' ' 31' ' ' ASN . 12.3 ptmt -140.87 117.55 7.68 Favored Pre-proline 0 C--N 1.327 -0.397 0 CA-C-O 121.434 0.635 . . . . 0.0 110.008 -179.943 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 78.5 Cg_endo -83.36 168.4 13.14 Favored 'Trans proline' 0 N--CA 1.453 -0.867 0 C-N-CA 122.351 2.034 . . . . 0.0 111.955 177.363 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -127.15 158.66 36.49 Favored 'General case' 0 C--N 1.319 -0.736 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.485 -177.416 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -105.11 138.04 41.94 Favored 'General case' 0 C--N 1.318 -0.783 0 CA-C-N 116.104 -0.498 . . . . 0.0 109.919 175.33 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 37' ' ' PHE . . . . . . . . . . . . . 9.9 m-30 -107.5 107.6 18.53 Favored 'General case' 0 C--N 1.318 -0.773 0 N-CA-C 109.164 -0.68 . . . . 0.0 109.164 175.867 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 16.2 tpt180 -89.24 120.2 30.39 Favored 'General case' 0 C--N 1.317 -0.839 0 CA-C-N 115.669 -0.696 . . . . 0.0 109.371 178.262 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 39' ' ' LEU . . . . . 0.713 HD13 ' HB2' ' A' ' 49' ' ' GLU . 2.0 mm? -79.03 148.42 32.5 Favored 'General case' 0 C--N 1.318 -0.764 0 CA-C-N 115.752 -0.658 . . . . 0.0 110.58 -177.468 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 100.51 39.42 3.22 Favored Glycine 0 N--CA 1.445 -0.724 0 C-N-CA 120.662 -0.78 . . . . 0.0 113.358 178.077 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 34.5 t70 66.67 7.51 5.22 Favored 'General case' 0 N--CA 1.472 0.644 0 CA-C-O 121.122 0.487 . . . . 0.0 112.16 171.431 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -55.63 -58.74 6.53 Favored 'General case' 0 C--N 1.328 -0.369 0 N-CA-C 112.052 0.39 . . . . 0.0 112.052 -177.741 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 37.1 m -143.41 9.46 1.62 Allowed 'General case' 0 C--N 1.324 -0.512 0 CA-C-O 121.073 0.463 . . . . 0.0 110.839 179.161 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 44' ' ' LEU . . . . . 0.436 HD13 ' HA ' ' A' ' 44' ' ' LEU . 4.2 mm? -115.09 148.9 38.36 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.885 -177.195 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 14.6 m -71.55 131.81 43.78 Favored 'General case' 0 N--CA 1.445 -0.688 0 N-CA-C 108.969 -0.752 . . . . 0.0 108.969 173.53 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 54.8 mt-10 -47.66 -43.92 26.68 Favored 'General case' 0 N--CA 1.468 0.472 0 O-C-N 123.534 0.521 . . . . 0.0 112.232 -169.509 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -61.41 -45.11 97.07 Favored Glycine 0 N--CA 1.448 -0.555 0 C-N-CA 120.642 -0.789 . . . . 0.0 112.696 -177.799 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 48' ' ' LEU . . . . . 0.403 HD13 ' C ' ' A' ' 48' ' ' LEU . 3.4 tm? -60.0 -54.39 46.64 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-O 120.95 0.405 . . . . 0.0 110.865 -177.879 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 49' ' ' GLU . . . . . 0.713 ' HB2' HD13 ' A' ' 39' ' ' LEU . 9.7 pt-20 -59.29 -40.25 85.58 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-N 115.458 -0.792 . . . . 0.0 111.39 -178.195 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 50' ' ' GLN . . . . . 0.702 ' HA ' HD23 ' A' ' 53' ' ' LEU . 83.4 mt-30 -69.14 -7.53 37.06 Favored 'General case' 0 CA--C 1.531 0.219 0 N-CA-C 113.302 0.853 . . . . 0.0 113.302 -179.78 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 51' ' ' HIS . . . . . . . . . . . . . 9.9 m-70 -103.35 -16.71 15.55 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-O 121.192 0.52 . . . . 0.0 110.019 179.687 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 52' ' ' LEU . . . . . 0.426 HD11 HG12 ' A' ' 138' ' ' ILE . 27.5 mt -104.98 8.07 34.32 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-N 115.51 -0.768 . . . . 0.0 113.057 -176.419 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 53' ' ' LEU . . . . . 0.702 HD23 ' HA ' ' A' ' 50' ' ' GLN . 2.0 pp -92.86 155.94 17.29 Favored 'General case' 0 C--N 1.322 -0.615 0 C-N-CA 120.462 -0.495 . . . . 0.0 110.501 174.45 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 54' ' ' GLY . . . . . 0.485 ' N ' HG13 ' A' ' 5' ' ' VAL . . . 94.21 -12.55 68.89 Favored Glycine 0 CA--C 1.532 1.126 0 N-CA-C 115.941 1.136 . . . . 0.0 115.941 176.312 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 55' ' ' LEU . . . . . 0.683 ' O ' HG12 ' A' ' 5' ' ' VAL . 1.0 OUTLIER -100.73 165.44 11.38 Favored 'General case' 0 N--CA 1.471 0.603 0 CA-C-N 119.4 1.6 . . . . 0.0 112.06 -176.062 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 56' ' ' LYS . . . . . 0.457 ' HA ' ' HA ' ' A' ' 4' ' ' SER . 16.0 tttm -96.38 157.1 16.05 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-N 115.738 -0.665 . . . . 0.0 111.372 -175.563 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 57' ' ' VAL . . . . . 0.621 HG23 HD12 ' A' ' 143' ' ' ILE . 51.1 t -59.57 142.05 15.56 Favored 'Isoleucine or valine' 0 C--O 1.234 0.262 0 N-CA-C 109.398 -0.593 . . . . 0.0 109.398 171.404 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 82.43 9.3 85.06 Favored Glycine 0 N--CA 1.445 -0.766 0 C-N-CA 120.513 -0.851 . . . . 0.0 111.716 -177.51 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 59' ' ' ASP . . . . . 0.523 ' C ' ' HG3' ' A' ' 60' ' ' LYS . 15.9 m-20 -116.32 162.33 17.67 Favored 'General case' 0 CA--C 1.509 -0.629 0 N-CA-C 109.738 -0.467 . . . . 0.0 109.738 173.667 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 60' ' ' LYS . . . . . 0.585 ' HG2' ' HG2' ' A' ' 139' ' ' GLU . 32.2 mtpt -143.14 143.55 31.85 Favored 'General case' 0 C--N 1.318 -0.795 0 CA-C-N 115.439 -0.801 . . . . 0.0 110.375 -167.477 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 6.1 t -143.32 131.92 22.43 Favored 'General case' 0 C--N 1.315 -0.908 0 CA-C-N 115.938 -0.574 . . . . 0.0 109.686 178.934 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 3.3 m -113.17 130.99 56.03 Favored 'General case' 0 N--CA 1.443 -0.801 0 N-CA-C 108.949 -0.76 . . . . 0.0 108.949 177.452 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 63' ' ' PHE . . . . . 0.426 ' O ' ' HB2' ' A' ' 136' ' ' PHE . 39.3 p90 -154.59 152.76 30.4 Favored 'General case' 0 C--N 1.32 -0.704 0 CA-C-O 120.914 0.388 . . . . 0.0 111.112 179.688 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 26.5 m -101.64 156.33 17.56 Favored 'General case' 0 C--N 1.321 -0.657 0 CA-C-N 116.015 -0.539 . . . . 0.0 109.779 175.397 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 74.7 mt -141.55 144.06 34.08 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 116.377 -0.374 . . . . 0.0 110.657 -178.432 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 41.7 mt-10 -80.54 159.06 70.41 Favored Pre-proline 0 C--N 1.322 -0.593 0 CA-C-N 115.747 -0.661 . . . . 0.0 109.358 174.575 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 67' ' ' PRO . . . . . 0.404 ' HB3' ' HA2' ' A' ' 131' ' ' GLY . 59.0 Cg_exo -49.88 -36.86 44.58 Favored 'Trans proline' 0 C--O 1.233 0.25 0 C-N-CA 122.454 2.103 . . . . 0.0 113.624 -176.184 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 4.3 p-10 -66.04 -15.46 63.06 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-O 120.744 0.306 . . . . 0.0 111.385 -179.052 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -111.13 -16.15 13.52 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 116.591 -0.277 . . . . 0.0 111.302 179.475 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 70' ' ' ALA . . . . . 0.492 ' O ' ' HB2' ' A' ' 71' ' ' PHE . . . -143.67 129.68 19.57 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.364 -0.38 . . . . 0.0 111.672 -177.23 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 71' ' ' PHE . . . . . 0.492 ' HB2' ' O ' ' A' ' 70' ' ' ALA . 3.3 m-30 76.31 -44.96 0.5 Allowed 'General case' 0 N--CA 1.472 0.65 0 C-N-CA 123.341 0.656 . . . . 0.0 111.785 176.837 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 114.14 146.28 9.26 Favored Glycine 0 N--CA 1.445 -0.721 0 C-N-CA 120.95 -0.643 . . . . 0.0 112.176 178.905 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 16.8 m -76.14 148.47 81.2 Favored Pre-proline 0 C--N 1.322 -0.595 0 CA-C-O 120.886 0.374 . . . . 0.0 111.119 176.002 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 74.3 Cg_endo -75.83 133.77 15.74 Favored 'Trans proline' 0 C--N 1.347 0.492 0 C-N-CA 122.929 2.42 . . . . 0.0 113.121 -173.856 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 75' ' ' SER . . . . . 0.47 ' HB3' ' OD1' ' A' ' 77' ' ' ASP . 16.6 m -91.93 114.16 61.2 Favored Pre-proline 0 N--CA 1.44 -0.945 0 CA-C-N 115.949 -0.569 . . . . 0.0 110.992 -179.086 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 76' ' ' PRO . . . . . 0.438 ' HD2' ' HA ' ' A' ' 75' ' ' SER . 33.8 Cg_endo -66.41 -19.39 55.37 Favored 'Trans proline' 0 C--N 1.345 0.373 0 C-N-CA 122.734 2.29 . . . . 0.0 112.222 177.183 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 77' ' ' ASP . . . . . 0.47 ' OD1' ' HB3' ' A' ' 75' ' ' SER . 8.2 p-10 -76.35 -5.9 49.18 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 121.359 0.6 . . . . 0.0 110.384 177.16 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 78' ' ' LEU . . . . . 0.458 ' HG ' ' HB2' ' A' ' 125' ' ' PHE . 0.7 OUTLIER -89.03 10.39 21.8 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-N 115.548 -0.751 . . . . 0.0 110.437 176.273 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 22.4 mt -117.24 107.46 22.35 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.635 0 N-CA-C 108.349 -0.982 . . . . 0.0 108.349 177.413 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 80' ' ' GLN . . . . . 0.588 ' O ' ' HB ' ' A' ' 123' ' ' VAL . 71.5 mt-30 -119.7 140.59 50.43 Favored 'General case' 0 C--N 1.313 -1.012 0 CA-C-N 115.895 -0.593 . . . . 0.0 111.37 -172.052 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 81' ' ' TYR . . . . . . . . . . . . . 73.6 m-85 -96.38 155.3 16.82 Favored 'General case' 0 C--N 1.313 -0.983 0 CA-C-N 115.946 -0.57 . . . . 0.0 109.524 173.331 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 82' ' ' PHE . . . . . 0.457 ' CD1' HG21 ' A' ' 123' ' ' VAL . 3.2 m-85 -148.89 167.57 25.36 Favored 'General case' 0 C--N 1.323 -0.586 0 N-CA-C 108.981 -0.748 . . . . 0.0 108.981 -160.371 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 11.6 t -99.61 128.12 45.71 Favored 'General case' 0 C--N 1.321 -0.645 0 CA-C-O 121.082 0.468 . . . . 0.0 110.102 175.533 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 84' ' ' ARG . . . . . 0.689 ' HD3' ' HA ' ' A' ' 119' ' ' ASP . 15.4 ptt180 -53.27 -20.66 4.43 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.237 -0.892 . . . . 0.0 113.151 -177.916 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 85' ' ' ARG . . . . . . . . . . . . . 5.3 mpt_? -71.14 -37.45 72.27 Favored 'General case' 0 CA--C 1.517 -0.323 0 CA-C-O 120.91 0.385 . . . . 0.0 110.785 -173.38 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 27.1 mm-40 -63.97 -33.92 76.82 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-N 115.697 -0.683 . . . . 0.0 110.598 179.941 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 87' ' ' PHE . . . . . 0.409 ' HE2' ' CE1' ' A' ' 101' ' ' PHE . 27.1 m-85 -86.69 -39.73 15.75 Favored 'General case' 0 CA--C 1.509 -0.609 0 CA-C-N 115.96 -0.564 . . . . 0.0 111.158 -178.361 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 88' ' ' MET . . . . . . . . . . . . . 56.1 ttp -60.66 -34.91 75.0 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-N 116.398 -0.365 . . . . 0.0 110.844 -177.101 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 22.1 t70 -55.13 -31.2 61.09 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 121.025 0.44 . . . . 0.0 111.265 175.631 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -100.82 7.6 43.64 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 116.021 -0.536 . . . . 0.0 110.749 178.658 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 105.27 136.79 8.75 Favored Glycine 0 N--CA 1.445 -0.745 0 N-CA-C 110.846 -0.902 . . . . 0.0 110.846 -175.226 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 44.5 mt-10 -61.15 128.69 89.83 Favored Pre-proline 0 C--N 1.322 -0.618 0 CA-C-O 121.321 0.581 . . . . 0.0 111.208 -176.485 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 93' ' ' PRO . . . . . 0.61 ' HG2' HD12 ' A' ' 116' ' ' ILE . 56.2 Cg_endo -71.76 165.46 32.48 Favored 'Trans proline' 0 N--CA 1.462 -0.329 0 C-N-CA 123.318 2.678 . . . . 0.0 112.65 -175.441 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 16.3 mt-10 -116.65 155.79 28.19 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.843 -175.344 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 95' ' ' ILE . . . . . 0.514 HG23 ' O ' ' A' ' 114' ' ' ARG . 22.3 mt -82.37 135.77 24.24 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.469 0 CA-C-N 115.886 -0.597 . . . . 0.0 110.781 -178.711 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 73.16 19.6 79.68 Favored Glycine 0 N--CA 1.45 -0.394 0 CA-C-N 115.747 -0.661 . . . . 0.0 112.582 -175.822 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -96.48 119.51 35.1 Favored 'General case' 0 N--CA 1.452 -0.339 0 CA-C-O 121.54 0.686 . . . . 0.0 112.622 -179.32 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 98' ' ' ILE . . . . . 0.618 ' HA ' ' HA ' ' A' ' 112' ' ' VAL . 6.3 mt -88.69 107.46 17.78 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.665 0 N-CA-C 108.179 -1.045 . . . . 0.0 108.179 174.577 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 99' ' ' MET . . . . . . . . . . . . . 4.9 mtm -127.5 144.3 51.08 Favored 'General case' 0 N--CA 1.443 -0.786 0 N-CA-C 107.625 -1.25 . . . . 0.0 107.625 -175.607 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 100' ' ' LEU . . . . . 0.459 ' HB3' ' HB3' ' A' ' 108' ' ' GLU . 4.1 mm? -75.62 105.0 6.42 Favored 'General case' 0 C--N 1.311 -1.107 0 CA-C-N 116.494 -0.321 . . . . 0.0 110.873 -176.893 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 101' ' ' PHE . . . . . 0.409 ' CE1' ' HE2' ' A' ' 87' ' ' PHE . 42.9 m-85 -92.65 109.95 21.37 Favored 'General case' 0 CA--C 1.516 -0.346 0 CA-C-O 121.692 0.758 . . . . 0.0 110.915 -178.652 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 102' ' ' THR . . . . . 0.485 ' HA ' ' HA ' ' A' ' 108' ' ' GLU . 12.1 m -63.55 112.2 2.69 Favored 'General case' 0 C--N 1.311 -1.089 0 CA-C-N 114.411 -1.268 . . . . 0.0 113.038 -179.08 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -74.49 171.06 14.45 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-N 113.2 -1.818 . . . . 0.0 112.934 -178.945 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 104' ' ' MET . . . . . 0.446 ' C ' ' H ' ' A' ' 106' ' ' GLY . 4.2 mpp? -57.01 -33.5 67.22 Favored 'General case' 0 N--CA 1.465 0.276 0 CA-C-N 115.824 -0.625 . . . . 0.0 111.641 179.111 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 9.3 p-10 -76.93 22.05 0.2 Allowed 'General case' 0 N--CA 1.468 0.427 0 CA-C-O 121.528 0.68 . . . . 0.0 110.813 177.526 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 106' ' ' GLY . . . . . 0.446 ' H ' ' C ' ' A' ' 104' ' ' MET . . . 65.95 -7.84 1.06 Allowed Glycine 0 C--N 1.333 0.415 0 CA-C-N 114.649 -1.16 . . . . 0.0 114.694 -178.321 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 23.3 t -87.22 144.62 26.74 Favored 'General case' 0 CA--C 1.502 -0.902 0 CA-C-O 121.476 0.655 . . . . 0.0 110.705 -172.117 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 108' ' ' GLU . . . . . 0.485 ' HA ' ' HA ' ' A' ' 102' ' ' THR . 2.7 mp0 -80.45 156.41 26.62 Favored 'General case' 0 C--N 1.301 -1.531 0 CA-C-N 114.852 -1.067 . . . . 0.0 109.732 177.369 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 109' ' ' MET . . . . . 0.414 ' O ' ' HA ' ' A' ' 100' ' ' LEU . 96.5 mmm -136.61 125.04 15.07 Favored Pre-proline 0 C--N 1.314 -0.97 0 N-CA-C 107.563 -1.273 . . . . 0.0 107.563 -164.648 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 31.1 Cg_endo -69.39 119.08 6.09 Favored 'Trans proline' 0 N--CA 1.453 -0.887 0 CA-C-N 120.199 1.107 . . . . 0.0 110.644 175.145 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 111' ' ' GLY . . . . . 0.471 ' HA2' ' HA ' ' A' ' 125' ' ' PHE . . . -144.58 120.81 1.47 Allowed Glycine 0 N--CA 1.443 -0.895 0 CA-C-N 115.294 -0.866 . . . . 0.0 111.015 -172.202 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 112' ' ' VAL . . . . . 0.618 ' HA ' ' HA ' ' A' ' 98' ' ' ILE . 7.1 p -101.89 108.11 23.05 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.856 0 CA-C-O 122.058 0.933 . . . . 0.0 110.602 -179.819 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 113' ' ' ILE . . . . . 0.591 HG23 ' O ' ' A' ' 122' ' ' THR . 25.6 mt -61.2 109.89 0.56 Allowed 'Isoleucine or valine' 0 C--N 1.314 -0.966 0 CA-C-N 114.717 -1.129 . . . . 0.0 110.271 171.717 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 114' ' ' ARG . . . . . 0.565 ' HD2' ' HB2' ' A' ' 115' ' ' GLU . 6.4 tmm_? -77.32 -32.56 55.37 Favored 'General case' 0 C--N 1.315 -0.908 0 CA-C-N 115.13 -0.941 . . . . 0.0 111.024 -173.833 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 115' ' ' GLU . . . . . 0.565 ' HB2' ' HD2' ' A' ' 114' ' ' ARG . 5.7 tt0 -159.98 160.9 33.91 Favored 'General case' 0 C--N 1.329 -0.315 0 N-CA-C 110.289 -0.263 . . . . 0.0 110.289 178.337 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 116' ' ' ILE . . . . . 0.61 HD12 ' HG2' ' A' ' 93' ' ' PRO . 29.4 mm -107.36 107.22 22.24 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.514 0 N-CA-C 109.581 -0.525 . . . . 0.0 109.581 173.909 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 117' ' ' ASN . . . . . 0.475 HD22 ' N ' ' A' ' 117' ' ' ASN . 0.9 OUTLIER -83.1 157.1 22.97 Favored 'General case' 0 C--N 1.313 -0.987 0 N-CA-C 108.906 -0.776 . . . . 0.0 108.906 178.33 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . -57.17 -48.54 79.15 Favored Glycine 0 N--CA 1.449 -0.457 0 C-N-CA 120.382 -0.913 . . . . 0.0 112.763 -172.987 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 119' ' ' ASP . . . . . 0.689 ' HA ' ' HD3' ' A' ' 84' ' ' ARG . 1.4 m-20 -107.8 -15.26 14.6 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-O 121.088 0.471 . . . . 0.0 111.346 -178.062 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 120' ' ' SER . . . . . 0.455 ' O ' ' HB2' ' A' ' 117' ' ' ASN . 32.4 t -123.38 157.76 32.63 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-N 115.878 -0.601 . . . . 0.0 111.158 -169.508 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 121' ' ' ILE . . . . . . . . . . . . . 50.0 mm -113.68 137.27 47.39 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.523 0 CA-C-O 121.165 0.507 . . . . 0.0 110.253 175.951 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 122' ' ' THR . . . . . 0.591 ' O ' HG23 ' A' ' 113' ' ' ILE . 3.6 m -93.98 142.21 27.64 Favored 'General case' 0 C--N 1.318 -0.776 0 CA-C-N 115.167 -0.924 . . . . 0.0 110.095 178.014 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 123' ' ' VAL . . . . . 0.588 ' HB ' ' O ' ' A' ' 80' ' ' GLN . 33.9 t -147.05 107.99 0.66 Allowed 'Isoleucine or valine' 0 N--CA 1.466 0.353 0 C-N-CA 117.085 -1.846 . . . . 0.0 110.385 -165.221 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 124' ' ' ASP . . . . . 0.546 ' HB3' HG13 ' A' ' 112' ' ' VAL . 28.6 t70 -107.98 101.64 10.88 Favored 'General case' 0 C--N 1.313 -1.006 0 C-N-CA 119.397 -0.921 . . . . 0.0 112.545 174.064 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 125' ' ' PHE . . . . . 0.471 ' HA ' ' HA2' ' A' ' 111' ' ' GLY . 83.5 m-85 -81.63 6.89 13.71 Favored 'General case' 0 N--CA 1.47 0.542 0 CA-C-N 116.285 -0.416 . . . . 0.0 110.894 178.459 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 7.7 m-80 -57.51 137.74 55.93 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-O 122.054 0.93 . . . . 0.0 111.023 179.656 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 127' ' ' HIS . . . . . 0.497 ' HB3' ' HD2' ' A' ' 128' ' ' PRO . 22.8 m170 -72.39 -174.23 0.29 Allowed Pre-proline 0 C--N 1.321 -0.632 0 CA-C-N 113.654 -1.612 . . . . 0.0 112.576 -168.481 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 128' ' ' PRO . . . . . 0.507 ' O ' ' N ' ' A' ' 130' ' ' ALA . 4.5 Cg_exo -42.13 174.92 0.0 OUTLIER 'Trans proline' 0 C--N 1.354 0.845 0 C-N-CA 124.671 3.58 . . . . 0.0 113.412 161.733 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 129' ' ' LEU . . . . . 0.44 HD21 HD11 ' A' ' 19' ' ' LEU . 3.6 tp -49.37 40.64 0.0 OUTLIER 'General case' 0 N--CA 1.488 1.428 0 C-N-CA 127.455 2.302 . . . . 0.0 116.097 -172.339 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 130' ' ' ALA . . . . . 0.507 ' N ' ' O ' ' A' ' 128' ' ' PRO . . . -88.11 175.17 7.85 Favored 'General case' 0 C--N 1.31 -1.122 0 N-CA-C 109.369 -0.604 . . . . 0.0 109.369 -178.897 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 131' ' ' GLY . . . . . 0.404 ' HA2' ' HB3' ' A' ' 67' ' ' PRO . . . 71.18 26.93 72.72 Favored Glycine 0 N--CA 1.449 -0.491 0 C-N-CA 120.473 -0.87 . . . . 0.0 113.287 178.27 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 132' ' ' GLN . . . . . . . . . . . . . 4.0 pt20 -148.03 157.22 43.4 Favored 'General case' 0 C--N 1.328 -0.358 0 N-CA-C 110.192 -0.299 . . . . 0.0 110.192 176.038 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 133' ' ' THR . . . . . . . . . . . . . 21.5 m -72.11 113.04 8.72 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 116.101 -0.499 . . . . 0.0 110.942 -176.183 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 134' ' ' VAL . . . . . 0.429 ' HB ' HD22 ' A' ' 17' ' ' LEU . 30.6 m -102.75 171.68 1.52 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.609 0 CA-C-O 121.556 0.693 . . . . 0.0 110.999 179.624 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 135' ' ' HIS . . . . . 0.659 ' O ' HD23 ' A' ' 17' ' ' LEU . 13.8 m-70 -132.66 140.56 48.21 Favored 'General case' 0 C--N 1.318 -0.768 0 N-CA-C 107.548 -1.279 . . . . 0.0 107.548 -172.236 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 136' ' ' PHE . . . . . 0.573 ' CZ ' HD21 ' A' ' 17' ' ' LEU . 9.3 m-85 -125.42 122.76 37.64 Favored 'General case' 0 C--N 1.311 -1.107 0 C-N-CA 120.492 -0.483 . . . . 0.0 112.188 -169.545 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 137' ' ' ASP . . . . . 0.632 ' O ' ' HA ' ' A' ' 15' ' ' PHE . 5.0 m-20 -115.82 100.8 8.26 Favored 'General case' 0 C--N 1.322 -0.628 0 N-CA-C 108.479 -0.934 . . . . 0.0 108.479 171.156 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 138' ' ' ILE . . . . . 0.5 ' CD1' ' HB3' ' A' ' 136' ' ' PHE . 4.4 mp -110.57 129.74 65.15 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.644 0 CA-C-O 121.229 0.538 . . . . 0.0 111.936 -177.535 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 139' ' ' GLU . . . . . 0.585 ' HG2' ' HG2' ' A' ' 60' ' ' LYS . 34.2 mt-10 -122.11 109.07 14.07 Favored 'General case' 0 N--CA 1.447 -0.601 0 CA-C-N 115.244 -0.889 . . . . 0.0 109.006 172.245 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 140' ' ' VAL . . . . . . . . . . . . . 58.9 t -59.63 119.55 4.15 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.499 0 CA-C-N 115.779 -0.646 . . . . 0.0 110.933 -179.276 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 141' ' ' LEU . . . . . 0.527 HD11 ' CD2' ' A' ' 14' ' ' HIS . 37.7 mt -90.51 -49.49 6.47 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 116.372 -0.376 . . . . 0.0 110.498 179.554 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 142' ' ' GLU . . . . . . . . . . . . . 44.3 mt-10 -156.87 158.88 37.53 Favored 'General case' 0 CA--C 1.519 -0.222 0 N-CA-C 108.835 -0.802 . . . . 0.0 108.835 -177.036 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 143' ' ' ILE . . . . . 0.621 HD12 HG23 ' A' ' 57' ' ' VAL . 97.4 mt -128.35 115.45 38.08 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.837 0 CA-C-O 121.139 0.495 . . . . 0.0 111.852 179.609 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 144' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -77.95 128.59 78.51 Favored Pre-proline 0 C--O 1.235 0.318 0 CA-C-N 115.397 -0.82 . . . . 0.0 109.069 172.582 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 145' ' ' PRO . . . . . . . . . . . . . 18.3 Cg_endo -60.35 152.77 64.69 Favored 'Trans proline' 0 C--O 1.233 0.228 0 C-N-CA 123.126 2.55 . . . . 0.0 114.183 -172.379 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 146' ' ' ALA . . . . . . . . . . . . . . . -98.73 136.83 38.21 Favored 'General case' 0 C--N 1.318 -0.768 0 CA-C-N 114.479 -1.237 . . . . 0.0 108.684 172.763 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 147' ' ' LEU . . . . . 0.404 HD13 ' HA ' ' A' ' 147' ' ' LEU . 3.7 mm? -81.46 15.08 2.18 Favored 'General case' 0 C--N 1.32 -0.682 0 N-CA-C 111.81 0.3 . . . . 0.0 111.81 -172.857 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 8.3 pt-20 . . . . . 0 C--N 1.324 -0.536 0 CA-C-N 116.54 -0.3 . . . . 0.0 111.072 176.624 . . . . . . . . 0 0 . 1 stop_ save_